<SEC-DOCUMENT>0001681622-23-000013.txt : 20230131
<SEC-HEADER>0001681622-23-000013.hdr.sgml : 20230131
<ACCEPTANCE-DATETIME>20230131161008
ACCESSION NUMBER:		0001681622-23-000013
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		93
CONFORMED PERIOD OF REPORT:	20221230
FILED AS OF DATE:		20230131
DATE AS OF CHANGE:		20230131

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Varex Imaging Corp
		CENTRAL INDEX KEY:			0001681622
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTRONIC COMPONENTS, NEC [3679]
		IRS NUMBER:				813434516
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0929

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37860
		FILM NUMBER:		23572658

	BUSINESS ADDRESS:	
		STREET 1:		1678 S. PIONEER ROAD
		CITY:			SALT LAKE CITY
		STATE:			UT
		ZIP:			84104
		BUSINESS PHONE:		801-972-5000

	MAIL ADDRESS:	
		STREET 1:		1678 S. PIONEER ROAD
		CITY:			SALT LAKE CITY
		STATE:			UT
		ZIP:			84104
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>var-20221230.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:b10c8d19-453b-4af7-a4e1-32028a0718a8,g:e90e04e8-fae8-401c-8aa8-facd054e09fb,d:4ab573909cb849339357193b017c7d37--><html xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:var="http://www.varex.com/20221230" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:srt="http://fasb.org/srt/2022" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:link="http://www.xbrl.org/2003/linkbase" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>var-20221230</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180L2ZyYWc6MjY4MmM5ZTI5ZjEwNDMyYzkwOWZjNTFjNzMzNTNhY2QvdGFibGU6ZWRlNDYxY2JhYmY3NDdjM2I5NTgwM2NkM2YyNGRlOWEvdGFibGVyYW5nZTplZGU0NjFjYmFiZjc0N2MzYjk1ODAzY2QzZjI0ZGU5YV8wLTEtMS0xLTgzMjg1_fde828de-1e70-409b-a8ee-900d01172697">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180L2ZyYWc6MjY4MmM5ZTI5ZjEwNDMyYzkwOWZjNTFjNzMzNTNhY2QvdGFibGU6ZWRlNDYxY2JhYmY3NDdjM2I5NTgwM2NkM2YyNGRlOWEvdGFibGVyYW5nZTplZGU0NjFjYmFiZjc0N2MzYjk1ODAzY2QzZjI0ZGU5YV8xLTEtMS0xLTgzMjg1_ec5f1489-76eb-4b24-9268-f7278365c73d">2023</ix:nonNumeric><ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180L2ZyYWc6MjY4MmM5ZTI5ZjEwNDMyYzkwOWZjNTFjNzMzNTNhY2QvdGFibGU6ZWRlNDYxY2JhYmY3NDdjM2I5NTgwM2NkM2YyNGRlOWEvdGFibGVyYW5nZTplZGU0NjFjYmFiZjc0N2MzYjk1ODAzY2QzZjI0ZGU5YV8yLTEtMS0xLTgzMjg1_a3c0f346-947e-4fa7-a0b9-2966419f5a95">Q1</ix:nonNumeric><ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180L2ZyYWc6MjY4MmM5ZTI5ZjEwNDMyYzkwOWZjNTFjNzMzNTNhY2QvdGFibGU6ZWRlNDYxY2JhYmY3NDdjM2I5NTgwM2NkM2YyNGRlOWEvdGFibGVyYW5nZTplZGU0NjFjYmFiZjc0N2MzYjk1ODAzY2QzZjI0ZGU5YV8zLTEtMS0xLTgzMjg1_55957140-3119-4165-8f80-944d87f20efb">0001681622</ix:nonNumeric><ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180L2ZyYWc6MjY4MmM5ZTI5ZjEwNDMyYzkwOWZjNTFjNzMzNTNhY2QvdGFibGU6ZWRlNDYxY2JhYmY3NDdjM2I5NTgwM2NkM2YyNGRlOWEvdGFibGVyYW5nZTplZGU0NjFjYmFiZjc0N2MzYjk1ODAzY2QzZjI0ZGU5YV80LTEtMS0xLTgzMjg1_7c61375d-6491-4eb2-99dc-c42c46f24693">09-29</ix:nonNumeric><ix:nonNumeric contextRef="if053d543d68e4983b97631e65183a5d1_D20211002-20220930" name="us-gaap:AccountingStandardsUpdateExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOjkwN2JhZTc1NjE4MDRhZGNhZjM3ZDc0NzQ5NGRmYWQ3L3RhYmxlcmFuZ2U6OTA3YmFlNzU2MTgwNGFkY2FmMzdkNzQ3NDk0ZGZhZDdfNS0wLTEtMS04MzI4NQ_91a4cd1c-cf54-4eef-9557-9e99df59c2df">http://fasb.org/us-gaap/2022#AccountingStandardsUpdate202006Member</ix:nonNumeric><ix:nonNumeric contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" name="us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjEyNTNlNzQwNjAwMzRlZjM4YmM3ZDQyNjA2OTE4NGNiL3RhYmxlcmFuZ2U6MTI1M2U3NDA2MDAzNGVmMzhiYzdkNDI2MDY5MTg0Y2JfMy0xLTEtMS04MzI4NQ_6fed9dde-ecf9-4697-bdfd-bda3b6c18e81">http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</ix:nonNumeric><ix:nonNumeric contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930" name="us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjEyNTNlNzQwNjAwMzRlZjM4YmM3ZDQyNjA2OTE4NGNiL3RhYmxlcmFuZ2U6MTI1M2U3NDA2MDAzNGVmMzhiYzdkNDI2MDY5MTg0Y2JfMy0xLTEtMS04MzI4NQ_7db859ec-ae05-400b-a6ff-3ee55890f062">http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</ix:nonNumeric><ix:nonNumeric contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" name="us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjEyNTNlNzQwNjAwMzRlZjM4YmM3ZDQyNjA2OTE4NGNiL3RhYmxlcmFuZ2U6MTI1M2U3NDA2MDAzNGVmMzhiYzdkNDI2MDY5MTg0Y2JfNi0xLTEtMS04MzI4NQ_21d67cfe-4f11-4971-a007-53438e019ae1">http://fasb.org/us-gaap/2022#AccruedLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930" name="us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjEyNTNlNzQwNjAwMzRlZjM4YmM3ZDQyNjA2OTE4NGNiL3RhYmxlcmFuZ2U6MTI1M2U3NDA2MDAzNGVmMzhiYzdkNDI2MDY5MTg0Y2JfNi0xLTEtMS04MzI4NQ_651facb0-63c0-4af0-8d59-d1e007979e09">http://fasb.org/us-gaap/2022#AccruedLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" name="us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjEyNTNlNzQwNjAwMzRlZjM4YmM3ZDQyNjA2OTE4NGNiL3RhYmxlcmFuZ2U6MTI1M2U3NDA2MDAzNGVmMzhiYzdkNDI2MDY5MTg0Y2JfOC0xLTEtMS04MzI4NQ_0e1c436b-8779-4e63-90c2-6287c33ec16d">http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930" name="us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjEyNTNlNzQwNjAwMzRlZjM4YmM3ZDQyNjA2OTE4NGNiL3RhYmxlcmFuZ2U6MTI1M2U3NDA2MDAzNGVmMzhiYzdkNDI2MDY5MTg0Y2JfOC0xLTEtMS04MzI4NQ_8cf1f2a5-8b40-40ac-84e4-96b9a215a402">http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" name="us-gaap:DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfMTAtMC0xLTEtODMyODU_79a5037b-581b-47d3-9fd4-71603055d303">http://fasb.org/us-gaap/2022#Assets</ix:nonNumeric><ix:nonNumeric contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" name="us-gaap:DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfMTYtMC0xLTEtMTAwNTk3_169dbe7d-a10b-4a1e-ab46-42af80460820">http://fasb.org/us-gaap/2022#Liabilities</ix:nonNumeric><ix:nonNumeric contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930" name="us-gaap:DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfOC0wLTEtMS04MzI4NQ_417fadeb-557f-4f83-a995-e688c949e009">http://fasb.org/us-gaap/2022#Assets</ix:nonNumeric><ix:nonNumeric contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930" name="us-gaap:DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfMTMtMC0xLTEtODMyODU_54db5ac7-0c5e-4cf6-bc9b-f0229d68f729">http://fasb.org/us-gaap/2022#Liabilities</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="var-20221230.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5812d3f486ea497b898b89043aa7f4ea_I20230126"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-01-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i7fe5aac364564006abc3881183388748_D20211002-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-02</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i97383852c2e44f9090e25f67836d6e81_I20221230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i967727602cae45adb24efc0f4e4bd947_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c89eaed981a4d4a95584393e114c1a2_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i37e38c715c44456aaf8bc01ef2b73582_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i946a5f2b729e4134a3046873942feac2_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic3cbcd23a7804aebb45bbf33e9654051_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90a3dedd81b74cfb9d7bf05623f3ea1b_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i964e8837dab84683972daafc904bc290_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if053d543d68e4983b97631e65183a5d1_D20211002-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-02</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5bbd4632766b486d8dd37f35093df0cb_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic809286b91a146ce974c75d48a3c4517_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a5ca132807b4f1596b0b257c552596b_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic28d182c3ed64ba2aebe358831333632_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i374334f7b3304f1d936a010e369e5949_D20221001-20221230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9bb651a6c0ed468da0c7878dd6d514ef_D20221001-20221230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i689d7483ede3410593772cdd559784d3_D20221001-20221230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib43fdaa870e547d083de4f40fcef4c40_D20221001-20221230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0fa88bead9c943b7807d5810cd828850_I20221230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4eb681e97f2345679fdea50eb3b491d1_I20221230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2322eead975b4c1dbc547b6270fb8adf_I20221230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i02e30707026c4e429d7a8e186437ad12_I20221230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i42e660b69d2d46dcb0355f9671f5a578_I20221230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5126bc5003f942bf8310df4804290940_I20221230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida04e40f3374405faf2b86c9faa3beae_I20211001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3aff7d47dfed4780bef288e0efb8de73_I20211001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id25e5cef067540a2b3d17a01b52d1080_I20211001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id72ff47fc82e4e879dbaa26a295898ce_I20211001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i15fe2e613bae4c76beaddadbd8d8e5e3_I20211001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ef993557e48462d926de8e9ccea2f7a_I20211001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i504e59968786494c96b1e46f5375a17d_I20211001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-10-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9fa7e713d284aa28f3ce117acb47880_D20211002-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-02</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief1f6f644eea437e9b8e1e8aa59dc455_D20211002-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-02</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib6692c6c33bf48afbda409fe7c7691e3_D20211002-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-02</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i66a2015d4ada4d51b8273eb10babd3c7_D20211002-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-02</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i484320e6452e4a568aeaaf3e75831c12_D20211002-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-02</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia7cd9a82501843e7840128314d4836e4_D20211002-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-02</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic84d7ad4df444a5ba010f733b23db58e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f85b75047844e478507cd67afb10862_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f1790e7c49848f68d840ef25c469adf_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia50a700a64ae4856ba15300cae774337_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic3cba6759b1f4b609890dbb223fb7ddb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7886797dc72447689ab1203828cf4a8a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4026880a25c245b7ae7af90aa89cf31c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>var:segment</xbrli:measure></xbrli:unit><xbrli:context id="i651cc3561a6c40d9a9e385495456c274_D20221001-20221230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">var:CanonMedicalSystemsCorporationFormerlyToshibaMedicalSystemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i288802e63c324225b21fea1834e54841_D20211002-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">var:CanonMedicalSystemsCorporationFormerlyToshibaMedicalSystemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-02</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0048ce751bf94b37a1dd1afdc4bea06a_D20221001-20221230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">var:CanonMedicalSystemsCorporationFormerlyToshibaMedicalSystemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i59fa34d2d760449bbe1edc7c303eea6d_D20211002-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">var:CanonMedicalSystemsCorporationFormerlyToshibaMedicalSystemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-02</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i67803683b0344dc78ee5545d3907c730_D20221001-20221230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idd5d9702aa2d44ef9138ad61434eaa2a_D20221001-20221230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d4da637b0cb434892a6570db3bf836d_I20221001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic8c656c39e5948888cffc7883844bcb7_I20221230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">var:ConvertibleNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i77268675d9614be1856e94103b41aef3_D20221001-20221230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib8a6b0f85dcb4a62be851b76f236b2a7_D20211002-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-02</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i04bcd73d30e04bdb841e13dae6931b40_D20221001-20221230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i41a6a4b942e94c2f93e0cfd38b7b56b9_D20211002-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-02</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia9142a51de834eb08ccfecaa6fcb247b_D20221001-20221230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5faba21f6b9a41c5961c60b0331ab68e_D20211002-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-02</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i582fbee024ae43e187bc82bf36e08c7f_D20221001-20221230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0d5d3a41d6e46a8981e7b39df4c4005_D20211002-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-02</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id11c0d105587406ea12579388d33acc6_I20221230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">var:DpiXHoldingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c5473e7e6e2416283c3708bf75140f0_I20221230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:OwnershipAxis">var:DpiXHoldingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">var:DpiXLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i651cdb90544d4fc5ae96aa228e377585_D20221001-20221230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">var:DpiXHoldingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e78a329a9904ab4ad46da4fa3ad9d85_D20211002-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">var:DpiXHoldingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-02</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i754dac8665dd449eb1ba41e245554f36_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">var:DpiXHoldingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i70ff6a02b02a447d974ae2a3ad5485bc_D20230101-20231231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">var:DpiXHoldingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">var:FixedCostCommitmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i043d35fe9e8748dba721e7442a223c87_D20221001-20221230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">var:VECImagingGmbHCo.KGMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i23fdde7b29af4c57aa6824e48992f27e_D20211002-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">var:VECImagingGmbHCo.KGMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-02</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ide9a8d3681694417a4a4545b01157b8d_I20221230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">var:VECImagingGmbHCo.KGMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic6403b22953a49d8b910f2bf553fd441_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">var:VECImagingGmbHCo.KGMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="instrument"><xbrli:measure>var:instrument</xbrli:measure></xbrli:unit><xbrli:context id="i4a06e1fd56de45429cf0fcaeadd92091_I20221230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="derivativecontract"><xbrli:measure>var:derivativeContract</xbrli:measure></xbrli:unit><xbrli:context id="i1b3aa766e2904db9b8ab4aa605bdb4ee_D20221001-20221230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4eac39f015bd47f5ba39e3bfcfcc6d4c_D20211002-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-02</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ide90c1ae15ab4bb9a3bd404689af0bbf_D20221001-20221230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i934533f99d1543b2ab6a4be93d73dd8f_D20211002-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-02</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c7f1146a6b1444882838f6b9709de23_I20221230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5332708454694b5dbb490975b393f380_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05ccff0411484bb0bee83af0018f0bf7_I20221230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i17e216dd46824f439789b35236b2e450_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e698835048a4495bf4ddd5aae18d2f8_I20221230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie4aa2eb507164e9faa338325c825f610_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c18314ffe0b4522b51d04b27d6bdac1_I20221230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib5065ecd379c4d4b96ce8728838e59d8_I20221230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6de4c85804eb455496852e854a916c0e_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if56b77a5f42444d7b50e5eabbf7d9892_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id8a794d22d5a488984d341691b20bb34_I20221230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2051d8990e80499790558d1c04489cd7_I20221230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i81f291e28b0849a882c21993a4683f38_I20221230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i488f141169664a4da02df7fb3f0314cf_I20221230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i000a217e3c2d4af68d6fb28636848da6_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i080aeddcac46466b8c187b8b0b5615b0_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24674ea6cbf44864812dadb6e95f2db8_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9240c6083244455c8602c53af33d914d_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i10a7807457d845b9ad4ed44aed8912db_I20221230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7fddba25d3464fc88f2322c862ad8fda_I20221230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6600d15de2c54873830ce25e54e2f1e4_I20221230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryBillSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id304dfd7514641719c5a17d4ab0bed7a_I20221230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i11d163dc0c7e4f778d0934c68fbd9ed9_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i09336e03a3124b3e8abcf83f054dfc6e_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76a7050d54304267a10c2a2ff2669153_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryBillSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i47928432e34e44fab0fa2e3e5ea1c268_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if73dd818790943af8e76d7d0bd61ece8_I20221230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id1e9242ff3354b2a960503fd1761aab2_I20221230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i92e88468ba3d48a7a063bee1e0f0318a_I20221230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f7a180ea39443b694aaf7dd07ad1096_I20221230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryBillSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i820b739701b04c498136aad1494d10a5_I20221230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ae6c3be3d534e909bf65cafdb441f13_I20221230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ca9a72270ef4471b61390923b253af8_I20221230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iabebb79ab33a45a88797388ed198ebff_I20221230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ce0938959034f01ba57216c7cb057f4_I20221230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryBillSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb5cc1f64aef49f38721631773798f1c_I20221230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic7b8fd0dd0134e8f856ea33530935168_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i37397c07155e4b5999d81334076d9104_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i258bf93e049d4d02a30c6b42cfdf1134_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib570e05ca31b4b8d9df07b036d129ecc_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryBillSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9fd818ca9813423087f30261388bf1ff_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1fb8bf62e0d742a9a0f377ab72636023_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i41d677cf97674dbd90329e0a86d4c071_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5b9b65169796488785c67752201e44e3_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b104c9b9bf14c9f912232bc060f93db_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryBillSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7cbc650905324d5a9d9f236aae761225_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib5c2f6e8743c4071bbe71b730ae4875d_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f985f58dae54b558355211719080563_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic599629ea0b04a37b5c016ca41d98210_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if4692f756aaa45aeb72bc012dbee325a_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryBillSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie75eb2768bab4d5b841b550e22dc7e31_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82c73512683b4d2096958ea2c1d31545_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">var:MedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i317f9c4181274f2493096e5cbd4ae801_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">var:IndustrialMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad2fceac1bb145229d93b69339db9f19_D20221001-20221230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">var:MedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaab56d5aa0be4d758038ec0908970ec8_D20221001-20221230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">var:IndustrialMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ed6fb1587e340578f31b77be6b9133b_I20221230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">var:MedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90a86f642a414830901c4fc2a48a1b03_I20221230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">var:IndustrialMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i71efe72866804c618d71d89eb6e37464_I20221230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c5261f66af24806b7d3a028cf3b8dc2_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib080390b901b4ad0b3394ec38916cf01_I20221230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice17b9b9dfca490ab810ee326594761a_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i00b01e43c8e144339e841ad785f9ced0_I20221230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">var:CustomerContractsandSupplierRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i77825c8e58b14473947ad5b24ebc5fe2_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">var:CustomerContractsandSupplierRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7b6a45a9d7f431e82a5e0541b5d665f_I20221230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifdafe244379e403ab68aa2010d767746_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ddb8748822a4dd79f1844c4e1de6408_I20221230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i329314c9f0c94232beff7031f1c86791_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if2ff80d284834bfcb7ca6f632c838139_D20221001-20221230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2fee5a0bbf6742f6bb3e66a2bb45060d_I20221230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">var:SeniorSecuredNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if0321a6e3bf3410dbde55beea3d74890_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">var:SeniorSecuredNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb047c1f6e044134babc50205637228f_D20221001-20221230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">var:SeniorSecuredNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69f1e52e1cba4369877e4bf54fb6f0fa_I20200609"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">var:ConvertibleNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia56e2cecd1c944d1be9cbd9438c698cb_D20200609-20200609"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">var:ConvertibleNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-09</xbrli:startDate><xbrli:endDate>2020-06-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d049c5854724aa9974c7beaa7a53f96_I20200605"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">var:ConvertibleNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e0cf62911af4732b7b65d582effb57a_D20200604-20200605"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">var:ConvertibleNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-04</xbrli:startDate><xbrli:endDate>2020-06-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97ab3a4749584f83846ca650afd01c56_I20200604"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">var:ConvertibleNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i798fb4265b0e4636a6a91ab2434ed003_D20221001-20221230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">var:ConvertibleNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id08284e24f7a44a1af87978abad620f1_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">var:SeniorSecuredNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icb3ccdc0c44b4d1ea6e36338c7054f16_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">var:AssetBasedLoanRevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i158d5c57020b4ef6a39dffc0260b3686_D20220930-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">var:AssetBasedLoanRevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-30</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c3e3d6ed3d54b1db390bab6a91c9dbc_I20221230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">var:AssetBasedLoanRevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe05cb3673834311b8aede71e8a50abf_I20180930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">var:JointVentureInSaudiArabiaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa0abd3404e2408cb290b091be08936f_I20150430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">var:MeVisMedicalSolutionsAGMeVisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2015-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i129fd5cad674437db5d8fc43fb2f24cc_D20170929-20170929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">var:MeVisMedicalSolutionsAGMeVisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-09-29</xbrli:startDate><xbrli:endDate>2017-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia34c4680d929483bb8b2f9d74fb41a7a_D20180928-20180928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">var:MeVisMedicalSolutionsAGMeVisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-28</xbrli:startDate><xbrli:endDate>2018-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic047dd7ba8bc4e4983adf9ec678cc993_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">var:MeVisMedicalSolutionsAGMeVisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6530ecc1b8854fcbb93120033ddfdde9_D20150801-20150831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2015-08-01</xbrli:startDate><xbrli:endDate>2015-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="eurPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="ia15cd7f933164e4fa3c90be25a2678a1_I20221230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">var:MeVisMedicalSolutionsAGMeVisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86ab0fdd202b48e9b5a3c7718d5598cc_D20221001-20221230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i601e32df192447cb959a2ba73a6fd2ba_D20211002-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-02</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc160449c61b40539d3867651037cc59_D20221001-20221230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3bf31d7d7f764d569a16bae11d856ce7_D20211002-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-02</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb7fcbc8943f416c813c5266235d9ae1_D20221001-20221230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i933696b07a5546158d133b6f7f13c96f_D20211002-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-02</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f1d152938084b8fb5c95daf2c0bebc9_D20221001-20221230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id8ef423cb3ad48e8887f0b4fd6e5cb77_D20211002-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-02</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic4686bc0f01748e7bf2ccd6382ecb978_D20221001-20221230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0a9c4e86e3f4f929c53ebd89df0858a_D20211002-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-02</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i78f307374103493aa2a778a18fffd8c0_D20221001-20221230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia84a05a959934c73ac14197dcf7f8950_D20211002-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-02</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i351ede538c104bba9d98c61dffb4fb78_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i18c5d964291c4ea790a03cf8d6140a16_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d50db1d5d424029913ff40e007c62a2_I20221230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe78209ddb124767b1ede71bb79ea8dc_I20221230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if28f02563bbd40d0a3a931501b82e58f_D20211002-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">var:MedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-02</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifbe1cf81bdb14d34b79718fe7f9ef5df_D20211002-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001681622</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">var:IndustrialMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-02</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i4ab573909cb849339357193b017c7d37_1"></div><div style="min-height:18pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;____________________________________________________________</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xL2ZyYWc6ZTg1YWY1NDM0NTQ2NDliOThiZWExNWU0MzYyMDg2NzMvdGV4dHJlZ2lvbjplODVhZjU0MzQ1NDY0OWI5OGJlYTE1ZTQzNjIwODY3M18yMDI3_5f316b4e-1152-4250-8e0e-3441ae5c7dcd">10-Q</ix:nonNumeric> </span></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;____________________________________________________________</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.873%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="dei:DocumentQuarterlyReport" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xL2ZyYWc6ZTg1YWY1NDM0NTQ2NDliOThiZWExNWU0MzYyMDg2NzMvdGFibGU6OTJiYjlmMzc1ZWYxNDI3YmIyMWU4MDY1YjY5OTdhOGEvdGFibGVyYW5nZTo5MmJiOWYzNzVlZjE0MjdiYjIxZTgwNjViNjk5N2E4YV8wLTAtMS0xLTgzMjg1_be3b0c1c-8cb7-408b-a4d9-9f143dc34aee">&#9746;</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xL2ZyYWc6ZTg1YWY1NDM0NTQ2NDliOThiZWExNWU0MzYyMDg2NzMvdGV4dHJlZ2lvbjplODVhZjU0MzQ1NDY0OWI5OGJlYTE1ZTQzNjIwODY3M18yNDQ_9063b9e8-747d-4611-bf2d-20f92e83f8fa">December&#160;30, 2022</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">or</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.873%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xL2ZyYWc6ZTg1YWY1NDM0NTQ2NDliOThiZWExNWU0MzYyMDg2NzMvdGFibGU6NDg0MTY0YmVjYWZjNGM0NjljM2RjZDkyOTE2OWM3MmEvdGFibGVyYW5nZTo0ODQxNjRiZWNhZmM0YzQ2OWMzZGNkOTI5MTY5YzcyYV8wLTAtMS0xLTgzMjg1_98e850c7-b1d1-4c3e-b74f-6e50cf2da892">&#9744;</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div></td></tr></table></div><div style="margin-top:4pt;text-indent:177.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; to &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission File Number <ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xL2ZyYWc6ZTg1YWY1NDM0NTQ2NDliOThiZWExNWU0MzYyMDg2NzMvdGV4dHJlZ2lvbjplODVhZjU0MzQ1NDY0OWI5OGJlYTE1ZTQzNjIwODY3M18yMDIw_2eee155b-10a9-4645-a074-5a7dae22acb8">001-37860</ix:nonNumeric> </span></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;____________________________________________________________&#160;</span></div><div style="text-align:center"><img src="var-20221230_g1.jpg" alt="var-20221230_g1.jpg" style="height:73px;margin-bottom:5pt;vertical-align:text-bottom;width:325px"/></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xL2ZyYWc6ZTg1YWY1NDM0NTQ2NDliOThiZWExNWU0MzYyMDg2NzMvdGV4dHJlZ2lvbjplODVhZjU0MzQ1NDY0OWI5OGJlYTE1ZTQzNjIwODY3M18yMDMw_a6c7490f-7b08-44b2-9ffc-d1d531a15318">VAREX IMAGING CORPORATION</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;____________________________________________________________&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.038%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.094%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.427%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.041%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xL2ZyYWc6ZTg1YWY1NDM0NTQ2NDliOThiZWExNWU0MzYyMDg2NzMvdGFibGU6ZTRiZjJhYmYxMGVjNDhiY2EzNjA1YzE5NWQ3NmUyODQvdGFibGVyYW5nZTplNGJmMmFiZjEwZWM0OGJjYTM2MDVjMTk1ZDc2ZTI4NF8wLTAtMS0xLTgzMjg1_d0f9f65a-bfa0-41a4-ab74-8f273af61210">Delaware</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xL2ZyYWc6ZTg1YWY1NDM0NTQ2NDliOThiZWExNWU0MzYyMDg2NzMvdGFibGU6ZTRiZjJhYmYxMGVjNDhiY2EzNjA1YzE5NWQ3NmUyODQvdGFibGVyYW5nZTplNGJmMmFiZjEwZWM0OGJjYTM2MDVjMTk1ZDc2ZTI4NF8wLTMtMS0xLTgzMjg1_38307b32-8954-4995-887b-781e174afc68">81-3434516</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;margin-top:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(State or other jurisdiction of</span></div><div style="margin-bottom:1pt;margin-top:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">incorporation or organization)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;margin-top:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(I.R.S. Employer</span></div><div style="margin-bottom:1pt;margin-top:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Identification Number)</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;margin-top:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xL2ZyYWc6ZTg1YWY1NDM0NTQ2NDliOThiZWExNWU0MzYyMDg2NzMvdGFibGU6ZTRiZjJhYmYxMGVjNDhiY2EzNjA1YzE5NWQ3NmUyODQvdGFibGVyYW5nZTplNGJmMmFiZjEwZWM0OGJjYTM2MDVjMTk1ZDc2ZTI4NF8zLTAtMS0xLTgzMjg1L3RleHRyZWdpb246YzJjNzk4MmVhYmU5NDg2YmEzNWMwZDA4YTg3YzU0N2FfNQ_fdf4e91a-62a1-4332-bbf2-c4f239bb84c1">1678 S. Pioneer Road</ix:nonNumeric>, <ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xL2ZyYWc6ZTg1YWY1NDM0NTQ2NDliOThiZWExNWU0MzYyMDg2NzMvdGFibGU6ZTRiZjJhYmYxMGVjNDhiY2EzNjA1YzE5NWQ3NmUyODQvdGFibGVyYW5nZTplNGJmMmFiZjEwZWM0OGJjYTM2MDVjMTk1ZDc2ZTI4NF8zLTAtMS0xLTgzMjg1L3RleHRyZWdpb246YzJjNzk4MmVhYmU5NDg2YmEzNWMwZDA4YTg3YzU0N2FfOQ_289a846c-f383-42ef-aea4-703e11deef30">Salt Lake City</ix:nonNumeric>, <ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xL2ZyYWc6ZTg1YWY1NDM0NTQ2NDliOThiZWExNWU0MzYyMDg2NzMvdGFibGU6ZTRiZjJhYmYxMGVjNDhiY2EzNjA1YzE5NWQ3NmUyODQvdGFibGVyYW5nZTplNGJmMmFiZjEwZWM0OGJjYTM2MDVjMTk1ZDc2ZTI4NF8zLTAtMS0xLTgzMjg1L3RleHRyZWdpb246YzJjNzk4MmVhYmU5NDg2YmEzNWMwZDA4YTg3YzU0N2FfMTM_743b2e0b-3212-41e4-84ea-c4c156ceacf4">Utah</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xL2ZyYWc6ZTg1YWY1NDM0NTQ2NDliOThiZWExNWU0MzYyMDg2NzMvdGFibGU6ZTRiZjJhYmYxMGVjNDhiY2EzNjA1YzE5NWQ3NmUyODQvdGFibGVyYW5nZTplNGJmMmFiZjEwZWM0OGJjYTM2MDVjMTk1ZDc2ZTI4NF8zLTMtMS0xLTgzMjg1L3RleHRyZWdpb246Yjc3MTlhNmRjMGJkNGEyMWIyMjBmNTYwZTRjZWNlYTNfNQ_caa72e46-9fa7-4591-a596-efee3974e05c">84104</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Address of principal executive offices)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Zip Code)</span></div></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xL2ZyYWc6ZTg1YWY1NDM0NTQ2NDliOThiZWExNWU0MzYyMDg2NzMvdGV4dHJlZ2lvbjplODVhZjU0MzQ1NDY0OWI5OGJlYTE1ZTQzNjIwODY3M18yMDI0_607702f2-bc80-4ac5-a735-24ba6a38e8de">801</ix:nonNumeric>) <ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xL2ZyYWc6ZTg1YWY1NDM0NTQ2NDliOThiZWExNWU0MzYyMDg2NzMvdGV4dHJlZ2lvbjplODVhZjU0MzQ1NDY0OWI5OGJlYTE1ZTQzNjIwODY3M18yMDI1_e898aca8-dbee-47fd-8e71-2abcb40fcee8">972-5000</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;____________________________________________________________&#160;</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.679%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Title of each class</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xL2ZyYWc6ZTg1YWY1NDM0NTQ2NDliOThiZWExNWU0MzYyMDg2NzMvdGFibGU6ZDU5NTc5YzM5Zjc3NDAwNGJlMmQzNDU2NjZmMTEyZWMvdGFibGVyYW5nZTpkNTk1NzljMzlmNzc0MDA0YmUyZDM0NTY2NmYxMTJlY18xLTAtMS0xLTgzMjg1_dabec9e7-73ba-4b72-bdd3-8a0cf1c9d4b7">Common Stock</ix:nonNumeric></span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xL2ZyYWc6ZTg1YWY1NDM0NTQ2NDliOThiZWExNWU0MzYyMDg2NzMvdGFibGU6ZDU5NTc5YzM5Zjc3NDAwNGJlMmQzNDU2NjZmMTEyZWMvdGFibGVyYW5nZTpkNTk1NzljMzlmNzc0MDA0YmUyZDM0NTY2NmYxMTJlY18xLTEtMS0xLTgzMjg1_bb0f5e5d-0cbf-4503-a344-bd99ef4792d8">VREX</ix:nonNumeric></span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xL2ZyYWc6ZTg1YWY1NDM0NTQ2NDliOThiZWExNWU0MzYyMDg2NzMvdGFibGU6ZDU5NTc5YzM5Zjc3NDAwNGJlMmQzNDU2NjZmMTEyZWMvdGFibGVyYW5nZTpkNTk1NzljMzlmNzc0MDA0YmUyZDM0NTY2NmYxMTJlY18xLTItMS0xLTgzMjg1_fbc077a8-81f9-4de9-97f0-6680055a3f61">The Nasdaq Global Select Market</ix:nonNumeric></span></div></td></tr></table></div><div style="margin-top:6pt;text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant: (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xL2ZyYWc6ZTg1YWY1NDM0NTQ2NDliOThiZWExNWU0MzYyMDg2NzMvdGV4dHJlZ2lvbjplODVhZjU0MzQ1NDY0OWI5OGJlYTE1ZTQzNjIwODY3M18yMDIx_97cf142f-9823-458d-84da-d25a695a26c6">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">No&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;</span></div><div style="margin-top:6pt;text-indent:31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xL2ZyYWc6ZTg1YWY1NDM0NTQ2NDliOThiZWExNWU0MzYyMDg2NzMvdGV4dHJlZ2lvbjplODVhZjU0MzQ1NDY0OWI5OGJlYTE1ZTQzNjIwODY3M18yMDIy_a74f53fd-61bf-493b-9652-094922a60727">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:6pt;text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act. </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:31.862%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.164%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.728%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.906%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.140%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.164%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.136%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xL2ZyYWc6ZTg1YWY1NDM0NTQ2NDliOThiZWExNWU0MzYyMDg2NzMvdGFibGU6ODVhMTVjZmYzODY4NDlmN2EzMWViMWJjYjk0YjI2YjIvdGFibGVyYW5nZTo4NWExNWNmZjM4Njg0OWY3YTMxZWIxYmNiOTRiMjZiMl8wLTAtMS0xLTgzMjg1_ee1c18ec-d8e8-4830-8a20-70ecda897063">Large Accelerated filer</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9746;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accelerated&#160;filer</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-Accelerated filer</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;&#160;&#160;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Smaller&#160;reporting&#160;company</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="dei:EntitySmallBusiness" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xL2ZyYWc6ZTg1YWY1NDM0NTQ2NDliOThiZWExNWU0MzYyMDg2NzMvdGFibGU6ODVhMTVjZmYzODY4NDlmN2EzMWViMWJjYjk0YjI2YjIvdGFibGVyYW5nZTo4NWExNWNmZjM4Njg0OWY3YTMxZWIxYmNiOTRiMjZiMl8yLTYtMS0xLTgzMjg1_7b93f9ea-078d-4d4e-93bd-7ec21166fc9f">&#9744;</ix:nonNumeric></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Emerging growth company</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xL2ZyYWc6ZTg1YWY1NDM0NTQ2NDliOThiZWExNWU0MzYyMDg2NzMvdGFibGU6ODVhMTVjZmYzODY4NDlmN2EzMWViMWJjYjk0YjI2YjIvdGFibGVyYW5nZTo4NWExNWNmZjM4Njg0OWY3YTMxZWIxYmNiOTRiMjZiMl80LTYtMS0xLTgzMjg1_0dca26ae-d270-48cc-8de2-0c97f92649e4">&#9744;</ix:nonNumeric></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).&#160;&#160;Yes&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> &#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="dei:EntityShellCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xL2ZyYWc6ZTg1YWY1NDM0NTQ2NDliOThiZWExNWU0MzYyMDg2NzMvdGV4dHJlZ2lvbjplODVhZjU0MzQ1NDY0OWI5OGJlYTE1ZTQzNjIwODY3M18yMDI2_0ef3d5ac-f654-40f4-becb-3d6a436c1dc6">&#9746;</ix:nonNumeric></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of January&#160;26, 2023, there were <ix:nonFraction unitRef="shares" contextRef="i5812d3f486ea497b898b89043aa7f4ea_I20230126" decimals="-5" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xL2ZyYWc6ZTg1YWY1NDM0NTQ2NDliOThiZWExNWU0MzYyMDg2NzMvdGV4dHJlZ2lvbjplODVhZjU0MzQ1NDY0OWI5OGJlYTE1ZTQzNjIwODY3M18xOTY2_57535776-21f0-4cf3-b350-c1942aa65ce7">40.1</ix:nonFraction>&#160;million shares of the registrant&#8217;s common stock outstanding.</span></div><div style="height:18pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i4ab573909cb849339357193b017c7d37_7"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VAREX IMAGING CORPORATION</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FORM 10-Q</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the Quarter Ended December&#160;30, 2022 </span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.886%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.770%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:75.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.968%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_10">Part&#160;I.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_10">Financial Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_10">2</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_13">Item&#160;1.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_13">Unaudited Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_13">2</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_16">Condensed Consolidated Statements of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_16">2</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_19">Condensed Consolidated Statements of Comprehensive Income</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_19">3</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;margin-top:1pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_22">Condensed Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_22">4</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_25">Condensed Consolidated Statements of Stockholders' Equity</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_25">5</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;margin-top:1pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_31">Condensed Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_31">6</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_34">Notes to the Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_34">7</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_97">Item&#160;2.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_97">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_97">27</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_121">Item&#160;3.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_121">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_121">35</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_124">Item&#160;4.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_124">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_124">36</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_127">Part&#160;II.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_127">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_127">37</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_130">Item&#160;1.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_130">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_130">37</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_133">Item&#160;1A.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_133">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_133">37</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_136">Item&#160;2.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_136">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_136">63</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_139">Item&#160;3.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_139">Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_139">63</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_142">Item&#160;4.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_142">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_142">63</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_145">Item&#160;5.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_145">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_145">63</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_148">Item&#160;6.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_148">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_148">64</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_151">Signatures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_151">65</a></span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><div id="i4ab573909cb849339357193b017c7d37_10"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL INFORMATION</span></div><div><span><br/></span></div><div id="i4ab573909cb849339357193b017c7d37_13"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1. Financial Statements</span></div><div><span><br/></span></div><div id="i4ab573909cb849339357193b017c7d37_16"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VAREX IMAGING CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS&#160;&#160;&#160;&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.788%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.763%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions, except per share amounts)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenues, net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xNi9mcmFnOmRlMjY3N2UzMGNmNzRiOTU5NjAzYjlkOGNhYjY1MDc4L3RhYmxlOjE4OGExZTBkNDZhMTQyMDJiZTdlY2RjN2FmYzgyY2Y1L3RhYmxlcmFuZ2U6MTg4YTFlMGQ0NmExNDIwMmJlN2VjZGM3YWZjODJjZjVfMi01LTEtMS04MzI4NQ_025f4dac-2283-4d45-a1e1-e77320f1ede6">205.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xNi9mcmFnOmRlMjY3N2UzMGNmNzRiOTU5NjAzYjlkOGNhYjY1MDc4L3RhYmxlOjE4OGExZTBkNDZhMTQyMDJiZTdlY2RjN2FmYzgyY2Y1L3RhYmxlcmFuZ2U6MTg4YTFlMGQ0NmExNDIwMmJlN2VjZGM3YWZjODJjZjVfMi03LTEtMS04MzI4NQ_2af209d5-3fb4-4c36-b6db-02f502a4f42c">198.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of revenues</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xNi9mcmFnOmRlMjY3N2UzMGNmNzRiOTU5NjAzYjlkOGNhYjY1MDc4L3RhYmxlOjE4OGExZTBkNDZhMTQyMDJiZTdlY2RjN2FmYzgyY2Y1L3RhYmxlcmFuZ2U6MTg4YTFlMGQ0NmExNDIwMmJlN2VjZGM3YWZjODJjZjVfMy01LTEtMS04MzI4NQ_ea60637c-e1a7-44c2-b894-18242790cee2">142.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xNi9mcmFnOmRlMjY3N2UzMGNmNzRiOTU5NjAzYjlkOGNhYjY1MDc4L3RhYmxlOjE4OGExZTBkNDZhMTQyMDJiZTdlY2RjN2FmYzgyY2Y1L3RhYmxlcmFuZ2U6MTg4YTFlMGQ0NmExNDIwMmJlN2VjZGM3YWZjODJjZjVfMy03LTEtMS04MzI4NQ_bcb99db9-914f-4300-bc21-5b8c58bd02dd">134.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xNi9mcmFnOmRlMjY3N2UzMGNmNzRiOTU5NjAzYjlkOGNhYjY1MDc4L3RhYmxlOjE4OGExZTBkNDZhMTQyMDJiZTdlY2RjN2FmYzgyY2Y1L3RhYmxlcmFuZ2U6MTg4YTFlMGQ0NmExNDIwMmJlN2VjZGM3YWZjODJjZjVfNC01LTEtMS04MzI4NQ_c1c0744d-0dd5-41e1-be9d-90ba8ec3b40d">63.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xNi9mcmFnOmRlMjY3N2UzMGNmNzRiOTU5NjAzYjlkOGNhYjY1MDc4L3RhYmxlOjE4OGExZTBkNDZhMTQyMDJiZTdlY2RjN2FmYzgyY2Y1L3RhYmxlcmFuZ2U6MTg4YTFlMGQ0NmExNDIwMmJlN2VjZGM3YWZjODJjZjVfNC03LTEtMS04MzI4NQ_1d853bf1-42d3-4a3f-9149-0fa35345b852">64.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xNi9mcmFnOmRlMjY3N2UzMGNmNzRiOTU5NjAzYjlkOGNhYjY1MDc4L3RhYmxlOjE4OGExZTBkNDZhMTQyMDJiZTdlY2RjN2FmYzgyY2Y1L3RhYmxlcmFuZ2U6MTg4YTFlMGQ0NmExNDIwMmJlN2VjZGM3YWZjODJjZjVfNi01LTEtMS04MzI4NQ_c3d5509d-78cb-4b5c-aed4-9ba32f4db3f1">20.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xNi9mcmFnOmRlMjY3N2UzMGNmNzRiOTU5NjAzYjlkOGNhYjY1MDc4L3RhYmxlOjE4OGExZTBkNDZhMTQyMDJiZTdlY2RjN2FmYzgyY2Y1L3RhYmxlcmFuZ2U6MTg4YTFlMGQ0NmExNDIwMmJlN2VjZGM3YWZjODJjZjVfNi03LTEtMS04MzI4NQ_eb256321-de87-4aad-b190-f8c159085616">17.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xNi9mcmFnOmRlMjY3N2UzMGNmNzRiOTU5NjAzYjlkOGNhYjY1MDc4L3RhYmxlOjE4OGExZTBkNDZhMTQyMDJiZTdlY2RjN2FmYzgyY2Y1L3RhYmxlcmFuZ2U6MTg4YTFlMGQ0NmExNDIwMmJlN2VjZGM3YWZjODJjZjVfNy01LTEtMS04MzI4NQ_21d5e7f7-39ee-4db4-bb0e-5c9e8b15eb19">30.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xNi9mcmFnOmRlMjY3N2UzMGNmNzRiOTU5NjAzYjlkOGNhYjY1MDc4L3RhYmxlOjE4OGExZTBkNDZhMTQyMDJiZTdlY2RjN2FmYzgyY2Y1L3RhYmxlcmFuZ2U6MTg4YTFlMGQ0NmExNDIwMmJlN2VjZGM3YWZjODJjZjVfNy03LTEtMS04MzI4NQ_24c9a500-1b85-4032-a40b-12be19d3073f">33.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xNi9mcmFnOmRlMjY3N2UzMGNmNzRiOTU5NjAzYjlkOGNhYjY1MDc4L3RhYmxlOjE4OGExZTBkNDZhMTQyMDJiZTdlY2RjN2FmYzgyY2Y1L3RhYmxlcmFuZ2U6MTg4YTFlMGQ0NmExNDIwMmJlN2VjZGM3YWZjODJjZjVfOS01LTEtMS04MzI4NQ_aee4b6df-46fe-40ca-9008-2259dd48029d">50.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xNi9mcmFnOmRlMjY3N2UzMGNmNzRiOTU5NjAzYjlkOGNhYjY1MDc4L3RhYmxlOjE4OGExZTBkNDZhMTQyMDJiZTdlY2RjN2FmYzgyY2Y1L3RhYmxlcmFuZ2U6MTg4YTFlMGQ0NmExNDIwMmJlN2VjZGM3YWZjODJjZjVfOS03LTEtMS04MzI4NQ_98cc5f1f-e6c9-43e3-a9f8-334b14e01793">50.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xNi9mcmFnOmRlMjY3N2UzMGNmNzRiOTU5NjAzYjlkOGNhYjY1MDc4L3RhYmxlOjE4OGExZTBkNDZhMTQyMDJiZTdlY2RjN2FmYzgyY2Y1L3RhYmxlcmFuZ2U6MTg4YTFlMGQ0NmExNDIwMmJlN2VjZGM3YWZjODJjZjVfMTAtNS0xLTEtODMyODU_8ade47d0-f433-4ce5-b591-68c0287bbdd5">13.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xNi9mcmFnOmRlMjY3N2UzMGNmNzRiOTU5NjAzYjlkOGNhYjY1MDc4L3RhYmxlOjE4OGExZTBkNDZhMTQyMDJiZTdlY2RjN2FmYzgyY2Y1L3RhYmxlcmFuZ2U6MTg4YTFlMGQ0NmExNDIwMmJlN2VjZGM3YWZjODJjZjVfMTAtNy0xLTEtODMyODU_5dfaa3b3-8245-4aae-8124-17c23ff813d6">14.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xNi9mcmFnOmRlMjY3N2UzMGNmNzRiOTU5NjAzYjlkOGNhYjY1MDc4L3RhYmxlOjE4OGExZTBkNDZhMTQyMDJiZTdlY2RjN2FmYzgyY2Y1L3RhYmxlcmFuZ2U6MTg4YTFlMGQ0NmExNDIwMmJlN2VjZGM3YWZjODJjZjVfMTEtNS0xLTEtODMyODU_c6ca2743-80d4-4560-ad51-d80dab0a26c4">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="us-gaap:InvestmentIncomeInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xNi9mcmFnOmRlMjY3N2UzMGNmNzRiOTU5NjAzYjlkOGNhYjY1MDc4L3RhYmxlOjE4OGExZTBkNDZhMTQyMDJiZTdlY2RjN2FmYzgyY2Y1L3RhYmxlcmFuZ2U6MTg4YTFlMGQ0NmExNDIwMmJlN2VjZGM3YWZjODJjZjVfMTEtNy0xLTEtODMyODU_91ba9b63-776d-49a2-acc0-0d09ff46c1d8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xNi9mcmFnOmRlMjY3N2UzMGNmNzRiOTU5NjAzYjlkOGNhYjY1MDc4L3RhYmxlOjE4OGExZTBkNDZhMTQyMDJiZTdlY2RjN2FmYzgyY2Y1L3RhYmxlcmFuZ2U6MTg4YTFlMGQ0NmExNDIwMmJlN2VjZGM3YWZjODJjZjVfMTItNS0xLTEtODMyODU_e8e9daa5-3bf0-4455-b10e-4eb30ab60428">7.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xNi9mcmFnOmRlMjY3N2UzMGNmNzRiOTU5NjAzYjlkOGNhYjY1MDc4L3RhYmxlOjE4OGExZTBkNDZhMTQyMDJiZTdlY2RjN2FmYzgyY2Y1L3RhYmxlcmFuZ2U6MTg4YTFlMGQ0NmExNDIwMmJlN2VjZGM3YWZjODJjZjVfMTItNy0xLTEtODMyODU_9a333569-9c50-4d6c-a68f-f8a23d22b452">9.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other expense, net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xNi9mcmFnOmRlMjY3N2UzMGNmNzRiOTU5NjAzYjlkOGNhYjY1MDc4L3RhYmxlOjE4OGExZTBkNDZhMTQyMDJiZTdlY2RjN2FmYzgyY2Y1L3RhYmxlcmFuZ2U6MTg4YTFlMGQ0NmExNDIwMmJlN2VjZGM3YWZjODJjZjVfMTMtNS0xLTEtODMyODU_9b6c121a-f230-440e-9d21-fc8a3eaf4f64">0.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xNi9mcmFnOmRlMjY3N2UzMGNmNzRiOTU5NjAzYjlkOGNhYjY1MDc4L3RhYmxlOjE4OGExZTBkNDZhMTQyMDJiZTdlY2RjN2FmYzgyY2Y1L3RhYmxlcmFuZ2U6MTg4YTFlMGQ0NmExNDIwMmJlN2VjZGM3YWZjODJjZjVfMTMtNy0xLTEtODMyODU_a1b512bc-eced-4fe8-b98d-7c1313df3f79">0.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest and other expense, net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xNi9mcmFnOmRlMjY3N2UzMGNmNzRiOTU5NjAzYjlkOGNhYjY1MDc4L3RhYmxlOjE4OGExZTBkNDZhMTQyMDJiZTdlY2RjN2FmYzgyY2Y1L3RhYmxlcmFuZ2U6MTg4YTFlMGQ0NmExNDIwMmJlN2VjZGM3YWZjODJjZjVfMTQtNS0xLTEtODMyODU_f4459ff1-6322-47ff-874c-d35ffc40493d">7.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xNi9mcmFnOmRlMjY3N2UzMGNmNzRiOTU5NjAzYjlkOGNhYjY1MDc4L3RhYmxlOjE4OGExZTBkNDZhMTQyMDJiZTdlY2RjN2FmYzgyY2Y1L3RhYmxlcmFuZ2U6MTg4YTFlMGQ0NmExNDIwMmJlN2VjZGM3YWZjODJjZjVfMTQtNy0xLTEtODMyODU_f6312b5c-4f2b-4106-9089-fd988f91c496">10.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income before taxes</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xNi9mcmFnOmRlMjY3N2UzMGNmNzRiOTU5NjAzYjlkOGNhYjY1MDc4L3RhYmxlOjE4OGExZTBkNDZhMTQyMDJiZTdlY2RjN2FmYzgyY2Y1L3RhYmxlcmFuZ2U6MTg4YTFlMGQ0NmExNDIwMmJlN2VjZGM3YWZjODJjZjVfMTUtNS0xLTEtODMyODU_27303c8f-e796-4f4e-a565-5aa06ee17d13">5.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xNi9mcmFnOmRlMjY3N2UzMGNmNzRiOTU5NjAzYjlkOGNhYjY1MDc4L3RhYmxlOjE4OGExZTBkNDZhMTQyMDJiZTdlY2RjN2FmYzgyY2Y1L3RhYmxlcmFuZ2U6MTg4YTFlMGQ0NmExNDIwMmJlN2VjZGM3YWZjODJjZjVfMTUtNy0xLTEtODMyODU_9eca60a2-e58f-441d-82df-4e7c28a48d58">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xNi9mcmFnOmRlMjY3N2UzMGNmNzRiOTU5NjAzYjlkOGNhYjY1MDc4L3RhYmxlOjE4OGExZTBkNDZhMTQyMDJiZTdlY2RjN2FmYzgyY2Y1L3RhYmxlcmFuZ2U6MTg4YTFlMGQ0NmExNDIwMmJlN2VjZGM3YWZjODJjZjVfMTYtNS0xLTEtODMyODU_dcb718e9-ffe8-4908-8eea-ec837daefb99">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xNi9mcmFnOmRlMjY3N2UzMGNmNzRiOTU5NjAzYjlkOGNhYjY1MDc4L3RhYmxlOjE4OGExZTBkNDZhMTQyMDJiZTdlY2RjN2FmYzgyY2Y1L3RhYmxlcmFuZ2U6MTg4YTFlMGQ0NmExNDIwMmJlN2VjZGM3YWZjODJjZjVfMTYtNy0xLTEtODMyODU_e10a354a-2d27-42d2-a284-bf6a3adef229">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xNi9mcmFnOmRlMjY3N2UzMGNmNzRiOTU5NjAzYjlkOGNhYjY1MDc4L3RhYmxlOjE4OGExZTBkNDZhMTQyMDJiZTdlY2RjN2FmYzgyY2Y1L3RhYmxlcmFuZ2U6MTg4YTFlMGQ0NmExNDIwMmJlN2VjZGM3YWZjODJjZjVfMTctNS0xLTEtODMyODU_7772502c-5d1a-4276-88df-2c549e9949ef">3.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xNi9mcmFnOmRlMjY3N2UzMGNmNzRiOTU5NjAzYjlkOGNhYjY1MDc4L3RhYmxlOjE4OGExZTBkNDZhMTQyMDJiZTdlY2RjN2FmYzgyY2Y1L3RhYmxlcmFuZ2U6MTg4YTFlMGQ0NmExNDIwMmJlN2VjZGM3YWZjODJjZjVfMTctNy0xLTEtODMyODU_44fe308a-12f3-428f-b390-0087f7077cd8">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xNi9mcmFnOmRlMjY3N2UzMGNmNzRiOTU5NjAzYjlkOGNhYjY1MDc4L3RhYmxlOjE4OGExZTBkNDZhMTQyMDJiZTdlY2RjN2FmYzgyY2Y1L3RhYmxlcmFuZ2U6MTg4YTFlMGQ0NmExNDIwMmJlN2VjZGM3YWZjODJjZjVfMTgtNS0xLTEtODMyODU_b3122bbb-d464-481a-bc06-b0b5209ec0e5">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xNi9mcmFnOmRlMjY3N2UzMGNmNzRiOTU5NjAzYjlkOGNhYjY1MDc4L3RhYmxlOjE4OGExZTBkNDZhMTQyMDJiZTdlY2RjN2FmYzgyY2Y1L3RhYmxlcmFuZ2U6MTg4YTFlMGQ0NmExNDIwMmJlN2VjZGM3YWZjODJjZjVfMTgtNy0xLTEtODMyODU_67319695-c133-497c-9da0-6ea69dae3ab9">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to Varex</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xNi9mcmFnOmRlMjY3N2UzMGNmNzRiOTU5NjAzYjlkOGNhYjY1MDc4L3RhYmxlOjE4OGExZTBkNDZhMTQyMDJiZTdlY2RjN2FmYzgyY2Y1L3RhYmxlcmFuZ2U6MTg4YTFlMGQ0NmExNDIwMmJlN2VjZGM3YWZjODJjZjVfMTktNS0xLTEtODMyODU_ee4dd9de-4f72-4538-bf5c-9717fdcd103f">3.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xNi9mcmFnOmRlMjY3N2UzMGNmNzRiOTU5NjAzYjlkOGNhYjY1MDc4L3RhYmxlOjE4OGExZTBkNDZhMTQyMDJiZTdlY2RjN2FmYzgyY2Y1L3RhYmxlcmFuZ2U6MTg4YTFlMGQ0NmExNDIwMmJlN2VjZGM3YWZjODJjZjVfMTktNy0xLTEtODMyODU_1d185f9b-653d-4402-96a5-77250980b877">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net income per common share attributable to Varex</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xNi9mcmFnOmRlMjY3N2UzMGNmNzRiOTU5NjAzYjlkOGNhYjY1MDc4L3RhYmxlOjE4OGExZTBkNDZhMTQyMDJiZTdlY2RjN2FmYzgyY2Y1L3RhYmxlcmFuZ2U6MTg4YTFlMGQ0NmExNDIwMmJlN2VjZGM3YWZjODJjZjVfMjEtNS0xLTEtODMyODU_400a5573-4296-4c92-96b0-860bd98349d8">0.08</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xNi9mcmFnOmRlMjY3N2UzMGNmNzRiOTU5NjAzYjlkOGNhYjY1MDc4L3RhYmxlOjE4OGExZTBkNDZhMTQyMDJiZTdlY2RjN2FmYzgyY2Y1L3RhYmxlcmFuZ2U6MTg4YTFlMGQ0NmExNDIwMmJlN2VjZGM3YWZjODJjZjVfMjEtNy0xLTEtODMyODU_9ff4ff34-11e8-4173-b184-be2b390ff5ea">0.04</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xNi9mcmFnOmRlMjY3N2UzMGNmNzRiOTU5NjAzYjlkOGNhYjY1MDc4L3RhYmxlOjE4OGExZTBkNDZhMTQyMDJiZTdlY2RjN2FmYzgyY2Y1L3RhYmxlcmFuZ2U6MTg4YTFlMGQ0NmExNDIwMmJlN2VjZGM3YWZjODJjZjVfMjItNS0xLTEtODMyODU_5634f0fa-ebd8-4186-a56a-f8887123f812">0.08</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xNi9mcmFnOmRlMjY3N2UzMGNmNzRiOTU5NjAzYjlkOGNhYjY1MDc4L3RhYmxlOjE4OGExZTBkNDZhMTQyMDJiZTdlY2RjN2FmYzgyY2Y1L3RhYmxlcmFuZ2U6MTg4YTFlMGQ0NmExNDIwMmJlN2VjZGM3YWZjODJjZjVfMjItNy0xLTEtODMyODU_2026c339-1588-440a-a855-5d52810f2ea0">0.03</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted average common shares outstanding</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xNi9mcmFnOmRlMjY3N2UzMGNmNzRiOTU5NjAzYjlkOGNhYjY1MDc4L3RhYmxlOjE4OGExZTBkNDZhMTQyMDJiZTdlY2RjN2FmYzgyY2Y1L3RhYmxlcmFuZ2U6MTg4YTFlMGQ0NmExNDIwMmJlN2VjZGM3YWZjODJjZjVfMjQtNS0xLTEtODMyODU_896ea89b-7686-47a5-b1c2-6eeef2d17e3d">40.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xNi9mcmFnOmRlMjY3N2UzMGNmNzRiOTU5NjAzYjlkOGNhYjY1MDc4L3RhYmxlOjE4OGExZTBkNDZhMTQyMDJiZTdlY2RjN2FmYzgyY2Y1L3RhYmxlcmFuZ2U6MTg4YTFlMGQ0NmExNDIwMmJlN2VjZGM3YWZjODJjZjVfMjQtNy0xLTEtODMyODU_36039cf6-4ee5-426e-b737-31cc771f8ee4">39.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xNi9mcmFnOmRlMjY3N2UzMGNmNzRiOTU5NjAzYjlkOGNhYjY1MDc4L3RhYmxlOjE4OGExZTBkNDZhMTQyMDJiZTdlY2RjN2FmYzgyY2Y1L3RhYmxlcmFuZ2U6MTg4YTFlMGQ0NmExNDIwMmJlN2VjZGM3YWZjODJjZjVfMjUtNS0xLTEtODMyODU_21320505-ae79-47e0-8a95-cbca965970a7">40.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xNi9mcmFnOmRlMjY3N2UzMGNmNzRiOTU5NjAzYjlkOGNhYjY1MDc4L3RhYmxlOjE4OGExZTBkNDZhMTQyMDJiZTdlY2RjN2FmYzgyY2Y1L3RhYmxlcmFuZ2U6MTg4YTFlMGQ0NmExNDIwMmJlN2VjZGM3YWZjODJjZjVfMjUtNy0xLTEtODMyODU_822ac626-2e24-4d90-abc1-826872bfcf07">43.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying Notes to the Condensed Consolidated Financial Statements.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i4ab573909cb849339357193b017c7d37_19"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_7">Table of Contents</a></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VAREX IMAGING CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.762%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xOS9mcmFnOjAxMTJkNzZlNDAxYjQxNzM4YThmMzQyNjE4NDE2ZjY2L3RhYmxlOjM2Njk2NjI4YzFkOTRlZTRhNTcyYjkzMDU1MGE1MGJkL3RhYmxlcmFuZ2U6MzY2OTY2MjhjMWQ5NGVlNGE1NzJiOTMwNTUwYTUwYmRfMi0xLTEtMS04MzI4NQ_05b360cc-5465-4341-8f2d-acd8e0c7038e">3.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xOS9mcmFnOjAxMTJkNzZlNDAxYjQxNzM4YThmMzQyNjE4NDE2ZjY2L3RhYmxlOjM2Njk2NjI4YzFkOTRlZTRhNTcyYjkzMDU1MGE1MGJkL3RhYmxlcmFuZ2U6MzY2OTY2MjhjMWQ5NGVlNGE1NzJiOTMwNTUwYTUwYmRfMi0zLTEtMS04MzI4NQ_bfd1f104-4f55-49e6-9533-51ce313635bd">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xOS9mcmFnOjAxMTJkNzZlNDAxYjQxNzM4YThmMzQyNjE4NDE2ZjY2L3RhYmxlOjM2Njk2NjI4YzFkOTRlZTRhNTcyYjkzMDU1MGE1MGJkL3RhYmxlcmFuZ2U6MzY2OTY2MjhjMWQ5NGVlNGE1NzJiOTMwNTUwYTUwYmRfOS0xLTEtMS05NDUxOQ_c4fca676-ea06-4fda-8077-175f3099833d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xOS9mcmFnOjAxMTJkNzZlNDAxYjQxNzM4YThmMzQyNjE4NDE2ZjY2L3RhYmxlOjM2Njk2NjI4YzFkOTRlZTRhNTcyYjkzMDU1MGE1MGJkL3RhYmxlcmFuZ2U6MzY2OTY2MjhjMWQ5NGVlNGE1NzJiOTMwNTUwYTUwYmRfOS0zLTEtMS05NDUxOQ_3acc2d76-2e5b-4482-81ae-1717cacb6f84">0.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xOS9mcmFnOjAxMTJkNzZlNDAxYjQxNzM4YThmMzQyNjE4NDE2ZjY2L3RhYmxlOjM2Njk2NjI4YzFkOTRlZTRhNTcyYjkzMDU1MGE1MGJkL3RhYmxlcmFuZ2U6MzY2OTY2MjhjMWQ5NGVlNGE1NzJiOTMwNTUwYTUwYmRfMTEtMS0xLTEtODMyODU_ee5576cc-76a5-43f6-bd05-04f85ff6f067">3.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xOS9mcmFnOjAxMTJkNzZlNDAxYjQxNzM4YThmMzQyNjE4NDE2ZjY2L3RhYmxlOjM2Njk2NjI4YzFkOTRlZTRhNTcyYjkzMDU1MGE1MGJkL3RhYmxlcmFuZ2U6MzY2OTY2MjhjMWQ5NGVlNGE1NzJiOTMwNTUwYTUwYmRfMTEtMy0xLTEtODMyODU_41534990-b23c-4b2c-9641-f0f04bc83c2f">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Comprehensive income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xOS9mcmFnOjAxMTJkNzZlNDAxYjQxNzM4YThmMzQyNjE4NDE2ZjY2L3RhYmxlOjM2Njk2NjI4YzFkOTRlZTRhNTcyYjkzMDU1MGE1MGJkL3RhYmxlcmFuZ2U6MzY2OTY2MjhjMWQ5NGVlNGE1NzJiOTMwNTUwYTUwYmRfMTItMS0xLTEtODMyODU_1df3b0fe-9a1c-4b87-bc5e-237bf403d90a">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xOS9mcmFnOjAxMTJkNzZlNDAxYjQxNzM4YThmMzQyNjE4NDE2ZjY2L3RhYmxlOjM2Njk2NjI4YzFkOTRlZTRhNTcyYjkzMDU1MGE1MGJkL3RhYmxlcmFuZ2U6MzY2OTY2MjhjMWQ5NGVlNGE1NzJiOTMwNTUwYTUwYmRfMTItMy0xLTEtODMyODU_9487e490-f955-4abf-9206-9b933a08a0c8">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income attributable to Varex</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xOS9mcmFnOjAxMTJkNzZlNDAxYjQxNzM4YThmMzQyNjE4NDE2ZjY2L3RhYmxlOjM2Njk2NjI4YzFkOTRlZTRhNTcyYjkzMDU1MGE1MGJkL3RhYmxlcmFuZ2U6MzY2OTY2MjhjMWQ5NGVlNGE1NzJiOTMwNTUwYTUwYmRfMTMtMS0xLTEtODMyODU_4171e0c7-351a-4c54-95df-8ef9489a43f5">3.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xOS9mcmFnOjAxMTJkNzZlNDAxYjQxNzM4YThmMzQyNjE4NDE2ZjY2L3RhYmxlOjM2Njk2NjI4YzFkOTRlZTRhNTcyYjkzMDU1MGE1MGJkL3RhYmxlcmFuZ2U6MzY2OTY2MjhjMWQ5NGVlNGE1NzJiOTMwNTUwYTUwYmRfMTMtMy0xLTEtODMyODU_02c28b77-a717-4b97-87b6-1cde8a5c8f98">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying Notes to the Condensed Consolidated Financial Statements.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i4ab573909cb849339357193b017c7d37_22"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VAREX IMAGING CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.722%"><tr><td style="width:1.0%"></td><td style="width:67.005%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.498%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.501%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions, except share and per share amounts)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assets</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current assets:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMy0xLTEtMS04MzI4NQ_b3d2e81f-df35-4594-bf2b-7778f846c1b4">81.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMy0zLTEtMS04MzI4NQ_33936b98-d55a-4b7d-aaf8-9079b58bd8ff">89.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts receivable, net of allowance for credit losses of $<ix:nonFraction unitRef="usd" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfNC0wLTEtMS04MzI4NS90ZXh0cmVnaW9uOmJlNmMwOWU3YjA2MTQyZTU5NmI0YTIwZTI1YzRjMDdlXzYz_a6448f22-3d22-40a4-b069-5da9f90034d8">0.4</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfNC0wLTEtMS04MzI4NS90ZXh0cmVnaW9uOmJlNmMwOWU3YjA2MTQyZTU5NmI0YTIwZTI1YzRjMDdlXzcw_172ae559-e28a-46c4-827e-de70096909d5">0.6</ix:nonFraction>&#160;million at December&#160;30, 2022 and September&#160;30, 2022, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfNC0xLTEtMS04MzI4NQ_43f35fa2-403c-4eec-8e67-439d416137db">157.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfNC0zLTEtMS04MzI4NQ_00a6e63a-7c1f-48ab-b9d7-8aa6c9801110">173.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfNS0xLTEtMS04MzI4NQ_8d447702-205d-4015-b7c0-beb946cfdbf0">320.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfNS0zLTEtMS04MzI4NQ_1a396338-d798-44f8-b92d-98c96676f865">303.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="-5" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfNi0xLTEtMS04MzI4NQ_5169827c-1ca8-40a2-8526-d4a87c623d61">47.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930" decimals="-5" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfNi0zLTEtMS04MzI4NQ_32900366-7001-4fb9-b046-ebaca3f8117d">44.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="-5" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfNy0xLTEtMS04MzI4NQ_e7f0ac68-64d1-4ad3-aa95-fc06486fe901">607.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930" decimals="-5" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfNy0zLTEtMS04MzI4NQ_2fae4125-47da-4c54-bd0a-9774b2e05cbe">609.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant, and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfOC0xLTEtMS04MzI4NQ_11f5ab57-76a7-4988-8ce5-d1eba5783b64">142.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfOC0zLTEtMS04MzI4NQ_ef8b92b0-abb7-4a91-bdce-a3d02142dbc8">141.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfOS0xLTEtMS04MzI4NQ_bafe09e2-74ae-4a68-b2a8-1bb126431f89">288.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfOS0zLTEtMS04MzI4NQ_7bffc651-f838-4c0d-bf33-900284197835">284.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets, net</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMTAtMS0xLTEtODMyODU_fb37c73a-23f8-44e3-a733-e589ce7b5d3d">31.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMTAtMy0xLTEtODMyODU_df901275-929e-4081-8fb7-f03a91e36200">33.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments in privately-held companies</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="-5" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMTEtMS0xLTEtODMyODU_93e44304-6a9e-4960-8cb1-7f048756f074">47.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930" decimals="-5" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMTEtMy0xLTEtODMyODU_9ac9764f-d48f-426d-91dc-f7b607231a69">46.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="-5" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMTItMS0xLTEtODMyODU_831220e7-3fe1-49e5-a4b1-6a6557658d78">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930" decimals="-5" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMTItMy0xLTEtODMyODU_9f483be5-a1c3-4b24-a9d5-212347c9795a">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMTMtMS0xLTEtODMyODU_80450684-af82-4952-b5a3-b99023afa595">22.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMTMtMy0xLTEtODMyODU_6bc259d4-9bbc-40a6-b6f6-732e53900c39">23.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMTQtMS0xLTEtODMyODU_9058114d-14e6-4576-af29-37f8bc3803f5">39.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMTQtMy0xLTEtODMyODU_ad8af03e-fbfd-43a3-b176-4fea736cf593">43.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total assets</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMTUtMS0xLTEtODMyODU_4b58bdbb-2382-4d9c-b1c0-e2b3eb7d221e">1,180.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMTUtMy0xLTEtODMyODU_2d7fc3e4-d2ee-454a-bf05-c48f9fc09996">1,184.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liabilities and stockholders' equity</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current liabilities:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="-5" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMTgtMS0xLTEtODMyODU_9a085ddc-fde1-445e-b3e3-eee8dc6bb4c3">86.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930" decimals="-5" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMTgtMy0xLTEtODMyODU_05a4c941-7cc0-488c-b803-2c2ad9425904">78.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued liabilities and other current liabilities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="-5" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMTktMS0xLTEtODMyODU_84786132-d10b-422c-a293-d855d69a3742">56.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930" decimals="-5" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMTktMy0xLTEtODMyODU_59556402-58b5-4b6c-abda-78724b48b181">81.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current operating lease liabilities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="-5" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMjAtMS0xLTEtODMyODU_8b284683-3de5-4585-9df0-360d90b29790">3.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930" decimals="-5" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMjAtMy0xLTEtODMyODU_a8c761e1-994b-4fcc-91b8-7d0c7afb8fce">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current maturities of long-term debt</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="-5" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMjEtMS0xLTEtODMyODU_61345ed0-b117-42d0-8aaf-76d8f2a3d472">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930" decimals="-5" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMjEtMy0xLTEtODMyODU_526c473d-1f07-42ea-a158-cb2c69506c1a">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred revenues</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMjItMS0xLTEtODMyODU_ff8af601-cf2f-4e68-a822-c0ca72cb1a87">9.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMjItMy0xLTEtODMyODU_bf4f660a-992d-4136-9561-cefea8f4deb6">7.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="-5" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMjMtMS0xLTEtODMyODU_8ace73ae-0104-45cf-8765-358f9893de13">157.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930" decimals="-5" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMjMtMy0xLTEtODMyODU_39264b39-c8ad-4ec9-bdf1-4dfe7195730c">173.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term debt, net</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMjQtMS0xLTEtODMyODU_85afee47-b04c-4906-9b3a-07ee8bc6f025">440.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMjQtMy0xLTEtODMyODU_3fc88612-99a2-4e74-b1cb-ded020e2a7c9">412.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="-5" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMjUtMS0xLTEtODMyODU_bc203b78-ef6c-4d16-8d9a-9410c65a5c5a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930" decimals="-5" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMjUtMy0xLTEtODMyODU_9a182633-81b0-4e72-8a67-8e70b886e641">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="-5" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMjYtMS0xLTEtODMyODU_d80ba7ce-6bf6-4f33-99b3-45c51efc0138">17.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930" decimals="-5" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMjYtMy0xLTEtODMyODU_f97f5c59-653c-439c-abfa-b004080a46da">18.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liabilities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMjctMS0xLTEtODMyODU_957f4a64-a693-42ca-969e-52c1dfbdb846">39.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMjctMy0xLTEtODMyODU_a802a20f-66d8-44ca-a95f-0d066f6ce62e">33.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="-5" name="us-gaap:Liabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMjgtMS0xLTEtODMyODU_965ba6ef-b6be-4b08-838b-829dc67df372">655.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930" decimals="-5" name="us-gaap:Liabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMjgtMy0xLTEtODMyODU_c54b0b91-812b-4e53-a267-9b0b32f8ab2a">637.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stockholders' equity:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMzItMC0xLTEtODMyODUvdGV4dHJlZ2lvbjphNzYxM2I0YTJmNmY0YWRmOGRlNTA0OGY3NzhlYzUwZl8yMQ_3ad35c37-db37-4372-a31a-5fb835f6cd92"><ix:nonFraction unitRef="usdPerShare" contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMzItMC0xLTEtODMyODUvdGV4dHJlZ2lvbjphNzYxM2I0YTJmNmY0YWRmOGRlNTA0OGY3NzhlYzUwZl8yMQ_6fb1724a-de5b-466c-9d52-476838c6c3ca">.01</ix:nonFraction></ix:nonFraction> par value: <ix:nonFraction unitRef="shares" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMzItMC0xLTEtODMyODUvdGV4dHJlZ2lvbjphNzYxM2I0YTJmNmY0YWRmOGRlNTA0OGY3NzhlYzUwZl8zNQ_479e7934-f2bd-4659-b677-8f5fca3755f0"><ix:nonFraction unitRef="shares" contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMzItMC0xLTEtODMyODUvdGV4dHJlZ2lvbjphNzYxM2I0YTJmNmY0YWRmOGRlNTA0OGY3NzhlYzUwZl8zNQ_a33fb543-4e91-4461-b61d-3cf59c3fd8f9">20,000,000</ix:nonFraction></ix:nonFraction> shares authorized, <ix:nonFraction unitRef="shares" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMzItMC0xLTEtODMyODUvdGV4dHJlZ2lvbjphNzYxM2I0YTJmNmY0YWRmOGRlNTA0OGY3NzhlYzUwZl81Nw_06c50ba4-601e-4d63-83a7-0a0f836a8cc2"><ix:nonFraction unitRef="shares" contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMzItMC0xLTEtODMyODUvdGV4dHJlZ2lvbjphNzYxM2I0YTJmNmY0YWRmOGRlNTA0OGY3NzhlYzUwZl81Nw_936a4b50-e8ae-48ac-aa12-f5849e3963e2">none</ix:nonFraction></ix:nonFraction> issued</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="-5" name="us-gaap:PreferredStockValueOutstanding" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMzItMS0xLTEtODMyODU_e5f15c2b-71a4-4082-88eb-14b0211c9601">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930" decimals="-5" name="us-gaap:PreferredStockValueOutstanding" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMzItMy0xLTEtODMyODU_5fe024b4-124c-4282-bd24-27a0f9abb8da">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMzMtMC0xLTEtODMyODUvdGV4dHJlZ2lvbjpkMmE3ZjRmNmVjZWY0NWZjODI4MjcyZjA4YzE5Mjk1YV8xOA_30acc44f-3018-48fc-b54e-a83ac9303eda"><ix:nonFraction unitRef="usdPerShare" contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMzMtMC0xLTEtODMyODUvdGV4dHJlZ2lvbjpkMmE3ZjRmNmVjZWY0NWZjODI4MjcyZjA4YzE5Mjk1YV8xOA_54853edf-643e-4153-b75f-ca115e8de2a3">.01</ix:nonFraction></ix:nonFraction> par value: <ix:nonFraction unitRef="shares" contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMzMtMC0xLTEtODMyODUvdGV4dHJlZ2lvbjpkMmE3ZjRmNmVjZWY0NWZjODI4MjcyZjA4YzE5Mjk1YV8zMg_754d9898-971e-4c68-9820-4549ce172d15"><ix:nonFraction unitRef="shares" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMzMtMC0xLTEtODMyODUvdGV4dHJlZ2lvbjpkMmE3ZjRmNmVjZWY0NWZjODI4MjcyZjA4YzE5Mjk1YV8zMg_790cb598-8cca-4733-8242-47396cdb5ac1">150,000,000</ix:nonFraction></ix:nonFraction> shares authorized</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:17.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares issued and outstanding: <ix:nonFraction unitRef="shares" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMzUtMC0xLTEtODMyODUvdGV4dHJlZ2lvbjplMWIxM2FhYzE0Yzc0YzlhYTYyYWEyZDk2NWNmY2NkZl8zNQ_6c60afe9-2e0f-43c3-9305-bec02f420b35"><ix:nonFraction unitRef="shares" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMzUtMC0xLTEtODMyODUvdGV4dHJlZ2lvbjplMWIxM2FhYzE0Yzc0YzlhYTYyYWEyZDk2NWNmY2NkZl8zNQ_8581c80a-bd50-4a7f-a36b-d13c116f2d5e">40,087,100</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMzUtMC0xLTEtODMyODUvdGV4dHJlZ2lvbjplMWIxM2FhYzE0Yzc0YzlhYTYyYWEyZDk2NWNmY2NkZl80Mg_3b80a620-5453-4e82-aa9d-902e80b90abe"><ix:nonFraction unitRef="shares" contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMzUtMC0xLTEtODMyODUvdGV4dHJlZ2lvbjplMWIxM2FhYzE0Yzc0YzlhYTYyYWEyZDk2NWNmY2NkZl80Mg_47d62fc0-ec51-4afc-bf08-c745e6fe3837">40,085,126</ix:nonFraction></ix:nonFraction> at December&#160;30, 2022 and September&#160;30, 2022, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="-5" name="us-gaap:CommonStockValueOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMzUtMS0xLTEtODMyODU_64f39575-0c8b-42e0-a7e4-56d4fbaac5b8">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930" decimals="-5" name="us-gaap:CommonStockValueOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMzUtMy0xLTEtODMyODU_7c4a2dda-26b1-4567-b1bf-8348d2fc8c04">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="-5" name="us-gaap:AdditionalPaidInCapital" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMzctMS0xLTEtODMyODU_80bbe91e-2101-471b-a9b2-f1547d55553b">437.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930" decimals="-5" name="us-gaap:AdditionalPaidInCapital" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMzctMy0xLTEtODMyODU_7aab8fc0-8dec-4ad7-8795-03f29261333f">469.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMzgtMS0xLTEtODMyODU_a1a8cf67-dacf-4dbb-b678-9980978f8eec">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMzgtMy0xLTEtODMyODU_9b19c509-7eb0-4c99-955d-0c5b5760e1aa">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="-5" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMzktMS0xLTEtODMyODU_8a179a41-8cbb-4b56-b5df-3ecd5f02cbd7">73.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930" decimals="-5" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMzktMy0xLTEtODMyODU_3e74f6f1-bbea-45ac-bb68-6a2cc33cd2b8">63.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Varex stockholders' equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfNDAtMS0xLTEtODMyODU_adf53036-556b-4618-8180-aefa8167dc67">511.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfNDAtMy0xLTEtODMyODU_e52e0f73-cbc9-46b4-9433-61c0bcf48fce">533.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="-5" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfNDEtMS0xLTEtODMyODU_9c509ca6-70df-4943-8948-aff37e7e9b83">13.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930" decimals="-5" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfNDEtMy0xLTEtODMyODU_fca16161-46d2-44c3-8e54-6b17ac0ecc50">13.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total stockholders' equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfNDItMS0xLTEtODMyODU_73d94111-56a2-4fe4-bfd2-892e0befa826">525.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfNDItMy0xLTEtODMyODU_8b9a046f-50e0-4a5b-b6cb-6587c1d9829e">546.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total liabilities and stockholders' equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="-5" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfNDMtMS0xLTEtODMyODU_695812ea-3bf9-4b89-8836-1dd3be7e9f4f">1,180.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930" decimals="-5" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfNDMtMy0xLTEtODMyODU_aad70108-bb8b-469e-ab69-9e1019b59ecb">1,184.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying Notes to the Condensed Consolidated Financial Statements.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="i4ab573909cb849339357193b017c7d37_25"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VAREX IMAGING CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.650%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.261%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.705%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.017%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="45" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended December 30, 2022</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Additional Paid-in Capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" rowspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Income</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Varex Equity</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Noncontrolling Interests</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Stockholders' Equity</span></td></tr><tr style="height:17pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2c89eaed981a4d4a95584393e114c1a2_I20220930" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOjkwN2JhZTc1NjE4MDRhZGNhZjM3ZDc0NzQ5NGRmYWQ3L3RhYmxlcmFuZ2U6OTA3YmFlNzU2MTgwNGFkY2FmMzdkNzQ3NDk0ZGZhZDdfNC0xLTEtMS04MzI4NQ_48ef3eba-d267-4353-a293-b09861c928cc">40.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c89eaed981a4d4a95584393e114c1a2_I20220930" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOjkwN2JhZTc1NjE4MDRhZGNhZjM3ZDc0NzQ5NGRmYWQ3L3RhYmxlcmFuZ2U6OTA3YmFlNzU2MTgwNGFkY2FmMzdkNzQ3NDk0ZGZhZDdfNC0zLTEtMS04MzI4NQ_9e6fcb9a-8661-44d0-b067-e4ab47f2e5b4">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37e38c715c44456aaf8bc01ef2b73582_I20220930" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOjkwN2JhZTc1NjE4MDRhZGNhZjM3ZDc0NzQ5NGRmYWQ3L3RhYmxlcmFuZ2U6OTA3YmFlNzU2MTgwNGFkY2FmMzdkNzQ3NDk0ZGZhZDdfNC01LTEtMS04MzI4NQ_b1e7d45f-8a86-4a5d-8fc3-7070e9d61783">469.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i946a5f2b729e4134a3046873942feac2_I20220930" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOjkwN2JhZTc1NjE4MDRhZGNhZjM3ZDc0NzQ5NGRmYWQ3L3RhYmxlcmFuZ2U6OTA3YmFlNzU2MTgwNGFkY2FmMzdkNzQ3NDk0ZGZhZDdfNC05LTEtMS04MzI4NQ_24725990-ae32-4d41-995e-3e2ebf4c6a6e">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3cbcd23a7804aebb45bbf33e9654051_I20220930" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOjkwN2JhZTc1NjE4MDRhZGNhZjM3ZDc0NzQ5NGRmYWQ3L3RhYmxlcmFuZ2U6OTA3YmFlNzU2MTgwNGFkY2FmMzdkNzQ3NDk0ZGZhZDdfNC0xMS0xLTEtODMyODU_82cdf6e9-5b36-436c-92ef-2eeb36e246e7">63.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90a3dedd81b74cfb9d7bf05623f3ea1b_I20220930" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOjkwN2JhZTc1NjE4MDRhZGNhZjM3ZDc0NzQ5NGRmYWQ3L3RhYmxlcmFuZ2U6OTA3YmFlNzU2MTgwNGFkY2FmMzdkNzQ3NDk0ZGZhZDdfNC0xMy0xLTEtODMyODU_d8a2feae-6657-4545-ab20-9f20cd1f57e5">533.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i964e8837dab84683972daafc904bc290_I20220930" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOjkwN2JhZTc1NjE4MDRhZGNhZjM3ZDc0NzQ5NGRmYWQ3L3RhYmxlcmFuZ2U6OTA3YmFlNzU2MTgwNGFkY2FmMzdkNzQ3NDk0ZGZhZDdfNC0xNS0xLTEtODMyODU_2d29c43a-924e-4105-a858-14db0f205a24">13.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOjkwN2JhZTc1NjE4MDRhZGNhZjM3ZDc0NzQ5NGRmYWQ3L3RhYmxlcmFuZ2U6OTA3YmFlNzU2MTgwNGFkY2FmMzdkNzQ3NDk0ZGZhZDdfNC0xNy0xLTEtODMyODU_30122f0b-5868-4bbe-ba16-20f19038f4a7">546.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOjkwN2JhZTc1NjE4MDRhZGNhZjM3ZDc0NzQ5NGRmYWQ3L3RhYmxlcmFuZ2U6OTA3YmFlNzU2MTgwNGFkY2FmMzdkNzQ3NDk0ZGZhZDdfNS0wLTEtMS04MzI4NQ_91a4cd1c-cf54-4eef-9557-9e99df59c2df">Cumulative effect of accounting change</span></span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5bbd4632766b486d8dd37f35093df0cb_I20220930" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOjkwN2JhZTc1NjE4MDRhZGNhZjM3ZDc0NzQ5NGRmYWQ3L3RhYmxlcmFuZ2U6OTA3YmFlNzU2MTgwNGFkY2FmMzdkNzQ3NDk0ZGZhZDdfNS01LTEtMS04MzI4NQ_622b11f1-446a-4377-a560-f102a1255a16">34.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic809286b91a146ce974c75d48a3c4517_I20220930" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOjkwN2JhZTc1NjE4MDRhZGNhZjM3ZDc0NzQ5NGRmYWQ3L3RhYmxlcmFuZ2U6OTA3YmFlNzU2MTgwNGFkY2FmMzdkNzQ3NDk0ZGZhZDdfNS0xMS0xLTEtODMyODU_bbbab542-0c8e-4ccd-89b1-a9a9c0d41c18">6.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a5ca132807b4f1596b0b257c552596b_I20220930" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOjkwN2JhZTc1NjE4MDRhZGNhZjM3ZDc0NzQ5NGRmYWQ3L3RhYmxlcmFuZ2U6OTA3YmFlNzU2MTgwNGFkY2FmMzdkNzQ3NDk0ZGZhZDdfNS0xMy0xLTEtODMyODU_23f8d301-1759-4511-a2ea-2707284b0a12">28.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic28d182c3ed64ba2aebe358831333632_I20220930" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOjkwN2JhZTc1NjE4MDRhZGNhZjM3ZDc0NzQ5NGRmYWQ3L3RhYmxlcmFuZ2U6OTA3YmFlNzU2MTgwNGFkY2FmMzdkNzQ3NDk0ZGZhZDdfNS0xNy0xLTEtODMyODU_c542c8d3-8d39-40d7-bafa-380ae0daff9a">28.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i374334f7b3304f1d936a010e369e5949_D20221001-20221230" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOjkwN2JhZTc1NjE4MDRhZGNhZjM3ZDc0NzQ5NGRmYWQ3L3RhYmxlcmFuZ2U6OTA3YmFlNzU2MTgwNGFkY2FmMzdkNzQ3NDk0ZGZhZDdfNi0xMS0xLTEtOTkzODY_abf3f842-cd32-4eac-8386-7ce93cab2fb1">3.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bb651a6c0ed468da0c7878dd6d514ef_D20221001-20221230" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOjkwN2JhZTc1NjE4MDRhZGNhZjM3ZDc0NzQ5NGRmYWQ3L3RhYmxlcmFuZ2U6OTA3YmFlNzU2MTgwNGFkY2FmMzdkNzQ3NDk0ZGZhZDdfNi0xMy0xLTEtOTkzODY_9a660abd-60e3-40a5-a3cd-a3cf7ab343ac">3.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i689d7483ede3410593772cdd559784d3_D20221001-20221230" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOjkwN2JhZTc1NjE4MDRhZGNhZjM3ZDc0NzQ5NGRmYWQ3L3RhYmxlcmFuZ2U6OTA3YmFlNzU2MTgwNGFkY2FmMzdkNzQ3NDk0ZGZhZDdfNi0xNS0xLTEtOTkzODY_319c1146-b420-4a1f-a78a-077dd8e28626">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOjkwN2JhZTc1NjE4MDRhZGNhZjM3ZDc0NzQ5NGRmYWQ3L3RhYmxlcmFuZ2U6OTA3YmFlNzU2MTgwNGFkY2FmMzdkNzQ3NDk0ZGZhZDdfNi0xNy0xLTEtOTkzODY_3b77ed8f-d890-4a6e-8f7f-5063911ff009">3.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib43fdaa870e547d083de4f40fcef4c40_D20221001-20221230" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOjkwN2JhZTc1NjE4MDRhZGNhZjM3ZDc0NzQ5NGRmYWQ3L3RhYmxlcmFuZ2U6OTA3YmFlNzU2MTgwNGFkY2FmMzdkNzQ3NDk0ZGZhZDdfMTAtNS0xLTEtODMyODU_ccce47a8-5eae-4718-a077-504d05c63a50">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bb651a6c0ed468da0c7878dd6d514ef_D20221001-20221230" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOjkwN2JhZTc1NjE4MDRhZGNhZjM3ZDc0NzQ5NGRmYWQ3L3RhYmxlcmFuZ2U6OTA3YmFlNzU2MTgwNGFkY2FmMzdkNzQ3NDk0ZGZhZDdfMTAtMTMtMS0xLTgzMjg1_6673dabb-d966-4e9d-bcf1-599a0a935589">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOjkwN2JhZTc1NjE4MDRhZGNhZjM3ZDc0NzQ5NGRmYWQ3L3RhYmxlcmFuZ2U6OTA3YmFlNzU2MTgwNGFkY2FmMzdkNzQ3NDk0ZGZhZDdfMTAtMTctMS0xLTgzMjg1_811db44e-39f7-494f-830f-bf0523ada486">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib43fdaa870e547d083de4f40fcef4c40_D20221001-20221230" decimals="-5" sign="-" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOjkwN2JhZTc1NjE4MDRhZGNhZjM3ZDc0NzQ5NGRmYWQ3L3RhYmxlcmFuZ2U6OTA3YmFlNzU2MTgwNGFkY2FmMzdkNzQ3NDk0ZGZhZDdfMjEtNS0xLTEtODMyODU_9025842b-342f-4fbc-ac02-9646d0ffd1cd">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i374334f7b3304f1d936a010e369e5949_D20221001-20221230" decimals="-5" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOjkwN2JhZTc1NjE4MDRhZGNhZjM3ZDc0NzQ5NGRmYWQ3L3RhYmxlcmFuZ2U6OTA3YmFlNzU2MTgwNGFkY2FmMzdkNzQ3NDk0ZGZhZDdfMjEtMTEtMS0xLTgzMjg1_4547f442-018c-4da5-bae1-59b2d9ae2472">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i689d7483ede3410593772cdd559784d3_D20221001-20221230" decimals="-5" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOjkwN2JhZTc1NjE4MDRhZGNhZjM3ZDc0NzQ5NGRmYWQ3L3RhYmxlcmFuZ2U6OTA3YmFlNzU2MTgwNGFkY2FmMzdkNzQ3NDk0ZGZhZDdfMjEtMTUtMS0xLTgzMjg1_4de2f759-d12a-420b-9a02-50405cc9f24a">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOjkwN2JhZTc1NjE4MDRhZGNhZjM3ZDc0NzQ5NGRmYWQ3L3RhYmxlcmFuZ2U6OTA3YmFlNzU2MTgwNGFkY2FmMzdkNzQ3NDk0ZGZhZDdfMjEtMTctMS0xLTgzMjg1_e30ff16d-bf22-458c-8661-97951a268abd">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0fa88bead9c943b7807d5810cd828850_I20221230" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOjkwN2JhZTc1NjE4MDRhZGNhZjM3ZDc0NzQ5NGRmYWQ3L3RhYmxlcmFuZ2U6OTA3YmFlNzU2MTgwNGFkY2FmMzdkNzQ3NDk0ZGZhZDdfMjItMS0xLTEtODMyODU_99bd234d-ec8c-44ed-bafa-4834faefeeff">40.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fa88bead9c943b7807d5810cd828850_I20221230" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOjkwN2JhZTc1NjE4MDRhZGNhZjM3ZDc0NzQ5NGRmYWQ3L3RhYmxlcmFuZ2U6OTA3YmFlNzU2MTgwNGFkY2FmMzdkNzQ3NDk0ZGZhZDdfMjItMy0xLTEtODMyODU_43cc90f6-d3bb-4b2d-ade4-e528fc08fc16">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4eb681e97f2345679fdea50eb3b491d1_I20221230" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOjkwN2JhZTc1NjE4MDRhZGNhZjM3ZDc0NzQ5NGRmYWQ3L3RhYmxlcmFuZ2U6OTA3YmFlNzU2MTgwNGFkY2FmMzdkNzQ3NDk0ZGZhZDdfMjItNS0xLTEtODMyODU_acc9a956-6d7b-4d72-9fd9-91ddbe00bfb8">437.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2322eead975b4c1dbc547b6270fb8adf_I20221230" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOjkwN2JhZTc1NjE4MDRhZGNhZjM3ZDc0NzQ5NGRmYWQ3L3RhYmxlcmFuZ2U6OTA3YmFlNzU2MTgwNGFkY2FmMzdkNzQ3NDk0ZGZhZDdfMjItOS0xLTEtODMyODU_bb7212f5-f6b4-41bb-9e52-5527ec893929">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e30707026c4e429d7a8e186437ad12_I20221230" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOjkwN2JhZTc1NjE4MDRhZGNhZjM3ZDc0NzQ5NGRmYWQ3L3RhYmxlcmFuZ2U6OTA3YmFlNzU2MTgwNGFkY2FmMzdkNzQ3NDk0ZGZhZDdfMjItMTEtMS0xLTgzMjg1_fe42b13a-c25c-430a-bfc4-94395a2d2084">73.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42e660b69d2d46dcb0355f9671f5a578_I20221230" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOjkwN2JhZTc1NjE4MDRhZGNhZjM3ZDc0NzQ5NGRmYWQ3L3RhYmxlcmFuZ2U6OTA3YmFlNzU2MTgwNGFkY2FmMzdkNzQ3NDk0ZGZhZDdfMjItMTMtMS0xLTgzMjg1_9ab749f6-1228-437b-8dac-80a7514f3bf3">511.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5126bc5003f942bf8310df4804290940_I20221230" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOjkwN2JhZTc1NjE4MDRhZGNhZjM3ZDc0NzQ5NGRmYWQ3L3RhYmxlcmFuZ2U6OTA3YmFlNzU2MTgwNGFkY2FmMzdkNzQ3NDk0ZGZhZDdfMjItMTUtMS0xLTgzMjg1_e8a5a40e-fc50-4ab8-86d5-d38062325c65">13.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOjkwN2JhZTc1NjE4MDRhZGNhZjM3ZDc0NzQ5NGRmYWQ3L3RhYmxlcmFuZ2U6OTA3YmFlNzU2MTgwNGFkY2FmMzdkNzQ3NDk0ZGZhZDdfMjItMTctMS0xLTgzMjg1_4f5f8fa6-6851-43ff-a741-1652f2e6c123">525.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-right:-18pt;text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.650%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.261%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.705%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.017%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="45" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended December 31, 2021</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Additional Paid-in Capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" rowspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Varex Equity</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Noncontrolling Interests</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Stockholders' Equity</span></td></tr><tr style="height:17pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">October 1, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ida04e40f3374405faf2b86c9faa3beae_I20211001" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOmRjNDIzMzk1MjljNDQyMjVhZjIyMzkxNTM4YzNjYjczL3RhYmxlcmFuZ2U6ZGM0MjMzOTUyOWM0NDIyNWFmMjIzOTE1MzhjM2NiNzNfNC0xLTEtMS04MzI4NQ_8d48188e-79e4-415a-854d-c33df7624e0a">39.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida04e40f3374405faf2b86c9faa3beae_I20211001" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOmRjNDIzMzk1MjljNDQyMjVhZjIyMzkxNTM4YzNjYjczL3RhYmxlcmFuZ2U6ZGM0MjMzOTUyOWM0NDIyNWFmMjIzOTE1MzhjM2NiNzNfNC0zLTEtMS04MzI4NQ_f78b108c-a3bc-4b7b-ab88-73c11a229668">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3aff7d47dfed4780bef288e0efb8de73_I20211001" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOmRjNDIzMzk1MjljNDQyMjVhZjIyMzkxNTM4YzNjYjczL3RhYmxlcmFuZ2U6ZGM0MjMzOTUyOWM0NDIyNWFmMjIzOTE1MzhjM2NiNzNfNC01LTEtMS04MzI4NQ_cb9fbb61-ac6c-4f5f-9e1d-6584aa04c299">449.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id25e5cef067540a2b3d17a01b52d1080_I20211001" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOmRjNDIzMzk1MjljNDQyMjVhZjIyMzkxNTM4YzNjYjczL3RhYmxlcmFuZ2U6ZGM0MjMzOTUyOWM0NDIyNWFmMjIzOTE1MzhjM2NiNzNfNC05LTEtMS04MzI4NQ_e5400692-0ed8-45ee-b8eb-7adc8f5fe82b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id72ff47fc82e4e879dbaa26a295898ce_I20211001" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOmRjNDIzMzk1MjljNDQyMjVhZjIyMzkxNTM4YzNjYjczL3RhYmxlcmFuZ2U6ZGM0MjMzOTUyOWM0NDIyNWFmMjIzOTE1MzhjM2NiNzNfNC0xMS0xLTEtODMyODU_b0b8d345-94b9-403e-90b5-165cabca035b">33.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15fe2e613bae4c76beaddadbd8d8e5e3_I20211001" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOmRjNDIzMzk1MjljNDQyMjVhZjIyMzkxNTM4YzNjYjczL3RhYmxlcmFuZ2U6ZGM0MjMzOTUyOWM0NDIyNWFmMjIzOTE1MzhjM2NiNzNfNC0xMy0xLTEtODMyODU_c8d8fdb1-bea2-46ab-9765-c97c8d6b10db">483.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ef993557e48462d926de8e9ccea2f7a_I20211001" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOmRjNDIzMzk1MjljNDQyMjVhZjIyMzkxNTM4YzNjYjczL3RhYmxlcmFuZ2U6ZGM0MjMzOTUyOWM0NDIyNWFmMjIzOTE1MzhjM2NiNzNfNC0xNS0xLTEtODMyODU_f1dfe87c-8298-45e7-8c57-36af24c28ee0">13.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i504e59968786494c96b1e46f5375a17d_I20211001" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOmRjNDIzMzk1MjljNDQyMjVhZjIyMzkxNTM4YzNjYjczL3RhYmxlcmFuZ2U6ZGM0MjMzOTUyOWM0NDIyNWFmMjIzOTE1MzhjM2NiNzNfNC0xNy0xLTEtODMyODU_f366655b-1bdd-4d32-925a-f7c29bbdb24b">496.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9fa7e713d284aa28f3ce117acb47880_D20211002-20211231" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOmRjNDIzMzk1MjljNDQyMjVhZjIyMzkxNTM4YzNjYjczL3RhYmxlcmFuZ2U6ZGM0MjMzOTUyOWM0NDIyNWFmMjIzOTE1MzhjM2NiNzNfNi0xMS0xLTEtODMyODU_55e495a1-07d5-417b-85e0-178707d8d4d1">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief1f6f644eea437e9b8e1e8aa59dc455_D20211002-20211231" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOmRjNDIzMzk1MjljNDQyMjVhZjIyMzkxNTM4YzNjYjczL3RhYmxlcmFuZ2U6ZGM0MjMzOTUyOWM0NDIyNWFmMjIzOTE1MzhjM2NiNzNfNi0xMy0xLTEtODMyODU_cfae9143-8855-419d-b1ff-60d24565d6e4">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6692c6c33bf48afbda409fe7c7691e3_D20211002-20211231" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOmRjNDIzMzk1MjljNDQyMjVhZjIyMzkxNTM4YzNjYjczL3RhYmxlcmFuZ2U6ZGM0MjMzOTUyOWM0NDIyNWFmMjIzOTE1MzhjM2NiNzNfNi0xNS0xLTEtODMyODU_99a66d8d-4c38-428c-876b-d357518efc83">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOmRjNDIzMzk1MjljNDQyMjVhZjIyMzkxNTM4YzNjYjczL3RhYmxlcmFuZ2U6ZGM0MjMzOTUyOWM0NDIyNWFmMjIzOTE1MzhjM2NiNzNfNi0xNy0xLTEtODMyODU_51ef5311-0409-4e9b-8ed2-7ea0700970dd">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i66a2015d4ada4d51b8273eb10babd3c7_D20211002-20211231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOmRjNDIzMzk1MjljNDQyMjVhZjIyMzkxNTM4YzNjYjczL3RhYmxlcmFuZ2U6ZGM0MjMzOTUyOWM0NDIyNWFmMjIzOTE1MzhjM2NiNzNfNy0xLTEtMS04MzI4NQ_ca5f9d66-284b-4c3a-91e1-51f371e8870a">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484320e6452e4a568aeaaf3e75831c12_D20211002-20211231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOmRjNDIzMzk1MjljNDQyMjVhZjIyMzkxNTM4YzNjYjczL3RhYmxlcmFuZ2U6ZGM0MjMzOTUyOWM0NDIyNWFmMjIzOTE1MzhjM2NiNzNfNy01LTEtMS04MzI4NQ_1902b903-de2a-4d0c-8795-fc3fd690045b">3.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief1f6f644eea437e9b8e1e8aa59dc455_D20211002-20211231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOmRjNDIzMzk1MjljNDQyMjVhZjIyMzkxNTM4YzNjYjczL3RhYmxlcmFuZ2U6ZGM0MjMzOTUyOWM0NDIyNWFmMjIzOTE1MzhjM2NiNzNfNy0xMy0xLTEtODMyODU_cf1c35ac-f67f-4e8f-ab54-f5015da013ae">3.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOmRjNDIzMzk1MjljNDQyMjVhZjIyMzkxNTM4YzNjYjczL3RhYmxlcmFuZ2U6ZGM0MjMzOTUyOWM0NDIyNWFmMjIzOTE1MzhjM2NiNzNfNy0xNy0xLTEtODMyODU_dd2fce91-bdb8-4b09-b973-d3694024b723">3.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock issued under employee stock purchase plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i66a2015d4ada4d51b8273eb10babd3c7_D20211002-20211231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOmRjNDIzMzk1MjljNDQyMjVhZjIyMzkxNTM4YzNjYjczL3RhYmxlcmFuZ2U6ZGM0MjMzOTUyOWM0NDIyNWFmMjIzOTE1MzhjM2NiNzNfMTAtMS0xLTEtODMyODU_58e8c33e-e69b-4cde-bc75-eb7f7ec23db2">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484320e6452e4a568aeaaf3e75831c12_D20211002-20211231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOmRjNDIzMzk1MjljNDQyMjVhZjIyMzkxNTM4YzNjYjczL3RhYmxlcmFuZ2U6ZGM0MjMzOTUyOWM0NDIyNWFmMjIzOTE1MzhjM2NiNzNfMTAtNS0xLTEtODMyODU_5a56b701-196f-4313-96e5-c5283a47109c">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief1f6f644eea437e9b8e1e8aa59dc455_D20211002-20211231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOmRjNDIzMzk1MjljNDQyMjVhZjIyMzkxNTM4YzNjYjczL3RhYmxlcmFuZ2U6ZGM0MjMzOTUyOWM0NDIyNWFmMjIzOTE1MzhjM2NiNzNfMTAtMTMtMS0xLTgzMjg1_8da80004-1c30-450f-aa9d-bb5ca14d16c5">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOmRjNDIzMzk1MjljNDQyMjVhZjIyMzkxNTM4YzNjYjczL3RhYmxlcmFuZ2U6ZGM0MjMzOTUyOWM0NDIyNWFmMjIzOTE1MzhjM2NiNzNfMTAtMTctMS0xLTgzMjg1_d27496dd-3095-4ce2-9c56-34f6c9c02c29">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484320e6452e4a568aeaaf3e75831c12_D20211002-20211231" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOmRjNDIzMzk1MjljNDQyMjVhZjIyMzkxNTM4YzNjYjczL3RhYmxlcmFuZ2U6ZGM0MjMzOTUyOWM0NDIyNWFmMjIzOTE1MzhjM2NiNzNfMTEtNS0xLTEtODMyODU_4cce9f7e-b92c-417d-9c48-e3b86851e95b">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief1f6f644eea437e9b8e1e8aa59dc455_D20211002-20211231" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOmRjNDIzMzk1MjljNDQyMjVhZjIyMzkxNTM4YzNjYjczL3RhYmxlcmFuZ2U6ZGM0MjMzOTUyOWM0NDIyNWFmMjIzOTE1MzhjM2NiNzNfMTEtMTMtMS0xLTgzMjg1_e54fa14a-454e-4bdb-8379-a399c5afa221">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOmRjNDIzMzk1MjljNDQyMjVhZjIyMzkxNTM4YzNjYjczL3RhYmxlcmFuZ2U6ZGM0MjMzOTUyOWM0NDIyNWFmMjIzOTE1MzhjM2NiNzNfMTEtMTctMS0xLTgzMjg1_0703576f-7ca5-4125-8528-c84b0ced415d">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia7cd9a82501843e7840128314d4836e4_D20211002-20211231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOmRjNDIzMzk1MjljNDQyMjVhZjIyMzkxNTM4YzNjYjczL3RhYmxlcmFuZ2U6ZGM0MjMzOTUyOWM0NDIyNWFmMjIzOTE1MzhjM2NiNzNfMTYtOS0xLTEtODMyODU_eb38b82a-62af-4e4d-9bc0-4fbeaa6c46ea">0.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief1f6f644eea437e9b8e1e8aa59dc455_D20211002-20211231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOmRjNDIzMzk1MjljNDQyMjVhZjIyMzkxNTM4YzNjYjczL3RhYmxlcmFuZ2U6ZGM0MjMzOTUyOWM0NDIyNWFmMjIzOTE1MzhjM2NiNzNfMTYtMTMtMS0xLTgzMjg1_8e99539b-97cc-452d-b35e-be639f9befe4">0.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOmRjNDIzMzk1MjljNDQyMjVhZjIyMzkxNTM4YzNjYjczL3RhYmxlcmFuZ2U6ZGM0MjMzOTUyOWM0NDIyNWFmMjIzOTE1MzhjM2NiNzNfMTYtMTctMS0xLTgzMjg1_d6972efc-3675-4f19-9c95-de4ec060ac5c">0.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib6692c6c33bf48afbda409fe7c7691e3_D20211002-20211231" decimals="-5" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOmRjNDIzMzk1MjljNDQyMjVhZjIyMzkxNTM4YzNjYjczL3RhYmxlcmFuZ2U6ZGM0MjMzOTUyOWM0NDIyNWFmMjIzOTE1MzhjM2NiNzNfMTgtMTUtMS0xLTgzMjg1_7f411c80-361c-4c52-a991-5163475ff3a1">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOmRjNDIzMzk1MjljNDQyMjVhZjIyMzkxNTM4YzNjYjczL3RhYmxlcmFuZ2U6ZGM0MjMzOTUyOWM0NDIyNWFmMjIzOTE1MzhjM2NiNzNfMTgtMTctMS0xLTgzMjg1_efb9029c-ef93-4c55-b2b6-0c07a679d5c6">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic84d7ad4df444a5ba010f733b23db58e_I20211231" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOmRjNDIzMzk1MjljNDQyMjVhZjIyMzkxNTM4YzNjYjczL3RhYmxlcmFuZ2U6ZGM0MjMzOTUyOWM0NDIyNWFmMjIzOTE1MzhjM2NiNzNfMTktMS0xLTEtODMyODU_e91970a9-7c04-40f8-85e0-c5590e27d9ac">39.6</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic84d7ad4df444a5ba010f733b23db58e_I20211231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOmRjNDIzMzk1MjljNDQyMjVhZjIyMzkxNTM4YzNjYjczL3RhYmxlcmFuZ2U6ZGM0MjMzOTUyOWM0NDIyNWFmMjIzOTE1MzhjM2NiNzNfMTktMy0xLTEtODMyODU_b482aaa7-6c2d-443f-b2a4-a2507e3caa22">0.4</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f85b75047844e478507cd67afb10862_I20211231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOmRjNDIzMzk1MjljNDQyMjVhZjIyMzkxNTM4YzNjYjczL3RhYmxlcmFuZ2U6ZGM0MjMzOTUyOWM0NDIyNWFmMjIzOTE1MzhjM2NiNzNfMTktNS0xLTEtODMyODU_f03f38f3-edef-49ba-a590-1452bbd5b693">458.0</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f1790e7c49848f68d840ef25c469adf_I20211231" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOmRjNDIzMzk1MjljNDQyMjVhZjIyMzkxNTM4YzNjYjczL3RhYmxlcmFuZ2U6ZGM0MjMzOTUyOWM0NDIyNWFmMjIzOTE1MzhjM2NiNzNfMTktOS0xLTEtODMyODU_27587a0a-b956-4317-9b06-1fd0c4bedbe7">0.5</ix:nonFraction>)</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia50a700a64ae4856ba15300cae774337_I20211231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOmRjNDIzMzk1MjljNDQyMjVhZjIyMzkxNTM4YzNjYjczL3RhYmxlcmFuZ2U6ZGM0MjMzOTUyOWM0NDIyNWFmMjIzOTE1MzhjM2NiNzNfMTktMTEtMS0xLTgzMjg1_17c48073-8b97-4ece-b5d8-2c4b8da7b532">34.9</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3cba6759b1f4b609890dbb223fb7ddb_I20211231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOmRjNDIzMzk1MjljNDQyMjVhZjIyMzkxNTM4YzNjYjczL3RhYmxlcmFuZ2U6ZGM0MjMzOTUyOWM0NDIyNWFmMjIzOTE1MzhjM2NiNzNfMTktMTMtMS0xLTgzMjg1_97094291-ab43-4123-9927-fa20a6cca61c">492.8</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7886797dc72447689ab1203828cf4a8a_I20211231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOmRjNDIzMzk1MjljNDQyMjVhZjIyMzkxNTM4YzNjYjczL3RhYmxlcmFuZ2U6ZGM0MjMzOTUyOWM0NDIyNWFmMjIzOTE1MzhjM2NiNzNfMTktMTUtMS0xLTgzMjg1_bbaa6e0c-36c7-4bf5-b1dc-ca4f7d10f90f">13.3</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4026880a25c245b7ae7af90aa89cf31c_I20211231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOmRjNDIzMzk1MjljNDQyMjVhZjIyMzkxNTM4YzNjYjczL3RhYmxlcmFuZ2U6ZGM0MjMzOTUyOWM0NDIyNWFmMjIzOTE1MzhjM2NiNzNfMTktMTctMS0xLTgzMjg1_aaf2b365-473b-4683-af58-5ac991cfe946">506.1</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;padding-left:9pt;padding-right:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying Notes to the Condensed Consolidated Financial Statements.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="i4ab573909cb849339357193b017c7d37_31"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VAREX IMAGING CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.762%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMy0xLTEtMS04MzI4NQ_45671c88-2f1d-4ae6-ae1b-af16da8ac15e">3.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMy0zLTEtMS04MzI4NQ_44fe308a-12f3-428f-b390-0087f7077cd8">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash (used in) provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfNS0xLTEtMS04MzI4NQ_7d188044-cc90-44ac-8a0f-2a7838036f1f">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfNS0zLTEtMS04MzI4NQ_cdd8b7e7-92e8-4a1f-ab94-9f11df31e529">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfNy0xLTEtMS04MzI4NQ_93a02890-3967-4df2-bca3-ddb92d79eecc">4.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfNy0zLTEtMS04MzI4NQ_48137a78-56ef-44c5-b6f3-a0ac1b4ec1a2">4.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfOC0xLTEtMS04MzI4NQ_b521c72a-db23-472c-9066-8c1a5d8ea758">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfOC0zLTEtMS04MzI4NQ_ccda35fb-d8ed-4fd7-a33f-def8fea261e0">3.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfOS0xLTEtMS04MzI4NQ_ef80d477-d643-4d0b-9a39-5cb44a197c2d">0.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfOS0zLTEtMS04MzI4NQ_a47db55a-1abc-4e63-8124-cbd3b397a52a">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Income) loss from equity method investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMTAtMS0xLTEtODMyODU_7a70e41b-065a-41af-be93-270691c3e181">1.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMTAtMy0xLTEtODMyODU_21d130af-7c03-4cd1-8e7b-afa2b167ee20">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of deferred loan costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" sign="-" name="us-gaap:AmortizationOfDeferredLoanOriginationFeesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMTItMS0xLTEtODMyODU_d9eaadc6-844b-4abf-8332-adbe10024753">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" sign="-" name="us-gaap:AmortizationOfDeferredLoanOriginationFeesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMTItMy0xLTEtODMyODU_efa72033-d922-4dff-84dc-6e155abf24e8">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventory write-down</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="us-gaap:InventoryWriteDown" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMTUtMS0xLTEtODMyODU_aa9b671f-8148-46ed-a1dc-3e0998391ad1">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="us-gaap:InventoryWriteDown" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMTUtMy0xLTEtODMyODU_86e925e1-e1e8-4845-ad99-85ad579dd28b">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on operating lease abandonment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="us-gaap:GainLossOnTerminationOfLease" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMTYtMS0xLTEtODMyODU_bc37aa2b-e3f7-4797-a799-44ec79340915">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" sign="-" name="us-gaap:GainLossOnTerminationOfLease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMTYtMy0xLTEtODMyODU_50939a91-3ff7-4107-93be-8198f145639f">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="us-gaap:OtherNoncashIncomeExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMTctMS0xLTEtODMyODU_6e4a448f-e038-43aa-bb0e-9f750d56c563">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMTctMy0xLTEtODMyODU_a5de8e54-580c-496b-a610-4915adfeb093">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in assets and liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMTktMS0xLTEtODMyODU_ad920c1c-aed6-4220-ad0c-ce484dd92925">15.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMTktMy0xLTEtODMyODU_876b99cf-6c35-4da3-b1d5-515e4a3985ad">28.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMjAtMS0xLTEtODMyODU_977f509e-14b9-4eb8-8516-f1c6475de06e">18.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMjAtMy0xLTEtODMyODU_7fa9a77a-0cba-4408-bd47-4215bb64b2d2">23.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMjEtMS0xLTEtODMyODU_debf6200-a657-4886-8574-0f3b2e77acf5">0.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMjEtMy0xLTEtODMyODU_84e73ad3-1437-402e-a84f-73e4ebaa0855">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMjItMS0xLTEtODMyODU_6f3bbead-5304-4d8b-be21-abc781ef9ef9">8.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMjItMy0xLTEtODMyODU_4382b475-0848-4d97-9b9e-e370c39d9fb4">13.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued liabilities and other current and long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMjMtMS0xLTEtODMyODU_a4554236-f1f4-4fce-b14b-87e63d1f2932">25.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMjMtMy0xLTEtODMyODU_301bb194-12d3-4e97-87ee-e8473326ef7b">30.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMjQtMS0xLTEtODMyODU_31c99eac-e887-4452-afbf-8b306d2f4110">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMjQtMy0xLTEtODMyODU_0332407a-ff91-43c8-801f-e7f38229a5e3">0.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash (used in) provided by operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMjYtMS0xLTEtODMyODU_c6ae84db-8904-45d5-8844-5909c91065f8">3.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMjYtMy0xLTEtODMyODU_00548a70-e895-4799-a0a0-bb03ca77a580">10.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMjgtMS0xLTEtODMyODU_164409f8-3c4b-4284-905b-49df7203852e">5.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMjgtMy0xLTEtODMyODU_4ec726b9-21a5-4361-97f2-feab077f2986">4.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on settlement of cash flow hedge</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="var:GainLossOnSettlementOfHedgeInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMjktMS0xLTEtODMyODU_2fb4ab72-5233-438b-957a-c2dc5594d356">0.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="var:GainLossOnSettlementOfHedgeInvestingActivities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMjktMy0xLTEtODMyODU_c8bfa62e-ee6b-4b5b-9153-1585cc54ab2a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from maturities of marketable debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMzEtMS0xLTEtODMyODU_07f23465-ba09-41bd-b7fb-846e9db99eb8">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMzEtMy0xLTEtODMyODU_873cccde-3765-4832-8416-84782f5d5055">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of marketable debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMzItMS0xLTEtODMyODU_28bc8d55-4739-4d38-b0b3-7a49408df79b">6.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMzItMy0xLTEtODMyODU_36c33ab4-1b62-4556-bb27-2f78e57d74c4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of marketable equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="us-gaap:PaymentsToAcquireMarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMzMtMS0xLTEtOTQ4MTA_5388972f-90e4-4364-acae-ced953d4f97d">2.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="us-gaap:PaymentsToAcquireMarketableSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMzMtMy0xLTEtOTQ4MTA_d3414585-6948-4862-a9ae-a35d748ea9bd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlement of net investment hedge</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="us-gaap:ProceedsFromHedgeInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMzUtMS0xLTEtMTAwMjQ3_50128536-c951-461c-831f-4a5f9ec45b96">7.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="us-gaap:ProceedsFromHedgeInvestingActivities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMzUtMy0xLTEtMTAwMjQ3_782e571a-3a06-488b-8467-32ce34d5a41a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from sales of business and assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="var:ProceedsFromSalesOfBusinessAndAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMzMtMS0xLTEtODMyODU_4c468cbe-5b46-41d2-b4e8-0cd6360310ab">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="var:ProceedsFromSalesOfBusinessAndAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMzMtMy0xLTEtODMyODU_f1cfb6a1-cb58-451d-acb0-00ff6d6cbfc8">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMzUtMS0xLTEtODMyODU_87798443-5b85-4740-91d8-437337543bd8">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMzUtMy0xLTEtODMyODU_868e66da-a3b8-4933-8333-bbc99c1e2804">0.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:30pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMzYtMS0xLTEtODMyODU_9761b973-ea04-4602-97e4-6ece4979f7f3">3.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMzYtMy0xLTEtODMyODU_3cf6cdbc-e4f9-47ce-91f1-ab1ee7312d62">2.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repayments of borrowing under credit agreements</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="us-gaap:RepaymentsOfLongTermLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfNDMtMS0xLTEtODMyODU_976473af-677e-4c5a-86e4-f9b14500d5a8">0.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="us-gaap:RepaymentsOfLongTermLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfNDMtMy0xLTEtODMyODU_3ff1647a-f8dc-4e66-ad7c-e8240ccd9209">0.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from exercise of stock options</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfNDYtMS0xLTEtODMyODU_68ff5001-1806-4a82-ab9c-97a4b088050f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="us-gaap:ProceedsFromStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfNDYtMy0xLTEtODMyODU_7476aee1-2d49-4fcd-a97d-d4024f49ba5e">3.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from shares issued under employee stock purchase plan</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="us-gaap:ProceedsFromStockPlans" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfNDgtMS0xLTEtODMyODU_4bd4eb02-4823-4534-978b-c51b40b224b7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="us-gaap:ProceedsFromStockPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfNDgtMy0xLTEtODMyODU_f2ec1ae1-e3cd-427f-8984-b530678cd626">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfNDktMS0xLTEtODMyODU_30ac7f95-be0c-410c-80e5-ed6754040275">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfNDktMy0xLTEtODMyODU_4ed0f0ca-dca8-42d8-8de1-302ea5edd77f">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:30pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash (used in) provided by financing activities</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfNTAtMS0xLTEtODMyODU_7c54a024-b89d-4c33-8c84-26176e4bccba">0.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfNTAtMy0xLTEtODMyODU_d8515fcd-5fb3-4125-8d45-af9bb366632a">5.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effects of exchange rate changes on cash and cash equivalents and restricted cash</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfNTEtMS0xLTEtODMyODU_d3b48fda-b7e2-4445-aedc-e290fde2875e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfNTEtMy0xLTEtODMyODU_41e85c5c-9caf-4a40-8b02-e299b046d614">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net (decrease) increase in cash and cash equivalents and restricted cash</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfNTItMS0xLTEtODMyODU_ec21e982-7087-4644-8a83-6bc81ec5b654">7.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfNTItMy0xLTEtODMyODU_9cc5ba3e-c605-40c5-a9e5-286a20b38cf1">13.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents and restricted cash at beginning of period</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfNTMtMS0xLTEtODMyODU_79b852db-ccc5-45f5-a7f2-47484382298a">90.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i504e59968786494c96b1e46f5375a17d_I20211001" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfNTMtMy0xLTEtODMyODU_27e1c774-05e9-4b4f-85bf-c60577df8331">146.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents and restricted cash at end of period</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfNTQtMS0xLTEtODMyODU_36b9a8bc-3a5c-4586-8113-3e8a7bd57e89">82.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4026880a25c245b7ae7af90aa89cf31c_I20211231" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfNTQtMy0xLTEtODMyODU_601f66d1-907c-45fb-ae88-5a9749b09713">159.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Supplemental cash flow information:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for interest</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfNTYtMS0xLTEtODMyODU_49f23fea-4d4c-48c8-b623-ee8a510a6358">13.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfNTYtMy0xLTEtODMyODU_b4ecc5c1-b654-45e3-b651-e3fa268f3933">14.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income taxes paid, net of refunds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfNTctMS0xLTEtODMyODU_bd733521-cce3-4ded-87ad-3b96b8464672">4.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfNTctMy0xLTEtODMyODU_f38ec624-b4d4-4ea8-88cf-999f67cc9204">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Supplemental non-cash activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of property, plant and equipment financed through accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="us-gaap:FairValueOfAssetsAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfNTktMS0xLTEtODMyODU_56805adc-f137-4edf-80f3-ead5aeb09888">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="us-gaap:FairValueOfAssetsAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfNTktMy0xLTEtODMyODU_cc84c99a-e219-4f6c-b7a4-0197974b705d">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying Notes to the Condensed Consolidated Financial Statements.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="i4ab573909cb849339357193b017c7d37_34"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VAREX IMAGING CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div id="i4ab573909cb849339357193b017c7d37_37"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1. <ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zNy9mcmFnOjE3NGY1MThhYjc5ZDRlMTFiMTQ0MmY3ZDQ4ZDI3MjAzL3RleHRyZWdpb246MTc0ZjUxOGFiNzlkNGUxMWIxNDQyZjdkNDhkMjcyMDNfMTYxNA_9d14c852-ac65-44f7-90b2-7ce9a8966f51" continuedAt="i03a0fe7cad0c4298b00cf8c3ae02f725" escape="true">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ix:nonNumeric></span></div><ix:continuation id="i03a0fe7cad0c4298b00cf8c3ae02f725" continuedAt="i94c6675831724d7dbcf3053cd6dbabaf"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Description of Business</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Varex Imaging Corporation (the &#8220;Company&#8221; or &#8220;Varex&#8221;) designs, manufactures, sells and services a broad range of medical products, which include X-ray imaging components including X-ray tubes, digital detectors and accessories, ionization chambers and buckys, high voltage connectors, image processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers. The Company sells its products to imaging system original equipment manufacturer (&#8220;OEM&#8221;) customers for incorporation into new medical diagnostic, radiation therapy, dental, and veterinary equipment, as well as to independent service companies and distributors, and directly to end-users for replacement purposes.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company also designs, manufactures, sells and services industrial products, which include Linatron&#174; X-ray linear accelerators, digital detectors, high voltage connectors, coolers, imaging processing software and image detection products for security and inspection purposes, such as cargo screening at ports and borders and nondestructive examination in a variety of applications. The Company generally sells security and inspection products to OEM customers who incorporate Varex&#8217;s products into their inspection or irradiation systems and processes. The Company conducts an active research and development program to focus on new technology and applications in both the medical and industrial X-ray imaging markets.</span></div></ix:continuation><div id="i4ab573909cb849339357193b017c7d37_40"></div><ix:continuation id="i94c6675831724d7dbcf3053cd6dbabaf" continuedAt="i7f7e4c1069354c1e9e45e8906c89d06d"><ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180MC9mcmFnOjI5OGNlZTNhOTFhNjQ3ZmY5ZDVmM2Q1YjVkZmQwMjUyL3RleHRyZWdpb246Mjk4Y2VlM2E5MWE2NDdmZjlkNWYzZDViNWRmZDAyNTJfMTU3Nw_ba3ff11e-3014-4c15-af23-6bd1f0570cd8" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The accompanying unaudited condensed consolidated financial statements have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;) and in accordance with accounting principles generally accepted in the United States (&#8220;GAAP&#8221;) for interim financial information. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. In the opinion of management, these condensed consolidated financial statements include all adjustments necessary for a fair presentation of the results for the interim periods. The Company has consolidated all of its majority owned subsidiaries and entities over which it has control. All intercompany balances and transactions have been eliminated as part of the consolidation.</span></div></ix:nonNumeric><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180MC9mcmFnOjI5OGNlZTNhOTFhNjQ3ZmY5ZDVmM2Q1YjVkZmQwMjUyL3RleHRyZWdpb246Mjk4Y2VlM2E5MWE2NDdmZjlkNWYzZDViNWRmZDAyNTJfMTU4OA_8d33b4fc-7196-4df3-9ed7-03efd99e5870" escape="true">These condensed consolidated financial statements and the accompanying notes are unaudited and should be read in conjunction with the consolidated financial statements and notes thereto for the fiscal year ended 2022 included in the Company&#8217;s Annual Report on Form 10-K, which was filed with the SEC on November&#160;18, 2022.</ix:nonNumeric> <ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="us-gaap:SubsequentEventsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180MC9mcmFnOjI5OGNlZTNhOTFhNjQ3ZmY5ZDVmM2Q1YjVkZmQwMjUyL3RleHRyZWdpb246Mjk4Y2VlM2E5MWE2NDdmZjlkNWYzZDViNWRmZDAyNTJfMTU4Mw_dbcd66ff-4359-4ffd-b954-0700cf478f8c" escape="true">The Company considers events or transactions that occur after the balance sheet date, but before the financial statements are issued, to provide additional evidence relative to certain estimates or to identify matters that require additional disclosures.</ix:nonNumeric> Except for the change in certain policies upon adoption of the accounting standard described below, there have been no material changes to the Company's significant accounting policies, compared to the accounting policies described in Note 1, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, in the Company&#8217;s Annual Report on Form&#160;10-K for fiscal year 2022. </span></div></ix:continuation><ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="us-gaap:PriorPeriodReclassificationAdjustmentDescription" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180MC9mcmFnOjI5OGNlZTNhOTFhNjQ3ZmY5ZDVmM2Q1YjVkZmQwMjUyL3RleHRyZWdpb246Mjk4Y2VlM2E5MWE2NDdmZjlkNWYzZDViNWRmZDAyNTJfOTM0NTg0ODgzODM4MQ_84cdbe46-adf7-4b2a-ac1c-ea676e1147e0" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassification of Prior Period Presentation</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Certain prior period amounts in the notes to the condensed consolidated financial statements have had a change in presentation to conform to current period presentation. This change does not affect previously reported results.</span></div></ix:nonNumeric><div id="i4ab573909cb849339357193b017c7d37_43"></div><ix:continuation id="i7f7e4c1069354c1e9e45e8906c89d06d" continuedAt="i7729f187618b4465873d9a9fcd2302be"><ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RleHRyZWdpb246ZjFhODQ2MDcxZDA4NGNkY2IyMWMxMTc1YjI5NWYyNDFfMjE1Mzc_5d4311e1-bc48-434d-b288-2d3a71644b6b" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segment Reporting</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company has <ix:nonFraction unitRef="segment" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="INF" name="us-gaap:NumberOfOperatingSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RleHRyZWdpb246ZjFhODQ2MDcxZDA4NGNkY2IyMWMxMTc1YjI5NWYyNDFfNDA_6636752e-3112-432a-92f5-3ad61bf94061">two</ix:nonFraction> reportable operating segments; (i) Medical and (ii) Industrial, which aligns with how its Chief Executive Officer, who is the Company's Chief Operating Decision Maker (&#8220;CODM&#8221;), reviews the Company&#8217;s performance. See Note 15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for further information on the Company&#8217;s segments.</span></div></ix:nonNumeric><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="us-gaap:FiscalPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RleHRyZWdpb246ZjFhODQ2MDcxZDA4NGNkY2IyMWMxMTc1YjI5NWYyNDFfMjE1Mjg_7d229a59-ac21-4947-a7c6-1e2f9e10894a" continuedAt="i2c697e6aca8e43f8bcfa3de626c206d9" escape="true">Fiscal Year</ix:nonNumeric></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i2c697e6aca8e43f8bcfa3de626c206d9">&#160;&#160;&#160;&#160;The fiscal years of the Company as reported are the 52 or 53-week period ending on the Friday nearest September&#160;30. Fiscal year 2023 is the 52-week period ending September&#160;29, 2023. Fiscal year 2022 was the 52-week period that ended on September&#160;30, 2022. The fiscal quarters ended&#160;December&#160;30, 2022 and&#160;December&#160;31, 2021&#160;were both 13-week periods.</ix:continuation> </span></div></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_7">Table of Contents</a></span></div></div><ix:continuation id="i7729f187618b4465873d9a9fcd2302be" continuedAt="ic76ed50d2eb64075a9a9214d77d932d5"><ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RleHRyZWdpb246ZjFhODQ2MDcxZDA4NGNkY2IyMWMxMTc1YjI5NWYyNDFfMjE1NzQ_76775abe-519a-4020-ba7e-7aad13429d6f" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. Such estimates include the valuation of inventories, valuation of goodwill and intangible assets, warranties, contract liabilities, long-lived asset valuations, impairment of investments, valuation of financial instruments, and taxes on income. Actual results could differ from these estimates.</span></div></ix:nonNumeric><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impact of COVID-19</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The coronavirus (&#8220;COVID-19&#8221;) pandemic, the COVID-19 variants, uneven vaccination rates across the globe, and the mitigation efforts by governments to control its spread have created uncertainties and disruptions in the economic and financial markets. While the impacts of COVID-19 on the Company's business have lessened, the extent to which COVID-19 will continue to impact the Company&#8217;s business and financial results depends on numerous evolving factors including: the magnitude and duration of COVID-19, the extent to which it will continue to impact worldwide macroeconomic conditions, including supply chain disruptions, interest rates, unemployment rates, the speed of the economic recovery, and governmental and business reactions to the pandemic. The Company has experienced continuing supply chain disruptions and other issues that are at least partially related to the ongoing COVID-19 pandemic. In addition, while the Company has from time to time taken significant precautions to maintain employee safety, such as implementing mask requirements, encouraging vaccination, and periodically asking non-production related employees to work remotely when possible, the Company has experienced, and may in the future experience, COVID-19 related employee absences that adversely impact its production or business. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company assessed certain accounting matters that generally require consideration of forecasted financial information in context with the information reasonably available to the Company, including the estimated future impacts of COVID-19, through the date of filing this report. The accounting matters assessed included, but were not limited to, the Company&#8217;s carrying value of goodwill, intangibles, long-lived assets, equity method investments, inventory and related reserves, and the allowance for credit losses. The Company&#8217;s assessment of the magnitude and duration of COVID-19, as well as other factors, could result in material negative impacts to the Company&#8217;s condensed consolidated financial statements in future reporting periods. These future developments are highly uncertain and the outcomes cannot be estimated with certainty. Actual results may differ from those estimates, and such differences may be material to the financial statements.</span></div><ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RleHRyZWdpb246ZjFhODQ2MDcxZDA4NGNkY2IyMWMxMTc1YjI5NWYyNDFfMjE1Njc_b138cffc-2223-4f2f-96d8-fabcbae34beb" continuedAt="ifde9c7c54c6f47e983fe9f96db002422" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company considers unrestricted currency on hand, demand deposits, time deposits and all highly-liquid investments with an original maturity of three months or less at the date of purchase to be cash and cash equivalents. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Cash</span></div></ix:nonNumeric><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ifde9c7c54c6f47e983fe9f96db002422">&#160;&#160;&#160;&#160;Restricted cash primarily consists of cash collateral related to certain leases and inventory arrangements. Restricted cash is included in other assets on the Company's Condensed Consolidated Balance Sheets.</ix:continuation> <ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RleHRyZWdpb246ZjFhODQ2MDcxZDA4NGNkY2IyMWMxMTc1YjI5NWYyNDFfMjE1MzI_397f4120-30de-4c90-ad3d-0b14431b030f" continuedAt="i62e8d8ece14a46e19d1aeb1052259147" escape="true"><ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RleHRyZWdpb246ZjFhODQ2MDcxZDA4NGNkY2IyMWMxMTc1YjI5NWYyNDFfMjE1MzI_6d0738fe-b005-4196-ba38-ebff57cd7fa3" continuedAt="ic6fc774696394c07aa068561716aa592" escape="true">Cash and cash equivalents and restricted cash as reported within the Condensed Consolidated Statements of Cash Flows consisted of the following:</ix:nonNumeric></ix:nonNumeric></span><ix:continuation id="i62e8d8ece14a46e19d1aeb1052259147"><ix:continuation id="ic6fc774696394c07aa068561716aa592"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.816%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.650%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.650%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.650%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.652%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Beginning of Period</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">End of Period</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Beginning of Period</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">End of Period</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RhYmxlOmE3NGE4OGVlMDNjYTQzODNiYmRhMWMwNzY2NWVhZWVjL3RhYmxlcmFuZ2U6YTc0YTg4ZWUwM2NhNDM4M2JiZGExYzA3NjY1ZWFlZWNfMy0xLTEtMS04MzI4NQ_b8f2be5c-d31e-403c-85d1-8c686cf455e3">89.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RhYmxlOmE3NGE4OGVlMDNjYTQzODNiYmRhMWMwNzY2NWVhZWVjL3RhYmxlcmFuZ2U6YTc0YTg4ZWUwM2NhNDM4M2JiZGExYzA3NjY1ZWFlZWNfMy0zLTEtMS04MzI4NQ_b3d2e81f-df35-4594-bf2b-7778f846c1b4">81.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i504e59968786494c96b1e46f5375a17d_I20211001" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RhYmxlOmE3NGE4OGVlMDNjYTQzODNiYmRhMWMwNzY2NWVhZWVjL3RhYmxlcmFuZ2U6YTc0YTg4ZWUwM2NhNDM4M2JiZGExYzA3NjY1ZWFlZWNfMy01LTEtMS04MzI4NQ_4ac586f9-9ce6-43f0-92ca-3240f9c5b976">144.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4026880a25c245b7ae7af90aa89cf31c_I20211231" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RhYmxlOmE3NGE4OGVlMDNjYTQzODNiYmRhMWMwNzY2NWVhZWVjL3RhYmxlcmFuZ2U6YTc0YTg4ZWUwM2NhNDM4M2JiZGExYzA3NjY1ZWFlZWNfMy03LTEtMS04MzI4NQ_2c11085f-8809-43c0-97f8-22db39fad4e3">157.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930" decimals="-5" name="us-gaap:RestrictedCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RhYmxlOmE3NGE4OGVlMDNjYTQzODNiYmRhMWMwNzY2NWVhZWVjL3RhYmxlcmFuZ2U6YTc0YTg4ZWUwM2NhNDM4M2JiZGExYzA3NjY1ZWFlZWNfNC0xLTEtMS04MzI4NQ_8827d241-f336-4b94-89a8-f29a260a30bd">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="-5" name="us-gaap:RestrictedCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RhYmxlOmE3NGE4OGVlMDNjYTQzODNiYmRhMWMwNzY2NWVhZWVjL3RhYmxlcmFuZ2U6YTc0YTg4ZWUwM2NhNDM4M2JiZGExYzA3NjY1ZWFlZWNfNC0zLTEtMS04MzI4NQ_0ee203c3-b034-48dc-a992-2016e3049495">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i504e59968786494c96b1e46f5375a17d_I20211001" decimals="-5" name="us-gaap:RestrictedCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RhYmxlOmE3NGE4OGVlMDNjYTQzODNiYmRhMWMwNzY2NWVhZWVjL3RhYmxlcmFuZ2U6YTc0YTg4ZWUwM2NhNDM4M2JiZGExYzA3NjY1ZWFlZWNfNC01LTEtMS04MzI4NQ_6fc4ebcf-ec48-43f0-9fc7-1214bd181c92">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4026880a25c245b7ae7af90aa89cf31c_I20211231" decimals="-5" name="us-gaap:RestrictedCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RhYmxlOmE3NGE4OGVlMDNjYTQzODNiYmRhMWMwNzY2NWVhZWVjL3RhYmxlcmFuZ2U6YTc0YTg4ZWUwM2NhNDM4M2JiZGExYzA3NjY1ZWFlZWNfNC03LTEtMS04MzI4NQ_a03b4e41-fbf0-483e-96b3-dc527aa123ee">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total as presented in the Condensed Consolidated Statements of Cash Flows</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RhYmxlOmE3NGE4OGVlMDNjYTQzODNiYmRhMWMwNzY2NWVhZWVjL3RhYmxlcmFuZ2U6YTc0YTg4ZWUwM2NhNDM4M2JiZGExYzA3NjY1ZWFlZWNfNS0xLTEtMS04MzI4NQ_58111cb2-d3b2-4f4d-97d5-e79bb065592e">90.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RhYmxlOmE3NGE4OGVlMDNjYTQzODNiYmRhMWMwNzY2NWVhZWVjL3RhYmxlcmFuZ2U6YTc0YTg4ZWUwM2NhNDM4M2JiZGExYzA3NjY1ZWFlZWNfNS0zLTEtMS04MzI4NQ_75a863c3-0779-48a4-bb92-6519d0053f6a">82.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i504e59968786494c96b1e46f5375a17d_I20211001" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RhYmxlOmE3NGE4OGVlMDNjYTQzODNiYmRhMWMwNzY2NWVhZWVjL3RhYmxlcmFuZ2U6YTc0YTg4ZWUwM2NhNDM4M2JiZGExYzA3NjY1ZWFlZWNfNS01LTEtMS04MzI4NQ_ab4ee12d-26d9-4167-bb75-3801ce20add0">146.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4026880a25c245b7ae7af90aa89cf31c_I20211231" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RhYmxlOmE3NGE4OGVlMDNjYTQzODNiYmRhMWMwNzY2NWVhZWVjL3RhYmxlcmFuZ2U6YTc0YTg4ZWUwM2NhNDM4M2JiZGExYzA3NjY1ZWFlZWNfNS03LTEtMS04MzI4NQ_909a8db2-0467-49d9-9865-9f57f7b8c38f">159.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></ix:continuation></div></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_7">Table of Contents</a></span></div></div><ix:continuation id="ic76ed50d2eb64075a9a9214d77d932d5" continuedAt="i5d12bddef4944ff8bc1e98b7eaf3c769"><ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="us-gaap:ConcentrationRiskCreditRisk" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RleHRyZWdpb246ZjFhODQ2MDcxZDA4NGNkY2IyMWMxMTc1YjI5NWYyNDFfMjE1NTU_e126c8e4-6b3c-47c6-9e6a-7f64d4b63bfc" continuedAt="icd3061a6bdd643d48b3fc6fe7247c701" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Risk</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Financial instruments that potentially expose the Company to concentrations of credit risk consist principally of cash, cash equivalents, marketable securities, certificates of deposit, and trade accounts receivable. Cash held with financial institutions may exceed the Federal Deposit Insurance Corporation insurance limits or similar limits in foreign jurisdictions. To date, the Company has not realized any losses on its deposits of cash and cash equivalents. The Company performs ongoing credit evaluations of its customers and, except for government tenders, group purchases and orders with a letter of credit, its industrial customers often provide a down payment. The Company maintains an allowance for credit losses based upon the expected collectability of all accounts receivable. The Company obtains some of the components in its products from a limited group of suppliers or from a single-source supplier. When these suppliers are unable to meet the Company's supply needs, the Company's production is negatively impacted. </span></div></ix:nonNumeric><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="icd3061a6bdd643d48b3fc6fe7247c701">&#160;&#160;&#160;&#160;Credit is extended to customers based on an evaluation of the customer&#8217;s financial condition, and collateral is not required. In certain circumstances, a customer may be required to prepay all or a portion of the contract price prior to transfer of control.</ix:continuation> <ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RleHRyZWdpb246ZjFhODQ2MDcxZDA4NGNkY2IyMWMxMTc1YjI5NWYyNDFfMjE1NDY_c5b36b09-cd2d-4e2f-907e-076e260e198a" continuedAt="icbcea76b41fc4192a521dc7912ffc150" escape="true">During the periods presented, one of the Company's customers accounted for a significant portion of revenues, as set forth below:</ix:nonNumeric></span><ix:continuation id="icbcea76b41fc4192a521dc7912ffc150"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.568%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canon Medical Systems Corporation</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i651cc3561a6c40d9a9e385495456c274_D20221001-20221230" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RhYmxlOjA5OTllMDE3OTk4MTRiZGI5MGRmZjVkNDBiOGM1NTIwL3RhYmxlcmFuZ2U6MDk5OWUwMTc5OTgxNGJkYjkwZGZmNWQ0MGI4YzU1MjBfMi0xLTEtMS04MzI4NQ_1db36e17-fb9f-44cc-a792-46aa5428eb49">20.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i288802e63c324225b21fea1834e54841_D20211002-20211231" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RhYmxlOjA5OTllMDE3OTk4MTRiZGI5MGRmZjVkNDBiOGM1NTIwL3RhYmxlcmFuZ2U6MDk5OWUwMTc5OTgxNGJkYjkwZGZmNWQ0MGI4YzU1MjBfMi0zLTEtMS04MzI4NQ_cdd8b59d-5ebd-4b9c-bb4e-112377f19731">19.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Canon Medical Systems Corporation accounted for <ix:nonFraction unitRef="number" contextRef="i0048ce751bf94b37a1dd1afdc4bea06a_D20221001-20221230" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RleHRyZWdpb246ZjFhODQ2MDcxZDA4NGNkY2IyMWMxMTc1YjI5NWYyNDFfNTgwNg_fbde0fcd-7034-4032-ba33-290ebd20bc9d">9.2</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i59fa34d2d760449bbe1edc7c303eea6d_D20211002-20220930" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RleHRyZWdpb246ZjFhODQ2MDcxZDA4NGNkY2IyMWMxMTc1YjI5NWYyNDFfNTgxMw_74a21404-54cf-49a1-9284-ef4ca6582dc6">10.3</ix:nonFraction>% of the Company&#8217;s accounts receivable as of December&#160;30, 2022 and September&#160;30, 2022, respectively.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="us-gaap:InvestmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RleHRyZWdpb246ZjFhODQ2MDcxZDA4NGNkY2IyMWMxMTc1YjI5NWYyNDFfMjE1NjI_f557d8b8-e964-4a25-9998-a4310790d64c" continuedAt="ic6de60ab870148f4bd2cc818cad046f4" escape="true">Investments</ix:nonNumeric></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ic6de60ab870148f4bd2cc818cad046f4" continuedAt="id0b1d017e53d4fd0a62ee3b623d722f3">&#160;&#160;&#160;&#160;The Company accounts for its equity investments in privately-held companies under the equity method of accounting if the Company has the ability to exercise significant influence in these investments. Distributions received from an equity method investment are classified using the&#160;cumulative earnings approach, which means that distributions up to the amount of cumulative equity in earnings recognized will be treated as returns on investment and classified as operating cash flows and those in excess of that amount will be treated as returns of investment and classified as investing cash flows. The Company reviews its equity investments in privately-held companies for impairment whenever events or changes in business circumstances are other than temporary and indicate that the carrying amount of the investments may not be fully recoverable. </ix:continuation>There were <ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="INF" name="us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RleHRyZWdpb246ZjFhODQ2MDcxZDA4NGNkY2IyMWMxMTc1YjI5NWYyNDFfNjc4Mg_628f8187-d353-4378-a8ca-5436cb76354c"><ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="INF" name="us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RleHRyZWdpb246ZjFhODQ2MDcxZDA4NGNkY2IyMWMxMTc1YjI5NWYyNDFfNjc4Mg_7717b1da-0d42-456c-989f-7f696180cdf0">no</ix:nonFraction></ix:nonFraction> impairments recorded during the three months ended December 30, 2022 and December&#160;31, 2021, respectively.</span></div><ix:continuation id="id0b1d017e53d4fd0a62ee3b623d722f3" continuedAt="ie757f05fd6df4d149be2d8d3af5eece1"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Marketable Securities</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's marketable securities consist primarily of financial instruments such as U.S. treasury securities, U.S. agency obligations, corporate bonds, commercial paper, money market funds, and equity securities. The Company classifies marketable debt securities as available-for-sale at the time of purchase and reevaluates such classifications as of each balance sheet date. All marketable debt securities are recorded at estimated fair value. Any unrealized gains or losses for marketable debt securities are included in accumulated other comprehensive income within the Condensed Consolidated Balance Sheets. Marketable equity securities are stated at fair value as determined by the most recently traded price of each security at the balance sheet date. All unrealized gains and losses on equity securities are recorded as part of other expense, net in the Company's condensed consolidated financial statements. See Note 7, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for further details.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span></div></ix:continuation><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ie757f05fd6df4d149be2d8d3af5eece1">&#160;&#160;&#160;&#160;When the fair value of a marketable debt security declines below its amortized cost basis, any portion of that decline attributable to credit losses, to the extent expected to be nonrecoverable before the sale of the security, is recognized in the Condensed Consolidated Statements of Operations. When the fair value of a marketable debt security declines below its amortized cost basis due to changes in interest rates, such amounts are recorded in other comprehensive loss, and are recognized in the Condensed Consolidated Statements of Operations only if the Company sells or intends to sell the security before recovery of its cost basis. There were <ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="INF" name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RleHRyZWdpb246ZjFhODQ2MDcxZDA4NGNkY2IyMWMxMTc1YjI5NWYyNDFfODA2OA_6854fb74-cbdb-4845-9cf6-5e348f7c36d5">no</ix:nonFraction> credit losses related to marketable debt securities recorded during the three months ended December 30, 2022.</ix:continuation> </span></div></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_7">Table of Contents</a></span></div></div><ix:continuation id="i5d12bddef4944ff8bc1e98b7eaf3c769" continuedAt="i209c396b705a4a948504f74894496545"><ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="us-gaap:CommitmentsAndContingenciesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RleHRyZWdpb246ZjFhODQ2MDcxZDA4NGNkY2IyMWMxMTc1YjI5NWYyNDFfMjE1MTc_5ebbce35-e841-4f9d-9d01-15e465cac5de" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Loss Contingencies</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;From time to time, the Company is involved in legal proceedings, claims and government inspections or investigations, customs and duties audits, other contingency matters, both inside and outside the United States, arising in the ordinary course of its business or otherwise.&#160;The Company accrues amounts for probable losses, to the extent they can be reasonably estimated, that it believes are adequate to address any liabilities related to legal proceedings and other loss contingencies that the Company believes will result in a probable loss (including, among other things, probable settlement value).&#160;A loss or a range of loss is disclosed when it is reasonably possible that a material loss will be incurred and can be estimated or when it is reasonably possible that the amount of a loss, when material, will exceed the recorded provision. When a loss contingency is probable but not reasonably estimable the nature of the contingency and the fact that an estimate cannot be made is disclosed.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="us-gaap:StandardProductWarrantyPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RleHRyZWdpb246ZjFhODQ2MDcxZDA4NGNkY2IyMWMxMTc1YjI5NWYyNDFfMjE1NDQ_ea66070d-9b61-4327-abf3-a90a6da4d517" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Product Warranty</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company warrants most of its products for a specific period of time, usually <ix:nonNumeric contextRef="i67803683b0344dc78ee5545d3907c730_D20221001-20221230" name="var:WarrantyTerm" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RleHRyZWdpb246ZjFhODQ2MDcxZDA4NGNkY2IyMWMxMTc1YjI5NWYyNDFfOTI2NA_e961ecd3-973b-4056-bbf4-fc1eb239e45a">12</ix:nonNumeric> to <ix:nonNumeric contextRef="idd5d9702aa2d44ef9138ad61434eaa2a_D20221001-20221230" name="var:WarrantyTerm" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RleHRyZWdpb246ZjFhODQ2MDcxZDA4NGNkY2IyMWMxMTc1YjI5NWYyNDFfOTI3MA_ea015fbb-3a01-4d26-abbf-b553767ac08d">24</ix:nonNumeric> months from delivery or acceptance, against material defects. The Company provides for the estimated future costs of warranty obligations in cost of revenues when the related revenues are recognized. The accrued warranty costs represent the best estimate at the time of sale of the total costs that the Company will incur to repair or replace product parts that fail while still under warranty.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The amount of the accrued estimated warranty costs obligation for established products is primarily based on historical experience of product failures, adjusted for current information on repair costs.&#160;For new products, estimates include the historical experience of similar products, as well as a reasonable allowance for warranty expenses associated with new products.&#160;On a quarterly basis, the Company reviews the accrued warranty costs and updates the historical warranty cost trends, if required.</span></div></ix:nonNumeric><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RleHRyZWdpb246ZjFhODQ2MDcxZDA4NGNkY2IyMWMxMTc1YjI5NWYyNDFfMjE1NjQ_b3130c42-5d26-4042-8476-009043399b59" continuedAt="ic435e9010f5e412aa90ef8b90d15740b" escape="true">The following table reflects the changes in the Company&#8217;s accrued product warranty:</ix:nonNumeric></span><ix:continuation id="ic435e9010f5e412aa90ef8b90d15740b"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued product warranty, at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930" decimals="-5" name="us-gaap:StandardProductWarrantyAccrual" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RhYmxlOjc3ZjM0OTFkYzY3MTQwNDU5M2UwYzBkN2NhMThkZTkxL3RhYmxlcmFuZ2U6NzdmMzQ5MWRjNjcxNDA0NTkzZTBjMGQ3Y2ExOGRlOTFfMi0xLTEtMS04MzI4NQ_99df5871-ad26-442e-8468-9e297e8cabe3">7.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i504e59968786494c96b1e46f5375a17d_I20211001" decimals="-5" name="us-gaap:StandardProductWarrantyAccrual" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RhYmxlOjc3ZjM0OTFkYzY3MTQwNDU5M2UwYzBkN2NhMThkZTkxL3RhYmxlcmFuZ2U6NzdmMzQ5MWRjNjcxNDA0NTkzZTBjMGQ3Y2ExOGRlOTFfMi0zLTEtMS04MzI4NQ_c79ac9f1-60a6-4490-8a7f-894945cd05f0">8.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">New accruals charged to cost of revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="us-gaap:StandardProductWarrantyAccrualWarrantiesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RhYmxlOjc3ZjM0OTFkYzY3MTQwNDU5M2UwYzBkN2NhMThkZTkxL3RhYmxlcmFuZ2U6NzdmMzQ5MWRjNjcxNDA0NTkzZTBjMGQ3Y2ExOGRlOTFfMy0xLTEtMS04MzI4NQ_79400634-33a5-48d8-8488-b78703024dd6">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="us-gaap:StandardProductWarrantyAccrualWarrantiesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RhYmxlOjc3ZjM0OTFkYzY3MTQwNDU5M2UwYzBkN2NhMThkZTkxL3RhYmxlcmFuZ2U6NzdmMzQ5MWRjNjcxNDA0NTkzZTBjMGQ3Y2ExOGRlOTFfMy0zLTEtMS04MzI4NQ_db6f7293-49f7-46b0-a6e7-d26816346e01">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Product warranty expenditures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="us-gaap:StandardProductWarrantyAccrualPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RhYmxlOjc3ZjM0OTFkYzY3MTQwNDU5M2UwYzBkN2NhMThkZTkxL3RhYmxlcmFuZ2U6NzdmMzQ5MWRjNjcxNDA0NTkzZTBjMGQ3Y2ExOGRlOTFfNC0xLTEtMS04MzI4NQ_113d384c-b40f-4de3-b44c-5fc99dc3db90">3.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="us-gaap:StandardProductWarrantyAccrualPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RhYmxlOjc3ZjM0OTFkYzY3MTQwNDU5M2UwYzBkN2NhMThkZTkxL3RhYmxlcmFuZ2U6NzdmMzQ5MWRjNjcxNDA0NTkzZTBjMGQ3Y2ExOGRlOTFfNC0zLTEtMS04MzI4NQ_b51d1b39-daf5-474b-b0c1-b49d9e36c2d3">2.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued product warranty, at end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="-5" name="us-gaap:StandardProductWarrantyAccrual" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RhYmxlOjc3ZjM0OTFkYzY3MTQwNDU5M2UwYzBkN2NhMThkZTkxL3RhYmxlcmFuZ2U6NzdmMzQ5MWRjNjcxNDA0NTkzZTBjMGQ3Y2ExOGRlOTFfNS0xLTEtMS04MzI4NQ_7d510fdc-7bd1-4628-86d0-2ee131a6d6d5">7.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4026880a25c245b7ae7af90aa89cf31c_I20211231" decimals="-5" name="us-gaap:StandardProductWarrantyAccrual" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RhYmxlOjc3ZjM0OTFkYzY3MTQwNDU5M2UwYzBkN2NhMThkZTkxL3RhYmxlcmFuZ2U6NzdmMzQ5MWRjNjcxNDA0NTkzZTBjMGQ3Y2ExOGRlOTFfNS0zLTEtMS04MzI4NQ_c39deac5-5d0f-4034-bfff-d6f16e5e19a9">7.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="us-gaap:LesseeLeasesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RleHRyZWdpb246ZjFhODQ2MDcxZDA4NGNkY2IyMWMxMTc1YjI5NWYyNDFfMjE1NTY_4e1e6b13-8015-457b-9ac9-228196039b6b" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company determines if an arrangement is or contains a lease at the inception of an arrangement. The Company's operating lease right-of-use ("ROU") assets represent the right to use an underlying asset over the lease term and lease liabilities represent its obligation to make lease payments arising from the lease. ROU assets may also include initial direct costs incurred and prepaid lease payments, less lease incentives. Lease liabilities and their corresponding ROU assets are recognized based on the present value of lease payments over the lease term, discounted using the Company's incremental borrowing rate. The Company recognizes operating leases with lease terms of more than twelve months in operating lease assets, current operating lease liabilities, and operating lease liabilities on its Condensed Consolidated Balance Sheets. The Company recognizes finance leases with lease terms of more than twelve months in property, plant, and equipment, net, accrued liabilities and other current liabilities, and other long-term liabilities on its Condensed Consolidated Balance Sheets. For purposes of calculating lease liabilities and the corresponding ROU assets, the Company's lease term may include options to extend or terminate the lease when it is reasonably certain that it will exercise that option.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RleHRyZWdpb246ZjFhODQ2MDcxZDA4NGNkY2IyMWMxMTc1YjI5NWYyNDFfMjE1MzA_f48e256f-7ef2-4c23-ba11-7446f6b5e820" continuedAt="i2b8f5f5a2020482b825c909827edc05f" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company&#8217;s revenues are derived primarily from the sale of hardware and services. The Company recognizes its revenues net of any value-added or sales tax and net of sales discounts.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company sells a high proportion of its X-ray products to a limited number of OEM customers. X-ray imaging components including X-ray tubes, digital detectors and image-processing tools and security and inspection products are generally sold on a stand-alone basis. However, the Company occasionally sells its digital detectors, X-ray tubes and imaging processing tools as a package that is optimized for digital X-ray imaging and sells its Linatron&#174; X-ray linear accelerators together with its image processing software and image detection products to OEM customers that incorporate them into their inspection or irradiation systems and processes. Service contracts are often sold with certain security and inspection products and computer-aided detection products.</span></div></ix:nonNumeric></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_7">Table of Contents</a></span></div></div><ix:continuation id="i209c396b705a4a948504f74894496545" continuedAt="idea4104df91847b7ab653900398143ae"><ix:continuation id="i2b8f5f5a2020482b825c909827edc05f" continuedAt="i2075943f55f04bf295534bc83a311990"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company determines revenue recognition through the following steps:</span></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Identification of the contract, or contracts, with a customer</span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Identification of the performance obligations in the contract</span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Determination of the transaction price</span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Allocation of the transaction price to the performance obligations in the contract</span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Recognition of revenue when, or as, a performance obligation is satisfied</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Transaction Price and Allocation to Performance Obligations</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Transaction prices of products or services are typically based on contracted rates. To the extent that the transaction price includes variable consideration, the Company estimates the amount of variable consideration that should be included in the transaction price utilizing the expected value method when there is a large number of transactions with similar characteristics or the most likely amount method when there are two possible outcomes, depending on the circumstances of the transaction, to which the Company expects to be entitled. Variable consideration is included in the transaction price if, in the Company&#8217;s judgment, it is probable that a significant future reversal of cumulative revenue under the contract will not occur. Estimates of variable consideration and determination of whether to include estimated amounts in the transaction price are based largely on an assessment of the Company&#8217;s anticipated performance and all information (historical, current, and forecasted) that is reasonably available.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company allows customers to return specific parts of purchased X-ray tubes for a partial refund credit, which is identified as variable consideration. For sales with a right of return, revenue is reduced for expected returns, a liability is recorded for expected returns, and an asset is recorded for the right to recover products from customers on settling the liability. The Company recognizes a reduction to revenue and cost of sales at the time of sale and a corresponding contract liability and contract asset. The Company records this estimate based on the historical volume of product returns and adjusts the estimate on a quarterly basis based on the current quarter sales and current quarter returns.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;If a contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. Contracts that contain multiple performance obligations require an allocation of the transaction price based on the estimated relative standalone selling prices of the promised products or services underlying each performance obligation. The Company determines standalone selling prices based on the price at which the performance obligation could be sold separately.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contracts and Performance Obligations</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company accounts for a contract with a customer when there is an approval and commitment from both parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and collectability of the consideration is probable. The Company's performance obligations consist mainly of transferring control of products and services identified in the contracts or purchase orders. For each contract, the Company considers the obligation to transfer products and services to the customer, which are distinct, to be performance obligations.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recognition of Revenue</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Revenue is recognized when, or as, obligations under the terms of a contract are satisfied, which occurs when control of the promised products or services is transferred to customers. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring products or services to a customer.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Product revenue is generally recognized when the customer obtains control of the Company&#8217;s product, which occurs at a point in time, and may be upon shipment or upon delivery based on the contractual shipping terms of a contract.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Service revenue is generally recognized over the term of the service contract. Services are expected to be transferred to the customer throughout the term of the contract, and the Company believes recognizing revenue ratably over the term of the contract best depicts the transfer of value to the customer.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disaggregation of Revenue</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Revenue is disaggregated from contracts between geography and by reportable operating segment, which the Company believes best depicts how the nature, amount, timing, and uncertainty of revenues and cash flows are affected by economic factors. Refer to Note 15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Information, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">included in this report, for the disaggregation of the Company&#8217;s revenue based on reportable operating segments and Note 2, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the disaggregation of revenue by geographic region.&#160;&#160;&#160;&#160;</span></div></ix:continuation></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_7">Table of Contents</a></span></div></div><ix:continuation id="idea4104df91847b7ab653900398143ae"><ix:continuation id="i2075943f55f04bf295534bc83a311990"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Balances</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Contract assets are included within the prepaid expenses and other current assets, and other assets balances in the Condensed Consolidated Balance Sheets. Contract liabilities, which includes refund liabilities and deferred revenue, are included within the accrued liabilities and other current liabilities, deferred revenues, and other long-term liabilities balances in the Condensed Consolidated Balance Sheets. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Deferred revenue represents the Company's obligation to transfer goods and/or services to its customers for which it has already received consideration (or the amount is due) from the customer. The Company's deferred revenue balance primarily relates to contract advances and billings for warranty contracts.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Deferred revenue that is estimated to be recognized during the following twelve-month period is recorded as deferred revenues and the remaining portion is recorded as other long-term liabilities in the Condensed Consolidated Balance Sheets.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Costs to Obtain or Fulfill a Customer Contract</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company has certain costs to obtain and fulfill a customer contract, such as commissions and shipping costs. The Company recognizes the incremental costs of obtaining contracts as an expense when incurred if the amortization period of the assets that the Company otherwise would have recognized is one year or less. Incremental costs of obtaining contracts that would be recognized over more than one year are not material. The Company accounts for shipping and handling activities related to contracts with customers as costs to fulfill the promise to transfer the associated products. These costs are included as a component of cost of revenues.</span></div></ix:continuation><ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RleHRyZWdpb246ZjFhODQ2MDcxZDA4NGNkY2IyMWMxMTc1YjI5NWYyNDFfMjE1NjU_42721955-9b2a-4f6c-be92-44103b733b4a" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In August 2020, the Financial Accounting Standards Board issued Accounting Standard Update ("ASU") 2020-06, Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity. The standard removed certain separation models in ASC 470-20 for convertible instruments, and, as a result, embedded conversion features are no longer separated from the host contract for convertible instruments with conversion features that are not required to be accounted for as derivatives under ASC 815. These convertible debt instruments are accounted for as a single liability measured at amortized cost. This results in the interest expense recognized for convertible debt instruments to be typically closer to the coupon interest rate. Further, the ASU made amendments to the earnings per share (&#8220;EPS&#8221;) guidance in Topic 260 for convertible instruments, the most significant impact of which was requiring the use of the if-converted method for diluted EPS calculation, and no longer allowing the net share settlement method. The Company adopted this ASU on October 1, 2022, using the modified retrospective method. On the date of adoption, the Company recorded an entry to reduce additional paid-in capital by $<ix:nonFraction unitRef="usd" contextRef="i5d4da637b0cb434892a6570db3bf836d_I20221001" decimals="-5" sign="-" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RleHRyZWdpb246ZjFhODQ2MDcxZDA4NGNkY2IyMWMxMTc1YjI5NWYyNDFfNTQ5NzU1ODg4MTcx_4c75f41b-389e-41f2-a1b6-8fbf96d932f3">34.6</ix:nonFraction>&#160;million, increase long-term debt, net by $<ix:nonFraction unitRef="usd" contextRef="i5d4da637b0cb434892a6570db3bf836d_I20221001" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RleHRyZWdpb246ZjFhODQ2MDcxZDA4NGNkY2IyMWMxMTc1YjI5NWYyNDFfNTQ5NzU1ODg4MjA0_460a56bf-9e5f-4af1-8834-183b7f28fe36">28.0</ix:nonFraction>&#160;million, decrease deferred tax assets by $<ix:nonFraction unitRef="usd" contextRef="i5d4da637b0cb434892a6570db3bf836d_I20221001" decimals="-5" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RleHRyZWdpb246ZjFhODQ2MDcxZDA4NGNkY2IyMWMxMTc1YjI5NWYyNDFfNTQ5NzU1ODg4MjM2_7ed2abf6-ada8-4ac8-ba4f-35ace2095021">0.1</ix:nonFraction>&#160;million, and increase retained earnings by $<ix:nonFraction unitRef="usd" contextRef="i5d4da637b0cb434892a6570db3bf836d_I20221001" decimals="-5" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RleHRyZWdpb246ZjFhODQ2MDcxZDA4NGNkY2IyMWMxMTc1YjI5NWYyNDFfNTQ5NzU1ODg4MzAy_a2912c84-61eb-4c48-b4b4-e47d406743be">6.5</ix:nonFraction>&#160;million for the after-tax impact of previously recognized amortization of the debt discount associated with the Company&#8217;s Convertible Notes (as defined herein). The unamortized discount on the Company's Convertible Notes (see Note 10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Borrowings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) was derecognized in the first quarter of fiscal year 2023 and the interest expense from its Convertible Notes decreased and became closer to the coupon rate of <ix:nonFraction unitRef="number" contextRef="ic8c656c39e5948888cffc7883844bcb7_I20221230" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RleHRyZWdpb246ZjFhODQ2MDcxZDA4NGNkY2IyMWMxMTc1YjI5NWYyNDFfNTQ5NzU1ODg1OTM2_f51d9a6f-b5c6-4120-a405-26f6bfdf2ec4">4.00</ix:nonFraction>%. The impact that the adoption of ASU 2020-06 has on the Company's net income per diluted share will depend on the amount of earnings in each period and the Company's share price and could result in additional dilution.</span></div></ix:nonNumeric></ix:continuation><div id="i4ab573909cb849339357193b017c7d37_46"></div><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2. <ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180Ni9mcmFnOjJhYzJkNGViZGI4ZDRmNjk5ZGJiZDdmNmRlMDQ4MjdhL3RleHRyZWdpb246MmFjMmQ0ZWJkYjhkNGY2OTlkYmJkN2Y2ZGUwNDgyN2FfOTg1_fe24d534-af54-4337-b901-5cd37dc48671" continuedAt="if2d4cb6eda03467fb5d19c288b432bf9" escape="true">REVENUE</ix:nonNumeric></span></div><ix:continuation id="if2d4cb6eda03467fb5d19c288b432bf9" continuedAt="ie1e3d7489c81439291f119f2675f44dd"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disaggregation of Revenue</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Revenue is disaggregated from contracts by geographic region and by reportable operating segment, which the Company believes best depicts how the nature, amount, timing, and uncertainty of revenues and cash flows are affected by economic factors.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180Ni9mcmFnOjJhYzJkNGViZGI4ZDRmNjk5ZGJiZDdmNmRlMDQ4MjdhL3RleHRyZWdpb246MmFjMmQ0ZWJkYjhkNGY2OTlkYmJkN2Y2ZGUwNDgyN2FfOTkx_8558eca7-2f5b-4311-876b-33dbee4b4b28" continuedAt="ic1d3a62b853d47d7aa51519e4c88bfbb" escape="true">The following table disaggregates the Company&#8217;s revenue by geographic region:</ix:nonNumeric></span><ix:continuation id="ic1d3a62b853d47d7aa51519e4c88bfbb"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.568%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Americas</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77268675d9614be1856e94103b41aef3_D20221001-20221230" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180Ni9mcmFnOjJhYzJkNGViZGI4ZDRmNjk5ZGJiZDdmNmRlMDQ4MjdhL3RhYmxlOmJiMWZlNGQ4MDAyMTQ1ZjJiYzk1OGNjY2YyYzM4ZGRmL3RhYmxlcmFuZ2U6YmIxZmU0ZDgwMDIxNDVmMmJjOTU4Y2NjZjJjMzhkZGZfMi0xLTEtMS04MzI4NQ_7435002d-9b43-46e8-b446-bb6c4859aec7">74.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8a6b0f85dcb4a62be851b76f236b2a7_D20211002-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180Ni9mcmFnOjJhYzJkNGViZGI4ZDRmNjk5ZGJiZDdmNmRlMDQ4MjdhL3RhYmxlOmJiMWZlNGQ4MDAyMTQ1ZjJiYzk1OGNjY2YyYzM4ZGRmL3RhYmxlcmFuZ2U6YmIxZmU0ZDgwMDIxNDVmMmJjOTU4Y2NjZjJjMzhkZGZfMi0zLTEtMS04MzI4NQ_eacc2fc9-bd5f-486c-9398-b1fbf33cc894">60.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">EMEA</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04bcd73d30e04bdb841e13dae6931b40_D20221001-20221230" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180Ni9mcmFnOjJhYzJkNGViZGI4ZDRmNjk5ZGJiZDdmNmRlMDQ4MjdhL3RhYmxlOmJiMWZlNGQ4MDAyMTQ1ZjJiYzk1OGNjY2YyYzM4ZGRmL3RhYmxlcmFuZ2U6YmIxZmU0ZDgwMDIxNDVmMmJjOTU4Y2NjZjJjMzhkZGZfMy0xLTEtMS04MzI4NQ_1e57aaf3-f66a-4a19-bd6c-ae191faf6f71">64.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a6a4b942e94c2f93e0cfd38b7b56b9_D20211002-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180Ni9mcmFnOjJhYzJkNGViZGI4ZDRmNjk5ZGJiZDdmNmRlMDQ4MjdhL3RhYmxlOmJiMWZlNGQ4MDAyMTQ1ZjJiYzk1OGNjY2YyYzM4ZGRmL3RhYmxlcmFuZ2U6YmIxZmU0ZDgwMDIxNDVmMmJjOTU4Y2NjZjJjMzhkZGZfMy0zLTEtMS04MzI4NQ_10bc7e47-66ab-4d6c-80da-28ed81eb64de">67.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">APAC</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9142a51de834eb08ccfecaa6fcb247b_D20221001-20221230" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180Ni9mcmFnOjJhYzJkNGViZGI4ZDRmNjk5ZGJiZDdmNmRlMDQ4MjdhL3RhYmxlOmJiMWZlNGQ4MDAyMTQ1ZjJiYzk1OGNjY2YyYzM4ZGRmL3RhYmxlcmFuZ2U6YmIxZmU0ZDgwMDIxNDVmMmJjOTU4Y2NjZjJjMzhkZGZfNC0xLTEtMS04MzI4NQ_9f255933-bb3f-4423-8cd5-a22f68c7e9c1">66.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5faba21f6b9a41c5961c60b0331ab68e_D20211002-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180Ni9mcmFnOjJhYzJkNGViZGI4ZDRmNjk5ZGJiZDdmNmRlMDQ4MjdhL3RhYmxlOmJiMWZlNGQ4MDAyMTQ1ZjJiYzk1OGNjY2YyYzM4ZGRmL3RhYmxlcmFuZ2U6YmIxZmU0ZDgwMDIxNDVmMmJjOTU4Y2NjZjJjMzhkZGZfNC0zLTEtMS04MzI4NQ_8cdeb81f-dd5b-4f75-b836-2e6629bd21c4">70.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180Ni9mcmFnOjJhYzJkNGViZGI4ZDRmNjk5ZGJiZDdmNmRlMDQ4MjdhL3RhYmxlOmJiMWZlNGQ4MDAyMTQ1ZjJiYzk1OGNjY2YyYzM4ZGRmL3RhYmxlcmFuZ2U6YmIxZmU0ZDgwMDIxNDVmMmJjOTU4Y2NjZjJjMzhkZGZfNS0xLTEtMS04MzI4NQ_e69cc7c7-cb9e-4332-b382-88b7074687a2">205.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180Ni9mcmFnOjJhYzJkNGViZGI4ZDRmNjk5ZGJiZDdmNmRlMDQ4MjdhL3RhYmxlOmJiMWZlNGQ4MDAyMTQ1ZjJiYzk1OGNjY2YyYzM4ZGRmL3RhYmxlcmFuZ2U6YmIxZmU0ZDgwMDIxNDVmMmJjOTU4Y2NjZjJjMzhkZGZfNS0zLTEtMS04MzI4NQ_8fc809be-74f0-4eea-8e52-4833e1b4f715">198.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_7">Table of Contents</a></span></div></div><ix:continuation id="ie1e3d7489c81439291f119f2675f44dd"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Revenue in the United States was $<ix:nonFraction unitRef="usd" contextRef="i582fbee024ae43e187bc82bf36e08c7f_D20221001-20221230" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180Ni9mcmFnOjJhYzJkNGViZGI4ZDRmNjk5ZGJiZDdmNmRlMDQ4MjdhL3RleHRyZWdpb246MmFjMmQ0ZWJkYjhkNGY2OTlkYmJkN2Y2ZGUwNDgyN2FfNDA1_bbd66330-a3f5-4d46-8942-901961311ee3">74.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="if0d5d3a41d6e46a8981e7b39df4c4005_D20211002-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180Ni9mcmFnOjJhYzJkNGViZGI4ZDRmNjk5ZGJiZDdmNmRlMDQ4MjdhL3RleHRyZWdpb246MmFjMmQ0ZWJkYjhkNGY2OTlkYmJkN2Y2ZGUwNDgyN2FfNDEy_66f2576a-fa20-4d99-b307-219d07cc7f43">58.8</ix:nonFraction> million for the three months ended December 30, 2022 and December&#160;31, 2021, respectively.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our products are sold in three geographic regions: the Americas, EMEA, and APAC. The Americas includes North America (primarily the United States) and Latin America. EMEA includes Europe, Russia, the Middle East, India and Africa. APAC includes Asia (other than India) and Australia. Revenues by region are based on the known final destination of products sold.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Refer to Note 15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for the disaggregation of the Company&#8217;s revenue based on reportable operating segments.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract Balances</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180Ni9mcmFnOjJhYzJkNGViZGI4ZDRmNjk5ZGJiZDdmNmRlMDQ4MjdhL3RleHRyZWdpb246MmFjMmQ0ZWJkYjhkNGY2OTlkYmJkN2Y2ZGUwNDgyN2FfOTg3_a43adbcd-7568-4267-86bf-f3e5541309a8" continuedAt="ife01b920600a41a19ab25a759512c826" escape="true">The following table summarizes the changes in the contract assets and refund liabilities for the three months ended December 30, 2022 and December&#160;31, 2021:</ix:nonNumeric></span><ix:continuation id="ife01b920600a41a19ab25a759512c826" continuedAt="ie40fabbf772f4e21851337a3ce66c070"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.568%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Contract Assets</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930" decimals="-5" name="us-gaap:ContractWithCustomerAssetNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180Ni9mcmFnOjJhYzJkNGViZGI4ZDRmNjk5ZGJiZDdmNmRlMDQ4MjdhL3RhYmxlOjM3MmE2NGIzYmJlNjRlZTk4NjNjYzNlNjAyYzkwZDA1L3RhYmxlcmFuZ2U6MzcyYTY0YjNiYmU2NGVlOTg2M2NjM2U2MDJjOTBkMDVfMy0xLTEtMS04MzI4NQ_17c929a0-e281-4ce1-bec3-c0f0598cdcc4">25.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i504e59968786494c96b1e46f5375a17d_I20211001" decimals="-5" name="us-gaap:ContractWithCustomerAssetNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180Ni9mcmFnOjJhYzJkNGViZGI4ZDRmNjk5ZGJiZDdmNmRlMDQ4MjdhL3RhYmxlOjM3MmE2NGIzYmJlNjRlZTk4NjNjYzNlNjAyYzkwZDA1L3RhYmxlcmFuZ2U6MzcyYTY0YjNiYmU2NGVlOTg2M2NjM2U2MDJjOTBkMDVfMy0zLTEtMS04MzI4NQ_ea3827f4-45e8-41a9-a8f6-4e2823bc2dee">24.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Costs recovered from product returns during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="us-gaap:ContractWithCustomerAssetCreditLossExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180Ni9mcmFnOjJhYzJkNGViZGI4ZDRmNjk5ZGJiZDdmNmRlMDQ4MjdhL3RhYmxlOjM3MmE2NGIzYmJlNjRlZTk4NjNjYzNlNjAyYzkwZDA1L3RhYmxlcmFuZ2U6MzcyYTY0YjNiYmU2NGVlOTg2M2NjM2U2MDJjOTBkMDVfNC0xLTEtMS04MzI4NQ_dbaf3766-3d13-4137-8ec7-5d4ea325e43e">1.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="us-gaap:ContractWithCustomerAssetCreditLossExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180Ni9mcmFnOjJhYzJkNGViZGI4ZDRmNjk5ZGJiZDdmNmRlMDQ4MjdhL3RhYmxlOjM3MmE2NGIzYmJlNjRlZTk4NjNjYzNlNjAyYzkwZDA1L3RhYmxlcmFuZ2U6MzcyYTY0YjNiYmU2NGVlOTg2M2NjM2U2MDJjOTBkMDVfNC0zLTEtMS04MzI4NQ_cecd9a26-03aa-40a4-a4e7-91dfe66a9fcd">1.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract asset from shipments of products, subject to return during the period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="var:ContractwithCustomerAssetShipments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180Ni9mcmFnOjJhYzJkNGViZGI4ZDRmNjk5ZGJiZDdmNmRlMDQ4MjdhL3RhYmxlOjM3MmE2NGIzYmJlNjRlZTk4NjNjYzNlNjAyYzkwZDA1L3RhYmxlcmFuZ2U6MzcyYTY0YjNiYmU2NGVlOTg2M2NjM2U2MDJjOTBkMDVfNS0xLTEtMS04MzI4NQ_5d7e0b9a-875b-4917-a377-17c684d48612">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="var:ContractwithCustomerAssetShipments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180Ni9mcmFnOjJhYzJkNGViZGI4ZDRmNjk5ZGJiZDdmNmRlMDQ4MjdhL3RhYmxlOjM3MmE2NGIzYmJlNjRlZTk4NjNjYzNlNjAyYzkwZDA1L3RhYmxlcmFuZ2U6MzcyYTY0YjNiYmU2NGVlOTg2M2NjM2U2MDJjOTBkMDVfNS0zLTEtMS04MzI4NQ_d23f7d9e-3c70-4599-9bbe-0561c75ad1a4">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="-5" name="us-gaap:ContractWithCustomerAssetNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180Ni9mcmFnOjJhYzJkNGViZGI4ZDRmNjk5ZGJiZDdmNmRlMDQ4MjdhL3RhYmxlOjM3MmE2NGIzYmJlNjRlZTk4NjNjYzNlNjAyYzkwZDA1L3RhYmxlcmFuZ2U6MzcyYTY0YjNiYmU2NGVlOTg2M2NjM2U2MDJjOTBkMDVfNy0xLTEtMS04MzI4NQ_a3c962e2-2f5b-411d-aa9a-6f8858a39125">25.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4026880a25c245b7ae7af90aa89cf31c_I20211231" decimals="-5" name="us-gaap:ContractWithCustomerAssetNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180Ni9mcmFnOjJhYzJkNGViZGI4ZDRmNjk5ZGJiZDdmNmRlMDQ4MjdhL3RhYmxlOjM3MmE2NGIzYmJlNjRlZTk4NjNjYzNlNjAyYzkwZDA1L3RhYmxlcmFuZ2U6MzcyYTY0YjNiYmU2NGVlOTg2M2NjM2U2MDJjOTBkMDVfNy0zLTEtMS04MzI4NQ_46deaafa-78cf-4a3f-adce-ad6d1a60221c">24.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div style="margin-top:6pt;text-align:center"><ix:continuation id="ie40fabbf772f4e21851337a3ce66c070"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.568%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Refund Liabilities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930" decimals="-5" name="us-gaap:ContractWithCustomerRefundLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180Ni9mcmFnOjJhYzJkNGViZGI4ZDRmNjk5ZGJiZDdmNmRlMDQ4MjdhL3RhYmxlOjJiMmZhOTJhNjY1NjQxNjg5YTM4MmUyZDQ3Yzk0MjBiL3RhYmxlcmFuZ2U6MmIyZmE5MmE2NjU2NDE2ODlhMzgyZTJkNDdjOTQyMGJfMy0xLTEtMS04MzI4NQ_63858c17-6cf7-4f3a-9409-987aa49b0044">28.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i504e59968786494c96b1e46f5375a17d_I20211001" decimals="-5" name="us-gaap:ContractWithCustomerRefundLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180Ni9mcmFnOjJhYzJkNGViZGI4ZDRmNjk5ZGJiZDdmNmRlMDQ4MjdhL3RhYmxlOjJiMmZhOTJhNjY1NjQxNjg5YTM4MmUyZDQ3Yzk0MjBiL3RhYmxlcmFuZ2U6MmIyZmE5MmE2NjU2NDE2ODlhMzgyZTJkNDdjOTQyMGJfMy0zLTEtMS04MzI4NQ_ed7e50e8-2e5b-4295-950b-42729f25e63f">27.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Release of refund liability included in beginning of year refund liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="var:ContractWithCustomerRefundLiabilityAmountReleased" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180Ni9mcmFnOjJhYzJkNGViZGI4ZDRmNjk5ZGJiZDdmNmRlMDQ4MjdhL3RhYmxlOjJiMmZhOTJhNjY1NjQxNjg5YTM4MmUyZDQ3Yzk0MjBiL3RhYmxlcmFuZ2U6MmIyZmE5MmE2NjU2NDE2ODlhMzgyZTJkNDdjOTQyMGJfNC0xLTEtMS04MzI4NQ_9dc65808-3562-40e3-a1d5-6e84f29516e5">1.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="var:ContractWithCustomerRefundLiabilityAmountReleased" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180Ni9mcmFnOjJhYzJkNGViZGI4ZDRmNjk5ZGJiZDdmNmRlMDQ4MjdhL3RhYmxlOjJiMmZhOTJhNjY1NjQxNjg5YTM4MmUyZDQ3Yzk0MjBiL3RhYmxlcmFuZ2U6MmIyZmE5MmE2NjU2NDE2ODlhMzgyZTJkNDdjOTQyMGJfNC0zLTEtMS04MzI4NQ_26e611f6-6360-41eb-8dc2-6ff7204dfc81">1.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additions to refund liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="var:ContractWithCustomerRefundLiabilityAdditions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180Ni9mcmFnOjJhYzJkNGViZGI4ZDRmNjk5ZGJiZDdmNmRlMDQ4MjdhL3RhYmxlOjJiMmZhOTJhNjY1NjQxNjg5YTM4MmUyZDQ3Yzk0MjBiL3RhYmxlcmFuZ2U6MmIyZmE5MmE2NjU2NDE2ODlhMzgyZTJkNDdjOTQyMGJfNS0xLTEtMS04MzI4NQ_9a166b8c-50d1-423b-91db-29295fcc9baf">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="var:ContractWithCustomerRefundLiabilityAdditions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180Ni9mcmFnOjJhYzJkNGViZGI4ZDRmNjk5ZGJiZDdmNmRlMDQ4MjdhL3RhYmxlOjJiMmZhOTJhNjY1NjQxNjg5YTM4MmUyZDQ3Yzk0MjBiL3RhYmxlcmFuZ2U6MmIyZmE5MmE2NjU2NDE2ODlhMzgyZTJkNDdjOTQyMGJfNS0zLTEtMS04MzI4NQ_38e70ab1-8f8d-45ed-b3df-01b6fa7c3482">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="-5" name="us-gaap:ContractWithCustomerRefundLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180Ni9mcmFnOjJhYzJkNGViZGI4ZDRmNjk5ZGJiZDdmNmRlMDQ4MjdhL3RhYmxlOjJiMmZhOTJhNjY1NjQxNjg5YTM4MmUyZDQ3Yzk0MjBiL3RhYmxlcmFuZ2U6MmIyZmE5MmE2NjU2NDE2ODlhMzgyZTJkNDdjOTQyMGJfNy0xLTEtMS04MzI4NQ_11a144b8-97ed-4d63-96e0-fd7bfe71e6c8">28.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4026880a25c245b7ae7af90aa89cf31c_I20211231" decimals="-5" name="us-gaap:ContractWithCustomerRefundLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180Ni9mcmFnOjJhYzJkNGViZGI4ZDRmNjk5ZGJiZDdmNmRlMDQ4MjdhL3RhYmxlOjJiMmZhOTJhNjY1NjQxNjg5YTM4MmUyZDQ3Yzk0MjBiL3RhYmxlcmFuZ2U6MmIyZmE5MmE2NjU2NDE2ODlhMzgyZTJkNDdjOTQyMGJfNy0zLTEtMS04MzI4NQ_d7f06918-aca5-43c9-aee9-143aade72c51">27.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During the three months ended December 30, 2022, the Company recognized revenue of $<ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180Ni9mcmFnOjJhYzJkNGViZGI4ZDRmNjk5ZGJiZDdmNmRlMDQ4MjdhL3RleHRyZWdpb246MmFjMmQ0ZWJkYjhkNGY2OTlkYmJkN2Y2ZGUwNDgyN2FfODE2_da8e007f-ceb8-47ed-b2a7-3a68464f896a">4.2</ix:nonFraction>&#160;million related to deferred revenues which existed at September&#160;30, 2022. During the three months ended December&#160;31, 2021, the Company recognized revenue of $<ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180Ni9mcmFnOjJhYzJkNGViZGI4ZDRmNjk5ZGJiZDdmNmRlMDQ4MjdhL3RleHRyZWdpb246MmFjMmQ0ZWJkYjhkNGY2OTlkYmJkN2Y2ZGUwNDgyN2FfOTI3_49391c05-79cb-44f7-b594-87960854a5fe">4.1</ix:nonFraction>&#160;million related to deferred revenues that existed at October&#160;1, 2021.</span></div></ix:continuation><div id="i4ab573909cb849339357193b017c7d37_49"></div><div style="margin-top:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3. <ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RleHRyZWdpb246YzExNGJiNGYyZjY0NDYzOWFkMGQ5OWVhZDEwMzkwNDRfMTIyOA_6d1cd216-a6a9-4dd6-aadb-00f24690d9d3" continuedAt="ibe047a78aa04425aab0466e0a2ad64b1" escape="true"><ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="us-gaap:LesseeFinanceLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RleHRyZWdpb246YzExNGJiNGYyZjY0NDYzOWFkMGQ5OWVhZDEwMzkwNDRfMTIyOA_956171b6-1129-4364-b81a-458b2653d6bb" continuedAt="id446c474b0b04e14803ebae9cb37ad84" escape="true">LEASES</ix:nonNumeric></ix:nonNumeric></span></div><div style="margin-top:6pt"><ix:continuation id="ibe047a78aa04425aab0466e0a2ad64b1" continuedAt="if0ff6dc7d8174160bfe0c70fb37c3583"><ix:continuation id="id446c474b0b04e14803ebae9cb37ad84" continuedAt="i8090f88aaef24394a6932154aca4c5b4"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company has operating and finance leases for office space, warehouse and manufacturing space, vehicles and certain equipment. During fiscal year 2022, the Company recorded a loss due to abandonment of $<ix:nonFraction unitRef="usd" contextRef="if053d543d68e4983b97631e65183a5d1_D20211002-20220930" decimals="-5" sign="-" name="us-gaap:GainLossOnTerminationOfLease" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RleHRyZWdpb246YzExNGJiNGYyZjY0NDYzOWFkMGQ5OWVhZDEwMzkwNDRfOTM0NTg0ODgzODc0OA_68449150-9fca-4189-988f-57c0780cdce1">1.9</ix:nonFraction>&#160;million, which is included in selling, general and administrative on the Condensed Consolidated Statements of Operations. <ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="var:AssetsAndLiabilitiesLesseeTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RleHRyZWdpb246YzExNGJiNGYyZjY0NDYzOWFkMGQ5OWVhZDEwMzkwNDRfMTIzMA_494758e1-b089-4c52-9e8d-78286bb78857" continuedAt="i8c76bd98fb6c4455b14f9d677ec2dba8" escape="true">The following table presents supplemental balance sheet information related to the Company's operating and finance leases: </ix:nonNumeric></span><ix:continuation id="i8c76bd98fb6c4455b14f9d677ec2dba8"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.511%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.569%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Operating lease assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjEyNTNlNzQwNjAwMzRlZjM4YmM3ZDQyNjA2OTE4NGNiL3RhYmxlcmFuZ2U6MTI1M2U3NDA2MDAzNGVmMzhiYzdkNDI2MDY5MTg0Y2JfMi0zLTEtMS04MzI4NQ_78d6cf6b-91ca-4fd8-8e33-07d0764c75d6">22.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjEyNTNlNzQwNjAwMzRlZjM4YmM3ZDQyNjA2OTE4NGNiL3RhYmxlcmFuZ2U6MTI1M2U3NDA2MDAzNGVmMzhiYzdkNDI2MDY5MTg0Y2JfMi01LTEtMS04MzI4NQ_4a4b1aad-7557-479e-9b32-bc9530d9930f">23.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance lease right-of-use assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjEyNTNlNzQwNjAwMzRlZjM4YmM3ZDQyNjA2OTE4NGNiL3RhYmxlcmFuZ2U6MTI1M2U3NDA2MDAzNGVmMzhiYzdkNDI2MDY5MTg0Y2JfMy0xLTEtMS04MzI4NQ_6fed9dde-ecf9-4697-bdfd-bda3b6c18e81"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjEyNTNlNzQwNjAwMzRlZjM4YmM3ZDQyNjA2OTE4NGNiL3RhYmxlcmFuZ2U6MTI1M2U3NDA2MDAzNGVmMzhiYzdkNDI2MDY5MTg0Y2JfMy0xLTEtMS04MzI4NQ_7db859ec-ae05-400b-a6ff-3ee55890f062">Property, plant, and equipment, net</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjEyNTNlNzQwNjAwMzRlZjM4YmM3ZDQyNjA2OTE4NGNiL3RhYmxlcmFuZ2U6MTI1M2U3NDA2MDAzNGVmMzhiYzdkNDI2MDY5MTg0Y2JfMy0zLTEtMS04MzI4NQ_32c4edb4-edfc-4dfe-a064-76b43e300718">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjEyNTNlNzQwNjAwMzRlZjM4YmM3ZDQyNjA2OTE4NGNiL3RhYmxlcmFuZ2U6MTI1M2U3NDA2MDAzNGVmMzhiYzdkNDI2MDY5MTg0Y2JfMy01LTEtMS04MzI4NQ_c0e1566f-9d41-4f3c-b871-6f968491a92e">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liabilities (current) </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Current operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="-5" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjEyNTNlNzQwNjAwMzRlZjM4YmM3ZDQyNjA2OTE4NGNiL3RhYmxlcmFuZ2U6MTI1M2U3NDA2MDAzNGVmMzhiYzdkNDI2MDY5MTg0Y2JfNS0zLTEtMS04MzI4NQ_a23e5501-dfe2-4667-af5f-ed1050f51480">3.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930" decimals="-5" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjEyNTNlNzQwNjAwMzRlZjM4YmM3ZDQyNjA2OTE4NGNiL3RhYmxlcmFuZ2U6MTI1M2U3NDA2MDAzNGVmMzhiYzdkNDI2MDY5MTg0Y2JfNS01LTEtMS04MzI4NQ_38713fb0-ff33-4c4d-95bf-434fdb659e1a">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance lease liabilities (current) </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjEyNTNlNzQwNjAwMzRlZjM4YmM3ZDQyNjA2OTE4NGNiL3RhYmxlcmFuZ2U6MTI1M2U3NDA2MDAzNGVmMzhiYzdkNDI2MDY5MTg0Y2JfNi0xLTEtMS04MzI4NQ_21d67cfe-4f11-4971-a007-53438e019ae1"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjEyNTNlNzQwNjAwMzRlZjM4YmM3ZDQyNjA2OTE4NGNiL3RhYmxlcmFuZ2U6MTI1M2U3NDA2MDAzNGVmMzhiYzdkNDI2MDY5MTg0Y2JfNi0xLTEtMS04MzI4NQ_651facb0-63c0-4af0-8d59-d1e007979e09">Accrued liabilities and other current liabilities</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="-5" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjEyNTNlNzQwNjAwMzRlZjM4YmM3ZDQyNjA2OTE4NGNiL3RhYmxlcmFuZ2U6MTI1M2U3NDA2MDAzNGVmMzhiYzdkNDI2MDY5MTg0Y2JfNi0zLTEtMS04MzI4NQ_a24690d2-e2dd-4f35-90d8-a20045d769f4">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930" decimals="-5" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjEyNTNlNzQwNjAwMzRlZjM4YmM3ZDQyNjA2OTE4NGNiL3RhYmxlcmFuZ2U6MTI1M2U3NDA2MDAzNGVmMzhiYzdkNDI2MDY5MTg0Y2JfNi01LTEtMS04MzI4NQ_4f2fcd29-4cc6-479d-8df0-39a42a76d309">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liabilities (non-current)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="-5" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjEyNTNlNzQwNjAwMzRlZjM4YmM3ZDQyNjA2OTE4NGNiL3RhYmxlcmFuZ2U6MTI1M2U3NDA2MDAzNGVmMzhiYzdkNDI2MDY5MTg0Y2JfNy0zLTEtMS04MzI4NQ_25c6c574-11c7-4468-abbe-e0626f4d4b5b">17.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930" decimals="-5" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjEyNTNlNzQwNjAwMzRlZjM4YmM3ZDQyNjA2OTE4NGNiL3RhYmxlcmFuZ2U6MTI1M2U3NDA2MDAzNGVmMzhiYzdkNDI2MDY5MTg0Y2JfNy01LTEtMS04MzI4NQ_b788def8-9096-4dc1-8b6e-c576caddf990">18.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance lease liabilities (non-current)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjEyNTNlNzQwNjAwMzRlZjM4YmM3ZDQyNjA2OTE4NGNiL3RhYmxlcmFuZ2U6MTI1M2U3NDA2MDAzNGVmMzhiYzdkNDI2MDY5MTg0Y2JfOC0xLTEtMS04MzI4NQ_0e1c436b-8779-4e63-90c2-6287c33ec16d"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjEyNTNlNzQwNjAwMzRlZjM4YmM3ZDQyNjA2OTE4NGNiL3RhYmxlcmFuZ2U6MTI1M2U3NDA2MDAzNGVmMzhiYzdkNDI2MDY5MTg0Y2JfOC0xLTEtMS04MzI4NQ_8cf1f2a5-8b40-40ac-84e4-96b9a215a402">Other long-term liabilities</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="-5" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjEyNTNlNzQwNjAwMzRlZjM4YmM3ZDQyNjA2OTE4NGNiL3RhYmxlcmFuZ2U6MTI1M2U3NDA2MDAzNGVmMzhiYzdkNDI2MDY5MTg0Y2JfOC0zLTEtMS04MzI4NQ_c8ff4f3c-2639-43f9-b077-f70423e15530">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930" decimals="-5" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjEyNTNlNzQwNjAwMzRlZjM4YmM3ZDQyNjA2OTE4NGNiL3RhYmxlcmFuZ2U6MTI1M2U3NDA2MDAzNGVmMzhiYzdkNDI2MDY5MTg0Y2JfOC01LTEtMS04MzI4NQ_5ffe6b70-8648-48aa-b211-e2ea8ac557ac">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></ix:continuation></ix:continuation></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_7">Table of Contents</a></span></div></div><ix:continuation id="if0ff6dc7d8174160bfe0c70fb37c3583"><ix:continuation id="i8090f88aaef24394a6932154aca4c5b4"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RleHRyZWdpb246YzExNGJiNGYyZjY0NDYzOWFkMGQ5OWVhZDEwMzkwNDRfMTIyNA_32488ed6-a736-4402-9aab-b6ef08fc1f91" continuedAt="i11d1a63576c84e08a0f8d91c8ca27648" escape="true">The following table provides information related to the Company&#8217;s operating and finance leases:</ix:nonNumeric></span><ix:continuation id="i11d1a63576c84e08a0f8d91c8ca27648" continuedAt="i30c545deeded42a29d553d5c2cbd869d"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.568%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating lease costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="us-gaap:OperatingLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjlmNjEwM2YzNjY4YjQyZjE4M2FhMzkzNzM4ZmVmODU1L3RhYmxlcmFuZ2U6OWY2MTAzZjM2NjhiNDJmMTgzYWEzOTM3MzhmZWY4NTVfMi0xLTEtMS04MzI4NQ_7712bc09-b055-460f-b5c0-f9a28e7fb6d6">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="us-gaap:OperatingLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjlmNjEwM2YzNjY4YjQyZjE4M2FhMzkzNzM4ZmVmODU1L3RhYmxlcmFuZ2U6OWY2MTAzZjM2NjhiNDJmMTgzYWEzOTM3MzhmZWY4NTVfMi0zLTEtMS04MzI4NQ_2e68da2e-47ed-44d5-a04c-f9b3a2cd9f9f">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total finance lease costs</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="var:LeaseCostFinanceLeaseCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjlmNjEwM2YzNjY4YjQyZjE4M2FhMzkzNzM4ZmVmODU1L3RhYmxlcmFuZ2U6OWY2MTAzZjM2NjhiNDJmMTgzYWEzOTM3MzhmZWY4NTVfNC0xLTEtMS04MzI4NQ_c19831f2-7b95-4d8c-b389-b9b7f650dccb">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="var:LeaseCostFinanceLeaseCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjlmNjEwM2YzNjY4YjQyZjE4M2FhMzkzNzM4ZmVmODU1L3RhYmxlcmFuZ2U6OWY2MTAzZjM2NjhiNDJmMTgzYWEzOTM3MzhmZWY4NTVfNC0zLTEtMS04MzI4NQ_f3bc918d-ad7f-4ea3-baa1-3983755b1012">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="us-gaap:OperatingLeasePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjlmNjEwM2YzNjY4YjQyZjE4M2FhMzkzNzM4ZmVmODU1L3RhYmxlcmFuZ2U6OWY2MTAzZjM2NjhiNDJmMTgzYWEzOTM3MzhmZWY4NTVfNi0xLTEtMS04MzI4NQ_10e120bd-0539-4a58-b75c-6cde0561ee6e">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="us-gaap:OperatingLeasePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjlmNjEwM2YzNjY4YjQyZjE4M2FhMzkzNzM4ZmVmODU1L3RhYmxlcmFuZ2U6OWY2MTAzZjM2NjhiNDJmMTgzYWEzOTM3MzhmZWY4NTVfNi0zLTEtMS04MzI4NQ_e76bb357-66e9-4129-91ed-2d7232730ca7">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financing cash flows from finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="us-gaap:FinanceLeasePrincipalPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjlmNjEwM2YzNjY4YjQyZjE4M2FhMzkzNzM4ZmVmODU1L3RhYmxlcmFuZ2U6OWY2MTAzZjM2NjhiNDJmMTgzYWEzOTM3MzhmZWY4NTVfNy0xLTEtMS04MzI4NQ_2f8120a3-9586-4027-abac-caebc6ce3ae2">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="us-gaap:FinanceLeasePrincipalPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjlmNjEwM2YzNjY4YjQyZjE4M2FhMzkzNzM4ZmVmODU1L3RhYmxlcmFuZ2U6OWY2MTAzZjM2NjhiNDJmMTgzYWEzOTM3MzhmZWY4NTVfNy0zLTEtMS04MzI4NQ_4a008841-af12-4024-bd90-9ebe1cb1a242">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total cash paid for amounts included in the measurement of lease liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="var:CashPaidForOperatingAndFinanceLeases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjlmNjEwM2YzNjY4YjQyZjE4M2FhMzkzNzM4ZmVmODU1L3RhYmxlcmFuZ2U6OWY2MTAzZjM2NjhiNDJmMTgzYWEzOTM3MzhmZWY4NTVfOC0xLTEtMS04MzI4NQ_d5b06888-611e-4ef0-9990-222a57273034">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="var:CashPaidForOperatingAndFinanceLeases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjlmNjEwM2YzNjY4YjQyZjE4M2FhMzkzNzM4ZmVmODU1L3RhYmxlcmFuZ2U6OWY2MTAzZjM2NjhiNDJmMTgzYWEzOTM3MzhmZWY4NTVfOC0zLTEtMS04MzI4NQ_74c6c1fd-c514-428e-9941-d81762995b8f">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncash operating right-of-use assets obtained in exchange for new lease liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjlmNjEwM2YzNjY4YjQyZjE4M2FhMzkzNzM4ZmVmODU1L3RhYmxlcmFuZ2U6OWY2MTAzZjM2NjhiNDJmMTgzYWEzOTM3MzhmZWY4NTVfMTAtMS0xLTEtODMyODU_32f70b21-43a2-4dc5-8f4a-cefecbbd6f17">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjlmNjEwM2YzNjY4YjQyZjE4M2FhMzkzNzM4ZmVmODU1L3RhYmxlcmFuZ2U6OWY2MTAzZjM2NjhiNDJmMTgzYWEzOTM3MzhmZWY4NTVfMTAtMy0xLTEtODMyODU_7602fffe-4f96-49cc-9357-b0ecb78dac95">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div style="margin-top:5pt"><ix:continuation id="i30c545deeded42a29d553d5c2cbd869d"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Includes variable and short-term lease expense, which were immaterial for the three months ended December 30, 2022 and December&#160;31, 2021.</span></ix:continuation></div></ix:continuation></ix:continuation><div id="i4ab573909cb849339357193b017c7d37_52"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4. <ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181Mi9mcmFnOjcxMjJjZGE5MDBkYTRhOTliNTExMzZiOGRiMTNiOTBjL3RleHRyZWdpb246NzEyMmNkYTkwMGRhNGE5OWI1MTEzNmI4ZGIxM2I5MGNfNDExNQ_ab05e2c9-1682-40ee-94e4-55b1ea1d8d86" continuedAt="i7f735bf5aee54584b428fc2bfd0b8072" escape="true">RELATED-PARTY TRANSACTIONS</ix:nonNumeric></span></div><ix:continuation id="i7f735bf5aee54584b428fc2bfd0b8072" continuedAt="if1a1a751fab9444e9eb00fafc03bfd2f"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investment in Privately-Held Companies</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company has a <ix:nonFraction unitRef="number" contextRef="id11c0d105587406ea12579388d33acc6_I20221230" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181Mi9mcmFnOjcxMjJjZGE5MDBkYTRhOTliNTExMzZiOGRiMTNiOTBjL3RleHRyZWdpb246NzEyMmNkYTkwMGRhNGE5OWI1MTEzNmI4ZGIxM2I5MGNfOTQ_e6b8c93c-231e-4a23-8a3f-874590ca26fb">40</ix:nonFraction>% ownership interest in dpiX Holding LLC (&#8220;dpiX Holding&#8221;), a holding company that has a <ix:nonFraction unitRef="number" contextRef="i3c5473e7e6e2416283c3708bf75140f0_I20221230" decimals="INF" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181Mi9mcmFnOjcxMjJjZGE5MDBkYTRhOTliNTExMzZiOGRiMTNiOTBjL3RleHRyZWdpb246NzEyMmNkYTkwMGRhNGE5OWI1MTEzNmI4ZGIxM2I5MGNfMTgz_69704e6d-3b2a-4a62-ac7a-94c28b8ff23f">100</ix:nonFraction>% ownership interest in dpiX LLC (&#8220;dpiX&#8221;), a supplier of amorphous silicon-based thin film transistor arrays for flat panels used in its digital image detectors. In accordance with the dpiX Holding operating agreement, net profits or losses are allocated to the members in accordance with their ownership interests.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The investment in dpiX Holding is accounted for under the equity method of accounting. When the Company recognizes its share of net profits or losses of dpiX Holding, profits or losses in inventory purchased from dpiX are eliminated. During the three months ended December 30, 2022 and December&#160;31, 2021, the Company recorded income (loss) on the equity investment in dpiX Holding of $<ix:nonFraction unitRef="usd" contextRef="i651cdb90544d4fc5ae96aa228e377585_D20221001-20221230" decimals="-5" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181Mi9mcmFnOjcxMjJjZGE5MDBkYTRhOTliNTExMzZiOGRiMTNiOTBjL3RleHRyZWdpb246NzEyMmNkYTkwMGRhNGE5OWI1MTEzNmI4ZGIxM2I5MGNfODEy_bff22aba-45f0-485d-9c21-55d0d223e9eb">2.0</ix:nonFraction> million and $(<ix:nonFraction unitRef="usd" contextRef="i1e78a329a9904ab4ad46da4fa3ad9d85_D20211002-20211231" decimals="-5" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181Mi9mcmFnOjcxMjJjZGE5MDBkYTRhOTliNTExMzZiOGRiMTNiOTBjL3RleHRyZWdpb246NzEyMmNkYTkwMGRhNGE5OWI1MTEzNmI4ZGIxM2I5MGNfMTA5OTUxMTYzNDc4Mw_2a2fb9d5-d2f6-4a7c-a3d5-9760b77152b3">0.7</ix:nonFraction>) million, respectively. The income and loss on the equity investment in dpiX Holding are included in other expense, net in the Condensed Consolidated Statements of Operations. The carrying value of the equity investment in dpiX Holding was $<ix:nonFraction unitRef="usd" contextRef="id11c0d105587406ea12579388d33acc6_I20221230" decimals="-5" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181Mi9mcmFnOjcxMjJjZGE5MDBkYTRhOTliNTExMzZiOGRiMTNiOTBjL3RleHRyZWdpb246NzEyMmNkYTkwMGRhNGE5OWI1MTEzNmI4ZGIxM2I5MGNfMTE1NA_0d499ecd-c3c1-400b-a5b5-a0754b47ad6d">44.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i754dac8665dd449eb1ba41e245554f36_I20220930" decimals="-5" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181Mi9mcmFnOjcxMjJjZGE5MDBkYTRhOTliNTExMzZiOGRiMTNiOTBjL3RleHRyZWdpb246NzEyMmNkYTkwMGRhNGE5OWI1MTEzNmI4ZGIxM2I5MGNfMTE2MQ_9e43e06d-9988-49f2-95b1-ec2d75cff95d">42.4</ix:nonFraction> million at December&#160;30, 2022 and September&#160;30, 2022, respectively.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During the three months ended December 30, 2022 and December&#160;31, 2021, the Company purchased glass transistor arrays from dpiX totaling $<ix:nonFraction unitRef="usd" contextRef="i651cdb90544d4fc5ae96aa228e377585_D20221001-20221230" decimals="-5" name="us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181Mi9mcmFnOjcxMjJjZGE5MDBkYTRhOTliNTExMzZiOGRiMTNiOTBjL3RleHRyZWdpb246NzEyMmNkYTkwMGRhNGE5OWI1MTEzNmI4ZGIxM2I5MGNfMTI4MA_b46c90ac-d5b7-4f43-90d1-c558fa49de6f">5.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i1e78a329a9904ab4ad46da4fa3ad9d85_D20211002-20211231" decimals="-5" name="us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181Mi9mcmFnOjcxMjJjZGE5MDBkYTRhOTliNTExMzZiOGRiMTNiOTBjL3RleHRyZWdpb246NzEyMmNkYTkwMGRhNGE5OWI1MTEzNmI4ZGIxM2I5MGNfMTI4Nw_3d4526cb-5257-47df-8fb8-6cc634014685">5.2</ix:nonFraction> million, respectively. These purchases of glass transistor arrays are included as a component of inventories on the Condensed Consolidated Balance Sheets or cost of revenues in the Condensed Consolidated Statements of Operations.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of December&#160;30, 2022, and September&#160;30, 2022, the Company had accounts payable to dpiX totaling $<ix:nonFraction unitRef="usd" contextRef="id11c0d105587406ea12579388d33acc6_I20221230" decimals="-5" name="us-gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181Mi9mcmFnOjcxMjJjZGE5MDBkYTRhOTliNTExMzZiOGRiMTNiOTBjL3RleHRyZWdpb246NzEyMmNkYTkwMGRhNGE5OWI1MTEzNmI4ZGIxM2I5MGNfMTY3MA_e3fa0740-abcd-4479-9196-f1d7b564aaf9">3.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i754dac8665dd449eb1ba41e245554f36_I20220930" decimals="-5" name="us-gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181Mi9mcmFnOjcxMjJjZGE5MDBkYTRhOTliNTExMzZiOGRiMTNiOTBjL3RleHRyZWdpb246NzEyMmNkYTkwMGRhNGE5OWI1MTEzNmI4ZGIxM2I5MGNfMTY3Nw_5702114d-c3ee-45d6-9590-59c79d87ac5f">3.1</ix:nonFraction>&#160;million, respectively. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; The Company has the right to <ix:nonFraction unitRef="number" contextRef="i651cdb90544d4fc5ae96aa228e377585_D20221001-20221230" decimals="2" name="var:PercentageOfManufacturingCapacity" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181Mi9mcmFnOjcxMjJjZGE5MDBkYTRhOTliNTExMzZiOGRiMTNiOTBjL3RleHRyZWdpb246NzEyMmNkYTkwMGRhNGE5OWI1MTEzNmI4ZGIxM2I5MGNfMTgzMw_96628223-082a-4616-bf46-4d5d0997fb55">50</ix:nonFraction>% of dpiX&#8217;s total manufacturing capacity. In addition, the Company is required to pay for <ix:nonFraction unitRef="number" contextRef="i651cdb90544d4fc5ae96aa228e377585_D20221001-20221230" decimals="2" name="var:PercentageOfFixedCosts" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181Mi9mcmFnOjcxMjJjZGE5MDBkYTRhOTliNTExMzZiOGRiMTNiOTBjL3RleHRyZWdpb246NzEyMmNkYTkwMGRhNGE5OWI1MTEzNmI4ZGIxM2I5MGNfMTkyNA_556d9af8-15cd-4694-97ed-548bd799f155">50</ix:nonFraction>% of dpiX's fixed costs, as determined at the beginning of each calendar year. In January 2023, the Company's fixed cost commitment was determined and approved by the dpiX board of directors to be $<ix:nonFraction unitRef="usd" contextRef="i70ff6a02b02a447d974ae2a3ad5485bc_D20230101-20231231" decimals="-5" name="var:RelatedPartyTransactionApprovedPurchasesFromRelatedParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181Mi9mcmFnOjcxMjJjZGE5MDBkYTRhOTliNTExMzZiOGRiMTNiOTBjL3RleHRyZWdpb246NzEyMmNkYTkwMGRhNGE5OWI1MTEzNmI4ZGIxM2I5MGNfMjEyMg_8204da03-2749-4efc-9f41-e91d71e686f1">13.1</ix:nonFraction> million for calendar year 2023. The amended agreement will continue unless the ownership structure of dpiX changes (as defined in the amended agreement).</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company has determined that dpiX Holding is a variable interest entity because at-risk equity holders, as a group, lack the characteristics of a controlling financial interest. Majority votes are required to direct the manufacturing activities, legal operations and other activities that most significantly affect dpiX&#8217;s economic performance. The Company does not have majority voting rights and no power to unilaterally direct the activities of dpiX Holding and therefore is not the primary beneficiary of dpiX Holding. The Company&#8217;s exposure to loss as a result of its involvement with dpiX Holding is limited to the carrying value of the Company&#8217;s investment of $<ix:nonFraction unitRef="usd" contextRef="id11c0d105587406ea12579388d33acc6_I20221230" decimals="-5" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181Mi9mcmFnOjcxMjJjZGE5MDBkYTRhOTliNTExMzZiOGRiMTNiOTBjL3RleHRyZWdpb246NzEyMmNkYTkwMGRhNGE5OWI1MTEzNmI4ZGIxM2I5MGNfMzA4Ng_0d499ecd-c3c1-400b-a5b5-a0754b47ad6d">44.4</ix:nonFraction>&#160;million and fixed cost commitments.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In November 2018, the Company (through one of its wholly-owned subsidiaries) and CETTEEN GmbH (&#8220;CETTEEN&#8221;), formed a German limited liability company that governs the affairs and conduct of the business of VEC Imaging GmbH &amp; Co. KG (&#8220;VEC&#8221;), a joint venture formed to develop technology for use in X-ray imaging components. In accordance with the VEC agreement, net profits or losses are allocated to the members in accordance with their ownership interest. The Company's investment in VEC is accounted for under the equity method of accounting. The Company has determined that VEC is a variable interest entity.</span></div></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="if1a1a751fab9444e9eb00fafc03bfd2f">&#160;&#160;&#160;&#160;During the three months ended December 30, 2022, and December&#160;31, 2021, the Company recorded a loss on the equity investment in VEC of $<ix:nonFraction unitRef="usd" contextRef="i043d35fe9e8748dba721e7442a223c87_D20221001-20221230" decimals="-5" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181Mi9mcmFnOjcxMjJjZGE5MDBkYTRhOTliNTExMzZiOGRiMTNiOTBjL3RleHRyZWdpb246NzEyMmNkYTkwMGRhNGE5OWI1MTEzNmI4ZGIxM2I5MGNfMzc0OA_31158989-9d0b-4075-b77f-d06d43a15a2b">0.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i23fdde7b29af4c57aa6824e48992f27e_D20211002-20211231" decimals="-5" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181Mi9mcmFnOjcxMjJjZGE5MDBkYTRhOTliNTExMzZiOGRiMTNiOTBjL3RleHRyZWdpb246NzEyMmNkYTkwMGRhNGE5OWI1MTEzNmI4ZGIxM2I5MGNfMzc1NQ_63ec8b01-7d62-4c8a-a12d-d5ddac0784fd">0.1</ix:nonFraction> million, respectively. The Company's investment in VEC was $<ix:nonFraction unitRef="usd" contextRef="ide9a8d3681694417a4a4545b01157b8d_I20221230" decimals="-5" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181Mi9mcmFnOjcxMjJjZGE5MDBkYTRhOTliNTExMzZiOGRiMTNiOTBjL3RleHRyZWdpb246NzEyMmNkYTkwMGRhNGE5OWI1MTEzNmI4ZGIxM2I5MGNfMzkyMA_bd26b383-8357-45d1-a6b2-b337f719a428">2.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ic6403b22953a49d8b910f2bf553fd441_I20220930" decimals="-5" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181Mi9mcmFnOjcxMjJjZGE5MDBkYTRhOTliNTExMzZiOGRiMTNiOTBjL3RleHRyZWdpb246NzEyMmNkYTkwMGRhNGE5OWI1MTEzNmI4ZGIxM2I5MGNfMzkyNw_effc7e03-7331-4c6e-827b-5137013b9e3d">2.5</ix:nonFraction> million at December&#160;30, 2022 and September&#160;30, 2022, respectively. As of December&#160;30, 2022 and September&#160;30, 2022 the Company had loans outstanding to VEC totaling $<ix:nonFraction unitRef="usd" contextRef="ic6403b22953a49d8b910f2bf553fd441_I20220930" decimals="-5" name="us-gaap:DueToRelatedPartiesCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181Mi9mcmFnOjcxMjJjZGE5MDBkYTRhOTliNTExMzZiOGRiMTNiOTBjL3RleHRyZWdpb246NzEyMmNkYTkwMGRhNGE5OWI1MTEzNmI4ZGIxM2I5MGNfMTY0OTI2NzQ0Njg2MQ_567f9bb1-11a0-40c8-b02f-04b87f3d0793"><ix:nonFraction unitRef="usd" contextRef="ide9a8d3681694417a4a4545b01157b8d_I20221230" decimals="-5" name="us-gaap:DueToRelatedPartiesCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181Mi9mcmFnOjcxMjJjZGE5MDBkYTRhOTliNTExMzZiOGRiMTNiOTBjL3RleHRyZWdpb246NzEyMmNkYTkwMGRhNGE5OWI1MTEzNmI4ZGIxM2I5MGNfMTY0OTI2NzQ0Njg2MQ_be923135-9fe4-460b-945c-d955e68cc785">0.6</ix:nonFraction></ix:nonFraction> million, and other receivables from VEC of $<ix:nonFraction unitRef="usd" contextRef="ide9a8d3681694417a4a4545b01157b8d_I20221230" decimals="-5" name="us-gaap:OtherReceivables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181Mi9mcmFnOjcxMjJjZGE5MDBkYTRhOTliNTExMzZiOGRiMTNiOTBjL3RleHRyZWdpb246NzEyMmNkYTkwMGRhNGE5OWI1MTEzNmI4ZGIxM2I5MGNfMTY0OTI2NzQ0Njg3NA_8833a475-45d5-4f56-95f8-c4a16cc30362">0.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ic6403b22953a49d8b910f2bf553fd441_I20220930" decimals="-5" name="us-gaap:OtherReceivables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181Mi9mcmFnOjcxMjJjZGE5MDBkYTRhOTliNTExMzZiOGRiMTNiOTBjL3RleHRyZWdpb246NzEyMmNkYTkwMGRhNGE5OWI1MTEzNmI4ZGIxM2I5MGNfMTY0OTI2NzQ0Njg2OA_96b0f504-f60f-4736-88ac-e12b5664fcff">0.3</ix:nonFraction> million at December&#160;30, 2022 and September&#160;30, 2022, respectively, which are recorded in prepaid expenses and other current assets in the Condensed Consolidated Balance Sheets.</ix:continuation> </span></div><div id="i4ab573909cb849339357193b017c7d37_55"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5. <ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181NS9mcmFnOmM1NmMxOGM5NDE2MTQ4YmI5NWE2MWE0YzBlYmIwOTY4L3RleHRyZWdpb246YzU2YzE4Yzk0MTYxNDhiYjk1YTYxYTRjMGViYjA5NjhfODI3_fe2a8b7c-64a1-4f57-ac22-0fca12260048" continuedAt="i57a9595579124f5bbf07e1009be75b36" escape="true">RESTRUCTURING</ix:nonNumeric></span></div><ix:continuation id="i57a9595579124f5bbf07e1009be75b36"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In July 2018, the Company committed to relocate the production of amorphous silicon glass for digital detectors from its Santa Clara facility to the dpiX fabrication facility in Colorado. In July 2019, the Company committed to close its Santa Clara facility and to relocate the remaining production to its other existing facilities.&#160;The Company ceased all operations at the Santa Clara facility as of October 2, 2020, and all activities related to the closure of the facility were completed by the end of December 2020.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Cash outflows associated with these restructuring charges are limited to employee termination expenses, facility closure and equipment sales and disposals. <ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181NS9mcmFnOmM1NmMxOGM5NDE2MTQ4YmI5NWE2MWE0YzBlYmIwOTY4L3RleHRyZWdpb246YzU2YzE4Yzk0MTYxNDhiYjk1YTYxYTRjMGViYjA5NjhfODI5_61d06dfc-5030-4bb0-aeef-c2dce4f909b9" continuedAt="i1597372a20ba44cca2d9a2f96131e645" escape="true">Below is a detail of restructuring charges incurred during the three months ended December 30, 2022 and December&#160;31, 2021, respectively, which predominantly relate to the Company's Medical segment:</ix:nonNumeric></span><ix:continuation id="i1597372a20ba44cca2d9a2f96131e645"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.650%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.427%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.569%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Location of Restructuring Charges in Condensed Consolidated Statements of Operations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets impairment charges</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="us-gaap:OtherAssetImpairmentCharges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181NS9mcmFnOmM1NmMxOGM5NDE2MTQ4YmI5NWE2MWE0YzBlYmIwOTY4L3RhYmxlOjBmNTJkNmUyNWNlODQxMDg5NGQ0YTNjY2Y5YzFjNGUwL3RhYmxlcmFuZ2U6MGY1MmQ2ZTI1Y2U4NDEwODk0ZDRhM2NjZjljMWM0ZTBfMi0zLTEtMS04MzI4NQ_ee4e7c7f-5a09-4f40-99e3-45ee32746312">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="us-gaap:OtherAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181NS9mcmFnOmM1NmMxOGM5NDE2MTQ4YmI5NWE2MWE0YzBlYmIwOTY4L3RhYmxlOjBmNTJkNmUyNWNlODQxMDg5NGQ0YTNjY2Y5YzFjNGUwL3RhYmxlcmFuZ2U6MGY1MmQ2ZTI1Y2U4NDEwODk0ZDRhM2NjZjljMWM0ZTBfMi01LTEtMS04MzI4NQ_6a7cb9a9-0551-4489-8742-4c83a8a578d9">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div></ix:continuation><div id="i4ab573909cb849339357193b017c7d37_58"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6. <ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181OC9mcmFnOmI2MjBmMTkwNjg5MTQ3YmNhOGFmNDQxNTI3NWFiNTBjL3RleHRyZWdpb246YjYyMGYxOTA2ODkxNDdiY2E4YWY0NDE1Mjc1YWI1MGNfNTAyMg_f1fd9c82-3f2a-4a3d-b634-913687354fbd" continuedAt="ide0014d5483e415ab931a4ad2b64fb90" escape="true">FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES</ix:nonNumeric></span></div><ix:continuation id="ide0014d5483e415ab931a4ad2b64fb90" continuedAt="icc79e87a48254223ba99c887d705e655"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As part of the Company&#8217;s overall risk management practices, the Company enters into financial derivatives to manage its financial exposures to foreign currency exchange rates and interest rates.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company records all derivatives on the Condensed Consolidated Balance Sheets at fair value. The accounting for changes in the fair value of derivatives depends on the intended use of the derivative, whether the Company has elected to designate a derivative in a hedging relationship and apply hedge accounting, and whether the hedging relationship has satisfied the criteria necessary to apply hedge accounting. A qualitative assessment of hedge effectiveness is performed on a quarterly basis, unless facts and circumstances indicate the hedge may no longer be highly effective, in which case the Company would test for effectiveness on a more frequent basis. The changes in fair value for all trades that are not designated for hedge accounting are recognized in current period income. The Company does not offset fair value amounts recognized for derivative instruments in its Condensed Consolidated Balance Sheets for presentation purposes.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Credit risk related to derivative transactions reflects the risk that a party to the transaction could fail to meet its obligation under the derivative contracts. Therefore, the Company&#8217;s exposure to the counterparty&#8217;s credit risk is generally limited to the amounts, if any, by which the counterparty&#8217;s obligations to the Company exceed the Company&#8217;s obligations to the counterparty. The Company&#8217;s policy is to enter into contracts only with financial institutions that meet certain minimum credit ratings to help mitigate counterparty credit risk.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivatives Designated as Hedging Instruments - Net Investment Hedges</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company&#160;uses cross currency swap contracts as net investment hedges to manage its risk of variability in foreign currency-denominated net investments in wholly-owned international operations. All changes in fair value of the derivatives designated as net investment hedges are reported in&#160;accumulated other comprehensive income along with the foreign currency translation adjustments on those investments. During the three months ended December 30, 2022, the Company terminated all <ix:nonFraction unitRef="instrument" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="INF" name="var:DerivativeNumberOfInstrumentsTerminated" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181OC9mcmFnOmI2MjBmMTkwNjg5MTQ3YmNhOGFmNDQxNTI3NWFiNTBjL3RleHRyZWdpb246YjYyMGYxOTA2ODkxNDdiY2E4YWY0NDE1Mjc1YWI1MGNfNzY5NjU4MTQwMTgzNg_e546a4bf-95dd-41dd-9f66-176600a98c51">three</ix:nonFraction> of its previously outstanding cross currency swap contracts which resulted in cash received upon settlement of $<ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="us-gaap:DerivativeCashReceivedOnHedge" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181OC9mcmFnOmI2MjBmMTkwNjg5MTQ3YmNhOGFmNDQxNTI3NWFiNTBjL3RleHRyZWdpb246YjYyMGYxOTA2ODkxNDdiY2E4YWY0NDE1Mjc1YWI1MGNfNTQ5NzU1ODIxNDI2_cfda90b7-16de-4a47-b888-3a3338e7b2d9">7.3</ix:nonFraction> million. The gain on the swap was recorded in accumulated other comprehensive income where it will remain until such time that substantial liquidation of the international operations should occur. Concurrent with the termination of the previous cross currency swaps, the Company entered into two new cross currency swaps which have been designated as net investment hedges.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="us-gaap:ScheduleOfDerivativeInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181OC9mcmFnOmI2MjBmMTkwNjg5MTQ3YmNhOGFmNDQxNTI3NWFiNTBjL3RleHRyZWdpb246YjYyMGYxOTA2ODkxNDdiY2E4YWY0NDE1Mjc1YWI1MGNfNTAyNQ_75838034-cae5-4948-8d9d-87f059be4a1d" continuedAt="i15e0e9d07fba4274ba6fe98124ba4312" escape="true">As of&#160;December&#160;30, 2022, the Company had the following outstanding derivatives designated as net investment hedging instruments:</ix:nonNumeric></span><ix:continuation id="i15e0e9d07fba4274ba6fe98124ba4312"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions, except number of instruments)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of Instruments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Notional Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="derivativecontract" contextRef="i4a06e1fd56de45429cf0fcaeadd92091_I20221230" decimals="INF" name="us-gaap:DerivativeNumberOfInstrumentsHeld" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181OC9mcmFnOmI2MjBmMTkwNjg5MTQ3YmNhOGFmNDQxNTI3NWFiNTBjL3RhYmxlOjVjNTk0YTFkNWY5YTQ1MTc5MGQ3ODQ2Njc2YzA5ZWFjL3RhYmxlcmFuZ2U6NWM1OTRhMWQ1ZjlhNDUxNzkwZDc4NDY2NzZjMDllYWNfMS0xLTEtMS04MzI4NQ_44039085-5372-49da-98ff-db551c4cebb7">2</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a06e1fd56de45429cf0fcaeadd92091_I20221230" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181OC9mcmFnOmI2MjBmMTkwNjg5MTQ3YmNhOGFmNDQxNTI3NWFiNTBjL3RhYmxlOjVjNTk0YTFkNWY5YTQ1MTc5MGQ3ODQ2Njc2YzA5ZWFjL3RhYmxlcmFuZ2U6NWM1OTRhMWQ1ZjlhNDUxNzkwZDc4NDY2NzZjMDllYWNfMS0zLTEtMS04MzI4NQ_d0f6217d-a5f9-4d76-8855-def41ffbde95">58.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_7">Table of Contents</a></span></div></div><ix:continuation id="icc79e87a48254223ba99c887d705e655"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="us-gaap:ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181OC9mcmFnOmI2MjBmMTkwNjg5MTQ3YmNhOGFmNDQxNTI3NWFiNTBjL3RleHRyZWdpb246YjYyMGYxOTA2ODkxNDdiY2E4YWY0NDE1Mjc1YWI1MGNfNTAzMw_00602794-2a00-4e7d-a81e-8bbc349ab49c" continuedAt="i1af18f48c0844177970ede417f20ae35" escape="true">The following table summarizes the amount of pre-tax income recognized from derivative instruments for the periods indicated and the line items in the accompanying statements of operations where the results are recorded for net investment hedges:</ix:nonNumeric></span></div><ix:continuation id="i1af18f48c0844177970ede417f20ae35"><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.666%"><tr><td style="width:1.0%"></td><td style="width:26.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.583%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.403%"></td><td style="width:0.1%"></td></tr><tr style="height:48pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount of (Loss) Gain Recognized in OCI on Derivative<br/>Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Location of Gain Recognized in Income on Derivative (Amount Excluded from Effectiveness Testing)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount of Gain Recognized in Income on Derivative (Amount Excluded from Effectiveness Testing)<br/>Three Months Ended</span></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1b3aa766e2904db9b8ab4aa605bdb4ee_D20221001-20221230" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181OC9mcmFnOmI2MjBmMTkwNjg5MTQ3YmNhOGFmNDQxNTI3NWFiNTBjL3RhYmxlOmYyM2I0NmMyNTlkYTQ4NDM4NzhjMzQ5OWQzZmFmZDQ1L3RhYmxlcmFuZ2U6ZjIzYjQ2YzI1OWRhNDg0Mzg3OGMzNDk5ZDNmYWZkNDVfMi0xLTEtMS04MzI4NQ_9906a473-3045-4bd9-897c-676a14ae50ec">4.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4eac39f015bd47f5ba39e3bfcfcc6d4c_D20211002-20211231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181OC9mcmFnOmI2MjBmMTkwNjg5MTQ3YmNhOGFmNDQxNTI3NWFiNTBjL3RhYmxlOmYyM2I0NmMyNTlkYTQ4NDM4NzhjMzQ5OWQzZmFmZDQ1L3RhYmxlcmFuZ2U6ZjIzYjQ2YzI1OWRhNDg0Mzg3OGMzNDk5ZDNmYWZkNDVfMi0zLTEtMS04MzI4NQ_3fb7841e-d231-451a-87bc-577261625df5">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 2.12pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide90c1ae15ab4bb9a3bd404689af0bbf_D20221001-20221230" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181OC9mcmFnOmI2MjBmMTkwNjg5MTQ3YmNhOGFmNDQxNTI3NWFiNTBjL3RhYmxlOmYyM2I0NmMyNTlkYTQ4NDM4NzhjMzQ5OWQzZmFmZDQ1L3RhYmxlcmFuZ2U6ZjIzYjQ2YzI1OWRhNDg0Mzg3OGMzNDk5ZDNmYWZkNDVfMi03LTEtMS04MzI4NQ_fcd84744-be8b-4c93-8573-8d0d6a64fc77">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i934533f99d1543b2ab6a4be93d73dd8f_D20211002-20211231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181OC9mcmFnOmI2MjBmMTkwNjg5MTQ3YmNhOGFmNDQxNTI3NWFiNTBjL3RhYmxlOmYyM2I0NmMyNTlkYTQ4NDM4NzhjMzQ5OWQzZmFmZDQ1L3RhYmxlcmFuZ2U6ZjIzYjQ2YzI1OWRhNDg0Mzg3OGMzNDk5ZDNmYWZkNDVfMi05LTEtMS04MzI4NQ_1989ca5e-578e-4df4-90b8-b4a99f0de7dc">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;These derivative instruments are subject to master netting agreements giving effect to rights of offset with each counterparty. None of the balances were eligible for netting. The following table summarizes the gross fair values of derivative instruments as of the periods indicated and the line items in the accompanying Condensed Consolidated Balance Sheets where the instruments are recorded:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.844%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.483%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.594%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.597%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivative Assets and Liabilities</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives Designated as Net Investment Hedges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c7f1146a6b1444882838f6b9709de23_I20221230" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181OC9mcmFnOmI2MjBmMTkwNjg5MTQ3YmNhOGFmNDQxNTI3NWFiNTBjL3RhYmxlOmUzNDBkZmZjYzY0NTQ3NTdiMjNiYjRmNjY2OWNlMzMzL3RhYmxlcmFuZ2U6ZTM0MGRmZmNjNjQ1NDc1N2IyM2JiNGY2NjY5Y2UzMzNfMi00LTEtMS04MzI4NQ_838438bd-eb21-40a9-90be-b11387184a45">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5332708454694b5dbb490975b393f380_I20220930" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181OC9mcmFnOmI2MjBmMTkwNjg5MTQ3YmNhOGFmNDQxNTI3NWFiNTBjL3RhYmxlOmUzNDBkZmZjYzY0NTQ3NTdiMjNiYjRmNjY2OWNlMzMzL3RhYmxlcmFuZ2U6ZTM0MGRmZmNjNjQ1NDc1N2IyM2JiNGY2NjY5Y2UzMzNfMi02LTEtMS04MzI4NQ_391ff96d-324c-4edf-bd77-3806607b2c1d">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05ccff0411484bb0bee83af0018f0bf7_I20221230" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181OC9mcmFnOmI2MjBmMTkwNjg5MTQ3YmNhOGFmNDQxNTI3NWFiNTBjL3RhYmxlOmUzNDBkZmZjYzY0NTQ3NTdiMjNiYjRmNjY2OWNlMzMzL3RhYmxlcmFuZ2U6ZTM0MGRmZmNjNjQ1NDc1N2IyM2JiNGY2NjY5Y2UzMzNfMy00LTEtMS04MzI4NQ_a2418b29-4ec2-4f1d-aa24-42caf56c9a0e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17e216dd46824f439789b35236b2e450_I20220930" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181OC9mcmFnOmI2MjBmMTkwNjg5MTQ3YmNhOGFmNDQxNTI3NWFiNTBjL3RhYmxlOmUzNDBkZmZjYzY0NTQ3NTdiMjNiYjRmNjY2OWNlMzMzL3RhYmxlcmFuZ2U6ZTM0MGRmZmNjNjQ1NDc1N2IyM2JiNGY2NjY5Y2UzMzNfMy02LTEtMS04MzI4NQ_271a76dc-c936-4abf-8ef9-f426d13920ea">6.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e698835048a4495bf4ddd5aae18d2f8_I20221230" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181OC9mcmFnOmI2MjBmMTkwNjg5MTQ3YmNhOGFmNDQxNTI3NWFiNTBjL3RhYmxlOmUzNDBkZmZjYzY0NTQ3NTdiMjNiYjRmNjY2OWNlMzMzL3RhYmxlcmFuZ2U6ZTM0MGRmZmNjNjQ1NDc1N2IyM2JiNGY2NjY5Y2UzMzNfNS00LTEtMS04MzI4NQ_a9fda2b2-7bc5-4d42-bb99-1dcefa36a679">4.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4aa2eb507164e9faa338325c825f610_I20220930" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181OC9mcmFnOmI2MjBmMTkwNjg5MTQ3YmNhOGFmNDQxNTI3NWFiNTBjL3RhYmxlOmUzNDBkZmZjYzY0NTQ3NTdiMjNiYjRmNjY2OWNlMzMzL3RhYmxlcmFuZ2U6ZTM0MGRmZmNjNjQ1NDc1N2IyM2JiNGY2NjY5Y2UzMzNfNS02LTEtMS04MzI4NQ_e26ce5eb-507f-4d28-ad04-8ff73588b3e9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div id="i4ab573909cb849339357193b017c7d37_61"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7. <ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RleHRyZWdpb246NDYzNjEwOTFkZjZlNGU3MGE1NzRjM2M1ZDk5ZTNlNmZfMTgyNQ_31831557-bfd7-4a1a-b00d-cebd371f5277" continuedAt="ieaf58ea40cd34a2c891eb7d0c49dcb5e" escape="true">FAIR VALUE</ix:nonNumeric></span></div><ix:continuation id="ieaf58ea40cd34a2c891eb7d0c49dcb5e" continuedAt="i627648a073bd4257ac87b773d2146691"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets and Liabilities Measured at Fair Value on a Recurring Basis</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The fair values of certain of the Company&#8217;s financial instruments, including bank deposits included in cash and cash equivalents, accounts receivable, net and accounts payable, approximate their fair values due to their short maturities. As of December&#160;30, 2022, the fair values of the Company's Convertible Notes and Senior Secured Notes, as defined in Note 10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Borrowings </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and measured using Level 1 inputs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> were $<ix:nonFraction unitRef="usd" contextRef="i6c18314ffe0b4522b51d04b27d6bdac1_I20221230" decimals="-5" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RleHRyZWdpb246NDYzNjEwOTFkZjZlNGU3MGE1NzRjM2M1ZDk5ZTNlNmZfNDQ0_80e4da97-79b4-4521-85cc-eb8d71a9d3bb">229.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ib5065ecd379c4d4b96ce8728838e59d8_I20221230" decimals="-5" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RleHRyZWdpb246NDYzNjEwOTFkZjZlNGU3MGE1NzRjM2M1ZDk5ZTNlNmZfNDUx_de5830c9-4405-46c2-ba5d-62b7870db3c5">239.3</ix:nonFraction> million, respectively. As of September&#160;30, 2022, the fair values of the Company's Convertible Notes and Senior Secured Notes, measured using Level 1 inputs, were $<ix:nonFraction unitRef="usd" contextRef="i6de4c85804eb455496852e854a916c0e_I20220930" decimals="-5" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RleHRyZWdpb246NDYzNjEwOTFkZjZlNGU3MGE1NzRjM2M1ZDk5ZTNlNmZfNTky_fbe1fc22-95db-46fb-b253-63dc1c39b0fe">250.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="if56b77a5f42444d7b50e5eabbf7d9892_I20220930" decimals="-5" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RleHRyZWdpb246NDYzNjEwOTFkZjZlNGU3MGE1NzRjM2M1ZDk5ZTNlNmZfNTk5_af2f68ce-28e9-4d8b-a3cf-01396aa6f888">241.3</ix:nonFraction> million, respectively. The Company has elected to use the income approach to value its derivative instruments using standard valuation techniques and Level 2 inputs, such as currency spot rates, forward points and credit default swap spreads.</span></div></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_7">Table of Contents</a></span></div></div><ix:continuation id="i627648a073bd4257ac87b773d2146691" continuedAt="i4ab5b18fc47a4b269e53506bf37f1a37"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RleHRyZWdpb246NDYzNjEwOTFkZjZlNGU3MGE1NzRjM2M1ZDk5ZTNlNmZfMTgzMg_c1d2c7a7-09b9-44f1-b336-9ece9e123bab" continuedAt="i37ac758772bc48de84fbe989c6a97522" escape="true"><ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RleHRyZWdpb246NDYzNjEwOTFkZjZlNGU3MGE1NzRjM2M1ZDk5ZTNlNmZfMTgzNQ_c1712e1c-e34f-4714-a46e-94a9b536399b" continuedAt="i04e69a0ca268476e9dbfeb800dedc4d4" escape="true">In the tables below, the Company has segregated all assets and liabilities that are measured at fair value on a recurring basis into the most appropriate level within the fair value hierarchy based on the inputs used to determine the fair value at the measurement date.</ix:nonNumeric></ix:nonNumeric></span><ix:continuation id="i37ac758772bc48de84fbe989c6a97522" continuedAt="if64c0e8ed2d04bdea4e630a9c3895422"><ix:continuation id="i04e69a0ca268476e9dbfeb800dedc4d4" continuedAt="ibccc17e8611b43c68f4e5efe2b45aecd"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.570%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value at December 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Quoted Prices in Active Markets for Identical Assets and Liabilities</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Level 1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Significant Other</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Observable Inputs</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Level 2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Significant Unobservable Inputs</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Level 3)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8a794d22d5a488984d341691b20bb34_I20221230" decimals="-5" name="us-gaap:MoneyMarketFundsAtCarryingValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfMi0xLTEtMS0xMDA1OTc_fc8d585a-0df4-47d2-a0c1-3613aaf4059e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2051d8990e80499790558d1c04489cd7_I20221230" decimals="-5" name="us-gaap:MoneyMarketFundsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfMi0zLTEtMS0xMDA1OTc_be3fbd3c-93fc-4120-9bd3-581859a941a4">21.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81f291e28b0849a882c21993a4683f38_I20221230" decimals="-5" name="us-gaap:MoneyMarketFundsAtCarryingValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfMi01LTEtMS0xMDA1OTc_37b6e51f-6c19-40d7-8165-814bcdb58857">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488f141169664a4da02df7fb3f0314cf_I20221230" decimals="-5" name="us-gaap:MoneyMarketFundsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfMi03LTEtMS0xMDA1OTc_e86c8d71-6525-46b6-95b7-791dca816e24">21.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8a794d22d5a488984d341691b20bb34_I20221230" decimals="-5" name="var:CommercialPaperReceivable" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfMy0xLTEtMS04MzI4NQ_43c284d0-52a6-4890-8f2a-dc7e2be574d1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2051d8990e80499790558d1c04489cd7_I20221230" decimals="-5" name="var:CommercialPaperReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfMy0zLTEtMS04MzI4NQ_69916f62-298d-4c10-9b9a-83d6b3e13b40">4.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81f291e28b0849a882c21993a4683f38_I20221230" decimals="-5" name="var:CommercialPaperReceivable" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfMy01LTEtMS04MzI4NQ_991200a8-dc91-4abe-b7fe-bf99820a0503">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488f141169664a4da02df7fb3f0314cf_I20221230" decimals="-5" name="var:CommercialPaperReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfMy03LTEtMS04MzI4NQ_34e95f9e-b923-4904-8b0d-a0d1d5a48a46">4.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate notes/bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8a794d22d5a488984d341691b20bb34_I20221230" decimals="-5" name="var:CorporateBonds" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfNC0xLTEtMS04MzI4NQ_5d1fa437-eecb-4b3c-a818-75ee82216cc2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2051d8990e80499790558d1c04489cd7_I20221230" decimals="-5" name="var:CorporateBonds" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfNC0zLTEtMS04MzI4NQ_e1221ad6-9dd8-4147-8fcb-13de160a02e5">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81f291e28b0849a882c21993a4683f38_I20221230" decimals="-5" name="var:CorporateBonds" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfNC01LTEtMS04MzI4NQ_fb51b70b-d31a-43d8-9a59-e99c7eb12c3c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488f141169664a4da02df7fb3f0314cf_I20221230" decimals="-5" name="var:CorporateBonds" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfNC03LTEtMS04MzI4NQ_9efeadb4-f4ee-4b9f-90f6-18eef4793dbd">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government agencies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8a794d22d5a488984d341691b20bb34_I20221230" decimals="-5" name="us-gaap:USGovernmentAgenciesSecuritiesAtCarryingValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfNS0xLTEtMS04MzI4NQ_05678122-a485-4aff-a617-1bef76e65e4d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2051d8990e80499790558d1c04489cd7_I20221230" decimals="-5" name="us-gaap:USGovernmentAgenciesSecuritiesAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfNS0zLTEtMS04MzI4NQ_6167a304-c095-46f3-8725-bdfaa7474c81">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81f291e28b0849a882c21993a4683f38_I20221230" decimals="-5" name="us-gaap:USGovernmentAgenciesSecuritiesAtCarryingValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfNS01LTEtMS04MzI4NQ_a10fca62-9065-4a58-b64a-ed161de74d5f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488f141169664a4da02df7fb3f0314cf_I20221230" decimals="-5" name="us-gaap:USGovernmentAgenciesSecuritiesAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfNS03LTEtMS04MzI4NQ_063f13e1-ad90-462c-a1d5-549c8d8ae956">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. Treasury bills</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8a794d22d5a488984d341691b20bb34_I20221230" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfNi0xLTEtMS04MzI4NQ_41ba84db-d6e1-4a3e-9d4c-f98fd6782175">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2051d8990e80499790558d1c04489cd7_I20221230" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfNi0zLTEtMS04MzI4NQ_e2c26281-9eb5-490e-8782-d37ba9a3943e">10.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81f291e28b0849a882c21993a4683f38_I20221230" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfNi01LTEtMS04MzI4NQ_8f92f548-9288-459e-b863-c6bf91bae1b5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488f141169664a4da02df7fb3f0314cf_I20221230" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfNi03LTEtMS04MzI4NQ_8a88cfca-1f0a-4dee-81ef-bac35497bd22">10.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivative assets</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8a794d22d5a488984d341691b20bb34_I20221230" decimals="-5" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfNy0xLTEtMS04MzI4NQ_88e02c4e-a519-4533-8552-cec389fc7b64">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2051d8990e80499790558d1c04489cd7_I20221230" decimals="-5" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfNy0zLTEtMS04MzI4NQ_fca98025-cac8-4e91-89e8-f1617894b3db">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81f291e28b0849a882c21993a4683f38_I20221230" decimals="-5" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfNy01LTEtMS04MzI4NQ_12cdcb3d-c287-4ce4-ab4d-49c5c4911557">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488f141169664a4da02df7fb3f0314cf_I20221230" decimals="-5" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfNy03LTEtMS04MzI4NQ_441563ad-8243-4a16-b972-fe60371c364e">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred compensation plan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8a794d22d5a488984d341691b20bb34_I20221230" decimals="-5" name="us-gaap:DeferredCompensationPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfOC0xLTEtMS04MzI4NQ_cdc2efff-043a-490e-a83d-6d8937e337ca">5.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2051d8990e80499790558d1c04489cd7_I20221230" decimals="-5" name="us-gaap:DeferredCompensationPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfOC0zLTEtMS04MzI4NQ_874fe074-a3ec-4a31-a948-4b72a1dd9b78">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81f291e28b0849a882c21993a4683f38_I20221230" decimals="-5" name="us-gaap:DeferredCompensationPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfOC01LTEtMS04MzI4NQ_6dea81b1-e7fa-4f60-9759-57abf2d3687c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488f141169664a4da02df7fb3f0314cf_I20221230" decimals="-5" name="us-gaap:DeferredCompensationPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfOC03LTEtMS04MzI4NQ_94494a69-5015-42d2-8996-b10e8b19636a">5.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Marketable equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8a794d22d5a488984d341691b20bb34_I20221230" decimals="-5" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfOS0xLTEtMS0xMDA1OTc_4973fafd-5dce-4667-8310-d55f46a67174">4.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2051d8990e80499790558d1c04489cd7_I20221230" decimals="-5" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfOS0zLTEtMS0xMDA1OTc_5dd1002b-50e2-4c9b-b5b5-8ea5a558fcac">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81f291e28b0849a882c21993a4683f38_I20221230" decimals="-5" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfOS01LTEtMS0xMDA1OTc_7fbf7cff-8218-467d-a634-7b4490a19ca0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488f141169664a4da02df7fb3f0314cf_I20221230" decimals="-5" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfOS03LTEtMS0xMDA1OTc_04fbd306-b5cb-4a7e-a524-a24cab002004">4.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfMTAtMC0xLTEtODMyODU_79a5037b-581b-47d3-9fd4-71603055d303">Total assets measured at fair value</span></span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8a794d22d5a488984d341691b20bb34_I20221230" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfMTAtMS0xLTEtMTAwNTk3_9b29efc7-97ab-42a8-a847-9a7df12f1e02">10.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2051d8990e80499790558d1c04489cd7_I20221230" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfMTAtMy0xLTEtMTAwNTk3_d8a214ad-fc19-434b-ba38-96af2a27108e">41.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81f291e28b0849a882c21993a4683f38_I20221230" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfMTAtNS0xLTEtMTAwNTk3_be5dd9d2-af51-4a0d-b74e-c961a9ee07ec">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488f141169664a4da02df7fb3f0314cf_I20221230" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfMTAtNy0xLTEtMTAwNTk3_7bc7aae9-24a6-417a-921b-17aeb5220664">52.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 16.75pt;text-indent:-9pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Liabilities:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivative liabilities</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8a794d22d5a488984d341691b20bb34_I20221230" decimals="-5" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfMTMtMS0xLTEtODMyODU_3f5f9ae1-c52a-45ae-8ef8-283b7db754b8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2051d8990e80499790558d1c04489cd7_I20221230" decimals="-5" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfMTMtMy0xLTEtODMyODU_ea2daa6b-b1f4-4de2-b477-8e8390665b61">4.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81f291e28b0849a882c21993a4683f38_I20221230" decimals="-5" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfMTMtNS0xLTEtODMyODU_4e7b818f-c6bf-4ebb-90a4-35805de1329e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488f141169664a4da02df7fb3f0314cf_I20221230" decimals="-5" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfMTMtNy0xLTEtODMyODU_7d46b4b5-cf8e-4a5b-a30e-9bc48b977508">4.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfMTYtMC0xLTEtMTAwNTk3_169dbe7d-a10b-4a1e-ab46-42af80460820">Total liabilities measured at fair value</span></span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8a794d22d5a488984d341691b20bb34_I20221230" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfMTYtMS0xLTEtMTAwNTk3_09bf53b6-4155-4521-bc95-ed1fa835f34a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2051d8990e80499790558d1c04489cd7_I20221230" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfMTYtMy0xLTEtMTAwNTk3_3a736a3e-ddad-4910-b155-a3d672343f74">4.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81f291e28b0849a882c21993a4683f38_I20221230" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfMTYtNS0xLTEtMTAwNTk3_51226296-2f7b-44bb-b526-a28d6b8bb71f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488f141169664a4da02df7fb3f0314cf_I20221230" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfMTYtNy0xLTEtMTAwNTk3_4bec1126-5c06-444b-80b9-a208abe991a9">4.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></ix:continuation></div><ix:continuation id="if64c0e8ed2d04bdea4e630a9c3895422"><ix:continuation id="ibccc17e8611b43c68f4e5efe2b45aecd"><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.570%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value at September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Quoted Prices in Active Markets for Identical Assets and Liabilities</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Level 1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Significant Other</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Observable Inputs</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Level 2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Significant Unobservable Inputs</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Level 3)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Assets:</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i000a217e3c2d4af68d6fb28636848da6_I20220930" decimals="-5" name="us-gaap:MoneyMarketFundsAtCarryingValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfMy0xLTEtMS04MzI4NQ_772e54b0-91e4-4054-9971-105b74d19fd3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i080aeddcac46466b8c187b8b0b5615b0_I20220930" decimals="-5" name="us-gaap:MoneyMarketFundsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfMy0zLTEtMS04MzI4NQ_7482ac41-6c01-4746-8f1c-be463f3692e1">36.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24674ea6cbf44864812dadb6e95f2db8_I20220930" decimals="-5" name="us-gaap:MoneyMarketFundsAtCarryingValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfMy01LTEtMS04MzI4NQ_a55401c7-5917-4493-a919-e8f51b751486">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9240c6083244455c8602c53af33d914d_I20220930" decimals="-5" name="us-gaap:MoneyMarketFundsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfMy03LTEtMS04MzI4NQ_fb4911bc-85ac-448e-92f2-fd1919ace08b">36.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i000a217e3c2d4af68d6fb28636848da6_I20220930" decimals="-5" name="var:CommercialPaperReceivable" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfNC0xLTEtMS04MzI4NQ_d65af685-69e2-47c1-828b-7aca63d62a2d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i080aeddcac46466b8c187b8b0b5615b0_I20220930" decimals="-5" name="var:CommercialPaperReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfNC0zLTEtMS04MzI4NQ_5039ac24-b8ac-4675-8761-e6b946ba8f16">5.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24674ea6cbf44864812dadb6e95f2db8_I20220930" decimals="-5" name="var:CommercialPaperReceivable" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfNC01LTEtMS04MzI4NQ_05557042-7327-4dde-aa16-3c69f3c27aa1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9240c6083244455c8602c53af33d914d_I20220930" decimals="-5" name="var:CommercialPaperReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfNC03LTEtMS04MzI4NQ_c55b575a-5d83-4b6d-8d66-002f4200a901">5.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate notes/bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i000a217e3c2d4af68d6fb28636848da6_I20220930" decimals="-5" name="var:CorporateBonds" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfNS0xLTEtMS04MzI4NQ_a3985753-31fc-4008-925e-49d2f445247c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i080aeddcac46466b8c187b8b0b5615b0_I20220930" decimals="-5" name="var:CorporateBonds" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfNS0zLTEtMS04MzI4NQ_0253c001-43b7-4755-baa4-84b9e6ef3a21">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24674ea6cbf44864812dadb6e95f2db8_I20220930" decimals="-5" name="var:CorporateBonds" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfNS01LTEtMS04MzI4NQ_cdff6ba6-73ca-4b2b-b048-db1d68caafd3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9240c6083244455c8602c53af33d914d_I20220930" decimals="-5" name="var:CorporateBonds" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfNS03LTEtMS04MzI4NQ_519089bb-59d3-4b15-b8d2-8d6d506451be">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government agencies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i000a217e3c2d4af68d6fb28636848da6_I20220930" decimals="-5" name="us-gaap:USGovernmentAgenciesSecuritiesAtCarryingValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfNi0xLTEtMS05NTYzNQ_23a3aa68-f08d-4ae5-95c9-2be2dc82e83f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i080aeddcac46466b8c187b8b0b5615b0_I20220930" decimals="-5" name="us-gaap:USGovernmentAgenciesSecuritiesAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfNi0zLTEtMS05NTYzNQ_128015c4-ec3f-405c-b385-1a334f450fd4">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24674ea6cbf44864812dadb6e95f2db8_I20220930" decimals="-5" name="us-gaap:USGovernmentAgenciesSecuritiesAtCarryingValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfNi01LTEtMS05NTYzNQ_7ab76d23-e033-41a7-96de-18b94e11dbaf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9240c6083244455c8602c53af33d914d_I20220930" decimals="-5" name="us-gaap:USGovernmentAgenciesSecuritiesAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfNi03LTEtMS05NTYzNQ_d31c4c14-ebbb-415d-9824-f216d1f6a113">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. Treasury bills</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i000a217e3c2d4af68d6fb28636848da6_I20220930" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfNy0xLTEtMS05NTYzNQ_462382f8-1690-4ae8-be1d-3ee47b355032">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i080aeddcac46466b8c187b8b0b5615b0_I20220930" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfNy0zLTEtMS05NTYzNQ_a43778af-a65f-4798-bbad-82c5f72129b9">10.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24674ea6cbf44864812dadb6e95f2db8_I20220930" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfNy01LTEtMS05NTYzNQ_c3979171-120c-4832-8738-c65b2675ec6b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9240c6083244455c8602c53af33d914d_I20220930" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfNy03LTEtMS05NTYzNQ_dc043b0c-eb74-4752-9d96-f8469dd01625">10.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivative assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i000a217e3c2d4af68d6fb28636848da6_I20220930" decimals="-5" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfNi0xLTEtMS04MzI4NQ_104802dd-5663-48e9-9aaa-a21878908a87">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i080aeddcac46466b8c187b8b0b5615b0_I20220930" decimals="-5" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfNi0zLTEtMS04MzI4NQ_f8e2a045-856b-43ba-a506-b6740a8f162c">7.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24674ea6cbf44864812dadb6e95f2db8_I20220930" decimals="-5" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfNi01LTEtMS04MzI4NQ_91395662-ac9e-4349-9298-8b37eb5930d3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9240c6083244455c8602c53af33d914d_I20220930" decimals="-5" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfNi03LTEtMS04MzI4NQ_807e8673-3b07-4dbc-871e-d585caf8235b">7.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred compensation plan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i000a217e3c2d4af68d6fb28636848da6_I20220930" decimals="-5" name="us-gaap:DeferredCompensationPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfOS0xLTEtMS0xMDA3NTA_54a279ad-9f0d-4f09-9d92-0a1dcd51a8c1">5.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i080aeddcac46466b8c187b8b0b5615b0_I20220930" decimals="-5" name="us-gaap:DeferredCompensationPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfOS0zLTEtMS0xMDA3NTA_cf6f8415-9cf9-4296-9d7b-c2e2a4bcb221">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24674ea6cbf44864812dadb6e95f2db8_I20220930" decimals="-5" name="us-gaap:DeferredCompensationPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfOS01LTEtMS0xMDA3NTA_27423983-916b-41b2-9cbd-869149b44e02">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9240c6083244455c8602c53af33d914d_I20220930" decimals="-5" name="us-gaap:DeferredCompensationPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfOS03LTEtMS0xMDA3NTA_9d5bc143-5fe8-4d4e-9428-fe4290c7bf23">5.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Marketable equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i000a217e3c2d4af68d6fb28636848da6_I20220930" decimals="-5" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfNy0xLTEtMS04MzI4NQ_ae91b5ce-d836-472b-aaed-1c9a89d9a402">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i080aeddcac46466b8c187b8b0b5615b0_I20220930" decimals="-5" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfNy0zLTEtMS04MzI4NQ_4377592d-b455-4ef5-95cb-bae7c3c12243">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24674ea6cbf44864812dadb6e95f2db8_I20220930" decimals="-5" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfNy01LTEtMS04MzI4NQ_9d6a6a48-cce7-4fde-b125-d8094a9c0c87">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9240c6083244455c8602c53af33d914d_I20220930" decimals="-5" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfNy03LTEtMS04MzI4NQ_ba4dc9ff-820f-4ba2-aa2a-7c628bcfdafe">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfOC0wLTEtMS04MzI4NQ_417fadeb-557f-4f83-a995-e688c949e009">Total assets measured at fair value</span></span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i000a217e3c2d4af68d6fb28636848da6_I20220930" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfOC0xLTEtMS04MzI4NQ_3e018e38-daa2-412e-8ee7-1afea331198b">7.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i080aeddcac46466b8c187b8b0b5615b0_I20220930" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfOC0zLTEtMS04MzI4NQ_e03b1b74-4cfe-4744-9ed7-610e1f2100b1">64.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24674ea6cbf44864812dadb6e95f2db8_I20220930" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfOC01LTEtMS04MzI4NQ_fdf3ef67-23db-4351-a4c8-82c57f825e9c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9240c6083244455c8602c53af33d914d_I20220930" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfOC03LTEtMS04MzI4NQ_a09e2179-4e69-4b40-86a0-3ab71531d1de">72.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivative liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i000a217e3c2d4af68d6fb28636848da6_I20220930" decimals="-5" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfMTEtMS0xLTEtODMyODU_7a5d5319-28e5-4e34-ad14-2ae5bb40df0d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i080aeddcac46466b8c187b8b0b5615b0_I20220930" decimals="-5" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfMTEtMy0xLTEtODMyODU_11e52e23-9a34-4454-9a77-2f3289bb4167">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24674ea6cbf44864812dadb6e95f2db8_I20220930" decimals="-5" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfMTEtNS0xLTEtODMyODU_6bc33e6f-4771-48e3-909d-007a72541546">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9240c6083244455c8602c53af33d914d_I20220930" decimals="-5" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfMTEtNy0xLTEtODMyODU_454acc8b-d1d8-4831-ad58-602ea48d0a67">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfMTMtMC0xLTEtODMyODU_54db5ac7-0c5e-4cf6-bc9b-f0229d68f729">Total liabilities measured at fair value</span></span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i000a217e3c2d4af68d6fb28636848da6_I20220930" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfMTMtMS0xLTEtODMyODU_cad9e9bf-b411-436f-ad24-397e2ee182f2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i080aeddcac46466b8c187b8b0b5615b0_I20220930" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfMTMtMy0xLTEtODMyODU_3d178a5c-db12-4460-86dd-629b957e622c">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24674ea6cbf44864812dadb6e95f2db8_I20220930" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfMTMtNS0xLTEtODMyODU_2ace6bd9-644e-4693-8d0e-0a9f8990254e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9240c6083244455c8602c53af33d914d_I20220930" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfMTMtNy0xLTEtODMyODU_79b77c71-5ae2-4f00-b4a1-6b365686ed8c">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The assets held under the Company's deferred compensation plan are classified in Level 1 as they relate primarily to publicly traded mutual funds for which there are observable market prices in active markets.</span></div></ix:continuation></ix:continuation></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_7">Table of Contents</a></span></div></div><ix:continuation id="i4ab5b18fc47a4b269e53506bf37f1a37"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Marketable Debt Securities</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="us-gaap:GainLossOnInvestmentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RleHRyZWdpb246NDYzNjEwOTFkZjZlNGU3MGE1NzRjM2M1ZDk5ZTNlNmZfMTgzMA_b133ca51-c0d6-4c5b-bcc6-a4f5bb554f6b" continuedAt="ife88681b566e460bbe300e3a25028e9a" escape="true">The following tables summarize the Company's marketable debt securities:</ix:nonNumeric></span></div><ix:continuation id="ife88681b566e460bbe300e3a25028e9a"><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.511%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.569%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Amortized Costs</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commercial paper</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10a7807457d845b9ad4ed44aed8912db_I20221230" decimals="-5" name="var:MarketableSecuritiesAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmIyZDJjYzYzMWEzYTQ1MzBhMmQ1OTkwNDQxYTkyZDVmL3RhYmxlcmFuZ2U6YjJkMmNjNjMxYTNhNDUzMGEyZDU5OTA0NDFhOTJkNWZfMy0xLTEtMS04MzI4NQ_76e22274-8401-4092-8fd6-ded677def2d6">4.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10a7807457d845b9ad4ed44aed8912db_I20221230" decimals="-5" name="var:MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmIyZDJjYzYzMWEzYTQ1MzBhMmQ1OTkwNDQxYTkyZDVmL3RhYmxlcmFuZ2U6YjJkMmNjNjMxYTNhNDUzMGEyZDU5OTA0NDFhOTJkNWZfMy01LTEtMS04MzI4NQ_a31f1695-a943-485d-b26c-16b48ca14310">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10a7807457d845b9ad4ed44aed8912db_I20221230" decimals="-5" name="us-gaap:MarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmIyZDJjYzYzMWEzYTQ1MzBhMmQ1OTkwNDQxYTkyZDVmL3RhYmxlcmFuZ2U6YjJkMmNjNjMxYTNhNDUzMGEyZDU5OTA0NDFhOTJkNWZfMy03LTEtMS04MzI4NQ_c781b692-f5a5-4d48-a338-2f49113ece7e">4.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate notes/bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fddba25d3464fc88f2322c862ad8fda_I20221230" decimals="-5" name="var:MarketableSecuritiesAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmIyZDJjYzYzMWEzYTQ1MzBhMmQ1OTkwNDQxYTkyZDVmL3RhYmxlcmFuZ2U6YjJkMmNjNjMxYTNhNDUzMGEyZDU5OTA0NDFhOTJkNWZfNC0xLTEtMS04MzI4NQ_2df0cdbb-67a0-47df-ba48-f84e0317b078">3.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fddba25d3464fc88f2322c862ad8fda_I20221230" decimals="-5" name="var:MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmIyZDJjYzYzMWEzYTQ1MzBhMmQ1OTkwNDQxYTkyZDVmL3RhYmxlcmFuZ2U6YjJkMmNjNjMxYTNhNDUzMGEyZDU5OTA0NDFhOTJkNWZfNC01LTEtMS04MzI4NQ_bbce25f3-401d-461b-8a18-918d86874ff6">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fddba25d3464fc88f2322c862ad8fda_I20221230" decimals="-5" name="us-gaap:MarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmIyZDJjYzYzMWEzYTQ1MzBhMmQ1OTkwNDQxYTkyZDVmL3RhYmxlcmFuZ2U6YjJkMmNjNjMxYTNhNDUzMGEyZDU5OTA0NDFhOTJkNWZfNC03LTEtMS04MzI4NQ_705a58c6-1d65-4430-8163-cf7efaeeef48">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. Treasury bills</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6600d15de2c54873830ce25e54e2f1e4_I20221230" decimals="-5" name="var:MarketableSecuritiesAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmIyZDJjYzYzMWEzYTQ1MzBhMmQ1OTkwNDQxYTkyZDVmL3RhYmxlcmFuZ2U6YjJkMmNjNjMxYTNhNDUzMGEyZDU5OTA0NDFhOTJkNWZfNS0xLTEtMS04MzI4NQ_ffb4cb80-08ca-46b5-891a-34391d20b748">10.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6600d15de2c54873830ce25e54e2f1e4_I20221230" decimals="-5" name="var:MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmIyZDJjYzYzMWEzYTQ1MzBhMmQ1OTkwNDQxYTkyZDVmL3RhYmxlcmFuZ2U6YjJkMmNjNjMxYTNhNDUzMGEyZDU5OTA0NDFhOTJkNWZfNS01LTEtMS04MzI4NQ_9edacf4d-60a6-404e-9719-3573138f248b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6600d15de2c54873830ce25e54e2f1e4_I20221230" decimals="-5" name="us-gaap:MarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmIyZDJjYzYzMWEzYTQ1MzBhMmQ1OTkwNDQxYTkyZDVmL3RhYmxlcmFuZ2U6YjJkMmNjNjMxYTNhNDUzMGEyZDU5OTA0NDFhOTJkNWZfNS03LTEtMS04MzI4NQ_1f81b8a4-8e4d-419e-93a4-e2ba30fd403d">10.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government agencies</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id304dfd7514641719c5a17d4ab0bed7a_I20221230" decimals="-5" name="var:MarketableSecuritiesAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmIyZDJjYzYzMWEzYTQ1MzBhMmQ1OTkwNDQxYTkyZDVmL3RhYmxlcmFuZ2U6YjJkMmNjNjMxYTNhNDUzMGEyZDU5OTA0NDFhOTJkNWZfNi0xLTEtMS05NTY1MA_115bb1b1-59aa-42b8-8407-4088240406e4">0.3</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id304dfd7514641719c5a17d4ab0bed7a_I20221230" decimals="-5" name="var:MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmIyZDJjYzYzMWEzYTQ1MzBhMmQ1OTkwNDQxYTkyZDVmL3RhYmxlcmFuZ2U6YjJkMmNjNjMxYTNhNDUzMGEyZDU5OTA0NDFhOTJkNWZfNi01LTEtMS05NTY1MA_a1a14f7a-03fe-461d-a476-a35842625492">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id304dfd7514641719c5a17d4ab0bed7a_I20221230" decimals="-5" name="us-gaap:MarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmIyZDJjYzYzMWEzYTQ1MzBhMmQ1OTkwNDQxYTkyZDVmL3RhYmxlcmFuZ2U6YjJkMmNjNjMxYTNhNDUzMGEyZDU5OTA0NDFhOTJkNWZfNi03LTEtMS05NTY1MA_4fea9528-3408-4e07-b5bd-acb87a551b19">0.3</ix:nonFraction></span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total marketable debt securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="-5" name="var:MarketableSecuritiesAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmIyZDJjYzYzMWEzYTQ1MzBhMmQ1OTkwNDQxYTkyZDVmL3RhYmxlcmFuZ2U6YjJkMmNjNjMxYTNhNDUzMGEyZDU5OTA0NDFhOTJkNWZfOS0xLTEtMS04MzI4NQ_d27509a0-27a7-4eab-8125-ecd0f9fc3cde">19.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="-5" name="var:MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmIyZDJjYzYzMWEzYTQ1MzBhMmQ1OTkwNDQxYTkyZDVmL3RhYmxlcmFuZ2U6YjJkMmNjNjMxYTNhNDUzMGEyZDU5OTA0NDFhOTJkNWZfOS01LTEtMS04MzI4NQ_2bf67272-5e70-4036-a357-996dff775612">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="-5" name="us-gaap:MarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmIyZDJjYzYzMWEzYTQ1MzBhMmQ1OTkwNDQxYTkyZDVmL3RhYmxlcmFuZ2U6YjJkMmNjNjMxYTNhNDUzMGEyZDU5OTA0NDFhOTJkNWZfOS03LTEtMS04MzI4NQ_b0b423ec-9475-4721-b551-8f558c71b7c7">19.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.511%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.569%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Amortized Costs</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commercial paper</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11d163dc0c7e4f778d0934c68fbd9ed9_I20220930" decimals="-5" name="var:MarketableSecuritiesAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjZkZGE2OWRlY2QxZjQyOWY4NzBjMDE0ZTcwOWVhODE0L3RhYmxlcmFuZ2U6NmRkYTY5ZGVjZDFmNDI5Zjg3MGMwMTRlNzA5ZWE4MTRfMy0xLTEtMS05NTcwNA_81ca5f8d-d0e6-46ee-9a99-6f9caf4e718a">5.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11d163dc0c7e4f778d0934c68fbd9ed9_I20220930" decimals="-5" name="var:MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjZkZGE2OWRlY2QxZjQyOWY4NzBjMDE0ZTcwOWVhODE0L3RhYmxlcmFuZ2U6NmRkYTY5ZGVjZDFmNDI5Zjg3MGMwMTRlNzA5ZWE4MTRfMy01LTEtMS05NTcwNA_daadac97-4c73-471a-9db5-25c8d1f38c04">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11d163dc0c7e4f778d0934c68fbd9ed9_I20220930" decimals="-5" name="us-gaap:MarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjZkZGE2OWRlY2QxZjQyOWY4NzBjMDE0ZTcwOWVhODE0L3RhYmxlcmFuZ2U6NmRkYTY5ZGVjZDFmNDI5Zjg3MGMwMTRlNzA5ZWE4MTRfMy03LTEtMS05NTcwNA_3a8a8fe4-4c13-4c77-b119-0e28955351f0">5.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate notes/bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09336e03a3124b3e8abcf83f054dfc6e_I20220930" decimals="-5" name="var:MarketableSecuritiesAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjZkZGE2OWRlY2QxZjQyOWY4NzBjMDE0ZTcwOWVhODE0L3RhYmxlcmFuZ2U6NmRkYTY5ZGVjZDFmNDI5Zjg3MGMwMTRlNzA5ZWE4MTRfNC0xLTEtMS05NTcwNA_7e0c9a34-0ade-4fcb-9d86-ea27ca0d861c">3.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09336e03a3124b3e8abcf83f054dfc6e_I20220930" decimals="-5" name="var:MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjZkZGE2OWRlY2QxZjQyOWY4NzBjMDE0ZTcwOWVhODE0L3RhYmxlcmFuZ2U6NmRkYTY5ZGVjZDFmNDI5Zjg3MGMwMTRlNzA5ZWE4MTRfNC01LTEtMS05NTcwNA_c309bb60-5cbc-4726-b913-09729c192a79">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09336e03a3124b3e8abcf83f054dfc6e_I20220930" decimals="-5" name="us-gaap:MarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjZkZGE2OWRlY2QxZjQyOWY4NzBjMDE0ZTcwOWVhODE0L3RhYmxlcmFuZ2U6NmRkYTY5ZGVjZDFmNDI5Zjg3MGMwMTRlNzA5ZWE4MTRfNC03LTEtMS05NTcwNA_6fe2e804-df98-4d0b-8083-d6f15cb9a22d">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. Treasury bills</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76a7050d54304267a10c2a2ff2669153_I20220930" decimals="-5" name="var:MarketableSecuritiesAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjZkZGE2OWRlY2QxZjQyOWY4NzBjMDE0ZTcwOWVhODE0L3RhYmxlcmFuZ2U6NmRkYTY5ZGVjZDFmNDI5Zjg3MGMwMTRlNzA5ZWE4MTRfNS0xLTEtMS05NTcwNA_06c54747-3564-49de-86b8-ac88d5d7ffdf">10.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76a7050d54304267a10c2a2ff2669153_I20220930" decimals="-5" name="var:MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjZkZGE2OWRlY2QxZjQyOWY4NzBjMDE0ZTcwOWVhODE0L3RhYmxlcmFuZ2U6NmRkYTY5ZGVjZDFmNDI5Zjg3MGMwMTRlNzA5ZWE4MTRfNS01LTEtMS05NTcwNA_0e801d5c-a9fc-45bd-9b15-b41ee6427eb7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76a7050d54304267a10c2a2ff2669153_I20220930" decimals="-5" name="us-gaap:MarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjZkZGE2OWRlY2QxZjQyOWY4NzBjMDE0ZTcwOWVhODE0L3RhYmxlcmFuZ2U6NmRkYTY5ZGVjZDFmNDI5Zjg3MGMwMTRlNzA5ZWE4MTRfNS03LTEtMS05NTcwNA_db492a49-b88c-4a53-a289-ee3b0892681a">10.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government agencies</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47928432e34e44fab0fa2e3e5ea1c268_I20220930" decimals="-5" name="var:MarketableSecuritiesAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjZkZGE2OWRlY2QxZjQyOWY4NzBjMDE0ZTcwOWVhODE0L3RhYmxlcmFuZ2U6NmRkYTY5ZGVjZDFmNDI5Zjg3MGMwMTRlNzA5ZWE4MTRfNi0xLTEtMS05NTcwNA_673be601-f62f-4975-87c6-28039a307752">0.3</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47928432e34e44fab0fa2e3e5ea1c268_I20220930" decimals="-5" name="var:MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjZkZGE2OWRlY2QxZjQyOWY4NzBjMDE0ZTcwOWVhODE0L3RhYmxlcmFuZ2U6NmRkYTY5ZGVjZDFmNDI5Zjg3MGMwMTRlNzA5ZWE4MTRfNi01LTEtMS05NTcwNA_29d77731-c1f5-4d71-ab78-3cbd0c6d3c17">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47928432e34e44fab0fa2e3e5ea1c268_I20220930" decimals="-5" name="us-gaap:MarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjZkZGE2OWRlY2QxZjQyOWY4NzBjMDE0ZTcwOWVhODE0L3RhYmxlcmFuZ2U6NmRkYTY5ZGVjZDFmNDI5Zjg3MGMwMTRlNzA5ZWE4MTRfNi03LTEtMS05NTcwNA_8d68d8bd-c863-4f10-83d2-86ada0fd3744">0.3</ix:nonFraction></span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total marketable debt securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930" decimals="-5" name="var:MarketableSecuritiesAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjZkZGE2OWRlY2QxZjQyOWY4NzBjMDE0ZTcwOWVhODE0L3RhYmxlcmFuZ2U6NmRkYTY5ZGVjZDFmNDI5Zjg3MGMwMTRlNzA5ZWE4MTRfOS0xLTEtMS05NTcwNA_6528371d-ad0b-428f-900d-e24a4af520c6">20.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930" decimals="-5" name="var:MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjZkZGE2OWRlY2QxZjQyOWY4NzBjMDE0ZTcwOWVhODE0L3RhYmxlcmFuZ2U6NmRkYTY5ZGVjZDFmNDI5Zjg3MGMwMTRlNzA5ZWE4MTRfOS01LTEtMS05NTcwNA_c7836924-30c8-47b9-968d-c4049469dc14">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930" decimals="-5" name="us-gaap:MarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjZkZGE2OWRlY2QxZjQyOWY4NzBjMDE0ZTcwOWVhODE0L3RhYmxlcmFuZ2U6NmRkYTY5ZGVjZDFmNDI5Zjg3MGMwMTRlNzA5ZWE4MTRfOS03LTEtMS05NTcwNA_fce15bd9-7ec3-405e-a84a-481ff5e7b5c3">20.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="us-gaap:MarketableSecuritiesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RleHRyZWdpb246NDYzNjEwOTFkZjZlNGU3MGE1NzRjM2M1ZDk5ZTNlNmZfMTgxNQ_754bf6a8-c2b9-4ddb-b2c0-64cde89a932f" continuedAt="i3e544b9b3c5946cd9b7e1a2c376cee99" escape="true">The contractual maturities of marketable debt securities as of December&#160;30, 2022, are shown in the table below. Actual maturities may differ from contractual maturities because borrowers may have the right to call or prepay obligations.</ix:nonNumeric></span></div><div style="margin-top:6pt"><ix:continuation id="i3e544b9b3c5946cd9b7e1a2c376cee99" continuedAt="i44bbd1785308463a9e331c7ca0991e80"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Amortized Costs</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contractual maturities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Due within one year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="-5" name="var:MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateRollingWithinOneYearAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjc0ZTkyNmIwNDEwMjQwODdhMjNmMDM4OWMyNTllNDEyL3RhYmxlcmFuZ2U6NzRlOTI2YjA0MTAyNDA4N2EyM2YwMzg5YzI1OWU0MTJfMy0xLTEtMS04MzI4NQ_1511c8f2-4f7e-4066-aa80-42d826721499">16.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="-5" name="var:MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateYearOne" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjc0ZTkyNmIwNDEwMjQwODdhMjNmMDM4OWMyNTllNDEyL3RhYmxlcmFuZ2U6NzRlOTI2YjA0MTAyNDA4N2EyM2YwMzg5YzI1OWU0MTJfMy0zLTEtMS04MzI4NQ_f40eddd2-1764-4dcd-bbc7-1c425730c42e">16.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Due after one year through five years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="-5" name="var:MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateRollingAfterOneThroughFiveYearsAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjc0ZTkyNmIwNDEwMjQwODdhMjNmMDM4OWMyNTllNDEyL3RhYmxlcmFuZ2U6NzRlOTI2YjA0MTAyNDA4N2EyM2YwMzg5YzI1OWU0MTJfNC0xLTEtMS04MzI4NQ_87414104-c0d1-47cf-ae73-50ae5f598cae">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="-5" name="var:MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjc0ZTkyNmIwNDEwMjQwODdhMjNmMDM4OWMyNTllNDEyL3RhYmxlcmFuZ2U6NzRlOTI2YjA0MTAyNDA4N2EyM2YwMzg5YzI1OWU0MTJfNC0zLTEtMS04MzI4NQ_0d0ffdff-b5f6-46ef-b86d-367d6842638a">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total marketable debt securities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="-5" name="var:MarketableSecuritiesAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjc0ZTkyNmIwNDEwMjQwODdhMjNmMDM4OWMyNTllNDEyL3RhYmxlcmFuZ2U6NzRlOTI2YjA0MTAyNDA4N2EyM2YwMzg5YzI1OWU0MTJfOS0xLTEtMS04MzI4NQ_a2f48f17-fb17-412c-b042-d2f48341fbe0">19.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="-5" name="us-gaap:MarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjc0ZTkyNmIwNDEwMjQwODdhMjNmMDM4OWMyNTllNDEyL3RhYmxlcmFuZ2U6NzRlOTI2YjA0MTAyNDA4N2EyM2YwMzg5YzI1OWU0MTJfOS0zLTEtMS04MzI4NQ_1007e095-117b-46a0-8d42-6ce980d8e19e">19.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During the three months ended December&#160;30, 2022, there were no gross realized gains or losses from the sale of certain marketable debt securities that were reclassified out of accumulated other comprehensive income.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:continuation id="i44bbd1785308463a9e331c7ca0991e80" continuedAt="i53f0c009e0e446bc992590ece6f349a2">The following tables summarize the balance sheet locations for marketable debt securities:</ix:continuation></span></div><ix:continuation id="i53f0c009e0e446bc992590ece6f349a2"><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.511%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.650%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.650%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.650%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.650%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.652%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Commercial paper</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Corporate notes/bonds</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Government agencies</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Treasury bills</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if73dd818790943af8e76d7d0bd61ece8_I20221230" decimals="-5" name="us-gaap:MarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmVlNTk1OGU2OGZlYzRkOThhNzFkODQ2NDU5YTUyOGQ1L3RhYmxlcmFuZ2U6ZWU1OTU4ZTY4ZmVjNGQ5OGE3MWQ4NDY0NTlhNTI4ZDVfMy0xLTEtMS04MzI4NQ_c024ffb0-ec1c-4b87-9574-06cbc4d0b58c">4.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1e9242ff3354b2a960503fd1761aab2_I20221230" decimals="-5" name="us-gaap:MarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmVlNTk1OGU2OGZlYzRkOThhNzFkODQ2NDU5YTUyOGQ1L3RhYmxlcmFuZ2U6ZWU1OTU4ZTY4ZmVjNGQ5OGE3MWQ4NDY0NTlhNTI4ZDVfMy0zLTEtMS04MzI4NQ_e55bea70-54a9-4ecc-87ff-72134855e738">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92e88468ba3d48a7a063bee1e0f0318a_I20221230" decimals="-5" name="us-gaap:MarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmVlNTk1OGU2OGZlYzRkOThhNzFkODQ2NDU5YTUyOGQ1L3RhYmxlcmFuZ2U6ZWU1OTU4ZTY4ZmVjNGQ5OGE3MWQ4NDY0NTlhNTI4ZDVfMy01LTEtMS04MzI4NQ_ccf36ebb-e81f-4d00-81ac-8fdb0349409c">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7a180ea39443b694aaf7dd07ad1096_I20221230" decimals="-5" name="us-gaap:MarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmVlNTk1OGU2OGZlYzRkOThhNzFkODQ2NDU5YTUyOGQ1L3RhYmxlcmFuZ2U6ZWU1OTU4ZTY4ZmVjNGQ5OGE3MWQ4NDY0NTlhNTI4ZDVfMy03LTEtMS04MzI4NQ_1ad10172-9b27-4c6c-9649-ae75eba50df1">9.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i820b739701b04c498136aad1494d10a5_I20221230" decimals="-5" name="us-gaap:MarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmVlNTk1OGU2OGZlYzRkOThhNzFkODQ2NDU5YTUyOGQ1L3RhYmxlcmFuZ2U6ZWU1OTU4ZTY4ZmVjNGQ5OGE3MWQ4NDY0NTlhNTI4ZDVfMy05LTEtMS0xMDA1Mzc_73ae59b0-f817-474e-9211-e41ce58c0c50">16.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ae6c3be3d534e909bf65cafdb441f13_I20221230" decimals="-5" name="us-gaap:MarketableSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmVlNTk1OGU2OGZlYzRkOThhNzFkODQ2NDU5YTUyOGQ1L3RhYmxlcmFuZ2U6ZWU1OTU4ZTY4ZmVjNGQ5OGE3MWQ4NDY0NTlhNTI4ZDVfNC0xLTEtMS04MzI4NQ_250bccdb-1ab3-431b-b728-9375743a1509">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ca9a72270ef4471b61390923b253af8_I20221230" decimals="-5" name="us-gaap:MarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmVlNTk1OGU2OGZlYzRkOThhNzFkODQ2NDU5YTUyOGQ1L3RhYmxlcmFuZ2U6ZWU1OTU4ZTY4ZmVjNGQ5OGE3MWQ4NDY0NTlhNTI4ZDVfNC0zLTEtMS04MzI4NQ_d4309e74-f8d3-4700-84a3-3e53a6dee4da">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabebb79ab33a45a88797388ed198ebff_I20221230" decimals="-5" name="us-gaap:MarketableSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmVlNTk1OGU2OGZlYzRkOThhNzFkODQ2NDU5YTUyOGQ1L3RhYmxlcmFuZ2U6ZWU1OTU4ZTY4ZmVjNGQ5OGE3MWQ4NDY0NTlhNTI4ZDVfNC01LTEtMS04MzI4NQ_b59d499f-f012-4a4e-9df3-be9fd5293bc5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ce0938959034f01ba57216c7cb057f4_I20221230" decimals="-5" name="us-gaap:MarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmVlNTk1OGU2OGZlYzRkOThhNzFkODQ2NDU5YTUyOGQ1L3RhYmxlcmFuZ2U6ZWU1OTU4ZTY4ZmVjNGQ5OGE3MWQ4NDY0NTlhNTI4ZDVfNC03LTEtMS04MzI4NQ_fe6babec-7a8d-456b-adb3-5ff2a94f0d48">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb5cc1f64aef49f38721631773798f1c_I20221230" decimals="-5" name="us-gaap:MarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmVlNTk1OGU2OGZlYzRkOThhNzFkODQ2NDU5YTUyOGQ1L3RhYmxlcmFuZ2U6ZWU1OTU4ZTY4ZmVjNGQ5OGE3MWQ4NDY0NTlhNTI4ZDVfNC05LTEtMS0xMDA1Mzc_e806266d-1da4-40a8-a2a2-e9fedb910abe">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total marketable debt securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10a7807457d845b9ad4ed44aed8912db_I20221230" decimals="-5" name="us-gaap:MarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmVlNTk1OGU2OGZlYzRkOThhNzFkODQ2NDU5YTUyOGQ1L3RhYmxlcmFuZ2U6ZWU1OTU4ZTY4ZmVjNGQ5OGE3MWQ4NDY0NTlhNTI4ZDVfOS0xLTEtMS04MzI4NQ_e5e8ed79-4e4b-429c-93d0-38d3883cd732">4.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fddba25d3464fc88f2322c862ad8fda_I20221230" decimals="-5" name="us-gaap:MarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmVlNTk1OGU2OGZlYzRkOThhNzFkODQ2NDU5YTUyOGQ1L3RhYmxlcmFuZ2U6ZWU1OTU4ZTY4ZmVjNGQ5OGE3MWQ4NDY0NTlhNTI4ZDVfOS0zLTEtMS04MzI4NQ_a797c8ba-3bbd-4eeb-87cc-f3581d63a41e">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id304dfd7514641719c5a17d4ab0bed7a_I20221230" decimals="-5" name="us-gaap:MarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmVlNTk1OGU2OGZlYzRkOThhNzFkODQ2NDU5YTUyOGQ1L3RhYmxlcmFuZ2U6ZWU1OTU4ZTY4ZmVjNGQ5OGE3MWQ4NDY0NTlhNTI4ZDVfOS01LTEtMS04MzI4NQ_a780c3df-4405-4a49-8467-036bdfba1136">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6600d15de2c54873830ce25e54e2f1e4_I20221230" decimals="-5" name="us-gaap:MarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmVlNTk1OGU2OGZlYzRkOThhNzFkODQ2NDU5YTUyOGQ1L3RhYmxlcmFuZ2U6ZWU1OTU4ZTY4ZmVjNGQ5OGE3MWQ4NDY0NTlhNTI4ZDVfOS03LTEtMS04MzI4NQ_f810e265-9ad5-4cc7-a95b-25eedfb6f7e3">10.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="-5" name="us-gaap:MarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmVlNTk1OGU2OGZlYzRkOThhNzFkODQ2NDU5YTUyOGQ1L3RhYmxlcmFuZ2U6ZWU1OTU4ZTY4ZmVjNGQ5OGE3MWQ4NDY0NTlhNTI4ZDVfOS05LTEtMS0xMDA1Mzc_1fcb1cd8-e8bc-45f9-991a-7cf0236b0375">19.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.650%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.511%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.650%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.650%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.650%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.652%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Commercial paper</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Corporate notes/bonds</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Government agencies</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Treasury bills</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7b8fd0dd0134e8f856ea33530935168_I20220930" decimals="-5" name="us-gaap:MarketableSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjkzZGJiODZiY2Q5ODRmNWE5MGE3ZGRlMWFjZjAxZDQyL3RhYmxlcmFuZ2U6OTNkYmI4NmJjZDk4NGY1YTkwYTdkZGUxYWNmMDFkNDJfMi0xLTEtMS0xMDA2ODU_9446eedf-02a6-4ca2-8f6f-9611e9ff2aaa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37397c07155e4b5999d81334076d9104_I20220930" decimals="-5" name="us-gaap:MarketableSecurities" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjkzZGJiODZiY2Q5ODRmNWE5MGE3ZGRlMWFjZjAxZDQyL3RhYmxlcmFuZ2U6OTNkYmI4NmJjZDk4NGY1YTkwYTdkZGUxYWNmMDFkNDJfMi0zLTEtMS0xMDA2ODU_e5aa8ad7-9a3c-4b6c-a350-a235101bd7a1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i258bf93e049d4d02a30c6b42cfdf1134_I20220930" decimals="-5" name="us-gaap:MarketableSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjkzZGJiODZiY2Q5ODRmNWE5MGE3ZGRlMWFjZjAxZDQyL3RhYmxlcmFuZ2U6OTNkYmI4NmJjZDk4NGY1YTkwYTdkZGUxYWNmMDFkNDJfMi01LTEtMS0xMDA2ODU_bcd86ecd-2f00-4a57-b270-793d8fdd276f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib570e05ca31b4b8d9df07b036d129ecc_I20220930" decimals="-5" name="us-gaap:MarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjkzZGJiODZiY2Q5ODRmNWE5MGE3ZGRlMWFjZjAxZDQyL3RhYmxlcmFuZ2U6OTNkYmI4NmJjZDk4NGY1YTkwYTdkZGUxYWNmMDFkNDJfMi03LTEtMS0xMDA2ODU_a593f156-237e-4da6-bede-969aac91871c">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fd818ca9813423087f30261388bf1ff_I20220930" decimals="-5" name="us-gaap:MarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjkzZGJiODZiY2Q5ODRmNWE5MGE3ZGRlMWFjZjAxZDQyL3RhYmxlcmFuZ2U6OTNkYmI4NmJjZDk4NGY1YTkwYTdkZGUxYWNmMDFkNDJfMi05LTEtMS0xMDA2ODU_16f4348c-d796-4de0-867f-808ac06990f0">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fb8bf62e0d742a9a0f377ab72636023_I20220930" decimals="-5" name="us-gaap:MarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjkzZGJiODZiY2Q5ODRmNWE5MGE3ZGRlMWFjZjAxZDQyL3RhYmxlcmFuZ2U6OTNkYmI4NmJjZDk4NGY1YTkwYTdkZGUxYWNmMDFkNDJfMy0xLTEtMS0xMDA2ODU_2d305e97-b768-4650-a96b-2a0ec23b46e8">5.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41d677cf97674dbd90329e0a86d4c071_I20220930" decimals="-5" name="us-gaap:MarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjkzZGJiODZiY2Q5ODRmNWE5MGE3ZGRlMWFjZjAxZDQyL3RhYmxlcmFuZ2U6OTNkYmI4NmJjZDk4NGY1YTkwYTdkZGUxYWNmMDFkNDJfMy0zLTEtMS0xMDA2ODU_54a44157-08a1-477e-ae37-2d36524b41db">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b9b65169796488785c67752201e44e3_I20220930" decimals="-5" name="us-gaap:MarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjkzZGJiODZiY2Q5ODRmNWE5MGE3ZGRlMWFjZjAxZDQyL3RhYmxlcmFuZ2U6OTNkYmI4NmJjZDk4NGY1YTkwYTdkZGUxYWNmMDFkNDJfMy01LTEtMS0xMDA2ODU_026464e3-f621-4c5d-871d-58508db441b2">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b104c9b9bf14c9f912232bc060f93db_I20220930" decimals="-5" name="us-gaap:MarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjkzZGJiODZiY2Q5ODRmNWE5MGE3ZGRlMWFjZjAxZDQyL3RhYmxlcmFuZ2U6OTNkYmI4NmJjZDk4NGY1YTkwYTdkZGUxYWNmMDFkNDJfMy03LTEtMS0xMDA2ODU_aacca1d2-ff26-4885-9dc1-e36b9fcb97f0">6.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cbc650905324d5a9d9f236aae761225_I20220930" decimals="-5" name="us-gaap:MarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjkzZGJiODZiY2Q5ODRmNWE5MGE3ZGRlMWFjZjAxZDQyL3RhYmxlcmFuZ2U6OTNkYmI4NmJjZDk4NGY1YTkwYTdkZGUxYWNmMDFkNDJfMy05LTEtMS0xMDA2ODU_f18d25fb-cf9a-470b-9ab2-3ca3597f8c0d">14.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5c2f6e8743c4071bbe71b730ae4875d_I20220930" decimals="-5" name="us-gaap:MarketableSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjkzZGJiODZiY2Q5ODRmNWE5MGE3ZGRlMWFjZjAxZDQyL3RhYmxlcmFuZ2U6OTNkYmI4NmJjZDk4NGY1YTkwYTdkZGUxYWNmMDFkNDJfNC0xLTEtMS0xMDA2ODU_f11235c0-ac3f-4112-8bf8-2cd05bc8af75">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f985f58dae54b558355211719080563_I20220930" decimals="-5" name="us-gaap:MarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjkzZGJiODZiY2Q5ODRmNWE5MGE3ZGRlMWFjZjAxZDQyL3RhYmxlcmFuZ2U6OTNkYmI4NmJjZDk4NGY1YTkwYTdkZGUxYWNmMDFkNDJfNC0zLTEtMS0xMDA2ODU_3ef168ee-eb5c-4fb3-bbc0-fa024fd92b7e">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic599629ea0b04a37b5c016ca41d98210_I20220930" decimals="-5" name="us-gaap:MarketableSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjkzZGJiODZiY2Q5ODRmNWE5MGE3ZGRlMWFjZjAxZDQyL3RhYmxlcmFuZ2U6OTNkYmI4NmJjZDk4NGY1YTkwYTdkZGUxYWNmMDFkNDJfNC01LTEtMS0xMDA2ODU_61937bf3-de16-4ca2-b61f-a73a4ee975d9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4692f756aaa45aeb72bc012dbee325a_I20220930" decimals="-5" name="us-gaap:MarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjkzZGJiODZiY2Q5ODRmNWE5MGE3ZGRlMWFjZjAxZDQyL3RhYmxlcmFuZ2U6OTNkYmI4NmJjZDk4NGY1YTkwYTdkZGUxYWNmMDFkNDJfNC03LTEtMS0xMDA2ODU_6c81a79d-5719-4c16-b701-2ae7ad88678e">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie75eb2768bab4d5b841b550e22dc7e31_I20220930" decimals="-5" name="us-gaap:MarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjkzZGJiODZiY2Q5ODRmNWE5MGE3ZGRlMWFjZjAxZDQyL3RhYmxlcmFuZ2U6OTNkYmI4NmJjZDk4NGY1YTkwYTdkZGUxYWNmMDFkNDJfNC05LTEtMS0xMDA2ODU_52ca98db-b787-41ae-bdb8-3a99ca18e8e1">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total marketable debt securities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11d163dc0c7e4f778d0934c68fbd9ed9_I20220930" decimals="-5" name="us-gaap:MarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjkzZGJiODZiY2Q5ODRmNWE5MGE3ZGRlMWFjZjAxZDQyL3RhYmxlcmFuZ2U6OTNkYmI4NmJjZDk4NGY1YTkwYTdkZGUxYWNmMDFkNDJfOS0xLTEtMS0xMDA2ODU_dc8c0ad6-0392-4e76-b97a-0297f0fedaf9">5.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09336e03a3124b3e8abcf83f054dfc6e_I20220930" decimals="-5" name="us-gaap:MarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjkzZGJiODZiY2Q5ODRmNWE5MGE3ZGRlMWFjZjAxZDQyL3RhYmxlcmFuZ2U6OTNkYmI4NmJjZDk4NGY1YTkwYTdkZGUxYWNmMDFkNDJfOS0zLTEtMS0xMDA2ODU_13d4336f-2e02-4680-b6ec-662318f319bb">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47928432e34e44fab0fa2e3e5ea1c268_I20220930" decimals="-5" name="us-gaap:MarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjkzZGJiODZiY2Q5ODRmNWE5MGE3ZGRlMWFjZjAxZDQyL3RhYmxlcmFuZ2U6OTNkYmI4NmJjZDk4NGY1YTkwYTdkZGUxYWNmMDFkNDJfOS01LTEtMS0xMDA2ODU_ca94ea67-ff02-4b2b-814e-de831173da2a">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76a7050d54304267a10c2a2ff2669153_I20220930" decimals="-5" name="us-gaap:MarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjkzZGJiODZiY2Q5ODRmNWE5MGE3ZGRlMWFjZjAxZDQyL3RhYmxlcmFuZ2U6OTNkYmI4NmJjZDk4NGY1YTkwYTdkZGUxYWNmMDFkNDJfOS03LTEtMS0xMDA2ODU_7f0bebfe-a1ee-4b99-88d5-d42a4884cc7c">10.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930" decimals="-5" name="us-gaap:MarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjkzZGJiODZiY2Q5ODRmNWE5MGE3ZGRlMWFjZjAxZDQyL3RhYmxlcmFuZ2U6OTNkYmI4NmJjZDk4NGY1YTkwYTdkZGUxYWNmMDFkNDJfOS05LTEtMS0xMDA2ODU_273bad25-7282-4d5d-a8f0-90c0873d700c">20.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:continuation></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><div id="i4ab573909cb849339357193b017c7d37_64"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_7">Table of Contents</a></span></div></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8. <ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="us-gaap:InventoryDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182NC9mcmFnOmNhMTc4NzJhN2ViMTQ4OGI4MTdkMTRjMTQ0ZTdkZjdiL3RleHRyZWdpb246Y2ExNzg3MmE3ZWIxNDg4YjgxN2QxNGMxNDRlN2RmN2JfODY_e6f6e5a8-fe54-4c73-af7a-18aeec250eca" continuedAt="i07cca097ca024092abefae79fdce9bef" escape="true">INVENTORIES</ix:nonNumeric></span></div><div style="margin-top:6pt"><ix:continuation id="i07cca097ca024092abefae79fdce9bef"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182NC9mcmFnOmNhMTc4NzJhN2ViMTQ4OGI4MTdkMTRjMTQ0ZTdkZjdiL3RleHRyZWdpb246Y2ExNzg3MmE3ZWIxNDg4YjgxN2QxNGMxNDRlN2RmN2JfODc_e3a67999-cd09-4ad6-8ffe-6f987010449c" continuedAt="ibacc1ad7652d4795b10829d7192a9772" escape="true">The following table summarizes the Company&#8217;s inventories:</ix:nonNumeric></span><ix:continuation id="ibacc1ad7652d4795b10829d7192a9772"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Raw materials and parts</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="-5" name="us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182NC9mcmFnOmNhMTc4NzJhN2ViMTQ4OGI4MTdkMTRjMTQ0ZTdkZjdiL3RhYmxlOmZmM2FlN2VlOTZhOTQ3ZGFiMjljYTE3MWU1Njk3YzQ0L3RhYmxlcmFuZ2U6ZmYzYWU3ZWU5NmE5NDdkYWIyOWNhMTcxZTU2OTdjNDRfMS0xLTEtMS04MzI4NQ_122a5ca1-8fb3-4ff0-956c-6eb0c959a52f">247.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930" decimals="-5" name="us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182NC9mcmFnOmNhMTc4NzJhN2ViMTQ4OGI4MTdkMTRjMTQ0ZTdkZjdiL3RhYmxlOmZmM2FlN2VlOTZhOTQ3ZGFiMjljYTE3MWU1Njk3YzQ0L3RhYmxlcmFuZ2U6ZmYzYWU3ZWU5NmE5NDdkYWIyOWNhMTcxZTU2OTdjNDRfMS0zLTEtMS04MzI4NQ_165e1ac5-f0c9-474c-b393-bbb79c28eceb">240.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="-5" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182NC9mcmFnOmNhMTc4NzJhN2ViMTQ4OGI4MTdkMTRjMTQ0ZTdkZjdiL3RhYmxlOmZmM2FlN2VlOTZhOTQ3ZGFiMjljYTE3MWU1Njk3YzQ0L3RhYmxlcmFuZ2U6ZmYzYWU3ZWU5NmE5NDdkYWIyOWNhMTcxZTU2OTdjNDRfMi0xLTEtMS04MzI4NQ_e4b56ca8-ab4e-470c-b549-f107ce8f3a44">25.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930" decimals="-5" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182NC9mcmFnOmNhMTc4NzJhN2ViMTQ4OGI4MTdkMTRjMTQ0ZTdkZjdiL3RhYmxlOmZmM2FlN2VlOTZhOTQ3ZGFiMjljYTE3MWU1Njk3YzQ0L3RhYmxlcmFuZ2U6ZmYzYWU3ZWU5NmE5NDdkYWIyOWNhMTcxZTU2OTdjNDRfMi0zLTEtMS04MzI4NQ_fc9149e0-d2ce-4113-abef-ff9521246f46">23.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="-5" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182NC9mcmFnOmNhMTc4NzJhN2ViMTQ4OGI4MTdkMTRjMTQ0ZTdkZjdiL3RhYmxlOmZmM2FlN2VlOTZhOTQ3ZGFiMjljYTE3MWU1Njk3YzQ0L3RhYmxlcmFuZ2U6ZmYzYWU3ZWU5NmE5NDdkYWIyOWNhMTcxZTU2OTdjNDRfMy0xLTEtMS04MzI4NQ_a2329df4-346d-40ec-a7ef-91186dd96683">47.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930" decimals="-5" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182NC9mcmFnOmNhMTc4NzJhN2ViMTQ4OGI4MTdkMTRjMTQ0ZTdkZjdiL3RhYmxlOmZmM2FlN2VlOTZhOTQ3ZGFiMjljYTE3MWU1Njk3YzQ0L3RhYmxlcmFuZ2U6ZmYzYWU3ZWU5NmE5NDdkYWIyOWNhMTcxZTU2OTdjNDRfMy0zLTEtMS04MzI4NQ_c36728a4-925d-4385-8fd7-a654e60b25d4">39.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total inventories</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182NC9mcmFnOmNhMTc4NzJhN2ViMTQ4OGI4MTdkMTRjMTQ0ZTdkZjdiL3RhYmxlOmZmM2FlN2VlOTZhOTQ3ZGFiMjljYTE3MWU1Njk3YzQ0L3RhYmxlcmFuZ2U6ZmYzYWU3ZWU5NmE5NDdkYWIyOWNhMTcxZTU2OTdjNDRfNC0xLTEtMS04MzI4NQ_1ebc8339-cf3b-487f-be8b-381e928c7143">320.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182NC9mcmFnOmNhMTc4NzJhN2ViMTQ4OGI4MTdkMTRjMTQ0ZTdkZjdiL3RhYmxlOmZmM2FlN2VlOTZhOTQ3ZGFiMjljYTE3MWU1Njk3YzQ0L3RhYmxlcmFuZ2U6ZmYzYWU3ZWU5NmE5NDdkYWIyOWNhMTcxZTU2OTdjNDRfNC0zLTEtMS04MzI4NQ_b3a1276f-75c1-4b5c-803e-ee0b257b33b2">303.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></ix:continuation></div><div id="i4ab573909cb849339357193b017c7d37_67"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9. <ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182Ny9mcmFnOjU5NzZjOWRhM2RhYTQyOGViMmM5MjhmMzRiNDVjNjc5L3RleHRyZWdpb246NTk3NmM5ZGEzZGFhNDI4ZWIyYzkyOGYzNGI0NWM2NzlfMzgw_76da0b30-6bc3-4e73-9478-2a6e9f2eb403" continuedAt="ib72d8a677a6744aca4ff9934e0b5888d" escape="true">GOODWILL AND INTANGIBLE ASSETS</ix:nonNumeric></span></div><ix:continuation id="ib72d8a677a6744aca4ff9934e0b5888d"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182Ny9mcmFnOjU5NzZjOWRhM2RhYTQyOGViMmM5MjhmMzRiNDVjNjc5L3RleHRyZWdpb246NTk3NmM5ZGEzZGFhNDI4ZWIyYzkyOGYzNGI0NWM2NzlfMzc2_50e664a8-c221-4935-8ae6-b6c5e2210818" continuedAt="if2258c62b1a445689d809b7c9e7a6db8" escape="true">The following table reflects goodwill by reportable operating segment:</ix:nonNumeric></span><ix:continuation id="if2258c62b1a445689d809b7c9e7a6db8"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.511%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.569%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Medical</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Industrial</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at September 30, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82c73512683b4d2096958ea2c1d31545_I20220930" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182Ny9mcmFnOjU5NzZjOWRhM2RhYTQyOGViMmM5MjhmMzRiNDVjNjc5L3RhYmxlOjM4MmM1Y2VhYTRlOTQ1MzM5MmNmYjYyMjNlNmUwNzAwL3RhYmxlcmFuZ2U6MzgyYzVjZWFhNGU5NDUzMzkyY2ZiNjIyM2U2ZTA3MDBfMS0xLTEtMS04MzI4NQ_2e7eb5b8-3f77-4ce9-a723-d7d3a24ced81">169.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i317f9c4181274f2493096e5cbd4ae801_I20220930" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182Ny9mcmFnOjU5NzZjOWRhM2RhYTQyOGViMmM5MjhmMzRiNDVjNjc5L3RhYmxlOjM4MmM1Y2VhYTRlOTQ1MzM5MmNmYjYyMjNlNmUwNzAwL3RhYmxlcmFuZ2U6MzgyYzVjZWFhNGU5NDUzMzkyY2ZiNjIyM2U2ZTA3MDBfMS0zLTEtMS04MzI4NQ_737ecf58-4658-44b4-a8d0-96a9ffc6951e">115.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182Ny9mcmFnOjU5NzZjOWRhM2RhYTQyOGViMmM5MjhmMzRiNDVjNjc5L3RhYmxlOjM4MmM1Y2VhYTRlOTQ1MzM5MmNmYjYyMjNlNmUwNzAwL3RhYmxlcmFuZ2U6MzgyYzVjZWFhNGU5NDUzMzkyY2ZiNjIyM2U2ZTA3MDBfMS01LTEtMS04MzI4NQ_f62b256f-fb26-4d75-8da5-e1f65937f18b">284.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad2fceac1bb145229d93b69339db9f19_D20221001-20221230" decimals="-5" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182Ny9mcmFnOjU5NzZjOWRhM2RhYTQyOGViMmM5MjhmMzRiNDVjNjc5L3RhYmxlOjM4MmM1Y2VhYTRlOTQ1MzM5MmNmYjYyMjNlNmUwNzAwL3RhYmxlcmFuZ2U6MzgyYzVjZWFhNGU5NDUzMzkyY2ZiNjIyM2U2ZTA3MDBfMi0xLTEtMS04MzI4NQ_e93aed4b-9f41-42a8-a778-49093e7faf6f">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaab56d5aa0be4d758038ec0908970ec8_D20221001-20221230" decimals="-5" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182Ny9mcmFnOjU5NzZjOWRhM2RhYTQyOGViMmM5MjhmMzRiNDVjNjc5L3RhYmxlOjM4MmM1Y2VhYTRlOTQ1MzM5MmNmYjYyMjNlNmUwNzAwL3RhYmxlcmFuZ2U6MzgyYzVjZWFhNGU5NDUzMzkyY2ZiNjIyM2U2ZTA3MDBfMi0zLTEtMS04MzI4NQ_d780e1ef-0f3e-4023-81bb-0c555335f51a">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182Ny9mcmFnOjU5NzZjOWRhM2RhYTQyOGViMmM5MjhmMzRiNDVjNjc5L3RhYmxlOjM4MmM1Y2VhYTRlOTQ1MzM5MmNmYjYyMjNlNmUwNzAwL3RhYmxlcmFuZ2U6MzgyYzVjZWFhNGU5NDUzMzkyY2ZiNjIyM2U2ZTA3MDBfMi01LTEtMS04MzI4NQ_950b3c40-32a9-475d-8003-d1fb0ab9dcd2">3.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Balance at December 30, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ed6fb1587e340578f31b77be6b9133b_I20221230" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182Ny9mcmFnOjU5NzZjOWRhM2RhYTQyOGViMmM5MjhmMzRiNDVjNjc5L3RhYmxlOjM4MmM1Y2VhYTRlOTQ1MzM5MmNmYjYyMjNlNmUwNzAwL3RhYmxlcmFuZ2U6MzgyYzVjZWFhNGU5NDUzMzkyY2ZiNjIyM2U2ZTA3MDBfNC0xLTEtMS04MzI4NQ_2bf21a59-191e-4578-998b-97d7cff387c5">171.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90a86f642a414830901c4fc2a48a1b03_I20221230" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182Ny9mcmFnOjU5NzZjOWRhM2RhYTQyOGViMmM5MjhmMzRiNDVjNjc5L3RhYmxlOjM4MmM1Y2VhYTRlOTQ1MzM5MmNmYjYyMjNlNmUwNzAwL3RhYmxlcmFuZ2U6MzgyYzVjZWFhNGU5NDUzMzkyY2ZiNjIyM2U2ZTA3MDBfNC0zLTEtMS04MzI4NQ_33dd1614-ba70-4f54-817a-91be1873d7ce">116.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182Ny9mcmFnOjU5NzZjOWRhM2RhYTQyOGViMmM5MjhmMzRiNDVjNjc5L3RhYmxlOjM4MmM1Y2VhYTRlOTQ1MzM5MmNmYjYyMjNlNmUwNzAwL3RhYmxlcmFuZ2U6MzgyYzVjZWFhNGU5NDUzMzkyY2ZiNjIyM2U2ZTA3MDBfNC01LTEtMS04MzI4NQ_221409f0-a9b0-4032-9240-f8b91c541a68">288.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182Ny9mcmFnOjU5NzZjOWRhM2RhYTQyOGViMmM5MjhmMzRiNDVjNjc5L3RleHRyZWdpb246NTk3NmM5ZGEzZGFhNDI4ZWIyYzkyOGYzNGI0NWM2NzlfMzgy_5046416e-6c95-41f9-a53b-d77046d6d610" continuedAt="iee8b1b78ecea4961ac9d2c11090217cf" escape="true">The following table reflects the gross carrying amount and accumulated amortization of the Company&#8217;s finite-lived intangible assets included in other assets in the Condensed Consolidated Balance Sheets:</ix:nonNumeric></span><ix:continuation id="iee8b1b78ecea4961ac9d2c11090217cf"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.677%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.150%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.427%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.427%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.327%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.150%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.427%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.156%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated Amortization</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated Amortization</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net Carrying Amount</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:9pt;padding-right:2.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquired existing technology</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71efe72866804c618d71d89eb6e37464_I20221230" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182Ny9mcmFnOjU5NzZjOWRhM2RhYTQyOGViMmM5MjhmMzRiNDVjNjc5L3RhYmxlOmNlNDYxNTM2ZWE1ODQyMmZhMzg5NTIyMDA2ZWNkMjQ3L3RhYmxlcmFuZ2U6Y2U0NjE1MzZlYTU4NDIyZmEzODk1MjIwMDZlY2QyNDdfMi0xLTEtMS04MzI4NQ_d7bf15ee-1c10-4417-afd1-04e493fd17b6">71.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i71efe72866804c618d71d89eb6e37464_I20221230" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182Ny9mcmFnOjU5NzZjOWRhM2RhYTQyOGViMmM5MjhmMzRiNDVjNjc5L3RhYmxlOmNlNDYxNTM2ZWE1ODQyMmZhMzg5NTIyMDA2ZWNkMjQ3L3RhYmxlcmFuZ2U6Y2U0NjE1MzZlYTU4NDIyZmEzODk1MjIwMDZlY2QyNDdfMi0zLTEtMS04MzI4NQ_4236388d-9175-410e-90d7-b3c92eb1313c">52.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71efe72866804c618d71d89eb6e37464_I20221230" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182Ny9mcmFnOjU5NzZjOWRhM2RhYTQyOGViMmM5MjhmMzRiNDVjNjc5L3RhYmxlOmNlNDYxNTM2ZWE1ODQyMmZhMzg5NTIyMDA2ZWNkMjQ3L3RhYmxlcmFuZ2U6Y2U0NjE1MzZlYTU4NDIyZmEzODk1MjIwMDZlY2QyNDdfMi01LTEtMS04MzI4NQ_7019d041-c8cc-42f2-9e5b-a2c1bc6040fc">19.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c5261f66af24806b7d3a028cf3b8dc2_I20220930" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182Ny9mcmFnOjU5NzZjOWRhM2RhYTQyOGViMmM5MjhmMzRiNDVjNjc5L3RhYmxlOmNlNDYxNTM2ZWE1ODQyMmZhMzg5NTIyMDA2ZWNkMjQ3L3RhYmxlcmFuZ2U6Y2U0NjE1MzZlYTU4NDIyZmEzODk1MjIwMDZlY2QyNDdfMi03LTEtMS04MzI4NQ_aa838dad-ae0e-4812-b539-c71493d4d30c">70.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c5261f66af24806b7d3a028cf3b8dc2_I20220930" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182Ny9mcmFnOjU5NzZjOWRhM2RhYTQyOGViMmM5MjhmMzRiNDVjNjc5L3RhYmxlOmNlNDYxNTM2ZWE1ODQyMmZhMzg5NTIyMDA2ZWNkMjQ3L3RhYmxlcmFuZ2U6Y2U0NjE1MzZlYTU4NDIyZmEzODk1MjIwMDZlY2QyNDdfMi05LTEtMS04MzI4NQ_bebf2dc9-cdb2-4dc2-a1b1-f31335e67f01">49.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c5261f66af24806b7d3a028cf3b8dc2_I20220930" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182Ny9mcmFnOjU5NzZjOWRhM2RhYTQyOGViMmM5MjhmMzRiNDVjNjc5L3RhYmxlOmNlNDYxNTM2ZWE1ODQyMmZhMzg5NTIyMDA2ZWNkMjQ3L3RhYmxlcmFuZ2U6Y2U0NjE1MzZlYTU4NDIyZmEzODk1MjIwMDZlY2QyNDdfMi0xMS0xLTEtODMyODU_c4dc1589-172c-4a45-a2f3-1301f4dd4557">20.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:9pt;padding-right:2.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patents, licenses and other</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib080390b901b4ad0b3394ec38916cf01_I20221230" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182Ny9mcmFnOjU5NzZjOWRhM2RhYTQyOGViMmM5MjhmMzRiNDVjNjc5L3RhYmxlOmNlNDYxNTM2ZWE1ODQyMmZhMzg5NTIyMDA2ZWNkMjQ3L3RhYmxlcmFuZ2U6Y2U0NjE1MzZlYTU4NDIyZmEzODk1MjIwMDZlY2QyNDdfMy0xLTEtMS04MzI4NQ_95935ea9-07bd-45d1-96e0-096944e1913b">12.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib080390b901b4ad0b3394ec38916cf01_I20221230" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182Ny9mcmFnOjU5NzZjOWRhM2RhYTQyOGViMmM5MjhmMzRiNDVjNjc5L3RhYmxlOmNlNDYxNTM2ZWE1ODQyMmZhMzg5NTIyMDA2ZWNkMjQ3L3RhYmxlcmFuZ2U6Y2U0NjE1MzZlYTU4NDIyZmEzODk1MjIwMDZlY2QyNDdfMy0zLTEtMS04MzI4NQ_45da5329-50ed-4efa-acca-6b5a6c2a7224">11.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib080390b901b4ad0b3394ec38916cf01_I20221230" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182Ny9mcmFnOjU5NzZjOWRhM2RhYTQyOGViMmM5MjhmMzRiNDVjNjc5L3RhYmxlOmNlNDYxNTM2ZWE1ODQyMmZhMzg5NTIyMDA2ZWNkMjQ3L3RhYmxlcmFuZ2U6Y2U0NjE1MzZlYTU4NDIyZmEzODk1MjIwMDZlY2QyNDdfMy01LTEtMS04MzI4NQ_7b9e48c3-b358-4969-b65a-9ed724d40277">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice17b9b9dfca490ab810ee326594761a_I20220930" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182Ny9mcmFnOjU5NzZjOWRhM2RhYTQyOGViMmM5MjhmMzRiNDVjNjc5L3RhYmxlOmNlNDYxNTM2ZWE1ODQyMmZhMzg5NTIyMDA2ZWNkMjQ3L3RhYmxlcmFuZ2U6Y2U0NjE1MzZlYTU4NDIyZmEzODk1MjIwMDZlY2QyNDdfMy03LTEtMS04MzI4NQ_d67b3ad3-d6e5-45ea-8432-38cc9b4aac5d">12.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ice17b9b9dfca490ab810ee326594761a_I20220930" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182Ny9mcmFnOjU5NzZjOWRhM2RhYTQyOGViMmM5MjhmMzRiNDVjNjc5L3RhYmxlOmNlNDYxNTM2ZWE1ODQyMmZhMzg5NTIyMDA2ZWNkMjQ3L3RhYmxlcmFuZ2U6Y2U0NjE1MzZlYTU4NDIyZmEzODk1MjIwMDZlY2QyNDdfMy05LTEtMS04MzI4NQ_e3ae74cc-a5b9-4ec6-b108-15eac957d9f6">11.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice17b9b9dfca490ab810ee326594761a_I20220930" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182Ny9mcmFnOjU5NzZjOWRhM2RhYTQyOGViMmM5MjhmMzRiNDVjNjc5L3RhYmxlOmNlNDYxNTM2ZWE1ODQyMmZhMzg5NTIyMDA2ZWNkMjQ3L3RhYmxlcmFuZ2U6Y2U0NjE1MzZlYTU4NDIyZmEzODk1MjIwMDZlY2QyNDdfMy0xMS0xLTEtODMyODU_f45069d2-90cd-4480-9df4-73e73b4b0bc3">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:9pt;padding-right:2.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer contracts and supplier relationship</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00b01e43c8e144339e841ad785f9ced0_I20221230" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182Ny9mcmFnOjU5NzZjOWRhM2RhYTQyOGViMmM5MjhmMzRiNDVjNjc5L3RhYmxlOmNlNDYxNTM2ZWE1ODQyMmZhMzg5NTIyMDA2ZWNkMjQ3L3RhYmxlcmFuZ2U6Y2U0NjE1MzZlYTU4NDIyZmEzODk1MjIwMDZlY2QyNDdfNC0xLTEtMS04MzI4NQ_90ae7d2f-2d4a-4e0e-b21a-8d95df33ea24">50.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00b01e43c8e144339e841ad785f9ced0_I20221230" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182Ny9mcmFnOjU5NzZjOWRhM2RhYTQyOGViMmM5MjhmMzRiNDVjNjc5L3RhYmxlOmNlNDYxNTM2ZWE1ODQyMmZhMzg5NTIyMDA2ZWNkMjQ3L3RhYmxlcmFuZ2U6Y2U0NjE1MzZlYTU4NDIyZmEzODk1MjIwMDZlY2QyNDdfNC0zLTEtMS04MzI4NQ_70907dff-e184-4124-965a-65297a8bf4ae">38.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00b01e43c8e144339e841ad785f9ced0_I20221230" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182Ny9mcmFnOjU5NzZjOWRhM2RhYTQyOGViMmM5MjhmMzRiNDVjNjc5L3RhYmxlOmNlNDYxNTM2ZWE1ODQyMmZhMzg5NTIyMDA2ZWNkMjQ3L3RhYmxlcmFuZ2U6Y2U0NjE1MzZlYTU4NDIyZmEzODk1MjIwMDZlY2QyNDdfNC01LTEtMS04MzI4NQ_b7049113-1ae4-4472-9619-9cc7687dccf2">11.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77825c8e58b14473947ad5b24ebc5fe2_I20220930" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182Ny9mcmFnOjU5NzZjOWRhM2RhYTQyOGViMmM5MjhmMzRiNDVjNjc5L3RhYmxlOmNlNDYxNTM2ZWE1ODQyMmZhMzg5NTIyMDA2ZWNkMjQ3L3RhYmxlcmFuZ2U6Y2U0NjE1MzZlYTU4NDIyZmEzODk1MjIwMDZlY2QyNDdfNC03LTEtMS04MzI4NQ_48decfb5-1e8e-43dd-9c97-0866c9a88604">49.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i77825c8e58b14473947ad5b24ebc5fe2_I20220930" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182Ny9mcmFnOjU5NzZjOWRhM2RhYTQyOGViMmM5MjhmMzRiNDVjNjc5L3RhYmxlOmNlNDYxNTM2ZWE1ODQyMmZhMzg5NTIyMDA2ZWNkMjQ3L3RhYmxlcmFuZ2U6Y2U0NjE1MzZlYTU4NDIyZmEzODk1MjIwMDZlY2QyNDdfNC05LTEtMS04MzI4NQ_b4dd8405-79db-4a02-bbe8-1e11431ed99f">36.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77825c8e58b14473947ad5b24ebc5fe2_I20220930" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182Ny9mcmFnOjU5NzZjOWRhM2RhYTQyOGViMmM5MjhmMzRiNDVjNjc5L3RhYmxlOmNlNDYxNTM2ZWE1ODQyMmZhMzg5NTIyMDA2ZWNkMjQ3L3RhYmxlcmFuZ2U6Y2U0NjE1MzZlYTU4NDIyZmEzODk1MjIwMDZlY2QyNDdfNC0xMS0xLTEtODMyODU_0158763b-7300-401c-a554-088873f498f1">12.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:6.75pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total intangible assets</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182Ny9mcmFnOjU5NzZjOWRhM2RhYTQyOGViMmM5MjhmMzRiNDVjNjc5L3RhYmxlOmNlNDYxNTM2ZWE1ODQyMmZhMzg5NTIyMDA2ZWNkMjQ3L3RhYmxlcmFuZ2U6Y2U0NjE1MzZlYTU4NDIyZmEzODk1MjIwMDZlY2QyNDdfNy0xLTEtMS04MzI4NQ_8c8c2d86-cd34-41a7-883e-aee5e5c3d8d4">134.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182Ny9mcmFnOjU5NzZjOWRhM2RhYTQyOGViMmM5MjhmMzRiNDVjNjc5L3RhYmxlOmNlNDYxNTM2ZWE1ODQyMmZhMzg5NTIyMDA2ZWNkMjQ3L3RhYmxlcmFuZ2U6Y2U0NjE1MzZlYTU4NDIyZmEzODk1MjIwMDZlY2QyNDdfNy0zLTEtMS04MzI4NQ_323561cd-62a6-4816-ad15-61713b928e9b">102.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182Ny9mcmFnOjU5NzZjOWRhM2RhYTQyOGViMmM5MjhmMzRiNDVjNjc5L3RhYmxlOmNlNDYxNTM2ZWE1ODQyMmZhMzg5NTIyMDA2ZWNkMjQ3L3RhYmxlcmFuZ2U6Y2U0NjE1MzZlYTU4NDIyZmEzODk1MjIwMDZlY2QyNDdfNy01LTEtMS04MzI4NQ_8e98feec-32c6-4b26-96fa-d931e098e7f7">31.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182Ny9mcmFnOjU5NzZjOWRhM2RhYTQyOGViMmM5MjhmMzRiNDVjNjc5L3RhYmxlOmNlNDYxNTM2ZWE1ODQyMmZhMzg5NTIyMDA2ZWNkMjQ3L3RhYmxlcmFuZ2U6Y2U0NjE1MzZlYTU4NDIyZmEzODk1MjIwMDZlY2QyNDdfNy03LTEtMS04MzI4NQ_ef4b7527-2cba-4257-91ca-596a17ccb99e">131.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182Ny9mcmFnOjU5NzZjOWRhM2RhYTQyOGViMmM5MjhmMzRiNDVjNjc5L3RhYmxlOmNlNDYxNTM2ZWE1ODQyMmZhMzg5NTIyMDA2ZWNkMjQ3L3RhYmxlcmFuZ2U6Y2U0NjE1MzZlYTU4NDIyZmEzODk1MjIwMDZlY2QyNDdfNy05LTEtMS04MzI4NQ_32d224e5-252c-4315-b9d4-9bca4b28cb90">98.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182Ny9mcmFnOjU5NzZjOWRhM2RhYTQyOGViMmM5MjhmMzRiNDVjNjc5L3RhYmxlOmNlNDYxNTM2ZWE1ODQyMmZhMzg5NTIyMDA2ZWNkMjQ3L3RhYmxlcmFuZ2U6Y2U0NjE1MzZlYTU4NDIyZmEzODk1MjIwMDZlY2QyNDdfNy0xMS0xLTEtODMyODU_093aeffc-e3b1-4312-80cb-74d4875f2d97">33.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Amortization expense for intangible assets was $<ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182Ny9mcmFnOjU5NzZjOWRhM2RhYTQyOGViMmM5MjhmMzRiNDVjNjc5L3RleHRyZWdpb246NTk3NmM5ZGEzZGFhNDI4ZWIyYzkyOGYzNGI0NWM2NzlfMjgz_29d851d5-d8f9-4d28-9b2e-f7ed47d053ed">3.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182Ny9mcmFnOjU5NzZjOWRhM2RhYTQyOGViMmM5MjhmMzRiNDVjNjc5L3RleHRyZWdpb246NTk3NmM5ZGEzZGFhNDI4ZWIyYzkyOGYzNGI0NWM2NzlfMjkw_08107ee0-fc31-4e80-a86a-babcefbabf05">3.8</ix:nonFraction> million for the three months ended December 30, 2022 and December&#160;31, 2021, respectively.</span></div></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><div id="i4ab573909cb849339357193b017c7d37_70"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_7">Table of Contents</a></span></div></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10. <ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RleHRyZWdpb246NDVhZDgwNGFmY2UzNGM3MDhjMjNlYWFlMzQxODRkOGRfNjUzOQ_d678f732-9873-4fb6-90a9-0c275ca46eb3" continuedAt="i50f350cce80e4f4682fc48aae279a895" escape="true">BORROWINGS</ix:nonNumeric></span></div><ix:continuation id="i50f350cce80e4f4682fc48aae279a895" continuedAt="i1e7dc2ba0873421da2f7f0f727f5000d"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="us-gaap:ScheduleOfDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RleHRyZWdpb246NDVhZDgwNGFmY2UzNGM3MDhjMjNlYWFlMzQxODRkOGRfNjU0MA_bc9fb8d5-9d63-4d67-9c10-bdd06d766355" continuedAt="if9252b6fa0614bb5b69c9c8bc5183c66" escape="true">The following table summarizes the Company's short-term and long-term debt:</ix:nonNumeric></span><ix:continuation id="if9252b6fa0614bb5b69c9c8bc5183c66" continuedAt="i6ef19ac9de214645b2a26ac0a3d74aa2"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.733%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.015%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions, except for percentages)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Contractual Interest Rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Effective Interest Rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current maturities of long-term debt</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other debt</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7b6a45a9d7f431e82a5e0541b5d665f_I20221230" decimals="-5" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RhYmxlOjQ4NTgzMzQwZjkxYTQ0ZWFiYTNkNmVhZDJjYTM2MjcyL3RhYmxlcmFuZ2U6NDg1ODMzNDBmOTFhNDRlYWJhM2Q2ZWFkMmNhMzYyNzJfNC0xLTEtMS04MzI4NQ_ffb07fed-ae6d-4fcd-805b-00e187d9d67b">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdafe244379e403ab68aa2010d767746_I20220930" decimals="-5" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RhYmxlOjQ4NTgzMzQwZjkxYTQ0ZWFiYTNkNmVhZDJjYTM2MjcyL3RhYmxlcmFuZ2U6NDg1ODMzNDBmOTFhNDRlYWJhM2Q2ZWFkMmNhMzYyNzJfNC0zLTEtMS04MzI4NQ_306beb10-fd3b-4d63-af27-e5a03f3d89e9">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Non-current maturities of long-term debt:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Convertible Senior Unsecured Notes</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ddb8748822a4dd79f1844c4e1de6408_I20221230" decimals="-5" name="var:LongtermDebtExcludingCurrentMaturitiesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RhYmxlOjQ4NTgzMzQwZjkxYTQ0ZWFiYTNkNmVhZDJjYTM2MjcyL3RhYmxlcmFuZ2U6NDg1ODMzNDBmOTFhNDRlYWJhM2Q2ZWFkMmNhMzYyNzJfOC0xLTEtMS04MzI4NQ_906f1790-98c0-4b53-8145-71ef68ca2992">200.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i329314c9f0c94232beff7031f1c86791_I20220930" decimals="-5" name="var:LongtermDebtExcludingCurrentMaturitiesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RhYmxlOjQ4NTgzMzQwZjkxYTQ0ZWFiYTNkNmVhZDJjYTM2MjcyL3RhYmxlcmFuZ2U6NDg1ODMzNDBmOTFhNDRlYWJhM2Q2ZWFkMmNhMzYyNzJfOC0zLTEtMS04MzI4NQ_16135b02-0bd6-4bb4-9c60-05e17403557f">200.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2ddb8748822a4dd79f1844c4e1de6408_I20221230" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RhYmxlOjQ4NTgzMzQwZjkxYTQ0ZWFiYTNkNmVhZDJjYTM2MjcyL3RhYmxlcmFuZ2U6NDg1ODMzNDBmOTFhNDRlYWJhM2Q2ZWFkMmNhMzYyNzJfOC01LTEtMS04MzI4NQ_720fe66e-57f3-46ff-9381-a6161c657a15">4.0</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if2ff80d284834bfcb7ca6f632c838139_D20221001-20221230" decimals="3" name="us-gaap:LongTermDebtWeightedAverageInterestRateOverTime" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RhYmxlOjQ4NTgzMzQwZjkxYTQ0ZWFiYTNkNmVhZDJjYTM2MjcyL3RhYmxlcmFuZ2U6NDg1ODMzNDBmOTFhNDRlYWJhM2Q2ZWFkMmNhMzYyNzJfOC03LTEtMS04MzI4NQ_5c34ae56-15ed-4c24-9801-6d3ffe6423cd">4.8</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Secured Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fee5a0bbf6742f6bb3e66a2bb45060d_I20221230" decimals="-5" name="var:LongtermDebtExcludingCurrentMaturitiesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RhYmxlOjQ4NTgzMzQwZjkxYTQ0ZWFiYTNkNmVhZDJjYTM2MjcyL3RhYmxlcmFuZ2U6NDg1ODMzNDBmOTFhNDRlYWJhM2Q2ZWFkMmNhMzYyNzJfOS0xLTEtMS04MzI4NQ_c38baa02-9f27-44db-b109-b977631a1cb5">243.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0321a6e3bf3410dbde55beea3d74890_I20220930" decimals="-5" name="var:LongtermDebtExcludingCurrentMaturitiesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RhYmxlOjQ4NTgzMzQwZjkxYTQ0ZWFiYTNkNmVhZDJjYTM2MjcyL3RhYmxlcmFuZ2U6NDg1ODMzNDBmOTFhNDRlYWJhM2Q2ZWFkMmNhMzYyNzJfOS0zLTEtMS04MzI4NQ_39696177-9b94-4e03-b408-fc85d1f5e826">243.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2fee5a0bbf6742f6bb3e66a2bb45060d_I20221230" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RhYmxlOjQ4NTgzMzQwZjkxYTQ0ZWFiYTNkNmVhZDJjYTM2MjcyL3RhYmxlcmFuZ2U6NDg1ODMzNDBmOTFhNDRlYWJhM2Q2ZWFkMmNhMzYyNzJfOS01LTEtMS04MzI4NQ_460cab0a-aaaa-4b4d-b4f8-f79af335915f">7.9</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idb047c1f6e044134babc50205637228f_D20221001-20221230" decimals="3" name="us-gaap:LongTermDebtWeightedAverageInterestRateOverTime" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RhYmxlOjQ4NTgzMzQwZjkxYTQ0ZWFiYTNkNmVhZDJjYTM2MjcyL3RhYmxlcmFuZ2U6NDg1ODMzNDBmOTFhNDRlYWJhM2Q2ZWFkMmNhMzYyNzJfOS03LTEtMS04MzI4NQ_95a9d9d2-a009-4022-915c-7a2456173627">8.2</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7b6a45a9d7f431e82a5e0541b5d665f_I20221230" decimals="-5" name="var:LongtermDebtExcludingCurrentMaturitiesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RhYmxlOjQ4NTgzMzQwZjkxYTQ0ZWFiYTNkNmVhZDJjYTM2MjcyL3RhYmxlcmFuZ2U6NDg1ODMzNDBmOTFhNDRlYWJhM2Q2ZWFkMmNhMzYyNzJfMTAtMS0xLTEtODMyODU_4ef87299-a05c-44bd-b161-2ae78e520588">4.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdafe244379e403ab68aa2010d767746_I20220930" decimals="-5" name="var:LongtermDebtExcludingCurrentMaturitiesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RhYmxlOjQ4NTgzMzQwZjkxYTQ0ZWFiYTNkNmVhZDJjYTM2MjcyL3RhYmxlcmFuZ2U6NDg1ODMzNDBmOTFhNDRlYWJhM2Q2ZWFkMmNhMzYyNzJfMTAtMy0xLTEtODMyODU_e5e694da-48dc-45ec-9915-b2aa92ec3460">4.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total non-current maturities of long-term debt:</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="-5" name="var:LongtermDebtExcludingCurrentMaturitiesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RhYmxlOjQ4NTgzMzQwZjkxYTQ0ZWFiYTNkNmVhZDJjYTM2MjcyL3RhYmxlcmFuZ2U6NDg1ODMzNDBmOTFhNDRlYWJhM2Q2ZWFkMmNhMzYyNzJfMTEtMS0xLTEtODMyODU_f71daaa0-da30-48e3-a5fd-7159f6930804">447.6</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930" decimals="-5" name="var:LongtermDebtExcludingCurrentMaturitiesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RhYmxlOjQ4NTgzMzQwZjkxYTQ0ZWFiYTNkNmVhZDJjYTM2MjcyL3RhYmxlcmFuZ2U6NDg1ODMzNDBmOTFhNDRlYWJhM2Q2ZWFkMmNhMzYyNzJfMTEtMy0xLTEtODMyODU_32fa521d-104f-48f2-a0c3-a4d48cab8d12">447.6</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unamortized issuance costs and debt discounts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unamortized discount - Convertible Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ddb8748822a4dd79f1844c4e1de6408_I20221230" decimals="-5" name="us-gaap:DebtInstrumentUnamortizedDiscount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RhYmxlOjQ4NTgzMzQwZjkxYTQ0ZWFiYTNkNmVhZDJjYTM2MjcyL3RhYmxlcmFuZ2U6NDg1ODMzNDBmOTFhNDRlYWJhM2Q2ZWFkMmNhMzYyNzJfMTMtMS0xLTEtODMyODU_a6f72754-5569-4a94-8f1b-f573da6e0b98">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i329314c9f0c94232beff7031f1c86791_I20220930" decimals="-5" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RhYmxlOjQ4NTgzMzQwZjkxYTQ0ZWFiYTNkNmVhZDJjYTM2MjcyL3RhYmxlcmFuZ2U6NDg1ODMzNDBmOTFhNDRlYWJhM2Q2ZWFkMmNhMzYyNzJfMTMtMy0xLTEtODMyODU_5c4d7161-ae8f-4146-8197-5a615dc24ffd">28.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unamortized issuance costs - Convertible Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ddb8748822a4dd79f1844c4e1de6408_I20221230" decimals="-5" name="us-gaap:DeferredFinanceCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RhYmxlOjQ4NTgzMzQwZjkxYTQ0ZWFiYTNkNmVhZDJjYTM2MjcyL3RhYmxlcmFuZ2U6NDg1ODMzNDBmOTFhNDRlYWJhM2Q2ZWFkMmNhMzYyNzJfMTQtMS0xLTEtODMyODU_2a35087a-f6a1-45d0-97a0-8758bb91ac7b">3.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i329314c9f0c94232beff7031f1c86791_I20220930" decimals="-5" name="us-gaap:DeferredFinanceCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RhYmxlOjQ4NTgzMzQwZjkxYTQ0ZWFiYTNkNmVhZDJjYTM2MjcyL3RhYmxlcmFuZ2U6NDg1ODMzNDBmOTFhNDRlYWJhM2Q2ZWFkMmNhMzYyNzJfMTQtMy0xLTEtODMyODU_bb14fd09-dfd3-45b3-9b96-82032af6bb89">3.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unamortized issuance costs - Senior Secured Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2fee5a0bbf6742f6bb3e66a2bb45060d_I20221230" decimals="-5" name="us-gaap:DeferredFinanceCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RhYmxlOjQ4NTgzMzQwZjkxYTQ0ZWFiYTNkNmVhZDJjYTM2MjcyL3RhYmxlcmFuZ2U6NDg1ODMzNDBmOTFhNDRlYWJhM2Q2ZWFkMmNhMzYyNzJfMTUtMS0xLTEtODMyODU_9e15a8e9-3b7f-481f-b6a9-e528770f5d65">3.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0321a6e3bf3410dbde55beea3d74890_I20220930" decimals="-5" name="us-gaap:DeferredFinanceCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RhYmxlOjQ4NTgzMzQwZjkxYTQ0ZWFiYTNkNmVhZDJjYTM2MjcyL3RhYmxlcmFuZ2U6NDg1ODMzNDBmOTFhNDRlYWJhM2Q2ZWFkMmNhMzYyNzJfMTUtMy0xLTEtODMyODU_a8422765-3bb4-4401-b461-68d2ea176c2c">3.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="-5" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RhYmxlOjQ4NTgzMzQwZjkxYTQ0ZWFiYTNkNmVhZDJjYTM2MjcyL3RhYmxlcmFuZ2U6NDg1ODMzNDBmOTFhNDRlYWJhM2Q2ZWFkMmNhMzYyNzJfMTYtMS0xLTEtODMyODU_7b67f82e-c54a-465f-9862-c4a165606fdc">6.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930" decimals="-5" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RhYmxlOjQ4NTgzMzQwZjkxYTQ0ZWFiYTNkNmVhZDJjYTM2MjcyL3RhYmxlcmFuZ2U6NDg1ODMzNDBmOTFhNDRlYWJhM2Q2ZWFkMmNhMzYyNzJfMTYtMy0xLTEtODMyODU_4e8e5937-9218-4692-b10b-8024b1c4a66b">35.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total debt outstanding, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RhYmxlOjQ4NTgzMzQwZjkxYTQ0ZWFiYTNkNmVhZDJjYTM2MjcyL3RhYmxlcmFuZ2U6NDg1ODMzNDBmOTFhNDRlYWJhM2Q2ZWFkMmNhMzYyNzJfMTctMS0xLTEtODMyODU_93b6ac24-f879-41b1-a50b-f9be103e1561">442.9</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RhYmxlOjQ4NTgzMzQwZjkxYTQ0ZWFiYTNkNmVhZDJjYTM2MjcyL3RhYmxlcmFuZ2U6NDg1ODMzNDBmOTFhNDRlYWJhM2Q2ZWFkMmNhMzYyNzJfMTctMy0xLTEtODMyODU_c85b5852-d038-49b7-9b9f-0dcd990e4f9e">414.4</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity component of Convertible Senior Unsecured Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ddb8748822a4dd79f1844c4e1de6408_I20221230" decimals="-5" name="us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RhYmxlOjQ4NTgzMzQwZjkxYTQ0ZWFiYTNkNmVhZDJjYTM2MjcyL3RhYmxlcmFuZ2U6NDg1ODMzNDBmOTFhNDRlYWJhM2Q2ZWFkMmNhMzYyNzJfMTktMS0xLTEtODMyODU_84dfc107-2340-4223-ba49-2e729dc51132">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i329314c9f0c94232beff7031f1c86791_I20220930" decimals="-5" name="us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RhYmxlOjQ4NTgzMzQwZjkxYTQ0ZWFiYTNkNmVhZDJjYTM2MjcyL3RhYmxlcmFuZ2U6NDg1ODMzNDBmOTFhNDRlYWJhM2Q2ZWFkMmNhMzYyNzJfMTktMy0xLTEtODMyODU_04997920-79ba-4357-862a-52e10a0d9b3d">49.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></ix:continuation></div><ix:continuation id="i6ef19ac9de214645b2a26ac0a3d74aa2"><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> In connection with the adoption of ASU 2020-06, the unamortized discount related to the Convertible Notes was derecognized and the carrying value of the issuance costs was adjusted in the first quarter of fiscal year 2023. Refer to Note 1, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Summary of Significant Accounting Policies </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">for further details. </span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Included in additional paid-in capital on the Condensed Consolidated Balance Sheets.</span></div></ix:continuation><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RleHRyZWdpb246NDVhZDgwNGFmY2UzNGM3MDhjMjNlYWFlMzQxODRkOGRfNjU0Ng_29012be7-95e9-4f8a-a5fb-6c5e2c6095b7" continuedAt="i8f3af846008a47c9ae023f941a4b1f45" escape="true">The following table summarizes the Company's interest expense:</ix:nonNumeric></span><ix:continuation id="i8f3af846008a47c9ae023f941a4b1f45"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.568%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contractual interest coupon and other</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="var:InterestExpenseDebtContractualInterestCoupon" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RhYmxlOjJkMjhmZDZkMWNlMTRkMGNhZWYzZTNlZjBmOTRhNDYzL3RhYmxlcmFuZ2U6MmQyOGZkNmQxY2UxNGQwY2FlZjNlM2VmMGY5NGE0NjNfMi0xLTEtMS04MzI4NQ_3554863e-a5ca-4443-9391-9760d485e293">6.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="var:InterestExpenseDebtContractualInterestCoupon" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RhYmxlOjJkMjhmZDZkMWNlMTRkMGNhZWYzZTNlZjBmOTRhNDYzL3RhYmxlcmFuZ2U6MmQyOGZkNmQxY2UxNGQwY2FlZjNlM2VmMGY5NGE0NjNfMi0zLTEtMS04MzI4NQ_5c842faa-8ddd-4d6e-be63-d70c1afcc46f">7.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="us-gaap:AmortizationOfFinancingCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RhYmxlOjJkMjhmZDZkMWNlMTRkMGNhZWYzZTNlZjBmOTRhNDYzL3RhYmxlcmFuZ2U6MmQyOGZkNmQxY2UxNGQwY2FlZjNlM2VmMGY5NGE0NjNfMy0xLTEtMS04MzI4NQ_3aabd322-69eb-45f8-89b9-7df02200bdd1">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="us-gaap:AmortizationOfFinancingCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RhYmxlOjJkMjhmZDZkMWNlMTRkMGNhZWYzZTNlZjBmOTRhNDYzL3RhYmxlcmFuZ2U6MmQyOGZkNmQxY2UxNGQwY2FlZjNlM2VmMGY5NGE0NjNfMy0zLTEtMS04MzI4NQ_9d689908-8841-40aa-96bf-82ee91064688">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of debt discounts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="us-gaap:AmortizationOfDebtDiscountPremium" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RhYmxlOjJkMjhmZDZkMWNlMTRkMGNhZWYzZTNlZjBmOTRhNDYzL3RhYmxlcmFuZ2U6MmQyOGZkNmQxY2UxNGQwY2FlZjNlM2VmMGY5NGE0NjNfNC0xLTEtMS04MzI4NQ_415fa4df-71e5-4826-af01-f20e05bb25c2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RhYmxlOjJkMjhmZDZkMWNlMTRkMGNhZWYzZTNlZjBmOTRhNDYzL3RhYmxlcmFuZ2U6MmQyOGZkNmQxY2UxNGQwY2FlZjNlM2VmMGY5NGE0NjNfNC0zLTEtMS04MzI4NQ_aaf85826-766c-4765-98a7-d53ba3fc8ab2">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total interest expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RhYmxlOjJkMjhmZDZkMWNlMTRkMGNhZWYzZTNlZjBmOTRhNDYzL3RhYmxlcmFuZ2U6MmQyOGZkNmQxY2UxNGQwY2FlZjNlM2VmMGY5NGE0NjNfNS0xLTEtMS04MzI4NQ_0988406d-e309-4cd9-a16b-f0e387b89894">7.5</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RhYmxlOjJkMjhmZDZkMWNlMTRkMGNhZWYzZTNlZjBmOTRhNDYzL3RhYmxlcmFuZ2U6MmQyOGZkNmQxY2UxNGQwY2FlZjNlM2VmMGY5NGE0NjNfNS0zLTEtMS04MzI4NQ_5a1c59c5-dbed-4053-b951-8e69a400bb93">9.9</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Convertible Senior Unsecured Notes</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On June 9, 2020, Varex issued $<ix:nonFraction unitRef="usd" contextRef="i69f1e52e1cba4369877e4bf54fb6f0fa_I20200609" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RleHRyZWdpb246NDVhZDgwNGFmY2UzNGM3MDhjMjNlYWFlMzQxODRkOGRfMzA4_475387e8-991e-40ad-9713-3fe5699ff72d">200.0</ix:nonFraction>&#160;million in aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="i69f1e52e1cba4369877e4bf54fb6f0fa_I20200609" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RleHRyZWdpb246NDVhZDgwNGFmY2UzNGM3MDhjMjNlYWFlMzQxODRkOGRfMzQ0_36d1794a-9285-4e25-907f-a883dea75cc3">4.00</ix:nonFraction>% Convertible Senior Unsecured Notes due 2025 (&#8220;Convertible Notes&#8221;). The net proceeds from the issuance of the Convertible Notes, after deducting transaction fees and offering expense payable by the Company, were approximately $<ix:nonFraction unitRef="usd" contextRef="ia56e2cecd1c944d1be9cbd9438c698cb_D20200609-20200609" decimals="-5" name="us-gaap:ProceedsFromConvertibleDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RleHRyZWdpb246NDVhZDgwNGFmY2UzNGM3MDhjMjNlYWFlMzQxODRkOGRfNTcw_b28bbb13-e9b4-4cbf-8223-dfb6d8c5e9dc">193.1</ix:nonFraction>&#160;million. The Convertible Notes bear interest at the annual rate of <ix:nonFraction unitRef="number" contextRef="i69f1e52e1cba4369877e4bf54fb6f0fa_I20200609" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RleHRyZWdpb246NDVhZDgwNGFmY2UzNGM3MDhjMjNlYWFlMzQxODRkOGRfNjMy_a096e8b9-65a6-43ed-875b-516c315f91d2">4.00</ix:nonFraction>%, payable semiannually on June 1 and December 1 of each year, beginning on December 1, 2020, and will mature on June 1, 2025, unless earlier converted or repurchased by Varex.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Convertible Notes are convertible into cash, shares of Varex common stock or a combination thereof, at Varex's election, at an initial conversion rate of <ix:nonFraction unitRef="shares" contextRef="ia56e2cecd1c944d1be9cbd9438c698cb_D20200609-20200609" decimals="INF" name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RleHRyZWdpb246NDVhZDgwNGFmY2UzNGM3MDhjMjNlYWFlMzQxODRkOGRfMTA5OTUxMTYyODU4NDk_34100924-df02-4489-92ea-9f7faf23dd45">48.048</ix:nonFraction> shares of common stock per $1,000 principal amount of Convertible Notes, which is equivalent to an initial conversion price of approximately $<ix:nonFraction unitRef="usdPerShare" contextRef="i9d049c5854724aa9974c7beaa7a53f96_I20200605" decimals="2" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RleHRyZWdpb246NDVhZDgwNGFmY2UzNGM3MDhjMjNlYWFlMzQxODRkOGRfMTA5OTUxMTYyODU4NzE_659704d7-88fc-4950-bb9d-a7f4fd78300e">20.81</ix:nonFraction> per share, subject to adjustment pursuant to the terms of the indenture governing the Convertible Notes. The Convertible Notes may be converted at any time after, and including, December 15, 2024 until the close of business on the second scheduled trading day immediately before the maturity date. The maximum number of shares issuable upon conversion of the Convertible Notes is <ix:nonFraction unitRef="shares" contextRef="i4e0cf62911af4732b7b65d582effb57a_D20200604-20200605" decimals="-5" name="us-gaap:DebtInstrumentConvertibleNumberOfEquityInstruments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RleHRyZWdpb246NDVhZDgwNGFmY2UzNGM3MDhjMjNlYWFlMzQxODRkOGRfMTA5OTUxMTYyODU5NzE_97fe4fb8-9ead-4e78-847f-4d94a8a02b06">9.6</ix:nonFraction>&#160;million.</span></div></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_7">Table of Contents</a></span></div></div><ix:continuation id="i1e7dc2ba0873421da2f7f0f727f5000d"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Call Spread </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On June 4, 2020 and June 5, 2020, in connection with the offering of the Convertible Notes, Varex entered into privately negotiated convertible note hedge transactions (collectively, the &#8220;Hedge Transactions&#8221;). The Hedge Transactions cover, subject to customary anti-dilution adjustments, the number of shares of Varex common stock that were initially covered by the Convertible Notes. The Hedge Transactions are expected generally to reduce the potential dilution and/or offset any cash payments Varex is required to make in excess of the principal amount due upon conversion of the Convertible Notes in the event that the market price of Varex common stock is greater than the strike price of the Hedge Transactions, which was initially $<ix:nonFraction unitRef="usdPerShare" contextRef="i9d049c5854724aa9974c7beaa7a53f96_I20200605" decimals="2" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RleHRyZWdpb246NDVhZDgwNGFmY2UzNGM3MDhjMjNlYWFlMzQxODRkOGRfMTUzOA_526a2740-2c21-44bc-ab42-58f7de661a53">20.81</ix:nonFraction> per share (subject to adjustment under the terms of the Hedge Transactions). The strike price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i9d049c5854724aa9974c7beaa7a53f96_I20200605" decimals="2" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RleHRyZWdpb246NDVhZDgwNGFmY2UzNGM3MDhjMjNlYWFlMzQxODRkOGRfMTYzOA_659704d7-88fc-4950-bb9d-a7f4fd78300e">20.81</ix:nonFraction> corresponds to the initial conversion price of the Convertible Notes. The number of shares underlying the Hedge Transactions is <ix:nonFraction unitRef="shares" contextRef="i4e0cf62911af4732b7b65d582effb57a_D20200604-20200605" decimals="-5" name="us-gaap:DebtInstrumentConvertibleNumberOfEquityInstruments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RleHRyZWdpb246NDVhZDgwNGFmY2UzNGM3MDhjMjNlYWFlMzQxODRkOGRfMTc2OQ_97fe4fb8-9ead-4e78-847f-4d94a8a02b06">9.6</ix:nonFraction>&#160;million.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On June 4, 2020 and June 5, 2020, Varex also entered into privately negotiated warrant transactions (collectively, the &#8220;Warrant Transactions&#8221; and, together with the Hedge Transactions, the &#8220;Call Spread Transactions&#8221;), whereby the Company sold warrants at a higher strike price relating to the same number of shares of Varex common stock that were initially covered by the Convertible Notes, subject to customary anti-dilution adjustments. The initial strike price of the warrants is $<ix:nonFraction unitRef="usdPerShare" contextRef="i97ab3a4749584f83846ca650afd01c56_I20200604" decimals="3" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RleHRyZWdpb246NDVhZDgwNGFmY2UzNGM3MDhjMjNlYWFlMzQxODRkOGRfMjIzNg_d8c4646f-4212-454d-9493-cf0d785b363a">24.975</ix:nonFraction> per share (subject to adjustment under the terms of the Warrant Transactions), which was <ix:nonFraction unitRef="number" contextRef="i97ab3a4749584f83846ca650afd01c56_I20200604" decimals="INF" name="var:ClassOfWarrantOrRightPercentIncreaseOfStrikePriceOverSalePrice" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RleHRyZWdpb246NDVhZDgwNGFmY2UzNGM3MDhjMjNlYWFlMzQxODRkOGRfMjMyOA_b846b031-34c7-4d84-a0c0-d001fa6caea4">50</ix:nonFraction>% above the last reported sale price of Varex common stock on June 4, 2020. The Warrant Transactions could have a dilutive effect to the Company's stockholders to the extent that the market price per share of Varex common stock, as measured under the terms of the Warrant Transactions, exceeds the applicable strike price of the warrants. The number of shares underlying the Warrant Transactions is <ix:nonFraction unitRef="shares" contextRef="i4e0cf62911af4732b7b65d582effb57a_D20200604-20200605" decimals="-5" name="us-gaap:DebtInstrumentConvertibleNumberOfEquityInstruments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RleHRyZWdpb246NDVhZDgwNGFmY2UzNGM3MDhjMjNlYWFlMzQxODRkOGRfMjcxOA_8d33de43-df21-4e42-b4c4-e58187b52e71">9.6</ix:nonFraction>&#160;million. The number of warrants outstanding as of December&#160;30, 2022 was <ix:nonFraction unitRef="shares" contextRef="i798fb4265b0e4636a6a91ab2434ed003_D20221001-20221230" decimals="-5" name="us-gaap:DebtInstrumentConvertibleNumberOfEquityInstruments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RleHRyZWdpb246NDVhZDgwNGFmY2UzNGM3MDhjMjNlYWFlMzQxODRkOGRfMjc3MA_f1ec9d54-abaa-4ee3-9289-a584120dfe2c">9.6</ix:nonFraction>&#160;million.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Senior Secured Notes</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Varex issued $<ix:nonFraction unitRef="usd" contextRef="id08284e24f7a44a1af87978abad620f1_I20200930" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RleHRyZWdpb246NDVhZDgwNGFmY2UzNGM3MDhjMjNlYWFlMzQxODRkOGRfMjgwOQ_a70fc5fc-9410-4cfd-8a87-682a7ee0708c">300.0</ix:nonFraction>&#160;million aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="id08284e24f7a44a1af87978abad620f1_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RleHRyZWdpb246NDVhZDgwNGFmY2UzNGM3MDhjMjNlYWFlMzQxODRkOGRfMjg0Mg_cd98b885-d3ad-46f2-94eb-f4a672a4b654">7.875</ix:nonFraction>% Senior Secured Notes due 2027 (the "Senior Secured Notes") pursuant to an indenture dated September 30, 2020. Interest payments are paid semiannually on April 15 and October 15 of each year, beginning on April 15, 2021. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Senior Secured Notes are secured by a first priority lien on substantially all of the assets of Varex and the assets and capital stock of its subsidiary guarantors (subject to exceptions), except for assets for which a first priority security interest is pledged for the ABL Facility (defined below), in which the Senior Secured Notes will have a second lien security interest. The Senior Secured Notes include negative covenants, subject to certain exceptions, restricting or limiting Varex's ability and the ability of its restricted subsidiaries to, among other things, incur liens on collateral; sell certain assets; incur additional indebtedness; pay dividends; issue preferred shares; consolidate, merge, or sell all or substantially all of its assets; and enter into certain transactions with their affiliates.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Asset-Based Loan</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On September 30, 2020, the Company entered into a revolving credit agreement consisting of a $<ix:nonFraction unitRef="usd" contextRef="icb3ccdc0c44b4d1ea6e36338c7054f16_I20200930" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RleHRyZWdpb246NDVhZDgwNGFmY2UzNGM3MDhjMjNlYWFlMzQxODRkOGRfNDU1MQ_3771a17c-a10d-47c9-bd4e-6b911c4a9ee8">100.0</ix:nonFraction>&#160;million asset-based loan revolving credit facility (the &#8220;Asset-Based Loan&#8221; or "ABL Facility"). Borrowings under the Asset-Based Loan bear interest at floating rates based on the Secured Overnight Financing Rate ("SOFR"), or a comparable rate, or a base rate, and an applicable margin based on Average Daily Excess Availability (as defined in the Asset-Based Loan Agreement). In addition, the Company is required to pay a quarterly commitment fee of <ix:nonFraction unitRef="number" contextRef="i158d5c57020b4ef6a39dffc0260b3686_D20220930-20220930" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RleHRyZWdpb246NDVhZDgwNGFmY2UzNGM3MDhjMjNlYWFlMzQxODRkOGRfNTI3NA_d819bba1-8519-43c4-b5dc-387bb06074f0">0.25</ix:nonFraction>%, based on the aggregate unused commitments under the Asset-Based Loan.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The ABL Facility matures on the earlier of September 30, 2025 or 91 days prior to the maturity of the Convertible Notes, at which time all outstanding amounts under the ABL Facility will be due and payable. The maximum availability under the ABL Facility is $<ix:nonFraction unitRef="usd" contextRef="i6c3e3d6ed3d54b1db390bab6a91c9dbc_I20221230" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RleHRyZWdpb246NDVhZDgwNGFmY2UzNGM3MDhjMjNlYWFlMzQxODRkOGRfNTczMg_ceda7c54-71cf-4c65-9b45-edb5bdd6e392">100.0</ix:nonFraction> million; however, the borrowing base under the ABL Facility fluctuates from month-to-month depending on the amount of eligible accounts receivable, inventory, and real estate. As of December&#160;30, 2022, the amount available under the ABL Facility was $<ix:nonFraction unitRef="usd" contextRef="i6c3e3d6ed3d54b1db390bab6a91c9dbc_I20221230" decimals="-6" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RleHRyZWdpb246NDVhZDgwNGFmY2UzNGM3MDhjMjNlYWFlMzQxODRkOGRfNTk2MQ_12efbad1-c88c-458b-b144-baf8c7d6214d">92.0</ix:nonFraction>&#160;million and the ABL Facility remains undrawn.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The ABL Facility includes various restrictive covenants that limit the Company's ability to engage in certain transactions, including the incurrence of debt, payment of dividends and other restrictive payments, existence of restrictions affecting subsidiaries, sales of stock and assets, certain affiliate transactions, modifications of debt documents and organizational documents, changes to line of business and fiscal year, incurrence of liens, making fundamental changes, prepayments of junior indebtedness, and certain other transactions.</span></div></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><div id="i4ab573909cb849339357193b017c7d37_73"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_7">Table of Contents</a></span></div></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11. <ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="us-gaap:MinorityInterestDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183My9mcmFnOjNhOTQ5ZjJjZDZjMDRkNWVhZmM1MGIyYmE2NzY2Y2MxL3RleHRyZWdpb246M2E5NDlmMmNkNmMwNGQ1ZWFmYzUwYjJiYTY3NjZjYzFfMjE2MQ_cf6b2987-4410-422e-9042-028c001e5587" continuedAt="ib105e7df308d44c284d6095d534c5c3d" escape="true">NONCONTROLLING INTERESTS</ix:nonNumeric></span></div><ix:continuation id="ib105e7df308d44c284d6095d534c5c3d"><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In September 2018, the Company entered into a partnership in Saudi Arabia. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has majority voting rights with an approximate <ix:nonFraction unitRef="number" contextRef="ibe05cb3673834311b8aede71e8a50abf_I20180930" decimals="2" name="us-gaap:MinorityInterestOwnershipPercentageByParent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183My9mcmFnOjNhOTQ5ZjJjZDZjMDRkNWVhZmM1MGIyYmE2NzY2Y2MxL3RleHRyZWdpb246M2E5NDlmMmNkNmMwNGQ1ZWFmYzUwYjJiYTY3NjZjYzFfNzY4_388b7a2a-dafc-4811-8581-4be763f5745c">75</ix:nonFraction>% interest. Accordingly, the Company has consolidated the operations of the Saudi Arabia partnership in its condensed consolidated financial statements and recorded the noncontrolling interests. The noncontrolling interest related to the partner&#8217;s <ix:nonFraction unitRef="number" contextRef="ibe05cb3673834311b8aede71e8a50abf_I20180930" decimals="2" name="us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183My9mcmFnOjNhOTQ5ZjJjZDZjMDRkNWVhZmM1MGIyYmE2NzY2Y2MxL3RleHRyZWdpb246M2E5NDlmMmNkNmMwNGQ1ZWFmYzUwYjJiYTY3NjZjYzFfMTAxNw_7f2ea2fb-aa8a-442d-9b55-f36868aa26df">25</ix:nonFraction>% interest in the joint venture is included in noncontrolling interests in the equity section of the Company&#8217;s Condensed Consolidated Balance Sheets. Income representing the noncontrolling partner's share of income from operations is included in the Company's Condensed Consolidated Statements of Operations.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In April 2015, the Company acquired <ix:nonFraction unitRef="number" contextRef="iaa0abd3404e2408cb290b091be08936f_I20150430" decimals="3" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183My9mcmFnOjNhOTQ5ZjJjZDZjMDRkNWVhZmM1MGIyYmE2NzY2Y2MxL3RleHRyZWdpb246M2E5NDlmMmNkNmMwNGQ1ZWFmYzUwYjJiYTY3NjZjYzFfMTM0MQ_0bb1e019-faca-416e-ac0b-050d1a95ed0f">73.5</ix:nonFraction>% of the then outstanding shares of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MeVis Medical Solutions AG (&#8220;MeVis&#8221;)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, a publicly traded company based in Bremen, Germany that provides image processing software and services for cancer screening. In August 2015, the Company, through one of its German subsidiaries, entered into a Domination and Profit and Loss Transfer Agreement (the &#8220;DPLTA&#8221;) with MeVis. In fiscal years 2017 and 2018, the Company purchased an additional <ix:nonFraction unitRef="number" contextRef="i129fd5cad674437db5d8fc43fb2f24cc_D20170929-20170929" decimals="3" name="var:PercentageOfAdditionalOutstandingSharesPurchased" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183My9mcmFnOjNhOTQ5ZjJjZDZjMDRkNWVhZmM1MGIyYmE2NzY2Y2MxL3RleHRyZWdpb246M2E5NDlmMmNkNmMwNGQ1ZWFmYzUwYjJiYTY3NjZjYzFfMTA5OTUxMTYzMDQ5NA_c3b339c4-a794-4c9a-be20-1b9884f70604"><ix:nonFraction unitRef="number" contextRef="ia34c4680d929483bb8b2f9d74fb41a7a_D20180928-20180928" decimals="3" name="var:PercentageOfAdditionalOutstandingSharesPurchased" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183My9mcmFnOjNhOTQ5ZjJjZDZjMDRkNWVhZmM1MGIyYmE2NzY2Y2MxL3RleHRyZWdpb246M2E5NDlmMmNkNmMwNGQ1ZWFmYzUwYjJiYTY3NjZjYzFfMTA5OTUxMTYzMDQ5NA_f9c1738d-22c1-4acd-8045-23e614671798">0.2</ix:nonFraction></ix:nonFraction>% of outstanding shares such that the Company now owns <ix:nonFraction unitRef="number" contextRef="ic047dd7ba8bc4e4983adf9ec678cc993_I20181231" decimals="INF" name="var:BusinessAcquisitionCumulativePercentageOfVotingInterestsAcquired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183My9mcmFnOjNhOTQ5ZjJjZDZjMDRkNWVhZmM1MGIyYmE2NzY2Y2MxL3RleHRyZWdpb246M2E5NDlmMmNkNmMwNGQ1ZWFmYzUwYjJiYTY3NjZjYzFfMjE5OTAyMzI1ODQ2NA_b2bf6bb6-b55f-43fc-85be-ebacd1e41bf2">73.7</ix:nonFraction>% of the outstanding shares of common stock of MeVis. Under the DPLTA, MeVis subordinates its management to the Company and undertakes to transfer all its annual profits and losses to the Company. In return, the DPLTA grants the noncontrolling shareholders of MeVis an annual recurring net compensation of &#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="i6530ecc1b8854fcbb93120033ddfdde9_D20150801-20150831" decimals="2" name="var:BusinessAcquisitionAnnualRecurringCompensation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183My9mcmFnOjNhOTQ5ZjJjZDZjMDRkNWVhZmM1MGIyYmE2NzY2Y2MxL3RleHRyZWdpb246M2E5NDlmMmNkNmMwNGQ1ZWFmYzUwYjJiYTY3NjZjYzFfMTk1NA_29dfeaf7-c7b2-444b-a575-9f6af6ed4c6e">0.95</ix:nonFraction> per MeVis share. At December&#160;30, 2022, noncontrolling shareholders together held approximately <ix:nonFraction unitRef="shares" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="-5" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183My9mcmFnOjNhOTQ5ZjJjZDZjMDRkNWVhZmM1MGIyYmE2NzY2Y2MxL3RleHRyZWdpb246M2E5NDlmMmNkNmMwNGQ1ZWFmYzUwYjJiYTY3NjZjYzFfMjAzOA_3a937206-ce61-40e3-9fee-022746759903">0.5</ix:nonFraction> million shares of MeVis, representing <ix:nonFraction unitRef="number" contextRef="ia15cd7f933164e4fa3c90be25a2678a1_I20221230" decimals="3" name="us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183My9mcmFnOjNhOTQ5ZjJjZDZjMDRkNWVhZmM1MGIyYmE2NzY2Y2MxL3RleHRyZWdpb246M2E5NDlmMmNkNmMwNGQ1ZWFmYzUwYjJiYTY3NjZjYzFfMjA3MQ_ec75f85a-d5c7-471d-b977-ae5191fb2206">26.3</ix:nonFraction>% of the outstanding shares.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="var:NoncontrollingInterestTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183My9mcmFnOjNhOTQ5ZjJjZDZjMDRkNWVhZmM1MGIyYmE2NzY2Y2MxL3RleHRyZWdpb246M2E5NDlmMmNkNmMwNGQ1ZWFmYzUwYjJiYTY3NjZjYzFfMjE1NQ_7191369c-bd7d-49e0-b0db-cefc0b83bb8c" continuedAt="i24cc45c15dcd47e9b06e4bcc22e4f079" escape="true">Changes in noncontrolling interests were as follows:</ix:nonNumeric></span><ix:continuation id="i24cc45c15dcd47e9b06e4bcc22e4f079"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interests, at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930" decimals="-5" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183My9mcmFnOjNhOTQ5ZjJjZDZjMDRkNWVhZmM1MGIyYmE2NzY2Y2MxL3RhYmxlOmEyODI2NGM3MzVmNzQ1MzM5ZmRlOGQ1MWY2NWNlNjA0L3RhYmxlcmFuZ2U6YTI4MjY0YzczNWY3NDUzMzlmZGU4ZDUxZjY1Y2U2MDRfMi0xLTEtMS04MzI4NQ_4e79cdde-9499-4caa-8274-d0aa92daf558">13.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i504e59968786494c96b1e46f5375a17d_I20211001" decimals="-5" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183My9mcmFnOjNhOTQ5ZjJjZDZjMDRkNWVhZmM1MGIyYmE2NzY2Y2MxL3RhYmxlOmEyODI2NGM3MzVmNzQ1MzM5ZmRlOGQ1MWY2NWNlNjA0L3RhYmxlcmFuZ2U6YTI4MjY0YzczNWY3NDUzMzlmZGU4ZDUxZjY1Y2U2MDRfMi0zLTEtMS04MzI4NQ_16ff1a76-2d46-458f-9243-65afeedb0746">13.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="var:NetIncomeLossAttributableToNoncontrollingInterestNetOfDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183My9mcmFnOjNhOTQ5ZjJjZDZjMDRkNWVhZmM1MGIyYmE2NzY2Y2MxL3RhYmxlOmEyODI2NGM3MzVmNzQ1MzM5ZmRlOGQ1MWY2NWNlNjA0L3RhYmxlcmFuZ2U6YTI4MjY0YzczNWY3NDUzMzlmZGU4ZDUxZjY1Y2U2MDRfMy0xLTEtMS04MzI4NQ_13a5af38-d4a1-48ca-a9a9-7a9f148e4c70">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="var:NetIncomeLossAttributableToNoncontrollingInterestNetOfDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183My9mcmFnOjNhOTQ5ZjJjZDZjMDRkNWVhZmM1MGIyYmE2NzY2Y2MxL3RhYmxlOmEyODI2NGM3MzVmNzQ1MzM5ZmRlOGQ1MWY2NWNlNjA0L3RhYmxlcmFuZ2U6YTI4MjY0YzczNWY3NDUzMzlmZGU4ZDUxZjY1Y2U2MDRfMy0zLTEtMS04MzI4NQ_2a38377d-5dd0-4f12-8cc4-8c85648c8c83">0.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" sign="-" name="var:NoncontrollingInterestOtherChanges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183My9mcmFnOjNhOTQ5ZjJjZDZjMDRkNWVhZmM1MGIyYmE2NzY2Y2MxL3RhYmxlOmEyODI2NGM3MzVmNzQ1MzM5ZmRlOGQ1MWY2NWNlNjA0L3RhYmxlcmFuZ2U6YTI4MjY0YzczNWY3NDUzMzlmZGU4ZDUxZjY1Y2U2MDRfNC0xLTEtMS04MzI4NQ_12fc9d1c-94e2-4d7a-8683-f7162834c9fd">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" sign="-" name="var:NoncontrollingInterestOtherChanges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183My9mcmFnOjNhOTQ5ZjJjZDZjMDRkNWVhZmM1MGIyYmE2NzY2Y2MxL3RhYmxlOmEyODI2NGM3MzVmNzQ1MzM5ZmRlOGQ1MWY2NWNlNjA0L3RhYmxlcmFuZ2U6YTI4MjY0YzczNWY3NDUzMzlmZGU4ZDUxZjY1Y2U2MDRfNC0zLTEtMS04MzI4NQ_bd56c054-5b91-4d60-8ce9-afa0dd6e9048">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interests, at end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="-5" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183My9mcmFnOjNhOTQ5ZjJjZDZjMDRkNWVhZmM1MGIyYmE2NzY2Y2MxL3RhYmxlOmEyODI2NGM3MzVmNzQ1MzM5ZmRlOGQ1MWY2NWNlNjA0L3RhYmxlcmFuZ2U6YTI4MjY0YzczNWY3NDUzMzlmZGU4ZDUxZjY1Y2U2MDRfNi0xLTEtMS04MzI4NQ_70d0c2e7-4e53-46df-ba7d-32ae4e237be7">13.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4026880a25c245b7ae7af90aa89cf31c_I20211231" decimals="-5" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183My9mcmFnOjNhOTQ5ZjJjZDZjMDRkNWVhZmM1MGIyYmE2NzY2Y2MxL3RhYmxlOmEyODI2NGM3MzVmNzQ1MzM5ZmRlOGQ1MWY2NWNlNjA0L3RhYmxlcmFuZ2U6YTI4MjY0YzczNWY3NDUzMzlmZGU4ZDUxZjY1Y2U2MDRfNi0zLTEtMS04MzI4NQ_fcc6b59e-c5c2-414e-9abc-206397c25322">13.3</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><div id="i4ab573909cb849339357193b017c7d37_76"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_7">Table of Contents</a></span></div></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12. <ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183Ni9mcmFnOjAxNjM5MGY4MmE3ZDRjNmJhNTY2ZTgxNDg1MTY2ZDQ0L3RleHRyZWdpb246MDE2MzkwZjgyYTdkNGM2YmE1NjZlODE0ODUxNjZkNDRfMTQ3Ng_d719418f-8b67-43e5-a237-6b09f6482209" continuedAt="i1fcb4e059ac54e20b61831eb8d3c91cf" escape="true">NET INCOME PER SHARE</ix:nonNumeric></span></div><ix:continuation id="i1fcb4e059ac54e20b61831eb8d3c91cf"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Basic net income per common share is computed by dividing the net income for the period by the weighted average number of shares of common stock outstanding during the reporting period. Diluted net income per common share reflects the effects of potentially dilutive securities, which is computed by dividing net income by the sum of the weighted average number of common shares outstanding and dilutive common shares.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183Ni9mcmFnOjAxNjM5MGY4MmE3ZDRjNmJhNTY2ZTgxNDg1MTY2ZDQ0L3RleHRyZWdpb246MDE2MzkwZjgyYTdkNGM2YmE1NjZlODE0ODUxNjZkNDRfMTQ4MQ_1638bbe7-97cd-426a-bb03-f4cf49c4e85f" continuedAt="i40e66ddefd59443f963ff428b4fa219f" escape="true">A reconciliation of the numerator and denominator used in the calculation of basic and diluted net income common share is as follows:</ix:nonNumeric></span><ix:continuation id="i40e66ddefd59443f963ff428b4fa219f"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.568%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions, except per share amounts)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Net income per share - basic</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net income attributable to Varex</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183Ni9mcmFnOjAxNjM5MGY4MmE3ZDRjNmJhNTY2ZTgxNDg1MTY2ZDQ0L3RhYmxlOjJkNDdlZTAzMjZmZjQ0ZDhiYTdjMDg3M2RhMGViNjdkL3RhYmxlcmFuZ2U6MmQ0N2VlMDMyNmZmNDRkOGJhN2MwODczZGEwZWI2N2RfMy0xLTEtMS04MzI4NQ_4fe027c8-7e67-4a84-971c-4b09ac34ed69">3.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183Ni9mcmFnOjAxNjM5MGY4MmE3ZDRjNmJhNTY2ZTgxNDg1MTY2ZDQ0L3RhYmxlOjJkNDdlZTAzMjZmZjQ0ZDhiYTdjMDg3M2RhMGViNjdkL3RhYmxlcmFuZ2U6MmQ0N2VlMDMyNmZmNDRkOGJhN2MwODczZGEwZWI2N2RfMy0zLTEtMS04MzI4NQ_bc92c7db-3355-45d9-ac17-f53da4090976">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Basic weighted average shares outstanding</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183Ni9mcmFnOjAxNjM5MGY4MmE3ZDRjNmJhNTY2ZTgxNDg1MTY2ZDQ0L3RhYmxlOjJkNDdlZTAzMjZmZjQ0ZDhiYTdjMDg3M2RhMGViNjdkL3RhYmxlcmFuZ2U6MmQ0N2VlMDMyNmZmNDRkOGJhN2MwODczZGEwZWI2N2RfNC0xLTEtMS04MzI4NQ_89bb18f0-b2aa-4d26-99af-1480b61253b2">40.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183Ni9mcmFnOjAxNjM5MGY4MmE3ZDRjNmJhNTY2ZTgxNDg1MTY2ZDQ0L3RhYmxlOjJkNDdlZTAzMjZmZjQ0ZDhiYTdjMDg3M2RhMGViNjdkL3RhYmxlcmFuZ2U6MmQ0N2VlMDMyNmZmNDRkOGJhN2MwODczZGEwZWI2N2RfNC0zLTEtMS04MzI4NQ_1d132363-8397-402d-a4cf-8832048e94f2">39.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Basic net income per share attributable to Varex</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183Ni9mcmFnOjAxNjM5MGY4MmE3ZDRjNmJhNTY2ZTgxNDg1MTY2ZDQ0L3RhYmxlOjJkNDdlZTAzMjZmZjQ0ZDhiYTdjMDg3M2RhMGViNjdkL3RhYmxlcmFuZ2U6MmQ0N2VlMDMyNmZmNDRkOGJhN2MwODczZGEwZWI2N2RfNS0xLTEtMS04MzI4NQ_10447bf3-333f-4ac6-b465-6266ebcf11c3">0.08</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183Ni9mcmFnOjAxNjM5MGY4MmE3ZDRjNmJhNTY2ZTgxNDg1MTY2ZDQ0L3RhYmxlOjJkNDdlZTAzMjZmZjQ0ZDhiYTdjMDg3M2RhMGViNjdkL3RhYmxlcmFuZ2U6MmQ0N2VlMDMyNmZmNDRkOGJhN2MwODczZGEwZWI2N2RfNS0zLTEtMS04MzI4NQ_cb5f5cef-d4a6-401d-bda5-a86f110994a1">0.04</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 13pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Net income per share - diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net income attributable to Varex</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183Ni9mcmFnOjAxNjM5MGY4MmE3ZDRjNmJhNTY2ZTgxNDg1MTY2ZDQ0L3RhYmxlOjJkNDdlZTAzMjZmZjQ0ZDhiYTdjMDg3M2RhMGViNjdkL3RhYmxlcmFuZ2U6MmQ0N2VlMDMyNmZmNDRkOGJhN2MwODczZGEwZWI2N2RfOC0xLTEtMS04MzI4NQ_1d4b25bd-50f8-49b4-8db7-d2d444e86e0c">3.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183Ni9mcmFnOjAxNjM5MGY4MmE3ZDRjNmJhNTY2ZTgxNDg1MTY2ZDQ0L3RhYmxlOjJkNDdlZTAzMjZmZjQ0ZDhiYTdjMDg3M2RhMGViNjdkL3RhYmxlcmFuZ2U6MmQ0N2VlMDMyNmZmNDRkOGJhN2MwODczZGEwZWI2N2RfOC0zLTEtMS04MzI4NQ_6540653b-8524-4553-b450-f1479e691af8">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 10pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic weighted average shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183Ni9mcmFnOjAxNjM5MGY4MmE3ZDRjNmJhNTY2ZTgxNDg1MTY2ZDQ0L3RhYmxlOjJkNDdlZTAzMjZmZjQ0ZDhiYTdjMDg3M2RhMGViNjdkL3RhYmxlcmFuZ2U6MmQ0N2VlMDMyNmZmNDRkOGJhN2MwODczZGEwZWI2N2RfMTItMS0xLTEtOTgxMDc_f1cd5938-5d91-4b42-b851-d130d7d67b26">40.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183Ni9mcmFnOjAxNjM5MGY4MmE3ZDRjNmJhNTY2ZTgxNDg1MTY2ZDQ0L3RhYmxlOjJkNDdlZTAzMjZmZjQ0ZDhiYTdjMDg3M2RhMGViNjdkL3RhYmxlcmFuZ2U6MmQ0N2VlMDMyNmZmNDRkOGJhN2MwODczZGEwZWI2N2RfMTItMy0xLTEtOTgxMDc_f920b728-d2ea-4b51-91e9-4f35e7a2e3ab">39.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dilutive effect of Convertible Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183Ni9mcmFnOjAxNjM5MGY4MmE3ZDRjNmJhNTY2ZTgxNDg1MTY2ZDQ0L3RhYmxlOjJkNDdlZTAzMjZmZjQ0ZDhiYTdjMDg3M2RhMGViNjdkL3RhYmxlcmFuZ2U6MmQ0N2VlMDMyNmZmNDRkOGJhN2MwODczZGEwZWI2N2RfMTMtMS0xLTEtOTgxMDc_a32ed214-d04f-4533-b579-708f8fafcd8f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183Ni9mcmFnOjAxNjM5MGY4MmE3ZDRjNmJhNTY2ZTgxNDg1MTY2ZDQ0L3RhYmxlOjJkNDdlZTAzMjZmZjQ0ZDhiYTdjMDg3M2RhMGViNjdkL3RhYmxlcmFuZ2U6MmQ0N2VlMDMyNmZmNDRkOGJhN2MwODczZGEwZWI2N2RfMTMtMy0xLTEtOTgxMDc_70dd2fb3-0bfa-4b6a-bb79-2851d2e47176">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dilutive effect of share-based awards and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183Ni9mcmFnOjAxNjM5MGY4MmE3ZDRjNmJhNTY2ZTgxNDg1MTY2ZDQ0L3RhYmxlOjJkNDdlZTAzMjZmZjQ0ZDhiYTdjMDg3M2RhMGViNjdkL3RhYmxlcmFuZ2U6MmQ0N2VlMDMyNmZmNDRkOGJhN2MwODczZGEwZWI2N2RfMTQtMS0xLTEtOTgxMDc_c1b39875-78f1-44ca-a016-efcc4b2586c3">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183Ni9mcmFnOjAxNjM5MGY4MmE3ZDRjNmJhNTY2ZTgxNDg1MTY2ZDQ0L3RhYmxlOjJkNDdlZTAzMjZmZjQ0ZDhiYTdjMDg3M2RhMGViNjdkL3RhYmxlcmFuZ2U6MmQ0N2VlMDMyNmZmNDRkOGJhN2MwODczZGEwZWI2N2RfMTQtMy0xLTEtOTgxMDc_6ff9b41b-2f79-4a30-bac4-2fbf2ba80ace">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dilutive effect of warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="var:IncrementalCommonSharesAttributableToDilutiveEffectOfWarrants" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183Ni9mcmFnOjAxNjM5MGY4MmE3ZDRjNmJhNTY2ZTgxNDg1MTY2ZDQ0L3RhYmxlOjJkNDdlZTAzMjZmZjQ0ZDhiYTdjMDg3M2RhMGViNjdkL3RhYmxlcmFuZ2U6MmQ0N2VlMDMyNmZmNDRkOGJhN2MwODczZGEwZWI2N2RfMTUtMS0xLTEtOTgxMDc_7b71c194-669c-4dbb-8bfe-542ebf625d54">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="var:IncrementalCommonSharesAttributableToDilutiveEffectOfWarrants" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183Ni9mcmFnOjAxNjM5MGY4MmE3ZDRjNmJhNTY2ZTgxNDg1MTY2ZDQ0L3RhYmxlOjJkNDdlZTAzMjZmZjQ0ZDhiYTdjMDg3M2RhMGViNjdkL3RhYmxlcmFuZ2U6MmQ0N2VlMDMyNmZmNDRkOGJhN2MwODczZGEwZWI2N2RfMTUtMy0xLTEtOTgxMDc_b91a55af-f93d-43db-ba71-f088031f49c3">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted weighted average shares outstanding</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183Ni9mcmFnOjAxNjM5MGY4MmE3ZDRjNmJhNTY2ZTgxNDg1MTY2ZDQ0L3RhYmxlOjJkNDdlZTAzMjZmZjQ0ZDhiYTdjMDg3M2RhMGViNjdkL3RhYmxlcmFuZ2U6MmQ0N2VlMDMyNmZmNDRkOGJhN2MwODczZGEwZWI2N2RfMTYtMS0xLTEtOTgxMDc_af097a95-38de-443e-9561-532b6617e9dd">40.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183Ni9mcmFnOjAxNjM5MGY4MmE3ZDRjNmJhNTY2ZTgxNDg1MTY2ZDQ0L3RhYmxlOjJkNDdlZTAzMjZmZjQ0ZDhiYTdjMDg3M2RhMGViNjdkL3RhYmxlcmFuZ2U6MmQ0N2VlMDMyNmZmNDRkOGJhN2MwODczZGEwZWI2N2RfMTYtMy0xLTEtOTgxMDc_d7da7dcb-a994-4215-bbff-581cc13f9ed7">43.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted net income per share attributable to Varex</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183Ni9mcmFnOjAxNjM5MGY4MmE3ZDRjNmJhNTY2ZTgxNDg1MTY2ZDQ0L3RhYmxlOjJkNDdlZTAzMjZmZjQ0ZDhiYTdjMDg3M2RhMGViNjdkL3RhYmxlcmFuZ2U6MmQ0N2VlMDMyNmZmNDRkOGJhN2MwODczZGEwZWI2N2RfMTctMS0xLTEtOTgyMTE_c2cfd4e9-fcf4-4b4b-bf15-7e36f85fda26">0.08</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183Ni9mcmFnOjAxNjM5MGY4MmE3ZDRjNmJhNTY2ZTgxNDg1MTY2ZDQ0L3RhYmxlOjJkNDdlZTAzMjZmZjQ0ZDhiYTdjMDg3M2RhMGViNjdkL3RhYmxlcmFuZ2U6MmQ0N2VlMDMyNmZmNDRkOGJhN2MwODczZGEwZWI2N2RfMTctMy0xLTEtOTgyMTE_f553991e-e505-4a6a-ab2b-62a8469534e3">0.03</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 10pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Anti-dilutive share summary</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:15pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted stock and options</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i86ab0fdd202b48e9b5a3c7718d5598cc_D20221001-20221230" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183Ni9mcmFnOjAxNjM5MGY4MmE3ZDRjNmJhNTY2ZTgxNDg1MTY2ZDQ0L3RhYmxlOjJkNDdlZTAzMjZmZjQ0ZDhiYTdjMDg3M2RhMGViNjdkL3RhYmxlcmFuZ2U6MmQ0N2VlMDMyNmZmNDRkOGJhN2MwODczZGEwZWI2N2RfMTctMS0xLTEtOTgxMDc_13812f8a-7b9d-40a0-8dee-2a74e2166d34">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i601e32df192447cb959a2ba73a6fd2ba_D20211002-20211231" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183Ni9mcmFnOjAxNjM5MGY4MmE3ZDRjNmJhNTY2ZTgxNDg1MTY2ZDQ0L3RhYmxlOjJkNDdlZTAzMjZmZjQ0ZDhiYTdjMDg3M2RhMGViNjdkL3RhYmxlcmFuZ2U6MmQ0N2VlMDMyNmZmNDRkOGJhN2MwODczZGEwZWI2N2RfMTctMy0xLTEtOTgxMDc_6b019c77-655d-4d29-a548-2a891c00506c">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Convertible notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idc160449c61b40539d3867651037cc59_D20221001-20221230" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183Ni9mcmFnOjAxNjM5MGY4MmE3ZDRjNmJhNTY2ZTgxNDg1MTY2ZDQ0L3RhYmxlOjJkNDdlZTAzMjZmZjQ0ZDhiYTdjMDg3M2RhMGViNjdkL3RhYmxlcmFuZ2U6MmQ0N2VlMDMyNmZmNDRkOGJhN2MwODczZGEwZWI2N2RfMjEtMS0xLTEtMTA1MzQ0_81734146-d39a-4018-b5cd-488f75b0d6e1">9.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3bf31d7d7f764d569a16bae11d856ce7_D20211002-20211231" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183Ni9mcmFnOjAxNjM5MGY4MmE3ZDRjNmJhNTY2ZTgxNDg1MTY2ZDQ0L3RhYmxlOjJkNDdlZTAzMjZmZjQ0ZDhiYTdjMDg3M2RhMGViNjdkL3RhYmxlcmFuZ2U6MmQ0N2VlMDMyNmZmNDRkOGJhN2MwODczZGEwZWI2N2RfMjEtMy0xLTEtMTA1MzQ0_ca3ab33c-c8db-4e44-898f-e77edb422b42">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ieb7fcbc8943f416c813c5266235d9ae1_D20221001-20221230" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183Ni9mcmFnOjAxNjM5MGY4MmE3ZDRjNmJhNTY2ZTgxNDg1MTY2ZDQ0L3RhYmxlOjJkNDdlZTAzMjZmZjQ0ZDhiYTdjMDg3M2RhMGViNjdkL3RhYmxlcmFuZ2U6MmQ0N2VlMDMyNmZmNDRkOGJhN2MwODczZGEwZWI2N2RfMjItMS0xLTEtMTA1MzQ0_ea0e17bc-d157-4e3f-b264-49ebb0183ce6">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i933696b07a5546158d133b6f7f13c96f_D20211002-20211231" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183Ni9mcmFnOjAxNjM5MGY4MmE3ZDRjNmJhNTY2ZTgxNDg1MTY2ZDQ0L3RhYmxlOjJkNDdlZTAzMjZmZjQ0ZDhiYTdjMDg3M2RhMGViNjdkL3RhYmxlcmFuZ2U6MmQ0N2VlMDMyNmZmNDRkOGJhN2MwODczZGEwZWI2N2RfMjItMy0xLTEtMTA1MzQ0_46221ab1-a404-4a2d-b4c8-45ab80c9cc5c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 4pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total anti-dilutive shares</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183Ni9mcmFnOjAxNjM5MGY4MmE3ZDRjNmJhNTY2ZTgxNDg1MTY2ZDQ0L3RhYmxlOjJkNDdlZTAzMjZmZjQ0ZDhiYTdjMDg3M2RhMGViNjdkL3RhYmxlcmFuZ2U6MmQ0N2VlMDMyNmZmNDRkOGJhN2MwODczZGEwZWI2N2RfMjMtMS0xLTEtMTA1Mzc0_68191a08-ef35-4545-a11f-4430de1a1194">14.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183Ni9mcmFnOjAxNjM5MGY4MmE3ZDRjNmJhNTY2ZTgxNDg1MTY2ZDQ0L3RhYmxlOjJkNDdlZTAzMjZmZjQ0ZDhiYTdjMDg3M2RhMGViNjdkL3RhYmxlcmFuZ2U6MmQ0N2VlMDMyNmZmNDRkOGJhN2MwODczZGEwZWI2N2RfMjMtMy0xLTEtMTA1Mzc0_541da55f-8780-4f13-81a7-e8bcf194260a">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Potentially dilutive shares, which are based on the weighted-average shares of common stock underlying stock options, unvested stock awards, purchase rights granted under the employee stock purchase plan, warrants and Convertible Notes using the treasury stock method or the if-converted method, as applicable, are included when calculating diluted net income per share attributable to Varex when their effect is dilutive. As of October 1, 2022, the Company adopted ASU 2020-06 using the modified retrospective method. The standard requires the Company to apply the if-converted method in relation to the Convertible Notes, which requires the Company to assume that the Convertible Notes were converted using only share settlement at the beginning of the period, resulting in an additional <ix:nonFraction unitRef="shares" contextRef="i4e0cf62911af4732b7b65d582effb57a_D20200604-20200605" decimals="-5" name="us-gaap:DebtInstrumentConvertibleNumberOfEquityInstruments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183Ni9mcmFnOjAxNjM5MGY4MmE3ZDRjNmJhNTY2ZTgxNDg1MTY2ZDQ0L3RleHRyZWdpb246MDE2MzkwZjgyYTdkNGM2YmE1NjZlODE0ODUxNjZkNDRfMTA5OTUxMTYyODgxMzA_97fe4fb8-9ead-4e78-847f-4d94a8a02b06">9.6</ix:nonFraction>&#160;million shares outstanding. Using this method, the numerator is affected by adding back interest expense and the denominator is affected by including the effect of potential share settlement, if the effect is dilutive. Prior to the adoption of ASU 2020-06, the Convertible Notes were accounted for using the treasury stock method for the purposes of net income per share. See Note 1, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Summary of Significant Accounting Policies, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">"Recently Adopted Accounting Pronouncements" for further details concerning the adoption of ASU 2020-06). Furthermore, in connection with the offering of the Convertible Notes, the Company entered into convertible note hedges and warrants (see Note 10, Borrowings). However, the Company's convertible note hedges are not included when calculating potentially dilutive shares since their effect is always anti-dilutive.</span></div></ix:continuation><div id="i4ab573909cb849339357193b017c7d37_79"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13. <ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RleHRyZWdpb246OGU5MGMxNDEzNzdiNGMzZGE1OTNjZjIwYWE3ZDljMGZfMTI2NQ_92135593-435e-43e2-9515-c0f24aeacb15" continuedAt="i9a86e62b422f4cb6bc7456658c7e73ea" escape="true">EMPLOYEE STOCK PLANS</ix:nonNumeric></span></div><ix:continuation id="i9a86e62b422f4cb6bc7456658c7e73ea" continuedAt="ib7af4ff993ce42f8ace0bb1df872e03d"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-Based Compensation Expense</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Share-based compensation expense recognized in the Condensed Consolidated Statements of Operations is based on awards ultimately expected to vest. Share-based compensation expense includes expenses related to the Company&#8217;s direct employees.</span></div></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_7">Table of Contents</a></span></div></div><ix:continuation id="ib7af4ff993ce42f8ace0bb1df872e03d"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RleHRyZWdpb246OGU5MGMxNDEzNzdiNGMzZGE1OTNjZjIwYWE3ZDljMGZfMTI3Ng_3cef7f9e-f150-482d-ac1b-1fe582606f63" continuedAt="i647bf5940ad14cb28fda5f00fb912ae7" escape="true">The table below summarizes the effect of recording share-based compensation expense and the option component of the employee stock purchase plan shares:</ix:nonNumeric></span></div><div style="margin-top:6pt"><ix:continuation id="i647bf5940ad14cb28fda5f00fb912ae7"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.568%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f1d152938084b8fb5c95daf2c0bebc9_D20221001-20221230" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOjIyMTgxMjAwNTViMTRjY2FiZjM2NDFlYzU2ZmM3YjAxL3RhYmxlcmFuZ2U6MjIxODEyMDA1NWIxNGNjYWJmMzY0MWVjNTZmYzdiMDFfMi0xLTEtMS04MzI4NQ_7378455c-3b23-4024-a3ea-69506e82eac9">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8ef423cb3ad48e8887f0b4fd6e5cb77_D20211002-20211231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOjIyMTgxMjAwNTViMTRjY2FiZjM2NDFlYzU2ZmM3YjAxL3RhYmxlcmFuZ2U6MjIxODEyMDA1NWIxNGNjYWJmMzY0MWVjNTZmYzdiMDFfMi0zLTEtMS04MzI4NQ_9c464259-f3b0-436c-805b-dcc81b6ce96c">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4686bc0f01748e7bf2ccd6382ecb978_D20221001-20221230" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOjIyMTgxMjAwNTViMTRjY2FiZjM2NDFlYzU2ZmM3YjAxL3RhYmxlcmFuZ2U6MjIxODEyMDA1NWIxNGNjYWJmMzY0MWVjNTZmYzdiMDFfMy0xLTEtMS04MzI4NQ_96b1a41a-8adb-4b1b-8ad0-0b2da98f4729">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a9c4e86e3f4f929c53ebd89df0858a_D20211002-20211231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOjIyMTgxMjAwNTViMTRjY2FiZjM2NDFlYzU2ZmM3YjAxL3RhYmxlcmFuZ2U6MjIxODEyMDA1NWIxNGNjYWJmMzY0MWVjNTZmYzdiMDFfMy0zLTEtMS04MzI4NQ_e8311697-7746-43df-aec5-9409fcff3717">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Selling, general and administrative</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78f307374103493aa2a778a18fffd8c0_D20221001-20221230" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOjIyMTgxMjAwNTViMTRjY2FiZjM2NDFlYzU2ZmM3YjAxL3RhYmxlcmFuZ2U6MjIxODEyMDA1NWIxNGNjYWJmMzY0MWVjNTZmYzdiMDFfNC0xLTEtMS04MzI4NQ_3d2aea49-f3c9-4513-a20a-514dd486fa43">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia84a05a959934c73ac14197dcf7f8950_D20211002-20211231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOjIyMTgxMjAwNTViMTRjY2FiZjM2NDFlYzU2ZmM3YjAxL3RhYmxlcmFuZ2U6MjIxODEyMDA1NWIxNGNjYWJmMzY0MWVjNTZmYzdiMDFfNC0zLTEtMS04MzI4NQ_1d036040-f109-4cd9-b4b8-bfe15fee4e41">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total share-based compensation expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOjIyMTgxMjAwNTViMTRjY2FiZjM2NDFlYzU2ZmM3YjAxL3RhYmxlcmFuZ2U6MjIxODEyMDA1NWIxNGNjYWJmMzY0MWVjNTZmYzdiMDFfNS0xLTEtMS04MzI4NQ_38ccf904-5246-49c4-8fd1-6572d3c024c6">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOjIyMTgxMjAwNTViMTRjY2FiZjM2NDFlYzU2ZmM3YjAxL3RhYmxlcmFuZ2U6MjIxODEyMDA1NWIxNGNjYWJmMzY0MWVjNTZmYzdiMDFfNS0zLTEtMS04MzI4NQ_81d06953-e199-4202-817a-8be6f9ab20db">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Option Activity</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RleHRyZWdpb246OGU5MGMxNDEzNzdiNGMzZGE1OTNjZjIwYWE3ZDljMGZfMTI2Nw_5f9dd13c-bd08-4ff5-9750-de23f67415ce" continuedAt="i3d76934f4915484ea076312862d7db17" escape="true">The following table summarizes the activity for stock options under Varex&#8217;s employee incentive plans for the Company's employees:</ix:nonNumeric></span><ix:continuation id="i3d76934f4915484ea076312862d7db17" continuedAt="i1b3f75f7e3334057bdb651f9b66fdb3e"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.705%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.987%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands, except per share amounts and the remaining term)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Price Range</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Weighted Average Exercise Price</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Weighted Average Remaining Term (in years)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Aggregate Intrinsic Value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at September 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOjVlZGMwNmQyNmU3YTQ4ODE4NjFkMmRkZWY1ZWM0MmZmL3RhYmxlcmFuZ2U6NWVkYzA2ZDI2ZTdhNDg4MTg2MWQyZGRlZjVlYzQyZmZfMi0xLTEtMS04MzI4NQ_fc837286-358d-4449-a125-67853ebf93ec">2,902</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i351ede538c104bba9d98c61dffb4fb78_I20220930" decimals="2" name="var:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingPrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOjVlZGMwNmQyNmU3YTQ4ODE4NjFkMmRkZWY1ZWM0MmZmL3RhYmxlcmFuZ2U6NWVkYzA2ZDI2ZTdhNDg4MTg2MWQyZGRlZjVlYzQyZmZfMi0zLTEtMS04MzI4NS90ZXh0cmVnaW9uOmMwMTRiN2UzY2EyNDQ2NmZiNDU5ZmU5MWM2NTk5MTYyXzQ_0c70bcd2-a201-4389-b4d6-19af2d8c8c8d">13.61</ix:nonFraction> - $<ix:nonFraction unitRef="usdPerShare" contextRef="i18c5d964291c4ea790a03cf8d6140a16_I20220930" decimals="2" name="var:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingPrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOjVlZGMwNmQyNmU3YTQ4ODE4NjFkMmRkZWY1ZWM0MmZmL3RhYmxlcmFuZ2U6NWVkYzA2ZDI2ZTdhNDg4MTg2MWQyZGRlZjVlYzQyZmZfMi0zLTEtMS04MzI4NS90ZXh0cmVnaW9uOmMwMTRiN2UzY2EyNDQ2NmZiNDU5ZmU5MWM2NTk5MTYyXzk_435477aa-3033-4dd9-a8f0-0fcb598f6e63">37.60</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOjVlZGMwNmQyNmU3YTQ4ODE4NjFkMmRkZWY1ZWM0MmZmL3RhYmxlcmFuZ2U6NWVkYzA2ZDI2ZTdhNDg4MTg2MWQyZGRlZjVlYzQyZmZfMi01LTEtMS04MzI4NQ_54e158cd-f4ed-4c9b-9f7e-f932c4ae75f8">28.97</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if053d543d68e4983b97631e65183a5d1_D20211002-20220930" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOjVlZGMwNmQyNmU3YTQ4ODE4NjFkMmRkZWY1ZWM0MmZmL3RhYmxlcmFuZ2U6NWVkYzA2ZDI2ZTdhNDg4MTg2MWQyZGRlZjVlYzQyZmZfMi03LTEtMS04MzI4NQ_e4ce2c7b-de12-4cec-ab02-d99eb3b0e889">4.5</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930" decimals="-2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOjVlZGMwNmQyNmU3YTQ4ODE4NjFkMmRkZWY1ZWM0MmZmL3RhYmxlcmFuZ2U6NWVkYzA2ZDI2ZTdhNDg4MTg2MWQyZGRlZjVlYzQyZmZfMi05LTEtMS04MzI4NQ_7486428b-9924-4795-8b5d-591e630cc879">1,361.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOjVlZGMwNmQyNmU3YTQ4ODE4NjFkMmRkZWY1ZWM0MmZmL3RhYmxlcmFuZ2U6NWVkYzA2ZDI2ZTdhNDg4MTg2MWQyZGRlZjVlYzQyZmZfMy0xLTEtMS04MzI4NQ_f41986a6-be6f-45fb-917c-e8bdc95afef5">385</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="2" name="var:SharebasedCompensationArrangementsbySharebasedPaymentAwardOptionsGrantsinPeriodPrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOjVlZGMwNmQyNmU3YTQ4ODE4NjFkMmRkZWY1ZWM0MmZmL3RhYmxlcmFuZ2U6NWVkYzA2ZDI2ZTdhNDg4MTg2MWQyZGRlZjVlYzQyZmZfMy0zLTEtMS04MzI4NS90ZXh0cmVnaW9uOmIxM2VmMGNiZWZkYjRlYjA5NTZhMTUzYzc3Y2MwODA3XzQ_3784d284-0741-482b-857c-9b36285b371e">22.13</ix:nonFraction> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOjVlZGMwNmQyNmU3YTQ4ODE4NjFkMmRkZWY1ZWM0MmZmL3RhYmxlcmFuZ2U6NWVkYzA2ZDI2ZTdhNDg4MTg2MWQyZGRlZjVlYzQyZmZfMy01LTEtMS04MzI4NQ_2cbd4b2f-dea7-4f83-8f1f-8366f86b9ae7">22.13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canceled, expired or forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOjVlZGMwNmQyNmU3YTQ4ODE4NjFkMmRkZWY1ZWM0MmZmL3RhYmxlcmFuZ2U6NWVkYzA2ZDI2ZTdhNDg4MTg2MWQyZGRlZjVlYzQyZmZfNC0xLTEtMS04MzI4NQ_895b04f4-72a5-4404-9a76-a545ee0b83f3">196</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i67803683b0344dc78ee5545d3907c730_D20221001-20221230" decimals="2" name="var:SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsForfeituresandExpirationsinPeriodPrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOjVlZGMwNmQyNmU3YTQ4ODE4NjFkMmRkZWY1ZWM0MmZmL3RhYmxlcmFuZ2U6NWVkYzA2ZDI2ZTdhNDg4MTg2MWQyZGRlZjVlYzQyZmZfNC0zLTEtMS04MzI4NS90ZXh0cmVnaW9uOjYwOGFhMTA5ZjI4MjRkMTViZmE3M2E5MjAwZmFlNDU5XzQ_67d5e29d-eec0-4798-9c6f-a7b7ad4c5ea0">25.06</ix:nonFraction> - $<ix:nonFraction unitRef="usdPerShare" contextRef="idd5d9702aa2d44ef9138ad61434eaa2a_D20221001-20221230" decimals="2" name="var:SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsForfeituresandExpirationsinPeriodPrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOjVlZGMwNmQyNmU3YTQ4ODE4NjFkMmRkZWY1ZWM0MmZmL3RhYmxlcmFuZ2U6NWVkYzA2ZDI2ZTdhNDg4MTg2MWQyZGRlZjVlYzQyZmZfNC0zLTEtMS04MzI4NS90ZXh0cmVnaW9uOjYwOGFhMTA5ZjI4MjRkMTViZmE3M2E5MjAwZmFlNDU5Xzk_288df20b-e849-4a5f-b1fe-ca2c89d1ab99">37.10</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOjVlZGMwNmQyNmU3YTQ4ODE4NjFkMmRkZWY1ZWM0MmZmL3RhYmxlcmFuZ2U6NWVkYzA2ZDI2ZTdhNDg4MTg2MWQyZGRlZjVlYzQyZmZfNC01LTEtMS04MzI4NQ_04edaea9-5e78-4130-b1ff-c65851ca714e">31.44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Outstanding at December 30, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOjVlZGMwNmQyNmU3YTQ4ODE4NjFkMmRkZWY1ZWM0MmZmL3RhYmxlcmFuZ2U6NWVkYzA2ZDI2ZTdhNDg4MTg2MWQyZGRlZjVlYzQyZmZfNi0xLTEtMS04MzI4NQ_e9189c6c-588e-4160-8e8f-0466e8821e4c">3,091</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i1d50db1d5d424029913ff40e007c62a2_I20221230" decimals="2" name="var:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingPrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOjVlZGMwNmQyNmU3YTQ4ODE4NjFkMmRkZWY1ZWM0MmZmL3RhYmxlcmFuZ2U6NWVkYzA2ZDI2ZTdhNDg4MTg2MWQyZGRlZjVlYzQyZmZfNi0zLTEtMS04MzI4NS90ZXh0cmVnaW9uOjcyNTkyZTBjZDA2MDRjNDZiOWU2OGU1NzJmNTFlMDQ0XzQ_1aa3e44c-508e-4271-a217-a0c62a49fbd6">13.61</ix:nonFraction> - $<ix:nonFraction unitRef="usdPerShare" contextRef="ibe78209ddb124767b1ede71bb79ea8dc_I20221230" decimals="2" name="var:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingPrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOjVlZGMwNmQyNmU3YTQ4ODE4NjFkMmRkZWY1ZWM0MmZmL3RhYmxlcmFuZ2U6NWVkYzA2ZDI2ZTdhNDg4MTg2MWQyZGRlZjVlYzQyZmZfNi0zLTEtMS04MzI4NS90ZXh0cmVnaW9uOjcyNTkyZTBjZDA2MDRjNDZiOWU2OGU1NzJmNTFlMDQ0Xzk_9f13db76-fab8-4918-bcf0-6c3381b5f0b0">37.60</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOjVlZGMwNmQyNmU3YTQ4ODE4NjFkMmRkZWY1ZWM0MmZmL3RhYmxlcmFuZ2U6NWVkYzA2ZDI2ZTdhNDg4MTg2MWQyZGRlZjVlYzQyZmZfNi01LTEtMS04MzI4NQ_d407ad46-5820-4f75-b5bf-fc5afad00db9">27.96</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOjVlZGMwNmQyNmU3YTQ4ODE4NjFkMmRkZWY1ZWM0MmZmL3RhYmxlcmFuZ2U6NWVkYzA2ZDI2ZTdhNDg4MTg2MWQyZGRlZjVlYzQyZmZfNi03LTEtMS04MzI4NQ_f75083a1-3a08-43a2-a1bd-824c5ff883d0">5.2</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="-2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOjVlZGMwNmQyNmU3YTQ4ODE4NjFkMmRkZWY1ZWM0MmZmL3RhYmxlcmFuZ2U6NWVkYzA2ZDI2ZTdhNDg4MTg2MWQyZGRlZjVlYzQyZmZfNi05LTEtMS04MzI4NQ_e12a8268-43e3-442b-a8e8-63ba87c0a070">1,209.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exercisable at December 30, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOjVlZGMwNmQyNmU3YTQ4ODE4NjFkMmRkZWY1ZWM0MmZmL3RhYmxlcmFuZ2U6NWVkYzA2ZDI2ZTdhNDg4MTg2MWQyZGRlZjVlYzQyZmZfOC0xLTEtMS04MzI4NQ_5ee37f74-8f54-4bf0-a84f-0859a9869877">2,070</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i1d50db1d5d424029913ff40e007c62a2_I20221230" decimals="2" name="var:SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisablePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOjVlZGMwNmQyNmU3YTQ4ODE4NjFkMmRkZWY1ZWM0MmZmL3RhYmxlcmFuZ2U6NWVkYzA2ZDI2ZTdhNDg4MTg2MWQyZGRlZjVlYzQyZmZfOC0zLTEtMS04MzI4NS90ZXh0cmVnaW9uOjQxYjhhMTI5YmMwYzQ2OGJiYzhkZTEzMzVhM2M2ZTY0XzQ_7ba7e2b8-1a5c-47a2-9953-3ddb11dd6edc">13.61</ix:nonFraction> - $<ix:nonFraction unitRef="usdPerShare" contextRef="ibe78209ddb124767b1ede71bb79ea8dc_I20221230" decimals="2" name="var:SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisablePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOjVlZGMwNmQyNmU3YTQ4ODE4NjFkMmRkZWY1ZWM0MmZmL3RhYmxlcmFuZ2U6NWVkYzA2ZDI2ZTdhNDg4MTg2MWQyZGRlZjVlYzQyZmZfOC0zLTEtMS04MzI4NS90ZXh0cmVnaW9uOjQxYjhhMTI5YmMwYzQ2OGJiYzhkZTEzMzVhM2M2ZTY0Xzk_db8183b7-9e3d-4b20-b5e5-0b3872fc75c9">37.60</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOjVlZGMwNmQyNmU3YTQ4ODE4NjFkMmRkZWY1ZWM0MmZmL3RhYmxlcmFuZ2U6NWVkYzA2ZDI2ZTdhNDg4MTg2MWQyZGRlZjVlYzQyZmZfOC01LTEtMS04MzI4NQ_c876f8e4-3fa2-4041-87d1-82cef74ec0b7">29.52</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOjVlZGMwNmQyNmU3YTQ4ODE4NjFkMmRkZWY1ZWM0MmZmL3RhYmxlcmFuZ2U6NWVkYzA2ZDI2ZTdhNDg4MTg2MWQyZGRlZjVlYzQyZmZfOC03LTEtMS04MzI4NQ_a85b1c9c-8eea-4d79-8c16-ae4dfa4cd08a">3.4</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="-2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOjVlZGMwNmQyNmU3YTQ4ODE4NjFkMmRkZWY1ZWM0MmZmL3RhYmxlcmFuZ2U6NWVkYzA2ZDI2ZTdhNDg4MTg2MWQyZGRlZjVlYzQyZmZfOC05LTEtMS04MzI4NQ_58c4fc8e-8829-4096-a1fb-f44ffa14a173">672.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:5pt"><ix:continuation id="i1b3f75f7e3334057bdb651f9b66fdb3e"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> The aggregate intrinsic value represents the total pre-tax intrinsic value, which is computed based on the difference between the exercise price and the closing price of Varex common stock of $<ix:nonFraction unitRef="usdPerShare" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="INF" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RleHRyZWdpb246OGU5MGMxNDEzNzdiNGMzZGE1OTNjZjIwYWE3ZDljMGZfODQ1_2d4e5e85-9612-49f7-a641-e5f1c61c3716">20.30</ix:nonFraction> as of December&#160;30, 2022, the last trading date of the Company's first quarter, and which represents the amount that would have been received by the option holders had all option holders exercised their options and sold the shares received upon exercise as of that date.</span></ix:continuation></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock Units, Restricted Stock Awards and Deferred Stock Units </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RleHRyZWdpb246OGU5MGMxNDEzNzdiNGMzZGE1OTNjZjIwYWE3ZDljMGZfMTI2OQ_0190e056-9bd6-4e9f-80db-1bc63946fbc4" continuedAt="i26897de43eac4d3abef5fab7e5330a69" escape="true">The following table summarizes the activity for restricted stock units, restricted stock awards and deferred stock units under Varex&#8217;s 2020 Omnibus Stock Plan and 2017 Omnibus Stock Plan:</ix:nonNumeric></span><ix:continuation id="i26897de43eac4d3abef5fab7e5330a69"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.762%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands, except per share amounts)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number&#160;of&#160;Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted&#160;Average Grant-Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at September 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOmExNDU5Zjg3OGFlZDQxZTFiOTZkZjM4NmFlZDkzY2QyL3RhYmxlcmFuZ2U6YTE0NTlmODc4YWVkNDFlMWI5NmRmMzg2YWVkOTNjZDJfMS0xLTEtMS04MzI4NQ_42980f10-70be-4225-9c88-17e81f543582">1,045</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOmExNDU5Zjg3OGFlZDQxZTFiOTZkZjM4NmFlZDkzY2QyL3RhYmxlcmFuZ2U6YTE0NTlmODc4YWVkNDFlMWI5NmRmMzg2YWVkOTNjZDJfMS0zLTEtMS04MzI4NQ_aa09323a-8bb3-4c9e-bb8e-ac784de5f62f">24.35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOmExNDU5Zjg3OGFlZDQxZTFiOTZkZjM4NmFlZDkzY2QyL3RhYmxlcmFuZ2U6YTE0NTlmODc4YWVkNDFlMWI5NmRmMzg2YWVkOTNjZDJfMi0xLTEtMS04MzI4NQ_ffaccdd0-43b0-41be-92a7-db84ea6d40e9">492</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOmExNDU5Zjg3OGFlZDQxZTFiOTZkZjM4NmFlZDkzY2QyL3RhYmxlcmFuZ2U6YTE0NTlmODc4YWVkNDFlMWI5NmRmMzg2YWVkOTNjZDJfMi0zLTEtMS04MzI4NQ_7beea28a-69c7-45c7-931b-ac42ac7738b3">20.12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOmExNDU5Zjg3OGFlZDQxZTFiOTZkZjM4NmFlZDkzY2QyL3RhYmxlcmFuZ2U6YTE0NTlmODc4YWVkNDFlMWI5NmRmMzg2YWVkOTNjZDJfMy0xLTEtMS04MzI4NQ_d2ba5b27-ce31-428f-a796-9b672cb4e303">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOmExNDU5Zjg3OGFlZDQxZTFiOTZkZjM4NmFlZDkzY2QyL3RhYmxlcmFuZ2U6YTE0NTlmODc4YWVkNDFlMWI5NmRmMzg2YWVkOTNjZDJfMy0zLTEtMS04MzI4NQ_4f07a545-d3f8-419e-b26b-4daee9255e31">23.70</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canceled or expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOmExNDU5Zjg3OGFlZDQxZTFiOTZkZjM4NmFlZDkzY2QyL3RhYmxlcmFuZ2U6YTE0NTlmODc4YWVkNDFlMWI5NmRmMzg2YWVkOTNjZDJfNC0xLTEtMS04MzI4NQ_d21e02e9-d53c-4617-b53f-583cab9de2e0">28</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOmExNDU5Zjg3OGFlZDQxZTFiOTZkZjM4NmFlZDkzY2QyL3RhYmxlcmFuZ2U6YTE0NTlmODc4YWVkNDFlMWI5NmRmMzg2YWVkOTNjZDJfNC0zLTEtMS04MzI4NQ_11624040-053f-42ea-9fd2-fae0e36928b7">25.50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Outstanding at December 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOmExNDU5Zjg3OGFlZDQxZTFiOTZkZjM4NmFlZDkzY2QyL3RhYmxlcmFuZ2U6YTE0NTlmODc4YWVkNDFlMWI5NmRmMzg2YWVkOTNjZDJfNS0xLTEtMS04MzI4NQ_c7b38ea9-e470-452b-aa3d-1bd0b881259c">1,506</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOmExNDU5Zjg3OGFlZDQxZTFiOTZkZjM4NmFlZDkzY2QyL3RhYmxlcmFuZ2U6YTE0NTlmODc4YWVkNDFlMWI5NmRmMzg2YWVkOTNjZDJfNS0zLTEtMS04MzI4NQ_1a8cdc40-b271-4fab-9a6d-9f360fd7bc35">22.95</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div id="i4ab573909cb849339357193b017c7d37_82"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14. <ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN184Mi9mcmFnOjE2NjdhMTA2ZmEzMTRiOTlhMmMwNjZiNTM0ZWY1ZDczL3RleHRyZWdpb246MTY2N2ExMDZmYTMxNGI5OWEyYzA2NmI1MzRlZjVkNzNfMTcxNg_849659a7-7f28-4c38-9b8e-f4f4d0a6b064" continuedAt="i85d3c1d3663d47418c462730bb34f28d" escape="true">TAXES ON INCOME</ix:nonNumeric></span></div><ix:continuation id="i85d3c1d3663d47418c462730bb34f28d" continuedAt="i3faec0026d4f40cc83be0ab7eac06f26"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the three months ended December 30, 2022, the Company recognized income tax expense of $<ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN184Mi9mcmFnOjE2NjdhMTA2ZmEzMTRiOTlhMmMwNjZiNTM0ZWY1ZDczL3RleHRyZWdpb246MTY2N2ExMDZmYTMxNGI5OWEyYzA2NmI1MzRlZjVkNzNfNzg_f473423d-5d0a-4ed9-9f14-ceb3fddfa3b9">2.2</ix:nonFraction> million on $<ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN184Mi9mcmFnOjE2NjdhMTA2ZmEzMTRiOTlhMmMwNjZiNTM0ZWY1ZDczL3RleHRyZWdpb246MTY2N2ExMDZmYTMxNGI5OWEyYzA2NmI1MzRlZjVkNzNfODQ_d7bf3cab-9717-44a7-8a20-b693ed92ac77">5.4</ix:nonFraction> million of pre-tax income. For the three months ended December&#160;31, 2021, the Company recognized income tax expense of $<ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN184Mi9mcmFnOjE2NjdhMTA2ZmEzMTRiOTlhMmMwNjZiNTM0ZWY1ZDczL3RleHRyZWdpb246MTY2N2ExMDZmYTMxNGI5OWEyYzA2NmI1MzRlZjVkNzNfMTcz_ee22540e-612a-43c6-9dff-c3788ef6b936">1.7</ix:nonFraction> million on $<ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN184Mi9mcmFnOjE2NjdhMTA2ZmEzMTRiOTlhMmMwNjZiNTM0ZWY1ZDczL3RleHRyZWdpb246MTY2N2ExMDZmYTMxNGI5OWEyYzA2NmI1MzRlZjVkNzNfMTc5_824f3b3e-0f9f-4418-8857-9500a0238a21">3.3</ix:nonFraction> million of pre-tax income. The Company is unable to recognize a tax benefit for pre-tax book losses in certain foreign jurisdictions but has recognized tax expense for profitable foreign jurisdictions.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's tax expense for the three months ended December 30, 2022 increased, primarily due to increased pre-tax income in certain jurisdictions, valuation allowance positions in the U.S. on deferred tax attributes, and losses in certain foreign jurisdictions for which no benefit can be recorded. </span></div></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i3faec0026d4f40cc83be0ab7eac06f26">&#160;&#160;&#160;&#160;The Company is maintaining its reinvestment assertion with respect to foreign earnings for the three months ended December 30, 2022, which is that all earnings prior to fiscal year 2018 are permanently reinvested for all countries, and that all earnings for Direct Conversion, located primarily in Sweden and Finland, are also indefinitely reinvested in those countries, but post fiscal year 2017 earnings in all other countries are not permanently reinvested. Due to the level of earnings available for repatriation, the treaty benefits applicable to jurisdictions in which those earnings are located, and the now favorable U.S. tax treatment of repatriated foreign earnings, the amount of deferred tax liability recorded related to the potential repatriation is approximately $<ix:nonFraction unitRef="usd" contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN184Mi9mcmFnOjE2NjdhMTA2ZmEzMTRiOTlhMmMwNjZiNTM0ZWY1ZDczL3RleHRyZWdpb246MTY2N2ExMDZmYTMxNGI5OWEyYzA2NmI1MzRlZjVkNzNfMTU1NQ_4a229ce5-271a-45a3-8c1c-5e87652e7f1d">0.1</ix:nonFraction>&#160;million. This estimated liability is for U.S. state income taxes and foreign withholding taxes that would apply if the foreign earnings were repatriated in the form of a dividend.</ix:continuation> </span></div><div id="i4ab573909cb849339357193b017c7d37_85"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15. <ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN184NS9mcmFnOjg2NDJmODU0ZTA4ZTRjMmU5MTAwZDVmMDFkMWE4YjllL3RleHRyZWdpb246ODY0MmY4NTRlMDhlNGMyZTkxMDBkNWYwMWQxYThiOWVfMjQxOQ_11affc4f-725d-4351-8285-ac266138bfcf" continuedAt="ie41a0cf389d64af0adea22a6c9b9facd" escape="true">SEGMENT INFORMATION</ix:nonNumeric></span></div><ix:continuation id="ie41a0cf389d64af0adea22a6c9b9facd" continuedAt="ie419256e192e48f09f90c9d113aa07d4"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company has <ix:nonFraction unitRef="segment" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="INF" name="us-gaap:NumberOfOperatingSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN184NS9mcmFnOjg2NDJmODU0ZTA4ZTRjMmU5MTAwZDVmMDFkMWE4YjllL3RleHRyZWdpb246ODY0MmY4NTRlMDhlNGMyZTkxMDBkNWYwMWQxYThiOWVfNDY_4e7ac51e-900f-4409-b7c2-30515bdb84f8">two</ix:nonFraction> reportable operating segments: Medical and Industrial, which aligns with how the CODM reviews the Company&#8217;s performance and evaluates the business for the allocation of resources. The segments align the Company&#8217;s products and service offerings with customer use in medical and industrial markets. The CODM allocates resources to and evaluates the financial performance of each operating segment primarily based on revenues and gross profit. The reportable operating segment structure provides alignment between business strategies and operating results.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Description of Segments</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Medical segment designs, manufactures, sells and services X-ray imaging components, including X-ray tubes, digital detectors, ionization chambers and buckys, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers. These components are used in a range of medical imaging applications including CT, mammography, oncology, cardiac, surgery, dental, and other diagnostic radiography uses.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Industrial segment designs, develops, manufactures, sells and services X-ray imaging products for use in a number of markets, including security applications for cargo screening at ports and borders and baggage screening at airports, and nondestructive testing, irradiation and inspection applications used in a number of other vertical markets. The Company's industrial products include Linatron&#174; X-ray linear accelerators, X-ray tubes, digital detectors, high voltage connectors and coolers. In addition, the Company licenses proprietary image-processing and detection software designed to work with other Varex products to provide packaged sub-assembly solutions to industrial customers.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Accordingly, the following information is provided for purposes of achieving an understanding of operations, but it may not be indicative of the financial results of the reported segments were they independent organizations. In addition, comparisons of the Company&#8217;s operations to similar operations of other companies may not be meaningful.</span></div></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_7">Table of Contents</a></span></div></div><ix:continuation id="ie419256e192e48f09f90c9d113aa07d4"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN184NS9mcmFnOjg2NDJmODU0ZTA4ZTRjMmU5MTAwZDVmMDFkMWE4YjllL3RleHRyZWdpb246ODY0MmY4NTRlMDhlNGMyZTkxMDBkNWYwMWQxYThiOWVfMjQxMw_af23ef2c-7f3e-4f86-b5a3-3db36c91c19d" continuedAt="i434041867a034a4b972703badfef18e2" escape="true">Information related to the Company&#8217;s segments is as follows:</ix:nonNumeric></span><ix:continuation id="i434041867a034a4b972703badfef18e2"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.762%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenues, net</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 9.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad2fceac1bb145229d93b69339db9f19_D20221001-20221230" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN184NS9mcmFnOjg2NDJmODU0ZTA4ZTRjMmU5MTAwZDVmMDFkMWE4YjllL3RhYmxlOmQ2YjY5MjBmNjFkNzQzYzc5MmM2NTEyMzE5ZGVhM2UxL3RhYmxlcmFuZ2U6ZDZiNjkyMGY2MWQ3NDNjNzkyYzY1MTIzMTlkZWEzZTFfMy0xLTEtMS04MzI4NQ_6b6dc8ec-7602-4715-ad61-92476e1e789f">160.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28f02563bbd40d0a3a931501b82e58f_D20211002-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN184NS9mcmFnOjg2NDJmODU0ZTA4ZTRjMmU5MTAwZDVmMDFkMWE4YjllL3RhYmxlOmQ2YjY5MjBmNjFkNzQzYzc5MmM2NTEyMzE5ZGVhM2UxL3RhYmxlcmFuZ2U6ZDZiNjkyMGY2MWQ3NDNjNzkyYzY1MTIzMTlkZWEzZTFfMy0zLTEtMS04MzI4NQ_d68bc136-edd4-4884-8132-ca0b2bd9087c">155.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 9.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Industrial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaab56d5aa0be4d758038ec0908970ec8_D20221001-20221230" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN184NS9mcmFnOjg2NDJmODU0ZTA4ZTRjMmU5MTAwZDVmMDFkMWE4YjllL3RhYmxlOmQ2YjY5MjBmNjFkNzQzYzc5MmM2NTEyMzE5ZGVhM2UxL3RhYmxlcmFuZ2U6ZDZiNjkyMGY2MWQ3NDNjNzkyYzY1MTIzMTlkZWEzZTFfNC0xLTEtMS04MzI4NQ_e5f7cafd-1b9d-4f6a-984a-8c73a25d3d9b">45.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbe1cf81bdb14d34b79718fe7f9ef5df_D20211002-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN184NS9mcmFnOjg2NDJmODU0ZTA4ZTRjMmU5MTAwZDVmMDFkMWE4YjllL3RhYmxlOmQ2YjY5MjBmNjFkNzQzYzc5MmM2NTEyMzE5ZGVhM2UxL3RhYmxlcmFuZ2U6ZDZiNjkyMGY2MWQ3NDNjNzkyYzY1MTIzMTlkZWEzZTFfNC0zLTEtMS04MzI4NQ_c8861d3f-5ad8-4f0b-b1b8-4781210651ea">43.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN184NS9mcmFnOjg2NDJmODU0ZTA4ZTRjMmU5MTAwZDVmMDFkMWE4YjllL3RhYmxlOmQ2YjY5MjBmNjFkNzQzYzc5MmM2NTEyMzE5ZGVhM2UxL3RhYmxlcmFuZ2U6ZDZiNjkyMGY2MWQ3NDNjNzkyYzY1MTIzMTlkZWEzZTFfNS0xLTEtMS04MzI4NQ_d50a7d54-ebeb-4ce6-b351-43d18cbc7f86">205.6</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN184NS9mcmFnOjg2NDJmODU0ZTA4ZTRjMmU5MTAwZDVmMDFkMWE4YjllL3RhYmxlOmQ2YjY5MjBmNjFkNzQzYzc5MmM2NTEyMzE5ZGVhM2UxL3RhYmxlcmFuZ2U6ZDZiNjkyMGY2MWQ3NDNjNzkyYzY1MTIzMTlkZWEzZTFfNS0zLTEtMS04MzI4NQ_4b2b3c1d-4301-4fc4-94e9-3fbf34e3d315">198.8</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 9.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad2fceac1bb145229d93b69339db9f19_D20221001-20221230" decimals="-5" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN184NS9mcmFnOjg2NDJmODU0ZTA4ZTRjMmU5MTAwZDVmMDFkMWE4YjllL3RhYmxlOmQ2YjY5MjBmNjFkNzQzYzc5MmM2NTEyMzE5ZGVhM2UxL3RhYmxlcmFuZ2U6ZDZiNjkyMGY2MWQ3NDNjNzkyYzY1MTIzMTlkZWEzZTFfNy0xLTEtMS04MzI4NQ_3d3b482f-9e7c-41ee-82d9-deb0a1bf6f51">46.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28f02563bbd40d0a3a931501b82e58f_D20211002-20211231" decimals="-5" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN184NS9mcmFnOjg2NDJmODU0ZTA4ZTRjMmU5MTAwZDVmMDFkMWE4YjllL3RhYmxlOmQ2YjY5MjBmNjFkNzQzYzc5MmM2NTEyMzE5ZGVhM2UxL3RhYmxlcmFuZ2U6ZDZiNjkyMGY2MWQ3NDNjNzkyYzY1MTIzMTlkZWEzZTFfNy0zLTEtMS04MzI4NQ_86df307d-d2ca-46a0-a624-33af114d17cf">46.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 9.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Industrial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaab56d5aa0be4d758038ec0908970ec8_D20221001-20221230" decimals="-5" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN184NS9mcmFnOjg2NDJmODU0ZTA4ZTRjMmU5MTAwZDVmMDFkMWE4YjllL3RhYmxlOmQ2YjY5MjBmNjFkNzQzYzc5MmM2NTEyMzE5ZGVhM2UxL3RhYmxlcmFuZ2U6ZDZiNjkyMGY2MWQ3NDNjNzkyYzY1MTIzMTlkZWEzZTFfOC0xLTEtMS04MzI4NQ_b9f56b02-526b-4a7d-b814-cbdc85360d1a">17.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbe1cf81bdb14d34b79718fe7f9ef5df_D20211002-20211231" decimals="-5" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN184NS9mcmFnOjg2NDJmODU0ZTA4ZTRjMmU5MTAwZDVmMDFkMWE4YjllL3RhYmxlOmQ2YjY5MjBmNjFkNzQzYzc5MmM2NTEyMzE5ZGVhM2UxL3RhYmxlcmFuZ2U6ZDZiNjkyMGY2MWQ3NDNjNzkyYzY1MTIzMTlkZWEzZTFfOC0zLTEtMS04MzI4NQ_6984f1f1-f0a9-4ff8-85b5-150c2ea8a15d">18.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total gross profit</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN184NS9mcmFnOjg2NDJmODU0ZTA4ZTRjMmU5MTAwZDVmMDFkMWE4YjllL3RhYmxlOmQ2YjY5MjBmNjFkNzQzYzc5MmM2NTEyMzE5ZGVhM2UxL3RhYmxlcmFuZ2U6ZDZiNjkyMGY2MWQ3NDNjNzkyYzY1MTIzMTlkZWEzZTFfOS0xLTEtMS04MzI4NQ_e92c1921-f1b6-4bba-93ed-05e84668f25f">63.3</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN184NS9mcmFnOjg2NDJmODU0ZTA4ZTRjMmU5MTAwZDVmMDFkMWE4YjllL3RhYmxlOmQ2YjY5MjBmNjFkNzQzYzc5MmM2NTEyMzE5ZGVhM2UxL3RhYmxlcmFuZ2U6ZDZiNjkyMGY2MWQ3NDNjNzkyYzY1MTIzMTlkZWEzZTFfOS0zLTEtMS04MzI4NQ_31e25729-5e4a-47f5-a0e4-9c534b283dc6">64.8</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN184NS9mcmFnOjg2NDJmODU0ZTA4ZTRjMmU5MTAwZDVmMDFkMWE4YjllL3RhYmxlOmQ2YjY5MjBmNjFkNzQzYzc5MmM2NTEyMzE5ZGVhM2UxL3RhYmxlcmFuZ2U6ZDZiNjkyMGY2MWQ3NDNjNzkyYzY1MTIzMTlkZWEzZTFfMTAtMS0xLTEtODMyODU_ac04c7b4-7f19-4624-a0aa-9fb7c41fd1dd">50.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN184NS9mcmFnOjg2NDJmODU0ZTA4ZTRjMmU5MTAwZDVmMDFkMWE4YjllL3RhYmxlOmQ2YjY5MjBmNjFkNzQzYzc5MmM2NTEyMzE5ZGVhM2UxL3RhYmxlcmFuZ2U6ZDZiNjkyMGY2MWQ3NDNjNzkyYzY1MTIzMTlkZWEzZTFfMTAtMy0xLTEtODMyODU_f7887913-16c1-4ae2-b648-23f1196a077d">50.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest and other expense, net</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN184NS9mcmFnOjg2NDJmODU0ZTA4ZTRjMmU5MTAwZDVmMDFkMWE4YjllL3RhYmxlOmQ2YjY5MjBmNjFkNzQzYzc5MmM2NTEyMzE5ZGVhM2UxL3RhYmxlcmFuZ2U6ZDZiNjkyMGY2MWQ3NDNjNzkyYzY1MTIzMTlkZWEzZTFfMTEtMS0xLTEtODMyODU_2981d0f9-d176-4f67-955b-887be5cb2ee0">7.6</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN184NS9mcmFnOjg2NDJmODU0ZTA4ZTRjMmU5MTAwZDVmMDFkMWE4YjllL3RhYmxlOmQ2YjY5MjBmNjFkNzQzYzc5MmM2NTEyMzE5ZGVhM2UxL3RhYmxlcmFuZ2U6ZDZiNjkyMGY2MWQ3NDNjNzkyYzY1MTIzMTlkZWEzZTFfMTEtMy0xLTEtODMyODU_8b5ae5ee-047b-4af5-93bf-1d2f4a3b1333">10.7</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income before taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN184NS9mcmFnOjg2NDJmODU0ZTA4ZTRjMmU5MTAwZDVmMDFkMWE4YjllL3RhYmxlOmQ2YjY5MjBmNjFkNzQzYzc5MmM2NTEyMzE5ZGVhM2UxL3RhYmxlcmFuZ2U6ZDZiNjkyMGY2MWQ3NDNjNzkyYzY1MTIzMTlkZWEzZTFfMTItMS0xLTEtODMyODU_d7bf3cab-9717-44a7-8a20-b693ed92ac77">5.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN184NS9mcmFnOjg2NDJmODU0ZTA4ZTRjMmU5MTAwZDVmMDFkMWE4YjllL3RhYmxlOmQ2YjY5MjBmNjFkNzQzYzc5MmM2NTEyMzE5ZGVhM2UxL3RhYmxlcmFuZ2U6ZDZiNjkyMGY2MWQ3NDNjNzkyYzY1MTIzMTlkZWEzZTFfMTItMy0xLTEtODMyODU_824f3b3e-0f9f-4418-8857-9500a0238a21">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN184NS9mcmFnOjg2NDJmODU0ZTA4ZTRjMmU5MTAwZDVmMDFkMWE4YjllL3RhYmxlOmQ2YjY5MjBmNjFkNzQzYzc5MmM2NTEyMzE5ZGVhM2UxL3RhYmxlcmFuZ2U6ZDZiNjkyMGY2MWQ3NDNjNzkyYzY1MTIzMTlkZWEzZTFfMTMtMS0xLTEtODMyODU_f473423d-5d0a-4ed9-9f14-ceb3fddfa3b9">2.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN184NS9mcmFnOjg2NDJmODU0ZTA4ZTRjMmU5MTAwZDVmMDFkMWE4YjllL3RhYmxlOmQ2YjY5MjBmNjFkNzQzYzc5MmM2NTEyMzE5ZGVhM2UxL3RhYmxlcmFuZ2U6ZDZiNjkyMGY2MWQ3NDNjNzkyYzY1MTIzMTlkZWEzZTFfMTMtMy0xLTEtODMyODU_ee22540e-612a-43c6-9dff-c3788ef6b936">1.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN184NS9mcmFnOjg2NDJmODU0ZTA4ZTRjMmU5MTAwZDVmMDFkMWE4YjllL3RhYmxlOmQ2YjY5MjBmNjFkNzQzYzc5MmM2NTEyMzE5ZGVhM2UxL3RhYmxlcmFuZ2U6ZDZiNjkyMGY2MWQ3NDNjNzkyYzY1MTIzMTlkZWEzZTFfMTQtMS0xLTEtODMyODU_05b360cc-5465-4341-8f2d-acd8e0c7038e">3.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN184NS9mcmFnOjg2NDJmODU0ZTA4ZTRjMmU5MTAwZDVmMDFkMWE4YjllL3RhYmxlOmQ2YjY5MjBmNjFkNzQzYzc5MmM2NTEyMzE5ZGVhM2UxL3RhYmxlcmFuZ2U6ZDZiNjkyMGY2MWQ3NDNjNzkyYzY1MTIzMTlkZWEzZTFfMTQtMy0xLTEtODMyODU_bfd1f104-4f55-49e6-9533-51ce313635bd">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Net income attributable to noncontrolling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN184NS9mcmFnOjg2NDJmODU0ZTA4ZTRjMmU5MTAwZDVmMDFkMWE4YjllL3RhYmxlOmQ2YjY5MjBmNjFkNzQzYzc5MmM2NTEyMzE5ZGVhM2UxL3RhYmxlcmFuZ2U6ZDZiNjkyMGY2MWQ3NDNjNzkyYzY1MTIzMTlkZWEzZTFfMTUtMS0xLTEtODMyODU_1df3b0fe-9a1c-4b87-bc5e-237bf403d90a">0.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN184NS9mcmFnOjg2NDJmODU0ZTA4ZTRjMmU5MTAwZDVmMDFkMWE4YjllL3RhYmxlOmQ2YjY5MjBmNjFkNzQzYzc5MmM2NTEyMzE5ZGVhM2UxL3RhYmxlcmFuZ2U6ZDZiNjkyMGY2MWQ3NDNjNzkyYzY1MTIzMTlkZWEzZTFfMTUtMy0xLTEtODMyODU_9487e490-f955-4abf-9206-9b933a08a0c8">0.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to Varex</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN184NS9mcmFnOjg2NDJmODU0ZTA4ZTRjMmU5MTAwZDVmMDFkMWE4YjllL3RhYmxlOmQ2YjY5MjBmNjFkNzQzYzc5MmM2NTEyMzE5ZGVhM2UxL3RhYmxlcmFuZ2U6ZDZiNjkyMGY2MWQ3NDNjNzkyYzY1MTIzMTlkZWEzZTFfMTYtMS0xLTEtODMyODU_4fe027c8-7e67-4a84-971c-4b09ac34ed69">3.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN184NS9mcmFnOjg2NDJmODU0ZTA4ZTRjMmU5MTAwZDVmMDFkMWE4YjllL3RhYmxlOmQ2YjY5MjBmNjFkNzQzYzc5MmM2NTEyMzE5ZGVhM2UxL3RhYmxlcmFuZ2U6ZDZiNjkyMGY2MWQ3NDNjNzkyYzY1MTIzMTlkZWEzZTFfMTYtMy0xLTEtODMyODU_bc92c7db-3355-45d9-ac17-f53da4090976">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company does not disclose total assets by segment as this information is not provided to the CODM.</span></div></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><div id="i4ab573909cb849339357193b017c7d37_97"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_7">Table of Contents</a></span></div></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Item 2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The following discussion and analysis of the financial condition and results should be read together with the unaudited condensed consolidated financial statements and notes thereto that are contained in this Quarterly Report on Form 10-Q (this "Quarterly Report") as well as our Annual Report on Form 10-K for the fiscal year ended September&#160;30, 2022 and our other filings, including the Current Reports on Form 8-K, that have been filed with the Securities and Exchange Commission (" SEC") through the date of this report.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In this Quarterly Report, unless otherwise specified or the context otherwise requires, the "Company," "Varex," "we," "us," and "our" refer to Varex Imaging Corporation.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Forward-Looking Statements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;This Quarterly Report contains &#8220;forward-looking&#8221; statements within the meaning of the Private Securities Litigation Reform Act of 1995, which provides a &#8220;safe harbor&#8221; for statements about future events, products and future financial performance that are based on the beliefs of, estimates made by, and information currently available to the management of Varex. Actual results and the outcome or timing of certain events described in these forward-looking statements are subject to risk and uncertainties and may differ significantly from those projected in these forward-looking statements. Important factors that could cause our actual results and financial condition to differ significantly from those projections or expectations include, among other things, the risks outlined in the Summary of Principal Risk Factors and further described in the Risk Factors listed in Part II, Item 1A &#8211;"Risk Factors" of this Quarterly Report.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Statements concerning: supply chain and logistics challenges; cost increases; the continuing impact of the ongoing COVID-19 pandemic on the global economy or the Company; the effects of inflation; industry or market segment outlook; market acceptance of or transition to new products or technology such as advanced X-ray tube and digital flat panel detector products; growth drivers; future orders, revenues, backlog, earnings or other financial results; and any statements using the terms &#8220;believe,&#8221; &#8220;expect,&#8221; &#8220;anticipate,&#8221; &#8220;can,&#8221; &#8220;should,&#8221; &#8220;would,&#8221; &#8220;could,&#8221; &#8220;estimate,&#8221; &#8220;may,&#8221; &#8220;intended,&#8221; &#8220;potential,&#8221; and &#8220;possible&#8221; or similar statements are forward-looking statements that involve risks and uncertainties that could cause our actual results and the outcome and timing of certain events to differ materially from those projected or management&#8217;s current expectations.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Any forward-looking statement made in this Quarterly Report (including in any exhibits or documents incorporated by reference) is based only on information currently available to Varex and its management and speaks only as of the date on which it is made. We have not assumed any obligation to, and you should not expect us to, update or revise those statements because of new information, future events or otherwise.</span></div><div id="i4ab573909cb849339357193b017c7d37_100"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Varex Imaging Corporation is a leading innovator, designer and manufacturer of X-ray imaging components including tubes, digital detectors, linear accelerators, image software processing solutions and stand-alone X-ray based systems in select application areas. Our components are used in medical diagnostic imaging, security inspection systems, and industrial quality inspection systems, as well as for analysis and measurement applications in industrial manufacturing applications. Global original equipment manufacturers (&#8220;OEMs&#8221;) incorporate our X-ray imaging components into their systems to detect, diagnose, protect, irradiate and inspect. Varex has approximately 2,300 full-time equivalent employees, located at engineering, manufacturing and service center sites in North America, Europe, and Asia.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our products are sold in three geographic regions: the Americas, EMEA, and APAC. The Americas includes North America (primarily the United States) and Latin America. EMEA includes Europe, Russia, the Middle East, India and Africa. APAC includes Asia (other than India) and Australia. Revenues by region are based on the known final destination of products sold.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our success depends, among other things, on our ability to anticipate and respond to changes in our markets, the direction of technological innovation and the demand from our customers. We continually invest in research and development and employ approximately 300 individuals in product development related activities. Our focus on innovation and product performance along with strong and long-term customer relationships allows us to collaborate with our customers to bring industry-leading products to the X-ray imaging market. We continue to work to improve the life and quality of our imaging components and leverage our scale as one of the largest independent X-ray imaging component suppliers to provide cost-effective solutions for our customers.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impact of COVID-19, Inflation and the General Economic Environment</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The unprecedented nature of the COVID-19 pandemic and its effect on the global economy began to significantly disrupt our business in fiscal year 2020 by initially reducing demand for our products followed by strong recovery in demand but increasing variability in supply of raw materials and manufacturing productivity.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During fiscal year 2022, demand for many of our products recovered to pre-pandemic levels and our business grew. We believe that demand for our products has increased due to increased investments in healthcare and diagnostics coupled with end-users (such as hospitals) making capital purchases that were previously deferred due to the uncertainty surrounding COVID-19. While we are encouraged by the recovery that we have seen, we remain cautious as many factors remain unpredictable and recent high rates of inflation have increased our costs and could negatively affect our future profit margins. The existence of inflation in the economy has resulted in, and may continue to result in, higher interest rates and capital costs, increased shipping costs, supply shortages, increased costs of labor and materials, weakening exchange rates and other similar effects.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We continue to experience supply chain, manufacturing, and logistics challenges that we expect will continue into 2023. As economies around the world continue to recover, shortages in raw materials have become more widespread. During the latter half of fiscal year 2021 and throughout fiscal year 2022, we experienced shortages of certain materials and used more of our inventory on hand than we have used historically. Shortages of materials, particularly micro-controller chips and associated electronic components, have caused and may continue to cause, delays in manufacturing products for our customers. In some cases, raw material shortages and delivery delays from our suppliers are communicated to us with very little advanced warning, which has caused operational and customer order fulfillment challenges. While we are dedicating significant resources to manage, mitigate, and resolve these issues, we currently expect supply chain, manufacturing, and logistics challenges to continue to impact our ability to deliver products to our customers over the next several quarters. Increased freight charges and shipping delays have also become more common and are expected to continue into the foreseeable future. Due to the rising cost environment, in addition to ongoing expense management, we began to raise prices on certain products in fiscal year 2022 and anticipate making further pricing adjustments throughout fiscal year 2023.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During the three months ended December 30, 2022, our manufacturing facilities continued to operate with minimal disruption. Notwithstanding the foregoing, local government lockdowns, particularly in China, have impacted, and could continue to impact, our manufacturing operations in affected countries.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The full extent to which the COVID-19 pandemic and ensuing supply chain, manufacturing and logistics challenges have and will directly or indirectly impact us, including our business, financial condition, and results of operations, will depend on future developments that are highly uncertain and cannot be accurately predicted. We will continue to actively monitor the situation and may take further actions we believe are in the best interest of the Company and our stockholders, which may include altering our business operations or other actions to benefit or protect our employees, customers or suppliers. For additional information on risks related to the pandemic and other supply chain risks that could impact our results, see Part II, Item 1A &#8211; "Risk Factors".</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Segments and Products</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We have two reportable operating segments: Medical and Industrial. The segments align our products and service offerings with customer use in medical and industrial markets. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medical</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In our Medical segment, we design, manufacture, sell and service X-ray imaging components, including X-ray tubes, digital detectors and accessories, ionization chambers and buckys, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers. These components are used in a range of medical imaging applications including CT, mammography, oncology, cardiac, surgery, dental, and other diagnostic radiography uses.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our X-ray imaging components are primarily sold to OEM customers. These OEM customers then design-in our products into their X-ray imaging systems for a variety of medical modalities. A substantial majority of medical X-ray imaging OEMs globally are our customers, and many of these have been our customers for over 25 years. We believe one of the reasons for customer loyalty is that our hardware and software products are tightly integrated with our customers' systems. We work very closely with our customers to create custom built components for their systems based on technology platforms that we have developed. Because our products are often customized for our customers' specific equipment, it can be costly and complex for our customers to switch to another provider. Once our components are designed into our customers' equipment, our customers will typically continue to buy from us for any replacement components and for service and support for that equipment. Some of our products are also included in product registrations for our customers' equipment that require regulatory approval to change. In addition to sales to OEM customers, we sell our products to independent service companies and distributors as well as directly to end-users for replacement purposes.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are one of the largest global manufacturers of X-ray imaging components and each year we produce over 28,000 X-ray tubes and 20,000 X-ray detectors. We estimate that our world-wide installed base of products includes more than 160,000 X-ray tubes, 170,000 X-ray detectors, 600,000 connect and control components and 16,000 software instances. Replacement and service of our existing installed base makes up a significant portion of our revenue. Many of our components need to be replaced regularly depending upon usage and other factors. For example, CT X-ray tubes generally need to be replaced every 2 to 6 years, in comparison to a general radiography tube which can last up to 10 years, depending on utilization. In China, the replacement cycle for CT X-ray tubes currently can be as frequent as every 10 to 20 months due to high utilization of imaging equipment. Other products such as X-ray detectors have a useful life of as much as 7 years or more, but can require more frequent service and repairs during their useful life. In addition, our detector customers often elect to upgrade products to newer technology before the end of a current product&#8217;s useful life. X-ray imaging software is a relatively small part of our business and includes maintenance revenue for software licenses.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The COVID-19 pandemic had a significant effect on hospitals, clinics and outpatient imaging centers as they encountered declines in elective procedures volume. As a result, they reduced the capital purchases of imaging equipment from OEMs, which led to lower demand for X-ray imaging components for us. Additionally, equipment installations were delayed, due to reduced access to healthcare institutions. Partially offsetting this was an increased demand for imaging equipment used to diagnose respiratory diseases, such as radiographic X-ray imaging systems and CT imaging systems. We have experienced growth in demand for our products as health systems globally have continued to address healthcare services gaps. However, we have not been able to convert all the demand into sales due to on-going supply chain related interruptions and uncertainties, particularly with the availability of micro-controller chips and other electronic components. As a result, uncertainty in overall sales volume is expected to continue at least through the fiscal year 2023.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In China, the government is broadening the availability of healthcare services. As a result, the number of diagnostic X-ray imaging systems, including CT, has grown significantly. We are developing CT X-ray tubes and related subsystems for Chinese OEMs as they introduce new systems in China. Over the long-term, our objective is to become the partner of choice both for OEMs and in the replacement market as CT systems become more widely adopted throughout the Chinese market.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In recent years our business in China has been impacted by the trade war with the United States in three principal ways: (1) importing raw materials from China to the United States has become more expensive, (2) importing raw materials and sub-assemblies from the United States to China has become more expensive, and (3) importing finished U.S. manufactured products into China has become more difficult and expensive. While the governments of both the United States and China have granted tariff exclusions that temporarily eliminate the additional duties payable for specific commodities, providing partial relief, these exclusions are temporary and/or must be solicited and approved on a shipment-by-shipment basis. There is no guarantee that such exclusions will be granted or extended by either government. In order to mitigate the impact of tariffs on materials imported from China, we have implemented changes to secure more non-China sources of materials used to manufacture our X-ray imaging products. To help mitigate the impact of tariffs on materials imported to China, and to be closer to our global customer base, we continue to expand manufacturing capabilities at our facilities in China, Germany, the Netherlands and the Philippines. We have also implemented local sourcing strategies to offer local content. This local-for-local strategy has been well received by both our local customers as well as global OEMs, and acts as a natural hedge against trade wars and other potential supply chain disruptions. Our mitigation efforts could prove less effective than anticipated if rising tensions between China and Taiwan lead to worsening trade relations between China and the United States.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Industrial</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In our Industrial segment, we design, develop, manufacture, sell and service X-ray imaging products for use in a number of markets, including security applications for cargo screening at ports and borders and baggage screening at airports, and nondestructive testing, irradiation and inspection applications used in a number of other vertical markets. Our industrial products include Linatron&#174; X-ray linear accelerators, X-ray tubes, digital detectors, high voltage connectors and coolers. In addition, we license proprietary image-processing and detection software designed to work with other Varex products to provide packaged sub-assembly solutions to our industrial customers. Our Industrial business benefits from the research and development investment and manufacturing economies of scale on the Medical side of our business, as we continue to find new applications for our technology. Along with more favorable pricing dynamics, this allows us to generally achieve higher gross profit for industrial products relative to our Medical business. In addition, our Industrial business benefits from our long-term service agreements for our Linatron&#174; products.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The security market primarily consists of cargo security for the screening of trucks, trains, and cargo containers at ports and borders as well as airport security for carry-on baggage, checked baggage and palletized cargo. The end customers for border protection systems are typically government agencies, many of which are in oil-based economies and war zones where there can be significant variation in buying patterns.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Non-destructive testing and inspection verticals utilize X-ray imaging to scan items for inspection of manufacturing defects and product integrity in a wide range of industries including the aerospace, automotive, electronics, oil and gas, food packaging, metal castings and 3D printing industries. In addition, new applications for X-ray sources are being developed, such as sterilization of food and its packaging. We provide X-ray sources, digital detectors, high voltage connectors and image processing software to OEM customers, system integrators and manufacturers in a variety of these verticals. We believe that the non-destructive testing market represents a significant growth opportunity for our business, and we are actively pursuing new potential applications for our products.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The economic downturn triggered by the COVID-19 pandemic reduced the demand for X-ray imaging equipment utilized in the non-destructive testing and security markets as manufacturers and end users focused on cash preservation and reduced spending for capital equipment. However, we have seen improved conditions in these markets, which continued during the three months ended December 30, 2022.</span></div><div id="i4ab573909cb849339357193b017c7d37_103"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies and Estimates</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The preparation of our condensed consolidated financial statements and related disclosures in conformity with GAAP requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses. These estimates and assumptions are based on historical experience and on various other factors that we believe are reasonable under the circumstances. Our critical accounting policies that are affected by accounting estimates require us to use judgments, often as a result of the need to make estimates and assumptions regarding matters that are inherently uncertain, and actual results could differ materially from these estimates. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We periodically review our accounting policies, estimates and assumptions and make adjustments when facts and circumstances dictate. Refer to our Annual Report on Form 10-K for the fiscal year ended September&#160;30, 2022 filed with the SEC on November&#160;18, 2022 and Note 1, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Summary of Significant Accounting Policies,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the Notes to the Condensed Consolidated Financial Statements of this report for further details. Our critical accounting policies that are affected by accounting estimates include valuation of inventories, assessment of recoverability of goodwill and intangible assets, and income taxes. Such accounting policies require us to use judgments, often as a result of the need to make estimates and assumptions regarding matters that are inherently uncertain, and actual results could differ materially from these estimates. Except for the change in certain policies upon adoption of the accounting standard described in Note 1, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Summary of Significant Accounting Policies </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of the Notes to the Condensed Consolidated Financial Statements of this report, there have been no material changes to the Company's significant accounting policies, compared to the accounting policies described in Note 1, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, in the Company&#8217;s Annual Report on Form&#160;10-K for fiscal year 2022.</span></div><div id="i4ab573909cb849339357193b017c7d37_106"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fiscal Year</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The fiscal years of the Company as reported are the 52 or 53-week period ending on the Friday nearest September&#160;30. Fiscal year 2023 is the 52-week period ending September&#160;29, 2023. Fiscal year 2022 was the 52-week period that ended on September&#160;30, 2022. The fiscal quarters ended&#160;December&#160;30, 2022 and&#160;December&#160;31, 2021&#160;were both 13-week periods. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Discussion of Results of Operations for the Three Months Ended December 30, 2022 Compared to the Three Months Ended December 31, 2021 </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenues, net</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.372%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.763%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medical</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">160.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">155.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Industrial</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">205.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">198.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Medical as a percentage of total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">77.9&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">78.3&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Industrial as a percentage of total revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">22.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">21.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Medical revenues increased $4.4 million, primarily due to increased sales of digital detectors for dental, radiographic, and fluoroscopic modalities, partially offset by lower oncology sales. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Industrial revenues increased $2.4 million, primarily due to increased sales of digital detectors for dynamic imaging applications, partially offset by lower sales of security inspection products.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Gross Profit</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.372%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.763%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medical</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Industrial</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9.6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total gross profit</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Medical gross margin</span></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">28.9&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">29.5&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Industrial gross margin</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">37.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">43.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Total gross margin</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">30.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">32.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The increase in Medical segment gross profit was primarily due to the increased sales of digital detectors for dental, radiographic, and fluoroscopic modalities, partially offset by increased material costs.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Industrial segment gross profit decreased primarily as a result of increased material costs, lower service revenue, and an unfavorable shift in product sales mix.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During the first quarter of fiscal year 2023, we experienced a more balanced operating environment driven by good demand for certain products, an improved supply chain, and our internal supply chain initiatives. Our product sales mix for both segments, however, shifted during the quarter and we experienced a decrease in sales of higher margin, higher-end CT tubes and certain medical detectors, coupled with lower service revenue from Industrial, which typically also carries a higher margin profile. We believe this shift was a result of our customers being cautious in response to an uncertain economic environment and difficulty in fulfilling backlog due to ongoing supply chain challenges they face for certain components. These factors contributed to our lower total gross margin during the quarter.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Expenses</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.372%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.763%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">As a percentage of total revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">9.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">8.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">As a percentage of total revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">14.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">16.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">As a percentage of total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">24.5&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">25.6&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We are committed to investing in the business to support long-term growth and believe long-term research and development expenses of approximately 8% to 10% of annual revenues is the appropriate range that will allow us to innovate and bring new products to market for our global OEM customers. Research and development costs increased to 9.7% of revenues for the first quarter of fiscal year 2023, primarily due to increased spending on labor and material costs supporting research and development initiatives.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, General and Administrative</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Selling, general and administrative expenses for the first quarter of fiscal year 2023 decreased $2.8 million and decreased to 14.7% of total revenues, primarily due to decreased restructuring costs and incentive compensation compared to the prior year.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest and Other Expense, Net</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table summarizes the Company&#8217;s interest and other expense, net:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.763%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7.5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9.9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest and other expense, net</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7.6)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10.7)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Interest and other expense, net decreased in the first quarter of fiscal year 2023 compared to the first quarter of 2022. Interest expense decreased due to the redemption of $27&#160;million of our Senior Secured Notes in March 2022, reduced fees on the ABL Facility agreement, and reduced interest expense due to the adoption of ASU 2020-06. See Note 1, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, "Recently Adopted Accounting Pronouncements" for further details concerning the adoption of ASU 2020-06. Other expense, net decreased due to increased income in certain investments in privately-held companies and equity investments, partially offset by increased foreign exchange expense. Interest income increased primarily due to an increase in investments made into marketable debt securities.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Taxes on Income</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the three months ended December 30, 2022 we recognized income tax expense of $2.2 million on $5.4 million of pre-tax income. For the three months ended December 31, 2021 we recognized income tax expense of $1.7 million on $3.3 million of pre-tax income. Our tax expense for the three months ended December 30, 2022 increased primarily due to increased pre-tax income in certain jurisdictions, valuation allowance positions in the United States on deferred tax attributes, and losses in certain foreign jurisdictions for which no benefit can be recorded.</span></div><div id="i4ab573909cb849339357193b017c7d37_112"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We assess our liquidity in terms of our ability to generate cash to fund our operations, including working capital and investing activities. We believe that our operating cash flow, cash on our balance sheet and availability under our ABL Facility are sufficient to meet our anticipated operating cash needs for at least the next 12 months and will be sufficient to allow us to continue to invest in our existing businesses, consummate strategic acquisitions and manage our capital structure on a short and long-term basis. We are currently not aware of any trends or demands, commitments, events, or uncertainties that will result in or that are reasonably likely to result in our liquidity increasing or decreasing in any material way that will impact our capital needs during or beyond the next 12 months. The maximum availability under our ABL Facility is $100.0 million; however, the borrowing base under the ABL Facility fluctuates from month-to-month depending on the amount of eligible accounts receivable, inventory, and real estate. As of December&#160;30, 2022 the amount available under our ABL Facility was $92.0&#160;million, and the ABL Facility remains undrawn. See Part II, Item 1A &#8211; &#8220;Risk Factors&#8221; for a further discussion. At December&#160;30, 2022 we had total debt of $442.9 million net of discounts and deferred issuance costs of $6.8 million.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and Cash Equivalents, Certificates of Deposit and Marketable Securities</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table summarizes our cash and cash equivalents, certificates of deposit and marketable securities:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.650%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.762%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$ Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">81.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">89.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Certificates of deposit not included in cash and cash equivalents</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Marketable securities not included in cash and cash equivalents</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">107.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">113.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5.6)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Borrowings</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table summarizes the changes in our debt outstanding:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.347%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions, except for percentages)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current maturities of long-term debt</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other debt</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Non-current maturities of long-term debt:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Convertible Senior Unsecured Notes</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Secured Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">243.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">243.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total non-current maturities of long-term debt:</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">447.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">447.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unamortized issuance costs and debt discounts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unamortized discount - Convertible Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(28.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unamortized issuance costs - Convertible Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unamortized issuance costs - Senior Secured Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(6.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(35.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">28.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total debt outstanding, net</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">442.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">414.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">28.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> In connection with the adoption of ASU 2020-06, the unamortized discount related to the Convertible Notes was derecognized and the carrying value of the issuance costs was adjusted in the first quarter of fiscal year 2023. Refer to Note 1, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Summary of Significant Accounting Policies </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">for further details. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Flows</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.762%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash flow (used in) provided by:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating activities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financing activities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effects of exchange rate changes on cash and cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 48.25pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net (decrease) increase in cash and cash equivalents and restricted cash</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7.8)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.1&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net cash (used in) provided by operating activities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Net cash (used in) provided by operating activities was $(3.7)&#160;million and $10.8&#160;million for the three months ended December 30, 2022 and December&#160;31, 2021, respectively. The decrease in cash provided by operating activities was primarily due to reduced collections from accounts receivable in the quarter and reduced payments for accounts payable, partially offset by decreased purchases of inventory when compared to the three months ended December&#160;31, 2021.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net cash used in investing activities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Net cash used in investing activities was $3.7&#160;million and $2.6&#160;million for the three months ended December 30, 2022 and December&#160;31, 2021, respectively. The increase in cash used in investing activities was primarily due to the purchase of marketable equity and debt securities during the three months ended December 30, 2022, partially offset by the settlement of net investment hedges.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net cash (used in) provided by financing activities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Net cash (used in) provided by financing activities was $(0.4) million and $5.0 million for the three months ended December 30, 2022 and December&#160;31, 2021, respectively. The increase in cash used in financing activities was primarily due to no proceeds from the exercise of stock options during the three months ended December 30, 2022 when compared to the three months ended December&#160;31, 2021.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contractual Obligations</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In October 2013, we entered into an amended agreement with dpiX and other parties that, among other things, provides us with the right to 50% of dpiX&#8217;s total manufacturing capacity produced after January 1, 2014. The amended agreement requires us to pay for 50% of the fixed costs (as defined in the amended agreement), as determined at the beginning of each calendar year. In January 2023, the fixed cost commitment was determined to be $13.1 million through the remainder of calendar year 2023. The amended agreement will continue unless the ownership structure of dpiX changes (as defined in the amended agreement).</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In October 2015, pursuant to a Domination and Profit and Loss Transfer Agreement (the &#8220;MeVis Agreement&#8221;), we committed to pay the noncontrolling shareholders of MeVis an annual recurring net compensation of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8364;0.95</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> per MeVis share. The annual net payment will continue for the life of the MeVis Agreement, which we anticipate will continue for as long as we remain as the controlling shareholder of MeVis. As of December&#160;30, 2022, noncontrolling shareholders together held approximately 0.5 million shares of MeVis, representing 26.3% of the outstanding shares.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During the third quarter of fiscal year 2020, we entered into a purchase agreement with a supplier to acquire certain equipment and intellectual property from the supplier that is utilized to manufacture X-ray cables utilized in our products. The total consideration to be paid by us for the acquired assets is expected to be &#165;1,084.7 million, subject to potential decreases for costs incurred by the Company. On April 14, 2022, we entered into a foreign currency hedge related to this Japanese Yen payment, which is expected to fix the purchase price of these assets at approximately $7.9&#160;million. As of December&#160;30, 2022, the Company has made payments totaling $6.4 million and estimates that our remaining cash payments to be made total $1.5 million.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In fiscal year 2022, the Company entered into several agreements with a third-party company, whose stock is publicly traded on a foreign exchange. Under these agreements, the Company will make certain milestone payments of up to $5.0&#160;million upon achievement of specified milestones. During fiscal year 2022, the first of these milestones was achieved and the Company paid $1.0&#160;million to the third-party company, which was recorded in research and development in the Condensed Consolidated Statements of Operations. The remaining milestones are expected to be achieved in fiscal year 2023.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; In addition, the Company agreed to acquire, through two separate purchases, a fixed number of shares for approximately $5.0&#160;million, representing 9.9% of the shares of the third-party company outstanding on the date the agreements were signed. The Company completed the acquisition of the first tranche of shares during fiscal year 2022 for approximately $2.4&#160;million and the second tranche of shares during the first quarter of fiscal year 2023 for approximately $2.7&#160;million. The Company has recorded this investment as marketable equity securities, which is included in other assets on the Condensed Consolidated Balance Sheets. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;From time to time, we are a party to or otherwise involved in legal proceedings, government inspections, investigations, customs and duty audits, and other claims and contingency matters, both inside and outside the United States, arising in the ordinary course of our business or otherwise.&#160;We accrue amounts for probable losses, to the extent they can be reasonably estimated, that we believe are adequate to address any liabilities related to legal proceedings as well as other loss contingencies that we believe will result in a probable loss (including, among other things, probable settlement value).&#160;A loss or a range of loss is disclosed when it is reasonably possible that a material loss will be incurred and can be estimated or when it is reasonably possible that the amount of a loss, when material, will exceed the recorded provision. We did not have any material contingent liabilities as of December&#160;30, 2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and September&#160;30, 2022. Legal expenses are expensed as incurred.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Days Sales Outstanding</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Trade accounts receivable days sales outstanding (&#8220;DSO&#8221;) was 70 days at December&#160;30, 2022 and 68 days at September&#160;30, 2022. Our accounts receivable and DSO are impacted by a number of factors, including the timing of product shipments, collections performance, payment terms, the mix of revenues from different regions and the effects of economic instability.</span></div><div id="i4ab573909cb849339357193b017c7d37_115"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Standards or Updates Not Yet Effective</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;See Note 1, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, of the accompanying Notes to the Condensed Consolidated Financial Statements for a description of recent accounting standards, including the expected dates of adoption and the estimated effects on our condensed consolidated financial statements.</span></div><div id="i4ab573909cb849339357193b017c7d37_118"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Backlog</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Backlog is the accumulation of all orders for which revenues have not been recognized and are still considered valid. Backlog also includes a small portion of billed service contracts that are included in deferred revenue. Our estimated total backlog at December&#160;30, 2022 was approximately $405 million.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Orders may be revised or canceled, either according to their terms or as customers' needs change. Consequently, it is difficult to predict with certainty the amount of backlog that will result in revenues. We perform a quarterly review to verify that outstanding orders in the backlog remain valid. Aged orders that are not expected to be converted to revenues are deemed dormant and are reflected as a reduction in the backlog amounts in the period identified. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In addition to orders for which revenues have not been recognized and are still considered valid, we have pricing agreements with many of our established customers that span multi-year periods. These pricing agreements include volume ranges under which orders are placed.</span></div><div id="i4ab573909cb849339357193b017c7d37_121"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3. Quantitative and Qualitative Disclosures about Market Risks</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We are exposed to four primary types of market risks: foreign currency exchange rate risk, credit and counterparty risk, interest rate risk and commodity price risk.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Exchange Rate Risk</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;A significant portion of our customers are outside the United States, while our financial statements are denominated, and our products are generally priced in U.S. Dollars. A strong U.S.&#160;Dollar may result in pricing pressure for our customers that are located outside the United States and that conduct their businesses in currencies other than the U.S. Dollar. Such pricing pressure has caused, and could continue to cause, some of our customers to ask for discounted prices, delay purchasing decisions, or consider moving to in-sourcing supply of components or migrating to lower cost alternatives. In addition, because our business is global and some payments may be made in local currency, fluctuations in foreign currency exchange rates can impact our revenues and expenses and/or the profitability in U.S. Dollars of products and services that we provide or purchase in foreign markets.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We may enter into foreign currency forward and option contracts with financial institutions to protect against foreign exchange risks associated with certain existing assets and liabilities, net investments in foreign subsidiaries, and forecast purchases denominated in foreign currencies. We may hedge portions of forecasted foreign currency exposure, typically for one to three months. In addition, we hold cross-currency swaps between the Euro and U.S. Dollar as a net investment hedge of our acquisition of Direct Conversion. Depending on the spot rate between the Euro and U.S. Dollar at the time of settlement and whether we have sufficient Euros available, we may have to borrow incrementally in U.S. Dollars to settle this obligation. Additionally, we may choose not to hedge certain foreign exchange exposures for a variety of reasons including, but not limited to, accounting considerations, the prohibitive economic cost of hedging particular exposures, or due to natural offsets among the different exposures. See Note 6, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Derivatives and Hedging Activities, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of the Notes to the Condensed Consolidated Financial Statements for further information.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit and Counterparty Risk</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We use a centralized approach to manage substantially all of our cash and to finance our operations. Our cash and cash equivalents and marketable securities may be exposed to a concentration of credit risk, and we may also be exposed to credit risk and interest rate risk to the extent that we enter into credit facilities.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We perform ongoing credit evaluations of our customers and we maintain what we believe to be strong credit controls in evaluating and granting customer credit, including performing ongoing evaluations of our customers&#8217; financial condition and creditworthiness and often using letters of credit or requiring certain customers to provide a down payment.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Risk</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Borrowings under our ABL Facility bear interest at floating interest rates. At December&#160;30, 2022, we had no borrowings subject to floating interest rates. See Note 10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Borrowings,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the Notes to the Condensed Consolidated Financial Statements for further information.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our exposure to interest rate risk also relates to our interest-bearing assets, primarily our cash and cash equivalents and marketable securities. Fixed rate securities may have their market value adversely affected due to a rise in interest rates, while floating rate securities may produce less income than expected if interest rates fall. Due in part to these factors, our future investment income may fluctuate due to changes in interest rates or we may suffer losses in principal if we are forced to sell securities that decline in market value due to changes in interest rates. </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commodity Price Risk</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We are exposed to market risks related to volatility in the prices of raw materials used in our products. The prices of these raw materials fluctuate in response to changes in supply and demand fundamentals and our product margins and level of profitability tend to fluctuate with changes in these raw materials prices. We try to protect against such volatility through various business strategies. During the three months ended December 30, 2022, we did not have any commodity derivative instruments in place to manage our exposure to price changes.</span></div><div id="i4ab573909cb849339357193b017c7d37_124"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;4. Controls and Procedures</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disclosure Controls and Procedures</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the "Exchange Act")) are designed to provide reasonable assurance that information required to be disclosed in the reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the rules and forms of the SEC and that such information is accumulated and communicated to management, including our principal executive and financial officers, as appropriate to allow timely decisions regarding disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluation the cost-benefit relationship of possible controls and procedures. Based on this evaluation, our Chief Executive Officer and our Chief Financial Officer, have concluded that our disclosure controls and procedures were effective as of December&#160;30, 2022.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in Internal Control Over Financial Reporting</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;There were no changes in our internal control over financial reporting during the quarter ended December&#160;30, 2022, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f) under the Exchange Act).</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><div id="i4ab573909cb849339357193b017c7d37_127"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OTHER INFORMATION</span></div><div id="i4ab573909cb849339357193b017c7d37_130"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1. Legal Proceedings</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We are subject to various claims, complaints and legal actions in the normal course of business from time to time. We are not aware of any currently pending litigation for which the outcome could have a material adverse effect on our operations or financial position.</span></div><div id="i4ab573909cb849339357193b017c7d37_133"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1A. Risk Factors</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summary of Principal Risk Factors</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Investing in Varex Imaging Corporation ("we," "our," "us," the "Company," "Varex," or "Varex Imaging") common stock involves risks. See below and Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations and Quantitative and Qualitative Disclosures about Market Risks for a discussion of the following principal risks and other risks that make an investment in Varex speculative or risky:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The global economy has been adversely impacted by economic instability and geopolitical tensions that have in the past adversely affected, and could in the future continue to adversely affect, our business, financial condition, operating results, cash flows and stock price.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We sell our products and services to a limited number of original equipment manufacturer (&#8220;OEM&#8221;) customers, many of which are also our competitors, and a reduction in or loss of business of one or more of these customers may materially reduce our sales.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may not be able to accurately predict customer demand or delivery schedules for our products.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We compete in highly competitive markets, and we may lose business to our customers or other companies with greater resources or with greater abilities to develop more effective technologies, or we could be forced to reduce our prices.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our success depends on the successful acquisition, development, introduction, and commercialization of new lines of business, new technologies, new generations of products and enhancements to or simplifications of existing product lines.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">More than half our revenue is generated from customers located outside the United States and is subject to global, regional, and country-specific economic instability, shifting political environments, changing tax treatment, and other risks associated with international operations and sales that could materially and adversely impact our business and financial results.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">COVID-19 has adversely impacted our operations, cash flow, and financial position, and in the future we could continue to be adversely impacted by the COVID-19 pandemic and continuing economic disruptions.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">It has become more difficult to attract and retain employees, which has impacted, and is likely to continue to impact, our ability to develop and manufacture products and operate our business.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may be unable to complete future acquisitions or realize expected benefits from acquisitions of or investments in new business, products, or technologies, which could harm our business.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Warranty claims may materially and adversely affect our business.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Product defects or misuse may result in material product liability or professional errors and omissions claims, litigation, investigation by regulatory authorities, or product recalls that could harm our future revenues and require us to pay material uninsured claims.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We are exposed to credit risk and fluctuations in the values of our investment portfolio.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Our business is subject to evolving Environmental, Social, and Governance (&#8220;ESG&#8221;) requirements and stakeholder expectations that could expose us to numerous risks.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A disruption at our manufacturing facilities, as well as fluctuating manufacturing costs, could materially and adversely affect our business.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our competitive position would be harmed if we are not able to maintain our intellectual property rights and protecting our intellectual property and defending against infringement claims can be costly.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Disruption of critical information systems or material breaches in the security of our systems may materially and adversely affect our business and customer relations.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Changes in import/export regulatory regimes, tariffs, and national policies could continue to negatively impact our business.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Compliance with laws, regulations, certifications and registrations across the globe applicable to the marketing, manufacturing, sale, and distribution of our products and to our operations generally, may be costly, and failure to comply may result in our inability to sell products, unfavorable legal proceedings, significant penalties and other harm to our business.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_7">Table of Contents</a></span></div></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Initiation of legal proceedings, defense against legal proceedings and unfavorable results of legal proceedings could materially and adversely affect our financial results.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We have significant debt obligations and could incur additional debt that could adversely affect our business, profitability, liquidity, credit rating, and ability to meet our obligations.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Conversion of the Convertible Notes may dilute the ownership interest of our stockholders or may otherwise depress the market price of our common stock or may adversely affect our financial condition and operating results, and certain hedging positions we entered may affect the value of the Convertible Notes and the volatility and value of our common stock.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our Asset-Based Loan credit facility and the indenture governing our Senior Secured Notes impose significant operating and financial restrictions that may limit current and future operating flexibility, and make it difficult to respond to economic or industry changes or to take certain actions, which could harm our long-term interest.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Liabilities related to our operations when we were part of Varian Medical Systems, Inc., a Siemens Healthineers Company ("Varian"), or liabilities associated with the spin-off from Varian, could materially and adversely affect our business, financial condition, results of operations, and cash flows.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following risk factors and other information included in this Quarterly Report on Form 10-Q (this "Quarterly Report") should be carefully considered. Although the risk factors described below are the ones management deems significant, additional risks and uncertainties not presently known to us or that we presently deem not material may also adversely affect our business operations. If any of the following risks or additional risks and uncertainties actually occur, our business, operating results, and financial condition could be adversely affected.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Relating to Our Business</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The global economy has been adversely impacted by economic instability and geopolitical tensions that have in the past adversely affected, and could in the future continue to adversely affect, our business, financial condition, operating results, cash flows and stock price.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In many markets where we operate, global economic instability and geopolitical tensions have contributed to volatility in commodity prices, and in the credit and capital markets; market, supply chain, and inventory disruptions; sustained inflation; exchange rate volatility; the imposition of sanctions and countermeasures; an energy crisis in Europe; and increased likelihood of new and unfavorable trade regulations. These conditions have shrunk capital equipment budgets, slowed decision-making and made it difficult for our customers and vendors to accurately forecast and plan future business activities. This, in turn, has caused our customers to be more cautious with, and sometimes freeze, delay, or dramatically reduce purchases and capital project expenditures. Some countries have adopted and may in the future adopt austerity or stimulus programs that could negatively affect our results from period to period. We have experienced, and continue to experience, difficulties in obtaining materials used to build our products and these difficulties have in the past impacted, and could in the future impact, our ability to deliver finished products to our customers. We believe that it will continue to be difficult to obtain certain materials throughout fiscal year 2023. We have used more of our inventory on hand than we have used historically and are purchasing materials that are critical to our processes, often at higher costs. Shortages of materials, particularly micro-controller chips and associated electronic components, have caused and may continue to cause, delays in manufacturing products for our customers. In some cases, raw material shortages and delivery delays from our suppliers are communicated to us with very little advanced warning, which has caused operational and customer order fulfillment challenges. During fiscal year 2022 and the first quarter of fiscal year 2023, inventory levels increased, however, uneven component flow and delayed deliveries impacted our ability to finish products resulting in higher inventory count. If our actions to mitigate such challenges are not successful, material shortages could slow or cause us to temporarily stop production of certain products. Production delays have had and could continue to have a material adverse effect on our business and results of operations. For example, if we are unable to deliver products to our customers without unreasonable delay, those customers may seek alternative suppliers or decide to in-source certain products. Further, our competitors with greater financial resources may be better able to restructure their manufacturing and supply chains in response to geopolitical and economic trends and thereby have a competitive advantage over us.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In addition to material shortages, supply chain logistics have become more challenging, could remain challenging, and result in higher costs and efforts. Our ability to move unfinished goods and finished products around the world has been and continues to be impacted by the decreased availability of global transportation networks. We have been and continue to be subject to price increases on both the components used to make our products, and for moving unfinished goods and finished products across the globe. Increased freight charges and shipping delays have also become more common during the pandemic and are expected to continue into the foreseeable future. If we are not able to mitigate these price increases and/or raise prices for our products, our operations, cash flow, and financial position could continue to be adversely impacted. See Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations for more information regarding the risks related to supply chain disruptions and logistical challenges on our business.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Inflation has the potential to increase our overall cost structure, particularly if we are unable to achieve commensurate increases in the prices we charge our customers. The existence of sustained inflation in the economy has resulted in, and may continue to result in, higher interest rates and capital costs, increased shipping costs, supply shortages, increased costs of labor, weakening exchange rates and other similar effects. As interest rates rise to address inflation or otherwise, we may experience further increases in capital and other costs.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Changes in monetary or other policies in the United States and abroad, including efforts to combat inflation, economic and/or political instability, or in reaction thereto, could affect foreign currency exchange rates. Furthermore, if one or more European countries were to replace the Euro with another currency, our sales in these countries, or in Europe generally, would likely be materially and adversely affected until stable exchange rates are established. Our products are generally priced in U.S. Dollars. Because our business is global and some payments may be made in local currency, fluctuations in foreign currency exchange rates can impact our results by affecting product demand and purchasing decisions, revenues and expenses, and/or the profitability in U.S. Dollars of products and services that we provide in foreign markets.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Although we may take measures to mitigate the impact of inflation and exchange rate fluctuation, if these measures are not effective, our business, financial condition, results of operations and liquidity could be materially adversely affected. Even if such measures are effective, the benefits of such measures may not be realized until after the costs of inflation have been incurred.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Additionally, fluctuations in commodities prices could materially and adversely affect our performance. Rising commodities prices have in the past increased, and may in the future increase, our costs and those of our medical OEM customers, which could in turn result in reduced demand for our products or impact our financial results. Further, our security product revenues from oil-producing countries, in which we have a significant customer base, have in the past suffered as a result of volatility in oil prices and remain sensitive to fluctuations in the future.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The uncertain economic environment has also impacted, and may in the future continue to impact, our service business, as customers&#8217; constrained budgets may result in pricing pressure, extended warranty provisions, and even cancellation of service contracts. In addition, concerns over continued economic instability could make it more difficult for us to collect outstanding receivables. A weak or deteriorating healthcare market would inevitably materially and adversely affect our business, financial conditions, and results of operations.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We sell our products and services to a limited number of OEM customers, many of which are also our competitors, and a reduction in or loss of business of one or more of these customers may materially reduce our sales.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We sell our products to a limited number of OEM customers, many of which are also our competitors with in-house X-ray component manufacturing operations. We had one customer during the three months ended December 30, 2022 that accounted for 20% of our revenue. Our ten largest customers as a group accounted for approximately 55% and 50% of our revenue for the three months ended December 30, 2022 and December&#160;31, 2021, respectively. Although we seek to broaden our customer base, we will continue to depend on sales to a relatively small number of major customers. Because we often take significant time to replace lost business, it is likely that our operating results would be materially and adversely affected if one or more of our major OEM customers were to cancel, delay, or reduce orders in the future.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Furthermore, we generate significant accounts receivables from the sale of our products and the provision of services directly to our major customers. We had one customer during the three months ended December 30, 2022 that accounted for 9.2% of our accounts receivable. If one or more of these customers were to cancel a product order or service contract (whether in accordance with its terms or otherwise), become insolvent or otherwise be unable or fail to pay for our products and/or services, our operating results and financial condition could be materially and adversely affected.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_7">Table of Contents</a></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not be able to accurately predict the demand or delivery schedules for our products.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;End-user product demand, economic uncertainties, the COVID-19 pandemic, natural disasters, armed conflict, geopolitical tensions, and other matters beyond our control make it difficult for our customers to accurately forecast and plan future business activities; which makes it difficult for us to accurately predict the demand for our products. Because the manufacture of our products requires some lead-time, changes in customer purchasing forecasts have previously impacted our business, resulting in excess inventory and slowdowns in sales. Similar inventory adjustments and slowdowns in sales are likely to occur in the future. Changes to customer forecasts can occur on short notice. Our customers also face inherent competitive issues and new product introduction delays which can result in changes in forecasts. The market and regulatory risks faced by our customers also ultimately impact our ability to forecast future business. Our agreements for imaging components contain purchasing estimates that are typically based on our customers&#8217; forward-looking forecasts rather than firm commitments, and actual purchasing volumes under the agreements may vary significantly from these estimates. The variation from forecasted purchasing volume may be due, in part, to the increasing life of X-ray tubes, which can result in reduced demand for replacement X-ray tubes in ways we may not be able to accurately forecast. Reductions in purchasing patterns have in the past and may in the future materially and adversely affect our operating results. In the past, decreased economic activity associated with the COVID-19 pandemic had a significant negative impact on the demand for our industrial products and a similar impact could occur again.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We compete in highly competitive markets, and we may lose business to our customers or other companies with greater resources or with greater abilities to develop more effective technologies, or we could be forced to reduce our prices.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We compete in markets characterized by rapidly-evolving technology, intense competition and pricing pressure. We often compete with companies that have greater financial, marketing and other resources than us. Some of the major diagnostic imaging systems companies, which are the primary OEM customers for our X-ray imaging components, also manufacture X-ray imaging components, including X-ray tubes, for use in their own imaging systems products. We must compete with these in-house manufacturing operations for business. If these customers manufacture a greater percentage of their components in-house or otherwise decrease purchases from external sources, which may occur for a number of reasons, including a strong U.S. Dollar, rising interest rates or a general economic slowdown, we could experience reductions in purchasing volume by, or loss of, one or more of these customers. Such a reduction or loss may have a material and adverse effect on our business. In addition, we compete against other stand-alone, independent X-ray tube manufacturers for both the OEM business of major diagnostic imaging equipment manufacturers and the independent servicing business for X-ray tubes.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The market for flat panel detectors is also very competitive, and we face intense competition from over a dozen smaller competitors. As a result of these competitive dynamics, to effectively retain the business of our customers and compete with our competitors we must have an advantage in one or more significant areas, such as lower product cost, better product quality and/or superior technology and/or performance. We have made price concessions to maintain existing customers and attract new customers, and may have to make additional price concessions in the future.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In our Industrial segment, we compete with other OEM suppliers primarily outside of the United States. The market for our X-ray tube and flat panel products used for nondestructive testing in industrial applications is small and highly fragmented. Some of our competitors outside of the United States may have resources and support from their governments that we do not, such as preferences for local manufacturers, and may not be subject to the same trade compliance regulations as us. Therefore, our ability to compete in certain high-growth markets may be limited compared to our competitors.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our competitors could develop technologies and products that are more effective than those we currently use or produce or that could render our products obsolete or noncompetitive. In addition, the timing of our competitors&#8217; introduction of products into the market could affect the market acceptance and sales of our products. Some competitors offer specialized products that provide, or may be perceived by customers to provide, an advantage over our products. Also, some of our non-U.S. competitors may not be subject to the same standards, regulatory and/or other legal requirements to which we are subject and, therefore, they could have a competitive advantage in developing, manufacturing and marketing products and services. Any inability to develop, gain regulatory approval for and supply commercial quantities of competitive products to the market as quickly and effectively as our competitors could limit market acceptance of our products and reduce our sales. Any of these competitive factors could negatively and materially affect our pricing, sales, revenues, market share and gross margins and our ability to maintain or increase our operating margins.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_7">Table of Contents</a></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our success depends on the successful development, introduction, and commercialization of new generations of products and enhancements to or simplifications of existing product lines.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We operate in a market characterized by rapid change and technological innovation, particularly with respect to flat panel technology. Our customers use our products in their medical diagnostic, security, and industrial imaging systems, and we must continually introduce new products at competitive costs while also improving existing products with higher quality, lower costs, and increased features. To be successful, we must anticipate our customers&#8217; needs and demands, as well as potential shifts in market preferences. Our failure to do so has in the past resulted, and may in the future result, in the loss of customers and an adverse impact to our financial performance. When the U.S. Dollar is strong compared to the operating currencies of our international customers, our ability to meet such customers&#8217; pricing expectations is particularly challenging and may result in erosion of product margin and market share.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We have in the past spent, and in the future may need to spend, more time and money than we expect to develop, market and introduce new products or enhancements, and, even if we succeed, we may not be able to recover all or a meaningful part of our investment. Once introduced, new products may materially and adversely impact sales of our existing products or make them less desirable or even obsolete, which could materially and adversely impact our revenues and operating results. In addition, certain costs, including installation and warranty costs, associated with new products may be proportionately greater than the costs associated with other products and may therefore disproportionately, materially, and adversely affect our gross and operating margins. If we are unable to lower these costs over time, our operating results could be materially and adversely affected. Some of the electronic components and integrated circuits used in our flat panel detectors are susceptible to discontinuance and obsolescence risks, which may force us to incorporate newer generations of these components, resulting in unplanned additional R&amp;D expenses, delays in the launch of new products, supply disruptions, or inventory write downs.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our ability to successfully develop and introduce new products and product enhancements and simplifications, and the revenues and costs associated with these efforts, are affected by our ability to, among other things:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">properly identify customer needs or long-term customer demands;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">prove the feasibility of new products;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">identify complementary technologies or intellectual property and, where appropriate, negotiate and maintain related licensing agreements or other arrangements to facilitate development of new products and product enhancements and simplifications;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">properly manage and control research and development costs;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">limit the time required from proof of feasibility to routine production;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">timely and efficiently comply with internal quality assurance systems and processes;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">limit the timing and cost of regulatory approvals;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">adequately protect the underlying intellectual property and, where licensed or jointly developed, ensure the continuity of our use of such intellectual property for the manufacture, sale and distribution of new products and product enhancements or simplifications;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">accurately predict and control costs associated with inventory overruns caused by the phase-in of new products and the phase-out of old products;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">price our products competitively and profitably, which can be particularly difficult with a strong U.S. Dollar;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">manufacture, deliver, and install our products in sufficient volumes on time and accurately predict and control costs associated with manufacturing installation, warranty, and maintenance of the products;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">appropriately manage our supply chain;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">manage customer acceptance and payment for products; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">anticipate, respond to, and compete successfully with competitors.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Furthermore, as discussed in greater detail elsewhere in this &#8220;Risk Factors&#8221; section, we cannot be sure that we will be able to successfully develop, manufacture, or introduce new products or enhancements, the roll-out of which involves compliance with complex quality assurance processes, including the Quality System Regulation of the U.S. Food and Drug Administration (&#8220;FDA&#8221;). Failure to complete these processes timely and efficiently could result in delays that could affect our ability to attract and retain customers or cause customers to delay or cancel orders, which would materially and adversely affect our revenues and operating results.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_7">Table of Contents</a></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">More than half of our revenue is generated from customers located outside the United States, and is subject to global, regional, and country-specific economic instability, shifting political environments, changing tax treatment, and other risks associated with international operations and sales that could materially and adversely affect our business and financial results.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We conduct business globally. Revenues generated from customers located outside the United States accounted for approximately 64% and 70% of our total revenues for the three months ended December 30, 2022 and December&#160;31, 2021, respectively. As a result, we must provide significant service and support globally. We intend to continue to expand our presence in international markets and expect to expend significant resources in doing so. We cannot be sure that we will be able to meet our sales, service, and support objectives or obligations in these international markets or recover our investment in these international markets. Our future results could be harmed by a variety of factors, including:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">currency fluctuations, and in particular the strength of the U.S. Dollar (which is our functional and reporting currency) relative to many currencies, which have adversely affected, and may in the future adversely affect our financial results and cause some customers to delay purchasing decisions, move to in-sourcing supply, migrate to lower cost alternatives, or ask for discounts;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the longer payment cycles associated with many customers located outside the United States;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">difficulties in interpreting or enforcing agreements and collecting receivables through many foreign countries&#8217; legal systems;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in restrictions on trade between the United States and other countries or unstable regional political and economic conditions;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in the political, regulatory, safety or economic conditions in a country or region;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the imposition by governments of additional taxes, tariffs, global economic sanctions programs, or other restrictions on foreign trade such as the tariffs put into place by both China and the United States;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">conflicts between countries, including the current military conflict between Russia and Ukraine, and related sanctions;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any inability to obtain required export or import licenses or approvals, including the inability to obtain required export licenses during a U.S. government shutdown;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">natural disasters and pandemics;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">failure to comply with export laws and requirements, which may result in civil or criminal penalties and restrictions on our ability to export our products, particularly our industrial linear accelerator products;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">risks unique to the Chinese market, including import barriers and preferences for local manufacturers;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">failure to obtain proper business licenses or other documentation or to otherwise comply with local laws and requirements regarding marketing, sales, service, or any other business we conduct in a foreign jurisdiction, which may result in civil or criminal penalties and restrictions on our ability to conduct business in that jurisdiction; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">difficulties in protecting our intellectual property in foreign countries.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Although our sales fluctuate from period to period, in recent years our international operations have represented a larger share of our business. The more we depend on international sales, the more vulnerable we become to these factors.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">COVID-19 has adversely impacted our operations, cash flow, and financial position, and in the future we could continue to be adversely impacted by the COVID-19 pandemic and continuing economic disruptions.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The pandemic caused by the spread of COVID-19 adversely impacted our operations, cash flow, and financial position. The pandemic created significant volatility, uncertainty and economic disruption that could continue into the future. In addition, in part due to the COVID-19 pandemic, we have observed an overall tightening and increasingly competitive labor market, which has resulted in increased wages offered by other employers and voluntary attrition of employees in the industry, making it more difficult to recruit, hire, and retain talent. New or continuing outbreaks of COVID-19 could have a negative impact on our business, future operating results, cash flows and financial condition. Local government lockdowns or prohibitions on travel could adversely affect our ability to manufacture or sell our products or to provide service to our customers or to meet and build relationships with customers, suppliers, or other third parties. For example, the Chinese government has in the past closed, and, in light of surging infection and morbidity rates in China from the easing of China&#8217;s zero COVID-19 policy, may in the future close, our factory in China for extended periods of time to combat COVID-19 infection rates in the region. Even though the effects of COVID-19 have been lessening worldwide, a resurgence of COVID-19 or other infections variants could have an adverse impact on our operating results, cash flows and financial condition. See Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations for more information regarding the risks related to COVID-19 on our business.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_7">Table of Contents</a></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">It has become more difficult to attract and retain employees, which has impacted, and is likely to continue to impact, our ability to develop and manufacture products and operate our business.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our future success depends, to a great degree, on our ability to retain, attract, expand, integrate, and train our management team and other key personnel, such as qualified engineering, service, sales, marketing, manufacturing and other staff. We compete for key personnel with other medical equipment and software manufacturers and technology companies, as well as universities and research institutions. Competition for qualified personnel has increased over the past years. As a result of the COVID-19 pandemic, we have observed an overall tightening and increasingly competitive labor market, which has resulted in increased wages offered by other employers and voluntary attrition of employees in the industry, making it more difficult to recruit, hire, and retain talent. Because competition is intense, particularly in Utah, where unemployment rates are relatively low, compensation-related costs have and could continue to increase significantly. If we are unable to hire and train qualified personnel, we may not be able to maintain or expand our business.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Additionally, our U.S.-based employees, including our senior management team, work for us on an at-will basis and there is no assurance that any such employee will remain with us. Replacing key employees, including our Chief Executive Officer, and management personnel may be difficult or costly and may take an extended period of time because of the limited number of individuals in our industry and where we are located with the breadth of skills and experience that we require. Further, in 2021 and into 2022, the labor market in the U.S. experienced significant increases in workers leaving their positions (often referred to as the "Great Resignation"), which made the market to replace these individuals competitive and resulted in significant wage inflation in response to labor shortages. During the Great Resignation, we have faced and may continue to face increased challenges of employee attraction and retention. To the extent we hire employees from competitors, we also may be subject to allegations that they have been improperly solicited or divulged proprietary or other confidential information.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may face additional risks from the acquisition or development of new lines of business.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;From time to time, we may acquire or develop new lines of business. There are substantial risks and uncertainties associated with new lines of business, particularly in instances where the markets are not fully developed or are ones we have not operated in before. Risks include developing knowledge of and experience in the new business, recruiting market professionals, new types or greater levels of liability exposure, increasing research and development expenditures, and developing and capitalizing on new relationships with experienced market participants. This may mean significant investment and involvement of our senior management to acquire or develop, then integrate, the business into our operations. Timelines for integration of new businesses may not be achieved, and price and profitability targets may not prove feasible, as new products can carry lower gross margins than existing products. External factors, such as compliance with regulations (including in the case of some evolving end-markets, fast-changing regulatory developments and legal uncertainties), competitive alternatives, and shifting market preferences may also impact whether implementation of a new business will be successful. Failure to manage these risks could have a material and adverse effect on our business, results of operations, and/or financial condition.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, some of our products are multi-purpose products designed and intended to be used by OEMs and end users for a wide range of imaging and irradiation purposes including for use in new and emerging industries. Certain of these industries may be subject to varying, inconsistent, and rapidly changing laws, regulations, administrative practices, enforcement approaches, judicial interpretations, and consumer perceptions. The demand for our products may be negatively impacted depending on how laws, regulations, administrative practices, enforcement approaches, judicial interpretations, and consumer perceptions develop, and we cannot reasonably predict the nature of these developments or the effect, if any, that these developments could have on our business.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be unable to complete future acquisitions or realize expected benefits from acquisitions of or investments in new businesses, products, or technologies, which could harm our business.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our ability to identify and take advantage of attractive acquisitions or other business development opportunities is an important component in implementing our overall business strategy. We must grow our business in response to changing technologies, customer demands, and competitive pressures. In some circumstances, we may decide to grow our business through the acquisition of complementary businesses, products, or technologies, rather than through internal development; however, there is no guarantee that these acquisitions will be successful or that we will realize a return on our investment.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Identifying suitable acquisition candidates can be difficult, time consuming, and costly, and we may not be able to identify suitable candidates or successfully complete or finance identified acquisitions, including as a result of failing to obtain regulatory or competition clearances, which could impair our growth and ability to compete. In addition, completing an acquisition can divert our management and key personnel from our current business operations, which could harm our business and affect our financial results. Even if we complete an acquisition, we may not be able to successfully integrate newly-acquired organizations, products, technologies, or employees into our operations or may not fully realize some of the expected synergies.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Integrating an acquisition can also be expensive and time consuming and may strain our resources. It may cost us more to commercialize new products than originally anticipated or cause us to increase our expenses related to research and development, either of which could materially and adversely impact our results of operations. In many instances, integrating a new business will also involve implementing or improving internal controls appropriate for a public company into a business that lacks them. It is also possible that an acquisition could increase our risk of litigation, as a third party may be more likely to assert a legal claim following an acquisition because of perceived deeper pockets or a perceived greater value of a claim. In addition, we may be unable to retain the employees of acquired companies or the acquired company&#8217;s customers, suppliers, distributors, or other partners for a variety of reasons, including the fact that these entities may be our competitors or may have close relationships with our competitors.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Further, we may find that we need to restructure or divest acquired businesses or assets of those businesses.&#160;Completed acquisitions may not produce the full efficiencies, growth, or benefits that were expected.&#160;If we decide to sell assets or a business, it may be difficult to identify buyers or alternative exit strategies on acceptable terms, in a timely manner, or at all, which could delay the accomplishment of our strategic objectives.&#160;We may be required to dispose of a business at a lower price or on less advantageous terms, or to recognize greater losses than we had anticipated.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;If we acquire a business, we allocate the total purchase price to the acquired business&#8217; tangible assets and liabilities, identifiable intangible assets, and liabilities based on their fair values as of the date of the acquisition and record the excess of the purchase price over those values as goodwill. If we fail to achieve the anticipated growth from an acquisition, or if we decide to sell assets or a business, we may be required to recognize an impairment loss on the write down of our assets and goodwill, which could materially and adversely affect our financial results. In addition, acquisitions can result in potentially dilutive issuances of equity securities or the incurrence of debt, contingent liabilities or expenses, or other charges, any of which could harm our business and affect our financial results.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We participate in joint ventures and other investments in privately-held and publicly traded companies. For example, we hold a 40% ownership interest in dpiX LLC, our major supplier of our amorphous silicon-based thin film transistor arrays for flat panels used in our digital image detectors, and a 50% interest in VEC Imaging GmbH &amp; Co. KG, a joint venture formed to develop technology for use in X-ray imaging components and we recently invested in another X-ray imaging components technology company. These and other investments are subject to risk of loss of investment capital as well as losses associated with contributed or jointly developed intellectual property. These types of investments are inherently risky, in some instances because the markets for the technologies or products these companies have under development may never materialize or may underperform relative to our expectations. If these companies do not succeed, we could lose some or all of our investment in these companies. In addition, we may incur significant costs and management resources to enforce our rights, protect our intellectual property and other assets, address disputes that have arisen or may arise, and/or unwind, dispose of or terminate our arrangements with respect to these investments. There is no guarantee that the time and money invested by us in these projects, or jointly developed intellectual property or product or product enhancements will yield the expected returns.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Warranty claims may materially and adversely affect our business.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We could experience an increase in warranty claims as a result of issues with product quality or product failures as a direct result of our design, manufacturing, or issues in our supply chain. Such an occurrence may damage our market reputation, cause sales to decline, or require repairs or voluntary remedial measures to enhance customer satisfaction, which could materially and adversely impact our financial results. Increased warranty claims on any given product could cause us to halt production on that product and significantly impair our liquidity and profitability, and could cause reputational harm to us. Because some categories of products tend to experience higher numbers of warranty claims than others, a shift in the types of products that our customers purchase could lead to an increase in warranty claims. If actual levels of warranty claims are greater than the level of claims we estimate, cost of sales could increase, and our financial condition could be materially and adversely affected. In addition, product quality issues could result in significant follow-on effects for us, including, among other things, reputational harm to us and our customers, loss of customers, and liability as a result of product quality issues. These outcomes would materially and adversely affect our business and financial condition.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_7">Table of Contents</a></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Product defects or misuse may result in material product liability or professional errors and omissions claims, litigation, investigation by regulatory authorities, or product recalls that could harm our future revenues and require us to pay material uninsured claims.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our business exposes us to potential product liability claims that are inherent in the manufacture, sale, installation, servicing, and support of components that are used in medical devices and other devices that deliver radiation. Because our products, through incorporation into OEMs&#8217; systems, are involved in the intentional delivery of radiation to the human body and other situations where people may come into contact with radiation (for example, when our security and inspection products are being used to scan cargo or in the diagnosis of medical problems), the possibility for significant personal injury or loss of life exists. Although our products are incorporated into OEMs&#8217; systems, and thus only perform pursuant to the design and operating systems of OEMs, we may also be subject to claims for property damage, personal injury, or economic loss related to or resulting from any errors or defects in our products or the installation, servicing, or support of our products. Any accident or mistreatment could subject us to legal costs, litigation, adverse publicity, and damage to our reputation, whether or not our products or services were a factor.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;If our X-ray inspection systems fail to detect the presence of bombs, explosives, weapons, contraband, or other threats to personal safety, we could be subject to product and other liability claims or negative publicity, which could result in increased costs, reduced sales, and a decline in the market price of our common stock. There are many factors beyond our control that could result in the failure of our products to detect the presence of bombs, explosives, weapons, contraband, or other threats to personal safety, including operator error and misuse of or malfunction of our equipment. The failure of our systems to detect the presence of these dangerous materials may lead to personal injury, loss of life, and extensive property damage and may result in potential claims against us.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Product liability actions are subject to uncertainty and may be expensive, time consuming, and disruptive to our operations. For these and other reasons, we may choose to settle product liability claims against us regardless of their actual merit. A product liability action determined against us could result in adverse publicity or significant damages, including the possibility of punitive damages, and our combined financial position, results of operations, or cash flows could be materially and adversely affected.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;If a product we design or manufacture were defective (whether due to design, labeling or manufacturing defects, improper use of the product, or other reasons), we may be required to correct or recall the product and notify regulatory authorities. The adverse publicity resulting from a correction or recall could damage our reputation and cause customers to review and potentially terminate their relationships with us. A product correction or recall could consume management time and have an adverse financial impact on our business, including incurring substantial costs, losing revenues, and accruing losses.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We maintain limited product liability insurance coverage. Our product liability insurance policies are expensive and have high deductible amounts and self-insured retentions. Our insurance coverage may prove to be inadequate, and future policies may not be available on acceptable terms or in sufficient amounts, if at all. If a material claim is not insured or is in excess of our insurance coverage, we could have to pay substantial damages, which could have a material and adverse effect on our financial position and/or results of operations.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are exposed to credit risk and fluctuations in the values of our investment portfolio.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our investments can be negatively affected by liquidity, credit deterioration, financial results, market and economic conditions, political risk, sovereign risk, interest rate fluctuations or other factors. As a result, the value and liquidity of our cash, cash equivalents and marketable securities may fluctuate substantially. Therefore, although we have not realized any significant losses on our cash, cash equivalents and marketable securities, future fluctuations in their value could result in significant losses and could have a material adverse impact on our financial condition and operating results. See Quantitative and Qualitative Disclosures about Market Risks for more information regarding the risks related to credit risks and fluctuations on our business.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_7">Table of Contents</a></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business is subject to evolving ESG requirements and stakeholder expectations that could expose us to numerous risks.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;&#160;&#160;&#160;Regulators, customers, consumers, investors, and other stakeholders are increasingly focusing on ESG issues and related disclosures. Changing ESG requirements and stakeholder expectations, including ESG requirements set forth in customer procurement policies, have resulted in, and are likely to continue to result in, increased general and administrative expenses and increased management time and attention spent complying with or meeting such regulations and expectations. For example, developing and acting on ESG initiatives, and collecting, measuring, and reporting ESG information and metrics can be costly, difficult and time consuming and is subject to evolving reporting standards, including the SEC&#8217;s proposed climate-related reporting requirements. We may also communicate certain ESG initiatives and goals in our SEC filings or in other public disclosures. These initiatives and goals could be difficult and expensive to implement, the technologies needed to implement them may not be cost effective and may not advance at a sufficient pace, and we could be criticized for the accuracy, adequacy, or completeness of the disclosure of our ESG initiatives. Further, statements about our ESG initiatives and goals, and progress against those goals, may be based on standards for measuring progress that are still developing, internal controls and processes that continue to evolve, and assumptions that are subject to change in the future. In addition, we could be criticized for the scope or nature of such initiatives or goals, or for any revisions to these goals. If our ESG-related data, processes and reporting are incomplete or inaccurate, or if we fail to achieve progress with respect to our ESG goals on a timely basis, or at all, our reputation, business, financial performance and growth could be adversely affected.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In addition, our customers have adopted, and may continue to adopt, procurement policies that require us to comply with social, and environmental responsibility provisions. An increasing number of investors have adopted, and may continue to adopt, ESG policies for their portfolio companies, and various voluntarily sustainability initiatives and organizations have promulgated different social and environmental responsibility and sustainability guidelines. These practices, policies, provisions, and initiatives are under active development, subject to change, can be unpredictable and conflicting, and may prove difficult and expensive for us to comply with and could negatively affect our reputation, business, or financial condition.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Relating to the Manufacture of our Products</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Supply chain disruptions, including the loss of a supplier, and any inability to obtain supplies of important components have impacted our ability to manufacture products, have caused delays in our ability to deliver products, and have increased our costs and may continue to do so.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As discussed under the heading "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risks Relating to Our Business</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" above, supply chain disruptions have had, and will likely continue to have, an impact on our ability to manufacture our products. We have experienced delays in receiving materials used to make our products due both to material shortages and shipping delays. These delays are likely to continue.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;Material shortages have caused, and could continue to cause, us to temporarily stop production of certain products or miss opportunities to pursue additional product sales. If we are unable to obtain the materials necessary to make our products or if we must pay more for those materials, it could have a material adverse effect on our business and financial results.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We obtain some of the components included in our products from a limited group of suppliers or from sole-source suppliers, such as wave guides for industrial linear accelerators, transistor arrays, cesium iodide coatings and specialized integrated circuits for flat panel detectors, X-ray tube targets, housings, glass frames, high-voltage cable, bearings and various other components. For example, our major supplier of our amorphous silicon-based thin film transistor arrays for flat panels used in our digital image detectors is dpiX LLC. Although we hold a 40% ownership interest in dpiX, we do not have majority voting rights or the power to direct the activities of dpiX. In addition, Varian is our sole source supplier for a key component in linear accelerators used in our security and inspection products subsystems, which are specially made for us. If current suppliers cease producing these or other components, there can be no assurance that the components will be available from other suppliers on reasonable terms or at all.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;If we lose any of these limited- or sole-source suppliers, if their operations are substantially interrupted, or if any of them fail to meet performance or quality specifications or delivery deadlines, we may be required to obtain and qualify one or more replacement suppliers or to manufacture the components internally. Such an event (1) may then also require us to redesign or modify our products to incorporate new parts and/or further require us to obtain clearance, qualification, or certification of these products, including by the FDA, or obtain other applicable regulatory approvals in other countries, or (2) could significantly increase costs for the affected products and cause material delays in delivery of those and other related products. In addition, manufacturing capacity limitations of any of our suppliers or other inability of these suppliers to meet increasing demand or delivery deadlines could limit growth opportunities for the affected product lines and damage customer relationships. Shortage of, and greater demand for, components and subassemblies could also increase manufacturing costs if the supply/demand imbalance increases the price of the components and subassemblies. Any of these events could materially and adversely affect our business and financial results. If we decide to manufacture a component that was previously purchased from an external supplier, we may not be able to manufacture the component as efficiently as the external supplier and may experience delays or problems in successfully manufacturing the component, which could materially and adversely affect our ability to manufacture and supply products to customers.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_7">Table of Contents</a></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Shortages, changes in source of, and increases in prices for, raw materials have negatively impacted our ability to manufacture products, have caused delays, and have increased our cost of goods.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We rely on the supplies of certain raw materials such as tungsten, lead, iridium, and copper for security and inspection products and copper, lead, tungsten, rhenium, molybdenum zirconium, and various high grades of steel alloy for X-ray tubes. Worldwide demand, availability, and pricing of these raw materials have been volatile. We have experienced and expect that we will continue to experience increases in raw material costs due to inflation and other market constraints. We expect that availability and pricing will continue to fluctuate in the future. If supplies are restricted or become unavailable or if prices increase further, this could constrain our manufacturing of affected products, reduce our profit margins, or otherwise materially and adversely affect our business.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We are required to disclose (1) the presence in our products of certain metals known as &#8220;conflict minerals,&#8221; which are metals mined from the Democratic Republic of the Congo and adjoining countries, and (2) procedures regarding our efforts to identify the sourcing of those minerals from this region. Our complex supply chain may inhibit our ability to sufficiently verify the origins of the relevant minerals used in our products through the due diligence procedures that we implement, which may harm our reputation. In addition, we may encounter challenges in satisfying customers who require that all of the components of our products are certified as conflict-free, which could place us at a competitive disadvantage if we are unable to do so. Moreover, complying with these rules requires investigative efforts, which has and will continue to cause us to incur associated costs and could materially and adversely affect the sourcing, supply, and pricing of materials used in our products or result in process or manufacturing modifications, all of which could materially and adversely affect our results of operations.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are not able to match our manufacturing capacity with demand for our products, our financial results may suffer.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Many of our products have a long production cycle, and we must anticipate demand for our products to ensure adequate manufacturing and testing capacity. If we are unable to anticipate demand, and our manufacturing or testing capacity does not keep pace with product demand, we will not be able to fulfill orders in a timely manner, which may negatively impact our financial results and overall business. Conversely, if demand for our products decreases, the fixed costs associated with excess manufacturing capacity may harm our financial results, including by decreasing gross margins and increasing research and development costs as a percentage of revenue.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">A disruption at our manufacturing facilities, as well as fluctuating manufacturing costs, could materially and adversely affect our business.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The majority of our products are manufactured at our facility in Salt Lake City, Utah. Our manufacturing operations are subject to potential power failures, the breakdown, failure, or substandard performance of equipment, the improper installation or operation of equipment, pandemics, and natural or other disasters. Loss or damage to our manufacturing facility due to any of these factors or otherwise could materially and adversely affect our ability to manufacture sufficient quantities of our products or otherwise deliver products to meet customer demand or contractual requirements, which may result in a loss of revenue and other adverse business consequences. Because of the time required to obtain regulatory approval and licensing of a manufacturing facility, we may not be able to replace any lost manufacturing capacity on a timely basis. The occurrence of these or any other operational issues at our manufacturing facilities could have a material and adverse effect on our business, financial condition, and results of operations.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Some of our products are manufactured in Wuxi, China; Walluf, Germany; Doetinchem, the Netherlands; and Calamba City, Philippines, which are subject to similar risks but may also face additional regulatory and political risks, which could impact our ability to manufacture and ship products in a timely manner or at all. We also manufacture security products in Las Vegas, Nevada, and these operations are also subject to potential power failures, the breakdown, failure, or substandard performance of equipment, the improper installation or operation of equipment, earthquakes, and other disasters, all of which could materially and adversely affect our ability to deliver products to meet customer demand. In addition, our costs associated with manufacturing our products can vary significantly from quarter to quarter, and fluctuations thereof may adversely affect our business, operating results, and/or financial condition.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_7">Table of Contents</a></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Delivery schedules for our security, industrial, and inspection products tend to be unpredictable.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We design, manufacture, sell, and service Linatron&#174; X-ray linear accelerators, image-processing software, and image detection products for security and inspection, such as cargo screening at ports and borders and nondestructive examination for a variety of applications, as well as industrial applications. We generally sell security and inspection products to OEMs who incorporate our products into their inspection or irradiation systems and processes, which are then sold to customs and other government agencies, as well as to commercial organizations in the casting, power, aerospace, chemical, petrochemical, and automotive industries. We believe growth in our security and inspection products will be driven by security cargo screening and border protection needs, as well as by the needs of customs agencies to verify shipments for assessing duties and taxes. This business is heavily influenced by domestic and international government policies on border and port security, political change, and government budgets. Orders for our security and inspection products have been and may continue to be unpredictable, as governmental agencies may place large orders with us or our OEM customers in a short time period and then may not place any orders for a long time period thereafter. Because it is difficult to predict our OEM customer delivery, the actual timing of sales and revenue recognition varies significantly.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The demand for our security and inspection products is heavily influenced by U.S. and foreign governmental policies on national and homeland security, border protection, and customs activities, which depend upon government budgets and appropriations that are subject to economic conditions, as well as political changes and oil prices. We have seen customers freeze or dramatically reduce purchases and capital project expenditures, delay projects, or act cautiously as governments around the world wrestle with spending priorities. As economic growth remains sluggish in various jurisdictions and appears to be deteriorating in others, and as concerns about levels of government employment and government debt continue, we expect that these effects will also continue. Bid awards in this business may be subject to challenge by third parties. These factors make this business more unpredictable and could cause volatility in our revenues and earnings.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our international manufacturing operations subject us to volatility and other risks, including high security risks, which could result in harm to our employees and contractors or substantial costs.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We conduct certain manufacturing operations internationally to reduce costs and streamline our manufacturing operations. There are administrative, legal, and governmental risks to operating internationally that could increase operating expenses or hamper the development of these operations. The risks from operating internationally that could increase our operating expenses and materially and adversely affect our operating results, financial condition, and ability to deliver our products and grow our business include, among others:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">difficulties in staffing and managing employee relations and foreign operations, particularly in attracting and retaining personnel qualified to design, sell, test, and support our products;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">fluctuations in currency exchange rates;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">difficulties in coordinating our operations globally and in maintaining uniform standards, controls, procedures, and policies across our operations;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">difficulties in enforcing contracts and protecting intellectual property, including in connection with our joint ventures;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">diversion of management attention;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">imposition of burdensome governmental regulations, including changing laws and regulations with respect to collection and maintenance of personally identifiable data;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">regional and country-specific political and economic instability, as discussed in greater detail below; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">inadequacy of the local infrastructure to support our operations.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our international locations expose us to higher security risks compared to our U.S. locations, which could result in both harm to our employees and contractors or substantial costs. Some of our services are performed in or adjacent to high-risk locations where the country or location and surrounding area is suffering from political, social, or economic turmoil, war or civil unrest, or has a high level of criminal or terrorist activity. In those locations where we have employees or operations, we may incur substantial costs to maintain the safety of our personnel. Despite these precautions, the safety of our personnel in these locations may continue to be at risk, and we may in the future suffer the loss of employees and contractors, which could harm our business reputation and operating results.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_7">Table of Contents</a></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our operations are vulnerable to interruption or loss due to natural or other disasters, the effects of climate change, power loss, strikes, and other events beyond our control.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We conduct some of our activities, including manufacturing, research and development, administration, and data processing at facilities located in areas that have in the past experienced or may in the future experience natural disasters. Our insurance coverage for such disasters may not be adequate or continue to be available at commercially-reasonable terms, or at all. A major disaster (such as a major fire, hurricane, earthquake, flood, tsunami, volcanic eruption or terrorist attack) or a climate change-related event affecting our facilities, or those of our suppliers, could significantly disrupt our operations and delay or prevent product manufacture and shipment during the time required to repair, rebuild, or replace our or our suppliers&#8217; damaged manufacturing facilities. These delays could be lengthy and costly. If any of our customers&#8217; facilities are adversely affected by such a disaster or event, shipments of our products could be delayed. Additionally, customers may delay purchases of our products until our operations return to normal. For example, following the earthquake and tsunami disasters in Japan in 2011, the operations of Canon Medical Systems Corporation, our largest customer, were impacted, and, as a consequence, orders to and product shipment from our business were delayed for several months. Even if our suppliers or customers are able to quickly respond to such a disaster or event, the ongoing effects of such a disaster or event could create some uncertainty in the operations of our business. In addition, our facilities may be subject to a shortage of available electrical power and other energy supplies. Any shortages may increase our costs for power and energy supplies or could result in blackouts, which could disrupt the operations of our affected facilities and harm our business. Further, our products are typically shipped from a limited number of ports, and any disaster, strike, or other event blocking shipment from these ports could delay or prevent shipments and harm our business. In addition, concerns about terrorism, the effects of a terrorist attack, political turmoil, or an outbreak of epidemic diseases could have a negative effect on our business operations, those of our suppliers and customers, and the ability to travel, resulting in adverse consequences on our revenues and financial performance.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Relating to our Intellectual Property and Information Systems</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our competitive position would be harmed if we are not able to maintain our intellectual property rights and protecting our intellectual property and defending against infringement claims can be costly.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We file applications as appropriate for patents covering new products and manufacturing processes. We cannot be sure, however, that patents will be issued from any of our pending or future patent applications. We also cannot be sure that our current patents, the claims allowed under our current patents, or patents for technologies licensed to us will be sufficiently broad to protect our technology position against competitors. We also jointly develop intellectual property with third parties and seek to protect our rights to such intellectual property through licenses and other contractual arrangements. Issued patents owned by, or licensed to, us may be challenged, invalidated, or circumvented, and the rights granted under the patents, licenses or other contractual arrangements may not provide us with competitive advantages or otherwise protect our interests. Asserting our patent rights against others in litigation or other legal proceedings is costly and diverts managerial resources. An adverse finding in patent infringement litigation could adversely impact our competitive position. In addition, we may not be able to detect patent infringement by others or may lose our competitive position in the market before we are able to do so.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We also rely on a combination of copyright, trade secret, and other laws, and contractual restrictions on disclosure, copying and transferring title (including confidentiality agreements with vendors, strategic partners, co-developers, employees, consultants, and other third parties), to protect our proprietary, and other confidential rights. These protections may prove to be inadequate, since agreements may still be breached, and we may not have adequate remedies for a breach. Our trade secrets may become known to or be independently developed by others, including as a result of misappropriation by unauthorized access to our technology systems. If our proprietary or confidential information is misappropriated, our business and financial results could be materially and adversely impacted. We have trademarks, both registered and unregistered, that are maintained and enforced to provide customer recognition for our products in the marketplace, but unauthorized parties may still use them. We also license certain patented or proprietary technologies from others. In some cases, products with substantial revenues may depend on these license rights. If we were to lose the rights to license these technologies, or our costs to license these technologies were to materially increase, our business would suffer. As we expand our manufacturing capabilities outside of the United States, more of our intellectual property may be held in jurisdictions that do not have robust intellectual property protections, which may make it harder for us to adequately protect our intellectual property.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_7">Table of Contents</a></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Third parties may claim that we are infringing upon their intellectual property, and we could suffer significant litigation or licensing expenses or be prevented from selling our products.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;There is a substantial amount of litigation over patent and other intellectual property rights in the industries in which we compete. Our competitors, like companies in many high technology businesses, continually review other companies&#8217; activities for possible conflicts with their own intellectual property rights. In addition, non-practicing entities may review our activities for conflicts with their patent rights. Determining whether a product infringes on a party&#8217;s intellectual property rights involves complex legal and factual issues, and the outcome of this type of litigation is often uncertain. Parties may claim that we are infringing upon their intellectual property rights or that we are in breach of related licensing agreements or other contractual arrangements. We may not be aware of intellectual property rights of others that relate to our products, services, or technologies. From time to time, we have received notices from parties asserting infringement, and we have been subject to lawsuits alleging infringement of patent or other intellectual property rights. Any dispute regarding patents or other intellectual property, including with respect to breaches of licensing agreements or other contractual arrangements, could be costly and time consuming and could divert our management and key personnel from our business operations. We may not prevail in a dispute. We do not maintain insurance for intellectual property infringement, so costs of defense, whether or not we are successful in defending an infringement claim, will be borne by us and could be significant. If we are unsuccessful in defending or appealing an infringement claim or claims alleging other contractual breaches, we may be subject to significant damages, and our combined financial position, results of operations, or cash flows could be materially and adversely affected. We may also be subject to injunctions against development and sale of our products, the effect of which could be to materially reduce our revenues. Furthermore, a third party claiming infringement may not be willing to license our rights to us, and even if a third-party rights holder is willing to do so, the amounts we might be required to pay under the associated royalty or license agreement could be significant. We could decide to alter our business strategy or voluntarily cease the allegedly infringing actions rather than face litigation or pay a royalty, which could materially and adversely impact our business and results of operations.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disruption of critical information systems or material breaches in the security of our systems may materially and adversely affect our business and customer relations.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Information technology (including technology from third party providers) helps us operate efficiently, interface with and support our customers, maintain financial accuracy and efficiency, and produce our financial statements. In the ordinary course of our business, we collect, process and store sensitive data, including intellectual property, proprietary business information and that of customers, suppliers and business partners, third parties accessing our website, patient data and personally identifiable information of customers and employees, in our data centers and on our networks, as well as in third party off-site data centers. Despite security measures, there is an increasing threat of information security attacks, including from computer viruses or other malicious codes, unauthorized access attempts, and cyber-attacks that pose risks to companies, including us. Because the techniques used to obtain unauthorized access, or to sabotage systems, change frequently, have become increasingly sophisticated and generally are not recognized until launched against a target, we may be unable to anticipate these techniques or to implement adequate preventative measures, which could result in data leaks or otherwise compromise our confidential or proprietary information and disrupt our operations. If we do not allocate and effectively manage the resources necessary to build and sustain the proper technology infrastructure, we could be subject to, among other things, transaction errors, processing inefficiencies, the loss of customers, business disruptions, or the loss of or damage to intellectual property through a security breach or misappropriation of intellectual property. Such security breaches could expose us to a risk of loss of information, litigation, and possible liability to employees, customers, and/or regulatory authorities. If our data management systems do not effectively collect, secure, store, process, and report relevant data for the operation of our business, whether due to equipment malfunction or constraints, software deficiencies, or human error, our ability to effectively plan, forecast, and execute our business plan and comply with applicable laws and regulations will be impaired, perhaps materially. Any such impairment could materially and adversely affect our financial condition, results of operations, cash flows, and the timeliness with which we report our operating results internally and externally.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We use certain cloud-based software. A security breach, whether of our products, of our customers&#8217; network security and systems, or of third-party hosting services could disrupt access to our customers&#8217; stored information and could lead to the loss of, damage to, or public disclosure of our customers&#8217; stored information, including patient health information. Such an event could have serious negative consequences, including possible patient injury, regulatory action, fines, penalties and damages, reduced demand for our solutions, an unwillingness of our customers to use our solutions, harm to our reputation and brand, and time-consuming and expensive litigation, any of which could have a material and adverse effect on our financial results.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Relating to Our Legal and Regulatory Environment</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in import/export regulatory regimes, tariffs, and national policies could continue to negatively impact our business.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Tariffs and changes in international trade agreements or trade-related laws and regulations may have an adverse impact on our business. As a component manufacturer, our products are integrated into the systems and products of our OEM customers. If the United States, China or other countries levy tariffs, duties or other additional taxes or restrictions on our customer&#8217;s products, the demand for such products, and our components included in such products, could decrease, which could have a material adverse effect on our business. Uncertainty over tariffs and trade wars could also cause our customers to delay or cancel orders for our products.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In the past, the United States has imposed tariffs on items imported from China and other countries that are incorporated into our products. Tariffs on items imported by us from China and other countries have increased our costs and have increased prices and lowered gross margins on some of our products, thereby having a direct adverse impact on our business and results of operations. China has imposed retaliatory tariffs that impact a number of our products, including U.S. origin X-ray tubes, heat exchange units, and certain flat panel detectors. The tariffs levied by China have increased our customers&#8217; costs for products imported into China, which has caused us to make price concessions on some products and has caused some customers to stop purchasing our products. We expect that tariffs will continue to have a negative effect on our business and results of operations, including the possibility of continued price concessions or loss of business. Tariffs could limit our ability to compete for increased market share in China, which could cause our long-term prospects in China to suffer. In addition, future tariffs could have a more significant impact on our business. The imposition of additional tariffs by the United States could result in the adoption of additional tariffs by China and other countries, as well as further retaliatory actions by any affected country, which could negatively impact the global market for imaging equipment and could have a significant adverse effect on our business.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In addition to tariffs, China&#8217;s stated policy of reducing its dependence on foreign manufacturers and technology companies may result in reduced demand for our products in China. Both the United States and China could pursue policies to reduce their dependence on foreign goods, which could have a material adverse impact on our business, results of operations and financial position. In addition, as a consequence of such policies, there are risks that the Chinese government may, among other things, require the use of local suppliers, compel companies that do business in China to partner with local companies to conduct business, or provide incentives to government-backed local customers to buy from local suppliers rather than companies like ours, all of which could adversely impact our business, results of operations and financial position.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Increasing tensions between China and Taiwan may cause the United States and/or China to impose higher tariffs, commence trade wars, move more quickly to reduce their dependence on each other&#8217;s goods, or enact boycotts against each other&#8217;s goods, this could cause significant disruptions in the markets and industries we serve, our supply chain, decrease demand from customers for the ultimate products using our solutions, and would materially harm our business, financial condition and results of operations.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">A change in the percentage of our total earnings from international sales or additional changes in tax laws could increase our effective tax rate.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our effective tax rate is impacted by tax laws in both the United States and in foreign countries. Earnings from our international subsidiaries are generally taxed at rates that differ from U.S. rates. A change in the percentage of our total earnings from our international subsidiaries, a change in the mix of particular tax jurisdictions between our international subsidiaries, or a change in currency exchange rates could cause our effective tax rate to increase. Furthermore, while U.S. tax reform imposed a current tax on cumulative undistributed earnings, these earnings could also become subject to incremental foreign withholding or U.S. state taxes should they actually be remitted to the United States, in which case our financial results could be materially and adversely affected.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Statutory changes included in proposed U.S. legislation, if passed, including interpretive guidance, could have a material impact on income tax expense, the effective tax rate, or the value of deferred tax assets and liabilities. Changes in the valuation of our deferred tax assets or liabilities, additional changes in tax laws or rates, changes in the interpretation of tax laws in other jurisdictions, or other changes beyond our control could materially and adversely affect our financial position and results of operations.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We have entities in certain jurisdictions with cumulative net operating losses for which no income tax benefit can be recorded due to full valuation allowance positions. There could be additional future losses in these and other jurisdictions that would negatively impact our effective tax rate.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Compliance with foreign laws and regulations applicable to the marketing, manufacturing, and distribution of our products may be costly, and failure to comply may result unfavorable legal proceedings, in significant penalties and other harm to our business.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Regulatory requirements affecting our operations and sales outside the United States vary from country to country, often differing significantly from those in the United States. In general, outside the United States, some of our products are regulated as medical devices by foreign governmental agencies similar to the FDA.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For us to market our products internationally, we must obtain clearances or approvals for products and product modifications. These processes (including, for example, the processes in the EU, the European Economic Area (&#8220;EEA&#8221;), Switzerland, Brazil, Australia, China, Japan and Canada) can be time consuming, expensive and uncertain, which can delay our ability to market products in those countries. Delays in the receipt of or failure to receive regulatory approvals, the inclusion of significant limitations on the indicated uses of a product, the loss of previously obtained approvals or failure to comply with existing or future regulatory requirements could restrict or prevent us from doing business in a country or subject us to a variety of enforcement actions and civil or criminal penalties, which would materially and adversely affect our business. In addition, compliance with changing regulatory schemes may add additional complexity, cost and delays in marketing or selling our products.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Within the EU/EEA, we must obtain, and in turn affix, a CE mark certification, which is a European marking of conformity that indicates that a product meets the essential requirements of the EU's Medical Device Directive (&#8220;MDD&#8221;) and the EU Medical Device Regulations. Compliance with the MDD is done through a self-certification process that is then verified by an independent certification body called a &#8220;Notified Body,&#8221; which is an organization empowered by the legislature to conduct this verification. Once the CE mark is affixed, the Notified Body will regularly audit us to ensure that we remain in compliance with the applicable European laws and MDD. By affixing the CE mark to our product, we are certifying that our products comply with the laws and regulations required by the EU/EEA countries, thereby allowing the free movement of our products within these countries and others that accept CE mark standards. If we cannot support our performance claims and demonstrate compliance with the applicable European laws and the MDD, we would lose our right to affix the CE mark to our products, which would prevent us from selling our products within the EU/EEA/Switzerland territory and in other countries that recognize the CE mark. In April 2017, the European Commission adopted two regulations on medical devices that impose stricter requirements for placing medical devices in the EU market, as well as for Notified Bodies. These regulations have resulted in the limited availability of recognized Notified Bodies, which could delay our ability to obtain CE marks. We may be subject to risks associated with additional testing, modification, certification, or amendment of our existing market authorizations, or we may be required to modify products already installed at our customers&#8217; facilities to comply with the official interpretations of these revised regulations.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We are also subject to international laws and regulations of general applicability relating to matters such as environmental protection, safe working conditions, and manufacturing practices, as well as others.&#160;These are often comparable to, if not more stringent than, the equivalent regulations in the United States.&#160;Sales overseas are also affected by regulation of matters such as product standards, packaging, labeling, environmental and product recycling requirements, import and export restrictions, tariffs, duties, and taxes.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In addition, we are required to timely file various reports with international regulatory authorities similar to the reports we are required to timely file with U.S. regulatory authorities, including reports required by international adverse event reporting regulations. If these reports are not timely filed, regulators may impose sanctions, including temporarily suspending our market authorizations or CE mark, and sales of our products may suffer.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Further, as we enter new businesses or pursue new business opportunities internationally, or as regulatory schemes change, we may become subject to additional laws, rules, and regulations. Becoming familiar with and implementing the infrastructure necessary to comply with these laws, rules, and regulations is costly. Additionally, in some countries, we rely or may rely in the future on foreign distributors and agents to assist in complying with foreign regulatory requirements, and we cannot be sure that they will always do so. The failure of us or our agents to comply with these laws, rules, and regulations could delay the introduction of new products, cause reputational harm, or result in investigations, fines, injunctions, civil penalties, criminal prosecution, or an inability to sell our products in or to import our products into certain countries, which could materially and adversely affect our business.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Compliance with U.S. laws and regulations applicable to the marketing, manufacturing, and distribution of our products may be costly, and failure or delays in obtaining regulatory clearances or approvals or failure to comply with applicable laws and regulations could prevent us from distributing our products, require us to recall our products, or result in unfavorable legal proceedings, significant penalties or other harm to our business.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Some of our products and those of OEMs that incorporate our products are subject to extensive and rigorous government regulation in the United States. Compliance with these laws and regulations is expensive and time-consuming, and failure to comply with these laws and regulations could materially and adversely affect our business.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Generally, our manufacturing operations for medical devices, and those of our third-party manufacturers, are required to comply with the Quality System Regulations (&#8220;QSR&#8221;) of the FDA, as well as other federal and state regulations for medical devices and radiation-emitting products. The FDA, through authorized auditing organizations, makes announced and unannounced periodic and on-going inspections of medical device manufacturers to determine compliance with QSR and, in connection with these inspections, issues reports known as Form FDA 483 reports when the FDA believes the manufacturer has failed to comply with applicable regulations and/or procedures. If Form FDA 483 reports are not addressed or corrective action is not taken in a timely manner and to the FDA&#8217;s satisfaction, the FDA may issue a warning letter or proceed directly to an enforcement action. Failure to respond in a timely manner to a warning letter, or any other notice of noncompliance and to promptly come into compliance could result in the FDA bringing an enforcement action, which could include the total shutdown of our production facilities, denial of importation rights to the United States for products manufactured in overseas locations, adverse publicity, and criminal and civil fines. The expense and costs of any corrective actions that we may take, which may include product recalls, correction and removal of products from customer sites, or changes to our product manufacturing and quality systems, could materially and adversely impact our financial results and may also divert management resources, attention, and time. Additionally, if a warning letter were issued, customers could delay purchasing decisions or cancel orders, and we could face increased pressure from our competitors, who could use the warning letter against us in competitive sales situations, either of which could materially and adversely affect our reputation, business, and stock price.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In addition, we are required to timely file various reports with the FDA, including reports required by the medical device reporting regulations (&#8220;MDRs&#8221;), that require we report to regulatory authorities if our devices may have caused or contributed to a death or serious injury, or malfunctioned in a way that would likely cause or contribute to a death or serious injury if the malfunction were to recur. If we initiate a correction or removal of a device to reduce a risk to health posed by the device, we would be required to submit a publicly-available correction and removal report to the FDA and, in many cases, similar reports to other regulatory agencies. This report could be classified by the FDA as a device recall, which could lead to increased scrutiny by the FDA, other international regulatory agencies, and our customers regarding the quality and safety of our devices. If these MDRs or correction and removal reports are not filed on a timely basis, regulators may impose sanctions, sales of our products may suffer, and we may be subject to product liability or regulatory enforcement actions, all of which could harm our business.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Government regulation may also cause significant delays or even prevent the marketing and full commercialization of future products or services that we may develop and/or may impose costly requirements on our business. Further, as we enter new businesses or pursue new business opportunities, we will become subject to additional laws, rules, and regulations, including FDA and foreign rules and regulations. Becoming familiar with and implementing the infrastructure necessary to comply with these laws, rules, and regulations is costly and time consuming. In addition, failure to comply with these laws, rules and regulations could delay the introduction of new products and could materially and adversely affect our business.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;If we or any of our suppliers, distributors, agents, or customers fail to comply with FDA, Federal Trade Commission, or other applicable U.S. regulatory requirements or are perceived to have failed to comply with regulations, we may face:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">adverse publicity affecting both us and our customers;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increased pressures from competitors;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">investigations by governmental authorities;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">fines, injunctions, civil penalties, and criminal prosecution;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">partial suspension or total shutdown of production facilities or the imposition of operating restrictions;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increased difficulty in obtaining required clearances or approvals or losses of clearances or approvals already granted;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">seizures or recalls of our products or those of our customers;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">delays in purchasing decisions by customers or cancellation of existing orders;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the inability to sell our products; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">difficulty in obtaining product liability or operating insurance at a reasonable cost, or at all.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We are also subject to federal and state laws and regulations of general applicability relating to matters such as environmental protection, safe working conditions, manufacturing practices, and other matters.&#160;Insurance coverage is not commercially available for violations of law, including the fines, penalties, or investigatory costs that we may incur as the consequence of regulatory violations. Consequently, we do not have insurance that would cover this type of liability.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_7">Table of Contents</a></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We sell certain X-ray tube products as replacements which are subject to medical device certification and product registration laws and regulations, which vary by country and are subject to change, and we may be unable to receive registration approval or renewal of existing registrations if we fail to meet regulatory approval requirements or if the approval process becomes commercially infeasible or impractical.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We market and distribute certain X-ray tubes through distributors and third-party/multi-vendor service organizations that are used as equivalent replacements for specific OEM tubes. We are subject to medical device certification and product registration laws, which vary by country and are subject to periodic reviews and changes by regulatory authorities in those countries. For example, to sell X-ray tubes for replacement applications in China, product registrations must be approved by the new National Medical Products Administration (&#8220;NMPA&#8221;). We must comply with the requirements of the NMPA, and we may not be able to receive registration approval or renewal of existing registrations if we fail to meet regulatory approval requirements or if the process of gaining approval becomes commercially infeasible or impractical. Certain of these local laws and regulations have the effect of serving as a barrier to trade and can be difficult to navigate predictably.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In addition, certain countries in which our products are sold require products to undergo re-registration if the product is altered in any significant way.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;These registration processes can be costly and time consuming, and customers may decide to purchase products from our competitors that do not have to be involved in a re-registration process. In addition, our inability to receive or renew product registrations may prevent us from marketing and/or distributing those particular products for replacement applications in the specific country.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Existing and future healthcare reforms, and changes to reimbursement rates, may indirectly have a material adverse effect on our business and results of operations.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Sales of our products to OEMs in the medical sector indirectly depend on whether adequate reimbursement is available for our customers&#8217; products from a variety of sources, such as government healthcare insurance programs, including U.S. Medicare and Medicaid programs, foreign government programs, private insurance plans, health maintenance organizations, and preferred provider organizations. Without adequate reimbursement, the demand for our customers&#8217; products, and therefore indirectly our products, may be limited.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Healthcare reform proposals and medical cost containment measures in the United States and in many foreign countries could limit the use of both ours and our customers&#8217; products, reduce reimbursement available for such use, further tax the sale or use of our products, and further increase the administrative and financial burden of compliance. These reforms and measures, including the uncertainty in the medical community regarding their nature and effect, could have a material and adverse effect on us and our customers&#8217; purchasing decisions regarding our products and treatments and could harm our business, results of operations, financial condition, and prospects. We cannot predict the specific healthcare programs and regulations that will be ultimately implemented by local, regional, and national governments globally. However, any changes that lower reimbursements for us or our customers&#8217; products and/or procedures using these products, including, for example, existing reimbursement incentives to convert from analog to digital X-ray systems, or changes that reduce medical procedure volumes or increase cost containment pressures on us or others in the healthcare sector could materially and adversely affect our business and results of operations.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to federal, state, and foreign laws governing our business practices which, if violated, could result in substantial penalties. Additionally, challenges to or investigations into our practices could cause adverse publicity and be costly to respond to and thus could harm our business.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Anti-corruption laws and regulations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We are subject to the U.S. Foreign Corrupt Practices Act and anti-corruption laws, as well as similar laws in foreign countries, such as the U.K. Bribery Act. In general, there is a worldwide trend to strengthen anti-corruption laws and their enforcement, and the healthcare industry and medical equipment manufacturers have been particular targets of these investigation and enforcement efforts. Any violation of these laws by us or our agents or distributors could create substantial liability for us, subject our officers and directors to personal liability, and cause a loss of reputation in the market. We operate in many countries, including India and China, where the public sector is perceived as being corrupt. Our strategic business plans include expanding our business in regions and countries that are rated as higher risk for corruption activity by Transparency International e.V., an international non-profit that publishes an annual corruption perception index. Becoming familiar with and implementing the infrastructure necessary to comply with laws, rules, and regulations applicable to new business activities and mitigating and protecting against corruption risks could be costly. Failure by us or our agents or distributors to comply with these laws, rules, and regulations could delay our expansion into high-growth markets and could materially and adversely affect our business. We will likely do more business, directly and potentially indirectly, in countries where the public sector is perceived to be corrupt. Increased business in higher-risk countries could subject us and our officers and directors to increased scrutiny and increased liability from our business operations.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Competition and trade compliance laws</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We are subject to various competition and trade compliance laws in the jurisdictions where we operate. Regulatory authorities in those jurisdictions may have the power to subject us to sanctions and impose changes or conditions in the way we conduct our business. An increasing number of jurisdictions provide private rights of action for competitors or consumers to assert claims of anti-competitive conduct and seek damages. Increased government scrutiny of our actions or enforcement or private rights of action could materially and adversely affect our business or damage our reputation. We may be required to conduct internal investigations or face audits or investigations by one or more domestic or foreign government agencies, which could be costly and time consuming and could divert our management and key personnel from our business operations. An adverse outcome under any such investigation or audit could subject us to fines and criminal or other penalties, which could materially and adversely affect our business and financial results. Furthermore, competition laws may prohibit or increase the cost of future acquisitions that we may desire to undertake.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Laws and ethical rules governing interactions with healthcare providers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We do not generally sell our products directly to healthcare providers, but may occasionally sell our products to healthcare providers through distributors or otherwise engage healthcare providers to provide services. The U.S. Medicare and Medicaid &#8220;anti-kickback&#8221; laws, and similar state laws, prohibit payments or other remuneration that is intended to induce hospitals, physicians, or others either to refer patients or to purchase, lease, or order, or to arrange for or recommend the purchase, lease, or order of healthcare products or services for which payment may be made under federal and state healthcare programs, such as Medicare and Medicaid. These laws affect our sales, marketing, and other promotional activities by limiting the kinds of financial arrangements we may have with hospitals, physicians, or other potential purchasers of our products. They particularly impact how we structure our sales offerings, including discount practices, customer support, education and training programs, physician consulting, research grants, and other fee-for-service arrangements. These laws are broadly written, and it is often difficult to determine precisely how these laws will be applied to specific circumstances.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Federal and state &#8220;false claims&#8221; laws generally prohibit knowingly presenting, or causing to be presented, claims for payment from Medicare, Medicaid, or other government payors that are false or fraudulent, or for items or services that were not provided as claimed. Although we do not submit claims directly to payors, manufacturers can be, and have been, held liable under these laws if they are deemed to &#8220;cause&#8221; the submission of false or fraudulent claims by providing inaccurate billing or coding information to customers or through certain other activities, including promoting products for uses not approved or cleared by the FDA, which is called off-label promotion. Violating &#8220;anti-kickback&#8221; and &#8220;false claims&#8221; laws can result in civil and criminal penalties, which can be substantial, as well as potential mandatory or discretionary exclusion from healthcare programs for noncompliance. Even an unsuccessful challenge or investigation into our practices could cause adverse publicity and be costly to defend and thus could harm our business and results of operations. Additionally, several recently-enacted state and federal laws, including laws in Massachusetts and Vermont, and the federal Physician Payment Sunshine Act, now require, among other things, extensive tracking and maintenance of databases regarding the disclosure of equity ownership and payments to physicians, healthcare providers, and hospitals.&#160;These laws may require us to implement the necessary and costly infrastructure to track and report certain payments to healthcare providers.&#160;Failure to comply with these tracking and reporting laws could subject us to significant civil monetary penalties.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Laws.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> From time to time, new laws or regulations may be adopted and compliance with these laws or regulations could be costly or time consuming. For example, in July 2021, the U.S. government passed the Uyghur Forced Labor Prevention Act (the &#8220;UFLPA&#8221;), which imposes importation limits on goods produced using forced labor in China, especially the Xinjiang Uyghur Autonomous Region, and imposes related sanctions. Guidance related to compliance with the UFLPA has not yet been issued, and we cannot yet evaluate the impact that compliance with the UFLPA will have on our business or financial condition.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We are subject to other laws in foreign countries where we conduct business. For example, within the EU, the control of unlawful marketing activities is a matter of national law in each of the member states. The member states of the EU closely monitor perceived unlawful marketing activity by companies. We could face civil, criminal, and administrative sanctions if any member state determines that we have breached our obligations under such state&#8217;s national laws. Industry associations also closely monitor the activities of member companies. If these organizations or authorities name us as having breached our obligations under their regulations, rules, or standards, our reputation would suffer, and our business and financial condition could be materially and adversely affected.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_7">Table of Contents</a></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Certain of our products are subject to regulations relating to use of radioactive material, compliance with which may be costly, and a failure to comply with these regulations may materially and adversely affect our business.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As a manufacturer and seller of medical devices and devices emitting radiation or utilizing radioactive by-product material, we and some of our suppliers and distributors are subject to extensive regulation by United States governmental authorities, such as the FDA, the Nuclear Regulatory Commission (&#8220;NRC&#8221;), and state and local regulatory agencies, which is intended to ensure the devices are safe and effective and comply with laws governing products which emit, produce, or control radiation. These regulations govern, among other things, the design, development, testing, manufacturing, packaging, labeling, distribution, import/export, sale, marketing, and disposal of our products. We are also subject to international laws and regulations that apply to manufacturers of radiation-emitting devices and products utilizing radioactive materials. These are often comparable to, if not more stringent than, the equivalent regulations in the United States.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our industrial and medical devices utilizing radioactive material are subject to NRC clearance and approval requirements, and the manufacture and sale of these products are subject to extensive federal and state regulation that varies from state to state and among regions. Our manufacture, distribution, installation, service, and removal of industrial devices utilizing radioactive material or emitting radiation also requires us to obtain a number of licenses and certifications for these devices and materials. Service of these products must also be performed in accordance with a specific radioactive materials licenses. Obtaining licenses and certifications may be time consuming, expensive, and uncertain.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The handling and disposal of radioactive materials resulting from the manufacture, use, or disposal of our products may impose significant costs and requirements. Disposal sites for the lawful disposal of materials generated by the manufacture, use, or decommissioning of our products may no longer accept these substances in the future or may accept them on unfavorable terms.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are unable to obtain required FDA clearances or approvals for a product or are unduly delayed in doing so, or the uses of that product are limited, our business could suffer.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Typically, our OEM customers are responsible for obtaining 510(k) pre-market notification clearance on their systems that integrate our products. A substantial majority of our products are &#8220;Class I&#8221; devices that do not require 510(k) clearance, but we do produce software that is classified as a Class II device subject to 510(k) clearance. Unless an exception applies, we may be required by FDA regulations to obtain a 510(k) pre-market notification clearance in connection with the manufacture of a new medical device or a new indication for use of, or other significant change in, an existing currently marketed medical device before we can market or sell those products in the United States. Modifications or enhancements to a product that could significantly affect its safety or effectiveness, or that would constitute a major change in the intended use of the device, technology, materials, labeling, packaging, or manufacturing process also require a new 510(k) clearance. Although manufacturers make the initial determination whether a change to a cleared device requires a new 510(k) clearance, we cannot ensure that the FDA will agree with our decisions not to seek additional approvals or clearances for particular modifications to our products or that we will be successful in obtaining new 510(k) clearances for modifications. Obtaining clearances or approvals is time consuming, expensive, and uncertain. We may not be able to obtain the necessary clearances or approvals or may be unduly delayed in doing so, which could harm our business. Furthermore, even if we are granted regulatory clearances or approvals, they may include significant limitations on the indicated uses of the product, which may limit the market for the product. If we are unable to obtain required FDA clearance or approval for a product or are unduly delayed in doing so, or the uses of that product were limited, our business could suffer.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Initiation of legal proceedings, defense against legal proceedings, and unfavorable results of legal proceedings could materially and adversely affect our financial results.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;From time to time, we are a party to or otherwise involved in legal proceedings, claims, government inspections, audits or investigations, and other legal matters, both inside and outside the United States, arising in the ordinary course of our business or otherwise. Legal proceedings are often lengthy, taking place over a period of years with interim motions or judgments subject to multiple levels of review (such as appeals or rehearings) before the outcome is final. Litigation and other legal proceedings, claims, government inspections, audits and investigations are subject to significant uncertainty and may be expensive, time consuming, and disruptive to our operations. For these and other reasons, we may choose to settle legal proceedings and claims, regardless of their actual merit.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;If a legal proceeding were ultimately resolved against us, it could result in significant compensatory damages, and, in certain circumstances, punitive damages, disgorgement of revenue or profits, remedial corporate measures, or injunctive relief imposed on us and, in certain cases, potential civil or criminal action, including against our employees, officers or directors, for which we may be required to, or we may elect to, provide indemnification. If our existing insurance does not cover the amount or types of damages awarded, or if other resolution or actions taken as a result of such legal proceeding were to restrain our ability to market one or more of our material products or services, or if we were required to, or elected to, indemnify an employee, officer or director, our combined financial position, results of operations, or cash flows could be materially and adversely affected. In addition, legal proceedings, and any adverse resolution thereof, can result in adverse publicity and damage to our reputation, which could materially and adversely impact our business.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Environmental laws impose compliance costs on our business and may also result in liability.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We are subject to environmental laws around the world.&#160;These laws regulate many aspects of our operations, including our handling, storage, transport, and disposal of hazardous substances, such as the chemicals and materials that we use in the course of our manufacturing operations. They can also impose cleanup liabilities, including with respect to discontinued operations. As a consequence, we can incur significant environmental costs and liabilities, some recurring and others not recurring. Although we follow procedures intended to comply with existing environmental laws, we, like other businesses, may mishandle or inadequately manage hazardous substances used in our manufacturing operations and can never completely eliminate the risk of contamination or injury from certain materials that we use in our business and, therefore, we cannot completely eliminate the prospect of resulting claims and damage payments.&#160;We may also be assessed fines and/or other penalties for failure to comply with environmental laws and regulations.&#160;Insurance has provided coverage for portions of cleanup costs resulting from historical occurrences, but we do not expect to maintain insurance coverage for costs or claims that might result from any future contamination.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Pursuant to the Separation and Distribution Agreement we entered into with Varian when we spun off from Varian, we are obligated to indemnify Varian for 20% of the cleanup liabilities related to prior corporate restructuring activities while a division of Varian. This includes facilities sold as part of Varian&#8217;s electron devices business in 1995 and thin film systems business in 1997. The U.S. Environmental Protection Agency (&#8220;EPA&#8221;) or third parties have named Varian as a potentially responsible party under the amended Comprehensive Environmental Response Compensation and Liability Act of 1980 (&#8220;CERCLA&#8221;), at sites to which Varian or the facilities of the businesses sold in 1995 and 1997 were alleged to have shipped waste for recycling or disposal (the &#8220;CERCLA sites&#8221;). We anticipate that we will be obligated to reimburse Varian for 20% of the liabilities of Varian related to these CERCLA sites (after adjusting for any insurance proceeds or tax benefits received by Varian). In connection with the CERCLA sites, to date Varian has been required to pay only a small portion of the total cleanup costs and we currently anticipate that any reimbursement to Varian in the future will not be material. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Future changes in environmental laws could also increase our costs of doing business, perhaps significantly. Several countries, including some in the EU, now require medical equipment manufacturers to bear certain disposal costs of products at the end of the product&#8217;s useful life, thereby increasing its costs. The EU has also adopted directives that may lead to restrictions on the use of certain hazardous substances or other regulated substances in some of our products sold there. These directives, along with another that requires substance information to be provided upon request, could increase our operating costs in order to maintain our access to certain markets. All of these costs, and any future violations or liabilities under environmental laws or regulations, could have a material adverse effect on our business.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Failure to maintain effective internal controls and procedures could negatively impact us.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We must, among other things, maintain effective internal controls and procedures for financial reporting and disclosure purposes. In the past, we have not always been successful in maintaining effective internal controls and procedures. Internal control over financial reporting is complex and may be revised over time to adapt to changes in our business or changes in applicable accounting rules. We cannot assure that our internal control over financial reporting will be effective in the future or that material weaknesses will not be discovered with respect to a prior period for which we had previously believed that internal controls were effective. If our internal controls and procedures are not effective, our financial statements may not accurately reflect the results of our business and operations. In addition, there could also be a negative reaction in the financial markets due to a loss of investor confidence in us and the reliability of our financial statements, which could affect our stock price.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Relating to Our Indebtedness</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have significant debt obligations that could adversely affect our business, profitability, liquidity, and ability to meet our obligations.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of December&#160;30, 2022, our total combined indebtedness was approximately $449.7 million. The borrowings under our Convertible Senior Unsecured Notes due 2025 (the &#8220;Convertible Notes&#8221;) bear interest at a fixed rate of 4.00% and borrowings under our Senior Secured Notes due 2027 (the &#8220;Senior Secured Notes&#8221;) bear interest at a fixed rate of 7.875%. For more information regarding our borrowings, see Note 10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Borrowings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the Notes to the Condensed Consolidated Financial Statements of this report.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our debt could potentially have important consequences to us and our investors, including:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">limiting our flexibility in planning for, or reacting to, changes in our business and the industry;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">limiting our ability to borrow additional funds as needed or increasing the costs of any such borrowing;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">making it more difficult for us to satisfy our obligations, including our debt obligations;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increasing our vulnerability to adverse economic and general industry conditions, including interest rate fluctuations, because a portion of our borrowings are and will continue to be at variable rates of interest;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">requiring us to dedicate a substantial portion of our cash flow from operations to payments on our debt, which would reduce the availability of our cash flow from operations to fund working capital, capital expenditures or other general corporate purposes;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">placing us at a disadvantage compared to competitors that may have proportionately less debt; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">limiting our ability to obtain additional debt or equity financing due to applicable financial and restrictive covenants in our debt agreements.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;If our cash requirements in the future are greater than expected, our cash flow from operations may not be sufficient to repay all of the outstanding debt as it becomes due, and we may not be able to borrow money, sell assets, or otherwise raise funds on acceptable terms, or at all, to refinance our debt. For example, holders of the Convertible Notes will have the right to require us to repurchase all or a portion of the Convertible Notes on the occurrence of a fundamental change at a repurchase price equal to 100% of the principal amount of the Convertible Notes to be repurchased, plus accrued and unpaid interest, if any, to, but excluding, the fundamental change repurchase date. Further, if a make-whole fundamental change as defined in the indenture governing the Convertible Notes occurs prior to the maturity date of the Convertible Notes, we will in some cases be required to increase the conversion rate for a holder that elects to convert its Convertible Notes in connection with such make-whole fundamental change. Unless we elect to deliver solely shares of common stock to settle a conversion of the Convertible Notes (other than paying cash in lieu of delivering any fractional share), we will be required to make cash payments for those Convertible Notes being converted. However, we may not have enough available cash or be able to obtain financing at the time we are required to make such repurchases of the Convertible Notes surrendered or pay cash with respect to the Convertible Notes being converted.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Despite our substantial indebtedness, we may still be able to incur significantly more debt. This could intensify the risks described above.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We and our subsidiaries may be able to incur substantial indebtedness in the future. As of December&#160;30, 2022, we had approximately $100&#160;million of additional available borrowing capacity (subject to borrowing base availability) under the revolving credit agreement that we entered into on September 30, 2020 (the &#8220;Asset-Based Loan,&#8221; or "ABL Facility"). In addition to any amounts that might be available to us for borrowing under the ABL Facility, subject to certain conditions, we will have the right to request an increase of aggregate commitments under the ABL Facility by an aggregate amount of up to $75&#160;million by obtaining additional commitments either from one or more of the lenders under the ABL Facility or other lending institutions.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Although the ABL Facility and the indenture governing our Senior Secured Notes contain restrictions on our and our subsidiaries&#8217; ability to incur additional indebtedness, these restrictions are subject to a number of important qualifications and exceptions, and the indebtedness incurred in compliance with these restrictions could be substantial. Furthermore, the covenants in the indenture governing our Convertible Notes do not restrict the incurrence of indebtedness by us or any of our subsidiaries, and the covenants that may be contained in any future debt instruments could allow us to incur a significant amount of additional indebtedness.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The more leveraged we become, the more we, and in turn holders of our notes, will be exposed to certain risks described above under &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risks Relating to Our Indebtedness&#8212;We have significant debt obligations that could adversely affect our business, profitability and ability to meet our obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#8221;</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The ABL Facility and the indenture governing our Senior Secured Notes impose significant operating and financial restrictions that may limit our current and future operating flexibility, particularly our ability to respond to changes in the economy or our industry or to take certain actions, which could harm our long-term interests and may limit our ability to make payments on the notes.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our ABL Facility and the indenture governing our Senior Secured Notes impose significant operational and financial restrictions on us that include, but are not limited to our ability to:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">incur, assume or permit to exist additional indebtedness (including guarantees thereof);</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pay dividends or certain other distributions on our capital stock or repurchase our capital stock or prepay subordinated indebtedness;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">prepay, redeem or repurchase certain debt;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">issue certain preferred stock or similar equity securities;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">incur liens on assets;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">make certain loans, investments or other restricted payments;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">allow to exist certain restrictions on the ability of our restricted subsidiaries to pay dividends or make other payments to us;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">engage in transactions with affiliates;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">alter the business that we conduct; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">sell certain assets or merge or consolidate with or into other companies. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As a result of these restrictions, we may be:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">limited in how we conduct our business;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">unable to raise additional debt or equity financing to operate during general economic or business downturns; or</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">unable to compete effectively or to take advantage of new business opportunities.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;A breach of the covenants under the indenture governing our Senior Secured Notes or the ABL Facility could result in an event of default under the applicable indebtedness. Such a default, if not cured or waived, may allow the creditors to accelerate the related debt and may result in the acceleration of any other debt that is subject to an applicable cross-acceleration or cross-default provision. In addition, an event of default under the ABL Facility would permit the lenders under the ABL Facility to terminate all commitments to extend further credit under the ABL Facility. Furthermore, if we were unable to repay the amounts due and payable under the ABL Facility, those lenders could proceed against the collateral securing such indebtedness. In the event our lenders or holders of the notes accelerate the repayment of our borrowings, we and our subsidiaries may not have sufficient assets to repay that indebtedness.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our ability to continue to have the necessary liquidity to operate our business may be adversely impacted by a number of factors, including uncertain conditions in the credit and financial markets, which could limit the availability and increase the cost of financing. A deterioration of our results of operations and cash flow resulting from decreases in consumer spending, could, among other things, impact our ability to comply with the fixed charge coverage ratio contained in our ABL Facility.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our historical sources of liquidity to fund ongoing cash requirements include cash flows from operations, cash and cash equivalents, borrowings through our previous credit facility and convertible debt offerings. The sufficiency and availability of credit may be adversely affected by a variety of factors, including, without limitation, the tightening of the credit markets, including lending by financial institutions who are sources of credit for our borrowing and liquidity; an increase in the cost of capital; the reduced availability of credit; our ability to execute our strategy; the level of our cash flows, which will be impacted by customer demand for our products; compliance with a fixed charge coverage ratio that is included in our ABL Facility; interest rate fluctuations and the adverse impact of the COVID-19 outbreak on the U.S. and world-wide economies and on our business. We cannot predict the future level of interest rates or the effect of any increase in interest rates on the availability or aggregate cost of our borrowings. We cannot be certain that any additional required financing, whether debt or equity, will be available in amounts needed or on terms acceptable to us, if at all.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The ABL Facility contains a minimum Fixed Charge Coverage Ratio of 1.00 to 1.00 that is tested when excess availability under the ABL is less than the greater of (i) 10.0% of the Loan Cap (the lesser of (a) the aggregate commitments under the ABL Facility and (b) the aggregate borrowing base) and (ii) $7.5&#160;million. If we have to borrow in excess of 10.0% of the Loan Cap and $7.5&#160;million, and we do not increase our earnings, we also would be at risk of not being in compliance with the ABL Facility&#8217;s fixed charge coverage ratio. Compliance with the fixed charge coverage ratio is dependent on the results of our operations, which are subject to a number of factors including current economic conditions. Adverse developments in the economy, including as a result of a number of events described in these Risk Factors, in the past have led and in the future could lead to reduced spending by our customers and end-users which could adversely impact our net sales and cash flow, which could affect our ability to comply with the fixed charge coverage ratio. In addition, the ABL Facility contains other affirmative and negative covenants that restrict our operating and financing activities. These provisions may limit our ability to, among other things, incur future indebtedness, contingent obligations or liens, guarantee indebtedness, make certain investments and capital expenditures, sell stock or assets, pay dividends and consummate certain mergers or acquisitions. Failure to comply with the fixed charge coverage ratio and other covenants, including the requirement to timely deliver financial statements within applicable grace periods, could result in an event of default. Upon an event of default, if the ABL Facility is not amended or the event of default is not waived, the lender could declare all amounts then outstanding, together with accrued interest, to be immediately due and payable. If this happens, we may not be able to make those payments or borrow sufficient funds from alternative sources to make those payments. Even if we were to obtain additional financing, that financing may be on unfavorable terms.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not be able to generate sufficient cash to service all of our indebtedness, and may be forced to take other actions to satisfy our obligations under our indebtedness, which may not be successful.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;If our cash flows and capital resources are insufficient to fund our debt service obligations, we may be forced to reduce or delay investments and capital expenditures, or to sell assets, seek additional capital or restructure or refinance our indebtedness, including the notes. These alternative measures may not be successful and may not permit us to meet our scheduled debt service obligations. If our operating results and available cash are insufficient to meet our debt service obligations, we could face substantial liquidity problems and might be required to dispose of material assets or operations to meet our debt service and other obligations. We may not be able to consummate those dispositions or to obtain the proceeds that we could realize from them, and these proceeds may not be adequate to meet any debt service obligations then due. Any future refinancing of our indebtedness could be at higher interest rates and may require us to comply with more onerous covenants which could further restrict our business operations. Additionally, the indentures relating to our notes limit the use of the proceeds from any disposition of our assets. As a result, the indentures may prevent us from using the proceeds from such dispositions to satisfy our debt service obligations.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our credit rating and ability to access well-functioning capital markets are important to our ability to secure future debt financing on acceptable terms. Our credit ratings may not reflect all risks associated with an investment in our secured notes.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our access to the debt markets and the terms of such access depend on multiple factors including the condition of the debt capital markets, our operating performance and our credit ratings. These ratings are based on a number of factors including an assessment of our financial strength and financial policies. Our borrowing costs will be dependent to some extent on the rating assigned to our debt. However, there can be no assurance that any particular rating assigned to us will remain in effect for any given period of time or that a rating will not be changed or withdrawn by a rating agency if, in that rating agency&#8217;s judgment, future circumstances relating to the basis of the rating so warrant. Incurrence of additional debt by us could adversely affect our credit rating. Any disruptions or turmoil in the capital markets or any downgrade of our credit rating could adversely affect our cost of funds, liquidity, competitive position and access to capital markets, which could materially and adversely affect our business operations, financial condition and results of operations. In addition, downgrading the credit rating of our debt securities or placing us on a watch list for possible future downgrading would likely have an adverse effect on the market price of our securities.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_7">Table of Contents</a></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We entered into certain hedging positions that may affect the value of the Convertible Notes and the volatility and value of our common stock.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In connection with the issuance of the Convertible Notes, we entered into certain convertible note hedge transactions. These hedge transactions are expected generally to reduce potential dilution of our common stock on any conversion of the Convertible Notes or offset any cash payments we are required to make in excess of the principal amount of such converted Convertible Notes, as the case may be, with such reduction or offset subject to a cap. The counterparties to these hedging positions or their respective affiliates may modify their hedge positions by entering into or unwinding various derivatives with respect to our common stock or purchasing or selling our common stock in secondary market transactions prior to the maturity of the Convertible Notes (and are likely to do so during any observation period related to a conversion of Convertible Notes or following any repurchase of Convertible Notes by us on any fundamental change repurchase date or otherwise). This activity could cause or avoid an increase or a decrease in the market price of our common stock or the Convertible Notes. In addition, if any such hedging positions fail to become effective, the counterparties to these hedging positions or their respective affiliates may unwind their hedge positions, which could adversely affect the value of our common stock.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Relating to Our Common Stock</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The trading price of our common stock may decline or fluctuate significantly and fluctuations in our operating results, including quarterly revenues, and margins, may cause our stock price to be volatile, which could cause losses for our stockholders.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During the year ended December&#160;30, 2022, our stock price has ranged from a low of $18.90 to a high of $32.41. We cannot guarantee that an active trading market will be sustained for our common stock. Nor can we predict the prices at which shares of our common stock may trade. We have experienced and expect in the future to experience fluctuations in our operating results, including revenues and margins, from period to period. These fluctuations may cause our stock price to be volatile, which could cause losses for our stockholders.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our quarterly and annual operating results, including our revenues and margins, may be affected by a number of other factors, including:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the introduction and timing of announcement of new products or product enhancements by us and our competitors;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in our or our competitors&#8217; pricing or discount levels;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in foreign currency exchange rates and other economic uncertainty;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in import/export regulatory regimes including the imposition of tariffs on our products or those of our customers;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in the relative portion of our revenues represented by our various products, including the relative mix between higher-margin and lower-margin products;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in the relative portion of our revenues represented by our international region as a whole and by regions within the overall region, as well as by individual countries (notably, those in emerging markets);</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">fluctuation in our effective tax rate, which may or may not be known to us in advance;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the availability of economic stimulus packages or other government funding, or reductions thereof;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">disruptions in the supply or changes in the costs of raw materials, labor, product components or transportation services;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes to our organizational structure, which may result in restructuring or other charges;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">disruptions in our operations, including our ability to manufacture products, caused by events such as earthquakes, fires, floods, terrorist attacks or the outbreak of epidemic diseases;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">developments relating to any litigation or administrative proceeding or inquiry, including governmental audits, as well as ongoing costs associated with legal proceedings and governmental audits; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">accounting changes and adoption of new accounting pronouncements.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Because many of our operating expenses are based on anticipated capacity levels, and a high percentage of these expenses are fixed for the short term, a small variation in the timing of revenue recognition can cause significant variations in operating results from quarter to quarter. If our gross margins fall below the expectation of securities analysts and investors, the trading price of our common stock may decline.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_7">Table of Contents</a></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Conversion of the Convertible Notes may dilute the ownership interest of our stockholders or may otherwise depress the market price of our common stock.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The conversion of the Convertible Notes may dilute the ownership interests of our stockholders. On conversion of the Convertible Notes, we have the option to pay or deliver, as the case may be, cash, shares of common stock, or a combination of cash and shares of common stock. If we elect to settle our conversion obligation in shares of common stock or a combination of cash and shares of common stock, any sales of our common stock issuable on such conversion could adversely affect prevailing market prices of our common stock. In addition, the existence of the Convertible Notes may encourage short selling by market participants because the conversion of the Convertible Notes could be used to satisfy short positions, or anticipated conversion of the Convertible Notes into shares of our common stock, any of which could depress the market price of our common stock.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The conditional conversion feature of the Convertible Notes, if triggered, may adversely affect our financial condition and operating results.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In the event the conditions for optional conversion of the Convertible Notes by holders are met before the close of business on the business day immediately preceding June 1, 2025, holders of the Convertible Notes will be entitled to convert the Convertible Notes at any time during specified periods at their option. If we elect to satisfy our conversion obligation by settling all or a portion of our conversion obligation in cash, it could adversely affect our liquidity. In addition, even if holders do not elect to convert their Convertible Notes, we could be required under applicable accounting rules to reclassify all or a portion of the outstanding principal of the Convertible Notes as a current rather than long-term liability, which would result in a material reduction of our net working capital and may seriously harm our business.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Certain provisions in our Amended and Restated Certificate of Incorporation, our Amended and Restated Bylaws, our Indenture, and of Delaware law, may prevent or delay an acquisition of our Company, which could decrease the trading price of our common stock.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our Amended and Restated Certificate of Incorporation, our Amended and Restated Bylaws, and Delaware law contain, provisions that are intended to deter coercive takeover practices and inadequate takeover bids by making such practices or bids unacceptably expensive to the bidder and to encourage prospective acquirers to negotiate with our board of directors rather than to attempt a hostile takeover. These provisions include, among others:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the inability of our stockholders to call a special meeting;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the inability of our stockholders to act without a meeting of stockholders;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">rules regarding how stockholders may present proposals or nominate directors for election at stockholder meetings;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the right of our board of directors to issue preferred stock without stockholder approval; and,</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ability of our directors, and not stockholders, to fill vacancies on our board of directors.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In addition, because we did not elect to be exempt from Section 203 of the Delaware General Corporation Law (the &#8220;DGCL&#8221;), this provision could also delay or prevent a change of control that stockholders may favor. Section&#160;203 provides that, subject to limited exceptions, persons that acquire, or who are affiliated with a person that acquires, more than 15% of the outstanding voting stock of a Delaware corporation (an &#8220;interested stockholder&#8221;) shall not engage in any business combination with that corporation, including by merger, consolidation, or acquisitions of additional shares, for a three-year period following the date on which the person became an interested stockholder, unless: (1)&#160;prior to such time, the board of directors of such corporation approved either the business combination or the transaction that resulted in the stockholder becoming an interested stockholder; (2) upon consummation of the transaction that resulted in the stockholder becoming an interested stockholder, the interested stockholder owned at least 85% of the voting stock of such corporation at the time the transaction commenced; or (3)&#160;on or subsequent to such time the business combination is approved by the board of directors of such corporation and authorized at a meeting of stockholders by the affirmative vote of at least&#160;two-thirds&#160;of the outstanding voting stock of such corporation not owned by the interested stockholder.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;These provisions are not intended to make us immune from takeovers. However, these provisions will apply even if the offer may be considered beneficial by some stockholders and could delay or prevent an acquisition that our board of directors determines is not in the best interests of us and our stockholders. These provisions may also prevent or discourage attempts to remove and replace incumbent directors.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Furthermore, certain provisions in our indenture governing the Convertible Notes may make it more difficult or expensive for a third party to acquire us. For example, our indenture requires us, at the holders&#8217; election, to repurchase the Convertible Notes for cash on the occurrence of a fundamental change and, in certain circumstances, to increase the conversion rate for a holder that converts our Convertible Notes in connection with a make-whole fundamental change. A takeover of us may trigger the requirement that we repurchase the Convertible Notes or increase the conversion rate, which could make it costlier for a third party to acquire us. Our indenture also prohibits us from engaging in a merger or acquisition unless, among other things, the surviving entity assumes the obligations under the Convertible Notes and our indenture. These and other provisions in our indenture could deter or prevent a third party from acquiring us even when the acquisition may be favorable to holders of the Convertible Notes or our stockholders.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liabilities related to our operations when we were part of Varian, or liabilities associated with our spin-off from Varian, could materially and adversely affect our business, financial condition, results of operations, and cash flows.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We entered into a Separation and Distribution Agreement when we spun off from Varian. The agreement provides for, among other things, indemnification obligations designed to make Varex financially responsible for liabilities allocable to Varex before the spin-off; and for information contained in our registration statement that describes Varex, our separation from Varian, and the transactions contemplated by the Separation and Distribution Agreement. The Separation and Distribution Agreement also provides for indemnification obligations designed to make Varian financially responsible for liabilities allocable to Varian before the spin-off. We may be subject to substantial liabilities if we were required to indemnify Varian or if Varian were required, but unable, to indemnify us. Either of these could negatively affect our business, financial position, results of operations, and/or cash flows.</span></div><div id="i4ab573909cb849339357193b017c7d37_136"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;2. Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i4ab573909cb849339357193b017c7d37_139"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;3. Defaults Upon Senior Securities</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i4ab573909cb849339357193b017c7d37_142"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;4. Mine Safety Disclosures</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="i4ab573909cb849339357193b017c7d37_145"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;5. Other Information</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><div id="i4ab573909cb849339357193b017c7d37_148"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;6.&#160;Exhibits</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibits required to be filed by Item&#160;601 of Regulation S-K:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.318%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit<br/>No.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Description</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1681622/000168162217000023/exhibit31-10xk.htm">Amended and Restated Certificate of Incorporation, dated January 27, 2017 (as corrected December 11, 2017) (incorporated by reference to Exhibit 3.1 to the Company&#8217;s Annual Report on Form 10-K filed November 27, 2018).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0001681622/000168162221000031/exhibit31-amendedandrestat.htm">Amended and Restated Bylaws of the Company, as amended February 11, 2021 (incorporated by reference to Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K filed February 16, 2021).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="varexq123exhibit311.htm">Chief Executive Officer Certification Pursuant to Rule 13a-14(a) of the Securities Exchange Act</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="varexq123exhibit312.htm">Chief Financial Officer Certification Pursuant to Rule 13a-14(a) of the Securities Exchange Act</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="varexq123exhibit321.htm">Certification pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="varexq123exhibit322.htm">Certification pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Schema Document</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Calculation Linkbase Document</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Definition Linkbase Document</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Label Linkbase Document</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Presentation Linkbase Document</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File - (formatted as Inline XBRL and contained in Exhibit 101)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">* </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith.</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><div id="i4ab573909cb849339357193b017c7d37_151"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4ab573909cb849339357193b017c7d37_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of Section&#160;13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.816%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:60.013%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">VAREX IMAGING CORPORATION</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 31, 2023</span></td><td colspan="3" style="padding:2px 3.25pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ SHUBHAM MAHESHWARI</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shubham Maheshwari</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chief Financial Officer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(Duly&#160;Authorized&#160;Officer&#160;and Principal Financial Officer) </span></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>varexq123exhibit311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i581e7c0860544d5a9955ca109aefe148_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF CHIEF EXECUTIVE OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO EXCHANGE ACT RULE 13a-14(a)&#47;15d-14(a)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION 302</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Sunny S. Sanyal, certify that&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;I have reviewed this Quarterly Report on Form 10-Q of Varex Imaging Corporation (the &#8220;registrant&#8221;)&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;&#160;&#160;&#160;&#160;</font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)&#160;&#160;&#160;&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)&#160;&#160;&#160;&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)&#160;&#160;&#160;&#160;Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)&#160;&#160;&#160;&#160;Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)&#160;&#160;&#160;&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)&#160;&#160;&#160;&#160;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:6.063%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.613%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.426%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 31, 2023</font></td><td colspan="3" style="padding:2px 3.25pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Sunny S. Sanyal</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Sunny S. Sanyal</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">President, Chief Executive Officer</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:right"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>varexq123exhibit312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ibab10529c0fa48969eb908ac519779aa_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF CHIEF FINANCIAL OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO EXCHANGE ACT RULE 13a-14(a)&#47;15d-14(a)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION 302</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Shubham Maheshwari, certify that&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;I have reviewed this Quarterly Report on Form 10-Q of Varex Imaging Corporation (the &#8220;registrant&#8221;)&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;&#160;&#160;&#160;&#160;</font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)&#160;&#160;&#160;&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)&#160;&#160;&#160;&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)&#160;&#160;&#160;&#160;Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)&#160;&#160;&#160;&#160;Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)&#160;&#160;&#160;&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)&#160;&#160;&#160;&#160;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:6.084%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.668%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.545%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.303%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 31, 2023</font></td><td colspan="3" style="padding:2px 3.25pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Shubham Maheshwari</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shubham Maheshwari</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chief Financial Officer</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>varexq123exhibit321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="if93cb98e2dfe418d9c1dcbd4600e58cb_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 18 U.S.C. SECTION 1350</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the accompanying Quarterly Report of Varex Imaging Corporation (the &#8220;Company&#8221;), on Form 10-Q for the quarter ended December&#160;30, 2022 (the &#8220;Report&#8221;), I, Sunny S. Sanyal, President and Chief Executive Officer of the Company, hereby certify pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002 that&#58;</font></div><div><font><br></font></div><div style="margin-bottom:8pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:6.084%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.668%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.237%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.611%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 31, 2023</font></td><td colspan="3" style="padding:2px 3.25pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Sunny S. Sanyal</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Sunny S. Sanyal</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">President, Chief Executive Officer</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="padding-left:36pt"><font><br></font></div><div><font><br></font></div><div style="margin-top:12pt"><font><br></font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>5
<FILENAME>varexq123exhibit322.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="id4d7b697072d4b989125d297c6c1883c_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.2</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 18 U.S.C. SECTION 1350</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the accompanying Quarterly Report of Varex Imaging Corporation (the &#8220;Company&#8221;), on Form 10-Q for the quarter ended December&#160;30, 2022 (the &#8220;Report&#8221;), I, Shubham Maheshwari, Chief Financial Officer of the Company, hereby certify pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002 that&#58;</font></div><div><font><br></font></div><div style="margin-bottom:8pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:6.084%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.668%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.130%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 31, 2023</font></td><td colspan="3" style="padding:2px 3.25pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Shubham Maheshwari</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shubham Maheshwari</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chief Financial Officer</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>var-20221230.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:b10c8d19-453b-4af7-a4e1-32028a0718a8,g:e90e04e8-fae8-401c-8aa8-facd054e09fb-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:var="http://www.varex.com/20221230" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.varex.com/20221230">
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="var-20221230_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="var-20221230_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="var-20221230_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="var-20221230_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.varex.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited" roleURI="http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited">
        <link:definition>0000002 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUnaudited" roleURI="http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUnaudited">
        <link:definition>0000003 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" roleURI="http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited">
        <link:definition>0000004 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical" roleURI="http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical">
        <link:definition>0000005 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited" roleURI="http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited">
        <link:definition>0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" roleURI="http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited">
        <link:definition>0000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" roleURI="http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES">
        <link:definition>0000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUE" roleURI="http://www.varex.com/role/REVENUE">
        <link:definition>0000009 - Disclosure - REVENUE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASES" roleURI="http://www.varex.com/role/LEASES">
        <link:definition>0000010 - Disclosure - LEASES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RELATEDPARTYTRANSACTIONS" roleURI="http://www.varex.com/role/RELATEDPARTYTRANSACTIONS">
        <link:definition>0000011 - Disclosure - RELATED PARTY TRANSACTIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RESTRUCTURING" roleURI="http://www.varex.com/role/RESTRUCTURING">
        <link:definition>0000012 - Disclosure - RESTRUCTURING</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALDERIVATIVESANDHEDGINGACTIVITIES" roleURI="http://www.varex.com/role/FINANCIALDERIVATIVESANDHEDGINGACTIVITIES">
        <link:definition>0000013 - Disclosure - FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUE" roleURI="http://www.varex.com/role/FAIRVALUE">
        <link:definition>0000014 - Disclosure - FAIR VALUE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVENTORIES" roleURI="http://www.varex.com/role/INVENTORIES">
        <link:definition>0000015 - Disclosure - INVENTORIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETS" roleURI="http://www.varex.com/role/GOODWILLANDINTANGIBLEASSETS">
        <link:definition>0000016 - Disclosure - GOODWILL AND INTANGIBLE ASSETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BORROWINGS" roleURI="http://www.varex.com/role/BORROWINGS">
        <link:definition>0000017 - Disclosure - BORROWINGS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NONCONTROLLINGINTERESTS" roleURI="http://www.varex.com/role/NONCONTROLLINGINTERESTS">
        <link:definition>0000018 - Disclosure - NONCONTROLLING INTERESTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NETINCOMEPERSHARE" roleURI="http://www.varex.com/role/NETINCOMEPERSHARE">
        <link:definition>0000019 - Disclosure - NET INCOME PER SHARE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EMPLOYEESTOCKPLANS" roleURI="http://www.varex.com/role/EMPLOYEESTOCKPLANS">
        <link:definition>0000020 - Disclosure - EMPLOYEE STOCK PLANS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TAXESONINCOME" roleURI="http://www.varex.com/role/TAXESONINCOME">
        <link:definition>0000021 - Disclosure - TAXES ON INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTINFORMATION" roleURI="http://www.varex.com/role/SEGMENTINFORMATION">
        <link:definition>0000022 - Disclosure - SEGMENT INFORMATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" roleURI="http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies">
        <link:definition>0000023 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" roleURI="http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables">
        <link:definition>0000024 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUETables" roleURI="http://www.varex.com/role/REVENUETables">
        <link:definition>0000025 - Disclosure - REVENUE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESTables" roleURI="http://www.varex.com/role/LEASESTables">
        <link:definition>0000026 - Disclosure - LEASES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RESTRUCTURINGTables" roleURI="http://www.varex.com/role/RESTRUCTURINGTables">
        <link:definition>0000027 - Disclosure - RESTRUCTURING (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALDERIVATIVESANDHEDGINGACTIVITIESTables" roleURI="http://www.varex.com/role/FINANCIALDERIVATIVESANDHEDGINGACTIVITIESTables">
        <link:definition>0000028 - Disclosure - FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUETables" roleURI="http://www.varex.com/role/FAIRVALUETables">
        <link:definition>0000029 - Disclosure - FAIR VALUE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVENTORIESTables" roleURI="http://www.varex.com/role/INVENTORIESTables">
        <link:definition>0000030 - Disclosure - INVENTORIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETSTables" roleURI="http://www.varex.com/role/GOODWILLANDINTANGIBLEASSETSTables">
        <link:definition>0000031 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BORROWINGSTables" roleURI="http://www.varex.com/role/BORROWINGSTables">
        <link:definition>0000032 - Disclosure - BORROWINGS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NONCONTROLLINGINTERESTSTables" roleURI="http://www.varex.com/role/NONCONTROLLINGINTERESTSTables">
        <link:definition>0000033 - Disclosure - NONCONTROLLING INTERESTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NETINCOMEPERSHARETables" roleURI="http://www.varex.com/role/NETINCOMEPERSHARETables">
        <link:definition>0000034 - Disclosure - NET INCOME PER SHARE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EMPLOYEESTOCKPLANSTables" roleURI="http://www.varex.com/role/EMPLOYEESTOCKPLANSTables">
        <link:definition>0000035 - Disclosure - EMPLOYEE STOCK PLANS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTINFORMATIONTables" roleURI="http://www.varex.com/role/SEGMENTINFORMATIONTables">
        <link:definition>0000036 - Disclosure - SEGMENT INFORMATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSegmentReportingDetails" roleURI="http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSegmentReportingDetails">
        <link:definition>0000037 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Segment Reporting (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESCashandCashEquivalentsandRestrictedCashDetails" roleURI="http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESCashandCashEquivalentsandRestrictedCashDetails">
        <link:definition>0000038 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Cash and Cash Equivalents and Restricted Cash (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESCustomerConcentrationRiskDetails" roleURI="http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESCustomerConcentrationRiskDetails">
        <link:definition>0000039 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Customer Concentration Risk (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESInvestmentsDetails" roleURI="http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESInvestmentsDetails">
        <link:definition>0000040 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESProductWarrantyDetails" roleURI="http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESProductWarrantyDetails">
        <link:definition>0000041 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Product Warranty (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRecentlyAdoptedAccountingStandardsDetails" roleURI="http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRecentlyAdoptedAccountingStandardsDetails">
        <link:definition>0000042 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Recently Adopted Accounting Standards (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUEDisaggregationofRevenueDetails" roleURI="http://www.varex.com/role/REVENUEDisaggregationofRevenueDetails">
        <link:definition>0000043 - Disclosure - REVENUE - Disaggregation of Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUESummaryofContractAssetsandLiabilitiesDetails" roleURI="http://www.varex.com/role/REVENUESummaryofContractAssetsandLiabilitiesDetails">
        <link:definition>0000044 - Disclosure - REVENUE - Summary of Contract Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESNarrativesDetails" roleURI="http://www.varex.com/role/LEASESNarrativesDetails">
        <link:definition>0000045 - Disclosure - LEASES - Narratives (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESScheduleofLeaseRightofUseAssetsandLiabilitiesDetails" roleURI="http://www.varex.com/role/LEASESScheduleofLeaseRightofUseAssetsandLiabilitiesDetails">
        <link:definition>0000046 - Disclosure - LEASES - Schedule of Lease Right-of-Use Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESScheduleofOperatingLeaseCostandSupplementalCashFlowInformationDetails" roleURI="http://www.varex.com/role/LEASESScheduleofOperatingLeaseCostandSupplementalCashFlowInformationDetails">
        <link:definition>0000047 - Disclosure - LEASES - Schedule of Operating Lease Cost and Supplemental Cash Flow Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RELATEDPARTYTRANSACTIONSInvestmentinPrivatelyHeldCompaniesDetails" roleURI="http://www.varex.com/role/RELATEDPARTYTRANSACTIONSInvestmentinPrivatelyHeldCompaniesDetails">
        <link:definition>0000048 - Disclosure - RELATED PARTY TRANSACTIONS - Investment in Privately-Held Companies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RESTRUCTURINGSummaryofRestructuringCostIncurredDetails" roleURI="http://www.varex.com/role/RESTRUCTURINGSummaryofRestructuringCostIncurredDetails">
        <link:definition>0000049 - Disclosure - RESTRUCTURING - Summary of Restructuring Cost Incurred (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALDERIVATIVESANDHEDGINGACTIVITIESNarrativeDetails" roleURI="http://www.varex.com/role/FINANCIALDERIVATIVESANDHEDGINGACTIVITIESNarrativeDetails">
        <link:definition>0000050 - Disclosure - FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALDERIVATIVESANDHEDGINGACTIVITIESSummaryofDerivativeInstrumentsDetails" roleURI="http://www.varex.com/role/FINANCIALDERIVATIVESANDHEDGINGACTIVITIESSummaryofDerivativeInstrumentsDetails">
        <link:definition>0000051 - Disclosure - FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES - Summary of Derivative Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALDERIVATIVESANDHEDGINGACTIVITIESSummaryofIncomeRecognizedFromDerivativeInstrumentsDetails" roleURI="http://www.varex.com/role/FINANCIALDERIVATIVESANDHEDGINGACTIVITIESSummaryofIncomeRecognizedFromDerivativeInstrumentsDetails">
        <link:definition>0000052 - Disclosure - FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES - Summary of Income Recognized From Derivative Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALDERIVATIVESANDHEDGINGACTIVITIESSummaryofDerivativesatFairValueDetails" roleURI="http://www.varex.com/role/FINANCIALDERIVATIVESANDHEDGINGACTIVITIESSummaryofDerivativesatFairValueDetails">
        <link:definition>0000053 - Disclosure - FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES - Summary of Derivatives at Fair Value (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUENarrativeDetails" roleURI="http://www.varex.com/role/FAIRVALUENarrativeDetails">
        <link:definition>0000054 - Disclosure - FAIR VALUE - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEScheduleofFairValueInputsDetails" roleURI="http://www.varex.com/role/FAIRVALUEScheduleofFairValueInputsDetails">
        <link:definition>0000055 - Disclosure - FAIR VALUE - Schedule of Fair Value Inputs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUESummaryofMarketableSecuritiesDetails" roleURI="http://www.varex.com/role/FAIRVALUESummaryofMarketableSecuritiesDetails">
        <link:definition>0000056 - Disclosure - FAIR VALUE - Summary of Marketable Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEContractualMaturitiesofMarketableSecuritiesDetails" roleURI="http://www.varex.com/role/FAIRVALUEContractualMaturitiesofMarketableSecuritiesDetails">
        <link:definition>0000057 - Disclosure - FAIR VALUE - Contractual Maturities of Marketable Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEBalanceSheetMarketableSecuritiesDetails" roleURI="http://www.varex.com/role/FAIRVALUEBalanceSheetMarketableSecuritiesDetails">
        <link:definition>0000058 - Disclosure - FAIR VALUE - Balance Sheet Marketable Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVENTORIESSummaryofInventoryDetails" roleURI="http://www.varex.com/role/INVENTORIESSummaryofInventoryDetails">
        <link:definition>0000059 - Disclosure - INVENTORIES - Summary of Inventory (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETSGoodwillRollforwardDetails" roleURI="http://www.varex.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillRollforwardDetails">
        <link:definition>0000060 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Goodwill Rollforward (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails" roleURI="http://www.varex.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails">
        <link:definition>0000061 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BORROWINGSScheduleofDebtDetails" roleURI="http://www.varex.com/role/BORROWINGSScheduleofDebtDetails">
        <link:definition>0000062 - Disclosure - BORROWINGS - Schedule of Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BORROWINGSScheduleofInterestExpenseDetails" roleURI="http://www.varex.com/role/BORROWINGSScheduleofInterestExpenseDetails">
        <link:definition>0000063 - Disclosure - BORROWINGS - Schedule of Interest Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BORROWINGSConvertibleSeniorUnsecuredNotesNarrativeDetails" roleURI="http://www.varex.com/role/BORROWINGSConvertibleSeniorUnsecuredNotesNarrativeDetails">
        <link:definition>0000064 - Disclosure - BORROWINGS - Convertible Senior Unsecured Notes Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BORROWINGSCallSpreadNarrativeDetails" roleURI="http://www.varex.com/role/BORROWINGSCallSpreadNarrativeDetails">
        <link:definition>0000065 - Disclosure - BORROWINGS - Call Spread Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BORROWINGSSeniorSecuredNotesNarrativeDetails" roleURI="http://www.varex.com/role/BORROWINGSSeniorSecuredNotesNarrativeDetails">
        <link:definition>0000066 - Disclosure - BORROWINGS - Senior Secured Notes Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BORROWINGSAssetBasedLoanNarrativeDetails" roleURI="http://www.varex.com/role/BORROWINGSAssetBasedLoanNarrativeDetails">
        <link:definition>0000067 - Disclosure - BORROWINGS - Asset-Based Loan Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NONCONTROLLINGINTERESTSNoncontrollingInterestDetails" roleURI="http://www.varex.com/role/NONCONTROLLINGINTERESTSNoncontrollingInterestDetails">
        <link:definition>0000068 - Disclosure - NONCONTROLLING INTERESTS - Noncontrolling Interest (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NETINCOMEPERSHAREReconciliationofNumeratorandDenominatorforBasicandDilutedNetLossIncomePerCommonShareDetails" roleURI="http://www.varex.com/role/NETINCOMEPERSHAREReconciliationofNumeratorandDenominatorforBasicandDilutedNetLossIncomePerCommonShareDetails">
        <link:definition>0000069 - Disclosure - NET INCOME PER SHARE - Reconciliation of Numerator and Denominator for Basic and Diluted Net (Loss) Income Per Common Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NETINCOMEPERSHARENarrativeDetails" roleURI="http://www.varex.com/role/NETINCOMEPERSHARENarrativeDetails">
        <link:definition>0000070 - Disclosure - NET INCOME PER SHARE - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EMPLOYEESTOCKPLANSSharebasedCompensationExpenseDetails" roleURI="http://www.varex.com/role/EMPLOYEESTOCKPLANSSharebasedCompensationExpenseDetails">
        <link:definition>0000071 - Disclosure - EMPLOYEE STOCK PLANS - Share-based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EMPLOYEESTOCKPLANSStockOptionActivityDetails" roleURI="http://www.varex.com/role/EMPLOYEESTOCKPLANSStockOptionActivityDetails">
        <link:definition>0000072 - Disclosure - EMPLOYEE STOCK PLANS - Stock Option Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EMPLOYEESTOCKPLANSRestrictedStockandPerformanceStockDetails" roleURI="http://www.varex.com/role/EMPLOYEESTOCKPLANSRestrictedStockandPerformanceStockDetails">
        <link:definition>0000073 - Disclosure - EMPLOYEE STOCK PLANS - Restricted Stock and Performance Stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TAXESONINCOMEDetails" roleURI="http://www.varex.com/role/TAXESONINCOMEDetails">
        <link:definition>0000074 - Disclosure - TAXES ON INCOME (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTINFORMATIONIncomeStatementInformationDetails" roleURI="http://www.varex.com/role/SEGMENTINFORMATIONIncomeStatementInformationDetails">
        <link:definition>0000075 - Disclosure - SEGMENT INFORMATION - Income Statement Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="var_ClassOfWarrantOrRightPercentIncreaseOfStrikePriceOverSalePrice" abstract="false" name="ClassOfWarrantOrRightPercentIncreaseOfStrikePriceOverSalePrice" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="var_CommercialPaperReceivable" abstract="false" name="CommercialPaperReceivable" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="var_ContractWithCustomerRefundLiabilityAdditions" abstract="false" name="ContractWithCustomerRefundLiabilityAdditions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="var_PercentageOfFixedCosts" abstract="false" name="PercentageOfFixedCosts" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="var_LongtermDebtExcludingCurrentMaturitiesGross" abstract="false" name="LongtermDebtExcludingCurrentMaturitiesGross" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="var_IncrementalCommonSharesAttributableToDilutiveEffectOfWarrants" abstract="false" name="IncrementalCommonSharesAttributableToDilutiveEffectOfWarrants" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="var_ProceedsFromSalesOfBusinessAndAssets" abstract="false" name="ProceedsFromSalesOfBusinessAndAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="var_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsForfeituresandExpirationsinPeriodPrice" abstract="false" name="SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsForfeituresandExpirationsinPeriodPrice" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="var_NetIncomeLossAttributableToNoncontrollingInterestNetOfDividends" abstract="false" name="NetIncomeLossAttributableToNoncontrollingInterestNetOfDividends" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="var_JointVentureInSaudiArabiaMember" abstract="true" name="JointVentureInSaudiArabiaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="var_ConvertibleNotesMember" abstract="true" name="ConvertibleNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="var_CanonMedicalSystemsCorporationFormerlyToshibaMedicalSystemsMember" abstract="true" name="CanonMedicalSystemsCorporationFormerlyToshibaMedicalSystemsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="var_AssetBasedLoanRevolvingCreditFacilityMember" abstract="true" name="AssetBasedLoanRevolvingCreditFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="var_CorporateBonds" abstract="false" name="CorporateBonds" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="var_MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughFive" abstract="false" name="MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughFive" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="var_IndustrialMember" abstract="true" name="IndustrialMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="var_BusinessAcquisitionCumulativePercentageOfVotingInterestsAcquired" abstract="false" name="BusinessAcquisitionCumulativePercentageOfVotingInterestsAcquired" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="var_PercentageOfManufacturingCapacity" abstract="false" name="PercentageOfManufacturingCapacity" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="var_RelatedPartyTransactionApprovedPurchasesFromRelatedParty" abstract="false" name="RelatedPartyTransactionApprovedPurchasesFromRelatedParty" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="var_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingPrice" abstract="false" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingPrice" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="var_BusinessAcquisitionAnnualRecurringCompensation" abstract="false" name="BusinessAcquisitionAnnualRecurringCompensation" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="var_AssetsAndLiabilitiesLesseeTableTextBlock" abstract="false" name="AssetsAndLiabilitiesLesseeTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="var_MarketableSecuritiesAmortizedCost" abstract="false" name="MarketableSecuritiesAmortizedCost" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="var_DerivativeNumberOfInstrumentsTerminated" abstract="false" name="DerivativeNumberOfInstrumentsTerminated" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="var_DpiXLLCMember" abstract="true" name="DpiXLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="var_LeaseCostFinanceLeaseCosts" abstract="false" name="LeaseCostFinanceLeaseCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="var_WarrantyTerm" abstract="false" name="WarrantyTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="var_MeVisMedicalSolutionsAGMeVisMember" abstract="true" name="MeVisMedicalSolutionsAGMeVisMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="var_VECImagingGmbHCo.KGMember" abstract="true" name="VECImagingGmbHCo.KGMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="var_GainLossOnSettlementOfHedgeInvestingActivities" abstract="false" name="GainLossOnSettlementOfHedgeInvestingActivities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="var_ExercisePriceRangeRollForward" abstract="true" name="ExercisePriceRangeRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="var_SeniorSecuredNotesMember" abstract="true" name="SeniorSecuredNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="var_FixedCostCommitmentsMember" abstract="true" name="FixedCostCommitmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="var_ContractwithCustomerAssetShipments" abstract="false" name="ContractwithCustomerAssetShipments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="var_MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateRollingWithinOneYearAmortizedCost" abstract="false" name="MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateRollingWithinOneYearAmortizedCost" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="var_MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" abstract="false" name="MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="var_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisablePrice" abstract="false" name="SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisablePrice" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="var_NoncontrollingInterestTableTextBlock" abstract="false" name="NoncontrollingInterestTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="var_PercentageOfAdditionalOutstandingSharesPurchased" abstract="false" name="PercentageOfAdditionalOutstandingSharesPurchased" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="var_MedicalMember" abstract="true" name="MedicalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="var_ContractWithCustomerRefundLiabilityAmountReleased" abstract="false" name="ContractWithCustomerRefundLiabilityAmountReleased" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="var_SharebasedCompensationArrangementsbySharebasedPaymentAwardOptionsGrantsinPeriodPrice" abstract="false" name="SharebasedCompensationArrangementsbySharebasedPaymentAwardOptionsGrantsinPeriodPrice" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="var_CustomerContractsandSupplierRelationshipsMember" abstract="true" name="CustomerContractsandSupplierRelationshipsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="var_InterestExpenseDebtContractualInterestCoupon" abstract="false" name="InterestExpenseDebtContractualInterestCoupon" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="var_DpiXHoldingMember" abstract="true" name="DpiXHoldingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="var_MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateYearOne" abstract="false" name="MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateYearOne" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="var_NoncontrollingInterestOtherChanges" abstract="false" name="NoncontrollingInterestOtherChanges" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="var_CashPaidForOperatingAndFinanceLeases" abstract="false" name="CashPaidForOperatingAndFinanceLeases" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="var_MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateRollingAfterOneThroughFiveYearsAmortizedCost" abstract="false" name="MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateRollingAfterOneThroughFiveYearsAmortizedCost" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>var-20221230_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:b10c8d19-453b-4af7-a4e1-32028a0718a8,g:e90e04e8-fae8-401c-8aa8-facd054e09fb-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited" xlink:type="simple" xlink:href="var-20221230.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"/>
  <link:calculationLink xlink:role="http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_d062a929-594d-45d6-a438-fb7e0b08587b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_33f1cfad-ee0b-4159-821e-ce2d6b4b8189" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_d062a929-594d-45d6-a438-fb7e0b08587b" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_33f1cfad-ee0b-4159-821e-ce2d6b4b8189" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_a5a60064-4213-4143-9028-4fbc94dc8db6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_d062a929-594d-45d6-a438-fb7e0b08587b" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_a5a60064-4213-4143-9028-4fbc94dc8db6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_44282ce5-4f75-49e0-8f64-10fec652255e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_4a5bf732-429d-46a2-8afd-e09f9fae9758" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_44282ce5-4f75-49e0-8f64-10fec652255e" xlink:to="loc_us-gaap_ProfitLoss_4a5bf732-429d-46a2-8afd-e09f9fae9758" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_1e630d41-9118-46af-9887-9fbf61a5d0ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_44282ce5-4f75-49e0-8f64-10fec652255e" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_1e630d41-9118-46af-9887-9fbf61a5d0ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_00085cfe-6325-45ab-b67b-8c98856fe9da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_a79bf204-fc6f-4a17-8a8f-abb473de4e01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_00085cfe-6325-45ab-b67b-8c98856fe9da" xlink:to="loc_us-gaap_GrossProfit_a79bf204-fc6f-4a17-8a8f-abb473de4e01" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_58ce3718-140b-4def-b65e-45e96740293e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_00085cfe-6325-45ab-b67b-8c98856fe9da" xlink:to="loc_us-gaap_OperatingExpenses_58ce3718-140b-4def-b65e-45e96740293e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_af98111c-e8a4-475e-aab2-98acbca891c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_15291f5b-9675-4618-9240-aca033743465" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_af98111c-e8a4-475e-aab2-98acbca891c0" xlink:to="loc_us-gaap_OperatingIncomeLoss_15291f5b-9675-4618-9240-aca033743465" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_859068cb-7cef-472b-94e5-69df1a354aa6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_af98111c-e8a4-475e-aab2-98acbca891c0" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_859068cb-7cef-472b-94e5-69df1a354aa6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_fd91ff98-3703-42f6-9d58-7666bf89633f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_570125f9-8d7e-4c72-8f15-559b8b1d4464" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_fd91ff98-3703-42f6-9d58-7666bf89633f" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_570125f9-8d7e-4c72-8f15-559b8b1d4464" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_bf1564cb-7f0f-4774-8e75-8dab6e48382e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_fd91ff98-3703-42f6-9d58-7666bf89633f" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_bf1564cb-7f0f-4774-8e75-8dab6e48382e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_ebdcdd8c-8195-4cf5-81ad-a556b7fe140c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_d9b40d51-9770-4b8f-bd90-d632b08d19bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_ebdcdd8c-8195-4cf5-81ad-a556b7fe140c" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_d9b40d51-9770-4b8f-bd90-d632b08d19bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_5f50d2f4-493d-47ab-a768-91c2aabc4a4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_ebdcdd8c-8195-4cf5-81ad-a556b7fe140c" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_5f50d2f4-493d-47ab-a768-91c2aabc4a4e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_db9bc4de-e1b3-4984-87c0-a3db1e7af374" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_8853d2cc-afbd-4bc0-87e7-9d622887ef41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_db9bc4de-e1b3-4984-87c0-a3db1e7af374" xlink:to="loc_us-gaap_InterestExpense_8853d2cc-afbd-4bc0-87e7-9d622887ef41" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_404fa520-f071-4e61-9da4-61006e52c86a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_db9bc4de-e1b3-4984-87c0-a3db1e7af374" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_404fa520-f071-4e61-9da4-61006e52c86a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_9b1e369b-4651-46d4-8396-59ed3a8a169e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_db9bc4de-e1b3-4984-87c0-a3db1e7af374" xlink:to="loc_us-gaap_InvestmentIncomeInterest_9b1e369b-4651-46d4-8396-59ed3a8a169e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUnaudited" xlink:type="simple" xlink:href="var-20221230.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUnaudited"/>
  <link:calculationLink xlink:role="http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_720fba71-8785-4fd2-acfa-4c80e387c312" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_7d4daee6-1152-4c5b-8fe0-e018078ee990" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_720fba71-8785-4fd2-acfa-4c80e387c312" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_7d4daee6-1152-4c5b-8fe0-e018078ee990" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_78eebb22-8141-47d4-85f8-f7c8a5772ae4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_720fba71-8785-4fd2-acfa-4c80e387c312" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_78eebb22-8141-47d4-85f8-f7c8a5772ae4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_ab95003b-bf0c-47b4-9150-cd1fb41c9b4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_93ffe5aa-4e88-4b38-ac27-3be72057d9e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_ab95003b-bf0c-47b4-9150-cd1fb41c9b4c" xlink:to="loc_us-gaap_ProfitLoss_93ffe5aa-4e88-4b38-ac27-3be72057d9e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_3986b11a-c8d1-45f6-9985-74fb7a24637a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_ab95003b-bf0c-47b4-9150-cd1fb41c9b4c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_3986b11a-c8d1-45f6-9985-74fb7a24637a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" xlink:type="simple" xlink:href="var-20221230.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"/>
  <link:calculationLink xlink:role="http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_6cecd171-bbe8-4445-85dc-842455b39d41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_72c7ed86-7a08-4b77-9506-8c296be0dca6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_6cecd171-bbe8-4445-85dc-842455b39d41" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_72c7ed86-7a08-4b77-9506-8c296be0dca6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_1750af91-3e6c-4238-a233-24cbeab4407b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_6cecd171-bbe8-4445-85dc-842455b39d41" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_1750af91-3e6c-4238-a233-24cbeab4407b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_4e0f7c05-cd8d-408f-84e9-c7f6b22cd8ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_6cecd171-bbe8-4445-85dc-842455b39d41" xlink:to="loc_us-gaap_InventoryNet_4e0f7c05-cd8d-408f-84e9-c7f6b22cd8ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_54b6d49f-e4d8-4f31-9f4e-bcc04fbfd0cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_6cecd171-bbe8-4445-85dc-842455b39d41" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_54b6d49f-e4d8-4f31-9f4e-bcc04fbfd0cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_d74c3d97-4a0b-48fc-be30-0c1d2187d54e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_14980ba0-8581-4f30-8d72-a2c9972680b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_d74c3d97-4a0b-48fc-be30-0c1d2187d54e" xlink:to="loc_us-gaap_LiabilitiesCurrent_14980ba0-8581-4f30-8d72-a2c9972680b5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_10751254-ee9c-408a-8a88-ec15a93329ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_d74c3d97-4a0b-48fc-be30-0c1d2187d54e" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_10751254-ee9c-408a-8a88-ec15a93329ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_4f291944-44c8-4d52-81b7-885df4c849b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_d74c3d97-4a0b-48fc-be30-0c1d2187d54e" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_4f291944-44c8-4d52-81b7-885df4c849b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_ab69f624-39e2-4152-bb89-9682f47a1dc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_d74c3d97-4a0b-48fc-be30-0c1d2187d54e" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_ab69f624-39e2-4152-bb89-9682f47a1dc6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_d885e6ad-60d3-4eff-935f-0a160d45eb5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_d74c3d97-4a0b-48fc-be30-0c1d2187d54e" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_d885e6ad-60d3-4eff-935f-0a160d45eb5e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_eb90a52e-2b2a-4dc1-b2ed-dc52faea6972" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValueOutstanding_184eb72f-3a42-4047-b391-fe4878b53fa5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValueOutstanding"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_eb90a52e-2b2a-4dc1-b2ed-dc52faea6972" xlink:to="loc_us-gaap_PreferredStockValueOutstanding_184eb72f-3a42-4047-b391-fe4878b53fa5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValueOutstanding_22a6a73e-23bb-4403-a71e-8c9d049da177" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValueOutstanding"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_eb90a52e-2b2a-4dc1-b2ed-dc52faea6972" xlink:to="loc_us-gaap_CommonStockValueOutstanding_22a6a73e-23bb-4403-a71e-8c9d049da177" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_392867fb-e71c-4f99-bb19-5b5009cb7c12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_eb90a52e-2b2a-4dc1-b2ed-dc52faea6972" xlink:to="loc_us-gaap_AdditionalPaidInCapital_392867fb-e71c-4f99-bb19-5b5009cb7c12" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_98e10643-651b-448f-b17a-b069741b4ab1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_eb90a52e-2b2a-4dc1-b2ed-dc52faea6972" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_98e10643-651b-448f-b17a-b069741b4ab1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_98dbce74-cd61-44af-9210-666000c5c617" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_eb90a52e-2b2a-4dc1-b2ed-dc52faea6972" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_98dbce74-cd61-44af-9210-666000c5c617" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_ce57e568-5326-464f-9031-c03aa3bd5b47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_18ae4ee9-10e2-4a7d-904d-275131b017fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_ce57e568-5326-464f-9031-c03aa3bd5b47" xlink:to="loc_us-gaap_Liabilities_18ae4ee9-10e2-4a7d-904d-275131b017fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ac9b6f04-7a85-4f99-baae-feeec3dd5e54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_ce57e568-5326-464f-9031-c03aa3bd5b47" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ac9b6f04-7a85-4f99-baae-feeec3dd5e54" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_fae363aa-8f86-4ce5-9167-c89148403709" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_7bc1851a-f1bb-4b6a-af85-6e09a28632ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_fae363aa-8f86-4ce5-9167-c89148403709" xlink:to="loc_us-gaap_AccountsPayableCurrent_7bc1851a-f1bb-4b6a-af85-6e09a28632ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_dc93c342-877b-485a-9c3e-1b1a2e19bab0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_fae363aa-8f86-4ce5-9167-c89148403709" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_dc93c342-877b-485a-9c3e-1b1a2e19bab0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_f1205e08-c7af-4437-b3af-8ff8a52d797f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_fae363aa-8f86-4ce5-9167-c89148403709" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_f1205e08-c7af-4437-b3af-8ff8a52d797f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_30e624b4-8890-434c-95b6-c4b67ab44456" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_fae363aa-8f86-4ce5-9167-c89148403709" xlink:to="loc_us-gaap_LongTermDebtCurrent_30e624b4-8890-434c-95b6-c4b67ab44456" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_bb407e5c-3cdf-4499-8e6c-e91a62ee75be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_fae363aa-8f86-4ce5-9167-c89148403709" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_bb407e5c-3cdf-4499-8e6c-e91a62ee75be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_f9b71bbe-f3f9-4f83-8aa8-5b0a3036c7f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_eb9e088b-cb6a-46f8-857f-13e02ad4680e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_f9b71bbe-f3f9-4f83-8aa8-5b0a3036c7f9" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_eb9e088b-cb6a-46f8-857f-13e02ad4680e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_7a392f50-fbad-4562-a891-92e182ceb6db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_f9b71bbe-f3f9-4f83-8aa8-5b0a3036c7f9" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_7a392f50-fbad-4562-a891-92e182ceb6db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_21fedbc7-337b-48b7-a9c9-045b306170e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_f9b71bbe-f3f9-4f83-8aa8-5b0a3036c7f9" xlink:to="loc_us-gaap_AssetsCurrent_21fedbc7-337b-48b7-a9c9-045b306170e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_3e03636f-095d-48ff-9ecc-527d32aa029e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_f9b71bbe-f3f9-4f83-8aa8-5b0a3036c7f9" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_3e03636f-095d-48ff-9ecc-527d32aa029e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_1a94f595-50ba-4b33-ad9d-a8895add31d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_f9b71bbe-f3f9-4f83-8aa8-5b0a3036c7f9" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_1a94f595-50ba-4b33-ad9d-a8895add31d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_1d5e4db7-9187-4f39-852e-98eb3a16d853" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_f9b71bbe-f3f9-4f83-8aa8-5b0a3036c7f9" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_1d5e4db7-9187-4f39-852e-98eb3a16d853" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_faa35d78-c1b5-491a-9d9e-cedaf31110fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_f9b71bbe-f3f9-4f83-8aa8-5b0a3036c7f9" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_faa35d78-c1b5-491a-9d9e-cedaf31110fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_a5c91063-2229-47c1-b255-f7a692777563" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_f9b71bbe-f3f9-4f83-8aa8-5b0a3036c7f9" xlink:to="loc_us-gaap_Goodwill_a5c91063-2229-47c1-b255-f7a692777563" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1fa2f3c1-3041-4203-b389-e9afb3384aa4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_7e12bda4-d1f6-419a-9590-2c93d9fa1ec4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1fa2f3c1-3041-4203-b389-e9afb3384aa4" xlink:to="loc_us-gaap_StockholdersEquity_7e12bda4-d1f6-419a-9590-2c93d9fa1ec4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_910ad3a9-437a-4fca-83d5-ce406b012fa4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1fa2f3c1-3041-4203-b389-e9afb3384aa4" xlink:to="loc_us-gaap_MinorityInterest_910ad3a9-437a-4fca-83d5-ce406b012fa4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" xlink:type="simple" xlink:href="var-20221230.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"/>
  <link:calculationLink xlink:role="http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1292f0ee-c1fc-4f0b-8a47-078b3b5516c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromHedgeInvestingActivities_97c268e1-8129-4ea5-b35a-cbcb17ae6bca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromHedgeInvestingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1292f0ee-c1fc-4f0b-8a47-078b3b5516c7" xlink:to="loc_us-gaap_ProceedsFromHedgeInvestingActivities_97c268e1-8129-4ea5-b35a-cbcb17ae6bca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_3d8b1a74-3ffd-4037-bd82-71da4be60a50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1292f0ee-c1fc-4f0b-8a47-078b3b5516c7" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_3d8b1a74-3ffd-4037-bd82-71da4be60a50" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_8cbbf5a8-1657-4307-a972-e7f42b0a5cc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1292f0ee-c1fc-4f0b-8a47-078b3b5516c7" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_8cbbf5a8-1657-4307-a972-e7f42b0a5cc2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_bfdb7f05-4eee-4424-aa72-61a79313cd0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1292f0ee-c1fc-4f0b-8a47-078b3b5516c7" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_bfdb7f05-4eee-4424-aa72-61a79313cd0e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_GainLossOnSettlementOfHedgeInvestingActivities_d8c8e888-8a61-4d2c-8500-fe4de2b32bcf" xlink:href="var-20221230.xsd#var_GainLossOnSettlementOfHedgeInvestingActivities"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1292f0ee-c1fc-4f0b-8a47-078b3b5516c7" xlink:to="loc_var_GainLossOnSettlementOfHedgeInvestingActivities_d8c8e888-8a61-4d2c-8500-fe4de2b32bcf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_ProceedsFromSalesOfBusinessAndAssets_4791de13-180f-4a73-ae2b-1dead33863fc" xlink:href="var-20221230.xsd#var_ProceedsFromSalesOfBusinessAndAssets"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1292f0ee-c1fc-4f0b-8a47-078b3b5516c7" xlink:to="loc_var_ProceedsFromSalesOfBusinessAndAssets_4791de13-180f-4a73-ae2b-1dead33863fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_4a193f63-b25c-40ec-9e26-40e58764b5bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1292f0ee-c1fc-4f0b-8a47-078b3b5516c7" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_4a193f63-b25c-40ec-9e26-40e58764b5bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_76920aa3-c44a-412e-9f7e-153da32656f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1292f0ee-c1fc-4f0b-8a47-078b3b5516c7" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_76920aa3-c44a-412e-9f7e-153da32656f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_9dcc37a9-1cc1-4517-b1e0-4f51b3b8a482" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fd10c990-daf8-4420-83a4-c1514594515b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_9dcc37a9-1cc1-4517-b1e0-4f51b3b8a482" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fd10c990-daf8-4420-83a4-c1514594515b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7d61d506-13ea-4c9f-a602-bd909747fd4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_9dcc37a9-1cc1-4517-b1e0-4f51b3b8a482" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7d61d506-13ea-4c9f-a602-bd909747fd4e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a9d8c8e8-cee4-4d44-be3e-51cc574b1bf8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_9dcc37a9-1cc1-4517-b1e0-4f51b3b8a482" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a9d8c8e8-cee4-4d44-be3e-51cc574b1bf8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d91518dd-5916-4400-819f-619853879cff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_9dcc37a9-1cc1-4517-b1e0-4f51b3b8a482" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d91518dd-5916-4400-819f-619853879cff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_73a19aca-f8fa-4386-a788-d3b46542bf46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_30e9d505-5e95-4840-a170-ab847bad4802" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermLinesOfCredit"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_73a19aca-f8fa-4386-a788-d3b46542bf46" xlink:to="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_30e9d505-5e95-4840-a170-ab847bad4802" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans_a98ed534-6c48-4660-ba7d-42568128b83a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_73a19aca-f8fa-4386-a788-d3b46542bf46" xlink:to="loc_us-gaap_ProceedsFromStockPlans_a98ed534-6c48-4660-ba7d-42568128b83a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_84c7070b-157f-4b22-9998-c3f8a2e68e2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_73a19aca-f8fa-4386-a788-d3b46542bf46" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_84c7070b-157f-4b22-9998-c3f8a2e68e2f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_cd85d2cd-6f7f-4557-b93e-1f5426980d2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_73a19aca-f8fa-4386-a788-d3b46542bf46" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_cd85d2cd-6f7f-4557-b93e-1f5426980d2e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c927180b-5489-40b2-b1db-379055740360" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_9cb28786-018c-45bb-b0e1-ae5ef757853f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c927180b-5489-40b2-b1db-379055740360" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_9cb28786-018c-45bb-b0e1-ae5ef757853f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDeferredLoanOriginationFeesNet_7efc5227-07cd-42b6-a5c2-83e4ad60b5df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfDeferredLoanOriginationFeesNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c927180b-5489-40b2-b1db-379055740360" xlink:to="loc_us-gaap_AmortizationOfDeferredLoanOriginationFeesNet_7efc5227-07cd-42b6-a5c2-83e4ad60b5df" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_b2bada27-d918-4a09-b317-71e79047100e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c927180b-5489-40b2-b1db-379055740360" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_b2bada27-d918-4a09-b317-71e79047100e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_1cc1d09f-ab3c-4781-99d3-ebecd7166352" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c927180b-5489-40b2-b1db-379055740360" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_1cc1d09f-ab3c-4781-99d3-ebecd7166352" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_9edab030-e7e1-4be5-b62a-f0a4a194ef70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c927180b-5489-40b2-b1db-379055740360" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_9edab030-e7e1-4be5-b62a-f0a4a194ef70" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_939981ba-aab7-4c04-b1aa-5c74e9190bdc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c927180b-5489-40b2-b1db-379055740360" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_939981ba-aab7-4c04-b1aa-5c74e9190bdc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_e0b0a414-b93d-434e-9fd2-5a3cc01e60c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c927180b-5489-40b2-b1db-379055740360" xlink:to="loc_us-gaap_ShareBasedCompensation_e0b0a414-b93d-434e-9fd2-5a3cc01e60c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_85b9bdde-9960-4152-acde-cd25dae0e7d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWriteDown"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c927180b-5489-40b2-b1db-379055740360" xlink:to="loc_us-gaap_InventoryWriteDown_85b9bdde-9960-4152-acde-cd25dae0e7d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_4c355203-a795-407e-8812-75d45f48884f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c927180b-5489-40b2-b1db-379055740360" xlink:to="loc_us-gaap_ProfitLoss_4c355203-a795-407e-8812-75d45f48884f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_576a0810-a078-4509-9759-498bfb13e71a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c927180b-5489-40b2-b1db-379055740360" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_576a0810-a078-4509-9759-498bfb13e71a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_e2ab0102-9b54-4e19-9500-eef0d239e759" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c927180b-5489-40b2-b1db-379055740360" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_e2ab0102-9b54-4e19-9500-eef0d239e759" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_de8df625-b5b6-4fd2-bb75-8a9bbcf0fb6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c927180b-5489-40b2-b1db-379055740360" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_de8df625-b5b6-4fd2-bb75-8a9bbcf0fb6f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_5d2bb1b8-cb39-4a82-a3a9-4a9c96d8dd41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c927180b-5489-40b2-b1db-379055740360" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_5d2bb1b8-cb39-4a82-a3a9-4a9c96d8dd41" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_f9244ef0-3bea-4a3b-a5d7-ca5fd40ff2ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c927180b-5489-40b2-b1db-379055740360" xlink:to="loc_us-gaap_Depreciation_f9244ef0-3bea-4a3b-a5d7-ca5fd40ff2ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_a63e35c7-699b-47fd-8718-8569b606e938" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions"/>
    <link:calculationArc order="15" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c927180b-5489-40b2-b1db-379055740360" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_a63e35c7-699b-47fd-8718-8569b606e938" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnTerminationOfLease_5a21e235-6b84-4ac1-bf1e-6b0b6018b833" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnTerminationOfLease"/>
    <link:calculationArc order="16" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c927180b-5489-40b2-b1db-379055740360" xlink:to="loc_us-gaap_GainLossOnTerminationOfLease_5a21e235-6b84-4ac1-bf1e-6b0b6018b833" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESCashandCashEquivalentsandRestrictedCashDetails" xlink:type="simple" xlink:href="var-20221230.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESCashandCashEquivalentsandRestrictedCashDetails"/>
  <link:calculationLink xlink:role="http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESCashandCashEquivalentsandRestrictedCashDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2f2082d6-99da-402b-92df-c8164928bd40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_18112ec8-9c71-4d5d-b92b-c79948e59801" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2f2082d6-99da-402b-92df-c8164928bd40" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_18112ec8-9c71-4d5d-b92b-c79948e59801" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_5b02c79c-bb62-4c86-902f-6498a212e929" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCash"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2f2082d6-99da-402b-92df-c8164928bd40" xlink:to="loc_us-gaap_RestrictedCash_5b02c79c-bb62-4c86-902f-6498a212e929" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.varex.com/role/LEASESScheduleofOperatingLeaseCostandSupplementalCashFlowInformationDetails" xlink:type="simple" xlink:href="var-20221230.xsd#LEASESScheduleofOperatingLeaseCostandSupplementalCashFlowInformationDetails"/>
  <link:calculationLink xlink:role="http://www.varex.com/role/LEASESScheduleofOperatingLeaseCostandSupplementalCashFlowInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_var_CashPaidForOperatingAndFinanceLeases_365295b6-2c29-42bc-ae98-49aa112adf03" xlink:href="var-20221230.xsd#var_CashPaidForOperatingAndFinanceLeases"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_2b0e9ca2-35ba-4b94-a1a5-5587f460f0c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_var_CashPaidForOperatingAndFinanceLeases_365295b6-2c29-42bc-ae98-49aa112adf03" xlink:to="loc_us-gaap_OperatingLeasePayments_2b0e9ca2-35ba-4b94-a1a5-5587f460f0c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_ebd92672-e395-42ec-bc26-c2bc3f18ba54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_var_CashPaidForOperatingAndFinanceLeases_365295b6-2c29-42bc-ae98-49aa112adf03" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_ebd92672-e395-42ec-bc26-c2bc3f18ba54" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.varex.com/role/FAIRVALUEScheduleofFairValueInputsDetails" xlink:type="simple" xlink:href="var-20221230.xsd#FAIRVALUEScheduleofFairValueInputsDetails"/>
  <link:calculationLink xlink:role="http://www.varex.com/role/FAIRVALUEScheduleofFairValueInputsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_110e4be2-e86a-479c-9664-abb81e488cb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_c5577773-34a6-4a97-ae40-4bd8a260c6d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_110e4be2-e86a-479c-9664-abb81e488cb7" xlink:to="loc_us-gaap_DerivativeLiabilities_c5577773-34a6-4a97-ae40-4bd8a260c6d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_527b9de9-001f-4661-afa2-14b303c20015" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesSecuritiesAtCarryingValue_d29ddf8e-d88e-48e2-87a2-1b98ef6c273f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesSecuritiesAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_527b9de9-001f-4661-afa2-14b303c20015" xlink:to="loc_us-gaap_USGovernmentAgenciesSecuritiesAtCarryingValue_d29ddf8e-d88e-48e2-87a2-1b98ef6c273f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsAtCarryingValue_ad9d8b9d-5dcd-4c1e-94e2-38316c8c8ca9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_527b9de9-001f-4661-afa2-14b303c20015" xlink:to="loc_us-gaap_MoneyMarketFundsAtCarryingValue_ad9d8b9d-5dcd-4c1e-94e2-38316c8c8ca9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_7a1731ab-2bd1-47f4-9514-a4a5d33ce136" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_527b9de9-001f-4661-afa2-14b303c20015" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_7a1731ab-2bd1-47f4-9514-a4a5d33ce136" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_285c806d-a066-4460-b0ad-023f9facb106" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_527b9de9-001f-4661-afa2-14b303c20015" xlink:to="loc_us-gaap_DerivativeAssets_285c806d-a066-4460-b0ad-023f9facb106" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_CorporateBonds_6ebb77ac-a3aa-420f-9686-e5c31a6790a9" xlink:href="var-20221230.xsd#var_CorporateBonds"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_527b9de9-001f-4661-afa2-14b303c20015" xlink:to="loc_var_CorporateBonds_6ebb77ac-a3aa-420f-9686-e5c31a6790a9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_CommercialPaperReceivable_e0c179b8-4a83-4556-81e6-304c5249cfce" xlink:href="var-20221230.xsd#var_CommercialPaperReceivable"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_527b9de9-001f-4661-afa2-14b303c20015" xlink:to="loc_var_CommercialPaperReceivable_e0c179b8-4a83-4556-81e6-304c5249cfce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_5de29b71-866b-4092-8b12-16ed4526bc89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_527b9de9-001f-4661-afa2-14b303c20015" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_5de29b71-866b-4092-8b12-16ed4526bc89" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationPlanAssets_2b51a4a5-41fe-46c7-8afc-52859d766e81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationPlanAssets"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_527b9de9-001f-4661-afa2-14b303c20015" xlink:to="loc_us-gaap_DeferredCompensationPlanAssets_2b51a4a5-41fe-46c7-8afc-52859d766e81" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.varex.com/role/FAIRVALUESummaryofMarketableSecuritiesDetails" xlink:type="simple" xlink:href="var-20221230.xsd#FAIRVALUESummaryofMarketableSecuritiesDetails"/>
  <link:calculationLink xlink:role="http://www.varex.com/role/FAIRVALUESummaryofMarketableSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_var_MarketableSecuritiesAmortizedCost_42471a9a-0be4-4612-87a2-16a78517ee76" xlink:href="var-20221230.xsd#var_MarketableSecuritiesAmortizedCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_b9ea4f17-d618-449e-9a20-a3290918987e" xlink:href="var-20221230.xsd#var_MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_var_MarketableSecuritiesAmortizedCost_42471a9a-0be4-4612-87a2-16a78517ee76" xlink:to="loc_var_MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_b9ea4f17-d618-449e-9a20-a3290918987e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecurities_a2628bfc-ad49-4bd6-bfa7-ff6756346b6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_var_MarketableSecuritiesAmortizedCost_42471a9a-0be4-4612-87a2-16a78517ee76" xlink:to="loc_us-gaap_MarketableSecurities_a2628bfc-ad49-4bd6-bfa7-ff6756346b6f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.varex.com/role/FAIRVALUEContractualMaturitiesofMarketableSecuritiesDetails" xlink:type="simple" xlink:href="var-20221230.xsd#FAIRVALUEContractualMaturitiesofMarketableSecuritiesDetails"/>
  <link:calculationLink xlink:role="http://www.varex.com/role/FAIRVALUEContractualMaturitiesofMarketableSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecurities_c486c690-ab35-481f-bc0e-d1cd0d3c438e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecurities"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateYearOne_5dc22c0b-2ddb-436b-b285-fa240a86d907" xlink:href="var-20221230.xsd#var_MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateYearOne"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_MarketableSecurities_c486c690-ab35-481f-bc0e-d1cd0d3c438e" xlink:to="loc_var_MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateYearOne_5dc22c0b-2ddb-436b-b285-fa240a86d907" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughFive_abb82283-2f89-49e2-bbc6-a10544abd4b0" xlink:href="var-20221230.xsd#var_MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughFive"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_MarketableSecurities_c486c690-ab35-481f-bc0e-d1cd0d3c438e" xlink:to="loc_var_MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughFive_abb82283-2f89-49e2-bbc6-a10544abd4b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_MarketableSecuritiesAmortizedCost_42c4e06b-2871-4ed2-93e6-ae572fc1722b" xlink:href="var-20221230.xsd#var_MarketableSecuritiesAmortizedCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateRollingWithinOneYearAmortizedCost_b31b8809-0106-469b-b912-7edaee7c7514" xlink:href="var-20221230.xsd#var_MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateRollingWithinOneYearAmortizedCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_var_MarketableSecuritiesAmortizedCost_42c4e06b-2871-4ed2-93e6-ae572fc1722b" xlink:to="loc_var_MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateRollingWithinOneYearAmortizedCost_b31b8809-0106-469b-b912-7edaee7c7514" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateRollingAfterOneThroughFiveYearsAmortizedCost_62d1c7ef-a231-4c21-acb9-1370a0b0ced3" xlink:href="var-20221230.xsd#var_MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateRollingAfterOneThroughFiveYearsAmortizedCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_var_MarketableSecuritiesAmortizedCost_42c4e06b-2871-4ed2-93e6-ae572fc1722b" xlink:to="loc_var_MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateRollingAfterOneThroughFiveYearsAmortizedCost_62d1c7ef-a231-4c21-acb9-1370a0b0ced3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.varex.com/role/INVENTORIESSummaryofInventoryDetails" xlink:type="simple" xlink:href="var-20221230.xsd#INVENTORIESSummaryofInventoryDetails"/>
  <link:calculationLink xlink:role="http://www.varex.com/role/INVENTORIESSummaryofInventoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_e9b63a00-eb43-45af-83cc-d50eb53e83bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_6235933e-b3a0-4acb-9166-3f952e5b8420" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_e9b63a00-eb43-45af-83cc-d50eb53e83bf" xlink:to="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_6235933e-b3a0-4acb-9166-3f952e5b8420" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_c8631011-652f-4294-b7ad-e8fbba532645" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_e9b63a00-eb43-45af-83cc-d50eb53e83bf" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_c8631011-652f-4294-b7ad-e8fbba532645" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_2eaf2fd7-f38e-4a2e-841f-2f502a1b2c3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_e9b63a00-eb43-45af-83cc-d50eb53e83bf" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_2eaf2fd7-f38e-4a2e-841f-2f502a1b2c3c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.varex.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails" xlink:type="simple" xlink:href="var-20221230.xsd#GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.varex.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_208d4d15-29e7-4bd1-b309-5276a8890f47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_ec2697d7-7ace-4162-9e2a-75ecd87c9873" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_208d4d15-29e7-4bd1-b309-5276a8890f47" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_ec2697d7-7ace-4162-9e2a-75ecd87c9873" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_8d1c7a00-d65c-4538-acd5-975f95dd6e20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_208d4d15-29e7-4bd1-b309-5276a8890f47" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_8d1c7a00-d65c-4538-acd5-975f95dd6e20" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.varex.com/role/BORROWINGSScheduleofDebtDetails" xlink:type="simple" xlink:href="var-20221230.xsd#BORROWINGSScheduleofDebtDetails"/>
  <link:calculationLink xlink:role="http://www.varex.com/role/BORROWINGSScheduleofDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_6da63cf7-5add-45f6-ab2e-2ff3834aadc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_9cb17d85-b88e-4a86-94a1-3e482e79f652" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_6da63cf7-5add-45f6-ab2e-2ff3834aadc0" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_9cb17d85-b88e-4a86-94a1-3e482e79f652" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_ae330223-9e67-47bc-9c0f-174dba940493" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_6da63cf7-5add-45f6-ab2e-2ff3834aadc0" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_ae330223-9e67-47bc-9c0f-174dba940493" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_fd89ae0f-6e4f-4bf1-99e2-e6985f89f4dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_LongtermDebtExcludingCurrentMaturitiesGross_d89321ea-0c9d-412f-ba80-541f3118ed05" xlink:href="var-20221230.xsd#var_LongtermDebtExcludingCurrentMaturitiesGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_fd89ae0f-6e4f-4bf1-99e2-e6985f89f4dd" xlink:to="loc_var_LongtermDebtExcludingCurrentMaturitiesGross_d89321ea-0c9d-412f-ba80-541f3118ed05" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_906ce880-c6eb-4b26-9c62-cd26dbe64fa1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_fd89ae0f-6e4f-4bf1-99e2-e6985f89f4dd" xlink:to="loc_us-gaap_LongTermDebtCurrent_906ce880-c6eb-4b26-9c62-cd26dbe64fa1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_56284f72-499c-4fa8-a64b-e26ea33a08c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_fd89ae0f-6e4f-4bf1-99e2-e6985f89f4dd" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_56284f72-499c-4fa8-a64b-e26ea33a08c9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.varex.com/role/BORROWINGSScheduleofInterestExpenseDetails" xlink:type="simple" xlink:href="var-20221230.xsd#BORROWINGSScheduleofInterestExpenseDetails"/>
  <link:calculationLink xlink:role="http://www.varex.com/role/BORROWINGSScheduleofInterestExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_7d3761f1-313d-4ee9-a355-eaa68dedf793" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_InterestExpenseDebtContractualInterestCoupon_038cdce0-fda7-4a60-951b-eedb1fe3c814" xlink:href="var-20221230.xsd#var_InterestExpenseDebtContractualInterestCoupon"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestExpense_7d3761f1-313d-4ee9-a355-eaa68dedf793" xlink:to="loc_var_InterestExpenseDebtContractualInterestCoupon_038cdce0-fda7-4a60-951b-eedb1fe3c814" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_c2bf817b-ef86-4167-a60a-c0236fdb31cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestExpense_7d3761f1-313d-4ee9-a355-eaa68dedf793" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_c2bf817b-ef86-4167-a60a-c0236fdb31cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_78e4fa6c-ab67-4eaf-b8b5-077114e25ada" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestExpense_7d3761f1-313d-4ee9-a355-eaa68dedf793" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_78e4fa6c-ab67-4eaf-b8b5-077114e25ada" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.varex.com/role/NETINCOMEPERSHAREReconciliationofNumeratorandDenominatorforBasicandDilutedNetLossIncomePerCommonShareDetails" xlink:type="simple" xlink:href="var-20221230.xsd#NETINCOMEPERSHAREReconciliationofNumeratorandDenominatorforBasicandDilutedNetLossIncomePerCommonShareDetails"/>
  <link:calculationLink xlink:role="http://www.varex.com/role/NETINCOMEPERSHAREReconciliationofNumeratorandDenominatorforBasicandDilutedNetLossIncomePerCommonShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b89c8d16-d583-4eae-b4c1-57cd26e86c1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_2908df32-045a-4590-9d2a-06fe5945ce28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b89c8d16-d583-4eae-b4c1-57cd26e86c1e" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_2908df32-045a-4590-9d2a-06fe5945ce28" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_d3b83a2a-3405-4078-b9af-512c3768d4be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b89c8d16-d583-4eae-b4c1-57cd26e86c1e" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_d3b83a2a-3405-4078-b9af-512c3768d4be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_768b31bf-2540-4c56-a18a-bfcb6545f7f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b89c8d16-d583-4eae-b4c1-57cd26e86c1e" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_768b31bf-2540-4c56-a18a-bfcb6545f7f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_IncrementalCommonSharesAttributableToDilutiveEffectOfWarrants_26245931-3c2e-4a62-aa47-80d29c5c2cf5" xlink:href="var-20221230.xsd#var_IncrementalCommonSharesAttributableToDilutiveEffectOfWarrants"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b89c8d16-d583-4eae-b4c1-57cd26e86c1e" xlink:to="loc_var_IncrementalCommonSharesAttributableToDilutiveEffectOfWarrants_26245931-3c2e-4a62-aa47-80d29c5c2cf5" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>var-20221230_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:b10c8d19-453b-4af7-a4e1-32028a0718a8,g:e90e04e8-fae8-401c-8aa8-facd054e09fb-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited" xlink:type="simple" xlink:href="var-20221230.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"/>
  <link:definitionLink xlink:role="http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited" xlink:type="extended" id="i40c15349be8845b3b61e5354bcc573cf_CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_7cc21925-b466-43e8-8433-de702f484dbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b8334716-55cc-45fb-8fe3-9507595b1461" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7cc21925-b466-43e8-8433-de702f484dbd" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b8334716-55cc-45fb-8fe3-9507595b1461" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_7119346a-6a67-4b10-a6a8-d7f2d3c5d729" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b8334716-55cc-45fb-8fe3-9507595b1461" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_7119346a-6a67-4b10-a6a8-d7f2d3c5d729" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a110d843-4781-418f-82d8-80c93105f074" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b8334716-55cc-45fb-8fe3-9507595b1461" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a110d843-4781-418f-82d8-80c93105f074" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_b24baf99-94b3-4e3b-a19b-0083d189405f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b8334716-55cc-45fb-8fe3-9507595b1461" xlink:to="loc_us-gaap_ProfitLoss_b24baf99-94b3-4e3b-a19b-0083d189405f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_416e70fb-b14a-4a32-92b4-7ff7eb1c3ed0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b8334716-55cc-45fb-8fe3-9507595b1461" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_416e70fb-b14a-4a32-92b4-7ff7eb1c3ed0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_c818c585-8a01-4e9e-85a3-b09f31c3145a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b8334716-55cc-45fb-8fe3-9507595b1461" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_c818c585-8a01-4e9e-85a3-b09f31c3145a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_22555fc6-0fa8-4567-a851-bbee4fc90b6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b8334716-55cc-45fb-8fe3-9507595b1461" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_22555fc6-0fa8-4567-a851-bbee4fc90b6c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_92dd3e4b-7d6c-4d6a-8e77-6ad10bd5f1e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b8334716-55cc-45fb-8fe3-9507595b1461" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_92dd3e4b-7d6c-4d6a-8e77-6ad10bd5f1e9" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_f1cb0b91-a706-401e-bab8-7deeb408b409" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b8334716-55cc-45fb-8fe3-9507595b1461" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_f1cb0b91-a706-401e-bab8-7deeb408b409" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_fd9b7acc-42dc-414c-8cdc-8db8ecf60e3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b8334716-55cc-45fb-8fe3-9507595b1461" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_fd9b7acc-42dc-414c-8cdc-8db8ecf60e3d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther_5a7c88f5-71e6-4cb9-9c16-374406ef35f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b8334716-55cc-45fb-8fe3-9507595b1461" xlink:to="loc_us-gaap_StockholdersEquityOther_5a7c88f5-71e6-4cb9-9c16-374406ef35f5" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_01b46e53-9a15-4283-ae6f-08d2aa6f0050" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5c47b008-22d2-440e-a63d-b033a18607c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_b4c4f463-42b8-49eb-90db-0144da07548f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7cc21925-b466-43e8-8433-de702f484dbd" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_b4c4f463-42b8-49eb-90db-0144da07548f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_fdceabb5-ebcb-4426-bf6f-535d47dd5933" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_7cc21925-b466-43e8-8433-de702f484dbd" xlink:to="loc_us-gaap_StatementTable_fdceabb5-ebcb-4426-bf6f-535d47dd5933" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_e46932d9-8793-46ce-bdbf-da90ee1b02d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_fdceabb5-ebcb-4426-bf6f-535d47dd5933" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_e46932d9-8793-46ce-bdbf-da90ee1b02d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_e46932d9-8793-46ce-bdbf-da90ee1b02d8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_e46932d9-8793-46ce-bdbf-da90ee1b02d8" xlink:to="loc_us-gaap_EquityComponentDomain_e46932d9-8793-46ce-bdbf-da90ee1b02d8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_dd677fb7-64f9-44a4-9d81-a1dce7f64914" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_e46932d9-8793-46ce-bdbf-da90ee1b02d8" xlink:to="loc_us-gaap_EquityComponentDomain_dd677fb7-64f9-44a4-9d81-a1dce7f64914" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_68cb615b-7568-428e-b387-c3a9547391e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_dd677fb7-64f9-44a4-9d81-a1dce7f64914" xlink:to="loc_us-gaap_ParentMember_68cb615b-7568-428e-b387-c3a9547391e5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_77965864-c7ca-4eff-99fb-2b4dcfa75c59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_68cb615b-7568-428e-b387-c3a9547391e5" xlink:to="loc_us-gaap_CommonStockMember_77965864-c7ca-4eff-99fb-2b4dcfa75c59" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_ce611bf0-fa01-4b01-bbf0-4b16298c2dc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_68cb615b-7568-428e-b387-c3a9547391e5" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_ce611bf0-fa01-4b01-bbf0-4b16298c2dc4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_84bae6ef-737a-47a9-b103-357eb7215f60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_68cb615b-7568-428e-b387-c3a9547391e5" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_84bae6ef-737a-47a9-b103-357eb7215f60" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_b4aefad2-3766-418e-9f0b-733005d5ceb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_68cb615b-7568-428e-b387-c3a9547391e5" xlink:to="loc_us-gaap_RetainedEarningsMember_b4aefad2-3766-418e-9f0b-733005d5ceb3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_b42e37b8-74b9-4fda-9744-dde0ab6bb965" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_dd677fb7-64f9-44a4-9d81-a1dce7f64914" xlink:to="loc_us-gaap_NoncontrollingInterestMember_b42e37b8-74b9-4fda-9744-dde0ab6bb965" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_fa6a0c27-0882-4133-aa9f-77b0080075b9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_fdceabb5-ebcb-4426-bf6f-535d47dd5933" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_fa6a0c27-0882-4133-aa9f-77b0080075b9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_fa6a0c27-0882-4133-aa9f-77b0080075b9_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_fa6a0c27-0882-4133-aa9f-77b0080075b9" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_fa6a0c27-0882-4133-aa9f-77b0080075b9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_39f9127e-81c7-4356-bdd0-92b255db457f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_fa6a0c27-0882-4133-aa9f-77b0080075b9" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_39f9127e-81c7-4356-bdd0-92b255db457f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_94db8443-0b41-4e26-88d9-8e24162129d1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_39f9127e-81c7-4356-bdd0-92b255db457f" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_94db8443-0b41-4e26-88d9-8e24162129d1" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESCustomerConcentrationRiskDetails" xlink:type="simple" xlink:href="var-20221230.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESCustomerConcentrationRiskDetails"/>
  <link:definitionLink xlink:role="http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESCustomerConcentrationRiskDetails" xlink:type="extended" id="if463a32cd7dc4059bcf708e54194afe6_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESCustomerConcentrationRiskDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_427c0021-5500-4706-8fc9-828971d4d695" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_f2d1a4e4-a74d-4a03-915d-59fe71c5a707" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_427c0021-5500-4706-8fc9-828971d4d695" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_f2d1a4e4-a74d-4a03-915d-59fe71c5a707" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_295a32c0-c992-4fbe-9d71-0edf35cadb17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_427c0021-5500-4706-8fc9-828971d4d695" xlink:to="loc_us-gaap_ConcentrationRiskTable_295a32c0-c992-4fbe-9d71-0edf35cadb17" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_bcf26b29-3cdb-442a-bb62-2e605ebfee92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_295a32c0-c992-4fbe-9d71-0edf35cadb17" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_bcf26b29-3cdb-442a-bb62-2e605ebfee92" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_bcf26b29-3cdb-442a-bb62-2e605ebfee92_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_bcf26b29-3cdb-442a-bb62-2e605ebfee92" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_bcf26b29-3cdb-442a-bb62-2e605ebfee92_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_3c6e7d87-d116-4a4f-ab4d-e213d4aa6686" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_bcf26b29-3cdb-442a-bb62-2e605ebfee92" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_3c6e7d87-d116-4a4f-ab4d-e213d4aa6686" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_0ede9f43-2ded-4f20-85b6-5ce0d190297e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_3c6e7d87-d116-4a4f-ab4d-e213d4aa6686" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_0ede9f43-2ded-4f20-85b6-5ce0d190297e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_b34a6404-8a9a-4135-b772-ccbe13cf14fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_295a32c0-c992-4fbe-9d71-0edf35cadb17" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_b34a6404-8a9a-4135-b772-ccbe13cf14fd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_b34a6404-8a9a-4135-b772-ccbe13cf14fd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_b34a6404-8a9a-4135-b772-ccbe13cf14fd" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_b34a6404-8a9a-4135-b772-ccbe13cf14fd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_2471535f-34d7-4c75-8e0a-b9ce4326454a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_b34a6404-8a9a-4135-b772-ccbe13cf14fd" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_2471535f-34d7-4c75-8e0a-b9ce4326454a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember_03223fbb-d101-4e9c-89e5-71028dfc9264" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_2471535f-34d7-4c75-8e0a-b9ce4326454a" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerMember_03223fbb-d101-4e9c-89e5-71028dfc9264" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_ee2bf0c4-daf5-483b-bc63-43fac340e1fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_2471535f-34d7-4c75-8e0a-b9ce4326454a" xlink:to="loc_us-gaap_AccountsReceivableMember_ee2bf0c4-daf5-483b-bc63-43fac340e1fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_abbf2d67-f0fa-4c46-8264-3f215409e15c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_295a32c0-c992-4fbe-9d71-0edf35cadb17" xlink:to="loc_srt_MajorCustomersAxis_abbf2d67-f0fa-4c46-8264-3f215409e15c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_abbf2d67-f0fa-4c46-8264-3f215409e15c_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_abbf2d67-f0fa-4c46-8264-3f215409e15c" xlink:to="loc_srt_NameOfMajorCustomerDomain_abbf2d67-f0fa-4c46-8264-3f215409e15c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_eab6cc40-1bb7-4d44-aed1-52e3db0135cf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_abbf2d67-f0fa-4c46-8264-3f215409e15c" xlink:to="loc_srt_NameOfMajorCustomerDomain_eab6cc40-1bb7-4d44-aed1-52e3db0135cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_CanonMedicalSystemsCorporationFormerlyToshibaMedicalSystemsMember_b07888e2-a353-43c4-b604-17f0c0a1706a" xlink:href="var-20221230.xsd#var_CanonMedicalSystemsCorporationFormerlyToshibaMedicalSystemsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_eab6cc40-1bb7-4d44-aed1-52e3db0135cf" xlink:to="loc_var_CanonMedicalSystemsCorporationFormerlyToshibaMedicalSystemsMember_b07888e2-a353-43c4-b604-17f0c0a1706a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESProductWarrantyDetails" xlink:type="simple" xlink:href="var-20221230.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESProductWarrantyDetails"/>
  <link:definitionLink xlink:role="http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESProductWarrantyDetails" xlink:type="extended" id="i2ef310f00fb74522bd862530452fa772_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESProductWarrantyDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyLiabilityLineItems_0bd87347-8e64-45a7-b8b4-fe06b1945310" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductWarrantyLiabilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_WarrantyTerm_8af8c02c-2fb9-48b7-bd93-5c6ffe6868f0" xlink:href="var-20221230.xsd#var_WarrantyTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductWarrantyLiabilityLineItems_0bd87347-8e64-45a7-b8b4-fe06b1945310" xlink:to="loc_var_WarrantyTerm_8af8c02c-2fb9-48b7-bd93-5c6ffe6868f0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_4a3827fd-5713-401f-a487-65f16c825451" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MovementInStandardProductWarrantyAccrualRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductWarrantyLiabilityLineItems_0bd87347-8e64-45a7-b8b4-fe06b1945310" xlink:to="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_4a3827fd-5713-401f-a487-65f16c825451" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrual_cd25ed03-ac40-47f3-8047-dae39703263c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StandardProductWarrantyAccrual"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_4a3827fd-5713-401f-a487-65f16c825451" xlink:to="loc_us-gaap_StandardProductWarrantyAccrual_cd25ed03-ac40-47f3-8047-dae39703263c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued_db506ce3-c287-4628-8ecb-0d672bdba793" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StandardProductWarrantyAccrualWarrantiesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_4a3827fd-5713-401f-a487-65f16c825451" xlink:to="loc_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued_db506ce3-c287-4628-8ecb-0d672bdba793" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrualPayments_343aff53-ee50-4ee1-bb9a-758cbc76e5d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StandardProductWarrantyAccrualPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_4a3827fd-5713-401f-a487-65f16c825451" xlink:to="loc_us-gaap_StandardProductWarrantyAccrualPayments_343aff53-ee50-4ee1-bb9a-758cbc76e5d9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrual_418761bc-64ce-4ac8-a102-2fc5c291669b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StandardProductWarrantyAccrual"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyLiabilityTable_bb173035-706d-4543-8fdd-8444f61fc49b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductWarrantyLiabilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ProductWarrantyLiabilityLineItems_0bd87347-8e64-45a7-b8b4-fe06b1945310" xlink:to="loc_us-gaap_ProductWarrantyLiabilityTable_bb173035-706d-4543-8fdd-8444f61fc49b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d93b43d1-19fc-4fbe-80a2-50170b62391e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ProductWarrantyLiabilityTable_bb173035-706d-4543-8fdd-8444f61fc49b" xlink:to="loc_srt_RangeAxis_d93b43d1-19fc-4fbe-80a2-50170b62391e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d93b43d1-19fc-4fbe-80a2-50170b62391e_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_d93b43d1-19fc-4fbe-80a2-50170b62391e" xlink:to="loc_srt_RangeMember_d93b43d1-19fc-4fbe-80a2-50170b62391e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b538b371-c16d-440d-b603-0e30ac0597d7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_d93b43d1-19fc-4fbe-80a2-50170b62391e" xlink:to="loc_srt_RangeMember_b538b371-c16d-440d-b603-0e30ac0597d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_5958e6f5-3ff0-4474-aeb0-a4927ab79d01" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_b538b371-c16d-440d-b603-0e30ac0597d7" xlink:to="loc_srt_MinimumMember_5958e6f5-3ff0-4474-aeb0-a4927ab79d01" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_33c5af32-8746-481f-a5b1-7c3c5421ea36" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_b538b371-c16d-440d-b603-0e30ac0597d7" xlink:to="loc_srt_MaximumMember_33c5af32-8746-481f-a5b1-7c3c5421ea36" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRecentlyAdoptedAccountingStandardsDetails" xlink:type="simple" xlink:href="var-20221230.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRecentlyAdoptedAccountingStandardsDetails"/>
  <link:definitionLink xlink:role="http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRecentlyAdoptedAccountingStandardsDetails" xlink:type="extended" id="i0973e4ecd35640ae9d01097676b5fd96_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRecentlyAdoptedAccountingStandardsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_9c726640-34b5-4dca-b927-ddc1e0f5eb14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_dbe0be7c-12b2-4233-802a-ef66e8ff33cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9c726640-34b5-4dca-b927-ddc1e0f5eb14" xlink:to="loc_us-gaap_AdditionalPaidInCapital_dbe0be7c-12b2-4233-802a-ef66e8ff33cc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_be7d339c-a539-4529-b1f5-3e801d429922" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9c726640-34b5-4dca-b927-ddc1e0f5eb14" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_be7d339c-a539-4529-b1f5-3e801d429922" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_b2fc8555-a729-49d3-957d-9ce8b5d03445" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9c726640-34b5-4dca-b927-ddc1e0f5eb14" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_b2fc8555-a729-49d3-957d-9ce8b5d03445" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_15ed22b4-3fe0-4d66-aba4-9c1a85add082" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9c726640-34b5-4dca-b927-ddc1e0f5eb14" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_15ed22b4-3fe0-4d66-aba4-9c1a85add082" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_9ac97037-ea10-43c4-9c50-e6069d0f01d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9c726640-34b5-4dca-b927-ddc1e0f5eb14" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_9ac97037-ea10-43c4-9c50-e6069d0f01d9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_6fe42ba3-2875-435a-be1b-29132577d3a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9c726640-34b5-4dca-b927-ddc1e0f5eb14" xlink:to="loc_us-gaap_DebtInstrumentTable_6fe42ba3-2875-435a-be1b-29132577d3a6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_fbc8cae3-e0e3-4f93-a3d5-905e1f4c0de8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_6fe42ba3-2875-435a-be1b-29132577d3a6" xlink:to="loc_us-gaap_DebtInstrumentAxis_fbc8cae3-e0e3-4f93-a3d5-905e1f4c0de8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_fbc8cae3-e0e3-4f93-a3d5-905e1f4c0de8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_fbc8cae3-e0e3-4f93-a3d5-905e1f4c0de8" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_fbc8cae3-e0e3-4f93-a3d5-905e1f4c0de8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_04b54bc5-e292-4bbd-b1b9-f6fddd1b1916" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_fbc8cae3-e0e3-4f93-a3d5-905e1f4c0de8" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_04b54bc5-e292-4bbd-b1b9-f6fddd1b1916" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_ConvertibleNotesMember_34618b4c-5829-4f43-8510-f48209acc693" xlink:href="var-20221230.xsd#var_ConvertibleNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_04b54bc5-e292-4bbd-b1b9-f6fddd1b1916" xlink:to="loc_var_ConvertibleNotesMember_34618b4c-5829-4f43-8510-f48209acc693" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_30d961fa-a3ed-4ce2-91b9-b862e4967a8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_6fe42ba3-2875-435a-be1b-29132577d3a6" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_30d961fa-a3ed-4ce2-91b9-b862e4967a8b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_30d961fa-a3ed-4ce2-91b9-b862e4967a8b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_30d961fa-a3ed-4ce2-91b9-b862e4967a8b" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_30d961fa-a3ed-4ce2-91b9-b862e4967a8b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_bbc3134e-cc48-46a9-83bc-bbf103c69758" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_30d961fa-a3ed-4ce2-91b9-b862e4967a8b" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_bbc3134e-cc48-46a9-83bc-bbf103c69758" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_58bec2da-4e67-44a9-829f-978c53c38844" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_bbc3134e-cc48-46a9-83bc-bbf103c69758" xlink:to="loc_us-gaap_ConvertibleDebtMember_58bec2da-4e67-44a9-829f-978c53c38844" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_8243237f-3622-4c4f-9e6d-f1e3d729df1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_6fe42ba3-2875-435a-be1b-29132577d3a6" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_8243237f-3622-4c4f-9e6d-f1e3d729df1c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_8243237f-3622-4c4f-9e6d-f1e3d729df1c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_8243237f-3622-4c4f-9e6d-f1e3d729df1c" xlink:to="loc_us-gaap_TypeOfAdoptionMember_8243237f-3622-4c4f-9e6d-f1e3d729df1c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_4f3feeb1-9179-4449-b9bf-64a89e7573b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_8243237f-3622-4c4f-9e6d-f1e3d729df1c" xlink:to="loc_us-gaap_TypeOfAdoptionMember_4f3feeb1-9179-4449-b9bf-64a89e7573b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202006Member_b87b9d62-fc6f-4915-8103-55d986531fc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate202006Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_4f3feeb1-9179-4449-b9bf-64a89e7573b7" xlink:to="loc_us-gaap_AccountingStandardsUpdate202006Member_b87b9d62-fc6f-4915-8103-55d986531fc8" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.varex.com/role/REVENUEDisaggregationofRevenueDetails" xlink:type="simple" xlink:href="var-20221230.xsd#REVENUEDisaggregationofRevenueDetails"/>
  <link:definitionLink xlink:role="http://www.varex.com/role/REVENUEDisaggregationofRevenueDetails" xlink:type="extended" id="ia0f21a5905f74f7c852298411f65736d_REVENUEDisaggregationofRevenueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_5ef7f789-56db-4dcf-ae96-0ba7d6315207" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_26ed6eb9-595c-4b03-a7a2-1d9b41096d3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_5ef7f789-56db-4dcf-ae96-0ba7d6315207" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_26ed6eb9-595c-4b03-a7a2-1d9b41096d3f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_e4f54849-0848-4c56-90c8-8242f33e9f55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_5ef7f789-56db-4dcf-ae96-0ba7d6315207" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_e4f54849-0848-4c56-90c8-8242f33e9f55" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_b8c1046e-8958-4486-98af-35f79d6b54c8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_e4f54849-0848-4c56-90c8-8242f33e9f55" xlink:to="loc_srt_StatementGeographicalAxis_b8c1046e-8958-4486-98af-35f79d6b54c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_b8c1046e-8958-4486-98af-35f79d6b54c8_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_b8c1046e-8958-4486-98af-35f79d6b54c8" xlink:to="loc_srt_SegmentGeographicalDomain_b8c1046e-8958-4486-98af-35f79d6b54c8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_3cb94f35-cb1a-4d5e-b4ed-6cb3877187b3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_b8c1046e-8958-4486-98af-35f79d6b54c8" xlink:to="loc_srt_SegmentGeographicalDomain_3cb94f35-cb1a-4d5e-b4ed-6cb3877187b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AmericasMember_84d23693-b4a8-4573-aab0-b3f3b50a0218" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AmericasMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_3cb94f35-cb1a-4d5e-b4ed-6cb3877187b3" xlink:to="loc_srt_AmericasMember_84d23693-b4a8-4573-aab0-b3f3b50a0218" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember_b1568733-eff5-4f7f-a215-121261b1e7fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EMEAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_3cb94f35-cb1a-4d5e-b4ed-6cb3877187b3" xlink:to="loc_us-gaap_EMEAMember_b1568733-eff5-4f7f-a215-121261b1e7fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_341e89d9-8b77-4808-bd50-8fce594a460a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AsiaPacificMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_3cb94f35-cb1a-4d5e-b4ed-6cb3877187b3" xlink:to="loc_srt_AsiaPacificMember_341e89d9-8b77-4808-bd50-8fce594a460a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_6af4cddc-1cf5-4578-8391-1c3fd00b1aa8" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_3cb94f35-cb1a-4d5e-b4ed-6cb3877187b3" xlink:to="loc_country_US_6af4cddc-1cf5-4578-8391-1c3fd00b1aa8" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.varex.com/role/RELATEDPARTYTRANSACTIONSInvestmentinPrivatelyHeldCompaniesDetails" xlink:type="simple" xlink:href="var-20221230.xsd#RELATEDPARTYTRANSACTIONSInvestmentinPrivatelyHeldCompaniesDetails"/>
  <link:definitionLink xlink:role="http://www.varex.com/role/RELATEDPARTYTRANSACTIONSInvestmentinPrivatelyHeldCompaniesDetails" xlink:type="extended" id="id7d902d9141d4e56a4ee5a20ef8fb60f_RELATEDPARTYTRANSACTIONSInvestmentinPrivatelyHeldCompaniesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_ebd5b9f5-1869-4c8a-be60-591f71ce9ed0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_ffabcd94-d4f8-454d-b0ef-4ad98390e2d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_ebd5b9f5-1869-4c8a-be60-591f71ce9ed0" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_ffabcd94-d4f8-454d-b0ef-4ad98390e2d9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_464dc59f-90c1-4fd3-86de-f305dd62ef94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_ebd5b9f5-1869-4c8a-be60-591f71ce9ed0" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_464dc59f-90c1-4fd3-86de-f305dd62ef94" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_53a695f8-e3f3-49ad-8d4d-a894d771b31b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_ebd5b9f5-1869-4c8a-be60-591f71ce9ed0" xlink:to="loc_us-gaap_EquityMethodInvestments_53a695f8-e3f3-49ad-8d4d-a894d771b31b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty_9bda4bcc-6594-4899-87f0-508c7cdbe6c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_ebd5b9f5-1869-4c8a-be60-591f71ce9ed0" xlink:to="loc_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty_9bda4bcc-6594-4899-87f0-508c7cdbe6c1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent_2985a5af-4731-4dbd-8cd6-06d3029b7b3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_ebd5b9f5-1869-4c8a-be60-591f71ce9ed0" xlink:to="loc_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent_2985a5af-4731-4dbd-8cd6-06d3029b7b3d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_PercentageOfManufacturingCapacity_b72165b3-3f29-4142-883c-333c95b53c2d" xlink:href="var-20221230.xsd#var_PercentageOfManufacturingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_ebd5b9f5-1869-4c8a-be60-591f71ce9ed0" xlink:to="loc_var_PercentageOfManufacturingCapacity_b72165b3-3f29-4142-883c-333c95b53c2d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_PercentageOfFixedCosts_df5e21da-25c8-487a-aaab-a11460c23b51" xlink:href="var-20221230.xsd#var_PercentageOfFixedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_ebd5b9f5-1869-4c8a-be60-591f71ce9ed0" xlink:to="loc_var_PercentageOfFixedCosts_df5e21da-25c8-487a-aaab-a11460c23b51" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_RelatedPartyTransactionApprovedPurchasesFromRelatedParty_73be8678-c95a-4151-9b1b-5232c436a702" xlink:href="var-20221230.xsd#var_RelatedPartyTransactionApprovedPurchasesFromRelatedParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_ebd5b9f5-1869-4c8a-be60-591f71ce9ed0" xlink:to="loc_var_RelatedPartyTransactionApprovedPurchasesFromRelatedParty_73be8678-c95a-4151-9b1b-5232c436a702" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent_8777bb08-248e-4de1-acb1-a262ec7d8a87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_ebd5b9f5-1869-4c8a-be60-591f71ce9ed0" xlink:to="loc_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent_8777bb08-248e-4de1-acb1-a262ec7d8a87" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivables_82016cbd-c945-4ae4-a304-2c7729d2d7a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_ebd5b9f5-1869-4c8a-be60-591f71ce9ed0" xlink:to="loc_us-gaap_OtherReceivables_82016cbd-c945-4ae4-a304-2c7729d2d7a0" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_6c8143bf-d3cd-47d7-bc5e-0b87ce1a6c8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_ebd5b9f5-1869-4c8a-be60-591f71ce9ed0" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_6c8143bf-d3cd-47d7-bc5e-0b87ce1a6c8c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_86a71025-f52d-459c-8ce7-d091b0ba7ee3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_6c8143bf-d3cd-47d7-bc5e-0b87ce1a6c8c" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_86a71025-f52d-459c-8ce7-d091b0ba7ee3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_86a71025-f52d-459c-8ce7-d091b0ba7ee3_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_86a71025-f52d-459c-8ce7-d091b0ba7ee3" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_86a71025-f52d-459c-8ce7-d091b0ba7ee3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_ef2f5557-1a6f-4192-bcf3-dcb85081a94b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_86a71025-f52d-459c-8ce7-d091b0ba7ee3" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_ef2f5557-1a6f-4192-bcf3-dcb85081a94b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_DpiXHoldingMember_da877d4d-5591-41fd-b1e2-0e39b84a5824" xlink:href="var-20221230.xsd#var_DpiXHoldingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_ef2f5557-1a6f-4192-bcf3-dcb85081a94b" xlink:to="loc_var_DpiXHoldingMember_da877d4d-5591-41fd-b1e2-0e39b84a5824" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_VECImagingGmbHCo.KGMember_d4bdca03-c6a4-417b-a336-50a4622db4e0" xlink:href="var-20221230.xsd#var_VECImagingGmbHCo.KGMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_ef2f5557-1a6f-4192-bcf3-dcb85081a94b" xlink:to="loc_var_VECImagingGmbHCo.KGMember_d4bdca03-c6a4-417b-a336-50a4622db4e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_DpiXLLCMember_8da03881-6799-4235-ae61-be978db979e9" xlink:href="var-20221230.xsd#var_DpiXLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_ef2f5557-1a6f-4192-bcf3-dcb85081a94b" xlink:to="loc_var_DpiXLLCMember_8da03881-6799-4235-ae61-be978db979e9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_4c3da058-73a2-4dbb-8e16-e58963d4e1d0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_6c8143bf-d3cd-47d7-bc5e-0b87ce1a6c8c" xlink:to="loc_srt_OwnershipAxis_4c3da058-73a2-4dbb-8e16-e58963d4e1d0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_4c3da058-73a2-4dbb-8e16-e58963d4e1d0_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_4c3da058-73a2-4dbb-8e16-e58963d4e1d0" xlink:to="loc_srt_OwnershipDomain_4c3da058-73a2-4dbb-8e16-e58963d4e1d0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_b351ec11-bf44-44a9-bada-c45436fe24fe" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_4c3da058-73a2-4dbb-8e16-e58963d4e1d0" xlink:to="loc_srt_OwnershipDomain_b351ec11-bf44-44a9-bada-c45436fe24fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_DpiXLLCMember_4f99b243-bdf9-42d2-8ca0-eb2c843c3eb7" xlink:href="var-20221230.xsd#var_DpiXLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_b351ec11-bf44-44a9-bada-c45436fe24fe" xlink:to="loc_var_DpiXLLCMember_4f99b243-bdf9-42d2-8ca0-eb2c843c3eb7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_DpiXHoldingMember_ae0fa668-2806-465c-88a5-656f2c4e7e02" xlink:href="var-20221230.xsd#var_DpiXHoldingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_b351ec11-bf44-44a9-bada-c45436fe24fe" xlink:to="loc_var_DpiXHoldingMember_ae0fa668-2806-465c-88a5-656f2c4e7e02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_571b1a19-fe75-4167-8a69-920a4f9de748" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_6c8143bf-d3cd-47d7-bc5e-0b87ce1a6c8c" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_571b1a19-fe75-4167-8a69-920a4f9de748" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_571b1a19-fe75-4167-8a69-920a4f9de748_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_571b1a19-fe75-4167-8a69-920a4f9de748" xlink:to="loc_us-gaap_RelatedPartyDomain_571b1a19-fe75-4167-8a69-920a4f9de748_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_98db1c20-5875-4329-870a-0b7de9bbd256" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_571b1a19-fe75-4167-8a69-920a4f9de748" xlink:to="loc_us-gaap_RelatedPartyDomain_98db1c20-5875-4329-870a-0b7de9bbd256" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvesteeMember_c48ea87d-5777-4ee2-aa63-317077a1541c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvesteeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_98db1c20-5875-4329-870a-0b7de9bbd256" xlink:to="loc_us-gaap_EquityMethodInvesteeMember_c48ea87d-5777-4ee2-aa63-317077a1541c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_066fbe8b-e45b-4b1f-a2f0-f92f6e84fa33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_6c8143bf-d3cd-47d7-bc5e-0b87ce1a6c8c" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_066fbe8b-e45b-4b1f-a2f0-f92f6e84fa33" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_066fbe8b-e45b-4b1f-a2f0-f92f6e84fa33_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_066fbe8b-e45b-4b1f-a2f0-f92f6e84fa33" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_066fbe8b-e45b-4b1f-a2f0-f92f6e84fa33_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_fc6e843c-2bb9-4f35-b680-1bf6bbe5c1a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_066fbe8b-e45b-4b1f-a2f0-f92f6e84fa33" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_fc6e843c-2bb9-4f35-b680-1bf6bbe5c1a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_FixedCostCommitmentsMember_e3d4f742-a1c9-46fa-a062-560112f2ad4d" xlink:href="var-20221230.xsd#var_FixedCostCommitmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_fc6e843c-2bb9-4f35-b680-1bf6bbe5c1a0" xlink:to="loc_var_FixedCostCommitmentsMember_e3d4f742-a1c9-46fa-a062-560112f2ad4d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_8e3003f4-7db9-44cd-b49a-c089ceaf90f6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_6c8143bf-d3cd-47d7-bc5e-0b87ce1a6c8c" xlink:to="loc_srt_StatementScenarioAxis_8e3003f4-7db9-44cd-b49a-c089ceaf90f6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_8e3003f4-7db9-44cd-b49a-c089ceaf90f6_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_8e3003f4-7db9-44cd-b49a-c089ceaf90f6" xlink:to="loc_srt_ScenarioUnspecifiedDomain_8e3003f4-7db9-44cd-b49a-c089ceaf90f6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_bb21e53d-3737-4c42-8683-1e3e10d4de53" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_8e3003f4-7db9-44cd-b49a-c089ceaf90f6" xlink:to="loc_srt_ScenarioUnspecifiedDomain_bb21e53d-3737-4c42-8683-1e3e10d4de53" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_80217ff3-77d6-4740-a7dd-1477b0a4cbaf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_bb21e53d-3737-4c42-8683-1e3e10d4de53" xlink:to="loc_srt_ScenarioForecastMember_80217ff3-77d6-4740-a7dd-1477b0a4cbaf" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.varex.com/role/FINANCIALDERIVATIVESANDHEDGINGACTIVITIESSummaryofDerivativeInstrumentsDetails" xlink:type="simple" xlink:href="var-20221230.xsd#FINANCIALDERIVATIVESANDHEDGINGACTIVITIESSummaryofDerivativeInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.varex.com/role/FINANCIALDERIVATIVESANDHEDGINGACTIVITIESSummaryofDerivativeInstrumentsDetails" xlink:type="extended" id="ic0248a2138144efea4d1280b1c88ba45_FINANCIALDERIVATIVESANDHEDGINGACTIVITIESSummaryofDerivativeInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_e1cb58ed-e213-4ff7-aa09-c4abb6ecdf6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNumberOfInstrumentsHeld_6bc2b27f-b6e4-4d7c-8fde-d370c86693e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNumberOfInstrumentsHeld"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_e1cb58ed-e213-4ff7-aa09-c4abb6ecdf6a" xlink:to="loc_us-gaap_DerivativeNumberOfInstrumentsHeld_6bc2b27f-b6e4-4d7c-8fde-d370c86693e9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_d9e322c1-8098-4625-91a7-c08429bc3e88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_e1cb58ed-e213-4ff7-aa09-c4abb6ecdf6a" xlink:to="loc_us-gaap_DerivativeNotionalAmount_d9e322c1-8098-4625-91a7-c08429bc3e88" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_1ff33744-f4a0-4676-a1d6-6ed04000792e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_e1cb58ed-e213-4ff7-aa09-c4abb6ecdf6a" xlink:to="loc_us-gaap_DerivativeTable_1ff33744-f4a0-4676-a1d6-6ed04000792e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_5b6bcee4-1bfe-44dc-a852-970a4047344c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_1ff33744-f4a0-4676-a1d6-6ed04000792e" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_5b6bcee4-1bfe-44dc-a852-970a4047344c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_5b6bcee4-1bfe-44dc-a852-970a4047344c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_5b6bcee4-1bfe-44dc-a852-970a4047344c" xlink:to="loc_us-gaap_HedgingRelationshipDomain_5b6bcee4-1bfe-44dc-a852-970a4047344c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_24dfda7c-761a-45a1-850d-7a4b7bdfdc3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_5b6bcee4-1bfe-44dc-a852-970a4047344c" xlink:to="loc_us-gaap_HedgingRelationshipDomain_24dfda7c-761a-45a1-850d-7a4b7bdfdc3b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_412f82fc-b587-44a6-ba0e-798c03cde081" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_24dfda7c-761a-45a1-850d-7a4b7bdfdc3b" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_412f82fc-b587-44a6-ba0e-798c03cde081" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_bccb1bf9-3ced-42a9-aa6b-70ac53a1dbc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_1ff33744-f4a0-4676-a1d6-6ed04000792e" xlink:to="loc_us-gaap_HedgingDesignationAxis_bccb1bf9-3ced-42a9-aa6b-70ac53a1dbc5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_bccb1bf9-3ced-42a9-aa6b-70ac53a1dbc5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_bccb1bf9-3ced-42a9-aa6b-70ac53a1dbc5" xlink:to="loc_us-gaap_HedgingDesignationDomain_bccb1bf9-3ced-42a9-aa6b-70ac53a1dbc5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_9c178681-4b3b-450e-bf6d-b5aa039b8e39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_bccb1bf9-3ced-42a9-aa6b-70ac53a1dbc5" xlink:to="loc_us-gaap_HedgingDesignationDomain_9c178681-4b3b-450e-bf6d-b5aa039b8e39" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_0a3d3d07-3719-4d13-9afb-55300860edb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_9c178681-4b3b-450e-bf6d-b5aa039b8e39" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_0a3d3d07-3719-4d13-9afb-55300860edb8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_db14e9f9-3c72-40cd-a5bd-6f0b393eb857" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_1ff33744-f4a0-4676-a1d6-6ed04000792e" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_db14e9f9-3c72-40cd-a5bd-6f0b393eb857" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_db14e9f9-3c72-40cd-a5bd-6f0b393eb857_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_db14e9f9-3c72-40cd-a5bd-6f0b393eb857" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_db14e9f9-3c72-40cd-a5bd-6f0b393eb857_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_1169b616-f87b-4171-8f31-cbe4ac978185" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_db14e9f9-3c72-40cd-a5bd-6f0b393eb857" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_1169b616-f87b-4171-8f31-cbe4ac978185" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_883c0eb7-2293-4c44-b0d9-7758051318fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1169b616-f87b-4171-8f31-cbe4ac978185" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_883c0eb7-2293-4c44-b0d9-7758051318fe" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.varex.com/role/FINANCIALDERIVATIVESANDHEDGINGACTIVITIESSummaryofIncomeRecognizedFromDerivativeInstrumentsDetails" xlink:type="simple" xlink:href="var-20221230.xsd#FINANCIALDERIVATIVESANDHEDGINGACTIVITIESSummaryofIncomeRecognizedFromDerivativeInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.varex.com/role/FINANCIALDERIVATIVESANDHEDGINGACTIVITIESSummaryofIncomeRecognizedFromDerivativeInstrumentsDetails" xlink:type="extended" id="i5b7dec7710394a7499b085ec0612d43c_FINANCIALDERIVATIVESANDHEDGINGACTIVITIESSummaryofIncomeRecognizedFromDerivativeInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_9f8db69f-0709-4f2a-a4e1-0a52ee856d43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_1c3f80b8-93e8-445d-b957-0f48fab472d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_9f8db69f-0709-4f2a-a4e1-0a52ee856d43" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_1c3f80b8-93e8-445d-b957-0f48fab472d3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_220460e2-0fdc-4349-a33f-4dfb581e9433" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_9f8db69f-0709-4f2a-a4e1-0a52ee856d43" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_220460e2-0fdc-4349-a33f-4dfb581e9433" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_ea8f5663-9b8b-4dd2-acc4-cb93157041f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_9f8db69f-0709-4f2a-a4e1-0a52ee856d43" xlink:to="loc_us-gaap_DerivativeTable_ea8f5663-9b8b-4dd2-acc4-cb93157041f0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_5ab12210-3057-4c3e-a30e-2eb0aa73febd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_ea8f5663-9b8b-4dd2-acc4-cb93157041f0" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_5ab12210-3057-4c3e-a30e-2eb0aa73febd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_5ab12210-3057-4c3e-a30e-2eb0aa73febd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_5ab12210-3057-4c3e-a30e-2eb0aa73febd" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_5ab12210-3057-4c3e-a30e-2eb0aa73febd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_82de87e7-f420-441e-a00c-12d2f0ea6fba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_5ab12210-3057-4c3e-a30e-2eb0aa73febd" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_82de87e7-f420-441e-a00c-12d2f0ea6fba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_d8539adc-3281-469a-a89f-e90fd25f21ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_82de87e7-f420-441e-a00c-12d2f0ea6fba" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_d8539adc-3281-469a-a89f-e90fd25f21ab" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_911795a9-ef86-4cda-994b-bc395aee74a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_ea8f5663-9b8b-4dd2-acc4-cb93157041f0" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_911795a9-ef86-4cda-994b-bc395aee74a9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_911795a9-ef86-4cda-994b-bc395aee74a9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_911795a9-ef86-4cda-994b-bc395aee74a9" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_911795a9-ef86-4cda-994b-bc395aee74a9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_703b63bc-42da-4765-95c4-6a8034a2cdd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_911795a9-ef86-4cda-994b-bc395aee74a9" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_703b63bc-42da-4765-95c4-6a8034a2cdd8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_768ed335-ab8b-4455-b22e-b325cc27af20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_703b63bc-42da-4765-95c4-6a8034a2cdd8" xlink:to="loc_us-gaap_InterestExpenseMember_768ed335-ab8b-4455-b22e-b325cc27af20" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.varex.com/role/FINANCIALDERIVATIVESANDHEDGINGACTIVITIESSummaryofDerivativesatFairValueDetails" xlink:type="simple" xlink:href="var-20221230.xsd#FINANCIALDERIVATIVESANDHEDGINGACTIVITIESSummaryofDerivativesatFairValueDetails"/>
  <link:definitionLink xlink:role="http://www.varex.com/role/FINANCIALDERIVATIVESANDHEDGINGACTIVITIESSummaryofDerivativesatFairValueDetails" xlink:type="extended" id="i0f6091abc4c041718636661428f178bb_FINANCIALDERIVATIVESANDHEDGINGACTIVITIESSummaryofDerivativesatFairValueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_640e8179-37a2-40f3-a70f-e1150ca9b100" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_bfe2dfe7-b7de-46d9-a979-105de353dc52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_640e8179-37a2-40f3-a70f-e1150ca9b100" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_bfe2dfe7-b7de-46d9-a979-105de353dc52" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_e12ff28a-28ef-4546-b47b-cabc890b0aef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_640e8179-37a2-40f3-a70f-e1150ca9b100" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_e12ff28a-28ef-4546-b47b-cabc890b0aef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_6e87a842-31fb-4938-b20a-a99b37aae9e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_640e8179-37a2-40f3-a70f-e1150ca9b100" xlink:to="loc_us-gaap_DerivativeTable_6e87a842-31fb-4938-b20a-a99b37aae9e2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_2a1dbddb-da3b-43fe-a46d-279810cf7351" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_6e87a842-31fb-4938-b20a-a99b37aae9e2" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_2a1dbddb-da3b-43fe-a46d-279810cf7351" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_2a1dbddb-da3b-43fe-a46d-279810cf7351_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_2a1dbddb-da3b-43fe-a46d-279810cf7351" xlink:to="loc_us-gaap_HedgingRelationshipDomain_2a1dbddb-da3b-43fe-a46d-279810cf7351_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_4a95f3f4-b96a-4506-ae14-153532f57187" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_2a1dbddb-da3b-43fe-a46d-279810cf7351" xlink:to="loc_us-gaap_HedgingRelationshipDomain_4a95f3f4-b96a-4506-ae14-153532f57187" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_4d69aa44-055b-4169-ab10-284b2d8a623f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_4a95f3f4-b96a-4506-ae14-153532f57187" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_4d69aa44-055b-4169-ab10-284b2d8a623f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_55ecb2eb-e116-4c1b-8b76-0dbf2037285d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_6e87a842-31fb-4938-b20a-a99b37aae9e2" xlink:to="loc_us-gaap_HedgingDesignationAxis_55ecb2eb-e116-4c1b-8b76-0dbf2037285d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_55ecb2eb-e116-4c1b-8b76-0dbf2037285d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_55ecb2eb-e116-4c1b-8b76-0dbf2037285d" xlink:to="loc_us-gaap_HedgingDesignationDomain_55ecb2eb-e116-4c1b-8b76-0dbf2037285d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_b6c7e4f3-589c-461f-b6e5-0d65c240f822" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_55ecb2eb-e116-4c1b-8b76-0dbf2037285d" xlink:to="loc_us-gaap_HedgingDesignationDomain_b6c7e4f3-589c-461f-b6e5-0d65c240f822" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_b44a5dc5-4ad7-44df-8df2-197d515abde2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_b6c7e4f3-589c-461f-b6e5-0d65c240f822" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_b44a5dc5-4ad7-44df-8df2-197d515abde2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_71a8cea0-b1f2-4206-a9b5-5a07b6b50bae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_6e87a842-31fb-4938-b20a-a99b37aae9e2" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_71a8cea0-b1f2-4206-a9b5-5a07b6b50bae" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_71a8cea0-b1f2-4206-a9b5-5a07b6b50bae_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_71a8cea0-b1f2-4206-a9b5-5a07b6b50bae" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_71a8cea0-b1f2-4206-a9b5-5a07b6b50bae_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_0a2731ed-31d0-44ae-b619-32010bb8e248" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_71a8cea0-b1f2-4206-a9b5-5a07b6b50bae" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_0a2731ed-31d0-44ae-b619-32010bb8e248" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentAssetsMember_fbd6b870-7704-40d1-a924-900014502a8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_0a2731ed-31d0-44ae-b619-32010bb8e248" xlink:to="loc_us-gaap_OtherCurrentAssetsMember_fbd6b870-7704-40d1-a924-900014502a8d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_0fb0b223-9204-46ee-835b-d2a8044873e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_0a2731ed-31d0-44ae-b619-32010bb8e248" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_0fb0b223-9204-46ee-835b-d2a8044873e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_77cf4daf-3649-40d2-9d5c-eddaa952cbdc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_0a2731ed-31d0-44ae-b619-32010bb8e248" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_77cf4daf-3649-40d2-9d5c-eddaa952cbdc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_bd1d460c-83e6-4673-8a3a-39709c746cd7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_6e87a842-31fb-4938-b20a-a99b37aae9e2" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_bd1d460c-83e6-4673-8a3a-39709c746cd7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_bd1d460c-83e6-4673-8a3a-39709c746cd7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_bd1d460c-83e6-4673-8a3a-39709c746cd7" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_bd1d460c-83e6-4673-8a3a-39709c746cd7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_8e4f8038-5bca-413a-90a6-bc7d5d11794a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_bd1d460c-83e6-4673-8a3a-39709c746cd7" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_8e4f8038-5bca-413a-90a6-bc7d5d11794a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_45589e92-31b0-4153-b9c4-20aa30e01040" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8e4f8038-5bca-413a-90a6-bc7d5d11794a" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_45589e92-31b0-4153-b9c4-20aa30e01040" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.varex.com/role/FAIRVALUENarrativeDetails" xlink:type="simple" xlink:href="var-20221230.xsd#FAIRVALUENarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.varex.com/role/FAIRVALUENarrativeDetails" xlink:type="extended" id="i95d824df889145e9bb26b8fc9b490c8a_FAIRVALUENarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a9a9bc1f-f20e-4a22-a97d-1ddaf0af5208" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue_43b6e7d9-ee77-49c7-98de-d363aa4095b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a9a9bc1f-f20e-4a22-a97d-1ddaf0af5208" xlink:to="loc_us-gaap_LongTermDebtFairValue_43b6e7d9-ee77-49c7-98de-d363aa4095b9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6d38b0e3-78cd-4ebb-953b-ba9910c44a95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a9a9bc1f-f20e-4a22-a97d-1ddaf0af5208" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6d38b0e3-78cd-4ebb-953b-ba9910c44a95" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_9d0429fc-be02-4de2-bd1c-334086e2530d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6d38b0e3-78cd-4ebb-953b-ba9910c44a95" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_9d0429fc-be02-4de2-bd1c-334086e2530d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_9d0429fc-be02-4de2-bd1c-334086e2530d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_9d0429fc-be02-4de2-bd1c-334086e2530d" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_9d0429fc-be02-4de2-bd1c-334086e2530d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_400b6cf3-4bea-45b3-b662-99634572c517" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_9d0429fc-be02-4de2-bd1c-334086e2530d" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_400b6cf3-4bea-45b3-b662-99634572c517" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_8d9d79da-6cab-4ab5-9ebc-08e0236075e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_400b6cf3-4bea-45b3-b662-99634572c517" xlink:to="loc_us-gaap_ConvertibleDebtMember_8d9d79da-6cab-4ab5-9ebc-08e0236075e0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_3925f7b4-2e13-44e9-9e66-adde433e4d02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_400b6cf3-4bea-45b3-b662-99634572c517" xlink:to="loc_us-gaap_SecuredDebtMember_3925f7b4-2e13-44e9-9e66-adde433e4d02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_8712f2b4-c5aa-43ed-863f-e96e5ca17b2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6d38b0e3-78cd-4ebb-953b-ba9910c44a95" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_8712f2b4-c5aa-43ed-863f-e96e5ca17b2e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8712f2b4-c5aa-43ed-863f-e96e5ca17b2e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_8712f2b4-c5aa-43ed-863f-e96e5ca17b2e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8712f2b4-c5aa-43ed-863f-e96e5ca17b2e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b1c2bcd0-431a-4dac-b31b-f11dc5ae0dfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_8712f2b4-c5aa-43ed-863f-e96e5ca17b2e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b1c2bcd0-431a-4dac-b31b-f11dc5ae0dfc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_9d444271-1e7c-4dba-baa7-664779c49a01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b1c2bcd0-431a-4dac-b31b-f11dc5ae0dfc" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_9d444271-1e7c-4dba-baa7-664779c49a01" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.varex.com/role/FAIRVALUEScheduleofFairValueInputsDetails" xlink:type="simple" xlink:href="var-20221230.xsd#FAIRVALUEScheduleofFairValueInputsDetails"/>
  <link:definitionLink xlink:role="http://www.varex.com/role/FAIRVALUEScheduleofFairValueInputsDetails" xlink:type="extended" id="i3d4ee973337d472a9c9b2cba64e9b08a_FAIRVALUEScheduleofFairValueInputsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6ed372ad-68d1-4996-a2b4-c79586f7758d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_cb93e68b-cc10-4663-afee-4c81d6022438" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6ed372ad-68d1-4996-a2b4-c79586f7758d" xlink:to="loc_us-gaap_AssetsAbstract_cb93e68b-cc10-4663-afee-4c81d6022438" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsAtCarryingValue_95651282-bcf4-4002-9762-aeea4e009b61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_cb93e68b-cc10-4663-afee-4c81d6022438" xlink:to="loc_us-gaap_MoneyMarketFundsAtCarryingValue_95651282-bcf4-4002-9762-aeea4e009b61" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_CommercialPaperReceivable_5d43b430-9e9a-4aae-b191-c49dda7e6628" xlink:href="var-20221230.xsd#var_CommercialPaperReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_cb93e68b-cc10-4663-afee-4c81d6022438" xlink:to="loc_var_CommercialPaperReceivable_5d43b430-9e9a-4aae-b191-c49dda7e6628" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_CorporateBonds_015dc1fc-dbd7-4d30-8414-f9e316bcb109" xlink:href="var-20221230.xsd#var_CorporateBonds"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_cb93e68b-cc10-4663-afee-4c81d6022438" xlink:to="loc_var_CorporateBonds_015dc1fc-dbd7-4d30-8414-f9e316bcb109" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesSecuritiesAtCarryingValue_0e473a73-43f4-4e9a-b81a-09e333e2c78d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesSecuritiesAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_cb93e68b-cc10-4663-afee-4c81d6022438" xlink:to="loc_us-gaap_USGovernmentAgenciesSecuritiesAtCarryingValue_0e473a73-43f4-4e9a-b81a-09e333e2c78d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_6c12aef6-d895-46d0-a024-52b42a9ca7fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_cb93e68b-cc10-4663-afee-4c81d6022438" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_6c12aef6-d895-46d0-a024-52b42a9ca7fa" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_cb062ef4-ee14-4b09-8abc-89304c3b18a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_cb93e68b-cc10-4663-afee-4c81d6022438" xlink:to="loc_us-gaap_DerivativeAssets_cb062ef4-ee14-4b09-8abc-89304c3b18a7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationPlanAssets_3ff525d1-4553-4284-b6a1-66c4f6cdb1f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_cb93e68b-cc10-4663-afee-4c81d6022438" xlink:to="loc_us-gaap_DeferredCompensationPlanAssets_3ff525d1-4553-4284-b6a1-66c4f6cdb1f5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_595d8c5b-9927-440d-9176-19d7afd63fef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_cb93e68b-cc10-4663-afee-4c81d6022438" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_595d8c5b-9927-440d-9176-19d7afd63fef" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_8cb605b7-e959-4690-acc8-6cbbfff37084" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_cb93e68b-cc10-4663-afee-4c81d6022438" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_8cb605b7-e959-4690-acc8-6cbbfff37084" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration_ea05d40e-e25e-400d-b0f4-d54dadd6de1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_cb93e68b-cc10-4663-afee-4c81d6022438" xlink:to="loc_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration_ea05d40e-e25e-400d-b0f4-d54dadd6de1d" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_62a4c27f-77de-4d00-a74e-582f19049d53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6ed372ad-68d1-4996-a2b4-c79586f7758d" xlink:to="loc_us-gaap_LiabilitiesAbstract_62a4c27f-77de-4d00-a74e-582f19049d53" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_ed169c8c-0d7e-40f0-a46d-31b847ded714" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_62a4c27f-77de-4d00-a74e-582f19049d53" xlink:to="loc_us-gaap_DerivativeLiabilities_ed169c8c-0d7e-40f0-a46d-31b847ded714" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_db49f033-fef1-4a41-bf0a-83da353397a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_62a4c27f-77de-4d00-a74e-582f19049d53" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_db49f033-fef1-4a41-bf0a-83da353397a6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration_7e75e491-ed7b-4028-a8db-b1fec24edb4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_62a4c27f-77de-4d00-a74e-582f19049d53" xlink:to="loc_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration_7e75e491-ed7b-4028-a8db-b1fec24edb4e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c4e811af-aaea-4b5c-a6a3-32fd64d9241d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6ed372ad-68d1-4996-a2b4-c79586f7758d" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c4e811af-aaea-4b5c-a6a3-32fd64d9241d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_179bc423-fbfe-459a-b651-e40c14e805a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c4e811af-aaea-4b5c-a6a3-32fd64d9241d" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_179bc423-fbfe-459a-b651-e40c14e805a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_179bc423-fbfe-459a-b651-e40c14e805a3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_179bc423-fbfe-459a-b651-e40c14e805a3" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_179bc423-fbfe-459a-b651-e40c14e805a3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_766c09b0-d31b-4f9d-b232-ba83b2333f72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_179bc423-fbfe-459a-b651-e40c14e805a3" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_766c09b0-d31b-4f9d-b232-ba83b2333f72" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_c1ff1161-ad8e-4cd7-ac31-e5f17362caa7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_766c09b0-d31b-4f9d-b232-ba83b2333f72" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_c1ff1161-ad8e-4cd7-ac31-e5f17362caa7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_57c8b432-8829-4453-b5db-6cbed3f49bba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_766c09b0-d31b-4f9d-b232-ba83b2333f72" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_57c8b432-8829-4453-b5db-6cbed3f49bba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_303416a9-4261-4266-93e7-ffa82c7f7a33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_766c09b0-d31b-4f9d-b232-ba83b2333f72" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_303416a9-4261-4266-93e7-ffa82c7f7a33" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_61ebadc0-f5f1-48a9-9336-e7c20b1c4f87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c4e811af-aaea-4b5c-a6a3-32fd64d9241d" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_61ebadc0-f5f1-48a9-9336-e7c20b1c4f87" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_61ebadc0-f5f1-48a9-9336-e7c20b1c4f87_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_61ebadc0-f5f1-48a9-9336-e7c20b1c4f87" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_61ebadc0-f5f1-48a9-9336-e7c20b1c4f87_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_ffe5abae-8aae-4aa2-b7c0-653ebdde2898" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_61ebadc0-f5f1-48a9-9336-e7c20b1c4f87" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_ffe5abae-8aae-4aa2-b7c0-653ebdde2898" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_b7664c4c-6dfb-45ba-b981-c123919a09c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_ffe5abae-8aae-4aa2-b7c0-653ebdde2898" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_b7664c4c-6dfb-45ba-b981-c123919a09c9" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.varex.com/role/FAIRVALUESummaryofMarketableSecuritiesDetails" xlink:type="simple" xlink:href="var-20221230.xsd#FAIRVALUESummaryofMarketableSecuritiesDetails"/>
  <link:definitionLink xlink:role="http://www.varex.com/role/FAIRVALUESummaryofMarketableSecuritiesDetails" xlink:type="extended" id="iaf730b7365524462bbbe0de47e9bde2b_FAIRVALUESummaryofMarketableSecuritiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLineItems_79a3363d-b7be-45aa-9786-af1e86e2cdab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_MarketableSecuritiesAmortizedCost_1d8ab5a5-c0c8-4deb-bf16-472fba9306b7" xlink:href="var-20221230.xsd#var_MarketableSecuritiesAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLineItems_79a3363d-b7be-45aa-9786-af1e86e2cdab" xlink:to="loc_var_MarketableSecuritiesAmortizedCost_1d8ab5a5-c0c8-4deb-bf16-472fba9306b7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_9d22c00e-d58f-438d-907b-d889dc870407" xlink:href="var-20221230.xsd#var_MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLineItems_79a3363d-b7be-45aa-9786-af1e86e2cdab" xlink:to="loc_var_MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_9d22c00e-d58f-438d-907b-d889dc870407" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecurities_e78e2b44-6087-4437-83e8-5a9cd312f538" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLineItems_79a3363d-b7be-45aa-9786-af1e86e2cdab" xlink:to="loc_us-gaap_MarketableSecurities_e78e2b44-6087-4437-83e8-5a9cd312f538" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareTable_5da94aaa-819d-4979-b05c-09b59ec8c216" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLineItems_79a3363d-b7be-45aa-9786-af1e86e2cdab" xlink:to="loc_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareTable_5da94aaa-819d-4979-b05c-09b59ec8c216" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_49386977-27b4-4489-af3a-59592724c95a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareTable_5da94aaa-819d-4979-b05c-09b59ec8c216" xlink:to="loc_us-gaap_InvestmentTypeAxis_49386977-27b4-4489-af3a-59592724c95a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_49386977-27b4-4489-af3a-59592724c95a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_49386977-27b4-4489-af3a-59592724c95a" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_49386977-27b4-4489-af3a-59592724c95a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_f3b79752-daf8-4efa-bdb2-9358d7f0f6e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_49386977-27b4-4489-af3a-59592724c95a" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_f3b79752-daf8-4efa-bdb2-9358d7f0f6e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_7d7c4064-6af2-477c-b886-629d1380c7f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_f3b79752-daf8-4efa-bdb2-9358d7f0f6e7" xlink:to="loc_us-gaap_CommercialPaperMember_7d7c4064-6af2-477c-b886-629d1380c7f7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateBondSecuritiesMember_6cdaeb78-5cc1-4477-a1b3-e2bb061a88d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateBondSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_f3b79752-daf8-4efa-bdb2-9358d7f0f6e7" xlink:to="loc_us-gaap_CorporateBondSecuritiesMember_6cdaeb78-5cc1-4477-a1b3-e2bb061a88d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryBillSecuritiesMember_7f492bf8-1079-40dc-9347-ab0eec71b0a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasuryBillSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_f3b79752-daf8-4efa-bdb2-9358d7f0f6e7" xlink:to="loc_us-gaap_USTreasuryBillSecuritiesMember_7f492bf8-1079-40dc-9347-ab0eec71b0a3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_d902fc45-08ed-4e05-8312-1129b502cb09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_f3b79752-daf8-4efa-bdb2-9358d7f0f6e7" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_d902fc45-08ed-4e05-8312-1129b502cb09" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.varex.com/role/FAIRVALUEBalanceSheetMarketableSecuritiesDetails" xlink:type="simple" xlink:href="var-20221230.xsd#FAIRVALUEBalanceSheetMarketableSecuritiesDetails"/>
  <link:definitionLink xlink:role="http://www.varex.com/role/FAIRVALUEBalanceSheetMarketableSecuritiesDetails" xlink:type="extended" id="i26057eb95a5045519f14e305c022c30d_FAIRVALUEBalanceSheetMarketableSecuritiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems_5de80d21-d31d-4b4f-b292-badc7ad760f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecurities_563bd780-44ed-4f21-9da8-c681e2467f59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems_5de80d21-d31d-4b4f-b292-badc7ad760f0" xlink:to="loc_us-gaap_MarketableSecurities_563bd780-44ed-4f21-9da8-c681e2467f59" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable_cdc84b16-2b3b-4bb6-8301-ca37e4fa493a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems_5de80d21-d31d-4b4f-b292-badc7ad760f0" xlink:to="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable_cdc84b16-2b3b-4bb6-8301-ca37e4fa493a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_cd4c11a7-9ccd-4606-bdb2-df36c5f387e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable_cdc84b16-2b3b-4bb6-8301-ca37e4fa493a" xlink:to="loc_us-gaap_InvestmentTypeAxis_cd4c11a7-9ccd-4606-bdb2-df36c5f387e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_cd4c11a7-9ccd-4606-bdb2-df36c5f387e3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_cd4c11a7-9ccd-4606-bdb2-df36c5f387e3" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_cd4c11a7-9ccd-4606-bdb2-df36c5f387e3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_62e7b7c1-76ee-490e-b68e-aa8f3fd22eee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_cd4c11a7-9ccd-4606-bdb2-df36c5f387e3" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_62e7b7c1-76ee-490e-b68e-aa8f3fd22eee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_f31d3c03-1369-4aa7-b231-e3b46f75fa0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_62e7b7c1-76ee-490e-b68e-aa8f3fd22eee" xlink:to="loc_us-gaap_CommercialPaperMember_f31d3c03-1369-4aa7-b231-e3b46f75fa0d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateBondSecuritiesMember_4ab100fb-ef40-48b7-9b43-fe1dcc3423d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateBondSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_62e7b7c1-76ee-490e-b68e-aa8f3fd22eee" xlink:to="loc_us-gaap_CorporateBondSecuritiesMember_4ab100fb-ef40-48b7-9b43-fe1dcc3423d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_44ef1d6d-43cf-4a59-b94a-f08167d371eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_62e7b7c1-76ee-490e-b68e-aa8f3fd22eee" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_44ef1d6d-43cf-4a59-b94a-f08167d371eb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryBillSecuritiesMember_d57db479-1caf-4115-a9bd-6874dbce219c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasuryBillSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_62e7b7c1-76ee-490e-b68e-aa8f3fd22eee" xlink:to="loc_us-gaap_USTreasuryBillSecuritiesMember_d57db479-1caf-4115-a9bd-6874dbce219c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_fb58d6d9-e8bb-4398-9c4e-b449836734e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable_cdc84b16-2b3b-4bb6-8301-ca37e4fa493a" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_fb58d6d9-e8bb-4398-9c4e-b449836734e8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_fb58d6d9-e8bb-4398-9c4e-b449836734e8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_fb58d6d9-e8bb-4398-9c4e-b449836734e8" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_fb58d6d9-e8bb-4398-9c4e-b449836734e8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_6c3ec1d1-190a-471b-ac83-427049eb0ef6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_fb58d6d9-e8bb-4398-9c4e-b449836734e8" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_6c3ec1d1-190a-471b-ac83-427049eb0ef6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_ba6621a1-0a2b-48a8-a0e8-c187df8c217e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_6c3ec1d1-190a-471b-ac83-427049eb0ef6" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_ba6621a1-0a2b-48a8-a0e8-c187df8c217e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_9f290868-512e-4538-bcb7-2725dc5f5e28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_6c3ec1d1-190a-471b-ac83-427049eb0ef6" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_9f290868-512e-4538-bcb7-2725dc5f5e28" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_cfee797f-d7d8-4e7a-b783-fafeef8ac7d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_6c3ec1d1-190a-471b-ac83-427049eb0ef6" xlink:to="loc_us-gaap_OtherAssetsMember_cfee797f-d7d8-4e7a-b783-fafeef8ac7d1" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.varex.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillRollforwardDetails" xlink:type="simple" xlink:href="var-20221230.xsd#GOODWILLANDINTANGIBLEASSETSGoodwillRollforwardDetails"/>
  <link:definitionLink xlink:role="http://www.varex.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillRollforwardDetails" xlink:type="extended" id="i7ed327af0d484398be08a1a4e0358157_GOODWILLANDINTANGIBLEASSETSGoodwillRollforwardDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_36668931-b82e-46e9-b8f1-fb00cc3802ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_cf79ec50-edad-4261-8883-e49b2f1b4aae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_36668931-b82e-46e9-b8f1-fb00cc3802ad" xlink:to="loc_us-gaap_GoodwillRollForward_cf79ec50-edad-4261-8883-e49b2f1b4aae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_ae518f64-978e-4a2a-aed4-b3244b1f51ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_cf79ec50-edad-4261-8883-e49b2f1b4aae" xlink:to="loc_us-gaap_Goodwill_ae518f64-978e-4a2a-aed4-b3244b1f51ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_2cf952e7-0628-4aa9-b883-46b90f609163" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_cf79ec50-edad-4261-8883-e49b2f1b4aae" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_2cf952e7-0628-4aa9-b883-46b90f609163" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_5cafcab4-0017-426c-9498-9682d77f3229" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_2203cce4-1158-4ae3-ad21-f5c1bbbe3773" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_36668931-b82e-46e9-b8f1-fb00cc3802ad" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_2203cce4-1158-4ae3-ad21-f5c1bbbe3773" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_e1fe7c28-ac29-47bb-87d1-dbf82bdab1c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_2203cce4-1158-4ae3-ad21-f5c1bbbe3773" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_e1fe7c28-ac29-47bb-87d1-dbf82bdab1c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e1fe7c28-ac29-47bb-87d1-dbf82bdab1c2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e1fe7c28-ac29-47bb-87d1-dbf82bdab1c2" xlink:to="loc_us-gaap_SegmentDomain_e1fe7c28-ac29-47bb-87d1-dbf82bdab1c2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_1b3d1114-2826-449f-b173-7177278f1744" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e1fe7c28-ac29-47bb-87d1-dbf82bdab1c2" xlink:to="loc_us-gaap_SegmentDomain_1b3d1114-2826-449f-b173-7177278f1744" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_MedicalMember_4fe37652-ed65-4d33-9a2b-285c307771c1" xlink:href="var-20221230.xsd#var_MedicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_1b3d1114-2826-449f-b173-7177278f1744" xlink:to="loc_var_MedicalMember_4fe37652-ed65-4d33-9a2b-285c307771c1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_IndustrialMember_910a5da7-07cd-420f-ab3a-8280f3bcb839" xlink:href="var-20221230.xsd#var_IndustrialMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_1b3d1114-2826-449f-b173-7177278f1744" xlink:to="loc_var_IndustrialMember_910a5da7-07cd-420f-ab3a-8280f3bcb839" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.varex.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails" xlink:type="simple" xlink:href="var-20221230.xsd#GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.varex.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails" xlink:type="extended" id="i0ad6db7bc688405e8223c29e0d123253_GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a1b06404-c9b3-443c-9f31-5ac2ecc8fcfd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_6567ac72-876e-4612-a7c3-4774a4eb678e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a1b06404-c9b3-443c-9f31-5ac2ecc8fcfd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_6567ac72-876e-4612-a7c3-4774a4eb678e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_ea08e58b-e6b1-4a9c-8c0a-2de59f650034" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a1b06404-c9b3-443c-9f31-5ac2ecc8fcfd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_ea08e58b-e6b1-4a9c-8c0a-2de59f650034" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_6fa114a7-8181-43c2-9170-c188f34168b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a1b06404-c9b3-443c-9f31-5ac2ecc8fcfd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_6fa114a7-8181-43c2-9170-c188f34168b9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_a3a7182c-9a51-4451-b616-d5ec4aab3073" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a1b06404-c9b3-443c-9f31-5ac2ecc8fcfd" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_a3a7182c-9a51-4451-b616-d5ec4aab3073" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_a0668769-e900-49ba-a493-635114050854" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a1b06404-c9b3-443c-9f31-5ac2ecc8fcfd" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_a0668769-e900-49ba-a493-635114050854" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f483ffb6-088b-4d83-bec4-2e98fd8b97ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_a0668769-e900-49ba-a493-635114050854" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f483ffb6-088b-4d83-bec4-2e98fd8b97ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_f483ffb6-088b-4d83-bec4-2e98fd8b97ad_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f483ffb6-088b-4d83-bec4-2e98fd8b97ad" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_f483ffb6-088b-4d83-bec4-2e98fd8b97ad_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3d4c7bd3-f447-419e-bac5-ae223aadf86c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f483ffb6-088b-4d83-bec4-2e98fd8b97ad" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3d4c7bd3-f447-419e-bac5-ae223aadf86c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_082e24f6-c2b3-4882-ad41-96fc66f7f9fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3d4c7bd3-f447-419e-bac5-ae223aadf86c" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_082e24f6-c2b3-4882-ad41-96fc66f7f9fe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntellectualPropertyMember_7230f891-5733-47df-a621-ecb5a9add167" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntellectualPropertyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3d4c7bd3-f447-419e-bac5-ae223aadf86c" xlink:to="loc_us-gaap_IntellectualPropertyMember_7230f891-5733-47df-a621-ecb5a9add167" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_CustomerContractsandSupplierRelationshipsMember_1973ac71-5a0b-496c-98c0-c647a8df497b" xlink:href="var-20221230.xsd#var_CustomerContractsandSupplierRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3d4c7bd3-f447-419e-bac5-ae223aadf86c" xlink:to="loc_var_CustomerContractsandSupplierRelationshipsMember_1973ac71-5a0b-496c-98c0-c647a8df497b" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.varex.com/role/BORROWINGSScheduleofDebtDetails" xlink:type="simple" xlink:href="var-20221230.xsd#BORROWINGSScheduleofDebtDetails"/>
  <link:definitionLink xlink:role="http://www.varex.com/role/BORROWINGSScheduleofDebtDetails" xlink:type="extended" id="if1b6820af8bb4bcba16ce2ce7fc3b438_BORROWINGSScheduleofDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_17edd53a-77f1-4c46-a84a-40c8ed5a5dfb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrentAbstract_6939fc81-42d4-4b0d-b767-3790d286f351" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_17edd53a-77f1-4c46-a84a-40c8ed5a5dfb" xlink:to="loc_us-gaap_LongTermDebtCurrentAbstract_6939fc81-42d4-4b0d-b767-3790d286f351" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_d21af215-31ec-4b45-96fd-0d27b72188b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtCurrentAbstract_6939fc81-42d4-4b0d-b767-3790d286f351" xlink:to="loc_us-gaap_LongTermDebtCurrent_d21af215-31ec-4b45-96fd-0d27b72188b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaturitiesOfLongTermDebtAbstract_9b8e5ad6-45f7-448e-af33-cd5a07b4d150" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaturitiesOfLongTermDebtAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_17edd53a-77f1-4c46-a84a-40c8ed5a5dfb" xlink:to="loc_us-gaap_MaturitiesOfLongTermDebtAbstract_9b8e5ad6-45f7-448e-af33-cd5a07b4d150" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_LongtermDebtExcludingCurrentMaturitiesGross_644ae8b2-a7d1-475a-95d6-a8df7acda986" xlink:href="var-20221230.xsd#var_LongtermDebtExcludingCurrentMaturitiesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MaturitiesOfLongTermDebtAbstract_9b8e5ad6-45f7-448e-af33-cd5a07b4d150" xlink:to="loc_var_LongtermDebtExcludingCurrentMaturitiesGross_644ae8b2-a7d1-475a-95d6-a8df7acda986" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_bfef94ab-9713-46eb-82f8-4ce6441597e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MaturitiesOfLongTermDebtAbstract_9b8e5ad6-45f7-448e-af33-cd5a07b4d150" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_bfef94ab-9713-46eb-82f8-4ce6441597e5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtWeightedAverageInterestRateOverTime_479f58df-5459-498d-b94f-06d518e68072" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtWeightedAverageInterestRateOverTime"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MaturitiesOfLongTermDebtAbstract_9b8e5ad6-45f7-448e-af33-cd5a07b4d150" xlink:to="loc_us-gaap_LongTermDebtWeightedAverageInterestRateOverTime_479f58df-5459-498d-b94f-06d518e68072" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNetAbstract_02eaf025-32b2-4879-beeb-28d512c0b105" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNetAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_17edd53a-77f1-4c46-a84a-40c8ed5a5dfb" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNetAbstract_02eaf025-32b2-4879-beeb-28d512c0b105" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_523e9348-4b80-419e-b763-5dd76b93ee41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNetAbstract_02eaf025-32b2-4879-beeb-28d512c0b105" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_523e9348-4b80-419e-b763-5dd76b93ee41" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_e9c01a97-a3a9-4b5d-946f-bc8528789aff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNetAbstract_02eaf025-32b2-4879-beeb-28d512c0b105" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_e9c01a97-a3a9-4b5d-946f-bc8528789aff" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_712e4163-baee-4e68-bae7-bd6b75c3b85e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNetAbstract_02eaf025-32b2-4879-beeb-28d512c0b105" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_712e4163-baee-4e68-bae7-bd6b75c3b85e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_5d6db931-8aa9-4051-8d64-6e968b7cb2a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_17edd53a-77f1-4c46-a84a-40c8ed5a5dfb" xlink:to="loc_us-gaap_LongTermDebt_5d6db931-8aa9-4051-8d64-6e968b7cb2a3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_dffc3ffa-a4fc-4d49-bc01-3802a1346292" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_17edd53a-77f1-4c46-a84a-40c8ed5a5dfb" xlink:to="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_dffc3ffa-a4fc-4d49-bc01-3802a1346292" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_61da7104-58c6-428e-bf00-ee9256492118" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_17edd53a-77f1-4c46-a84a-40c8ed5a5dfb" xlink:to="loc_us-gaap_DebtInstrumentTable_61da7104-58c6-428e-bf00-ee9256492118" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_8451ff26-47b8-42f6-8571-4158f3cc1807" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_61da7104-58c6-428e-bf00-ee9256492118" xlink:to="loc_us-gaap_DebtInstrumentAxis_8451ff26-47b8-42f6-8571-4158f3cc1807" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_8451ff26-47b8-42f6-8571-4158f3cc1807_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_8451ff26-47b8-42f6-8571-4158f3cc1807" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_8451ff26-47b8-42f6-8571-4158f3cc1807_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b3ba936d-e223-43d4-9a73-c232b5a41b28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_8451ff26-47b8-42f6-8571-4158f3cc1807" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b3ba936d-e223-43d4-9a73-c232b5a41b28" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDebtSecuritiesMember_dca030e0-e759-4f98-941d-e77917735d16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b3ba936d-e223-43d4-9a73-c232b5a41b28" xlink:to="loc_us-gaap_OtherDebtSecuritiesMember_dca030e0-e759-4f98-941d-e77917735d16" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_SeniorSecuredNotesMember_06b071ec-29e9-4070-9abb-ad78e6d9c461" xlink:href="var-20221230.xsd#var_SeniorSecuredNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b3ba936d-e223-43d4-9a73-c232b5a41b28" xlink:to="loc_var_SeniorSecuredNotesMember_06b071ec-29e9-4070-9abb-ad78e6d9c461" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_8a7485a1-e647-49d6-ace2-e58fbf07eb44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_61da7104-58c6-428e-bf00-ee9256492118" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_8a7485a1-e647-49d6-ace2-e58fbf07eb44" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_8a7485a1-e647-49d6-ace2-e58fbf07eb44_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_8a7485a1-e647-49d6-ace2-e58fbf07eb44" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_8a7485a1-e647-49d6-ace2-e58fbf07eb44_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_813e8996-c1e3-4d43-8cc0-c62cc34e074c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_8a7485a1-e647-49d6-ace2-e58fbf07eb44" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_813e8996-c1e3-4d43-8cc0-c62cc34e074c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_cd064c42-ba56-403b-b533-73d04a1f7515" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_813e8996-c1e3-4d43-8cc0-c62cc34e074c" xlink:to="loc_us-gaap_ConvertibleDebtMember_cd064c42-ba56-403b-b533-73d04a1f7515" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_8ac0e9ce-4030-40cf-a886-d0ed2ff4c147" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_813e8996-c1e3-4d43-8cc0-c62cc34e074c" xlink:to="loc_us-gaap_SecuredDebtMember_8ac0e9ce-4030-40cf-a886-d0ed2ff4c147" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.varex.com/role/BORROWINGSConvertibleSeniorUnsecuredNotesNarrativeDetails" xlink:type="simple" xlink:href="var-20221230.xsd#BORROWINGSConvertibleSeniorUnsecuredNotesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.varex.com/role/BORROWINGSConvertibleSeniorUnsecuredNotesNarrativeDetails" xlink:type="extended" id="i8f0e602d6d3d4f1aa6ea632c2244fad1_BORROWINGSConvertibleSeniorUnsecuredNotesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_37ba782c-62cc-47b1-98d9-7f039e0d4f30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_0b318419-f960-4ad3-9259-2a6b27585095" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_37ba782c-62cc-47b1-98d9-7f039e0d4f30" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_0b318419-f960-4ad3-9259-2a6b27585095" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_b3ac60b5-f509-4a70-86ce-ede5f86be1c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_37ba782c-62cc-47b1-98d9-7f039e0d4f30" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_b3ac60b5-f509-4a70-86ce-ede5f86be1c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_f7fe3f4b-cd41-4eeb-baca-eba38c13fc9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_37ba782c-62cc-47b1-98d9-7f039e0d4f30" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_f7fe3f4b-cd41-4eeb-baca-eba38c13fc9f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_6e3289c6-963e-4c5f-8362-8f678900de97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_37ba782c-62cc-47b1-98d9-7f039e0d4f30" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_6e3289c6-963e-4c5f-8362-8f678900de97" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_0106c5b1-10c2-4311-8944-222045cd6f9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_37ba782c-62cc-47b1-98d9-7f039e0d4f30" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_0106c5b1-10c2-4311-8944-222045cd6f9c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments_cd8d983f-d46f-4623-8359-f24ef3327b55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_37ba782c-62cc-47b1-98d9-7f039e0d4f30" xlink:to="loc_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments_cd8d983f-d46f-4623-8359-f24ef3327b55" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_5da3e60e-c297-4eb2-b216-5ded0e6a8db0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_37ba782c-62cc-47b1-98d9-7f039e0d4f30" xlink:to="loc_us-gaap_DebtInstrumentTable_5da3e60e-c297-4eb2-b216-5ded0e6a8db0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_bca8bfed-ba8f-46e4-ad09-03457faa9104" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_5da3e60e-c297-4eb2-b216-5ded0e6a8db0" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_bca8bfed-ba8f-46e4-ad09-03457faa9104" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_bca8bfed-ba8f-46e4-ad09-03457faa9104_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_bca8bfed-ba8f-46e4-ad09-03457faa9104" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_bca8bfed-ba8f-46e4-ad09-03457faa9104_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_5afad2d2-d893-48d4-8b45-5563778c63e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_bca8bfed-ba8f-46e4-ad09-03457faa9104" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_5afad2d2-d893-48d4-8b45-5563778c63e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_dac277cb-0444-4f4d-aae3-1bc15805f92d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5afad2d2-d893-48d4-8b45-5563778c63e0" xlink:to="loc_us-gaap_ConvertibleDebtMember_dac277cb-0444-4f4d-aae3-1bc15805f92d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_46535224-b1ed-4ef8-b6f6-9894f05a7b25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_5da3e60e-c297-4eb2-b216-5ded0e6a8db0" xlink:to="loc_us-gaap_DebtInstrumentAxis_46535224-b1ed-4ef8-b6f6-9894f05a7b25" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_46535224-b1ed-4ef8-b6f6-9894f05a7b25_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_46535224-b1ed-4ef8-b6f6-9894f05a7b25" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_46535224-b1ed-4ef8-b6f6-9894f05a7b25_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_016ee7d2-5d42-476e-994a-c655338c7b5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_46535224-b1ed-4ef8-b6f6-9894f05a7b25" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_016ee7d2-5d42-476e-994a-c655338c7b5f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_ConvertibleNotesMember_350e5cca-2264-4bb9-a351-2f590894ac0a" xlink:href="var-20221230.xsd#var_ConvertibleNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_016ee7d2-5d42-476e-994a-c655338c7b5f" xlink:to="loc_var_ConvertibleNotesMember_350e5cca-2264-4bb9-a351-2f590894ac0a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.varex.com/role/BORROWINGSCallSpreadNarrativeDetails" xlink:type="simple" xlink:href="var-20221230.xsd#BORROWINGSCallSpreadNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.varex.com/role/BORROWINGSCallSpreadNarrativeDetails" xlink:type="extended" id="i44caa872c3e4478dbae8a268b4142045_BORROWINGSCallSpreadNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_2d51cfe3-a68e-46cf-b768-198175d9c667" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_5c96c5c9-8481-4cd1-8ce0-19744c3e7a57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2d51cfe3-a68e-46cf-b768-198175d9c667" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_5c96c5c9-8481-4cd1-8ce0-19744c3e7a57" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments_69b1fee2-364a-47d1-b945-585d37812a44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2d51cfe3-a68e-46cf-b768-198175d9c667" xlink:to="loc_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments_69b1fee2-364a-47d1-b945-585d37812a44" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_d5f25f80-f19b-4983-8b34-2f1199a434a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2d51cfe3-a68e-46cf-b768-198175d9c667" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_d5f25f80-f19b-4983-8b34-2f1199a434a4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_ClassOfWarrantOrRightPercentIncreaseOfStrikePriceOverSalePrice_23bee8bf-6885-485d-88e7-1102024c5751" xlink:href="var-20221230.xsd#var_ClassOfWarrantOrRightPercentIncreaseOfStrikePriceOverSalePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2d51cfe3-a68e-46cf-b768-198175d9c667" xlink:to="loc_var_ClassOfWarrantOrRightPercentIncreaseOfStrikePriceOverSalePrice_23bee8bf-6885-485d-88e7-1102024c5751" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_8210ef5d-fe68-4c4d-80cc-7cff2969eb1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2d51cfe3-a68e-46cf-b768-198175d9c667" xlink:to="loc_us-gaap_DebtInstrumentTable_8210ef5d-fe68-4c4d-80cc-7cff2969eb1d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_a92c97d3-e360-4b92-9a1c-aac26228ffc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_8210ef5d-fe68-4c4d-80cc-7cff2969eb1d" xlink:to="loc_us-gaap_DebtInstrumentAxis_a92c97d3-e360-4b92-9a1c-aac26228ffc4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a92c97d3-e360-4b92-9a1c-aac26228ffc4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_a92c97d3-e360-4b92-9a1c-aac26228ffc4" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a92c97d3-e360-4b92-9a1c-aac26228ffc4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_6e53cabb-92ad-4857-96ac-ab489933056d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_a92c97d3-e360-4b92-9a1c-aac26228ffc4" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_6e53cabb-92ad-4857-96ac-ab489933056d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_ConvertibleNotesMember_edba21ab-eae1-42b6-805c-8b690e41b48f" xlink:href="var-20221230.xsd#var_ConvertibleNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e53cabb-92ad-4857-96ac-ab489933056d" xlink:to="loc_var_ConvertibleNotesMember_edba21ab-eae1-42b6-805c-8b690e41b48f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_d90afc10-7a41-4c91-9eff-cdf401f1c850" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_8210ef5d-fe68-4c4d-80cc-7cff2969eb1d" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_d90afc10-7a41-4c91-9eff-cdf401f1c850" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_d90afc10-7a41-4c91-9eff-cdf401f1c850_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d90afc10-7a41-4c91-9eff-cdf401f1c850" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_d90afc10-7a41-4c91-9eff-cdf401f1c850_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_5043fbbf-fac1-4bc2-9d25-7044cea93729" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d90afc10-7a41-4c91-9eff-cdf401f1c850" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_5043fbbf-fac1-4bc2-9d25-7044cea93729" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_e98a140b-01eb-4469-b627-5b6e8b5d5d51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5043fbbf-fac1-4bc2-9d25-7044cea93729" xlink:to="loc_us-gaap_ConvertibleDebtMember_e98a140b-01eb-4469-b627-5b6e8b5d5d51" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.varex.com/role/BORROWINGSSeniorSecuredNotesNarrativeDetails" xlink:type="simple" xlink:href="var-20221230.xsd#BORROWINGSSeniorSecuredNotesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.varex.com/role/BORROWINGSSeniorSecuredNotesNarrativeDetails" xlink:type="extended" id="ib524b77e8b0d4b61a6c94f0a8d6f64b8_BORROWINGSSeniorSecuredNotesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_236f0bd4-9604-43f3-895b-d8aa3bae909a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_784eb663-71dd-420a-b9e9-b8d3d6537087" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_236f0bd4-9604-43f3-895b-d8aa3bae909a" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_784eb663-71dd-420a-b9e9-b8d3d6537087" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_22585f5f-cef5-45de-bf05-abe525b87840" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_236f0bd4-9604-43f3-895b-d8aa3bae909a" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_22585f5f-cef5-45de-bf05-abe525b87840" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_a24934c2-8943-4f28-a634-66bf20289906" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_236f0bd4-9604-43f3-895b-d8aa3bae909a" xlink:to="loc_us-gaap_DebtInstrumentTable_a24934c2-8943-4f28-a634-66bf20289906" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_a05269fd-f588-4535-ab94-361d8faf3e8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_a24934c2-8943-4f28-a634-66bf20289906" xlink:to="loc_us-gaap_DebtInstrumentAxis_a05269fd-f588-4535-ab94-361d8faf3e8f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a05269fd-f588-4535-ab94-361d8faf3e8f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_a05269fd-f588-4535-ab94-361d8faf3e8f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a05269fd-f588-4535-ab94-361d8faf3e8f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c4f0f3a2-d4f1-481d-885e-457ae19aac4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_a05269fd-f588-4535-ab94-361d8faf3e8f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c4f0f3a2-d4f1-481d-885e-457ae19aac4c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_SeniorSecuredNotesMember_ca4ee8a9-457d-4f43-9684-deafbb1dec05" xlink:href="var-20221230.xsd#var_SeniorSecuredNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c4f0f3a2-d4f1-481d-885e-457ae19aac4c" xlink:to="loc_var_SeniorSecuredNotesMember_ca4ee8a9-457d-4f43-9684-deafbb1dec05" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_a96ec389-b2a1-41cc-8e8e-39738b2f2139" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_a24934c2-8943-4f28-a634-66bf20289906" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_a96ec389-b2a1-41cc-8e8e-39738b2f2139" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_a96ec389-b2a1-41cc-8e8e-39738b2f2139_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_a96ec389-b2a1-41cc-8e8e-39738b2f2139" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_a96ec389-b2a1-41cc-8e8e-39738b2f2139_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_26d79947-6dd2-4853-b557-c354dc1d2389" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_a96ec389-b2a1-41cc-8e8e-39738b2f2139" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_26d79947-6dd2-4853-b557-c354dc1d2389" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_82ae1040-bffa-4a1f-bf9e-c6527f1fbe9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_26d79947-6dd2-4853-b557-c354dc1d2389" xlink:to="loc_us-gaap_SecuredDebtMember_82ae1040-bffa-4a1f-bf9e-c6527f1fbe9f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.varex.com/role/BORROWINGSAssetBasedLoanNarrativeDetails" xlink:type="simple" xlink:href="var-20221230.xsd#BORROWINGSAssetBasedLoanNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.varex.com/role/BORROWINGSAssetBasedLoanNarrativeDetails" xlink:type="extended" id="id7c5fca8090a427f99016765d5d349e2_BORROWINGSAssetBasedLoanNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_9265e434-b438-4b6c-9a60-6e3ba5095e0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_443bd879-be85-45cd-b669-daf1ff8ab5fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9265e434-b438-4b6c-9a60-6e3ba5095e0c" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_443bd879-be85-45cd-b669-daf1ff8ab5fc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_50920123-e0df-478d-a4d9-ea02d407ccc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9265e434-b438-4b6c-9a60-6e3ba5095e0c" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_50920123-e0df-478d-a4d9-ea02d407ccc9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_6079b52e-56f7-49e4-a8b3-14ac6e0ceda6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9265e434-b438-4b6c-9a60-6e3ba5095e0c" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_6079b52e-56f7-49e4-a8b3-14ac6e0ceda6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_75eb6f2a-687e-42bc-98dc-bdc04ee79cc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9265e434-b438-4b6c-9a60-6e3ba5095e0c" xlink:to="loc_us-gaap_DebtInstrumentTable_75eb6f2a-687e-42bc-98dc-bdc04ee79cc6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_9fe9ac33-e2bf-48e1-b98a-4051d5edb98e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_75eb6f2a-687e-42bc-98dc-bdc04ee79cc6" xlink:to="loc_us-gaap_CreditFacilityAxis_9fe9ac33-e2bf-48e1-b98a-4051d5edb98e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_9fe9ac33-e2bf-48e1-b98a-4051d5edb98e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_9fe9ac33-e2bf-48e1-b98a-4051d5edb98e" xlink:to="loc_us-gaap_CreditFacilityDomain_9fe9ac33-e2bf-48e1-b98a-4051d5edb98e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_15624e26-9979-4319-af86-18a596652492" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_9fe9ac33-e2bf-48e1-b98a-4051d5edb98e" xlink:to="loc_us-gaap_CreditFacilityDomain_15624e26-9979-4319-af86-18a596652492" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_c6c82187-4384-44e2-a2c9-ab011994525a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_15624e26-9979-4319-af86-18a596652492" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_c6c82187-4384-44e2-a2c9-ab011994525a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_70eaa0cd-61db-4a65-b9da-18dc54479a7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_75eb6f2a-687e-42bc-98dc-bdc04ee79cc6" xlink:to="loc_us-gaap_DebtInstrumentAxis_70eaa0cd-61db-4a65-b9da-18dc54479a7d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_70eaa0cd-61db-4a65-b9da-18dc54479a7d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_70eaa0cd-61db-4a65-b9da-18dc54479a7d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_70eaa0cd-61db-4a65-b9da-18dc54479a7d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_60345bc0-019c-4253-9769-ca29bd8dfb11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_70eaa0cd-61db-4a65-b9da-18dc54479a7d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_60345bc0-019c-4253-9769-ca29bd8dfb11" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_AssetBasedLoanRevolvingCreditFacilityMember_f85fc05a-1b23-45a1-9d02-a7640de2ea7e" xlink:href="var-20221230.xsd#var_AssetBasedLoanRevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_60345bc0-019c-4253-9769-ca29bd8dfb11" xlink:to="loc_var_AssetBasedLoanRevolvingCreditFacilityMember_f85fc05a-1b23-45a1-9d02-a7640de2ea7e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_2441697d-6570-4f98-b3fa-f2a47c4b9701" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_75eb6f2a-687e-42bc-98dc-bdc04ee79cc6" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_2441697d-6570-4f98-b3fa-f2a47c4b9701" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_2441697d-6570-4f98-b3fa-f2a47c4b9701_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_2441697d-6570-4f98-b3fa-f2a47c4b9701" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_2441697d-6570-4f98-b3fa-f2a47c4b9701_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_cb33b684-6861-4c11-b4f0-41c154d9f30c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_2441697d-6570-4f98-b3fa-f2a47c4b9701" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_cb33b684-6861-4c11-b4f0-41c154d9f30c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_0a84389f-9605-4138-8e05-99afbf3d49a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_cb33b684-6861-4c11-b4f0-41c154d9f30c" xlink:to="loc_us-gaap_SecuredDebtMember_0a84389f-9605-4138-8e05-99afbf3d49a4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_6ad241a7-6729-4c8a-955a-993bd75fcfb0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_75eb6f2a-687e-42bc-98dc-bdc04ee79cc6" xlink:to="loc_srt_RangeAxis_6ad241a7-6729-4c8a-955a-993bd75fcfb0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6ad241a7-6729-4c8a-955a-993bd75fcfb0_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_6ad241a7-6729-4c8a-955a-993bd75fcfb0" xlink:to="loc_srt_RangeMember_6ad241a7-6729-4c8a-955a-993bd75fcfb0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_9b287bc7-e49e-4b6e-a585-7ec2d4037d0c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_6ad241a7-6729-4c8a-955a-993bd75fcfb0" xlink:to="loc_srt_RangeMember_9b287bc7-e49e-4b6e-a585-7ec2d4037d0c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_eba90597-8e56-4e01-b4de-8cadb2225a26" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_9b287bc7-e49e-4b6e-a585-7ec2d4037d0c" xlink:to="loc_srt_MinimumMember_eba90597-8e56-4e01-b4de-8cadb2225a26" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.varex.com/role/NONCONTROLLINGINTERESTSNoncontrollingInterestDetails" xlink:type="simple" xlink:href="var-20221230.xsd#NONCONTROLLINGINTERESTSNoncontrollingInterestDetails"/>
  <link:definitionLink xlink:role="http://www.varex.com/role/NONCONTROLLINGINTERESTSNoncontrollingInterestDetails" xlink:type="extended" id="ifcf10665fd2d4536b2169d7fdafc57c8_NONCONTROLLINGINTERESTSNoncontrollingInterestDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems_1268a5b0-2b84-4893-b22f-3033b0ea12e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_78d82cd4-d306-485f-bd87-738307559380" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_1268a5b0-2b84-4893-b22f-3033b0ea12e2" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_78d82cd4-d306-485f-bd87-738307559380" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_e6b735a0-cdd4-445b-83c1-d62f90846040" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_1268a5b0-2b84-4893-b22f-3033b0ea12e2" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_e6b735a0-cdd4-445b-83c1-d62f90846040" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_9457cf48-857b-41b4-952f-a9d1463c20c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_1268a5b0-2b84-4893-b22f-3033b0ea12e2" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_9457cf48-857b-41b4-952f-a9d1463c20c2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_PercentageOfAdditionalOutstandingSharesPurchased_081afa12-adf5-486e-8bb6-c472cfd5300d" xlink:href="var-20221230.xsd#var_PercentageOfAdditionalOutstandingSharesPurchased"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_1268a5b0-2b84-4893-b22f-3033b0ea12e2" xlink:to="loc_var_PercentageOfAdditionalOutstandingSharesPurchased_081afa12-adf5-486e-8bb6-c472cfd5300d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_BusinessAcquisitionCumulativePercentageOfVotingInterestsAcquired_daefc796-a53c-436a-b26e-6a2ab193ffe7" xlink:href="var-20221230.xsd#var_BusinessAcquisitionCumulativePercentageOfVotingInterestsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_1268a5b0-2b84-4893-b22f-3033b0ea12e2" xlink:to="loc_var_BusinessAcquisitionCumulativePercentageOfVotingInterestsAcquired_daefc796-a53c-436a-b26e-6a2ab193ffe7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_BusinessAcquisitionAnnualRecurringCompensation_67340009-89d5-4a17-b6fe-74312b5a02fa" xlink:href="var-20221230.xsd#var_BusinessAcquisitionAnnualRecurringCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_1268a5b0-2b84-4893-b22f-3033b0ea12e2" xlink:to="loc_var_BusinessAcquisitionAnnualRecurringCompensation_67340009-89d5-4a17-b6fe-74312b5a02fa" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_1e8baf28-b6bc-4be8-bbba-0ae7ee86fd4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_1268a5b0-2b84-4893-b22f-3033b0ea12e2" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_1e8baf28-b6bc-4be8-bbba-0ae7ee86fd4d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInMinorityInterestRollForward_8cc55572-22fc-4c8d-afd4-c0a0837cd456" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MovementInMinorityInterestRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_1268a5b0-2b84-4893-b22f-3033b0ea12e2" xlink:to="loc_us-gaap_MovementInMinorityInterestRollForward_8cc55572-22fc-4c8d-afd4-c0a0837cd456" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_e72ccf81-2d3d-48da-8865-6a4b2792f28c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_8cc55572-22fc-4c8d-afd4-c0a0837cd456" xlink:to="loc_us-gaap_MinorityInterest_e72ccf81-2d3d-48da-8865-6a4b2792f28c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_NetIncomeLossAttributableToNoncontrollingInterestNetOfDividends_a1f98b3c-9deb-4562-9f1b-30b78add746f" xlink:href="var-20221230.xsd#var_NetIncomeLossAttributableToNoncontrollingInterestNetOfDividends"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_8cc55572-22fc-4c8d-afd4-c0a0837cd456" xlink:to="loc_var_NetIncomeLossAttributableToNoncontrollingInterestNetOfDividends_a1f98b3c-9deb-4562-9f1b-30b78add746f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_NoncontrollingInterestOtherChanges_ef7945fd-80f4-4754-9d65-262ea4b38ee6" xlink:href="var-20221230.xsd#var_NoncontrollingInterestOtherChanges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_8cc55572-22fc-4c8d-afd4-c0a0837cd456" xlink:to="loc_var_NoncontrollingInterestOtherChanges_ef7945fd-80f4-4754-9d65-262ea4b38ee6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_a2985cf6-7dae-49be-9a57-d8411d05f5bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable_6eadf4b8-8418-409c-91a9-58acfa4bc531" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_MinorityInterestLineItems_1268a5b0-2b84-4893-b22f-3033b0ea12e2" xlink:to="loc_us-gaap_MinorityInterestTable_6eadf4b8-8418-409c-91a9-58acfa4bc531" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_edb2a226-d9ae-456e-bced-a5081db40789" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_MinorityInterestTable_6eadf4b8-8418-409c-91a9-58acfa4bc531" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_edb2a226-d9ae-456e-bced-a5081db40789" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_edb2a226-d9ae-456e-bced-a5081db40789_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_edb2a226-d9ae-456e-bced-a5081db40789" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_edb2a226-d9ae-456e-bced-a5081db40789_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_96332eca-45ba-4d98-89ea-cd16d9f69f85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_edb2a226-d9ae-456e-bced-a5081db40789" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_96332eca-45ba-4d98-89ea-cd16d9f69f85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_MeVisMedicalSolutionsAGMeVisMember_7e490a94-7193-4240-8300-2cacff917a5d" xlink:href="var-20221230.xsd#var_MeVisMedicalSolutionsAGMeVisMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_96332eca-45ba-4d98-89ea-cd16d9f69f85" xlink:to="loc_var_MeVisMedicalSolutionsAGMeVisMember_7e490a94-7193-4240-8300-2cacff917a5d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_d480384d-7199-4ce5-bb0b-ca848c91bf38" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_MinorityInterestTable_6eadf4b8-8418-409c-91a9-58acfa4bc531" xlink:to="loc_srt_OwnershipAxis_d480384d-7199-4ce5-bb0b-ca848c91bf38" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_d480384d-7199-4ce5-bb0b-ca848c91bf38_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_d480384d-7199-4ce5-bb0b-ca848c91bf38" xlink:to="loc_srt_OwnershipDomain_d480384d-7199-4ce5-bb0b-ca848c91bf38_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_9bd1f3ec-8b38-4604-921c-857343ca674a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_d480384d-7199-4ce5-bb0b-ca848c91bf38" xlink:to="loc_srt_OwnershipDomain_9bd1f3ec-8b38-4604-921c-857343ca674a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_JointVentureInSaudiArabiaMember_aa4769b8-f1e7-44ba-8f44-c8c9c842c543" xlink:href="var-20221230.xsd#var_JointVentureInSaudiArabiaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_9bd1f3ec-8b38-4604-921c-857343ca674a" xlink:to="loc_var_JointVentureInSaudiArabiaMember_aa4769b8-f1e7-44ba-8f44-c8c9c842c543" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_MeVisMedicalSolutionsAGMeVisMember_c13d11c2-42cc-4d6f-b948-a75944f17f01" xlink:href="var-20221230.xsd#var_MeVisMedicalSolutionsAGMeVisMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_9bd1f3ec-8b38-4604-921c-857343ca674a" xlink:to="loc_var_MeVisMedicalSolutionsAGMeVisMember_c13d11c2-42cc-4d6f-b948-a75944f17f01" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.varex.com/role/NETINCOMEPERSHAREReconciliationofNumeratorandDenominatorforBasicandDilutedNetLossIncomePerCommonShareDetails" xlink:type="simple" xlink:href="var-20221230.xsd#NETINCOMEPERSHAREReconciliationofNumeratorandDenominatorforBasicandDilutedNetLossIncomePerCommonShareDetails"/>
  <link:definitionLink xlink:role="http://www.varex.com/role/NETINCOMEPERSHAREReconciliationofNumeratorandDenominatorforBasicandDilutedNetLossIncomePerCommonShareDetails" xlink:type="extended" id="ic272c13dc5cc4dc486341ccad8d7ae96_NETINCOMEPERSHAREReconciliationofNumeratorandDenominatorforBasicandDilutedNetLossIncomePerCommonShareDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_260508a3-c1d9-44e4-960c-0af50e2353b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_3ea483cc-5279-4959-9718-3a57432adc87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_260508a3-c1d9-44e4-960c-0af50e2353b8" xlink:to="loc_us-gaap_NetIncomeLoss_3ea483cc-5279-4959-9718-3a57432adc87" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_850a4573-f6f8-4476-a1e9-d6b0f852e73d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_260508a3-c1d9-44e4-960c-0af50e2353b8" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_850a4573-f6f8-4476-a1e9-d6b0f852e73d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_c60f884a-9888-4a81-a3f0-5fb73507fc0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_260508a3-c1d9-44e4-960c-0af50e2353b8" xlink:to="loc_us-gaap_EarningsPerShareBasic_c60f884a-9888-4a81-a3f0-5fb73507fc0f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_6c5f84f4-aeae-49b7-b0df-b5875bbb312b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_260508a3-c1d9-44e4-960c-0af50e2353b8" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_6c5f84f4-aeae-49b7-b0df-b5875bbb312b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_f16a7414-04b3-4bf4-8756-b7544bf7cdd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_260508a3-c1d9-44e4-960c-0af50e2353b8" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_f16a7414-04b3-4bf4-8756-b7544bf7cdd2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_5e98264d-c93d-4436-bddd-4cba5543ccdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_260508a3-c1d9-44e4-960c-0af50e2353b8" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_5e98264d-c93d-4436-bddd-4cba5543ccdb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_IncrementalCommonSharesAttributableToDilutiveEffectOfWarrants_d653ca40-20f2-4a07-b92b-194e720299e1" xlink:href="var-20221230.xsd#var_IncrementalCommonSharesAttributableToDilutiveEffectOfWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_260508a3-c1d9-44e4-960c-0af50e2353b8" xlink:to="loc_var_IncrementalCommonSharesAttributableToDilutiveEffectOfWarrants_d653ca40-20f2-4a07-b92b-194e720299e1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_178c9aac-6af8-40d7-b9a8-ae857074e7ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_260508a3-c1d9-44e4-960c-0af50e2353b8" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_178c9aac-6af8-40d7-b9a8-ae857074e7ac" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_d51f20db-3074-4280-a4c6-fd48faaa885b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_260508a3-c1d9-44e4-960c-0af50e2353b8" xlink:to="loc_us-gaap_EarningsPerShareDiluted_d51f20db-3074-4280-a4c6-fd48faaa885b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_60bd9bd8-c0ba-4678-8bf0-ef4272eb11f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_260508a3-c1d9-44e4-960c-0af50e2353b8" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_60bd9bd8-c0ba-4678-8bf0-ef4272eb11f7" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_f78d5f16-758b-45ed-b60f-b156110dd5d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_260508a3-c1d9-44e4-960c-0af50e2353b8" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_f78d5f16-758b-45ed-b60f-b156110dd5d7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_2ba5eb16-88c7-44a3-92fe-47b47b2f7ab3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_f78d5f16-758b-45ed-b60f-b156110dd5d7" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_2ba5eb16-88c7-44a3-92fe-47b47b2f7ab3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_2ba5eb16-88c7-44a3-92fe-47b47b2f7ab3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_2ba5eb16-88c7-44a3-92fe-47b47b2f7ab3" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_2ba5eb16-88c7-44a3-92fe-47b47b2f7ab3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_6c0e24dc-c32c-4e71-b93b-aea22f416e5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_2ba5eb16-88c7-44a3-92fe-47b47b2f7ab3" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_6c0e24dc-c32c-4e71-b93b-aea22f416e5e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_bae7bcf8-27e4-41d7-9fff-bbef0fb9c570" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_6c0e24dc-c32c-4e71-b93b-aea22f416e5e" xlink:to="loc_us-gaap_RestrictedStockMember_bae7bcf8-27e4-41d7-9fff-bbef0fb9c570" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtSecuritiesMember_bea0d51f-30cb-4b52-8d1e-709d4405a74a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_6c0e24dc-c32c-4e71-b93b-aea22f416e5e" xlink:to="loc_us-gaap_ConvertibleDebtSecuritiesMember_bea0d51f-30cb-4b52-8d1e-709d4405a74a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_8c4acd99-e6d4-4f77-9bff-303631ada62b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_6c0e24dc-c32c-4e71-b93b-aea22f416e5e" xlink:to="loc_us-gaap_WarrantMember_8c4acd99-e6d4-4f77-9bff-303631ada62b" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.varex.com/role/NETINCOMEPERSHARENarrativeDetails" xlink:type="simple" xlink:href="var-20221230.xsd#NETINCOMEPERSHARENarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.varex.com/role/NETINCOMEPERSHARENarrativeDetails" xlink:type="extended" id="id320f1b895254b4e9a99e62105296872_NETINCOMEPERSHARENarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_7f366828-95e7-4bdf-b91e-0393490ebd4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments_2434d191-f95b-40d3-b145-a718b45333a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_7f366828-95e7-4bdf-b91e-0393490ebd4a" xlink:to="loc_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments_2434d191-f95b-40d3-b145-a718b45333a3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_1268e78f-7332-425f-bb4a-0a0b963356cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_7f366828-95e7-4bdf-b91e-0393490ebd4a" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_1268e78f-7332-425f-bb4a-0a0b963356cc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_611c26fb-e5ed-480f-8d81-6f47c4bb10a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_1268e78f-7332-425f-bb4a-0a0b963356cc" xlink:to="loc_us-gaap_DebtInstrumentAxis_611c26fb-e5ed-480f-8d81-6f47c4bb10a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_611c26fb-e5ed-480f-8d81-6f47c4bb10a4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_611c26fb-e5ed-480f-8d81-6f47c4bb10a4" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_611c26fb-e5ed-480f-8d81-6f47c4bb10a4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_3e860076-aeb9-419e-b40f-e34d962a0ad3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_611c26fb-e5ed-480f-8d81-6f47c4bb10a4" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_3e860076-aeb9-419e-b40f-e34d962a0ad3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_ConvertibleNotesMember_10270833-e3df-4830-a38c-dd2ec6ce9f70" xlink:href="var-20221230.xsd#var_ConvertibleNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3e860076-aeb9-419e-b40f-e34d962a0ad3" xlink:to="loc_var_ConvertibleNotesMember_10270833-e3df-4830-a38c-dd2ec6ce9f70" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_9865fc64-7687-4b9b-ba90-1a5b6d755fb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_1268e78f-7332-425f-bb4a-0a0b963356cc" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_9865fc64-7687-4b9b-ba90-1a5b6d755fb1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_9865fc64-7687-4b9b-ba90-1a5b6d755fb1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_9865fc64-7687-4b9b-ba90-1a5b6d755fb1" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_9865fc64-7687-4b9b-ba90-1a5b6d755fb1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_efae15f3-094f-4d51-82c2-3742f188afd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_9865fc64-7687-4b9b-ba90-1a5b6d755fb1" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_efae15f3-094f-4d51-82c2-3742f188afd5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_e5d63669-c085-444e-9279-11e369ae8fbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_efae15f3-094f-4d51-82c2-3742f188afd5" xlink:to="loc_us-gaap_ConvertibleDebtMember_e5d63669-c085-444e-9279-11e369ae8fbb" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.varex.com/role/EMPLOYEESTOCKPLANSSharebasedCompensationExpenseDetails" xlink:type="simple" xlink:href="var-20221230.xsd#EMPLOYEESTOCKPLANSSharebasedCompensationExpenseDetails"/>
  <link:definitionLink xlink:role="http://www.varex.com/role/EMPLOYEESTOCKPLANSSharebasedCompensationExpenseDetails" xlink:type="extended" id="ib892f10aa2614a92a1992db67f48660e_EMPLOYEESTOCKPLANSSharebasedCompensationExpenseDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_d870fda9-d901-4e08-a2a6-c969a8c8f7fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_84ee6281-1ee6-4757-bd41-7398d03bdf23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_d870fda9-d901-4e08-a2a6-c969a8c8f7fd" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_84ee6281-1ee6-4757-bd41-7398d03bdf23" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_2ee74b29-fe65-43f5-84d2-5a20b21743b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_d870fda9-d901-4e08-a2a6-c969a8c8f7fd" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_2ee74b29-fe65-43f5-84d2-5a20b21743b6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_10eb5214-d1fb-47d1-a78d-46f8dc197e08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_2ee74b29-fe65-43f5-84d2-5a20b21743b6" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_10eb5214-d1fb-47d1-a78d-46f8dc197e08" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_10eb5214-d1fb-47d1-a78d-46f8dc197e08_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_10eb5214-d1fb-47d1-a78d-46f8dc197e08" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_10eb5214-d1fb-47d1-a78d-46f8dc197e08_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_d2474d7b-9213-4fc5-b1b8-b38a562dcc02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_10eb5214-d1fb-47d1-a78d-46f8dc197e08" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_d2474d7b-9213-4fc5-b1b8-b38a562dcc02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_92704c1e-b0a3-46a4-be9e-1ac2a340a811" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d2474d7b-9213-4fc5-b1b8-b38a562dcc02" xlink:to="loc_us-gaap_CostOfSalesMember_92704c1e-b0a3-46a4-be9e-1ac2a340a811" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_d292499b-48fa-4de8-872b-275af3e15d9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d2474d7b-9213-4fc5-b1b8-b38a562dcc02" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_d292499b-48fa-4de8-872b-275af3e15d9a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_eea52948-1e7d-47dd-a928-0e46722f447f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d2474d7b-9213-4fc5-b1b8-b38a562dcc02" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_eea52948-1e7d-47dd-a928-0e46722f447f" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.varex.com/role/EMPLOYEESTOCKPLANSStockOptionActivityDetails" xlink:type="simple" xlink:href="var-20221230.xsd#EMPLOYEESTOCKPLANSStockOptionActivityDetails"/>
  <link:definitionLink xlink:role="http://www.varex.com/role/EMPLOYEESTOCKPLANSStockOptionActivityDetails" xlink:type="extended" id="ife2324b871f845c19ac20bfcbfa2aced_EMPLOYEESTOCKPLANSStockOptionActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e37c6e9b-f8f7-49bb-a506-21254efc62ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_05632c1a-41e2-435e-89cf-fc1b3a6647ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e37c6e9b-f8f7-49bb-a506-21254efc62ab" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_05632c1a-41e2-435e-89cf-fc1b3a6647ed" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_d59fff4c-6af0-4d32-b886-a2ac85e80a85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_05632c1a-41e2-435e-89cf-fc1b3a6647ed" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_d59fff4c-6af0-4d32-b886-a2ac85e80a85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_32d4942c-f2c6-419e-a6cc-ceec55876c8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_05632c1a-41e2-435e-89cf-fc1b3a6647ed" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_32d4942c-f2c6-419e-a6cc-ceec55876c8f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_b7a06878-f2f4-4c65-a99d-b35e21961bf2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_05632c1a-41e2-435e-89cf-fc1b3a6647ed" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_b7a06878-f2f4-4c65-a99d-b35e21961bf2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_74e6b3e0-b997-4e68-bb1f-a046fd1e1928" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_d8c1f139-b130-445d-94fa-3115735b93a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e37c6e9b-f8f7-49bb-a506-21254efc62ab" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_d8c1f139-b130-445d-94fa-3115735b93a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_ExercisePriceRangeRollForward_d239d339-99be-45c2-aa04-1acb1ae72d49" xlink:href="var-20221230.xsd#var_ExercisePriceRangeRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e37c6e9b-f8f7-49bb-a506-21254efc62ab" xlink:to="loc_var_ExercisePriceRangeRollForward_d239d339-99be-45c2-aa04-1acb1ae72d49" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingPrice_c09e7322-c47b-4c49-93ab-de1037c52055" xlink:href="var-20221230.xsd#var_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingPrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_var_ExercisePriceRangeRollForward_d239d339-99be-45c2-aa04-1acb1ae72d49" xlink:to="loc_var_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingPrice_c09e7322-c47b-4c49-93ab-de1037c52055" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_SharebasedCompensationArrangementsbySharebasedPaymentAwardOptionsGrantsinPeriodPrice_1e92d656-3f6c-4999-8b12-7adf7c0cdd18" xlink:href="var-20221230.xsd#var_SharebasedCompensationArrangementsbySharebasedPaymentAwardOptionsGrantsinPeriodPrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_var_ExercisePriceRangeRollForward_d239d339-99be-45c2-aa04-1acb1ae72d49" xlink:to="loc_var_SharebasedCompensationArrangementsbySharebasedPaymentAwardOptionsGrantsinPeriodPrice_1e92d656-3f6c-4999-8b12-7adf7c0cdd18" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsForfeituresandExpirationsinPeriodPrice_37409bb0-e17c-4ca7-946e-7fb4a0f3dbe8" xlink:href="var-20221230.xsd#var_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsForfeituresandExpirationsinPeriodPrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_var_ExercisePriceRangeRollForward_d239d339-99be-45c2-aa04-1acb1ae72d49" xlink:to="loc_var_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsForfeituresandExpirationsinPeriodPrice_37409bb0-e17c-4ca7-946e-7fb4a0f3dbe8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingPrice_77e9cb0d-e321-4adc-9380-15bde38fce19" xlink:href="var-20221230.xsd#var_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingPrice"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisablePrice_60256ab6-6bc1-4771-b6d1-f8f4e87e2be8" xlink:href="var-20221230.xsd#var_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisablePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e37c6e9b-f8f7-49bb-a506-21254efc62ab" xlink:to="loc_var_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisablePrice_60256ab6-6bc1-4771-b6d1-f8f4e87e2be8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_3f8e53be-a5b3-401e-b9aa-ab8cf81e1b7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e37c6e9b-f8f7-49bb-a506-21254efc62ab" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_3f8e53be-a5b3-401e-b9aa-ab8cf81e1b7b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_63111b53-300d-4354-8887-2834d6cdb2ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_3f8e53be-a5b3-401e-b9aa-ab8cf81e1b7b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_63111b53-300d-4354-8887-2834d6cdb2ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_513291fa-f4c2-4e97-8c2e-71b02e7e679d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_3f8e53be-a5b3-401e-b9aa-ab8cf81e1b7b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_513291fa-f4c2-4e97-8c2e-71b02e7e679d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_b783c3c0-fde6-4987-96da-169199c10789" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_3f8e53be-a5b3-401e-b9aa-ab8cf81e1b7b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_b783c3c0-fde6-4987-96da-169199c10789" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_7614194b-67c8-4530-829e-69210d8ab4b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_ad67b1c3-3b95-4bf9-a6ec-25e38f08bb72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e37c6e9b-f8f7-49bb-a506-21254efc62ab" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_ad67b1c3-3b95-4bf9-a6ec-25e38f08bb72" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_a51ada8e-b7ea-4bdc-821b-7bccf4933ada" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e37c6e9b-f8f7-49bb-a506-21254efc62ab" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_a51ada8e-b7ea-4bdc-821b-7bccf4933ada" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_75b03d03-a0f3-4850-b79b-935b7befdad5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_a51ada8e-b7ea-4bdc-821b-7bccf4933ada" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_75b03d03-a0f3-4850-b79b-935b7befdad5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_92601f91-d4e0-4dbf-9d78-69a055963c92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_a51ada8e-b7ea-4bdc-821b-7bccf4933ada" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_92601f91-d4e0-4dbf-9d78-69a055963c92" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_e5c44319-e7b9-4765-a40b-ae8c2773de4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_a51ada8e-b7ea-4bdc-821b-7bccf4933ada" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_e5c44319-e7b9-4765-a40b-ae8c2773de4c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_bd5526e7-a7ec-4583-b789-ccf4ec2b57a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_a51ada8e-b7ea-4bdc-821b-7bccf4933ada" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_bd5526e7-a7ec-4583-b789-ccf4ec2b57a8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_00e4a7ba-5d48-45b5-a98f-558bdd220ec2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e37c6e9b-f8f7-49bb-a506-21254efc62ab" xlink:to="loc_us-gaap_SharePrice_00e4a7ba-5d48-45b5-a98f-558bdd220ec2" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cbb982c3-8f2c-4b62-806f-f869e0cbe895" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e37c6e9b-f8f7-49bb-a506-21254efc62ab" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cbb982c3-8f2c-4b62-806f-f869e0cbe895" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_109c9e6f-7ca0-4e38-9640-8e8a2bab16a3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cbb982c3-8f2c-4b62-806f-f869e0cbe895" xlink:to="loc_srt_RangeAxis_109c9e6f-7ca0-4e38-9640-8e8a2bab16a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_109c9e6f-7ca0-4e38-9640-8e8a2bab16a3_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_109c9e6f-7ca0-4e38-9640-8e8a2bab16a3" xlink:to="loc_srt_RangeMember_109c9e6f-7ca0-4e38-9640-8e8a2bab16a3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_098683a3-9a5c-4bab-a2e2-9a97efb7f7e7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_109c9e6f-7ca0-4e38-9640-8e8a2bab16a3" xlink:to="loc_srt_RangeMember_098683a3-9a5c-4bab-a2e2-9a97efb7f7e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_8d0c5328-346c-4d2f-b72e-0111ad625f54" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_098683a3-9a5c-4bab-a2e2-9a97efb7f7e7" xlink:to="loc_srt_MinimumMember_8d0c5328-346c-4d2f-b72e-0111ad625f54" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_fafbe104-3655-487c-915f-47ee32d6e7a8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_098683a3-9a5c-4bab-a2e2-9a97efb7f7e7" xlink:to="loc_srt_MaximumMember_fafbe104-3655-487c-915f-47ee32d6e7a8" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.varex.com/role/SEGMENTINFORMATIONIncomeStatementInformationDetails" xlink:type="simple" xlink:href="var-20221230.xsd#SEGMENTINFORMATIONIncomeStatementInformationDetails"/>
  <link:definitionLink xlink:role="http://www.varex.com/role/SEGMENTINFORMATIONIncomeStatementInformationDetails" xlink:type="extended" id="i06a83548c915499c8542f1713a5f372a_SEGMENTINFORMATIONIncomeStatementInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_f0fdf0e2-e911-41f3-b7f2-86beb7beee73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_dda4b92b-1ce8-45de-b496-1eeb4c5e9254" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f0fdf0e2-e911-41f3-b7f2-86beb7beee73" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_dda4b92b-1ce8-45de-b496-1eeb4c5e9254" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_e66afbd7-13e0-4754-be7e-448ba8ec89cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f0fdf0e2-e911-41f3-b7f2-86beb7beee73" xlink:to="loc_us-gaap_GrossProfit_e66afbd7-13e0-4754-be7e-448ba8ec89cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_dae4285f-6588-4a8a-b311-bdfd9d335809" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f0fdf0e2-e911-41f3-b7f2-86beb7beee73" xlink:to="loc_us-gaap_OperatingExpenses_dae4285f-6588-4a8a-b311-bdfd9d335809" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_f97bb009-5f9f-44b4-9e99-c5de6b6a9afc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f0fdf0e2-e911-41f3-b7f2-86beb7beee73" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_f97bb009-5f9f-44b4-9e99-c5de6b6a9afc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_5ccf144e-2b81-430a-b6d7-1542f50f6005" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f0fdf0e2-e911-41f3-b7f2-86beb7beee73" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_5ccf144e-2b81-430a-b6d7-1542f50f6005" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_24eaf338-d4be-45c4-ad85-2e2a5be81559" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f0fdf0e2-e911-41f3-b7f2-86beb7beee73" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_24eaf338-d4be-45c4-ad85-2e2a5be81559" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_b4e233b9-85dd-474c-89f3-7dfed43b0dba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f0fdf0e2-e911-41f3-b7f2-86beb7beee73" xlink:to="loc_us-gaap_ProfitLoss_b4e233b9-85dd-474c-89f3-7dfed43b0dba" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_9aca93f5-831f-4d8d-ba7a-fd382f11bd80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f0fdf0e2-e911-41f3-b7f2-86beb7beee73" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_9aca93f5-831f-4d8d-ba7a-fd382f11bd80" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_19b974cb-3edc-4d7e-ac5b-9944cd62d138" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f0fdf0e2-e911-41f3-b7f2-86beb7beee73" xlink:to="loc_us-gaap_NetIncomeLoss_19b974cb-3edc-4d7e-ac5b-9944cd62d138" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e149f665-f813-4295-b9a7-20d138c7d886" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f0fdf0e2-e911-41f3-b7f2-86beb7beee73" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e149f665-f813-4295-b9a7-20d138c7d886" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_ee8f3911-a691-4c16-bc4f-42db76ebd3fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e149f665-f813-4295-b9a7-20d138c7d886" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_ee8f3911-a691-4c16-bc4f-42db76ebd3fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_ee8f3911-a691-4c16-bc4f-42db76ebd3fe_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ee8f3911-a691-4c16-bc4f-42db76ebd3fe" xlink:to="loc_us-gaap_SegmentDomain_ee8f3911-a691-4c16-bc4f-42db76ebd3fe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_9a280a7a-49b0-482d-914e-b38a68a1c5ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ee8f3911-a691-4c16-bc4f-42db76ebd3fe" xlink:to="loc_us-gaap_SegmentDomain_9a280a7a-49b0-482d-914e-b38a68a1c5ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_MedicalMember_63675da8-52ca-4b44-8efb-89a52eb47cbc" xlink:href="var-20221230.xsd#var_MedicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_9a280a7a-49b0-482d-914e-b38a68a1c5ed" xlink:to="loc_var_MedicalMember_63675da8-52ca-4b44-8efb-89a52eb47cbc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_IndustrialMember_862b9b95-b89e-43b5-ae2f-4fb5cecf61c4" xlink:href="var-20221230.xsd#var_IndustrialMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_9a280a7a-49b0-482d-914e-b38a68a1c5ed" xlink:to="loc_var_IndustrialMember_862b9b95-b89e-43b5-ae2f-4fb5cecf61c4" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd#eedm"/>
  <link:definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202006Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate202006Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember" xlink:to="loc_us-gaap_AccountingStandardsUpdate202006Member" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="loc_us-gaap_Assets" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract" xlink:to="loc_us-gaap_Liabilities" xlink:type="arc" order="1"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>var-20221230_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:b10c8d19-453b-4af7-a4e1-32028a0718a8,g:e90e04e8-fae8-401c-8aa8-facd054e09fb-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_var_VECImagingGmbHCo.KGMember_981502fc-5260-4bac-9b97-b74775b5f4fc_terseLabel_en-US" xlink:label="lab_var_VECImagingGmbHCo.KGMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">VEC Imaging GmbH &amp; Co. KG</link:label>
    <link:label id="lab_var_VECImagingGmbHCo.KGMember_label_en-US" xlink:label="lab_var_VECImagingGmbHCo.KGMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">VEC Imaging GmbH &amp; Co. KG [Member]</link:label>
    <link:label id="lab_var_VECImagingGmbHCo.KGMember_documentation_en-US" xlink:label="lab_var_VECImagingGmbHCo.KGMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">VEC Imaging GmbH &amp; Co. KG [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_var_VECImagingGmbHCo.KGMember" xlink:href="var-20221230.xsd#var_VECImagingGmbHCo.KGMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_var_VECImagingGmbHCo.KGMember" xlink:to="lab_var_VECImagingGmbHCo.KGMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_95968c8c-5465-4a4c-a146-60ad6ff8ddd7_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_85fd30de-07cf-46f0-a7b3-7581ffec8b21_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_8282fb55-d039-4bbb-b310-fd15721b709e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash and Cash Equivalents [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_e6e8b16c-f11a-4cb7-977d-1c510f474897_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_a12fbbd1-515a-4348-9cda-d6d94b93c06c_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_2623921d-2173-4a88-baaf-791e35f8b321_verboseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_18af08a3-13a2-47dc-b7c1-e17659c98f45_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:to="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_91204c00-b9b9-479a-8e11-8bdd9c252105_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_449193c7-86b5-4822-bed0-d78cb15b0589_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_0e15ba6e-db30-4e1f-9045-5514e9250c0b_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnTerminationOfLease_df51a0cd-d86d-4a5a-990a-e659a45f146a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnTerminationOfLease" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on operating lease abandonment</link:label>
    <link:label id="lab_us-gaap_GainLossOnTerminationOfLease_label_en-US" xlink:label="lab_us-gaap_GainLossOnTerminationOfLease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Termination of Lease</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnTerminationOfLease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnTerminationOfLease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnTerminationOfLease" xlink:to="lab_us-gaap_GainLossOnTerminationOfLease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_d8fec2e8-42b5-4b9f-8f55-62aebc746d2a_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Treasury bills</link:label>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsFairValueDisclosure" xlink:to="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_984929d0-173d-411e-b74f-312c6686df9a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_1696900f-00fc-499d-a487-d04e84a34c28_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_ec433778-c8bc-4e0d-bc5f-efbc2fa6fdf4_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_var_BusinessAcquisitionCumulativePercentageOfVotingInterestsAcquired_a1d0daf7-a07f-4ce6-b499-440f8f8cb512_terseLabel_en-US" xlink:label="lab_var_BusinessAcquisitionCumulativePercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative percentage of voting interests acquired</link:label>
    <link:label id="lab_var_BusinessAcquisitionCumulativePercentageOfVotingInterestsAcquired_label_en-US" xlink:label="lab_var_BusinessAcquisitionCumulativePercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Cumulative Percentage Of Voting Interests Acquired</link:label>
    <link:label id="lab_var_BusinessAcquisitionCumulativePercentageOfVotingInterestsAcquired_documentation_en-US" xlink:label="lab_var_BusinessAcquisitionCumulativePercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Cumulative Percentage Of Voting Interests Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_var_BusinessAcquisitionCumulativePercentageOfVotingInterestsAcquired" xlink:href="var-20221230.xsd#var_BusinessAcquisitionCumulativePercentageOfVotingInterestsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_var_BusinessAcquisitionCumulativePercentageOfVotingInterestsAcquired" xlink:to="lab_var_BusinessAcquisitionCumulativePercentageOfVotingInterestsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtWeightedAverageInterestRateOverTime_561b9fb9-fc59-4c3b-b37b-636fef4abbbc_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtWeightedAverageInterestRateOverTime" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Interest Rate</link:label>
    <link:label id="lab_us-gaap_LongTermDebtWeightedAverageInterestRateOverTime_label_en-US" xlink:label="lab_us-gaap_LongTermDebtWeightedAverageInterestRateOverTime" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Weighted Average Interest Rate, over Time</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtWeightedAverageInterestRateOverTime" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtWeightedAverageInterestRateOverTime"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtWeightedAverageInterestRateOverTime" xlink:to="lab_us-gaap_LongTermDebtWeightedAverageInterestRateOverTime" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_b982d03c-e743-45e5-8434-5fc9e42c7b69_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_93acf555-483c-4341-9fc5-94d1a16af7fc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationPlanAssets_6a67bf72-b63d-4375-bba4-ad999f200ee6_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred compensation plan</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationPlanAssets_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationPlanAssets" xlink:to="lab_us-gaap_DeferredCompensationPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_b1f65028-8d50-49e3-80d3-15ae896bf4c4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_0aa3c881-2a69-441d-8980-4d38f8bc08fe_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_04c9ca7a-7959-46fb-9fcb-3ee35926286e_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_var_ExercisePriceRangeRollForward_a4777c78-1724-485c-836b-173a95d3d083_terseLabel_en-US" xlink:label="lab_var_ExercisePriceRangeRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Price Range</link:label>
    <link:label id="lab_var_ExercisePriceRangeRollForward_label_en-US" xlink:label="lab_var_ExercisePriceRangeRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range [Roll Forward]</link:label>
    <link:label id="lab_var_ExercisePriceRangeRollForward_documentation_en-US" xlink:label="lab_var_ExercisePriceRangeRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range [Rollforward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_var_ExercisePriceRangeRollForward" xlink:href="var-20221230.xsd#var_ExercisePriceRangeRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_var_ExercisePriceRangeRollForward" xlink:to="lab_var_ExercisePriceRangeRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_8f2019e7-fcc5-4789-a461-a31cd65dc1bc_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MaturitiesOfLongTermDebtAbstract_77f4d4f1-8696-482f-b160-9546dfa341c7_terseLabel_en-US" xlink:label="lab_us-gaap_MaturitiesOfLongTermDebtAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current maturities of long-term debt:</link:label>
    <link:label id="lab_us-gaap_MaturitiesOfLongTermDebtAbstract_label_en-US" xlink:label="lab_us-gaap_MaturitiesOfLongTermDebtAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities of Long-Term Debt [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaturitiesOfLongTermDebtAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaturitiesOfLongTermDebtAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MaturitiesOfLongTermDebtAbstract" xlink:to="lab_us-gaap_MaturitiesOfLongTermDebtAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_c85dabc8-a7ec-4bf1-918d-555fe8369792_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_47a933e4-16a4-41ff-9e5c-267c60e1d2c6_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Interest Rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3064c81a-5185-427f-a186-5aa5fdbbbed3_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentAssetsMember_d2cdc4b5-7e5a-45f3-aa68-da8167d7488d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_OtherCurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentAssetsMember" xlink:to="lab_us-gaap_OtherCurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_a57db6dc-59b1-440b-8515-cef373ac94a3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration_9501521c-d226-4e70-bf27-000616b37e4f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration" xlink:to="lab_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_0753a5e8-d17a-4afc-a7fc-f7a0854a5efb_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant, and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquitySharesOutstanding_01ef3712-de7c-4ea6-88c8-804e2c7b829b_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary equity, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesOutstanding_label_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquitySharesOutstanding" xlink:to="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_var_BusinessAcquisitionAnnualRecurringCompensation_0765c0ee-e369-439a-a23a-0e0e7ca8a2b0_terseLabel_en-US" xlink:label="lab_var_BusinessAcquisitionAnnualRecurringCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual recurring compensation (in euros per share)</link:label>
    <link:label id="lab_var_BusinessAcquisitionAnnualRecurringCompensation_label_en-US" xlink:label="lab_var_BusinessAcquisitionAnnualRecurringCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Annual Recurring Compensation</link:label>
    <link:label id="lab_var_BusinessAcquisitionAnnualRecurringCompensation_documentation_en-US" xlink:label="lab_var_BusinessAcquisitionAnnualRecurringCompensation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Annual Recurring Compensation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_var_BusinessAcquisitionAnnualRecurringCompensation" xlink:href="var-20221230.xsd#var_BusinessAcquisitionAnnualRecurringCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_var_BusinessAcquisitionAnnualRecurringCompensation" xlink:to="lab_var_BusinessAcquisitionAnnualRecurringCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_var_MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughFive_704aedd2-d7d7-42fc-b6a2-e5e8a8230aaa_terseLabel_en-US" xlink:label="lab_var_MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after one year through five years</link:label>
    <link:label id="lab_var_MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughFive_label_en-US" xlink:label="lab_var_MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Maturity, Allocated and Single Maturity Date, After Year One Through Five</link:label>
    <link:label id="lab_var_MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughFive_documentation_en-US" xlink:label="lab_var_MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughFive" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Maturity, Allocated and Single Maturity Date, After Year One Through Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_var_MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughFive" xlink:href="var-20221230.xsd#var_MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_var_MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughFive" xlink:to="lab_var_MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_f9b4b773-9f3b-4646-a2e3-b878a9f073a2_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to Varex</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_0d1c5872-13e8-4656-a11a-7260f5f062aa_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to Varex - basic</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_5485ec0d-f40e-479d-9806-52e1b4d45c5e_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_f9a8b2b2-2ae4-4f94-93d3-864d75974451_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anti-dilutive shares (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_7ebb9738-2955-4249-854d-1325bd8a9698_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LEASES</link:label>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Finance Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:to="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_5f706bff-503e-4e96-9a68-49a802be8890_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLineItems_d787ff05-3d2e-444a-a988-f54e9d704825_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLineItems" xlink:to="lab_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_var_CustomerContractsandSupplierRelationshipsMember_c72b7210-e48c-42e1-8b7c-f51ec757757e_terseLabel_en-US" xlink:label="lab_var_CustomerContractsandSupplierRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer contracts and supplier relationship</link:label>
    <link:label id="lab_var_CustomerContractsandSupplierRelationshipsMember_label_en-US" xlink:label="lab_var_CustomerContractsandSupplierRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Contracts and Supplier Relationships [Member]</link:label>
    <link:label id="lab_var_CustomerContractsandSupplierRelationshipsMember_documentation_en-US" xlink:label="lab_var_CustomerContractsandSupplierRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Contracts and Supplier Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_var_CustomerContractsandSupplierRelationshipsMember" xlink:href="var-20221230.xsd#var_CustomerContractsandSupplierRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_var_CustomerContractsandSupplierRelationshipsMember" xlink:to="lab_var_CustomerContractsandSupplierRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_f75fcaef-6f1d-4a33-8df3-bed7f32164c9_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareTable_8c1ec3af-f214-4b26-8fa9-a70c8f7df304_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareTable_label_en-US" xlink:label="lab_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareTable" xlink:to="lab_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredDebtMember_52664870-8f1c-4911-aac4-f629e57cc251_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt</link:label>
    <link:label id="lab_us-gaap_SecuredDebtMember_label_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredDebtMember" xlink:to="lab_us-gaap_SecuredDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseMember_c41b40cf-ef2c-40ab-aa76-bd2914551507_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseMember_label_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseMember" xlink:to="lab_us-gaap_InterestExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementScenarioAxis_3d0866ec-793e-4841-ae3b-c8199bf6b169_terseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_label_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNetAbstract_e0d9247a-1f45-4b3c-86a0-15faf21111ee_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized issuance costs and debt discounts</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNetAbstract_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNetAbstract" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_6f1a1b10-33af-4c26-9833-d9f90923fb3d_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets measured at fair value</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipAxis_4355c156-5424-453f-9c61-510b3060c294_terseLabel_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:label id="lab_srt_OwnershipAxis_label_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipAxis" xlink:to="lab_srt_OwnershipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_6b5f8d04-b4fd-41a0-9fe3-7000b3ff57ed_terseLabel_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_label_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EquityMethodInvesteeNameDomain" xlink:to="lab_srt_EquityMethodInvesteeNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_651ab1a0-74f9-4791-9a23-e9b61f1c6346_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LEASES</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems_ced6469c-a442-4697-8734-4bd485c01c64_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems" xlink:to="lab_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_a877a4fc-bb6a-438b-848a-61c40c359bc9_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_b63d7d9d-f132-4989-8871-a67e62839e8a_periodStartLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_f01c7af8-53b6-48d5-baf8-ee06f1f41371_periodEndLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetNet" xlink:to="lab_us-gaap_ContractWithCustomerAssetNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_4468e447-af50-4ccb-91aa-a14752c68265_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_var_CommercialPaperReceivable_4c925c85-bd28-409b-9332-1d4bf6fd8f11_terseLabel_en-US" xlink:label="lab_var_CommercialPaperReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper</link:label>
    <link:label id="lab_var_CommercialPaperReceivable_label_en-US" xlink:label="lab_var_CommercialPaperReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper Receivable</link:label>
    <link:label id="lab_var_CommercialPaperReceivable_documentation_en-US" xlink:label="lab_var_CommercialPaperReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_var_CommercialPaperReceivable" xlink:href="var-20221230.xsd#var_CommercialPaperReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_var_CommercialPaperReceivable" xlink:to="lab_var_CommercialPaperReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_63ba53ba-e07b-4976-a07c-dc12bf1efffc_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental cash flow information:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_c2ae2858-3742-4829-86c4-14d1093a140e_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_c721c030-6916-4be7-80d7-43eb52ff5ab6_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable operating segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestAbstract_58e22a51-4049-49ac-a56b-2e9b276b7eca_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Abstract]</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestAbstract" xlink:to="lab_us-gaap_NoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_e370766d-9720-4027-9955-39dc3ce91029_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_4aca74d9-579b-4eec-9f30-be0e1f54292e_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValueOutstanding_5b8aad3c-8339-459a-af58-9cd89aa2a29d_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValueOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $.01 par value: 150,000,000 shares authorized Shares issued and outstanding: 40,087,100 and 40,085,126 at December&#160;30, 2022 and September&#160;30, 2022, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValueOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockValueOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValueOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValueOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValueOutstanding" xlink:to="lab_us-gaap_CommonStockValueOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_02ecc5a4-d84a-4ebb-b39e-f688a0e23903_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_52bf9774-ba6d-4269-8590-5650f8d4d076_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_8e50bac7-6605-400e-a9d5-410f8d50eff4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_411922bc-13f6-4bbd-a890-f7e80068b570_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive effect of Convertible Notes (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_var_FixedCostCommitmentsMember_84d25c32-ab1f-471e-9160-43bc3ce8ac47_terseLabel_en-US" xlink:label="lab_var_FixedCostCommitmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed Cost Commitments</link:label>
    <link:label id="lab_var_FixedCostCommitmentsMember_label_en-US" xlink:label="lab_var_FixedCostCommitmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed Cost Commitments [Member]</link:label>
    <link:label id="lab_var_FixedCostCommitmentsMember_documentation_en-US" xlink:label="lab_var_FixedCostCommitmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed Cost Commitments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_var_FixedCostCommitmentsMember" xlink:href="var-20221230.xsd#var_FixedCostCommitmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_var_FixedCostCommitmentsMember" xlink:to="lab_var_FixedCostCommitmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_efe0dbb2-6bb3-42c3-a69f-5977e206bf10_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities of undistributed foreign earnings</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Undistributed Foreign Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_var_ContractwithCustomerAssetShipments_4919386a-17ba-4d5e-87d9-18bd0314320d_terseLabel_en-US" xlink:label="lab_var_ContractwithCustomerAssetShipments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract asset from shipments of products, subject to return during the period</link:label>
    <link:label id="lab_var_ContractwithCustomerAssetShipments_label_en-US" xlink:label="lab_var_ContractwithCustomerAssetShipments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, Shipments</link:label>
    <link:label id="lab_var_ContractwithCustomerAssetShipments_documentation_en-US" xlink:label="lab_var_ContractwithCustomerAssetShipments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, Shipments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_var_ContractwithCustomerAssetShipments" xlink:href="var-20221230.xsd#var_ContractwithCustomerAssetShipments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_var_ContractwithCustomerAssetShipments" xlink:to="lab_var_ContractwithCustomerAssetShipments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_49e8aaf0-272a-4646-8ca4-55af6018e546_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_ac6b2047-84a5-4afd-92a4-a9609b25a7a7_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, outstanding, weighted average remaining contractual term (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_var_MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_372d584d-3a11-44f4-949b-52ad4644c91f_negatedTerseLabel_en-US" xlink:label="lab_var_MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Losses</link:label>
    <link:label id="lab_var_MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_var_MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Accumulated Gross Unrealized Loss, Before Tax</link:label>
    <link:label id="lab_var_MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_documentation_en-US" xlink:label="lab_var_MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Accumulated Gross Unrealized Loss, Before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_var_MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="var-20221230.xsd#var_MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_var_MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_var_MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_var_DpiXHoldingMember_ff02026a-daa6-4fb5-9d5a-8d2cd078f350_terseLabel_en-US" xlink:label="lab_var_DpiXHoldingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">dpiX Holding</link:label>
    <link:label id="lab_var_DpiXHoldingMember_label_en-US" xlink:label="lab_var_DpiXHoldingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">dpiX Holding [Member]</link:label>
    <link:label id="lab_var_DpiXHoldingMember_documentation_en-US" xlink:label="lab_var_DpiXHoldingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">dpiX Holding [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_var_DpiXHoldingMember" xlink:href="var-20221230.xsd#var_DpiXHoldingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_var_DpiXHoldingMember" xlink:to="lab_var_DpiXHoldingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_var_LongtermDebtExcludingCurrentMaturitiesGross_5e8a2aed-837a-49c6-b7db-f9de837c7d5f_terseLabel_en-US" xlink:label="lab_var_LongtermDebtExcludingCurrentMaturitiesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total non-current maturities of long-term debt:</link:label>
    <link:label id="lab_var_LongtermDebtExcludingCurrentMaturitiesGross_label_en-US" xlink:label="lab_var_LongtermDebtExcludingCurrentMaturitiesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt Excluding Current Maturities, Gross</link:label>
    <link:label id="lab_var_LongtermDebtExcludingCurrentMaturitiesGross_documentation_en-US" xlink:label="lab_var_LongtermDebtExcludingCurrentMaturitiesGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt Excluding Current Maturities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_var_LongtermDebtExcludingCurrentMaturitiesGross" xlink:href="var-20221230.xsd#var_LongtermDebtExcludingCurrentMaturitiesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_var_LongtermDebtExcludingCurrentMaturitiesGross" xlink:to="lab_var_LongtermDebtExcludingCurrentMaturitiesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_b1ceb29b-1222-4787-974f-52376ac03951_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash (used in) provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_08bb5164-9f1d-4af0-96bf-3ad3e2600b96_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_5ea28d71-b833-4b17-a363-9011ea79fe2d_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities (current)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssets_b08a9ede-0825-453a-a1e6-f46c23577497_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative assets</link:label>
    <link:label id="lab_us-gaap_DerivativeAssets_label_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssets" xlink:to="lab_us-gaap_DerivativeAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_6209e903-0b4c-4ea3-88e9-2ba542ba57bd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_069e2cdc-986e-40cd-a352-03c172d1bc43_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDomain_009f9fcf-d843-41af-92a4-7c88033aa4f2_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain" xlink:to="lab_us-gaap_RelatedPartyTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_b1b9baf7-a98b-4a09-bdc5-aeb2217a667a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_var_ContractWithCustomerRefundLiabilityAmountReleased_39cf1fd5-4c26-4bf7-bae9-f7e0d4238081_negatedLabel_en-US" xlink:label="lab_var_ContractWithCustomerRefundLiabilityAmountReleased" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Release of refund liability included in beginning of year refund liability</link:label>
    <link:label id="lab_var_ContractWithCustomerRefundLiabilityAmountReleased_label_en-US" xlink:label="lab_var_ContractWithCustomerRefundLiabilityAmountReleased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Refund Liability, Amount Released</link:label>
    <link:label id="lab_var_ContractWithCustomerRefundLiabilityAmountReleased_documentation_en-US" xlink:label="lab_var_ContractWithCustomerRefundLiabilityAmountReleased" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Refund Liability, Amount Released</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_var_ContractWithCustomerRefundLiabilityAmountReleased" xlink:href="var-20221230.xsd#var_ContractWithCustomerRefundLiabilityAmountReleased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_var_ContractWithCustomerRefundLiabilityAmountReleased" xlink:to="lab_var_ContractWithCustomerRefundLiabilityAmountReleased" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_fbc828e1-6b4a-462b-9b52-dbd82e43989e_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, net</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_b39edc97-cc10-47ef-ba54-3eeefe9b9938_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb0e82ff-bfad-4fe6-b75c-32a008518b28_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_cfcd157b-29f5-4983-a92f-a833c8321b01_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of Gain Recognized in Income on Derivative (Amount Excluded from Effectiveness Testing)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_04373d3d-5abb-4c2f-a5ff-ab7c6df7ff35_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_9abb4894-1491-4d7b-b7f0-2f96464f6523_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_1354e371-7dc2-4e4d-b1fb-e5d772e9da0d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of voting interests acquired</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Percentage of Voting Interests Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_b11763cb-e217-4bb8-b72a-55310b99a13a_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f057c6a6-2f23-4e67-b13b-42b75dbb7e21_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_5b1a4e85-1cb5-4dd0-bd80-abb22861e454_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_8976c784-d8a2-4374-bcf4-f3f09a185ffd_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_14d31583-ce67-4011-8f9d-57f0dd1e29e9_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_6134d2b1-ffdd-49e7-9f23-fdd469095fd0_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_c3bbfd20-6f92-484e-abaa-f893540f5cd8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_be12142a-6fc7-4d26-b9cd-7a62d3bd51c4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number&#160;of&#160;Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_849648fc-3855-42b0-b200-1186c4f87ed1_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_96030246-d6a0-4054-8fd3-d956dde5c5ac_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canceled, expired or forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1f172277-ae2c-405d-9211-3053bff5d8cc_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrualPayments_0329f5be-cd9a-488a-b7af-9fb54dd84efa_negatedLabel_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrualPayments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product warranty expenditures</link:label>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrualPayments_label_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrualPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard Product Warranty Accrual, Decrease for Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrualPayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StandardProductWarrantyAccrualPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandardProductWarrantyAccrualPayments" xlink:to="lab_us-gaap_StandardProductWarrantyAccrualPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_da71d6c0-e236-4375-ae8c-46fece3b7657_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock units, nonvested, beginning of period (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_d8895c99-1275-462d-97bf-70a61b7f9732_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock units, nonvested, end of period (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_5f4222cf-68c0-493d-8447-ac5c13e9fc84_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_3823c316-f42b-423b-84d6-b9827ac8fa1d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BORROWINGS</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_a05b1405-8720-40bb-939d-73182662176a_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_738f65ce-c73e-49c1-a857-38700b1514e5_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_04aa00e7-68bd-47a1-8c6f-977761a21380_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities and other current and long-term liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_0064f4a4-c44a-4a76-8ccf-36e4fe1f56ea_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTable" xlink:to="lab_us-gaap_ConcentrationRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_cc816d64-6c32-4b84-b1dd-2b3c1e893d47_terseLabel_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired existing technology</link:label>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_label_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:to="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_98d5a6a4-7cee-4a9e-895b-911f93293e65_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of (Loss) Gain Recognized in OCI on Derivative</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_2d001c71-c0c7-4d15-945f-93325ec168fb_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Contract Asset and Liabilities</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:to="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_8defa150-7fa6-48e9-a20c-cf183c31cd9d_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_var_PercentageOfAdditionalOutstandingSharesPurchased_de0a389b-b88e-45d7-b679-d6dc38880dbd_terseLabel_en-US" xlink:label="lab_var_PercentageOfAdditionalOutstandingSharesPurchased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of additional outstanding shares purchased</link:label>
    <link:label id="lab_var_PercentageOfAdditionalOutstandingSharesPurchased_label_en-US" xlink:label="lab_var_PercentageOfAdditionalOutstandingSharesPurchased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Additional Outstanding Shares Purchased</link:label>
    <link:label id="lab_var_PercentageOfAdditionalOutstandingSharesPurchased_documentation_en-US" xlink:label="lab_var_PercentageOfAdditionalOutstandingSharesPurchased" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Additional Outstanding Shares Purchased</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_var_PercentageOfAdditionalOutstandingSharesPurchased" xlink:href="var-20221230.xsd#var_PercentageOfAdditionalOutstandingSharesPurchased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_var_PercentageOfAdditionalOutstandingSharesPurchased" xlink:to="lab_var_PercentageOfAdditionalOutstandingSharesPurchased" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate202006Member_2d3c58bb-2aab-4316-b06f-c59f9d5c3956_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate202006Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2020-06</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate202006Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate202006Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2020-06 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202006Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate202006Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate202006Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate202006Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_31436375-af72-44a2-b7a7-4628b91d9325_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_var_ClassOfWarrantOrRightPercentIncreaseOfStrikePriceOverSalePrice_39aeedea-bbb6-4a16-b5bb-ee9cb4ee15a8_terseLabel_en-US" xlink:label="lab_var_ClassOfWarrantOrRightPercentIncreaseOfStrikePriceOverSalePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent increase of strike price over sale price</link:label>
    <link:label id="lab_var_ClassOfWarrantOrRightPercentIncreaseOfStrikePriceOverSalePrice_label_en-US" xlink:label="lab_var_ClassOfWarrantOrRightPercentIncreaseOfStrikePriceOverSalePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Of Warrant Or Right, Percent Increase Of Strike Price Over Sale Price</link:label>
    <link:label id="lab_var_ClassOfWarrantOrRightPercentIncreaseOfStrikePriceOverSalePrice_documentation_en-US" xlink:label="lab_var_ClassOfWarrantOrRightPercentIncreaseOfStrikePriceOverSalePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Of Warrant Or Right, Percent Increase Of Strike Price Over Sale Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_var_ClassOfWarrantOrRightPercentIncreaseOfStrikePriceOverSalePrice" xlink:href="var-20221230.xsd#var_ClassOfWarrantOrRightPercentIncreaseOfStrikePriceOverSalePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_var_ClassOfWarrantOrRightPercentIncreaseOfStrikePriceOverSalePrice" xlink:to="lab_var_ClassOfWarrantOrRightPercentIncreaseOfStrikePriceOverSalePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_e99306da-5f2f-4188-b181-a39b77180905_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_026144ee-d1aa-40e8-bbbe-7005c49fd649_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income per common share attributable to Varex</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_08417294-5619-4d2b-8d10-eb01eb8268de_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_var_NoncontrollingInterestTableTextBlock_0b356e76-07b9-41d7-a078-02268d02d0c4_terseLabel_en-US" xlink:label="lab_var_NoncontrollingInterestTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest</link:label>
    <link:label id="lab_var_NoncontrollingInterestTableTextBlock_label_en-US" xlink:label="lab_var_NoncontrollingInterestTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Table Text Block]</link:label>
    <link:label id="lab_var_NoncontrollingInterestTableTextBlock_documentation_en-US" xlink:label="lab_var_NoncontrollingInterestTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_var_NoncontrollingInterestTableTextBlock" xlink:href="var-20221230.xsd#var_NoncontrollingInterestTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_var_NoncontrollingInterestTableTextBlock" xlink:to="lab_var_NoncontrollingInterestTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_d10e9aca-5802-406c-8bfc-dc76808730d5_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_1224bb91-47f2-4ef4-8934-20139c3ab0d0_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNi" xlink:to="lab_us-gaap_EquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_5e2f51c2-270d-4f55-b47c-584188c918a3_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities and other current liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_var_DpiXLLCMember_dd21dc66-e056-4a8e-8a9d-581de5dffc34_terseLabel_en-US" xlink:label="lab_var_DpiXLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dpi X LLC</link:label>
    <link:label id="lab_var_DpiXLLCMember_label_en-US" xlink:label="lab_var_DpiXLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dpi X LLC [Member]</link:label>
    <link:label id="lab_var_DpiXLLCMember_documentation_en-US" xlink:label="lab_var_DpiXLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dpi X LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_var_DpiXLLCMember" xlink:href="var-20221230.xsd#var_DpiXLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_var_DpiXLLCMember" xlink:to="lab_var_DpiXLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_36dc7573-ddf2-4ebb-9901-6c93dc864b11_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current maturities of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_eb548595-cca0-47ae-8880-b57c9e00b7f9_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash (used in) provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtFairValue_1c46343b-b0ed-43fa-94c6-dcd38c26f54f_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, fair value</link:label>
    <link:label id="lab_us-gaap_LongTermDebtFairValue_label_en-US" xlink:label="lab_us-gaap_LongTermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtFairValue" xlink:to="lab_us-gaap_LongTermDebtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_6ae1217c-3cec-4837-b901-8f0704fa2a18_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_d72ce334-4a75-4020-a71a-2c8cdf9aec17_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2f2518a5-7fc4-4de4-8e0c-40839428504f_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f2daee9d-b6e3-4627-8d7b-11bbe6cd09f9_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_1146a801-7744-4777-aa20-8dd5ff2d8797_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_8fb21f51-45ba-4631-b903-d9a3cb562b39_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_ba8d5ef4-6440-4131-99ff-406aa2ea0018_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_9c27508c-f5c1-457f-9eb6-3d40e4d723ba_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET INCOME PER SHARE</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDisclosureTextBlock_bd95ab38-2a28-4b17-a7a4-d92be86e6908_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NONCONTROLLING INTERESTS</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDisclosureTextBlock" xlink:to="lab_us-gaap_MinorityInterestDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MajorCustomersAxis_986c870c-209a-4708-87b1-56e082a7d2b8_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_label_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_017dda7c-8516-40dc-80c6-2de4a55eeee9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_0899a6a4-6932-4837-89fe-2576dc9afcbe_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease liabilities (non-current)</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_f736fc08-4875-4e64-9d83-139c0f5df3ef_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_d73fb648-58b2-452f-bd77-08a946628c84_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:to="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_e118fada-c716-43e3-8db9-5d1ec6558656_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, exercisable, weighted average remaining contractual term (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent_428766c5-029b-4b9e-8fa5-c8e85f956bf5_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable, related parties</link:label>
    <link:label id="lab_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Related Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent" xlink:to="lab_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_65fc2368-b81a-42c9-9f51-042ff4356eac_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockPlans_1651d701-f1a1-4108-93e0-9eaddc0ae922_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from shares issued under employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockPlans_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockPlans" xlink:to="lab_us-gaap_ProceedsFromStockPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_a6313315-b6b8-4720-9952-2142baeed6d3_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_af44696c-84b7-4f7e-9e93-0f6ac81f0820_terseLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging</link:label>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_label_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetInvestmentHedgingMember" xlink:to="lab_us-gaap_NetInvestmentHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_0fa2c636-d0fd-45a5-8707-20ccd71cf5ad_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_ecbcbc2e-c37b-45fc-92a4-7c0df3ff3061_terseLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_8166fb6e-9378-4932-95af-38e7f2ef2803_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_var_CashPaidForOperatingAndFinanceLeases_7ed1cabc-d2cc-4a4f-a10c-28cbc366e9d6_totalLabel_en-US" xlink:label="lab_var_CashPaidForOperatingAndFinanceLeases" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cash paid for amounts included in the measurement of lease liabilities</link:label>
    <link:label id="lab_var_CashPaidForOperatingAndFinanceLeases_label_en-US" xlink:label="lab_var_CashPaidForOperatingAndFinanceLeases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Paid For Operating And Finance Leases</link:label>
    <link:label id="lab_var_CashPaidForOperatingAndFinanceLeases_documentation_en-US" xlink:label="lab_var_CashPaidForOperatingAndFinanceLeases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Paid For Operating And Finance Leases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_var_CashPaidForOperatingAndFinanceLeases" xlink:href="var-20221230.xsd#var_CashPaidForOperatingAndFinanceLeases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_var_CashPaidForOperatingAndFinanceLeases" xlink:to="lab_var_CashPaidForOperatingAndFinanceLeases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesTextBlock_2eb41f4b-79e1-4e3b-8cd2-37d66bbe1ae3_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Marketable Securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesTextBlock_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesTextBlock" xlink:to="lab_us-gaap_MarketableSecuritiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_30ad4e5c-2661-494f-a582-360c6bce1648_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_aa5ef11f-beb3-4dd3-8710-8095ad353ee3_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EMEAMember_517cfe42-897b-4504-8071-573fe13eccdc_terseLabel_en-US" xlink:label="lab_us-gaap_EMEAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EMEA</link:label>
    <link:label id="lab_us-gaap_EMEAMember_label_en-US" xlink:label="lab_us-gaap_EMEAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EMEA [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EMEAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EMEAMember" xlink:to="lab_us-gaap_EMEAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_bf2758fa-daec-4671-b5c5-7aa4bb89ba50_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_c3d2c0be-d809-4324-92e0-16693b6ad751_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ffeff267-1522-4179-83ba-757065946870_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_76d0db1c-b317-4959-b323-14a0486ba8d9_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' equity, outstanding, beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_adbe5359-6ece-4f35-9d0b-4161c1048ace_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' equity, outstanding, ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_1291833d-4fd3-4d54-ab9b-aa6af4008ed6_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_997d7484-8241-4fee-a7aa-d73ce5900013_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_c9d63f0f-57bc-40d6-b642-b1fad389eaca_verboseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_b6023912-e5a2-49aa-bd90-7a473754206d_periodStartLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests, at beginning of period</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_b4f77d62-915b-4a4a-991e-56ec074e8757_periodEndLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests, at end of period</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_46a0d64b-724b-4c8c-b0cf-26f473c7856b_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_71515b83-cd0b-42b7-9e98-e0db3dbede4e_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ChangeInContractWithCustomerAssetAbstract_962f971c-9af4-433f-b0f8-2d3b53572028_terseLabel_en-US" xlink:label="lab_us-gaap_ChangeInContractWithCustomerAssetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Assets</link:label>
    <link:label id="lab_us-gaap_ChangeInContractWithCustomerAssetAbstract_label_en-US" xlink:label="lab_us-gaap_ChangeInContractWithCustomerAssetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Contract with Customer, Asset [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInContractWithCustomerAssetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInContractWithCustomerAssetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ChangeInContractWithCustomerAssetAbstract" xlink:to="lab_us-gaap_ChangeInContractWithCustomerAssetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_ff47e510-6002-4d91-92d4-5138b27f8728_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value per share (in USD per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWriteDown_b7148373-879a-4627-85a0-1626b2aba676_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWriteDown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory write-down</link:label>
    <link:label id="lab_us-gaap_InventoryWriteDown_label_en-US" xlink:label="lab_us-gaap_InventoryWriteDown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Write-down</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWriteDown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWriteDown" xlink:to="lab_us-gaap_InventoryWriteDown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_857840dc-d4ce-475c-9a1d-dd5edcb6f734_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized issuance costs</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsNet" xlink:to="lab_us-gaap_DeferredFinanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ce31bc69-e0ac-4f07-bd01-99daf306b04b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_c96d7c5a-4740-413d-a347-d304c853f539_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_label_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_c625ce69-927a-49b7-a242-7c5f0367495b_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for New Accounting Pronouncements [Axis]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_95ba3468-d15c-459b-81c1-436a0c5468f6_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FAIR VALUE</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharePrice_87954234-5114-402f-b7e7-f5edf88a3f28_terseLabel_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share price (in USD per share)</link:label>
    <link:label id="lab_us-gaap_SharePrice_label_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharePrice" xlink:to="lab_us-gaap_SharePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_29c5b20f-c476-46e4-9673-9055efd94db6_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_264d759f-3c26-4502-9129-dc2ac07a98d3_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtSecuritiesMember_f8dd555a-4b6a-4d28-b820-a4bd7e9fd70b_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible notes</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtSecuritiesMember" xlink:to="lab_us-gaap_ConvertibleDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_38d2c4a9-0948-4a84-896c-a9401af4d996_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_e7787721-285e-4ffc-81e6-4b4ed10d75a3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Foreign Currency Transaction and Translation Gain (Loss), Arising During Period, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsPolicyPolicyTextBlock_cb31d62c-4ebb-416b-b115-10376e86d2bd_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_SubsequentEventsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1f4cba4b-9c5c-4dbb-8d8f-bbd38ac97b81_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock units, grants in period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_ca44f981-a3dc-4c49-b52a-5ee9c4d55e61_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_aa933ec3-02f2-4138-8e4a-a6cb83bd77cd_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_9b83cb49-4cf6-4a72-ad26-01205091386f_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_97097938-6b5e-45e4-8931-284a06e6e116_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration risk, percentage</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_e387b926-98a4-4ca1-923a-860efa24d56c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TAXES ON INCOME</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent_1a9155f7-2afc-434a-b89b-a41796b0adc1_terseLabel_en-US" xlink:label="lab_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due to related parties</link:label>
    <link:label id="lab_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due to Related Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:to="lab_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerRefundLiability_5a092f7d-d35c-4a76-bdf5-b3ef5f4ea10a_periodStartLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerRefundLiability" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerRefundLiability_f60f7245-f1a8-4bb9-9221-ea899cb4810e_periodEndLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerRefundLiability" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerRefundLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerRefundLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Refund Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerRefundLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerRefundLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerRefundLiability" xlink:to="lab_us-gaap_ContractWithCustomerRefundLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_50b41e4c-bc06-4bfc-b5e4-b01cc5e3d6ea_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_14a74bdf-39df-4cd4-9566-6c0908b45403_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_28d3d798-81c6-48ea-a249-5ba8674a5a54_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValueOutstanding_ea548d12-5762-4077-aa0c-ca8b7febb5ef_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValueOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, $.01 par value: 20,000,000 shares authorized, none issued</link:label>
    <link:label id="lab_us-gaap_PreferredStockValueOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockValueOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValueOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValueOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValueOutstanding" xlink:to="lab_us-gaap_PreferredStockValueOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_284effa4-f347-40d7-bb39-13c4cbea5418_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant exercise price (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_f3e3c21a-aa6e-430c-a087-8515b0c9287d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_b7c5aed7-72e5-4b45-a2a8-5214810a98ca_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for interest</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_b6a57b1e-109f-4442-aa77-49570de0a16d_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_28c1c0f5-17ee-4f3f-878e-3322e43ea6ab_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic net income per share attributable to Varex (in USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsMember_90e245d4-ef19-460f-8a4c-cbeacfa9b3b3_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsMember" xlink:to="lab_us-gaap_OtherAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_var_SeniorSecuredNotesMember_bc32a9b9-18ad-4d05-b5ab-22f3f69e79f1_terseLabel_en-US" xlink:label="lab_var_SeniorSecuredNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Secured Notes</link:label>
    <link:label id="lab_var_SeniorSecuredNotesMember_label_en-US" xlink:label="lab_var_SeniorSecuredNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Secured Notes [Member]</link:label>
    <link:label id="lab_var_SeniorSecuredNotesMember_documentation_en-US" xlink:label="lab_var_SeniorSecuredNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Secured Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_var_SeniorSecuredNotesMember" xlink:href="var-20221230.xsd#var_SeniorSecuredNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_var_SeniorSecuredNotesMember" xlink:to="lab_var_SeniorSecuredNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_b2cd7cc2-68a7-4ada-a9d9-72b13f7b6969_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restrictions on Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restrictions on Cash and Cash Equivalents [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_d35b5ae2-2edc-472d-8342-5ef0d4828a45_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_6a513dab-394f-48bc-ad35-fc41baef7e81_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Varex stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_1fed2e67-0eee-4051-902a-ba1a2cfeaf99_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_71b21715-1cdd-4461-984f-6f5050c25edc_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock units, canceled or expired (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipDomain_58039338-d2c4-46f6-abb9-5de920669254_terseLabel_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:label id="lab_srt_OwnershipDomain_label_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipDomain" xlink:to="lab_srt_OwnershipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_b1c52862-440d-488a-b3e9-eedc90d39225_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestLineItems_16276756-f65e-4e81-95a1-36149891ef6c_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Line Items]</link:label>
    <link:label id="lab_us-gaap_MinorityInterestLineItems_label_en-US" xlink:label="lab_us-gaap_MinorityInterestLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestLineItems" xlink:to="lab_us-gaap_MinorityInterestLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_2a7cc04c-e0f8-4e45-a5d6-869014542506_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_b7ab97f9-16d1-4f78-aa75-fe69635a5b70_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Current Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:to="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7692a7c1-7b79-4a6f-a497-d878158e5ad9_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_c6911daa-b652-418c-8333-54571783ba53_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_335635c1-5df8-48e2-b4f7-3a1535cede31_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_462da641-0e2c-4bd4-b89f-75319ea66c4f_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MoneyMarketFundsAtCarryingValue_ac4f1143-fba7-460b-bb91-ccd75603c28f_terseLabel_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money market funds</link:label>
    <link:label id="lab_us-gaap_MoneyMarketFundsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money Market Funds, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsAtCarryingValue" xlink:to="lab_us-gaap_MoneyMarketFundsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_b2c065a1-7d48-4fd3-b944-ead705df62c4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_1e00467b-5843-45d8-ba66-74cc845d39f8_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Lease Cost and Supplemental Cash Flow Information</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_var_AssetBasedLoanRevolvingCreditFacilityMember_e9b5dd12-48b1-4707-8fea-fa5a4b070183_terseLabel_en-US" xlink:label="lab_var_AssetBasedLoanRevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset-Based Loan</link:label>
    <link:label id="lab_var_AssetBasedLoanRevolvingCreditFacilityMember_label_en-US" xlink:label="lab_var_AssetBasedLoanRevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset-Based Loan Revolving Credit Facility [Member]</link:label>
    <link:label id="lab_var_AssetBasedLoanRevolvingCreditFacilityMember_documentation_en-US" xlink:label="lab_var_AssetBasedLoanRevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset-Based Loan Revolving Credit Facility</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_var_AssetBasedLoanRevolvingCreditFacilityMember" xlink:href="var-20221230.xsd#var_AssetBasedLoanRevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_var_AssetBasedLoanRevolvingCreditFacilityMember" xlink:to="lab_var_AssetBasedLoanRevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_303fa9a4-e841-47c1-9ccf-305ffe3ea699_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_b2a9f49e-a51e-4b08-9a5f-dc1b618e59e0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock units, vested in period (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_80e80547-7f85-4a17-8609-6bf5f9cb835b_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_5714c8dc-76e3-4cf3-850b-703b1b5f3eac_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_7577fd4a-8d5b-4e8b-a2bf-429851b01833_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_001bc6ba-90c9-47ae-b3cf-35ef7aff1d20_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities (non-current)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_181bab66-626d-4293-a9be-cc8b37a2fb00_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAxis_8e03b1bb-ae0d-49ab-a1ae-83b0b53605ed_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromHedgeInvestingActivities_25ef8f76-68fe-4dc1-9df7-4925cd75ee59_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromHedgeInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement of net investment hedge</link:label>
    <link:label id="lab_us-gaap_ProceedsFromHedgeInvestingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromHedgeInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Hedge, Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromHedgeInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromHedgeInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromHedgeInvestingActivities" xlink:to="lab_us-gaap_ProceedsFromHedgeInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_5c70c46f-5445-4173-8f9a-ccb9de11d65f_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromConvertibleDebt_f102129e-c060-4aa1-b6fd-6520396e7534_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowings under credit agreements</link:label>
    <link:label id="lab_us-gaap_ProceedsFromConvertibleDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromConvertibleDebt" xlink:to="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_e22d6239-9133-46f5-812b-66fb8aeef5b1_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net of allowance for credit losses of $0.4&#160;million and $0.6&#160;million at December&#160;30, 2022 and September&#160;30, 2022, respectively</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_4ca8525b-635c-47c3-8df3-39fdf4f91dcc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_58c30d90-27c3-41cc-b703-1512c1afbb61_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of marketable equity securities</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:to="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_8dff6fa1-caf1-4b99-85e1-041a4f48fda9_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_cad57105-51d7-43b0-aa6f-11c1ef34c3bd_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_51a11eb8-84a7-4260-9d0b-4a9d26972857_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_f2c4f577-a7ef-4be7-9749-ebd6ba3ae876_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, exercisable, weighted average exercise price (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_c998087c-144f-4634-8d61-f42446c4b2a4_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RELATED PARTY TRANSACTIONS</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_ed1cb4e5-371e-46eb-b42d-ab466eb8f52a_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting</link:label>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_c8d1b525-f1f3-41f5-951e-d457197d48a3_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_a316adc6-c480-4496-a8f9-3899c2aec808_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_0d521f90-b2e4-4423-9b14-6e7f628742de_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_c6e95275-7506-4296-852d-8145518a3f31_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing cash flows from finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_label_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:to="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MovementInMinorityInterestRollForward_e20e7122-c6fe-43d7-a732-6c04c4910381_terseLabel_en-US" xlink:label="lab_us-gaap_MovementInMinorityInterestRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_MovementInMinorityInterestRollForward_label_en-US" xlink:label="lab_us-gaap_MovementInMinorityInterestRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInMinorityInterestRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MovementInMinorityInterestRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward" xlink:to="lab_us-gaap_MovementInMinorityInterestRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOfAssetsAcquired_698aa644-c5bd-4f0a-9478-40bd185d6301_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOfAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property, plant and equipment financed through accounts payable</link:label>
    <link:label id="lab_us-gaap_FairValueOfAssetsAcquired_label_en-US" xlink:label="lab_us-gaap_FairValueOfAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfAssetsAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfAssetsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOfAssetsAcquired" xlink:to="lab_us-gaap_FairValueOfAssetsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_354e0e0f-1b1d-4260-9467-f0af50c452a1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Income) loss from equity method investments</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments, Net of Dividends or Distributions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_c6b6fe36-97f8-4c4b-b532-0d904ed24352_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock units, nonvested, beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_8ac40e43-fea6-43fc-9976-5ff9994abd57_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock units, nonvested, ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_7cadf99e-ed47-4362-8046-e0e551263671_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest and other expense, net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_76929e84-a7f6-416d-973b-47b46de1efda_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest and other expense, net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_6cdf83a1-af7f-4fa6-8d27-39a33b068e39_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Carrying Amount</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_5ca8ece2-9092-4fe1-80ed-01cd6a2b85ef_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_ff0785dd-9c9c-4c13-b39a-da2de9242da2_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_4c8bafb0-1de6-42f3-8466-f028b39ab3a7_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_736142b2-b42c-447a-b7cc-970de6d5003f_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USTreasuryBillSecuritiesMember_69afabd7-84ca-4353-969e-35f226230138_terseLabel_en-US" xlink:label="lab_us-gaap_USTreasuryBillSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Treasury bills</link:label>
    <link:label id="lab_us-gaap_USTreasuryBillSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USTreasuryBillSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Treasury Bill Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryBillSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasuryBillSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USTreasuryBillSecuritiesMember" xlink:to="lab_us-gaap_USTreasuryBillSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_244eabbe-d113-42fd-8f18-7c2ad59ae306_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_feca4de2-f30b-4afc-8a4d-7bbd664346b3_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current, Statement of Financial Position [Extensible List]</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_796f1630-4b1c-4fc0-a849-a0a05efb9237_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_20e5b6e4-7d29-419b-8e70-3e5107a55802_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_ab4ed2a0-b991-4855-898e-a88ae24e2ab1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation, Stock Options, Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_6355d947-05a2-418e-8654-4bae57629b16_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_47951b8a-2788-4045-9a47-e99bd43653e8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_cced6f9d-28ee-43f8-a8d1-4f7d301e4dda_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recently Adopted Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_eb705d6d-f621-4cd9-8f0b-dc07fc7e4985_terseLabel_en-US" xlink:label="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial conversion rate (in shares)</link:label>
    <link:label id="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_label_en-US" xlink:label="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Conversion, Converted Instrument, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:to="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_8d5ee42d-ec28-42e6-8ba5-73ea7de5ef7a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_5e96686f-ee61-4026-aa0d-76abec061488_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares, outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_2a485c3a-e968-4a12-a250-5b63dd8fe60b_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares, outstanding, beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_0aedf881-543e-4c52-a6ad-9f36d4f454e6_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares, outstanding, ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_4dcccf8c-faa0-4d4a-a343-7d83e7bcbfce_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in privately-held companies</link:label>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_label_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:to="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_1e5db890-455c-4559-b7df-8d89a9a44190_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_387fa768-9268-4fc9-880e-aca108d0cb59_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at September 30, 2022</link:label>
    <link:label id="lab_us-gaap_Goodwill_418f1b87-2db9-4b43-8701-94aed91d39ff_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at December 30, 2022</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_bda56d71-db1e-4639-8489-d3aa59579f80_terseLabel_en-US" xlink:label="lab_us-gaap_MovementInStandardProductWarrantyAccrualRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Movement in Standard Product Warranty Accrual [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_label_en-US" xlink:label="lab_us-gaap_MovementInStandardProductWarrantyAccrualRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Movement in Standard Product Warranty Accrual [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MovementInStandardProductWarrantyAccrualRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward" xlink:to="lab_us-gaap_MovementInStandardProductWarrantyAccrualRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_var_PercentageOfManufacturingCapacity_c77dfb63-5be9-4327-888c-e53d867199a8_terseLabel_en-US" xlink:label="lab_var_PercentageOfManufacturingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of manufacturing capacity</link:label>
    <link:label id="lab_var_PercentageOfManufacturingCapacity_label_en-US" xlink:label="lab_var_PercentageOfManufacturingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Manufacturing Capacity</link:label>
    <link:label id="lab_var_PercentageOfManufacturingCapacity_documentation_en-US" xlink:label="lab_var_PercentageOfManufacturingCapacity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The percentage of manufacturing capacity that the entity has the guaranteed right to purchase up to.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_var_PercentageOfManufacturingCapacity" xlink:href="var-20221230.xsd#var_PercentageOfManufacturingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_var_PercentageOfManufacturingCapacity" xlink:to="lab_var_PercentageOfManufacturingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_4bb231f9-a5cc-429b-a2a9-f487c9b5dec5_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities measured at fair value</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_var_ProceedsFromSalesOfBusinessAndAssets_a5d2860b-5f6f-4aac-8b2b-2f941f159fc2_terseLabel_en-US" xlink:label="lab_var_ProceedsFromSalesOfBusinessAndAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sales of business and assets</link:label>
    <link:label id="lab_var_ProceedsFromSalesOfBusinessAndAssets_label_en-US" xlink:label="lab_var_ProceedsFromSalesOfBusinessAndAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Sales Of Business And Assets</link:label>
    <link:label id="lab_var_ProceedsFromSalesOfBusinessAndAssets_documentation_en-US" xlink:label="lab_var_ProceedsFromSalesOfBusinessAndAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Sales Of Business And Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_var_ProceedsFromSalesOfBusinessAndAssets" xlink:href="var-20221230.xsd#var_ProceedsFromSalesOfBusinessAndAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_var_ProceedsFromSalesOfBusinessAndAssets" xlink:to="lab_var_ProceedsFromSalesOfBusinessAndAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvesteeMember_d5610f51-a001-4545-a8ce-191465c0dc45_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvesteeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investee</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvesteeMember_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvesteeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investee [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvesteeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvesteeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvesteeMember" xlink:to="lab_us-gaap_EquityMethodInvesteeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_56535eff-517c-4946-9dba-61bde2b0d4cb_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income to net cash (used in) provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_b8f4604d-53bf-414a-a8ce-e7369bcd4982_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GOODWILL AND INTANGIBLE ASSETS</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrual_a7200fde-237a-4a2e-8d7d-a2f93328ac46_periodStartLabel_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrual" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued product warranty, at beginning of period</link:label>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrual_0297e06e-86f8-4de0-b353-3b6474f24721_periodEndLabel_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrual" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued product warranty, at end of period</link:label>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrual_label_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrual" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard Product Warranty Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrual" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StandardProductWarrantyAccrual"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandardProductWarrantyAccrual" xlink:to="lab_us-gaap_StandardProductWarrantyAccrual" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_debbfea3-fb91-4ef3-b860-132005c412ae_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_24add4b6-6eea-4fd9-a386-04b3e07fc636_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_10291d9e-914e-4df4-b6e6-873675004450_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_c12916f1-1d92-4641-b7b9-a14a0859c69d_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_f6335d95-a3ba-4dba-9629-226685727d97_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_736752b4-721a-4cd4-b54d-dbdbe990da50_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Product Warranty Liability</link:label>
    <link:label id="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Product Warranty Liability [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_ed03eb48-14f7-4545-826a-211089d5e12c_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in USD per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_9b9c321a-544f-4db2-a005-940a603bb44e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_590e6e56-920f-44e0-bc96-da8d54957d96_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_2d436db1-d20c-46b9-987b-6c5c1a8746ea_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_var_IncrementalCommonSharesAttributableToDilutiveEffectOfWarrants_171185b4-3f8b-4457-84e4-fcd210cadf19_terseLabel_en-US" xlink:label="lab_var_IncrementalCommonSharesAttributableToDilutiveEffectOfWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive effect of warrants (in shares)</link:label>
    <link:label id="lab_var_IncrementalCommonSharesAttributableToDilutiveEffectOfWarrants_label_en-US" xlink:label="lab_var_IncrementalCommonSharesAttributableToDilutiveEffectOfWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable To Dilutive Effect Of Warrants</link:label>
    <link:label id="lab_var_IncrementalCommonSharesAttributableToDilutiveEffectOfWarrants_documentation_en-US" xlink:label="lab_var_IncrementalCommonSharesAttributableToDilutiveEffectOfWarrants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable To Dilutive Effect Of Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_var_IncrementalCommonSharesAttributableToDilutiveEffectOfWarrants" xlink:href="var-20221230.xsd#var_IncrementalCommonSharesAttributableToDilutiveEffectOfWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_var_IncrementalCommonSharesAttributableToDilutiveEffectOfWarrants" xlink:to="lab_var_IncrementalCommonSharesAttributableToDilutiveEffectOfWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_e0de62f4-08c5-4761-a2bf-5de062c86bd6_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_57d2afdc-2181-44c4-b383-05b7b6c7015c_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_8ece7009-8e35-4de1-b874-b2044381ca06_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration_830e1811-0300-4e26-b09c-19f6e73dfc38_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration" xlink:to="lab_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_1e214837-e931-48d9-9a58-73b9d1361e02_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of revenues</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_84dac67a-e60c-497c-a1ef-1f3ad5930a97_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_a7e79609-62d0-4d44-982b-5655829b8fd0_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c8582ce8-05fb-47e8-b0c0-1b6f5fe0b3a8_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted weighted average shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_var_InterestExpenseDebtContractualInterestCoupon_d511bf27-b698-442c-a1c4-316aa33b78da_terseLabel_en-US" xlink:label="lab_var_InterestExpenseDebtContractualInterestCoupon" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual interest coupon and other</link:label>
    <link:label id="lab_var_InterestExpenseDebtContractualInterestCoupon_label_en-US" xlink:label="lab_var_InterestExpenseDebtContractualInterestCoupon" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt, Contractual Interest Coupon</link:label>
    <link:label id="lab_var_InterestExpenseDebtContractualInterestCoupon_documentation_en-US" xlink:label="lab_var_InterestExpenseDebtContractualInterestCoupon" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt, Contractual Interest Coupon</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_var_InterestExpenseDebtContractualInterestCoupon" xlink:href="var-20221230.xsd#var_InterestExpenseDebtContractualInterestCoupon"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_var_InterestExpenseDebtContractualInterestCoupon" xlink:to="lab_var_InterestExpenseDebtContractualInterestCoupon" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilities_e239f01e-539a-4249-bf0e-667f89aaa55c_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative liabilities</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilities_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilities" xlink:to="lab_us-gaap_DerivativeLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_beb09c44-f053-4cde-8c53-7eed5fc25785_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_32a898e0-deb1-4b8d-964c-cb610a3bf5d5_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative liabilities fair value, gross</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Subject to Master Netting Arrangement, before Offset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisRollingMaturityAbstract_4b6582fa-350e-493e-a252-8536c34d3a59_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisRollingMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Costs</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisRollingMaturityAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisRollingMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Rolling Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisRollingMaturityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisRollingMaturityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisRollingMaturityAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisRollingMaturityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableMember_1eeefc0c-05f0-4b19-b89b-95bae45df9f7_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableMember_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableMember" xlink:to="lab_us-gaap_AccountsReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecurities_ccd8ba3a-8f90-462f-8177-10c605b1345d_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total marketable debt securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecurities_532e00c6-5ac8-4575-aa20-560e0eaf7e21_totalLabel_en-US" xlink:label="lab_us-gaap_MarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total marketable debt securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecurities_label_en-US" xlink:label="lab_us-gaap_MarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecurities" xlink:to="lab_us-gaap_MarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_6a7b5024-edee-4af7-b1c5-d7d39badde0f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_3edaa439-7cc2-487b-953f-972b0d5f38d8_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_var_RelatedPartyTransactionApprovedPurchasesFromRelatedParty_009e672f-2442-4bb6-8810-b9f64cd8ca7e_terseLabel_en-US" xlink:label="lab_var_RelatedPartyTransactionApprovedPurchasesFromRelatedParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases approved from related party</link:label>
    <link:label id="lab_var_RelatedPartyTransactionApprovedPurchasesFromRelatedParty_label_en-US" xlink:label="lab_var_RelatedPartyTransactionApprovedPurchasesFromRelatedParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Approved Purchases From Related Party</link:label>
    <link:label id="lab_var_RelatedPartyTransactionApprovedPurchasesFromRelatedParty_documentation_en-US" xlink:label="lab_var_RelatedPartyTransactionApprovedPurchasesFromRelatedParty" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Approved Purchases From Related Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_var_RelatedPartyTransactionApprovedPurchasesFromRelatedParty" xlink:href="var-20221230.xsd#var_RelatedPartyTransactionApprovedPurchasesFromRelatedParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_var_RelatedPartyTransactionApprovedPurchasesFromRelatedParty" xlink:to="lab_var_RelatedPartyTransactionApprovedPurchasesFromRelatedParty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_4cd69c47-8a17-48e6-b244-cd2757d514a4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock units, grants in period (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AsiaPacificMember_f2f5fb87-10dd-4531-a844-d9ea30ca680a_terseLabel_en-US" xlink:label="lab_srt_AsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APAC</link:label>
    <link:label id="lab_srt_AsiaPacificMember_label_en-US" xlink:label="lab_srt_AsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia Pacific [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AsiaPacificMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AsiaPacificMember" xlink:to="lab_srt_AsiaPacificMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_d9d2ccf5-367d-4e90-a746-1512922e6142_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion price (in USD per share)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_5a331eac-3a8b-4999-8702-50235fe31836_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtMember_7227eb02-cc20-4731-ba1e-a6d843deefa8_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtMember_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtMember" xlink:to="lab_us-gaap_ConvertibleDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_90bdc219-e4b9-4eb0-9d21-424a9c9c1bcb_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, exercisable, aggregate intrinsic value</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_var_NetIncomeLossAttributableToNoncontrollingInterestNetOfDividends_cb5dda2c-9cd7-4383-882e-172669943161_verboseLabel_en-US" xlink:label="lab_var_NetIncomeLossAttributableToNoncontrollingInterestNetOfDividends" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to noncontrolling interests</link:label>
    <link:label id="lab_var_NetIncomeLossAttributableToNoncontrollingInterestNetOfDividends_label_en-US" xlink:label="lab_var_NetIncomeLossAttributableToNoncontrollingInterestNetOfDividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable To Noncontrolling Interest, Net Of Dividends</link:label>
    <link:label id="lab_var_NetIncomeLossAttributableToNoncontrollingInterestNetOfDividends_documentation_en-US" xlink:label="lab_var_NetIncomeLossAttributableToNoncontrollingInterestNetOfDividends" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable To Noncontrolling Interest, Net Of Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_var_NetIncomeLossAttributableToNoncontrollingInterestNetOfDividends" xlink:href="var-20221230.xsd#var_NetIncomeLossAttributableToNoncontrollingInterestNetOfDividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_var_NetIncomeLossAttributableToNoncontrollingInterestNetOfDividends" xlink:to="lab_var_NetIncomeLossAttributableToNoncontrollingInterestNetOfDividends" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_f61aff52-93e1-4e0e-ba44-bee99195da6c_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetCreditLossExpense_b8cc5a48-758a-4cab-a27b-39ce442f5569_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetCreditLossExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs recovered from product returns during the period</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetCreditLossExpense_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetCreditLossExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetCreditLossExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetCreditLossExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetCreditLossExpense" xlink:to="lab_us-gaap_ContractWithCustomerAssetCreditLossExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_bbce1150-f687-4481-9b43-3429dbc618df_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents and restricted cash at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_422fade2-de7b-4463-82e2-09a60776ebe9_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents and restricted cash at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a6c3780e-0243-420b-99c8-510e1609de4b_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total as presented in the Condensed Consolidated Statements of Cash Flows</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_f4da3a8f-a02f-4396-979a-21cf059f7858_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_04af35e3-b425-42e2-b3b1-b8c9b16b9cb6_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Net income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_3f37a98c-27b3-4d18-b323-6c59b5eea820_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Comprehensive income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_var_PercentageOfFixedCosts_e02f8987-71eb-4ce6-8ad8-70cb5eadd088_terseLabel_en-US" xlink:label="lab_var_PercentageOfFixedCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of fixed costs</link:label>
    <link:label id="lab_var_PercentageOfFixedCosts_label_en-US" xlink:label="lab_var_PercentageOfFixedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Fixed Costs</link:label>
    <link:label id="lab_var_PercentageOfFixedCosts_documentation_en-US" xlink:label="lab_var_PercentageOfFixedCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The percentage of fixed costs as defined in the agreement and determined at the beginning of each calendar year that the entity is required to pay.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_var_PercentageOfFixedCosts" xlink:href="var-20221230.xsd#var_PercentageOfFixedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_var_PercentageOfFixedCosts" xlink:to="lab_var_PercentageOfFixedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_3e7f0540-1990-43d5-8570-49abbda9e67b_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_14cc64e2-6ad7-4a1e-9ba2-8057f6557277_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from exercise of stock options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_123da0f2-9b2a-4813-9730-d1f4bb8055f1_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares, issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestments_0ec55e87-13ca-496f-9e09-6888aa5d0f17_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments" xlink:to="lab_us-gaap_EquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_73b8d3e9-5b55-4b0e-bd81-741355a56900_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskLineItems" xlink:to="lab_us-gaap_ConcentrationRiskLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_var_CanonMedicalSystemsCorporationFormerlyToshibaMedicalSystemsMember_34b6de66-54db-469f-bc58-828223bafaeb_terseLabel_en-US" xlink:label="lab_var_CanonMedicalSystemsCorporationFormerlyToshibaMedicalSystemsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canon Medical Systems Corporation</link:label>
    <link:label id="lab_var_CanonMedicalSystemsCorporationFormerlyToshibaMedicalSystemsMember_label_en-US" xlink:label="lab_var_CanonMedicalSystemsCorporationFormerlyToshibaMedicalSystemsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canon Medical Systems Corporation (Formerly Toshiba Medical Systems) [Member]</link:label>
    <link:label id="lab_var_CanonMedicalSystemsCorporationFormerlyToshibaMedicalSystemsMember_documentation_en-US" xlink:label="lab_var_CanonMedicalSystemsCorporationFormerlyToshibaMedicalSystemsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canon Medical Systems Corporation (Formerly Toshiba Medical Systems) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_var_CanonMedicalSystemsCorporationFormerlyToshibaMedicalSystemsMember" xlink:href="var-20221230.xsd#var_CanonMedicalSystemsCorporationFormerlyToshibaMedicalSystemsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_var_CanonMedicalSystemsCorporationFormerlyToshibaMedicalSystemsMember" xlink:to="lab_var_CanonMedicalSystemsCorporationFormerlyToshibaMedicalSystemsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_22b4ea27-e315-4fe0-8192-4b05a5eaf7d5_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenues</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ParentMember_dc1ae272-f303-42e3-b010-73cbfa3b0ad9_terseLabel_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Varex Equity</link:label>
    <link:label id="lab_us-gaap_ParentMember_label_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ParentMember" xlink:to="lab_us-gaap_ParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_var_AssetsAndLiabilitiesLesseeTableTextBlock_66b6777f-e3e5-4c3c-bb13-3002f1c62f02_terseLabel_en-US" xlink:label="lab_var_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Supplemental Balance Sheet Information</link:label>
    <link:label id="lab_var_AssetsAndLiabilitiesLesseeTableTextBlock_label_en-US" xlink:label="lab_var_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets And Liabilities, Lessee [Table Text Block]</link:label>
    <link:label id="lab_var_AssetsAndLiabilitiesLesseeTableTextBlock_documentation_en-US" xlink:label="lab_var_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets And Liabilities, Lessee [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_var_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:href="var-20221230.xsd#var_AssetsAndLiabilitiesLesseeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_var_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:to="lab_var_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_dad3d213-9e7a-4891-8650-e840f6d78ffe_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_e4d3b2ea-6b78-4c63-81bc-9abf949fbe3f_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease liabilities (current)</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1a330894-f381-40be-a4aa-aa845c6e703b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_b9b70309-2dfb-4521-88c6-207be27b8d72_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_165548a1-6467-43f4-9072-50f411c0a792_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_d89ef93f-5bdf-47c8-9aa2-bccccf81ab5c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating lease costs</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_83964919-1548-4d91-abd9-59da6bc56882_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Face amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_3fdac6f3-57c7-43eb-b4f8-f3c635ceee66_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeAxis" xlink:to="lab_us-gaap_InvestmentTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_3ddfa453-3ab0-4cb0-8bb7-b104c56932c4_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments and Marketable Securities</link:label>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentPolicyTextBlock" xlink:to="lab_us-gaap_InvestmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_205343a4-1cac-420c-adfd-c7402d6ae9a5_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued under employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_6e082671-e738-421c-a03a-2b681862cfb6_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income attributable to Varex</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_var_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsForfeituresandExpirationsinPeriodPrice_0a993804-d006-44ca-ae36-8efa0f582695_terseLabel_en-US" xlink:label="lab_var_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsForfeituresandExpirationsinPeriodPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canceled, expired or forfeited (in USD per share)</link:label>
    <link:label id="lab_var_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsForfeituresandExpirationsinPeriodPrice_label_en-US" xlink:label="lab_var_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsForfeituresandExpirationsinPeriodPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Price</link:label>
    <link:label id="lab_var_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsForfeituresandExpirationsinPeriodPrice_documentation_en-US" xlink:label="lab_var_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsForfeituresandExpirationsinPeriodPrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_var_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsForfeituresandExpirationsinPeriodPrice" xlink:href="var-20221230.xsd#var_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsForfeituresandExpirationsinPeriodPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_var_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsForfeituresandExpirationsinPeriodPrice" xlink:to="lab_var_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsForfeituresandExpirationsinPeriodPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USGovernmentAgenciesSecuritiesAtCarryingValue_c67f5f7a-f27e-4f49-93c7-073ca451a0c1_terseLabel_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesSecuritiesAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government agencies</link:label>
    <link:label id="lab_us-gaap_USGovernmentAgenciesSecuritiesAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesSecuritiesAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Government Agencies Securities, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesSecuritiesAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesSecuritiesAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USGovernmentAgenciesSecuritiesAtCarryingValue" xlink:to="lab_us-gaap_USGovernmentAgenciesSecuritiesAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_5d2fb086-6120-4827-bc6a-2ccb8d9958f6_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_798555f1-b5fc-4c80-aff4-7b66a9be7f92_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_d584761b-c612-4778-b7c9-888b93abdb40_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c116a47a-5449-46cd-8d03-06aed117a25f_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_30f1b8c3-a1b1-4528-8f8d-c466b885c72c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_15971f92-6de8-4f1e-b54d-949f79589674_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_8752a4eb-2a90-4953-8809-cf89e8f4a9de_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, exercisable (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty_a64c107a-5b0b-42cd-8b98-ee86d8c66532_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases from related party</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Purchases from Related Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty" xlink:to="lab_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty" xlink:type="arc" order="1"/>
    <link:label id="lab_var_LeaseCostFinanceLeaseCosts_25e1e54d-6b4b-45b4-869e-79bc8baf95d0_terseLabel_en-US" xlink:label="lab_var_LeaseCostFinanceLeaseCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total finance lease costs</link:label>
    <link:label id="lab_var_LeaseCostFinanceLeaseCosts_label_en-US" xlink:label="lab_var_LeaseCostFinanceLeaseCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost, Finance Lease Costs</link:label>
    <link:label id="lab_var_LeaseCostFinanceLeaseCosts_documentation_en-US" xlink:label="lab_var_LeaseCostFinanceLeaseCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost, Finance Lease Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_var_LeaseCostFinanceLeaseCosts" xlink:href="var-20221230.xsd#var_LeaseCostFinanceLeaseCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_var_LeaseCostFinanceLeaseCosts" xlink:to="lab_var_LeaseCostFinanceLeaseCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CrossCurrencyInterestRateContractMember_55370180-d283-43e3-99dc-2eb314d794e3_terseLabel_en-US" xlink:label="lab_us-gaap_CrossCurrencyInterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross currency swap contracts</link:label>
    <link:label id="lab_us-gaap_CrossCurrencyInterestRateContractMember_label_en-US" xlink:label="lab_us-gaap_CrossCurrencyInterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Interest Rate Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CrossCurrencyInterestRateContractMember" xlink:to="lab_us-gaap_CrossCurrencyInterestRateContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrentAbstract_dbcb4fc9-ec3c-4887-8598-98114ab7620b_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current maturities of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Current Maturities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrentAbstract" xlink:to="lab_us-gaap_LongTermDebtCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_d071cd2e-8110-4712-9d35-94d0d5cecbf8_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_var_GainLossOnSettlementOfHedgeInvestingActivities_28f43cdc-61de-49a7-962e-339aa8341700_negatedTerseLabel_en-US" xlink:label="lab_var_GainLossOnSettlementOfHedgeInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on settlement of cash flow hedge</link:label>
    <link:label id="lab_var_GainLossOnSettlementOfHedgeInvestingActivities_label_en-US" xlink:label="lab_var_GainLossOnSettlementOfHedgeInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) On Settlement Of Hedge, Investing Activities</link:label>
    <link:label id="lab_var_GainLossOnSettlementOfHedgeInvestingActivities_documentation_en-US" xlink:label="lab_var_GainLossOnSettlementOfHedgeInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) On Settlement Of Hedge, Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_var_GainLossOnSettlementOfHedgeInvestingActivities" xlink:href="var-20221230.xsd#var_GainLossOnSettlementOfHedgeInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_var_GainLossOnSettlementOfHedgeInvestingActivities" xlink:to="lab_var_GainLossOnSettlementOfHedgeInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued_c265414c-cb62-4f8e-967e-108457f2b979_terseLabel_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New accruals charged to cost of revenues</link:label>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued_label_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard Product Warranty Accrual, Increase for Warranties Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StandardProductWarrantyAccrualWarrantiesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued" xlink:to="lab_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_c0fccc69-6cfd-4a2c-9f58-294db9d368e8_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued under employee stock purchase plan (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_var_MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateRollingWithinOneYearAmortizedCost_0589f868-d02b-46b2-a9ea-9b9d2e4b6b96_terseLabel_en-US" xlink:label="lab_var_MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateRollingWithinOneYearAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due within one year</link:label>
    <link:label id="lab_var_MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateRollingWithinOneYearAmortizedCost_label_en-US" xlink:label="lab_var_MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateRollingWithinOneYearAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Maturity, Allocated and Single Maturity Date, Rolling Within One Year, Amortized Cost</link:label>
    <link:label id="lab_var_MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateRollingWithinOneYearAmortizedCost_documentation_en-US" xlink:label="lab_var_MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateRollingWithinOneYearAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Maturity, Allocated and Single Maturity Date, Rolling Within One Year, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_var_MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateRollingWithinOneYearAmortizedCost" xlink:href="var-20221230.xsd#var_MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateRollingWithinOneYearAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_var_MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateRollingWithinOneYearAmortizedCost" xlink:to="lab_var_MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateRollingWithinOneYearAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_b6a49ce1-ef61-442a-8c9e-bf2b89de1321_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2c4b977f-5c13-4922-a92a-29922f8ed5c2_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_35fa5320-d414-4108-b324-1609679d9670_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_96f56188-915e-463f-8539-2be53ba7f597_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized issuance costs and debt discounts, total</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock_e806d60c-514b-400e-a357-5f237283111d_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Interest Expense</link:label>
    <link:label id="lab_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock_label_en-US" xlink:label="lab_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income and Interest Expense Disclosure [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock" xlink:to="lab_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNumberOfInstrumentsHeld_3c334be9-42b1-4dd8-b50d-de6134c901c9_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNumberOfInstrumentsHeld" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeNumberOfInstrumentsHeld_label_en-US" xlink:label="lab_us-gaap_DerivativeNumberOfInstrumentsHeld" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Number of Instruments Held</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNumberOfInstrumentsHeld" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNumberOfInstrumentsHeld"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNumberOfInstrumentsHeld" xlink:to="lab_us-gaap_DerivativeNumberOfInstrumentsHeld" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_af8342ec-e064-4f37-b60d-8b5692e485ac_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityOther_83391a3b-7dd8-4833-9ad1-b181d15f4c50_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityOther_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityOther" xlink:to="lab_us-gaap_StockholdersEquityOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_d12ef27f-e7c9-47ec-8323-d6b6b257c8de_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_81c7b7c4-3ea7-4497-a610-ff82f64262fb_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAbstract" xlink:to="lab_us-gaap_LiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_3b0c9b7a-9567-4508-9f28-3220b66a920b_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2c6ebb5d-0826-488b-8658-83cfbd9db5fa_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effects of exchange rate changes on cash and cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_7a5710d7-54d7-411a-99d8-72582665e646_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flows from operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_45129a10-3eb7-4f15-b60b-463d8ad1c2a1_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_5de8adb5-f73d-4f08-8d03-465eb27823e9_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_e9839201-bafe-428c-8288-1c353a004730_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock units, canceled or expired in period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_c7563614-07a1-40da-82f4-d9010996cab4_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt outstanding, net</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_2115ae51-9d0d-48a4-a696-d8a1ca1d45ac_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expense, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_d13bfff0-29e6-4011-8925-c86200a3d037_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_var_DerivativeNumberOfInstrumentsTerminated_9382afeb-b141-4dc9-b9f8-0053d187a093_terseLabel_en-US" xlink:label="lab_var_DerivativeNumberOfInstrumentsTerminated" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative number of instruments terminated</link:label>
    <link:label id="lab_var_DerivativeNumberOfInstrumentsTerminated_label_en-US" xlink:label="lab_var_DerivativeNumberOfInstrumentsTerminated" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Number Of Instruments Terminated</link:label>
    <link:label id="lab_var_DerivativeNumberOfInstrumentsTerminated_documentation_en-US" xlink:label="lab_var_DerivativeNumberOfInstrumentsTerminated" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Number Of Instruments Terminated</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_var_DerivativeNumberOfInstrumentsTerminated" xlink:href="var-20221230.xsd#var_DerivativeNumberOfInstrumentsTerminated"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_var_DerivativeNumberOfInstrumentsTerminated" xlink:to="lab_var_DerivativeNumberOfInstrumentsTerminated" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_059a1399-7967-41c1-ae6b-c2cfe631510a_netLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_2092e337-80c8-4c6f-9868-45164deb0857_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RESTRUCTURING</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_3b7aaddf-5792-43b0-b55d-d870c506b57f_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_50551d23-9104-4ead-b76b-71e67c36f43c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductWarrantyLiabilityLineItems_9c5afd0c-8b9f-4463-b6e3-b895dc2817f9_terseLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyLiabilityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Warranty Liability [Line Items]</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyLiabilityLineItems_label_en-US" xlink:label="lab_us-gaap_ProductWarrantyLiabilityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Warranty Liability [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyLiabilityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductWarrantyLiabilityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantyLiabilityLineItems" xlink:to="lab_us-gaap_ProductWarrantyLiabilityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_61d1f757-455b-4bc8-bbbf-d31b067a5fd9_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_44b4560c-37b5-4c68-b09c-a4b076bf4477_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_290bae94-49e9-4b24-abc1-6b62e36a0d8e_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_d9bb2a6d-ff0f-4a48-a366-477dfe6a7429_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_var_ContractWithCustomerRefundLiabilityAdditions_2e45da9a-74c9-416d-9f9c-6cb620419180_terseLabel_en-US" xlink:label="lab_var_ContractWithCustomerRefundLiabilityAdditions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions to refund liabilities</link:label>
    <link:label id="lab_var_ContractWithCustomerRefundLiabilityAdditions_label_en-US" xlink:label="lab_var_ContractWithCustomerRefundLiabilityAdditions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Refund Liability, Additions</link:label>
    <link:label id="lab_var_ContractWithCustomerRefundLiabilityAdditions_documentation_en-US" xlink:label="lab_var_ContractWithCustomerRefundLiabilityAdditions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Refund Liability, Additions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_var_ContractWithCustomerRefundLiabilityAdditions" xlink:href="var-20221230.xsd#var_ContractWithCustomerRefundLiabilityAdditions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_var_ContractWithCustomerRefundLiabilityAdditions" xlink:to="lab_var_ContractWithCustomerRefundLiabilityAdditions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_4dbdddfd-1618-40ef-a217-edb74f0c98b4_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Restricted Cash</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_32cdbb49-8616-47e5-b7fe-6112573f519b_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_96ba4144-c4fa-4b82-893f-01d6014fbce8_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiscalPeriod_34f7ecdb-9a82-43d6-bbe2-934c4500befe_terseLabel_en-US" xlink:label="lab_us-gaap_FiscalPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal Year</link:label>
    <link:label id="lab_us-gaap_FiscalPeriod_label_en-US" xlink:label="lab_us-gaap_FiscalPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal Period, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiscalPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiscalPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiscalPeriod" xlink:to="lab_us-gaap_FiscalPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_8c3b6300-5da2-4986-be6d-1f51e9ca9716_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenues</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_a11ef4a4-f7b4-44c8-909e-f4b43c92cda9_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_a271510c-c435-4522-9cd8-df4a1766f633_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_22024710-82d5-4762-92b3-3160ef3fa50e_verboseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives Designated as Net Investment Hedges</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_3b93f0e3-0435-43b3-8250-cccdec9925c7_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes paid, net of refunds</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_b16d3b4a-02d9-4f50-8178-3e21960ec7af_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with customer, liability, revenue recognized</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_df6c4d74-ecc9-4693-ba75-c22a868af63b_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Smaller Reporting Company</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_de72a787-e268-4924-8b68-2aaf434a0f91_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_92ef17b1-8bdc-4b1b-a0d4-8b1a2d4bed69_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Carrying Amount</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable_e42de500-9680-440a-9ee2-adf7451d14f2_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosure of Asset and Liability Not Measured at Fair Value [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosure of Asset and Liability Not Measured at Fair Value [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable" xlink:to="lab_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_var_MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateRollingAfterOneThroughFiveYearsAmortizedCost_853686a7-88a7-4819-bb18-003c94c31edb_terseLabel_en-US" xlink:label="lab_var_MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateRollingAfterOneThroughFiveYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after one year through five years</link:label>
    <link:label id="lab_var_MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateRollingAfterOneThroughFiveYearsAmortizedCost_label_en-US" xlink:label="lab_var_MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateRollingAfterOneThroughFiveYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Maturity, Allocated and Single Maturity Date, Rolling After One Through Five Years, Amortized Cost</link:label>
    <link:label id="lab_var_MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateRollingAfterOneThroughFiveYearsAmortizedCost_documentation_en-US" xlink:label="lab_var_MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateRollingAfterOneThroughFiveYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Maturity, Allocated and Single Maturity Date, Rolling After One Through Five Years, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_var_MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateRollingAfterOneThroughFiveYearsAmortizedCost" xlink:href="var-20221230.xsd#var_MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateRollingAfterOneThroughFiveYearsAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_var_MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateRollingAfterOneThroughFiveYearsAmortizedCost" xlink:to="lab_var_MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateRollingAfterOneThroughFiveYearsAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCash_fcd3d111-369f-4772-a391-72b5e17b3cf8_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCash_label_en-US" xlink:label="lab_us-gaap_RestrictedCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCash" xlink:to="lab_us-gaap_RestrictedCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_18855e71-ccd7-45b6-92b0-07cff8bb9328_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_d61075d3-50f0-412b-907e-15b575ba288c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of marketable debt securities</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:to="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_14de9ca3-cb24-4928-95af-526391a3a2d6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_e306937e-2ad2-4349-bfb7-386e9f8be568_terseLabel_en-US" xlink:label="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Customers with a Significant Portion of Revenue</link:label>
    <link:label id="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_label_en-US" xlink:label="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedules of Concentration of Risk, by Risk Factor [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:to="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfDebtDiscountPremium_2e8ff9b2-5e31-4859-ba3a-8970409e2456_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of debt discounts</link:label>
    <link:label id="lab_us-gaap_AmortizationOfDebtDiscountPremium_label_en-US" xlink:label="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Discount (Premium)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfDebtDiscountPremium" xlink:to="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_ef3355a4-af0e-4e09-91b6-16b390973c8e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, outstanding, aggregate intrinsic value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_var_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingPrice_bf226902-aaba-42bc-9a73-7dd9619c71a5_periodStartLabel_en-US" xlink:label="lab_var_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingPrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at period beginning (in USD per share)</link:label>
    <link:label id="lab_var_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingPrice_a8d16158-4cf8-4821-b3e4-3b249bd5d9d0_periodEndLabel_en-US" xlink:label="lab_var_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingPrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at period ending (in USD per share)</link:label>
    <link:label id="lab_var_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingPrice_label_en-US" xlink:label="lab_var_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement By Share-based Payment Award, Options, Outstanding, Price</link:label>
    <link:label id="lab_var_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingPrice_documentation_en-US" xlink:label="lab_var_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingPrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement By Share-based Payment Award, Options, Outstanding, Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_var_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingPrice" xlink:href="var-20221230.xsd#var_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_var_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingPrice" xlink:to="lab_var_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_df655974-ef95-4e10-85ab-ea6212d91522_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_4bc011f4-08fd-4c36-b1be-52dbba80338e_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_225d28d8-c748-4d8c-a651-2afa9c44078a_terseLabel_en-US" xlink:label="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Refund Liabilities</link:label>
    <link:label id="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_label_en-US" xlink:label="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Contract with Customer, Liability [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInContractWithCustomerLiabilityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:to="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_e0e58bf6-8eb1-4eb6-ba65-38b7e4a82815_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interest, ownership percentage by noncontrolling owners</link:label>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_label_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:to="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:type="arc" order="1"/>
    <link:label id="lab_var_MarketableSecuritiesAmortizedCost_99338bcb-7c92-41fe-a7a0-a4ee8d401684_totalLabel_en-US" xlink:label="lab_var_MarketableSecuritiesAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total marketable debt securities</link:label>
    <link:label id="lab_var_MarketableSecuritiesAmortizedCost_label_en-US" xlink:label="lab_var_MarketableSecuritiesAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Amortized Cost</link:label>
    <link:label id="lab_var_MarketableSecuritiesAmortizedCost_documentation_en-US" xlink:label="lab_var_MarketableSecuritiesAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_var_MarketableSecuritiesAmortizedCost" xlink:href="var-20221230.xsd#var_MarketableSecuritiesAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_var_MarketableSecuritiesAmortizedCost" xlink:to="lab_var_MarketableSecuritiesAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_1e84ac65-2894-414c-8876-7906037e595c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_9694763f-41a3-43ef-a3d2-33b0f32977a0_terseLabel_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government agencies</link:label>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Government Agencies Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:to="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_531aba9a-66a5-4383-91ce-3762b25d38db_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEGMENT INFORMATION</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_5a193fba-770c-4d2f-8860-24d67b4c554d_verboseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherReceivables_7b965837-e4b1-49e9-a587-d8a8f02afd17_terseLabel_en-US" xlink:label="lab_us-gaap_OtherReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other receivables</link:label>
    <link:label id="lab_us-gaap_OtherReceivables_label_en-US" xlink:label="lab_us-gaap_OtherReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherReceivables" xlink:to="lab_us-gaap_OtherReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestTable_524d69fe-ffdb-4624-bad2-ac8e7a81072d_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Table]</link:label>
    <link:label id="lab_us-gaap_MinorityInterestTable_label_en-US" xlink:label="lab_us-gaap_MinorityInterestTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestTable" xlink:to="lab_us-gaap_MinorityInterestTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_f129d38a-9d0f-43ea-ab4a-66103352a23c_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and stockholders' equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_6ab247f2-c054-48b6-ab1f-fcdedae4ec1e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4c602dd6-bdb1-42f2-b6e9-910ba3e11a99_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_e7690e89-e39d-439f-a264-ecc1bcd129ab_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canceled, expired or forfeited (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeCashReceivedOnHedge_5c0324d6-a199-4401-a373-187f4aa63bfa_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeCashReceivedOnHedge" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, cash received on hedge</link:label>
    <link:label id="lab_us-gaap_DerivativeCashReceivedOnHedge_label_en-US" xlink:label="lab_us-gaap_DerivativeCashReceivedOnHedge" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Cash Received on Hedge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCashReceivedOnHedge" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeCashReceivedOnHedge"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeCashReceivedOnHedge" xlink:to="lab_us-gaap_DerivativeCashReceivedOnHedge" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_393e450a-e955-40eb-9337-a65bbf801c68_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_735465bf-b7f7-4bc5-b3ed-0d60cecfb377_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_45e1ae41-2d78-45d0-9946-1f72e4a6c557_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_var_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisablePrice_5e22a826-3245-4cb0-8f7c-c957fc3cfdc7_terseLabel_en-US" xlink:label="lab_var_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisablePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable (in USD per share)</link:label>
    <link:label id="lab_var_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisablePrice_label_en-US" xlink:label="lab_var_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisablePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Price</link:label>
    <link:label id="lab_var_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisablePrice_documentation_en-US" xlink:label="lab_var_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisablePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_var_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisablePrice" xlink:href="var-20221230.xsd#var_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisablePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_var_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisablePrice" xlink:to="lab_var_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisablePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_var_WarrantyTerm_2f6e6915-859c-4549-be9d-b9dac15051a3_terseLabel_en-US" xlink:label="lab_var_WarrantyTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warranty term</link:label>
    <link:label id="lab_var_WarrantyTerm_label_en-US" xlink:label="lab_var_WarrantyTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warranty Term</link:label>
    <link:label id="lab_var_WarrantyTerm_documentation_en-US" xlink:label="lab_var_WarrantyTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warranty Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_var_WarrantyTerm" xlink:href="var-20221230.xsd#var_WarrantyTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_var_WarrantyTerm" xlink:to="lab_var_WarrantyTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_27fe5570-d15f-47f0-9917-c0a65623fb72_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_e5e0e882-09eb-41f9-bc3a-36b4a7c62e12_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized discount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_25bfd5c5-a866-4bc6-9dd9-2cab71ae5db1_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_bb401af6-9e70-40b8-97cb-2bcc9e67afc6_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_var_NoncontrollingInterestOtherChanges_0f4bb407-9f1e-4efa-8fc9-873e038000ef_terseLabel_en-US" xlink:label="lab_var_NoncontrollingInterestOtherChanges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_var_NoncontrollingInterestOtherChanges_label_en-US" xlink:label="lab_var_NoncontrollingInterestOtherChanges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Other Changes</link:label>
    <link:label id="lab_var_NoncontrollingInterestOtherChanges_documentation_en-US" xlink:label="lab_var_NoncontrollingInterestOtherChanges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Other Changes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_var_NoncontrollingInterestOtherChanges" xlink:href="var-20221230.xsd#var_NoncontrollingInterestOtherChanges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_var_NoncontrollingInterestOtherChanges" xlink:to="lab_var_NoncontrollingInterestOtherChanges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantMember_99d1d3f6-c6fc-477b-9f4a-53441b6739e8_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants</link:label>
    <link:label id="lab_us-gaap_WarrantMember_label_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantMember" xlink:to="lab_us-gaap_WarrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_69e1a2e7-cc33-4386-972a-eb1ff6750afa_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_62c62538-9b0c-463a-82dd-948f1269bf46_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f3bc19d7-4a90-4e3b-8c45-b576ada60dfc_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_68c90b4e-6eb1-4dc9-9e34-de8fcf5e603b_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic weighted average shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_602cfa34-2d02-4ae3-9b96-c58fd1e96dc6_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_e298ca2d-029f-408d-bab4-10759d262cd8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity component of convertible senior unsecured notes</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Carrying Amount of Equity Component</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:to="lab_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_2c4220d5-209f-48c1-9212-315f8605e1df_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investment, ownership percentage</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_adc772a3-e4ec-408b-ab68-00f4a3ee9bf7_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_var_MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateYearOne_b98df586-910e-4edc-b146-6e7547255fd8_terseLabel_en-US" xlink:label="lab_var_MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateYearOne" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due within one year</link:label>
    <link:label id="lab_var_MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateYearOne_label_en-US" xlink:label="lab_var_MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateYearOne" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Maturity, Allocated And Single Maturity Date, Year One</link:label>
    <link:label id="lab_var_MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateYearOne_documentation_en-US" xlink:label="lab_var_MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateYearOne" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Maturity, Allocated And Single Maturity Date, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_var_MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateYearOne" xlink:href="var-20221230.xsd#var_MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateYearOne"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_var_MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateYearOne" xlink:to="lab_var_MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateYearOne" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_a5919b09-2854-4141-82a8-8cd5a0277660_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental non-cash activities:</link:label>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_label_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Investing and Financing Items [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_6be0865e-e5ae-4f48-a7df-e35b4c1822dc_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_332e675f-4ea2-4fcf-ba98-39d779349a45_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding beginning balance (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c7888651-3f33-4ca2-9db1-680e886c369b_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding ending balance (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_566c62de-fb10-4b47-ad4a-808cf9d0ddcd_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional Value</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockMember_a08eae6e-1edf-4263-9581-27df388f10ac_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock and options</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_a8234a81-f498-4536-9552-68124b25b3e7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_37b43eff-91e2-4fee-a8a9-9290026ac35c_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues, net</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_587c7710-e19b-4f8b-a7e3-ed4db6e962a0_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues, net</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateBondSecuritiesMember_ec1e006e-3c86-47c0-94bc-ab591ff74807_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateBondSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate notes/bonds</link:label>
    <link:label id="lab_us-gaap_CorporateBondSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateBondSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Bond Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateBondSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateBondSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateBondSecuritiesMember" xlink:to="lab_us-gaap_CorporateBondSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsMember_d23f5a9f-ff44-4f3a-b0ec-f0208d1c9567_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsMember" xlink:to="lab_us-gaap_CashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_2f61a3d4-fab7-4c65-b341-f4033370967d_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover page.</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_5b72802e-fce0-401b-b527-d293d625d77a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_c55646a3-6e18-4d64-b66c-987492f30dbb_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_263c9b05-c2f8-4d97-b069-4f72264d3526_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Unobservable Inputs (Level 3)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_c7b862c8-81f4-4e7f-8b47-681a5cd218c9_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EMPLOYEE STOCK PLANS</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_174c732f-15ab-4753-8d5c-a6e1cb0b7a11_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_6fd03d4e-55ee-42a1-91ba-d9fe97414cf6_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, allowance for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_5647c455-2b67-4993-891b-5679a6cad00d_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work-in-process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_3652cd03-2623-443c-8d9a-9f023df9521d_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">REVENUE</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_4e3f7176-4272-4f93-bce5-2cfa0f648390_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_5edb7a84-c6f7-4164-be14-36a312342c4d_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:to="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_f6f9b5d4-f8e7-477d-905e-8f9a42a93397_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioForecastMember_3a500df5-370e-4171-87f2-d5e8dffe7b7c_terseLabel_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario, Forecast</link:label>
    <link:label id="lab_srt_ScenarioForecastMember_label_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioForecastMember" xlink:to="lab_srt_ScenarioForecastMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_0e570061-c50b-4849-a25d-3b79ebaa43fa_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders' equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_3584a1d0-6c09-40ae-933a-84fdcbca5432_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials and parts</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials and Supplies, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_d97fdfd0-1550-4ce2-92a6-fc0bfd55a76b_verboseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of debt issuance costs</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCosts" xlink:to="lab_us-gaap_AmortizationOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_399f4c61-05a2-4fa8-85f6-7c35c7deae5f_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_6accf44b-3d68-431a-8c41-25db15630375_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_01a010c6-dd5e-4665-a598-408cf085dae9_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit_d45344d9-54e8-4893-b655-9f9ecfdd7e25_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of borrowing under credit agreements</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-Term Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:to="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_55f4bae7-72e3-42bd-83ef-94ca4a48b4e8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Investment Hedges</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Investment Hedges, Statements of Financial Performance and Financial Position, Location [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_297785a4-c9db-42cd-8c94-3698111eb06a_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive effect of share-based awards and other (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_var_MedicalMember_d279431d-fd26-4895-93f1-80da102f59e3_terseLabel_en-US" xlink:label="lab_var_MedicalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical</link:label>
    <link:label id="lab_var_MedicalMember_label_en-US" xlink:label="lab_var_MedicalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical [Member]</link:label>
    <link:label id="lab_var_MedicalMember_documentation_en-US" xlink:label="lab_var_MedicalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_var_MedicalMember" xlink:href="var-20221230.xsd#var_MedicalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_var_MedicalMember" xlink:to="lab_var_MedicalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StandardProductWarrantyPolicy_c78952b2-8b18-4968-8ff0-de61ca8534e3_terseLabel_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Warranty</link:label>
    <link:label id="lab_us-gaap_StandardProductWarrantyPolicy_label_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard Product Warranty, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StandardProductWarrantyPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandardProductWarrantyPolicy" xlink:to="lab_us-gaap_StandardProductWarrantyPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_c4a7127a-9e74-4ef0-98c6-162da0319221_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_635434a6-c2ce-41f7-8f9f-c829b59b5733_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Other Observable Inputs (Level 2)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_e77fd680-772a-4f79-b448-7fc95711a342_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_c6da9951-0a19-4336-be26-28780f082fc4_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to Varex - diluted</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_ef159a24-81dc-4485-9c12-352280a0ba3d_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_ab379c9f-310c-4fad-820d-e0f7c299d88a_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_3d34905a-7a02-4837-81f1-897f27b1810e_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_911657e5-e9ca-4a8a-8dfc-a87537546450_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted net income per share attributable to Varex (in USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByParent_587b05e1-f438-419b-8a8c-83a67eafbb40_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Majority voting rights, percent</link:label>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByParent_label_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Ownership Percentage by Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:to="lab_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments_adb6753c-591e-4b97-9b9d-474bce426c21_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of equity instruments for convertible debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Number of Equity Instruments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments" xlink:to="lab_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_9c73e9e1-c406-4e1d-be39-baf546f4fdfe_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_var_JointVentureInSaudiArabiaMember_1c71b298-ad40-4703-80a1-65ef37604736_terseLabel_en-US" xlink:label="lab_var_JointVentureInSaudiArabiaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint Venture In Saudi Arabia</link:label>
    <link:label id="lab_var_JointVentureInSaudiArabiaMember_label_en-US" xlink:label="lab_var_JointVentureInSaudiArabiaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint Venture In Saudi Arabia [Member]</link:label>
    <link:label id="lab_var_JointVentureInSaudiArabiaMember_documentation_en-US" xlink:label="lab_var_JointVentureInSaudiArabiaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint Venture In Saudi Arabia [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_var_JointVentureInSaudiArabiaMember" xlink:href="var-20221230.xsd#var_JointVentureInSaudiArabiaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_var_JointVentureInSaudiArabiaMember" xlink:to="lab_var_JointVentureInSaudiArabiaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_e1333de0-7c66-49f3-84bd-55f7134a9b16_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_643d5019-62a0-438f-9bad-c784ac8708b0_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_var_IndustrialMember_10f862d7-8fa5-47f0-b1cd-f5979ca9a8a5_terseLabel_en-US" xlink:label="lab_var_IndustrialMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Industrial</link:label>
    <link:label id="lab_var_IndustrialMember_label_en-US" xlink:label="lab_var_IndustrialMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Industrial [Member]</link:label>
    <link:label id="lab_var_IndustrialMember_documentation_en-US" xlink:label="lab_var_IndustrialMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Industrial [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_var_IndustrialMember" xlink:href="var-20221230.xsd#var_IndustrialMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_var_IndustrialMember" xlink:to="lab_var_IndustrialMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntellectualPropertyMember_ac1bc45b-8def-452d-bbf8-6cbce4556b4b_terseLabel_en-US" xlink:label="lab_us-gaap_IntellectualPropertyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents, licenses and other</link:label>
    <link:label id="lab_us-gaap_IntellectualPropertyMember_label_en-US" xlink:label="lab_us-gaap_IntellectualPropertyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intellectual Property [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntellectualPropertyMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntellectualPropertyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntellectualPropertyMember" xlink:to="lab_us-gaap_IntellectualPropertyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_f706f3a9-4bf2-4c3b-bda1-89a149709ac8_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer concentration risk</link:label>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_var_ConvertibleNotesMember_2708c797-b3ed-4cb7-9941-f0717444d5bf_terseLabel_en-US" xlink:label="lab_var_ConvertibleNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes</link:label>
    <link:label id="lab_var_ConvertibleNotesMember_label_en-US" xlink:label="lab_var_ConvertibleNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes [Member]</link:label>
    <link:label id="lab_var_ConvertibleNotesMember_documentation_en-US" xlink:label="lab_var_ConvertibleNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_var_ConvertibleNotesMember" xlink:href="var-20221230.xsd#var_ConvertibleNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_var_ConvertibleNotesMember" xlink:to="lab_var_ConvertibleNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetImpairmentCharges_37141b91-bae9-4db5-8e5f-5e2144c9f259_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets impairment charges</link:label>
    <link:label id="lab_us-gaap_OtherAssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_OtherAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetImpairmentCharges" xlink:to="lab_us-gaap_OtherAssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_09dc1c07-cdd5-4353-a764-37afe688883d_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Used capacity, commitment fee percentage</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Commitment Fee Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:to="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_0dfb2618-dcde-47d9-8fa4-9ff4414c6ba4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_18db1c19-716f-41a9-a4c5-e0415d944c21_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AmericasMember_3edae2e2-64e2-400f-9fd6-d7e4db8aefba_terseLabel_en-US" xlink:label="lab_srt_AmericasMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Americas</link:label>
    <link:label id="lab_srt_AmericasMember_label_en-US" xlink:label="lab_srt_AmericasMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Americas [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AmericasMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AmericasMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AmericasMember" xlink:to="lab_srt_AmericasMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerMember_08347db3-c7f0-4a0e-b49d-7995df3d5bfe_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from contract with customer</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerMember_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerMember" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_8f8d970b-2bdc-449d-b9c4-a5f22ea773a6_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative assets fair value, gross</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Subject to Master Netting Arrangement, before Offset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_067ac0e1-962e-48f6-8b32-65083989f83e_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_fbdf6166-2dfe-4e80-a5b9-2f0261c70b5a_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_bef682d4-a070-429e-80d3-876654b8b62d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_8fd9794a-3633-41a7-8581-243ae4dac15c_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Remaining Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_bc5fa013-8c03-4617-839f-11b6a5c4f7f8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_87bc9b06-e136-47c3-ae87-671590c64f17_totalLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_0567cace-833b-4f86-81a1-17bed0195881_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_7f5e9903-066d-431a-9a26-ab8c38af609a_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_e115607a-1dde-4787-b1c4-bfc41a306846_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from maturities of marketable debt securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale and Maturity of Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesUnrealizedGainLoss_63ce248a-6752-42d9-8129-98964091c3b1_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable securities credit loss</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesUnrealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Unrealized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:to="lab_us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_0ce0340d-7ff0-47eb-9c0f-ceaf0d4e1a63_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INVENTORIES</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureTextBlock" xlink:to="lab_us-gaap_InventoryDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_b6a08e00-a95e-40b1-83e4-33f55a1b3052_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock units, vested in period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_70b07d7b-f831-4f1f-8705-be5284a28032_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureAbstract" xlink:to="lab_us-gaap_InventoryDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_cb66cbc2-417a-415f-9291-71530ece51d8_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_e1c28201-a773-4524-a7e1-c3365887db2d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:to="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_c613451c-3d1f-41a8-9720-6de3352604e9_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investment, amount written off</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Other than Temporary Impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:to="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_75d606fc-35b1-4872-ae3a-bbeb8c243ab4_terseLabel_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification of Prior Period Presentation</link:label>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_label_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification, Comparability Adjustment [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_16e4b984-0648-4f75-b98e-95480931030e_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue by Geographic Location</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_bac84533-79af-46ba-9a95-76260f6306f7_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_910fa1eb-916e-41b7-8502-4e69d424e052_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (decrease) increase in cash and cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_d8532480-4dd7-48ad-bf18-91f2b7a89326_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Restructuring Costs Incurred</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_19b18842-5e4e-4eb1-8f2b-47baad948d8f_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_31254551-a9fe-4b13-b795-fdd0ff16d633_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_f1162069-d330-447d-b295-4cb5ba12abb3_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfDeferredLoanOriginationFeesNet_caf4d0a0-6128-4be1-baca-3ac828fa2e2b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfDeferredLoanOriginationFeesNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of deferred loan costs</link:label>
    <link:label id="lab_us-gaap_AmortizationOfDeferredLoanOriginationFeesNet_label_en-US" xlink:label="lab_us-gaap_AmortizationOfDeferredLoanOriginationFeesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Deferred Loan Origination Fees, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDeferredLoanOriginationFeesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfDeferredLoanOriginationFeesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfDeferredLoanOriginationFeesNet" xlink:to="lab_us-gaap_AmortizationOfDeferredLoanOriginationFeesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_940b6c70-6cc1-4e89-93c5-ca2edc1f25d2_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest" xlink:to="lab_us-gaap_InvestmentIncomeInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_92256cbd-e160-4442-916d-facb0ec1c7a1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_038888f7-f39e-4722-846b-43c3d8bb14c2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted&#160;Average Grant-Date Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_25cff79e-7e4c-4566-a801-75da443dda6c_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_85d4b785-2d5f-47cf-bbcd-3af240c1d3ec_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_var_MeVisMedicalSolutionsAGMeVisMember_68023af8-3dac-4e1b-a5d0-69daad171d51_terseLabel_en-US" xlink:label="lab_var_MeVisMedicalSolutionsAGMeVisMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MeVis Medical Solutions AG (MeVis)</link:label>
    <link:label id="lab_var_MeVisMedicalSolutionsAGMeVisMember_label_en-US" xlink:label="lab_var_MeVisMedicalSolutionsAGMeVisMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MeVis Medical Solutions AG (MeVis) [Member]</link:label>
    <link:label id="lab_var_MeVisMedicalSolutionsAGMeVisMember_documentation_en-US" xlink:label="lab_var_MeVisMedicalSolutionsAGMeVisMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MeVis Medical Solutions AG (MeVis) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_var_MeVisMedicalSolutionsAGMeVisMember" xlink:href="var-20221230.xsd#var_MeVisMedicalSolutionsAGMeVisMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_var_MeVisMedicalSolutionsAGMeVisMember" xlink:to="lab_var_MeVisMedicalSolutionsAGMeVisMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_363bb197-4213-4906-8bfb-c68fa5366212_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration of Risk</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_23e53719-c9e5-4b4f-8d88-d8bcfebe7e6a_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Adoption [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_label_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfAdoptionMember" xlink:to="lab_us-gaap_TypeOfAdoptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_8b73451a-636b-4268-b55d-0f35c4702965_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_24fc8612-c144-4480-877d-54c575b924ba_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_fd2d2288-fc1d-44f1-a982-f502557345c6_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherDebtSecuritiesMember_6f59d32a-0671-4f7f-a3f6-e29fe5e4bd30_terseLabel_en-US" xlink:label="lab_us-gaap_OtherDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other debt</link:label>
    <link:label id="lab_us-gaap_OtherDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_OtherDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Debt Obligations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherDebtSecuritiesMember" xlink:to="lab_us-gaap_OtherDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_0a407390-5cd5-4917-8105-ed3ad0ddb483_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_var_CorporateBonds_ced1bce1-9177-44f6-b259-14d7d5fb0345_terseLabel_en-US" xlink:label="lab_var_CorporateBonds" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate notes/bonds</link:label>
    <link:label id="lab_var_CorporateBonds_label_en-US" xlink:label="lab_var_CorporateBonds" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Bonds</link:label>
    <link:label id="lab_var_CorporateBonds_documentation_en-US" xlink:label="lab_var_CorporateBonds" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Bonds</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_var_CorporateBonds" xlink:href="var-20221230.xsd#var_CorporateBonds"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_var_CorporateBonds" xlink:to="lab_var_CorporateBonds" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_93949d02-d94e-414f-8a0d-e6b80729df3d_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnInvestmentsTextBlock_adf2a8e2-e6c3-4c25-b932-7c2c6af3e001_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Gains and (Losses) on Marketable Securities</link:label>
    <link:label id="lab_us-gaap_GainLossOnInvestmentsTextBlock_label_en-US" xlink:label="lab_us-gaap_GainLossOnInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Securities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestmentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestmentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnInvestmentsTextBlock" xlink:to="lab_us-gaap_GainLossOnInvestmentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductWarrantyLiabilityTable_eec730c9-d5c4-4ebe-a18c-9d0b4944ca2a_terseLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyLiabilityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Warranty Liability [Table]</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyLiabilityTable_label_en-US" xlink:label="lab_us-gaap_ProductWarrantyLiabilityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Warranty Liability [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyLiabilityTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductWarrantyLiabilityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantyLiabilityTable" xlink:to="lab_us-gaap_ProductWarrantyLiabilityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_0d4eb21e-5198-4866-bdd6-f2c903d0cdd8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_bcfad5a0-0ff8-4f33-8a3b-492828dd8207_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_62e05d7a-41be-454d-9008-1fbd712cde69_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from equity method investments</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_var_SharebasedCompensationArrangementsbySharebasedPaymentAwardOptionsGrantsinPeriodPrice_ee282560-8239-477d-99b3-44843e75a693_terseLabel_en-US" xlink:label="lab_var_SharebasedCompensationArrangementsbySharebasedPaymentAwardOptionsGrantsinPeriodPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in USD per share)</link:label>
    <link:label id="lab_var_SharebasedCompensationArrangementsbySharebasedPaymentAwardOptionsGrantsinPeriodPrice_label_en-US" xlink:label="lab_var_SharebasedCompensationArrangementsbySharebasedPaymentAwardOptionsGrantsinPeriodPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SharebasedCompensationArrangementsbySharebasedPaymentAwardOptionsGrantsinPeriodPrice</link:label>
    <link:label id="lab_var_SharebasedCompensationArrangementsbySharebasedPaymentAwardOptionsGrantsinPeriodPrice_documentation_en-US" xlink:label="lab_var_SharebasedCompensationArrangementsbySharebasedPaymentAwardOptionsGrantsinPeriodPrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SharebasedCompensationArrangementsbySharebasedPaymentAwardOptionsGrantsinPeriodPrice</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_var_SharebasedCompensationArrangementsbySharebasedPaymentAwardOptionsGrantsinPeriodPrice" xlink:href="var-20221230.xsd#var_SharebasedCompensationArrangementsbySharebasedPaymentAwardOptionsGrantsinPeriodPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_var_SharebasedCompensationArrangementsbySharebasedPaymentAwardOptionsGrantsinPeriodPrice" xlink:to="lab_var_SharebasedCompensationArrangementsbySharebasedPaymentAwardOptionsGrantsinPeriodPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_94ffaf8d-54db-4e25-aace-c1513cbe7432_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_4f1c84c8-52d8-4006-8e51-671abe7054f3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_b448c41b-6d84-4043-becd-5ea01c7a1b31_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_b567ee4a-326e-49c6-986a-f69f070a64ed_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_b46527b0-a371-464b-aa9a-baa3d2464aa1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income Per Share, Basic and Diluted</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_797a6cf0-0b78-446c-b6a7-f5d04c5d7169_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash operating right-of-use assets obtained in exchange for new lease liabilities</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_7c2fb554-c809-4e82-a02d-15c079e783c2_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of revenues</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_c6cb4ef9-2260-4f63-a808-8cca59a3b79e_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_ebecfa91-27c9-480c-af3d-9fad394acbb3_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible List]</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:to="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>var-20221230_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:b10c8d19-453b-4af7-a4e1-32028a0718a8,g:e90e04e8-fae8-401c-8aa8-facd054e09fb-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.varex.com/role/Cover" xlink:type="simple" xlink:href="var-20221230.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.varex.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_6ed21491-c8fd-4d5d-bc1e-a35bd17b9679" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_73902f3a-bf35-46cc-8350-a7dfa3bc1225" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6ed21491-c8fd-4d5d-bc1e-a35bd17b9679" xlink:to="loc_dei_DocumentType_73902f3a-bf35-46cc-8350-a7dfa3bc1225" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_fee8639f-729c-453e-b366-84c3ec410efe" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6ed21491-c8fd-4d5d-bc1e-a35bd17b9679" xlink:to="loc_dei_DocumentQuarterlyReport_fee8639f-729c-453e-b366-84c3ec410efe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_29474fdd-ca81-4a4a-8c1a-146188e57070" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6ed21491-c8fd-4d5d-bc1e-a35bd17b9679" xlink:to="loc_dei_DocumentPeriodEndDate_29474fdd-ca81-4a4a-8c1a-146188e57070" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_eca8a161-57d6-45ba-91a6-b46b00162873" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6ed21491-c8fd-4d5d-bc1e-a35bd17b9679" xlink:to="loc_dei_DocumentTransitionReport_eca8a161-57d6-45ba-91a6-b46b00162873" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_e9703297-93fa-4fb4-b40d-061f4599b89a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6ed21491-c8fd-4d5d-bc1e-a35bd17b9679" xlink:to="loc_dei_EntityFileNumber_e9703297-93fa-4fb4-b40d-061f4599b89a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_eae9b85f-c8f6-4aab-93cb-90e9f2e1c03b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6ed21491-c8fd-4d5d-bc1e-a35bd17b9679" xlink:to="loc_dei_EntityRegistrantName_eae9b85f-c8f6-4aab-93cb-90e9f2e1c03b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_9b949495-4590-443f-b4cd-bd589d5ffdaf" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6ed21491-c8fd-4d5d-bc1e-a35bd17b9679" xlink:to="loc_dei_EntityIncorporationStateCountryCode_9b949495-4590-443f-b4cd-bd589d5ffdaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_e13936e5-8cc1-4c05-9b68-17ded349f339" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6ed21491-c8fd-4d5d-bc1e-a35bd17b9679" xlink:to="loc_dei_EntityTaxIdentificationNumber_e13936e5-8cc1-4c05-9b68-17ded349f339" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_25ba148b-dfe5-45ca-a250-867785693711" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6ed21491-c8fd-4d5d-bc1e-a35bd17b9679" xlink:to="loc_dei_EntityAddressAddressLine1_25ba148b-dfe5-45ca-a250-867785693711" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_6d89aa0b-ee6c-488a-a8be-5c322cfc917f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6ed21491-c8fd-4d5d-bc1e-a35bd17b9679" xlink:to="loc_dei_EntityAddressCityOrTown_6d89aa0b-ee6c-488a-a8be-5c322cfc917f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_f137fe4b-9f88-4ace-9c95-aebc14638c54" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6ed21491-c8fd-4d5d-bc1e-a35bd17b9679" xlink:to="loc_dei_EntityAddressStateOrProvince_f137fe4b-9f88-4ace-9c95-aebc14638c54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_13f6e922-2d1f-40bb-b219-acaabb94a5b6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6ed21491-c8fd-4d5d-bc1e-a35bd17b9679" xlink:to="loc_dei_EntityAddressPostalZipCode_13f6e922-2d1f-40bb-b219-acaabb94a5b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_b9962bca-2298-4030-837a-c7aa773e1d50" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6ed21491-c8fd-4d5d-bc1e-a35bd17b9679" xlink:to="loc_dei_CityAreaCode_b9962bca-2298-4030-837a-c7aa773e1d50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_dab6deb2-b408-49d5-8e33-f4cb6e3f0ea1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6ed21491-c8fd-4d5d-bc1e-a35bd17b9679" xlink:to="loc_dei_LocalPhoneNumber_dab6deb2-b408-49d5-8e33-f4cb6e3f0ea1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_9dc296b4-8484-47c7-a44e-e094e73ffab5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6ed21491-c8fd-4d5d-bc1e-a35bd17b9679" xlink:to="loc_dei_Security12bTitle_9dc296b4-8484-47c7-a44e-e094e73ffab5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_840ea2e2-c19e-44c1-9324-5d9eaeb4e7cb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6ed21491-c8fd-4d5d-bc1e-a35bd17b9679" xlink:to="loc_dei_TradingSymbol_840ea2e2-c19e-44c1-9324-5d9eaeb4e7cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_254f826b-97a4-4978-8efc-ab3288ab4766" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6ed21491-c8fd-4d5d-bc1e-a35bd17b9679" xlink:to="loc_dei_SecurityExchangeName_254f826b-97a4-4978-8efc-ab3288ab4766" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_52f1212b-ca26-48d7-b6f9-289a05db5556" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6ed21491-c8fd-4d5d-bc1e-a35bd17b9679" xlink:to="loc_dei_EntityCurrentReportingStatus_52f1212b-ca26-48d7-b6f9-289a05db5556" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_89abed55-8d27-4167-8aab-69f5e9f24e5b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6ed21491-c8fd-4d5d-bc1e-a35bd17b9679" xlink:to="loc_dei_EntityInteractiveDataCurrent_89abed55-8d27-4167-8aab-69f5e9f24e5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_d4ff8ef7-2b5c-4ac1-aa82-75d201a45c65" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6ed21491-c8fd-4d5d-bc1e-a35bd17b9679" xlink:to="loc_dei_EntityFilerCategory_d4ff8ef7-2b5c-4ac1-aa82-75d201a45c65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_f5666683-1d17-4538-8d35-dcb3d5dac76b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6ed21491-c8fd-4d5d-bc1e-a35bd17b9679" xlink:to="loc_dei_EntitySmallBusiness_f5666683-1d17-4538-8d35-dcb3d5dac76b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_1ed5394d-4dbb-4611-bee4-52ceec866c2c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6ed21491-c8fd-4d5d-bc1e-a35bd17b9679" xlink:to="loc_dei_EntityEmergingGrowthCompany_1ed5394d-4dbb-4611-bee4-52ceec866c2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_e9ed09d3-973d-4f07-8178-74c83754a2b8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6ed21491-c8fd-4d5d-bc1e-a35bd17b9679" xlink:to="loc_dei_EntityShellCompany_e9ed09d3-973d-4f07-8178-74c83754a2b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_e407f4c8-f87e-4889-89aa-dcc4a7e5f748" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6ed21491-c8fd-4d5d-bc1e-a35bd17b9679" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_e407f4c8-f87e-4889-89aa-dcc4a7e5f748" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_63b777fd-8f8b-4a86-b270-0bbe5ae3ce98" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6ed21491-c8fd-4d5d-bc1e-a35bd17b9679" xlink:to="loc_dei_AmendmentFlag_63b777fd-8f8b-4a86-b270-0bbe5ae3ce98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_86324023-7cdd-42d0-bf9a-c5120023eb10" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6ed21491-c8fd-4d5d-bc1e-a35bd17b9679" xlink:to="loc_dei_DocumentFiscalYearFocus_86324023-7cdd-42d0-bf9a-c5120023eb10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_412c5b91-63ff-4511-9e7f-db56f684c968" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6ed21491-c8fd-4d5d-bc1e-a35bd17b9679" xlink:to="loc_dei_DocumentFiscalPeriodFocus_412c5b91-63ff-4511-9e7f-db56f684c968" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_deef6a03-50c3-459f-8d04-8009a6c816a7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6ed21491-c8fd-4d5d-bc1e-a35bd17b9679" xlink:to="loc_dei_EntityCentralIndexKey_deef6a03-50c3-459f-8d04-8009a6c816a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_2cfac8a0-f9b5-488d-a69b-4b7726f69e32" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6ed21491-c8fd-4d5d-bc1e-a35bd17b9679" xlink:to="loc_dei_CurrentFiscalYearEndDate_2cfac8a0-f9b5-488d-a69b-4b7726f69e32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited" xlink:type="simple" xlink:href="var-20221230.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"/>
  <link:presentationLink xlink:role="http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_24aa1544-5f86-4e3b-9557-7f0793be07cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_01f9eb39-acf5-48b2-8c8e-19d3185b6d6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_24aa1544-5f86-4e3b-9557-7f0793be07cc" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_01f9eb39-acf5-48b2-8c8e-19d3185b6d6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_72805f7f-07d1-44a7-ac61-5d91a3735b88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_24aa1544-5f86-4e3b-9557-7f0793be07cc" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_72805f7f-07d1-44a7-ac61-5d91a3735b88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_9b2f2c68-a3f8-4c7e-86bd-eb2a95a78c74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_24aa1544-5f86-4e3b-9557-7f0793be07cc" xlink:to="loc_us-gaap_GrossProfit_9b2f2c68-a3f8-4c7e-86bd-eb2a95a78c74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_0d2f0818-827a-45fe-b9ea-7733127683fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_24aa1544-5f86-4e3b-9557-7f0793be07cc" xlink:to="loc_us-gaap_OperatingExpensesAbstract_0d2f0818-827a-45fe-b9ea-7733127683fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_f4e4fe40-7cc8-4b30-a947-329109d73dc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_0d2f0818-827a-45fe-b9ea-7733127683fc" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_f4e4fe40-7cc8-4b30-a947-329109d73dc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_0896fa9c-02a9-4c61-896e-8bf03ffb8e5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_0d2f0818-827a-45fe-b9ea-7733127683fc" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_0896fa9c-02a9-4c61-896e-8bf03ffb8e5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_0731db16-ebfd-4ed4-87ce-e10d8558ad6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_0d2f0818-827a-45fe-b9ea-7733127683fc" xlink:to="loc_us-gaap_OperatingExpenses_0731db16-ebfd-4ed4-87ce-e10d8558ad6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_e67e08c9-ecf4-4f3e-bc74-e4cac570339e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_24aa1544-5f86-4e3b-9557-7f0793be07cc" xlink:to="loc_us-gaap_OperatingIncomeLoss_e67e08c9-ecf4-4f3e-bc74-e4cac570339e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_c1dc526e-c4b5-45b6-a78b-2e034e72c1e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_24aa1544-5f86-4e3b-9557-7f0793be07cc" xlink:to="loc_us-gaap_InvestmentIncomeInterest_c1dc526e-c4b5-45b6-a78b-2e034e72c1e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_4c9ac020-682e-4802-88ac-edb008ff3bfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_24aa1544-5f86-4e3b-9557-7f0793be07cc" xlink:to="loc_us-gaap_InterestExpense_4c9ac020-682e-4802-88ac-edb008ff3bfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_5a251935-7983-4b36-b88c-55954ccce91d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_24aa1544-5f86-4e3b-9557-7f0793be07cc" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_5a251935-7983-4b36-b88c-55954ccce91d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_db82b9ee-3c93-4234-9ac0-cabd0115a9c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_24aa1544-5f86-4e3b-9557-7f0793be07cc" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_db82b9ee-3c93-4234-9ac0-cabd0115a9c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_dba792ec-c6d1-4812-af3e-2baee84b2daa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_24aa1544-5f86-4e3b-9557-7f0793be07cc" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_dba792ec-c6d1-4812-af3e-2baee84b2daa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_90ef39f8-1e7d-45dd-9d4a-e70eddfc38ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_24aa1544-5f86-4e3b-9557-7f0793be07cc" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_90ef39f8-1e7d-45dd-9d4a-e70eddfc38ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_a3be5129-3e8e-4619-ae33-e809d7f474de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_24aa1544-5f86-4e3b-9557-7f0793be07cc" xlink:to="loc_us-gaap_ProfitLoss_a3be5129-3e8e-4619-ae33-e809d7f474de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_57f96050-bc94-4a5d-bbb4-0efdc28cdaf8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_24aa1544-5f86-4e3b-9557-7f0793be07cc" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_57f96050-bc94-4a5d-bbb4-0efdc28cdaf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_26f37f04-00eb-4a13-b26b-bfba5257da5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_24aa1544-5f86-4e3b-9557-7f0793be07cc" xlink:to="loc_us-gaap_NetIncomeLoss_26f37f04-00eb-4a13-b26b-bfba5257da5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_b8b7e19d-fd6d-4646-91c0-dbe08dd385e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_24aa1544-5f86-4e3b-9557-7f0793be07cc" xlink:to="loc_us-gaap_EarningsPerShareAbstract_b8b7e19d-fd6d-4646-91c0-dbe08dd385e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_ecf7736d-ae6b-46b1-986f-1e6cb7c9ecf6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b8b7e19d-fd6d-4646-91c0-dbe08dd385e2" xlink:to="loc_us-gaap_EarningsPerShareBasic_ecf7736d-ae6b-46b1-986f-1e6cb7c9ecf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_8e835877-3b94-4201-87be-f2d4cc67157d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b8b7e19d-fd6d-4646-91c0-dbe08dd385e2" xlink:to="loc_us-gaap_EarningsPerShareDiluted_8e835877-3b94-4201-87be-f2d4cc67157d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_fec615f4-49a8-43c7-8cc9-7532822c8f6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_24aa1544-5f86-4e3b-9557-7f0793be07cc" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_fec615f4-49a8-43c7-8cc9-7532822c8f6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1fe464a3-afff-4dcd-aff2-2b12ba7d4480" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_fec615f4-49a8-43c7-8cc9-7532822c8f6e" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1fe464a3-afff-4dcd-aff2-2b12ba7d4480" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_5ac90ae7-64d5-4ce4-927f-4ce97627ec84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_fec615f4-49a8-43c7-8cc9-7532822c8f6e" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_5ac90ae7-64d5-4ce4-927f-4ce97627ec84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUnaudited" xlink:type="simple" xlink:href="var-20221230.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUnaudited"/>
  <link:presentationLink xlink:role="http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_222afe89-48b7-49a5-8620-032c97da1823" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_b22ba7b1-f5ea-47ac-a599-447aa60344dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_222afe89-48b7-49a5-8620-032c97da1823" xlink:to="loc_us-gaap_ProfitLoss_b22ba7b1-f5ea-47ac-a599-447aa60344dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_0b50a994-d075-4b31-b867-0a257c802122" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_222afe89-48b7-49a5-8620-032c97da1823" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_0b50a994-d075-4b31-b867-0a257c802122" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_dff06785-da74-41a0-8f14-98aa39c75623" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_0b50a994-d075-4b31-b867-0a257c802122" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_dff06785-da74-41a0-8f14-98aa39c75623" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_b55ecf69-0f67-4d69-b560-b27b7c6bf095" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_222afe89-48b7-49a5-8620-032c97da1823" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_b55ecf69-0f67-4d69-b560-b27b7c6bf095" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_acfb4a10-52f4-4a63-a81d-555e88e239b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_222afe89-48b7-49a5-8620-032c97da1823" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_acfb4a10-52f4-4a63-a81d-555e88e239b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_710cd1aa-a132-4e80-b5d0-1bb4153ec29e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_222afe89-48b7-49a5-8620-032c97da1823" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_710cd1aa-a132-4e80-b5d0-1bb4153ec29e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" xlink:type="simple" xlink:href="var-20221230.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"/>
  <link:presentationLink xlink:role="http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_e9bb3fd0-e436-48b6-837c-149ba035f2b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_c4099570-8b2c-4044-8604-741fe52a3767" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e9bb3fd0-e436-48b6-837c-149ba035f2b3" xlink:to="loc_us-gaap_AssetsAbstract_c4099570-8b2c-4044-8604-741fe52a3767" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_8318811e-482a-45da-a589-ac5acc1a5191" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c4099570-8b2c-4044-8604-741fe52a3767" xlink:to="loc_us-gaap_AssetsCurrentAbstract_8318811e-482a-45da-a589-ac5acc1a5191" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f43fc0d7-b12a-4dcd-a39e-a5650f0acb1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_8318811e-482a-45da-a589-ac5acc1a5191" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f43fc0d7-b12a-4dcd-a39e-a5650f0acb1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_ef7aff50-8983-4e9d-b68c-1ab6c900a50d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_8318811e-482a-45da-a589-ac5acc1a5191" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_ef7aff50-8983-4e9d-b68c-1ab6c900a50d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_d5bbf472-b2be-435a-8818-80c8bcdee87f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_8318811e-482a-45da-a589-ac5acc1a5191" xlink:to="loc_us-gaap_InventoryNet_d5bbf472-b2be-435a-8818-80c8bcdee87f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_ac326ba8-0da4-4068-bc9d-a8ce0f2207b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_8318811e-482a-45da-a589-ac5acc1a5191" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_ac326ba8-0da4-4068-bc9d-a8ce0f2207b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_b780025a-1c46-4d41-b5b8-61de976bd096" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_8318811e-482a-45da-a589-ac5acc1a5191" xlink:to="loc_us-gaap_AssetsCurrent_b780025a-1c46-4d41-b5b8-61de976bd096" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_804e2497-94ef-4ffc-9931-dd849add3f29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c4099570-8b2c-4044-8604-741fe52a3767" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_804e2497-94ef-4ffc-9931-dd849add3f29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_a1dcf630-53dd-4462-a247-f9c85a70e5a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c4099570-8b2c-4044-8604-741fe52a3767" xlink:to="loc_us-gaap_Goodwill_a1dcf630-53dd-4462-a247-f9c85a70e5a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_cd43d678-5407-43ce-94da-2fbe8dba6ebd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c4099570-8b2c-4044-8604-741fe52a3767" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_cd43d678-5407-43ce-94da-2fbe8dba6ebd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_fbc98a8f-8299-46ef-886c-e165efb85a2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c4099570-8b2c-4044-8604-741fe52a3767" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_fbc98a8f-8299-46ef-886c-e165efb85a2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_7d3cc2b9-bc70-45f5-bfd6-013d68b1df42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c4099570-8b2c-4044-8604-741fe52a3767" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_7d3cc2b9-bc70-45f5-bfd6-013d68b1df42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_9d87d22c-aeaa-44b4-8360-c67521252a8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c4099570-8b2c-4044-8604-741fe52a3767" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_9d87d22c-aeaa-44b4-8360-c67521252a8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_e7b8a87a-f716-41e6-9e18-b304b174114b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c4099570-8b2c-4044-8604-741fe52a3767" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_e7b8a87a-f716-41e6-9e18-b304b174114b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_b344914d-9b6f-4488-bc3b-b7a037851c76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c4099570-8b2c-4044-8604-741fe52a3767" xlink:to="loc_us-gaap_Assets_b344914d-9b6f-4488-bc3b-b7a037851c76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7b1c4550-cc78-4db9-bfdf-87d06312c3fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e9bb3fd0-e436-48b6-837c-149ba035f2b3" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7b1c4550-cc78-4db9-bfdf-87d06312c3fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_d8256f34-e64f-433a-9801-e6b6773e0c1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7b1c4550-cc78-4db9-bfdf-87d06312c3fe" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_d8256f34-e64f-433a-9801-e6b6773e0c1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_6e6b21a4-1aeb-4b60-b8e3-d76020a093e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d8256f34-e64f-433a-9801-e6b6773e0c1c" xlink:to="loc_us-gaap_AccountsPayableCurrent_6e6b21a4-1aeb-4b60-b8e3-d76020a093e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_92e6c912-4d15-4bca-8530-5637f31c3bf5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d8256f34-e64f-433a-9801-e6b6773e0c1c" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_92e6c912-4d15-4bca-8530-5637f31c3bf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_63c4bd78-6d58-40b7-a68d-ad5a322b57ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d8256f34-e64f-433a-9801-e6b6773e0c1c" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_63c4bd78-6d58-40b7-a68d-ad5a322b57ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_6a9891f5-35e0-4808-a35e-529e886efbb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d8256f34-e64f-433a-9801-e6b6773e0c1c" xlink:to="loc_us-gaap_LongTermDebtCurrent_6a9891f5-35e0-4808-a35e-529e886efbb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_a39194a6-d99a-4df9-a510-aa68b3b3dddd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d8256f34-e64f-433a-9801-e6b6773e0c1c" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_a39194a6-d99a-4df9-a510-aa68b3b3dddd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_f3f3e935-df88-48e1-8654-05562db14d27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d8256f34-e64f-433a-9801-e6b6773e0c1c" xlink:to="loc_us-gaap_LiabilitiesCurrent_f3f3e935-df88-48e1-8654-05562db14d27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_cbc10a5f-80d2-4d89-9675-98efd33aa510" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7b1c4550-cc78-4db9-bfdf-87d06312c3fe" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_cbc10a5f-80d2-4d89-9675-98efd33aa510" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_4161be69-0487-481f-a04c-3cac01be6111" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7b1c4550-cc78-4db9-bfdf-87d06312c3fe" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_4161be69-0487-481f-a04c-3cac01be6111" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_6eb34281-0289-4127-baf3-5352e944e93d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7b1c4550-cc78-4db9-bfdf-87d06312c3fe" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_6eb34281-0289-4127-baf3-5352e944e93d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_9bc30901-bf73-48f8-8589-b40f45cd4998" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7b1c4550-cc78-4db9-bfdf-87d06312c3fe" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_9bc30901-bf73-48f8-8589-b40f45cd4998" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_565d2c61-475f-443b-a668-afab8505cc00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7b1c4550-cc78-4db9-bfdf-87d06312c3fe" xlink:to="loc_us-gaap_Liabilities_565d2c61-475f-443b-a668-afab8505cc00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_6e98a985-abc6-42f8-bd69-03901abbba12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7b1c4550-cc78-4db9-bfdf-87d06312c3fe" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_6e98a985-abc6-42f8-bd69-03901abbba12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValueOutstanding_0e84c70f-c775-4f30-90ff-0339c31fdabb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValueOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_6e98a985-abc6-42f8-bd69-03901abbba12" xlink:to="loc_us-gaap_PreferredStockValueOutstanding_0e84c70f-c775-4f30-90ff-0339c31fdabb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValueOutstanding_15ebeda3-6198-46e8-a1f1-f2efd12595c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValueOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_6e98a985-abc6-42f8-bd69-03901abbba12" xlink:to="loc_us-gaap_CommonStockValueOutstanding_15ebeda3-6198-46e8-a1f1-f2efd12595c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_300e0359-d6e2-4804-8205-b4b9742e1599" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_6e98a985-abc6-42f8-bd69-03901abbba12" xlink:to="loc_us-gaap_AdditionalPaidInCapital_300e0359-d6e2-4804-8205-b4b9742e1599" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_b9ae5068-d4b8-40bf-bcf4-eb0abd97fbb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_6e98a985-abc6-42f8-bd69-03901abbba12" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_b9ae5068-d4b8-40bf-bcf4-eb0abd97fbb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_1a5d63dd-339e-49fa-83a0-344d791c1ba3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_6e98a985-abc6-42f8-bd69-03901abbba12" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_1a5d63dd-339e-49fa-83a0-344d791c1ba3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_d69b86b7-8ff9-4a97-9112-17feb35adb6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_6e98a985-abc6-42f8-bd69-03901abbba12" xlink:to="loc_us-gaap_StockholdersEquity_d69b86b7-8ff9-4a97-9112-17feb35adb6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_2e403f6f-6783-4e61-bf2a-32bfff78d3cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_6e98a985-abc6-42f8-bd69-03901abbba12" xlink:to="loc_us-gaap_MinorityInterest_2e403f6f-6783-4e61-bf2a-32bfff78d3cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e8531a1d-e572-43bf-a7aa-87ffe1b9ab65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_6e98a985-abc6-42f8-bd69-03901abbba12" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e8531a1d-e572-43bf-a7aa-87ffe1b9ab65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_8ea3f489-1c72-479e-ba96-423306aba5f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7b1c4550-cc78-4db9-bfdf-87d06312c3fe" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_8ea3f489-1c72-479e-ba96-423306aba5f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical" xlink:type="simple" xlink:href="var-20221230.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical"/>
  <link:presentationLink xlink:role="http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_0b813d55-0b89-4768-9ede-81e391af783c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_b8d26ecb-a98b-473f-a80b-8b2494df7477" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0b813d55-0b89-4768-9ede-81e391af783c" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_b8d26ecb-a98b-473f-a80b-8b2494df7477" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_93466979-e9ae-4ba9-9fc3-135ca3415f87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0b813d55-0b89-4768-9ede-81e391af783c" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_93466979-e9ae-4ba9-9fc3-135ca3415f87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_520806a9-dfb7-4429-8fbe-e242bb42b63f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0b813d55-0b89-4768-9ede-81e391af783c" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_520806a9-dfb7-4429-8fbe-e242bb42b63f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_a9e590bc-5792-4ee3-b7c6-ffd250ce09cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0b813d55-0b89-4768-9ede-81e391af783c" xlink:to="loc_us-gaap_PreferredStockSharesIssued_a9e590bc-5792-4ee3-b7c6-ffd250ce09cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_8f0c091c-8428-4e0d-9cbc-cdb19e89edda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0b813d55-0b89-4768-9ede-81e391af783c" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_8f0c091c-8428-4e0d-9cbc-cdb19e89edda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_a0bbb66b-60f6-43df-9fdb-c7c84c956471" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0b813d55-0b89-4768-9ede-81e391af783c" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_a0bbb66b-60f6-43df-9fdb-c7c84c956471" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_47673ef8-d443-4712-8478-d9b966b98050" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0b813d55-0b89-4768-9ede-81e391af783c" xlink:to="loc_us-gaap_CommonStockSharesIssued_47673ef8-d443-4712-8478-d9b966b98050" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_fa1a1d98-9165-4497-8ce4-4c2e53cad415" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0b813d55-0b89-4768-9ede-81e391af783c" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_fa1a1d98-9165-4497-8ce4-4c2e53cad415" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited" xlink:type="simple" xlink:href="var-20221230.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"/>
  <link:presentationLink xlink:role="http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_5b8f2838-9d9f-4da9-9832-0101e0abb8a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_fdceabb5-ebcb-4426-bf6f-535d47dd5933" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_5b8f2838-9d9f-4da9-9832-0101e0abb8a0" xlink:to="loc_us-gaap_StatementTable_fdceabb5-ebcb-4426-bf6f-535d47dd5933" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_e46932d9-8793-46ce-bdbf-da90ee1b02d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_fdceabb5-ebcb-4426-bf6f-535d47dd5933" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_e46932d9-8793-46ce-bdbf-da90ee1b02d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_dd677fb7-64f9-44a4-9d81-a1dce7f64914" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_e46932d9-8793-46ce-bdbf-da90ee1b02d8" xlink:to="loc_us-gaap_EquityComponentDomain_dd677fb7-64f9-44a4-9d81-a1dce7f64914" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_68cb615b-7568-428e-b387-c3a9547391e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ParentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_dd677fb7-64f9-44a4-9d81-a1dce7f64914" xlink:to="loc_us-gaap_ParentMember_68cb615b-7568-428e-b387-c3a9547391e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_77965864-c7ca-4eff-99fb-2b4dcfa75c59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_68cb615b-7568-428e-b387-c3a9547391e5" xlink:to="loc_us-gaap_CommonStockMember_77965864-c7ca-4eff-99fb-2b4dcfa75c59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_ce611bf0-fa01-4b01-bbf0-4b16298c2dc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_68cb615b-7568-428e-b387-c3a9547391e5" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_ce611bf0-fa01-4b01-bbf0-4b16298c2dc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_84bae6ef-737a-47a9-b103-357eb7215f60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_68cb615b-7568-428e-b387-c3a9547391e5" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_84bae6ef-737a-47a9-b103-357eb7215f60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_b4aefad2-3766-418e-9f0b-733005d5ceb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_68cb615b-7568-428e-b387-c3a9547391e5" xlink:to="loc_us-gaap_RetainedEarningsMember_b4aefad2-3766-418e-9f0b-733005d5ceb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_b42e37b8-74b9-4fda-9744-dde0ab6bb965" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_dd677fb7-64f9-44a4-9d81-a1dce7f64914" xlink:to="loc_us-gaap_NoncontrollingInterestMember_b42e37b8-74b9-4fda-9744-dde0ab6bb965" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_fa6a0c27-0882-4133-aa9f-77b0080075b9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_fdceabb5-ebcb-4426-bf6f-535d47dd5933" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_fa6a0c27-0882-4133-aa9f-77b0080075b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_39f9127e-81c7-4356-bdd0-92b255db457f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_fa6a0c27-0882-4133-aa9f-77b0080075b9" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_39f9127e-81c7-4356-bdd0-92b255db457f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_94db8443-0b41-4e26-88d9-8e24162129d1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_39f9127e-81c7-4356-bdd0-92b255db457f" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_94db8443-0b41-4e26-88d9-8e24162129d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_7cc21925-b466-43e8-8433-de702f484dbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_fdceabb5-ebcb-4426-bf6f-535d47dd5933" xlink:to="loc_us-gaap_StatementLineItems_7cc21925-b466-43e8-8433-de702f484dbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b8334716-55cc-45fb-8fe3-9507595b1461" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7cc21925-b466-43e8-8433-de702f484dbd" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b8334716-55cc-45fb-8fe3-9507595b1461" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_7119346a-6a67-4b10-a6a8-d7f2d3c5d729" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b8334716-55cc-45fb-8fe3-9507595b1461" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_7119346a-6a67-4b10-a6a8-d7f2d3c5d729" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a110d843-4781-418f-82d8-80c93105f074" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b8334716-55cc-45fb-8fe3-9507595b1461" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a110d843-4781-418f-82d8-80c93105f074" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_b24baf99-94b3-4e3b-a19b-0083d189405f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b8334716-55cc-45fb-8fe3-9507595b1461" xlink:to="loc_us-gaap_ProfitLoss_b24baf99-94b3-4e3b-a19b-0083d189405f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_416e70fb-b14a-4a32-92b4-7ff7eb1c3ed0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b8334716-55cc-45fb-8fe3-9507595b1461" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_416e70fb-b14a-4a32-92b4-7ff7eb1c3ed0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_c818c585-8a01-4e9e-85a3-b09f31c3145a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b8334716-55cc-45fb-8fe3-9507595b1461" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_c818c585-8a01-4e9e-85a3-b09f31c3145a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_22555fc6-0fa8-4567-a851-bbee4fc90b6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b8334716-55cc-45fb-8fe3-9507595b1461" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_22555fc6-0fa8-4567-a851-bbee4fc90b6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_92dd3e4b-7d6c-4d6a-8e77-6ad10bd5f1e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b8334716-55cc-45fb-8fe3-9507595b1461" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_92dd3e4b-7d6c-4d6a-8e77-6ad10bd5f1e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_f1cb0b91-a706-401e-bab8-7deeb408b409" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b8334716-55cc-45fb-8fe3-9507595b1461" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_f1cb0b91-a706-401e-bab8-7deeb408b409" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_fd9b7acc-42dc-414c-8cdc-8db8ecf60e3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b8334716-55cc-45fb-8fe3-9507595b1461" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_fd9b7acc-42dc-414c-8cdc-8db8ecf60e3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther_5a7c88f5-71e6-4cb9-9c16-374406ef35f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityOther"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b8334716-55cc-45fb-8fe3-9507595b1461" xlink:to="loc_us-gaap_StockholdersEquityOther_5a7c88f5-71e6-4cb9-9c16-374406ef35f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_01b46e53-9a15-4283-ae6f-08d2aa6f0050" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b8334716-55cc-45fb-8fe3-9507595b1461" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_01b46e53-9a15-4283-ae6f-08d2aa6f0050" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5c47b008-22d2-440e-a63d-b033a18607c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b8334716-55cc-45fb-8fe3-9507595b1461" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5c47b008-22d2-440e-a63d-b033a18607c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_b4c4f463-42b8-49eb-90db-0144da07548f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7cc21925-b466-43e8-8433-de702f484dbd" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_b4c4f463-42b8-49eb-90db-0144da07548f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" xlink:type="simple" xlink:href="var-20221230.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"/>
  <link:presentationLink xlink:role="http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_dcc98ae1-55d3-4e3e-a9d1-ff1629b0447c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_d4f83912-fc26-4321-8c43-21b7b49cdf4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_dcc98ae1-55d3-4e3e-a9d1-ff1629b0447c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_d4f83912-fc26-4321-8c43-21b7b49cdf4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_4c045e44-1e92-4f7a-b6c3-ded0ca65ce04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_d4f83912-fc26-4321-8c43-21b7b49cdf4c" xlink:to="loc_us-gaap_ProfitLoss_4c045e44-1e92-4f7a-b6c3-ded0ca65ce04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3d49b6b8-7067-4456-a18c-3460777ce864" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_d4f83912-fc26-4321-8c43-21b7b49cdf4c" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3d49b6b8-7067-4456-a18c-3460777ce864" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_aa8bba76-6874-4eb5-af08-0bcdbd1406fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3d49b6b8-7067-4456-a18c-3460777ce864" xlink:to="loc_us-gaap_ShareBasedCompensation_aa8bba76-6874-4eb5-af08-0bcdbd1406fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_06d864bf-b2d5-4895-a0b2-0f2f3c80ab8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3d49b6b8-7067-4456-a18c-3460777ce864" xlink:to="loc_us-gaap_Depreciation_06d864bf-b2d5-4895-a0b2-0f2f3c80ab8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_f084b1ee-c046-446a-8260-10bc07b53477" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3d49b6b8-7067-4456-a18c-3460777ce864" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_f084b1ee-c046-446a-8260-10bc07b53477" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_2a65ff97-29f7-4d77-83ec-5e60829b86f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3d49b6b8-7067-4456-a18c-3460777ce864" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_2a65ff97-29f7-4d77-83ec-5e60829b86f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_ebdf99ad-c5ec-44fd-bece-684e75c23b64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3d49b6b8-7067-4456-a18c-3460777ce864" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_ebdf99ad-c5ec-44fd-bece-684e75c23b64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDeferredLoanOriginationFeesNet_fcf08734-ffe2-4ec0-9822-b8fd357f8c0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfDeferredLoanOriginationFeesNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3d49b6b8-7067-4456-a18c-3460777ce864" xlink:to="loc_us-gaap_AmortizationOfDeferredLoanOriginationFeesNet_fcf08734-ffe2-4ec0-9822-b8fd357f8c0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_0eb0c614-f98b-4048-9df2-61ae4d699194" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWriteDown"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3d49b6b8-7067-4456-a18c-3460777ce864" xlink:to="loc_us-gaap_InventoryWriteDown_0eb0c614-f98b-4048-9df2-61ae4d699194" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnTerminationOfLease_d69a65a8-b70a-4322-af33-b9f25b59709d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnTerminationOfLease"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3d49b6b8-7067-4456-a18c-3460777ce864" xlink:to="loc_us-gaap_GainLossOnTerminationOfLease_d69a65a8-b70a-4322-af33-b9f25b59709d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_d2e51b51-040b-4aeb-ba54-c30610276530" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3d49b6b8-7067-4456-a18c-3460777ce864" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_d2e51b51-040b-4aeb-ba54-c30610276530" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_8ddec211-053d-4790-9b7b-09144488d629" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3d49b6b8-7067-4456-a18c-3460777ce864" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_8ddec211-053d-4790-9b7b-09144488d629" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_bb9b63df-89b0-4ef0-a8d4-11f7498a493d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_8ddec211-053d-4790-9b7b-09144488d629" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_bb9b63df-89b0-4ef0-a8d4-11f7498a493d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_c50ff453-6c48-40a1-86d0-998472345604" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_8ddec211-053d-4790-9b7b-09144488d629" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_c50ff453-6c48-40a1-86d0-998472345604" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_33d34559-fe21-4a7e-aa4a-f16eedb4bf78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_8ddec211-053d-4790-9b7b-09144488d629" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_33d34559-fe21-4a7e-aa4a-f16eedb4bf78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_cc5ccadb-c3d7-4ae1-b135-3f8a9652bf6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_8ddec211-053d-4790-9b7b-09144488d629" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_cc5ccadb-c3d7-4ae1-b135-3f8a9652bf6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_6425bc6e-9439-4da4-81cb-e7c7bdaf3372" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_8ddec211-053d-4790-9b7b-09144488d629" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_6425bc6e-9439-4da4-81cb-e7c7bdaf3372" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_9204bd1c-f804-4015-8ab6-c31bde01369a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_8ddec211-053d-4790-9b7b-09144488d629" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_9204bd1c-f804-4015-8ab6-c31bde01369a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6fea59dd-4402-44d2-9da2-bceb9619567b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_d4f83912-fc26-4321-8c43-21b7b49cdf4c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6fea59dd-4402-44d2-9da2-bceb9619567b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e64a8dc7-f154-43eb-a993-29fea67a7464" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_dcc98ae1-55d3-4e3e-a9d1-ff1629b0447c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e64a8dc7-f154-43eb-a993-29fea67a7464" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_7b60e504-c706-47a5-a1c7-f7571c3415e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e64a8dc7-f154-43eb-a993-29fea67a7464" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_7b60e504-c706-47a5-a1c7-f7571c3415e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_GainLossOnSettlementOfHedgeInvestingActivities_df2d4c56-84aa-4d6f-a4d8-925197eb1579" xlink:href="var-20221230.xsd#var_GainLossOnSettlementOfHedgeInvestingActivities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e64a8dc7-f154-43eb-a993-29fea67a7464" xlink:to="loc_var_GainLossOnSettlementOfHedgeInvestingActivities_df2d4c56-84aa-4d6f-a4d8-925197eb1579" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_459e1571-9e09-4d21-81e9-87cd85aae08b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e64a8dc7-f154-43eb-a993-29fea67a7464" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_459e1571-9e09-4d21-81e9-87cd85aae08b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_9f96b54d-5def-4088-8264-bd5c6ed60426" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e64a8dc7-f154-43eb-a993-29fea67a7464" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_9f96b54d-5def-4088-8264-bd5c6ed60426" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_5036a669-3fd6-4f82-a8b7-9b234fcd21b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e64a8dc7-f154-43eb-a993-29fea67a7464" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_5036a669-3fd6-4f82-a8b7-9b234fcd21b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromHedgeInvestingActivities_2e153152-c7e5-4ead-90c1-7ef8ca21cd3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromHedgeInvestingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e64a8dc7-f154-43eb-a993-29fea67a7464" xlink:to="loc_us-gaap_ProceedsFromHedgeInvestingActivities_2e153152-c7e5-4ead-90c1-7ef8ca21cd3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_ProceedsFromSalesOfBusinessAndAssets_b153b3b1-e68e-4044-9173-6ac897d8d64a" xlink:href="var-20221230.xsd#var_ProceedsFromSalesOfBusinessAndAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e64a8dc7-f154-43eb-a993-29fea67a7464" xlink:to="loc_var_ProceedsFromSalesOfBusinessAndAssets_b153b3b1-e68e-4044-9173-6ac897d8d64a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_63375bb6-266f-4199-83e7-05b4d4a04a49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e64a8dc7-f154-43eb-a993-29fea67a7464" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_63375bb6-266f-4199-83e7-05b4d4a04a49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ec15d629-1f80-4db1-8ec6-ff8eeffca0b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e64a8dc7-f154-43eb-a993-29fea67a7464" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ec15d629-1f80-4db1-8ec6-ff8eeffca0b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e0eac330-9fee-4e0b-800a-aad195915819" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_dcc98ae1-55d3-4e3e-a9d1-ff1629b0447c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e0eac330-9fee-4e0b-800a-aad195915819" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_7dd7594a-b7e0-41bf-9065-0a5a252567bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermLinesOfCredit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e0eac330-9fee-4e0b-800a-aad195915819" xlink:to="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_7dd7594a-b7e0-41bf-9065-0a5a252567bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_7ca5ff63-c006-48eb-9637-9be605e3a616" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e0eac330-9fee-4e0b-800a-aad195915819" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_7ca5ff63-c006-48eb-9637-9be605e3a616" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans_4d4ff291-43b0-4897-a6b4-bf76753484f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e0eac330-9fee-4e0b-800a-aad195915819" xlink:to="loc_us-gaap_ProceedsFromStockPlans_4d4ff291-43b0-4897-a6b4-bf76753484f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_6641c9d4-cad7-47cc-92a5-24ecefa10032" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e0eac330-9fee-4e0b-800a-aad195915819" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_6641c9d4-cad7-47cc-92a5-24ecefa10032" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7656bfc0-d9f3-477d-8c9d-d0e5824749f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e0eac330-9fee-4e0b-800a-aad195915819" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7656bfc0-d9f3-477d-8c9d-d0e5824749f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b0fa8975-bf71-4df7-a141-db7caeefc995" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_dcc98ae1-55d3-4e3e-a9d1-ff1629b0447c" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b0fa8975-bf71-4df7-a141-db7caeefc995" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6d166d07-19d4-4976-887f-b255c2a1ddf3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_dcc98ae1-55d3-4e3e-a9d1-ff1629b0447c" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6d166d07-19d4-4976-887f-b255c2a1ddf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b4c93aaf-52ba-4099-8a63-5a87ef265d4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_dcc98ae1-55d3-4e3e-a9d1-ff1629b0447c" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b4c93aaf-52ba-4099-8a63-5a87ef265d4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_bf667bf6-a226-4aea-9ab9-d9ffddafc9de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_dcc98ae1-55d3-4e3e-a9d1-ff1629b0447c" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_bf667bf6-a226-4aea-9ab9-d9ffddafc9de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_5437b487-e6fc-495b-829e-102153dbff37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_dcc98ae1-55d3-4e3e-a9d1-ff1629b0447c" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_5437b487-e6fc-495b-829e-102153dbff37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_5ee05dd8-1e9b-42fd-a887-d3247374be4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_5437b487-e6fc-495b-829e-102153dbff37" xlink:to="loc_us-gaap_InterestPaidNet_5ee05dd8-1e9b-42fd-a887-d3247374be4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_35c08df9-a88f-418b-8e01-a02dbd73ea65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_5437b487-e6fc-495b-829e-102153dbff37" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_35c08df9-a88f-418b-8e01-a02dbd73ea65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_1fb7ac36-ff59-4081-8a95-9ce513b51aff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_dcc98ae1-55d3-4e3e-a9d1-ff1629b0447c" xlink:to="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_1fb7ac36-ff59-4081-8a95-9ce513b51aff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfAssetsAcquired_51284ba4-6edd-48bc-b75d-391f5e3dd8bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfAssetsAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_1fb7ac36-ff59-4081-8a95-9ce513b51aff" xlink:to="loc_us-gaap_FairValueOfAssetsAcquired_51284ba4-6edd-48bc-b75d-391f5e3dd8bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="simple" xlink:href="var-20221230.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"/>
  <link:presentationLink xlink:role="http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_a35798a3-0e0b-4965-801e-4b4b204b26ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_a7ac39e6-c201-4a34-a849-baf38a1440fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a35798a3-0e0b-4965-801e-4b4b204b26ab" xlink:to="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_a7ac39e6-c201-4a34-a849-baf38a1440fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.varex.com/role/REVENUE" xlink:type="simple" xlink:href="var-20221230.xsd#REVENUE"/>
  <link:presentationLink xlink:role="http://www.varex.com/role/REVENUE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_3ac75196-98eb-4dfa-904b-827410e8fba1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_4f54f8ba-b3ee-4e42-9f61-a19ad668c5ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_3ac75196-98eb-4dfa-904b-827410e8fba1" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_4f54f8ba-b3ee-4e42-9f61-a19ad668c5ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.varex.com/role/LEASES" xlink:type="simple" xlink:href="var-20221230.xsd#LEASES"/>
  <link:presentationLink xlink:role="http://www.varex.com/role/LEASES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_0b46ee4e-1948-4c55-bb84-c3c1325a0594" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_a19cfd64-d38c-41e0-9d98-4ff270036a6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0b46ee4e-1948-4c55-bb84-c3c1325a0594" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_a19cfd64-d38c-41e0-9d98-4ff270036a6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock_2b2ea225-02e0-4622-9d6e-00abe96cf8f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0b46ee4e-1948-4c55-bb84-c3c1325a0594" xlink:to="loc_us-gaap_LesseeFinanceLeasesTextBlock_2b2ea225-02e0-4622-9d6e-00abe96cf8f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.varex.com/role/RELATEDPARTYTRANSACTIONS" xlink:type="simple" xlink:href="var-20221230.xsd#RELATEDPARTYTRANSACTIONS"/>
  <link:presentationLink xlink:role="http://www.varex.com/role/RELATEDPARTYTRANSACTIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_1f9dbeb7-a14a-41e7-970c-b27f495824fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_119b54a7-1528-485e-ba26-2064ce1a3876" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_1f9dbeb7-a14a-41e7-970c-b27f495824fd" xlink:to="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_119b54a7-1528-485e-ba26-2064ce1a3876" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.varex.com/role/RESTRUCTURING" xlink:type="simple" xlink:href="var-20221230.xsd#RESTRUCTURING"/>
  <link:presentationLink xlink:role="http://www.varex.com/role/RESTRUCTURING" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_b82d4d68-0dc7-46c6-9bca-2fa539d88261" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_2dd58d2b-ad8c-4513-ac8c-f3ae9be355a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_b82d4d68-0dc7-46c6-9bca-2fa539d88261" xlink:to="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_2dd58d2b-ad8c-4513-ac8c-f3ae9be355a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.varex.com/role/FINANCIALDERIVATIVESANDHEDGINGACTIVITIES" xlink:type="simple" xlink:href="var-20221230.xsd#FINANCIALDERIVATIVESANDHEDGINGACTIVITIES"/>
  <link:presentationLink xlink:role="http://www.varex.com/role/FINANCIALDERIVATIVESANDHEDGINGACTIVITIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_1cb77bce-ffbc-4760-898a-cf5a320557f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_b434795a-5b75-4026-8a8a-ec923ba8f9e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_1cb77bce-ffbc-4760-898a-cf5a320557f3" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_b434795a-5b75-4026-8a8a-ec923ba8f9e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.varex.com/role/FAIRVALUE" xlink:type="simple" xlink:href="var-20221230.xsd#FAIRVALUE"/>
  <link:presentationLink xlink:role="http://www.varex.com/role/FAIRVALUE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_34ae49f0-150d-450a-81d5-7835b7557428" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_de939fa9-f69e-4e42-b1f5-588e2009971e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_34ae49f0-150d-450a-81d5-7835b7557428" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_de939fa9-f69e-4e42-b1f5-588e2009971e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.varex.com/role/INVENTORIES" xlink:type="simple" xlink:href="var-20221230.xsd#INVENTORIES"/>
  <link:presentationLink xlink:role="http://www.varex.com/role/INVENTORIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_4fbfd62b-24c9-44d2-a9bc-5bbbbb7f6289" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock_d3f0407c-aa98-4eed-a7d6-e34f553fe439" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_4fbfd62b-24c9-44d2-a9bc-5bbbbb7f6289" xlink:to="loc_us-gaap_InventoryDisclosureTextBlock_d3f0407c-aa98-4eed-a7d6-e34f553fe439" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.varex.com/role/GOODWILLANDINTANGIBLEASSETS" xlink:type="simple" xlink:href="var-20221230.xsd#GOODWILLANDINTANGIBLEASSETS"/>
  <link:presentationLink xlink:role="http://www.varex.com/role/GOODWILLANDINTANGIBLEASSETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_fe90e8fe-c210-4a6e-a1ec-d0f8b02b1c01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_9e5d05a1-371b-4aaa-8240-bf82a40ba081" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_fe90e8fe-c210-4a6e-a1ec-d0f8b02b1c01" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_9e5d05a1-371b-4aaa-8240-bf82a40ba081" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.varex.com/role/BORROWINGS" xlink:type="simple" xlink:href="var-20221230.xsd#BORROWINGS"/>
  <link:presentationLink xlink:role="http://www.varex.com/role/BORROWINGS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_6390aca6-72d6-44fd-8a7e-faa8ced455c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_c1408343-336d-4b47-bb55-49e2bce1f68a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_6390aca6-72d6-44fd-8a7e-faa8ced455c9" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_c1408343-336d-4b47-bb55-49e2bce1f68a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.varex.com/role/NONCONTROLLINGINTERESTS" xlink:type="simple" xlink:href="var-20221230.xsd#NONCONTROLLINGINTERESTS"/>
  <link:presentationLink xlink:role="http://www.varex.com/role/NONCONTROLLINGINTERESTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestAbstract_d313b34a-0568-48b4-90b2-cea6746b75bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDisclosureTextBlock_bc401079-8f7f-4614-a69d-2b463cc11a0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestAbstract_d313b34a-0568-48b4-90b2-cea6746b75bd" xlink:to="loc_us-gaap_MinorityInterestDisclosureTextBlock_bc401079-8f7f-4614-a69d-2b463cc11a0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.varex.com/role/NETINCOMEPERSHARE" xlink:type="simple" xlink:href="var-20221230.xsd#NETINCOMEPERSHARE"/>
  <link:presentationLink xlink:role="http://www.varex.com/role/NETINCOMEPERSHARE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_8537b365-2cd5-495c-bd51-b06c80ccbf91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_486d46e6-0e6f-498a-8522-0597cae873f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_8537b365-2cd5-495c-bd51-b06c80ccbf91" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_486d46e6-0e6f-498a-8522-0597cae873f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.varex.com/role/EMPLOYEESTOCKPLANS" xlink:type="simple" xlink:href="var-20221230.xsd#EMPLOYEESTOCKPLANS"/>
  <link:presentationLink xlink:role="http://www.varex.com/role/EMPLOYEESTOCKPLANS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8b7e7886-2845-4492-971b-602a035e9e37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_568c0db6-a389-4085-99da-e8705fdbf3fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8b7e7886-2845-4492-971b-602a035e9e37" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_568c0db6-a389-4085-99da-e8705fdbf3fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.varex.com/role/TAXESONINCOME" xlink:type="simple" xlink:href="var-20221230.xsd#TAXESONINCOME"/>
  <link:presentationLink xlink:role="http://www.varex.com/role/TAXESONINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_95d73e33-825c-4eb6-9d19-68b7bc3a0837" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_6f593318-f186-4845-9851-e0047e52aa0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_95d73e33-825c-4eb6-9d19-68b7bc3a0837" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_6f593318-f186-4845-9851-e0047e52aa0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.varex.com/role/SEGMENTINFORMATION" xlink:type="simple" xlink:href="var-20221230.xsd#SEGMENTINFORMATION"/>
  <link:presentationLink xlink:role="http://www.varex.com/role/SEGMENTINFORMATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_cb910785-8ca0-4a32-94df-4bcf306fd9e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_b71d06bf-9796-441d-9b69-49985c667a2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_cb910785-8ca0-4a32-94df-4bcf306fd9e7" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_b71d06bf-9796-441d-9b69-49985c667a2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="simple" xlink:href="var-20221230.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"/>
  <link:presentationLink xlink:role="http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_2bd96778-fe2e-40e6-ad4e-f4908fcfba8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_e1527506-0abf-4ceb-99c9-01f3bc29a510" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2bd96778-fe2e-40e6-ad4e-f4908fcfba8e" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_e1527506-0abf-4ceb-99c9-01f3bc29a510" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_4fd327f8-8b3f-4978-ab1d-72a1b05c7f6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2bd96778-fe2e-40e6-ad4e-f4908fcfba8e" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_4fd327f8-8b3f-4978-ab1d-72a1b05c7f6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsPolicyPolicyTextBlock_8b37fd6f-bdaf-4d82-bcd3-3f2713655ae8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsPolicyPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2bd96778-fe2e-40e6-ad4e-f4908fcfba8e" xlink:to="loc_us-gaap_SubsequentEventsPolicyPolicyTextBlock_8b37fd6f-bdaf-4d82-bcd3-3f2713655ae8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_3f04eb06-7b6b-4060-9122-db1edad5f13f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2bd96778-fe2e-40e6-ad4e-f4908fcfba8e" xlink:to="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_3f04eb06-7b6b-4060-9122-db1edad5f13f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_8bb4bab5-ead0-4383-9e10-b34c1c17c91d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2bd96778-fe2e-40e6-ad4e-f4908fcfba8e" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_8bb4bab5-ead0-4383-9e10-b34c1c17c91d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_20a568fa-f8bd-40b2-8261-57b7f52cfc8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2bd96778-fe2e-40e6-ad4e-f4908fcfba8e" xlink:to="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_20a568fa-f8bd-40b2-8261-57b7f52cfc8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiscalPeriod_54b6f618-6bb1-4e1d-8c7f-2238babda6ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiscalPeriod"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2bd96778-fe2e-40e6-ad4e-f4908fcfba8e" xlink:to="loc_us-gaap_FiscalPeriod_54b6f618-6bb1-4e1d-8c7f-2238babda6ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_dde59e7e-7441-4329-b586-88921cb30870" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2bd96778-fe2e-40e6-ad4e-f4908fcfba8e" xlink:to="loc_us-gaap_UseOfEstimates_dde59e7e-7441-4329-b586-88921cb30870" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_dbfc4852-ba8b-45c7-8069-00b3a2089b35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2bd96778-fe2e-40e6-ad4e-f4908fcfba8e" xlink:to="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_dbfc4852-ba8b-45c7-8069-00b3a2089b35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock_05d76e87-9478-4260-ad27-6f6b0db09dbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2bd96778-fe2e-40e6-ad4e-f4908fcfba8e" xlink:to="loc_us-gaap_InvestmentPolicyTextBlock_05d76e87-9478-4260-ad27-6f6b0db09dbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_4586ff0f-7460-49f7-8a8f-9175553e3ebd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2bd96778-fe2e-40e6-ad4e-f4908fcfba8e" xlink:to="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_4586ff0f-7460-49f7-8a8f-9175553e3ebd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyPolicy_0736ddd8-3e98-4b27-a538-114154849377" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StandardProductWarrantyPolicy"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2bd96778-fe2e-40e6-ad4e-f4908fcfba8e" xlink:to="loc_us-gaap_StandardProductWarrantyPolicy_0736ddd8-3e98-4b27-a538-114154849377" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_28c72354-8b35-4cc4-b191-4df216d0809b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2bd96778-fe2e-40e6-ad4e-f4908fcfba8e" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_28c72354-8b35-4cc4-b191-4df216d0809b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_d5bc46ff-c9d3-4c47-8429-6d0acbe61c9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2bd96778-fe2e-40e6-ad4e-f4908fcfba8e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_d5bc46ff-c9d3-4c47-8429-6d0acbe61c9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_42003d03-5c84-4a0b-aedd-45df3ec24031" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2bd96778-fe2e-40e6-ad4e-f4908fcfba8e" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_42003d03-5c84-4a0b-aedd-45df3ec24031" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="simple" xlink:href="var-20221230.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"/>
  <link:presentationLink xlink:role="http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_59cdf137-63c9-4334-b010-6e5c499a2aad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_96dfd8b3-d806-4c82-950d-6d03250f1435" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_59cdf137-63c9-4334-b010-6e5c499a2aad" xlink:to="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_96dfd8b3-d806-4c82-950d-6d03250f1435" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_b1b7620e-ff65-4b5b-92c1-0f5e13171359" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_59cdf137-63c9-4334-b010-6e5c499a2aad" xlink:to="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_b1b7620e-ff65-4b5b-92c1-0f5e13171359" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_b4cf3b45-00e4-4f69-8024-4787604ea01c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_59cdf137-63c9-4334-b010-6e5c499a2aad" xlink:to="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_b4cf3b45-00e4-4f69-8024-4787604ea01c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_6a478dbc-dbcb-482d-8c26-814a7face3d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_59cdf137-63c9-4334-b010-6e5c499a2aad" xlink:to="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_6a478dbc-dbcb-482d-8c26-814a7face3d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.varex.com/role/REVENUETables" xlink:type="simple" xlink:href="var-20221230.xsd#REVENUETables"/>
  <link:presentationLink xlink:role="http://www.varex.com/role/REVENUETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_8ac0c233-ea9c-4dbd-a0db-1338ff6f3b74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_bd49dbe5-8248-458e-a3a1-6703ff5d559e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_8ac0c233-ea9c-4dbd-a0db-1338ff6f3b74" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_bd49dbe5-8248-458e-a3a1-6703ff5d559e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_d2768796-f59a-49b3-984b-39fdd62769c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_8ac0c233-ea9c-4dbd-a0db-1338ff6f3b74" xlink:to="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_d2768796-f59a-49b3-984b-39fdd62769c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.varex.com/role/LEASESTables" xlink:type="simple" xlink:href="var-20221230.xsd#LEASESTables"/>
  <link:presentationLink xlink:role="http://www.varex.com/role/LEASESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_adadd2a7-57c2-47c1-9211-34558fe3c53e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_AssetsAndLiabilitiesLesseeTableTextBlock_5ec69cfa-dbf1-4a61-9e51-32cef50a8077" xlink:href="var-20221230.xsd#var_AssetsAndLiabilitiesLesseeTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_adadd2a7-57c2-47c1-9211-34558fe3c53e" xlink:to="loc_var_AssetsAndLiabilitiesLesseeTableTextBlock_5ec69cfa-dbf1-4a61-9e51-32cef50a8077" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_55faf520-d4f7-4eb8-8803-36b924c957fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_adadd2a7-57c2-47c1-9211-34558fe3c53e" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_55faf520-d4f7-4eb8-8803-36b924c957fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.varex.com/role/RESTRUCTURINGTables" xlink:type="simple" xlink:href="var-20221230.xsd#RESTRUCTURINGTables"/>
  <link:presentationLink xlink:role="http://www.varex.com/role/RESTRUCTURINGTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_b3187386-452e-4611-bb56-6558d41e20b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_4cbe0eaa-2c6a-4b83-bd26-516c086498ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_b3187386-452e-4611-bb56-6558d41e20b1" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_4cbe0eaa-2c6a-4b83-bd26-516c086498ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.varex.com/role/FINANCIALDERIVATIVESANDHEDGINGACTIVITIESTables" xlink:type="simple" xlink:href="var-20221230.xsd#FINANCIALDERIVATIVESANDHEDGINGACTIVITIESTables"/>
  <link:presentationLink xlink:role="http://www.varex.com/role/FINANCIALDERIVATIVESANDHEDGINGACTIVITIESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_1c8bb80f-72fe-4de7-984a-b2f997d99408" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_43c657d9-c6b9-4c9b-99a2-3973451f697c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_1c8bb80f-72fe-4de7-984a-b2f997d99408" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_43c657d9-c6b9-4c9b-99a2-3973451f697c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_ebb7b59e-31ea-46c5-9d49-712c2d5cf06c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_1c8bb80f-72fe-4de7-984a-b2f997d99408" xlink:to="loc_us-gaap_ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_ebb7b59e-31ea-46c5-9d49-712c2d5cf06c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.varex.com/role/FAIRVALUETables" xlink:type="simple" xlink:href="var-20221230.xsd#FAIRVALUETables"/>
  <link:presentationLink xlink:role="http://www.varex.com/role/FAIRVALUETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_094138ca-a872-4355-8b75-f4498f8c329b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_bc6e4592-da30-447c-aa6b-e5a9007ec84e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_094138ca-a872-4355-8b75-f4498f8c329b" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_bc6e4592-da30-447c-aa6b-e5a9007ec84e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_e4408c05-d928-4922-8dc1-09c1eac9ef73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_094138ca-a872-4355-8b75-f4498f8c329b" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_e4408c05-d928-4922-8dc1-09c1eac9ef73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestmentsTextBlock_7d08c918-7b71-4349-bc8b-1f978a54ab3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestmentsTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_094138ca-a872-4355-8b75-f4498f8c329b" xlink:to="loc_us-gaap_GainLossOnInvestmentsTextBlock_7d08c918-7b71-4349-bc8b-1f978a54ab3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesTextBlock_74514c88-8730-4801-8154-e3aaad38d2e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_094138ca-a872-4355-8b75-f4498f8c329b" xlink:to="loc_us-gaap_MarketableSecuritiesTextBlock_74514c88-8730-4801-8154-e3aaad38d2e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.varex.com/role/INVENTORIESTables" xlink:type="simple" xlink:href="var-20221230.xsd#INVENTORIESTables"/>
  <link:presentationLink xlink:role="http://www.varex.com/role/INVENTORIESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_18f0a778-490a-4ead-84e8-4fdadb8ec396" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_36c1df9e-eda3-4b6b-b04f-28dcdee6b4cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_18f0a778-490a-4ead-84e8-4fdadb8ec396" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_36c1df9e-eda3-4b6b-b04f-28dcdee6b4cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.varex.com/role/GOODWILLANDINTANGIBLEASSETSTables" xlink:type="simple" xlink:href="var-20221230.xsd#GOODWILLANDINTANGIBLEASSETSTables"/>
  <link:presentationLink xlink:role="http://www.varex.com/role/GOODWILLANDINTANGIBLEASSETSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_bd132d61-312a-417b-814c-f09f4b586927" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_dc416a10-c2cf-4944-9ec0-0bf2f127452e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_bd132d61-312a-417b-814c-f09f4b586927" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_dc416a10-c2cf-4944-9ec0-0bf2f127452e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_59add157-ccee-4425-8589-840ac5ee5462" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_bd132d61-312a-417b-814c-f09f4b586927" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_59add157-ccee-4425-8589-840ac5ee5462" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.varex.com/role/BORROWINGSTables" xlink:type="simple" xlink:href="var-20221230.xsd#BORROWINGSTables"/>
  <link:presentationLink xlink:role="http://www.varex.com/role/BORROWINGSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_aa2d7c27-2924-42b6-8b15-3089b6ab4006" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_56bc47e5-2863-43c2-a94b-c1afb4fc2ce6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_aa2d7c27-2924-42b6-8b15-3089b6ab4006" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_56bc47e5-2863-43c2-a94b-c1afb4fc2ce6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock_28a49ac8-dd93-4d17-8e86-ed321e6ab131" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_aa2d7c27-2924-42b6-8b15-3089b6ab4006" xlink:to="loc_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock_28a49ac8-dd93-4d17-8e86-ed321e6ab131" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.varex.com/role/NONCONTROLLINGINTERESTSTables" xlink:type="simple" xlink:href="var-20221230.xsd#NONCONTROLLINGINTERESTSTables"/>
  <link:presentationLink xlink:role="http://www.varex.com/role/NONCONTROLLINGINTERESTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestAbstract_8b440b9f-f5e7-4f6b-87e1-cb88ac94b9e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_NoncontrollingInterestTableTextBlock_06fc68aa-0456-4b7a-b010-3505abb46c79" xlink:href="var-20221230.xsd#var_NoncontrollingInterestTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestAbstract_8b440b9f-f5e7-4f6b-87e1-cb88ac94b9e4" xlink:to="loc_var_NoncontrollingInterestTableTextBlock_06fc68aa-0456-4b7a-b010-3505abb46c79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.varex.com/role/NETINCOMEPERSHARETables" xlink:type="simple" xlink:href="var-20221230.xsd#NETINCOMEPERSHARETables"/>
  <link:presentationLink xlink:role="http://www.varex.com/role/NETINCOMEPERSHARETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_1e21dc93-6f8e-4931-91eb-49ebe5f78792" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_a57c7ef3-1918-4a72-8498-6db0b0f9a78d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_1e21dc93-6f8e-4931-91eb-49ebe5f78792" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_a57c7ef3-1918-4a72-8498-6db0b0f9a78d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.varex.com/role/EMPLOYEESTOCKPLANSTables" xlink:type="simple" xlink:href="var-20221230.xsd#EMPLOYEESTOCKPLANSTables"/>
  <link:presentationLink xlink:role="http://www.varex.com/role/EMPLOYEESTOCKPLANSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4ba3bfd0-70f1-469b-bcf8-3b0208afa279" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_011b1ad1-108a-46b2-9b10-1385d0677f21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4ba3bfd0-70f1-469b-bcf8-3b0208afa279" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_011b1ad1-108a-46b2-9b10-1385d0677f21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_67fb8422-bb64-45f4-b5d3-a942f34626d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4ba3bfd0-70f1-469b-bcf8-3b0208afa279" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_67fb8422-bb64-45f4-b5d3-a942f34626d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_669854e1-c2d0-4535-9933-cb21f32d2d59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4ba3bfd0-70f1-469b-bcf8-3b0208afa279" xlink:to="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_669854e1-c2d0-4535-9933-cb21f32d2d59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.varex.com/role/SEGMENTINFORMATIONTables" xlink:type="simple" xlink:href="var-20221230.xsd#SEGMENTINFORMATIONTables"/>
  <link:presentationLink xlink:role="http://www.varex.com/role/SEGMENTINFORMATIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_694053af-2dd3-4118-9c0f-d8beeca6a0c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_0655d161-b4f8-4856-8758-937da6c78e15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_694053af-2dd3-4118-9c0f-d8beeca6a0c9" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_0655d161-b4f8-4856-8758-937da6c78e15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSegmentReportingDetails" xlink:type="simple" xlink:href="var-20221230.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSegmentReportingDetails"/>
  <link:presentationLink xlink:role="http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSegmentReportingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_e949d014-e112-4f5f-b207-b26ee8b856e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_34039f01-1e3c-45b4-9885-9dae165723aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e949d014-e112-4f5f-b207-b26ee8b856e1" xlink:to="loc_us-gaap_NumberOfOperatingSegments_34039f01-1e3c-45b4-9885-9dae165723aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESCashandCashEquivalentsandRestrictedCashDetails" xlink:type="simple" xlink:href="var-20221230.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESCashandCashEquivalentsandRestrictedCashDetails"/>
  <link:presentationLink xlink:role="http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESCashandCashEquivalentsandRestrictedCashDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_20d70971-9891-41e2-8aee-473eef2f1b66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_d220f7a6-bc28-4e05-b35d-4ed81fd36c80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_20d70971-9891-41e2-8aee-473eef2f1b66" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_d220f7a6-bc28-4e05-b35d-4ed81fd36c80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_03f279aa-4748-4731-8a71-906af40743ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCash"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_20d70971-9891-41e2-8aee-473eef2f1b66" xlink:to="loc_us-gaap_RestrictedCash_03f279aa-4748-4731-8a71-906af40743ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c8de2627-5cd4-42f2-a6b6-1a1be81fa6d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_20d70971-9891-41e2-8aee-473eef2f1b66" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c8de2627-5cd4-42f2-a6b6-1a1be81fa6d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESCustomerConcentrationRiskDetails" xlink:type="simple" xlink:href="var-20221230.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESCustomerConcentrationRiskDetails"/>
  <link:presentationLink xlink:role="http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESCustomerConcentrationRiskDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_757e9df7-1084-4543-be7d-dfe048abac8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_295a32c0-c992-4fbe-9d71-0edf35cadb17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_757e9df7-1084-4543-be7d-dfe048abac8d" xlink:to="loc_us-gaap_ConcentrationRiskTable_295a32c0-c992-4fbe-9d71-0edf35cadb17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_bcf26b29-3cdb-442a-bb62-2e605ebfee92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_295a32c0-c992-4fbe-9d71-0edf35cadb17" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_bcf26b29-3cdb-442a-bb62-2e605ebfee92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_3c6e7d87-d116-4a4f-ab4d-e213d4aa6686" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_bcf26b29-3cdb-442a-bb62-2e605ebfee92" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_3c6e7d87-d116-4a4f-ab4d-e213d4aa6686" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_0ede9f43-2ded-4f20-85b6-5ce0d190297e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_3c6e7d87-d116-4a4f-ab4d-e213d4aa6686" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_0ede9f43-2ded-4f20-85b6-5ce0d190297e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_b34a6404-8a9a-4135-b772-ccbe13cf14fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_295a32c0-c992-4fbe-9d71-0edf35cadb17" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_b34a6404-8a9a-4135-b772-ccbe13cf14fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_2471535f-34d7-4c75-8e0a-b9ce4326454a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_b34a6404-8a9a-4135-b772-ccbe13cf14fd" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_2471535f-34d7-4c75-8e0a-b9ce4326454a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember_03223fbb-d101-4e9c-89e5-71028dfc9264" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_2471535f-34d7-4c75-8e0a-b9ce4326454a" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerMember_03223fbb-d101-4e9c-89e5-71028dfc9264" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_ee2bf0c4-daf5-483b-bc63-43fac340e1fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_2471535f-34d7-4c75-8e0a-b9ce4326454a" xlink:to="loc_us-gaap_AccountsReceivableMember_ee2bf0c4-daf5-483b-bc63-43fac340e1fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_abbf2d67-f0fa-4c46-8264-3f215409e15c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_295a32c0-c992-4fbe-9d71-0edf35cadb17" xlink:to="loc_srt_MajorCustomersAxis_abbf2d67-f0fa-4c46-8264-3f215409e15c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_eab6cc40-1bb7-4d44-aed1-52e3db0135cf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_abbf2d67-f0fa-4c46-8264-3f215409e15c" xlink:to="loc_srt_NameOfMajorCustomerDomain_eab6cc40-1bb7-4d44-aed1-52e3db0135cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_CanonMedicalSystemsCorporationFormerlyToshibaMedicalSystemsMember_b07888e2-a353-43c4-b604-17f0c0a1706a" xlink:href="var-20221230.xsd#var_CanonMedicalSystemsCorporationFormerlyToshibaMedicalSystemsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_eab6cc40-1bb7-4d44-aed1-52e3db0135cf" xlink:to="loc_var_CanonMedicalSystemsCorporationFormerlyToshibaMedicalSystemsMember_b07888e2-a353-43c4-b604-17f0c0a1706a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_427c0021-5500-4706-8fc9-828971d4d695" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_295a32c0-c992-4fbe-9d71-0edf35cadb17" xlink:to="loc_us-gaap_ConcentrationRiskLineItems_427c0021-5500-4706-8fc9-828971d4d695" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_f2d1a4e4-a74d-4a03-915d-59fe71c5a707" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_427c0021-5500-4706-8fc9-828971d4d695" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_f2d1a4e4-a74d-4a03-915d-59fe71c5a707" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESInvestmentsDetails" xlink:type="simple" xlink:href="var-20221230.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESInvestmentsDetails"/>
  <link:presentationLink xlink:role="http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_63d2982f-992a-40b5-a009-feb10e84406d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_8e7ed67c-9291-4af6-8574-151a4bf8bac9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_63d2982f-992a-40b5-a009-feb10e84406d" xlink:to="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_8e7ed67c-9291-4af6-8574-151a4bf8bac9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss_f0b5aac6-b3c5-4c5f-8cb0-85accf261036" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_63d2982f-992a-40b5-a009-feb10e84406d" xlink:to="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss_f0b5aac6-b3c5-4c5f-8cb0-85accf261036" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESProductWarrantyDetails" xlink:type="simple" xlink:href="var-20221230.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESProductWarrantyDetails"/>
  <link:presentationLink xlink:role="http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESProductWarrantyDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_325f55fa-b403-4f4a-99db-b3d7b2821df5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyLiabilityTable_bb173035-706d-4543-8fdd-8444f61fc49b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductWarrantyLiabilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_325f55fa-b403-4f4a-99db-b3d7b2821df5" xlink:to="loc_us-gaap_ProductWarrantyLiabilityTable_bb173035-706d-4543-8fdd-8444f61fc49b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d93b43d1-19fc-4fbe-80a2-50170b62391e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductWarrantyLiabilityTable_bb173035-706d-4543-8fdd-8444f61fc49b" xlink:to="loc_srt_RangeAxis_d93b43d1-19fc-4fbe-80a2-50170b62391e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b538b371-c16d-440d-b603-0e30ac0597d7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_d93b43d1-19fc-4fbe-80a2-50170b62391e" xlink:to="loc_srt_RangeMember_b538b371-c16d-440d-b603-0e30ac0597d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_5958e6f5-3ff0-4474-aeb0-a4927ab79d01" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_b538b371-c16d-440d-b603-0e30ac0597d7" xlink:to="loc_srt_MinimumMember_5958e6f5-3ff0-4474-aeb0-a4927ab79d01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_33c5af32-8746-481f-a5b1-7c3c5421ea36" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_b538b371-c16d-440d-b603-0e30ac0597d7" xlink:to="loc_srt_MaximumMember_33c5af32-8746-481f-a5b1-7c3c5421ea36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyLiabilityLineItems_0bd87347-8e64-45a7-b8b4-fe06b1945310" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductWarrantyLiabilityLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductWarrantyLiabilityTable_bb173035-706d-4543-8fdd-8444f61fc49b" xlink:to="loc_us-gaap_ProductWarrantyLiabilityLineItems_0bd87347-8e64-45a7-b8b4-fe06b1945310" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_WarrantyTerm_8af8c02c-2fb9-48b7-bd93-5c6ffe6868f0" xlink:href="var-20221230.xsd#var_WarrantyTerm"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductWarrantyLiabilityLineItems_0bd87347-8e64-45a7-b8b4-fe06b1945310" xlink:to="loc_var_WarrantyTerm_8af8c02c-2fb9-48b7-bd93-5c6ffe6868f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_4a3827fd-5713-401f-a487-65f16c825451" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MovementInStandardProductWarrantyAccrualRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductWarrantyLiabilityLineItems_0bd87347-8e64-45a7-b8b4-fe06b1945310" xlink:to="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_4a3827fd-5713-401f-a487-65f16c825451" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrual_cd25ed03-ac40-47f3-8047-dae39703263c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StandardProductWarrantyAccrual"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_4a3827fd-5713-401f-a487-65f16c825451" xlink:to="loc_us-gaap_StandardProductWarrantyAccrual_cd25ed03-ac40-47f3-8047-dae39703263c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued_db506ce3-c287-4628-8ecb-0d672bdba793" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StandardProductWarrantyAccrualWarrantiesIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_4a3827fd-5713-401f-a487-65f16c825451" xlink:to="loc_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued_db506ce3-c287-4628-8ecb-0d672bdba793" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrualPayments_343aff53-ee50-4ee1-bb9a-758cbc76e5d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StandardProductWarrantyAccrualPayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_4a3827fd-5713-401f-a487-65f16c825451" xlink:to="loc_us-gaap_StandardProductWarrantyAccrualPayments_343aff53-ee50-4ee1-bb9a-758cbc76e5d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrual_418761bc-64ce-4ac8-a102-2fc5c291669b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StandardProductWarrantyAccrual"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_4a3827fd-5713-401f-a487-65f16c825451" xlink:to="loc_us-gaap_StandardProductWarrantyAccrual_418761bc-64ce-4ac8-a102-2fc5c291669b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRecentlyAdoptedAccountingStandardsDetails" xlink:type="simple" xlink:href="var-20221230.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRecentlyAdoptedAccountingStandardsDetails"/>
  <link:presentationLink xlink:role="http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRecentlyAdoptedAccountingStandardsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_868102de-f0a3-4403-bf05-897780687a19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_6fe42ba3-2875-435a-be1b-29132577d3a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_868102de-f0a3-4403-bf05-897780687a19" xlink:to="loc_us-gaap_DebtInstrumentTable_6fe42ba3-2875-435a-be1b-29132577d3a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_fbc8cae3-e0e3-4f93-a3d5-905e1f4c0de8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_6fe42ba3-2875-435a-be1b-29132577d3a6" xlink:to="loc_us-gaap_DebtInstrumentAxis_fbc8cae3-e0e3-4f93-a3d5-905e1f4c0de8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_04b54bc5-e292-4bbd-b1b9-f6fddd1b1916" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_fbc8cae3-e0e3-4f93-a3d5-905e1f4c0de8" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_04b54bc5-e292-4bbd-b1b9-f6fddd1b1916" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_ConvertibleNotesMember_34618b4c-5829-4f43-8510-f48209acc693" xlink:href="var-20221230.xsd#var_ConvertibleNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_04b54bc5-e292-4bbd-b1b9-f6fddd1b1916" xlink:to="loc_var_ConvertibleNotesMember_34618b4c-5829-4f43-8510-f48209acc693" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_30d961fa-a3ed-4ce2-91b9-b862e4967a8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_6fe42ba3-2875-435a-be1b-29132577d3a6" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_30d961fa-a3ed-4ce2-91b9-b862e4967a8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_bbc3134e-cc48-46a9-83bc-bbf103c69758" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_30d961fa-a3ed-4ce2-91b9-b862e4967a8b" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_bbc3134e-cc48-46a9-83bc-bbf103c69758" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_58bec2da-4e67-44a9-829f-978c53c38844" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_bbc3134e-cc48-46a9-83bc-bbf103c69758" xlink:to="loc_us-gaap_ConvertibleDebtMember_58bec2da-4e67-44a9-829f-978c53c38844" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_8243237f-3622-4c4f-9e6d-f1e3d729df1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_6fe42ba3-2875-435a-be1b-29132577d3a6" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_8243237f-3622-4c4f-9e6d-f1e3d729df1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_4f3feeb1-9179-4449-b9bf-64a89e7573b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_8243237f-3622-4c4f-9e6d-f1e3d729df1c" xlink:to="loc_us-gaap_TypeOfAdoptionMember_4f3feeb1-9179-4449-b9bf-64a89e7573b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202006Member_b87b9d62-fc6f-4915-8103-55d986531fc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate202006Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_4f3feeb1-9179-4449-b9bf-64a89e7573b7" xlink:to="loc_us-gaap_AccountingStandardsUpdate202006Member_b87b9d62-fc6f-4915-8103-55d986531fc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_9c726640-34b5-4dca-b927-ddc1e0f5eb14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_6fe42ba3-2875-435a-be1b-29132577d3a6" xlink:to="loc_us-gaap_DebtInstrumentLineItems_9c726640-34b5-4dca-b927-ddc1e0f5eb14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_dbe0be7c-12b2-4233-802a-ef66e8ff33cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9c726640-34b5-4dca-b927-ddc1e0f5eb14" xlink:to="loc_us-gaap_AdditionalPaidInCapital_dbe0be7c-12b2-4233-802a-ef66e8ff33cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_be7d339c-a539-4529-b1f5-3e801d429922" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9c726640-34b5-4dca-b927-ddc1e0f5eb14" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_be7d339c-a539-4529-b1f5-3e801d429922" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_b2fc8555-a729-49d3-957d-9ce8b5d03445" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9c726640-34b5-4dca-b927-ddc1e0f5eb14" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_b2fc8555-a729-49d3-957d-9ce8b5d03445" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_15ed22b4-3fe0-4d66-aba4-9c1a85add082" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9c726640-34b5-4dca-b927-ddc1e0f5eb14" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_15ed22b4-3fe0-4d66-aba4-9c1a85add082" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_9ac97037-ea10-43c4-9c50-e6069d0f01d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9c726640-34b5-4dca-b927-ddc1e0f5eb14" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_9ac97037-ea10-43c4-9c50-e6069d0f01d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.varex.com/role/REVENUEDisaggregationofRevenueDetails" xlink:type="simple" xlink:href="var-20221230.xsd#REVENUEDisaggregationofRevenueDetails"/>
  <link:presentationLink xlink:role="http://www.varex.com/role/REVENUEDisaggregationofRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_08a2db0c-076d-49fe-9180-03159584d301" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_e4f54849-0848-4c56-90c8-8242f33e9f55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_08a2db0c-076d-49fe-9180-03159584d301" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_e4f54849-0848-4c56-90c8-8242f33e9f55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_b8c1046e-8958-4486-98af-35f79d6b54c8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_e4f54849-0848-4c56-90c8-8242f33e9f55" xlink:to="loc_srt_StatementGeographicalAxis_b8c1046e-8958-4486-98af-35f79d6b54c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_3cb94f35-cb1a-4d5e-b4ed-6cb3877187b3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_b8c1046e-8958-4486-98af-35f79d6b54c8" xlink:to="loc_srt_SegmentGeographicalDomain_3cb94f35-cb1a-4d5e-b4ed-6cb3877187b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AmericasMember_84d23693-b4a8-4573-aab0-b3f3b50a0218" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AmericasMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_3cb94f35-cb1a-4d5e-b4ed-6cb3877187b3" xlink:to="loc_srt_AmericasMember_84d23693-b4a8-4573-aab0-b3f3b50a0218" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember_b1568733-eff5-4f7f-a215-121261b1e7fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EMEAMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_3cb94f35-cb1a-4d5e-b4ed-6cb3877187b3" xlink:to="loc_us-gaap_EMEAMember_b1568733-eff5-4f7f-a215-121261b1e7fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_341e89d9-8b77-4808-bd50-8fce594a460a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AsiaPacificMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_3cb94f35-cb1a-4d5e-b4ed-6cb3877187b3" xlink:to="loc_srt_AsiaPacificMember_341e89d9-8b77-4808-bd50-8fce594a460a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_6af4cddc-1cf5-4578-8391-1c3fd00b1aa8" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_3cb94f35-cb1a-4d5e-b4ed-6cb3877187b3" xlink:to="loc_country_US_6af4cddc-1cf5-4578-8391-1c3fd00b1aa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_5ef7f789-56db-4dcf-ae96-0ba7d6315207" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_e4f54849-0848-4c56-90c8-8242f33e9f55" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_5ef7f789-56db-4dcf-ae96-0ba7d6315207" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_26ed6eb9-595c-4b03-a7a2-1d9b41096d3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_5ef7f789-56db-4dcf-ae96-0ba7d6315207" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_26ed6eb9-595c-4b03-a7a2-1d9b41096d3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.varex.com/role/REVENUESummaryofContractAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="var-20221230.xsd#REVENUESummaryofContractAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.varex.com/role/REVENUESummaryofContractAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_527dd979-e9b1-4819-8c02-d68941e4dfc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInContractWithCustomerAssetAbstract_f2dcd488-4c0c-4171-843a-4c5cc03b885d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInContractWithCustomerAssetAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_527dd979-e9b1-4819-8c02-d68941e4dfc3" xlink:to="loc_us-gaap_ChangeInContractWithCustomerAssetAbstract_f2dcd488-4c0c-4171-843a-4c5cc03b885d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet_c04a7e36-1bb8-471f-bebe-98d36cf5a01c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInContractWithCustomerAssetAbstract_f2dcd488-4c0c-4171-843a-4c5cc03b885d" xlink:to="loc_us-gaap_ContractWithCustomerAssetNet_c04a7e36-1bb8-471f-bebe-98d36cf5a01c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetCreditLossExpense_b1ba2421-bea4-4fb8-a7a6-cd713b57e70f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetCreditLossExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInContractWithCustomerAssetAbstract_f2dcd488-4c0c-4171-843a-4c5cc03b885d" xlink:to="loc_us-gaap_ContractWithCustomerAssetCreditLossExpense_b1ba2421-bea4-4fb8-a7a6-cd713b57e70f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_ContractwithCustomerAssetShipments_a22ec65a-6d2f-4c7b-b6f1-abd3dfb5cbf6" xlink:href="var-20221230.xsd#var_ContractwithCustomerAssetShipments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInContractWithCustomerAssetAbstract_f2dcd488-4c0c-4171-843a-4c5cc03b885d" xlink:to="loc_var_ContractwithCustomerAssetShipments_a22ec65a-6d2f-4c7b-b6f1-abd3dfb5cbf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet_82ca3e4a-d163-46c9-b52e-f8847c0aa18e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInContractWithCustomerAssetAbstract_f2dcd488-4c0c-4171-843a-4c5cc03b885d" xlink:to="loc_us-gaap_ContractWithCustomerAssetNet_82ca3e4a-d163-46c9-b52e-f8847c0aa18e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_724c9094-b5f7-4867-b188-bdff228478e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInContractWithCustomerLiabilityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_527dd979-e9b1-4819-8c02-d68941e4dfc3" xlink:to="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_724c9094-b5f7-4867-b188-bdff228478e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerRefundLiability_80248bdb-9258-4d65-9a7b-e746833df8bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerRefundLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_724c9094-b5f7-4867-b188-bdff228478e1" xlink:to="loc_us-gaap_ContractWithCustomerRefundLiability_80248bdb-9258-4d65-9a7b-e746833df8bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_ContractWithCustomerRefundLiabilityAmountReleased_95e1b135-44c8-494f-844c-429335c40308" xlink:href="var-20221230.xsd#var_ContractWithCustomerRefundLiabilityAmountReleased"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_724c9094-b5f7-4867-b188-bdff228478e1" xlink:to="loc_var_ContractWithCustomerRefundLiabilityAmountReleased_95e1b135-44c8-494f-844c-429335c40308" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_ContractWithCustomerRefundLiabilityAdditions_a7aebb42-b6fd-48bf-9ccd-8b28c0e4bf04" xlink:href="var-20221230.xsd#var_ContractWithCustomerRefundLiabilityAdditions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_724c9094-b5f7-4867-b188-bdff228478e1" xlink:to="loc_var_ContractWithCustomerRefundLiabilityAdditions_a7aebb42-b6fd-48bf-9ccd-8b28c0e4bf04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerRefundLiability_5a80bc8f-6e9a-4e1b-ba3f-c5ee4f3a5c8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerRefundLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_724c9094-b5f7-4867-b188-bdff228478e1" xlink:to="loc_us-gaap_ContractWithCustomerRefundLiability_5a80bc8f-6e9a-4e1b-ba3f-c5ee4f3a5c8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_c0c8e70a-e5af-4c68-bc40-20603bfed267" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_527dd979-e9b1-4819-8c02-d68941e4dfc3" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_c0c8e70a-e5af-4c68-bc40-20603bfed267" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.varex.com/role/LEASESNarrativesDetails" xlink:type="simple" xlink:href="var-20221230.xsd#LEASESNarrativesDetails"/>
  <link:presentationLink xlink:role="http://www.varex.com/role/LEASESNarrativesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_7b537c53-5b70-4570-8943-9b3b0fa1008d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnTerminationOfLease_0d83b491-046f-40a9-a390-9e3af1f3ab24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnTerminationOfLease"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_7b537c53-5b70-4570-8943-9b3b0fa1008d" xlink:to="loc_us-gaap_GainLossOnTerminationOfLease_0d83b491-046f-40a9-a390-9e3af1f3ab24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.varex.com/role/LEASESScheduleofLeaseRightofUseAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="var-20221230.xsd#LEASESScheduleofLeaseRightofUseAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.varex.com/role/LEASESScheduleofLeaseRightofUseAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_1ac2251d-92bd-49f2-b1f4-93c42037bd60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_377459b3-bd3e-4534-89bd-359595687990" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1ac2251d-92bd-49f2-b1f4-93c42037bd60" xlink:to="loc_us-gaap_AssetsAbstract_377459b3-bd3e-4534-89bd-359595687990" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_daf4f496-cb29-4008-acf7-7217a09967b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_377459b3-bd3e-4534-89bd-359595687990" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_daf4f496-cb29-4008-acf7-7217a09967b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_a3e1f24f-1dbc-4f4d-bc71-4c36e01317ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_377459b3-bd3e-4534-89bd-359595687990" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_a3e1f24f-1dbc-4f4d-bc71-4c36e01317ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_cdf9cd51-34c9-4aa0-83d4-1f4ec52438f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1ac2251d-92bd-49f2-b1f4-93c42037bd60" xlink:to="loc_us-gaap_LiabilitiesAbstract_cdf9cd51-34c9-4aa0-83d4-1f4ec52438f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_a19d7375-b00b-47af-9cb4-2d0cb9a3040b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_cdf9cd51-34c9-4aa0-83d4-1f4ec52438f8" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_a19d7375-b00b-47af-9cb4-2d0cb9a3040b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_c73f475f-f527-4bcb-b1b6-4758ecaab056" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_cdf9cd51-34c9-4aa0-83d4-1f4ec52438f8" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_c73f475f-f527-4bcb-b1b6-4758ecaab056" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_9bd03cb0-6d34-4070-8bd6-125e8571c98b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_cdf9cd51-34c9-4aa0-83d4-1f4ec52438f8" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_9bd03cb0-6d34-4070-8bd6-125e8571c98b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_ac14981f-8d42-4e6a-9019-a09b2e1bc4c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_cdf9cd51-34c9-4aa0-83d4-1f4ec52438f8" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_ac14981f-8d42-4e6a-9019-a09b2e1bc4c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_cb35a1da-0d74-482c-a427-d493603b44be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1ac2251d-92bd-49f2-b1f4-93c42037bd60" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_cb35a1da-0d74-482c-a427-d493603b44be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_f1672cfe-999a-47f7-a09d-cfabd7b5fe42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1ac2251d-92bd-49f2-b1f4-93c42037bd60" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_f1672cfe-999a-47f7-a09d-cfabd7b5fe42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_de8b77ae-2bd8-476e-88c7-60ee24f7f199" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1ac2251d-92bd-49f2-b1f4-93c42037bd60" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_de8b77ae-2bd8-476e-88c7-60ee24f7f199" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.varex.com/role/LEASESScheduleofOperatingLeaseCostandSupplementalCashFlowInformationDetails" xlink:type="simple" xlink:href="var-20221230.xsd#LEASESScheduleofOperatingLeaseCostandSupplementalCashFlowInformationDetails"/>
  <link:presentationLink xlink:role="http://www.varex.com/role/LEASESScheduleofOperatingLeaseCostandSupplementalCashFlowInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_dd3f92b3-074c-46ba-8c38-7ecccbf2b6ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_84857ea2-db28-48c9-a75b-a6dd87c7a9ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_dd3f92b3-074c-46ba-8c38-7ecccbf2b6ee" xlink:to="loc_us-gaap_OperatingLeaseCost_84857ea2-db28-48c9-a75b-a6dd87c7a9ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_LeaseCostFinanceLeaseCosts_e63b1628-16de-4409-9bab-29a42a8bd5a6" xlink:href="var-20221230.xsd#var_LeaseCostFinanceLeaseCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_dd3f92b3-074c-46ba-8c38-7ecccbf2b6ee" xlink:to="loc_var_LeaseCostFinanceLeaseCosts_e63b1628-16de-4409-9bab-29a42a8bd5a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_34e088bd-d182-4a15-a8d9-d37686787e5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_dd3f92b3-074c-46ba-8c38-7ecccbf2b6ee" xlink:to="loc_us-gaap_OperatingLeasePayments_34e088bd-d182-4a15-a8d9-d37686787e5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_97a7261d-6917-45ec-9184-8b10f857f811" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_dd3f92b3-074c-46ba-8c38-7ecccbf2b6ee" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_97a7261d-6917-45ec-9184-8b10f857f811" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_CashPaidForOperatingAndFinanceLeases_3aa1f3f0-5a88-4645-ae41-2959e04abf3b" xlink:href="var-20221230.xsd#var_CashPaidForOperatingAndFinanceLeases"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_dd3f92b3-074c-46ba-8c38-7ecccbf2b6ee" xlink:to="loc_var_CashPaidForOperatingAndFinanceLeases_3aa1f3f0-5a88-4645-ae41-2959e04abf3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_e8234403-4097-4f96-ad1d-73c94cc5a743" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_dd3f92b3-074c-46ba-8c38-7ecccbf2b6ee" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_e8234403-4097-4f96-ad1d-73c94cc5a743" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.varex.com/role/RELATEDPARTYTRANSACTIONSInvestmentinPrivatelyHeldCompaniesDetails" xlink:type="simple" xlink:href="var-20221230.xsd#RELATEDPARTYTRANSACTIONSInvestmentinPrivatelyHeldCompaniesDetails"/>
  <link:presentationLink xlink:role="http://www.varex.com/role/RELATEDPARTYTRANSACTIONSInvestmentinPrivatelyHeldCompaniesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_42c54ee0-5928-45d9-811a-56a110636a99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_6c8143bf-d3cd-47d7-bc5e-0b87ce1a6c8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_42c54ee0-5928-45d9-811a-56a110636a99" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_6c8143bf-d3cd-47d7-bc5e-0b87ce1a6c8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_86a71025-f52d-459c-8ce7-d091b0ba7ee3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_6c8143bf-d3cd-47d7-bc5e-0b87ce1a6c8c" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_86a71025-f52d-459c-8ce7-d091b0ba7ee3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_ef2f5557-1a6f-4192-bcf3-dcb85081a94b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_86a71025-f52d-459c-8ce7-d091b0ba7ee3" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_ef2f5557-1a6f-4192-bcf3-dcb85081a94b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_DpiXHoldingMember_da877d4d-5591-41fd-b1e2-0e39b84a5824" xlink:href="var-20221230.xsd#var_DpiXHoldingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_ef2f5557-1a6f-4192-bcf3-dcb85081a94b" xlink:to="loc_var_DpiXHoldingMember_da877d4d-5591-41fd-b1e2-0e39b84a5824" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_VECImagingGmbHCo.KGMember_d4bdca03-c6a4-417b-a336-50a4622db4e0" xlink:href="var-20221230.xsd#var_VECImagingGmbHCo.KGMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_ef2f5557-1a6f-4192-bcf3-dcb85081a94b" xlink:to="loc_var_VECImagingGmbHCo.KGMember_d4bdca03-c6a4-417b-a336-50a4622db4e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_DpiXLLCMember_8da03881-6799-4235-ae61-be978db979e9" xlink:href="var-20221230.xsd#var_DpiXLLCMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_ef2f5557-1a6f-4192-bcf3-dcb85081a94b" xlink:to="loc_var_DpiXLLCMember_8da03881-6799-4235-ae61-be978db979e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_4c3da058-73a2-4dbb-8e16-e58963d4e1d0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_6c8143bf-d3cd-47d7-bc5e-0b87ce1a6c8c" xlink:to="loc_srt_OwnershipAxis_4c3da058-73a2-4dbb-8e16-e58963d4e1d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_b351ec11-bf44-44a9-bada-c45436fe24fe" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_4c3da058-73a2-4dbb-8e16-e58963d4e1d0" xlink:to="loc_srt_OwnershipDomain_b351ec11-bf44-44a9-bada-c45436fe24fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_DpiXLLCMember_4f99b243-bdf9-42d2-8ca0-eb2c843c3eb7" xlink:href="var-20221230.xsd#var_DpiXLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_b351ec11-bf44-44a9-bada-c45436fe24fe" xlink:to="loc_var_DpiXLLCMember_4f99b243-bdf9-42d2-8ca0-eb2c843c3eb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_DpiXHoldingMember_ae0fa668-2806-465c-88a5-656f2c4e7e02" xlink:href="var-20221230.xsd#var_DpiXHoldingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_b351ec11-bf44-44a9-bada-c45436fe24fe" xlink:to="loc_var_DpiXHoldingMember_ae0fa668-2806-465c-88a5-656f2c4e7e02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_571b1a19-fe75-4167-8a69-920a4f9de748" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_6c8143bf-d3cd-47d7-bc5e-0b87ce1a6c8c" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_571b1a19-fe75-4167-8a69-920a4f9de748" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_98db1c20-5875-4329-870a-0b7de9bbd256" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_571b1a19-fe75-4167-8a69-920a4f9de748" xlink:to="loc_us-gaap_RelatedPartyDomain_98db1c20-5875-4329-870a-0b7de9bbd256" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvesteeMember_c48ea87d-5777-4ee2-aa63-317077a1541c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvesteeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_98db1c20-5875-4329-870a-0b7de9bbd256" xlink:to="loc_us-gaap_EquityMethodInvesteeMember_c48ea87d-5777-4ee2-aa63-317077a1541c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_066fbe8b-e45b-4b1f-a2f0-f92f6e84fa33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_6c8143bf-d3cd-47d7-bc5e-0b87ce1a6c8c" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_066fbe8b-e45b-4b1f-a2f0-f92f6e84fa33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_fc6e843c-2bb9-4f35-b680-1bf6bbe5c1a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_066fbe8b-e45b-4b1f-a2f0-f92f6e84fa33" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_fc6e843c-2bb9-4f35-b680-1bf6bbe5c1a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_FixedCostCommitmentsMember_e3d4f742-a1c9-46fa-a062-560112f2ad4d" xlink:href="var-20221230.xsd#var_FixedCostCommitmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_fc6e843c-2bb9-4f35-b680-1bf6bbe5c1a0" xlink:to="loc_var_FixedCostCommitmentsMember_e3d4f742-a1c9-46fa-a062-560112f2ad4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_8e3003f4-7db9-44cd-b49a-c089ceaf90f6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_6c8143bf-d3cd-47d7-bc5e-0b87ce1a6c8c" xlink:to="loc_srt_StatementScenarioAxis_8e3003f4-7db9-44cd-b49a-c089ceaf90f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_bb21e53d-3737-4c42-8683-1e3e10d4de53" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_8e3003f4-7db9-44cd-b49a-c089ceaf90f6" xlink:to="loc_srt_ScenarioUnspecifiedDomain_bb21e53d-3737-4c42-8683-1e3e10d4de53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_80217ff3-77d6-4740-a7dd-1477b0a4cbaf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_bb21e53d-3737-4c42-8683-1e3e10d4de53" xlink:to="loc_srt_ScenarioForecastMember_80217ff3-77d6-4740-a7dd-1477b0a4cbaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_ebd5b9f5-1869-4c8a-be60-591f71ce9ed0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_6c8143bf-d3cd-47d7-bc5e-0b87ce1a6c8c" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_ebd5b9f5-1869-4c8a-be60-591f71ce9ed0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_ffabcd94-d4f8-454d-b0ef-4ad98390e2d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_ebd5b9f5-1869-4c8a-be60-591f71ce9ed0" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_ffabcd94-d4f8-454d-b0ef-4ad98390e2d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_464dc59f-90c1-4fd3-86de-f305dd62ef94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_ebd5b9f5-1869-4c8a-be60-591f71ce9ed0" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_464dc59f-90c1-4fd3-86de-f305dd62ef94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_53a695f8-e3f3-49ad-8d4d-a894d771b31b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_ebd5b9f5-1869-4c8a-be60-591f71ce9ed0" xlink:to="loc_us-gaap_EquityMethodInvestments_53a695f8-e3f3-49ad-8d4d-a894d771b31b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty_9bda4bcc-6594-4899-87f0-508c7cdbe6c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_ebd5b9f5-1869-4c8a-be60-591f71ce9ed0" xlink:to="loc_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty_9bda4bcc-6594-4899-87f0-508c7cdbe6c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent_2985a5af-4731-4dbd-8cd6-06d3029b7b3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_ebd5b9f5-1869-4c8a-be60-591f71ce9ed0" xlink:to="loc_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent_2985a5af-4731-4dbd-8cd6-06d3029b7b3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_PercentageOfManufacturingCapacity_b72165b3-3f29-4142-883c-333c95b53c2d" xlink:href="var-20221230.xsd#var_PercentageOfManufacturingCapacity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_ebd5b9f5-1869-4c8a-be60-591f71ce9ed0" xlink:to="loc_var_PercentageOfManufacturingCapacity_b72165b3-3f29-4142-883c-333c95b53c2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_PercentageOfFixedCosts_df5e21da-25c8-487a-aaab-a11460c23b51" xlink:href="var-20221230.xsd#var_PercentageOfFixedCosts"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_ebd5b9f5-1869-4c8a-be60-591f71ce9ed0" xlink:to="loc_var_PercentageOfFixedCosts_df5e21da-25c8-487a-aaab-a11460c23b51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_RelatedPartyTransactionApprovedPurchasesFromRelatedParty_73be8678-c95a-4151-9b1b-5232c436a702" xlink:href="var-20221230.xsd#var_RelatedPartyTransactionApprovedPurchasesFromRelatedParty"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_ebd5b9f5-1869-4c8a-be60-591f71ce9ed0" xlink:to="loc_var_RelatedPartyTransactionApprovedPurchasesFromRelatedParty_73be8678-c95a-4151-9b1b-5232c436a702" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent_8777bb08-248e-4de1-acb1-a262ec7d8a87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesCurrentAndNoncurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_ebd5b9f5-1869-4c8a-be60-591f71ce9ed0" xlink:to="loc_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent_8777bb08-248e-4de1-acb1-a262ec7d8a87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivables_82016cbd-c945-4ae4-a304-2c7729d2d7a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivables"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_ebd5b9f5-1869-4c8a-be60-591f71ce9ed0" xlink:to="loc_us-gaap_OtherReceivables_82016cbd-c945-4ae4-a304-2c7729d2d7a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.varex.com/role/RESTRUCTURINGSummaryofRestructuringCostIncurredDetails" xlink:type="simple" xlink:href="var-20221230.xsd#RESTRUCTURINGSummaryofRestructuringCostIncurredDetails"/>
  <link:presentationLink xlink:role="http://www.varex.com/role/RESTRUCTURINGSummaryofRestructuringCostIncurredDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_6ee69708-47f7-46f8-b254-87aaf90ef7cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetImpairmentCharges_271064d7-e455-4832-988e-ffd76a584e76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetImpairmentCharges"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_6ee69708-47f7-46f8-b254-87aaf90ef7cc" xlink:to="loc_us-gaap_OtherAssetImpairmentCharges_271064d7-e455-4832-988e-ffd76a584e76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.varex.com/role/FINANCIALDERIVATIVESANDHEDGINGACTIVITIESNarrativeDetails" xlink:type="simple" xlink:href="var-20221230.xsd#FINANCIALDERIVATIVESANDHEDGINGACTIVITIESNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.varex.com/role/FINANCIALDERIVATIVESANDHEDGINGACTIVITIESNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_09b23adc-08f2-4f29-a8a5-7f718d909d63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_DerivativeNumberOfInstrumentsTerminated_c86c4851-63d3-4665-a2a2-e37a305d54ca" xlink:href="var-20221230.xsd#var_DerivativeNumberOfInstrumentsTerminated"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_09b23adc-08f2-4f29-a8a5-7f718d909d63" xlink:to="loc_var_DerivativeNumberOfInstrumentsTerminated_c86c4851-63d3-4665-a2a2-e37a305d54ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCashReceivedOnHedge_276e7f3d-4fc3-4b97-b59f-0f496296be1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeCashReceivedOnHedge"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_09b23adc-08f2-4f29-a8a5-7f718d909d63" xlink:to="loc_us-gaap_DerivativeCashReceivedOnHedge_276e7f3d-4fc3-4b97-b59f-0f496296be1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.varex.com/role/FINANCIALDERIVATIVESANDHEDGINGACTIVITIESSummaryofDerivativeInstrumentsDetails" xlink:type="simple" xlink:href="var-20221230.xsd#FINANCIALDERIVATIVESANDHEDGINGACTIVITIESSummaryofDerivativeInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.varex.com/role/FINANCIALDERIVATIVESANDHEDGINGACTIVITIESSummaryofDerivativeInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_6d9b6e55-f2ac-4ba9-92f8-5b816ee3fd71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_1ff33744-f4a0-4676-a1d6-6ed04000792e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_6d9b6e55-f2ac-4ba9-92f8-5b816ee3fd71" xlink:to="loc_us-gaap_DerivativeTable_1ff33744-f4a0-4676-a1d6-6ed04000792e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_5b6bcee4-1bfe-44dc-a852-970a4047344c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_1ff33744-f4a0-4676-a1d6-6ed04000792e" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_5b6bcee4-1bfe-44dc-a852-970a4047344c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_24dfda7c-761a-45a1-850d-7a4b7bdfdc3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_5b6bcee4-1bfe-44dc-a852-970a4047344c" xlink:to="loc_us-gaap_HedgingRelationshipDomain_24dfda7c-761a-45a1-850d-7a4b7bdfdc3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_412f82fc-b587-44a6-ba0e-798c03cde081" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_24dfda7c-761a-45a1-850d-7a4b7bdfdc3b" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_412f82fc-b587-44a6-ba0e-798c03cde081" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_bccb1bf9-3ced-42a9-aa6b-70ac53a1dbc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_1ff33744-f4a0-4676-a1d6-6ed04000792e" xlink:to="loc_us-gaap_HedgingDesignationAxis_bccb1bf9-3ced-42a9-aa6b-70ac53a1dbc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_9c178681-4b3b-450e-bf6d-b5aa039b8e39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_bccb1bf9-3ced-42a9-aa6b-70ac53a1dbc5" xlink:to="loc_us-gaap_HedgingDesignationDomain_9c178681-4b3b-450e-bf6d-b5aa039b8e39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_0a3d3d07-3719-4d13-9afb-55300860edb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_9c178681-4b3b-450e-bf6d-b5aa039b8e39" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_0a3d3d07-3719-4d13-9afb-55300860edb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_db14e9f9-3c72-40cd-a5bd-6f0b393eb857" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_1ff33744-f4a0-4676-a1d6-6ed04000792e" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_db14e9f9-3c72-40cd-a5bd-6f0b393eb857" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_1169b616-f87b-4171-8f31-cbe4ac978185" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_db14e9f9-3c72-40cd-a5bd-6f0b393eb857" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_1169b616-f87b-4171-8f31-cbe4ac978185" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_883c0eb7-2293-4c44-b0d9-7758051318fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1169b616-f87b-4171-8f31-cbe4ac978185" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_883c0eb7-2293-4c44-b0d9-7758051318fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_e1cb58ed-e213-4ff7-aa09-c4abb6ecdf6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_1ff33744-f4a0-4676-a1d6-6ed04000792e" xlink:to="loc_us-gaap_DerivativeLineItems_e1cb58ed-e213-4ff7-aa09-c4abb6ecdf6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNumberOfInstrumentsHeld_6bc2b27f-b6e4-4d7c-8fde-d370c86693e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNumberOfInstrumentsHeld"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_e1cb58ed-e213-4ff7-aa09-c4abb6ecdf6a" xlink:to="loc_us-gaap_DerivativeNumberOfInstrumentsHeld_6bc2b27f-b6e4-4d7c-8fde-d370c86693e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_d9e322c1-8098-4625-91a7-c08429bc3e88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_e1cb58ed-e213-4ff7-aa09-c4abb6ecdf6a" xlink:to="loc_us-gaap_DerivativeNotionalAmount_d9e322c1-8098-4625-91a7-c08429bc3e88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.varex.com/role/FINANCIALDERIVATIVESANDHEDGINGACTIVITIESSummaryofIncomeRecognizedFromDerivativeInstrumentsDetails" xlink:type="simple" xlink:href="var-20221230.xsd#FINANCIALDERIVATIVESANDHEDGINGACTIVITIESSummaryofIncomeRecognizedFromDerivativeInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.varex.com/role/FINANCIALDERIVATIVESANDHEDGINGACTIVITIESSummaryofIncomeRecognizedFromDerivativeInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_e2ac8020-277a-44a1-8d24-f7437f4f88a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_ea8f5663-9b8b-4dd2-acc4-cb93157041f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_e2ac8020-277a-44a1-8d24-f7437f4f88a1" xlink:to="loc_us-gaap_DerivativeTable_ea8f5663-9b8b-4dd2-acc4-cb93157041f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_5ab12210-3057-4c3e-a30e-2eb0aa73febd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_ea8f5663-9b8b-4dd2-acc4-cb93157041f0" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_5ab12210-3057-4c3e-a30e-2eb0aa73febd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_82de87e7-f420-441e-a00c-12d2f0ea6fba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_5ab12210-3057-4c3e-a30e-2eb0aa73febd" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_82de87e7-f420-441e-a00c-12d2f0ea6fba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_d8539adc-3281-469a-a89f-e90fd25f21ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_82de87e7-f420-441e-a00c-12d2f0ea6fba" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_d8539adc-3281-469a-a89f-e90fd25f21ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_911795a9-ef86-4cda-994b-bc395aee74a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_ea8f5663-9b8b-4dd2-acc4-cb93157041f0" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_911795a9-ef86-4cda-994b-bc395aee74a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_703b63bc-42da-4765-95c4-6a8034a2cdd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_911795a9-ef86-4cda-994b-bc395aee74a9" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_703b63bc-42da-4765-95c4-6a8034a2cdd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_768ed335-ab8b-4455-b22e-b325cc27af20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_703b63bc-42da-4765-95c4-6a8034a2cdd8" xlink:to="loc_us-gaap_InterestExpenseMember_768ed335-ab8b-4455-b22e-b325cc27af20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_9f8db69f-0709-4f2a-a4e1-0a52ee856d43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_ea8f5663-9b8b-4dd2-acc4-cb93157041f0" xlink:to="loc_us-gaap_DerivativeLineItems_9f8db69f-0709-4f2a-a4e1-0a52ee856d43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_1c3f80b8-93e8-445d-b957-0f48fab472d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_9f8db69f-0709-4f2a-a4e1-0a52ee856d43" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_1c3f80b8-93e8-445d-b957-0f48fab472d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_220460e2-0fdc-4349-a33f-4dfb581e9433" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_9f8db69f-0709-4f2a-a4e1-0a52ee856d43" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_220460e2-0fdc-4349-a33f-4dfb581e9433" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.varex.com/role/FINANCIALDERIVATIVESANDHEDGINGACTIVITIESSummaryofDerivativesatFairValueDetails" xlink:type="simple" xlink:href="var-20221230.xsd#FINANCIALDERIVATIVESANDHEDGINGACTIVITIESSummaryofDerivativesatFairValueDetails"/>
  <link:presentationLink xlink:role="http://www.varex.com/role/FINANCIALDERIVATIVESANDHEDGINGACTIVITIESSummaryofDerivativesatFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_e511dca3-cb23-4bd9-9070-47e6d2b95853" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_6e87a842-31fb-4938-b20a-a99b37aae9e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_e511dca3-cb23-4bd9-9070-47e6d2b95853" xlink:to="loc_us-gaap_DerivativeTable_6e87a842-31fb-4938-b20a-a99b37aae9e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_2a1dbddb-da3b-43fe-a46d-279810cf7351" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_6e87a842-31fb-4938-b20a-a99b37aae9e2" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_2a1dbddb-da3b-43fe-a46d-279810cf7351" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_4a95f3f4-b96a-4506-ae14-153532f57187" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_2a1dbddb-da3b-43fe-a46d-279810cf7351" xlink:to="loc_us-gaap_HedgingRelationshipDomain_4a95f3f4-b96a-4506-ae14-153532f57187" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_4d69aa44-055b-4169-ab10-284b2d8a623f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_4a95f3f4-b96a-4506-ae14-153532f57187" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_4d69aa44-055b-4169-ab10-284b2d8a623f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_55ecb2eb-e116-4c1b-8b76-0dbf2037285d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_6e87a842-31fb-4938-b20a-a99b37aae9e2" xlink:to="loc_us-gaap_HedgingDesignationAxis_55ecb2eb-e116-4c1b-8b76-0dbf2037285d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_b6c7e4f3-589c-461f-b6e5-0d65c240f822" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_55ecb2eb-e116-4c1b-8b76-0dbf2037285d" xlink:to="loc_us-gaap_HedgingDesignationDomain_b6c7e4f3-589c-461f-b6e5-0d65c240f822" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_b44a5dc5-4ad7-44df-8df2-197d515abde2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_b6c7e4f3-589c-461f-b6e5-0d65c240f822" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_b44a5dc5-4ad7-44df-8df2-197d515abde2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_71a8cea0-b1f2-4206-a9b5-5a07b6b50bae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_6e87a842-31fb-4938-b20a-a99b37aae9e2" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_71a8cea0-b1f2-4206-a9b5-5a07b6b50bae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_0a2731ed-31d0-44ae-b619-32010bb8e248" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_71a8cea0-b1f2-4206-a9b5-5a07b6b50bae" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_0a2731ed-31d0-44ae-b619-32010bb8e248" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentAssetsMember_fbd6b870-7704-40d1-a924-900014502a8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_0a2731ed-31d0-44ae-b619-32010bb8e248" xlink:to="loc_us-gaap_OtherCurrentAssetsMember_fbd6b870-7704-40d1-a924-900014502a8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_0fb0b223-9204-46ee-835b-d2a8044873e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_0a2731ed-31d0-44ae-b619-32010bb8e248" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_0fb0b223-9204-46ee-835b-d2a8044873e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_77cf4daf-3649-40d2-9d5c-eddaa952cbdc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_0a2731ed-31d0-44ae-b619-32010bb8e248" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_77cf4daf-3649-40d2-9d5c-eddaa952cbdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_bd1d460c-83e6-4673-8a3a-39709c746cd7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_6e87a842-31fb-4938-b20a-a99b37aae9e2" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_bd1d460c-83e6-4673-8a3a-39709c746cd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_8e4f8038-5bca-413a-90a6-bc7d5d11794a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_bd1d460c-83e6-4673-8a3a-39709c746cd7" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_8e4f8038-5bca-413a-90a6-bc7d5d11794a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_45589e92-31b0-4153-b9c4-20aa30e01040" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8e4f8038-5bca-413a-90a6-bc7d5d11794a" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_45589e92-31b0-4153-b9c4-20aa30e01040" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_640e8179-37a2-40f3-a70f-e1150ca9b100" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_6e87a842-31fb-4938-b20a-a99b37aae9e2" xlink:to="loc_us-gaap_DerivativeLineItems_640e8179-37a2-40f3-a70f-e1150ca9b100" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_bfe2dfe7-b7de-46d9-a979-105de353dc52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_640e8179-37a2-40f3-a70f-e1150ca9b100" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_bfe2dfe7-b7de-46d9-a979-105de353dc52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_e12ff28a-28ef-4546-b47b-cabc890b0aef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_640e8179-37a2-40f3-a70f-e1150ca9b100" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_e12ff28a-28ef-4546-b47b-cabc890b0aef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.varex.com/role/FAIRVALUENarrativeDetails" xlink:type="simple" xlink:href="var-20221230.xsd#FAIRVALUENarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.varex.com/role/FAIRVALUENarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_a7ae7ed2-7903-4e05-9d5a-20a3763c79bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6d38b0e3-78cd-4ebb-953b-ba9910c44a95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_a7ae7ed2-7903-4e05-9d5a-20a3763c79bc" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6d38b0e3-78cd-4ebb-953b-ba9910c44a95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_9d0429fc-be02-4de2-bd1c-334086e2530d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6d38b0e3-78cd-4ebb-953b-ba9910c44a95" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_9d0429fc-be02-4de2-bd1c-334086e2530d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_400b6cf3-4bea-45b3-b662-99634572c517" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_9d0429fc-be02-4de2-bd1c-334086e2530d" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_400b6cf3-4bea-45b3-b662-99634572c517" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_8d9d79da-6cab-4ab5-9ebc-08e0236075e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_400b6cf3-4bea-45b3-b662-99634572c517" xlink:to="loc_us-gaap_ConvertibleDebtMember_8d9d79da-6cab-4ab5-9ebc-08e0236075e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_3925f7b4-2e13-44e9-9e66-adde433e4d02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_400b6cf3-4bea-45b3-b662-99634572c517" xlink:to="loc_us-gaap_SecuredDebtMember_3925f7b4-2e13-44e9-9e66-adde433e4d02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_8712f2b4-c5aa-43ed-863f-e96e5ca17b2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6d38b0e3-78cd-4ebb-953b-ba9910c44a95" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_8712f2b4-c5aa-43ed-863f-e96e5ca17b2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b1c2bcd0-431a-4dac-b31b-f11dc5ae0dfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_8712f2b4-c5aa-43ed-863f-e96e5ca17b2e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b1c2bcd0-431a-4dac-b31b-f11dc5ae0dfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_9d444271-1e7c-4dba-baa7-664779c49a01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b1c2bcd0-431a-4dac-b31b-f11dc5ae0dfc" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_9d444271-1e7c-4dba-baa7-664779c49a01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a9a9bc1f-f20e-4a22-a97d-1ddaf0af5208" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6d38b0e3-78cd-4ebb-953b-ba9910c44a95" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a9a9bc1f-f20e-4a22-a97d-1ddaf0af5208" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue_43b6e7d9-ee77-49c7-98de-d363aa4095b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a9a9bc1f-f20e-4a22-a97d-1ddaf0af5208" xlink:to="loc_us-gaap_LongTermDebtFairValue_43b6e7d9-ee77-49c7-98de-d363aa4095b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.varex.com/role/FAIRVALUEScheduleofFairValueInputsDetails" xlink:type="simple" xlink:href="var-20221230.xsd#FAIRVALUEScheduleofFairValueInputsDetails"/>
  <link:presentationLink xlink:role="http://www.varex.com/role/FAIRVALUEScheduleofFairValueInputsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_95e03e97-7189-40a8-82ef-d4db43c4e85b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c4e811af-aaea-4b5c-a6a3-32fd64d9241d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_95e03e97-7189-40a8-82ef-d4db43c4e85b" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c4e811af-aaea-4b5c-a6a3-32fd64d9241d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_179bc423-fbfe-459a-b651-e40c14e805a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c4e811af-aaea-4b5c-a6a3-32fd64d9241d" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_179bc423-fbfe-459a-b651-e40c14e805a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_766c09b0-d31b-4f9d-b232-ba83b2333f72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_179bc423-fbfe-459a-b651-e40c14e805a3" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_766c09b0-d31b-4f9d-b232-ba83b2333f72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_c1ff1161-ad8e-4cd7-ac31-e5f17362caa7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_766c09b0-d31b-4f9d-b232-ba83b2333f72" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_c1ff1161-ad8e-4cd7-ac31-e5f17362caa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_57c8b432-8829-4453-b5db-6cbed3f49bba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_766c09b0-d31b-4f9d-b232-ba83b2333f72" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_57c8b432-8829-4453-b5db-6cbed3f49bba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_303416a9-4261-4266-93e7-ffa82c7f7a33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_766c09b0-d31b-4f9d-b232-ba83b2333f72" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_303416a9-4261-4266-93e7-ffa82c7f7a33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_61ebadc0-f5f1-48a9-9336-e7c20b1c4f87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c4e811af-aaea-4b5c-a6a3-32fd64d9241d" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_61ebadc0-f5f1-48a9-9336-e7c20b1c4f87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_ffe5abae-8aae-4aa2-b7c0-653ebdde2898" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_61ebadc0-f5f1-48a9-9336-e7c20b1c4f87" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_ffe5abae-8aae-4aa2-b7c0-653ebdde2898" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_b7664c4c-6dfb-45ba-b981-c123919a09c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_ffe5abae-8aae-4aa2-b7c0-653ebdde2898" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_b7664c4c-6dfb-45ba-b981-c123919a09c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6ed372ad-68d1-4996-a2b4-c79586f7758d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c4e811af-aaea-4b5c-a6a3-32fd64d9241d" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6ed372ad-68d1-4996-a2b4-c79586f7758d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_cb93e68b-cc10-4663-afee-4c81d6022438" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6ed372ad-68d1-4996-a2b4-c79586f7758d" xlink:to="loc_us-gaap_AssetsAbstract_cb93e68b-cc10-4663-afee-4c81d6022438" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsAtCarryingValue_95651282-bcf4-4002-9762-aeea4e009b61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_cb93e68b-cc10-4663-afee-4c81d6022438" xlink:to="loc_us-gaap_MoneyMarketFundsAtCarryingValue_95651282-bcf4-4002-9762-aeea4e009b61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_CommercialPaperReceivable_5d43b430-9e9a-4aae-b191-c49dda7e6628" xlink:href="var-20221230.xsd#var_CommercialPaperReceivable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_cb93e68b-cc10-4663-afee-4c81d6022438" xlink:to="loc_var_CommercialPaperReceivable_5d43b430-9e9a-4aae-b191-c49dda7e6628" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_CorporateBonds_015dc1fc-dbd7-4d30-8414-f9e316bcb109" xlink:href="var-20221230.xsd#var_CorporateBonds"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_cb93e68b-cc10-4663-afee-4c81d6022438" xlink:to="loc_var_CorporateBonds_015dc1fc-dbd7-4d30-8414-f9e316bcb109" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesSecuritiesAtCarryingValue_0e473a73-43f4-4e9a-b81a-09e333e2c78d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesSecuritiesAtCarryingValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_cb93e68b-cc10-4663-afee-4c81d6022438" xlink:to="loc_us-gaap_USGovernmentAgenciesSecuritiesAtCarryingValue_0e473a73-43f4-4e9a-b81a-09e333e2c78d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_6c12aef6-d895-46d0-a024-52b42a9ca7fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_cb93e68b-cc10-4663-afee-4c81d6022438" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_6c12aef6-d895-46d0-a024-52b42a9ca7fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_cb062ef4-ee14-4b09-8abc-89304c3b18a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_cb93e68b-cc10-4663-afee-4c81d6022438" xlink:to="loc_us-gaap_DerivativeAssets_cb062ef4-ee14-4b09-8abc-89304c3b18a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationPlanAssets_3ff525d1-4553-4284-b6a1-66c4f6cdb1f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationPlanAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_cb93e68b-cc10-4663-afee-4c81d6022438" xlink:to="loc_us-gaap_DeferredCompensationPlanAssets_3ff525d1-4553-4284-b6a1-66c4f6cdb1f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_595d8c5b-9927-440d-9176-19d7afd63fef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_cb93e68b-cc10-4663-afee-4c81d6022438" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_595d8c5b-9927-440d-9176-19d7afd63fef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_8cb605b7-e959-4690-acc8-6cbbfff37084" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_cb93e68b-cc10-4663-afee-4c81d6022438" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_8cb605b7-e959-4690-acc8-6cbbfff37084" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration_ea05d40e-e25e-400d-b0f4-d54dadd6de1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_cb93e68b-cc10-4663-afee-4c81d6022438" xlink:to="loc_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration_ea05d40e-e25e-400d-b0f4-d54dadd6de1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_62a4c27f-77de-4d00-a74e-582f19049d53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6ed372ad-68d1-4996-a2b4-c79586f7758d" xlink:to="loc_us-gaap_LiabilitiesAbstract_62a4c27f-77de-4d00-a74e-582f19049d53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_ed169c8c-0d7e-40f0-a46d-31b847ded714" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_62a4c27f-77de-4d00-a74e-582f19049d53" xlink:to="loc_us-gaap_DerivativeLiabilities_ed169c8c-0d7e-40f0-a46d-31b847ded714" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_db49f033-fef1-4a41-bf0a-83da353397a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_62a4c27f-77de-4d00-a74e-582f19049d53" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_db49f033-fef1-4a41-bf0a-83da353397a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration_7e75e491-ed7b-4028-a8db-b1fec24edb4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_62a4c27f-77de-4d00-a74e-582f19049d53" xlink:to="loc_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration_7e75e491-ed7b-4028-a8db-b1fec24edb4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.varex.com/role/FAIRVALUESummaryofMarketableSecuritiesDetails" xlink:type="simple" xlink:href="var-20221230.xsd#FAIRVALUESummaryofMarketableSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.varex.com/role/FAIRVALUESummaryofMarketableSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_6c99a142-881c-4fe6-aad2-08b8412d38d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareTable_5da94aaa-819d-4979-b05c-09b59ec8c216" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_6c99a142-881c-4fe6-aad2-08b8412d38d0" xlink:to="loc_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareTable_5da94aaa-819d-4979-b05c-09b59ec8c216" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_49386977-27b4-4489-af3a-59592724c95a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareTable_5da94aaa-819d-4979-b05c-09b59ec8c216" xlink:to="loc_us-gaap_InvestmentTypeAxis_49386977-27b4-4489-af3a-59592724c95a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_f3b79752-daf8-4efa-bdb2-9358d7f0f6e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_49386977-27b4-4489-af3a-59592724c95a" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_f3b79752-daf8-4efa-bdb2-9358d7f0f6e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_7d7c4064-6af2-477c-b886-629d1380c7f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_f3b79752-daf8-4efa-bdb2-9358d7f0f6e7" xlink:to="loc_us-gaap_CommercialPaperMember_7d7c4064-6af2-477c-b886-629d1380c7f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateBondSecuritiesMember_6cdaeb78-5cc1-4477-a1b3-e2bb061a88d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateBondSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_f3b79752-daf8-4efa-bdb2-9358d7f0f6e7" xlink:to="loc_us-gaap_CorporateBondSecuritiesMember_6cdaeb78-5cc1-4477-a1b3-e2bb061a88d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryBillSecuritiesMember_7f492bf8-1079-40dc-9347-ab0eec71b0a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasuryBillSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_f3b79752-daf8-4efa-bdb2-9358d7f0f6e7" xlink:to="loc_us-gaap_USTreasuryBillSecuritiesMember_7f492bf8-1079-40dc-9347-ab0eec71b0a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_d902fc45-08ed-4e05-8312-1129b502cb09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_f3b79752-daf8-4efa-bdb2-9358d7f0f6e7" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_d902fc45-08ed-4e05-8312-1129b502cb09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLineItems_79a3363d-b7be-45aa-9786-af1e86e2cdab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareTable_5da94aaa-819d-4979-b05c-09b59ec8c216" xlink:to="loc_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLineItems_79a3363d-b7be-45aa-9786-af1e86e2cdab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_MarketableSecuritiesAmortizedCost_1d8ab5a5-c0c8-4deb-bf16-472fba9306b7" xlink:href="var-20221230.xsd#var_MarketableSecuritiesAmortizedCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLineItems_79a3363d-b7be-45aa-9786-af1e86e2cdab" xlink:to="loc_var_MarketableSecuritiesAmortizedCost_1d8ab5a5-c0c8-4deb-bf16-472fba9306b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_9d22c00e-d58f-438d-907b-d889dc870407" xlink:href="var-20221230.xsd#var_MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLineItems_79a3363d-b7be-45aa-9786-af1e86e2cdab" xlink:to="loc_var_MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_9d22c00e-d58f-438d-907b-d889dc870407" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecurities_e78e2b44-6087-4437-83e8-5a9cd312f538" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLineItems_79a3363d-b7be-45aa-9786-af1e86e2cdab" xlink:to="loc_us-gaap_MarketableSecurities_e78e2b44-6087-4437-83e8-5a9cd312f538" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.varex.com/role/FAIRVALUEContractualMaturitiesofMarketableSecuritiesDetails" xlink:type="simple" xlink:href="var-20221230.xsd#FAIRVALUEContractualMaturitiesofMarketableSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.varex.com/role/FAIRVALUEContractualMaturitiesofMarketableSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_a5839958-b6db-4123-a867-c7347ba9f9bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisRollingMaturityAbstract_96c4c8c2-b2a4-471e-ac7c-b2366e5ea45f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisRollingMaturityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_a5839958-b6db-4123-a867-c7347ba9f9bc" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisRollingMaturityAbstract_96c4c8c2-b2a4-471e-ac7c-b2366e5ea45f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateRollingWithinOneYearAmortizedCost_ef30e362-56cc-4228-a781-21a7c924928d" xlink:href="var-20221230.xsd#var_MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateRollingWithinOneYearAmortizedCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisRollingMaturityAbstract_96c4c8c2-b2a4-471e-ac7c-b2366e5ea45f" xlink:to="loc_var_MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateRollingWithinOneYearAmortizedCost_ef30e362-56cc-4228-a781-21a7c924928d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateRollingAfterOneThroughFiveYearsAmortizedCost_c69bc5c8-65ed-43f0-8274-08d7e98e1e83" xlink:href="var-20221230.xsd#var_MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateRollingAfterOneThroughFiveYearsAmortizedCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisRollingMaturityAbstract_96c4c8c2-b2a4-471e-ac7c-b2366e5ea45f" xlink:to="loc_var_MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateRollingAfterOneThroughFiveYearsAmortizedCost_c69bc5c8-65ed-43f0-8274-08d7e98e1e83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_MarketableSecuritiesAmortizedCost_27b1b093-280c-4c30-82a6-4fb4def0f266" xlink:href="var-20221230.xsd#var_MarketableSecuritiesAmortizedCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisRollingMaturityAbstract_96c4c8c2-b2a4-471e-ac7c-b2366e5ea45f" xlink:to="loc_var_MarketableSecuritiesAmortizedCost_27b1b093-280c-4c30-82a6-4fb4def0f266" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_9cb0d971-2a06-43ec-aa38-1501c227daf0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_a5839958-b6db-4123-a867-c7347ba9f9bc" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_9cb0d971-2a06-43ec-aa38-1501c227daf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateYearOne_d58ecf0b-33ec-4bdd-a331-8a76a9cd03c1" xlink:href="var-20221230.xsd#var_MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateYearOne"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_9cb0d971-2a06-43ec-aa38-1501c227daf0" xlink:to="loc_var_MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateYearOne_d58ecf0b-33ec-4bdd-a331-8a76a9cd03c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughFive_36ae981b-4c2f-4954-8f76-1556955886ae" xlink:href="var-20221230.xsd#var_MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughFive"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_9cb0d971-2a06-43ec-aa38-1501c227daf0" xlink:to="loc_var_MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughFive_36ae981b-4c2f-4954-8f76-1556955886ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecurities_2de999ae-75a3-4be4-9587-bd5d4e94c294" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_9cb0d971-2a06-43ec-aa38-1501c227daf0" xlink:to="loc_us-gaap_MarketableSecurities_2de999ae-75a3-4be4-9587-bd5d4e94c294" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.varex.com/role/FAIRVALUEBalanceSheetMarketableSecuritiesDetails" xlink:type="simple" xlink:href="var-20221230.xsd#FAIRVALUEBalanceSheetMarketableSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.varex.com/role/FAIRVALUEBalanceSheetMarketableSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_f6850590-e58b-4513-9400-272503e44bba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable_cdc84b16-2b3b-4bb6-8301-ca37e4fa493a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_f6850590-e58b-4513-9400-272503e44bba" xlink:to="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable_cdc84b16-2b3b-4bb6-8301-ca37e4fa493a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_cd4c11a7-9ccd-4606-bdb2-df36c5f387e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable_cdc84b16-2b3b-4bb6-8301-ca37e4fa493a" xlink:to="loc_us-gaap_InvestmentTypeAxis_cd4c11a7-9ccd-4606-bdb2-df36c5f387e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_62e7b7c1-76ee-490e-b68e-aa8f3fd22eee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_cd4c11a7-9ccd-4606-bdb2-df36c5f387e3" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_62e7b7c1-76ee-490e-b68e-aa8f3fd22eee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_f31d3c03-1369-4aa7-b231-e3b46f75fa0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_62e7b7c1-76ee-490e-b68e-aa8f3fd22eee" xlink:to="loc_us-gaap_CommercialPaperMember_f31d3c03-1369-4aa7-b231-e3b46f75fa0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateBondSecuritiesMember_4ab100fb-ef40-48b7-9b43-fe1dcc3423d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateBondSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_62e7b7c1-76ee-490e-b68e-aa8f3fd22eee" xlink:to="loc_us-gaap_CorporateBondSecuritiesMember_4ab100fb-ef40-48b7-9b43-fe1dcc3423d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_44ef1d6d-43cf-4a59-b94a-f08167d371eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_62e7b7c1-76ee-490e-b68e-aa8f3fd22eee" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_44ef1d6d-43cf-4a59-b94a-f08167d371eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryBillSecuritiesMember_d57db479-1caf-4115-a9bd-6874dbce219c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasuryBillSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_62e7b7c1-76ee-490e-b68e-aa8f3fd22eee" xlink:to="loc_us-gaap_USTreasuryBillSecuritiesMember_d57db479-1caf-4115-a9bd-6874dbce219c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_fb58d6d9-e8bb-4398-9c4e-b449836734e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable_cdc84b16-2b3b-4bb6-8301-ca37e4fa493a" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_fb58d6d9-e8bb-4398-9c4e-b449836734e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_6c3ec1d1-190a-471b-ac83-427049eb0ef6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_fb58d6d9-e8bb-4398-9c4e-b449836734e8" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_6c3ec1d1-190a-471b-ac83-427049eb0ef6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_ba6621a1-0a2b-48a8-a0e8-c187df8c217e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_6c3ec1d1-190a-471b-ac83-427049eb0ef6" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_ba6621a1-0a2b-48a8-a0e8-c187df8c217e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_9f290868-512e-4538-bcb7-2725dc5f5e28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_6c3ec1d1-190a-471b-ac83-427049eb0ef6" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_9f290868-512e-4538-bcb7-2725dc5f5e28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_cfee797f-d7d8-4e7a-b783-fafeef8ac7d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_6c3ec1d1-190a-471b-ac83-427049eb0ef6" xlink:to="loc_us-gaap_OtherAssetsMember_cfee797f-d7d8-4e7a-b783-fafeef8ac7d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems_5de80d21-d31d-4b4f-b292-badc7ad760f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable_cdc84b16-2b3b-4bb6-8301-ca37e4fa493a" xlink:to="loc_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems_5de80d21-d31d-4b4f-b292-badc7ad760f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecurities_563bd780-44ed-4f21-9da8-c681e2467f59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems_5de80d21-d31d-4b4f-b292-badc7ad760f0" xlink:to="loc_us-gaap_MarketableSecurities_563bd780-44ed-4f21-9da8-c681e2467f59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.varex.com/role/INVENTORIESSummaryofInventoryDetails" xlink:type="simple" xlink:href="var-20221230.xsd#INVENTORIESSummaryofInventoryDetails"/>
  <link:presentationLink xlink:role="http://www.varex.com/role/INVENTORIESSummaryofInventoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_7d2d55af-dc2a-4669-9d35-5ac5efbd71dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_a8783b6a-a33d-459f-aad4-2ebf4f10594f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_7d2d55af-dc2a-4669-9d35-5ac5efbd71dc" xlink:to="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_a8783b6a-a33d-459f-aad4-2ebf4f10594f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_93d9c239-5f6a-4122-b8da-2a7149efc9f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_7d2d55af-dc2a-4669-9d35-5ac5efbd71dc" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_93d9c239-5f6a-4122-b8da-2a7149efc9f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_fce79f80-4d3f-4fad-9a85-30abe217f4d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_7d2d55af-dc2a-4669-9d35-5ac5efbd71dc" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_fce79f80-4d3f-4fad-9a85-30abe217f4d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_aa02558f-ab40-4b3f-b882-c6ede606f378" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_7d2d55af-dc2a-4669-9d35-5ac5efbd71dc" xlink:to="loc_us-gaap_InventoryNet_aa02558f-ab40-4b3f-b882-c6ede606f378" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.varex.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillRollforwardDetails" xlink:type="simple" xlink:href="var-20221230.xsd#GOODWILLANDINTANGIBLEASSETSGoodwillRollforwardDetails"/>
  <link:presentationLink xlink:role="http://www.varex.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillRollforwardDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0259337f-0064-4c88-9709-2181f699a52e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_2203cce4-1158-4ae3-ad21-f5c1bbbe3773" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0259337f-0064-4c88-9709-2181f699a52e" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_2203cce4-1158-4ae3-ad21-f5c1bbbe3773" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_e1fe7c28-ac29-47bb-87d1-dbf82bdab1c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_2203cce4-1158-4ae3-ad21-f5c1bbbe3773" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_e1fe7c28-ac29-47bb-87d1-dbf82bdab1c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_1b3d1114-2826-449f-b173-7177278f1744" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e1fe7c28-ac29-47bb-87d1-dbf82bdab1c2" xlink:to="loc_us-gaap_SegmentDomain_1b3d1114-2826-449f-b173-7177278f1744" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_MedicalMember_4fe37652-ed65-4d33-9a2b-285c307771c1" xlink:href="var-20221230.xsd#var_MedicalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_1b3d1114-2826-449f-b173-7177278f1744" xlink:to="loc_var_MedicalMember_4fe37652-ed65-4d33-9a2b-285c307771c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_IndustrialMember_910a5da7-07cd-420f-ab3a-8280f3bcb839" xlink:href="var-20221230.xsd#var_IndustrialMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_1b3d1114-2826-449f-b173-7177278f1744" xlink:to="loc_var_IndustrialMember_910a5da7-07cd-420f-ab3a-8280f3bcb839" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_36668931-b82e-46e9-b8f1-fb00cc3802ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_2203cce4-1158-4ae3-ad21-f5c1bbbe3773" xlink:to="loc_us-gaap_GoodwillLineItems_36668931-b82e-46e9-b8f1-fb00cc3802ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_cf79ec50-edad-4261-8883-e49b2f1b4aae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_36668931-b82e-46e9-b8f1-fb00cc3802ad" xlink:to="loc_us-gaap_GoodwillRollForward_cf79ec50-edad-4261-8883-e49b2f1b4aae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_ae518f64-978e-4a2a-aed4-b3244b1f51ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_cf79ec50-edad-4261-8883-e49b2f1b4aae" xlink:to="loc_us-gaap_Goodwill_ae518f64-978e-4a2a-aed4-b3244b1f51ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_2cf952e7-0628-4aa9-b883-46b90f609163" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_cf79ec50-edad-4261-8883-e49b2f1b4aae" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_2cf952e7-0628-4aa9-b883-46b90f609163" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_5cafcab4-0017-426c-9498-9682d77f3229" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_cf79ec50-edad-4261-8883-e49b2f1b4aae" xlink:to="loc_us-gaap_Goodwill_5cafcab4-0017-426c-9498-9682d77f3229" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.varex.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails" xlink:type="simple" xlink:href="var-20221230.xsd#GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.varex.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_74a23cc2-b561-40b4-b749-e5348c539641" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_a0668769-e900-49ba-a493-635114050854" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_74a23cc2-b561-40b4-b749-e5348c539641" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_a0668769-e900-49ba-a493-635114050854" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f483ffb6-088b-4d83-bec4-2e98fd8b97ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_a0668769-e900-49ba-a493-635114050854" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f483ffb6-088b-4d83-bec4-2e98fd8b97ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3d4c7bd3-f447-419e-bac5-ae223aadf86c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f483ffb6-088b-4d83-bec4-2e98fd8b97ad" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3d4c7bd3-f447-419e-bac5-ae223aadf86c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_082e24f6-c2b3-4882-ad41-96fc66f7f9fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3d4c7bd3-f447-419e-bac5-ae223aadf86c" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_082e24f6-c2b3-4882-ad41-96fc66f7f9fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntellectualPropertyMember_7230f891-5733-47df-a621-ecb5a9add167" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntellectualPropertyMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3d4c7bd3-f447-419e-bac5-ae223aadf86c" xlink:to="loc_us-gaap_IntellectualPropertyMember_7230f891-5733-47df-a621-ecb5a9add167" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_CustomerContractsandSupplierRelationshipsMember_1973ac71-5a0b-496c-98c0-c647a8df497b" xlink:href="var-20221230.xsd#var_CustomerContractsandSupplierRelationshipsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3d4c7bd3-f447-419e-bac5-ae223aadf86c" xlink:to="loc_var_CustomerContractsandSupplierRelationshipsMember_1973ac71-5a0b-496c-98c0-c647a8df497b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a1b06404-c9b3-443c-9f31-5ac2ecc8fcfd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_a0668769-e900-49ba-a493-635114050854" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a1b06404-c9b3-443c-9f31-5ac2ecc8fcfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_6567ac72-876e-4612-a7c3-4774a4eb678e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a1b06404-c9b3-443c-9f31-5ac2ecc8fcfd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_6567ac72-876e-4612-a7c3-4774a4eb678e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_ea08e58b-e6b1-4a9c-8c0a-2de59f650034" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a1b06404-c9b3-443c-9f31-5ac2ecc8fcfd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_ea08e58b-e6b1-4a9c-8c0a-2de59f650034" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_6fa114a7-8181-43c2-9170-c188f34168b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a1b06404-c9b3-443c-9f31-5ac2ecc8fcfd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_6fa114a7-8181-43c2-9170-c188f34168b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_a3a7182c-9a51-4451-b616-d5ec4aab3073" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a1b06404-c9b3-443c-9f31-5ac2ecc8fcfd" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_a3a7182c-9a51-4451-b616-d5ec4aab3073" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.varex.com/role/BORROWINGSScheduleofDebtDetails" xlink:type="simple" xlink:href="var-20221230.xsd#BORROWINGSScheduleofDebtDetails"/>
  <link:presentationLink xlink:role="http://www.varex.com/role/BORROWINGSScheduleofDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_c295edec-bb1f-4b03-986d-e9f7ca115259" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_61da7104-58c6-428e-bf00-ee9256492118" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_c295edec-bb1f-4b03-986d-e9f7ca115259" xlink:to="loc_us-gaap_DebtInstrumentTable_61da7104-58c6-428e-bf00-ee9256492118" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_8451ff26-47b8-42f6-8571-4158f3cc1807" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_61da7104-58c6-428e-bf00-ee9256492118" xlink:to="loc_us-gaap_DebtInstrumentAxis_8451ff26-47b8-42f6-8571-4158f3cc1807" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b3ba936d-e223-43d4-9a73-c232b5a41b28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_8451ff26-47b8-42f6-8571-4158f3cc1807" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b3ba936d-e223-43d4-9a73-c232b5a41b28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDebtSecuritiesMember_dca030e0-e759-4f98-941d-e77917735d16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b3ba936d-e223-43d4-9a73-c232b5a41b28" xlink:to="loc_us-gaap_OtherDebtSecuritiesMember_dca030e0-e759-4f98-941d-e77917735d16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_SeniorSecuredNotesMember_06b071ec-29e9-4070-9abb-ad78e6d9c461" xlink:href="var-20221230.xsd#var_SeniorSecuredNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b3ba936d-e223-43d4-9a73-c232b5a41b28" xlink:to="loc_var_SeniorSecuredNotesMember_06b071ec-29e9-4070-9abb-ad78e6d9c461" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_8a7485a1-e647-49d6-ace2-e58fbf07eb44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_61da7104-58c6-428e-bf00-ee9256492118" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_8a7485a1-e647-49d6-ace2-e58fbf07eb44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_813e8996-c1e3-4d43-8cc0-c62cc34e074c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_8a7485a1-e647-49d6-ace2-e58fbf07eb44" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_813e8996-c1e3-4d43-8cc0-c62cc34e074c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_cd064c42-ba56-403b-b533-73d04a1f7515" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_813e8996-c1e3-4d43-8cc0-c62cc34e074c" xlink:to="loc_us-gaap_ConvertibleDebtMember_cd064c42-ba56-403b-b533-73d04a1f7515" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_8ac0e9ce-4030-40cf-a886-d0ed2ff4c147" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_813e8996-c1e3-4d43-8cc0-c62cc34e074c" xlink:to="loc_us-gaap_SecuredDebtMember_8ac0e9ce-4030-40cf-a886-d0ed2ff4c147" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_17edd53a-77f1-4c46-a84a-40c8ed5a5dfb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_61da7104-58c6-428e-bf00-ee9256492118" xlink:to="loc_us-gaap_DebtInstrumentLineItems_17edd53a-77f1-4c46-a84a-40c8ed5a5dfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrentAbstract_6939fc81-42d4-4b0d-b767-3790d286f351" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_17edd53a-77f1-4c46-a84a-40c8ed5a5dfb" xlink:to="loc_us-gaap_LongTermDebtCurrentAbstract_6939fc81-42d4-4b0d-b767-3790d286f351" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_d21af215-31ec-4b45-96fd-0d27b72188b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtCurrentAbstract_6939fc81-42d4-4b0d-b767-3790d286f351" xlink:to="loc_us-gaap_LongTermDebtCurrent_d21af215-31ec-4b45-96fd-0d27b72188b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaturitiesOfLongTermDebtAbstract_9b8e5ad6-45f7-448e-af33-cd5a07b4d150" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaturitiesOfLongTermDebtAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_17edd53a-77f1-4c46-a84a-40c8ed5a5dfb" xlink:to="loc_us-gaap_MaturitiesOfLongTermDebtAbstract_9b8e5ad6-45f7-448e-af33-cd5a07b4d150" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_LongtermDebtExcludingCurrentMaturitiesGross_644ae8b2-a7d1-475a-95d6-a8df7acda986" xlink:href="var-20221230.xsd#var_LongtermDebtExcludingCurrentMaturitiesGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MaturitiesOfLongTermDebtAbstract_9b8e5ad6-45f7-448e-af33-cd5a07b4d150" xlink:to="loc_var_LongtermDebtExcludingCurrentMaturitiesGross_644ae8b2-a7d1-475a-95d6-a8df7acda986" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_bfef94ab-9713-46eb-82f8-4ce6441597e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MaturitiesOfLongTermDebtAbstract_9b8e5ad6-45f7-448e-af33-cd5a07b4d150" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_bfef94ab-9713-46eb-82f8-4ce6441597e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtWeightedAverageInterestRateOverTime_479f58df-5459-498d-b94f-06d518e68072" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtWeightedAverageInterestRateOverTime"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MaturitiesOfLongTermDebtAbstract_9b8e5ad6-45f7-448e-af33-cd5a07b4d150" xlink:to="loc_us-gaap_LongTermDebtWeightedAverageInterestRateOverTime_479f58df-5459-498d-b94f-06d518e68072" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNetAbstract_02eaf025-32b2-4879-beeb-28d512c0b105" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNetAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_17edd53a-77f1-4c46-a84a-40c8ed5a5dfb" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNetAbstract_02eaf025-32b2-4879-beeb-28d512c0b105" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_523e9348-4b80-419e-b763-5dd76b93ee41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNetAbstract_02eaf025-32b2-4879-beeb-28d512c0b105" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_523e9348-4b80-419e-b763-5dd76b93ee41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_e9c01a97-a3a9-4b5d-946f-bc8528789aff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNetAbstract_02eaf025-32b2-4879-beeb-28d512c0b105" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_e9c01a97-a3a9-4b5d-946f-bc8528789aff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_712e4163-baee-4e68-bae7-bd6b75c3b85e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNetAbstract_02eaf025-32b2-4879-beeb-28d512c0b105" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_712e4163-baee-4e68-bae7-bd6b75c3b85e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_5d6db931-8aa9-4051-8d64-6e968b7cb2a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_17edd53a-77f1-4c46-a84a-40c8ed5a5dfb" xlink:to="loc_us-gaap_LongTermDebt_5d6db931-8aa9-4051-8d64-6e968b7cb2a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_dffc3ffa-a4fc-4d49-bc01-3802a1346292" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_17edd53a-77f1-4c46-a84a-40c8ed5a5dfb" xlink:to="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_dffc3ffa-a4fc-4d49-bc01-3802a1346292" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.varex.com/role/BORROWINGSScheduleofInterestExpenseDetails" xlink:type="simple" xlink:href="var-20221230.xsd#BORROWINGSScheduleofInterestExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.varex.com/role/BORROWINGSScheduleofInterestExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_46cbb840-b4d0-45da-ac7e-e03bc66d8b6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_InterestExpenseDebtContractualInterestCoupon_3593ab5f-c040-4fd3-bbb1-e2f6c048e347" xlink:href="var-20221230.xsd#var_InterestExpenseDebtContractualInterestCoupon"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_46cbb840-b4d0-45da-ac7e-e03bc66d8b6e" xlink:to="loc_var_InterestExpenseDebtContractualInterestCoupon_3593ab5f-c040-4fd3-bbb1-e2f6c048e347" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_0a2cc91c-7c86-4196-834d-15d5b374929b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_46cbb840-b4d0-45da-ac7e-e03bc66d8b6e" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_0a2cc91c-7c86-4196-834d-15d5b374929b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_4ec6a8e5-d7f3-4e63-90f6-f5a81de2c1a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_46cbb840-b4d0-45da-ac7e-e03bc66d8b6e" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_4ec6a8e5-d7f3-4e63-90f6-f5a81de2c1a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_a920ae9c-c2e0-4248-b4f2-d1aa544b9498" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_46cbb840-b4d0-45da-ac7e-e03bc66d8b6e" xlink:to="loc_us-gaap_InterestExpense_a920ae9c-c2e0-4248-b4f2-d1aa544b9498" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.varex.com/role/BORROWINGSConvertibleSeniorUnsecuredNotesNarrativeDetails" xlink:type="simple" xlink:href="var-20221230.xsd#BORROWINGSConvertibleSeniorUnsecuredNotesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.varex.com/role/BORROWINGSConvertibleSeniorUnsecuredNotesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_e1653fce-228d-456a-b0f5-fdf336f7c82f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_5da3e60e-c297-4eb2-b216-5ded0e6a8db0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e1653fce-228d-456a-b0f5-fdf336f7c82f" xlink:to="loc_us-gaap_DebtInstrumentTable_5da3e60e-c297-4eb2-b216-5ded0e6a8db0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_bca8bfed-ba8f-46e4-ad09-03457faa9104" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_5da3e60e-c297-4eb2-b216-5ded0e6a8db0" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_bca8bfed-ba8f-46e4-ad09-03457faa9104" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_5afad2d2-d893-48d4-8b45-5563778c63e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_bca8bfed-ba8f-46e4-ad09-03457faa9104" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_5afad2d2-d893-48d4-8b45-5563778c63e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_dac277cb-0444-4f4d-aae3-1bc15805f92d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5afad2d2-d893-48d4-8b45-5563778c63e0" xlink:to="loc_us-gaap_ConvertibleDebtMember_dac277cb-0444-4f4d-aae3-1bc15805f92d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_46535224-b1ed-4ef8-b6f6-9894f05a7b25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_5da3e60e-c297-4eb2-b216-5ded0e6a8db0" xlink:to="loc_us-gaap_DebtInstrumentAxis_46535224-b1ed-4ef8-b6f6-9894f05a7b25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_016ee7d2-5d42-476e-994a-c655338c7b5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_46535224-b1ed-4ef8-b6f6-9894f05a7b25" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_016ee7d2-5d42-476e-994a-c655338c7b5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_ConvertibleNotesMember_350e5cca-2264-4bb9-a351-2f590894ac0a" xlink:href="var-20221230.xsd#var_ConvertibleNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_016ee7d2-5d42-476e-994a-c655338c7b5f" xlink:to="loc_var_ConvertibleNotesMember_350e5cca-2264-4bb9-a351-2f590894ac0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_37ba782c-62cc-47b1-98d9-7f039e0d4f30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_5da3e60e-c297-4eb2-b216-5ded0e6a8db0" xlink:to="loc_us-gaap_DebtInstrumentLineItems_37ba782c-62cc-47b1-98d9-7f039e0d4f30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_0b318419-f960-4ad3-9259-2a6b27585095" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_37ba782c-62cc-47b1-98d9-7f039e0d4f30" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_0b318419-f960-4ad3-9259-2a6b27585095" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_b3ac60b5-f509-4a70-86ce-ede5f86be1c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_37ba782c-62cc-47b1-98d9-7f039e0d4f30" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_b3ac60b5-f509-4a70-86ce-ede5f86be1c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_f7fe3f4b-cd41-4eeb-baca-eba38c13fc9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_37ba782c-62cc-47b1-98d9-7f039e0d4f30" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_f7fe3f4b-cd41-4eeb-baca-eba38c13fc9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_6e3289c6-963e-4c5f-8362-8f678900de97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_37ba782c-62cc-47b1-98d9-7f039e0d4f30" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_6e3289c6-963e-4c5f-8362-8f678900de97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_0106c5b1-10c2-4311-8944-222045cd6f9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_37ba782c-62cc-47b1-98d9-7f039e0d4f30" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_0106c5b1-10c2-4311-8944-222045cd6f9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments_cd8d983f-d46f-4623-8359-f24ef3327b55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_37ba782c-62cc-47b1-98d9-7f039e0d4f30" xlink:to="loc_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments_cd8d983f-d46f-4623-8359-f24ef3327b55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.varex.com/role/BORROWINGSCallSpreadNarrativeDetails" xlink:type="simple" xlink:href="var-20221230.xsd#BORROWINGSCallSpreadNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.varex.com/role/BORROWINGSCallSpreadNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_b036da49-a207-41d9-8502-40bb1e866166" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_8210ef5d-fe68-4c4d-80cc-7cff2969eb1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_b036da49-a207-41d9-8502-40bb1e866166" xlink:to="loc_us-gaap_DebtInstrumentTable_8210ef5d-fe68-4c4d-80cc-7cff2969eb1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_a92c97d3-e360-4b92-9a1c-aac26228ffc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_8210ef5d-fe68-4c4d-80cc-7cff2969eb1d" xlink:to="loc_us-gaap_DebtInstrumentAxis_a92c97d3-e360-4b92-9a1c-aac26228ffc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_6e53cabb-92ad-4857-96ac-ab489933056d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_a92c97d3-e360-4b92-9a1c-aac26228ffc4" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_6e53cabb-92ad-4857-96ac-ab489933056d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_ConvertibleNotesMember_edba21ab-eae1-42b6-805c-8b690e41b48f" xlink:href="var-20221230.xsd#var_ConvertibleNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e53cabb-92ad-4857-96ac-ab489933056d" xlink:to="loc_var_ConvertibleNotesMember_edba21ab-eae1-42b6-805c-8b690e41b48f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_d90afc10-7a41-4c91-9eff-cdf401f1c850" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_8210ef5d-fe68-4c4d-80cc-7cff2969eb1d" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_d90afc10-7a41-4c91-9eff-cdf401f1c850" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_5043fbbf-fac1-4bc2-9d25-7044cea93729" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d90afc10-7a41-4c91-9eff-cdf401f1c850" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_5043fbbf-fac1-4bc2-9d25-7044cea93729" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_e98a140b-01eb-4469-b627-5b6e8b5d5d51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5043fbbf-fac1-4bc2-9d25-7044cea93729" xlink:to="loc_us-gaap_ConvertibleDebtMember_e98a140b-01eb-4469-b627-5b6e8b5d5d51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_2d51cfe3-a68e-46cf-b768-198175d9c667" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_8210ef5d-fe68-4c4d-80cc-7cff2969eb1d" xlink:to="loc_us-gaap_DebtInstrumentLineItems_2d51cfe3-a68e-46cf-b768-198175d9c667" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_5c96c5c9-8481-4cd1-8ce0-19744c3e7a57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2d51cfe3-a68e-46cf-b768-198175d9c667" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_5c96c5c9-8481-4cd1-8ce0-19744c3e7a57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments_69b1fee2-364a-47d1-b945-585d37812a44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2d51cfe3-a68e-46cf-b768-198175d9c667" xlink:to="loc_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments_69b1fee2-364a-47d1-b945-585d37812a44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_d5f25f80-f19b-4983-8b34-2f1199a434a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2d51cfe3-a68e-46cf-b768-198175d9c667" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_d5f25f80-f19b-4983-8b34-2f1199a434a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_ClassOfWarrantOrRightPercentIncreaseOfStrikePriceOverSalePrice_23bee8bf-6885-485d-88e7-1102024c5751" xlink:href="var-20221230.xsd#var_ClassOfWarrantOrRightPercentIncreaseOfStrikePriceOverSalePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2d51cfe3-a68e-46cf-b768-198175d9c667" xlink:to="loc_var_ClassOfWarrantOrRightPercentIncreaseOfStrikePriceOverSalePrice_23bee8bf-6885-485d-88e7-1102024c5751" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.varex.com/role/BORROWINGSSeniorSecuredNotesNarrativeDetails" xlink:type="simple" xlink:href="var-20221230.xsd#BORROWINGSSeniorSecuredNotesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.varex.com/role/BORROWINGSSeniorSecuredNotesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_74a6bf2f-26f0-4ac9-833d-70f083d2bb92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_a24934c2-8943-4f28-a634-66bf20289906" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_74a6bf2f-26f0-4ac9-833d-70f083d2bb92" xlink:to="loc_us-gaap_DebtInstrumentTable_a24934c2-8943-4f28-a634-66bf20289906" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_a05269fd-f588-4535-ab94-361d8faf3e8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a24934c2-8943-4f28-a634-66bf20289906" xlink:to="loc_us-gaap_DebtInstrumentAxis_a05269fd-f588-4535-ab94-361d8faf3e8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c4f0f3a2-d4f1-481d-885e-457ae19aac4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_a05269fd-f588-4535-ab94-361d8faf3e8f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c4f0f3a2-d4f1-481d-885e-457ae19aac4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_SeniorSecuredNotesMember_ca4ee8a9-457d-4f43-9684-deafbb1dec05" xlink:href="var-20221230.xsd#var_SeniorSecuredNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c4f0f3a2-d4f1-481d-885e-457ae19aac4c" xlink:to="loc_var_SeniorSecuredNotesMember_ca4ee8a9-457d-4f43-9684-deafbb1dec05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_a96ec389-b2a1-41cc-8e8e-39738b2f2139" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a24934c2-8943-4f28-a634-66bf20289906" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_a96ec389-b2a1-41cc-8e8e-39738b2f2139" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_26d79947-6dd2-4853-b557-c354dc1d2389" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_a96ec389-b2a1-41cc-8e8e-39738b2f2139" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_26d79947-6dd2-4853-b557-c354dc1d2389" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_82ae1040-bffa-4a1f-bf9e-c6527f1fbe9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_26d79947-6dd2-4853-b557-c354dc1d2389" xlink:to="loc_us-gaap_SecuredDebtMember_82ae1040-bffa-4a1f-bf9e-c6527f1fbe9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_236f0bd4-9604-43f3-895b-d8aa3bae909a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a24934c2-8943-4f28-a634-66bf20289906" xlink:to="loc_us-gaap_DebtInstrumentLineItems_236f0bd4-9604-43f3-895b-d8aa3bae909a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_784eb663-71dd-420a-b9e9-b8d3d6537087" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_236f0bd4-9604-43f3-895b-d8aa3bae909a" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_784eb663-71dd-420a-b9e9-b8d3d6537087" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_22585f5f-cef5-45de-bf05-abe525b87840" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_236f0bd4-9604-43f3-895b-d8aa3bae909a" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_22585f5f-cef5-45de-bf05-abe525b87840" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.varex.com/role/BORROWINGSAssetBasedLoanNarrativeDetails" xlink:type="simple" xlink:href="var-20221230.xsd#BORROWINGSAssetBasedLoanNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.varex.com/role/BORROWINGSAssetBasedLoanNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_860eccba-9273-475c-8a04-3ae23e835484" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_75eb6f2a-687e-42bc-98dc-bdc04ee79cc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_860eccba-9273-475c-8a04-3ae23e835484" xlink:to="loc_us-gaap_DebtInstrumentTable_75eb6f2a-687e-42bc-98dc-bdc04ee79cc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_9fe9ac33-e2bf-48e1-b98a-4051d5edb98e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_75eb6f2a-687e-42bc-98dc-bdc04ee79cc6" xlink:to="loc_us-gaap_CreditFacilityAxis_9fe9ac33-e2bf-48e1-b98a-4051d5edb98e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_15624e26-9979-4319-af86-18a596652492" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_9fe9ac33-e2bf-48e1-b98a-4051d5edb98e" xlink:to="loc_us-gaap_CreditFacilityDomain_15624e26-9979-4319-af86-18a596652492" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_c6c82187-4384-44e2-a2c9-ab011994525a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_15624e26-9979-4319-af86-18a596652492" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_c6c82187-4384-44e2-a2c9-ab011994525a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_70eaa0cd-61db-4a65-b9da-18dc54479a7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_75eb6f2a-687e-42bc-98dc-bdc04ee79cc6" xlink:to="loc_us-gaap_DebtInstrumentAxis_70eaa0cd-61db-4a65-b9da-18dc54479a7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_60345bc0-019c-4253-9769-ca29bd8dfb11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_70eaa0cd-61db-4a65-b9da-18dc54479a7d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_60345bc0-019c-4253-9769-ca29bd8dfb11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_AssetBasedLoanRevolvingCreditFacilityMember_f85fc05a-1b23-45a1-9d02-a7640de2ea7e" xlink:href="var-20221230.xsd#var_AssetBasedLoanRevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_60345bc0-019c-4253-9769-ca29bd8dfb11" xlink:to="loc_var_AssetBasedLoanRevolvingCreditFacilityMember_f85fc05a-1b23-45a1-9d02-a7640de2ea7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_2441697d-6570-4f98-b3fa-f2a47c4b9701" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_75eb6f2a-687e-42bc-98dc-bdc04ee79cc6" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_2441697d-6570-4f98-b3fa-f2a47c4b9701" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_cb33b684-6861-4c11-b4f0-41c154d9f30c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_2441697d-6570-4f98-b3fa-f2a47c4b9701" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_cb33b684-6861-4c11-b4f0-41c154d9f30c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_0a84389f-9605-4138-8e05-99afbf3d49a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_cb33b684-6861-4c11-b4f0-41c154d9f30c" xlink:to="loc_us-gaap_SecuredDebtMember_0a84389f-9605-4138-8e05-99afbf3d49a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_6ad241a7-6729-4c8a-955a-993bd75fcfb0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_75eb6f2a-687e-42bc-98dc-bdc04ee79cc6" xlink:to="loc_srt_RangeAxis_6ad241a7-6729-4c8a-955a-993bd75fcfb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_9b287bc7-e49e-4b6e-a585-7ec2d4037d0c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_6ad241a7-6729-4c8a-955a-993bd75fcfb0" xlink:to="loc_srt_RangeMember_9b287bc7-e49e-4b6e-a585-7ec2d4037d0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_eba90597-8e56-4e01-b4de-8cadb2225a26" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_9b287bc7-e49e-4b6e-a585-7ec2d4037d0c" xlink:to="loc_srt_MinimumMember_eba90597-8e56-4e01-b4de-8cadb2225a26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_9265e434-b438-4b6c-9a60-6e3ba5095e0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_75eb6f2a-687e-42bc-98dc-bdc04ee79cc6" xlink:to="loc_us-gaap_DebtInstrumentLineItems_9265e434-b438-4b6c-9a60-6e3ba5095e0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_443bd879-be85-45cd-b669-daf1ff8ab5fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9265e434-b438-4b6c-9a60-6e3ba5095e0c" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_443bd879-be85-45cd-b669-daf1ff8ab5fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_50920123-e0df-478d-a4d9-ea02d407ccc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9265e434-b438-4b6c-9a60-6e3ba5095e0c" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_50920123-e0df-478d-a4d9-ea02d407ccc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_6079b52e-56f7-49e4-a8b3-14ac6e0ceda6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9265e434-b438-4b6c-9a60-6e3ba5095e0c" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_6079b52e-56f7-49e4-a8b3-14ac6e0ceda6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.varex.com/role/NONCONTROLLINGINTERESTSNoncontrollingInterestDetails" xlink:type="simple" xlink:href="var-20221230.xsd#NONCONTROLLINGINTERESTSNoncontrollingInterestDetails"/>
  <link:presentationLink xlink:role="http://www.varex.com/role/NONCONTROLLINGINTERESTSNoncontrollingInterestDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestAbstract_5f26cceb-09be-4d56-91e2-785a37755646" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable_6eadf4b8-8418-409c-91a9-58acfa4bc531" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestAbstract_5f26cceb-09be-4d56-91e2-785a37755646" xlink:to="loc_us-gaap_MinorityInterestTable_6eadf4b8-8418-409c-91a9-58acfa4bc531" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_edb2a226-d9ae-456e-bced-a5081db40789" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_6eadf4b8-8418-409c-91a9-58acfa4bc531" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_edb2a226-d9ae-456e-bced-a5081db40789" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_96332eca-45ba-4d98-89ea-cd16d9f69f85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_edb2a226-d9ae-456e-bced-a5081db40789" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_96332eca-45ba-4d98-89ea-cd16d9f69f85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_MeVisMedicalSolutionsAGMeVisMember_7e490a94-7193-4240-8300-2cacff917a5d" xlink:href="var-20221230.xsd#var_MeVisMedicalSolutionsAGMeVisMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_96332eca-45ba-4d98-89ea-cd16d9f69f85" xlink:to="loc_var_MeVisMedicalSolutionsAGMeVisMember_7e490a94-7193-4240-8300-2cacff917a5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_d480384d-7199-4ce5-bb0b-ca848c91bf38" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_6eadf4b8-8418-409c-91a9-58acfa4bc531" xlink:to="loc_srt_OwnershipAxis_d480384d-7199-4ce5-bb0b-ca848c91bf38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_9bd1f3ec-8b38-4604-921c-857343ca674a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_d480384d-7199-4ce5-bb0b-ca848c91bf38" xlink:to="loc_srt_OwnershipDomain_9bd1f3ec-8b38-4604-921c-857343ca674a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_JointVentureInSaudiArabiaMember_aa4769b8-f1e7-44ba-8f44-c8c9c842c543" xlink:href="var-20221230.xsd#var_JointVentureInSaudiArabiaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_9bd1f3ec-8b38-4604-921c-857343ca674a" xlink:to="loc_var_JointVentureInSaudiArabiaMember_aa4769b8-f1e7-44ba-8f44-c8c9c842c543" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_MeVisMedicalSolutionsAGMeVisMember_c13d11c2-42cc-4d6f-b948-a75944f17f01" xlink:href="var-20221230.xsd#var_MeVisMedicalSolutionsAGMeVisMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_9bd1f3ec-8b38-4604-921c-857343ca674a" xlink:to="loc_var_MeVisMedicalSolutionsAGMeVisMember_c13d11c2-42cc-4d6f-b948-a75944f17f01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems_1268a5b0-2b84-4893-b22f-3033b0ea12e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_6eadf4b8-8418-409c-91a9-58acfa4bc531" xlink:to="loc_us-gaap_MinorityInterestLineItems_1268a5b0-2b84-4893-b22f-3033b0ea12e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_78d82cd4-d306-485f-bd87-738307559380" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_1268a5b0-2b84-4893-b22f-3033b0ea12e2" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_78d82cd4-d306-485f-bd87-738307559380" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_e6b735a0-cdd4-445b-83c1-d62f90846040" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_1268a5b0-2b84-4893-b22f-3033b0ea12e2" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_e6b735a0-cdd4-445b-83c1-d62f90846040" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_9457cf48-857b-41b4-952f-a9d1463c20c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_1268a5b0-2b84-4893-b22f-3033b0ea12e2" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_9457cf48-857b-41b4-952f-a9d1463c20c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_PercentageOfAdditionalOutstandingSharesPurchased_081afa12-adf5-486e-8bb6-c472cfd5300d" xlink:href="var-20221230.xsd#var_PercentageOfAdditionalOutstandingSharesPurchased"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_1268a5b0-2b84-4893-b22f-3033b0ea12e2" xlink:to="loc_var_PercentageOfAdditionalOutstandingSharesPurchased_081afa12-adf5-486e-8bb6-c472cfd5300d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_BusinessAcquisitionCumulativePercentageOfVotingInterestsAcquired_daefc796-a53c-436a-b26e-6a2ab193ffe7" xlink:href="var-20221230.xsd#var_BusinessAcquisitionCumulativePercentageOfVotingInterestsAcquired"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_1268a5b0-2b84-4893-b22f-3033b0ea12e2" xlink:to="loc_var_BusinessAcquisitionCumulativePercentageOfVotingInterestsAcquired_daefc796-a53c-436a-b26e-6a2ab193ffe7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_BusinessAcquisitionAnnualRecurringCompensation_67340009-89d5-4a17-b6fe-74312b5a02fa" xlink:href="var-20221230.xsd#var_BusinessAcquisitionAnnualRecurringCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_1268a5b0-2b84-4893-b22f-3033b0ea12e2" xlink:to="loc_var_BusinessAcquisitionAnnualRecurringCompensation_67340009-89d5-4a17-b6fe-74312b5a02fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_1e8baf28-b6bc-4be8-bbba-0ae7ee86fd4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_1268a5b0-2b84-4893-b22f-3033b0ea12e2" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_1e8baf28-b6bc-4be8-bbba-0ae7ee86fd4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInMinorityInterestRollForward_8cc55572-22fc-4c8d-afd4-c0a0837cd456" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MovementInMinorityInterestRollForward"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_1268a5b0-2b84-4893-b22f-3033b0ea12e2" xlink:to="loc_us-gaap_MovementInMinorityInterestRollForward_8cc55572-22fc-4c8d-afd4-c0a0837cd456" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_e72ccf81-2d3d-48da-8865-6a4b2792f28c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_8cc55572-22fc-4c8d-afd4-c0a0837cd456" xlink:to="loc_us-gaap_MinorityInterest_e72ccf81-2d3d-48da-8865-6a4b2792f28c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_NetIncomeLossAttributableToNoncontrollingInterestNetOfDividends_a1f98b3c-9deb-4562-9f1b-30b78add746f" xlink:href="var-20221230.xsd#var_NetIncomeLossAttributableToNoncontrollingInterestNetOfDividends"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_8cc55572-22fc-4c8d-afd4-c0a0837cd456" xlink:to="loc_var_NetIncomeLossAttributableToNoncontrollingInterestNetOfDividends_a1f98b3c-9deb-4562-9f1b-30b78add746f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_NoncontrollingInterestOtherChanges_ef7945fd-80f4-4754-9d65-262ea4b38ee6" xlink:href="var-20221230.xsd#var_NoncontrollingInterestOtherChanges"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_8cc55572-22fc-4c8d-afd4-c0a0837cd456" xlink:to="loc_var_NoncontrollingInterestOtherChanges_ef7945fd-80f4-4754-9d65-262ea4b38ee6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_a2985cf6-7dae-49be-9a57-d8411d05f5bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_8cc55572-22fc-4c8d-afd4-c0a0837cd456" xlink:to="loc_us-gaap_MinorityInterest_a2985cf6-7dae-49be-9a57-d8411d05f5bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.varex.com/role/NETINCOMEPERSHAREReconciliationofNumeratorandDenominatorforBasicandDilutedNetLossIncomePerCommonShareDetails" xlink:type="simple" xlink:href="var-20221230.xsd#NETINCOMEPERSHAREReconciliationofNumeratorandDenominatorforBasicandDilutedNetLossIncomePerCommonShareDetails"/>
  <link:presentationLink xlink:role="http://www.varex.com/role/NETINCOMEPERSHAREReconciliationofNumeratorandDenominatorforBasicandDilutedNetLossIncomePerCommonShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_ffc03f27-da71-4467-b740-172ab3c610a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_f78d5f16-758b-45ed-b60f-b156110dd5d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_ffc03f27-da71-4467-b740-172ab3c610a9" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_f78d5f16-758b-45ed-b60f-b156110dd5d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_2ba5eb16-88c7-44a3-92fe-47b47b2f7ab3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_f78d5f16-758b-45ed-b60f-b156110dd5d7" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_2ba5eb16-88c7-44a3-92fe-47b47b2f7ab3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_6c0e24dc-c32c-4e71-b93b-aea22f416e5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_2ba5eb16-88c7-44a3-92fe-47b47b2f7ab3" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_6c0e24dc-c32c-4e71-b93b-aea22f416e5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_bae7bcf8-27e4-41d7-9fff-bbef0fb9c570" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_6c0e24dc-c32c-4e71-b93b-aea22f416e5e" xlink:to="loc_us-gaap_RestrictedStockMember_bae7bcf8-27e4-41d7-9fff-bbef0fb9c570" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtSecuritiesMember_bea0d51f-30cb-4b52-8d1e-709d4405a74a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_6c0e24dc-c32c-4e71-b93b-aea22f416e5e" xlink:to="loc_us-gaap_ConvertibleDebtSecuritiesMember_bea0d51f-30cb-4b52-8d1e-709d4405a74a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_8c4acd99-e6d4-4f77-9bff-303631ada62b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_6c0e24dc-c32c-4e71-b93b-aea22f416e5e" xlink:to="loc_us-gaap_WarrantMember_8c4acd99-e6d4-4f77-9bff-303631ada62b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_260508a3-c1d9-44e4-960c-0af50e2353b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_f78d5f16-758b-45ed-b60f-b156110dd5d7" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_260508a3-c1d9-44e4-960c-0af50e2353b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_3ea483cc-5279-4959-9718-3a57432adc87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_260508a3-c1d9-44e4-960c-0af50e2353b8" xlink:to="loc_us-gaap_NetIncomeLoss_3ea483cc-5279-4959-9718-3a57432adc87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_850a4573-f6f8-4476-a1e9-d6b0f852e73d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_260508a3-c1d9-44e4-960c-0af50e2353b8" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_850a4573-f6f8-4476-a1e9-d6b0f852e73d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_c60f884a-9888-4a81-a3f0-5fb73507fc0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_260508a3-c1d9-44e4-960c-0af50e2353b8" xlink:to="loc_us-gaap_EarningsPerShareBasic_c60f884a-9888-4a81-a3f0-5fb73507fc0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_6c5f84f4-aeae-49b7-b0df-b5875bbb312b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_260508a3-c1d9-44e4-960c-0af50e2353b8" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_6c5f84f4-aeae-49b7-b0df-b5875bbb312b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_f16a7414-04b3-4bf4-8756-b7544bf7cdd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_260508a3-c1d9-44e4-960c-0af50e2353b8" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_f16a7414-04b3-4bf4-8756-b7544bf7cdd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_5e98264d-c93d-4436-bddd-4cba5543ccdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_260508a3-c1d9-44e4-960c-0af50e2353b8" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_5e98264d-c93d-4436-bddd-4cba5543ccdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_IncrementalCommonSharesAttributableToDilutiveEffectOfWarrants_d653ca40-20f2-4a07-b92b-194e720299e1" xlink:href="var-20221230.xsd#var_IncrementalCommonSharesAttributableToDilutiveEffectOfWarrants"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_260508a3-c1d9-44e4-960c-0af50e2353b8" xlink:to="loc_var_IncrementalCommonSharesAttributableToDilutiveEffectOfWarrants_d653ca40-20f2-4a07-b92b-194e720299e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_178c9aac-6af8-40d7-b9a8-ae857074e7ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_260508a3-c1d9-44e4-960c-0af50e2353b8" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_178c9aac-6af8-40d7-b9a8-ae857074e7ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_d51f20db-3074-4280-a4c6-fd48faaa885b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_260508a3-c1d9-44e4-960c-0af50e2353b8" xlink:to="loc_us-gaap_EarningsPerShareDiluted_d51f20db-3074-4280-a4c6-fd48faaa885b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_60bd9bd8-c0ba-4678-8bf0-ef4272eb11f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_260508a3-c1d9-44e4-960c-0af50e2353b8" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_60bd9bd8-c0ba-4678-8bf0-ef4272eb11f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.varex.com/role/NETINCOMEPERSHARENarrativeDetails" xlink:type="simple" xlink:href="var-20221230.xsd#NETINCOMEPERSHARENarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.varex.com/role/NETINCOMEPERSHARENarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_c647f054-dd74-480c-aa6a-47ca50510ea2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_1268e78f-7332-425f-bb4a-0a0b963356cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_c647f054-dd74-480c-aa6a-47ca50510ea2" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_1268e78f-7332-425f-bb4a-0a0b963356cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_611c26fb-e5ed-480f-8d81-6f47c4bb10a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_1268e78f-7332-425f-bb4a-0a0b963356cc" xlink:to="loc_us-gaap_DebtInstrumentAxis_611c26fb-e5ed-480f-8d81-6f47c4bb10a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_3e860076-aeb9-419e-b40f-e34d962a0ad3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_611c26fb-e5ed-480f-8d81-6f47c4bb10a4" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_3e860076-aeb9-419e-b40f-e34d962a0ad3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_ConvertibleNotesMember_10270833-e3df-4830-a38c-dd2ec6ce9f70" xlink:href="var-20221230.xsd#var_ConvertibleNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3e860076-aeb9-419e-b40f-e34d962a0ad3" xlink:to="loc_var_ConvertibleNotesMember_10270833-e3df-4830-a38c-dd2ec6ce9f70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_9865fc64-7687-4b9b-ba90-1a5b6d755fb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_1268e78f-7332-425f-bb4a-0a0b963356cc" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_9865fc64-7687-4b9b-ba90-1a5b6d755fb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_efae15f3-094f-4d51-82c2-3742f188afd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_9865fc64-7687-4b9b-ba90-1a5b6d755fb1" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_efae15f3-094f-4d51-82c2-3742f188afd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_e5d63669-c085-444e-9279-11e369ae8fbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_efae15f3-094f-4d51-82c2-3742f188afd5" xlink:to="loc_us-gaap_ConvertibleDebtMember_e5d63669-c085-444e-9279-11e369ae8fbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_7f366828-95e7-4bdf-b91e-0393490ebd4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_1268e78f-7332-425f-bb4a-0a0b963356cc" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_7f366828-95e7-4bdf-b91e-0393490ebd4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments_2434d191-f95b-40d3-b145-a718b45333a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_7f366828-95e7-4bdf-b91e-0393490ebd4a" xlink:to="loc_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments_2434d191-f95b-40d3-b145-a718b45333a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.varex.com/role/EMPLOYEESTOCKPLANSSharebasedCompensationExpenseDetails" xlink:type="simple" xlink:href="var-20221230.xsd#EMPLOYEESTOCKPLANSSharebasedCompensationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.varex.com/role/EMPLOYEESTOCKPLANSSharebasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0b5af71e-800a-4281-8bd8-cbc9409b3b3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_2ee74b29-fe65-43f5-84d2-5a20b21743b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0b5af71e-800a-4281-8bd8-cbc9409b3b3e" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_2ee74b29-fe65-43f5-84d2-5a20b21743b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_10eb5214-d1fb-47d1-a78d-46f8dc197e08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_2ee74b29-fe65-43f5-84d2-5a20b21743b6" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_10eb5214-d1fb-47d1-a78d-46f8dc197e08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_d2474d7b-9213-4fc5-b1b8-b38a562dcc02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_10eb5214-d1fb-47d1-a78d-46f8dc197e08" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_d2474d7b-9213-4fc5-b1b8-b38a562dcc02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_92704c1e-b0a3-46a4-be9e-1ac2a340a811" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d2474d7b-9213-4fc5-b1b8-b38a562dcc02" xlink:to="loc_us-gaap_CostOfSalesMember_92704c1e-b0a3-46a4-be9e-1ac2a340a811" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_d292499b-48fa-4de8-872b-275af3e15d9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d2474d7b-9213-4fc5-b1b8-b38a562dcc02" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_d292499b-48fa-4de8-872b-275af3e15d9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_eea52948-1e7d-47dd-a928-0e46722f447f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d2474d7b-9213-4fc5-b1b8-b38a562dcc02" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_eea52948-1e7d-47dd-a928-0e46722f447f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_d870fda9-d901-4e08-a2a6-c969a8c8f7fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_2ee74b29-fe65-43f5-84d2-5a20b21743b6" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_d870fda9-d901-4e08-a2a6-c969a8c8f7fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_84ee6281-1ee6-4757-bd41-7398d03bdf23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_d870fda9-d901-4e08-a2a6-c969a8c8f7fd" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_84ee6281-1ee6-4757-bd41-7398d03bdf23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.varex.com/role/EMPLOYEESTOCKPLANSStockOptionActivityDetails" xlink:type="simple" xlink:href="var-20221230.xsd#EMPLOYEESTOCKPLANSStockOptionActivityDetails"/>
  <link:presentationLink xlink:role="http://www.varex.com/role/EMPLOYEESTOCKPLANSStockOptionActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e4631cde-cfcc-410b-a274-3ae71f7c39f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cbb982c3-8f2c-4b62-806f-f869e0cbe895" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e4631cde-cfcc-410b-a274-3ae71f7c39f8" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cbb982c3-8f2c-4b62-806f-f869e0cbe895" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_109c9e6f-7ca0-4e38-9640-8e8a2bab16a3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cbb982c3-8f2c-4b62-806f-f869e0cbe895" xlink:to="loc_srt_RangeAxis_109c9e6f-7ca0-4e38-9640-8e8a2bab16a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_098683a3-9a5c-4bab-a2e2-9a97efb7f7e7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_109c9e6f-7ca0-4e38-9640-8e8a2bab16a3" xlink:to="loc_srt_RangeMember_098683a3-9a5c-4bab-a2e2-9a97efb7f7e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_8d0c5328-346c-4d2f-b72e-0111ad625f54" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_098683a3-9a5c-4bab-a2e2-9a97efb7f7e7" xlink:to="loc_srt_MinimumMember_8d0c5328-346c-4d2f-b72e-0111ad625f54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_fafbe104-3655-487c-915f-47ee32d6e7a8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_098683a3-9a5c-4bab-a2e2-9a97efb7f7e7" xlink:to="loc_srt_MaximumMember_fafbe104-3655-487c-915f-47ee32d6e7a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e37c6e9b-f8f7-49bb-a506-21254efc62ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cbb982c3-8f2c-4b62-806f-f869e0cbe895" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e37c6e9b-f8f7-49bb-a506-21254efc62ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_05632c1a-41e2-435e-89cf-fc1b3a6647ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e37c6e9b-f8f7-49bb-a506-21254efc62ab" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_05632c1a-41e2-435e-89cf-fc1b3a6647ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_d59fff4c-6af0-4d32-b886-a2ac85e80a85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_05632c1a-41e2-435e-89cf-fc1b3a6647ed" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_d59fff4c-6af0-4d32-b886-a2ac85e80a85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_32d4942c-f2c6-419e-a6cc-ceec55876c8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_05632c1a-41e2-435e-89cf-fc1b3a6647ed" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_32d4942c-f2c6-419e-a6cc-ceec55876c8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_b7a06878-f2f4-4c65-a99d-b35e21961bf2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_05632c1a-41e2-435e-89cf-fc1b3a6647ed" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_b7a06878-f2f4-4c65-a99d-b35e21961bf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_74e6b3e0-b997-4e68-bb1f-a046fd1e1928" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_05632c1a-41e2-435e-89cf-fc1b3a6647ed" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_74e6b3e0-b997-4e68-bb1f-a046fd1e1928" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_d8c1f139-b130-445d-94fa-3115735b93a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e37c6e9b-f8f7-49bb-a506-21254efc62ab" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_d8c1f139-b130-445d-94fa-3115735b93a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_ExercisePriceRangeRollForward_d239d339-99be-45c2-aa04-1acb1ae72d49" xlink:href="var-20221230.xsd#var_ExercisePriceRangeRollForward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e37c6e9b-f8f7-49bb-a506-21254efc62ab" xlink:to="loc_var_ExercisePriceRangeRollForward_d239d339-99be-45c2-aa04-1acb1ae72d49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingPrice_c09e7322-c47b-4c49-93ab-de1037c52055" xlink:href="var-20221230.xsd#var_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingPrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_var_ExercisePriceRangeRollForward_d239d339-99be-45c2-aa04-1acb1ae72d49" xlink:to="loc_var_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingPrice_c09e7322-c47b-4c49-93ab-de1037c52055" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_SharebasedCompensationArrangementsbySharebasedPaymentAwardOptionsGrantsinPeriodPrice_1e92d656-3f6c-4999-8b12-7adf7c0cdd18" xlink:href="var-20221230.xsd#var_SharebasedCompensationArrangementsbySharebasedPaymentAwardOptionsGrantsinPeriodPrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_var_ExercisePriceRangeRollForward_d239d339-99be-45c2-aa04-1acb1ae72d49" xlink:to="loc_var_SharebasedCompensationArrangementsbySharebasedPaymentAwardOptionsGrantsinPeriodPrice_1e92d656-3f6c-4999-8b12-7adf7c0cdd18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsForfeituresandExpirationsinPeriodPrice_37409bb0-e17c-4ca7-946e-7fb4a0f3dbe8" xlink:href="var-20221230.xsd#var_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsForfeituresandExpirationsinPeriodPrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_var_ExercisePriceRangeRollForward_d239d339-99be-45c2-aa04-1acb1ae72d49" xlink:to="loc_var_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsForfeituresandExpirationsinPeriodPrice_37409bb0-e17c-4ca7-946e-7fb4a0f3dbe8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingPrice_77e9cb0d-e321-4adc-9380-15bde38fce19" xlink:href="var-20221230.xsd#var_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingPrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_var_ExercisePriceRangeRollForward_d239d339-99be-45c2-aa04-1acb1ae72d49" xlink:to="loc_var_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingPrice_77e9cb0d-e321-4adc-9380-15bde38fce19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisablePrice_60256ab6-6bc1-4771-b6d1-f8f4e87e2be8" xlink:href="var-20221230.xsd#var_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisablePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e37c6e9b-f8f7-49bb-a506-21254efc62ab" xlink:to="loc_var_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisablePrice_60256ab6-6bc1-4771-b6d1-f8f4e87e2be8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_3f8e53be-a5b3-401e-b9aa-ab8cf81e1b7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e37c6e9b-f8f7-49bb-a506-21254efc62ab" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_3f8e53be-a5b3-401e-b9aa-ab8cf81e1b7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_63111b53-300d-4354-8887-2834d6cdb2ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_3f8e53be-a5b3-401e-b9aa-ab8cf81e1b7b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_63111b53-300d-4354-8887-2834d6cdb2ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_513291fa-f4c2-4e97-8c2e-71b02e7e679d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_3f8e53be-a5b3-401e-b9aa-ab8cf81e1b7b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_513291fa-f4c2-4e97-8c2e-71b02e7e679d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_b783c3c0-fde6-4987-96da-169199c10789" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_3f8e53be-a5b3-401e-b9aa-ab8cf81e1b7b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_b783c3c0-fde6-4987-96da-169199c10789" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_7614194b-67c8-4530-829e-69210d8ab4b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_3f8e53be-a5b3-401e-b9aa-ab8cf81e1b7b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_7614194b-67c8-4530-829e-69210d8ab4b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_ad67b1c3-3b95-4bf9-a6ec-25e38f08bb72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e37c6e9b-f8f7-49bb-a506-21254efc62ab" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_ad67b1c3-3b95-4bf9-a6ec-25e38f08bb72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_a51ada8e-b7ea-4bdc-821b-7bccf4933ada" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e37c6e9b-f8f7-49bb-a506-21254efc62ab" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_a51ada8e-b7ea-4bdc-821b-7bccf4933ada" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_75b03d03-a0f3-4850-b79b-935b7befdad5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_a51ada8e-b7ea-4bdc-821b-7bccf4933ada" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_75b03d03-a0f3-4850-b79b-935b7befdad5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_92601f91-d4e0-4dbf-9d78-69a055963c92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_a51ada8e-b7ea-4bdc-821b-7bccf4933ada" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_92601f91-d4e0-4dbf-9d78-69a055963c92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_e5c44319-e7b9-4765-a40b-ae8c2773de4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_a51ada8e-b7ea-4bdc-821b-7bccf4933ada" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_e5c44319-e7b9-4765-a40b-ae8c2773de4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_bd5526e7-a7ec-4583-b789-ccf4ec2b57a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_a51ada8e-b7ea-4bdc-821b-7bccf4933ada" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_bd5526e7-a7ec-4583-b789-ccf4ec2b57a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_00e4a7ba-5d48-45b5-a98f-558bdd220ec2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e37c6e9b-f8f7-49bb-a506-21254efc62ab" xlink:to="loc_us-gaap_SharePrice_00e4a7ba-5d48-45b5-a98f-558bdd220ec2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.varex.com/role/EMPLOYEESTOCKPLANSRestrictedStockandPerformanceStockDetails" xlink:type="simple" xlink:href="var-20221230.xsd#EMPLOYEESTOCKPLANSRestrictedStockandPerformanceStockDetails"/>
  <link:presentationLink xlink:role="http://www.varex.com/role/EMPLOYEESTOCKPLANSRestrictedStockandPerformanceStockDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f3a45753-afca-4373-afea-24de9384d115" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_8a454339-f496-4694-acf6-c9fece1a45cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f3a45753-afca-4373-afea-24de9384d115" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_8a454339-f496-4694-acf6-c9fece1a45cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_5b0bc9c0-6842-4612-a5dc-4d6dfff7772b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_8a454339-f496-4694-acf6-c9fece1a45cb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_5b0bc9c0-6842-4612-a5dc-4d6dfff7772b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_09b3b64b-8d9a-494e-93c1-9e7ca23c4caa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_8a454339-f496-4694-acf6-c9fece1a45cb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_09b3b64b-8d9a-494e-93c1-9e7ca23c4caa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_9a050c18-7d00-4e02-a244-5ab0da6cdbae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_8a454339-f496-4694-acf6-c9fece1a45cb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_9a050c18-7d00-4e02-a244-5ab0da6cdbae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_f92411dc-cacd-4a05-9912-7db4d2ca1492" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_8a454339-f496-4694-acf6-c9fece1a45cb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_f92411dc-cacd-4a05-9912-7db4d2ca1492" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_21a39afb-5fbf-4659-9778-24392f5e39c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_8a454339-f496-4694-acf6-c9fece1a45cb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_21a39afb-5fbf-4659-9778-24392f5e39c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_8b5a6b3c-e298-492b-bcce-c11f686133bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f3a45753-afca-4373-afea-24de9384d115" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_8b5a6b3c-e298-492b-bcce-c11f686133bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_e73f5b71-54a5-42cb-b6bb-9f71c4adb4eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_8b5a6b3c-e298-492b-bcce-c11f686133bd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_e73f5b71-54a5-42cb-b6bb-9f71c4adb4eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_7d165e0d-f2eb-4d08-98b4-39643d2f1c58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_8b5a6b3c-e298-492b-bcce-c11f686133bd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_7d165e0d-f2eb-4d08-98b4-39643d2f1c58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_72342cc9-fec4-4db6-806c-cd7f21765fa8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_8b5a6b3c-e298-492b-bcce-c11f686133bd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_72342cc9-fec4-4db6-806c-cd7f21765fa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c7a04ac4-612c-41af-a5ce-7debbc2fa62a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_8b5a6b3c-e298-492b-bcce-c11f686133bd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c7a04ac4-612c-41af-a5ce-7debbc2fa62a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_91bfbf9b-8876-4b7d-8d91-826d240b0ca8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_8b5a6b3c-e298-492b-bcce-c11f686133bd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_91bfbf9b-8876-4b7d-8d91-826d240b0ca8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.varex.com/role/TAXESONINCOMEDetails" xlink:type="simple" xlink:href="var-20221230.xsd#TAXESONINCOMEDetails"/>
  <link:presentationLink xlink:role="http://www.varex.com/role/TAXESONINCOMEDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_9352c5a7-82fd-41c9-bf22-444d8a15875b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_3cbae0ef-b7ee-4292-bced-046cfd23ec75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9352c5a7-82fd-41c9-bf22-444d8a15875b" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_3cbae0ef-b7ee-4292-bced-046cfd23ec75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c8320ca7-bad4-4294-8feb-0abdb3589b59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9352c5a7-82fd-41c9-bf22-444d8a15875b" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c8320ca7-bad4-4294-8feb-0abdb3589b59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_0297dd38-512d-4119-8c9d-e27e01309917" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9352c5a7-82fd-41c9-bf22-444d8a15875b" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_0297dd38-512d-4119-8c9d-e27e01309917" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.varex.com/role/SEGMENTINFORMATIONIncomeStatementInformationDetails" xlink:type="simple" xlink:href="var-20221230.xsd#SEGMENTINFORMATIONIncomeStatementInformationDetails"/>
  <link:presentationLink xlink:role="http://www.varex.com/role/SEGMENTINFORMATIONIncomeStatementInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_68682263-ad32-4905-a334-785efc4405ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_8bc59e2d-baa5-4347-97db-bf315eb292b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_68682263-ad32-4905-a334-785efc4405ef" xlink:to="loc_us-gaap_NumberOfOperatingSegments_8bc59e2d-baa5-4347-97db-bf315eb292b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e149f665-f813-4295-b9a7-20d138c7d886" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_68682263-ad32-4905-a334-785efc4405ef" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e149f665-f813-4295-b9a7-20d138c7d886" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_ee8f3911-a691-4c16-bc4f-42db76ebd3fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e149f665-f813-4295-b9a7-20d138c7d886" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_ee8f3911-a691-4c16-bc4f-42db76ebd3fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_9a280a7a-49b0-482d-914e-b38a68a1c5ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ee8f3911-a691-4c16-bc4f-42db76ebd3fe" xlink:to="loc_us-gaap_SegmentDomain_9a280a7a-49b0-482d-914e-b38a68a1c5ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_MedicalMember_63675da8-52ca-4b44-8efb-89a52eb47cbc" xlink:href="var-20221230.xsd#var_MedicalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_9a280a7a-49b0-482d-914e-b38a68a1c5ed" xlink:to="loc_var_MedicalMember_63675da8-52ca-4b44-8efb-89a52eb47cbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_var_IndustrialMember_862b9b95-b89e-43b5-ae2f-4fb5cecf61c4" xlink:href="var-20221230.xsd#var_IndustrialMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_9a280a7a-49b0-482d-914e-b38a68a1c5ed" xlink:to="loc_var_IndustrialMember_862b9b95-b89e-43b5-ae2f-4fb5cecf61c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_f0fdf0e2-e911-41f3-b7f2-86beb7beee73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e149f665-f813-4295-b9a7-20d138c7d886" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_f0fdf0e2-e911-41f3-b7f2-86beb7beee73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_dda4b92b-1ce8-45de-b496-1eeb4c5e9254" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f0fdf0e2-e911-41f3-b7f2-86beb7beee73" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_dda4b92b-1ce8-45de-b496-1eeb4c5e9254" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_e66afbd7-13e0-4754-be7e-448ba8ec89cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f0fdf0e2-e911-41f3-b7f2-86beb7beee73" xlink:to="loc_us-gaap_GrossProfit_e66afbd7-13e0-4754-be7e-448ba8ec89cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_dae4285f-6588-4a8a-b311-bdfd9d335809" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f0fdf0e2-e911-41f3-b7f2-86beb7beee73" xlink:to="loc_us-gaap_OperatingExpenses_dae4285f-6588-4a8a-b311-bdfd9d335809" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_f97bb009-5f9f-44b4-9e99-c5de6b6a9afc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f0fdf0e2-e911-41f3-b7f2-86beb7beee73" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_f97bb009-5f9f-44b4-9e99-c5de6b6a9afc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_5ccf144e-2b81-430a-b6d7-1542f50f6005" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f0fdf0e2-e911-41f3-b7f2-86beb7beee73" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_5ccf144e-2b81-430a-b6d7-1542f50f6005" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_24eaf338-d4be-45c4-ad85-2e2a5be81559" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f0fdf0e2-e911-41f3-b7f2-86beb7beee73" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_24eaf338-d4be-45c4-ad85-2e2a5be81559" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_b4e233b9-85dd-474c-89f3-7dfed43b0dba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f0fdf0e2-e911-41f3-b7f2-86beb7beee73" xlink:to="loc_us-gaap_ProfitLoss_b4e233b9-85dd-474c-89f3-7dfed43b0dba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_9aca93f5-831f-4d8d-ba7a-fd382f11bd80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f0fdf0e2-e911-41f3-b7f2-86beb7beee73" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_9aca93f5-831f-4d8d-ba7a-fd382f11bd80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_19b974cb-3edc-4d7e-ac5b-9944cd62d138" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f0fdf0e2-e911-41f3-b7f2-86beb7beee73" xlink:to="loc_us-gaap_NetIncomeLoss_19b974cb-3edc-4d7e-ac5b-9944cd62d138" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>var-20221230_g1.jpg
<TEXT>
begin 644 var-20221230_g1.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" (X"9 # 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]4Z*** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBJ.M3WMKH]_-IMLEYJ,=O(]M;2R>6DLH4E$+8.T%L#.#C- %
MZBO@N;_@I?JUO,\4OP]MHY48J\;ZDX92.""#%P<TS_AYMJ?_ $(%I_X,V_\
MC5=_U&O_ "_BCC^MT>Y][T5\$?\ #S;4_P#H0+3_ ,&;?_&J/^'FVI_]"!:?
M^#-O_C5'U&O_ "_B@^MT>Y][T5\*Z+_P4NFNM8L8=2\$V]GITDZ)<W$>H,[1
M1E@&<+Y?S$#)QWQBON:&>.YA2:)UDBD4.CJ<AE(R"#7/5H5*-N=6N;4ZT*M^
M1DE%%%8&P4444 %%%?)OQ\_;4UWX&_$J^\,7'@BVO;=(X[BTO&U!D^T0N.&V
M^6<88.IYZH:UITIUI<L-S.I4C37-(^LJ*^"/^'FVI_\ 0@6G_@S;_P"-4?\
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MZ"BBBD,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MDHQW9$Y*$7)GMU%?F[_P\D^)G_0#\)_^ ES_ /)%'_#R3XF?] /PG_X"7/\
M\D5W_P!GUSD^N4C](J*_-W_AY)\3/^@'X3_\!+G_ .2*/^'DGQ,_Z ?A/_P$
MN?\ Y(H_L^N'URD?I%17YN_\/)/B9_T _"?_ ("7/_R11_P\D^)G_0#\)_\
M@)<__)%']GUP^N4C](J*_-W_ (>2?$S_ * ?A/\ \!+G_P"2*/\ AY)\3/\
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M_P#DBC_AY)\3/^@'X3_\!+G_ .2*/[/KA]<I'Z145^;O_#R3XF?] /PG_P"
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M  \D^)G_ $ _"?\ X"7/_P D4?V?7#ZY2/TBHK\W?^'DGQ,_Z ?A/_P$N?\
MY(H_X>2?$S_H!^$__ 2Y_P#DBC^SZX?7*1^D5%?F[_P\D^)G_0#\)_\ @)<_
M_)%'_#R3XF?] /PG_P" ES_\D4?V?7#ZY2/TBHK\W?\ AY)\3/\ H!^$_P#P
M$N?_ )(H_P"'DGQ,_P"@'X3_ / 2Y_\ DBC^SZX?7*1^D5%?F[_P\D^)G_0#
M\)_^ ES_ /)%'_#R3XF?] /PG_X"7/\ \D4?V?7#ZY2/TBHK\W?^'DGQ,_Z
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M !^C_AX!\0_^@-X9_P# 6X_^/T>TB']O8+N_N/O^BO@#_AX!\0_^@-X9_P#
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MS8C^%(_-VBBBOKCYL**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M'GP9_P!@Z;_T;7H8'^.OF<6,_@OY'QI1117U!\^%%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5][?\
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MZ;/H*BBBO"/7"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MZ W"D?).!_M8(;_:!Z @5[Y7R=2$J<G"6Z/I(352*E$****S+"BBB@ HHHH
M**** "OSZ_X*8?\ (\^#/^P=-_Z-K]!:_/K_ (*8?\CSX,_[!TW_ *-KT,#_
M !U\SBQG\%_(^-****^H/GPHHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M9_F>[@ZO/#E>Z-.BBBO+/0"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M6\?Q$?OI1] 0@/\ M2#M7WA7SF85N>?LULOS/<P5+EASO=A1117E'HA1110
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M]I_X$W'_ ,<H_P"&.O@Y_P!"/:?^!-Q_\<KV:BCVU7^9_>'LJ?\ *ON/&?\
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M0I<03+T>-U#*P^H(-6Z^5O\ @GW\5QXP^%D_A2\FW:EX;DV1ACDO:R$M&?\
M@+;U]@$]:^J:^-JTW2FX/H?44YJI!274****R- HHHH **** "BBB@ HHHH
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MU?*/_!23_DANA_\ 8QP?^DUU75A?X\?4YL1_"D?F[1117UQ\V%%%% %[0?\
MD.:=_P!?,?\ Z$*_<*OP]T'_ )#FG?\ 7S'_ .A"OW"KPLSWA\_T/7P&TOD%
M%%%>(>L%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M***\4]4**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_ Z]=HJX2<)*2Z$RBIQ<7U/PO(*D@C!HKW']LCX3_P#"J_C9JJ6L'DZ-K/\
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MUG4YS<ZA?W$ES<3-_$[L68_F:];+Z/--U'LCS<;5Y8\BZF?1117T1X@4444
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MTMXR"P/^\=J?5Q7ZH(HC4*H"JHP% P *VIKJ?9\/86\I8F731?J.HHHKH/N
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M12.E8UJBHTW-FM*FZDU%'V_\)_AW8_"CX>:)X6L-K1:?;A))0,>=*?FDD/\
MO.6/MG%==117QTFY-MGTZ2BK(****0PHHHH **** "BBB@ HHHH ***YCXE^
M.['X8^ ]<\4:B1]FTVV:;86QYK]$C!]6<JH]VII.3LA-I*[/BC_@HK\8O[3U
MS3?AWIT^;?3]M]J>P]9V7]U&?]U&+$=/WB]Q7Q;6GXG\1W_C#Q%J6MZI,;C4
M=0N'NKB3U=V).!V'/ [  5F5]A0I*C34$?,5:CJS<F%%%%;F0445Z]^RO\'3
M\:/B]IFEW,)DT2Q_T_4SV,*$?N_^!L57UPS'M43DJ<7*6R*C%SDHKJ?<'["_
MP;'PV^$T>N7T'EZYXEVWDFX?-';8_<)^()<_[X':OI*F1QK%&J(H1%&%51@
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MVK]%*^>S"MS25-=#VL%2Y8NH^H4445Y!Z84444 %%%% !1110 4444 %%%%
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MUN4WUP7BC8Y\N(?+&GX(%'X5RU<<GS.Y^39ABOK>(E5Z=/0****D\X*^ROV
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M/_*59?\ QFC_ (;?^-?_ $.G_E*LO_C->%T4>PI?R+[D'MJG\S^\]T_X;?\
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MTIUJCG&\GOW/UZHHHKY,^D"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MC"JS$^:@^CY..P=:\%K]1_VY?A2?B/\ !>ZU*TA\S5_#;-J,.!EFAQB=![;
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M&_V1/B[XH9?L_@F^M$."7U)DM !])64_D,UG*I"/Q22+C"4MD>/T5]B^"?\
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M)44FE)69S8G#T\52=*HM&?C.RM&Q5@593@J1@@T5]G_MC?LTF87?Q \+6N9
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MU/M%F&/"W4:DD#TWQ@_C&H[U^BE?(XJE[&JX]#Z3#U/:TT^H4445RG2%%%%
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MP%'VE3G>R_,\_&5>2'(MV<W1117TAX04444 /AADN9HX88VEED8(D: EF8G
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MFG9GTZ::N@HHHI#"BBB@ HHHH **** "BBB@ KY1_P""DG_)#=#_ .QC@_\
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MK9Q^<FFR6(B,ZCEE5@Y^;;D@8Y(QWKXO(*D@C!K]T*_.;]NS]G(^!_$+^/M
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M.*^UZZ*<;*Y^AY#A?94'6EO+\@HHHK8^H"BBB@ HHHH **** "BBB@ HHHH
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M/ ?_ "//AW_L(V__ *-6OVSKP<SWA\SV,!M(****\4]4**** "BBB@ HHHH
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MGLRG!!]O2OS!^,WPBU;X,^,[C1-2!FMVS)97RJ0ES#GAAZ,.C+V/J,$_J]7
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M%K;QM-+*W1$4$L3[ "K-?.7[;WQ._P"$.^&"^'K2;9J7B%S 0I^9;9<&4_\
M LJGN&;TI-V5SFQ5>.&HRK2Z(^(OBU\0+CXH?$36_$DY8)>3GR(V/^KA7Y8T
M_!0,^^3WKD:**XC\AG.523G+=A11109EC2]-N=:U*TT^RA:XO+N9(((5ZO(S
M!54>Y) _&OUF^%_@6V^&G@'1/#5J59;"W5))%&!)*?FD?_@3EC^-?$O[#/PR
M/BKXD3^)[N+=I^@)NBW+D/<N"$^NU=S>QV5^@E=%-:7/ON'\+R4Y8B6\M%Z?
M\/\ D%%%%;'UH4444 5[Z\@TVSN+NZE6"UMXVEEE<X5$499B?0 &OR>^+WQ
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MI*%95H7ZBT445RG0%%%% !1110 4444 %%%% !1110 4444 %?GU_P %,/\
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MRO9G!C*?/3YENC\^:***^F/!"I+6YEL[F*X@D:&>)Q)'(APRL#D$'U!%1T4
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MD%:K*O4E4GNW<****1B(H).!R:_4C]F[X9_\*K^$ND:9-%Y6IW*_;;_CGSI
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M_P#R/7Z144?VA7#ZG2/S=_X=M_$S_H.>$_\ P+N?_D>C_AVW\3/^@YX3_P#
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MJ%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M&@PJJ!@ #L,5+7:E96/U_#T8X>C&E'9(****9T!1110 4444 %%%% !1110
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MJ7&5^SQD$J?]]BJ?\#K]=E4*H50  , #H*\3,:VBI+U9ZN!I[U&.HHHKPCV
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MK\^O^"F'_(\^#/\ L'3?^C:]# _QU\SBQG\%_(^-****^H/GPHHHH W? ?\
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M[J%H+JWD:&6)QAD=20RGW!!K]RJ_,O\ ;Z^$_P#P@OQ<'B.SAV:5XF0W/RC
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M(/\ EF3^YD/T8E"?]M!VKU,OK<E3D>S_ #//QE+GASK='P;1117TAX04444
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M_P"'DGQ,_P"@'X3_ / 2Y_\ DBOE&BCZK0_E#ZQ5_F/J[_AY)\3/^@'X3_\
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MJS[')<KYVL566G1?K_D.HHHKH/N@HHHH **** "BBB@ HHHH **** "BBB@
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MI$UQ=W,JPPQ)]YW8@*H]R2*_6+X3^ ;?X8?#S1/#=OM+6< $\BCB29OFD?\
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MSZN/PH****DH**** "HKBXBL[>6>>5(((E+R22,%5% R22>@ [U+7PO^U_\
MM,?\)+<7/@;PK=YTB%MFI7\+<73CK"A!YC!ZG^(C'0?-,I<JN<&-QE/!4G4G
MOT7=G(?M4_M(R_%K66T'0YGB\(V,GRL,J;Z0?\M&']P<[1[Y/) 7Y^HHKD;N
M[L_+,1B*F*J.K4=VPHHHI',%%%% !7KW[-_P"O?C9XJS.)+;PS8.K7]XHP6[
MB%#_ 'V'?^$')[ \W\&_A%J_QF\96^B:8IBMUQ)>WS*2EM#GECZL>BKW/H,D
M?I[X#\#:1\./"UCH&AVPMK"T7 [O(W\3N>[,>2?Y# K2$>;5GT>4Y8\7/VM5
M>XOQ\O\ ,U-'T>R\/Z7::;IMM'96%K&L,%O",*B 8  J[1174?HZ22L@HHHH
M&%%%% !1110 4444 %%%% !1110 4444 %%%% !7R1^V-^S9_;MO<^/?#%K_
M ,3*%"^JV4*_\?" ?ZY0/XU'WA_$!GJ#N^MZ*F4>96./%X6GC*3I5/\ AO,_
M&>BOJ+]K[]FS_A"KZ;QIX9M<>'[I\WUI$!BRE8_>4#I&Q/3^$\=" /EVN1IQ
M=F?E>*PU3"572J+5?CYA1112.0**** /I']DO]I1OAKJ4?A7Q'<,?"UY+^YG
MD.?L$K=_^N;'J.Q.[^]G]!4<2*&4AE89# Y!%?C37V+^QW^TM]G:T\ >*;O$
M1(BTB^F/W3T%NQ]/[I/^[_=K:$^C/LLES3DMA:[TZ/\ 3_(^TZ***Z#[D***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K\SO
MV_?A/_P@_P 6D\2V<&S2_$R&X8J/E6Z3 F'_  +*/[EF]*_3&O&_VL?A/_PM
MSX+ZSI]O#YVKV _M'3@HRQFC!)0>N]"ZX]6'I79A*WL:J;V>ARXFG[2FUU1^
M2=%%%?6'S@4444 ?I=^P#\6/^$V^$[^&;V8/JGAIQ H8_,]J^3$?^ D.GL%7
MUKZBK\D/V4/BN?A'\:-&U"XF\K2+]O[.U#<V%$,A #G_ ''"-]%/K7ZWU\OC
MJ7LZK:V9]!A*GM*=GN@HHHKSSM"BBB@#YB_;Z^$__"=?",>([.'?JOAES<G:
M,EK5L"8?\!PC^P1O6OS,K]R+ZQ@U.RN+.ZB6>UN(VBEB<95T8$,I]B"17XW_
M !L^&L_PC^*'B#PM+O:*RN";:5QS+;L T3>Y*$9]P1VKW\NJWBZ3Z'C8ZG:2
MJ+J</1117LGEA7TU^P/\6/\ A!?B[_PCMY-LTKQ,@M?F.%6Z7)A/_ LLGN77
MTKYEJ:RO)]-O(+NUE:"YMY%EBE0X9'4@J1[@@5E5IJK!P?4TIS=.:DNA^Y5%
M<+\$?B5!\7/A;X?\41%1->6X%S&O_+.X7Y95^F\''L0>]=U7QTHN+<7T/J(R
M4DF@HHHJ1A7Y>_MV?"?_ (5Y\9)M8M(1'I'B56OX]HPJW ($Z_7<0_\ VUK]
M0J\+_;*^%'_"T_@GJHM8#+K&B_\ $SLMOWFV ^8@]=T9; [L%KMP=7V557V>
MAR8JG[2F[;H_*.BBBOJSYT**** /T^_81^+'_"PO@W#HMW/YFK^&66PD#'+-
M;$$V[?0*&C'_ %R]Z^DJ_*#]C?XL#X5_&S2VNI_*T?6?^)9>[CA5#L/+D/8;
M9 N3V4MZU^K]?+8VE[*JVMGJ?0X6I[2FK[H****X#L"OGC]MCXF?\(5\*CH=
MK)LU+Q$YM1@X*VZX,S?B"J?20^E?0]?FO^V5XHU+Q!\=-7M+Z)[:#2HX[.TA
M<_\ +/:'W\<?.7+>N"H/2LYNR/#SC$O#X1\N\M/\_P #P^BBBN4_, HHHH ^
MC?V'_AE_PE_Q-D\17<)?3O#Z"9"P^5KE\B,?\! 9_8JOK7Z%UY1^S+\,?^%6
M_"/2;">+R]4O1]OO\C#"60 A#_NJ%7ZJ?6O5ZZX+E1^J97A?JN%C%[O5_,**
M**L]<**** /GK]M;XFGP1\*6T:UFV:GXB9K1=IPRVX ,S?B"J?\ ;0U^=E>O
M_M5?$S_A9?Q@U2:WE\S2],/]G6>#P50G>X_WG+'/IM]*\@KDG+F9^6YMBOK6
M*DULM%\@HHHJ#Q@KZ,_8A^&9\8?$YO$-U%OT[P\@F4L.&N6R(A^&&?V*KZU\
MYU^H'[,?PR_X5;\(])L;B'RM5OA]OO\ <,,)9 ,(?3:H1<>JGUK2$;L]_)<+
M]8Q2D]HZ_P"7]>1ZQ11174?I@4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M!S?Q&\#V/Q*\"ZWX8U$?Z)J=LUNS[03&QY1P/56"L/=17XT^+?"]_P""?$^J
M:#JL7DZCIMP]M.G;<I(R/4'J#W!!K]NJ\J\=_LN_##XE^);GQ!XC\+KJ&KW*
MHLURM[<P[]JA5RL<BKD  9QGBO1PF*6'NI;,X<3AW6LX[GY"45^KG_#$'P4_
MZ$O_ ,JM[_\ 'J/^&(/@I_T)?_E5O?\ X]7I?VE2[/\ #_,X?J-3NOZ^1^4=
M%?JY_P ,0?!3_H2__*K>_P#QZC_AB#X*?]"7_P"56]_^/4?VE2[/\/\ ,/J-
M3NOZ^1^4=%?JY_PQ!\%/^A+_ /*K>_\ QZEC_8C^"L<BN/!0)4Y&[4[TC\09
ML&C^TJ79_A_F'U&IW7]?(P/V%_@Y_P *V^$L>MWT'EZWXEVWDFX?-';@'R$_
M$$O_ -M,=J^DJ9'&L4:HBA$4855&  .@ I]>!4J.I-S?4]BG!4XJ*Z!11169
MH%%%% !1110 4444 %%%% !1110!\I?\% _C W@SX;VWA"PFV:GXD+"<HWS1
MVB$;_IO8A?<!Q7YN5^P/Q"_9J^'/Q6\0_P!N>*O#[ZMJ?E+ )FU"ZC"QKG"A
M4E50,DG@=23WKFO^&(/@I_T)?_E5O?\ X]7LX;%T:%/EL[]?ZN>77PU6M/FN
MK'Y1T5^KG_#$'P4_Z$O_ ,JM[_\ 'J/^&(/@I_T)?_E5O?\ X]75_:5+L_P_
MS.?ZC4[K^OD?E'17ZN?\,0?!3_H2_P#RJWO_ ,>H_P"&(/@I_P!"7_Y5;W_X
M]1_:5+L_P_S#ZC4[K^OD>#_\$X_A(6DUGXB7\/RKG3=,+=SP9Y /^^$!]W%?
M=E8G@_P;HWP_\-V.@>'[%-.TBR4I!;(S,%!8L?F8EB2222222:VZ\2O6]M4<
MSUJ-/V4%$****YS8**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** /AC_@H]\)05T7XAV,/((TS4BH[<M#(?_'T)
M/J@KX6K]MO&'@_1_'OAN_P! U^R74-(OD"7%LSL@<!@P^92&!! (((.17DO_
M  Q!\%/^A+_\JM[_ /'J]G#8Z-*GR33T/+KX252?-![GY1T5^KG_  Q!\%/^
MA+_\JM[_ /'J/^&(/@I_T)?_ )5;W_X]75_:5+L_P_S.?ZC4[K^OD?E'17ZN
M?\,0?!3_ *$O_P JM[_\>H_X8@^"G_0E_P#E5O?_ (]1_:5+L_P_S#ZC4[K^
MOD<O^P5\7AX^^$X\-WLY?6?#)6VPYRSVK9,+?\!PT?L$7/6OIRO,_AS^SC\/
M/A+KLFL>$] ?2-1D@:W>5=0NI0\9()4K)(RGE5/3M7IE>'6E"=1RALSUJ,91
M@HSW04445@;!1110 5\H_P#!23_DANA_]C'!_P"DUU7U=7)?$GX5^%_B]H<&
MC>+=+_M;38+E;N.'[1+#ME564-F-E)^5V&,XYZ=*VHS5.I&;Z&56#J0<5U/Q
M<HK]7/\ AB#X*?\ 0E_^56]_^/4?\,0?!3_H2_\ RJWO_P >KW?[2I=G^'^9
MY'U&IW7]?(_*.BOU<_X8@^"G_0E_^56]_P#CU'_#$'P4_P"A+_\ *K>__'J/
M[2I=G^'^8?4:G=?U\C\Z_P!FW_DOWP__ .PU:_\ HP5^Q%>.>&_V0_A)X0\0
M:?K>D>$_LFJ6$ZW-M/\ VE=OY<BG*MM:4J>>Q!%>QUY6+Q$<1)./0]##4948
MM2"BBBN$[ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH ^=OVR/V<Q\:?!0U;1K<-XPT:-FM0H^:[ASEH#[]63_:R.-Q-?ERZ-&S*R
ME74X*L,$'TK]SZ\<\2_LA_"/Q=KU_K6J>$(YM1OI3/<2QWUU"'D/5MB2JH)/
M)P!DDGO7JX7&*C'DGJNAYV(PKJRYH;GY)45^KG_#$'P4_P"A+_\ *K>__'J/
M^&(/@I_T)?\ Y5;W_P"/5W?VE2[/\/\ ,Y/J-3NOZ^1^4=%?JY_PQ!\%/^A+
M_P#*K>__ !ZC_AB#X*?]"7_Y5;W_ ./4?VE2[/\ #_,/J-3NOZ^1^4=??G[!
M_P"TL-9L;?X:^);O_3[5,:+=2M_KHE&3;DG^) ,KZJ".-HS[!_PQ!\%/^A+_
M /*K>_\ QZI]._8Q^#VCZA;7UEX3DM;RVD6:&>'5[Y7C=2"K*1/P00#^%<]?
M&4*\.5I_A_F;4<-6HRYDU_7R/;:***\0]8**** "BBB@ HHHH *_/K_@IA_R
M//@S_L'3?^C:_06O/?B9\ ? ?QAOK*\\7Z%_:]S9QF*!_MEQ!L4G)&(Y%!Y]
M:ZL-5C1JJ<MCGQ%-U:;C$_'&BOU<_P"&(/@I_P!"7_Y5;W_X]1_PQ!\%/^A+
M_P#*K>__ !ZO9_M*EV?X?YGE_4:G=?U\C\HZ*_5S_AB#X*?]"7_Y5;W_ ./4
M?\,0?!3_ *$O_P JM[_\>H_M*EV?X?YA]1J=U_7R/RCHK]7/^&(/@I_T)?\
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MF1;-MQ^5;E<F!OJ26C^L@K@QM+VM)M;K4[,+4]G42>S/TZHHHKY8^A"BBB@
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M445V', )4@@X-?KG^RO\5_\ A;_P8T759Y?-U:T7^S]1R<MY\8 W'W=2C_\
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M!9_I(/2OH:NJG&R/T[)L+]6PJ;WEK_D%%%%:'NA1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M4^:(Y[#< #[$BOQSNK6:QNIK:XB:&XA=HY(W&&1@<$$=B"*^EP%;VE+E>Z/
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M%UAX\\(Z/XBTQ_,L=2MH[F+G)4,,E3_M Y!'8@U^)=?H#_P3E^+']J>&M7\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O%/VO?A/\
M\+:^">KVUM#YNL:6/[3L-HRS/&#OC&.3O0NH']XJ>U>UT5<)NG)270B45.+B
M^I^%]%>Q?M8?"?\ X5'\:-9T^WA\G1]0/]HZ=M&%$,A.4'IL<.H'HH]:\=K[
M*$E4BI+J?+RBX2<7T"BBBK)/:/V1?BQ_PJ7XU:1=7,WE:/JA_LV_R<*L<A&V
M0_[CA&)] WK7ZT5^%]?K7^R9\6#\7/@KH]_<S&;6-/']FZB6.6::,##GU+H4
M<GU9AVKP\QI;55Z,]? U-Z;/9:***\,]8**** *NJ:;;:SIMUI]] ES9743P
M3PR#*R1LI5E/L02/QK\:_C'\.;GX2_$S7_"MR686%R5@E;K+ WS1/]2C*3Z'
M([5^SU?$O_!1WX3_ &S2M%^(5C!F6T(TW464?\LV),+GZ,67/_311VKT\!5]
MG4Y'LSS\93YZ?,MT?!-%%%?2GA!5C3=1N='U&UO[.9K:\M95GAF3[T<BD,K#
MW! /X57HH _9OX-_$:V^+'PS\/\ BFWVJU_; SQK_P LYURLJ?@ZL!ZC![UV
MM? W_!./XL?8M7UKX>WTP$5Z#J6FAC_RU4 3(/4L@5@.WEN>]??-?(8BE[&J
MX]#Z:A4]K34@HHHKF-PKP3]M3X4?\+.^">HS6T6_5]!SJ=K@?,RHI\Y/Q3<<
M=RBU[W364,I5@"",$'H:TIS=.:FNA$XJ<7%]3\,:*]3_ &FOA2WP=^,6N:'%
M$8]+E?[;IQQP;>0DJH_W3N3ZH:\LK[&$E.*DMF?+RBXMQ?0****LD]Y_8M^*
MW_"L/C9IL5U-Y6CZZ!IEWN/RJSG]RY^DFT9[*S5^J]?A@K%6#*2&!R".HK]>
M?V9/BL/C#\&]#UJ67S=4A3[#J.3S]HC #,?]X;7_ .!UX68TM557H>O@:F]-
MGJU%%%>(>L%%%% !117E_P"T?\3!\*_A-J^JPS"/4[A?L5ASSY\@(##_ '5#
M/_P&DW;4RJU(T:<JD]EJ?#G[67Q,_P"%D?&#4A;R^9I6CYTZTP?E.PGS''KN
M?=SW 6O&J1F).3R:6N-N[N?D%>M+$5959;MA1112, K].?V6?AB?AC\(=+M[
MB+R]5U+_ (F-[N&&5Y -J'TVH$4CU#>M?#G[,7PR'Q1^+VDV-Q#YNE6)_M"^
M##*M%&00A]F<HI]F)[5^H5;TUU/M>'L+\6)EZ+]0HHHK<^V"BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBLS5/$ND:+QJ&JV5@?2
MZN$C[9_B(HW TZ*Y/_A;?@;_ *'/P]_X-8/_ (NK5G\1?"FI$"T\3Z-=$ML'
MDZA$_P Q[<-UJN678GF7<Z*BF0S1W$:R1.LD;#(9#D'Z&GU)04444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1145Q<16L9DGE2&,=7D8*/S- $M%<Q<?
M$_P;9R!+CQ;H<#D9"R:E"IQZX+4R/XK>"9I%CC\8:!(['"JNIP$D^@&ZJY9=
MB>9=SJJ*H:=KFFZQDV&H6M\ "?\ 1IEDZ=>A/J/SJ_4E!1110 4444 %%%%
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M **K[+KY[%JU>5CW,-_!B%%%%<9TA1110 4444 %%%% !1110 4444 %%%%
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MZ;6OW4_>=3TB!'3^/_=Z_HK17>\=5=/D>_<X_J=-3YE]PU$6-555"JHP%48
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MM!]%%=U77%<JL?J>6X7ZIAHTWON_5_U8****L],**** "BBB@ HHHH ****
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MM_VUOV4_^$VL[GQ[X1LL^(K=-VHV$"\WT8_Y:*!UE4=1_$H]0 >(_P""9/\
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MB3. 3VKZLK"I2G2TFK&L*D*GPNX4445D:!1110 4444 %%%% !1110 4444
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M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /S _X* _\
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M C8GW8!7^CBGF47RQD+ 2UE$]7HHHKP3V0HHHH _,[_@HE_R7ZW_ .P+;?\
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M>J%%%% !1110 4444 %%%% !1110 4444 %%%% !1110!\O_ /!1+_D@-O\
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M^D4%?JY7Y1_MO_\ )T/C3_MR_P#2*"O5RW^*_3]4>=COX:]?\SPNOU-_8/\
M^3:O#_\ U\WG_I0]?EE7ZF_L'_\ )M7A_P#Z^;S_ -*'KOS'^"O7_,X\#_%?
MH?0=%%%?-GNA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %8OC'Q
M9IO@7POJOB'5YQ;Z;IUNUQ-)WVJ.@'<DX '<D"MJO@7_ (*&?'+^TM2MOAKI
M%P?L]FRW>KM&>'E(S%"?90=Y'3+)W6NC#T77J*!A6J*E!R/E7XJ?$;4OBSX^
MUCQ3JAQ<7\Q9(0Q*P1CA(U]E4 >^">]<G17UI^PI^SG8_$C5-0\8>*=-BU#P
M[8;K6UL[J/='<W!'S,0>&5%/_?3#^[7U-2<,/3YGLCYZ$)5IV6[/DNBOV'_X
M9M^%?_1/_#__ ( 1_P"%'_#-OPK_ .B?^'__   C_P *\[^TH?RL[OJ$^Z/Q
MXHK]A_\ AFWX5_\ 1/\ P_\ ^ $?^%'_  S;\*_^B?\ A_\ \ (_\*/[2A_*
MP^H3[H_'BBOV'_X9M^%?_1/_  __ . $?^%'_#-OPK_Z)_X?_P# "/\ PH_M
M*'\K#ZA/NC\>**_8?_AFWX5_]$_\/_\ @!'_ (56U']F'X5ZEI]U:'P+HMN)
MXFB,UO9I'*FX$;D8#*L,Y![$4_[2I_RL/J$^Z/R!KZ=_83^.?_"M_B+_ ,(M
MJESY?A[Q$ZQ*7/R07G2-_8-]P_5">%KP_P"+'PWU#X2_$'6?"VI9::PF*QS;
M=HGB/,<H]F4@^Q)':N35BK!E)# Y!'45Z,XQKTW'HSAC*5&=^J/W/HKP[]D7
MXXCXU?"VV>^G#^)-(VV>I*3EI"!\DY_WP,G_ &@]>XU\A.#IR<);H^EA)3BI
M+J%%%%06%%%% !1110 4444 %%%% !1110 4444 %%%% !7YK?\ !0/X3R>$
M/BI%XMM8"NE>(XPTCJ/E2[C 5P?3<H1O<E_2OTIKA?C1\)],^-/P]U+PQJ>(
M_/'F6MUMRUM<*#LE'TR01W5F'>NO"UO85%)[=3FQ%+VU-QZGXTU]+_L1_M"0
M?"/QI/X?UVX$'AC774-/(?DM+D<)(?16'RL?93T4UX/X\\"ZS\-O%FH>'=>M
M&L]3L9#&ZG.UQ_"Z'^)6&"#W!K KZ>I"-:'*]F?/PE*E/F6Z/W/!# $'(I:_
M.?\ 9A_;@N?A[:V?A;QT9M1\.1 16NI1@R7%DO96'62,=L?,H&!N& /T \+>
M+M%\;:/#JN@:I:ZOITWW+BTE#K]#CH1W!Y'<5\M6P\Z#M):=SZ*E6A65X[FQ
M1117,;A1110 4444 87CS_D1O$7_ &#KC_T4U?B97ZR?M"?M'^!/ACX9UG2=
M2U=+O7;FTEMX]*L,33AG0J"XSB,#.?F(. < ]*_)NOH,MC*,9-K<\7'23DDG
ML=7\)/\ DJW@S_L-67_H]*_:6OQ:^$G_ "5;P9_V&K+_ -'I7[2UCF7Q1-<!
M\,@HHHKQ3U0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /E__@HE
M_P D!M_^PU;?^BY:_,^OTP_X*)?\D!M_^PU;?^BY:_,^OI<O_@_,\'&_Q?D>
MZ?L0?\G0^"_^WW_TBGK]7*_*/]B#_DZ'P7_V^_\ I%/7ZN5Y^9?Q5Z?JSMP/
M\-^O^04445Y1Z(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '"_'
MC_DAOQ$_[%S4?_2:2OQIK]EOCQ_R0WXB?]BYJ/\ Z325^--?09;\$O4\;'_%
M$[KX#_\ )<OAW_V,>G?^E,=?LM7XT_ ?_DN7P[_[&/3O_2F.OV6K#,OCB:X#
MX9!1117C'J!3)(TGC>.1%DC<%65AD$'J"*?10!^>?[8?['C>#FO/''@>S+:"
MQ,NHZ5"N38GJ98P/^67JO\'7[OW?CNOW.=%D5E90RL,%6&01Z5^>O[8?['C>
M#FO/''@>S+:"Q,NHZ5"N38GJ98P/^67JO\'7[OW?>P>,YK4ZCUZ,\?%86WOP
M/E3P?XPUCP#XDL=>T&^DT[5+.3S(9XCT]01T92,@J>""0:_3_P" _P"TMH_Q
M^^'^H@^7IWBJSLW^WZ9NZ_*1YT6>6C)_%2<'L6_*>M3PSXHU7P;K=MJ^BWTN
MGZC;DF.>$X."""".A!!((/!!(-=V(PT:Z\T<="O*B_(RZW? ?_(\^'?^PC;_
M /HU:PJW? ?_ "//AW_L(V__ *-6NJ6S.>.Z/VSHHHKXD^L"BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH *\@_:L^%+_ !>^"NM:5:P^=J]F!J.G
MJ!R9HP3M'NR%T'NXKU^BKA)PDI+H3**G%Q?4_#!E*L58$,#@@]15_P .Z]?>
M%=>T[6=,G-MJ%A<1W-O,O\+HP93^8KZA_;D_9NF\!^)KCQWH%J3X;U67?>QP
MJ<65RQY)]$D)R#T#$CC*U\G5]?3J1K04ELSYBI"5*?*S]B_@3\9M*^.7@"R\
M0:>R17@ BU"Q!^:UN /F7_=/53W!'?('HM?C3\'OC-XD^"7BN/6_#MR%+ )=
M6<V3!=1@YV.O\B.1G@]:_3'X&_M3^"OCA9PPVEXFD>(BO[W1+Z0++N[^4W E
M7KRO..H%?/8K"2HMRCK'\CV\/B8U%RRW/9:***\X[@HHHH **** "OS=_P""
MDG_)<M#_ .Q<@_\ 2FZK]"O%'B[1/!.DRZIK^JVFD:?$/FN+R41K]!GJ?0#D
MU^7O[97Q@\/_ !H^+-MJWAEYY]-L=,CT_P"T3Q&,3,LLTA=%/S;<2@?, <@\
M5ZF7QE[7FMH>?C9+V?+?4\)K],/^"=O_ "0&X_[#5S_Z+BK\SZ_3#_@G;_R0
M&X_[#5S_ .BXJ]+,/X/S.'!?Q?D?4%%%%?,GO!1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% %35=+M=:TN\TZ^A6XLKR%[>>%_NO&ZE64^Q!(K\:OB]\/+K
MX4_$G7_"UUN8Z?<LD,C#F6$_-$__  )"I_'%?M!7Q%_P4>^$_P!JT[1/B%8P
M_/;$:;J14?\ +-B3#(?HQ92?]M!7IX"KR5.1[,\_&4^>',MT?!E%%%?2GA!5
MK2]4NM$U2SU&QF:WO;.9+B"9/O)(C!E8>X(!_"JM% '[/?"#XBVOQ7^&V@>*
M;7:OV^V5IHU.?*F'RRI^#AA],5V5?!7_  3C^+'V74M:^'M].?+N@=2TT,>!
M(H FC'U4*P'^P_K7WK7R&(I>QJ.'0^FH5/:TU(****YC<**** /SH_X*(?"?
M_A&_'^G^-K* )8:]'Y-V4'"W<8 R?3?'M^I1S7R-7["?M&?"Q/C%\(=>\/+&
MKZB8OM.GL?X;F/+( >V[E"?1S7X^R1O#(\<B-'(A*LK#!!'4$5]/@:OM*7*]
MT>!C*?)4NMF-HHHKT3A"OT5_X)W_ !9/B3P#J'@B]F+WV@OY]H&.2UK(Q) _
MW)"?PD4=J_.JO2?V=?BF_P '?B[H/B)G*Z>LOV:_4<[K:3Y9..^WAQ[H*Y,5
M2]M2<>IT8>I[*HGT/V'HID<B3QI)&ZR1N RLIR"#T(-/KY(^E"BBB@#.\1:#
M9>*M!U'1M2B$^GZA;R6MQ&?XHW4JP_(FOQE^)7@6]^&?CW7/"]_DW.F730;\
M8\Q.J2 =@R%6'LU?M77PC_P4>^%'ESZ'\0K*' DQI>H[1_$,M#(?PWJ2?1!7
MJ9?5Y*G(]F>=C:?-#G70^':***^D/#"K_A_7+WPOKNG:QITQM]0T^XCNK>4?
MPR(P93^8%4**6X'[4_#3QU9?$[P#H7BG3\"VU2U6?R\Y\I^CQD^JN&4^ZFNG
MKX:_X)P?%?=%KGP]OIN4)U/30Q['"SQC/OL< >KFON6OD,12]C4<#Z:C4]K!
M2"BBBN<W"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M+U7^#K]W[OO8/&<UJ=1Z]&>/BL+;WX'QW6[X#_Y'GP[_ -A&W_\ 1JUA5N^
M_P#D>?#O_81M_P#T:M>Q+9GEQW1^V=%%%?$GU@4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110!1UK1;'Q%I-WIFIVD5_I]W&T,]M.H9)$(P0
M0:_-S]IS]B_5_A5<77B'PE#<:SX/),DD:@R7&GCJ0X'+1CLXZ ?-_>/Z8TA
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M 4444 %%%% !1110 4444 %%%% !45S:PWMN\%Q%'/#(-KQR*&5AZ$'K4M%
M'E?B?]EOX4>+G=]0\#:6DCG+26*-:,3ZDPE.:\YU3_@GK\*-0W>0-;TS/3[+
M?AL?3S$?_)KZ:HK>->K':3,94:<MXH^4?^';?PS_ .@YXL_\"[;_ .1ZGL_^
M"<OPOMI-TFI>)KL?W)KV #_QV$&OJ>BK^M5_YF3]7I?RGA6@_L2_!W0663_A
M%?[1E7^._O)I1_WQO"_I7J_AGP)X;\%P^5H&@:;HJ8VD6%I'#D>^T#/XUO45
MC*I.?Q2;-8TX1^%6"BBBLRPHHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M*DH**** "BBB@ I" P((R*6B@#RNZ_9;^$]Y<RSR^!-(,LKEV*Q%1N)R< '
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..BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139750428924224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br> shares in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 30, 2022</div></th>
<th class="th"><div>Jan. 26, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 30,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-37860<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">VAREX IMAGING CORPORATION<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">81-3434516<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1678 S. Pioneer Road<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Salt Lake City<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">UT<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">84104<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">801<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">972-5000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">VREX<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Smaller Reporting Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001681622<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--09-29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139750432276768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues, net</a></td>
<td class="nump">$ 205.6<span></span>
</td>
<td class="nump">$ 198.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of revenues</a></td>
<td class="nump">142.3<span></span>
</td>
<td class="nump">134.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">63.3<span></span>
</td>
<td class="nump">64.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">20.0<span></span>
</td>
<td class="nump">17.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">30.3<span></span>
</td>
<td class="nump">33.1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">50.3<span></span>
</td>
<td class="nump">50.8<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">13.0<span></span>
</td>
<td class="nump">14.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(7.5)<span></span>
</td>
<td class="num">(9.9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expense, net</a></td>
<td class="num">(0.6)<span></span>
</td>
<td class="num">(0.8)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Interest and other expense, net</a></td>
<td class="num">(7.6)<span></span>
</td>
<td class="num">(10.7)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before taxes</a></td>
<td class="nump">5.4<span></span>
</td>
<td class="nump">3.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">2.2<span></span>
</td>
<td class="nump">1.7<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">3.2<span></span>
</td>
<td class="nump">1.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Less: Net income attributable to noncontrolling interests</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to Varex</a></td>
<td class="nump">$ 3.1<span></span>
</td>
<td class="nump">$ 1.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net income per common share attributable to Varex</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in USD per share)</a></td>
<td class="nump">$ 0.08<span></span>
</td>
<td class="nump">$ 0.04<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in USD per share)</a></td>
<td class="nump">$ 0.08<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average common shares outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">40.1<span></span>
</td>
<td class="nump">39.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">40.6<span></span>
</td>
<td class="nump">43.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139750432198224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 3.2<span></span>
</td>
<td class="nump">$ 1.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive loss</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustments</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.5)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Total comprehensive income</a></td>
<td class="nump">3.2<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Less: Comprehensive income attributable to noncontrolling interests</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income attributable to Varex</a></td>
<td class="nump">$ 3.1<span></span>
</td>
<td class="nump">$ 0.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139750360874176">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 81.5<span></span>
</td>
<td class="nump">$ 89.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net of allowance for credit losses of $0.4&#160;million and $0.6&#160;million at December&#160;30, 2022 and September&#160;30, 2022, respectively</a></td>
<td class="nump">157.9<span></span>
</td>
<td class="nump">173.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">320.3<span></span>
</td>
<td class="nump">303.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">47.6<span></span>
</td>
<td class="nump">44.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">607.3<span></span>
</td>
<td class="nump">609.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization', window );">Property, plant, and equipment, net</a></td>
<td class="nump">142.9<span></span>
</td>
<td class="nump">141.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">288.2<span></span>
</td>
<td class="nump">284.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">31.7<span></span>
</td>
<td class="nump">33.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Investments in privately-held companies</a></td>
<td class="nump">47.8<span></span>
</td>
<td class="nump">46.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred tax assets</a></td>
<td class="nump">1.9<span></span>
</td>
<td class="nump">2.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease assets</a></td>
<td class="nump">22.1<span></span>
</td>
<td class="nump">23.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">39.0<span></span>
</td>
<td class="nump">43.2<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">1,180.9<span></span>
</td>
<td class="nump">1,184.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">86.2<span></span>
</td>
<td class="nump">78.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities and other current liabilities</a></td>
<td class="nump">56.0<span></span>
</td>
<td class="nump">81.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current operating lease liabilities</a></td>
<td class="nump">3.9<span></span>
</td>
<td class="nump">4.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current maturities of long-term debt</a></td>
<td class="nump">2.1<span></span>
</td>
<td class="nump">2.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenues</a></td>
<td class="nump">9.2<span></span>
</td>
<td class="nump">7.4<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">157.4<span></span>
</td>
<td class="nump">173.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, net</a></td>
<td class="nump">440.8<span></span>
</td>
<td class="nump">412.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred tax liabilities</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities</a></td>
<td class="nump">17.9<span></span>
</td>
<td class="nump">18.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">39.8<span></span>
</td>
<td class="nump">33.8<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">655.9<span></span>
</td>
<td class="nump">637.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Stockholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValueOutstanding', window );">Preferred stock, $.01 par value: 20,000,000 shares authorized, none issued</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValueOutstanding', window );">Common stock, $.01 par value: 150,000,000 shares authorized Shares issued and outstanding: 40,087,100 and 40,085,126 at December&#160;30, 2022 and September&#160;30, 2022, respectively</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">437.9<span></span>
</td>
<td class="nump">469.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">73.3<span></span>
</td>
<td class="nump">63.8<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Varex stockholders' equity</a></td>
<td class="nump">511.7<span></span>
</td>
<td class="nump">533.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="nump">13.3<span></span>
</td>
<td class="nump">13.3<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total stockholders' equity</a></td>
<td class="nump">525.0<span></span>
</td>
<td class="nump">546.7<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders' equity</a></td>
<td class="nump">$ 1,180.9<span></span>
</td>
<td class="nump">$ 1,184.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValueOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of all classes of common stock held by shareholders. May be all or portion of the number of common shares authorized. These shares exclude common shares repurchased by the entity and held as treasury shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValueOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity method investee and investment in and advance to affiliate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValueOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by shareholders, which is net of related treasury stock. May be all or a portion of the number of preferred shares authorized. These shares represent the ownership interest of the preferred shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValueOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139750428897856">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Accounts receivable, allowance for doubtful accounts</a></td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="nump">$ 0.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in USD per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">20,000,000<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value per share (in USD per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">150,000,000<span></span>
</td>
<td class="nump">150,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares, issued (in shares)</a></td>
<td class="nump">40,087,100<span></span>
</td>
<td class="nump">40,085,126<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares, outstanding (in shares)</a></td>
<td class="nump">40,087,100<span></span>
</td>
<td class="nump">40,085,126<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139750434379648">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Cumulative Effect, Period of Adoption, Adjustment</div></th>
<th class="th"><div>Total Varex Equity</div></th>
<th class="th">
<div>Total Varex Equity </div>
<div>Cumulative Effect, Period of Adoption, Adjustment</div>
</th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th">
<div>Additional Paid-in Capital </div>
<div>Cumulative Effect, Period of Adoption, Adjustment</div>
</th>
<th class="th"><div>Accumulated Other Comprehensive Income (Loss)</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th">
<div>Retained Earnings </div>
<div>Cumulative Effect, Period of Adoption, Adjustment</div>
</th>
<th class="th"><div>Noncontrolling Interests</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares, outstanding, beginning balance (in shares) at Oct. 01, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' equity, outstanding, beginning balance at Oct. 01, 2021</a></td>
<td class="nump">$ 496.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 483.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="nump">$ 449.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 33.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">1.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">3.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Common stock issued under employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Common stock issued under employee stock purchase plan</a></td>
<td class="nump">1.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">3.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax', window );">Foreign currency translation adjustments</a></td>
<td class="num">(0.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Other</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares, outstanding, ending balance (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' equity, outstanding, ending balance at Dec. 31, 2021</a></td>
<td class="nump">506.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">492.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="nump">458.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.5)<span></span>
</td>
<td class="nump">34.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.3<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares, outstanding, beginning balance (in shares) at Oct. 01, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' equity, outstanding, beginning balance at Oct. 01, 2021</a></td>
<td class="nump">$ 496.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">483.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="nump">449.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">33.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.2<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares, outstanding, ending balance (in shares) at Sep. 30, 2022</a></td>
<td class="nump">40,085,126<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' equity, outstanding, ending balance at Sep. 30, 2022</a></td>
<td class="nump">$ 546.7<span></span>
</td>
<td class="num">$ (28.1)<span></span>
</td>
<td class="nump">533.4<span></span>
</td>
<td class="num">$ (28.1)<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="nump">469.1<span></span>
</td>
<td class="num">$ (34.6)<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">63.8<span></span>
</td>
<td class="nump">$ 6.5<span></span>
</td>
<td class="nump">13.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingStandardsUpdateExtensibleList', window );">Accounting Standards Update [Extensible List]</a></td>
<td class="text">Accounting Standards Update 2020-06<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 3.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">3.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Other</a></td>
<td class="num">$ (0.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares, outstanding, ending balance (in shares) at Dec. 30, 2022</a></td>
<td class="nump">40,087,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' equity, outstanding, ending balance at Dec. 30, 2022</a></td>
<td class="nump">$ 525.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 511.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="nump">$ 437.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="nump">$ 73.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingStandardsUpdateExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates amendment to accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL126732908-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092918&amp;loc=SL128093175-196984<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092918&amp;loc=SL128093175-196984<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 832<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128342835&amp;loc=SL128342857-244232<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL122642865-165497<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092918&amp;loc=SL128093175-196984<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL120254526-165497<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 32: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL122150809-237846<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 45: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL122642865-165497<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126986314&amp;loc=SL124402458-218513<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126986314&amp;loc=SL124402458-218513<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL120254526-165497<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 50: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 51: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 52: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 53: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 54: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 55: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 56: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 57: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 58: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 59: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 60: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 61: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 62: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 63: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 832<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128342835&amp;loc=SL128342857-244232<br><br>Reference 64: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 65: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 66: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 67: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 68: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingStandardsUpdateExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11178-113907<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126961718&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit), before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126980362&amp;loc=d3e28129-110885<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32262-110900<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30755-110894<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139750360881376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 3.2<span></span>
</td>
<td class="nump">$ 1.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash (used in) provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation expense</a></td>
<td class="nump">3.3<span></span>
</td>
<td class="nump">3.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">4.6<span></span>
</td>
<td class="nump">4.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="nump">3.4<span></span>
</td>
<td class="nump">3.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred taxes</a></td>
<td class="num">(0.2)<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions', window );">(Income) loss from equity method investments</a></td>
<td class="num">(1.3)<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfDeferredLoanOriginationFeesNet', window );">Amortization of deferred loan costs</a></td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">2.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWriteDown', window );">Inventory write-down</a></td>
<td class="nump">2.0<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnTerminationOfLease', window );">Loss on operating lease abandonment</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">1.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other, net</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="nump">15.6<span></span>
</td>
<td class="nump">28.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(18.8)<span></span>
</td>
<td class="num">(23.8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other assets</a></td>
<td class="num">(0.4)<span></span>
</td>
<td class="nump">3.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">8.0<span></span>
</td>
<td class="nump">13.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued liabilities and other current and long-term liabilities</a></td>
<td class="num">(25.4)<span></span>
</td>
<td class="num">(30.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Deferred revenues</a></td>
<td class="nump">1.7<span></span>
</td>
<td class="num">(0.5)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash (used in) provided by operating activities</a></td>
<td class="num">(3.7)<span></span>
</td>
<td class="nump">10.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property, plant and equipment</a></td>
<td class="num">(5.5)<span></span>
</td>
<td class="num">(4.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_var_GainLossOnSettlementOfHedgeInvestingActivities', window );">Loss on settlement of cash flow hedge</a></td>
<td class="num">(0.3)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities', window );">Proceeds from maturities of marketable debt securities</a></td>
<td class="nump">4.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt', window );">Purchase of marketable debt securities</a></td>
<td class="num">(6.3)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireMarketableSecurities', window );">Purchase of marketable equity securities</a></td>
<td class="num">(2.7)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromHedgeInvestingActivities', window );">Settlement of net investment hedge</a></td>
<td class="nump">7.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_var_ProceedsFromSalesOfBusinessAndAssets', window );">Proceeds from sales of business and assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">1.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other, net</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(3.7)<span></span>
</td>
<td class="num">(2.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermLinesOfCredit', window );">Repayments of borrowing under credit agreements</a></td>
<td class="num">(0.5)<span></span>
</td>
<td class="num">(0.3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of stock options</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">3.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockPlans', window );">Proceeds from shares issued under employee stock purchase plan</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">1.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other, net</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash (used in) provided by financing activities</a></td>
<td class="num">(0.4)<span></span>
</td>
<td class="nump">5.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effects of exchange rate changes on cash and cash equivalents and restricted cash</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net (decrease) increase in cash and cash equivalents and restricted cash</a></td>
<td class="num">(7.8)<span></span>
</td>
<td class="nump">13.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents and restricted cash at beginning of period</a></td>
<td class="nump">90.6<span></span>
</td>
<td class="nump">146.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents and restricted cash at end of period</a></td>
<td class="nump">82.8<span></span>
</td>
<td class="nump">159.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="nump">13.7<span></span>
</td>
<td class="nump">14.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income taxes paid, net of refunds</a></td>
<td class="nump">4.5<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Supplemental non-cash activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfAssetsAcquired', window );">Purchases of property, plant and equipment financed through accounts payable</a></td>
<td class="nump">$ 2.0<span></span>
</td>
<td class="nump">$ 0.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDeferredLoanOriginationFeesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net increase(decrease) in interest income during the period representing the allocation of deferred loan origination fees less deferred loan origination costs using the effective interest method over the term of the debt arrangement to which they pertain taking into account the effect of prepayments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126974470&amp;loc=d3e8622-111531<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDeferredLoanOriginationFeesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfAssetsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of assets acquired in noncash investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfAssetsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnTerminationOfLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on termination of lease before expiration of lease term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 40<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123386189&amp;loc=SL77918607-209975<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnTerminationOfLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the undistributed income (or loss) of equity method investments, net of dividends or other distributions received from unconsolidated subsidiaries, certain corporate joint ventures, and certain noncontrolled corporations; such investments are accounted for under the equity method of accounting. This element excludes distributions that constitute a return of investment, which are classified as investing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 310<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126938201&amp;loc=d3e55415-109406<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4542-108314<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3151-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for purchase of marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromHedgeInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow for a financial contract that meets the hedge criteria as either a cash flow hedge, fair value hedge, or hedge of a net investment in a foreign operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 27<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3581-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromHedgeInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from sale, maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3151-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the stock plan during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the settlement of obligation drawn from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_var_GainLossOnSettlementOfHedgeInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) On Settlement Of Hedge, Investing Activities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">var_GainLossOnSettlementOfHedgeInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>var_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_var_ProceedsFromSalesOfBusinessAndAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Sales Of Business And Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">var_ProceedsFromSalesOfBusinessAndAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>var_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139750432194672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock', window );">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Description of Business</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Varex Imaging Corporation (the &#8220;Company&#8221; or &#8220;Varex&#8221;) designs, manufactures, sells and services a broad range of medical products, which include X-ray imaging components including X-ray tubes, digital detectors and accessories, ionization chambers and buckys, high voltage connectors, image processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers. The Company sells its products to imaging system original equipment manufacturer (&#8220;OEM&#8221;) customers for incorporation into new medical diagnostic, radiation therapy, dental, and veterinary equipment, as well as to independent service companies and distributors, and directly to end-users for replacement purposes.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company also designs, manufactures, sells and services industrial products, which include Linatron&#174; X-ray linear accelerators, digital detectors, high voltage connectors, coolers, imaging processing software and image detection products for security and inspection purposes, such as cargo screening at ports and borders and nondestructive examination in a variety of applications. The Company generally sells security and inspection products to OEM customers who incorporate Varex&#8217;s products into their inspection or irradiation systems and processes. The Company conducts an active research and development program to focus on new technology and applications in both the medical and industrial X-ray imaging markets.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The accompanying unaudited condensed consolidated financial statements have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;) and in accordance with accounting principles generally accepted in the United States (&#8220;GAAP&#8221;) for interim financial information. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. In the opinion of management, these condensed consolidated financial statements include all adjustments necessary for a fair presentation of the results for the interim periods. The Company has consolidated all of its majority owned subsidiaries and entities over which it has control. All intercompany balances and transactions have been eliminated as part of the consolidation.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;These condensed consolidated financial statements and the accompanying notes are unaudited and should be read in conjunction with the consolidated financial statements and notes thereto for the fiscal year ended 2022 included in the Company&#8217;s Annual Report on Form 10-K, which was filed with the SEC on November&#160;18, 2022. The Company considers events or transactions that occur after the balance sheet date, but before the financial statements are issued, to provide additional evidence relative to certain estimates or to identify matters that require additional disclosures. Except for the change in certain policies upon adoption of the accounting standard described below, there have been no material changes to the Company's significant accounting policies, compared to the accounting policies described in Note 1, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, in the Company&#8217;s Annual Report on Form&#160;10-K for fiscal year 2022. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segment Reporting</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company has two reportable operating segments; (i) Medical and (ii) Industrial, which aligns with how its Chief Executive Officer, who is the Company's Chief Operating Decision Maker (&#8220;CODM&#8221;), reviews the Company&#8217;s performance. See Note 15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for further information on the Company&#8217;s segments.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fiscal Year</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The fiscal years of the Company as reported are the 52 or 53-week period ending on the Friday nearest September&#160;30. Fiscal year 2023 is the 52-week period ending September&#160;29, 2023. Fiscal year 2022 was the 52-week period that ended on September&#160;30, 2022. The fiscal quarters ended&#160;December&#160;30, 2022 and&#160;December&#160;31, 2021&#160;were both 13-week periods. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. Such estimates include the valuation of inventories, valuation of goodwill and intangible assets, warranties, contract liabilities, long-lived asset valuations, impairment of investments, valuation of financial instruments, and taxes on income. Actual results could differ from these estimates.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impact of COVID-19</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The coronavirus (&#8220;COVID-19&#8221;) pandemic, the COVID-19 variants, uneven vaccination rates across the globe, and the mitigation efforts by governments to control its spread have created uncertainties and disruptions in the economic and financial markets. While the impacts of COVID-19 on the Company's business have lessened, the extent to which COVID-19 will continue to impact the Company&#8217;s business and financial results depends on numerous evolving factors including: the magnitude and duration of COVID-19, the extent to which it will continue to impact worldwide macroeconomic conditions, including supply chain disruptions, interest rates, unemployment rates, the speed of the economic recovery, and governmental and business reactions to the pandemic. The Company has experienced continuing supply chain disruptions and other issues that are at least partially related to the ongoing COVID-19 pandemic. In addition, while the Company has from time to time taken significant precautions to maintain employee safety, such as implementing mask requirements, encouraging vaccination, and periodically asking non-production related employees to work remotely when possible, the Company has experienced, and may in the future experience, COVID-19 related employee absences that adversely impact its production or business. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company assessed certain accounting matters that generally require consideration of forecasted financial information in context with the information reasonably available to the Company, including the estimated future impacts of COVID-19, through the date of filing this report. The accounting matters assessed included, but were not limited to, the Company&#8217;s carrying value of goodwill, intangibles, long-lived assets, equity method investments, inventory and related reserves, and the allowance for credit losses. The Company&#8217;s assessment of the magnitude and duration of COVID-19, as well as other factors, could result in material negative impacts to the Company&#8217;s condensed consolidated financial statements in future reporting periods. These future developments are highly uncertain and the outcomes cannot be estimated with certainty. Actual results may differ from those estimates, and such differences may be material to the financial statements.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company considers unrestricted currency on hand, demand deposits, time deposits and all highly-liquid investments with an original maturity of three months or less at the date of purchase to be cash and cash equivalents. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Cash</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Restricted cash primarily consists of cash collateral related to certain leases and inventory arrangements. Restricted cash is included in other assets on the Company's Condensed Consolidated Balance Sheets. Cash and cash equivalents and restricted cash as reported within the Condensed Consolidated Statements of Cash Flows consisted of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.816%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.650%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.650%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.650%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.652%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Beginning of Period</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">End of Period</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Beginning of Period</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">End of Period</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">89.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">81.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">144.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">157.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total as presented in the Condensed Consolidated Statements of Cash Flows</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">90.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">146.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">159.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Risk</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Financial instruments that potentially expose the Company to concentrations of credit risk consist principally of cash, cash equivalents, marketable securities, certificates of deposit, and trade accounts receivable. Cash held with financial institutions may exceed the Federal Deposit Insurance Corporation insurance limits or similar limits in foreign jurisdictions. To date, the Company has not realized any losses on its deposits of cash and cash equivalents. The Company performs ongoing credit evaluations of its customers and, except for government tenders, group purchases and orders with a letter of credit, its industrial customers often provide a down payment. The Company maintains an allowance for credit losses based upon the expected collectability of all accounts receivable. The Company obtains some of the components in its products from a limited group of suppliers or from a single-source supplier. When these suppliers are unable to meet the Company's supply needs, the Company's production is negatively impacted. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Credit is extended to customers based on an evaluation of the customer&#8217;s financial condition, and collateral is not required. In certain circumstances, a customer may be required to prepay all or a portion of the contract price prior to transfer of control. During the periods presented, one of the Company's customers accounted for a significant portion of revenues, as set forth below:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.568%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canon Medical Systems Corporation</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Canon Medical Systems Corporation accounted for 9.2% and 10.3% of the Company&#8217;s accounts receivable as of December&#160;30, 2022 and September&#160;30, 2022, respectively.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company accounts for its equity investments in privately-held companies under the equity method of accounting if the Company has the ability to exercise significant influence in these investments. Distributions received from an equity method investment are classified using the&#160;cumulative earnings approach, which means that distributions up to the amount of cumulative equity in earnings recognized will be treated as returns on investment and classified as operating cash flows and those in excess of that amount will be treated as returns of investment and classified as investing cash flows. The Company reviews its equity investments in privately-held companies for impairment whenever events or changes in business circumstances are other than temporary and indicate that the carrying amount of the investments may not be fully recoverable. There were no impairments recorded during the three months ended December 30, 2022 and December&#160;31, 2021, respectively.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Marketable Securities</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's marketable securities consist primarily of financial instruments such as U.S. treasury securities, U.S. agency obligations, corporate bonds, commercial paper, money market funds, and equity securities. The Company classifies marketable debt securities as available-for-sale at the time of purchase and reevaluates such classifications as of each balance sheet date. All marketable debt securities are recorded at estimated fair value. Any unrealized gains or losses for marketable debt securities are included in accumulated other comprehensive income within the Condensed Consolidated Balance Sheets. Marketable equity securities are stated at fair value as determined by the most recently traded price of each security at the balance sheet date. All unrealized gains and losses on equity securities are recorded as part of other expense, net in the Company's condensed consolidated financial statements. See Note 7, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for further details.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;When the fair value of a marketable debt security declines below its amortized cost basis, any portion of that decline attributable to credit losses, to the extent expected to be nonrecoverable before the sale of the security, is recognized in the Condensed Consolidated Statements of Operations. When the fair value of a marketable debt security declines below its amortized cost basis due to changes in interest rates, such amounts are recorded in other comprehensive loss, and are recognized in the Condensed Consolidated Statements of Operations only if the Company sells or intends to sell the security before recovery of its cost basis. There were no credit losses related to marketable debt securities recorded during the three months ended December 30, 2022. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Loss Contingencies</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;From time to time, the Company is involved in legal proceedings, claims and government inspections or investigations, customs and duties audits, other contingency matters, both inside and outside the United States, arising in the ordinary course of its business or otherwise.&#160;The Company accrues amounts for probable losses, to the extent they can be reasonably estimated, that it believes are adequate to address any liabilities related to legal proceedings and other loss contingencies that the Company believes will result in a probable loss (including, among other things, probable settlement value).&#160;A loss or a range of loss is disclosed when it is reasonably possible that a material loss will be incurred and can be estimated or when it is reasonably possible that the amount of a loss, when material, will exceed the recorded provision. When a loss contingency is probable but not reasonably estimable the nature of the contingency and the fact that an estimate cannot be made is disclosed.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Product Warranty</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company warrants most of its products for a specific period of time, usually 12 to 24 months from delivery or acceptance, against material defects. The Company provides for the estimated future costs of warranty obligations in cost of revenues when the related revenues are recognized. The accrued warranty costs represent the best estimate at the time of sale of the total costs that the Company will incur to repair or replace product parts that fail while still under warranty.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The amount of the accrued estimated warranty costs obligation for established products is primarily based on historical experience of product failures, adjusted for current information on repair costs.&#160;For new products, estimates include the historical experience of similar products, as well as a reasonable allowance for warranty expenses associated with new products.&#160;On a quarterly basis, the Company reviews the accrued warranty costs and updates the historical warranty cost trends, if required.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table reflects the changes in the Company&#8217;s accrued product warranty:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued product warranty, at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">New accruals charged to cost of revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Product warranty expenditures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued product warranty, at end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company determines if an arrangement is or contains a lease at the inception of an arrangement. The Company's operating lease right-of-use ("ROU") assets represent the right to use an underlying asset over the lease term and lease liabilities represent its obligation to make lease payments arising from the lease. ROU assets may also include initial direct costs incurred and prepaid lease payments, less lease incentives. Lease liabilities and their corresponding ROU assets are recognized based on the present value of lease payments over the lease term, discounted using the Company's incremental borrowing rate. The Company recognizes operating leases with lease terms of more than twelve months in operating lease assets, current operating lease liabilities, and operating lease liabilities on its Condensed Consolidated Balance Sheets. The Company recognizes finance leases with lease terms of more than twelve months in property, plant, and equipment, net, accrued liabilities and other current liabilities, and other long-term liabilities on its Condensed Consolidated Balance Sheets. For purposes of calculating lease liabilities and the corresponding ROU assets, the Company's lease term may include options to extend or terminate the lease when it is reasonably certain that it will exercise that option.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company&#8217;s revenues are derived primarily from the sale of hardware and services. The Company recognizes its revenues net of any value-added or sales tax and net of sales discounts.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company sells a high proportion of its X-ray products to a limited number of OEM customers. X-ray imaging components including X-ray tubes, digital detectors and image-processing tools and security and inspection products are generally sold on a stand-alone basis. However, the Company occasionally sells its digital detectors, X-ray tubes and imaging processing tools as a package that is optimized for digital X-ray imaging and sells its Linatron&#174; X-ray linear accelerators together with its image processing software and image detection products to OEM customers that incorporate them into their inspection or irradiation systems and processes. Service contracts are often sold with certain security and inspection products and computer-aided detection products.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company determines revenue recognition through the following steps:</span></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Identification of the contract, or contracts, with a customer</span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Identification of the performance obligations in the contract</span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Determination of the transaction price</span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Allocation of the transaction price to the performance obligations in the contract</span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Recognition of revenue when, or as, a performance obligation is satisfied</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Transaction Price and Allocation to Performance Obligations</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Transaction prices of products or services are typically based on contracted rates. To the extent that the transaction price includes variable consideration, the Company estimates the amount of variable consideration that should be included in the transaction price utilizing the expected value method when there is a large number of transactions with similar characteristics or the most likely amount method when there are two possible outcomes, depending on the circumstances of the transaction, to which the Company expects to be entitled. Variable consideration is included in the transaction price if, in the Company&#8217;s judgment, it is probable that a significant future reversal of cumulative revenue under the contract will not occur. Estimates of variable consideration and determination of whether to include estimated amounts in the transaction price are based largely on an assessment of the Company&#8217;s anticipated performance and all information (historical, current, and forecasted) that is reasonably available.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company allows customers to return specific parts of purchased X-ray tubes for a partial refund credit, which is identified as variable consideration. For sales with a right of return, revenue is reduced for expected returns, a liability is recorded for expected returns, and an asset is recorded for the right to recover products from customers on settling the liability. The Company recognizes a reduction to revenue and cost of sales at the time of sale and a corresponding contract liability and contract asset. The Company records this estimate based on the historical volume of product returns and adjusts the estimate on a quarterly basis based on the current quarter sales and current quarter returns.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;If a contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. Contracts that contain multiple performance obligations require an allocation of the transaction price based on the estimated relative standalone selling prices of the promised products or services underlying each performance obligation. The Company determines standalone selling prices based on the price at which the performance obligation could be sold separately.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contracts and Performance Obligations</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company accounts for a contract with a customer when there is an approval and commitment from both parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and collectability of the consideration is probable. The Company's performance obligations consist mainly of transferring control of products and services identified in the contracts or purchase orders. For each contract, the Company considers the obligation to transfer products and services to the customer, which are distinct, to be performance obligations.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recognition of Revenue</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Revenue is recognized when, or as, obligations under the terms of a contract are satisfied, which occurs when control of the promised products or services is transferred to customers. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring products or services to a customer.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Product revenue is generally recognized when the customer obtains control of the Company&#8217;s product, which occurs at a point in time, and may be upon shipment or upon delivery based on the contractual shipping terms of a contract.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Service revenue is generally recognized over the term of the service contract. Services are expected to be transferred to the customer throughout the term of the contract, and the Company believes recognizing revenue ratably over the term of the contract best depicts the transfer of value to the customer.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disaggregation of Revenue</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Revenue is disaggregated from contracts between geography and by reportable operating segment, which the Company believes best depicts how the nature, amount, timing, and uncertainty of revenues and cash flows are affected by economic factors. Refer to Note 15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Information, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">included in this report, for the disaggregation of the Company&#8217;s revenue based on reportable operating segments and Note 2, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the disaggregation of revenue by geographic region.&#160;&#160;&#160;&#160;</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Balances</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Contract assets are included within the prepaid expenses and other current assets, and other assets balances in the Condensed Consolidated Balance Sheets. Contract liabilities, which includes refund liabilities and deferred revenue, are included within the accrued liabilities and other current liabilities, deferred revenues, and other long-term liabilities balances in the Condensed Consolidated Balance Sheets. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Deferred revenue represents the Company's obligation to transfer goods and/or services to its customers for which it has already received consideration (or the amount is due) from the customer. The Company's deferred revenue balance primarily relates to contract advances and billings for warranty contracts.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Deferred revenue that is estimated to be recognized during the following twelve-month period is recorded as deferred revenues and the remaining portion is recorded as other long-term liabilities in the Condensed Consolidated Balance Sheets.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Costs to Obtain or Fulfill a Customer Contract</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company has certain costs to obtain and fulfill a customer contract, such as commissions and shipping costs. The Company recognizes the incremental costs of obtaining contracts as an expense when incurred if the amortization period of the assets that the Company otherwise would have recognized is one year or less. Incremental costs of obtaining contracts that would be recognized over more than one year are not material. The Company accounts for shipping and handling activities related to contracts with customers as costs to fulfill the promise to transfer the associated products. These costs are included as a component of cost of revenues.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In August 2020, the Financial Accounting Standards Board issued Accounting Standard Update ("ASU") 2020-06, Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity. The standard removed certain separation models in ASC 470-20 for convertible instruments, and, as a result, embedded conversion features are no longer separated from the host contract for convertible instruments with conversion features that are not required to be accounted for as derivatives under ASC 815. These convertible debt instruments are accounted for as a single liability measured at amortized cost. This results in the interest expense recognized for convertible debt instruments to be typically closer to the coupon interest rate. Further, the ASU made amendments to the earnings per share (&#8220;EPS&#8221;) guidance in Topic 260 for convertible instruments, the most significant impact of which was requiring the use of the if-converted method for diluted EPS calculation, and no longer allowing the net share settlement method. The Company adopted this ASU on October 1, 2022, using the modified retrospective method. On the date of adoption, the Company recorded an entry to reduce additional paid-in capital by $34.6&#160;million, increase long-term debt, net by $28.0&#160;million, decrease deferred tax assets by $0.1&#160;million, and increase retained earnings by $6.5&#160;million for the after-tax impact of previously recognized amortization of the debt discount associated with the Company&#8217;s Convertible Notes (as defined herein). The unamortized discount on the Company's Convertible Notes (see Note 10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Borrowings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) was derecognized in the first quarter of fiscal year 2023 and the interest expense from its Convertible Notes decreased and became closer to the coupon rate of 4.00%. The impact that the adoption of ASU 2020-06 has on the Company's net income per diluted share will depend on the amount of earnings in each period and the Company's share price and could result in additional dilution.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI https://asc.fasb.org/topic&amp;trid=2197479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI https://asc.fasb.org/topic&amp;trid=2134479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI https://asc.fasb.org/topic&amp;trid=2122394<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139750436384048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">REVENUE</a></td>
<td class="text">REVENUE<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disaggregation of Revenue</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Revenue is disaggregated from contracts by geographic region and by reportable operating segment, which the Company believes best depicts how the nature, amount, timing, and uncertainty of revenues and cash flows are affected by economic factors.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table disaggregates the Company&#8217;s revenue by geographic region:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.568%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Americas</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">74.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">EMEA</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">APAC</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">205.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">198.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Revenue in the United States was $74.1 million and $58.8 million for the three months ended December 30, 2022 and December&#160;31, 2021, respectively.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our products are sold in three geographic regions: the Americas, EMEA, and APAC. The Americas includes North America (primarily the United States) and Latin America. EMEA includes Europe, Russia, the Middle East, India and Africa. APAC includes Asia (other than India) and Australia. Revenues by region are based on the known final destination of products sold.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Refer to Note 15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for the disaggregation of the Company&#8217;s revenue based on reportable operating segments.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract Balances</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table summarizes the changes in the contract assets and refund liabilities for the three months ended December 30, 2022 and December&#160;31, 2021:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.568%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Contract Assets</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Costs recovered from product returns during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract asset from shipments of products, subject to return during the period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.568%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Refund Liabilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Release of refund liability included in beginning of year refund liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additions to refund liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During the three months ended December 30, 2022, the Company recognized revenue of $4.2&#160;million related to deferred revenues which existed at September&#160;30, 2022. During the three months ended December&#160;31, 2021, the Company recognized revenue of $4.1&#160;million related to deferred revenues that existed at October&#160;1, 2021.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI https://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139750432438960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">LEASES</a></td>
<td class="text">LEASES<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company has operating and finance leases for office space, warehouse and manufacturing space, vehicles and certain equipment. During fiscal year 2022, the Company recorded a loss due to abandonment of $1.9&#160;million, which is included in selling, general and administrative on the Condensed Consolidated Statements of Operations. The following table presents supplemental balance sheet information related to the Company's operating and finance leases: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.511%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.569%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Operating lease assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance lease right-of-use assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjEyNTNlNzQwNjAwMzRlZjM4YmM3ZDQyNjA2OTE4NGNiL3RhYmxlcmFuZ2U6MTI1M2U3NDA2MDAzNGVmMzhiYzdkNDI2MDY5MTg0Y2JfMy0xLTEtMS04MzI4NQ_6fed9dde-ecf9-4697-bdfd-bda3b6c18e81"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjEyNTNlNzQwNjAwMzRlZjM4YmM3ZDQyNjA2OTE4NGNiL3RhYmxlcmFuZ2U6MTI1M2U3NDA2MDAzNGVmMzhiYzdkNDI2MDY5MTg0Y2JfMy0xLTEtMS04MzI4NQ_7db859ec-ae05-400b-a6ff-3ee55890f062">Property, plant, and equipment, net</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liabilities (current) </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Current operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance lease liabilities (current) </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjEyNTNlNzQwNjAwMzRlZjM4YmM3ZDQyNjA2OTE4NGNiL3RhYmxlcmFuZ2U6MTI1M2U3NDA2MDAzNGVmMzhiYzdkNDI2MDY5MTg0Y2JfNi0xLTEtMS04MzI4NQ_21d67cfe-4f11-4971-a007-53438e019ae1"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjEyNTNlNzQwNjAwMzRlZjM4YmM3ZDQyNjA2OTE4NGNiL3RhYmxlcmFuZ2U6MTI1M2U3NDA2MDAzNGVmMzhiYzdkNDI2MDY5MTg0Y2JfNi0xLTEtMS04MzI4NQ_651facb0-63c0-4af0-8d59-d1e007979e09">Accrued liabilities and other current liabilities</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liabilities (non-current)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance lease liabilities (non-current)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjEyNTNlNzQwNjAwMzRlZjM4YmM3ZDQyNjA2OTE4NGNiL3RhYmxlcmFuZ2U6MTI1M2U3NDA2MDAzNGVmMzhiYzdkNDI2MDY5MTg0Y2JfOC0xLTEtMS04MzI4NQ_0e1c436b-8779-4e63-90c2-6287c33ec16d"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjEyNTNlNzQwNjAwMzRlZjM4YmM3ZDQyNjA2OTE4NGNiL3RhYmxlcmFuZ2U6MTI1M2U3NDA2MDAzNGVmMzhiYzdkNDI2MDY5MTg0Y2JfOC0xLTEtMS04MzI4NQ_8cf1f2a5-8b40-40ac-84e4-96b9a215a402">Other long-term liabilities</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table provides information related to the Company&#8217;s operating and finance leases:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.568%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating lease costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total finance lease costs</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financing cash flows from finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total cash paid for amounts included in the measurement of lease liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncash operating right-of-use assets obtained in exchange for new lease liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Includes variable and short-term lease expense, which were immaterial for the three months ended December 30, 2022 and December&#160;31, 2021.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeasesTextBlock', window );">LEASES</a></td>
<td class="text">LEASES<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company has operating and finance leases for office space, warehouse and manufacturing space, vehicles and certain equipment. During fiscal year 2022, the Company recorded a loss due to abandonment of $1.9&#160;million, which is included in selling, general and administrative on the Condensed Consolidated Statements of Operations. The following table presents supplemental balance sheet information related to the Company's operating and finance leases: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.511%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.569%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Operating lease assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance lease right-of-use assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjEyNTNlNzQwNjAwMzRlZjM4YmM3ZDQyNjA2OTE4NGNiL3RhYmxlcmFuZ2U6MTI1M2U3NDA2MDAzNGVmMzhiYzdkNDI2MDY5MTg0Y2JfMy0xLTEtMS04MzI4NQ_6fed9dde-ecf9-4697-bdfd-bda3b6c18e81"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjEyNTNlNzQwNjAwMzRlZjM4YmM3ZDQyNjA2OTE4NGNiL3RhYmxlcmFuZ2U6MTI1M2U3NDA2MDAzNGVmMzhiYzdkNDI2MDY5MTg0Y2JfMy0xLTEtMS04MzI4NQ_7db859ec-ae05-400b-a6ff-3ee55890f062">Property, plant, and equipment, net</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liabilities (current) </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Current operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance lease liabilities (current) </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjEyNTNlNzQwNjAwMzRlZjM4YmM3ZDQyNjA2OTE4NGNiL3RhYmxlcmFuZ2U6MTI1M2U3NDA2MDAzNGVmMzhiYzdkNDI2MDY5MTg0Y2JfNi0xLTEtMS04MzI4NQ_21d67cfe-4f11-4971-a007-53438e019ae1"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjEyNTNlNzQwNjAwMzRlZjM4YmM3ZDQyNjA2OTE4NGNiL3RhYmxlcmFuZ2U6MTI1M2U3NDA2MDAzNGVmMzhiYzdkNDI2MDY5MTg0Y2JfNi0xLTEtMS04MzI4NQ_651facb0-63c0-4af0-8d59-d1e007979e09">Accrued liabilities and other current liabilities</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liabilities (non-current)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance lease liabilities (non-current)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjEyNTNlNzQwNjAwMzRlZjM4YmM3ZDQyNjA2OTE4NGNiL3RhYmxlcmFuZ2U6MTI1M2U3NDA2MDAzNGVmMzhiYzdkNDI2MDY5MTg0Y2JfOC0xLTEtMS04MzI4NQ_0e1c436b-8779-4e63-90c2-6287c33ec16d"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjEyNTNlNzQwNjAwMzRlZjM4YmM3ZDQyNjA2OTE4NGNiL3RhYmxlcmFuZ2U6MTI1M2U3NDA2MDAzNGVmMzhiYzdkNDI2MDY5MTg0Y2JfOC0xLTEtMS04MzI4NQ_8cf1f2a5-8b40-40ac-84e4-96b9a215a402">Other long-term liabilities</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table provides information related to the Company&#8217;s operating and finance leases:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.568%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating lease costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total finance lease costs</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financing cash flows from finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total cash paid for amounts included in the measurement of lease liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncash operating right-of-use assets obtained in exchange for new lease liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Includes variable and short-term lease expense, which were immaterial for the three months ended December 30, 2022 and December&#160;31, 2021.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeFinanceLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeFinanceLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139750435498336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY TRANSACTIONS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">RELATED PARTY TRANSACTIONS</a></td>
<td class="text">RELATED-PARTY TRANSACTIONS<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investment in Privately-Held Companies</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company has a 40% ownership interest in dpiX Holding LLC (&#8220;dpiX Holding&#8221;), a holding company that has a 100% ownership interest in dpiX LLC (&#8220;dpiX&#8221;), a supplier of amorphous silicon-based thin film transistor arrays for flat panels used in its digital image detectors. In accordance with the dpiX Holding operating agreement, net profits or losses are allocated to the members in accordance with their ownership interests.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The investment in dpiX Holding is accounted for under the equity method of accounting. When the Company recognizes its share of net profits or losses of dpiX Holding, profits or losses in inventory purchased from dpiX are eliminated. During the three months ended December 30, 2022 and December&#160;31, 2021, the Company recorded income (loss) on the equity investment in dpiX Holding of $2.0 million and $(0.7) million, respectively. The income and loss on the equity investment in dpiX Holding are included in other expense, net in the Condensed Consolidated Statements of Operations. The carrying value of the equity investment in dpiX Holding was $44.4 million and $42.4 million at December&#160;30, 2022 and September&#160;30, 2022, respectively.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During the three months ended December 30, 2022 and December&#160;31, 2021, the Company purchased glass transistor arrays from dpiX totaling $5.0 million and $5.2 million, respectively. These purchases of glass transistor arrays are included as a component of inventories on the Condensed Consolidated Balance Sheets or cost of revenues in the Condensed Consolidated Statements of Operations.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of December&#160;30, 2022, and September&#160;30, 2022, the Company had accounts payable to dpiX totaling $3.3 million and $3.1&#160;million, respectively. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; The Company has the right to 50% of dpiX&#8217;s total manufacturing capacity. In addition, the Company is required to pay for 50% of dpiX's fixed costs, as determined at the beginning of each calendar year. In January 2023, the Company's fixed cost commitment was determined and approved by the dpiX board of directors to be $13.1 million for calendar year 2023. The amended agreement will continue unless the ownership structure of dpiX changes (as defined in the amended agreement).</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company has determined that dpiX Holding is a variable interest entity because at-risk equity holders, as a group, lack the characteristics of a controlling financial interest. Majority votes are required to direct the manufacturing activities, legal operations and other activities that most significantly affect dpiX&#8217;s economic performance. The Company does not have majority voting rights and no power to unilaterally direct the activities of dpiX Holding and therefore is not the primary beneficiary of dpiX Holding. The Company&#8217;s exposure to loss as a result of its involvement with dpiX Holding is limited to the carrying value of the Company&#8217;s investment of $44.4&#160;million and fixed cost commitments.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In November 2018, the Company (through one of its wholly-owned subsidiaries) and CETTEEN GmbH (&#8220;CETTEEN&#8221;), formed a German limited liability company that governs the affairs and conduct of the business of VEC Imaging GmbH &amp; Co. KG (&#8220;VEC&#8221;), a joint venture formed to develop technology for use in X-ray imaging components. In accordance with the VEC agreement, net profits or losses are allocated to the members in accordance with their ownership interest. The Company's investment in VEC is accounted for under the equity method of accounting. The Company has determined that VEC is a variable interest entity.</span></div>&#160;&#160;&#160;&#160;During the three months ended December 30, 2022, and December&#160;31, 2021, the Company recorded a loss on the equity investment in VEC of $0.3 million and $0.1 million, respectively. The Company's investment in VEC was $2.2 million and $2.5 million at December&#160;30, 2022 and September&#160;30, 2022, respectively. As of December&#160;30, 2022 and September&#160;30, 2022 the Company had loans outstanding to VEC totaling $0.6 million, and other receivables from VEC of $0.4 million and $0.3 million at December&#160;30, 2022 and September&#160;30, 2022, respectively, which are recorded in prepaid expenses and other current assets in the Condensed Consolidated Balance Sheets.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI https://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139750436485744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESTRUCTURING<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock', window );">RESTRUCTURING</a></td>
<td class="text">RESTRUCTURING<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In July 2018, the Company committed to relocate the production of amorphous silicon glass for digital detectors from its Santa Clara facility to the dpiX fabrication facility in Colorado. In July 2019, the Company committed to close its Santa Clara facility and to relocate the remaining production to its other existing facilities.&#160;The Company ceased all operations at the Santa Clara facility as of October 2, 2020, and all activities related to the closure of the facility were completed by the end of December 2020.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Cash outflows associated with these restructuring charges are limited to employee termination expenses, facility closure and equipment sales and disposals. Below is a detail of restructuring charges incurred during the three months ended December 30, 2022 and December&#160;31, 2021, respectively, which predominantly relate to the Company's Medical segment:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:27.650%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:35.427%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.569%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Location of Restructuring Charges in Condensed Consolidated Statements of Operations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets impairment charges</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(e))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -URI https://asc.fasb.org/topic&amp;trid=2175745<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139750438001888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES</a></td>
<td class="text">FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As part of the Company&#8217;s overall risk management practices, the Company enters into financial derivatives to manage its financial exposures to foreign currency exchange rates and interest rates.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company records all derivatives on the Condensed Consolidated Balance Sheets at fair value. The accounting for changes in the fair value of derivatives depends on the intended use of the derivative, whether the Company has elected to designate a derivative in a hedging relationship and apply hedge accounting, and whether the hedging relationship has satisfied the criteria necessary to apply hedge accounting. A qualitative assessment of hedge effectiveness is performed on a quarterly basis, unless facts and circumstances indicate the hedge may no longer be highly effective, in which case the Company would test for effectiveness on a more frequent basis. The changes in fair value for all trades that are not designated for hedge accounting are recognized in current period income. The Company does not offset fair value amounts recognized for derivative instruments in its Condensed Consolidated Balance Sheets for presentation purposes.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Credit risk related to derivative transactions reflects the risk that a party to the transaction could fail to meet its obligation under the derivative contracts. Therefore, the Company&#8217;s exposure to the counterparty&#8217;s credit risk is generally limited to the amounts, if any, by which the counterparty&#8217;s obligations to the Company exceed the Company&#8217;s obligations to the counterparty. The Company&#8217;s policy is to enter into contracts only with financial institutions that meet certain minimum credit ratings to help mitigate counterparty credit risk.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivatives Designated as Hedging Instruments - Net Investment Hedges</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company&#160;uses cross currency swap contracts as net investment hedges to manage its risk of variability in foreign currency-denominated net investments in wholly-owned international operations. All changes in fair value of the derivatives designated as net investment hedges are reported in&#160;accumulated other comprehensive income along with the foreign currency translation adjustments on those investments. During the three months ended December 30, 2022, the Company terminated all three of its previously outstanding cross currency swap contracts which resulted in cash received upon settlement of $7.3 million. The gain on the swap was recorded in accumulated other comprehensive income where it will remain until such time that substantial liquidation of the international operations should occur. Concurrent with the termination of the previous cross currency swaps, the Company entered into two new cross currency swaps which have been designated as net investment hedges.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of&#160;December&#160;30, 2022, the Company had the following outstanding derivatives designated as net investment hedging instruments:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions, except number of instruments)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of Instruments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Notional Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table summarizes the amount of pre-tax income recognized from derivative instruments for the periods indicated and the line items in the accompanying statements of operations where the results are recorded for net investment hedges:</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.666%"><tr><td style="width:1.0%"/><td style="width:26.342%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.583%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.403%"/><td style="width:0.1%"/></tr><tr style="height:48pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount of (Loss) Gain Recognized in OCI on Derivative<br/>Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Location of Gain Recognized in Income on Derivative (Amount Excluded from Effectiveness Testing)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount of Gain Recognized in Income on Derivative (Amount Excluded from Effectiveness Testing)<br/>Three Months Ended</span></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 2.12pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;These derivative instruments are subject to master netting agreements giving effect to rights of offset with each counterparty. None of the balances were eligible for netting. The following table summarizes the gross fair values of derivative instruments as of the periods indicated and the line items in the accompanying Condensed Consolidated Balance Sheets where the instruments are recorded:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.844%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.483%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.594%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.597%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivative Assets and Liabilities</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives Designated as Net Investment Hedges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI https://asc.fasb.org/topic&amp;trid=2229140<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=d3e90205-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139750435609904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">FAIR VALUE</a></td>
<td class="text">FAIR VALUE<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets and Liabilities Measured at Fair Value on a Recurring Basis</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The fair values of certain of the Company&#8217;s financial instruments, including bank deposits included in cash and cash equivalents, accounts receivable, net and accounts payable, approximate their fair values due to their short maturities. As of December&#160;30, 2022, the fair values of the Company's Convertible Notes and Senior Secured Notes, as defined in Note 10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Borrowings </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and measured using Level 1 inputs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> were $229.0 million and $239.3 million, respectively. As of September&#160;30, 2022, the fair values of the Company's Convertible Notes and Senior Secured Notes, measured using Level 1 inputs, were $250.2 million and $241.3 million, respectively. The Company has elected to use the income approach to value its derivative instruments using standard valuation techniques and Level 2 inputs, such as currency spot rates, forward points and credit default swap spreads.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In the tables below, the Company has segregated all assets and liabilities that are measured at fair value on a recurring basis into the most appropriate level within the fair value hierarchy based on the inputs used to determine the fair value at the measurement date.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value at December 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Quoted Prices in Active Markets for Identical Assets and Liabilities</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Level 1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Significant Other</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Observable Inputs</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Level 2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Significant Unobservable Inputs</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Level 3)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate notes/bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government agencies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. Treasury bills</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivative assets</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred compensation plan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Marketable equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfMTAtMC0xLTEtODMyODU_79a5037b-581b-47d3-9fd4-71603055d303">Total assets measured at fair value</span></span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 16.75pt;text-indent:-9pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Liabilities:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivative liabilities</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfMTYtMC0xLTEtMTAwNTk3_169dbe7d-a10b-4a1e-ab46-42af80460820">Total liabilities measured at fair value</span></span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value at September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Quoted Prices in Active Markets for Identical Assets and Liabilities</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Level 1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Significant Other</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Observable Inputs</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Level 2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Significant Unobservable Inputs</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Level 3)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Assets:</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate notes/bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government agencies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. Treasury bills</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivative assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred compensation plan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Marketable equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfOC0wLTEtMS04MzI4NQ_417fadeb-557f-4f83-a995-e688c949e009">Total assets measured at fair value</span></span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">72.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivative liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfMTMtMC0xLTEtODMyODU_54db5ac7-0c5e-4cf6-bc9b-f0229d68f729">Total liabilities measured at fair value</span></span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The assets held under the Company's deferred compensation plan are classified in Level 1 as they relate primarily to publicly traded mutual funds for which there are observable market prices in active markets.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Marketable Debt Securities</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following tables summarize the Company's marketable debt securities:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.511%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.569%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Amortized Costs</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commercial paper</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate notes/bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. Treasury bills</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government agencies</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total marketable debt securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.511%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.569%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Amortized Costs</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commercial paper</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate notes/bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. Treasury bills</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government agencies</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total marketable debt securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The contractual maturities of marketable debt securities as of December&#160;30, 2022, are shown in the table below. Actual maturities may differ from contractual maturities because borrowers may have the right to call or prepay obligations.</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Amortized Costs</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contractual maturities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Due within one year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Due after one year through five years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total marketable debt securities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During the three months ended December&#160;30, 2022, there were no gross realized gains or losses from the sale of certain marketable debt securities that were reclassified out of accumulated other comprehensive income.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following tables summarize the balance sheet locations for marketable debt securities:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:27.511%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.650%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.650%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.650%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.650%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.652%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Commercial paper</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Corporate notes/bonds</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Government agencies</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Treasury bills</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total marketable debt securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:27.650%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.511%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.650%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.650%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.650%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.652%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Commercial paper</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Corporate notes/bonds</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Government agencies</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Treasury bills</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total marketable debt securities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139750435609904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">INVENTORIES</a></td>
<td class="text">INVENTORIES<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table summarizes the Company&#8217;s inventories:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Raw materials and parts</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">247.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">240.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total inventories</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">320.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">303.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI https://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139750435609904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">GOODWILL AND INTANGIBLE ASSETS</a></td>
<td class="text">GOODWILL AND INTANGIBLE ASSETS<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table reflects goodwill by reportable operating segment:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.511%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.569%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Medical</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Industrial</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at September 30, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">169.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">115.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">284.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Balance at December 30, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">171.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">116.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">288.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table reflects the gross carrying amount and accumulated amortization of the Company&#8217;s finite-lived intangible assets included in other assets in the Condensed Consolidated Balance Sheets:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:26.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.150%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.427%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.427%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.150%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.427%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.156%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated Amortization</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated Amortization</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net Carrying Amount</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:9pt;padding-right:2.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquired existing technology</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">71.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(52.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(49.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:9pt;padding-right:2.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patents, licenses and other</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:9pt;padding-right:2.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer contracts and supplier relationship</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(38.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(36.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:6.75pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total intangible assets</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">134.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(102.6)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">131.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(98.3)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Amortization expense for intangible assets was $3.4 million and $3.8 million for the three months ended December 30, 2022 and December&#160;31, 2021, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI https://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139750437918704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BORROWINGS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">BORROWINGS</a></td>
<td class="text">BORROWINGS<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table summarizes the Company's short-term and long-term debt:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.733%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.015%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions, except for percentages)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Contractual Interest Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Effective Interest Rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current maturities of long-term debt</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other debt</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Non-current maturities of long-term debt:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Convertible Senior Unsecured Notes</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.0%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.8%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Secured Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">243.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">243.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.9%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.2%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total non-current maturities of long-term debt:</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">447.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">447.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unamortized issuance costs and debt discounts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unamortized discount - Convertible Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(28.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unamortized issuance costs - Convertible Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unamortized issuance costs - Senior Secured Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(6.8)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(35.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total debt outstanding, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">442.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">414.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity component of Convertible Senior Unsecured Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> In connection with the adoption of ASU 2020-06, the unamortized discount related to the Convertible Notes was derecognized and the carrying value of the issuance costs was adjusted in the first quarter of fiscal year 2023. Refer to Note 1, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Summary of Significant Accounting Policies </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">for further details. </span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Included in additional paid-in capital on the Condensed Consolidated Balance Sheets.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table summarizes the Company's interest expense:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.568%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contractual interest coupon and other</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of debt discounts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total interest expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">7.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">9.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Convertible Senior Unsecured Notes</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On June 9, 2020, Varex issued $200.0&#160;million in aggregate principal amount of 4.00% Convertible Senior Unsecured Notes due 2025 (&#8220;Convertible Notes&#8221;). The net proceeds from the issuance of the Convertible Notes, after deducting transaction fees and offering expense payable by the Company, were approximately $193.1&#160;million. The Convertible Notes bear interest at the annual rate of 4.00%, payable semiannually on June 1 and December 1 of each year, beginning on December 1, 2020, and will mature on June 1, 2025, unless earlier converted or repurchased by Varex.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Convertible Notes are convertible into cash, shares of Varex common stock or a combination thereof, at Varex's election, at an initial conversion rate of 48.048 shares of common stock per $1,000 principal amount of Convertible Notes, which is equivalent to an initial conversion price of approximately $20.81 per share, subject to adjustment pursuant to the terms of the indenture governing the Convertible Notes. The Convertible Notes may be converted at any time after, and including, December 15, 2024 until the close of business on the second scheduled trading day immediately before the maturity date. The maximum number of shares issuable upon conversion of the Convertible Notes is 9.6&#160;million.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Call Spread </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On June 4, 2020 and June 5, 2020, in connection with the offering of the Convertible Notes, Varex entered into privately negotiated convertible note hedge transactions (collectively, the &#8220;Hedge Transactions&#8221;). The Hedge Transactions cover, subject to customary anti-dilution adjustments, the number of shares of Varex common stock that were initially covered by the Convertible Notes. The Hedge Transactions are expected generally to reduce the potential dilution and/or offset any cash payments Varex is required to make in excess of the principal amount due upon conversion of the Convertible Notes in the event that the market price of Varex common stock is greater than the strike price of the Hedge Transactions, which was initially $20.81 per share (subject to adjustment under the terms of the Hedge Transactions). The strike price of $20.81 corresponds to the initial conversion price of the Convertible Notes. The number of shares underlying the Hedge Transactions is 9.6&#160;million.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On June 4, 2020 and June 5, 2020, Varex also entered into privately negotiated warrant transactions (collectively, the &#8220;Warrant Transactions&#8221; and, together with the Hedge Transactions, the &#8220;Call Spread Transactions&#8221;), whereby the Company sold warrants at a higher strike price relating to the same number of shares of Varex common stock that were initially covered by the Convertible Notes, subject to customary anti-dilution adjustments. The initial strike price of the warrants is $24.975 per share (subject to adjustment under the terms of the Warrant Transactions), which was 50% above the last reported sale price of Varex common stock on June 4, 2020. The Warrant Transactions could have a dilutive effect to the Company's stockholders to the extent that the market price per share of Varex common stock, as measured under the terms of the Warrant Transactions, exceeds the applicable strike price of the warrants. The number of shares underlying the Warrant Transactions is 9.6&#160;million. The number of warrants outstanding as of December&#160;30, 2022 was 9.6&#160;million.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Senior Secured Notes</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Varex issued $300.0&#160;million aggregate principal amount of 7.875% Senior Secured Notes due 2027 (the "Senior Secured Notes") pursuant to an indenture dated September 30, 2020. Interest payments are paid semiannually on April 15 and October 15 of each year, beginning on April 15, 2021. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Senior Secured Notes are secured by a first priority lien on substantially all of the assets of Varex and the assets and capital stock of its subsidiary guarantors (subject to exceptions), except for assets for which a first priority security interest is pledged for the ABL Facility (defined below), in which the Senior Secured Notes will have a second lien security interest. The Senior Secured Notes include negative covenants, subject to certain exceptions, restricting or limiting Varex's ability and the ability of its restricted subsidiaries to, among other things, incur liens on collateral; sell certain assets; incur additional indebtedness; pay dividends; issue preferred shares; consolidate, merge, or sell all or substantially all of its assets; and enter into certain transactions with their affiliates.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Asset-Based Loan</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On September 30, 2020, the Company entered into a revolving credit agreement consisting of a $100.0&#160;million asset-based loan revolving credit facility (the &#8220;Asset-Based Loan&#8221; or "ABL Facility"). Borrowings under the Asset-Based Loan bear interest at floating rates based on the Secured Overnight Financing Rate ("SOFR"), or a comparable rate, or a base rate, and an applicable margin based on Average Daily Excess Availability (as defined in the Asset-Based Loan Agreement). In addition, the Company is required to pay a quarterly commitment fee of 0.25%, based on the aggregate unused commitments under the Asset-Based Loan.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The ABL Facility matures on the earlier of September 30, 2025 or 91 days prior to the maturity of the Convertible Notes, at which time all outstanding amounts under the ABL Facility will be due and payable. The maximum availability under the ABL Facility is $100.0 million; however, the borrowing base under the ABL Facility fluctuates from month-to-month depending on the amount of eligible accounts receivable, inventory, and real estate. As of December&#160;30, 2022, the amount available under the ABL Facility was $92.0&#160;million and the ABL Facility remains undrawn.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The ABL Facility includes various restrictive covenants that limit the Company's ability to engage in certain transactions, including the incurrence of debt, payment of dividends and other restrictive payments, existence of restrictions affecting subsidiaries, sales of stock and assets, certain affiliate transactions, modifications of debt documents and organizational documents, changes to line of business and fiscal year, incurrence of liens, making fundamental changes, prepayments of junior indebtedness, and certain other transactions.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139750435609904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NONCONTROLLING INTERESTS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestAbstract', window );"><strong>Noncontrolling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDisclosureTextBlock', window );">NONCONTROLLING INTERESTS</a></td>
<td class="text">NONCONTROLLING INTERESTS<div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In September 2018, the Company entered into a partnership in Saudi Arabia. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has majority voting rights with an approximate 75% interest. Accordingly, the Company has consolidated the operations of the Saudi Arabia partnership in its condensed consolidated financial statements and recorded the noncontrolling interests. The noncontrolling interest related to the partner&#8217;s 25% interest in the joint venture is included in noncontrolling interests in the equity section of the Company&#8217;s Condensed Consolidated Balance Sheets. Income representing the noncontrolling partner's share of income from operations is included in the Company's Condensed Consolidated Statements of Operations.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In April 2015, the Company acquired 73.5% of the then outstanding shares of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MeVis Medical Solutions AG (&#8220;MeVis&#8221;)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, a publicly traded company based in Bremen, Germany that provides image processing software and services for cancer screening. In August 2015, the Company, through one of its German subsidiaries, entered into a Domination and Profit and Loss Transfer Agreement (the &#8220;DPLTA&#8221;) with MeVis. In fiscal years 2017 and 2018, the Company purchased an additional 0.2% of outstanding shares such that the Company now owns 73.7% of the outstanding shares of common stock of MeVis. Under the DPLTA, MeVis subordinates its management to the Company and undertakes to transfer all its annual profits and losses to the Company. In return, the DPLTA grants the noncontrolling shareholders of MeVis an annual recurring net compensation of &#8364;0.95 per MeVis share. At December&#160;30, 2022, noncontrolling shareholders together held approximately 0.5 million shares of MeVis, representing 26.3% of the outstanding shares.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Changes in noncontrolling interests were as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interests, at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interests, at end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for noncontrolling interest in consolidated subsidiaries, which could include the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI https://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139750435491024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET INCOME PER SHARE<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">NET INCOME PER SHARE</a></td>
<td class="text">NET INCOME PER SHARE<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Basic net income per common share is computed by dividing the net income for the period by the weighted average number of shares of common stock outstanding during the reporting period. Diluted net income per common share reflects the effects of potentially dilutive securities, which is computed by dividing net income by the sum of the weighted average number of common shares outstanding and dilutive common shares.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;A reconciliation of the numerator and denominator used in the calculation of basic and diluted net income common share is as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.568%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions, except per share amounts)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Net income per share - basic</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net income attributable to Varex</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Basic weighted average shares outstanding</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Basic net income per share attributable to Varex</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.08&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.04&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 13pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Net income per share - diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net income attributable to Varex</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 10pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic weighted average shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dilutive effect of Convertible Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dilutive effect of share-based awards and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dilutive effect of warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted weighted average shares outstanding</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted net income per share attributable to Varex</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.08&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.03&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 10pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Anti-dilutive share summary</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:15pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted stock and options</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Convertible notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 4pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total anti-dilutive shares</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Potentially dilutive shares, which are based on the weighted-average shares of common stock underlying stock options, unvested stock awards, purchase rights granted under the employee stock purchase plan, warrants and Convertible Notes using the treasury stock method or the if-converted method, as applicable, are included when calculating diluted net income per share attributable to Varex when their effect is dilutive. As of October 1, 2022, the Company adopted ASU 2020-06 using the modified retrospective method. The standard requires the Company to apply the if-converted method in relation to the Convertible Notes, which requires the Company to assume that the Convertible Notes were converted using only share settlement at the beginning of the period, resulting in an additional 9.6&#160;million shares outstanding. Using this method, the numerator is affected by adding back interest expense and the denominator is affected by including the effect of potential share settlement, if the effect is dilutive. Prior to the adoption of ASU 2020-06, the Convertible Notes were accounted for using the treasury stock method for the purposes of net income per share. See Note 1, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Summary of Significant Accounting Policies, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">"Recently Adopted Accounting Pronouncements" for further details concerning the adoption of ASU 2020-06). Furthermore, in connection with the offering of the Convertible Notes, the Company entered into convertible note hedges and warrants (see Note 10, Borrowings). However, the Company's convertible note hedges are not included when calculating potentially dilutive shares since their effect is always anti-dilutive.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139750435609904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EMPLOYEE STOCK PLANS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">EMPLOYEE STOCK PLANS</a></td>
<td class="text">EMPLOYEE STOCK PLANS<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-Based Compensation Expense</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Share-based compensation expense recognized in the Condensed Consolidated Statements of Operations is based on awards ultimately expected to vest. Share-based compensation expense includes expenses related to the Company&#8217;s direct employees.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The table below summarizes the effect of recording share-based compensation expense and the option component of the employee stock purchase plan shares:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.568%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Selling, general and administrative</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total share-based compensation expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Option Activity</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table summarizes the activity for stock options under Varex&#8217;s employee incentive plans for the Company's employees:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.705%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.987%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands, except per share amounts and the remaining term)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Price Range</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Weighted Average Exercise Price</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Weighted Average Remaining Term (in years)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Aggregate Intrinsic Value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at September 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,902&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$13.61 - $37.60</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28.97&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,361.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">385&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$22.13 </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22.13&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canceled, expired or forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(196)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$25.06 - $37.10</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Outstanding at December 30, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,091&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$13.61 - $37.60</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27.96&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,209.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exercisable at December 30, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,070&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$13.61 - $37.60</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29.52&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">672.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> The aggregate intrinsic value represents the total pre-tax intrinsic value, which is computed based on the difference between the exercise price and the closing price of Varex common stock of $20.30 as of December&#160;30, 2022, the last trading date of the Company's first quarter, and which represents the amount that would have been received by the option holders had all option holders exercised their options and sold the shares received upon exercise as of that date.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock Units, Restricted Stock Awards and Deferred Stock Units </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table summarizes the activity for restricted stock units, restricted stock awards and deferred stock units under Varex&#8217;s 2020 Omnibus Stock Plan and 2017 Omnibus Stock Plan:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.762%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands, except per share amounts)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number&#160;of&#160;Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted&#160;Average Grant-Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at September 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,045&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.35&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">492&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.12&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23.70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canceled or expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25.50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Outstanding at December 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,506&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22.95&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139750428895232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>TAXES ON INCOME<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">TAXES ON INCOME</a></td>
<td class="text">TAXES ON INCOME<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the three months ended December 30, 2022, the Company recognized income tax expense of $2.2 million on $5.4 million of pre-tax income. For the three months ended December&#160;31, 2021, the Company recognized income tax expense of $1.7 million on $3.3 million of pre-tax income. The Company is unable to recognize a tax benefit for pre-tax book losses in certain foreign jurisdictions but has recognized tax expense for profitable foreign jurisdictions.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's tax expense for the three months ended December 30, 2022 increased, primarily due to increased pre-tax income in certain jurisdictions, valuation allowance positions in the U.S. on deferred tax attributes, and losses in certain foreign jurisdictions for which no benefit can be recorded. </span></div>&#160;&#160;&#160;&#160;The Company is maintaining its reinvestment assertion with respect to foreign earnings for the three months ended December 30, 2022, which is that all earnings prior to fiscal year 2018 are permanently reinvested for all countries, and that all earnings for Direct Conversion, located primarily in Sweden and Finland, are also indefinitely reinvested in those countries, but post fiscal year 2017 earnings in all other countries are not permanently reinvested. Due to the level of earnings available for repatriation, the treaty benefits applicable to jurisdictions in which those earnings are located, and the now favorable U.S. tax treatment of repatriated foreign earnings, the amount of deferred tax liability recorded related to the potential repatriation is approximately $0.1&#160;million. This estimated liability is for U.S. state income taxes and foreign withholding taxes that would apply if the foreign earnings were repatriated in the form of a dividend.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139750435491024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT INFORMATION<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">SEGMENT INFORMATION</a></td>
<td class="text">SEGMENT INFORMATION<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company has two reportable operating segments: Medical and Industrial, which aligns with how the CODM reviews the Company&#8217;s performance and evaluates the business for the allocation of resources. The segments align the Company&#8217;s products and service offerings with customer use in medical and industrial markets. The CODM allocates resources to and evaluates the financial performance of each operating segment primarily based on revenues and gross profit. The reportable operating segment structure provides alignment between business strategies and operating results.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Description of Segments</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Medical segment designs, manufactures, sells and services X-ray imaging components, including X-ray tubes, digital detectors, ionization chambers and buckys, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers. These components are used in a range of medical imaging applications including CT, mammography, oncology, cardiac, surgery, dental, and other diagnostic radiography uses.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Industrial segment designs, develops, manufactures, sells and services X-ray imaging products for use in a number of markets, including security applications for cargo screening at ports and borders and baggage screening at airports, and nondestructive testing, irradiation and inspection applications used in a number of other vertical markets. The Company's industrial products include Linatron&#174; X-ray linear accelerators, X-ray tubes, digital detectors, high voltage connectors and coolers. In addition, the Company licenses proprietary image-processing and detection software designed to work with other Varex products to provide packaged sub-assembly solutions to industrial customers.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Accordingly, the following information is provided for purposes of achieving an understanding of operations, but it may not be indicative of the financial results of the reported segments were they independent organizations. In addition, comparisons of the Company&#8217;s operations to similar operations of other companies may not be meaningful.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Information related to the Company&#8217;s segments is as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.762%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenues, net</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 9.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">160.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">155.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 9.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Industrial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">205.6&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">198.8&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 9.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 9.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Industrial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total gross profit</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63.3&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64.8&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest and other expense, net</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7.6)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10.7)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income before taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Net income attributable to noncontrolling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to Varex</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company does not disclose total assets by segment as this information is not provided to the CODM.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI https://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139750441171200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The accompanying unaudited condensed consolidated financial statements have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;) and in accordance with accounting principles generally accepted in the United States (&#8220;GAAP&#8221;) for interim financial information. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. In the opinion of management, these condensed consolidated financial statements include all adjustments necessary for a fair presentation of the results for the interim periods. The Company has consolidated all of its majority owned subsidiaries and entities over which it has control. All intercompany balances and transactions have been eliminated as part of the consolidation.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Consolidation</a></td>
<td class="text">These condensed consolidated financial statements and the accompanying notes are unaudited and should be read in conjunction with the consolidated financial statements and notes thereto for the fiscal year ended 2022 included in the Company&#8217;s Annual Report on Form 10-K, which was filed with the SEC on November&#160;18, 2022.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsPolicyPolicyTextBlock', window );">Subsequent Events</a></td>
<td class="text">The Company considers events or transactions that occur after the balance sheet date, but before the financial statements are issued, to provide additional evidence relative to certain estimates or to identify matters that require additional disclosures.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Reclassification of Prior Period Presentation</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassification of Prior Period Presentation</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Certain prior period amounts in the notes to the condensed consolidated financial statements have had a change in presentation to conform to current period presentation. This change does not affect previously reported results.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Risk</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Risk</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Financial instruments that potentially expose the Company to concentrations of credit risk consist principally of cash, cash equivalents, marketable securities, certificates of deposit, and trade accounts receivable. Cash held with financial institutions may exceed the Federal Deposit Insurance Corporation insurance limits or similar limits in foreign jurisdictions. To date, the Company has not realized any losses on its deposits of cash and cash equivalents. The Company performs ongoing credit evaluations of its customers and, except for government tenders, group purchases and orders with a letter of credit, its industrial customers often provide a down payment. The Company maintains an allowance for credit losses based upon the expected collectability of all accounts receivable. The Company obtains some of the components in its products from a limited group of suppliers or from a single-source supplier. When these suppliers are unable to meet the Company's supply needs, the Company's production is negatively impacted. </span></div>&#160;&#160;&#160;&#160;Credit is extended to customers based on an evaluation of the customer&#8217;s financial condition, and collateral is not required. In certain circumstances, a customer may be required to prepay all or a portion of the contract price prior to transfer of control.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segment Reporting</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segment Reporting</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company has two reportable operating segments; (i) Medical and (ii) Industrial, which aligns with how its Chief Executive Officer, who is the Company's Chief Operating Decision Maker (&#8220;CODM&#8221;), reviews the Company&#8217;s performance. See Note 15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for further information on the Company&#8217;s segments.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiscalPeriod', window );">Fiscal Year</a></td>
<td class="text">Fiscal Year&#160;&#160;&#160;&#160;The fiscal years of the Company as reported are the 52 or 53-week period ending on the Friday nearest September&#160;30. Fiscal year 2023 is the 52-week period ending September&#160;29, 2023. Fiscal year 2022 was the 52-week period that ended on September&#160;30, 2022. The fiscal quarters ended&#160;December&#160;30, 2022 and&#160;December&#160;31, 2021&#160;were both 13-week periods.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. Such estimates include the valuation of inventories, valuation of goodwill and intangible assets, warranties, contract liabilities, long-lived asset valuations, impairment of investments, valuation of financial instruments, and taxes on income. Actual results could differ from these estimates.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Cash and Cash Equivalents, Restricted Cash</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company considers unrestricted currency on hand, demand deposits, time deposits and all highly-liquid investments with an original maturity of three months or less at the date of purchase to be cash and cash equivalents. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Cash</span></div>&#160;&#160;&#160;&#160;Restricted cash primarily consists of cash collateral related to certain leases and inventory arrangements. Restricted cash is included in other assets on the Company's Condensed Consolidated Balance Sheets.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentPolicyTextBlock', window );">Investments and Marketable Securities</a></td>
<td class="text">Investments&#160;&#160;&#160;&#160;The Company accounts for its equity investments in privately-held companies under the equity method of accounting if the Company has the ability to exercise significant influence in these investments. Distributions received from an equity method investment are classified using the&#160;cumulative earnings approach, which means that distributions up to the amount of cumulative equity in earnings recognized will be treated as returns on investment and classified as operating cash flows and those in excess of that amount will be treated as returns of investment and classified as investing cash flows. The Company reviews its equity investments in privately-held companies for impairment whenever events or changes in business circumstances are other than temporary and indicate that the carrying amount of the investments may not be fully recoverable. <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Marketable Securities</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's marketable securities consist primarily of financial instruments such as U.S. treasury securities, U.S. agency obligations, corporate bonds, commercial paper, money market funds, and equity securities. The Company classifies marketable debt securities as available-for-sale at the time of purchase and reevaluates such classifications as of each balance sheet date. All marketable debt securities are recorded at estimated fair value. Any unrealized gains or losses for marketable debt securities are included in accumulated other comprehensive income within the Condensed Consolidated Balance Sheets. Marketable equity securities are stated at fair value as determined by the most recently traded price of each security at the balance sheet date. All unrealized gains and losses on equity securities are recorded as part of other expense, net in the Company's condensed consolidated financial statements. See Note 7, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for further details.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span></div>&#160;&#160;&#160;&#160;When the fair value of a marketable debt security declines below its amortized cost basis, any portion of that decline attributable to credit losses, to the extent expected to be nonrecoverable before the sale of the security, is recognized in the Condensed Consolidated Statements of Operations. When the fair value of a marketable debt security declines below its amortized cost basis due to changes in interest rates, such amounts are recorded in other comprehensive loss, and are recognized in the Condensed Consolidated Statements of Operations only if the Company sells or intends to sell the security before recovery of its cost basis. There were no credit losses related to marketable debt securities recorded during the three months ended December 30, 2022.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock', window );">Loss Contingencies</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Loss Contingencies</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;From time to time, the Company is involved in legal proceedings, claims and government inspections or investigations, customs and duties audits, other contingency matters, both inside and outside the United States, arising in the ordinary course of its business or otherwise.&#160;The Company accrues amounts for probable losses, to the extent they can be reasonably estimated, that it believes are adequate to address any liabilities related to legal proceedings and other loss contingencies that the Company believes will result in a probable loss (including, among other things, probable settlement value).&#160;A loss or a range of loss is disclosed when it is reasonably possible that a material loss will be incurred and can be estimated or when it is reasonably possible that the amount of a loss, when material, will exceed the recorded provision. When a loss contingency is probable but not reasonably estimable the nature of the contingency and the fact that an estimate cannot be made is disclosed.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyPolicy', window );">Product Warranty</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Product Warranty</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company warrants most of its products for a specific period of time, usually 12 to 24 months from delivery or acceptance, against material defects. The Company provides for the estimated future costs of warranty obligations in cost of revenues when the related revenues are recognized. The accrued warranty costs represent the best estimate at the time of sale of the total costs that the Company will incur to repair or replace product parts that fail while still under warranty.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The amount of the accrued estimated warranty costs obligation for established products is primarily based on historical experience of product failures, adjusted for current information on repair costs.&#160;For new products, estimates include the historical experience of similar products, as well as a reasonable allowance for warranty expenses associated with new products.&#160;On a quarterly basis, the Company reviews the accrued warranty costs and updates the historical warranty cost trends, if required.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company determines if an arrangement is or contains a lease at the inception of an arrangement. The Company's operating lease right-of-use ("ROU") assets represent the right to use an underlying asset over the lease term and lease liabilities represent its obligation to make lease payments arising from the lease. ROU assets may also include initial direct costs incurred and prepaid lease payments, less lease incentives. Lease liabilities and their corresponding ROU assets are recognized based on the present value of lease payments over the lease term, discounted using the Company's incremental borrowing rate. The Company recognizes operating leases with lease terms of more than twelve months in operating lease assets, current operating lease liabilities, and operating lease liabilities on its Condensed Consolidated Balance Sheets. The Company recognizes finance leases with lease terms of more than twelve months in property, plant, and equipment, net, accrued liabilities and other current liabilities, and other long-term liabilities on its Condensed Consolidated Balance Sheets. For purposes of calculating lease liabilities and the corresponding ROU assets, the Company's lease term may include options to extend or terminate the lease when it is reasonably certain that it will exercise that option.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company&#8217;s revenues are derived primarily from the sale of hardware and services. The Company recognizes its revenues net of any value-added or sales tax and net of sales discounts.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company sells a high proportion of its X-ray products to a limited number of OEM customers. X-ray imaging components including X-ray tubes, digital detectors and image-processing tools and security and inspection products are generally sold on a stand-alone basis. However, the Company occasionally sells its digital detectors, X-ray tubes and imaging processing tools as a package that is optimized for digital X-ray imaging and sells its Linatron&#174; X-ray linear accelerators together with its image processing software and image detection products to OEM customers that incorporate them into their inspection or irradiation systems and processes. Service contracts are often sold with certain security and inspection products and computer-aided detection products.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company determines revenue recognition through the following steps:</span></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Identification of the contract, or contracts, with a customer</span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Identification of the performance obligations in the contract</span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Determination of the transaction price</span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Allocation of the transaction price to the performance obligations in the contract</span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Recognition of revenue when, or as, a performance obligation is satisfied</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Transaction Price and Allocation to Performance Obligations</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Transaction prices of products or services are typically based on contracted rates. To the extent that the transaction price includes variable consideration, the Company estimates the amount of variable consideration that should be included in the transaction price utilizing the expected value method when there is a large number of transactions with similar characteristics or the most likely amount method when there are two possible outcomes, depending on the circumstances of the transaction, to which the Company expects to be entitled. Variable consideration is included in the transaction price if, in the Company&#8217;s judgment, it is probable that a significant future reversal of cumulative revenue under the contract will not occur. Estimates of variable consideration and determination of whether to include estimated amounts in the transaction price are based largely on an assessment of the Company&#8217;s anticipated performance and all information (historical, current, and forecasted) that is reasonably available.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company allows customers to return specific parts of purchased X-ray tubes for a partial refund credit, which is identified as variable consideration. For sales with a right of return, revenue is reduced for expected returns, a liability is recorded for expected returns, and an asset is recorded for the right to recover products from customers on settling the liability. The Company recognizes a reduction to revenue and cost of sales at the time of sale and a corresponding contract liability and contract asset. The Company records this estimate based on the historical volume of product returns and adjusts the estimate on a quarterly basis based on the current quarter sales and current quarter returns.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;If a contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. Contracts that contain multiple performance obligations require an allocation of the transaction price based on the estimated relative standalone selling prices of the promised products or services underlying each performance obligation. The Company determines standalone selling prices based on the price at which the performance obligation could be sold separately.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contracts and Performance Obligations</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company accounts for a contract with a customer when there is an approval and commitment from both parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and collectability of the consideration is probable. The Company's performance obligations consist mainly of transferring control of products and services identified in the contracts or purchase orders. For each contract, the Company considers the obligation to transfer products and services to the customer, which are distinct, to be performance obligations.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recognition of Revenue</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Revenue is recognized when, or as, obligations under the terms of a contract are satisfied, which occurs when control of the promised products or services is transferred to customers. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring products or services to a customer.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Product revenue is generally recognized when the customer obtains control of the Company&#8217;s product, which occurs at a point in time, and may be upon shipment or upon delivery based on the contractual shipping terms of a contract.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Service revenue is generally recognized over the term of the service contract. Services are expected to be transferred to the customer throughout the term of the contract, and the Company believes recognizing revenue ratably over the term of the contract best depicts the transfer of value to the customer.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disaggregation of Revenue</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Revenue is disaggregated from contracts between geography and by reportable operating segment, which the Company believes best depicts how the nature, amount, timing, and uncertainty of revenues and cash flows are affected by economic factors. Refer to Note 15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Information, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">included in this report, for the disaggregation of the Company&#8217;s revenue based on reportable operating segments and Note 2, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the disaggregation of revenue by geographic region.&#160;&#160;&#160;&#160;</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Balances</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Contract assets are included within the prepaid expenses and other current assets, and other assets balances in the Condensed Consolidated Balance Sheets. Contract liabilities, which includes refund liabilities and deferred revenue, are included within the accrued liabilities and other current liabilities, deferred revenues, and other long-term liabilities balances in the Condensed Consolidated Balance Sheets. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Deferred revenue represents the Company's obligation to transfer goods and/or services to its customers for which it has already received consideration (or the amount is due) from the customer. The Company's deferred revenue balance primarily relates to contract advances and billings for warranty contracts.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Deferred revenue that is estimated to be recognized during the following twelve-month period is recorded as deferred revenues and the remaining portion is recorded as other long-term liabilities in the Condensed Consolidated Balance Sheets.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Costs to Obtain or Fulfill a Customer Contract</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company has certain costs to obtain and fulfill a customer contract, such as commissions and shipping costs. The Company recognizes the incremental costs of obtaining contracts as an expense when incurred if the amortization period of the assets that the Company otherwise would have recognized is one year or less. Incremental costs of obtaining contracts that would be recognized over more than one year are not material. The Company accounts for shipping and handling activities related to contracts with customers as costs to fulfill the promise to transfer the associated products. These costs are included as a component of cost of revenues.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Adopted Accounting Pronouncements</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In August 2020, the Financial Accounting Standards Board issued Accounting Standard Update ("ASU") 2020-06, Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity. The standard removed certain separation models in ASC 470-20 for convertible instruments, and, as a result, embedded conversion features are no longer separated from the host contract for convertible instruments with conversion features that are not required to be accounted for as derivatives under ASC 815. These convertible debt instruments are accounted for as a single liability measured at amortized cost. This results in the interest expense recognized for convertible debt instruments to be typically closer to the coupon interest rate. Further, the ASU made amendments to the earnings per share (&#8220;EPS&#8221;) guidance in Topic 260 for convertible instruments, the most significant impact of which was requiring the use of the if-converted method for diluted EPS calculation, and no longer allowing the net share settlement method. The Company adopted this ASU on October 1, 2022, using the modified retrospective method. On the date of adoption, the Company recorded an entry to reduce additional paid-in capital by $34.6&#160;million, increase long-term debt, net by $28.0&#160;million, decrease deferred tax assets by $0.1&#160;million, and increase retained earnings by $6.5&#160;million for the after-tax impact of previously recognized amortization of the debt discount associated with the Company&#8217;s Convertible Notes (as defined herein). The unamortized discount on the Company's Convertible Notes (see Note 10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Borrowings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) was derecognized in the first quarter of fiscal year 2023 and the interest expense from its Convertible Notes decreased and became closer to the coupon rate of 4.00%. The impact that the adoption of ASU 2020-06 has on the Company's net income per diluted share will depend on the amount of earnings in each period and the Company's share price and could result in additional dilution.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126907703&amp;loc=d3e12565-110249<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 450<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6491354&amp;loc=d3e6049-115624<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941378&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiscalPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining an entity's fiscal year or other fiscal period. This disclosure may include identification of the fiscal period end-date, the length of the fiscal period, any reporting period lag between the entity and its subsidiaries, or equity investees. If a reporting lag exists, the closing date of the entity having a different period end is generally noted, along with an explanation of the necessity for using different closing dates. Any intervening events that materially affect the entity's financial position or results of operations are generally also disclosed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=d3e5291-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiscalPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment in financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429488&amp;loc=d3e326-107755<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI https://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for standard warranties including the methodology for measuring the liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126907703&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reporting subsequent events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139750435821472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock', window );">Schedule of Cash and Cash Equivalents</a></td>
<td class="text">Cash and cash equivalents and restricted cash as reported within the Condensed Consolidated Statements of Cash Flows consisted of the following:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.816%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.650%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.650%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.650%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.652%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Beginning of Period</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">End of Period</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Beginning of Period</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">End of Period</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">89.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">81.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">144.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">157.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total as presented in the Condensed Consolidated Statements of Cash Flows</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">90.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">146.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">159.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock', window );">Restrictions on Cash and Cash Equivalents</a></td>
<td class="text">Cash and cash equivalents and restricted cash as reported within the Condensed Consolidated Statements of Cash Flows consisted of the following:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.816%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.650%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.650%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.650%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.652%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Beginning of Period</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">End of Period</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Beginning of Period</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">End of Period</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">89.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">81.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">144.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">157.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total as presented in the Condensed Consolidated Statements of Cash Flows</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">90.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">146.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">159.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock', window );">Summary of Customers with a Significant Portion of Revenue</a></td>
<td class="text">During the periods presented, one of the Company's customers accounted for a significant portion of revenues, as set forth below:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.568%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canon Medical Systems Corporation</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock', window );">Schedule of Product Warranty Liability</a></td>
<td class="text">The following table reflects the changes in the Company&#8217;s accrued product warranty:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued product warranty, at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">New accruals charged to cost of revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Product warranty expenditures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued product warranty, at end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of cash and cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126907703&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6327-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6442-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139750435384992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue by Geographic Location</a></td>
<td class="text">The following table disaggregates the Company&#8217;s revenue by geographic region:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.568%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Americas</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">74.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">EMEA</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">APAC</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">205.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">198.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock', window );">Summary of Contract Asset and Liabilities</a></td>
<td class="text">The following table summarizes the changes in the contract assets and refund liabilities for the three months ended December 30, 2022 and December&#160;31, 2021:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.568%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Contract Assets</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Costs recovered from product returns during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract asset from shipments of products, subject to return during the period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.568%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Refund Liabilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Release of refund liability included in beginning of year refund liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additions to refund liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139750435323568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_var_AssetsAndLiabilitiesLesseeTableTextBlock', window );">Schedule of Supplemental Balance Sheet Information</a></td>
<td class="text">The following table presents supplemental balance sheet information related to the Company's operating and finance leases: <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.511%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.569%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Operating lease assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance lease right-of-use assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjEyNTNlNzQwNjAwMzRlZjM4YmM3ZDQyNjA2OTE4NGNiL3RhYmxlcmFuZ2U6MTI1M2U3NDA2MDAzNGVmMzhiYzdkNDI2MDY5MTg0Y2JfMy0xLTEtMS04MzI4NQ_6fed9dde-ecf9-4697-bdfd-bda3b6c18e81"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjEyNTNlNzQwNjAwMzRlZjM4YmM3ZDQyNjA2OTE4NGNiL3RhYmxlcmFuZ2U6MTI1M2U3NDA2MDAzNGVmMzhiYzdkNDI2MDY5MTg0Y2JfMy0xLTEtMS04MzI4NQ_7db859ec-ae05-400b-a6ff-3ee55890f062">Property, plant, and equipment, net</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liabilities (current) </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Current operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance lease liabilities (current) </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjEyNTNlNzQwNjAwMzRlZjM4YmM3ZDQyNjA2OTE4NGNiL3RhYmxlcmFuZ2U6MTI1M2U3NDA2MDAzNGVmMzhiYzdkNDI2MDY5MTg0Y2JfNi0xLTEtMS04MzI4NQ_21d67cfe-4f11-4971-a007-53438e019ae1"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjEyNTNlNzQwNjAwMzRlZjM4YmM3ZDQyNjA2OTE4NGNiL3RhYmxlcmFuZ2U6MTI1M2U3NDA2MDAzNGVmMzhiYzdkNDI2MDY5MTg0Y2JfNi0xLTEtMS04MzI4NQ_651facb0-63c0-4af0-8d59-d1e007979e09">Accrued liabilities and other current liabilities</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liabilities (non-current)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance lease liabilities (non-current)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjEyNTNlNzQwNjAwMzRlZjM4YmM3ZDQyNjA2OTE4NGNiL3RhYmxlcmFuZ2U6MTI1M2U3NDA2MDAzNGVmMzhiYzdkNDI2MDY5MTg0Y2JfOC0xLTEtMS04MzI4NQ_0e1c436b-8779-4e63-90c2-6287c33ec16d"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjEyNTNlNzQwNjAwMzRlZjM4YmM3ZDQyNjA2OTE4NGNiL3RhYmxlcmFuZ2U6MTI1M2U3NDA2MDAzNGVmMzhiYzdkNDI2MDY5MTg0Y2JfOC0xLTEtMS04MzI4NQ_8cf1f2a5-8b40-40ac-84e4-96b9a215a402">Other long-term liabilities</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Schedule of Lease Cost and Supplemental Cash Flow Information</a></td>
<td class="text">The following table provides information related to the Company&#8217;s operating and finance leases:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.568%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating lease costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total finance lease costs</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financing cash flows from finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total cash paid for amounts included in the measurement of lease liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncash operating right-of-use assets obtained in exchange for new lease liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Includes variable and short-term lease expense, which were immaterial for the three months ended December 30, 2022 and December&#160;31, 2021.</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_var_AssetsAndLiabilitiesLesseeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Assets And Liabilities, Lessee [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">var_AssetsAndLiabilitiesLesseeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>var_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139750435302304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESTRUCTURING (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock', window );">Summary of Restructuring Costs Incurred</a></td>
<td class="text">Below is a detail of restructuring charges incurred during the three months ended December 30, 2022 and December&#160;31, 2021, respectively, which predominantly relate to the Company's Medical segment:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:27.650%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:35.427%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.569%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Location of Restructuring Charges in Condensed Consolidated Statements of Operations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets impairment charges</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139750435378336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock', window );">Schedule of Derivative Instruments</a></td>
<td class="text">As of&#160;December&#160;30, 2022, the Company had the following outstanding derivatives designated as net investment hedging instruments:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions, except number of instruments)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of Instruments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Notional Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock', window );">Schedule of Net Investment Hedges</a></td>
<td class="text">The following table summarizes the amount of pre-tax income recognized from derivative instruments for the periods indicated and the line items in the accompanying statements of operations where the results are recorded for net investment hedges:<div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.666%"><tr><td style="width:1.0%"/><td style="width:26.342%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.583%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.403%"/><td style="width:0.1%"/></tr><tr style="height:48pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount of (Loss) Gain Recognized in OCI on Derivative<br/>Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Location of Gain Recognized in Income on Derivative (Amount Excluded from Effectiveness Testing)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount of Gain Recognized in Income on Derivative (Amount Excluded from Effectiveness Testing)<br/>Three Months Ended</span></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 2.12pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;These derivative instruments are subject to master netting agreements giving effect to rights of offset with each counterparty. None of the balances were eligible for netting. The following table summarizes the gross fair values of derivative instruments as of the periods indicated and the line items in the accompanying Condensed Consolidated Balance Sheets where the instruments are recorded:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.844%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.483%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.594%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.597%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivative Assets and Liabilities</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives Designated as Net Investment Hedges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41620-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41638-113959<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41678-113959<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41641-113959<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for net investment hedges of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139750431731792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock', window );">Fair Value, Liabilities Measured on Recurring Basis</a></td>
<td class="text">In the tables below, the Company has segregated all assets and liabilities that are measured at fair value on a recurring basis into the most appropriate level within the fair value hierarchy based on the inputs used to determine the fair value at the measurement date.<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value at December 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Quoted Prices in Active Markets for Identical Assets and Liabilities</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Level 1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Significant Other</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Observable Inputs</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Level 2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Significant Unobservable Inputs</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Level 3)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate notes/bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government agencies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. Treasury bills</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivative assets</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred compensation plan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Marketable equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfMTAtMC0xLTEtODMyODU_79a5037b-581b-47d3-9fd4-71603055d303">Total assets measured at fair value</span></span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 16.75pt;text-indent:-9pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Liabilities:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivative liabilities</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfMTYtMC0xLTEtMTAwNTk3_169dbe7d-a10b-4a1e-ab46-42af80460820">Total liabilities measured at fair value</span></span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value at September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Quoted Prices in Active Markets for Identical Assets and Liabilities</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Level 1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Significant Other</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Observable Inputs</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Level 2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Significant Unobservable Inputs</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Level 3)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Assets:</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate notes/bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government agencies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. Treasury bills</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivative assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred compensation plan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Marketable equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfOC0wLTEtMS04MzI4NQ_417fadeb-557f-4f83-a995-e688c949e009">Total assets measured at fair value</span></span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">72.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivative liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfMTMtMC0xLTEtODMyODU_54db5ac7-0c5e-4cf6-bc9b-f0229d68f729">Total liabilities measured at fair value</span></span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The assets held under the Company's deferred compensation plan are classified in Level 1 as they relate primarily to publicly traded mutual funds for which there are observable market prices in active markets.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock', window );">Fair Value, Assets Measured on Recurring Basis</a></td>
<td class="text">In the tables below, the Company has segregated all assets and liabilities that are measured at fair value on a recurring basis into the most appropriate level within the fair value hierarchy based on the inputs used to determine the fair value at the measurement date.<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value at December 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Quoted Prices in Active Markets for Identical Assets and Liabilities</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Level 1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Significant Other</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Observable Inputs</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Level 2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Significant Unobservable Inputs</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Level 3)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate notes/bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government agencies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. Treasury bills</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivative assets</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred compensation plan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Marketable equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfMTAtMC0xLTEtODMyODU_79a5037b-581b-47d3-9fd4-71603055d303">Total assets measured at fair value</span></span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 16.75pt;text-indent:-9pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Liabilities:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivative liabilities</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfMTYtMC0xLTEtMTAwNTk3_169dbe7d-a10b-4a1e-ab46-42af80460820">Total liabilities measured at fair value</span></span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value at September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Quoted Prices in Active Markets for Identical Assets and Liabilities</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Level 1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Significant Other</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Observable Inputs</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Level 2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Significant Unobservable Inputs</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Level 3)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Assets:</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate notes/bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government agencies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. Treasury bills</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivative assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred compensation plan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Marketable equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfOC0wLTEtMS04MzI4NQ_417fadeb-557f-4f83-a995-e688c949e009">Total assets measured at fair value</span></span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">72.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivative liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfMTMtMC0xLTEtODMyODU_54db5ac7-0c5e-4cf6-bc9b-f0229d68f729">Total liabilities measured at fair value</span></span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The assets held under the Company's deferred compensation plan are classified in Level 1 as they relate primarily to publicly traded mutual funds for which there are observable market prices in active markets.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnInvestmentsTextBlock', window );">Schedule of Gains and (Losses) on Marketable Securities</a></td>
<td class="text">The following tables summarize the Company's marketable debt securities:<div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.511%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.569%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Amortized Costs</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commercial paper</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate notes/bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. Treasury bills</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government agencies</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total marketable debt securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.511%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.569%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Amortized Costs</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commercial paper</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate notes/bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. Treasury bills</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government agencies</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total marketable debt securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesTextBlock', window );">Schedule of Marketable Securities</a></td>
<td class="text">The contractual maturities of marketable debt securities as of December&#160;30, 2022, are shown in the table below. Actual maturities may differ from contractual maturities because borrowers may have the right to call or prepay obligations.<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Amortized Costs</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contractual maturities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Due within one year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Due after one year through five years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total marketable debt securities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table>The following tables summarize the balance sheet locations for marketable debt securities:<div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:27.511%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.650%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.650%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.650%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.650%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.652%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Commercial paper</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Corporate notes/bonds</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Government agencies</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Treasury bills</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total marketable debt securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:27.650%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.511%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.650%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.650%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.650%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.652%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Commercial paper</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Corporate notes/bonds</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Government agencies</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Treasury bills</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total marketable debt securities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnInvestmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of realized and unrealized gain (loss) on investment in security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnInvestmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139750435480448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Inventory, Current</a></td>
<td class="text">The following table summarizes the Company&#8217;s inventories:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Raw materials and parts</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">247.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">240.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total inventories</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">320.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">303.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139750435372592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of Goodwill</a></td>
<td class="text">The following table reflects goodwill by reportable operating segment:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.511%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.569%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Medical</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Industrial</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at September 30, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">169.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">115.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">284.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Balance at December 30, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">171.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">116.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">288.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Finite-Lived Intangible Assets</a></td>
<td class="text">The following table reflects the gross carrying amount and accumulated amortization of the Company&#8217;s finite-lived intangible assets included in other assets in the Condensed Consolidated Balance Sheets:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:26.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.150%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.427%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.427%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.150%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.427%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.156%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated Amortization</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated Amortization</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net Carrying Amount</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:9pt;padding-right:2.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquired existing technology</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">71.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(52.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(49.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:9pt;padding-right:2.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patents, licenses and other</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:9pt;padding-right:2.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer contracts and supplier relationship</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(38.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(36.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:6.75pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total intangible assets</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">134.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(102.6)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">131.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(98.3)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=SL108378252-109267<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139750435500976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BORROWINGS (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Schedule of Debt</a></td>
<td class="text">The following table summarizes the Company's short-term and long-term debt:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.733%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.015%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions, except for percentages)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Contractual Interest Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Effective Interest Rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current maturities of long-term debt</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other debt</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Non-current maturities of long-term debt:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Convertible Senior Unsecured Notes</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.0%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.8%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Secured Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">243.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">243.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.9%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.2%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total non-current maturities of long-term debt:</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">447.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">447.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unamortized issuance costs and debt discounts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unamortized discount - Convertible Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(28.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unamortized issuance costs - Convertible Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unamortized issuance costs - Senior Secured Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(6.8)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(35.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total debt outstanding, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">442.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">414.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity component of Convertible Senior Unsecured Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> In connection with the adoption of ASU 2020-06, the unamortized discount related to the Convertible Notes was derecognized and the carrying value of the issuance costs was adjusted in the first quarter of fiscal year 2023. Refer to Note 1, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Summary of Significant Accounting Policies </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">for further details. </span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Included in additional paid-in capital on the Condensed Consolidated Balance Sheets.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock', window );">Schedule of Interest Expense</a></td>
<td class="text">The following table summarizes the Company's interest expense:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.568%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contractual interest coupon and other</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of debt discounts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total interest expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">7.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">9.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of interest income and expense, including, but not limited to, interest income and expense from investments, loans, and securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139750435364496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NONCONTROLLING INTERESTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestAbstract', window );"><strong>Noncontrolling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_var_NoncontrollingInterestTableTextBlock', window );">Noncontrolling Interest</a></td>
<td class="text">Changes in noncontrolling interests were as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interests, at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interests, at end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_var_NoncontrollingInterestTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interest</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">var_NoncontrollingInterestTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>var_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139750428810096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET INCOME PER SHARE (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Income Per Share, Basic and Diluted</a></td>
<td class="text">A reconciliation of the numerator and denominator used in the calculation of basic and diluted net income common share is as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.568%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions, except per share amounts)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Net income per share - basic</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net income attributable to Varex</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Basic weighted average shares outstanding</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Basic net income per share attributable to Varex</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.08&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.04&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 13pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Net income per share - diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net income attributable to Varex</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 10pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic weighted average shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dilutive effect of Convertible Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dilutive effect of share-based awards and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dilutive effect of warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted weighted average shares outstanding</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted net income per share attributable to Varex</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.08&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.03&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 10pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Anti-dilutive share summary</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:15pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted stock and options</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Convertible notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 4pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total anti-dilutive shares</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139750436433344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EMPLOYEE STOCK PLANS (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs</a></td>
<td class="text">The table below summarizes the effect of recording share-based compensation expense and the option component of the employee stock purchase plan shares:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.568%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Selling, general and administrative</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total share-based compensation expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Share-based Compensation, Stock Options, Activity</a></td>
<td class="text">The following table summarizes the activity for stock options under Varex&#8217;s employee incentive plans for the Company's employees:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.705%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.987%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands, except per share amounts and the remaining term)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Price Range</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Weighted Average Exercise Price</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Weighted Average Remaining Term (in years)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Aggregate Intrinsic Value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at September 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,902&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$13.61 - $37.60</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28.97&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,361.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">385&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$22.13 </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22.13&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canceled, expired or forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(196)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$25.06 - $37.10</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Outstanding at December 30, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,091&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$13.61 - $37.60</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27.96&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,209.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exercisable at December 30, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,070&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$13.61 - $37.60</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29.52&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">672.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> The aggregate intrinsic value represents the total pre-tax intrinsic value, which is computed based on the difference between the exercise price and the closing price of Varex common stock of $20.30 as of December&#160;30, 2022, the last trading date of the Company's first quarter, and which represents the amount that would have been received by the option holders had all option holders exercised their options and sold the shares received upon exercise as of that date.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock', window );">Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity</a></td>
<td class="text">The following table summarizes the activity for restricted stock units, restricted stock awards and deferred stock units under Varex&#8217;s 2020 Omnibus Stock Plan and 2017 Omnibus Stock Plan:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.762%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands, except per share amounts)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number&#160;of&#160;Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted&#160;Average Grant-Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at September 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,045&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.35&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">492&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.12&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23.70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canceled or expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25.50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Outstanding at December 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,506&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22.95&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139750435394384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT INFORMATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Segment Reporting Information, by Segment</a></td>
<td class="text">Information related to the Company&#8217;s segments is as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.762%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenues, net</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 9.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">160.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">155.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 9.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Industrial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">205.6&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">198.8&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 9.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 9.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Industrial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total gross profit</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63.3&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64.8&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest and other expense, net</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7.6)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10.7)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income before taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Net income attributable to noncontrolling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to Varex</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139750434316768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Segment Reporting (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 30, 2022 </div>
<div>segment</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of reportable operating segments</a></td>
<td class="nump">2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139750428329232">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Cash and Cash Equivalents and Restricted Cash (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Oct. 01, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 81.5<span></span>
</td>
<td class="nump">$ 89.4<span></span>
</td>
<td class="nump">$ 157.8<span></span>
</td>
<td class="nump">$ 144.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCash', window );">Restricted cash</a></td>
<td class="nump">1.3<span></span>
</td>
<td class="nump">1.2<span></span>
</td>
<td class="nump">1.4<span></span>
</td>
<td class="nump">1.5<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Total as presented in the Condensed Consolidated Statements of Cash Flows</a></td>
<td class="nump">$ 82.8<span></span>
</td>
<td class="nump">$ 90.6<span></span>
</td>
<td class="nump">$ 159.2<span></span>
</td>
<td class="nump">$ 146.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139750428847024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Customer Concentration Risk (Details) - Customer concentration risk - Canon Medical Systems Corporation<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Revenue from contract with customer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">20.10%<span></span>
</td>
<td class="nump">19.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">9.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.30%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=var_CanonMedicalSystemsCorporationFormerlyToshibaMedicalSystemsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=var_CanonMedicalSystemsCorporationFormerlyToshibaMedicalSystemsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139750436388128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Investments (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment', window );">Equity method investment, amount written off</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss', window );">Marketable securities credit loss</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents an other than temporary decline in value that has been recognized against an investment accounted for under the equity method of accounting. The excess of the carrying amount over the fair value of the investment represents the amount of the write down which is or was reflected in earnings. The written down value is a new cost basis with the adjusted value of the investment becoming its new carrying value subject to the equity accounting method. Evidence of a loss in value might include, but would not necessarily be limited to, absence of an ability to recover the carrying amount of the investment or inability of the investee to sustain an earnings capacity which would justify the carrying amount of the investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 35<br> -Paragraph 32<br> -URI https://asc.fasb.org/extlink&amp;oid=126903467&amp;loc=d3e32787-111569<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment in marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139750441172720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Product Warranty (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MovementInStandardProductWarrantyAccrualRollForward', window );"><strong>Movement in Standard Product Warranty Accrual [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyAccrual', window );">Accrued product warranty, at beginning of period</a></td>
<td class="nump">$ 7.9<span></span>
</td>
<td class="nump">$ 8.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued', window );">New accruals charged to cost of revenues</a></td>
<td class="nump">2.8<span></span>
</td>
<td class="nump">1.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyAccrualPayments', window );">Product warranty expenditures</a></td>
<td class="num">(3.0)<span></span>
</td>
<td class="num">(2.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyAccrual', window );">Accrued product warranty, at end of period</a></td>
<td class="nump">$ 7.7<span></span>
</td>
<td class="nump">$ 7.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductWarrantyLiabilityLineItems', window );"><strong>Product Warranty Liability [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_var_WarrantyTerm', window );">Warranty term</a></td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductWarrantyLiabilityLineItems', window );"><strong>Product Warranty Liability [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_var_WarrantyTerm', window );">Warranty term</a></td>
<td class="text">24 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MovementInStandardProductWarrantyAccrualRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MovementInStandardProductWarrantyAccrualRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyLiabilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyLiabilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyAccrual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount as of the balance sheet date of the aggregate standard product warranty liability. Does not include the balance for the extended product warranty liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)(1),(c)(5)<br> -URI https://asc.fasb.org/extlink&amp;oid=126907703&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyAccrual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyAccrualPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in the standard product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard product warranty. Excludes extended product warranties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph ((c)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126907703&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyAccrualPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in the standard product warranty accrual from warranties issued. Excludes extended product warranties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph ((c)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126907703&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyAccrualWarrantiesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_var_WarrantyTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warranty Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">var_WarrantyTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>var_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139750432172224">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Recently Adopted Accounting Standards (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 30, 2022</div></th>
<th class="th"><div>Oct. 01, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jun. 09, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="num">$ (437.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (469.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, net</a></td>
<td class="nump">440.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">412.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred tax assets</a></td>
<td class="nump">1.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">$ 73.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 63.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate202006Member', window );">Accounting Standards Update 2020-06</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred tax assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Contractual interest rate</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=var_ConvertibleNotesMember', window );">Convertible Notes | Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Contractual interest rate</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate202006Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate202006Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=var_ConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=var_ConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139750434142176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE - Disaggregation of Revenue (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues, net</a></td>
<td class="nump">$ 205.6<span></span>
</td>
<td class="nump">$ 198.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AmericasMember', window );">Americas</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues, net</a></td>
<td class="nump">74.8<span></span>
</td>
<td class="nump">60.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_EMEAMember', window );">EMEA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues, net</a></td>
<td class="nump">64.0<span></span>
</td>
<td class="nump">67.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember', window );">APAC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues, net</a></td>
<td class="nump">66.8<span></span>
</td>
<td class="nump">70.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">UNITED STATES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues, net</a></td>
<td class="nump">$ 74.1<span></span>
</td>
<td class="nump">$ 58.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AmericasMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AmericasMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_EMEAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_EMEAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AsiaPacificMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139750434534992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE - Summary of Contract Assets and Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ChangeInContractWithCustomerAssetAbstract', window );"><strong>Contract Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Balance at beginning of period</a></td>
<td class="nump">$ 25.4<span></span>
</td>
<td class="nump">$ 24.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetCreditLossExpense', window );">Costs recovered from product returns during the period</a></td>
<td class="num">(1.5)<span></span>
</td>
<td class="num">(1.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_var_ContractwithCustomerAssetShipments', window );">Contract asset from shipments of products, subject to return during the period</a></td>
<td class="nump">1.5<span></span>
</td>
<td class="nump">1.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Balance at end of period</a></td>
<td class="nump">25.4<span></span>
</td>
<td class="nump">24.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ChangeInContractWithCustomerLiabilityAbstract', window );"><strong>Refund Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerRefundLiability', window );">Balance at beginning of period</a></td>
<td class="nump">28.2<span></span>
</td>
<td class="nump">27.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_var_ContractWithCustomerRefundLiabilityAmountReleased', window );">Release of refund liability included in beginning of year refund liability</a></td>
<td class="num">(1.6)<span></span>
</td>
<td class="num">(1.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_var_ContractWithCustomerRefundLiabilityAdditions', window );">Additions to refund liabilities</a></td>
<td class="nump">1.7<span></span>
</td>
<td class="nump">1.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerRefundLiability', window );">Balance at end of period</a></td>
<td class="nump">28.3<span></span>
</td>
<td class="nump">27.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Contract with customer, liability, revenue recognized</a></td>
<td class="nump">$ 4.2<span></span>
</td>
<td class="nump">$ 4.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInContractWithCustomerAssetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInContractWithCustomerAssetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInContractWithCustomerLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInContractWithCustomerLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetCreditLossExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetCreditLossExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130533-203044<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerRefundLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability for consideration received or receivable from customer which is not included in transaction price, when consideration is expected to be refunded to customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 55<br> -Paragraph 27<br> -URI https://asc.fasb.org/extlink&amp;oid=126920602&amp;loc=SL49130611-203046-203046<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerRefundLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_var_ContractWithCustomerRefundLiabilityAdditions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Refund Liability, Additions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">var_ContractWithCustomerRefundLiabilityAdditions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>var_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_var_ContractWithCustomerRefundLiabilityAmountReleased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Refund Liability, Amount Released</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">var_ContractWithCustomerRefundLiabilityAmountReleased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>var_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_var_ContractwithCustomerAssetShipments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract with Customer, Asset, Shipments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">var_ContractwithCustomerAssetShipments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>var_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139750432292496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES - Narratives (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnTerminationOfLease', window );">Loss on operating lease abandonment</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 1.9<span></span>
</td>
<td class="nump">$ 1.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnTerminationOfLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on termination of lease before expiration of lease term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 40<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123386189&amp;loc=SL77918607-209975<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnTerminationOfLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139750432262144">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LEASES - Schedule of Lease Right-of-Use Assets and Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">$ 22.1<span></span>
</td>
<td class="nump">$ 23.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Finance lease right-of-use assets</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities (current)</a></td>
<td class="nump">3.9<span></span>
</td>
<td class="nump">4.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Finance lease liabilities (current)</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities (non-current)</a></td>
<td class="nump">17.9<span></span>
</td>
<td class="nump">18.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Finance lease liabilities (non-current)</a></td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]</a></td>
<td class="text">Property, plant, and equipment, net<span></span>
</td>
<td class="text">Property, plant, and equipment, net<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Liability, Current, Statement of Financial Position [Extensible List]</a></td>
<td class="text">Accrued liabilities and other current liabilities<span></span>
</td>
<td class="text">Accrued liabilities and other current liabilities<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]</a></td>
<td class="text">Other long-term liabilities<span></span>
</td>
<td class="text">Other long-term liabilities<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes current finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes noncurrent finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139750434362832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES - Schedule of Operating Lease Cost and Supplemental Cash Flow Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Total operating lease costs</a></td>
<td class="nump">$ 1.5<span></span>
</td>
<td class="nump">$ 2.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_var_LeaseCostFinanceLeaseCosts', window );">Total finance lease costs</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash flows from operating leases</a></td>
<td class="nump">1.6<span></span>
</td>
<td class="nump">1.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Financing cash flows from finance leases</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_var_CashPaidForOperatingAndFinanceLeases', window );">Total cash paid for amounts included in the measurement of lease liabilities</a></td>
<td class="nump">1.7<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Noncash operating right-of-use assets obtained in exchange for new lease liabilities</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_var_CashPaidForOperatingAndFinanceLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash Paid For Operating And Finance Leases</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">var_CashPaidForOperatingAndFinanceLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>var_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_var_LeaseCostFinanceLeaseCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease, Cost, Finance Lease Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">var_LeaseCostFinanceLeaseCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>var_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139750355065472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY TRANSACTIONS - Investment in Privately-Held Companies (Details) - Equity Method Investee - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=var_DpiXHoldingMember', window );">dpiX Holding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity method investment, ownership percentage</a></td>
<td class="nump">40.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Income (loss) from equity method investments</a></td>
<td class="nump">$ 2.0<span></span>
</td>
<td class="num">$ (0.7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investments</a></td>
<td class="nump">44.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 42.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty', window );">Purchases from related party</a></td>
<td class="nump">5.0<span></span>
</td>
<td class="nump">5.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent', window );">Accounts payable, related parties</a></td>
<td class="nump">$ 3.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_var_PercentageOfManufacturingCapacity', window );">Percentage of manufacturing capacity</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_var_PercentageOfFixedCosts', window );">Percentage of fixed costs</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=var_DpiXHoldingMember', window );">dpiX Holding | Fixed Cost Commitments | Scenario, Forecast</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_var_RelatedPartyTransactionApprovedPurchasesFromRelatedParty', window );">Purchases approved from related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=var_VECImagingGmbHCo.KGMember', window );">VEC Imaging GmbH &amp; Co. KG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Income (loss) from equity method investments</a></td>
<td class="num">$ (0.3)<span></span>
</td>
<td class="num">$ (0.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investments</a></td>
<td class="nump">2.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent', window );">Due to related parties</a></td>
<td class="nump">0.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivables', window );">Other receivables</a></td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=var_DpiXLLCMember', window );">Dpi X LLC | dpiX Holding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity method investment, ownership percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount for accounts payable to related parties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of obligations due all related parties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(3),(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToRelatedPartiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount due from parties in nontrade transactions, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchases during the period (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_var_PercentageOfFixedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of fixed costs as defined in the agreement and determined at the beginning of each calendar year that the entity is required to pay.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">var_PercentageOfFixedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>var_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_var_PercentageOfManufacturingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of manufacturing capacity that the entity has the guaranteed right to purchase up to.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">var_PercentageOfManufacturingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>var_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_var_RelatedPartyTransactionApprovedPurchasesFromRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Related Party Transaction, Approved Purchases From Related Party</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">var_RelatedPartyTransactionApprovedPurchasesFromRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>var_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=var_DpiXHoldingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=var_DpiXHoldingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_EquityMethodInvesteeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_EquityMethodInvesteeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=var_FixedCostCommitmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=var_FixedCostCommitmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=var_VECImagingGmbHCo.KGMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=var_VECImagingGmbHCo.KGMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=var_DpiXLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=var_DpiXLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=var_DpiXHoldingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=var_DpiXHoldingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139750434373088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESTRUCTURING - Summary of Restructuring Cost Incurred (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetImpairmentCharges', window );">Other assets impairment charges</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 1.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The charge against earnings resulting from the write down of long lived assets other than goodwill due to the difference between the carrying value and lower fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2921-110230<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139750434476288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES - Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 30, 2022 </div>
<div>USD ($) </div>
<div>instrument</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_var_DerivativeNumberOfInstrumentsTerminated', window );">Derivative number of instruments terminated | instrument</a></td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeCashReceivedOnHedge', window );">Derivative, cash received on hedge | $</a></td>
<td class="nump">$ 7.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeCashReceivedOnHedge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash received during the period on settlement of a hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeCashReceivedOnHedge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_var_DerivativeNumberOfInstrumentsTerminated">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Derivative Number Of Instruments Terminated</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">var_DerivativeNumberOfInstrumentsTerminated</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>var_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139750434377248">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES - Summary of Derivative Instruments (Details) - Net Investment Hedging - Designated as Hedging Instrument - Cross currency swap contracts<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 30, 2022 </div>
<div>USD ($) </div>
<div>derivativeContract</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNumberOfInstrumentsHeld', window );">Number of Instruments | derivativeContract</a></td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional Value | $</a></td>
<td class="nump">$ 58.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNumberOfInstrumentsHeld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of derivative instruments of a particular group held by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNumberOfInstrumentsHeld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139750436225744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES - Summary of Income Recognized From Derivative Instruments (Details) - Cross currency swap contracts - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Amount of (Loss) Gain Recognized in OCI on Derivative</a></td>
<td class="num">$ (4.0)<span></span>
</td>
<td class="nump">$ 0.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Interest Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Amount of Gain Recognized in Income on Derivative (Amount Excluded from Effectiveness Testing)</a></td>
<td class="nump">$ 0.2<span></span>
</td>
<td class="nump">$ 0.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061190-113977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139750432186064">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES - Summary of Derivatives at Fair Value (Details) - Net Investment Hedging - Derivatives Designated as Net Investment Hedges - Cross currency swap contracts - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Prepaid expenses and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative assets fair value, gross</a></td>
<td class="nump">$ 1.1<span></span>
</td>
<td class="nump">$ 1.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative assets fair value, gross</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">6.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Other long-term liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative liabilities fair value, gross</a></td>
<td class="nump">$ 4.7<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139750434524080">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FAIR VALUE - Narrative (Details) - Level 1 - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long-term debt, fair value</a></td>
<td class="nump">$ 229.0<span></span>
</td>
<td class="nump">$ 250.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Secured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long-term debt, fair value</a></td>
<td class="nump">$ 239.3<span></span>
</td>
<td class="nump">$ 241.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139750433982976">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FAIR VALUE - Schedule of Fair Value Inputs (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration', window );">Derivative Asset, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Assets<span></span>
</td>
<td class="text">Assets<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration', window );">Derivative Liability, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Liabilities<span></span>
</td>
<td class="text">Liabilities<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MoneyMarketFundsAtCarryingValue', window );">Money market funds</a></td>
<td class="nump">$ 21.5<span></span>
</td>
<td class="nump">$ 36.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_var_CommercialPaperReceivable', window );">Commercial paper</a></td>
<td class="nump">4.9<span></span>
</td>
<td class="nump">5.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_var_CorporateBonds', window );">Corporate notes/bonds</a></td>
<td class="nump">3.6<span></span>
</td>
<td class="nump">3.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_USGovernmentAgenciesSecuritiesAtCarryingValue', window );">Government agencies</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">U.S. Treasury bills</a></td>
<td class="nump">10.3<span></span>
</td>
<td class="nump">10.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative assets</a></td>
<td class="nump">1.1<span></span>
</td>
<td class="nump">7.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationPlanAssets', window );">Deferred compensation plan</a></td>
<td class="nump">5.8<span></span>
</td>
<td class="nump">5.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Marketable equity securities</a></td>
<td class="nump">4.5<span></span>
</td>
<td class="nump">2.5<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value</a></td>
<td class="nump">52.0<span></span>
</td>
<td class="nump">72.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="nump">4.7<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities measured at fair value</a></td>
<td class="nump">4.7<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1) | Fair Value, Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MoneyMarketFundsAtCarryingValue', window );">Money market funds</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_var_CommercialPaperReceivable', window );">Commercial paper</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_var_CorporateBonds', window );">Corporate notes/bonds</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_USGovernmentAgenciesSecuritiesAtCarryingValue', window );">Government agencies</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">U.S. Treasury bills</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationPlanAssets', window );">Deferred compensation plan</a></td>
<td class="nump">5.8<span></span>
</td>
<td class="nump">5.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Marketable equity securities</a></td>
<td class="nump">4.5<span></span>
</td>
<td class="nump">2.5<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value</a></td>
<td class="nump">10.3<span></span>
</td>
<td class="nump">7.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities measured at fair value</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Significant Other Observable Inputs (Level 2) | Fair Value, Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MoneyMarketFundsAtCarryingValue', window );">Money market funds</a></td>
<td class="nump">21.5<span></span>
</td>
<td class="nump">36.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_var_CommercialPaperReceivable', window );">Commercial paper</a></td>
<td class="nump">4.9<span></span>
</td>
<td class="nump">5.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_var_CorporateBonds', window );">Corporate notes/bonds</a></td>
<td class="nump">3.6<span></span>
</td>
<td class="nump">3.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_USGovernmentAgenciesSecuritiesAtCarryingValue', window );">Government agencies</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">U.S. Treasury bills</a></td>
<td class="nump">10.3<span></span>
</td>
<td class="nump">10.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative assets</a></td>
<td class="nump">1.1<span></span>
</td>
<td class="nump">7.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationPlanAssets', window );">Deferred compensation plan</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Marketable equity securities</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value</a></td>
<td class="nump">41.7<span></span>
</td>
<td class="nump">64.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="nump">4.7<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities measured at fair value</a></td>
<td class="nump">4.7<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Significant Unobservable Inputs (Level 3) | Fair Value, Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MoneyMarketFundsAtCarryingValue', window );">Money market funds</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_var_CommercialPaperReceivable', window );">Commercial paper</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_var_CorporateBonds', window );">Corporate notes/bonds</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_USGovernmentAgenciesSecuritiesAtCarryingValue', window );">Government agencies</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">U.S. Treasury bills</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationPlanAssets', window );">Deferred compensation plan</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Marketable equity securities</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities measured at fair value</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of assets held under deferred compensation agreements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes derivative asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes derivative liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=123594786&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MoneyMarketFundsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investment in short-term money-market instruments (such as commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and so forth) which are highly liquid (that is, readily convertible to known amounts of cash) and so near their maturity that they present an insignificant risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify as cash equivalents by definition. Original maturity means an original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three-years ago does not become a cash equivalent when its remaining maturity is three months.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MoneyMarketFundsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_USGovernmentAgenciesSecuritiesAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt securities issued by a United States government agency such as Government National Mortgage Association (Ginnie Mae), Federal Home Loan Mortgage Corporation (Freddie Mac), and Federal National Mortgage Association (Fannie Mae), which are short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three-years ago does not become a cash equivalent when its remaining maturity is three months.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_USGovernmentAgenciesSecuritiesAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_var_CommercialPaperReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commercial Paper Receivable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">var_CommercialPaperReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>var_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_var_CorporateBonds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Corporate Bonds</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">var_CorporateBonds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>var_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139750434158256">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FAIR VALUE - Summary of Marketable Securities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLineItems', window );"><strong>Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_var_MarketableSecuritiesAmortizedCost', window );">Total marketable debt securities</a></td>
<td class="nump">$ 19.2<span></span>
</td>
<td class="nump">$ 20.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_var_MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Total marketable debt securities</a></td>
<td class="nump">19.1<span></span>
</td>
<td class="nump">20.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_CommercialPaperMember', window );">Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLineItems', window );"><strong>Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_var_MarketableSecuritiesAmortizedCost', window );">Total marketable debt securities</a></td>
<td class="nump">4.9<span></span>
</td>
<td class="nump">5.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_var_MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Total marketable debt securities</a></td>
<td class="nump">4.9<span></span>
</td>
<td class="nump">5.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_CorporateBondSecuritiesMember', window );">Corporate notes/bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLineItems', window );"><strong>Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_var_MarketableSecuritiesAmortizedCost', window );">Total marketable debt securities</a></td>
<td class="nump">3.7<span></span>
</td>
<td class="nump">3.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_var_MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Total marketable debt securities</a></td>
<td class="nump">3.6<span></span>
</td>
<td class="nump">3.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_USTreasuryBillSecuritiesMember', window );">U.S. Treasury bills</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLineItems', window );"><strong>Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_var_MarketableSecuritiesAmortizedCost', window );">Total marketable debt securities</a></td>
<td class="nump">10.3<span></span>
</td>
<td class="nump">10.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_var_MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Total marketable debt securities</a></td>
<td class="nump">10.3<span></span>
</td>
<td class="nump">10.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">Government agencies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLineItems', window );"><strong>Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_var_MarketableSecuritiesAmortizedCost', window );">Total marketable debt securities</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_var_MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Total marketable debt securities</a></td>
<td class="nump">$ 0.3<span></span>
</td>
<td class="nump">$ 0.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_var_MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Marketable Securities, Accumulated Gross Unrealized Loss, Before Tax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">var_MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>var_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_var_MarketableSecuritiesAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Marketable Securities, Amortized Cost</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">var_MarketableSecuritiesAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>var_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_CorporateBondSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_CorporateBondSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_USTreasuryBillSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_USTreasuryBillSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139750434125088">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FAIR VALUE - Contractual Maturities of Marketable Securities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisRollingMaturityAbstract', window );"><strong>Amortized Costs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_var_MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateRollingWithinOneYearAmortizedCost', window );">Due within one year</a></td>
<td class="nump">$ 16.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_var_MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateRollingAfterOneThroughFiveYearsAmortizedCost', window );">Due after one year through five years</a></td>
<td class="nump">2.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_var_MarketableSecuritiesAmortizedCost', window );">Total marketable debt securities</a></td>
<td class="nump">19.2<span></span>
</td>
<td class="nump">$ 20.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_var_MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateYearOne', window );">Due within one year</a></td>
<td class="nump">16.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_var_MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughFive', window );">Due after one year through five years</a></td>
<td class="nump">2.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Total marketable debt securities</a></td>
<td class="nump">$ 19.1<span></span>
</td>
<td class="nump">$ 20.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisRollingMaturityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisRollingMaturityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_var_MarketableSecuritiesAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Marketable Securities, Amortized Cost</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">var_MarketableSecuritiesAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>var_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_var_MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Marketable Securities, Maturity, Allocated and Single Maturity Date, After Year One Through Five</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">var_MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>var_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_var_MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateRollingAfterOneThroughFiveYearsAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Marketable Securities, Maturity, Allocated and Single Maturity Date, Rolling After One Through Five Years, Amortized Cost</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">var_MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateRollingAfterOneThroughFiveYearsAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>var_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_var_MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateRollingWithinOneYearAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Marketable Securities, Maturity, Allocated and Single Maturity Date, Rolling Within One Year, Amortized Cost</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">var_MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateRollingWithinOneYearAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>var_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_var_MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateYearOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Marketable Securities, Maturity, Allocated And Single Maturity Date, Year One</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">var_MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateYearOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>var_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139750354821840">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FAIR VALUE - Balance Sheet Marketable Securities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems', window );"><strong>Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Total marketable debt securities</a></td>
<td class="nump">$ 19.1<span></span>
</td>
<td class="nump">$ 20.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems', window );"><strong>Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Total marketable debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember', window );">Prepaid expenses and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems', window );"><strong>Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Total marketable debt securities</a></td>
<td class="nump">16.7<span></span>
</td>
<td class="nump">14.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember', window );">Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems', window );"><strong>Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Total marketable debt securities</a></td>
<td class="nump">2.4<span></span>
</td>
<td class="nump">2.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_CommercialPaperMember', window );">Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems', window );"><strong>Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Total marketable debt securities</a></td>
<td class="nump">4.9<span></span>
</td>
<td class="nump">5.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_CommercialPaperMember', window );">Commercial paper | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems', window );"><strong>Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Total marketable debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_CommercialPaperMember', window );">Commercial paper | Prepaid expenses and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems', window );"><strong>Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Total marketable debt securities</a></td>
<td class="nump">4.9<span></span>
</td>
<td class="nump">5.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_CommercialPaperMember', window );">Commercial paper | Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems', window );"><strong>Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Total marketable debt securities</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_CorporateBondSecuritiesMember', window );">Corporate notes/bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems', window );"><strong>Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Total marketable debt securities</a></td>
<td class="nump">3.6<span></span>
</td>
<td class="nump">3.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_CorporateBondSecuritiesMember', window );">Corporate notes/bonds | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems', window );"><strong>Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Total marketable debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_CorporateBondSecuritiesMember', window );">Corporate notes/bonds | Prepaid expenses and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems', window );"><strong>Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Total marketable debt securities</a></td>
<td class="nump">2.4<span></span>
</td>
<td class="nump">1.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_CorporateBondSecuritiesMember', window );">Corporate notes/bonds | Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems', window );"><strong>Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Total marketable debt securities</a></td>
<td class="nump">1.2<span></span>
</td>
<td class="nump">1.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">Government agencies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems', window );"><strong>Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Total marketable debt securities</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">Government agencies | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems', window );"><strong>Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Total marketable debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">Government agencies | Prepaid expenses and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems', window );"><strong>Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Total marketable debt securities</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">Government agencies | Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems', window );"><strong>Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Total marketable debt securities</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_USTreasuryBillSecuritiesMember', window );">U.S. Treasury bills</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems', window );"><strong>Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Total marketable debt securities</a></td>
<td class="nump">10.3<span></span>
</td>
<td class="nump">10.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_USTreasuryBillSecuritiesMember', window );">U.S. Treasury bills | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems', window );"><strong>Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Total marketable debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_USTreasuryBillSecuritiesMember', window );">U.S. Treasury bills | Prepaid expenses and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems', window );"><strong>Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Total marketable debt securities</a></td>
<td class="nump">9.1<span></span>
</td>
<td class="nump">6.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_USTreasuryBillSecuritiesMember', window );">U.S. Treasury bills | Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems', window );"><strong>Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Total marketable debt securities</a></td>
<td class="nump">$ 1.2<span></span>
</td>
<td class="nump">$ 0.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_CorporateBondSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_CorporateBondSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_USTreasuryBillSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_USTreasuryBillSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139750431737008">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INVENTORIES - Summary of Inventory (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves', window );">Raw materials and parts</a></td>
<td class="nump">$ 247.5<span></span>
</td>
<td class="nump">$ 240.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work-in-process</a></td>
<td class="nump">25.1<span></span>
</td>
<td class="nump">23.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">47.7<span></span>
</td>
<td class="nump">39.7<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total inventories</a></td>
<td class="nump">$ 320.3<span></span>
</td>
<td class="nump">$ 303.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregated amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed. This amount is net of valuation reserves and adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139750434240016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS - Goodwill Rollforward (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 30, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance at September 30, 2022</a></td>
<td class="nump">$ 284.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustments</a></td>
<td class="nump">3.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance at December 30, 2022</a></td>
<td class="nump">288.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=var_MedicalMember', window );">Medical</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance at September 30, 2022</a></td>
<td class="nump">169.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustments</a></td>
<td class="nump">2.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance at December 30, 2022</a></td>
<td class="nump">171.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=var_IndustrialMember', window );">Industrial</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance at September 30, 2022</a></td>
<td class="nump">115.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustments</a></td>
<td class="nump">1.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance at December 30, 2022</a></td>
<td class="nump">$ 116.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=var_MedicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=var_MedicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=var_IndustrialMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=var_IndustrialMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139750433740064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS - Intangible Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 134.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 131.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(102.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(98.3)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">31.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="nump">3.4<span></span>
</td>
<td class="nump">$ 3.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember', window );">Acquired existing technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">71.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(52.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(49.9)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">19.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IntellectualPropertyMember', window );">Patents, licenses and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">12.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(11.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11.6)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">0.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=var_CustomerContractsandSupplierRelationshipsMember', window );">Customer contracts and supplier relationship</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">50.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(38.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(36.8)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 11.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IntellectualPropertyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IntellectualPropertyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=var_CustomerContractsandSupplierRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=var_CustomerContractsandSupplierRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139750360923328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BORROWINGS - Schedule of Debt (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrentAbstract', window );"><strong>Current maturities of long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current maturities of long-term debt</a></td>
<td class="nump">$ 2.1<span></span>
</td>
<td class="nump">$ 2.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MaturitiesOfLongTermDebtAbstract', window );"><strong>Non-current maturities of long-term debt:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_var_LongtermDebtExcludingCurrentMaturitiesGross', window );">Total non-current maturities of long-term debt:</a></td>
<td class="nump">447.6<span></span>
</td>
<td class="nump">447.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNetAbstract', window );"><strong>Unamortized issuance costs and debt discounts</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Unamortized issuance costs and debt discounts, total</a></td>
<td class="num">(6.8)<span></span>
</td>
<td class="num">(35.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt outstanding, net</a></td>
<td class="nump">442.9<span></span>
</td>
<td class="nump">414.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MaturitiesOfLongTermDebtAbstract', window );"><strong>Non-current maturities of long-term debt:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_var_LongtermDebtExcludingCurrentMaturitiesGross', window );">Total non-current maturities of long-term debt:</a></td>
<td class="nump">$ 200.0<span></span>
</td>
<td class="nump">200.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Contractual Interest Rate</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtWeightedAverageInterestRateOverTime', window );">Effective Interest Rate</a></td>
<td class="nump">4.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNetAbstract', window );"><strong>Unamortized issuance costs and debt discounts</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Unamortized discount</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="num">(28.7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Unamortized issuance costs</a></td>
<td class="num">(3.5)<span></span>
</td>
<td class="num">(3.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent', window );">Equity component of convertible senior unsecured notes</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">49.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=us-gaap_OtherDebtSecuritiesMember', window );">Other debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrentAbstract', window );"><strong>Current maturities of long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current maturities of long-term debt</a></td>
<td class="nump">2.1<span></span>
</td>
<td class="nump">2.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MaturitiesOfLongTermDebtAbstract', window );"><strong>Non-current maturities of long-term debt:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_var_LongtermDebtExcludingCurrentMaturitiesGross', window );">Total non-current maturities of long-term debt:</a></td>
<td class="nump">4.6<span></span>
</td>
<td class="nump">4.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=var_SeniorSecuredNotesMember', window );">Senior Secured Notes | Secured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MaturitiesOfLongTermDebtAbstract', window );"><strong>Non-current maturities of long-term debt:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_var_LongtermDebtExcludingCurrentMaturitiesGross', window );">Total non-current maturities of long-term debt:</a></td>
<td class="nump">$ 243.0<span></span>
</td>
<td class="nump">243.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Contractual Interest Rate</a></td>
<td class="nump">7.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.875%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtWeightedAverageInterestRateOverTime', window );">Effective Interest Rate</a></td>
<td class="nump">8.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNetAbstract', window );"><strong>Unamortized issuance costs and debt discounts</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Unamortized issuance costs</a></td>
<td class="num">$ (3.3)<span></span>
</td>
<td class="num">$ (3.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of the equity component of convertible debt which may be settled in cash upon conversion.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unamortized debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtWeightedAverageInterestRateOverTime">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average interest rate of long-term debt outstanding calculated over time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtWeightedAverageInterestRateOverTime</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MaturitiesOfLongTermDebtAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MaturitiesOfLongTermDebtAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_var_LongtermDebtExcludingCurrentMaturitiesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long-term Debt Excluding Current Maturities, Gross</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">var_LongtermDebtExcludingCurrentMaturitiesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>var_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=us-gaap_OtherDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=us-gaap_OtherDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=var_SeniorSecuredNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=var_SeniorSecuredNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139750434459488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BORROWINGS - Schedule of Interest Expense (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_var_InterestExpenseDebtContractualInterestCoupon', window );">Contractual interest coupon and other</a></td>
<td class="nump">$ 6.9<span></span>
</td>
<td class="nump">$ 7.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of debt issuance costs</a></td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of debt discounts</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">2.1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Total interest expense</a></td>
<td class="nump">$ 7.5<span></span>
</td>
<td class="nump">$ 9.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_var_InterestExpenseDebtContractualInterestCoupon">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest Expense, Debt, Contractual Interest Coupon</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">var_InterestExpenseDebtContractualInterestCoupon</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>var_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139750355037104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BORROWINGS - Convertible Senior Unsecured Notes Narrative (Details) - Convertible Debt<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 09, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 05, 2020 </div>
<div>shares </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 30, 2022 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Contractual interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount | $</a></td>
<td class="nump">$ 200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Contractual interest rate</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Borrowings under credit agreements | $</a></td>
<td class="nump">$ 193,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Initial conversion rate (in shares) | shares</a></td>
<td class="nump">48.048<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price (in USD per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20.81<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments', window );">Number of equity instruments for convertible debt | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,600,000<span></span>
</td>
<td class="nump">9,600,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031898-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity instruments that the holder of the debt instrument would receive if the debt was converted to equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21521-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21506-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=var_ConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=var_ConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139750435961888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BORROWINGS - Call Spread Narrative (Details) - Convertible Notes - Convertible Debt<br> shares in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 05, 2020 </div>
<div>shares </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 30, 2022 </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 04, 2020 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price (in USD per share)</a></td>
<td class="nump">$ 20.81<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments', window );">Number of equity instruments for convertible debt | shares</a></td>
<td class="nump">9.6<span></span>
</td>
<td class="nump">9.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (in USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24.975<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_var_ClassOfWarrantOrRightPercentIncreaseOfStrikePriceOverSalePrice', window );">Percent increase of strike price over sale price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031898-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity instruments that the holder of the debt instrument would receive if the debt was converted to equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21521-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21506-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_var_ClassOfWarrantOrRightPercentIncreaseOfStrikePriceOverSalePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right, Percent Increase Of Strike Price Over Sale Price</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">var_ClassOfWarrantOrRightPercentIncreaseOfStrikePriceOverSalePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>var_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=var_ConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=var_ConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139750435992336">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>BORROWINGS - Senior Secured Notes Narrative (Details) - Senior Secured Notes - Secured Debt - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Contractual interest rate</a></td>
<td class="nump">7.90%<span></span>
</td>
<td class="nump">7.875%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=var_SeniorSecuredNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=var_SeniorSecuredNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139750433705328">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>BORROWINGS - Asset-Based Loan Narrative (Details) - Revolving Credit Facility - Asset-Based Loan - Secured Debt - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="nump">$ 100,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity', window );">Available borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 92,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Used capacity, commitment fee percentage</a></td>
<td class="nump">0.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=var_AssetBasedLoanRevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=var_AssetBasedLoanRevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139750434044160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NONCONTROLLING INTERESTS - Noncontrolling Interest (Details)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 28, 2018</div></th>
<th class="th"><div>Sep. 29, 2017</div></th>
<th class="th">
<div>Aug. 31, 2015 </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Dec. 30, 2022 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Apr. 30, 2015</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_var_BusinessAcquisitionAnnualRecurringCompensation', window );">Annual recurring compensation (in euros per share) | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0.95<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Temporary equity, shares outstanding (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MovementInMinorityInterestRollForward', window );"><strong>Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests, at beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13.3<span></span>
</td>
<td class="nump">$ 13.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_var_NetIncomeLossAttributableToNoncontrollingInterestNetOfDividends', window );">Net income attributable to noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_var_NoncontrollingInterestOtherChanges', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests, at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13.3<span></span>
</td>
<td class="nump">$ 13.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=var_JointVentureInSaudiArabiaMember', window );">Joint Venture In Saudi Arabia</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Majority voting rights, percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners', window );">Noncontrolling interest, ownership percentage by noncontrolling owners</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=var_MeVisMedicalSolutionsAGMeVisMember', window );">MeVis Medical Solutions AG (MeVis)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners', window );">Noncontrolling interest, ownership percentage by noncontrolling owners</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_var_PercentageOfAdditionalOutstandingSharesPurchased', window );">Percentage of additional outstanding shares purchased</a></td>
<td class="nump">0.20%<span></span>
</td>
<td class="nump">0.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_var_BusinessAcquisitionCumulativePercentageOfVotingInterestsAcquired', window );">Cumulative percentage of voting interests acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">73.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=var_MeVisMedicalSolutionsAGMeVisMember', window );">MeVis Medical Solutions AG (MeVis)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of voting interests acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">73.50%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The parent entity's interest in net assets of the subsidiary, expressed as a percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MovementInMinorityInterestRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MovementInMinorityInterestRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_var_BusinessAcquisitionAnnualRecurringCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition, Annual Recurring Compensation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">var_BusinessAcquisitionAnnualRecurringCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>var_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_var_BusinessAcquisitionCumulativePercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition, Cumulative Percentage Of Voting Interests Acquired</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">var_BusinessAcquisitionCumulativePercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>var_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_var_NetIncomeLossAttributableToNoncontrollingInterestNetOfDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Income (Loss) Attributable To Noncontrolling Interest, Net Of Dividends</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">var_NetIncomeLossAttributableToNoncontrollingInterestNetOfDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>var_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_var_NoncontrollingInterestOtherChanges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interest, Other Changes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">var_NoncontrollingInterestOtherChanges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>var_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_var_PercentageOfAdditionalOutstandingSharesPurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage Of Additional Outstanding Shares Purchased</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">var_PercentageOfAdditionalOutstandingSharesPurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>var_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=var_JointVentureInSaudiArabiaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=var_JointVentureInSaudiArabiaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=var_MeVisMedicalSolutionsAGMeVisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=var_MeVisMedicalSolutionsAGMeVisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=var_MeVisMedicalSolutionsAGMeVisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=var_MeVisMedicalSolutionsAGMeVisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139750354986256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET INCOME PER SHARE - Reconciliation of Numerator and Denominator for Basic and Diluted Net (Loss) Income Per Common Share (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to Varex - basic</a></td>
<td class="nump">$ 3.1<span></span>
</td>
<td class="nump">$ 1.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic weighted average shares outstanding (in shares)</a></td>
<td class="nump">40.1<span></span>
</td>
<td class="nump">39.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net income per share attributable to Varex (in USD per share)</a></td>
<td class="nump">$ 0.08<span></span>
</td>
<td class="nump">$ 0.04<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted', window );">Net income attributable to Varex - diluted</a></td>
<td class="nump">$ 3.1<span></span>
</td>
<td class="nump">$ 1.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities', window );">Dilutive effect of Convertible Notes (in shares)</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">2.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive effect of share-based awards and other (in shares)</a></td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_var_IncrementalCommonSharesAttributableToDilutiveEffectOfWarrants', window );">Dilutive effect of warrants (in shares)</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted weighted average shares outstanding (in shares)</a></td>
<td class="nump">40.6<span></span>
</td>
<td class="nump">43.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income per share attributable to Varex (in USD per share)</a></td>
<td class="nump">$ 0.08<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive shares (in shares)</a></td>
<td class="nump">14.5<span></span>
</td>
<td class="nump">2.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember', window );">Restricted stock and options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive shares (in shares)</a></td>
<td class="nump">3.0<span></span>
</td>
<td class="nump">2.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleDebtSecuritiesMember', window );">Convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive shares (in shares)</a></td>
<td class="nump">9.6<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive shares (in shares)</a></td>
<td class="nump">1.9<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible debt securities using the if-converted method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e2029-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126962052&amp;loc=d3e4991-113900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1707-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1500-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_var_IncrementalCommonSharesAttributableToDilutiveEffectOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Incremental Common Shares Attributable To Dilutive Effect Of Warrants</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">var_IncrementalCommonSharesAttributableToDilutiveEffectOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>var_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139750435472256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET INCOME PER SHARE - Narrative (Details) - shares<br> shares in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 05, 2020</div></th>
<th class="th"><div>Dec. 30, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=var_ConvertibleNotesMember', window );">Convertible Notes | Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments', window );">Number of equity instruments for convertible debt</a></td>
<td class="nump">9.6<span></span>
</td>
<td class="nump">9.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity instruments that the holder of the debt instrument would receive if the debt was converted to equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21521-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21506-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=var_ConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=var_ConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139750434404784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EMPLOYEE STOCK PLANS - Share-based Compensation Expense (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense</a></td>
<td class="nump">$ 3.3<span></span>
</td>
<td class="nump">$ 3.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense</a></td>
<td class="nump">0.8<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, general and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense</a></td>
<td class="nump">$ 2.1<span></span>
</td>
<td class="nump">$ 2.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139750434049296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EMPLOYEE STOCK PLANS - Stock Option Activity (Details) - USD ($)<br> $ / shares in Units, shares in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Options</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, beginning balance (in shares)</a></td>
<td class="nump">2,902<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="nump">385<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Canceled, expired or forfeited (in shares)</a></td>
<td class="num">(196)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, ending balance (in shares)</a></td>
<td class="nump">3,091<span></span>
</td>
<td class="nump">2,902<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Options, exercisable (in shares)</a></td>
<td class="nump">2,070<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_var_ExercisePriceRangeRollForward', window );"><strong>Price Range</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_var_SharebasedCompensationArrangementsbySharebasedPaymentAwardOptionsGrantsinPeriodPrice', window );">Granted (in USD per share)</a></td>
<td class="nump">$ 22.13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Options outstanding beginning balance (in USD per share)</a></td>
<td class="nump">28.97<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in USD per share)</a></td>
<td class="nump">22.13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Canceled, expired or forfeited (in USD per share)</a></td>
<td class="nump">31.44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Options outstanding ending balance (in USD per share)</a></td>
<td class="nump">27.96<span></span>
</td>
<td class="nump">$ 28.97<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Options, exercisable, weighted average exercise price (in USD per share)</a></td>
<td class="nump">$ 29.52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Options, outstanding, weighted average remaining contractual term (in years)</a></td>
<td class="text">5 years 2 months 12 days<span></span>
</td>
<td class="text">4 years 6 months<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Options, exercisable, weighted average remaining contractual term (in years)</a></td>
<td class="text">3 years 4 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Options, outstanding, aggregate intrinsic value</a></td>
<td class="nump">$ 1,209,500<span></span>
</td>
<td class="nump">$ 1,361,400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Options, exercisable, aggregate intrinsic value</a></td>
<td class="nump">$ 672,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price (in USD per share)</a></td>
<td class="nump">$ 20.30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_var_ExercisePriceRangeRollForward', window );"><strong>Price Range</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_var_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingPrice', window );">Outstanding at period beginning (in USD per share)</a></td>
<td class="nump">13.61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_var_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsForfeituresandExpirationsinPeriodPrice', window );">Canceled, expired or forfeited (in USD per share)</a></td>
<td class="nump">25.06<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_var_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingPrice', window );">Outstanding at period ending (in USD per share)</a></td>
<td class="nump">13.61<span></span>
</td>
<td class="nump">$ 13.61<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_var_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisablePrice', window );">Exercisable (in USD per share)</a></td>
<td class="nump">13.61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_var_ExercisePriceRangeRollForward', window );"><strong>Price Range</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_var_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingPrice', window );">Outstanding at period beginning (in USD per share)</a></td>
<td class="nump">37.60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_var_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsForfeituresandExpirationsinPeriodPrice', window );">Canceled, expired or forfeited (in USD per share)</a></td>
<td class="nump">37.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_var_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingPrice', window );">Outstanding at period ending (in USD per share)</a></td>
<td class="nump">37.60<span></span>
</td>
<td class="nump">$ 37.60<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_var_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisablePrice', window );">Exercisable (in USD per share)</a></td>
<td class="nump">$ 37.60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_var_ExercisePriceRangeRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise Price Range [Rollforward]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">var_ExercisePriceRangeRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>var_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_var_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement By Share-based Payment Award, Options, Outstanding, Price</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">var_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>var_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_var_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisablePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Price</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">var_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisablePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>var_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_var_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsForfeituresandExpirationsinPeriodPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Price</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">var_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsForfeituresandExpirationsinPeriodPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>var_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_var_SharebasedCompensationArrangementsbySharebasedPaymentAwardOptionsGrantsinPeriodPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>SharebasedCompensationArrangementsbySharebasedPaymentAwardOptionsGrantsinPeriodPrice</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">var_SharebasedCompensationArrangementsbySharebasedPaymentAwardOptionsGrantsinPeriodPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>var_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139750354975456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EMPLOYEE STOCK PLANS - Restricted Stock and Performance Stock (Details)<br> shares in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 30, 2022 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number&#160;of&#160;Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Restricted stock units, nonvested, beginning balance (in shares) | shares</a></td>
<td class="nump">1,045<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Restricted stock units, grants in period (in shares) | shares</a></td>
<td class="nump">492<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Restricted stock units, vested in period (in shares) | shares</a></td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Restricted stock units, canceled or expired in period (in shares) | shares</a></td>
<td class="num">(28)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Restricted stock units, nonvested, ending balance (in shares) | shares</a></td>
<td class="nump">1,506<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted&#160;Average Grant-Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Restricted stock units, nonvested, beginning of period (in USD per share) | $ / shares</a></td>
<td class="nump">$ 24.35<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Restricted stock units, grants in period (in USD per share) | $ / shares</a></td>
<td class="nump">20.12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Restricted stock units, vested in period (in USD per share) | $ / shares</a></td>
<td class="nump">23.70<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Restricted stock units, canceled or expired (in USD per share) | $ / shares</a></td>
<td class="nump">25.50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Restricted stock units, nonvested, end of period (in USD per share) | $ / shares</a></td>
<td class="nump">$ 22.95<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139750441176128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>TAXES ON INCOME (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">$ 2.2<span></span>
</td>
<td class="nump">$ 1.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before taxes</a></td>
<td class="nump">5.4<span></span>
</td>
<td class="nump">$ 3.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings', window );">Deferred tax liabilities of undistributed foreign earnings</a></td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from undistributed earnings of subsidiary and other recognized entity not within country of domicile. Includes, but is not limited to, other basis differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139750355020448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT INFORMATION - Income Statement Information (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 30, 2022 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of reportable operating segments | segment</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues, net</a></td>
<td class="nump">$ 205.6<span></span>
</td>
<td class="nump">$ 198.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">63.3<span></span>
</td>
<td class="nump">64.8<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">50.3<span></span>
</td>
<td class="nump">50.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Interest and other expense, net</a></td>
<td class="num">(7.6)<span></span>
</td>
<td class="num">(10.7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before taxes</a></td>
<td class="nump">5.4<span></span>
</td>
<td class="nump">3.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">2.2<span></span>
</td>
<td class="nump">1.7<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">3.2<span></span>
</td>
<td class="nump">1.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Less: Net income attributable to noncontrolling interests</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to Varex</a></td>
<td class="nump">3.1<span></span>
</td>
<td class="nump">1.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=var_MedicalMember', window );">Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues, net</a></td>
<td class="nump">160.1<span></span>
</td>
<td class="nump">155.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">46.3<span></span>
</td>
<td class="nump">46.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=var_IndustrialMember', window );">Industrial</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues, net</a></td>
<td class="nump">45.5<span></span>
</td>
<td class="nump">43.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">$ 17.0<span></span>
</td>
<td class="nump">$ 18.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=var_MedicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=var_MedicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=var_IndustrialMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=var_IndustrialMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>var-20221230_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2022"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:var="http://www.varex.com/20221230"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="var-20221230.xsd" xlink:type="simple"/>
    <context id="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-30</endDate>
        </period>
    </context>
    <context id="i5812d3f486ea497b898b89043aa7f4ea_I20230126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
        </entity>
        <period>
            <instant>2023-01-26</instant>
        </period>
    </context>
    <context id="i7fe5aac364564006abc3881183388748_D20211002-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
        </entity>
        <period>
            <startDate>2021-10-02</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i97383852c2e44f9090e25f67836d6e81_I20221230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
        </entity>
        <period>
            <instant>2022-12-30</instant>
        </period>
    </context>
    <context id="i967727602cae45adb24efc0f4e4bd947_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i2c89eaed981a4d4a95584393e114c1a2_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i37e38c715c44456aaf8bc01ef2b73582_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i946a5f2b729e4134a3046873942feac2_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ic3cbcd23a7804aebb45bbf33e9654051_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i90a3dedd81b74cfb9d7bf05623f3ea1b_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i964e8837dab84683972daafc904bc290_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="if053d543d68e4983b97631e65183a5d1_D20211002-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
        </entity>
        <period>
            <startDate>2021-10-02</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i5bbd4632766b486d8dd37f35093df0cb_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ic809286b91a146ce974c75d48a3c4517_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i5a5ca132807b4f1596b0b257c552596b_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ic28d182c3ed64ba2aebe358831333632_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i374334f7b3304f1d936a010e369e5949_D20221001-20221230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-30</endDate>
        </period>
    </context>
    <context id="i9bb651a6c0ed468da0c7878dd6d514ef_D20221001-20221230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-30</endDate>
        </period>
    </context>
    <context id="i689d7483ede3410593772cdd559784d3_D20221001-20221230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-30</endDate>
        </period>
    </context>
    <context id="ib43fdaa870e547d083de4f40fcef4c40_D20221001-20221230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-30</endDate>
        </period>
    </context>
    <context id="i0fa88bead9c943b7807d5810cd828850_I20221230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-30</instant>
        </period>
    </context>
    <context id="i4eb681e97f2345679fdea50eb3b491d1_I20221230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-30</instant>
        </period>
    </context>
    <context id="i2322eead975b4c1dbc547b6270fb8adf_I20221230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-30</instant>
        </period>
    </context>
    <context id="i02e30707026c4e429d7a8e186437ad12_I20221230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-30</instant>
        </period>
    </context>
    <context id="i42e660b69d2d46dcb0355f9671f5a578_I20221230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-30</instant>
        </period>
    </context>
    <context id="i5126bc5003f942bf8310df4804290940_I20221230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-30</instant>
        </period>
    </context>
    <context id="ida04e40f3374405faf2b86c9faa3beae_I20211001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-01</instant>
        </period>
    </context>
    <context id="i3aff7d47dfed4780bef288e0efb8de73_I20211001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-01</instant>
        </period>
    </context>
    <context id="id25e5cef067540a2b3d17a01b52d1080_I20211001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-01</instant>
        </period>
    </context>
    <context id="id72ff47fc82e4e879dbaa26a295898ce_I20211001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-01</instant>
        </period>
    </context>
    <context id="i15fe2e613bae4c76beaddadbd8d8e5e3_I20211001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-01</instant>
        </period>
    </context>
    <context id="i5ef993557e48462d926de8e9ccea2f7a_I20211001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-01</instant>
        </period>
    </context>
    <context id="i504e59968786494c96b1e46f5375a17d_I20211001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
        </entity>
        <period>
            <instant>2021-10-01</instant>
        </period>
    </context>
    <context id="if9fa7e713d284aa28f3ce117acb47880_D20211002-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-02</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ief1f6f644eea437e9b8e1e8aa59dc455_D20211002-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-02</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib6692c6c33bf48afbda409fe7c7691e3_D20211002-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-02</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i66a2015d4ada4d51b8273eb10babd3c7_D20211002-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-02</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i484320e6452e4a568aeaaf3e75831c12_D20211002-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-02</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia7cd9a82501843e7840128314d4836e4_D20211002-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-02</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic84d7ad4df444a5ba010f733b23db58e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8f85b75047844e478507cd67afb10862_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0f1790e7c49848f68d840ef25c469adf_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia50a700a64ae4856ba15300cae774337_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic3cba6759b1f4b609890dbb223fb7ddb_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7886797dc72447689ab1203828cf4a8a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4026880a25c245b7ae7af90aa89cf31c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i651cc3561a6c40d9a9e385495456c274_D20221001-20221230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">var:CanonMedicalSystemsCorporationFormerlyToshibaMedicalSystemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-30</endDate>
        </period>
    </context>
    <context id="i288802e63c324225b21fea1834e54841_D20211002-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">var:CanonMedicalSystemsCorporationFormerlyToshibaMedicalSystemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-02</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0048ce751bf94b37a1dd1afdc4bea06a_D20221001-20221230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">var:CanonMedicalSystemsCorporationFormerlyToshibaMedicalSystemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-30</endDate>
        </period>
    </context>
    <context id="i59fa34d2d760449bbe1edc7c303eea6d_D20211002-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">var:CanonMedicalSystemsCorporationFormerlyToshibaMedicalSystemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-02</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i67803683b0344dc78ee5545d3907c730_D20221001-20221230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-30</endDate>
        </period>
    </context>
    <context id="idd5d9702aa2d44ef9138ad61434eaa2a_D20221001-20221230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-30</endDate>
        </period>
    </context>
    <context id="i5d4da637b0cb434892a6570db3bf836d_I20221001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-01</instant>
        </period>
    </context>
    <context id="ic8c656c39e5948888cffc7883844bcb7_I20221230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">var:ConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-30</instant>
        </period>
    </context>
    <context id="i77268675d9614be1856e94103b41aef3_D20221001-20221230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-30</endDate>
        </period>
    </context>
    <context id="ib8a6b0f85dcb4a62be851b76f236b2a7_D20211002-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-02</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i04bcd73d30e04bdb841e13dae6931b40_D20221001-20221230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-30</endDate>
        </period>
    </context>
    <context id="i41a6a4b942e94c2f93e0cfd38b7b56b9_D20211002-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-02</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia9142a51de834eb08ccfecaa6fcb247b_D20221001-20221230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-30</endDate>
        </period>
    </context>
    <context id="i5faba21f6b9a41c5961c60b0331ab68e_D20211002-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-02</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i582fbee024ae43e187bc82bf36e08c7f_D20221001-20221230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-30</endDate>
        </period>
    </context>
    <context id="if0d5d3a41d6e46a8981e7b39df4c4005_D20211002-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-02</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id11c0d105587406ea12579388d33acc6_I20221230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">var:DpiXHoldingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-30</instant>
        </period>
    </context>
    <context id="i3c5473e7e6e2416283c3708bf75140f0_I20221230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">var:DpiXHoldingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">var:DpiXLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-30</instant>
        </period>
    </context>
    <context id="i651cdb90544d4fc5ae96aa228e377585_D20221001-20221230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">var:DpiXHoldingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-30</endDate>
        </period>
    </context>
    <context id="i1e78a329a9904ab4ad46da4fa3ad9d85_D20211002-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">var:DpiXHoldingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-02</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i754dac8665dd449eb1ba41e245554f36_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">var:DpiXHoldingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i70ff6a02b02a447d974ae2a3ad5485bc_D20230101-20231231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">var:DpiXHoldingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">var:FixedCostCommitmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="i043d35fe9e8748dba721e7442a223c87_D20221001-20221230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">var:VECImagingGmbHCo.KGMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-30</endDate>
        </period>
    </context>
    <context id="i23fdde7b29af4c57aa6824e48992f27e_D20211002-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">var:VECImagingGmbHCo.KGMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-02</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ide9a8d3681694417a4a4545b01157b8d_I20221230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">var:VECImagingGmbHCo.KGMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-30</instant>
        </period>
    </context>
    <context id="ic6403b22953a49d8b910f2bf553fd441_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">var:VECImagingGmbHCo.KGMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i4a06e1fd56de45429cf0fcaeadd92091_I20221230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-30</instant>
        </period>
    </context>
    <context id="i1b3aa766e2904db9b8ab4aa605bdb4ee_D20221001-20221230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-30</endDate>
        </period>
    </context>
    <context id="i4eac39f015bd47f5ba39e3bfcfcc6d4c_D20211002-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-02</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ide90c1ae15ab4bb9a3bd404689af0bbf_D20221001-20221230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-30</endDate>
        </period>
    </context>
    <context id="i934533f99d1543b2ab6a4be93d73dd8f_D20211002-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-02</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5c7f1146a6b1444882838f6b9709de23_I20221230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-30</instant>
        </period>
    </context>
    <context id="i5332708454694b5dbb490975b393f380_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i05ccff0411484bb0bee83af0018f0bf7_I20221230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-30</instant>
        </period>
    </context>
    <context id="i17e216dd46824f439789b35236b2e450_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i3e698835048a4495bf4ddd5aae18d2f8_I20221230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-30</instant>
        </period>
    </context>
    <context id="ie4aa2eb507164e9faa338325c825f610_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i6c18314ffe0b4522b51d04b27d6bdac1_I20221230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-30</instant>
        </period>
    </context>
    <context id="ib5065ecd379c4d4b96ce8728838e59d8_I20221230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-30</instant>
        </period>
    </context>
    <context id="i6de4c85804eb455496852e854a916c0e_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="if56b77a5f42444d7b50e5eabbf7d9892_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="id8a794d22d5a488984d341691b20bb34_I20221230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-30</instant>
        </period>
    </context>
    <context id="i2051d8990e80499790558d1c04489cd7_I20221230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-30</instant>
        </period>
    </context>
    <context id="i81f291e28b0849a882c21993a4683f38_I20221230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-30</instant>
        </period>
    </context>
    <context id="i488f141169664a4da02df7fb3f0314cf_I20221230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-30</instant>
        </period>
    </context>
    <context id="i000a217e3c2d4af68d6fb28636848da6_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i080aeddcac46466b8c187b8b0b5615b0_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i24674ea6cbf44864812dadb6e95f2db8_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i9240c6083244455c8602c53af33d914d_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i10a7807457d845b9ad4ed44aed8912db_I20221230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-30</instant>
        </period>
    </context>
    <context id="i7fddba25d3464fc88f2322c862ad8fda_I20221230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-30</instant>
        </period>
    </context>
    <context id="i6600d15de2c54873830ce25e54e2f1e4_I20221230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryBillSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-30</instant>
        </period>
    </context>
    <context id="id304dfd7514641719c5a17d4ab0bed7a_I20221230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-30</instant>
        </period>
    </context>
    <context id="i11d163dc0c7e4f778d0934c68fbd9ed9_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i09336e03a3124b3e8abcf83f054dfc6e_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i76a7050d54304267a10c2a2ff2669153_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryBillSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i47928432e34e44fab0fa2e3e5ea1c268_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="if73dd818790943af8e76d7d0bd61ece8_I20221230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-30</instant>
        </period>
    </context>
    <context id="id1e9242ff3354b2a960503fd1761aab2_I20221230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-30</instant>
        </period>
    </context>
    <context id="i92e88468ba3d48a7a063bee1e0f0318a_I20221230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-30</instant>
        </period>
    </context>
    <context id="i6f7a180ea39443b694aaf7dd07ad1096_I20221230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryBillSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-30</instant>
        </period>
    </context>
    <context id="i820b739701b04c498136aad1494d10a5_I20221230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-30</instant>
        </period>
    </context>
    <context id="i6ae6c3be3d534e909bf65cafdb441f13_I20221230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-30</instant>
        </period>
    </context>
    <context id="i6ca9a72270ef4471b61390923b253af8_I20221230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-30</instant>
        </period>
    </context>
    <context id="iabebb79ab33a45a88797388ed198ebff_I20221230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-30</instant>
        </period>
    </context>
    <context id="i3ce0938959034f01ba57216c7cb057f4_I20221230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryBillSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-30</instant>
        </period>
    </context>
    <context id="ibb5cc1f64aef49f38721631773798f1c_I20221230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-30</instant>
        </period>
    </context>
    <context id="ic7b8fd0dd0134e8f856ea33530935168_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i37397c07155e4b5999d81334076d9104_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i258bf93e049d4d02a30c6b42cfdf1134_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ib570e05ca31b4b8d9df07b036d129ecc_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryBillSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i9fd818ca9813423087f30261388bf1ff_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i1fb8bf62e0d742a9a0f377ab72636023_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i41d677cf97674dbd90329e0a86d4c071_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i5b9b65169796488785c67752201e44e3_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i0b104c9b9bf14c9f912232bc060f93db_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryBillSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i7cbc650905324d5a9d9f236aae761225_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ib5c2f6e8743c4071bbe71b730ae4875d_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i0f985f58dae54b558355211719080563_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ic599629ea0b04a37b5c016ca41d98210_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="if4692f756aaa45aeb72bc012dbee325a_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryBillSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ie75eb2768bab4d5b841b550e22dc7e31_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i82c73512683b4d2096958ea2c1d31545_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">var:MedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i317f9c4181274f2493096e5cbd4ae801_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">var:IndustrialMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="iad2fceac1bb145229d93b69339db9f19_D20221001-20221230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">var:MedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-30</endDate>
        </period>
    </context>
    <context id="iaab56d5aa0be4d758038ec0908970ec8_D20221001-20221230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">var:IndustrialMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-30</endDate>
        </period>
    </context>
    <context id="i6ed6fb1587e340578f31b77be6b9133b_I20221230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">var:MedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-30</instant>
        </period>
    </context>
    <context id="i90a86f642a414830901c4fc2a48a1b03_I20221230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">var:IndustrialMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-30</instant>
        </period>
    </context>
    <context id="i71efe72866804c618d71d89eb6e37464_I20221230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-30</instant>
        </period>
    </context>
    <context id="i8c5261f66af24806b7d3a028cf3b8dc2_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ib080390b901b4ad0b3394ec38916cf01_I20221230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-30</instant>
        </period>
    </context>
    <context id="ice17b9b9dfca490ab810ee326594761a_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i00b01e43c8e144339e841ad785f9ced0_I20221230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">var:CustomerContractsandSupplierRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-30</instant>
        </period>
    </context>
    <context id="i77825c8e58b14473947ad5b24ebc5fe2_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">var:CustomerContractsandSupplierRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ie7b6a45a9d7f431e82a5e0541b5d665f_I20221230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-30</instant>
        </period>
    </context>
    <context id="ifdafe244379e403ab68aa2010d767746_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i2ddb8748822a4dd79f1844c4e1de6408_I20221230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-30</instant>
        </period>
    </context>
    <context id="i329314c9f0c94232beff7031f1c86791_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="if2ff80d284834bfcb7ca6f632c838139_D20221001-20221230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-30</endDate>
        </period>
    </context>
    <context id="i2fee5a0bbf6742f6bb3e66a2bb45060d_I20221230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">var:SeniorSecuredNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-30</instant>
        </period>
    </context>
    <context id="if0321a6e3bf3410dbde55beea3d74890_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">var:SeniorSecuredNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="idb047c1f6e044134babc50205637228f_D20221001-20221230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">var:SeniorSecuredNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-30</endDate>
        </period>
    </context>
    <context id="i69f1e52e1cba4369877e4bf54fb6f0fa_I20200609">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">var:ConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-09</instant>
        </period>
    </context>
    <context id="ia56e2cecd1c944d1be9cbd9438c698cb_D20200609-20200609">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">var:ConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-09</startDate>
            <endDate>2020-06-09</endDate>
        </period>
    </context>
    <context id="i9d049c5854724aa9974c7beaa7a53f96_I20200605">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">var:ConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-05</instant>
        </period>
    </context>
    <context id="i4e0cf62911af4732b7b65d582effb57a_D20200604-20200605">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">var:ConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-04</startDate>
            <endDate>2020-06-05</endDate>
        </period>
    </context>
    <context id="i97ab3a4749584f83846ca650afd01c56_I20200604">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">var:ConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-04</instant>
        </period>
    </context>
    <context id="i798fb4265b0e4636a6a91ab2434ed003_D20221001-20221230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">var:ConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-30</endDate>
        </period>
    </context>
    <context id="id08284e24f7a44a1af87978abad620f1_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">var:SeniorSecuredNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="icb3ccdc0c44b4d1ea6e36338c7054f16_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">var:AssetBasedLoanRevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i158d5c57020b4ef6a39dffc0260b3686_D20220930-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">var:AssetBasedLoanRevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-30</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i6c3e3d6ed3d54b1db390bab6a91c9dbc_I20221230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">var:AssetBasedLoanRevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-30</instant>
        </period>
    </context>
    <context id="ibe05cb3673834311b8aede71e8a50abf_I20180930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">var:JointVentureInSaudiArabiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-30</instant>
        </period>
    </context>
    <context id="iaa0abd3404e2408cb290b091be08936f_I20150430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">var:MeVisMedicalSolutionsAGMeVisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-04-30</instant>
        </period>
    </context>
    <context id="i129fd5cad674437db5d8fc43fb2f24cc_D20170929-20170929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">var:MeVisMedicalSolutionsAGMeVisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-09-29</startDate>
            <endDate>2017-09-29</endDate>
        </period>
    </context>
    <context id="ia34c4680d929483bb8b2f9d74fb41a7a_D20180928-20180928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">var:MeVisMedicalSolutionsAGMeVisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-28</startDate>
            <endDate>2018-09-28</endDate>
        </period>
    </context>
    <context id="ic047dd7ba8bc4e4983adf9ec678cc993_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">var:MeVisMedicalSolutionsAGMeVisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i6530ecc1b8854fcbb93120033ddfdde9_D20150801-20150831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
        </entity>
        <period>
            <startDate>2015-08-01</startDate>
            <endDate>2015-08-31</endDate>
        </period>
    </context>
    <context id="ia15cd7f933164e4fa3c90be25a2678a1_I20221230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">var:MeVisMedicalSolutionsAGMeVisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-30</instant>
        </period>
    </context>
    <context id="i86ab0fdd202b48e9b5a3c7718d5598cc_D20221001-20221230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-30</endDate>
        </period>
    </context>
    <context id="i601e32df192447cb959a2ba73a6fd2ba_D20211002-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-02</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="idc160449c61b40539d3867651037cc59_D20221001-20221230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-30</endDate>
        </period>
    </context>
    <context id="i3bf31d7d7f764d569a16bae11d856ce7_D20211002-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-02</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ieb7fcbc8943f416c813c5266235d9ae1_D20221001-20221230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-30</endDate>
        </period>
    </context>
    <context id="i933696b07a5546158d133b6f7f13c96f_D20211002-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-02</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i9f1d152938084b8fb5c95daf2c0bebc9_D20221001-20221230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-30</endDate>
        </period>
    </context>
    <context id="id8ef423cb3ad48e8887f0b4fd6e5cb77_D20211002-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-02</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic4686bc0f01748e7bf2ccd6382ecb978_D20221001-20221230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-30</endDate>
        </period>
    </context>
    <context id="if0a9c4e86e3f4f929c53ebd89df0858a_D20211002-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-02</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i78f307374103493aa2a778a18fffd8c0_D20221001-20221230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-30</endDate>
        </period>
    </context>
    <context id="ia84a05a959934c73ac14197dcf7f8950_D20211002-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-02</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i351ede538c104bba9d98c61dffb4fb78_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i18c5d964291c4ea790a03cf8d6140a16_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i1d50db1d5d424029913ff40e007c62a2_I20221230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-30</instant>
        </period>
    </context>
    <context id="ibe78209ddb124767b1ede71bb79ea8dc_I20221230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-30</instant>
        </period>
    </context>
    <context id="if28f02563bbd40d0a3a931501b82e58f_D20211002-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">var:MedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-02</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ifbe1cf81bdb14d34b79718fe7f9ef5df_D20211002-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001681622</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">var:IndustrialMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-02</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="segment">
        <measure>var:segment</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="instrument">
        <measure>var:instrument</measure>
    </unit>
    <unit id="derivativecontract">
        <measure>var:derivativeContract</measure>
    </unit>
    <unit id="eurPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:EUR</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180L2ZyYWc6MjY4MmM5ZTI5ZjEwNDMyYzkwOWZjNTFjNzMzNTNhY2QvdGFibGU6ZWRlNDYxY2JhYmY3NDdjM2I5NTgwM2NkM2YyNGRlOWEvdGFibGVyYW5nZTplZGU0NjFjYmFiZjc0N2MzYjk1ODAzY2QzZjI0ZGU5YV8wLTEtMS0xLTgzMjg1_fde828de-1e70-409b-a8ee-900d01172697">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180L2ZyYWc6MjY4MmM5ZTI5ZjEwNDMyYzkwOWZjNTFjNzMzNTNhY2QvdGFibGU6ZWRlNDYxY2JhYmY3NDdjM2I5NTgwM2NkM2YyNGRlOWEvdGFibGVyYW5nZTplZGU0NjFjYmFiZjc0N2MzYjk1ODAzY2QzZjI0ZGU5YV8xLTEtMS0xLTgzMjg1_ec5f1489-76eb-4b24-9268-f7278365c73d">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180L2ZyYWc6MjY4MmM5ZTI5ZjEwNDMyYzkwOWZjNTFjNzMzNTNhY2QvdGFibGU6ZWRlNDYxY2JhYmY3NDdjM2I5NTgwM2NkM2YyNGRlOWEvdGFibGVyYW5nZTplZGU0NjFjYmFiZjc0N2MzYjk1ODAzY2QzZjI0ZGU5YV8yLTEtMS0xLTgzMjg1_a3c0f346-947e-4fa7-a0b9-2966419f5a95">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180L2ZyYWc6MjY4MmM5ZTI5ZjEwNDMyYzkwOWZjNTFjNzMzNTNhY2QvdGFibGU6ZWRlNDYxY2JhYmY3NDdjM2I5NTgwM2NkM2YyNGRlOWEvdGFibGVyYW5nZTplZGU0NjFjYmFiZjc0N2MzYjk1ODAzY2QzZjI0ZGU5YV8zLTEtMS0xLTgzMjg1_55957140-3119-4165-8f80-944d87f20efb">0001681622</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180L2ZyYWc6MjY4MmM5ZTI5ZjEwNDMyYzkwOWZjNTFjNzMzNTNhY2QvdGFibGU6ZWRlNDYxY2JhYmY3NDdjM2I5NTgwM2NkM2YyNGRlOWEvdGFibGVyYW5nZTplZGU0NjFjYmFiZjc0N2MzYjk1ODAzY2QzZjI0ZGU5YV80LTEtMS0xLTgzMjg1_7c61375d-6491-4eb2-99dc-c42c46f24693">--09-29</dei:CurrentFiscalYearEndDate>
    <us-gaap:AccountingStandardsUpdateExtensibleList
      contextRef="if053d543d68e4983b97631e65183a5d1_D20211002-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOjkwN2JhZTc1NjE4MDRhZGNhZjM3ZDc0NzQ5NGRmYWQ3L3RhYmxlcmFuZ2U6OTA3YmFlNzU2MTgwNGFkY2FmMzdkNzQ3NDk0ZGZhZDdfNS0wLTEtMS04MzI4NQ_91a4cd1c-cf54-4eef-9557-9e99df59c2df">http://fasb.org/us-gaap/2022#AccountingStandardsUpdate202006Member</us-gaap:AccountingStandardsUpdateExtensibleList>
    <us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjEyNTNlNzQwNjAwMzRlZjM4YmM3ZDQyNjA2OTE4NGNiL3RhYmxlcmFuZ2U6MTI1M2U3NDA2MDAzNGVmMzhiYzdkNDI2MDY5MTg0Y2JfMy0xLTEtMS04MzI4NQ_6fed9dde-ecf9-4697-bdfd-bda3b6c18e81">http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjEyNTNlNzQwNjAwMzRlZjM4YmM3ZDQyNjA2OTE4NGNiL3RhYmxlcmFuZ2U6MTI1M2U3NDA2MDAzNGVmMzhiYzdkNDI2MDY5MTg0Y2JfMy0xLTEtMS04MzI4NQ_7db859ec-ae05-400b-a6ff-3ee55890f062">http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjEyNTNlNzQwNjAwMzRlZjM4YmM3ZDQyNjA2OTE4NGNiL3RhYmxlcmFuZ2U6MTI1M2U3NDA2MDAzNGVmMzhiYzdkNDI2MDY5MTg0Y2JfNi0xLTEtMS04MzI4NQ_21d67cfe-4f11-4971-a007-53438e019ae1">http://fasb.org/us-gaap/2022#AccruedLiabilitiesCurrent</us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjEyNTNlNzQwNjAwMzRlZjM4YmM3ZDQyNjA2OTE4NGNiL3RhYmxlcmFuZ2U6MTI1M2U3NDA2MDAzNGVmMzhiYzdkNDI2MDY5MTg0Y2JfNi0xLTEtMS04MzI4NQ_651facb0-63c0-4af0-8d59-d1e007979e09">http://fasb.org/us-gaap/2022#AccruedLiabilitiesCurrent</us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjEyNTNlNzQwNjAwMzRlZjM4YmM3ZDQyNjA2OTE4NGNiL3RhYmxlcmFuZ2U6MTI1M2U3NDA2MDAzNGVmMzhiYzdkNDI2MDY5MTg0Y2JfOC0xLTEtMS04MzI4NQ_0e1c436b-8779-4e63-90c2-6287c33ec16d">http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent</us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
      contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjEyNTNlNzQwNjAwMzRlZjM4YmM3ZDQyNjA2OTE4NGNiL3RhYmxlcmFuZ2U6MTI1M2U3NDA2MDAzNGVmMzhiYzdkNDI2MDY5MTg0Y2JfOC0xLTEtMS04MzI4NQ_8cf1f2a5-8b40-40ac-84e4-96b9a215a402">http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent</us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfMTAtMC0xLTEtODMyODU_79a5037b-581b-47d3-9fd4-71603055d303">http://fasb.org/us-gaap/2022#Assets</us-gaap:DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration>
    <us-gaap:DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfMTYtMC0xLTEtMTAwNTk3_169dbe7d-a10b-4a1e-ab46-42af80460820">http://fasb.org/us-gaap/2022#Liabilities</us-gaap:DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration>
    <us-gaap:DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration
      contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfOC0wLTEtMS04MzI4NQ_417fadeb-557f-4f83-a995-e688c949e009">http://fasb.org/us-gaap/2022#Assets</us-gaap:DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration>
    <us-gaap:DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration
      contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfMTMtMC0xLTEtODMyODU_54db5ac7-0c5e-4cf6-bc9b-f0229d68f729">http://fasb.org/us-gaap/2022#Liabilities</us-gaap:DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration>
    <dei:DocumentType
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xL2ZyYWc6ZTg1YWY1NDM0NTQ2NDliOThiZWExNWU0MzYyMDg2NzMvdGV4dHJlZ2lvbjplODVhZjU0MzQ1NDY0OWI5OGJlYTE1ZTQzNjIwODY3M18yMDI3_5f316b4e-1152-4250-8e0e-3441ae5c7dcd">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xL2ZyYWc6ZTg1YWY1NDM0NTQ2NDliOThiZWExNWU0MzYyMDg2NzMvdGFibGU6OTJiYjlmMzc1ZWYxNDI3YmIyMWU4MDY1YjY5OTdhOGEvdGFibGVyYW5nZTo5MmJiOWYzNzVlZjE0MjdiYjIxZTgwNjViNjk5N2E4YV8wLTAtMS0xLTgzMjg1_be3b0c1c-8cb7-408b-a4d9-9f143dc34aee">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xL2ZyYWc6ZTg1YWY1NDM0NTQ2NDliOThiZWExNWU0MzYyMDg2NzMvdGV4dHJlZ2lvbjplODVhZjU0MzQ1NDY0OWI5OGJlYTE1ZTQzNjIwODY3M18yNDQ_9063b9e8-747d-4611-bf2d-20f92e83f8fa">2022-12-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xL2ZyYWc6ZTg1YWY1NDM0NTQ2NDliOThiZWExNWU0MzYyMDg2NzMvdGFibGU6NDg0MTY0YmVjYWZjNGM0NjljM2RjZDkyOTE2OWM3MmEvdGFibGVyYW5nZTo0ODQxNjRiZWNhZmM0YzQ2OWMzZGNkOTI5MTY5YzcyYV8wLTAtMS0xLTgzMjg1_98e850c7-b1d1-4c3e-b74f-6e50cf2da892">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xL2ZyYWc6ZTg1YWY1NDM0NTQ2NDliOThiZWExNWU0MzYyMDg2NzMvdGV4dHJlZ2lvbjplODVhZjU0MzQ1NDY0OWI5OGJlYTE1ZTQzNjIwODY3M18yMDIw_2eee155b-10a9-4645-a074-5a7dae22acb8">001-37860</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xL2ZyYWc6ZTg1YWY1NDM0NTQ2NDliOThiZWExNWU0MzYyMDg2NzMvdGV4dHJlZ2lvbjplODVhZjU0MzQ1NDY0OWI5OGJlYTE1ZTQzNjIwODY3M18yMDMw_a6c7490f-7b08-44b2-9ffc-d1d531a15318">VAREX IMAGING CORPORATION</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xL2ZyYWc6ZTg1YWY1NDM0NTQ2NDliOThiZWExNWU0MzYyMDg2NzMvdGFibGU6ZTRiZjJhYmYxMGVjNDhiY2EzNjA1YzE5NWQ3NmUyODQvdGFibGVyYW5nZTplNGJmMmFiZjEwZWM0OGJjYTM2MDVjMTk1ZDc2ZTI4NF8wLTAtMS0xLTgzMjg1_d0f9f65a-bfa0-41a4-ab74-8f273af61210">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xL2ZyYWc6ZTg1YWY1NDM0NTQ2NDliOThiZWExNWU0MzYyMDg2NzMvdGFibGU6ZTRiZjJhYmYxMGVjNDhiY2EzNjA1YzE5NWQ3NmUyODQvdGFibGVyYW5nZTplNGJmMmFiZjEwZWM0OGJjYTM2MDVjMTk1ZDc2ZTI4NF8wLTMtMS0xLTgzMjg1_38307b32-8954-4995-887b-781e174afc68">81-3434516</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xL2ZyYWc6ZTg1YWY1NDM0NTQ2NDliOThiZWExNWU0MzYyMDg2NzMvdGFibGU6ZTRiZjJhYmYxMGVjNDhiY2EzNjA1YzE5NWQ3NmUyODQvdGFibGVyYW5nZTplNGJmMmFiZjEwZWM0OGJjYTM2MDVjMTk1ZDc2ZTI4NF8zLTAtMS0xLTgzMjg1L3RleHRyZWdpb246YzJjNzk4MmVhYmU5NDg2YmEzNWMwZDA4YTg3YzU0N2FfNQ_fdf4e91a-62a1-4332-bbf2-c4f239bb84c1">1678 S. Pioneer Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xL2ZyYWc6ZTg1YWY1NDM0NTQ2NDliOThiZWExNWU0MzYyMDg2NzMvdGFibGU6ZTRiZjJhYmYxMGVjNDhiY2EzNjA1YzE5NWQ3NmUyODQvdGFibGVyYW5nZTplNGJmMmFiZjEwZWM0OGJjYTM2MDVjMTk1ZDc2ZTI4NF8zLTAtMS0xLTgzMjg1L3RleHRyZWdpb246YzJjNzk4MmVhYmU5NDg2YmEzNWMwZDA4YTg3YzU0N2FfOQ_289a846c-f383-42ef-aea4-703e11deef30">Salt Lake City</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xL2ZyYWc6ZTg1YWY1NDM0NTQ2NDliOThiZWExNWU0MzYyMDg2NzMvdGFibGU6ZTRiZjJhYmYxMGVjNDhiY2EzNjA1YzE5NWQ3NmUyODQvdGFibGVyYW5nZTplNGJmMmFiZjEwZWM0OGJjYTM2MDVjMTk1ZDc2ZTI4NF8zLTAtMS0xLTgzMjg1L3RleHRyZWdpb246YzJjNzk4MmVhYmU5NDg2YmEzNWMwZDA4YTg3YzU0N2FfMTM_743b2e0b-3212-41e4-84ea-c4c156ceacf4">UT</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xL2ZyYWc6ZTg1YWY1NDM0NTQ2NDliOThiZWExNWU0MzYyMDg2NzMvdGFibGU6ZTRiZjJhYmYxMGVjNDhiY2EzNjA1YzE5NWQ3NmUyODQvdGFibGVyYW5nZTplNGJmMmFiZjEwZWM0OGJjYTM2MDVjMTk1ZDc2ZTI4NF8zLTMtMS0xLTgzMjg1L3RleHRyZWdpb246Yjc3MTlhNmRjMGJkNGEyMWIyMjBmNTYwZTRjZWNlYTNfNQ_caa72e46-9fa7-4591-a596-efee3974e05c">84104</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xL2ZyYWc6ZTg1YWY1NDM0NTQ2NDliOThiZWExNWU0MzYyMDg2NzMvdGV4dHJlZ2lvbjplODVhZjU0MzQ1NDY0OWI5OGJlYTE1ZTQzNjIwODY3M18yMDI0_607702f2-bc80-4ac5-a735-24ba6a38e8de">801</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xL2ZyYWc6ZTg1YWY1NDM0NTQ2NDliOThiZWExNWU0MzYyMDg2NzMvdGV4dHJlZ2lvbjplODVhZjU0MzQ1NDY0OWI5OGJlYTE1ZTQzNjIwODY3M18yMDI1_e898aca8-dbee-47fd-8e71-2abcb40fcee8">972-5000</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xL2ZyYWc6ZTg1YWY1NDM0NTQ2NDliOThiZWExNWU0MzYyMDg2NzMvdGFibGU6ZDU5NTc5YzM5Zjc3NDAwNGJlMmQzNDU2NjZmMTEyZWMvdGFibGVyYW5nZTpkNTk1NzljMzlmNzc0MDA0YmUyZDM0NTY2NmYxMTJlY18xLTAtMS0xLTgzMjg1_dabec9e7-73ba-4b72-bdd3-8a0cf1c9d4b7">Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xL2ZyYWc6ZTg1YWY1NDM0NTQ2NDliOThiZWExNWU0MzYyMDg2NzMvdGFibGU6ZDU5NTc5YzM5Zjc3NDAwNGJlMmQzNDU2NjZmMTEyZWMvdGFibGVyYW5nZTpkNTk1NzljMzlmNzc0MDA0YmUyZDM0NTY2NmYxMTJlY18xLTEtMS0xLTgzMjg1_bb0f5e5d-0cbf-4503-a344-bd99ef4792d8">VREX</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xL2ZyYWc6ZTg1YWY1NDM0NTQ2NDliOThiZWExNWU0MzYyMDg2NzMvdGFibGU6ZDU5NTc5YzM5Zjc3NDAwNGJlMmQzNDU2NjZmMTEyZWMvdGFibGVyYW5nZTpkNTk1NzljMzlmNzc0MDA0YmUyZDM0NTY2NmYxMTJlY18xLTItMS0xLTgzMjg1_fbc077a8-81f9-4de9-97f0-6680055a3f61">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xL2ZyYWc6ZTg1YWY1NDM0NTQ2NDliOThiZWExNWU0MzYyMDg2NzMvdGV4dHJlZ2lvbjplODVhZjU0MzQ1NDY0OWI5OGJlYTE1ZTQzNjIwODY3M18yMDIx_97cf142f-9823-458d-84da-d25a695a26c6">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xL2ZyYWc6ZTg1YWY1NDM0NTQ2NDliOThiZWExNWU0MzYyMDg2NzMvdGV4dHJlZ2lvbjplODVhZjU0MzQ1NDY0OWI5OGJlYTE1ZTQzNjIwODY3M18yMDIy_a74f53fd-61bf-493b-9652-094922a60727">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xL2ZyYWc6ZTg1YWY1NDM0NTQ2NDliOThiZWExNWU0MzYyMDg2NzMvdGFibGU6ODVhMTVjZmYzODY4NDlmN2EzMWViMWJjYjk0YjI2YjIvdGFibGVyYW5nZTo4NWExNWNmZjM4Njg0OWY3YTMxZWIxYmNiOTRiMjZiMl8wLTAtMS0xLTgzMjg1_ee1c18ec-d8e8-4830-8a20-70ecda897063">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xL2ZyYWc6ZTg1YWY1NDM0NTQ2NDliOThiZWExNWU0MzYyMDg2NzMvdGFibGU6ODVhMTVjZmYzODY4NDlmN2EzMWViMWJjYjk0YjI2YjIvdGFibGVyYW5nZTo4NWExNWNmZjM4Njg0OWY3YTMxZWIxYmNiOTRiMjZiMl8yLTYtMS0xLTgzMjg1_7b93f9ea-078d-4d4e-93bd-7ec21166fc9f">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xL2ZyYWc6ZTg1YWY1NDM0NTQ2NDliOThiZWExNWU0MzYyMDg2NzMvdGFibGU6ODVhMTVjZmYzODY4NDlmN2EzMWViMWJjYjk0YjI2YjIvdGFibGVyYW5nZTo4NWExNWNmZjM4Njg0OWY3YTMxZWIxYmNiOTRiMjZiMl80LTYtMS0xLTgzMjg1_0dca26ae-d270-48cc-8de2-0c97f92649e4">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xL2ZyYWc6ZTg1YWY1NDM0NTQ2NDliOThiZWExNWU0MzYyMDg2NzMvdGV4dHJlZ2lvbjplODVhZjU0MzQ1NDY0OWI5OGJlYTE1ZTQzNjIwODY3M18yMDI2_0ef3d5ac-f654-40f4-becb-3d6a436c1dc6">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i5812d3f486ea497b898b89043aa7f4ea_I20230126"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xL2ZyYWc6ZTg1YWY1NDM0NTQ2NDliOThiZWExNWU0MzYyMDg2NzMvdGV4dHJlZ2lvbjplODVhZjU0MzQ1NDY0OWI5OGJlYTE1ZTQzNjIwODY3M18xOTY2_57535776-21f0-4cf3-b350-c1942aa65ce7"
      unitRef="shares">40100000</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xNi9mcmFnOmRlMjY3N2UzMGNmNzRiOTU5NjAzYjlkOGNhYjY1MDc4L3RhYmxlOjE4OGExZTBkNDZhMTQyMDJiZTdlY2RjN2FmYzgyY2Y1L3RhYmxlcmFuZ2U6MTg4YTFlMGQ0NmExNDIwMmJlN2VjZGM3YWZjODJjZjVfMi01LTEtMS04MzI4NQ_025f4dac-2283-4d45-a1e1-e77320f1ede6"
      unitRef="usd">205600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xNi9mcmFnOmRlMjY3N2UzMGNmNzRiOTU5NjAzYjlkOGNhYjY1MDc4L3RhYmxlOjE4OGExZTBkNDZhMTQyMDJiZTdlY2RjN2FmYzgyY2Y1L3RhYmxlcmFuZ2U6MTg4YTFlMGQ0NmExNDIwMmJlN2VjZGM3YWZjODJjZjVfMi03LTEtMS04MzI4NQ_2af209d5-3fb4-4c36-b6db-02f502a4f42c"
      unitRef="usd">198800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xNi9mcmFnOmRlMjY3N2UzMGNmNzRiOTU5NjAzYjlkOGNhYjY1MDc4L3RhYmxlOjE4OGExZTBkNDZhMTQyMDJiZTdlY2RjN2FmYzgyY2Y1L3RhYmxlcmFuZ2U6MTg4YTFlMGQ0NmExNDIwMmJlN2VjZGM3YWZjODJjZjVfMy01LTEtMS04MzI4NQ_ea60637c-e1a7-44c2-b894-18242790cee2"
      unitRef="usd">142300000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xNi9mcmFnOmRlMjY3N2UzMGNmNzRiOTU5NjAzYjlkOGNhYjY1MDc4L3RhYmxlOjE4OGExZTBkNDZhMTQyMDJiZTdlY2RjN2FmYzgyY2Y1L3RhYmxlcmFuZ2U6MTg4YTFlMGQ0NmExNDIwMmJlN2VjZGM3YWZjODJjZjVfMy03LTEtMS04MzI4NQ_bcb99db9-914f-4300-bc21-5b8c58bd02dd"
      unitRef="usd">134000000.0</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xNi9mcmFnOmRlMjY3N2UzMGNmNzRiOTU5NjAzYjlkOGNhYjY1MDc4L3RhYmxlOjE4OGExZTBkNDZhMTQyMDJiZTdlY2RjN2FmYzgyY2Y1L3RhYmxlcmFuZ2U6MTg4YTFlMGQ0NmExNDIwMmJlN2VjZGM3YWZjODJjZjVfNC01LTEtMS04MzI4NQ_c1c0744d-0dd5-41e1-be9d-90ba8ec3b40d"
      unitRef="usd">63300000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xNi9mcmFnOmRlMjY3N2UzMGNmNzRiOTU5NjAzYjlkOGNhYjY1MDc4L3RhYmxlOjE4OGExZTBkNDZhMTQyMDJiZTdlY2RjN2FmYzgyY2Y1L3RhYmxlcmFuZ2U6MTg4YTFlMGQ0NmExNDIwMmJlN2VjZGM3YWZjODJjZjVfNC03LTEtMS04MzI4NQ_1d853bf1-42d3-4a3f-9149-0fa35345b852"
      unitRef="usd">64800000</us-gaap:GrossProfit>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xNi9mcmFnOmRlMjY3N2UzMGNmNzRiOTU5NjAzYjlkOGNhYjY1MDc4L3RhYmxlOjE4OGExZTBkNDZhMTQyMDJiZTdlY2RjN2FmYzgyY2Y1L3RhYmxlcmFuZ2U6MTg4YTFlMGQ0NmExNDIwMmJlN2VjZGM3YWZjODJjZjVfNi01LTEtMS04MzI4NQ_c3d5509d-78cb-4b5c-aed4-9ba32f4db3f1"
      unitRef="usd">20000000.0</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xNi9mcmFnOmRlMjY3N2UzMGNmNzRiOTU5NjAzYjlkOGNhYjY1MDc4L3RhYmxlOjE4OGExZTBkNDZhMTQyMDJiZTdlY2RjN2FmYzgyY2Y1L3RhYmxlcmFuZ2U6MTg4YTFlMGQ0NmExNDIwMmJlN2VjZGM3YWZjODJjZjVfNi03LTEtMS04MzI4NQ_eb256321-de87-4aad-b190-f8c159085616"
      unitRef="usd">17700000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xNi9mcmFnOmRlMjY3N2UzMGNmNzRiOTU5NjAzYjlkOGNhYjY1MDc4L3RhYmxlOjE4OGExZTBkNDZhMTQyMDJiZTdlY2RjN2FmYzgyY2Y1L3RhYmxlcmFuZ2U6MTg4YTFlMGQ0NmExNDIwMmJlN2VjZGM3YWZjODJjZjVfNy01LTEtMS04MzI4NQ_21d5e7f7-39ee-4db4-bb0e-5c9e8b15eb19"
      unitRef="usd">30300000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xNi9mcmFnOmRlMjY3N2UzMGNmNzRiOTU5NjAzYjlkOGNhYjY1MDc4L3RhYmxlOjE4OGExZTBkNDZhMTQyMDJiZTdlY2RjN2FmYzgyY2Y1L3RhYmxlcmFuZ2U6MTg4YTFlMGQ0NmExNDIwMmJlN2VjZGM3YWZjODJjZjVfNy03LTEtMS04MzI4NQ_24c9a500-1b85-4032-a40b-12be19d3073f"
      unitRef="usd">33100000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xNi9mcmFnOmRlMjY3N2UzMGNmNzRiOTU5NjAzYjlkOGNhYjY1MDc4L3RhYmxlOjE4OGExZTBkNDZhMTQyMDJiZTdlY2RjN2FmYzgyY2Y1L3RhYmxlcmFuZ2U6MTg4YTFlMGQ0NmExNDIwMmJlN2VjZGM3YWZjODJjZjVfOS01LTEtMS04MzI4NQ_aee4b6df-46fe-40ca-9008-2259dd48029d"
      unitRef="usd">50300000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xNi9mcmFnOmRlMjY3N2UzMGNmNzRiOTU5NjAzYjlkOGNhYjY1MDc4L3RhYmxlOjE4OGExZTBkNDZhMTQyMDJiZTdlY2RjN2FmYzgyY2Y1L3RhYmxlcmFuZ2U6MTg4YTFlMGQ0NmExNDIwMmJlN2VjZGM3YWZjODJjZjVfOS03LTEtMS04MzI4NQ_98cc5f1f-e6c9-43e3-a9f8-334b14e01793"
      unitRef="usd">50800000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xNi9mcmFnOmRlMjY3N2UzMGNmNzRiOTU5NjAzYjlkOGNhYjY1MDc4L3RhYmxlOjE4OGExZTBkNDZhMTQyMDJiZTdlY2RjN2FmYzgyY2Y1L3RhYmxlcmFuZ2U6MTg4YTFlMGQ0NmExNDIwMmJlN2VjZGM3YWZjODJjZjVfMTAtNS0xLTEtODMyODU_8ade47d0-f433-4ce5-b591-68c0287bbdd5"
      unitRef="usd">13000000.0</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xNi9mcmFnOmRlMjY3N2UzMGNmNzRiOTU5NjAzYjlkOGNhYjY1MDc4L3RhYmxlOjE4OGExZTBkNDZhMTQyMDJiZTdlY2RjN2FmYzgyY2Y1L3RhYmxlcmFuZ2U6MTg4YTFlMGQ0NmExNDIwMmJlN2VjZGM3YWZjODJjZjVfMTAtNy0xLTEtODMyODU_5dfaa3b3-8245-4aae-8124-17c23ff813d6"
      unitRef="usd">14000000.0</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xNi9mcmFnOmRlMjY3N2UzMGNmNzRiOTU5NjAzYjlkOGNhYjY1MDc4L3RhYmxlOjE4OGExZTBkNDZhMTQyMDJiZTdlY2RjN2FmYzgyY2Y1L3RhYmxlcmFuZ2U6MTg4YTFlMGQ0NmExNDIwMmJlN2VjZGM3YWZjODJjZjVfMTEtNS0xLTEtODMyODU_c6ca2743-80d4-4560-ad51-d80dab0a26c4"
      unitRef="usd">500000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xNi9mcmFnOmRlMjY3N2UzMGNmNzRiOTU5NjAzYjlkOGNhYjY1MDc4L3RhYmxlOjE4OGExZTBkNDZhMTQyMDJiZTdlY2RjN2FmYzgyY2Y1L3RhYmxlcmFuZ2U6MTg4YTFlMGQ0NmExNDIwMmJlN2VjZGM3YWZjODJjZjVfMTEtNy0xLTEtODMyODU_91ba9b63-776d-49a2-acc0-0d09ff46c1d8"
      unitRef="usd">0</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InterestExpense
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xNi9mcmFnOmRlMjY3N2UzMGNmNzRiOTU5NjAzYjlkOGNhYjY1MDc4L3RhYmxlOjE4OGExZTBkNDZhMTQyMDJiZTdlY2RjN2FmYzgyY2Y1L3RhYmxlcmFuZ2U6MTg4YTFlMGQ0NmExNDIwMmJlN2VjZGM3YWZjODJjZjVfMTItNS0xLTEtODMyODU_e8e9daa5-3bf0-4455-b10e-4eb30ab60428"
      unitRef="usd">7500000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xNi9mcmFnOmRlMjY3N2UzMGNmNzRiOTU5NjAzYjlkOGNhYjY1MDc4L3RhYmxlOjE4OGExZTBkNDZhMTQyMDJiZTdlY2RjN2FmYzgyY2Y1L3RhYmxlcmFuZ2U6MTg4YTFlMGQ0NmExNDIwMmJlN2VjZGM3YWZjODJjZjVfMTItNy0xLTEtODMyODU_9a333569-9c50-4d6c-a68f-f8a23d22b452"
      unitRef="usd">9900000</us-gaap:InterestExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xNi9mcmFnOmRlMjY3N2UzMGNmNzRiOTU5NjAzYjlkOGNhYjY1MDc4L3RhYmxlOjE4OGExZTBkNDZhMTQyMDJiZTdlY2RjN2FmYzgyY2Y1L3RhYmxlcmFuZ2U6MTg4YTFlMGQ0NmExNDIwMmJlN2VjZGM3YWZjODJjZjVfMTMtNS0xLTEtODMyODU_9b6c121a-f230-440e-9d21-fc8a3eaf4f64"
      unitRef="usd">-600000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xNi9mcmFnOmRlMjY3N2UzMGNmNzRiOTU5NjAzYjlkOGNhYjY1MDc4L3RhYmxlOjE4OGExZTBkNDZhMTQyMDJiZTdlY2RjN2FmYzgyY2Y1L3RhYmxlcmFuZ2U6MTg4YTFlMGQ0NmExNDIwMmJlN2VjZGM3YWZjODJjZjVfMTMtNy0xLTEtODMyODU_a1b512bc-eced-4fe8-b98d-7c1313df3f79"
      unitRef="usd">-800000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xNi9mcmFnOmRlMjY3N2UzMGNmNzRiOTU5NjAzYjlkOGNhYjY1MDc4L3RhYmxlOjE4OGExZTBkNDZhMTQyMDJiZTdlY2RjN2FmYzgyY2Y1L3RhYmxlcmFuZ2U6MTg4YTFlMGQ0NmExNDIwMmJlN2VjZGM3YWZjODJjZjVfMTQtNS0xLTEtODMyODU_f4459ff1-6322-47ff-874c-d35ffc40493d"
      unitRef="usd">-7600000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xNi9mcmFnOmRlMjY3N2UzMGNmNzRiOTU5NjAzYjlkOGNhYjY1MDc4L3RhYmxlOjE4OGExZTBkNDZhMTQyMDJiZTdlY2RjN2FmYzgyY2Y1L3RhYmxlcmFuZ2U6MTg4YTFlMGQ0NmExNDIwMmJlN2VjZGM3YWZjODJjZjVfMTQtNy0xLTEtODMyODU_f6312b5c-4f2b-4106-9089-fd988f91c496"
      unitRef="usd">-10700000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xNi9mcmFnOmRlMjY3N2UzMGNmNzRiOTU5NjAzYjlkOGNhYjY1MDc4L3RhYmxlOjE4OGExZTBkNDZhMTQyMDJiZTdlY2RjN2FmYzgyY2Y1L3RhYmxlcmFuZ2U6MTg4YTFlMGQ0NmExNDIwMmJlN2VjZGM3YWZjODJjZjVfMTUtNS0xLTEtODMyODU_27303c8f-e796-4f4e-a565-5aa06ee17d13"
      unitRef="usd">5400000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xNi9mcmFnOmRlMjY3N2UzMGNmNzRiOTU5NjAzYjlkOGNhYjY1MDc4L3RhYmxlOjE4OGExZTBkNDZhMTQyMDJiZTdlY2RjN2FmYzgyY2Y1L3RhYmxlcmFuZ2U6MTg4YTFlMGQ0NmExNDIwMmJlN2VjZGM3YWZjODJjZjVfMTUtNy0xLTEtODMyODU_9eca60a2-e58f-441d-82df-4e7c28a48d58"
      unitRef="usd">3300000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xNi9mcmFnOmRlMjY3N2UzMGNmNzRiOTU5NjAzYjlkOGNhYjY1MDc4L3RhYmxlOjE4OGExZTBkNDZhMTQyMDJiZTdlY2RjN2FmYzgyY2Y1L3RhYmxlcmFuZ2U6MTg4YTFlMGQ0NmExNDIwMmJlN2VjZGM3YWZjODJjZjVfMTYtNS0xLTEtODMyODU_dcb718e9-ffe8-4908-8eea-ec837daefb99"
      unitRef="usd">2200000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xNi9mcmFnOmRlMjY3N2UzMGNmNzRiOTU5NjAzYjlkOGNhYjY1MDc4L3RhYmxlOjE4OGExZTBkNDZhMTQyMDJiZTdlY2RjN2FmYzgyY2Y1L3RhYmxlcmFuZ2U6MTg4YTFlMGQ0NmExNDIwMmJlN2VjZGM3YWZjODJjZjVfMTYtNy0xLTEtODMyODU_e10a354a-2d27-42d2-a284-bf6a3adef229"
      unitRef="usd">1700000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xNi9mcmFnOmRlMjY3N2UzMGNmNzRiOTU5NjAzYjlkOGNhYjY1MDc4L3RhYmxlOjE4OGExZTBkNDZhMTQyMDJiZTdlY2RjN2FmYzgyY2Y1L3RhYmxlcmFuZ2U6MTg4YTFlMGQ0NmExNDIwMmJlN2VjZGM3YWZjODJjZjVfMTctNS0xLTEtODMyODU_7772502c-5d1a-4276-88df-2c549e9949ef"
      unitRef="usd">3200000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xNi9mcmFnOmRlMjY3N2UzMGNmNzRiOTU5NjAzYjlkOGNhYjY1MDc4L3RhYmxlOjE4OGExZTBkNDZhMTQyMDJiZTdlY2RjN2FmYzgyY2Y1L3RhYmxlcmFuZ2U6MTg4YTFlMGQ0NmExNDIwMmJlN2VjZGM3YWZjODJjZjVfMTctNy0xLTEtODMyODU_44fe308a-12f3-428f-b390-0087f7077cd8"
      unitRef="usd">1600000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xNi9mcmFnOmRlMjY3N2UzMGNmNzRiOTU5NjAzYjlkOGNhYjY1MDc4L3RhYmxlOjE4OGExZTBkNDZhMTQyMDJiZTdlY2RjN2FmYzgyY2Y1L3RhYmxlcmFuZ2U6MTg4YTFlMGQ0NmExNDIwMmJlN2VjZGM3YWZjODJjZjVfMTgtNS0xLTEtODMyODU_b3122bbb-d464-481a-bc06-b0b5209ec0e5"
      unitRef="usd">100000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xNi9mcmFnOmRlMjY3N2UzMGNmNzRiOTU5NjAzYjlkOGNhYjY1MDc4L3RhYmxlOjE4OGExZTBkNDZhMTQyMDJiZTdlY2RjN2FmYzgyY2Y1L3RhYmxlcmFuZ2U6MTg4YTFlMGQ0NmExNDIwMmJlN2VjZGM3YWZjODJjZjVfMTgtNy0xLTEtODMyODU_67319695-c133-497c-9da0-6ea69dae3ab9"
      unitRef="usd">200000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xNi9mcmFnOmRlMjY3N2UzMGNmNzRiOTU5NjAzYjlkOGNhYjY1MDc4L3RhYmxlOjE4OGExZTBkNDZhMTQyMDJiZTdlY2RjN2FmYzgyY2Y1L3RhYmxlcmFuZ2U6MTg4YTFlMGQ0NmExNDIwMmJlN2VjZGM3YWZjODJjZjVfMTktNS0xLTEtODMyODU_ee4dd9de-4f72-4538-bf5c-9717fdcd103f"
      unitRef="usd">3100000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xNi9mcmFnOmRlMjY3N2UzMGNmNzRiOTU5NjAzYjlkOGNhYjY1MDc4L3RhYmxlOjE4OGExZTBkNDZhMTQyMDJiZTdlY2RjN2FmYzgyY2Y1L3RhYmxlcmFuZ2U6MTg4YTFlMGQ0NmExNDIwMmJlN2VjZGM3YWZjODJjZjVfMTktNy0xLTEtODMyODU_1d185f9b-653d-4402-96a5-77250980b877"
      unitRef="usd">1400000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xNi9mcmFnOmRlMjY3N2UzMGNmNzRiOTU5NjAzYjlkOGNhYjY1MDc4L3RhYmxlOjE4OGExZTBkNDZhMTQyMDJiZTdlY2RjN2FmYzgyY2Y1L3RhYmxlcmFuZ2U6MTg4YTFlMGQ0NmExNDIwMmJlN2VjZGM3YWZjODJjZjVfMjEtNS0xLTEtODMyODU_400a5573-4296-4c92-96b0-860bd98349d8"
      unitRef="usdPerShare">0.08</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xNi9mcmFnOmRlMjY3N2UzMGNmNzRiOTU5NjAzYjlkOGNhYjY1MDc4L3RhYmxlOjE4OGExZTBkNDZhMTQyMDJiZTdlY2RjN2FmYzgyY2Y1L3RhYmxlcmFuZ2U6MTg4YTFlMGQ0NmExNDIwMmJlN2VjZGM3YWZjODJjZjVfMjEtNy0xLTEtODMyODU_9ff4ff34-11e8-4173-b184-be2b390ff5ea"
      unitRef="usdPerShare">0.04</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xNi9mcmFnOmRlMjY3N2UzMGNmNzRiOTU5NjAzYjlkOGNhYjY1MDc4L3RhYmxlOjE4OGExZTBkNDZhMTQyMDJiZTdlY2RjN2FmYzgyY2Y1L3RhYmxlcmFuZ2U6MTg4YTFlMGQ0NmExNDIwMmJlN2VjZGM3YWZjODJjZjVfMjItNS0xLTEtODMyODU_5634f0fa-ebd8-4186-a56a-f8887123f812"
      unitRef="usdPerShare">0.08</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xNi9mcmFnOmRlMjY3N2UzMGNmNzRiOTU5NjAzYjlkOGNhYjY1MDc4L3RhYmxlOjE4OGExZTBkNDZhMTQyMDJiZTdlY2RjN2FmYzgyY2Y1L3RhYmxlcmFuZ2U6MTg4YTFlMGQ0NmExNDIwMmJlN2VjZGM3YWZjODJjZjVfMjItNy0xLTEtODMyODU_2026c339-1588-440a-a855-5d52810f2ea0"
      unitRef="usdPerShare">0.03</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xNi9mcmFnOmRlMjY3N2UzMGNmNzRiOTU5NjAzYjlkOGNhYjY1MDc4L3RhYmxlOjE4OGExZTBkNDZhMTQyMDJiZTdlY2RjN2FmYzgyY2Y1L3RhYmxlcmFuZ2U6MTg4YTFlMGQ0NmExNDIwMmJlN2VjZGM3YWZjODJjZjVfMjQtNS0xLTEtODMyODU_896ea89b-7686-47a5-b1c2-6eeef2d17e3d"
      unitRef="shares">40100000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xNi9mcmFnOmRlMjY3N2UzMGNmNzRiOTU5NjAzYjlkOGNhYjY1MDc4L3RhYmxlOjE4OGExZTBkNDZhMTQyMDJiZTdlY2RjN2FmYzgyY2Y1L3RhYmxlcmFuZ2U6MTg4YTFlMGQ0NmExNDIwMmJlN2VjZGM3YWZjODJjZjVfMjQtNy0xLTEtODMyODU_36039cf6-4ee5-426e-b737-31cc771f8ee4"
      unitRef="shares">39500000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xNi9mcmFnOmRlMjY3N2UzMGNmNzRiOTU5NjAzYjlkOGNhYjY1MDc4L3RhYmxlOjE4OGExZTBkNDZhMTQyMDJiZTdlY2RjN2FmYzgyY2Y1L3RhYmxlcmFuZ2U6MTg4YTFlMGQ0NmExNDIwMmJlN2VjZGM3YWZjODJjZjVfMjUtNS0xLTEtODMyODU_21320505-ae79-47e0-8a95-cbca965970a7"
      unitRef="shares">40600000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xNi9mcmFnOmRlMjY3N2UzMGNmNzRiOTU5NjAzYjlkOGNhYjY1MDc4L3RhYmxlOjE4OGExZTBkNDZhMTQyMDJiZTdlY2RjN2FmYzgyY2Y1L3RhYmxlcmFuZ2U6MTg4YTFlMGQ0NmExNDIwMmJlN2VjZGM3YWZjODJjZjVfMjUtNy0xLTEtODMyODU_822ac626-2e24-4d90-abc1-826872bfcf07"
      unitRef="shares">43900000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ProfitLoss
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xOS9mcmFnOjAxMTJkNzZlNDAxYjQxNzM4YThmMzQyNjE4NDE2ZjY2L3RhYmxlOjM2Njk2NjI4YzFkOTRlZTRhNTcyYjkzMDU1MGE1MGJkL3RhYmxlcmFuZ2U6MzY2OTY2MjhjMWQ5NGVlNGE1NzJiOTMwNTUwYTUwYmRfMi0xLTEtMS04MzI4NQ_05b360cc-5465-4341-8f2d-acd8e0c7038e"
      unitRef="usd">3200000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xOS9mcmFnOjAxMTJkNzZlNDAxYjQxNzM4YThmMzQyNjE4NDE2ZjY2L3RhYmxlOjM2Njk2NjI4YzFkOTRlZTRhNTcyYjkzMDU1MGE1MGJkL3RhYmxlcmFuZ2U6MzY2OTY2MjhjMWQ5NGVlNGE1NzJiOTMwNTUwYTUwYmRfMi0zLTEtMS04MzI4NQ_bfd1f104-4f55-49e6-9533-51ce313635bd"
      unitRef="usd">1600000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xOS9mcmFnOjAxMTJkNzZlNDAxYjQxNzM4YThmMzQyNjE4NDE2ZjY2L3RhYmxlOjM2Njk2NjI4YzFkOTRlZTRhNTcyYjkzMDU1MGE1MGJkL3RhYmxlcmFuZ2U6MzY2OTY2MjhjMWQ5NGVlNGE1NzJiOTMwNTUwYTUwYmRfOS0xLTEtMS05NDUxOQ_c4fca676-ea06-4fda-8077-175f3099833d"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xOS9mcmFnOjAxMTJkNzZlNDAxYjQxNzM4YThmMzQyNjE4NDE2ZjY2L3RhYmxlOjM2Njk2NjI4YzFkOTRlZTRhNTcyYjkzMDU1MGE1MGJkL3RhYmxlcmFuZ2U6MzY2OTY2MjhjMWQ5NGVlNGE1NzJiOTMwNTUwYTUwYmRfOS0zLTEtMS05NDUxOQ_3acc2d76-2e5b-4482-81ae-1717cacb6f84"
      unitRef="usd">-500000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xOS9mcmFnOjAxMTJkNzZlNDAxYjQxNzM4YThmMzQyNjE4NDE2ZjY2L3RhYmxlOjM2Njk2NjI4YzFkOTRlZTRhNTcyYjkzMDU1MGE1MGJkL3RhYmxlcmFuZ2U6MzY2OTY2MjhjMWQ5NGVlNGE1NzJiOTMwNTUwYTUwYmRfMTEtMS0xLTEtODMyODU_ee5576cc-76a5-43f6-bd05-04f85ff6f067"
      unitRef="usd">3200000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xOS9mcmFnOjAxMTJkNzZlNDAxYjQxNzM4YThmMzQyNjE4NDE2ZjY2L3RhYmxlOjM2Njk2NjI4YzFkOTRlZTRhNTcyYjkzMDU1MGE1MGJkL3RhYmxlcmFuZ2U6MzY2OTY2MjhjMWQ5NGVlNGE1NzJiOTMwNTUwYTUwYmRfMTEtMy0xLTEtODMyODU_41534990-b23c-4b2c-9641-f0f04bc83c2f"
      unitRef="usd">1100000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xOS9mcmFnOjAxMTJkNzZlNDAxYjQxNzM4YThmMzQyNjE4NDE2ZjY2L3RhYmxlOjM2Njk2NjI4YzFkOTRlZTRhNTcyYjkzMDU1MGE1MGJkL3RhYmxlcmFuZ2U6MzY2OTY2MjhjMWQ5NGVlNGE1NzJiOTMwNTUwYTUwYmRfMTItMS0xLTEtODMyODU_1df3b0fe-9a1c-4b87-bc5e-237bf403d90a"
      unitRef="usd">100000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xOS9mcmFnOjAxMTJkNzZlNDAxYjQxNzM4YThmMzQyNjE4NDE2ZjY2L3RhYmxlOjM2Njk2NjI4YzFkOTRlZTRhNTcyYjkzMDU1MGE1MGJkL3RhYmxlcmFuZ2U6MzY2OTY2MjhjMWQ5NGVlNGE1NzJiOTMwNTUwYTUwYmRfMTItMy0xLTEtODMyODU_9487e490-f955-4abf-9206-9b933a08a0c8"
      unitRef="usd">200000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xOS9mcmFnOjAxMTJkNzZlNDAxYjQxNzM4YThmMzQyNjE4NDE2ZjY2L3RhYmxlOjM2Njk2NjI4YzFkOTRlZTRhNTcyYjkzMDU1MGE1MGJkL3RhYmxlcmFuZ2U6MzY2OTY2MjhjMWQ5NGVlNGE1NzJiOTMwNTUwYTUwYmRfMTMtMS0xLTEtODMyODU_4171e0c7-351a-4c54-95df-8ef9489a43f5"
      unitRef="usd">3100000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18xOS9mcmFnOjAxMTJkNzZlNDAxYjQxNzM4YThmMzQyNjE4NDE2ZjY2L3RhYmxlOjM2Njk2NjI4YzFkOTRlZTRhNTcyYjkzMDU1MGE1MGJkL3RhYmxlcmFuZ2U6MzY2OTY2MjhjMWQ5NGVlNGE1NzJiOTMwNTUwYTUwYmRfMTMtMy0xLTEtODMyODU_02c28b77-a717-4b97-87b6-1cde8a5c8f98"
      unitRef="usd">900000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMy0xLTEtMS04MzI4NQ_b3d2e81f-df35-4594-bf2b-7778f846c1b4"
      unitRef="usd">81500000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMy0zLTEtMS04MzI4NQ_33936b98-d55a-4b7d-aaf8-9079b58bd8ff"
      unitRef="usd">89400000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfNC0wLTEtMS04MzI4NS90ZXh0cmVnaW9uOmJlNmMwOWU3YjA2MTQyZTU5NmI0YTIwZTI1YzRjMDdlXzYz_a6448f22-3d22-40a4-b069-5da9f90034d8"
      unitRef="usd">400000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfNC0wLTEtMS04MzI4NS90ZXh0cmVnaW9uOmJlNmMwOWU3YjA2MTQyZTU5NmI0YTIwZTI1YzRjMDdlXzcw_172ae559-e28a-46c4-827e-de70096909d5"
      unitRef="usd">600000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfNC0xLTEtMS04MzI4NQ_43f35fa2-403c-4eec-8e67-439d416137db"
      unitRef="usd">157900000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfNC0zLTEtMS04MzI4NQ_00a6e63a-7c1f-48ab-b9d7-8aa6c9801110"
      unitRef="usd">173300000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfNS0xLTEtMS04MzI4NQ_8d447702-205d-4015-b7c0-beb946cfdbf0"
      unitRef="usd">320300000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfNS0zLTEtMS04MzI4NQ_1a396338-d798-44f8-b92d-98c96676f865"
      unitRef="usd">303200000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfNi0xLTEtMS04MzI4NQ_5169827c-1ca8-40a2-8526-d4a87c623d61"
      unitRef="usd">47600000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfNi0zLTEtMS04MzI4NQ_32900366-7001-4fb9-b046-ebaca3f8117d"
      unitRef="usd">44000000.0</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfNy0xLTEtMS04MzI4NQ_e7f0ac68-64d1-4ad3-aa95-fc06486fe901"
      unitRef="usd">607300000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfNy0zLTEtMS04MzI4NQ_2fae4125-47da-4c54-bd0a-9774b2e05cbe"
      unitRef="usd">609900000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfOC0xLTEtMS04MzI4NQ_11f5ab57-76a7-4988-8ce5-d1eba5783b64"
      unitRef="usd">142900000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfOC0zLTEtMS04MzI4NQ_ef8b92b0-abb7-4a91-bdce-a3d02142dbc8"
      unitRef="usd">141300000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:Goodwill
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfOS0xLTEtMS04MzI4NQ_bafe09e2-74ae-4a68-b2a8-1bb126431f89"
      unitRef="usd">288200000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfOS0zLTEtMS04MzI4NQ_7bffc651-f838-4c0d-bf33-900284197835"
      unitRef="usd">284500000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMTAtMS0xLTEtODMyODU_fb37c73a-23f8-44e3-a733-e589ce7b5d3d"
      unitRef="usd">31700000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMTAtMy0xLTEtODMyODU_df901275-929e-4081-8fb7-f03a91e36200"
      unitRef="usd">33600000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMTEtMS0xLTEtODMyODU_93e44304-6a9e-4960-8cb1-7f048756f074"
      unitRef="usd">47800000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMTEtMy0xLTEtODMyODU_9ac9764f-d48f-426d-91dc-f7b607231a69"
      unitRef="usd">46400000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMTItMS0xLTEtODMyODU_831220e7-3fe1-49e5-a4b1-6a6557658d78"
      unitRef="usd">1900000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMTItMy0xLTEtODMyODU_9f483be5-a1c3-4b24-a9d5-212347c9795a"
      unitRef="usd">2300000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMTMtMS0xLTEtODMyODU_80450684-af82-4952-b5a3-b99023afa595"
      unitRef="usd">22100000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMTMtMy0xLTEtODMyODU_6bc259d4-9bbc-40a6-b6f6-732e53900c39"
      unitRef="usd">23200000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMTQtMS0xLTEtODMyODU_9058114d-14e6-4576-af29-37f8bc3803f5"
      unitRef="usd">39000000.0</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMTQtMy0xLTEtODMyODU_ad8af03e-fbfd-43a3-b176-4fea736cf593"
      unitRef="usd">43200000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMTUtMS0xLTEtODMyODU_4b58bdbb-2382-4d9c-b1c0-e2b3eb7d221e"
      unitRef="usd">1180900000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMTUtMy0xLTEtODMyODU_2d7fc3e4-d2ee-454a-bf05-c48f9fc09996"
      unitRef="usd">1184400000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMTgtMS0xLTEtODMyODU_9a085ddc-fde1-445e-b3e3-eee8dc6bb4c3"
      unitRef="usd">86200000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMTgtMy0xLTEtODMyODU_05a4c941-7cc0-488c-b803-2c2ad9425904"
      unitRef="usd">78200000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMTktMS0xLTEtODMyODU_84786132-d10b-422c-a293-d855d69a3742"
      unitRef="usd">56000000.0</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMTktMy0xLTEtODMyODU_59556402-58b5-4b6c-abda-78724b48b181"
      unitRef="usd">81400000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMjAtMS0xLTEtODMyODU_8b284683-3de5-4585-9df0-360d90b29790"
      unitRef="usd">3900000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMjAtMy0xLTEtODMyODU_a8c761e1-994b-4fcc-91b8-7d0c7afb8fce"
      unitRef="usd">4000000.0</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMjEtMS0xLTEtODMyODU_61345ed0-b117-42d0-8aaf-76d8f2a3d472"
      unitRef="usd">2100000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMjEtMy0xLTEtODMyODU_526c473d-1f07-42ea-a158-cb2c69506c1a"
      unitRef="usd">2100000</us-gaap:LongTermDebtCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMjItMS0xLTEtODMyODU_ff8af601-cf2f-4e68-a822-c0ca72cb1a87"
      unitRef="usd">9200000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMjItMy0xLTEtODMyODU_bf4f660a-992d-4136-9561-cefea8f4deb6"
      unitRef="usd">7400000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMjMtMS0xLTEtODMyODU_8ace73ae-0104-45cf-8765-358f9893de13"
      unitRef="usd">157400000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMjMtMy0xLTEtODMyODU_39264b39-c8ad-4ec9-bdf1-4dfe7195730c"
      unitRef="usd">173100000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMjQtMS0xLTEtODMyODU_85afee47-b04c-4906-9b3a-07ee8bc6f025"
      unitRef="usd">440800000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMjQtMy0xLTEtODMyODU_3fc88612-99a2-4e74-b1cb-ded020e2a7c9"
      unitRef="usd">412300000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMjUtMS0xLTEtODMyODU_bc203b78-ef6c-4d16-8d9a-9410c65a5c5a"
      unitRef="usd">0</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMjUtMy0xLTEtODMyODU_9a182633-81b0-4e72-8a67-8e70b886e641"
      unitRef="usd">500000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMjYtMS0xLTEtODMyODU_d80ba7ce-6bf6-4f33-99b3-45c51efc0138"
      unitRef="usd">17900000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMjYtMy0xLTEtODMyODU_f97f5c59-653c-439c-abfa-b004080a46da"
      unitRef="usd">18000000.0</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMjctMS0xLTEtODMyODU_957f4a64-a693-42ca-969e-52c1dfbdb846"
      unitRef="usd">39800000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMjctMy0xLTEtODMyODU_a802a20f-66d8-44ca-a95f-0d066f6ce62e"
      unitRef="usd">33800000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMjgtMS0xLTEtODMyODU_965ba6ef-b6be-4b08-838b-829dc67df372"
      unitRef="usd">655900000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMjgtMy0xLTEtODMyODU_c54b0b91-812b-4e53-a267-9b0b32f8ab2a"
      unitRef="usd">637700000</us-gaap:Liabilities>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMzItMC0xLTEtODMyODUvdGV4dHJlZ2lvbjphNzYxM2I0YTJmNmY0YWRmOGRlNTA0OGY3NzhlYzUwZl8yMQ_3ad35c37-db37-4372-a31a-5fb835f6cd92"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMzItMC0xLTEtODMyODUvdGV4dHJlZ2lvbjphNzYxM2I0YTJmNmY0YWRmOGRlNTA0OGY3NzhlYzUwZl8yMQ_6fb1724a-de5b-466c-9d52-476838c6c3ca"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMzItMC0xLTEtODMyODUvdGV4dHJlZ2lvbjphNzYxM2I0YTJmNmY0YWRmOGRlNTA0OGY3NzhlYzUwZl8zNQ_479e7934-f2bd-4659-b677-8f5fca3755f0"
      unitRef="shares">20000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMzItMC0xLTEtODMyODUvdGV4dHJlZ2lvbjphNzYxM2I0YTJmNmY0YWRmOGRlNTA0OGY3NzhlYzUwZl8zNQ_a33fb543-4e91-4461-b61d-3cf59c3fd8f9"
      unitRef="shares">20000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMzItMC0xLTEtODMyODUvdGV4dHJlZ2lvbjphNzYxM2I0YTJmNmY0YWRmOGRlNTA0OGY3NzhlYzUwZl81Nw_06c50ba4-601e-4d63-83a7-0a0f836a8cc2"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMzItMC0xLTEtODMyODUvdGV4dHJlZ2lvbjphNzYxM2I0YTJmNmY0YWRmOGRlNTA0OGY3NzhlYzUwZl81Nw_936a4b50-e8ae-48ac-aa12-f5849e3963e2"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValueOutstanding
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMzItMS0xLTEtODMyODU_e5f15c2b-71a4-4082-88eb-14b0211c9601"
      unitRef="usd">0</us-gaap:PreferredStockValueOutstanding>
    <us-gaap:PreferredStockValueOutstanding
      contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMzItMy0xLTEtODMyODU_5fe024b4-124c-4282-bd24-27a0f9abb8da"
      unitRef="usd">0</us-gaap:PreferredStockValueOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMzMtMC0xLTEtODMyODUvdGV4dHJlZ2lvbjpkMmE3ZjRmNmVjZWY0NWZjODI4MjcyZjA4YzE5Mjk1YV8xOA_30acc44f-3018-48fc-b54e-a83ac9303eda"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMzMtMC0xLTEtODMyODUvdGV4dHJlZ2lvbjpkMmE3ZjRmNmVjZWY0NWZjODI4MjcyZjA4YzE5Mjk1YV8xOA_54853edf-643e-4153-b75f-ca115e8de2a3"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMzMtMC0xLTEtODMyODUvdGV4dHJlZ2lvbjpkMmE3ZjRmNmVjZWY0NWZjODI4MjcyZjA4YzE5Mjk1YV8zMg_754d9898-971e-4c68-9820-4549ce172d15"
      unitRef="shares">150000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMzMtMC0xLTEtODMyODUvdGV4dHJlZ2lvbjpkMmE3ZjRmNmVjZWY0NWZjODI4MjcyZjA4YzE5Mjk1YV8zMg_790cb598-8cca-4733-8242-47396cdb5ac1"
      unitRef="shares">150000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMzUtMC0xLTEtODMyODUvdGV4dHJlZ2lvbjplMWIxM2FhYzE0Yzc0YzlhYTYyYWEyZDk2NWNmY2NkZl8zNQ_6c60afe9-2e0f-43c3-9305-bec02f420b35"
      unitRef="shares">40087100</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMzUtMC0xLTEtODMyODUvdGV4dHJlZ2lvbjplMWIxM2FhYzE0Yzc0YzlhYTYyYWEyZDk2NWNmY2NkZl8zNQ_8581c80a-bd50-4a7f-a36b-d13c116f2d5e"
      unitRef="shares">40087100</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMzUtMC0xLTEtODMyODUvdGV4dHJlZ2lvbjplMWIxM2FhYzE0Yzc0YzlhYTYyYWEyZDk2NWNmY2NkZl80Mg_3b80a620-5453-4e82-aa9d-902e80b90abe"
      unitRef="shares">40085126</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMzUtMC0xLTEtODMyODUvdGV4dHJlZ2lvbjplMWIxM2FhYzE0Yzc0YzlhYTYyYWEyZDk2NWNmY2NkZl80Mg_47d62fc0-ec51-4afc-bf08-c745e6fe3837"
      unitRef="shares">40085126</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValueOutstanding
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMzUtMS0xLTEtODMyODU_64f39575-0c8b-42e0-a7e4-56d4fbaac5b8"
      unitRef="usd">400000</us-gaap:CommonStockValueOutstanding>
    <us-gaap:CommonStockValueOutstanding
      contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMzUtMy0xLTEtODMyODU_7c4a2dda-26b1-4567-b1bf-8348d2fc8c04"
      unitRef="usd">400000</us-gaap:CommonStockValueOutstanding>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMzctMS0xLTEtODMyODU_80bbe91e-2101-471b-a9b2-f1547d55553b"
      unitRef="usd">437900000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMzctMy0xLTEtODMyODU_7aab8fc0-8dec-4ad7-8795-03f29261333f"
      unitRef="usd">469100000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMzgtMS0xLTEtODMyODU_a1a8cf67-dacf-4dbb-b678-9980978f8eec"
      unitRef="usd">100000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMzgtMy0xLTEtODMyODU_9b19c509-7eb0-4c99-955d-0c5b5760e1aa"
      unitRef="usd">100000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMzktMS0xLTEtODMyODU_8a179a41-8cbb-4b56-b5df-3ecd5f02cbd7"
      unitRef="usd">73300000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfMzktMy0xLTEtODMyODU_3e74f6f1-bbea-45ac-bb68-6a2cc33cd2b8"
      unitRef="usd">63800000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfNDAtMS0xLTEtODMyODU_adf53036-556b-4618-8180-aefa8167dc67"
      unitRef="usd">511700000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfNDAtMy0xLTEtODMyODU_e52e0f73-cbc9-46b4-9433-61c0bcf48fce"
      unitRef="usd">533400000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfNDEtMS0xLTEtODMyODU_9c509ca6-70df-4943-8948-aff37e7e9b83"
      unitRef="usd">13300000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfNDEtMy0xLTEtODMyODU_fca16161-46d2-44c3-8e54-6b17ac0ecc50"
      unitRef="usd">13300000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfNDItMS0xLTEtODMyODU_73d94111-56a2-4fe4-bfd2-892e0befa826"
      unitRef="usd">525000000.0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfNDItMy0xLTEtODMyODU_8b9a046f-50e0-4a5b-b6cb-6587c1d9829e"
      unitRef="usd">546700000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfNDMtMS0xLTEtODMyODU_695812ea-3bf9-4b89-8836-1dd3be7e9f4f"
      unitRef="usd">1180900000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yMi9mcmFnOmQ4YjNkOTRjMDFlMDQ3Zjg4YjY0ZGJiYzc5NjRhMGE3L3RhYmxlOmExNDcwYzJmMGRmYzQ1MmU4NThiZDYxZmM3ZGUwYjdkL3RhYmxlcmFuZ2U6YTE0NzBjMmYwZGZjNDUyZTg1OGJkNjFmYzdkZTBiN2RfNDMtMy0xLTEtODMyODU_aad70108-bb8b-469e-ab69-9e1019b59ecb"
      unitRef="usd">1184400000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i2c89eaed981a4d4a95584393e114c1a2_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOjkwN2JhZTc1NjE4MDRhZGNhZjM3ZDc0NzQ5NGRmYWQ3L3RhYmxlcmFuZ2U6OTA3YmFlNzU2MTgwNGFkY2FmMzdkNzQ3NDk0ZGZhZDdfNC0xLTEtMS04MzI4NQ_48ef3eba-d267-4353-a293-b09861c928cc"
      unitRef="shares">40100000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2c89eaed981a4d4a95584393e114c1a2_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOjkwN2JhZTc1NjE4MDRhZGNhZjM3ZDc0NzQ5NGRmYWQ3L3RhYmxlcmFuZ2U6OTA3YmFlNzU2MTgwNGFkY2FmMzdkNzQ3NDk0ZGZhZDdfNC0zLTEtMS04MzI4NQ_9e6fcb9a-8661-44d0-b067-e4ab47f2e5b4"
      unitRef="usd">400000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i37e38c715c44456aaf8bc01ef2b73582_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOjkwN2JhZTc1NjE4MDRhZGNhZjM3ZDc0NzQ5NGRmYWQ3L3RhYmxlcmFuZ2U6OTA3YmFlNzU2MTgwNGFkY2FmMzdkNzQ3NDk0ZGZhZDdfNC01LTEtMS04MzI4NQ_b1e7d45f-8a86-4a5d-8fc3-7070e9d61783"
      unitRef="usd">469100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i946a5f2b729e4134a3046873942feac2_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOjkwN2JhZTc1NjE4MDRhZGNhZjM3ZDc0NzQ5NGRmYWQ3L3RhYmxlcmFuZ2U6OTA3YmFlNzU2MTgwNGFkY2FmMzdkNzQ3NDk0ZGZhZDdfNC05LTEtMS04MzI4NQ_24725990-ae32-4d41-995e-3e2ebf4c6a6e"
      unitRef="usd">100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic3cbcd23a7804aebb45bbf33e9654051_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOjkwN2JhZTc1NjE4MDRhZGNhZjM3ZDc0NzQ5NGRmYWQ3L3RhYmxlcmFuZ2U6OTA3YmFlNzU2MTgwNGFkY2FmMzdkNzQ3NDk0ZGZhZDdfNC0xMS0xLTEtODMyODU_82cdf6e9-5b36-436c-92ef-2eeb36e246e7"
      unitRef="usd">63800000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i90a3dedd81b74cfb9d7bf05623f3ea1b_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOjkwN2JhZTc1NjE4MDRhZGNhZjM3ZDc0NzQ5NGRmYWQ3L3RhYmxlcmFuZ2U6OTA3YmFlNzU2MTgwNGFkY2FmMzdkNzQ3NDk0ZGZhZDdfNC0xMy0xLTEtODMyODU_d8a2feae-6657-4545-ab20-9f20cd1f57e5"
      unitRef="usd">533400000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i964e8837dab84683972daafc904bc290_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOjkwN2JhZTc1NjE4MDRhZGNhZjM3ZDc0NzQ5NGRmYWQ3L3RhYmxlcmFuZ2U6OTA3YmFlNzU2MTgwNGFkY2FmMzdkNzQ3NDk0ZGZhZDdfNC0xNS0xLTEtODMyODU_2d29c43a-924e-4105-a858-14db0f205a24"
      unitRef="usd">13300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOjkwN2JhZTc1NjE4MDRhZGNhZjM3ZDc0NzQ5NGRmYWQ3L3RhYmxlcmFuZ2U6OTA3YmFlNzU2MTgwNGFkY2FmMzdkNzQ3NDk0ZGZhZDdfNC0xNy0xLTEtODMyODU_30122f0b-5868-4bbe-ba16-20f19038f4a7"
      unitRef="usd">546700000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5bbd4632766b486d8dd37f35093df0cb_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOjkwN2JhZTc1NjE4MDRhZGNhZjM3ZDc0NzQ5NGRmYWQ3L3RhYmxlcmFuZ2U6OTA3YmFlNzU2MTgwNGFkY2FmMzdkNzQ3NDk0ZGZhZDdfNS01LTEtMS04MzI4NQ_622b11f1-446a-4377-a560-f102a1255a16"
      unitRef="usd">-34600000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic809286b91a146ce974c75d48a3c4517_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOjkwN2JhZTc1NjE4MDRhZGNhZjM3ZDc0NzQ5NGRmYWQ3L3RhYmxlcmFuZ2U6OTA3YmFlNzU2MTgwNGFkY2FmMzdkNzQ3NDk0ZGZhZDdfNS0xMS0xLTEtODMyODU_bbbab542-0c8e-4ccd-89b1-a9a9c0d41c18"
      unitRef="usd">6500000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5a5ca132807b4f1596b0b257c552596b_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOjkwN2JhZTc1NjE4MDRhZGNhZjM3ZDc0NzQ5NGRmYWQ3L3RhYmxlcmFuZ2U6OTA3YmFlNzU2MTgwNGFkY2FmMzdkNzQ3NDk0ZGZhZDdfNS0xMy0xLTEtODMyODU_23f8d301-1759-4511-a2ea-2707284b0a12"
      unitRef="usd">-28100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic28d182c3ed64ba2aebe358831333632_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOjkwN2JhZTc1NjE4MDRhZGNhZjM3ZDc0NzQ5NGRmYWQ3L3RhYmxlcmFuZ2U6OTA3YmFlNzU2MTgwNGFkY2FmMzdkNzQ3NDk0ZGZhZDdfNS0xNy0xLTEtODMyODU_c542c8d3-8d39-40d7-bafa-380ae0daff9a"
      unitRef="usd">-28100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i374334f7b3304f1d936a010e369e5949_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOjkwN2JhZTc1NjE4MDRhZGNhZjM3ZDc0NzQ5NGRmYWQ3L3RhYmxlcmFuZ2U6OTA3YmFlNzU2MTgwNGFkY2FmMzdkNzQ3NDk0ZGZhZDdfNi0xMS0xLTEtOTkzODY_abf3f842-cd32-4eac-8386-7ce93cab2fb1"
      unitRef="usd">3100000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i9bb651a6c0ed468da0c7878dd6d514ef_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOjkwN2JhZTc1NjE4MDRhZGNhZjM3ZDc0NzQ5NGRmYWQ3L3RhYmxlcmFuZ2U6OTA3YmFlNzU2MTgwNGFkY2FmMzdkNzQ3NDk0ZGZhZDdfNi0xMy0xLTEtOTkzODY_9a660abd-60e3-40a5-a3cd-a3cf7ab343ac"
      unitRef="usd">3100000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i689d7483ede3410593772cdd559784d3_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOjkwN2JhZTc1NjE4MDRhZGNhZjM3ZDc0NzQ5NGRmYWQ3L3RhYmxlcmFuZ2U6OTA3YmFlNzU2MTgwNGFkY2FmMzdkNzQ3NDk0ZGZhZDdfNi0xNS0xLTEtOTkzODY_319c1146-b420-4a1f-a78a-077dd8e28626"
      unitRef="usd">100000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOjkwN2JhZTc1NjE4MDRhZGNhZjM3ZDc0NzQ5NGRmYWQ3L3RhYmxlcmFuZ2U6OTA3YmFlNzU2MTgwNGFkY2FmMzdkNzQ3NDk0ZGZhZDdfNi0xNy0xLTEtOTkzODY_3b77ed8f-d890-4a6e-8f7f-5063911ff009"
      unitRef="usd">3200000</us-gaap:ProfitLoss>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ib43fdaa870e547d083de4f40fcef4c40_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOjkwN2JhZTc1NjE4MDRhZGNhZjM3ZDc0NzQ5NGRmYWQ3L3RhYmxlcmFuZ2U6OTA3YmFlNzU2MTgwNGFkY2FmMzdkNzQ3NDk0ZGZhZDdfMTAtNS0xLTEtODMyODU_ccce47a8-5eae-4718-a077-504d05c63a50"
      unitRef="usd">3300000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i9bb651a6c0ed468da0c7878dd6d514ef_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOjkwN2JhZTc1NjE4MDRhZGNhZjM3ZDc0NzQ5NGRmYWQ3L3RhYmxlcmFuZ2U6OTA3YmFlNzU2MTgwNGFkY2FmMzdkNzQ3NDk0ZGZhZDdfMTAtMTMtMS0xLTgzMjg1_6673dabb-d966-4e9d-bcf1-599a0a935589"
      unitRef="usd">3300000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOjkwN2JhZTc1NjE4MDRhZGNhZjM3ZDc0NzQ5NGRmYWQ3L3RhYmxlcmFuZ2U6OTA3YmFlNzU2MTgwNGFkY2FmMzdkNzQ3NDk0ZGZhZDdfMTAtMTctMS0xLTgzMjg1_811db44e-39f7-494f-830f-bf0523ada486"
      unitRef="usd">3300000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockholdersEquityOther
      contextRef="ib43fdaa870e547d083de4f40fcef4c40_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOjkwN2JhZTc1NjE4MDRhZGNhZjM3ZDc0NzQ5NGRmYWQ3L3RhYmxlcmFuZ2U6OTA3YmFlNzU2MTgwNGFkY2FmMzdkNzQ3NDk0ZGZhZDdfMjEtNS0xLTEtODMyODU_9025842b-342f-4fbc-ac02-9646d0ffd1cd"
      unitRef="usd">-100000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="i374334f7b3304f1d936a010e369e5949_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOjkwN2JhZTc1NjE4MDRhZGNhZjM3ZDc0NzQ5NGRmYWQ3L3RhYmxlcmFuZ2U6OTA3YmFlNzU2MTgwNGFkY2FmMzdkNzQ3NDk0ZGZhZDdfMjEtMTEtMS0xLTgzMjg1_4547f442-018c-4da5-bae1-59b2d9ae2472"
      unitRef="usd">100000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="i689d7483ede3410593772cdd559784d3_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOjkwN2JhZTc1NjE4MDRhZGNhZjM3ZDc0NzQ5NGRmYWQ3L3RhYmxlcmFuZ2U6OTA3YmFlNzU2MTgwNGFkY2FmMzdkNzQ3NDk0ZGZhZDdfMjEtMTUtMS0xLTgzMjg1_4de2f759-d12a-420b-9a02-50405cc9f24a"
      unitRef="usd">100000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOjkwN2JhZTc1NjE4MDRhZGNhZjM3ZDc0NzQ5NGRmYWQ3L3RhYmxlcmFuZ2U6OTA3YmFlNzU2MTgwNGFkY2FmMzdkNzQ3NDk0ZGZhZDdfMjEtMTctMS0xLTgzMjg1_e30ff16d-bf22-458c-8661-97951a268abd"
      unitRef="usd">100000</us-gaap:StockholdersEquityOther>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i0fa88bead9c943b7807d5810cd828850_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOjkwN2JhZTc1NjE4MDRhZGNhZjM3ZDc0NzQ5NGRmYWQ3L3RhYmxlcmFuZ2U6OTA3YmFlNzU2MTgwNGFkY2FmMzdkNzQ3NDk0ZGZhZDdfMjItMS0xLTEtODMyODU_99bd234d-ec8c-44ed-bafa-4834faefeeff"
      unitRef="shares">40100000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0fa88bead9c943b7807d5810cd828850_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOjkwN2JhZTc1NjE4MDRhZGNhZjM3ZDc0NzQ5NGRmYWQ3L3RhYmxlcmFuZ2U6OTA3YmFlNzU2MTgwNGFkY2FmMzdkNzQ3NDk0ZGZhZDdfMjItMy0xLTEtODMyODU_43cc90f6-d3bb-4b2d-ade4-e528fc08fc16"
      unitRef="usd">400000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4eb681e97f2345679fdea50eb3b491d1_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOjkwN2JhZTc1NjE4MDRhZGNhZjM3ZDc0NzQ5NGRmYWQ3L3RhYmxlcmFuZ2U6OTA3YmFlNzU2MTgwNGFkY2FmMzdkNzQ3NDk0ZGZhZDdfMjItNS0xLTEtODMyODU_acc9a956-6d7b-4d72-9fd9-91ddbe00bfb8"
      unitRef="usd">437900000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2322eead975b4c1dbc547b6270fb8adf_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOjkwN2JhZTc1NjE4MDRhZGNhZjM3ZDc0NzQ5NGRmYWQ3L3RhYmxlcmFuZ2U6OTA3YmFlNzU2MTgwNGFkY2FmMzdkNzQ3NDk0ZGZhZDdfMjItOS0xLTEtODMyODU_bb7212f5-f6b4-41bb-9e52-5527ec893929"
      unitRef="usd">100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i02e30707026c4e429d7a8e186437ad12_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOjkwN2JhZTc1NjE4MDRhZGNhZjM3ZDc0NzQ5NGRmYWQ3L3RhYmxlcmFuZ2U6OTA3YmFlNzU2MTgwNGFkY2FmMzdkNzQ3NDk0ZGZhZDdfMjItMTEtMS0xLTgzMjg1_fe42b13a-c25c-430a-bfc4-94395a2d2084"
      unitRef="usd">73300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i42e660b69d2d46dcb0355f9671f5a578_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOjkwN2JhZTc1NjE4MDRhZGNhZjM3ZDc0NzQ5NGRmYWQ3L3RhYmxlcmFuZ2U6OTA3YmFlNzU2MTgwNGFkY2FmMzdkNzQ3NDk0ZGZhZDdfMjItMTMtMS0xLTgzMjg1_9ab749f6-1228-437b-8dac-80a7514f3bf3"
      unitRef="usd">511700000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5126bc5003f942bf8310df4804290940_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOjkwN2JhZTc1NjE4MDRhZGNhZjM3ZDc0NzQ5NGRmYWQ3L3RhYmxlcmFuZ2U6OTA3YmFlNzU2MTgwNGFkY2FmMzdkNzQ3NDk0ZGZhZDdfMjItMTUtMS0xLTgzMjg1_e8a5a40e-fc50-4ab8-86d5-d38062325c65"
      unitRef="usd">13300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOjkwN2JhZTc1NjE4MDRhZGNhZjM3ZDc0NzQ5NGRmYWQ3L3RhYmxlcmFuZ2U6OTA3YmFlNzU2MTgwNGFkY2FmMzdkNzQ3NDk0ZGZhZDdfMjItMTctMS0xLTgzMjg1_4f5f8fa6-6851-43ff-a741-1652f2e6c123"
      unitRef="usd">525000000.0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ida04e40f3374405faf2b86c9faa3beae_I20211001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOmRjNDIzMzk1MjljNDQyMjVhZjIyMzkxNTM4YzNjYjczL3RhYmxlcmFuZ2U6ZGM0MjMzOTUyOWM0NDIyNWFmMjIzOTE1MzhjM2NiNzNfNC0xLTEtMS04MzI4NQ_8d48188e-79e4-415a-854d-c33df7624e0a"
      unitRef="shares">39400000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ida04e40f3374405faf2b86c9faa3beae_I20211001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOmRjNDIzMzk1MjljNDQyMjVhZjIyMzkxNTM4YzNjYjczL3RhYmxlcmFuZ2U6ZGM0MjMzOTUyOWM0NDIyNWFmMjIzOTE1MzhjM2NiNzNfNC0zLTEtMS04MzI4NQ_f78b108c-a3bc-4b7b-ab88-73c11a229668"
      unitRef="usd">400000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3aff7d47dfed4780bef288e0efb8de73_I20211001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOmRjNDIzMzk1MjljNDQyMjVhZjIyMzkxNTM4YzNjYjczL3RhYmxlcmFuZ2U6ZGM0MjMzOTUyOWM0NDIyNWFmMjIzOTE1MzhjM2NiNzNfNC01LTEtMS04MzI4NQ_cb9fbb61-ac6c-4f5f-9e1d-6584aa04c299"
      unitRef="usd">449400000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id25e5cef067540a2b3d17a01b52d1080_I20211001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOmRjNDIzMzk1MjljNDQyMjVhZjIyMzkxNTM4YzNjYjczL3RhYmxlcmFuZ2U6ZGM0MjMzOTUyOWM0NDIyNWFmMjIzOTE1MzhjM2NiNzNfNC05LTEtMS04MzI4NQ_e5400692-0ed8-45ee-b8eb-7adc8f5fe82b"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id72ff47fc82e4e879dbaa26a295898ce_I20211001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOmRjNDIzMzk1MjljNDQyMjVhZjIyMzkxNTM4YzNjYjczL3RhYmxlcmFuZ2U6ZGM0MjMzOTUyOWM0NDIyNWFmMjIzOTE1MzhjM2NiNzNfNC0xMS0xLTEtODMyODU_b0b8d345-94b9-403e-90b5-165cabca035b"
      unitRef="usd">33500000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i15fe2e613bae4c76beaddadbd8d8e5e3_I20211001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOmRjNDIzMzk1MjljNDQyMjVhZjIyMzkxNTM4YzNjYjczL3RhYmxlcmFuZ2U6ZGM0MjMzOTUyOWM0NDIyNWFmMjIzOTE1MzhjM2NiNzNfNC0xMy0xLTEtODMyODU_c8d8fdb1-bea2-46ab-9765-c97c8d6b10db"
      unitRef="usd">483300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5ef993557e48462d926de8e9ccea2f7a_I20211001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOmRjNDIzMzk1MjljNDQyMjVhZjIyMzkxNTM4YzNjYjczL3RhYmxlcmFuZ2U6ZGM0MjMzOTUyOWM0NDIyNWFmMjIzOTE1MzhjM2NiNzNfNC0xNS0xLTEtODMyODU_f1dfe87c-8298-45e7-8c57-36af24c28ee0"
      unitRef="usd">13200000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i504e59968786494c96b1e46f5375a17d_I20211001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOmRjNDIzMzk1MjljNDQyMjVhZjIyMzkxNTM4YzNjYjczL3RhYmxlcmFuZ2U6ZGM0MjMzOTUyOWM0NDIyNWFmMjIzOTE1MzhjM2NiNzNfNC0xNy0xLTEtODMyODU_f366655b-1bdd-4d32-925a-f7c29bbdb24b"
      unitRef="usd">496500000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="if9fa7e713d284aa28f3ce117acb47880_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOmRjNDIzMzk1MjljNDQyMjVhZjIyMzkxNTM4YzNjYjczL3RhYmxlcmFuZ2U6ZGM0MjMzOTUyOWM0NDIyNWFmMjIzOTE1MzhjM2NiNzNfNi0xMS0xLTEtODMyODU_55e495a1-07d5-417b-85e0-178707d8d4d1"
      unitRef="usd">1400000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ief1f6f644eea437e9b8e1e8aa59dc455_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOmRjNDIzMzk1MjljNDQyMjVhZjIyMzkxNTM4YzNjYjczL3RhYmxlcmFuZ2U6ZGM0MjMzOTUyOWM0NDIyNWFmMjIzOTE1MzhjM2NiNzNfNi0xMy0xLTEtODMyODU_cfae9143-8855-419d-b1ff-60d24565d6e4"
      unitRef="usd">1400000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ib6692c6c33bf48afbda409fe7c7691e3_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOmRjNDIzMzk1MjljNDQyMjVhZjIyMzkxNTM4YzNjYjczL3RhYmxlcmFuZ2U6ZGM0MjMzOTUyOWM0NDIyNWFmMjIzOTE1MzhjM2NiNzNfNi0xNS0xLTEtODMyODU_99a66d8d-4c38-428c-876b-d357518efc83"
      unitRef="usd">200000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOmRjNDIzMzk1MjljNDQyMjVhZjIyMzkxNTM4YzNjYjczL3RhYmxlcmFuZ2U6ZGM0MjMzOTUyOWM0NDIyNWFmMjIzOTE1MzhjM2NiNzNfNi0xNy0xLTEtODMyODU_51ef5311-0409-4e9b-8ed2-7ea0700970dd"
      unitRef="usd">1600000</us-gaap:ProfitLoss>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i66a2015d4ada4d51b8273eb10babd3c7_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOmRjNDIzMzk1MjljNDQyMjVhZjIyMzkxNTM4YzNjYjczL3RhYmxlcmFuZ2U6ZGM0MjMzOTUyOWM0NDIyNWFmMjIzOTE1MzhjM2NiNzNfNy0xLTEtMS04MzI4NQ_ca5f9d66-284b-4c3a-91e1-51f371e8870a"
      unitRef="shares">100000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i484320e6452e4a568aeaaf3e75831c12_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOmRjNDIzMzk1MjljNDQyMjVhZjIyMzkxNTM4YzNjYjczL3RhYmxlcmFuZ2U6ZGM0MjMzOTUyOWM0NDIyNWFmMjIzOTE1MzhjM2NiNzNfNy01LTEtMS04MzI4NQ_1902b903-de2a-4d0c-8795-fc3fd690045b"
      unitRef="usd">3500000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ief1f6f644eea437e9b8e1e8aa59dc455_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOmRjNDIzMzk1MjljNDQyMjVhZjIyMzkxNTM4YzNjYjczL3RhYmxlcmFuZ2U6ZGM0MjMzOTUyOWM0NDIyNWFmMjIzOTE1MzhjM2NiNzNfNy0xMy0xLTEtODMyODU_cf1c35ac-f67f-4e8f-ab54-f5015da013ae"
      unitRef="usd">3500000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOmRjNDIzMzk1MjljNDQyMjVhZjIyMzkxNTM4YzNjYjczL3RhYmxlcmFuZ2U6ZGM0MjMzOTUyOWM0NDIyNWFmMjIzOTE1MzhjM2NiNzNfNy0xNy0xLTEtODMyODU_dd2fce91-bdb8-4b09-b973-d3694024b723"
      unitRef="usd">3500000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i66a2015d4ada4d51b8273eb10babd3c7_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOmRjNDIzMzk1MjljNDQyMjVhZjIyMzkxNTM4YzNjYjczL3RhYmxlcmFuZ2U6ZGM0MjMzOTUyOWM0NDIyNWFmMjIzOTE1MzhjM2NiNzNfMTAtMS0xLTEtODMyODU_58e8c33e-e69b-4cde-bc75-eb7f7ec23db2"
      unitRef="shares">100000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i484320e6452e4a568aeaaf3e75831c12_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOmRjNDIzMzk1MjljNDQyMjVhZjIyMzkxNTM4YzNjYjczL3RhYmxlcmFuZ2U6ZGM0MjMzOTUyOWM0NDIyNWFmMjIzOTE1MzhjM2NiNzNfMTAtNS0xLTEtODMyODU_5a56b701-196f-4313-96e5-c5283a47109c"
      unitRef="usd">1700000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="ief1f6f644eea437e9b8e1e8aa59dc455_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOmRjNDIzMzk1MjljNDQyMjVhZjIyMzkxNTM4YzNjYjczL3RhYmxlcmFuZ2U6ZGM0MjMzOTUyOWM0NDIyNWFmMjIzOTE1MzhjM2NiNzNfMTAtMTMtMS0xLTgzMjg1_8da80004-1c30-450f-aa9d-bb5ca14d16c5"
      unitRef="usd">1700000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOmRjNDIzMzk1MjljNDQyMjVhZjIyMzkxNTM4YzNjYjczL3RhYmxlcmFuZ2U6ZGM0MjMzOTUyOWM0NDIyNWFmMjIzOTE1MzhjM2NiNzNfMTAtMTctMS0xLTgzMjg1_d27496dd-3095-4ce2-9c56-34f6c9c02c29"
      unitRef="usd">1700000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i484320e6452e4a568aeaaf3e75831c12_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOmRjNDIzMzk1MjljNDQyMjVhZjIyMzkxNTM4YzNjYjczL3RhYmxlcmFuZ2U6ZGM0MjMzOTUyOWM0NDIyNWFmMjIzOTE1MzhjM2NiNzNfMTEtNS0xLTEtODMyODU_4cce9f7e-b92c-417d-9c48-e3b86851e95b"
      unitRef="usd">3400000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ief1f6f644eea437e9b8e1e8aa59dc455_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOmRjNDIzMzk1MjljNDQyMjVhZjIyMzkxNTM4YzNjYjczL3RhYmxlcmFuZ2U6ZGM0MjMzOTUyOWM0NDIyNWFmMjIzOTE1MzhjM2NiNzNfMTEtMTMtMS0xLTgzMjg1_e54fa14a-454e-4bdb-8379-a399c5afa221"
      unitRef="usd">3400000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOmRjNDIzMzk1MjljNDQyMjVhZjIyMzkxNTM4YzNjYjczL3RhYmxlcmFuZ2U6ZGM0MjMzOTUyOWM0NDIyNWFmMjIzOTE1MzhjM2NiNzNfMTEtMTctMS0xLTgzMjg1_0703576f-7ca5-4125-8528-c84b0ced415d"
      unitRef="usd">3400000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax
      contextRef="ia7cd9a82501843e7840128314d4836e4_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOmRjNDIzMzk1MjljNDQyMjVhZjIyMzkxNTM4YzNjYjczL3RhYmxlcmFuZ2U6ZGM0MjMzOTUyOWM0NDIyNWFmMjIzOTE1MzhjM2NiNzNfMTYtOS0xLTEtODMyODU_eb38b82a-62af-4e4d-9bc0-4fbeaa6c46ea"
      unitRef="usd">500000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax
      contextRef="ief1f6f644eea437e9b8e1e8aa59dc455_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOmRjNDIzMzk1MjljNDQyMjVhZjIyMzkxNTM4YzNjYjczL3RhYmxlcmFuZ2U6ZGM0MjMzOTUyOWM0NDIyNWFmMjIzOTE1MzhjM2NiNzNfMTYtMTMtMS0xLTgzMjg1_8e99539b-97cc-452d-b35e-be639f9befe4"
      unitRef="usd">500000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOmRjNDIzMzk1MjljNDQyMjVhZjIyMzkxNTM4YzNjYjczL3RhYmxlcmFuZ2U6ZGM0MjMzOTUyOWM0NDIyNWFmMjIzOTE1MzhjM2NiNzNfMTYtMTctMS0xLTgzMjg1_d6972efc-3675-4f19-9c95-de4ec060ac5c"
      unitRef="usd">500000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax>
    <us-gaap:StockholdersEquityOther
      contextRef="ib6692c6c33bf48afbda409fe7c7691e3_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOmRjNDIzMzk1MjljNDQyMjVhZjIyMzkxNTM4YzNjYjczL3RhYmxlcmFuZ2U6ZGM0MjMzOTUyOWM0NDIyNWFmMjIzOTE1MzhjM2NiNzNfMTgtMTUtMS0xLTgzMjg1_7f411c80-361c-4c52-a991-5163475ff3a1"
      unitRef="usd">100000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOmRjNDIzMzk1MjljNDQyMjVhZjIyMzkxNTM4YzNjYjczL3RhYmxlcmFuZ2U6ZGM0MjMzOTUyOWM0NDIyNWFmMjIzOTE1MzhjM2NiNzNfMTgtMTctMS0xLTgzMjg1_efb9029c-ef93-4c55-b2b6-0c07a679d5c6"
      unitRef="usd">100000</us-gaap:StockholdersEquityOther>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ic84d7ad4df444a5ba010f733b23db58e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOmRjNDIzMzk1MjljNDQyMjVhZjIyMzkxNTM4YzNjYjczL3RhYmxlcmFuZ2U6ZGM0MjMzOTUyOWM0NDIyNWFmMjIzOTE1MzhjM2NiNzNfMTktMS0xLTEtODMyODU_e91970a9-7c04-40f8-85e0-c5590e27d9ac"
      unitRef="shares">39600000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic84d7ad4df444a5ba010f733b23db58e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOmRjNDIzMzk1MjljNDQyMjVhZjIyMzkxNTM4YzNjYjczL3RhYmxlcmFuZ2U6ZGM0MjMzOTUyOWM0NDIyNWFmMjIzOTE1MzhjM2NiNzNfMTktMy0xLTEtODMyODU_b482aaa7-6c2d-443f-b2a4-a2507e3caa22"
      unitRef="usd">400000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8f85b75047844e478507cd67afb10862_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOmRjNDIzMzk1MjljNDQyMjVhZjIyMzkxNTM4YzNjYjczL3RhYmxlcmFuZ2U6ZGM0MjMzOTUyOWM0NDIyNWFmMjIzOTE1MzhjM2NiNzNfMTktNS0xLTEtODMyODU_f03f38f3-edef-49ba-a590-1452bbd5b693"
      unitRef="usd">458000000.0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0f1790e7c49848f68d840ef25c469adf_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOmRjNDIzMzk1MjljNDQyMjVhZjIyMzkxNTM4YzNjYjczL3RhYmxlcmFuZ2U6ZGM0MjMzOTUyOWM0NDIyNWFmMjIzOTE1MzhjM2NiNzNfMTktOS0xLTEtODMyODU_27587a0a-b956-4317-9b06-1fd0c4bedbe7"
      unitRef="usd">-500000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia50a700a64ae4856ba15300cae774337_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOmRjNDIzMzk1MjljNDQyMjVhZjIyMzkxNTM4YzNjYjczL3RhYmxlcmFuZ2U6ZGM0MjMzOTUyOWM0NDIyNWFmMjIzOTE1MzhjM2NiNzNfMTktMTEtMS0xLTgzMjg1_17c48073-8b97-4ece-b5d8-2c4b8da7b532"
      unitRef="usd">34900000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic3cba6759b1f4b609890dbb223fb7ddb_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOmRjNDIzMzk1MjljNDQyMjVhZjIyMzkxNTM4YzNjYjczL3RhYmxlcmFuZ2U6ZGM0MjMzOTUyOWM0NDIyNWFmMjIzOTE1MzhjM2NiNzNfMTktMTMtMS0xLTgzMjg1_97094291-ab43-4123-9927-fa20a6cca61c"
      unitRef="usd">492800000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7886797dc72447689ab1203828cf4a8a_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOmRjNDIzMzk1MjljNDQyMjVhZjIyMzkxNTM4YzNjYjczL3RhYmxlcmFuZ2U6ZGM0MjMzOTUyOWM0NDIyNWFmMjIzOTE1MzhjM2NiNzNfMTktMTUtMS0xLTgzMjg1_bbaa6e0c-36c7-4bf5-b1dc-ca4f7d10f90f"
      unitRef="usd">13300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4026880a25c245b7ae7af90aa89cf31c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18yNS9mcmFnOmI2MmY2MzI2ODkzNzRjNGQ4NDk3NzBmMWRmODEyMTk0L3RhYmxlOmRjNDIzMzk1MjljNDQyMjVhZjIyMzkxNTM4YzNjYjczL3RhYmxlcmFuZ2U6ZGM0MjMzOTUyOWM0NDIyNWFmMjIzOTE1MzhjM2NiNzNfMTktMTctMS0xLTgzMjg1_aaf2b365-473b-4683-af58-5ac991cfe946"
      unitRef="usd">506100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMy0xLTEtMS04MzI4NQ_45671c88-2f1d-4ae6-ae1b-af16da8ac15e"
      unitRef="usd">3200000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMy0zLTEtMS04MzI4NQ_44fe308a-12f3-428f-b390-0087f7077cd8"
      unitRef="usd">1600000</us-gaap:ProfitLoss>
    <us-gaap:ShareBasedCompensation
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfNS0xLTEtMS04MzI4NQ_7d188044-cc90-44ac-8a0f-2a7838036f1f"
      unitRef="usd">3300000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfNS0zLTEtMS04MzI4NQ_cdd8b7e7-92e8-4a1f-ab94-9f11df31e529"
      unitRef="usd">3400000</us-gaap:ShareBasedCompensation>
    <us-gaap:Depreciation
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfNy0xLTEtMS04MzI4NQ_93a02890-3967-4df2-bca3-ddb92d79eecc"
      unitRef="usd">4600000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfNy0zLTEtMS04MzI4NQ_48137a78-56ef-44c5-b6f3-a0ac1b4ec1a2"
      unitRef="usd">4800000</us-gaap:Depreciation>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfOC0xLTEtMS04MzI4NQ_b521c72a-db23-472c-9066-8c1a5d8ea758"
      unitRef="usd">3400000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfOC0zLTEtMS04MzI4NQ_ccda35fb-d8ed-4fd7-a33f-def8fea261e0"
      unitRef="usd">3800000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfOS0xLTEtMS04MzI4NQ_ef80d477-d643-4d0b-9a39-5cb44a197c2d"
      unitRef="usd">-200000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfOS0zLTEtMS04MzI4NQ_a47db55a-1abc-4e63-8124-cbd3b397a52a"
      unitRef="usd">200000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMTAtMS0xLTEtODMyODU_7a70e41b-065a-41af-be93-270691c3e181"
      unitRef="usd">1300000</us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions>
    <us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMTAtMy0xLTEtODMyODU_21d130af-7c03-4cd1-8e7b-afa2b167ee20"
      unitRef="usd">-500000</us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions>
    <us-gaap:AmortizationOfDeferredLoanOriginationFeesNet
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMTItMS0xLTEtODMyODU_d9eaadc6-844b-4abf-8332-adbe10024753"
      unitRef="usd">-600000</us-gaap:AmortizationOfDeferredLoanOriginationFeesNet>
    <us-gaap:AmortizationOfDeferredLoanOriginationFeesNet
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMTItMy0xLTEtODMyODU_efa72033-d922-4dff-84dc-6e155abf24e8"
      unitRef="usd">-2600000</us-gaap:AmortizationOfDeferredLoanOriginationFeesNet>
    <us-gaap:InventoryWriteDown
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMTUtMS0xLTEtODMyODU_aa9b671f-8148-46ed-a1dc-3e0998391ad1"
      unitRef="usd">2000000.0</us-gaap:InventoryWriteDown>
    <us-gaap:InventoryWriteDown
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMTUtMy0xLTEtODMyODU_86e925e1-e1e8-4845-ad99-85ad579dd28b"
      unitRef="usd">400000</us-gaap:InventoryWriteDown>
    <us-gaap:GainLossOnTerminationOfLease
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMTYtMS0xLTEtODMyODU_bc37aa2b-e3f7-4797-a799-44ec79340915"
      unitRef="usd">0</us-gaap:GainLossOnTerminationOfLease>
    <us-gaap:GainLossOnTerminationOfLease
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMTYtMy0xLTEtODMyODU_50939a91-3ff7-4107-93be-8198f145639f"
      unitRef="usd">-1900000</us-gaap:GainLossOnTerminationOfLease>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMTctMS0xLTEtODMyODU_6e4a448f-e038-43aa-bb0e-9f750d56c563"
      unitRef="usd">0</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMTctMy0xLTEtODMyODU_a5de8e54-580c-496b-a610-4915adfeb093"
      unitRef="usd">-1100000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMTktMS0xLTEtODMyODU_ad920c1c-aed6-4220-ad0c-ce484dd92925"
      unitRef="usd">-15600000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMTktMy0xLTEtODMyODU_876b99cf-6c35-4da3-b1d5-515e4a3985ad"
      unitRef="usd">-28400000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMjAtMS0xLTEtODMyODU_977f509e-14b9-4eb8-8516-f1c6475de06e"
      unitRef="usd">18800000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMjAtMy0xLTEtODMyODU_7fa9a77a-0cba-4408-bd47-4215bb64b2d2"
      unitRef="usd">23800000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMjEtMS0xLTEtODMyODU_debf6200-a657-4886-8574-0f3b2e77acf5"
      unitRef="usd">400000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMjEtMy0xLTEtODMyODU_84e73ad3-1437-402e-a84f-73e4ebaa0855"
      unitRef="usd">-3400000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMjItMS0xLTEtODMyODU_6f3bbead-5304-4d8b-be21-abc781ef9ef9"
      unitRef="usd">8000000.0</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMjItMy0xLTEtODMyODU_4382b475-0848-4d97-9b9e-e370c39d9fb4"
      unitRef="usd">13500000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMjMtMS0xLTEtODMyODU_a4554236-f1f4-4fce-b14b-87e63d1f2932"
      unitRef="usd">-25400000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMjMtMy0xLTEtODMyODU_301bb194-12d3-4e97-87ee-e8473326ef7b"
      unitRef="usd">-30500000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMjQtMS0xLTEtODMyODU_31c99eac-e887-4452-afbf-8b306d2f4110"
      unitRef="usd">1700000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMjQtMy0xLTEtODMyODU_0332407a-ff91-43c8-801f-e7f38229a5e3"
      unitRef="usd">-500000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMjYtMS0xLTEtODMyODU_c6ae84db-8904-45d5-8844-5909c91065f8"
      unitRef="usd">-3700000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMjYtMy0xLTEtODMyODU_00548a70-e895-4799-a0a0-bb03ca77a580"
      unitRef="usd">10800000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMjgtMS0xLTEtODMyODU_164409f8-3c4b-4284-905b-49df7203852e"
      unitRef="usd">5500000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMjgtMy0xLTEtODMyODU_4ec726b9-21a5-4361-97f2-feab077f2986"
      unitRef="usd">4100000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <var:GainLossOnSettlementOfHedgeInvestingActivities
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMjktMS0xLTEtODMyODU_2fb4ab72-5233-438b-957a-c2dc5594d356"
      unitRef="usd">300000</var:GainLossOnSettlementOfHedgeInvestingActivities>
    <var:GainLossOnSettlementOfHedgeInvestingActivities
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMjktMy0xLTEtODMyODU_c8bfa62e-ee6b-4b5b-9153-1585cc54ab2a"
      unitRef="usd">0</var:GainLossOnSettlementOfHedgeInvestingActivities>
    <us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMzEtMS0xLTEtODMyODU_07f23465-ba09-41bd-b7fb-846e9db99eb8"
      unitRef="usd">4000000.0</us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMzEtMy0xLTEtODMyODU_873cccde-3765-4832-8416-84782f5d5055"
      unitRef="usd">0</us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMzItMS0xLTEtODMyODU_28bc8d55-4739-4d38-b0b3-7a49408df79b"
      unitRef="usd">6300000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMzItMy0xLTEtODMyODU_36c33ab4-1b62-4556-bb27-2f78e57d74c4"
      unitRef="usd">0</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMzMtMS0xLTEtOTQ4MTA_5388972f-90e4-4364-acae-ced953d4f97d"
      unitRef="usd">2700000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMzMtMy0xLTEtOTQ4MTA_d3414585-6948-4862-a9ae-a35d748ea9bd"
      unitRef="usd">0</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:ProceedsFromHedgeInvestingActivities
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMzUtMS0xLTEtMTAwMjQ3_50128536-c951-461c-831f-4a5f9ec45b96"
      unitRef="usd">7000000.0</us-gaap:ProceedsFromHedgeInvestingActivities>
    <us-gaap:ProceedsFromHedgeInvestingActivities
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMzUtMy0xLTEtMTAwMjQ3_782e571a-3a06-488b-8467-32ce34d5a41a"
      unitRef="usd">0</us-gaap:ProceedsFromHedgeInvestingActivities>
    <var:ProceedsFromSalesOfBusinessAndAssets
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMzMtMS0xLTEtODMyODU_4c468cbe-5b46-41d2-b4e8-0cd6360310ab"
      unitRef="usd">0</var:ProceedsFromSalesOfBusinessAndAssets>
    <var:ProceedsFromSalesOfBusinessAndAssets
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMzMtMy0xLTEtODMyODU_f1cfb6a1-cb58-451d-acb0-00ff6d6cbfc8"
      unitRef="usd">1700000</var:ProceedsFromSalesOfBusinessAndAssets>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMzUtMS0xLTEtODMyODU_87798443-5b85-4740-91d8-437337543bd8"
      unitRef="usd">-100000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMzUtMy0xLTEtODMyODU_868e66da-a3b8-4933-8333-bbc99c1e2804"
      unitRef="usd">200000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMzYtMS0xLTEtODMyODU_9761b973-ea04-4602-97e4-6ece4979f7f3"
      unitRef="usd">-3700000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfMzYtMy0xLTEtODMyODU_3cf6cdbc-e4f9-47ce-91f1-ab1ee7312d62"
      unitRef="usd">-2600000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:RepaymentsOfLongTermLinesOfCredit
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfNDMtMS0xLTEtODMyODU_976473af-677e-4c5a-86e4-f9b14500d5a8"
      unitRef="usd">500000</us-gaap:RepaymentsOfLongTermLinesOfCredit>
    <us-gaap:RepaymentsOfLongTermLinesOfCredit
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfNDMtMy0xLTEtODMyODU_3ff1647a-f8dc-4e66-ad7c-e8240ccd9209"
      unitRef="usd">300000</us-gaap:RepaymentsOfLongTermLinesOfCredit>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfNDYtMS0xLTEtODMyODU_68ff5001-1806-4a82-ab9c-97a4b088050f"
      unitRef="usd">0</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfNDYtMy0xLTEtODMyODU_7476aee1-2d49-4fcd-a97d-d4024f49ba5e"
      unitRef="usd">3500000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockPlans
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfNDgtMS0xLTEtODMyODU_4bd4eb02-4823-4534-978b-c51b40b224b7"
      unitRef="usd">0</us-gaap:ProceedsFromStockPlans>
    <us-gaap:ProceedsFromStockPlans
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfNDgtMy0xLTEtODMyODU_f2ec1ae1-e3cd-427f-8984-b530678cd626"
      unitRef="usd">1700000</us-gaap:ProceedsFromStockPlans>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfNDktMS0xLTEtODMyODU_30ac7f95-be0c-410c-80e5-ed6754040275"
      unitRef="usd">100000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfNDktMy0xLTEtODMyODU_4ed0f0ca-dca8-42d8-8de1-302ea5edd77f"
      unitRef="usd">100000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfNTAtMS0xLTEtODMyODU_7c54a024-b89d-4c33-8c84-26176e4bccba"
      unitRef="usd">-400000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfNTAtMy0xLTEtODMyODU_d8515fcd-5fb3-4125-8d45-af9bb366632a"
      unitRef="usd">5000000.0</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfNTEtMS0xLTEtODMyODU_d3b48fda-b7e2-4445-aedc-e290fde2875e"
      unitRef="usd">0</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfNTEtMy0xLTEtODMyODU_41e85c5c-9caf-4a40-8b02-e299b046d614"
      unitRef="usd">-100000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfNTItMS0xLTEtODMyODU_ec21e982-7087-4644-8a83-6bc81ec5b654"
      unitRef="usd">-7800000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfNTItMy0xLTEtODMyODU_9cc5ba3e-c605-40c5-a9e5-286a20b38cf1"
      unitRef="usd">13100000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfNTMtMS0xLTEtODMyODU_79b852db-ccc5-45f5-a7f2-47484382298a"
      unitRef="usd">90600000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i504e59968786494c96b1e46f5375a17d_I20211001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfNTMtMy0xLTEtODMyODU_27e1c774-05e9-4b4f-85bf-c60577df8331"
      unitRef="usd">146100000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfNTQtMS0xLTEtODMyODU_36b9a8bc-3a5c-4586-8113-3e8a7bd57e89"
      unitRef="usd">82800000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i4026880a25c245b7ae7af90aa89cf31c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfNTQtMy0xLTEtODMyODU_601f66d1-907c-45fb-ae88-5a9749b09713"
      unitRef="usd">159200000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfNTYtMS0xLTEtODMyODU_49f23fea-4d4c-48c8-b623-ee8a510a6358"
      unitRef="usd">13700000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfNTYtMy0xLTEtODMyODU_b4ecc5c1-b654-45e3-b651-e3fa268f3933"
      unitRef="usd">14800000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfNTctMS0xLTEtODMyODU_bd733521-cce3-4ded-87ad-3b96b8464672"
      unitRef="usd">4500000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfNTctMy0xLTEtODMyODU_f38ec624-b4d4-4ea8-88cf-999f67cc9204"
      unitRef="usd">400000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:FairValueOfAssetsAcquired
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfNTktMS0xLTEtODMyODU_56805adc-f137-4edf-80f3-ead5aeb09888"
      unitRef="usd">2000000.0</us-gaap:FairValueOfAssetsAcquired>
    <us-gaap:FairValueOfAssetsAcquired
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zMS9mcmFnOmZlOGFlODBmZDNhMDQ0ODc5OGVkZTgwODJmZjA2ZTcxL3RhYmxlOjY5ZDA4MWY2NzdkYjRjNTQ4YWQyZTQxZDQ3NDZhMjVmL3RhYmxlcmFuZ2U6NjlkMDgxZjY3N2RiNGM1NDhhZDJlNDFkNDc0NmEyNWZfNTktMy0xLTEtODMyODU_cc84c99a-e219-4f6c-b7a4-0197974b705d"
      unitRef="usd">800000</us-gaap:FairValueOfAssetsAcquired>
    <us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN18zNy9mcmFnOjE3NGY1MThhYjc5ZDRlMTFiMTQ0MmY3ZDQ4ZDI3MjAzL3RleHRyZWdpb246MTc0ZjUxOGFiNzlkNGUxMWIxNDQyZjdkNDhkMjcyMDNfMTYxNA_9d14c852-ac65-44f7-90b2-7ce9a8966f51">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Description of Business&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Varex Imaging Corporation (the &#x201c;Company&#x201d; or &#x201c;Varex&#x201d;) designs, manufactures, sells and services a broad range of medical products, which include X-ray imaging components including X-ray tubes, digital detectors and accessories, ionization chambers and buckys, high voltage connectors, image processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers. The Company sells its products to imaging system original equipment manufacturer (&#x201c;OEM&#x201d;) customers for incorporation into new medical diagnostic, radiation therapy, dental, and veterinary equipment, as well as to independent service companies and distributors, and directly to end-users for replacement purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company also designs, manufactures, sells and services industrial products, which include Linatron&#xae; X-ray linear accelerators, digital detectors, high voltage connectors, coolers, imaging processing software and image detection products for security and inspection purposes, such as cargo screening at ports and borders and nondestructive examination in a variety of applications. The Company generally sells security and inspection products to OEM customers who incorporate Varex&#x2019;s products into their inspection or irradiation systems and processes. The Company conducts an active research and development program to focus on new technology and applications in both the medical and industrial X-ray imaging markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The accompanying unaudited condensed consolidated financial statements have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission (&#x201c;SEC&#x201d;) and in accordance with accounting principles generally accepted in the United States (&#x201c;GAAP&#x201d;) for interim financial information. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. In the opinion of management, these condensed consolidated financial statements include all adjustments necessary for a fair presentation of the results for the interim periods. The Company has consolidated all of its majority owned subsidiaries and entities over which it has control. All intercompany balances and transactions have been eliminated as part of the consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;These condensed consolidated financial statements and the accompanying notes are unaudited and should be read in conjunction with the consolidated financial statements and notes thereto for the fiscal year ended 2022 included in the Company&#x2019;s Annual Report on Form 10-K, which was filed with the SEC on November&#160;18, 2022. The Company considers events or transactions that occur after the balance sheet date, but before the financial statements are issued, to provide additional evidence relative to certain estimates or to identify matters that require additional disclosures. Except for the change in certain policies upon adoption of the accounting standard described below, there have been no material changes to the Company's significant accounting policies, compared to the accounting policies described in Note 1, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Summary of Significant Accounting Policies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, in the Company&#x2019;s Annual Report on Form&#160;10-K for fiscal year 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Segment Reporting&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company has two reportable operating segments; (i) Medical and (ii) Industrial, which aligns with how its Chief Executive Officer, who is the Company's Chief Operating Decision Maker (&#x201c;CODM&#x201d;), reviews the Company&#x2019;s performance. See Note 15, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Segment Information&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for further information on the Company&#x2019;s segments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fiscal Year&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The fiscal years of the Company as reported are the 52 or 53-week period ending on the Friday nearest September&#160;30. Fiscal year 2023 is the 52-week period ending September&#160;29, 2023. Fiscal year 2022 was the 52-week period that ended on September&#160;30, 2022. The fiscal quarters ended&#160;December&#160;30, 2022 and&#160;December&#160;31, 2021&#160;were both 13-week periods. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. Such estimates include the valuation of inventories, valuation of goodwill and intangible assets, warranties, contract liabilities, long-lived asset valuations, impairment of investments, valuation of financial instruments, and taxes on income. Actual results could differ from these estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Impact of COVID-19&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The coronavirus (&#x201c;COVID-19&#x201d;) pandemic, the COVID-19 variants, uneven vaccination rates across the globe, and the mitigation efforts by governments to control its spread have created uncertainties and disruptions in the economic and financial markets. While the impacts of COVID-19 on the Company's business have lessened, the extent to which COVID-19 will continue to impact the Company&#x2019;s business and financial results depends on numerous evolving factors including: the magnitude and duration of COVID-19, the extent to which it will continue to impact worldwide macroeconomic conditions, including supply chain disruptions, interest rates, unemployment rates, the speed of the economic recovery, and governmental and business reactions to the pandemic. The Company has experienced continuing supply chain disruptions and other issues that are at least partially related to the ongoing COVID-19 pandemic. In addition, while the Company has from time to time taken significant precautions to maintain employee safety, such as implementing mask requirements, encouraging vaccination, and periodically asking non-production related employees to work remotely when possible, the Company has experienced, and may in the future experience, COVID-19 related employee absences that adversely impact its production or business. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company assessed certain accounting matters that generally require consideration of forecasted financial information in context with the information reasonably available to the Company, including the estimated future impacts of COVID-19, through the date of filing this report. The accounting matters assessed included, but were not limited to, the Company&#x2019;s carrying value of goodwill, intangibles, long-lived assets, equity method investments, inventory and related reserves, and the allowance for credit losses. The Company&#x2019;s assessment of the magnitude and duration of COVID-19, as well as other factors, could result in material negative impacts to the Company&#x2019;s condensed consolidated financial statements in future reporting periods. These future developments are highly uncertain and the outcomes cannot be estimated with certainty. Actual results may differ from those estimates, and such differences may be material to the financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company considers unrestricted currency on hand, demand deposits, time deposits and all highly-liquid investments with an original maturity of three months or less at the date of purchase to be cash and cash equivalents. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restricted Cash&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Restricted cash primarily consists of cash collateral related to certain leases and inventory arrangements. Restricted cash is included in other assets on the Company's Condensed Consolidated Balance Sheets. Cash and cash equivalents and restricted cash as reported within the Condensed Consolidated Statements of Cash Flows consisted of the following:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.650%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.650%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.650%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.652%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Beginning of Period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;End of Period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Beginning of Period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;End of Period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;89.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;81.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;144.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;157.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total as presented in the Condensed Consolidated Statements of Cash Flows&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;90.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;82.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;146.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;159.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Concentration of Risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Financial instruments that potentially expose the Company to concentrations of credit risk consist principally of cash, cash equivalents, marketable securities, certificates of deposit, and trade accounts receivable. Cash held with financial institutions may exceed the Federal Deposit Insurance Corporation insurance limits or similar limits in foreign jurisdictions. To date, the Company has not realized any losses on its deposits of cash and cash equivalents. The Company performs ongoing credit evaluations of its customers and, except for government tenders, group purchases and orders with a letter of credit, its industrial customers often provide a down payment. The Company maintains an allowance for credit losses based upon the expected collectability of all accounts receivable. The Company obtains some of the components in its products from a limited group of suppliers or from a single-source supplier. When these suppliers are unable to meet the Company's supply needs, the Company's production is negatively impacted. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Credit is extended to customers based on an evaluation of the customer&#x2019;s financial condition, and collateral is not required. In certain circumstances, a customer may be required to prepay all or a portion of the contract price prior to transfer of control. During the periods presented, one of the Company's customers accounted for a significant portion of revenues, as set forth below:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Canon Medical Systems Corporation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Canon Medical Systems Corporation accounted for 9.2% and 10.3% of the Company&#x2019;s accounts receivable as of December&#160;30, 2022 and September&#160;30, 2022, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Investments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company accounts for its equity investments in privately-held companies under the equity method of accounting if the Company has the ability to exercise significant influence in these investments. Distributions received from an equity method investment are classified using the&#160;cumulative earnings approach, which means that distributions up to the amount of cumulative equity in earnings recognized will be treated as returns on investment and classified as operating cash flows and those in excess of that amount will be treated as returns of investment and classified as investing cash flows. The Company reviews its equity investments in privately-held companies for impairment whenever events or changes in business circumstances are other than temporary and indicate that the carrying amount of the investments may not be fully recoverable. There were no impairments recorded during the three months ended December 30, 2022 and December&#160;31, 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Marketable Securities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company's marketable securities consist primarily of financial instruments such as U.S. treasury securities, U.S. agency obligations, corporate bonds, commercial paper, money market funds, and equity securities. The Company classifies marketable debt securities as available-for-sale at the time of purchase and reevaluates such classifications as of each balance sheet date. All marketable debt securities are recorded at estimated fair value. Any unrealized gains or losses for marketable debt securities are included in accumulated other comprehensive income within the Condensed Consolidated Balance Sheets. Marketable equity securities are stated at fair value as determined by the most recently traded price of each security at the balance sheet date. All unrealized gains and losses on equity securities are recorded as part of other expense, net in the Company's condensed consolidated financial statements. See Note 7, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for further details.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;When the fair value of a marketable debt security declines below its amortized cost basis, any portion of that decline attributable to credit losses, to the extent expected to be nonrecoverable before the sale of the security, is recognized in the Condensed Consolidated Statements of Operations. When the fair value of a marketable debt security declines below its amortized cost basis due to changes in interest rates, such amounts are recorded in other comprehensive loss, and are recognized in the Condensed Consolidated Statements of Operations only if the Company sells or intends to sell the security before recovery of its cost basis. There were no credit losses related to marketable debt securities recorded during the three months ended December 30, 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Loss Contingencies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;From time to time, the Company is involved in legal proceedings, claims and government inspections or investigations, customs and duties audits, other contingency matters, both inside and outside the United States, arising in the ordinary course of its business or otherwise.&#160;The Company accrues amounts for probable losses, to the extent they can be reasonably estimated, that it believes are adequate to address any liabilities related to legal proceedings and other loss contingencies that the Company believes will result in a probable loss (including, among other things, probable settlement value).&#160;A loss or a range of loss is disclosed when it is reasonably possible that a material loss will be incurred and can be estimated or when it is reasonably possible that the amount of a loss, when material, will exceed the recorded provision. When a loss contingency is probable but not reasonably estimable the nature of the contingency and the fact that an estimate cannot be made is disclosed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Product Warranty&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company warrants most of its products for a specific period of time, usually 12 to 24 months from delivery or acceptance, against material defects. The Company provides for the estimated future costs of warranty obligations in cost of revenues when the related revenues are recognized. The accrued warranty costs represent the best estimate at the time of sale of the total costs that the Company will incur to repair or replace product parts that fail while still under warranty.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The amount of the accrued estimated warranty costs obligation for established products is primarily based on historical experience of product failures, adjusted for current information on repair costs.&#160;For new products, estimates include the historical experience of similar products, as well as a reasonable allowance for warranty expenses associated with new products.&#160;On a quarterly basis, the Company reviews the accrued warranty costs and updates the historical warranty cost trends, if required.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The following table reflects the changes in the Company&#x2019;s accrued product warranty:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued product warranty, at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;New accruals charged to cost of revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Product warranty expenditures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued product warranty, at end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company determines if an arrangement is or contains a lease at the inception of an arrangement. The Company's operating lease right-of-use ("ROU") assets represent the right to use an underlying asset over the lease term and lease liabilities represent its obligation to make lease payments arising from the lease. ROU assets may also include initial direct costs incurred and prepaid lease payments, less lease incentives. Lease liabilities and their corresponding ROU assets are recognized based on the present value of lease payments over the lease term, discounted using the Company's incremental borrowing rate. The Company recognizes operating leases with lease terms of more than twelve months in operating lease assets, current operating lease liabilities, and operating lease liabilities on its Condensed Consolidated Balance Sheets. The Company recognizes finance leases with lease terms of more than twelve months in property, plant, and equipment, net, accrued liabilities and other current liabilities, and other long-term liabilities on its Condensed Consolidated Balance Sheets. For purposes of calculating lease liabilities and the corresponding ROU assets, the Company's lease term may include options to extend or terminate the lease when it is reasonably certain that it will exercise that option.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company&#x2019;s revenues are derived primarily from the sale of hardware and services. The Company recognizes its revenues net of any value-added or sales tax and net of sales discounts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company sells a high proportion of its X-ray products to a limited number of OEM customers. X-ray imaging components including X-ray tubes, digital detectors and image-processing tools and security and inspection products are generally sold on a stand-alone basis. However, the Company occasionally sells its digital detectors, X-ray tubes and imaging processing tools as a package that is optimized for digital X-ray imaging and sells its Linatron&#xae; X-ray linear accelerators together with its image processing software and image detection products to OEM customers that incorporate them into their inspection or irradiation systems and processes. Service contracts are often sold with certain security and inspection products and computer-aided detection products.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company determines revenue recognition through the following steps:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:63pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Identification of the contract, or contracts, with a customer&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:63pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Identification of the performance obligations in the contract&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:63pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Determination of the transaction price&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:63pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Allocation of the transaction price to the performance obligations in the contract&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:63pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Recognition of revenue when, or as, a performance obligation is satisfied&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Transaction Price and Allocation to Performance Obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Transaction prices of products or services are typically based on contracted rates. To the extent that the transaction price includes variable consideration, the Company estimates the amount of variable consideration that should be included in the transaction price utilizing the expected value method when there is a large number of transactions with similar characteristics or the most likely amount method when there are two possible outcomes, depending on the circumstances of the transaction, to which the Company expects to be entitled. Variable consideration is included in the transaction price if, in the Company&#x2019;s judgment, it is probable that a significant future reversal of cumulative revenue under the contract will not occur. Estimates of variable consideration and determination of whether to include estimated amounts in the transaction price are based largely on an assessment of the Company&#x2019;s anticipated performance and all information (historical, current, and forecasted) that is reasonably available.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company allows customers to return specific parts of purchased X-ray tubes for a partial refund credit, which is identified as variable consideration. For sales with a right of return, revenue is reduced for expected returns, a liability is recorded for expected returns, and an asset is recorded for the right to recover products from customers on settling the liability. The Company recognizes a reduction to revenue and cost of sales at the time of sale and a corresponding contract liability and contract asset. The Company records this estimate based on the historical volume of product returns and adjusts the estimate on a quarterly basis based on the current quarter sales and current quarter returns.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;If a contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. Contracts that contain multiple performance obligations require an allocation of the transaction price based on the estimated relative standalone selling prices of the promised products or services underlying each performance obligation. The Company determines standalone selling prices based on the price at which the performance obligation could be sold separately.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contracts and Performance Obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company accounts for a contract with a customer when there is an approval and commitment from both parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and collectability of the consideration is probable. The Company's performance obligations consist mainly of transferring control of products and services identified in the contracts or purchase orders. For each contract, the Company considers the obligation to transfer products and services to the customer, which are distinct, to be performance obligations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recognition of Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Revenue is recognized when, or as, obligations under the terms of a contract are satisfied, which occurs when control of the promised products or services is transferred to customers. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring products or services to a customer.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Product revenue is generally recognized when the customer obtains control of the Company&#x2019;s product, which occurs at a point in time, and may be upon shipment or upon delivery based on the contractual shipping terms of a contract.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Service revenue is generally recognized over the term of the service contract. Services are expected to be transferred to the customer throughout the term of the contract, and the Company believes recognizing revenue ratably over the term of the contract best depicts the transfer of value to the customer.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Disaggregation of Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Revenue is disaggregated from contracts between geography and by reportable operating segment, which the Company believes best depicts how the nature, amount, timing, and uncertainty of revenues and cash flows are affected by economic factors. Refer to Note 15, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Segment Information, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;included in this report, for the disaggregation of the Company&#x2019;s revenue based on reportable operating segments and Note 2, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for the disaggregation of revenue by geographic region.&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contract Balances&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Contract assets are included within the prepaid expenses and other current assets, and other assets balances in the Condensed Consolidated Balance Sheets. Contract liabilities, which includes refund liabilities and deferred revenue, are included within the accrued liabilities and other current liabilities, deferred revenues, and other long-term liabilities balances in the Condensed Consolidated Balance Sheets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Deferred revenue represents the Company's obligation to transfer goods and/or services to its customers for which it has already received consideration (or the amount is due) from the customer. The Company's deferred revenue balance primarily relates to contract advances and billings for warranty contracts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Deferred revenue that is estimated to be recognized during the following twelve-month period is recorded as deferred revenues and the remaining portion is recorded as other long-term liabilities in the Condensed Consolidated Balance Sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Costs to Obtain or Fulfill a Customer Contract&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company has certain costs to obtain and fulfill a customer contract, such as commissions and shipping costs. The Company recognizes the incremental costs of obtaining contracts as an expense when incurred if the amortization period of the assets that the Company otherwise would have recognized is one year or less. Incremental costs of obtaining contracts that would be recognized over more than one year are not material. The Company accounts for shipping and handling activities related to contracts with customers as costs to fulfill the promise to transfer the associated products. These costs are included as a component of cost of revenues.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In August 2020, the Financial Accounting Standards Board issued Accounting Standard Update ("ASU") 2020-06, Accounting for Convertible Instruments and Contracts in an Entity&#x2019;s Own Equity. The standard removed certain separation models in ASC 470-20 for convertible instruments, and, as a result, embedded conversion features are no longer separated from the host contract for convertible instruments with conversion features that are not required to be accounted for as derivatives under ASC 815. These convertible debt instruments are accounted for as a single liability measured at amortized cost. This results in the interest expense recognized for convertible debt instruments to be typically closer to the coupon interest rate. Further, the ASU made amendments to the earnings per share (&#x201c;EPS&#x201d;) guidance in Topic 260 for convertible instruments, the most significant impact of which was requiring the use of the if-converted method for diluted EPS calculation, and no longer allowing the net share settlement method. The Company adopted this ASU on October 1, 2022, using the modified retrospective method. On the date of adoption, the Company recorded an entry to reduce additional paid-in capital by $34.6&#160;million, increase long-term debt, net by $28.0&#160;million, decrease deferred tax assets by $0.1&#160;million, and increase retained earnings by $6.5&#160;million for the after-tax impact of previously recognized amortization of the debt discount associated with the Company&#x2019;s Convertible Notes (as defined herein). The unamortized discount on the Company's Convertible Notes (see Note 10, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Borrowings&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) was derecognized in the first quarter of fiscal year 2023 and the interest expense from its Convertible Notes decreased and became closer to the coupon rate of 4.00%. The impact that the adoption of ASU 2020-06 has on the Company's net income per diluted share will depend on the amount of earnings in each period and the Company's share price and could result in additional dilution.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180MC9mcmFnOjI5OGNlZTNhOTFhNjQ3ZmY5ZDVmM2Q1YjVkZmQwMjUyL3RleHRyZWdpb246Mjk4Y2VlM2E5MWE2NDdmZjlkNWYzZDViNWRmZDAyNTJfMTU3Nw_ba3ff11e-3014-4c15-af23-6bd1f0570cd8">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The accompanying unaudited condensed consolidated financial statements have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission (&#x201c;SEC&#x201d;) and in accordance with accounting principles generally accepted in the United States (&#x201c;GAAP&#x201d;) for interim financial information. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. In the opinion of management, these condensed consolidated financial statements include all adjustments necessary for a fair presentation of the results for the interim periods. The Company has consolidated all of its majority owned subsidiaries and entities over which it has control. All intercompany balances and transactions have been eliminated as part of the consolidation.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180MC9mcmFnOjI5OGNlZTNhOTFhNjQ3ZmY5ZDVmM2Q1YjVkZmQwMjUyL3RleHRyZWdpb246Mjk4Y2VlM2E5MWE2NDdmZjlkNWYzZDViNWRmZDAyNTJfMTU4OA_8d33b4fc-7196-4df3-9ed7-03efd99e5870">These condensed consolidated financial statements and the accompanying notes are unaudited and should be read in conjunction with the consolidated financial statements and notes thereto for the fiscal year ended 2022 included in the Company&#x2019;s Annual Report on Form 10-K, which was filed with the SEC on November&#160;18, 2022.</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:SubsequentEventsPolicyPolicyTextBlock
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180MC9mcmFnOjI5OGNlZTNhOTFhNjQ3ZmY5ZDVmM2Q1YjVkZmQwMjUyL3RleHRyZWdpb246Mjk4Y2VlM2E5MWE2NDdmZjlkNWYzZDViNWRmZDAyNTJfMTU4Mw_dbcd66ff-4359-4ffd-b954-0700cf478f8c">The Company considers events or transactions that occur after the balance sheet date, but before the financial statements are issued, to provide additional evidence relative to certain estimates or to identify matters that require additional disclosures.</us-gaap:SubsequentEventsPolicyPolicyTextBlock>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180MC9mcmFnOjI5OGNlZTNhOTFhNjQ3ZmY5ZDVmM2Q1YjVkZmQwMjUyL3RleHRyZWdpb246Mjk4Y2VlM2E5MWE2NDdmZjlkNWYzZDViNWRmZDAyNTJfOTM0NTg0ODgzODM4MQ_84cdbe46-adf7-4b2a-ac1c-ea676e1147e0">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Reclassification of Prior Period Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Certain prior period amounts in the notes to the condensed consolidated financial statements have had a change in presentation to conform to current period presentation. This change does not affect previously reported results.&lt;/span&gt;&lt;/div&gt;</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RleHRyZWdpb246ZjFhODQ2MDcxZDA4NGNkY2IyMWMxMTc1YjI5NWYyNDFfMjE1Mzc_5d4311e1-bc48-434d-b288-2d3a71644b6b">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Segment Reporting&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company has two reportable operating segments; (i) Medical and (ii) Industrial, which aligns with how its Chief Executive Officer, who is the Company's Chief Operating Decision Maker (&#x201c;CODM&#x201d;), reviews the Company&#x2019;s performance. See Note 15, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Segment Information&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for further information on the Company&#x2019;s segments.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RleHRyZWdpb246ZjFhODQ2MDcxZDA4NGNkY2IyMWMxMTc1YjI5NWYyNDFfNDA_6636752e-3112-432a-92f5-3ad61bf94061"
      unitRef="segment">2</us-gaap:NumberOfOperatingSegments>
    <us-gaap:FiscalPeriod
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RleHRyZWdpb246ZjFhODQ2MDcxZDA4NGNkY2IyMWMxMTc1YjI5NWYyNDFfMjE1Mjg_7d229a59-ac21-4947-a7c6-1e2f9e10894a">Fiscal Year&#160;&#160;&#160;&#160;The fiscal years of the Company as reported are the 52 or 53-week period ending on the Friday nearest September&#160;30. Fiscal year 2023 is the 52-week period ending September&#160;29, 2023. Fiscal year 2022 was the 52-week period that ended on September&#160;30, 2022. The fiscal quarters ended&#160;December&#160;30, 2022 and&#160;December&#160;31, 2021&#160;were both 13-week periods.</us-gaap:FiscalPeriod>
    <us-gaap:UseOfEstimates
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RleHRyZWdpb246ZjFhODQ2MDcxZDA4NGNkY2IyMWMxMTc1YjI5NWYyNDFfMjE1NzQ_76775abe-519a-4020-ba7e-7aad13429d6f">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. Such estimates include the valuation of inventories, valuation of goodwill and intangible assets, warranties, contract liabilities, long-lived asset valuations, impairment of investments, valuation of financial instruments, and taxes on income. Actual results could differ from these estimates.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RleHRyZWdpb246ZjFhODQ2MDcxZDA4NGNkY2IyMWMxMTc1YjI5NWYyNDFfMjE1Njc_b138cffc-2223-4f2f-96d8-fabcbae34beb">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company considers unrestricted currency on hand, demand deposits, time deposits and all highly-liquid investments with an original maturity of three months or less at the date of purchase to be cash and cash equivalents. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restricted Cash&lt;/span&gt;&lt;/div&gt;&#160;&#160;&#160;&#160;Restricted cash primarily consists of cash collateral related to certain leases and inventory arrangements. Restricted cash is included in other assets on the Company's Condensed Consolidated Balance Sheets.</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RleHRyZWdpb246ZjFhODQ2MDcxZDA4NGNkY2IyMWMxMTc1YjI5NWYyNDFfMjE1MzI_397f4120-30de-4c90-ad3d-0b14431b030f">Cash and cash equivalents and restricted cash as reported within the Condensed Consolidated Statements of Cash Flows consisted of the following:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.650%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.650%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.650%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.652%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Beginning of Period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;End of Period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Beginning of Period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;End of Period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;89.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;81.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;144.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;157.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total as presented in the Condensed Consolidated Statements of Cash Flows&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;90.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;82.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;146.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;159.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock>
    <us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RleHRyZWdpb246ZjFhODQ2MDcxZDA4NGNkY2IyMWMxMTc1YjI5NWYyNDFfMjE1MzI_6d0738fe-b005-4196-ba38-ebff57cd7fa3">Cash and cash equivalents and restricted cash as reported within the Condensed Consolidated Statements of Cash Flows consisted of the following:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.650%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.650%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.650%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.652%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Beginning of Period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;End of Period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Beginning of Period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;End of Period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;89.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;81.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;144.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;157.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total as presented in the Condensed Consolidated Statements of Cash Flows&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;90.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;82.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;146.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;159.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RhYmxlOmE3NGE4OGVlMDNjYTQzODNiYmRhMWMwNzY2NWVhZWVjL3RhYmxlcmFuZ2U6YTc0YTg4ZWUwM2NhNDM4M2JiZGExYzA3NjY1ZWFlZWNfMy0xLTEtMS04MzI4NQ_b8f2be5c-d31e-403c-85d1-8c686cf455e3"
      unitRef="usd">89400000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RhYmxlOmE3NGE4OGVlMDNjYTQzODNiYmRhMWMwNzY2NWVhZWVjL3RhYmxlcmFuZ2U6YTc0YTg4ZWUwM2NhNDM4M2JiZGExYzA3NjY1ZWFlZWNfMy0zLTEtMS04MzI4NQ_b3d2e81f-df35-4594-bf2b-7778f846c1b4"
      unitRef="usd">81500000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i504e59968786494c96b1e46f5375a17d_I20211001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RhYmxlOmE3NGE4OGVlMDNjYTQzODNiYmRhMWMwNzY2NWVhZWVjL3RhYmxlcmFuZ2U6YTc0YTg4ZWUwM2NhNDM4M2JiZGExYzA3NjY1ZWFlZWNfMy01LTEtMS04MzI4NQ_4ac586f9-9ce6-43f0-92ca-3240f9c5b976"
      unitRef="usd">144600000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i4026880a25c245b7ae7af90aa89cf31c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RhYmxlOmE3NGE4OGVlMDNjYTQzODNiYmRhMWMwNzY2NWVhZWVjL3RhYmxlcmFuZ2U6YTc0YTg4ZWUwM2NhNDM4M2JiZGExYzA3NjY1ZWFlZWNfMy03LTEtMS04MzI4NQ_2c11085f-8809-43c0-97f8-22db39fad4e3"
      unitRef="usd">157800000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCash
      contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RhYmxlOmE3NGE4OGVlMDNjYTQzODNiYmRhMWMwNzY2NWVhZWVjL3RhYmxlcmFuZ2U6YTc0YTg4ZWUwM2NhNDM4M2JiZGExYzA3NjY1ZWFlZWNfNC0xLTEtMS04MzI4NQ_8827d241-f336-4b94-89a8-f29a260a30bd"
      unitRef="usd">1200000</us-gaap:RestrictedCash>
    <us-gaap:RestrictedCash
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RhYmxlOmE3NGE4OGVlMDNjYTQzODNiYmRhMWMwNzY2NWVhZWVjL3RhYmxlcmFuZ2U6YTc0YTg4ZWUwM2NhNDM4M2JiZGExYzA3NjY1ZWFlZWNfNC0zLTEtMS04MzI4NQ_0ee203c3-b034-48dc-a992-2016e3049495"
      unitRef="usd">1300000</us-gaap:RestrictedCash>
    <us-gaap:RestrictedCash
      contextRef="i504e59968786494c96b1e46f5375a17d_I20211001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RhYmxlOmE3NGE4OGVlMDNjYTQzODNiYmRhMWMwNzY2NWVhZWVjL3RhYmxlcmFuZ2U6YTc0YTg4ZWUwM2NhNDM4M2JiZGExYzA3NjY1ZWFlZWNfNC01LTEtMS04MzI4NQ_6fc4ebcf-ec48-43f0-9fc7-1214bd181c92"
      unitRef="usd">1500000</us-gaap:RestrictedCash>
    <us-gaap:RestrictedCash
      contextRef="i4026880a25c245b7ae7af90aa89cf31c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RhYmxlOmE3NGE4OGVlMDNjYTQzODNiYmRhMWMwNzY2NWVhZWVjL3RhYmxlcmFuZ2U6YTc0YTg4ZWUwM2NhNDM4M2JiZGExYzA3NjY1ZWFlZWNfNC03LTEtMS04MzI4NQ_a03b4e41-fbf0-483e-96b3-dc527aa123ee"
      unitRef="usd">1400000</us-gaap:RestrictedCash>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RhYmxlOmE3NGE4OGVlMDNjYTQzODNiYmRhMWMwNzY2NWVhZWVjL3RhYmxlcmFuZ2U6YTc0YTg4ZWUwM2NhNDM4M2JiZGExYzA3NjY1ZWFlZWNfNS0xLTEtMS04MzI4NQ_58111cb2-d3b2-4f4d-97d5-e79bb065592e"
      unitRef="usd">90600000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RhYmxlOmE3NGE4OGVlMDNjYTQzODNiYmRhMWMwNzY2NWVhZWVjL3RhYmxlcmFuZ2U6YTc0YTg4ZWUwM2NhNDM4M2JiZGExYzA3NjY1ZWFlZWNfNS0zLTEtMS04MzI4NQ_75a863c3-0779-48a4-bb92-6519d0053f6a"
      unitRef="usd">82800000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i504e59968786494c96b1e46f5375a17d_I20211001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RhYmxlOmE3NGE4OGVlMDNjYTQzODNiYmRhMWMwNzY2NWVhZWVjL3RhYmxlcmFuZ2U6YTc0YTg4ZWUwM2NhNDM4M2JiZGExYzA3NjY1ZWFlZWNfNS01LTEtMS04MzI4NQ_ab4ee12d-26d9-4167-bb75-3801ce20add0"
      unitRef="usd">146100000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i4026880a25c245b7ae7af90aa89cf31c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RhYmxlOmE3NGE4OGVlMDNjYTQzODNiYmRhMWMwNzY2NWVhZWVjL3RhYmxlcmFuZ2U6YTc0YTg4ZWUwM2NhNDM4M2JiZGExYzA3NjY1ZWFlZWNfNS03LTEtMS04MzI4NQ_909a8db2-0467-49d9-9865-9f57f7b8c38f"
      unitRef="usd">159200000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:ConcentrationRiskCreditRisk
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RleHRyZWdpb246ZjFhODQ2MDcxZDA4NGNkY2IyMWMxMTc1YjI5NWYyNDFfMjE1NTU_e126c8e4-6b3c-47c6-9e6a-7f64d4b63bfc">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Concentration of Risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Financial instruments that potentially expose the Company to concentrations of credit risk consist principally of cash, cash equivalents, marketable securities, certificates of deposit, and trade accounts receivable. Cash held with financial institutions may exceed the Federal Deposit Insurance Corporation insurance limits or similar limits in foreign jurisdictions. To date, the Company has not realized any losses on its deposits of cash and cash equivalents. The Company performs ongoing credit evaluations of its customers and, except for government tenders, group purchases and orders with a letter of credit, its industrial customers often provide a down payment. The Company maintains an allowance for credit losses based upon the expected collectability of all accounts receivable. The Company obtains some of the components in its products from a limited group of suppliers or from a single-source supplier. When these suppliers are unable to meet the Company's supply needs, the Company's production is negatively impacted. &lt;/span&gt;&lt;/div&gt;&#160;&#160;&#160;&#160;Credit is extended to customers based on an evaluation of the customer&#x2019;s financial condition, and collateral is not required. In certain circumstances, a customer may be required to prepay all or a portion of the contract price prior to transfer of control.</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RleHRyZWdpb246ZjFhODQ2MDcxZDA4NGNkY2IyMWMxMTc1YjI5NWYyNDFfMjE1NDY_c5b36b09-cd2d-4e2f-907e-076e260e198a">During the periods presented, one of the Company's customers accounted for a significant portion of revenues, as set forth below:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Canon Medical Systems Corporation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i651cc3561a6c40d9a9e385495456c274_D20221001-20221230"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RhYmxlOjA5OTllMDE3OTk4MTRiZGI5MGRmZjVkNDBiOGM1NTIwL3RhYmxlcmFuZ2U6MDk5OWUwMTc5OTgxNGJkYjkwZGZmNWQ0MGI4YzU1MjBfMi0xLTEtMS04MzI4NQ_1db36e17-fb9f-44cc-a792-46aa5428eb49"
      unitRef="number">0.201</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i288802e63c324225b21fea1834e54841_D20211002-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RhYmxlOjA5OTllMDE3OTk4MTRiZGI5MGRmZjVkNDBiOGM1NTIwL3RhYmxlcmFuZ2U6MDk5OWUwMTc5OTgxNGJkYjkwZGZmNWQ0MGI4YzU1MjBfMi0zLTEtMS04MzI4NQ_cdd8b59d-5ebd-4b9c-bb4e-112377f19731"
      unitRef="number">0.192</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i0048ce751bf94b37a1dd1afdc4bea06a_D20221001-20221230"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RleHRyZWdpb246ZjFhODQ2MDcxZDA4NGNkY2IyMWMxMTc1YjI5NWYyNDFfNTgwNg_fbde0fcd-7034-4032-ba33-290ebd20bc9d"
      unitRef="number">0.092</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i59fa34d2d760449bbe1edc7c303eea6d_D20211002-20220930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RleHRyZWdpb246ZjFhODQ2MDcxZDA4NGNkY2IyMWMxMTc1YjI5NWYyNDFfNTgxMw_74a21404-54cf-49a1-9284-ef4ca6582dc6"
      unitRef="number">0.103</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:InvestmentPolicyTextBlock
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RleHRyZWdpb246ZjFhODQ2MDcxZDA4NGNkY2IyMWMxMTc1YjI5NWYyNDFfMjE1NjI_f557d8b8-e964-4a25-9998-a4310790d64c">Investments&#160;&#160;&#160;&#160;The Company accounts for its equity investments in privately-held companies under the equity method of accounting if the Company has the ability to exercise significant influence in these investments. Distributions received from an equity method investment are classified using the&#160;cumulative earnings approach, which means that distributions up to the amount of cumulative equity in earnings recognized will be treated as returns on investment and classified as operating cash flows and those in excess of that amount will be treated as returns of investment and classified as investing cash flows. The Company reviews its equity investments in privately-held companies for impairment whenever events or changes in business circumstances are other than temporary and indicate that the carrying amount of the investments may not be fully recoverable. &lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Marketable Securities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company's marketable securities consist primarily of financial instruments such as U.S. treasury securities, U.S. agency obligations, corporate bonds, commercial paper, money market funds, and equity securities. The Company classifies marketable debt securities as available-for-sale at the time of purchase and reevaluates such classifications as of each balance sheet date. All marketable debt securities are recorded at estimated fair value. Any unrealized gains or losses for marketable debt securities are included in accumulated other comprehensive income within the Condensed Consolidated Balance Sheets. Marketable equity securities are stated at fair value as determined by the most recently traded price of each security at the balance sheet date. All unrealized gains and losses on equity securities are recorded as part of other expense, net in the Company's condensed consolidated financial statements. See Note 7, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for further details.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&#160;&#160;&#160;&#160;When the fair value of a marketable debt security declines below its amortized cost basis, any portion of that decline attributable to credit losses, to the extent expected to be nonrecoverable before the sale of the security, is recognized in the Condensed Consolidated Statements of Operations. When the fair value of a marketable debt security declines below its amortized cost basis due to changes in interest rates, such amounts are recorded in other comprehensive loss, and are recognized in the Condensed Consolidated Statements of Operations only if the Company sells or intends to sell the security before recovery of its cost basis. There were no credit losses related to marketable debt securities recorded during the three months ended December 30, 2022.</us-gaap:InvestmentPolicyTextBlock>
    <us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RleHRyZWdpb246ZjFhODQ2MDcxZDA4NGNkY2IyMWMxMTc1YjI5NWYyNDFfNjc4Mg_628f8187-d353-4378-a8ca-5436cb76354c"
      unitRef="usd">0</us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment>
    <us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RleHRyZWdpb246ZjFhODQ2MDcxZDA4NGNkY2IyMWMxMTc1YjI5NWYyNDFfNjc4Mg_7717b1da-0d42-456c-989f-7f696180cdf0"
      unitRef="usd">0</us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RleHRyZWdpb246ZjFhODQ2MDcxZDA4NGNkY2IyMWMxMTc1YjI5NWYyNDFfODA2OA_6854fb74-cbdb-4845-9cf6-5e348f7c36d5"
      unitRef="usd">0</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:CommitmentsAndContingenciesPolicyTextBlock
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RleHRyZWdpb246ZjFhODQ2MDcxZDA4NGNkY2IyMWMxMTc1YjI5NWYyNDFfMjE1MTc_5ebbce35-e841-4f9d-9d01-15e465cac5de">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Loss Contingencies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;From time to time, the Company is involved in legal proceedings, claims and government inspections or investigations, customs and duties audits, other contingency matters, both inside and outside the United States, arising in the ordinary course of its business or otherwise.&#160;The Company accrues amounts for probable losses, to the extent they can be reasonably estimated, that it believes are adequate to address any liabilities related to legal proceedings and other loss contingencies that the Company believes will result in a probable loss (including, among other things, probable settlement value).&#160;A loss or a range of loss is disclosed when it is reasonably possible that a material loss will be incurred and can be estimated or when it is reasonably possible that the amount of a loss, when material, will exceed the recorded provision. When a loss contingency is probable but not reasonably estimable the nature of the contingency and the fact that an estimate cannot be made is disclosed.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesPolicyTextBlock>
    <us-gaap:StandardProductWarrantyPolicy
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RleHRyZWdpb246ZjFhODQ2MDcxZDA4NGNkY2IyMWMxMTc1YjI5NWYyNDFfMjE1NDQ_ea66070d-9b61-4327-abf3-a90a6da4d517">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Product Warranty&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company warrants most of its products for a specific period of time, usually 12 to 24 months from delivery or acceptance, against material defects. The Company provides for the estimated future costs of warranty obligations in cost of revenues when the related revenues are recognized. The accrued warranty costs represent the best estimate at the time of sale of the total costs that the Company will incur to repair or replace product parts that fail while still under warranty.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The amount of the accrued estimated warranty costs obligation for established products is primarily based on historical experience of product failures, adjusted for current information on repair costs.&#160;For new products, estimates include the historical experience of similar products, as well as a reasonable allowance for warranty expenses associated with new products.&#160;On a quarterly basis, the Company reviews the accrued warranty costs and updates the historical warranty cost trends, if required.&lt;/span&gt;&lt;/div&gt;</us-gaap:StandardProductWarrantyPolicy>
    <var:WarrantyTerm
      contextRef="i67803683b0344dc78ee5545d3907c730_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RleHRyZWdpb246ZjFhODQ2MDcxZDA4NGNkY2IyMWMxMTc1YjI5NWYyNDFfOTI2NA_e961ecd3-973b-4056-bbf4-fc1eb239e45a">P12M</var:WarrantyTerm>
    <var:WarrantyTerm
      contextRef="idd5d9702aa2d44ef9138ad61434eaa2a_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RleHRyZWdpb246ZjFhODQ2MDcxZDA4NGNkY2IyMWMxMTc1YjI5NWYyNDFfOTI3MA_ea015fbb-3a01-4d26-abbf-b553767ac08d">P24M</var:WarrantyTerm>
    <us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RleHRyZWdpb246ZjFhODQ2MDcxZDA4NGNkY2IyMWMxMTc1YjI5NWYyNDFfMjE1NjQ_b3130c42-5d26-4042-8476-009043399b59">The following table reflects the changes in the Company&#x2019;s accrued product warranty:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued product warranty, at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;New accruals charged to cost of revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Product warranty expenditures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued product warranty, at end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock>
    <us-gaap:StandardProductWarrantyAccrual
      contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RhYmxlOjc3ZjM0OTFkYzY3MTQwNDU5M2UwYzBkN2NhMThkZTkxL3RhYmxlcmFuZ2U6NzdmMzQ5MWRjNjcxNDA0NTkzZTBjMGQ3Y2ExOGRlOTFfMi0xLTEtMS04MzI4NQ_99df5871-ad26-442e-8468-9e297e8cabe3"
      unitRef="usd">7900000</us-gaap:StandardProductWarrantyAccrual>
    <us-gaap:StandardProductWarrantyAccrual
      contextRef="i504e59968786494c96b1e46f5375a17d_I20211001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RhYmxlOjc3ZjM0OTFkYzY3MTQwNDU5M2UwYzBkN2NhMThkZTkxL3RhYmxlcmFuZ2U6NzdmMzQ5MWRjNjcxNDA0NTkzZTBjMGQ3Y2ExOGRlOTFfMi0zLTEtMS04MzI4NQ_c79ac9f1-60a6-4490-8a7f-894945cd05f0"
      unitRef="usd">8500000</us-gaap:StandardProductWarrantyAccrual>
    <us-gaap:StandardProductWarrantyAccrualWarrantiesIssued
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RhYmxlOjc3ZjM0OTFkYzY3MTQwNDU5M2UwYzBkN2NhMThkZTkxL3RhYmxlcmFuZ2U6NzdmMzQ5MWRjNjcxNDA0NTkzZTBjMGQ3Y2ExOGRlOTFfMy0xLTEtMS04MzI4NQ_79400634-33a5-48d8-8488-b78703024dd6"
      unitRef="usd">2800000</us-gaap:StandardProductWarrantyAccrualWarrantiesIssued>
    <us-gaap:StandardProductWarrantyAccrualWarrantiesIssued
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RhYmxlOjc3ZjM0OTFkYzY3MTQwNDU5M2UwYzBkN2NhMThkZTkxL3RhYmxlcmFuZ2U6NzdmMzQ5MWRjNjcxNDA0NTkzZTBjMGQ3Y2ExOGRlOTFfMy0zLTEtMS04MzI4NQ_db6f7293-49f7-46b0-a6e7-d26816346e01"
      unitRef="usd">1200000</us-gaap:StandardProductWarrantyAccrualWarrantiesIssued>
    <us-gaap:StandardProductWarrantyAccrualPayments
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RhYmxlOjc3ZjM0OTFkYzY3MTQwNDU5M2UwYzBkN2NhMThkZTkxL3RhYmxlcmFuZ2U6NzdmMzQ5MWRjNjcxNDA0NTkzZTBjMGQ3Y2ExOGRlOTFfNC0xLTEtMS04MzI4NQ_113d384c-b40f-4de3-b44c-5fc99dc3db90"
      unitRef="usd">3000000.0</us-gaap:StandardProductWarrantyAccrualPayments>
    <us-gaap:StandardProductWarrantyAccrualPayments
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RhYmxlOjc3ZjM0OTFkYzY3MTQwNDU5M2UwYzBkN2NhMThkZTkxL3RhYmxlcmFuZ2U6NzdmMzQ5MWRjNjcxNDA0NTkzZTBjMGQ3Y2ExOGRlOTFfNC0zLTEtMS04MzI4NQ_b51d1b39-daf5-474b-b0c1-b49d9e36c2d3"
      unitRef="usd">2500000</us-gaap:StandardProductWarrantyAccrualPayments>
    <us-gaap:StandardProductWarrantyAccrual
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RhYmxlOjc3ZjM0OTFkYzY3MTQwNDU5M2UwYzBkN2NhMThkZTkxL3RhYmxlcmFuZ2U6NzdmMzQ5MWRjNjcxNDA0NTkzZTBjMGQ3Y2ExOGRlOTFfNS0xLTEtMS04MzI4NQ_7d510fdc-7bd1-4628-86d0-2ee131a6d6d5"
      unitRef="usd">7700000</us-gaap:StandardProductWarrantyAccrual>
    <us-gaap:StandardProductWarrantyAccrual
      contextRef="i4026880a25c245b7ae7af90aa89cf31c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RhYmxlOjc3ZjM0OTFkYzY3MTQwNDU5M2UwYzBkN2NhMThkZTkxL3RhYmxlcmFuZ2U6NzdmMzQ5MWRjNjcxNDA0NTkzZTBjMGQ3Y2ExOGRlOTFfNS0zLTEtMS04MzI4NQ_c39deac5-5d0f-4034-bfff-d6f16e5e19a9"
      unitRef="usd">7200000</us-gaap:StandardProductWarrantyAccrual>
    <us-gaap:LesseeLeasesPolicyTextBlock
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RleHRyZWdpb246ZjFhODQ2MDcxZDA4NGNkY2IyMWMxMTc1YjI5NWYyNDFfMjE1NTY_4e1e6b13-8015-457b-9ac9-228196039b6b">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company determines if an arrangement is or contains a lease at the inception of an arrangement. The Company's operating lease right-of-use ("ROU") assets represent the right to use an underlying asset over the lease term and lease liabilities represent its obligation to make lease payments arising from the lease. ROU assets may also include initial direct costs incurred and prepaid lease payments, less lease incentives. Lease liabilities and their corresponding ROU assets are recognized based on the present value of lease payments over the lease term, discounted using the Company's incremental borrowing rate. The Company recognizes operating leases with lease terms of more than twelve months in operating lease assets, current operating lease liabilities, and operating lease liabilities on its Condensed Consolidated Balance Sheets. The Company recognizes finance leases with lease terms of more than twelve months in property, plant, and equipment, net, accrued liabilities and other current liabilities, and other long-term liabilities on its Condensed Consolidated Balance Sheets. For purposes of calculating lease liabilities and the corresponding ROU assets, the Company's lease term may include options to extend or terminate the lease when it is reasonably certain that it will exercise that option.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RleHRyZWdpb246ZjFhODQ2MDcxZDA4NGNkY2IyMWMxMTc1YjI5NWYyNDFfMjE1MzA_f48e256f-7ef2-4c23-ba11-7446f6b5e820">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company&#x2019;s revenues are derived primarily from the sale of hardware and services. The Company recognizes its revenues net of any value-added or sales tax and net of sales discounts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company sells a high proportion of its X-ray products to a limited number of OEM customers. X-ray imaging components including X-ray tubes, digital detectors and image-processing tools and security and inspection products are generally sold on a stand-alone basis. However, the Company occasionally sells its digital detectors, X-ray tubes and imaging processing tools as a package that is optimized for digital X-ray imaging and sells its Linatron&#xae; X-ray linear accelerators together with its image processing software and image detection products to OEM customers that incorporate them into their inspection or irradiation systems and processes. Service contracts are often sold with certain security and inspection products and computer-aided detection products.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company determines revenue recognition through the following steps:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:63pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Identification of the contract, or contracts, with a customer&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:63pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Identification of the performance obligations in the contract&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:63pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Determination of the transaction price&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:63pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Allocation of the transaction price to the performance obligations in the contract&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:63pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Recognition of revenue when, or as, a performance obligation is satisfied&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Transaction Price and Allocation to Performance Obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Transaction prices of products or services are typically based on contracted rates. To the extent that the transaction price includes variable consideration, the Company estimates the amount of variable consideration that should be included in the transaction price utilizing the expected value method when there is a large number of transactions with similar characteristics or the most likely amount method when there are two possible outcomes, depending on the circumstances of the transaction, to which the Company expects to be entitled. Variable consideration is included in the transaction price if, in the Company&#x2019;s judgment, it is probable that a significant future reversal of cumulative revenue under the contract will not occur. Estimates of variable consideration and determination of whether to include estimated amounts in the transaction price are based largely on an assessment of the Company&#x2019;s anticipated performance and all information (historical, current, and forecasted) that is reasonably available.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company allows customers to return specific parts of purchased X-ray tubes for a partial refund credit, which is identified as variable consideration. For sales with a right of return, revenue is reduced for expected returns, a liability is recorded for expected returns, and an asset is recorded for the right to recover products from customers on settling the liability. The Company recognizes a reduction to revenue and cost of sales at the time of sale and a corresponding contract liability and contract asset. The Company records this estimate based on the historical volume of product returns and adjusts the estimate on a quarterly basis based on the current quarter sales and current quarter returns.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;If a contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. Contracts that contain multiple performance obligations require an allocation of the transaction price based on the estimated relative standalone selling prices of the promised products or services underlying each performance obligation. The Company determines standalone selling prices based on the price at which the performance obligation could be sold separately.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contracts and Performance Obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company accounts for a contract with a customer when there is an approval and commitment from both parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and collectability of the consideration is probable. The Company's performance obligations consist mainly of transferring control of products and services identified in the contracts or purchase orders. For each contract, the Company considers the obligation to transfer products and services to the customer, which are distinct, to be performance obligations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recognition of Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Revenue is recognized when, or as, obligations under the terms of a contract are satisfied, which occurs when control of the promised products or services is transferred to customers. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring products or services to a customer.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Product revenue is generally recognized when the customer obtains control of the Company&#x2019;s product, which occurs at a point in time, and may be upon shipment or upon delivery based on the contractual shipping terms of a contract.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Service revenue is generally recognized over the term of the service contract. Services are expected to be transferred to the customer throughout the term of the contract, and the Company believes recognizing revenue ratably over the term of the contract best depicts the transfer of value to the customer.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Disaggregation of Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Revenue is disaggregated from contracts between geography and by reportable operating segment, which the Company believes best depicts how the nature, amount, timing, and uncertainty of revenues and cash flows are affected by economic factors. Refer to Note 15, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Segment Information, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;included in this report, for the disaggregation of the Company&#x2019;s revenue based on reportable operating segments and Note 2, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for the disaggregation of revenue by geographic region.&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contract Balances&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Contract assets are included within the prepaid expenses and other current assets, and other assets balances in the Condensed Consolidated Balance Sheets. Contract liabilities, which includes refund liabilities and deferred revenue, are included within the accrued liabilities and other current liabilities, deferred revenues, and other long-term liabilities balances in the Condensed Consolidated Balance Sheets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Deferred revenue represents the Company's obligation to transfer goods and/or services to its customers for which it has already received consideration (or the amount is due) from the customer. The Company's deferred revenue balance primarily relates to contract advances and billings for warranty contracts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Deferred revenue that is estimated to be recognized during the following twelve-month period is recorded as deferred revenues and the remaining portion is recorded as other long-term liabilities in the Condensed Consolidated Balance Sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Costs to Obtain or Fulfill a Customer Contract&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company has certain costs to obtain and fulfill a customer contract, such as commissions and shipping costs. The Company recognizes the incremental costs of obtaining contracts as an expense when incurred if the amortization period of the assets that the Company otherwise would have recognized is one year or less. Incremental costs of obtaining contracts that would be recognized over more than one year are not material. The Company accounts for shipping and handling activities related to contracts with customers as costs to fulfill the promise to transfer the associated products. These costs are included as a component of cost of revenues.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RleHRyZWdpb246ZjFhODQ2MDcxZDA4NGNkY2IyMWMxMTc1YjI5NWYyNDFfMjE1NjU_42721955-9b2a-4f6c-be92-44103b733b4a">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In August 2020, the Financial Accounting Standards Board issued Accounting Standard Update ("ASU") 2020-06, Accounting for Convertible Instruments and Contracts in an Entity&#x2019;s Own Equity. The standard removed certain separation models in ASC 470-20 for convertible instruments, and, as a result, embedded conversion features are no longer separated from the host contract for convertible instruments with conversion features that are not required to be accounted for as derivatives under ASC 815. These convertible debt instruments are accounted for as a single liability measured at amortized cost. This results in the interest expense recognized for convertible debt instruments to be typically closer to the coupon interest rate. Further, the ASU made amendments to the earnings per share (&#x201c;EPS&#x201d;) guidance in Topic 260 for convertible instruments, the most significant impact of which was requiring the use of the if-converted method for diluted EPS calculation, and no longer allowing the net share settlement method. The Company adopted this ASU on October 1, 2022, using the modified retrospective method. On the date of adoption, the Company recorded an entry to reduce additional paid-in capital by $34.6&#160;million, increase long-term debt, net by $28.0&#160;million, decrease deferred tax assets by $0.1&#160;million, and increase retained earnings by $6.5&#160;million for the after-tax impact of previously recognized amortization of the debt discount associated with the Company&#x2019;s Convertible Notes (as defined herein). The unamortized discount on the Company's Convertible Notes (see Note 10, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Borrowings&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) was derecognized in the first quarter of fiscal year 2023 and the interest expense from its Convertible Notes decreased and became closer to the coupon rate of 4.00%. The impact that the adoption of ASU 2020-06 has on the Company's net income per diluted share will depend on the amount of earnings in each period and the Company's share price and could result in additional dilution.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i5d4da637b0cb434892a6570db3bf836d_I20221001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RleHRyZWdpb246ZjFhODQ2MDcxZDA4NGNkY2IyMWMxMTc1YjI5NWYyNDFfNTQ5NzU1ODg4MTcx_4c75f41b-389e-41f2-a1b6-8fbf96d932f3"
      unitRef="usd">-34600000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i5d4da637b0cb434892a6570db3bf836d_I20221001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RleHRyZWdpb246ZjFhODQ2MDcxZDA4NGNkY2IyMWMxMTc1YjI5NWYyNDFfNTQ5NzU1ODg4MjA0_460a56bf-9e5f-4af1-8834-183b7f28fe36"
      unitRef="usd">28000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i5d4da637b0cb434892a6570db3bf836d_I20221001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RleHRyZWdpb246ZjFhODQ2MDcxZDA4NGNkY2IyMWMxMTc1YjI5NWYyNDFfNTQ5NzU1ODg4MjM2_7ed2abf6-ada8-4ac8-ba4f-35ace2095021"
      unitRef="usd">100000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i5d4da637b0cb434892a6570db3bf836d_I20221001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RleHRyZWdpb246ZjFhODQ2MDcxZDA4NGNkY2IyMWMxMTc1YjI5NWYyNDFfNTQ5NzU1ODg4MzAy_a2912c84-61eb-4c48-b4b4-e47d406743be"
      unitRef="usd">6500000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic8c656c39e5948888cffc7883844bcb7_I20221230"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180My9mcmFnOmYxYTg0NjA3MWQwODRjZGNiMjFjMTE3NWIyOTVmMjQxL3RleHRyZWdpb246ZjFhODQ2MDcxZDA4NGNkY2IyMWMxMTc1YjI5NWYyNDFfNTQ5NzU1ODg1OTM2_f51d9a6f-b5c6-4120-a405-26f6bfdf2ec4"
      unitRef="number">0.0400</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180Ni9mcmFnOjJhYzJkNGViZGI4ZDRmNjk5ZGJiZDdmNmRlMDQ4MjdhL3RleHRyZWdpb246MmFjMmQ0ZWJkYjhkNGY2OTlkYmJkN2Y2ZGUwNDgyN2FfOTg1_fe24d534-af54-4337-b901-5cd37dc48671">REVENUE&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Disaggregation of Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Revenue is disaggregated from contracts by geographic region and by reportable operating segment, which the Company believes best depicts how the nature, amount, timing, and uncertainty of revenues and cash flows are affected by economic factors.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The following table disaggregates the Company&#x2019;s revenue by geographic region:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Americas&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;74.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;EMEA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;64.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;67.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;APAC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;66.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;205.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;198.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Revenue in the United States was $74.1 million and $58.8 million for the three months ended December 30, 2022 and December&#160;31, 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Our products are sold in three geographic regions: the Americas, EMEA, and APAC. The Americas includes North America (primarily the United States) and Latin America. EMEA includes Europe, Russia, the Middle East, India and Africa. APAC includes Asia (other than India) and Australia. Revenues by region are based on the known final destination of products sold.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Refer to Note 15, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Segment Information&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for the disaggregation of the Company&#x2019;s revenue based on reportable operating segments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contract Balances&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The following table summarizes the changes in the contract assets and refund liabilities for the three months ended December 30, 2022 and December&#160;31, 2021:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Contract Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Costs recovered from product returns during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contract asset from shipments of products, subject to return during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Refund Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Release of refund liability included in beginning of year refund liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Additions to refund liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;During the three months ended December 30, 2022, the Company recognized revenue of $4.2&#160;million related to deferred revenues which existed at September&#160;30, 2022. During the three months ended December&#160;31, 2021, the Company recognized revenue of $4.1&#160;million related to deferred revenues that existed at October&#160;1, 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180Ni9mcmFnOjJhYzJkNGViZGI4ZDRmNjk5ZGJiZDdmNmRlMDQ4MjdhL3RleHRyZWdpb246MmFjMmQ0ZWJkYjhkNGY2OTlkYmJkN2Y2ZGUwNDgyN2FfOTkx_8558eca7-2f5b-4311-876b-33dbee4b4b28">The following table disaggregates the Company&#x2019;s revenue by geographic region:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Americas&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;74.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;EMEA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;64.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;67.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;APAC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;66.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;205.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;198.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i77268675d9614be1856e94103b41aef3_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180Ni9mcmFnOjJhYzJkNGViZGI4ZDRmNjk5ZGJiZDdmNmRlMDQ4MjdhL3RhYmxlOmJiMWZlNGQ4MDAyMTQ1ZjJiYzk1OGNjY2YyYzM4ZGRmL3RhYmxlcmFuZ2U6YmIxZmU0ZDgwMDIxNDVmMmJjOTU4Y2NjZjJjMzhkZGZfMi0xLTEtMS04MzI4NQ_7435002d-9b43-46e8-b446-bb6c4859aec7"
      unitRef="usd">74800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib8a6b0f85dcb4a62be851b76f236b2a7_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180Ni9mcmFnOjJhYzJkNGViZGI4ZDRmNjk5ZGJiZDdmNmRlMDQ4MjdhL3RhYmxlOmJiMWZlNGQ4MDAyMTQ1ZjJiYzk1OGNjY2YyYzM4ZGRmL3RhYmxlcmFuZ2U6YmIxZmU0ZDgwMDIxNDVmMmJjOTU4Y2NjZjJjMzhkZGZfMi0zLTEtMS04MzI4NQ_eacc2fc9-bd5f-486c-9398-b1fbf33cc894"
      unitRef="usd">60500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i04bcd73d30e04bdb841e13dae6931b40_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180Ni9mcmFnOjJhYzJkNGViZGI4ZDRmNjk5ZGJiZDdmNmRlMDQ4MjdhL3RhYmxlOmJiMWZlNGQ4MDAyMTQ1ZjJiYzk1OGNjY2YyYzM4ZGRmL3RhYmxlcmFuZ2U6YmIxZmU0ZDgwMDIxNDVmMmJjOTU4Y2NjZjJjMzhkZGZfMy0xLTEtMS04MzI4NQ_1e57aaf3-f66a-4a19-bd6c-ae191faf6f71"
      unitRef="usd">64000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i41a6a4b942e94c2f93e0cfd38b7b56b9_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180Ni9mcmFnOjJhYzJkNGViZGI4ZDRmNjk5ZGJiZDdmNmRlMDQ4MjdhL3RhYmxlOmJiMWZlNGQ4MDAyMTQ1ZjJiYzk1OGNjY2YyYzM4ZGRmL3RhYmxlcmFuZ2U6YmIxZmU0ZDgwMDIxNDVmMmJjOTU4Y2NjZjJjMzhkZGZfMy0zLTEtMS04MzI4NQ_10bc7e47-66ab-4d6c-80da-28ed81eb64de"
      unitRef="usd">67400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia9142a51de834eb08ccfecaa6fcb247b_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180Ni9mcmFnOjJhYzJkNGViZGI4ZDRmNjk5ZGJiZDdmNmRlMDQ4MjdhL3RhYmxlOmJiMWZlNGQ4MDAyMTQ1ZjJiYzk1OGNjY2YyYzM4ZGRmL3RhYmxlcmFuZ2U6YmIxZmU0ZDgwMDIxNDVmMmJjOTU4Y2NjZjJjMzhkZGZfNC0xLTEtMS04MzI4NQ_9f255933-bb3f-4423-8cd5-a22f68c7e9c1"
      unitRef="usd">66800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5faba21f6b9a41c5961c60b0331ab68e_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180Ni9mcmFnOjJhYzJkNGViZGI4ZDRmNjk5ZGJiZDdmNmRlMDQ4MjdhL3RhYmxlOmJiMWZlNGQ4MDAyMTQ1ZjJiYzk1OGNjY2YyYzM4ZGRmL3RhYmxlcmFuZ2U6YmIxZmU0ZDgwMDIxNDVmMmJjOTU4Y2NjZjJjMzhkZGZfNC0zLTEtMS04MzI4NQ_8cdeb81f-dd5b-4f75-b836-2e6629bd21c4"
      unitRef="usd">70900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180Ni9mcmFnOjJhYzJkNGViZGI4ZDRmNjk5ZGJiZDdmNmRlMDQ4MjdhL3RhYmxlOmJiMWZlNGQ4MDAyMTQ1ZjJiYzk1OGNjY2YyYzM4ZGRmL3RhYmxlcmFuZ2U6YmIxZmU0ZDgwMDIxNDVmMmJjOTU4Y2NjZjJjMzhkZGZfNS0xLTEtMS04MzI4NQ_e69cc7c7-cb9e-4332-b382-88b7074687a2"
      unitRef="usd">205600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180Ni9mcmFnOjJhYzJkNGViZGI4ZDRmNjk5ZGJiZDdmNmRlMDQ4MjdhL3RhYmxlOmJiMWZlNGQ4MDAyMTQ1ZjJiYzk1OGNjY2YyYzM4ZGRmL3RhYmxlcmFuZ2U6YmIxZmU0ZDgwMDIxNDVmMmJjOTU4Y2NjZjJjMzhkZGZfNS0zLTEtMS04MzI4NQ_8fc809be-74f0-4eea-8e52-4833e1b4f715"
      unitRef="usd">198800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i582fbee024ae43e187bc82bf36e08c7f_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180Ni9mcmFnOjJhYzJkNGViZGI4ZDRmNjk5ZGJiZDdmNmRlMDQ4MjdhL3RleHRyZWdpb246MmFjMmQ0ZWJkYjhkNGY2OTlkYmJkN2Y2ZGUwNDgyN2FfNDA1_bbd66330-a3f5-4d46-8942-901961311ee3"
      unitRef="usd">74100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if0d5d3a41d6e46a8981e7b39df4c4005_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180Ni9mcmFnOjJhYzJkNGViZGI4ZDRmNjk5ZGJiZDdmNmRlMDQ4MjdhL3RleHRyZWdpb246MmFjMmQ0ZWJkYjhkNGY2OTlkYmJkN2Y2ZGUwNDgyN2FfNDEy_66f2576a-fa20-4d99-b307-219d07cc7f43"
      unitRef="usd">58800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180Ni9mcmFnOjJhYzJkNGViZGI4ZDRmNjk5ZGJiZDdmNmRlMDQ4MjdhL3RleHRyZWdpb246MmFjMmQ0ZWJkYjhkNGY2OTlkYmJkN2Y2ZGUwNDgyN2FfOTg3_a43adbcd-7568-4267-86bf-f3e5541309a8">The following table summarizes the changes in the contract assets and refund liabilities for the three months ended December 30, 2022 and December&#160;31, 2021:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Contract Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Costs recovered from product returns during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contract asset from shipments of products, subject to return during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Refund Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Release of refund liability included in beginning of year refund liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Additions to refund liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180Ni9mcmFnOjJhYzJkNGViZGI4ZDRmNjk5ZGJiZDdmNmRlMDQ4MjdhL3RhYmxlOjM3MmE2NGIzYmJlNjRlZTk4NjNjYzNlNjAyYzkwZDA1L3RhYmxlcmFuZ2U6MzcyYTY0YjNiYmU2NGVlOTg2M2NjM2U2MDJjOTBkMDVfMy0xLTEtMS04MzI4NQ_17c929a0-e281-4ce1-bec3-c0f0598cdcc4"
      unitRef="usd">25400000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="i504e59968786494c96b1e46f5375a17d_I20211001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180Ni9mcmFnOjJhYzJkNGViZGI4ZDRmNjk5ZGJiZDdmNmRlMDQ4MjdhL3RhYmxlOjM3MmE2NGIzYmJlNjRlZTk4NjNjYzNlNjAyYzkwZDA1L3RhYmxlcmFuZ2U6MzcyYTY0YjNiYmU2NGVlOTg2M2NjM2U2MDJjOTBkMDVfMy0zLTEtMS04MzI4NQ_ea3827f4-45e8-41a9-a8f6-4e2823bc2dee"
      unitRef="usd">24300000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetCreditLossExpense
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180Ni9mcmFnOjJhYzJkNGViZGI4ZDRmNjk5ZGJiZDdmNmRlMDQ4MjdhL3RhYmxlOjM3MmE2NGIzYmJlNjRlZTk4NjNjYzNlNjAyYzkwZDA1L3RhYmxlcmFuZ2U6MzcyYTY0YjNiYmU2NGVlOTg2M2NjM2U2MDJjOTBkMDVfNC0xLTEtMS04MzI4NQ_dbaf3766-3d13-4137-8ec7-5d4ea325e43e"
      unitRef="usd">1500000</us-gaap:ContractWithCustomerAssetCreditLossExpense>
    <us-gaap:ContractWithCustomerAssetCreditLossExpense
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180Ni9mcmFnOjJhYzJkNGViZGI4ZDRmNjk5ZGJiZDdmNmRlMDQ4MjdhL3RhYmxlOjM3MmE2NGIzYmJlNjRlZTk4NjNjYzNlNjAyYzkwZDA1L3RhYmxlcmFuZ2U6MzcyYTY0YjNiYmU2NGVlOTg2M2NjM2U2MDJjOTBkMDVfNC0zLTEtMS04MzI4NQ_cecd9a26-03aa-40a4-a4e7-91dfe66a9fcd"
      unitRef="usd">1500000</us-gaap:ContractWithCustomerAssetCreditLossExpense>
    <var:ContractwithCustomerAssetShipments
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180Ni9mcmFnOjJhYzJkNGViZGI4ZDRmNjk5ZGJiZDdmNmRlMDQ4MjdhL3RhYmxlOjM3MmE2NGIzYmJlNjRlZTk4NjNjYzNlNjAyYzkwZDA1L3RhYmxlcmFuZ2U6MzcyYTY0YjNiYmU2NGVlOTg2M2NjM2U2MDJjOTBkMDVfNS0xLTEtMS04MzI4NQ_5d7e0b9a-875b-4917-a377-17c684d48612"
      unitRef="usd">1500000</var:ContractwithCustomerAssetShipments>
    <var:ContractwithCustomerAssetShipments
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180Ni9mcmFnOjJhYzJkNGViZGI4ZDRmNjk5ZGJiZDdmNmRlMDQ4MjdhL3RhYmxlOjM3MmE2NGIzYmJlNjRlZTk4NjNjYzNlNjAyYzkwZDA1L3RhYmxlcmFuZ2U6MzcyYTY0YjNiYmU2NGVlOTg2M2NjM2U2MDJjOTBkMDVfNS0zLTEtMS04MzI4NQ_d23f7d9e-3c70-4599-9bbe-0561c75ad1a4"
      unitRef="usd">1800000</var:ContractwithCustomerAssetShipments>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180Ni9mcmFnOjJhYzJkNGViZGI4ZDRmNjk5ZGJiZDdmNmRlMDQ4MjdhL3RhYmxlOjM3MmE2NGIzYmJlNjRlZTk4NjNjYzNlNjAyYzkwZDA1L3RhYmxlcmFuZ2U6MzcyYTY0YjNiYmU2NGVlOTg2M2NjM2U2MDJjOTBkMDVfNy0xLTEtMS04MzI4NQ_a3c962e2-2f5b-411d-aa9a-6f8858a39125"
      unitRef="usd">25400000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="i4026880a25c245b7ae7af90aa89cf31c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180Ni9mcmFnOjJhYzJkNGViZGI4ZDRmNjk5ZGJiZDdmNmRlMDQ4MjdhL3RhYmxlOjM3MmE2NGIzYmJlNjRlZTk4NjNjYzNlNjAyYzkwZDA1L3RhYmxlcmFuZ2U6MzcyYTY0YjNiYmU2NGVlOTg2M2NjM2U2MDJjOTBkMDVfNy0zLTEtMS04MzI4NQ_46deaafa-78cf-4a3f-adce-ad6d1a60221c"
      unitRef="usd">24600000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerRefundLiability
      contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180Ni9mcmFnOjJhYzJkNGViZGI4ZDRmNjk5ZGJiZDdmNmRlMDQ4MjdhL3RhYmxlOjJiMmZhOTJhNjY1NjQxNjg5YTM4MmUyZDQ3Yzk0MjBiL3RhYmxlcmFuZ2U6MmIyZmE5MmE2NjU2NDE2ODlhMzgyZTJkNDdjOTQyMGJfMy0xLTEtMS04MzI4NQ_63858c17-6cf7-4f3a-9409-987aa49b0044"
      unitRef="usd">28200000</us-gaap:ContractWithCustomerRefundLiability>
    <us-gaap:ContractWithCustomerRefundLiability
      contextRef="i504e59968786494c96b1e46f5375a17d_I20211001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180Ni9mcmFnOjJhYzJkNGViZGI4ZDRmNjk5ZGJiZDdmNmRlMDQ4MjdhL3RhYmxlOjJiMmZhOTJhNjY1NjQxNjg5YTM4MmUyZDQ3Yzk0MjBiL3RhYmxlcmFuZ2U6MmIyZmE5MmE2NjU2NDE2ODlhMzgyZTJkNDdjOTQyMGJfMy0zLTEtMS04MzI4NQ_ed7e50e8-2e5b-4295-950b-42729f25e63f"
      unitRef="usd">27000000.0</us-gaap:ContractWithCustomerRefundLiability>
    <var:ContractWithCustomerRefundLiabilityAmountReleased
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180Ni9mcmFnOjJhYzJkNGViZGI4ZDRmNjk5ZGJiZDdmNmRlMDQ4MjdhL3RhYmxlOjJiMmZhOTJhNjY1NjQxNjg5YTM4MmUyZDQ3Yzk0MjBiL3RhYmxlcmFuZ2U6MmIyZmE5MmE2NjU2NDE2ODlhMzgyZTJkNDdjOTQyMGJfNC0xLTEtMS04MzI4NQ_9dc65808-3562-40e3-a1d5-6e84f29516e5"
      unitRef="usd">1600000</var:ContractWithCustomerRefundLiabilityAmountReleased>
    <var:ContractWithCustomerRefundLiabilityAmountReleased
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180Ni9mcmFnOjJhYzJkNGViZGI4ZDRmNjk5ZGJiZDdmNmRlMDQ4MjdhL3RhYmxlOjJiMmZhOTJhNjY1NjQxNjg5YTM4MmUyZDQ3Yzk0MjBiL3RhYmxlcmFuZ2U6MmIyZmE5MmE2NjU2NDE2ODlhMzgyZTJkNDdjOTQyMGJfNC0zLTEtMS04MzI4NQ_26e611f6-6360-41eb-8dc2-6ff7204dfc81"
      unitRef="usd">1600000</var:ContractWithCustomerRefundLiabilityAmountReleased>
    <var:ContractWithCustomerRefundLiabilityAdditions
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180Ni9mcmFnOjJhYzJkNGViZGI4ZDRmNjk5ZGJiZDdmNmRlMDQ4MjdhL3RhYmxlOjJiMmZhOTJhNjY1NjQxNjg5YTM4MmUyZDQ3Yzk0MjBiL3RhYmxlcmFuZ2U6MmIyZmE5MmE2NjU2NDE2ODlhMzgyZTJkNDdjOTQyMGJfNS0xLTEtMS04MzI4NQ_9a166b8c-50d1-423b-91db-29295fcc9baf"
      unitRef="usd">1700000</var:ContractWithCustomerRefundLiabilityAdditions>
    <var:ContractWithCustomerRefundLiabilityAdditions
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180Ni9mcmFnOjJhYzJkNGViZGI4ZDRmNjk5ZGJiZDdmNmRlMDQ4MjdhL3RhYmxlOjJiMmZhOTJhNjY1NjQxNjg5YTM4MmUyZDQ3Yzk0MjBiL3RhYmxlcmFuZ2U6MmIyZmE5MmE2NjU2NDE2ODlhMzgyZTJkNDdjOTQyMGJfNS0zLTEtMS04MzI4NQ_38e70ab1-8f8d-45ed-b3df-01b6fa7c3482"
      unitRef="usd">1900000</var:ContractWithCustomerRefundLiabilityAdditions>
    <us-gaap:ContractWithCustomerRefundLiability
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180Ni9mcmFnOjJhYzJkNGViZGI4ZDRmNjk5ZGJiZDdmNmRlMDQ4MjdhL3RhYmxlOjJiMmZhOTJhNjY1NjQxNjg5YTM4MmUyZDQ3Yzk0MjBiL3RhYmxlcmFuZ2U6MmIyZmE5MmE2NjU2NDE2ODlhMzgyZTJkNDdjOTQyMGJfNy0xLTEtMS04MzI4NQ_11a144b8-97ed-4d63-96e0-fd7bfe71e6c8"
      unitRef="usd">28300000</us-gaap:ContractWithCustomerRefundLiability>
    <us-gaap:ContractWithCustomerRefundLiability
      contextRef="i4026880a25c245b7ae7af90aa89cf31c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180Ni9mcmFnOjJhYzJkNGViZGI4ZDRmNjk5ZGJiZDdmNmRlMDQ4MjdhL3RhYmxlOjJiMmZhOTJhNjY1NjQxNjg5YTM4MmUyZDQ3Yzk0MjBiL3RhYmxlcmFuZ2U6MmIyZmE5MmE2NjU2NDE2ODlhMzgyZTJkNDdjOTQyMGJfNy0zLTEtMS04MzI4NQ_d7f06918-aca5-43c9-aee9-143aade72c51"
      unitRef="usd">27300000</us-gaap:ContractWithCustomerRefundLiability>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180Ni9mcmFnOjJhYzJkNGViZGI4ZDRmNjk5ZGJiZDdmNmRlMDQ4MjdhL3RleHRyZWdpb246MmFjMmQ0ZWJkYjhkNGY2OTlkYmJkN2Y2ZGUwNDgyN2FfODE2_da8e007f-ceb8-47ed-b2a7-3a68464f896a"
      unitRef="usd">4200000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180Ni9mcmFnOjJhYzJkNGViZGI4ZDRmNjk5ZGJiZDdmNmRlMDQ4MjdhL3RleHRyZWdpb246MmFjMmQ0ZWJkYjhkNGY2OTlkYmJkN2Y2ZGUwNDgyN2FfOTI3_49391c05-79cb-44f7-b594-87960854a5fe"
      unitRef="usd">4100000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RleHRyZWdpb246YzExNGJiNGYyZjY0NDYzOWFkMGQ5OWVhZDEwMzkwNDRfMTIyOA_6d1cd216-a6a9-4dd6-aadb-00f24690d9d3">LEASES&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company has operating and finance leases for office space, warehouse and manufacturing space, vehicles and certain equipment. During fiscal year 2022, the Company recorded a loss due to abandonment of $1.9&#160;million, which is included in selling, general and administrative on the Condensed Consolidated Statements of Operations. The following table presents supplemental balance sheet information related to the Company's operating and finance leases: &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.511%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Operating lease assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjEyNTNlNzQwNjAwMzRlZjM4YmM3ZDQyNjA2OTE4NGNiL3RhYmxlcmFuZ2U6MTI1M2U3NDA2MDAzNGVmMzhiYzdkNDI2MDY5MTg0Y2JfMy0xLTEtMS04MzI4NQ_6fed9dde-ecf9-4697-bdfd-bda3b6c18e81"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjEyNTNlNzQwNjAwMzRlZjM4YmM3ZDQyNjA2OTE4NGNiL3RhYmxlcmFuZ2U6MTI1M2U3NDA2MDAzNGVmMzhiYzdkNDI2MDY5MTg0Y2JfMy0xLTEtMS04MzI4NQ_7db859ec-ae05-400b-a6ff-3ee55890f062"&gt;Property, plant, and equipment, net&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities (current) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Current operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance lease liabilities (current) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjEyNTNlNzQwNjAwMzRlZjM4YmM3ZDQyNjA2OTE4NGNiL3RhYmxlcmFuZ2U6MTI1M2U3NDA2MDAzNGVmMzhiYzdkNDI2MDY5MTg0Y2JfNi0xLTEtMS04MzI4NQ_21d67cfe-4f11-4971-a007-53438e019ae1"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjEyNTNlNzQwNjAwMzRlZjM4YmM3ZDQyNjA2OTE4NGNiL3RhYmxlcmFuZ2U6MTI1M2U3NDA2MDAzNGVmMzhiYzdkNDI2MDY5MTg0Y2JfNi0xLTEtMS04MzI4NQ_651facb0-63c0-4af0-8d59-d1e007979e09"&gt;Accrued liabilities and other current liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities (non-current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance lease liabilities (non-current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjEyNTNlNzQwNjAwMzRlZjM4YmM3ZDQyNjA2OTE4NGNiL3RhYmxlcmFuZ2U6MTI1M2U3NDA2MDAzNGVmMzhiYzdkNDI2MDY5MTg0Y2JfOC0xLTEtMS04MzI4NQ_0e1c436b-8779-4e63-90c2-6287c33ec16d"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjEyNTNlNzQwNjAwMzRlZjM4YmM3ZDQyNjA2OTE4NGNiL3RhYmxlcmFuZ2U6MTI1M2U3NDA2MDAzNGVmMzhiYzdkNDI2MDY5MTg0Y2JfOC0xLTEtMS04MzI4NQ_8cf1f2a5-8b40-40ac-84e4-96b9a215a402"&gt;Other long-term liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The following table provides information related to the Company&#x2019;s operating and finance leases:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total operating lease costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total finance lease costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Financing cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total cash paid for amounts included in the measurement of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Noncash operating right-of-use assets obtained in exchange for new lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Includes variable and short-term lease expense, which were immaterial for the three months ended December 30, 2022 and December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeFinanceLeasesTextBlock
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RleHRyZWdpb246YzExNGJiNGYyZjY0NDYzOWFkMGQ5OWVhZDEwMzkwNDRfMTIyOA_956171b6-1129-4364-b81a-458b2653d6bb">LEASES&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company has operating and finance leases for office space, warehouse and manufacturing space, vehicles and certain equipment. During fiscal year 2022, the Company recorded a loss due to abandonment of $1.9&#160;million, which is included in selling, general and administrative on the Condensed Consolidated Statements of Operations. The following table presents supplemental balance sheet information related to the Company's operating and finance leases: &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.511%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Operating lease assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjEyNTNlNzQwNjAwMzRlZjM4YmM3ZDQyNjA2OTE4NGNiL3RhYmxlcmFuZ2U6MTI1M2U3NDA2MDAzNGVmMzhiYzdkNDI2MDY5MTg0Y2JfMy0xLTEtMS04MzI4NQ_6fed9dde-ecf9-4697-bdfd-bda3b6c18e81"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjEyNTNlNzQwNjAwMzRlZjM4YmM3ZDQyNjA2OTE4NGNiL3RhYmxlcmFuZ2U6MTI1M2U3NDA2MDAzNGVmMzhiYzdkNDI2MDY5MTg0Y2JfMy0xLTEtMS04MzI4NQ_7db859ec-ae05-400b-a6ff-3ee55890f062"&gt;Property, plant, and equipment, net&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities (current) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Current operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance lease liabilities (current) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjEyNTNlNzQwNjAwMzRlZjM4YmM3ZDQyNjA2OTE4NGNiL3RhYmxlcmFuZ2U6MTI1M2U3NDA2MDAzNGVmMzhiYzdkNDI2MDY5MTg0Y2JfNi0xLTEtMS04MzI4NQ_21d67cfe-4f11-4971-a007-53438e019ae1"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjEyNTNlNzQwNjAwMzRlZjM4YmM3ZDQyNjA2OTE4NGNiL3RhYmxlcmFuZ2U6MTI1M2U3NDA2MDAzNGVmMzhiYzdkNDI2MDY5MTg0Y2JfNi0xLTEtMS04MzI4NQ_651facb0-63c0-4af0-8d59-d1e007979e09"&gt;Accrued liabilities and other current liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities (non-current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance lease liabilities (non-current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjEyNTNlNzQwNjAwMzRlZjM4YmM3ZDQyNjA2OTE4NGNiL3RhYmxlcmFuZ2U6MTI1M2U3NDA2MDAzNGVmMzhiYzdkNDI2MDY5MTg0Y2JfOC0xLTEtMS04MzI4NQ_0e1c436b-8779-4e63-90c2-6287c33ec16d"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjEyNTNlNzQwNjAwMzRlZjM4YmM3ZDQyNjA2OTE4NGNiL3RhYmxlcmFuZ2U6MTI1M2U3NDA2MDAzNGVmMzhiYzdkNDI2MDY5MTg0Y2JfOC0xLTEtMS04MzI4NQ_8cf1f2a5-8b40-40ac-84e4-96b9a215a402"&gt;Other long-term liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The following table provides information related to the Company&#x2019;s operating and finance leases:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total operating lease costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total finance lease costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Financing cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total cash paid for amounts included in the measurement of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Noncash operating right-of-use assets obtained in exchange for new lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Includes variable and short-term lease expense, which were immaterial for the three months ended December 30, 2022 and December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeFinanceLeasesTextBlock>
    <us-gaap:GainLossOnTerminationOfLease
      contextRef="if053d543d68e4983b97631e65183a5d1_D20211002-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RleHRyZWdpb246YzExNGJiNGYyZjY0NDYzOWFkMGQ5OWVhZDEwMzkwNDRfOTM0NTg0ODgzODc0OA_68449150-9fca-4189-988f-57c0780cdce1"
      unitRef="usd">-1900000</us-gaap:GainLossOnTerminationOfLease>
    <var:AssetsAndLiabilitiesLesseeTableTextBlock
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RleHRyZWdpb246YzExNGJiNGYyZjY0NDYzOWFkMGQ5OWVhZDEwMzkwNDRfMTIzMA_494758e1-b089-4c52-9e8d-78286bb78857">The following table presents supplemental balance sheet information related to the Company's operating and finance leases: &lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.511%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Operating lease assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjEyNTNlNzQwNjAwMzRlZjM4YmM3ZDQyNjA2OTE4NGNiL3RhYmxlcmFuZ2U6MTI1M2U3NDA2MDAzNGVmMzhiYzdkNDI2MDY5MTg0Y2JfMy0xLTEtMS04MzI4NQ_6fed9dde-ecf9-4697-bdfd-bda3b6c18e81"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjEyNTNlNzQwNjAwMzRlZjM4YmM3ZDQyNjA2OTE4NGNiL3RhYmxlcmFuZ2U6MTI1M2U3NDA2MDAzNGVmMzhiYzdkNDI2MDY5MTg0Y2JfMy0xLTEtMS04MzI4NQ_7db859ec-ae05-400b-a6ff-3ee55890f062"&gt;Property, plant, and equipment, net&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities (current) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Current operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance lease liabilities (current) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjEyNTNlNzQwNjAwMzRlZjM4YmM3ZDQyNjA2OTE4NGNiL3RhYmxlcmFuZ2U6MTI1M2U3NDA2MDAzNGVmMzhiYzdkNDI2MDY5MTg0Y2JfNi0xLTEtMS04MzI4NQ_21d67cfe-4f11-4971-a007-53438e019ae1"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjEyNTNlNzQwNjAwMzRlZjM4YmM3ZDQyNjA2OTE4NGNiL3RhYmxlcmFuZ2U6MTI1M2U3NDA2MDAzNGVmMzhiYzdkNDI2MDY5MTg0Y2JfNi0xLTEtMS04MzI4NQ_651facb0-63c0-4af0-8d59-d1e007979e09"&gt;Accrued liabilities and other current liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities (non-current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance lease liabilities (non-current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjEyNTNlNzQwNjAwMzRlZjM4YmM3ZDQyNjA2OTE4NGNiL3RhYmxlcmFuZ2U6MTI1M2U3NDA2MDAzNGVmMzhiYzdkNDI2MDY5MTg0Y2JfOC0xLTEtMS04MzI4NQ_0e1c436b-8779-4e63-90c2-6287c33ec16d"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjEyNTNlNzQwNjAwMzRlZjM4YmM3ZDQyNjA2OTE4NGNiL3RhYmxlcmFuZ2U6MTI1M2U3NDA2MDAzNGVmMzhiYzdkNDI2MDY5MTg0Y2JfOC0xLTEtMS04MzI4NQ_8cf1f2a5-8b40-40ac-84e4-96b9a215a402"&gt;Other long-term liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</var:AssetsAndLiabilitiesLesseeTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjEyNTNlNzQwNjAwMzRlZjM4YmM3ZDQyNjA2OTE4NGNiL3RhYmxlcmFuZ2U6MTI1M2U3NDA2MDAzNGVmMzhiYzdkNDI2MDY5MTg0Y2JfMi0zLTEtMS04MzI4NQ_78d6cf6b-91ca-4fd8-8e33-07d0764c75d6"
      unitRef="usd">22100000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjEyNTNlNzQwNjAwMzRlZjM4YmM3ZDQyNjA2OTE4NGNiL3RhYmxlcmFuZ2U6MTI1M2U3NDA2MDAzNGVmMzhiYzdkNDI2MDY5MTg0Y2JfMi01LTEtMS04MzI4NQ_4a4b1aad-7557-479e-9b32-bc9530d9930f"
      unitRef="usd">23200000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjEyNTNlNzQwNjAwMzRlZjM4YmM3ZDQyNjA2OTE4NGNiL3RhYmxlcmFuZ2U6MTI1M2U3NDA2MDAzNGVmMzhiYzdkNDI2MDY5MTg0Y2JfMy0zLTEtMS04MzI4NQ_32c4edb4-edfc-4dfe-a064-76b43e300718"
      unitRef="usd">300000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjEyNTNlNzQwNjAwMzRlZjM4YmM3ZDQyNjA2OTE4NGNiL3RhYmxlcmFuZ2U6MTI1M2U3NDA2MDAzNGVmMzhiYzdkNDI2MDY5MTg0Y2JfMy01LTEtMS04MzI4NQ_c0e1566f-9d41-4f3c-b871-6f968491a92e"
      unitRef="usd">300000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjEyNTNlNzQwNjAwMzRlZjM4YmM3ZDQyNjA2OTE4NGNiL3RhYmxlcmFuZ2U6MTI1M2U3NDA2MDAzNGVmMzhiYzdkNDI2MDY5MTg0Y2JfNS0zLTEtMS04MzI4NQ_a23e5501-dfe2-4667-af5f-ed1050f51480"
      unitRef="usd">3900000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjEyNTNlNzQwNjAwMzRlZjM4YmM3ZDQyNjA2OTE4NGNiL3RhYmxlcmFuZ2U6MTI1M2U3NDA2MDAzNGVmMzhiYzdkNDI2MDY5MTg0Y2JfNS01LTEtMS04MzI4NQ_38713fb0-ff33-4c4d-95bf-434fdb659e1a"
      unitRef="usd">4000000.0</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjEyNTNlNzQwNjAwMzRlZjM4YmM3ZDQyNjA2OTE4NGNiL3RhYmxlcmFuZ2U6MTI1M2U3NDA2MDAzNGVmMzhiYzdkNDI2MDY5MTg0Y2JfNi0zLTEtMS04MzI4NQ_a24690d2-e2dd-4f35-90d8-a20045d769f4"
      unitRef="usd">200000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjEyNTNlNzQwNjAwMzRlZjM4YmM3ZDQyNjA2OTE4NGNiL3RhYmxlcmFuZ2U6MTI1M2U3NDA2MDAzNGVmMzhiYzdkNDI2MDY5MTg0Y2JfNi01LTEtMS04MzI4NQ_4f2fcd29-4cc6-479d-8df0-39a42a76d309"
      unitRef="usd">200000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjEyNTNlNzQwNjAwMzRlZjM4YmM3ZDQyNjA2OTE4NGNiL3RhYmxlcmFuZ2U6MTI1M2U3NDA2MDAzNGVmMzhiYzdkNDI2MDY5MTg0Y2JfNy0zLTEtMS04MzI4NQ_25c6c574-11c7-4468-abbe-e0626f4d4b5b"
      unitRef="usd">17900000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjEyNTNlNzQwNjAwMzRlZjM4YmM3ZDQyNjA2OTE4NGNiL3RhYmxlcmFuZ2U6MTI1M2U3NDA2MDAzNGVmMzhiYzdkNDI2MDY5MTg0Y2JfNy01LTEtMS04MzI4NQ_b788def8-9096-4dc1-8b6e-c576caddf990"
      unitRef="usd">18000000.0</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjEyNTNlNzQwNjAwMzRlZjM4YmM3ZDQyNjA2OTE4NGNiL3RhYmxlcmFuZ2U6MTI1M2U3NDA2MDAzNGVmMzhiYzdkNDI2MDY5MTg0Y2JfOC0zLTEtMS04MzI4NQ_c8ff4f3c-2639-43f9-b077-f70423e15530"
      unitRef="usd">100000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjEyNTNlNzQwNjAwMzRlZjM4YmM3ZDQyNjA2OTE4NGNiL3RhYmxlcmFuZ2U6MTI1M2U3NDA2MDAzNGVmMzhiYzdkNDI2MDY5MTg0Y2JfOC01LTEtMS04MzI4NQ_5ffe6b70-8648-48aa-b211-e2ea8ac557ac"
      unitRef="usd">100000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RleHRyZWdpb246YzExNGJiNGYyZjY0NDYzOWFkMGQ5OWVhZDEwMzkwNDRfMTIyNA_32488ed6-a736-4402-9aab-b6ef08fc1f91">The following table provides information related to the Company&#x2019;s operating and finance leases:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total operating lease costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total finance lease costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Financing cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total cash paid for amounts included in the measurement of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Noncash operating right-of-use assets obtained in exchange for new lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Includes variable and short-term lease expense, which were immaterial for the three months ended December 30, 2022 and December&#160;31, 2021.&lt;/span&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjlmNjEwM2YzNjY4YjQyZjE4M2FhMzkzNzM4ZmVmODU1L3RhYmxlcmFuZ2U6OWY2MTAzZjM2NjhiNDJmMTgzYWEzOTM3MzhmZWY4NTVfMi0xLTEtMS04MzI4NQ_7712bc09-b055-460f-b5c0-f9a28e7fb6d6"
      unitRef="usd">1500000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjlmNjEwM2YzNjY4YjQyZjE4M2FhMzkzNzM4ZmVmODU1L3RhYmxlcmFuZ2U6OWY2MTAzZjM2NjhiNDJmMTgzYWEzOTM3MzhmZWY4NTVfMi0zLTEtMS04MzI4NQ_2e68da2e-47ed-44d5-a04c-f9b3a2cd9f9f"
      unitRef="usd">2000000.0</us-gaap:OperatingLeaseCost>
    <var:LeaseCostFinanceLeaseCosts
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjlmNjEwM2YzNjY4YjQyZjE4M2FhMzkzNzM4ZmVmODU1L3RhYmxlcmFuZ2U6OWY2MTAzZjM2NjhiNDJmMTgzYWEzOTM3MzhmZWY4NTVfNC0xLTEtMS04MzI4NQ_c19831f2-7b95-4d8c-b389-b9b7f650dccb"
      unitRef="usd">100000</var:LeaseCostFinanceLeaseCosts>
    <var:LeaseCostFinanceLeaseCosts
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjlmNjEwM2YzNjY4YjQyZjE4M2FhMzkzNzM4ZmVmODU1L3RhYmxlcmFuZ2U6OWY2MTAzZjM2NjhiNDJmMTgzYWEzOTM3MzhmZWY4NTVfNC0zLTEtMS04MzI4NQ_f3bc918d-ad7f-4ea3-baa1-3983755b1012"
      unitRef="usd">100000</var:LeaseCostFinanceLeaseCosts>
    <us-gaap:OperatingLeasePayments
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjlmNjEwM2YzNjY4YjQyZjE4M2FhMzkzNzM4ZmVmODU1L3RhYmxlcmFuZ2U6OWY2MTAzZjM2NjhiNDJmMTgzYWEzOTM3MzhmZWY4NTVfNi0xLTEtMS04MzI4NQ_10e120bd-0539-4a58-b75c-6cde0561ee6e"
      unitRef="usd">1600000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjlmNjEwM2YzNjY4YjQyZjE4M2FhMzkzNzM4ZmVmODU1L3RhYmxlcmFuZ2U6OWY2MTAzZjM2NjhiNDJmMTgzYWEzOTM3MzhmZWY4NTVfNi0zLTEtMS04MzI4NQ_e76bb357-66e9-4129-91ed-2d7232730ca7"
      unitRef="usd">1900000</us-gaap:OperatingLeasePayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjlmNjEwM2YzNjY4YjQyZjE4M2FhMzkzNzM4ZmVmODU1L3RhYmxlcmFuZ2U6OWY2MTAzZjM2NjhiNDJmMTgzYWEzOTM3MzhmZWY4NTVfNy0xLTEtMS04MzI4NQ_2f8120a3-9586-4027-abac-caebc6ce3ae2"
      unitRef="usd">100000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjlmNjEwM2YzNjY4YjQyZjE4M2FhMzkzNzM4ZmVmODU1L3RhYmxlcmFuZ2U6OWY2MTAzZjM2NjhiNDJmMTgzYWEzOTM3MzhmZWY4NTVfNy0zLTEtMS04MzI4NQ_4a008841-af12-4024-bd90-9ebe1cb1a242"
      unitRef="usd">100000</us-gaap:FinanceLeasePrincipalPayments>
    <var:CashPaidForOperatingAndFinanceLeases
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjlmNjEwM2YzNjY4YjQyZjE4M2FhMzkzNzM4ZmVmODU1L3RhYmxlcmFuZ2U6OWY2MTAzZjM2NjhiNDJmMTgzYWEzOTM3MzhmZWY4NTVfOC0xLTEtMS04MzI4NQ_d5b06888-611e-4ef0-9990-222a57273034"
      unitRef="usd">1700000</var:CashPaidForOperatingAndFinanceLeases>
    <var:CashPaidForOperatingAndFinanceLeases
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjlmNjEwM2YzNjY4YjQyZjE4M2FhMzkzNzM4ZmVmODU1L3RhYmxlcmFuZ2U6OWY2MTAzZjM2NjhiNDJmMTgzYWEzOTM3MzhmZWY4NTVfOC0zLTEtMS04MzI4NQ_74c6c1fd-c514-428e-9941-d81762995b8f"
      unitRef="usd">2000000.0</var:CashPaidForOperatingAndFinanceLeases>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjlmNjEwM2YzNjY4YjQyZjE4M2FhMzkzNzM4ZmVmODU1L3RhYmxlcmFuZ2U6OWY2MTAzZjM2NjhiNDJmMTgzYWEzOTM3MzhmZWY4NTVfMTAtMS0xLTEtODMyODU_32f70b21-43a2-4dc5-8f4a-cefecbbd6f17"
      unitRef="usd">0</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN180OS9mcmFnOmMxMTRiYjRmMmY2NDQ2MzlhZDBkOTllYWQxMDM5MDQ0L3RhYmxlOjlmNjEwM2YzNjY4YjQyZjE4M2FhMzkzNzM4ZmVmODU1L3RhYmxlcmFuZ2U6OWY2MTAzZjM2NjhiNDJmMTgzYWEzOTM3MzhmZWY4NTVfMTAtMy0xLTEtODMyODU_7602fffe-4f96-49cc-9357-b0ecb78dac95"
      unitRef="usd">100000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181Mi9mcmFnOjcxMjJjZGE5MDBkYTRhOTliNTExMzZiOGRiMTNiOTBjL3RleHRyZWdpb246NzEyMmNkYTkwMGRhNGE5OWI1MTEzNmI4ZGIxM2I5MGNfNDExNQ_ab05e2c9-1682-40ee-94e4-55b1ea1d8d86">RELATED-PARTY TRANSACTIONS&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Investment in Privately-Held Companies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company has a 40% ownership interest in dpiX Holding LLC (&#x201c;dpiX Holding&#x201d;), a holding company that has a 100% ownership interest in dpiX LLC (&#x201c;dpiX&#x201d;), a supplier of amorphous silicon-based thin film transistor arrays for flat panels used in its digital image detectors. In accordance with the dpiX Holding operating agreement, net profits or losses are allocated to the members in accordance with their ownership interests.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The investment in dpiX Holding is accounted for under the equity method of accounting. When the Company recognizes its share of net profits or losses of dpiX Holding, profits or losses in inventory purchased from dpiX are eliminated. During the three months ended December 30, 2022 and December&#160;31, 2021, the Company recorded income (loss) on the equity investment in dpiX Holding of $2.0 million and $(0.7) million, respectively. The income and loss on the equity investment in dpiX Holding are included in other expense, net in the Condensed Consolidated Statements of Operations. The carrying value of the equity investment in dpiX Holding was $44.4 million and $42.4 million at December&#160;30, 2022 and September&#160;30, 2022, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;During the three months ended December 30, 2022 and December&#160;31, 2021, the Company purchased glass transistor arrays from dpiX totaling $5.0 million and $5.2 million, respectively. These purchases of glass transistor arrays are included as a component of inventories on the Condensed Consolidated Balance Sheets or cost of revenues in the Condensed Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;As of December&#160;30, 2022, and September&#160;30, 2022, the Company had accounts payable to dpiX totaling $3.3 million and $3.1&#160;million, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160; The Company has the right to 50% of dpiX&#x2019;s total manufacturing capacity. In addition, the Company is required to pay for 50% of dpiX's fixed costs, as determined at the beginning of each calendar year. In January 2023, the Company's fixed cost commitment was determined and approved by the dpiX board of directors to be $13.1 million for calendar year 2023. The amended agreement will continue unless the ownership structure of dpiX changes (as defined in the amended agreement).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company has determined that dpiX Holding is a variable interest entity because at-risk equity holders, as a group, lack the characteristics of a controlling financial interest. Majority votes are required to direct the manufacturing activities, legal operations and other activities that most significantly affect dpiX&#x2019;s economic performance. The Company does not have majority voting rights and no power to unilaterally direct the activities of dpiX Holding and therefore is not the primary beneficiary of dpiX Holding. The Company&#x2019;s exposure to loss as a result of its involvement with dpiX Holding is limited to the carrying value of the Company&#x2019;s investment of $44.4&#160;million and fixed cost commitments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In November 2018, the Company (through one of its wholly-owned subsidiaries) and CETTEEN GmbH (&#x201c;CETTEEN&#x201d;), formed a German limited liability company that governs the affairs and conduct of the business of VEC Imaging GmbH &amp;amp; Co. KG (&#x201c;VEC&#x201d;), a joint venture formed to develop technology for use in X-ray imaging components. In accordance with the VEC agreement, net profits or losses are allocated to the members in accordance with their ownership interest. The Company's investment in VEC is accounted for under the equity method of accounting. The Company has determined that VEC is a variable interest entity.&lt;/span&gt;&lt;/div&gt;&#160;&#160;&#160;&#160;During the three months ended December 30, 2022, and December&#160;31, 2021, the Company recorded a loss on the equity investment in VEC of $0.3 million and $0.1 million, respectively. The Company's investment in VEC was $2.2 million and $2.5 million at December&#160;30, 2022 and September&#160;30, 2022, respectively. As of December&#160;30, 2022 and September&#160;30, 2022 the Company had loans outstanding to VEC totaling $0.6 million, and other receivables from VEC of $0.4 million and $0.3 million at December&#160;30, 2022 and September&#160;30, 2022, respectively, which are recorded in prepaid expenses and other current assets in the Condensed Consolidated Balance Sheets.</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="id11c0d105587406ea12579388d33acc6_I20221230"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181Mi9mcmFnOjcxMjJjZGE5MDBkYTRhOTliNTExMzZiOGRiMTNiOTBjL3RleHRyZWdpb246NzEyMmNkYTkwMGRhNGE5OWI1MTEzNmI4ZGIxM2I5MGNfOTQ_e6b8c93c-231e-4a23-8a3f-874590ca26fb"
      unitRef="number">0.40</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i3c5473e7e6e2416283c3708bf75140f0_I20221230"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181Mi9mcmFnOjcxMjJjZGE5MDBkYTRhOTliNTExMzZiOGRiMTNiOTBjL3RleHRyZWdpb246NzEyMmNkYTkwMGRhNGE5OWI1MTEzNmI4ZGIxM2I5MGNfMTgz_69704e6d-3b2a-4a62-ac7a-94c28b8ff23f"
      unitRef="number">1</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i651cdb90544d4fc5ae96aa228e377585_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181Mi9mcmFnOjcxMjJjZGE5MDBkYTRhOTliNTExMzZiOGRiMTNiOTBjL3RleHRyZWdpb246NzEyMmNkYTkwMGRhNGE5OWI1MTEzNmI4ZGIxM2I5MGNfODEy_bff22aba-45f0-485d-9c21-55d0d223e9eb"
      unitRef="usd">2000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i1e78a329a9904ab4ad46da4fa3ad9d85_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181Mi9mcmFnOjcxMjJjZGE5MDBkYTRhOTliNTExMzZiOGRiMTNiOTBjL3RleHRyZWdpb246NzEyMmNkYTkwMGRhNGE5OWI1MTEzNmI4ZGIxM2I5MGNfMTA5OTUxMTYzNDc4Mw_2a2fb9d5-d2f6-4a7c-a3d5-9760b77152b3"
      unitRef="usd">-700000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="id11c0d105587406ea12579388d33acc6_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181Mi9mcmFnOjcxMjJjZGE5MDBkYTRhOTliNTExMzZiOGRiMTNiOTBjL3RleHRyZWdpb246NzEyMmNkYTkwMGRhNGE5OWI1MTEzNmI4ZGIxM2I5MGNfMTE1NA_0d499ecd-c3c1-400b-a5b5-a0754b47ad6d"
      unitRef="usd">44400000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="i754dac8665dd449eb1ba41e245554f36_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181Mi9mcmFnOjcxMjJjZGE5MDBkYTRhOTliNTExMzZiOGRiMTNiOTBjL3RleHRyZWdpb246NzEyMmNkYTkwMGRhNGE5OWI1MTEzNmI4ZGIxM2I5MGNfMTE2MQ_9e43e06d-9988-49f2-95b1-ec2d75cff95d"
      unitRef="usd">42400000</us-gaap:EquityMethodInvestments>
    <us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty
      contextRef="i651cdb90544d4fc5ae96aa228e377585_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181Mi9mcmFnOjcxMjJjZGE5MDBkYTRhOTliNTExMzZiOGRiMTNiOTBjL3RleHRyZWdpb246NzEyMmNkYTkwMGRhNGE5OWI1MTEzNmI4ZGIxM2I5MGNfMTI4MA_b46c90ac-d5b7-4f43-90d1-c558fa49de6f"
      unitRef="usd">5000000</us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty>
    <us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty
      contextRef="i1e78a329a9904ab4ad46da4fa3ad9d85_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181Mi9mcmFnOjcxMjJjZGE5MDBkYTRhOTliNTExMzZiOGRiMTNiOTBjL3RleHRyZWdpb246NzEyMmNkYTkwMGRhNGE5OWI1MTEzNmI4ZGIxM2I5MGNfMTI4Nw_3d4526cb-5257-47df-8fb8-6cc634014685"
      unitRef="usd">5200000</us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty>
    <us-gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent
      contextRef="id11c0d105587406ea12579388d33acc6_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181Mi9mcmFnOjcxMjJjZGE5MDBkYTRhOTliNTExMzZiOGRiMTNiOTBjL3RleHRyZWdpb246NzEyMmNkYTkwMGRhNGE5OWI1MTEzNmI4ZGIxM2I5MGNfMTY3MA_e3fa0740-abcd-4479-9196-f1d7b564aaf9"
      unitRef="usd">3300000</us-gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent>
    <us-gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent
      contextRef="i754dac8665dd449eb1ba41e245554f36_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181Mi9mcmFnOjcxMjJjZGE5MDBkYTRhOTliNTExMzZiOGRiMTNiOTBjL3RleHRyZWdpb246NzEyMmNkYTkwMGRhNGE5OWI1MTEzNmI4ZGIxM2I5MGNfMTY3Nw_5702114d-c3ee-45d6-9590-59c79d87ac5f"
      unitRef="usd">3100000</us-gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent>
    <var:PercentageOfManufacturingCapacity
      contextRef="i651cdb90544d4fc5ae96aa228e377585_D20221001-20221230"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181Mi9mcmFnOjcxMjJjZGE5MDBkYTRhOTliNTExMzZiOGRiMTNiOTBjL3RleHRyZWdpb246NzEyMmNkYTkwMGRhNGE5OWI1MTEzNmI4ZGIxM2I5MGNfMTgzMw_96628223-082a-4616-bf46-4d5d0997fb55"
      unitRef="number">0.50</var:PercentageOfManufacturingCapacity>
    <var:PercentageOfFixedCosts
      contextRef="i651cdb90544d4fc5ae96aa228e377585_D20221001-20221230"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181Mi9mcmFnOjcxMjJjZGE5MDBkYTRhOTliNTExMzZiOGRiMTNiOTBjL3RleHRyZWdpb246NzEyMmNkYTkwMGRhNGE5OWI1MTEzNmI4ZGIxM2I5MGNfMTkyNA_556d9af8-15cd-4694-97ed-548bd799f155"
      unitRef="number">0.50</var:PercentageOfFixedCosts>
    <var:RelatedPartyTransactionApprovedPurchasesFromRelatedParty
      contextRef="i70ff6a02b02a447d974ae2a3ad5485bc_D20230101-20231231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181Mi9mcmFnOjcxMjJjZGE5MDBkYTRhOTliNTExMzZiOGRiMTNiOTBjL3RleHRyZWdpb246NzEyMmNkYTkwMGRhNGE5OWI1MTEzNmI4ZGIxM2I5MGNfMjEyMg_8204da03-2749-4efc-9f41-e91d71e686f1"
      unitRef="usd">13100000</var:RelatedPartyTransactionApprovedPurchasesFromRelatedParty>
    <us-gaap:EquityMethodInvestments
      contextRef="id11c0d105587406ea12579388d33acc6_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181Mi9mcmFnOjcxMjJjZGE5MDBkYTRhOTliNTExMzZiOGRiMTNiOTBjL3RleHRyZWdpb246NzEyMmNkYTkwMGRhNGE5OWI1MTEzNmI4ZGIxM2I5MGNfMzA4Ng_0d499ecd-c3c1-400b-a5b5-a0754b47ad6d"
      unitRef="usd">44400000</us-gaap:EquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i043d35fe9e8748dba721e7442a223c87_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181Mi9mcmFnOjcxMjJjZGE5MDBkYTRhOTliNTExMzZiOGRiMTNiOTBjL3RleHRyZWdpb246NzEyMmNkYTkwMGRhNGE5OWI1MTEzNmI4ZGIxM2I5MGNfMzc0OA_31158989-9d0b-4075-b77f-d06d43a15a2b"
      unitRef="usd">-300000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i23fdde7b29af4c57aa6824e48992f27e_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181Mi9mcmFnOjcxMjJjZGE5MDBkYTRhOTliNTExMzZiOGRiMTNiOTBjL3RleHRyZWdpb246NzEyMmNkYTkwMGRhNGE5OWI1MTEzNmI4ZGIxM2I5MGNfMzc1NQ_63ec8b01-7d62-4c8a-a12d-d5ddac0784fd"
      unitRef="usd">-100000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="ide9a8d3681694417a4a4545b01157b8d_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181Mi9mcmFnOjcxMjJjZGE5MDBkYTRhOTliNTExMzZiOGRiMTNiOTBjL3RleHRyZWdpb246NzEyMmNkYTkwMGRhNGE5OWI1MTEzNmI4ZGIxM2I5MGNfMzkyMA_bd26b383-8357-45d1-a6b2-b337f719a428"
      unitRef="usd">2200000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="ic6403b22953a49d8b910f2bf553fd441_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181Mi9mcmFnOjcxMjJjZGE5MDBkYTRhOTliNTExMzZiOGRiMTNiOTBjL3RleHRyZWdpb246NzEyMmNkYTkwMGRhNGE5OWI1MTEzNmI4ZGIxM2I5MGNfMzkyNw_effc7e03-7331-4c6e-827b-5137013b9e3d"
      unitRef="usd">2500000</us-gaap:EquityMethodInvestments>
    <us-gaap:DueToRelatedPartiesCurrentAndNoncurrent
      contextRef="ic6403b22953a49d8b910f2bf553fd441_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181Mi9mcmFnOjcxMjJjZGE5MDBkYTRhOTliNTExMzZiOGRiMTNiOTBjL3RleHRyZWdpb246NzEyMmNkYTkwMGRhNGE5OWI1MTEzNmI4ZGIxM2I5MGNfMTY0OTI2NzQ0Njg2MQ_567f9bb1-11a0-40c8-b02f-04b87f3d0793"
      unitRef="usd">600000</us-gaap:DueToRelatedPartiesCurrentAndNoncurrent>
    <us-gaap:DueToRelatedPartiesCurrentAndNoncurrent
      contextRef="ide9a8d3681694417a4a4545b01157b8d_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181Mi9mcmFnOjcxMjJjZGE5MDBkYTRhOTliNTExMzZiOGRiMTNiOTBjL3RleHRyZWdpb246NzEyMmNkYTkwMGRhNGE5OWI1MTEzNmI4ZGIxM2I5MGNfMTY0OTI2NzQ0Njg2MQ_be923135-9fe4-460b-945c-d955e68cc785"
      unitRef="usd">600000</us-gaap:DueToRelatedPartiesCurrentAndNoncurrent>
    <us-gaap:OtherReceivables
      contextRef="ide9a8d3681694417a4a4545b01157b8d_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181Mi9mcmFnOjcxMjJjZGE5MDBkYTRhOTliNTExMzZiOGRiMTNiOTBjL3RleHRyZWdpb246NzEyMmNkYTkwMGRhNGE5OWI1MTEzNmI4ZGIxM2I5MGNfMTY0OTI2NzQ0Njg3NA_8833a475-45d5-4f56-95f8-c4a16cc30362"
      unitRef="usd">400000</us-gaap:OtherReceivables>
    <us-gaap:OtherReceivables
      contextRef="ic6403b22953a49d8b910f2bf553fd441_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181Mi9mcmFnOjcxMjJjZGE5MDBkYTRhOTliNTExMzZiOGRiMTNiOTBjL3RleHRyZWdpb246NzEyMmNkYTkwMGRhNGE5OWI1MTEzNmI4ZGIxM2I5MGNfMTY0OTI2NzQ0Njg2OA_96b0f504-f60f-4736-88ac-e12b5664fcff"
      unitRef="usd">300000</us-gaap:OtherReceivables>
    <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181NS9mcmFnOmM1NmMxOGM5NDE2MTQ4YmI5NWE2MWE0YzBlYmIwOTY4L3RleHRyZWdpb246YzU2YzE4Yzk0MTYxNDhiYjk1YTYxYTRjMGViYjA5NjhfODI3_fe2a8b7c-64a1-4f57-ac22-0fca12260048">RESTRUCTURING&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In July 2018, the Company committed to relocate the production of amorphous silicon glass for digital detectors from its Santa Clara facility to the dpiX fabrication facility in Colorado. In July 2019, the Company committed to close its Santa Clara facility and to relocate the remaining production to its other existing facilities.&#160;The Company ceased all operations at the Santa Clara facility as of October 2, 2020, and all activities related to the closure of the facility were completed by the end of December 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Cash outflows associated with these restructuring charges are limited to employee termination expenses, facility closure and equipment sales and disposals. Below is a detail of restructuring charges incurred during the three months ended December 30, 2022 and December&#160;31, 2021, respectively, which predominantly relate to the Company's Medical segment:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.650%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.427%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Location of Restructuring Charges in Condensed Consolidated Statements of Operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other assets impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181NS9mcmFnOmM1NmMxOGM5NDE2MTQ4YmI5NWE2MWE0YzBlYmIwOTY4L3RleHRyZWdpb246YzU2YzE4Yzk0MTYxNDhiYjk1YTYxYTRjMGViYjA5NjhfODI5_61d06dfc-5030-4bb0-aeef-c2dce4f909b9">Below is a detail of restructuring charges incurred during the three months ended December 30, 2022 and December&#160;31, 2021, respectively, which predominantly relate to the Company's Medical segment:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.650%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.427%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Location of Restructuring Charges in Condensed Consolidated Statements of Operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other assets impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock>
    <us-gaap:OtherAssetImpairmentCharges
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181NS9mcmFnOmM1NmMxOGM5NDE2MTQ4YmI5NWE2MWE0YzBlYmIwOTY4L3RhYmxlOjBmNTJkNmUyNWNlODQxMDg5NGQ0YTNjY2Y5YzFjNGUwL3RhYmxlcmFuZ2U6MGY1MmQ2ZTI1Y2U4NDEwODk0ZDRhM2NjZjljMWM0ZTBfMi0zLTEtMS04MzI4NQ_ee4e7c7f-5a09-4f40-99e3-45ee32746312"
      unitRef="usd">0</us-gaap:OtherAssetImpairmentCharges>
    <us-gaap:OtherAssetImpairmentCharges
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181NS9mcmFnOmM1NmMxOGM5NDE2MTQ4YmI5NWE2MWE0YzBlYmIwOTY4L3RhYmxlOjBmNTJkNmUyNWNlODQxMDg5NGQ0YTNjY2Y5YzFjNGUwL3RhYmxlcmFuZ2U6MGY1MmQ2ZTI1Y2U4NDEwODk0ZDRhM2NjZjljMWM0ZTBfMi01LTEtMS04MzI4NQ_6a7cb9a9-0551-4489-8742-4c83a8a578d9"
      unitRef="usd">1800000</us-gaap:OtherAssetImpairmentCharges>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181OC9mcmFnOmI2MjBmMTkwNjg5MTQ3YmNhOGFmNDQxNTI3NWFiNTBjL3RleHRyZWdpb246YjYyMGYxOTA2ODkxNDdiY2E4YWY0NDE1Mjc1YWI1MGNfNTAyMg_f1fd9c82-3f2a-4a3d-b634-913687354fbd">FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;As part of the Company&#x2019;s overall risk management practices, the Company enters into financial derivatives to manage its financial exposures to foreign currency exchange rates and interest rates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company records all derivatives on the Condensed Consolidated Balance Sheets at fair value. The accounting for changes in the fair value of derivatives depends on the intended use of the derivative, whether the Company has elected to designate a derivative in a hedging relationship and apply hedge accounting, and whether the hedging relationship has satisfied the criteria necessary to apply hedge accounting. A qualitative assessment of hedge effectiveness is performed on a quarterly basis, unless facts and circumstances indicate the hedge may no longer be highly effective, in which case the Company would test for effectiveness on a more frequent basis. The changes in fair value for all trades that are not designated for hedge accounting are recognized in current period income. The Company does not offset fair value amounts recognized for derivative instruments in its Condensed Consolidated Balance Sheets for presentation purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Credit risk related to derivative transactions reflects the risk that a party to the transaction could fail to meet its obligation under the derivative contracts. Therefore, the Company&#x2019;s exposure to the counterparty&#x2019;s credit risk is generally limited to the amounts, if any, by which the counterparty&#x2019;s obligations to the Company exceed the Company&#x2019;s obligations to the counterparty. The Company&#x2019;s policy is to enter into contracts only with financial institutions that meet certain minimum credit ratings to help mitigate counterparty credit risk.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Derivatives Designated as Hedging Instruments - Net Investment Hedges&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company&#160;uses cross currency swap contracts as net investment hedges to manage its risk of variability in foreign currency-denominated net investments in wholly-owned international operations. All changes in fair value of the derivatives designated as net investment hedges are reported in&#160;accumulated other comprehensive income along with the foreign currency translation adjustments on those investments. During the three months ended December 30, 2022, the Company terminated all three of its previously outstanding cross currency swap contracts which resulted in cash received upon settlement of $7.3 million. The gain on the swap was recorded in accumulated other comprehensive income where it will remain until such time that substantial liquidation of the international operations should occur. Concurrent with the termination of the previous cross currency swaps, the Company entered into two new cross currency swaps which have been designated as net investment hedges.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;As of&#160;December&#160;30, 2022, the Company had the following outstanding derivatives designated as net investment hedging instruments:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(In millions, except number of instruments)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Number of Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Notional Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cross currency swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The following table summarizes the amount of pre-tax income recognized from derivative instruments for the periods indicated and the line items in the accompanying statements of operations where the results are recorded for net investment hedges:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.666%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.342%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.583%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:48pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amount of (Loss) Gain Recognized in OCI on Derivative&lt;br/&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Location of Gain Recognized in Income on Derivative (Amount Excluded from Effectiveness Testing)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amount of Gain Recognized in Income on Derivative (Amount Excluded from Effectiveness Testing)&lt;br/&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:23pt"&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cross currency swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 2.12pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;These derivative instruments are subject to master netting agreements giving effect to rights of offset with each counterparty. None of the balances were eligible for netting. The following table summarizes the gross fair values of derivative instruments as of the periods indicated and the line items in the accompanying Condensed Consolidated Balance Sheets where the instruments are recorded:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.594%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.597%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Derivative Assets and Liabilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Derivatives Designated as Net Investment Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cross currency swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cross currency swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cross currency swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <var:DerivativeNumberOfInstrumentsTerminated
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181OC9mcmFnOmI2MjBmMTkwNjg5MTQ3YmNhOGFmNDQxNTI3NWFiNTBjL3RleHRyZWdpb246YjYyMGYxOTA2ODkxNDdiY2E4YWY0NDE1Mjc1YWI1MGNfNzY5NjU4MTQwMTgzNg_e546a4bf-95dd-41dd-9f66-176600a98c51"
      unitRef="instrument">3</var:DerivativeNumberOfInstrumentsTerminated>
    <us-gaap:DerivativeCashReceivedOnHedge
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181OC9mcmFnOmI2MjBmMTkwNjg5MTQ3YmNhOGFmNDQxNTI3NWFiNTBjL3RleHRyZWdpb246YjYyMGYxOTA2ODkxNDdiY2E4YWY0NDE1Mjc1YWI1MGNfNTQ5NzU1ODIxNDI2_cfda90b7-16de-4a47-b888-3a3338e7b2d9"
      unitRef="usd">7300000</us-gaap:DerivativeCashReceivedOnHedge>
    <us-gaap:ScheduleOfDerivativeInstrumentsTextBlock
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181OC9mcmFnOmI2MjBmMTkwNjg5MTQ3YmNhOGFmNDQxNTI3NWFiNTBjL3RleHRyZWdpb246YjYyMGYxOTA2ODkxNDdiY2E4YWY0NDE1Mjc1YWI1MGNfNTAyNQ_75838034-cae5-4948-8d9d-87f059be4a1d">As of&#160;December&#160;30, 2022, the Company had the following outstanding derivatives designated as net investment hedging instruments:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(In millions, except number of instruments)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Number of Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Notional Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cross currency swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDerivativeInstrumentsTextBlock>
    <us-gaap:DerivativeNumberOfInstrumentsHeld
      contextRef="i4a06e1fd56de45429cf0fcaeadd92091_I20221230"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181OC9mcmFnOmI2MjBmMTkwNjg5MTQ3YmNhOGFmNDQxNTI3NWFiNTBjL3RhYmxlOjVjNTk0YTFkNWY5YTQ1MTc5MGQ3ODQ2Njc2YzA5ZWFjL3RhYmxlcmFuZ2U6NWM1OTRhMWQ1ZjlhNDUxNzkwZDc4NDY2NzZjMDllYWNfMS0xLTEtMS04MzI4NQ_44039085-5372-49da-98ff-db551c4cebb7"
      unitRef="derivativecontract">2</us-gaap:DerivativeNumberOfInstrumentsHeld>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i4a06e1fd56de45429cf0fcaeadd92091_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181OC9mcmFnOmI2MjBmMTkwNjg5MTQ3YmNhOGFmNDQxNTI3NWFiNTBjL3RhYmxlOjVjNTk0YTFkNWY5YTQ1MTc5MGQ3ODQ2Njc2YzA5ZWFjL3RhYmxlcmFuZ2U6NWM1OTRhMWQ1ZjlhNDUxNzkwZDc4NDY2NzZjMDllYWNfMS0zLTEtMS04MzI4NQ_d0f6217d-a5f9-4d76-8855-def41ffbde95"
      unitRef="usd">58700000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181OC9mcmFnOmI2MjBmMTkwNjg5MTQ3YmNhOGFmNDQxNTI3NWFiNTBjL3RleHRyZWdpb246YjYyMGYxOTA2ODkxNDdiY2E4YWY0NDE1Mjc1YWI1MGNfNTAzMw_00602794-2a00-4e7d-a81e-8bbc349ab49c">The following table summarizes the amount of pre-tax income recognized from derivative instruments for the periods indicated and the line items in the accompanying statements of operations where the results are recorded for net investment hedges:&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.666%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.342%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.583%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:48pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amount of (Loss) Gain Recognized in OCI on Derivative&lt;br/&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Location of Gain Recognized in Income on Derivative (Amount Excluded from Effectiveness Testing)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amount of Gain Recognized in Income on Derivative (Amount Excluded from Effectiveness Testing)&lt;br/&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:23pt"&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cross currency swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 2.12pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;These derivative instruments are subject to master netting agreements giving effect to rights of offset with each counterparty. None of the balances were eligible for netting. The following table summarizes the gross fair values of derivative instruments as of the periods indicated and the line items in the accompanying Condensed Consolidated Balance Sheets where the instruments are recorded:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.594%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.597%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Derivative Assets and Liabilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Derivatives Designated as Net Investment Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cross currency swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cross currency swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cross currency swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i1b3aa766e2904db9b8ab4aa605bdb4ee_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181OC9mcmFnOmI2MjBmMTkwNjg5MTQ3YmNhOGFmNDQxNTI3NWFiNTBjL3RhYmxlOmYyM2I0NmMyNTlkYTQ4NDM4NzhjMzQ5OWQzZmFmZDQ1L3RhYmxlcmFuZ2U6ZjIzYjQ2YzI1OWRhNDg0Mzg3OGMzNDk5ZDNmYWZkNDVfMi0xLTEtMS04MzI4NQ_9906a473-3045-4bd9-897c-676a14ae50ec"
      unitRef="usd">-4000000.0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i4eac39f015bd47f5ba39e3bfcfcc6d4c_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181OC9mcmFnOmI2MjBmMTkwNjg5MTQ3YmNhOGFmNDQxNTI3NWFiNTBjL3RhYmxlOmYyM2I0NmMyNTlkYTQ4NDM4NzhjMzQ5OWQzZmFmZDQ1L3RhYmxlcmFuZ2U6ZjIzYjQ2YzI1OWRhNDg0Mzg3OGMzNDk5ZDNmYWZkNDVfMi0zLTEtMS04MzI4NQ_3fb7841e-d231-451a-87bc-577261625df5"
      unitRef="usd">800000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="ide90c1ae15ab4bb9a3bd404689af0bbf_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181OC9mcmFnOmI2MjBmMTkwNjg5MTQ3YmNhOGFmNDQxNTI3NWFiNTBjL3RhYmxlOmYyM2I0NmMyNTlkYTQ4NDM4NzhjMzQ5OWQzZmFmZDQ1L3RhYmxlcmFuZ2U6ZjIzYjQ2YzI1OWRhNDg0Mzg3OGMzNDk5ZDNmYWZkNDVfMi03LTEtMS04MzI4NQ_fcd84744-be8b-4c93-8573-8d0d6a64fc77"
      unitRef="usd">200000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i934533f99d1543b2ab6a4be93d73dd8f_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181OC9mcmFnOmI2MjBmMTkwNjg5MTQ3YmNhOGFmNDQxNTI3NWFiNTBjL3RhYmxlOmYyM2I0NmMyNTlkYTQ4NDM4NzhjMzQ5OWQzZmFmZDQ1L3RhYmxlcmFuZ2U6ZjIzYjQ2YzI1OWRhNDg0Mzg3OGMzNDk5ZDNmYWZkNDVfMi05LTEtMS04MzI4NQ_1989ca5e-578e-4df4-90b8-b4a99f0de7dc"
      unitRef="usd">300000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i5c7f1146a6b1444882838f6b9709de23_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181OC9mcmFnOmI2MjBmMTkwNjg5MTQ3YmNhOGFmNDQxNTI3NWFiNTBjL3RhYmxlOmUzNDBkZmZjYzY0NTQ3NTdiMjNiYjRmNjY2OWNlMzMzL3RhYmxlcmFuZ2U6ZTM0MGRmZmNjNjQ1NDc1N2IyM2JiNGY2NjY5Y2UzMzNfMi00LTEtMS04MzI4NQ_838438bd-eb21-40a9-90be-b11387184a45"
      unitRef="usd">1100000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i5332708454694b5dbb490975b393f380_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181OC9mcmFnOmI2MjBmMTkwNjg5MTQ3YmNhOGFmNDQxNTI3NWFiNTBjL3RhYmxlOmUzNDBkZmZjYzY0NTQ3NTdiMjNiYjRmNjY2OWNlMzMzL3RhYmxlcmFuZ2U6ZTM0MGRmZmNjNjQ1NDc1N2IyM2JiNGY2NjY5Y2UzMzNfMi02LTEtMS04MzI4NQ_391ff96d-324c-4edf-bd77-3806607b2c1d"
      unitRef="usd">1200000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i05ccff0411484bb0bee83af0018f0bf7_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181OC9mcmFnOmI2MjBmMTkwNjg5MTQ3YmNhOGFmNDQxNTI3NWFiNTBjL3RhYmxlOmUzNDBkZmZjYzY0NTQ3NTdiMjNiYjRmNjY2OWNlMzMzL3RhYmxlcmFuZ2U6ZTM0MGRmZmNjNjQ1NDc1N2IyM2JiNGY2NjY5Y2UzMzNfMy00LTEtMS04MzI4NQ_a2418b29-4ec2-4f1d-aa24-42caf56c9a0e"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i17e216dd46824f439789b35236b2e450_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181OC9mcmFnOmI2MjBmMTkwNjg5MTQ3YmNhOGFmNDQxNTI3NWFiNTBjL3RhYmxlOmUzNDBkZmZjYzY0NTQ3NTdiMjNiYjRmNjY2OWNlMzMzL3RhYmxlcmFuZ2U6ZTM0MGRmZmNjNjQ1NDc1N2IyM2JiNGY2NjY5Y2UzMzNfMy02LTEtMS04MzI4NQ_271a76dc-c936-4abf-8ef9-f426d13920ea"
      unitRef="usd">6300000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i3e698835048a4495bf4ddd5aae18d2f8_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181OC9mcmFnOmI2MjBmMTkwNjg5MTQ3YmNhOGFmNDQxNTI3NWFiNTBjL3RhYmxlOmUzNDBkZmZjYzY0NTQ3NTdiMjNiYjRmNjY2OWNlMzMzL3RhYmxlcmFuZ2U6ZTM0MGRmZmNjNjQ1NDc1N2IyM2JiNGY2NjY5Y2UzMzNfNS00LTEtMS04MzI4NQ_a9fda2b2-7bc5-4d42-bb99-1dcefa36a679"
      unitRef="usd">4700000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ie4aa2eb507164e9faa338325c825f610_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN181OC9mcmFnOmI2MjBmMTkwNjg5MTQ3YmNhOGFmNDQxNTI3NWFiNTBjL3RhYmxlOmUzNDBkZmZjYzY0NTQ3NTdiMjNiYjRmNjY2OWNlMzMzL3RhYmxlcmFuZ2U6ZTM0MGRmZmNjNjQ1NDc1N2IyM2JiNGY2NjY5Y2UzMzNfNS02LTEtMS04MzI4NQ_e26ce5eb-507f-4d28-ad04-8ff73588b3e9"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RleHRyZWdpb246NDYzNjEwOTFkZjZlNGU3MGE1NzRjM2M1ZDk5ZTNlNmZfMTgyNQ_31831557-bfd7-4a1a-b00d-cebd371f5277">FAIR VALUE&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Assets and Liabilities Measured at Fair Value on a Recurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The fair values of certain of the Company&#x2019;s financial instruments, including bank deposits included in cash and cash equivalents, accounts receivable, net and accounts payable, approximate their fair values due to their short maturities. As of December&#160;30, 2022, the fair values of the Company's Convertible Notes and Senior Secured Notes, as defined in Note 10, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Borrowings &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and measured using Level 1 inputs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; were $229.0 million and $239.3 million, respectively. As of September&#160;30, 2022, the fair values of the Company's Convertible Notes and Senior Secured Notes, measured using Level 1 inputs, were $250.2 million and $241.3 million, respectively. The Company has elected to use the income approach to value its derivative instruments using standard valuation techniques and Level 2 inputs, such as currency spot rates, forward points and credit default swap spreads.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In the tables below, the Company has segregated all assets and liabilities that are measured at fair value on a recurring basis into the most appropriate level within the fair value hierarchy based on the inputs used to determine the fair value at the measurement date.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value at December 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Quoted Prices in Active Markets for Identical Assets and Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(Level 1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Significant Other&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Observable Inputs&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(Level 2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Significant Unobservable Inputs&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(Level 3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Corporate notes/bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Government agencies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S. Treasury bills&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:15.75pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Derivative assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:15.75pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred compensation plan&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Marketable equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfMTAtMC0xLTEtODMyODU_79a5037b-581b-47d3-9fd4-71603055d303"&gt;Total assets measured at fair value&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 16.75pt;text-indent:-9pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Liabilities:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:15.75pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Derivative liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfMTYtMC0xLTEtMTAwNTk3_169dbe7d-a10b-4a1e-ab46-42af80460820"&gt;Total liabilities measured at fair value&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value at September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Quoted Prices in Active Markets for Identical Assets and Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(Level 1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Significant Other&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Observable Inputs&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(Level 2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Significant Unobservable Inputs&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(Level 3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Assets:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Corporate notes/bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Government agencies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S. Treasury bills&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Derivative assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred compensation plan&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Marketable equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfOC0wLTEtMS04MzI4NQ_417fadeb-557f-4f83-a995-e688c949e009"&gt;Total assets measured at fair value&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;64.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;72.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Derivative liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfMTMtMC0xLTEtODMyODU_54db5ac7-0c5e-4cf6-bc9b-f0229d68f729"&gt;Total liabilities measured at fair value&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The assets held under the Company's deferred compensation plan are classified in Level 1 as they relate primarily to publicly traded mutual funds for which there are observable market prices in active markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Marketable Debt Securities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The following tables summarize the Company's marketable debt securities:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.511%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Amortized Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Corporate notes/bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S. Treasury bills&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Government agencies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total marketable debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.511%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Amortized Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Corporate notes/bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S. Treasury bills&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Government agencies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total marketable debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The contractual maturities of marketable debt securities as of December&#160;30, 2022, are shown in the table below. Actual maturities may differ from contractual maturities because borrowers may have the right to call or prepay obligations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Amortized Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contractual maturities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Due within one year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Due after one year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total marketable debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;During the three months ended December&#160;30, 2022, there were no gross realized gains or losses from the sale of certain marketable debt securities that were reclassified out of accumulated other comprehensive income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The following tables summarize the balance sheet locations for marketable debt securities:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.511%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.650%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.650%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.650%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.650%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.652%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Corporate notes/bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Government agencies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Treasury bills&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total marketable debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.650%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.511%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.650%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.650%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.650%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.652%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Corporate notes/bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Government agencies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Treasury bills&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total marketable debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:LongTermDebtFairValue
      contextRef="i6c18314ffe0b4522b51d04b27d6bdac1_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RleHRyZWdpb246NDYzNjEwOTFkZjZlNGU3MGE1NzRjM2M1ZDk5ZTNlNmZfNDQ0_80e4da97-79b4-4521-85cc-eb8d71a9d3bb"
      unitRef="usd">229000000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="ib5065ecd379c4d4b96ce8728838e59d8_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RleHRyZWdpb246NDYzNjEwOTFkZjZlNGU3MGE1NzRjM2M1ZDk5ZTNlNmZfNDUx_de5830c9-4405-46c2-ba5d-62b7870db3c5"
      unitRef="usd">239300000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="i6de4c85804eb455496852e854a916c0e_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RleHRyZWdpb246NDYzNjEwOTFkZjZlNGU3MGE1NzRjM2M1ZDk5ZTNlNmZfNTky_fbe1fc22-95db-46fb-b253-63dc1c39b0fe"
      unitRef="usd">250200000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="if56b77a5f42444d7b50e5eabbf7d9892_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RleHRyZWdpb246NDYzNjEwOTFkZjZlNGU3MGE1NzRjM2M1ZDk5ZTNlNmZfNTk5_af2f68ce-28e9-4d8b-a3cf-01396aa6f888"
      unitRef="usd">241300000</us-gaap:LongTermDebtFairValue>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RleHRyZWdpb246NDYzNjEwOTFkZjZlNGU3MGE1NzRjM2M1ZDk5ZTNlNmZfMTgzMg_c1d2c7a7-09b9-44f1-b336-9ece9e123bab">In the tables below, the Company has segregated all assets and liabilities that are measured at fair value on a recurring basis into the most appropriate level within the fair value hierarchy based on the inputs used to determine the fair value at the measurement date.&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value at December 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Quoted Prices in Active Markets for Identical Assets and Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(Level 1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Significant Other&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Observable Inputs&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(Level 2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Significant Unobservable Inputs&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(Level 3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Corporate notes/bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Government agencies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S. Treasury bills&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:15.75pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Derivative assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:15.75pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred compensation plan&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Marketable equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfMTAtMC0xLTEtODMyODU_79a5037b-581b-47d3-9fd4-71603055d303"&gt;Total assets measured at fair value&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 16.75pt;text-indent:-9pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Liabilities:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:15.75pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Derivative liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfMTYtMC0xLTEtMTAwNTk3_169dbe7d-a10b-4a1e-ab46-42af80460820"&gt;Total liabilities measured at fair value&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value at September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Quoted Prices in Active Markets for Identical Assets and Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(Level 1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Significant Other&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Observable Inputs&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(Level 2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Significant Unobservable Inputs&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(Level 3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Assets:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Corporate notes/bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Government agencies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S. Treasury bills&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Derivative assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred compensation plan&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Marketable equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfOC0wLTEtMS04MzI4NQ_417fadeb-557f-4f83-a995-e688c949e009"&gt;Total assets measured at fair value&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;64.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;72.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Derivative liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfMTMtMC0xLTEtODMyODU_54db5ac7-0c5e-4cf6-bc9b-f0229d68f729"&gt;Total liabilities measured at fair value&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The assets held under the Company's deferred compensation plan are classified in Level 1 as they relate primarily to publicly traded mutual funds for which there are observable market prices in active markets.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RleHRyZWdpb246NDYzNjEwOTFkZjZlNGU3MGE1NzRjM2M1ZDk5ZTNlNmZfMTgzNQ_c1712e1c-e34f-4714-a46e-94a9b536399b">In the tables below, the Company has segregated all assets and liabilities that are measured at fair value on a recurring basis into the most appropriate level within the fair value hierarchy based on the inputs used to determine the fair value at the measurement date.&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value at December 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Quoted Prices in Active Markets for Identical Assets and Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(Level 1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Significant Other&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Observable Inputs&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(Level 2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Significant Unobservable Inputs&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(Level 3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Corporate notes/bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Government agencies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S. Treasury bills&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:15.75pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Derivative assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:15.75pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred compensation plan&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Marketable equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfMTAtMC0xLTEtODMyODU_79a5037b-581b-47d3-9fd4-71603055d303"&gt;Total assets measured at fair value&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 16.75pt;text-indent:-9pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Liabilities:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:15.75pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Derivative liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfMTYtMC0xLTEtMTAwNTk3_169dbe7d-a10b-4a1e-ab46-42af80460820"&gt;Total liabilities measured at fair value&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value at September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Quoted Prices in Active Markets for Identical Assets and Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(Level 1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Significant Other&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Observable Inputs&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(Level 2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Significant Unobservable Inputs&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(Level 3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Assets:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Corporate notes/bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Government agencies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S. Treasury bills&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Derivative assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred compensation plan&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Marketable equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfOC0wLTEtMS04MzI4NQ_417fadeb-557f-4f83-a995-e688c949e009"&gt;Total assets measured at fair value&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;64.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;72.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Derivative liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfMTMtMC0xLTEtODMyODU_54db5ac7-0c5e-4cf6-bc9b-f0229d68f729"&gt;Total liabilities measured at fair value&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The assets held under the Company's deferred compensation plan are classified in Level 1 as they relate primarily to publicly traded mutual funds for which there are observable market prices in active markets.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="id8a794d22d5a488984d341691b20bb34_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfMi0xLTEtMS0xMDA1OTc_fc8d585a-0df4-47d2-a0c1-3613aaf4059e"
      unitRef="usd">0</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="i2051d8990e80499790558d1c04489cd7_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfMi0zLTEtMS0xMDA1OTc_be3fbd3c-93fc-4120-9bd3-581859a941a4"
      unitRef="usd">21500000</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="i81f291e28b0849a882c21993a4683f38_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfMi01LTEtMS0xMDA1OTc_37b6e51f-6c19-40d7-8165-814bcdb58857"
      unitRef="usd">0</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="i488f141169664a4da02df7fb3f0314cf_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfMi03LTEtMS0xMDA1OTc_e86c8d71-6525-46b6-95b7-791dca816e24"
      unitRef="usd">21500000</us-gaap:MoneyMarketFundsAtCarryingValue>
    <var:CommercialPaperReceivable
      contextRef="id8a794d22d5a488984d341691b20bb34_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfMy0xLTEtMS04MzI4NQ_43c284d0-52a6-4890-8f2a-dc7e2be574d1"
      unitRef="usd">0</var:CommercialPaperReceivable>
    <var:CommercialPaperReceivable
      contextRef="i2051d8990e80499790558d1c04489cd7_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfMy0zLTEtMS04MzI4NQ_69916f62-298d-4c10-9b9a-83d6b3e13b40"
      unitRef="usd">4900000</var:CommercialPaperReceivable>
    <var:CommercialPaperReceivable
      contextRef="i81f291e28b0849a882c21993a4683f38_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfMy01LTEtMS04MzI4NQ_991200a8-dc91-4abe-b7fe-bf99820a0503"
      unitRef="usd">0</var:CommercialPaperReceivable>
    <var:CommercialPaperReceivable
      contextRef="i488f141169664a4da02df7fb3f0314cf_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfMy03LTEtMS04MzI4NQ_34e95f9e-b923-4904-8b0d-a0d1d5a48a46"
      unitRef="usd">4900000</var:CommercialPaperReceivable>
    <var:CorporateBonds
      contextRef="id8a794d22d5a488984d341691b20bb34_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfNC0xLTEtMS04MzI4NQ_5d1fa437-eecb-4b3c-a818-75ee82216cc2"
      unitRef="usd">0</var:CorporateBonds>
    <var:CorporateBonds
      contextRef="i2051d8990e80499790558d1c04489cd7_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfNC0zLTEtMS04MzI4NQ_e1221ad6-9dd8-4147-8fcb-13de160a02e5"
      unitRef="usd">3600000</var:CorporateBonds>
    <var:CorporateBonds
      contextRef="i81f291e28b0849a882c21993a4683f38_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfNC01LTEtMS04MzI4NQ_fb51b70b-d31a-43d8-9a59-e99c7eb12c3c"
      unitRef="usd">0</var:CorporateBonds>
    <var:CorporateBonds
      contextRef="i488f141169664a4da02df7fb3f0314cf_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfNC03LTEtMS04MzI4NQ_9efeadb4-f4ee-4b9f-90f6-18eef4793dbd"
      unitRef="usd">3600000</var:CorporateBonds>
    <us-gaap:USGovernmentAgenciesSecuritiesAtCarryingValue
      contextRef="id8a794d22d5a488984d341691b20bb34_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfNS0xLTEtMS04MzI4NQ_05678122-a485-4aff-a617-1bef76e65e4d"
      unitRef="usd">0</us-gaap:USGovernmentAgenciesSecuritiesAtCarryingValue>
    <us-gaap:USGovernmentAgenciesSecuritiesAtCarryingValue
      contextRef="i2051d8990e80499790558d1c04489cd7_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfNS0zLTEtMS04MzI4NQ_6167a304-c095-46f3-8725-bdfaa7474c81"
      unitRef="usd">300000</us-gaap:USGovernmentAgenciesSecuritiesAtCarryingValue>
    <us-gaap:USGovernmentAgenciesSecuritiesAtCarryingValue
      contextRef="i81f291e28b0849a882c21993a4683f38_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfNS01LTEtMS04MzI4NQ_a10fca62-9065-4a58-b64a-ed161de74d5f"
      unitRef="usd">0</us-gaap:USGovernmentAgenciesSecuritiesAtCarryingValue>
    <us-gaap:USGovernmentAgenciesSecuritiesAtCarryingValue
      contextRef="i488f141169664a4da02df7fb3f0314cf_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfNS03LTEtMS04MzI4NQ_063f13e1-ad90-462c-a1d5-549c8d8ae956"
      unitRef="usd">300000</us-gaap:USGovernmentAgenciesSecuritiesAtCarryingValue>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="id8a794d22d5a488984d341691b20bb34_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfNi0xLTEtMS04MzI4NQ_41ba84db-d6e1-4a3e-9d4c-f98fd6782175"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i2051d8990e80499790558d1c04489cd7_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfNi0zLTEtMS04MzI4NQ_e2c26281-9eb5-490e-8782-d37ba9a3943e"
      unitRef="usd">10300000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i81f291e28b0849a882c21993a4683f38_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfNi01LTEtMS04MzI4NQ_8f92f548-9288-459e-b863-c6bf91bae1b5"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i488f141169664a4da02df7fb3f0314cf_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfNi03LTEtMS04MzI4NQ_8a88cfca-1f0a-4dee-81ef-bac35497bd22"
      unitRef="usd">10300000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:DerivativeAssets
      contextRef="id8a794d22d5a488984d341691b20bb34_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfNy0xLTEtMS04MzI4NQ_88e02c4e-a519-4533-8552-cec389fc7b64"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i2051d8990e80499790558d1c04489cd7_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfNy0zLTEtMS04MzI4NQ_fca98025-cac8-4e91-89e8-f1617894b3db"
      unitRef="usd">1100000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i81f291e28b0849a882c21993a4683f38_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfNy01LTEtMS04MzI4NQ_12cdcb3d-c287-4ce4-ab4d-49c5c4911557"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i488f141169664a4da02df7fb3f0314cf_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfNy03LTEtMS04MzI4NQ_441563ad-8243-4a16-b972-fe60371c364e"
      unitRef="usd">1100000</us-gaap:DerivativeAssets>
    <us-gaap:DeferredCompensationPlanAssets
      contextRef="id8a794d22d5a488984d341691b20bb34_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfOC0xLTEtMS04MzI4NQ_cdc2efff-043a-490e-a83d-6d8937e337ca"
      unitRef="usd">5800000</us-gaap:DeferredCompensationPlanAssets>
    <us-gaap:DeferredCompensationPlanAssets
      contextRef="i2051d8990e80499790558d1c04489cd7_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfOC0zLTEtMS04MzI4NQ_874fe074-a3ec-4a31-a948-4b72a1dd9b78"
      unitRef="usd">0</us-gaap:DeferredCompensationPlanAssets>
    <us-gaap:DeferredCompensationPlanAssets
      contextRef="i81f291e28b0849a882c21993a4683f38_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfOC01LTEtMS04MzI4NQ_6dea81b1-e7fa-4f60-9759-57abf2d3687c"
      unitRef="usd">0</us-gaap:DeferredCompensationPlanAssets>
    <us-gaap:DeferredCompensationPlanAssets
      contextRef="i488f141169664a4da02df7fb3f0314cf_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfOC03LTEtMS04MzI4NQ_94494a69-5015-42d2-8996-b10e8b19636a"
      unitRef="usd">5800000</us-gaap:DeferredCompensationPlanAssets>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="id8a794d22d5a488984d341691b20bb34_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfOS0xLTEtMS0xMDA1OTc_4973fafd-5dce-4667-8310-d55f46a67174"
      unitRef="usd">4500000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i2051d8990e80499790558d1c04489cd7_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfOS0zLTEtMS0xMDA1OTc_5dd1002b-50e2-4c9b-b5b5-8ea5a558fcac"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i81f291e28b0849a882c21993a4683f38_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfOS01LTEtMS0xMDA1OTc_7fbf7cff-8218-467d-a634-7b4490a19ca0"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i488f141169664a4da02df7fb3f0314cf_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfOS03LTEtMS0xMDA1OTc_04fbd306-b5cb-4a7e-a524-a24cab002004"
      unitRef="usd">4500000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="id8a794d22d5a488984d341691b20bb34_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfMTAtMS0xLTEtMTAwNTk3_9b29efc7-97ab-42a8-a847-9a7df12f1e02"
      unitRef="usd">10300000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i2051d8990e80499790558d1c04489cd7_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfMTAtMy0xLTEtMTAwNTk3_d8a214ad-fc19-434b-ba38-96af2a27108e"
      unitRef="usd">41700000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i81f291e28b0849a882c21993a4683f38_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfMTAtNS0xLTEtMTAwNTk3_be5dd9d2-af51-4a0d-b74e-c961a9ee07ec"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i488f141169664a4da02df7fb3f0314cf_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfMTAtNy0xLTEtMTAwNTk3_7bc7aae9-24a6-417a-921b-17aeb5220664"
      unitRef="usd">52000000.0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:DerivativeLiabilities
      contextRef="id8a794d22d5a488984d341691b20bb34_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfMTMtMS0xLTEtODMyODU_3f5f9ae1-c52a-45ae-8ef8-283b7db754b8"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i2051d8990e80499790558d1c04489cd7_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfMTMtMy0xLTEtODMyODU_ea2daa6b-b1f4-4de2-b477-8e8390665b61"
      unitRef="usd">4700000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i81f291e28b0849a882c21993a4683f38_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfMTMtNS0xLTEtODMyODU_4e7b818f-c6bf-4ebb-90a4-35805de1329e"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i488f141169664a4da02df7fb3f0314cf_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfMTMtNy0xLTEtODMyODU_7d46b4b5-cf8e-4a5b-a30e-9bc48b977508"
      unitRef="usd">4700000</us-gaap:DerivativeLiabilities>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="id8a794d22d5a488984d341691b20bb34_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfMTYtMS0xLTEtMTAwNTk3_09bf53b6-4155-4521-bc95-ed1fa835f34a"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i2051d8990e80499790558d1c04489cd7_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfMTYtMy0xLTEtMTAwNTk3_3a736a3e-ddad-4910-b155-a3d672343f74"
      unitRef="usd">4700000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i81f291e28b0849a882c21993a4683f38_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfMTYtNS0xLTEtMTAwNTk3_51226296-2f7b-44bb-b526-a28d6b8bb71f"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i488f141169664a4da02df7fb3f0314cf_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjU2YmNmNDIzN2Y4MDQzNjc5NTcyNjgxNWI5ZWNkZjhkL3RhYmxlcmFuZ2U6NTZiY2Y0MjM3ZjgwNDM2Nzk1NzI2ODE1YjllY2RmOGRfMTYtNy0xLTEtMTAwNTk3_4bec1126-5c06-444b-80b9-a208abe991a9"
      unitRef="usd">4700000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="i000a217e3c2d4af68d6fb28636848da6_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfMy0xLTEtMS04MzI4NQ_772e54b0-91e4-4054-9971-105b74d19fd3"
      unitRef="usd">0</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="i080aeddcac46466b8c187b8b0b5615b0_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfMy0zLTEtMS04MzI4NQ_7482ac41-6c01-4746-8f1c-be463f3692e1"
      unitRef="usd">36600000</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="i24674ea6cbf44864812dadb6e95f2db8_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfMy01LTEtMS04MzI4NQ_a55401c7-5917-4493-a919-e8f51b751486"
      unitRef="usd">0</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="i9240c6083244455c8602c53af33d914d_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfMy03LTEtMS04MzI4NQ_fb4911bc-85ac-448e-92f2-fd1919ace08b"
      unitRef="usd">36600000</us-gaap:MoneyMarketFundsAtCarryingValue>
    <var:CommercialPaperReceivable
      contextRef="i000a217e3c2d4af68d6fb28636848da6_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfNC0xLTEtMS04MzI4NQ_d65af685-69e2-47c1-828b-7aca63d62a2d"
      unitRef="usd">0</var:CommercialPaperReceivable>
    <var:CommercialPaperReceivable
      contextRef="i080aeddcac46466b8c187b8b0b5615b0_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfNC0zLTEtMS04MzI4NQ_5039ac24-b8ac-4675-8761-e6b946ba8f16"
      unitRef="usd">5900000</var:CommercialPaperReceivable>
    <var:CommercialPaperReceivable
      contextRef="i24674ea6cbf44864812dadb6e95f2db8_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfNC01LTEtMS04MzI4NQ_05557042-7327-4dde-aa16-3c69f3c27aa1"
      unitRef="usd">0</var:CommercialPaperReceivable>
    <var:CommercialPaperReceivable
      contextRef="i9240c6083244455c8602c53af33d914d_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfNC03LTEtMS04MzI4NQ_c55b575a-5d83-4b6d-8d66-002f4200a901"
      unitRef="usd">5900000</var:CommercialPaperReceivable>
    <var:CorporateBonds
      contextRef="i000a217e3c2d4af68d6fb28636848da6_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfNS0xLTEtMS04MzI4NQ_a3985753-31fc-4008-925e-49d2f445247c"
      unitRef="usd">0</var:CorporateBonds>
    <var:CorporateBonds
      contextRef="i080aeddcac46466b8c187b8b0b5615b0_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfNS0zLTEtMS04MzI4NQ_0253c001-43b7-4755-baa4-84b9e6ef3a21"
      unitRef="usd">3600000</var:CorporateBonds>
    <var:CorporateBonds
      contextRef="i24674ea6cbf44864812dadb6e95f2db8_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfNS01LTEtMS04MzI4NQ_cdff6ba6-73ca-4b2b-b048-db1d68caafd3"
      unitRef="usd">0</var:CorporateBonds>
    <var:CorporateBonds
      contextRef="i9240c6083244455c8602c53af33d914d_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfNS03LTEtMS04MzI4NQ_519089bb-59d3-4b15-b8d2-8d6d506451be"
      unitRef="usd">3600000</var:CorporateBonds>
    <us-gaap:USGovernmentAgenciesSecuritiesAtCarryingValue
      contextRef="i000a217e3c2d4af68d6fb28636848da6_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfNi0xLTEtMS05NTYzNQ_23a3aa68-f08d-4ae5-95c9-2be2dc82e83f"
      unitRef="usd">0</us-gaap:USGovernmentAgenciesSecuritiesAtCarryingValue>
    <us-gaap:USGovernmentAgenciesSecuritiesAtCarryingValue
      contextRef="i080aeddcac46466b8c187b8b0b5615b0_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfNi0zLTEtMS05NTYzNQ_128015c4-ec3f-405c-b385-1a334f450fd4"
      unitRef="usd">300000</us-gaap:USGovernmentAgenciesSecuritiesAtCarryingValue>
    <us-gaap:USGovernmentAgenciesSecuritiesAtCarryingValue
      contextRef="i24674ea6cbf44864812dadb6e95f2db8_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfNi01LTEtMS05NTYzNQ_7ab76d23-e033-41a7-96de-18b94e11dbaf"
      unitRef="usd">0</us-gaap:USGovernmentAgenciesSecuritiesAtCarryingValue>
    <us-gaap:USGovernmentAgenciesSecuritiesAtCarryingValue
      contextRef="i9240c6083244455c8602c53af33d914d_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfNi03LTEtMS05NTYzNQ_d31c4c14-ebbb-415d-9824-f216d1f6a113"
      unitRef="usd">300000</us-gaap:USGovernmentAgenciesSecuritiesAtCarryingValue>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i000a217e3c2d4af68d6fb28636848da6_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfNy0xLTEtMS05NTYzNQ_462382f8-1690-4ae8-be1d-3ee47b355032"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i080aeddcac46466b8c187b8b0b5615b0_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfNy0zLTEtMS05NTYzNQ_a43778af-a65f-4798-bbad-82c5f72129b9"
      unitRef="usd">10200000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i24674ea6cbf44864812dadb6e95f2db8_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfNy01LTEtMS05NTYzNQ_c3979171-120c-4832-8738-c65b2675ec6b"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i9240c6083244455c8602c53af33d914d_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfNy03LTEtMS05NTYzNQ_dc043b0c-eb74-4752-9d96-f8469dd01625"
      unitRef="usd">10200000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:DerivativeAssets
      contextRef="i000a217e3c2d4af68d6fb28636848da6_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfNi0xLTEtMS04MzI4NQ_104802dd-5663-48e9-9aaa-a21878908a87"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i080aeddcac46466b8c187b8b0b5615b0_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfNi0zLTEtMS04MzI4NQ_f8e2a045-856b-43ba-a506-b6740a8f162c"
      unitRef="usd">7500000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i24674ea6cbf44864812dadb6e95f2db8_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfNi01LTEtMS04MzI4NQ_91395662-ac9e-4349-9298-8b37eb5930d3"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i9240c6083244455c8602c53af33d914d_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfNi03LTEtMS04MzI4NQ_807e8673-3b07-4dbc-871e-d585caf8235b"
      unitRef="usd">7500000</us-gaap:DerivativeAssets>
    <us-gaap:DeferredCompensationPlanAssets
      contextRef="i000a217e3c2d4af68d6fb28636848da6_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfOS0xLTEtMS0xMDA3NTA_54a279ad-9f0d-4f09-9d92-0a1dcd51a8c1"
      unitRef="usd">5400000</us-gaap:DeferredCompensationPlanAssets>
    <us-gaap:DeferredCompensationPlanAssets
      contextRef="i080aeddcac46466b8c187b8b0b5615b0_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfOS0zLTEtMS0xMDA3NTA_cf6f8415-9cf9-4296-9d7b-c2e2a4bcb221"
      unitRef="usd">0</us-gaap:DeferredCompensationPlanAssets>
    <us-gaap:DeferredCompensationPlanAssets
      contextRef="i24674ea6cbf44864812dadb6e95f2db8_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfOS01LTEtMS0xMDA3NTA_27423983-916b-41b2-9cbd-869149b44e02"
      unitRef="usd">0</us-gaap:DeferredCompensationPlanAssets>
    <us-gaap:DeferredCompensationPlanAssets
      contextRef="i9240c6083244455c8602c53af33d914d_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfOS03LTEtMS0xMDA3NTA_9d5bc143-5fe8-4d4e-9428-fe4290c7bf23"
      unitRef="usd">5400000</us-gaap:DeferredCompensationPlanAssets>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i000a217e3c2d4af68d6fb28636848da6_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfNy0xLTEtMS04MzI4NQ_ae91b5ce-d836-472b-aaed-1c9a89d9a402"
      unitRef="usd">2500000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i080aeddcac46466b8c187b8b0b5615b0_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfNy0zLTEtMS04MzI4NQ_4377592d-b455-4ef5-95cb-bae7c3c12243"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i24674ea6cbf44864812dadb6e95f2db8_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfNy01LTEtMS04MzI4NQ_9d6a6a48-cce7-4fde-b125-d8094a9c0c87"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i9240c6083244455c8602c53af33d914d_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfNy03LTEtMS04MzI4NQ_ba4dc9ff-820f-4ba2-aa2a-7c628bcfdafe"
      unitRef="usd">2500000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i000a217e3c2d4af68d6fb28636848da6_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfOC0xLTEtMS04MzI4NQ_3e018e38-daa2-412e-8ee7-1afea331198b"
      unitRef="usd">7900000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i080aeddcac46466b8c187b8b0b5615b0_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfOC0zLTEtMS04MzI4NQ_e03b1b74-4cfe-4744-9ed7-610e1f2100b1"
      unitRef="usd">64100000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i24674ea6cbf44864812dadb6e95f2db8_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfOC01LTEtMS04MzI4NQ_fdf3ef67-23db-4351-a4c8-82c57f825e9c"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i9240c6083244455c8602c53af33d914d_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfOC03LTEtMS04MzI4NQ_a09e2179-4e69-4b40-86a0-3ab71531d1de"
      unitRef="usd">72000000.0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:DerivativeLiabilities
      contextRef="i000a217e3c2d4af68d6fb28636848da6_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfMTEtMS0xLTEtODMyODU_7a5d5319-28e5-4e34-ad14-2ae5bb40df0d"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i080aeddcac46466b8c187b8b0b5615b0_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfMTEtMy0xLTEtODMyODU_11e52e23-9a34-4454-9a77-2f3289bb4167"
      unitRef="usd">300000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i24674ea6cbf44864812dadb6e95f2db8_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfMTEtNS0xLTEtODMyODU_6bc33e6f-4771-48e3-909d-007a72541546"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i9240c6083244455c8602c53af33d914d_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfMTEtNy0xLTEtODMyODU_454acc8b-d1d8-4831-ad58-602ea48d0a67"
      unitRef="usd">300000</us-gaap:DerivativeLiabilities>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i000a217e3c2d4af68d6fb28636848da6_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfMTMtMS0xLTEtODMyODU_cad9e9bf-b411-436f-ad24-397e2ee182f2"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i080aeddcac46466b8c187b8b0b5615b0_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfMTMtMy0xLTEtODMyODU_3d178a5c-db12-4460-86dd-629b957e622c"
      unitRef="usd">300000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i24674ea6cbf44864812dadb6e95f2db8_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfMTMtNS0xLTEtODMyODU_2ace6bd9-644e-4693-8d0e-0a9f8990254e"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i9240c6083244455c8602c53af33d914d_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmJjOTg0OTFlYzAxYjQwMzBiOWVhNDk1YTljNTQwMzFiL3RhYmxlcmFuZ2U6YmM5ODQ5MWVjMDFiNDAzMGI5ZWE0OTVhOWM1NDAzMWJfMTMtNy0xLTEtODMyODU_79b77c71-5ae2-4f00-b4a1-6b365686ed8c"
      unitRef="usd">300000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:GainLossOnInvestmentsTextBlock
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RleHRyZWdpb246NDYzNjEwOTFkZjZlNGU3MGE1NzRjM2M1ZDk5ZTNlNmZfMTgzMA_b133ca51-c0d6-4c5b-bcc6-a4f5bb554f6b">The following tables summarize the Company's marketable debt securities:&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.511%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Amortized Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Corporate notes/bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S. Treasury bills&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Government agencies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total marketable debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.511%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Amortized Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Corporate notes/bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S. Treasury bills&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Government agencies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total marketable debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:GainLossOnInvestmentsTextBlock>
    <var:MarketableSecuritiesAmortizedCost
      contextRef="i10a7807457d845b9ad4ed44aed8912db_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmIyZDJjYzYzMWEzYTQ1MzBhMmQ1OTkwNDQxYTkyZDVmL3RhYmxlcmFuZ2U6YjJkMmNjNjMxYTNhNDUzMGEyZDU5OTA0NDFhOTJkNWZfMy0xLTEtMS04MzI4NQ_76e22274-8401-4092-8fd6-ded677def2d6"
      unitRef="usd">4900000</var:MarketableSecuritiesAmortizedCost>
    <var:MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i10a7807457d845b9ad4ed44aed8912db_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmIyZDJjYzYzMWEzYTQ1MzBhMmQ1OTkwNDQxYTkyZDVmL3RhYmxlcmFuZ2U6YjJkMmNjNjMxYTNhNDUzMGEyZDU5OTA0NDFhOTJkNWZfMy01LTEtMS04MzI4NQ_a31f1695-a943-485d-b26c-16b48ca14310"
      unitRef="usd">0</var:MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:MarketableSecurities
      contextRef="i10a7807457d845b9ad4ed44aed8912db_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmIyZDJjYzYzMWEzYTQ1MzBhMmQ1OTkwNDQxYTkyZDVmL3RhYmxlcmFuZ2U6YjJkMmNjNjMxYTNhNDUzMGEyZDU5OTA0NDFhOTJkNWZfMy03LTEtMS04MzI4NQ_c781b692-f5a5-4d48-a338-2f49113ece7e"
      unitRef="usd">4900000</us-gaap:MarketableSecurities>
    <var:MarketableSecuritiesAmortizedCost
      contextRef="i7fddba25d3464fc88f2322c862ad8fda_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmIyZDJjYzYzMWEzYTQ1MzBhMmQ1OTkwNDQxYTkyZDVmL3RhYmxlcmFuZ2U6YjJkMmNjNjMxYTNhNDUzMGEyZDU5OTA0NDFhOTJkNWZfNC0xLTEtMS04MzI4NQ_2df0cdbb-67a0-47df-ba48-f84e0317b078"
      unitRef="usd">3700000</var:MarketableSecuritiesAmortizedCost>
    <var:MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i7fddba25d3464fc88f2322c862ad8fda_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmIyZDJjYzYzMWEzYTQ1MzBhMmQ1OTkwNDQxYTkyZDVmL3RhYmxlcmFuZ2U6YjJkMmNjNjMxYTNhNDUzMGEyZDU5OTA0NDFhOTJkNWZfNC01LTEtMS04MzI4NQ_bbce25f3-401d-461b-8a18-918d86874ff6"
      unitRef="usd">100000</var:MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:MarketableSecurities
      contextRef="i7fddba25d3464fc88f2322c862ad8fda_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmIyZDJjYzYzMWEzYTQ1MzBhMmQ1OTkwNDQxYTkyZDVmL3RhYmxlcmFuZ2U6YjJkMmNjNjMxYTNhNDUzMGEyZDU5OTA0NDFhOTJkNWZfNC03LTEtMS04MzI4NQ_705a58c6-1d65-4430-8163-cf7efaeeef48"
      unitRef="usd">3600000</us-gaap:MarketableSecurities>
    <var:MarketableSecuritiesAmortizedCost
      contextRef="i6600d15de2c54873830ce25e54e2f1e4_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmIyZDJjYzYzMWEzYTQ1MzBhMmQ1OTkwNDQxYTkyZDVmL3RhYmxlcmFuZ2U6YjJkMmNjNjMxYTNhNDUzMGEyZDU5OTA0NDFhOTJkNWZfNS0xLTEtMS04MzI4NQ_ffb4cb80-08ca-46b5-891a-34391d20b748"
      unitRef="usd">10300000</var:MarketableSecuritiesAmortizedCost>
    <var:MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i6600d15de2c54873830ce25e54e2f1e4_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmIyZDJjYzYzMWEzYTQ1MzBhMmQ1OTkwNDQxYTkyZDVmL3RhYmxlcmFuZ2U6YjJkMmNjNjMxYTNhNDUzMGEyZDU5OTA0NDFhOTJkNWZfNS01LTEtMS04MzI4NQ_9edacf4d-60a6-404e-9719-3573138f248b"
      unitRef="usd">0</var:MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:MarketableSecurities
      contextRef="i6600d15de2c54873830ce25e54e2f1e4_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmIyZDJjYzYzMWEzYTQ1MzBhMmQ1OTkwNDQxYTkyZDVmL3RhYmxlcmFuZ2U6YjJkMmNjNjMxYTNhNDUzMGEyZDU5OTA0NDFhOTJkNWZfNS03LTEtMS04MzI4NQ_1f81b8a4-8e4d-419e-93a4-e2ba30fd403d"
      unitRef="usd">10300000</us-gaap:MarketableSecurities>
    <var:MarketableSecuritiesAmortizedCost
      contextRef="id304dfd7514641719c5a17d4ab0bed7a_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmIyZDJjYzYzMWEzYTQ1MzBhMmQ1OTkwNDQxYTkyZDVmL3RhYmxlcmFuZ2U6YjJkMmNjNjMxYTNhNDUzMGEyZDU5OTA0NDFhOTJkNWZfNi0xLTEtMS05NTY1MA_115bb1b1-59aa-42b8-8407-4088240406e4"
      unitRef="usd">300000</var:MarketableSecuritiesAmortizedCost>
    <var:MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="id304dfd7514641719c5a17d4ab0bed7a_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmIyZDJjYzYzMWEzYTQ1MzBhMmQ1OTkwNDQxYTkyZDVmL3RhYmxlcmFuZ2U6YjJkMmNjNjMxYTNhNDUzMGEyZDU5OTA0NDFhOTJkNWZfNi01LTEtMS05NTY1MA_a1a14f7a-03fe-461d-a476-a35842625492"
      unitRef="usd">0</var:MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:MarketableSecurities
      contextRef="id304dfd7514641719c5a17d4ab0bed7a_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmIyZDJjYzYzMWEzYTQ1MzBhMmQ1OTkwNDQxYTkyZDVmL3RhYmxlcmFuZ2U6YjJkMmNjNjMxYTNhNDUzMGEyZDU5OTA0NDFhOTJkNWZfNi03LTEtMS05NTY1MA_4fea9528-3408-4e07-b5bd-acb87a551b19"
      unitRef="usd">300000</us-gaap:MarketableSecurities>
    <var:MarketableSecuritiesAmortizedCost
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmIyZDJjYzYzMWEzYTQ1MzBhMmQ1OTkwNDQxYTkyZDVmL3RhYmxlcmFuZ2U6YjJkMmNjNjMxYTNhNDUzMGEyZDU5OTA0NDFhOTJkNWZfOS0xLTEtMS04MzI4NQ_d27509a0-27a7-4eab-8125-ecd0f9fc3cde"
      unitRef="usd">19200000</var:MarketableSecuritiesAmortizedCost>
    <var:MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmIyZDJjYzYzMWEzYTQ1MzBhMmQ1OTkwNDQxYTkyZDVmL3RhYmxlcmFuZ2U6YjJkMmNjNjMxYTNhNDUzMGEyZDU5OTA0NDFhOTJkNWZfOS01LTEtMS04MzI4NQ_2bf67272-5e70-4036-a357-996dff775612"
      unitRef="usd">100000</var:MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:MarketableSecurities
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmIyZDJjYzYzMWEzYTQ1MzBhMmQ1OTkwNDQxYTkyZDVmL3RhYmxlcmFuZ2U6YjJkMmNjNjMxYTNhNDUzMGEyZDU5OTA0NDFhOTJkNWZfOS03LTEtMS04MzI4NQ_b0b423ec-9475-4721-b551-8f558c71b7c7"
      unitRef="usd">19100000</us-gaap:MarketableSecurities>
    <var:MarketableSecuritiesAmortizedCost
      contextRef="i11d163dc0c7e4f778d0934c68fbd9ed9_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjZkZGE2OWRlY2QxZjQyOWY4NzBjMDE0ZTcwOWVhODE0L3RhYmxlcmFuZ2U6NmRkYTY5ZGVjZDFmNDI5Zjg3MGMwMTRlNzA5ZWE4MTRfMy0xLTEtMS05NTcwNA_81ca5f8d-d0e6-46ee-9a99-6f9caf4e718a"
      unitRef="usd">5900000</var:MarketableSecuritiesAmortizedCost>
    <var:MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i11d163dc0c7e4f778d0934c68fbd9ed9_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjZkZGE2OWRlY2QxZjQyOWY4NzBjMDE0ZTcwOWVhODE0L3RhYmxlcmFuZ2U6NmRkYTY5ZGVjZDFmNDI5Zjg3MGMwMTRlNzA5ZWE4MTRfMy01LTEtMS05NTcwNA_daadac97-4c73-471a-9db5-25c8d1f38c04"
      unitRef="usd">0</var:MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:MarketableSecurities
      contextRef="i11d163dc0c7e4f778d0934c68fbd9ed9_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjZkZGE2OWRlY2QxZjQyOWY4NzBjMDE0ZTcwOWVhODE0L3RhYmxlcmFuZ2U6NmRkYTY5ZGVjZDFmNDI5Zjg3MGMwMTRlNzA5ZWE4MTRfMy03LTEtMS05NTcwNA_3a8a8fe4-4c13-4c77-b119-0e28955351f0"
      unitRef="usd">5900000</us-gaap:MarketableSecurities>
    <var:MarketableSecuritiesAmortizedCost
      contextRef="i09336e03a3124b3e8abcf83f054dfc6e_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjZkZGE2OWRlY2QxZjQyOWY4NzBjMDE0ZTcwOWVhODE0L3RhYmxlcmFuZ2U6NmRkYTY5ZGVjZDFmNDI5Zjg3MGMwMTRlNzA5ZWE4MTRfNC0xLTEtMS05NTcwNA_7e0c9a34-0ade-4fcb-9d86-ea27ca0d861c"
      unitRef="usd">3700000</var:MarketableSecuritiesAmortizedCost>
    <var:MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i09336e03a3124b3e8abcf83f054dfc6e_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjZkZGE2OWRlY2QxZjQyOWY4NzBjMDE0ZTcwOWVhODE0L3RhYmxlcmFuZ2U6NmRkYTY5ZGVjZDFmNDI5Zjg3MGMwMTRlNzA5ZWE4MTRfNC01LTEtMS05NTcwNA_c309bb60-5cbc-4726-b913-09729c192a79"
      unitRef="usd">100000</var:MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:MarketableSecurities
      contextRef="i09336e03a3124b3e8abcf83f054dfc6e_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjZkZGE2OWRlY2QxZjQyOWY4NzBjMDE0ZTcwOWVhODE0L3RhYmxlcmFuZ2U6NmRkYTY5ZGVjZDFmNDI5Zjg3MGMwMTRlNzA5ZWE4MTRfNC03LTEtMS05NTcwNA_6fe2e804-df98-4d0b-8083-d6f15cb9a22d"
      unitRef="usd">3600000</us-gaap:MarketableSecurities>
    <var:MarketableSecuritiesAmortizedCost
      contextRef="i76a7050d54304267a10c2a2ff2669153_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjZkZGE2OWRlY2QxZjQyOWY4NzBjMDE0ZTcwOWVhODE0L3RhYmxlcmFuZ2U6NmRkYTY5ZGVjZDFmNDI5Zjg3MGMwMTRlNzA5ZWE4MTRfNS0xLTEtMS05NTcwNA_06c54747-3564-49de-86b8-ac88d5d7ffdf"
      unitRef="usd">10200000</var:MarketableSecuritiesAmortizedCost>
    <var:MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i76a7050d54304267a10c2a2ff2669153_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjZkZGE2OWRlY2QxZjQyOWY4NzBjMDE0ZTcwOWVhODE0L3RhYmxlcmFuZ2U6NmRkYTY5ZGVjZDFmNDI5Zjg3MGMwMTRlNzA5ZWE4MTRfNS01LTEtMS05NTcwNA_0e801d5c-a9fc-45bd-9b15-b41ee6427eb7"
      unitRef="usd">0</var:MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:MarketableSecurities
      contextRef="i76a7050d54304267a10c2a2ff2669153_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjZkZGE2OWRlY2QxZjQyOWY4NzBjMDE0ZTcwOWVhODE0L3RhYmxlcmFuZ2U6NmRkYTY5ZGVjZDFmNDI5Zjg3MGMwMTRlNzA5ZWE4MTRfNS03LTEtMS05NTcwNA_db492a49-b88c-4a53-a289-ee3b0892681a"
      unitRef="usd">10200000</us-gaap:MarketableSecurities>
    <var:MarketableSecuritiesAmortizedCost
      contextRef="i47928432e34e44fab0fa2e3e5ea1c268_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjZkZGE2OWRlY2QxZjQyOWY4NzBjMDE0ZTcwOWVhODE0L3RhYmxlcmFuZ2U6NmRkYTY5ZGVjZDFmNDI5Zjg3MGMwMTRlNzA5ZWE4MTRfNi0xLTEtMS05NTcwNA_673be601-f62f-4975-87c6-28039a307752"
      unitRef="usd">300000</var:MarketableSecuritiesAmortizedCost>
    <var:MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i47928432e34e44fab0fa2e3e5ea1c268_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjZkZGE2OWRlY2QxZjQyOWY4NzBjMDE0ZTcwOWVhODE0L3RhYmxlcmFuZ2U6NmRkYTY5ZGVjZDFmNDI5Zjg3MGMwMTRlNzA5ZWE4MTRfNi01LTEtMS05NTcwNA_29d77731-c1f5-4d71-ab78-3cbd0c6d3c17"
      unitRef="usd">0</var:MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:MarketableSecurities
      contextRef="i47928432e34e44fab0fa2e3e5ea1c268_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjZkZGE2OWRlY2QxZjQyOWY4NzBjMDE0ZTcwOWVhODE0L3RhYmxlcmFuZ2U6NmRkYTY5ZGVjZDFmNDI5Zjg3MGMwMTRlNzA5ZWE4MTRfNi03LTEtMS05NTcwNA_8d68d8bd-c863-4f10-83d2-86ada0fd3744"
      unitRef="usd">300000</us-gaap:MarketableSecurities>
    <var:MarketableSecuritiesAmortizedCost
      contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjZkZGE2OWRlY2QxZjQyOWY4NzBjMDE0ZTcwOWVhODE0L3RhYmxlcmFuZ2U6NmRkYTY5ZGVjZDFmNDI5Zjg3MGMwMTRlNzA5ZWE4MTRfOS0xLTEtMS05NTcwNA_6528371d-ad0b-428f-900d-e24a4af520c6"
      unitRef="usd">20100000</var:MarketableSecuritiesAmortizedCost>
    <var:MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjZkZGE2OWRlY2QxZjQyOWY4NzBjMDE0ZTcwOWVhODE0L3RhYmxlcmFuZ2U6NmRkYTY5ZGVjZDFmNDI5Zjg3MGMwMTRlNzA5ZWE4MTRfOS01LTEtMS05NTcwNA_c7836924-30c8-47b9-968d-c4049469dc14"
      unitRef="usd">100000</var:MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:MarketableSecurities
      contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjZkZGE2OWRlY2QxZjQyOWY4NzBjMDE0ZTcwOWVhODE0L3RhYmxlcmFuZ2U6NmRkYTY5ZGVjZDFmNDI5Zjg3MGMwMTRlNzA5ZWE4MTRfOS03LTEtMS05NTcwNA_fce15bd9-7ec3-405e-a84a-481ff5e7b5c3"
      unitRef="usd">20000000.0</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecuritiesTextBlock
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RleHRyZWdpb246NDYzNjEwOTFkZjZlNGU3MGE1NzRjM2M1ZDk5ZTNlNmZfMTgxNQ_754bf6a8-c2b9-4ddb-b2c0-64cde89a932f">The contractual maturities of marketable debt securities as of December&#160;30, 2022, are shown in the table below. Actual maturities may differ from contractual maturities because borrowers may have the right to call or prepay obligations.&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Amortized Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contractual maturities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Due within one year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Due after one year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total marketable debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;The following tables summarize the balance sheet locations for marketable debt securities:&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.511%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.650%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.650%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.650%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.650%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.652%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Corporate notes/bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Government agencies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Treasury bills&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total marketable debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.650%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.511%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.650%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.650%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.650%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.652%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Corporate notes/bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Government agencies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Treasury bills&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total marketable debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:MarketableSecuritiesTextBlock>
    <var:MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateRollingWithinOneYearAmortizedCost
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjc0ZTkyNmIwNDEwMjQwODdhMjNmMDM4OWMyNTllNDEyL3RhYmxlcmFuZ2U6NzRlOTI2YjA0MTAyNDA4N2EyM2YwMzg5YzI1OWU0MTJfMy0xLTEtMS04MzI4NQ_1511c8f2-4f7e-4066-aa80-42d826721499"
      unitRef="usd">16800000</var:MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateRollingWithinOneYearAmortizedCost>
    <var:MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateYearOne
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjc0ZTkyNmIwNDEwMjQwODdhMjNmMDM4OWMyNTllNDEyL3RhYmxlcmFuZ2U6NzRlOTI2YjA0MTAyNDA4N2EyM2YwMzg5YzI1OWU0MTJfMy0zLTEtMS04MzI4NQ_f40eddd2-1764-4dcd-bbc7-1c425730c42e"
      unitRef="usd">16700000</var:MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateYearOne>
    <var:MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateRollingAfterOneThroughFiveYearsAmortizedCost
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjc0ZTkyNmIwNDEwMjQwODdhMjNmMDM4OWMyNTllNDEyL3RhYmxlcmFuZ2U6NzRlOTI2YjA0MTAyNDA4N2EyM2YwMzg5YzI1OWU0MTJfNC0xLTEtMS04MzI4NQ_87414104-c0d1-47cf-ae73-50ae5f598cae"
      unitRef="usd">2400000</var:MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateRollingAfterOneThroughFiveYearsAmortizedCost>
    <var:MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughFive
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjc0ZTkyNmIwNDEwMjQwODdhMjNmMDM4OWMyNTllNDEyL3RhYmxlcmFuZ2U6NzRlOTI2YjA0MTAyNDA4N2EyM2YwMzg5YzI1OWU0MTJfNC0zLTEtMS04MzI4NQ_0d0ffdff-b5f6-46ef-b86d-367d6842638a"
      unitRef="usd">2400000</var:MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughFive>
    <var:MarketableSecuritiesAmortizedCost
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjc0ZTkyNmIwNDEwMjQwODdhMjNmMDM4OWMyNTllNDEyL3RhYmxlcmFuZ2U6NzRlOTI2YjA0MTAyNDA4N2EyM2YwMzg5YzI1OWU0MTJfOS0xLTEtMS04MzI4NQ_a2f48f17-fb17-412c-b042-d2f48341fbe0"
      unitRef="usd">19200000</var:MarketableSecuritiesAmortizedCost>
    <us-gaap:MarketableSecurities
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjc0ZTkyNmIwNDEwMjQwODdhMjNmMDM4OWMyNTllNDEyL3RhYmxlcmFuZ2U6NzRlOTI2YjA0MTAyNDA4N2EyM2YwMzg5YzI1OWU0MTJfOS0zLTEtMS04MzI4NQ_1007e095-117b-46a0-8d42-6ce980d8e19e"
      unitRef="usd">19100000</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities
      contextRef="if73dd818790943af8e76d7d0bd61ece8_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmVlNTk1OGU2OGZlYzRkOThhNzFkODQ2NDU5YTUyOGQ1L3RhYmxlcmFuZ2U6ZWU1OTU4ZTY4ZmVjNGQ5OGE3MWQ4NDY0NTlhNTI4ZDVfMy0xLTEtMS04MzI4NQ_c024ffb0-ec1c-4b87-9574-06cbc4d0b58c"
      unitRef="usd">4900000</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities
      contextRef="id1e9242ff3354b2a960503fd1761aab2_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmVlNTk1OGU2OGZlYzRkOThhNzFkODQ2NDU5YTUyOGQ1L3RhYmxlcmFuZ2U6ZWU1OTU4ZTY4ZmVjNGQ5OGE3MWQ4NDY0NTlhNTI4ZDVfMy0zLTEtMS04MzI4NQ_e55bea70-54a9-4ecc-87ff-72134855e738"
      unitRef="usd">2400000</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities
      contextRef="i92e88468ba3d48a7a063bee1e0f0318a_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmVlNTk1OGU2OGZlYzRkOThhNzFkODQ2NDU5YTUyOGQ1L3RhYmxlcmFuZ2U6ZWU1OTU4ZTY4ZmVjNGQ5OGE3MWQ4NDY0NTlhNTI4ZDVfMy01LTEtMS04MzI4NQ_ccf36ebb-e81f-4d00-81ac-8fdb0349409c"
      unitRef="usd">300000</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities
      contextRef="i6f7a180ea39443b694aaf7dd07ad1096_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmVlNTk1OGU2OGZlYzRkOThhNzFkODQ2NDU5YTUyOGQ1L3RhYmxlcmFuZ2U6ZWU1OTU4ZTY4ZmVjNGQ5OGE3MWQ4NDY0NTlhNTI4ZDVfMy03LTEtMS04MzI4NQ_1ad10172-9b27-4c6c-9649-ae75eba50df1"
      unitRef="usd">9100000</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities
      contextRef="i820b739701b04c498136aad1494d10a5_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmVlNTk1OGU2OGZlYzRkOThhNzFkODQ2NDU5YTUyOGQ1L3RhYmxlcmFuZ2U6ZWU1OTU4ZTY4ZmVjNGQ5OGE3MWQ4NDY0NTlhNTI4ZDVfMy05LTEtMS0xMDA1Mzc_73ae59b0-f817-474e-9211-e41ce58c0c50"
      unitRef="usd">16700000</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities
      contextRef="i6ae6c3be3d534e909bf65cafdb441f13_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmVlNTk1OGU2OGZlYzRkOThhNzFkODQ2NDU5YTUyOGQ1L3RhYmxlcmFuZ2U6ZWU1OTU4ZTY4ZmVjNGQ5OGE3MWQ4NDY0NTlhNTI4ZDVfNC0xLTEtMS04MzI4NQ_250bccdb-1ab3-431b-b728-9375743a1509"
      unitRef="usd">0</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities
      contextRef="i6ca9a72270ef4471b61390923b253af8_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmVlNTk1OGU2OGZlYzRkOThhNzFkODQ2NDU5YTUyOGQ1L3RhYmxlcmFuZ2U6ZWU1OTU4ZTY4ZmVjNGQ5OGE3MWQ4NDY0NTlhNTI4ZDVfNC0zLTEtMS04MzI4NQ_d4309e74-f8d3-4700-84a3-3e53a6dee4da"
      unitRef="usd">1200000</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities
      contextRef="iabebb79ab33a45a88797388ed198ebff_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmVlNTk1OGU2OGZlYzRkOThhNzFkODQ2NDU5YTUyOGQ1L3RhYmxlcmFuZ2U6ZWU1OTU4ZTY4ZmVjNGQ5OGE3MWQ4NDY0NTlhNTI4ZDVfNC01LTEtMS04MzI4NQ_b59d499f-f012-4a4e-9df3-be9fd5293bc5"
      unitRef="usd">0</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities
      contextRef="i3ce0938959034f01ba57216c7cb057f4_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmVlNTk1OGU2OGZlYzRkOThhNzFkODQ2NDU5YTUyOGQ1L3RhYmxlcmFuZ2U6ZWU1OTU4ZTY4ZmVjNGQ5OGE3MWQ4NDY0NTlhNTI4ZDVfNC03LTEtMS04MzI4NQ_fe6babec-7a8d-456b-adb3-5ff2a94f0d48"
      unitRef="usd">1200000</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities
      contextRef="ibb5cc1f64aef49f38721631773798f1c_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmVlNTk1OGU2OGZlYzRkOThhNzFkODQ2NDU5YTUyOGQ1L3RhYmxlcmFuZ2U6ZWU1OTU4ZTY4ZmVjNGQ5OGE3MWQ4NDY0NTlhNTI4ZDVfNC05LTEtMS0xMDA1Mzc_e806266d-1da4-40a8-a2a2-e9fedb910abe"
      unitRef="usd">2400000</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities
      contextRef="i10a7807457d845b9ad4ed44aed8912db_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmVlNTk1OGU2OGZlYzRkOThhNzFkODQ2NDU5YTUyOGQ1L3RhYmxlcmFuZ2U6ZWU1OTU4ZTY4ZmVjNGQ5OGE3MWQ4NDY0NTlhNTI4ZDVfOS0xLTEtMS04MzI4NQ_e5e8ed79-4e4b-429c-93d0-38d3883cd732"
      unitRef="usd">4900000</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities
      contextRef="i7fddba25d3464fc88f2322c862ad8fda_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmVlNTk1OGU2OGZlYzRkOThhNzFkODQ2NDU5YTUyOGQ1L3RhYmxlcmFuZ2U6ZWU1OTU4ZTY4ZmVjNGQ5OGE3MWQ4NDY0NTlhNTI4ZDVfOS0zLTEtMS04MzI4NQ_a797c8ba-3bbd-4eeb-87cc-f3581d63a41e"
      unitRef="usd">3600000</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities
      contextRef="id304dfd7514641719c5a17d4ab0bed7a_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmVlNTk1OGU2OGZlYzRkOThhNzFkODQ2NDU5YTUyOGQ1L3RhYmxlcmFuZ2U6ZWU1OTU4ZTY4ZmVjNGQ5OGE3MWQ4NDY0NTlhNTI4ZDVfOS01LTEtMS04MzI4NQ_a780c3df-4405-4a49-8467-036bdfba1136"
      unitRef="usd">300000</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities
      contextRef="i6600d15de2c54873830ce25e54e2f1e4_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmVlNTk1OGU2OGZlYzRkOThhNzFkODQ2NDU5YTUyOGQ1L3RhYmxlcmFuZ2U6ZWU1OTU4ZTY4ZmVjNGQ5OGE3MWQ4NDY0NTlhNTI4ZDVfOS03LTEtMS04MzI4NQ_f810e265-9ad5-4cc7-a95b-25eedfb6f7e3"
      unitRef="usd">10300000</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOmVlNTk1OGU2OGZlYzRkOThhNzFkODQ2NDU5YTUyOGQ1L3RhYmxlcmFuZ2U6ZWU1OTU4ZTY4ZmVjNGQ5OGE3MWQ4NDY0NTlhNTI4ZDVfOS05LTEtMS0xMDA1Mzc_1fcb1cd8-e8bc-45f9-991a-7cf0236b0375"
      unitRef="usd">19100000</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities
      contextRef="ic7b8fd0dd0134e8f856ea33530935168_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjkzZGJiODZiY2Q5ODRmNWE5MGE3ZGRlMWFjZjAxZDQyL3RhYmxlcmFuZ2U6OTNkYmI4NmJjZDk4NGY1YTkwYTdkZGUxYWNmMDFkNDJfMi0xLTEtMS0xMDA2ODU_9446eedf-02a6-4ca2-8f6f-9611e9ff2aaa"
      unitRef="usd">0</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities
      contextRef="i37397c07155e4b5999d81334076d9104_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjkzZGJiODZiY2Q5ODRmNWE5MGE3ZGRlMWFjZjAxZDQyL3RhYmxlcmFuZ2U6OTNkYmI4NmJjZDk4NGY1YTkwYTdkZGUxYWNmMDFkNDJfMi0zLTEtMS0xMDA2ODU_e5aa8ad7-9a3c-4b6c-a350-a235101bd7a1"
      unitRef="usd">0</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities
      contextRef="i258bf93e049d4d02a30c6b42cfdf1134_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjkzZGJiODZiY2Q5ODRmNWE5MGE3ZGRlMWFjZjAxZDQyL3RhYmxlcmFuZ2U6OTNkYmI4NmJjZDk4NGY1YTkwYTdkZGUxYWNmMDFkNDJfMi01LTEtMS0xMDA2ODU_bcd86ecd-2f00-4a57-b270-793d8fdd276f"
      unitRef="usd">0</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities
      contextRef="ib570e05ca31b4b8d9df07b036d129ecc_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjkzZGJiODZiY2Q5ODRmNWE5MGE3ZGRlMWFjZjAxZDQyL3RhYmxlcmFuZ2U6OTNkYmI4NmJjZDk4NGY1YTkwYTdkZGUxYWNmMDFkNDJfMi03LTEtMS0xMDA2ODU_a593f156-237e-4da6-bede-969aac91871c"
      unitRef="usd">3300000</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities
      contextRef="i9fd818ca9813423087f30261388bf1ff_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjkzZGJiODZiY2Q5ODRmNWE5MGE3ZGRlMWFjZjAxZDQyL3RhYmxlcmFuZ2U6OTNkYmI4NmJjZDk4NGY1YTkwYTdkZGUxYWNmMDFkNDJfMi05LTEtMS0xMDA2ODU_16f4348c-d796-4de0-867f-808ac06990f0"
      unitRef="usd">3300000</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities
      contextRef="i1fb8bf62e0d742a9a0f377ab72636023_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjkzZGJiODZiY2Q5ODRmNWE5MGE3ZGRlMWFjZjAxZDQyL3RhYmxlcmFuZ2U6OTNkYmI4NmJjZDk4NGY1YTkwYTdkZGUxYWNmMDFkNDJfMy0xLTEtMS0xMDA2ODU_2d305e97-b768-4650-a96b-2a0ec23b46e8"
      unitRef="usd">5900000</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities
      contextRef="i41d677cf97674dbd90329e0a86d4c071_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjkzZGJiODZiY2Q5ODRmNWE5MGE3ZGRlMWFjZjAxZDQyL3RhYmxlcmFuZ2U6OTNkYmI4NmJjZDk4NGY1YTkwYTdkZGUxYWNmMDFkNDJfMy0zLTEtMS0xMDA2ODU_54a44157-08a1-477e-ae37-2d36524b41db"
      unitRef="usd">1900000</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities
      contextRef="i5b9b65169796488785c67752201e44e3_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjkzZGJiODZiY2Q5ODRmNWE5MGE3ZGRlMWFjZjAxZDQyL3RhYmxlcmFuZ2U6OTNkYmI4NmJjZDk4NGY1YTkwYTdkZGUxYWNmMDFkNDJfMy01LTEtMS0xMDA2ODU_026464e3-f621-4c5d-871d-58508db441b2"
      unitRef="usd">300000</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities
      contextRef="i0b104c9b9bf14c9f912232bc060f93db_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjkzZGJiODZiY2Q5ODRmNWE5MGE3ZGRlMWFjZjAxZDQyL3RhYmxlcmFuZ2U6OTNkYmI4NmJjZDk4NGY1YTkwYTdkZGUxYWNmMDFkNDJfMy03LTEtMS0xMDA2ODU_aacca1d2-ff26-4885-9dc1-e36b9fcb97f0"
      unitRef="usd">6400000</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities
      contextRef="i7cbc650905324d5a9d9f236aae761225_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjkzZGJiODZiY2Q5ODRmNWE5MGE3ZGRlMWFjZjAxZDQyL3RhYmxlcmFuZ2U6OTNkYmI4NmJjZDk4NGY1YTkwYTdkZGUxYWNmMDFkNDJfMy05LTEtMS0xMDA2ODU_f18d25fb-cf9a-470b-9ab2-3ca3597f8c0d"
      unitRef="usd">14500000</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities
      contextRef="ib5c2f6e8743c4071bbe71b730ae4875d_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjkzZGJiODZiY2Q5ODRmNWE5MGE3ZGRlMWFjZjAxZDQyL3RhYmxlcmFuZ2U6OTNkYmI4NmJjZDk4NGY1YTkwYTdkZGUxYWNmMDFkNDJfNC0xLTEtMS0xMDA2ODU_f11235c0-ac3f-4112-8bf8-2cd05bc8af75"
      unitRef="usd">0</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities
      contextRef="i0f985f58dae54b558355211719080563_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjkzZGJiODZiY2Q5ODRmNWE5MGE3ZGRlMWFjZjAxZDQyL3RhYmxlcmFuZ2U6OTNkYmI4NmJjZDk4NGY1YTkwYTdkZGUxYWNmMDFkNDJfNC0zLTEtMS0xMDA2ODU_3ef168ee-eb5c-4fb3-bbc0-fa024fd92b7e"
      unitRef="usd">1700000</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities
      contextRef="ic599629ea0b04a37b5c016ca41d98210_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjkzZGJiODZiY2Q5ODRmNWE5MGE3ZGRlMWFjZjAxZDQyL3RhYmxlcmFuZ2U6OTNkYmI4NmJjZDk4NGY1YTkwYTdkZGUxYWNmMDFkNDJfNC01LTEtMS0xMDA2ODU_61937bf3-de16-4ca2-b61f-a73a4ee975d9"
      unitRef="usd">0</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities
      contextRef="if4692f756aaa45aeb72bc012dbee325a_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjkzZGJiODZiY2Q5ODRmNWE5MGE3ZGRlMWFjZjAxZDQyL3RhYmxlcmFuZ2U6OTNkYmI4NmJjZDk4NGY1YTkwYTdkZGUxYWNmMDFkNDJfNC03LTEtMS0xMDA2ODU_6c81a79d-5719-4c16-b701-2ae7ad88678e"
      unitRef="usd">500000</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities
      contextRef="ie75eb2768bab4d5b841b550e22dc7e31_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjkzZGJiODZiY2Q5ODRmNWE5MGE3ZGRlMWFjZjAxZDQyL3RhYmxlcmFuZ2U6OTNkYmI4NmJjZDk4NGY1YTkwYTdkZGUxYWNmMDFkNDJfNC05LTEtMS0xMDA2ODU_52ca98db-b787-41ae-bdb8-3a99ca18e8e1"
      unitRef="usd">2200000</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities
      contextRef="i11d163dc0c7e4f778d0934c68fbd9ed9_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjkzZGJiODZiY2Q5ODRmNWE5MGE3ZGRlMWFjZjAxZDQyL3RhYmxlcmFuZ2U6OTNkYmI4NmJjZDk4NGY1YTkwYTdkZGUxYWNmMDFkNDJfOS0xLTEtMS0xMDA2ODU_dc8c0ad6-0392-4e76-b97a-0297f0fedaf9"
      unitRef="usd">5900000</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities
      contextRef="i09336e03a3124b3e8abcf83f054dfc6e_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjkzZGJiODZiY2Q5ODRmNWE5MGE3ZGRlMWFjZjAxZDQyL3RhYmxlcmFuZ2U6OTNkYmI4NmJjZDk4NGY1YTkwYTdkZGUxYWNmMDFkNDJfOS0zLTEtMS0xMDA2ODU_13d4336f-2e02-4680-b6ec-662318f319bb"
      unitRef="usd">3600000</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities
      contextRef="i47928432e34e44fab0fa2e3e5ea1c268_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjkzZGJiODZiY2Q5ODRmNWE5MGE3ZGRlMWFjZjAxZDQyL3RhYmxlcmFuZ2U6OTNkYmI4NmJjZDk4NGY1YTkwYTdkZGUxYWNmMDFkNDJfOS01LTEtMS0xMDA2ODU_ca94ea67-ff02-4b2b-814e-de831173da2a"
      unitRef="usd">300000</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities
      contextRef="i76a7050d54304267a10c2a2ff2669153_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjkzZGJiODZiY2Q5ODRmNWE5MGE3ZGRlMWFjZjAxZDQyL3RhYmxlcmFuZ2U6OTNkYmI4NmJjZDk4NGY1YTkwYTdkZGUxYWNmMDFkNDJfOS03LTEtMS0xMDA2ODU_7f0bebfe-a1ee-4b99-88d5-d42a4884cc7c"
      unitRef="usd">10200000</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities
      contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182MS9mcmFnOjQ2MzYxMDkxZGY2ZTRlNzBhNTc0YzNjNWQ5OWUzZTZmL3RhYmxlOjkzZGJiODZiY2Q5ODRmNWE5MGE3ZGRlMWFjZjAxZDQyL3RhYmxlcmFuZ2U6OTNkYmI4NmJjZDk4NGY1YTkwYTdkZGUxYWNmMDFkNDJfOS05LTEtMS0xMDA2ODU_273bad25-7282-4d5d-a8f0-90c0873d700c"
      unitRef="usd">20000000.0</us-gaap:MarketableSecurities>
    <us-gaap:InventoryDisclosureTextBlock
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182NC9mcmFnOmNhMTc4NzJhN2ViMTQ4OGI4MTdkMTRjMTQ0ZTdkZjdiL3RleHRyZWdpb246Y2ExNzg3MmE3ZWIxNDg4YjgxN2QxNGMxNDRlN2RmN2JfODY_e6f6e5a8-fe54-4c73-af7a-18aeec250eca">INVENTORIES&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The following table summarizes the Company&#x2019;s inventories:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Raw materials and parts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;247.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;240.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;320.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;303.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182NC9mcmFnOmNhMTc4NzJhN2ViMTQ4OGI4MTdkMTRjMTQ0ZTdkZjdiL3RleHRyZWdpb246Y2ExNzg3MmE3ZWIxNDg4YjgxN2QxNGMxNDRlN2RmN2JfODc_e3a67999-cd09-4ad6-8ffe-6f987010449c">The following table summarizes the Company&#x2019;s inventories:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Raw materials and parts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;247.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;240.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;320.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;303.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182NC9mcmFnOmNhMTc4NzJhN2ViMTQ4OGI4MTdkMTRjMTQ0ZTdkZjdiL3RhYmxlOmZmM2FlN2VlOTZhOTQ3ZGFiMjljYTE3MWU1Njk3YzQ0L3RhYmxlcmFuZ2U6ZmYzYWU3ZWU5NmE5NDdkYWIyOWNhMTcxZTU2OTdjNDRfMS0xLTEtMS04MzI4NQ_122a5ca1-8fb3-4ff0-956c-6eb0c959a52f"
      unitRef="usd">247500000</us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves>
    <us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves
      contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182NC9mcmFnOmNhMTc4NzJhN2ViMTQ4OGI4MTdkMTRjMTQ0ZTdkZjdiL3RhYmxlOmZmM2FlN2VlOTZhOTQ3ZGFiMjljYTE3MWU1Njk3YzQ0L3RhYmxlcmFuZ2U6ZmYzYWU3ZWU5NmE5NDdkYWIyOWNhMTcxZTU2OTdjNDRfMS0zLTEtMS04MzI4NQ_165e1ac5-f0c9-474c-b393-bbb79c28eceb"
      unitRef="usd">240300000</us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182NC9mcmFnOmNhMTc4NzJhN2ViMTQ4OGI4MTdkMTRjMTQ0ZTdkZjdiL3RhYmxlOmZmM2FlN2VlOTZhOTQ3ZGFiMjljYTE3MWU1Njk3YzQ0L3RhYmxlcmFuZ2U6ZmYzYWU3ZWU5NmE5NDdkYWIyOWNhMTcxZTU2OTdjNDRfMi0xLTEtMS04MzI4NQ_e4b56ca8-ab4e-470c-b549-f107ce8f3a44"
      unitRef="usd">25100000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182NC9mcmFnOmNhMTc4NzJhN2ViMTQ4OGI4MTdkMTRjMTQ0ZTdkZjdiL3RhYmxlOmZmM2FlN2VlOTZhOTQ3ZGFiMjljYTE3MWU1Njk3YzQ0L3RhYmxlcmFuZ2U6ZmYzYWU3ZWU5NmE5NDdkYWIyOWNhMTcxZTU2OTdjNDRfMi0zLTEtMS04MzI4NQ_fc9149e0-d2ce-4113-abef-ff9521246f46"
      unitRef="usd">23200000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182NC9mcmFnOmNhMTc4NzJhN2ViMTQ4OGI4MTdkMTRjMTQ0ZTdkZjdiL3RhYmxlOmZmM2FlN2VlOTZhOTQ3ZGFiMjljYTE3MWU1Njk3YzQ0L3RhYmxlcmFuZ2U6ZmYzYWU3ZWU5NmE5NDdkYWIyOWNhMTcxZTU2OTdjNDRfMy0xLTEtMS04MzI4NQ_a2329df4-346d-40ec-a7ef-91186dd96683"
      unitRef="usd">47700000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182NC9mcmFnOmNhMTc4NzJhN2ViMTQ4OGI4MTdkMTRjMTQ0ZTdkZjdiL3RhYmxlOmZmM2FlN2VlOTZhOTQ3ZGFiMjljYTE3MWU1Njk3YzQ0L3RhYmxlcmFuZ2U6ZmYzYWU3ZWU5NmE5NDdkYWIyOWNhMTcxZTU2OTdjNDRfMy0zLTEtMS04MzI4NQ_c36728a4-925d-4385-8fd7-a654e60b25d4"
      unitRef="usd">39700000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182NC9mcmFnOmNhMTc4NzJhN2ViMTQ4OGI4MTdkMTRjMTQ0ZTdkZjdiL3RhYmxlOmZmM2FlN2VlOTZhOTQ3ZGFiMjljYTE3MWU1Njk3YzQ0L3RhYmxlcmFuZ2U6ZmYzYWU3ZWU5NmE5NDdkYWIyOWNhMTcxZTU2OTdjNDRfNC0xLTEtMS04MzI4NQ_1ebc8339-cf3b-487f-be8b-381e928c7143"
      unitRef="usd">320300000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182NC9mcmFnOmNhMTc4NzJhN2ViMTQ4OGI4MTdkMTRjMTQ0ZTdkZjdiL3RhYmxlOmZmM2FlN2VlOTZhOTQ3ZGFiMjljYTE3MWU1Njk3YzQ0L3RhYmxlcmFuZ2U6ZmYzYWU3ZWU5NmE5NDdkYWIyOWNhMTcxZTU2OTdjNDRfNC0zLTEtMS04MzI4NQ_b3a1276f-75c1-4b5c-803e-ee0b257b33b2"
      unitRef="usd">303200000</us-gaap:InventoryNet>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182Ny9mcmFnOjU5NzZjOWRhM2RhYTQyOGViMmM5MjhmMzRiNDVjNjc5L3RleHRyZWdpb246NTk3NmM5ZGEzZGFhNDI4ZWIyYzkyOGYzNGI0NWM2NzlfMzgw_76da0b30-6bc3-4e73-9478-2a6e9f2eb403">GOODWILL AND INTANGIBLE ASSETS&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The following table reflects goodwill by reportable operating segment:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.511%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Medical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Industrial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;169.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;115.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;284.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Balance at December 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;171.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;116.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;288.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The following table reflects the gross carrying amount and accumulated amortization of the Company&#x2019;s finite-lived intangible assets included in other assets in the Condensed Consolidated Balance Sheets:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.427%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.427%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.427%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.156%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net Carrying Amount&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:2pt;padding-left:9pt;padding-right:2.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Acquired existing technology&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;71.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(52.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(49.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:2pt;padding-left:9pt;padding-right:2.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Patents, licenses and other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(11.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(11.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:2pt;padding-left:9pt;padding-right:2.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer contracts and supplier relationship&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(38.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(36.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:2pt;padding-left:6.75pt;padding-right:2.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;134.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(102.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;131.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(98.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Amortization expense for intangible assets was $3.4 million and $3.8 million for the three months ended December 30, 2022 and December&#160;31, 2021, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182Ny9mcmFnOjU5NzZjOWRhM2RhYTQyOGViMmM5MjhmMzRiNDVjNjc5L3RleHRyZWdpb246NTk3NmM5ZGEzZGFhNDI4ZWIyYzkyOGYzNGI0NWM2NzlfMzc2_50e664a8-c221-4935-8ae6-b6c5e2210818">The following table reflects goodwill by reportable operating segment:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.511%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Medical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Industrial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;169.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;115.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;284.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Balance at December 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;171.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;116.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;288.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="i82c73512683b4d2096958ea2c1d31545_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182Ny9mcmFnOjU5NzZjOWRhM2RhYTQyOGViMmM5MjhmMzRiNDVjNjc5L3RhYmxlOjM4MmM1Y2VhYTRlOTQ1MzM5MmNmYjYyMjNlNmUwNzAwL3RhYmxlcmFuZ2U6MzgyYzVjZWFhNGU5NDUzMzkyY2ZiNjIyM2U2ZTA3MDBfMS0xLTEtMS04MzI4NQ_2e7eb5b8-3f77-4ce9-a723-d7d3a24ced81"
      unitRef="usd">169400000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i317f9c4181274f2493096e5cbd4ae801_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182Ny9mcmFnOjU5NzZjOWRhM2RhYTQyOGViMmM5MjhmMzRiNDVjNjc5L3RhYmxlOjM4MmM1Y2VhYTRlOTQ1MzM5MmNmYjYyMjNlNmUwNzAwL3RhYmxlcmFuZ2U6MzgyYzVjZWFhNGU5NDUzMzkyY2ZiNjIyM2U2ZTA3MDBfMS0zLTEtMS04MzI4NQ_737ecf58-4658-44b4-a8d0-96a9ffc6951e"
      unitRef="usd">115100000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182Ny9mcmFnOjU5NzZjOWRhM2RhYTQyOGViMmM5MjhmMzRiNDVjNjc5L3RhYmxlOjM4MmM1Y2VhYTRlOTQ1MzM5MmNmYjYyMjNlNmUwNzAwL3RhYmxlcmFuZ2U6MzgyYzVjZWFhNGU5NDUzMzkyY2ZiNjIyM2U2ZTA3MDBfMS01LTEtMS04MzI4NQ_f62b256f-fb26-4d75-8da5-e1f65937f18b"
      unitRef="usd">284500000</us-gaap:Goodwill>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="iad2fceac1bb145229d93b69339db9f19_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182Ny9mcmFnOjU5NzZjOWRhM2RhYTQyOGViMmM5MjhmMzRiNDVjNjc5L3RhYmxlOjM4MmM1Y2VhYTRlOTQ1MzM5MmNmYjYyMjNlNmUwNzAwL3RhYmxlcmFuZ2U6MzgyYzVjZWFhNGU5NDUzMzkyY2ZiNjIyM2U2ZTA3MDBfMi0xLTEtMS04MzI4NQ_e93aed4b-9f41-42a8-a778-49093e7faf6f"
      unitRef="usd">2200000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="iaab56d5aa0be4d758038ec0908970ec8_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182Ny9mcmFnOjU5NzZjOWRhM2RhYTQyOGViMmM5MjhmMzRiNDVjNjc5L3RhYmxlOjM4MmM1Y2VhYTRlOTQ1MzM5MmNmYjYyMjNlNmUwNzAwL3RhYmxlcmFuZ2U6MzgyYzVjZWFhNGU5NDUzMzkyY2ZiNjIyM2U2ZTA3MDBfMi0zLTEtMS04MzI4NQ_d780e1ef-0f3e-4023-81bb-0c555335f51a"
      unitRef="usd">1500000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182Ny9mcmFnOjU5NzZjOWRhM2RhYTQyOGViMmM5MjhmMzRiNDVjNjc5L3RhYmxlOjM4MmM1Y2VhYTRlOTQ1MzM5MmNmYjYyMjNlNmUwNzAwL3RhYmxlcmFuZ2U6MzgyYzVjZWFhNGU5NDUzMzkyY2ZiNjIyM2U2ZTA3MDBfMi01LTEtMS04MzI4NQ_950b3c40-32a9-475d-8003-d1fb0ab9dcd2"
      unitRef="usd">3700000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="i6ed6fb1587e340578f31b77be6b9133b_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182Ny9mcmFnOjU5NzZjOWRhM2RhYTQyOGViMmM5MjhmMzRiNDVjNjc5L3RhYmxlOjM4MmM1Y2VhYTRlOTQ1MzM5MmNmYjYyMjNlNmUwNzAwL3RhYmxlcmFuZ2U6MzgyYzVjZWFhNGU5NDUzMzkyY2ZiNjIyM2U2ZTA3MDBfNC0xLTEtMS04MzI4NQ_2bf21a59-191e-4578-998b-97d7cff387c5"
      unitRef="usd">171600000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i90a86f642a414830901c4fc2a48a1b03_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182Ny9mcmFnOjU5NzZjOWRhM2RhYTQyOGViMmM5MjhmMzRiNDVjNjc5L3RhYmxlOjM4MmM1Y2VhYTRlOTQ1MzM5MmNmYjYyMjNlNmUwNzAwL3RhYmxlcmFuZ2U6MzgyYzVjZWFhNGU5NDUzMzkyY2ZiNjIyM2U2ZTA3MDBfNC0zLTEtMS04MzI4NQ_33dd1614-ba70-4f54-817a-91be1873d7ce"
      unitRef="usd">116600000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182Ny9mcmFnOjU5NzZjOWRhM2RhYTQyOGViMmM5MjhmMzRiNDVjNjc5L3RhYmxlOjM4MmM1Y2VhYTRlOTQ1MzM5MmNmYjYyMjNlNmUwNzAwL3RhYmxlcmFuZ2U6MzgyYzVjZWFhNGU5NDUzMzkyY2ZiNjIyM2U2ZTA3MDBfNC01LTEtMS04MzI4NQ_221409f0-a9b0-4032-9240-f8b91c541a68"
      unitRef="usd">288200000</us-gaap:Goodwill>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182Ny9mcmFnOjU5NzZjOWRhM2RhYTQyOGViMmM5MjhmMzRiNDVjNjc5L3RleHRyZWdpb246NTk3NmM5ZGEzZGFhNDI4ZWIyYzkyOGYzNGI0NWM2NzlfMzgy_5046416e-6c95-41f9-a53b-d77046d6d610">The following table reflects the gross carrying amount and accumulated amortization of the Company&#x2019;s finite-lived intangible assets included in other assets in the Condensed Consolidated Balance Sheets:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.427%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.427%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.427%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.156%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net Carrying Amount&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:2pt;padding-left:9pt;padding-right:2.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Acquired existing technology&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;71.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(52.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(49.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:2pt;padding-left:9pt;padding-right:2.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Patents, licenses and other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(11.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(11.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:2pt;padding-left:9pt;padding-right:2.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer contracts and supplier relationship&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(38.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(36.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:2pt;padding-left:6.75pt;padding-right:2.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;134.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(102.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;131.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(98.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i71efe72866804c618d71d89eb6e37464_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182Ny9mcmFnOjU5NzZjOWRhM2RhYTQyOGViMmM5MjhmMzRiNDVjNjc5L3RhYmxlOmNlNDYxNTM2ZWE1ODQyMmZhMzg5NTIyMDA2ZWNkMjQ3L3RhYmxlcmFuZ2U6Y2U0NjE1MzZlYTU4NDIyZmEzODk1MjIwMDZlY2QyNDdfMi0xLTEtMS04MzI4NQ_d7bf15ee-1c10-4417-afd1-04e493fd17b6"
      unitRef="usd">71500000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i71efe72866804c618d71d89eb6e37464_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182Ny9mcmFnOjU5NzZjOWRhM2RhYTQyOGViMmM5MjhmMzRiNDVjNjc5L3RhYmxlOmNlNDYxNTM2ZWE1ODQyMmZhMzg5NTIyMDA2ZWNkMjQ3L3RhYmxlcmFuZ2U6Y2U0NjE1MzZlYTU4NDIyZmEzODk1MjIwMDZlY2QyNDdfMi0zLTEtMS04MzI4NQ_4236388d-9175-410e-90d7-b3c92eb1313c"
      unitRef="usd">52300000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i71efe72866804c618d71d89eb6e37464_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182Ny9mcmFnOjU5NzZjOWRhM2RhYTQyOGViMmM5MjhmMzRiNDVjNjc5L3RhYmxlOmNlNDYxNTM2ZWE1ODQyMmZhMzg5NTIyMDA2ZWNkMjQ3L3RhYmxlcmFuZ2U6Y2U0NjE1MzZlYTU4NDIyZmEzODk1MjIwMDZlY2QyNDdfMi01LTEtMS04MzI4NQ_7019d041-c8cc-42f2-9e5b-a2c1bc6040fc"
      unitRef="usd">19200000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i8c5261f66af24806b7d3a028cf3b8dc2_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182Ny9mcmFnOjU5NzZjOWRhM2RhYTQyOGViMmM5MjhmMzRiNDVjNjc5L3RhYmxlOmNlNDYxNTM2ZWE1ODQyMmZhMzg5NTIyMDA2ZWNkMjQ3L3RhYmxlcmFuZ2U6Y2U0NjE1MzZlYTU4NDIyZmEzODk1MjIwMDZlY2QyNDdfMi03LTEtMS04MzI4NQ_aa838dad-ae0e-4812-b539-c71493d4d30c"
      unitRef="usd">70000000.0</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i8c5261f66af24806b7d3a028cf3b8dc2_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182Ny9mcmFnOjU5NzZjOWRhM2RhYTQyOGViMmM5MjhmMzRiNDVjNjc5L3RhYmxlOmNlNDYxNTM2ZWE1ODQyMmZhMzg5NTIyMDA2ZWNkMjQ3L3RhYmxlcmFuZ2U6Y2U0NjE1MzZlYTU4NDIyZmEzODk1MjIwMDZlY2QyNDdfMi05LTEtMS04MzI4NQ_bebf2dc9-cdb2-4dc2-a1b1-f31335e67f01"
      unitRef="usd">49900000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i8c5261f66af24806b7d3a028cf3b8dc2_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182Ny9mcmFnOjU5NzZjOWRhM2RhYTQyOGViMmM5MjhmMzRiNDVjNjc5L3RhYmxlOmNlNDYxNTM2ZWE1ODQyMmZhMzg5NTIyMDA2ZWNkMjQ3L3RhYmxlcmFuZ2U6Y2U0NjE1MzZlYTU4NDIyZmEzODk1MjIwMDZlY2QyNDdfMi0xMS0xLTEtODMyODU_c4dc1589-172c-4a45-a2f3-1301f4dd4557"
      unitRef="usd">20100000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ib080390b901b4ad0b3394ec38916cf01_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182Ny9mcmFnOjU5NzZjOWRhM2RhYTQyOGViMmM5MjhmMzRiNDVjNjc5L3RhYmxlOmNlNDYxNTM2ZWE1ODQyMmZhMzg5NTIyMDA2ZWNkMjQ3L3RhYmxlcmFuZ2U6Y2U0NjE1MzZlYTU4NDIyZmEzODk1MjIwMDZlY2QyNDdfMy0xLTEtMS04MzI4NQ_95935ea9-07bd-45d1-96e0-096944e1913b"
      unitRef="usd">12500000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ib080390b901b4ad0b3394ec38916cf01_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182Ny9mcmFnOjU5NzZjOWRhM2RhYTQyOGViMmM5MjhmMzRiNDVjNjc5L3RhYmxlOmNlNDYxNTM2ZWE1ODQyMmZhMzg5NTIyMDA2ZWNkMjQ3L3RhYmxlcmFuZ2U6Y2U0NjE1MzZlYTU4NDIyZmEzODk1MjIwMDZlY2QyNDdfMy0zLTEtMS04MzI4NQ_45da5329-50ed-4efa-acca-6b5a6c2a7224"
      unitRef="usd">11800000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ib080390b901b4ad0b3394ec38916cf01_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182Ny9mcmFnOjU5NzZjOWRhM2RhYTQyOGViMmM5MjhmMzRiNDVjNjc5L3RhYmxlOmNlNDYxNTM2ZWE1ODQyMmZhMzg5NTIyMDA2ZWNkMjQ3L3RhYmxlcmFuZ2U6Y2U0NjE1MzZlYTU4NDIyZmEzODk1MjIwMDZlY2QyNDdfMy01LTEtMS04MzI4NQ_7b9e48c3-b358-4969-b65a-9ed724d40277"
      unitRef="usd">700000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ice17b9b9dfca490ab810ee326594761a_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182Ny9mcmFnOjU5NzZjOWRhM2RhYTQyOGViMmM5MjhmMzRiNDVjNjc5L3RhYmxlOmNlNDYxNTM2ZWE1ODQyMmZhMzg5NTIyMDA2ZWNkMjQ3L3RhYmxlcmFuZ2U6Y2U0NjE1MzZlYTU4NDIyZmEzODk1MjIwMDZlY2QyNDdfMy03LTEtMS04MzI4NQ_d67b3ad3-d6e5-45ea-8432-38cc9b4aac5d"
      unitRef="usd">12300000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ice17b9b9dfca490ab810ee326594761a_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182Ny9mcmFnOjU5NzZjOWRhM2RhYTQyOGViMmM5MjhmMzRiNDVjNjc5L3RhYmxlOmNlNDYxNTM2ZWE1ODQyMmZhMzg5NTIyMDA2ZWNkMjQ3L3RhYmxlcmFuZ2U6Y2U0NjE1MzZlYTU4NDIyZmEzODk1MjIwMDZlY2QyNDdfMy05LTEtMS04MzI4NQ_e3ae74cc-a5b9-4ec6-b108-15eac957d9f6"
      unitRef="usd">11600000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ice17b9b9dfca490ab810ee326594761a_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182Ny9mcmFnOjU5NzZjOWRhM2RhYTQyOGViMmM5MjhmMzRiNDVjNjc5L3RhYmxlOmNlNDYxNTM2ZWE1ODQyMmZhMzg5NTIyMDA2ZWNkMjQ3L3RhYmxlcmFuZ2U6Y2U0NjE1MzZlYTU4NDIyZmEzODk1MjIwMDZlY2QyNDdfMy0xMS0xLTEtODMyODU_f45069d2-90cd-4480-9df4-73e73b4b0bc3"
      unitRef="usd">700000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i00b01e43c8e144339e841ad785f9ced0_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182Ny9mcmFnOjU5NzZjOWRhM2RhYTQyOGViMmM5MjhmMzRiNDVjNjc5L3RhYmxlOmNlNDYxNTM2ZWE1ODQyMmZhMzg5NTIyMDA2ZWNkMjQ3L3RhYmxlcmFuZ2U6Y2U0NjE1MzZlYTU4NDIyZmEzODk1MjIwMDZlY2QyNDdfNC0xLTEtMS04MzI4NQ_90ae7d2f-2d4a-4e0e-b21a-8d95df33ea24"
      unitRef="usd">50300000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i00b01e43c8e144339e841ad785f9ced0_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182Ny9mcmFnOjU5NzZjOWRhM2RhYTQyOGViMmM5MjhmMzRiNDVjNjc5L3RhYmxlOmNlNDYxNTM2ZWE1ODQyMmZhMzg5NTIyMDA2ZWNkMjQ3L3RhYmxlcmFuZ2U6Y2U0NjE1MzZlYTU4NDIyZmEzODk1MjIwMDZlY2QyNDdfNC0zLTEtMS04MzI4NQ_70907dff-e184-4124-965a-65297a8bf4ae"
      unitRef="usd">38500000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i00b01e43c8e144339e841ad785f9ced0_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182Ny9mcmFnOjU5NzZjOWRhM2RhYTQyOGViMmM5MjhmMzRiNDVjNjc5L3RhYmxlOmNlNDYxNTM2ZWE1ODQyMmZhMzg5NTIyMDA2ZWNkMjQ3L3RhYmxlcmFuZ2U6Y2U0NjE1MzZlYTU4NDIyZmEzODk1MjIwMDZlY2QyNDdfNC01LTEtMS04MzI4NQ_b7049113-1ae4-4472-9619-9cc7687dccf2"
      unitRef="usd">11800000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i77825c8e58b14473947ad5b24ebc5fe2_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182Ny9mcmFnOjU5NzZjOWRhM2RhYTQyOGViMmM5MjhmMzRiNDVjNjc5L3RhYmxlOmNlNDYxNTM2ZWE1ODQyMmZhMzg5NTIyMDA2ZWNkMjQ3L3RhYmxlcmFuZ2U6Y2U0NjE1MzZlYTU4NDIyZmEzODk1MjIwMDZlY2QyNDdfNC03LTEtMS04MzI4NQ_48decfb5-1e8e-43dd-9c97-0866c9a88604"
      unitRef="usd">49600000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i77825c8e58b14473947ad5b24ebc5fe2_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182Ny9mcmFnOjU5NzZjOWRhM2RhYTQyOGViMmM5MjhmMzRiNDVjNjc5L3RhYmxlOmNlNDYxNTM2ZWE1ODQyMmZhMzg5NTIyMDA2ZWNkMjQ3L3RhYmxlcmFuZ2U6Y2U0NjE1MzZlYTU4NDIyZmEzODk1MjIwMDZlY2QyNDdfNC05LTEtMS04MzI4NQ_b4dd8405-79db-4a02-bbe8-1e11431ed99f"
      unitRef="usd">36800000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i77825c8e58b14473947ad5b24ebc5fe2_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182Ny9mcmFnOjU5NzZjOWRhM2RhYTQyOGViMmM5MjhmMzRiNDVjNjc5L3RhYmxlOmNlNDYxNTM2ZWE1ODQyMmZhMzg5NTIyMDA2ZWNkMjQ3L3RhYmxlcmFuZ2U6Y2U0NjE1MzZlYTU4NDIyZmEzODk1MjIwMDZlY2QyNDdfNC0xMS0xLTEtODMyODU_0158763b-7300-401c-a554-088873f498f1"
      unitRef="usd">12800000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182Ny9mcmFnOjU5NzZjOWRhM2RhYTQyOGViMmM5MjhmMzRiNDVjNjc5L3RhYmxlOmNlNDYxNTM2ZWE1ODQyMmZhMzg5NTIyMDA2ZWNkMjQ3L3RhYmxlcmFuZ2U6Y2U0NjE1MzZlYTU4NDIyZmEzODk1MjIwMDZlY2QyNDdfNy0xLTEtMS04MzI4NQ_8c8c2d86-cd34-41a7-883e-aee5e5c3d8d4"
      unitRef="usd">134300000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182Ny9mcmFnOjU5NzZjOWRhM2RhYTQyOGViMmM5MjhmMzRiNDVjNjc5L3RhYmxlOmNlNDYxNTM2ZWE1ODQyMmZhMzg5NTIyMDA2ZWNkMjQ3L3RhYmxlcmFuZ2U6Y2U0NjE1MzZlYTU4NDIyZmEzODk1MjIwMDZlY2QyNDdfNy0zLTEtMS04MzI4NQ_323561cd-62a6-4816-ad15-61713b928e9b"
      unitRef="usd">102600000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182Ny9mcmFnOjU5NzZjOWRhM2RhYTQyOGViMmM5MjhmMzRiNDVjNjc5L3RhYmxlOmNlNDYxNTM2ZWE1ODQyMmZhMzg5NTIyMDA2ZWNkMjQ3L3RhYmxlcmFuZ2U6Y2U0NjE1MzZlYTU4NDIyZmEzODk1MjIwMDZlY2QyNDdfNy01LTEtMS04MzI4NQ_8e98feec-32c6-4b26-96fa-d931e098e7f7"
      unitRef="usd">31700000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182Ny9mcmFnOjU5NzZjOWRhM2RhYTQyOGViMmM5MjhmMzRiNDVjNjc5L3RhYmxlOmNlNDYxNTM2ZWE1ODQyMmZhMzg5NTIyMDA2ZWNkMjQ3L3RhYmxlcmFuZ2U6Y2U0NjE1MzZlYTU4NDIyZmEzODk1MjIwMDZlY2QyNDdfNy03LTEtMS04MzI4NQ_ef4b7527-2cba-4257-91ca-596a17ccb99e"
      unitRef="usd">131900000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182Ny9mcmFnOjU5NzZjOWRhM2RhYTQyOGViMmM5MjhmMzRiNDVjNjc5L3RhYmxlOmNlNDYxNTM2ZWE1ODQyMmZhMzg5NTIyMDA2ZWNkMjQ3L3RhYmxlcmFuZ2U6Y2U0NjE1MzZlYTU4NDIyZmEzODk1MjIwMDZlY2QyNDdfNy05LTEtMS04MzI4NQ_32d224e5-252c-4315-b9d4-9bca4b28cb90"
      unitRef="usd">98300000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182Ny9mcmFnOjU5NzZjOWRhM2RhYTQyOGViMmM5MjhmMzRiNDVjNjc5L3RhYmxlOmNlNDYxNTM2ZWE1ODQyMmZhMzg5NTIyMDA2ZWNkMjQ3L3RhYmxlcmFuZ2U6Y2U0NjE1MzZlYTU4NDIyZmEzODk1MjIwMDZlY2QyNDdfNy0xMS0xLTEtODMyODU_093aeffc-e3b1-4312-80cb-74d4875f2d97"
      unitRef="usd">33600000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182Ny9mcmFnOjU5NzZjOWRhM2RhYTQyOGViMmM5MjhmMzRiNDVjNjc5L3RleHRyZWdpb246NTk3NmM5ZGEzZGFhNDI4ZWIyYzkyOGYzNGI0NWM2NzlfMjgz_29d851d5-d8f9-4d28-9b2e-f7ed47d053ed"
      unitRef="usd">3400000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN182Ny9mcmFnOjU5NzZjOWRhM2RhYTQyOGViMmM5MjhmMzRiNDVjNjc5L3RleHRyZWdpb246NTk3NmM5ZGEzZGFhNDI4ZWIyYzkyOGYzNGI0NWM2NzlfMjkw_08107ee0-fc31-4e80-a86a-babcefbabf05"
      unitRef="usd">3800000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RleHRyZWdpb246NDVhZDgwNGFmY2UzNGM3MDhjMjNlYWFlMzQxODRkOGRfNjUzOQ_d678f732-9873-4fb6-90a9-0c275ca46eb3">BORROWINGS&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The following table summarizes the Company's short-term and long-term debt:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.733%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.015%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(In millions, except for percentages)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Contractual Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Effective Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Current maturities of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Non-current maturities of long-term debt:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Convertible Senior Unsecured Notes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;200.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;200.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.8%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Senior Secured Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;243.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;243.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.9%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8.2%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total non-current maturities of long-term debt:&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;447.6&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;447.6&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unamortized issuance costs and debt discounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unamortized discount - Convertible Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(28.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unamortized issuance costs - Convertible Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unamortized issuance costs - Senior Secured Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(6.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(35.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total debt outstanding, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;442.9&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;414.4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Equity component of Convertible Senior Unsecured Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; In connection with the adoption of ASU 2020-06, the unamortized discount related to the Convertible Notes was derecognized and the carrying value of the issuance costs was adjusted in the first quarter of fiscal year 2023. Refer to Note 1, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Summary of Significant Accounting Policies &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;for further details. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Included in additional paid-in capital on the Condensed Consolidated Balance Sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The following table summarizes the Company's interest expense:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contractual interest coupon and other&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amortization of debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amortization of debt discounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;7.5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;9.9&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Convertible Senior Unsecured Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;On June 9, 2020, Varex issued $200.0&#160;million in aggregate principal amount of 4.00% Convertible Senior Unsecured Notes due 2025 (&#x201c;Convertible Notes&#x201d;). The net proceeds from the issuance of the Convertible Notes, after deducting transaction fees and offering expense payable by the Company, were approximately $193.1&#160;million. The Convertible Notes bear interest at the annual rate of 4.00%, payable semiannually on June 1 and December 1 of each year, beginning on December 1, 2020, and will mature on June 1, 2025, unless earlier converted or repurchased by Varex.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Convertible Notes are convertible into cash, shares of Varex common stock or a combination thereof, at Varex's election, at an initial conversion rate of 48.048 shares of common stock per $1,000 principal amount of Convertible Notes, which is equivalent to an initial conversion price of approximately $20.81 per share, subject to adjustment pursuant to the terms of the indenture governing the Convertible Notes. The Convertible Notes may be converted at any time after, and including, December 15, 2024 until the close of business on the second scheduled trading day immediately before the maturity date. The maximum number of shares issuable upon conversion of the Convertible Notes is 9.6&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Call Spread &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;On June 4, 2020 and June 5, 2020, in connection with the offering of the Convertible Notes, Varex entered into privately negotiated convertible note hedge transactions (collectively, the &#x201c;Hedge Transactions&#x201d;). The Hedge Transactions cover, subject to customary anti-dilution adjustments, the number of shares of Varex common stock that were initially covered by the Convertible Notes. The Hedge Transactions are expected generally to reduce the potential dilution and/or offset any cash payments Varex is required to make in excess of the principal amount due upon conversion of the Convertible Notes in the event that the market price of Varex common stock is greater than the strike price of the Hedge Transactions, which was initially $20.81 per share (subject to adjustment under the terms of the Hedge Transactions). The strike price of $20.81 corresponds to the initial conversion price of the Convertible Notes. The number of shares underlying the Hedge Transactions is 9.6&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;On June 4, 2020 and June 5, 2020, Varex also entered into privately negotiated warrant transactions (collectively, the &#x201c;Warrant Transactions&#x201d; and, together with the Hedge Transactions, the &#x201c;Call Spread Transactions&#x201d;), whereby the Company sold warrants at a higher strike price relating to the same number of shares of Varex common stock that were initially covered by the Convertible Notes, subject to customary anti-dilution adjustments. The initial strike price of the warrants is $24.975 per share (subject to adjustment under the terms of the Warrant Transactions), which was 50% above the last reported sale price of Varex common stock on June 4, 2020. The Warrant Transactions could have a dilutive effect to the Company's stockholders to the extent that the market price per share of Varex common stock, as measured under the terms of the Warrant Transactions, exceeds the applicable strike price of the warrants. The number of shares underlying the Warrant Transactions is 9.6&#160;million. The number of warrants outstanding as of December&#160;30, 2022 was 9.6&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Senior Secured Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Varex issued $300.0&#160;million aggregate principal amount of 7.875% Senior Secured Notes due 2027 (the "Senior Secured Notes") pursuant to an indenture dated September 30, 2020. Interest payments are paid semiannually on April 15 and October 15 of each year, beginning on April 15, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Senior Secured Notes are secured by a first priority lien on substantially all of the assets of Varex and the assets and capital stock of its subsidiary guarantors (subject to exceptions), except for assets for which a first priority security interest is pledged for the ABL Facility (defined below), in which the Senior Secured Notes will have a second lien security interest. The Senior Secured Notes include negative covenants, subject to certain exceptions, restricting or limiting Varex's ability and the ability of its restricted subsidiaries to, among other things, incur liens on collateral; sell certain assets; incur additional indebtedness; pay dividends; issue preferred shares; consolidate, merge, or sell all or substantially all of its assets; and enter into certain transactions with their affiliates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Asset-Based Loan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;On September 30, 2020, the Company entered into a revolving credit agreement consisting of a $100.0&#160;million asset-based loan revolving credit facility (the &#x201c;Asset-Based Loan&#x201d; or "ABL Facility"). Borrowings under the Asset-Based Loan bear interest at floating rates based on the Secured Overnight Financing Rate ("SOFR"), or a comparable rate, or a base rate, and an applicable margin based on Average Daily Excess Availability (as defined in the Asset-Based Loan Agreement). In addition, the Company is required to pay a quarterly commitment fee of 0.25%, based on the aggregate unused commitments under the Asset-Based Loan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The ABL Facility matures on the earlier of September 30, 2025 or 91 days prior to the maturity of the Convertible Notes, at which time all outstanding amounts under the ABL Facility will be due and payable. The maximum availability under the ABL Facility is $100.0 million; however, the borrowing base under the ABL Facility fluctuates from month-to-month depending on the amount of eligible accounts receivable, inventory, and real estate. As of December&#160;30, 2022, the amount available under the ABL Facility was $92.0&#160;million and the ABL Facility remains undrawn.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The ABL Facility includes various restrictive covenants that limit the Company's ability to engage in certain transactions, including the incurrence of debt, payment of dividends and other restrictive payments, existence of restrictions affecting subsidiaries, sales of stock and assets, certain affiliate transactions, modifications of debt documents and organizational documents, changes to line of business and fiscal year, incurrence of liens, making fundamental changes, prepayments of junior indebtedness, and certain other transactions.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtTableTextBlock
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RleHRyZWdpb246NDVhZDgwNGFmY2UzNGM3MDhjMjNlYWFlMzQxODRkOGRfNjU0MA_bc9fb8d5-9d63-4d67-9c10-bdd06d766355">The following table summarizes the Company's short-term and long-term debt:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.733%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.015%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(In millions, except for percentages)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Contractual Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Effective Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Current maturities of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Non-current maturities of long-term debt:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Convertible Senior Unsecured Notes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;200.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;200.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.8%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Senior Secured Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;243.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;243.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.9%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8.2%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total non-current maturities of long-term debt:&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;447.6&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;447.6&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unamortized issuance costs and debt discounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unamortized discount - Convertible Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(28.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unamortized issuance costs - Convertible Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unamortized issuance costs - Senior Secured Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(6.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(35.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total debt outstanding, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;442.9&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;414.4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Equity component of Convertible Senior Unsecured Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; In connection with the adoption of ASU 2020-06, the unamortized discount related to the Convertible Notes was derecognized and the carrying value of the issuance costs was adjusted in the first quarter of fiscal year 2023. Refer to Note 1, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Summary of Significant Accounting Policies &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;for further details. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Included in additional paid-in capital on the Condensed Consolidated Balance Sheets.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:LongTermDebtCurrent
      contextRef="ie7b6a45a9d7f431e82a5e0541b5d665f_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RhYmxlOjQ4NTgzMzQwZjkxYTQ0ZWFiYTNkNmVhZDJjYTM2MjcyL3RhYmxlcmFuZ2U6NDg1ODMzNDBmOTFhNDRlYWJhM2Q2ZWFkMmNhMzYyNzJfNC0xLTEtMS04MzI4NQ_ffb07fed-ae6d-4fcd-805b-00e187d9d67b"
      unitRef="usd">2100000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="ifdafe244379e403ab68aa2010d767746_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RhYmxlOjQ4NTgzMzQwZjkxYTQ0ZWFiYTNkNmVhZDJjYTM2MjcyL3RhYmxlcmFuZ2U6NDg1ODMzNDBmOTFhNDRlYWJhM2Q2ZWFkMmNhMzYyNzJfNC0zLTEtMS04MzI4NQ_306beb10-fd3b-4d63-af27-e5a03f3d89e9"
      unitRef="usd">2100000</us-gaap:LongTermDebtCurrent>
    <var:LongtermDebtExcludingCurrentMaturitiesGross
      contextRef="i2ddb8748822a4dd79f1844c4e1de6408_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RhYmxlOjQ4NTgzMzQwZjkxYTQ0ZWFiYTNkNmVhZDJjYTM2MjcyL3RhYmxlcmFuZ2U6NDg1ODMzNDBmOTFhNDRlYWJhM2Q2ZWFkMmNhMzYyNzJfOC0xLTEtMS04MzI4NQ_906f1790-98c0-4b53-8145-71ef68ca2992"
      unitRef="usd">200000000.0</var:LongtermDebtExcludingCurrentMaturitiesGross>
    <var:LongtermDebtExcludingCurrentMaturitiesGross
      contextRef="i329314c9f0c94232beff7031f1c86791_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RhYmxlOjQ4NTgzMzQwZjkxYTQ0ZWFiYTNkNmVhZDJjYTM2MjcyL3RhYmxlcmFuZ2U6NDg1ODMzNDBmOTFhNDRlYWJhM2Q2ZWFkMmNhMzYyNzJfOC0zLTEtMS04MzI4NQ_16135b02-0bd6-4bb4-9c60-05e17403557f"
      unitRef="usd">200000000.0</var:LongtermDebtExcludingCurrentMaturitiesGross>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i2ddb8748822a4dd79f1844c4e1de6408_I20221230"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RhYmxlOjQ4NTgzMzQwZjkxYTQ0ZWFiYTNkNmVhZDJjYTM2MjcyL3RhYmxlcmFuZ2U6NDg1ODMzNDBmOTFhNDRlYWJhM2Q2ZWFkMmNhMzYyNzJfOC01LTEtMS04MzI4NQ_720fe66e-57f3-46ff-9381-a6161c657a15"
      unitRef="number">0.040</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtWeightedAverageInterestRateOverTime
      contextRef="if2ff80d284834bfcb7ca6f632c838139_D20221001-20221230"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RhYmxlOjQ4NTgzMzQwZjkxYTQ0ZWFiYTNkNmVhZDJjYTM2MjcyL3RhYmxlcmFuZ2U6NDg1ODMzNDBmOTFhNDRlYWJhM2Q2ZWFkMmNhMzYyNzJfOC03LTEtMS04MzI4NQ_5c34ae56-15ed-4c24-9801-6d3ffe6423cd"
      unitRef="number">0.048</us-gaap:LongTermDebtWeightedAverageInterestRateOverTime>
    <var:LongtermDebtExcludingCurrentMaturitiesGross
      contextRef="i2fee5a0bbf6742f6bb3e66a2bb45060d_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RhYmxlOjQ4NTgzMzQwZjkxYTQ0ZWFiYTNkNmVhZDJjYTM2MjcyL3RhYmxlcmFuZ2U6NDg1ODMzNDBmOTFhNDRlYWJhM2Q2ZWFkMmNhMzYyNzJfOS0xLTEtMS04MzI4NQ_c38baa02-9f27-44db-b109-b977631a1cb5"
      unitRef="usd">243000000.0</var:LongtermDebtExcludingCurrentMaturitiesGross>
    <var:LongtermDebtExcludingCurrentMaturitiesGross
      contextRef="if0321a6e3bf3410dbde55beea3d74890_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RhYmxlOjQ4NTgzMzQwZjkxYTQ0ZWFiYTNkNmVhZDJjYTM2MjcyL3RhYmxlcmFuZ2U6NDg1ODMzNDBmOTFhNDRlYWJhM2Q2ZWFkMmNhMzYyNzJfOS0zLTEtMS04MzI4NQ_39696177-9b94-4e03-b408-fc85d1f5e826"
      unitRef="usd">243000000.0</var:LongtermDebtExcludingCurrentMaturitiesGross>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i2fee5a0bbf6742f6bb3e66a2bb45060d_I20221230"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RhYmxlOjQ4NTgzMzQwZjkxYTQ0ZWFiYTNkNmVhZDJjYTM2MjcyL3RhYmxlcmFuZ2U6NDg1ODMzNDBmOTFhNDRlYWJhM2Q2ZWFkMmNhMzYyNzJfOS01LTEtMS04MzI4NQ_460cab0a-aaaa-4b4d-b4f8-f79af335915f"
      unitRef="number">0.079</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtWeightedAverageInterestRateOverTime
      contextRef="idb047c1f6e044134babc50205637228f_D20221001-20221230"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RhYmxlOjQ4NTgzMzQwZjkxYTQ0ZWFiYTNkNmVhZDJjYTM2MjcyL3RhYmxlcmFuZ2U6NDg1ODMzNDBmOTFhNDRlYWJhM2Q2ZWFkMmNhMzYyNzJfOS03LTEtMS04MzI4NQ_95a9d9d2-a009-4022-915c-7a2456173627"
      unitRef="number">0.082</us-gaap:LongTermDebtWeightedAverageInterestRateOverTime>
    <var:LongtermDebtExcludingCurrentMaturitiesGross
      contextRef="ie7b6a45a9d7f431e82a5e0541b5d665f_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RhYmxlOjQ4NTgzMzQwZjkxYTQ0ZWFiYTNkNmVhZDJjYTM2MjcyL3RhYmxlcmFuZ2U6NDg1ODMzNDBmOTFhNDRlYWJhM2Q2ZWFkMmNhMzYyNzJfMTAtMS0xLTEtODMyODU_4ef87299-a05c-44bd-b161-2ae78e520588"
      unitRef="usd">4600000</var:LongtermDebtExcludingCurrentMaturitiesGross>
    <var:LongtermDebtExcludingCurrentMaturitiesGross
      contextRef="ifdafe244379e403ab68aa2010d767746_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RhYmxlOjQ4NTgzMzQwZjkxYTQ0ZWFiYTNkNmVhZDJjYTM2MjcyL3RhYmxlcmFuZ2U6NDg1ODMzNDBmOTFhNDRlYWJhM2Q2ZWFkMmNhMzYyNzJfMTAtMy0xLTEtODMyODU_e5e694da-48dc-45ec-9915-b2aa92ec3460"
      unitRef="usd">4600000</var:LongtermDebtExcludingCurrentMaturitiesGross>
    <var:LongtermDebtExcludingCurrentMaturitiesGross
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RhYmxlOjQ4NTgzMzQwZjkxYTQ0ZWFiYTNkNmVhZDJjYTM2MjcyL3RhYmxlcmFuZ2U6NDg1ODMzNDBmOTFhNDRlYWJhM2Q2ZWFkMmNhMzYyNzJfMTEtMS0xLTEtODMyODU_f71daaa0-da30-48e3-a5fd-7159f6930804"
      unitRef="usd">447600000</var:LongtermDebtExcludingCurrentMaturitiesGross>
    <var:LongtermDebtExcludingCurrentMaturitiesGross
      contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RhYmxlOjQ4NTgzMzQwZjkxYTQ0ZWFiYTNkNmVhZDJjYTM2MjcyL3RhYmxlcmFuZ2U6NDg1ODMzNDBmOTFhNDRlYWJhM2Q2ZWFkMmNhMzYyNzJfMTEtMy0xLTEtODMyODU_32fa521d-104f-48f2-a0c3-a4d48cab8d12"
      unitRef="usd">447600000</var:LongtermDebtExcludingCurrentMaturitiesGross>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="i2ddb8748822a4dd79f1844c4e1de6408_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RhYmxlOjQ4NTgzMzQwZjkxYTQ0ZWFiYTNkNmVhZDJjYTM2MjcyL3RhYmxlcmFuZ2U6NDg1ODMzNDBmOTFhNDRlYWJhM2Q2ZWFkMmNhMzYyNzJfMTMtMS0xLTEtODMyODU_a6f72754-5569-4a94-8f1b-f573da6e0b98"
      unitRef="usd">0</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="i329314c9f0c94232beff7031f1c86791_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RhYmxlOjQ4NTgzMzQwZjkxYTQ0ZWFiYTNkNmVhZDJjYTM2MjcyL3RhYmxlcmFuZ2U6NDg1ODMzNDBmOTFhNDRlYWJhM2Q2ZWFkMmNhMzYyNzJfMTMtMy0xLTEtODMyODU_5c4d7161-ae8f-4146-8197-5a615dc24ffd"
      unitRef="usd">28700000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i2ddb8748822a4dd79f1844c4e1de6408_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RhYmxlOjQ4NTgzMzQwZjkxYTQ0ZWFiYTNkNmVhZDJjYTM2MjcyL3RhYmxlcmFuZ2U6NDg1ODMzNDBmOTFhNDRlYWJhM2Q2ZWFkMmNhMzYyNzJfMTQtMS0xLTEtODMyODU_2a35087a-f6a1-45d0-97a0-8758bb91ac7b"
      unitRef="usd">3500000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i329314c9f0c94232beff7031f1c86791_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RhYmxlOjQ4NTgzMzQwZjkxYTQ0ZWFiYTNkNmVhZDJjYTM2MjcyL3RhYmxlcmFuZ2U6NDg1ODMzNDBmOTFhNDRlYWJhM2Q2ZWFkMmNhMzYyNzJfMTQtMy0xLTEtODMyODU_bb14fd09-dfd3-45b3-9b96-82032af6bb89"
      unitRef="usd">3100000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i2fee5a0bbf6742f6bb3e66a2bb45060d_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RhYmxlOjQ4NTgzMzQwZjkxYTQ0ZWFiYTNkNmVhZDJjYTM2MjcyL3RhYmxlcmFuZ2U6NDg1ODMzNDBmOTFhNDRlYWJhM2Q2ZWFkMmNhMzYyNzJfMTUtMS0xLTEtODMyODU_9e15a8e9-3b7f-481f-b6a9-e528770f5d65"
      unitRef="usd">3300000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="if0321a6e3bf3410dbde55beea3d74890_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RhYmxlOjQ4NTgzMzQwZjkxYTQ0ZWFiYTNkNmVhZDJjYTM2MjcyL3RhYmxlcmFuZ2U6NDg1ODMzNDBmOTFhNDRlYWJhM2Q2ZWFkMmNhMzYyNzJfMTUtMy0xLTEtODMyODU_a8422765-3bb4-4401-b461-68d2ea176c2c"
      unitRef="usd">3500000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RhYmxlOjQ4NTgzMzQwZjkxYTQ0ZWFiYTNkNmVhZDJjYTM2MjcyL3RhYmxlcmFuZ2U6NDg1ODMzNDBmOTFhNDRlYWJhM2Q2ZWFkMmNhMzYyNzJfMTYtMS0xLTEtODMyODU_7b67f82e-c54a-465f-9862-c4a165606fdc"
      unitRef="usd">6800000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RhYmxlOjQ4NTgzMzQwZjkxYTQ0ZWFiYTNkNmVhZDJjYTM2MjcyL3RhYmxlcmFuZ2U6NDg1ODMzNDBmOTFhNDRlYWJhM2Q2ZWFkMmNhMzYyNzJfMTYtMy0xLTEtODMyODU_4e8e5937-9218-4692-b10b-8024b1c4a66b"
      unitRef="usd">35300000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:LongTermDebt
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RhYmxlOjQ4NTgzMzQwZjkxYTQ0ZWFiYTNkNmVhZDJjYTM2MjcyL3RhYmxlcmFuZ2U6NDg1ODMzNDBmOTFhNDRlYWJhM2Q2ZWFkMmNhMzYyNzJfMTctMS0xLTEtODMyODU_93b6ac24-f879-41b1-a50b-f9be103e1561"
      unitRef="usd">442900000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RhYmxlOjQ4NTgzMzQwZjkxYTQ0ZWFiYTNkNmVhZDJjYTM2MjcyL3RhYmxlcmFuZ2U6NDg1ODMzNDBmOTFhNDRlYWJhM2Q2ZWFkMmNhMzYyNzJfMTctMy0xLTEtODMyODU_c85b5852-d038-49b7-9b9f-0dcd990e4f9e"
      unitRef="usd">414400000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent
      contextRef="i2ddb8748822a4dd79f1844c4e1de6408_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RhYmxlOjQ4NTgzMzQwZjkxYTQ0ZWFiYTNkNmVhZDJjYTM2MjcyL3RhYmxlcmFuZ2U6NDg1ODMzNDBmOTFhNDRlYWJhM2Q2ZWFkMmNhMzYyNzJfMTktMS0xLTEtODMyODU_84dfc107-2340-4223-ba49-2e729dc51132"
      unitRef="usd">0</us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent>
    <us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent
      contextRef="i329314c9f0c94232beff7031f1c86791_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RhYmxlOjQ4NTgzMzQwZjkxYTQ0ZWFiYTNkNmVhZDJjYTM2MjcyL3RhYmxlcmFuZ2U6NDg1ODMzNDBmOTFhNDRlYWJhM2Q2ZWFkMmNhMzYyNzJfMTktMy0xLTEtODMyODU_04997920-79ba-4357-862a-52e10a0d9b3d"
      unitRef="usd">49700000</us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent>
    <us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RleHRyZWdpb246NDVhZDgwNGFmY2UzNGM3MDhjMjNlYWFlMzQxODRkOGRfNjU0Ng_29012be7-95e9-4f8a-a5fb-6c5e2c6095b7">The following table summarizes the Company's interest expense:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contractual interest coupon and other&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amortization of debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amortization of debt discounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;7.5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;9.9&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock>
    <var:InterestExpenseDebtContractualInterestCoupon
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RhYmxlOjJkMjhmZDZkMWNlMTRkMGNhZWYzZTNlZjBmOTRhNDYzL3RhYmxlcmFuZ2U6MmQyOGZkNmQxY2UxNGQwY2FlZjNlM2VmMGY5NGE0NjNfMi0xLTEtMS04MzI4NQ_3554863e-a5ca-4443-9391-9760d485e293"
      unitRef="usd">6900000</var:InterestExpenseDebtContractualInterestCoupon>
    <var:InterestExpenseDebtContractualInterestCoupon
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RhYmxlOjJkMjhmZDZkMWNlMTRkMGNhZWYzZTNlZjBmOTRhNDYzL3RhYmxlcmFuZ2U6MmQyOGZkNmQxY2UxNGQwY2FlZjNlM2VmMGY5NGE0NjNfMi0zLTEtMS04MzI4NQ_5c842faa-8ddd-4d6e-be63-d70c1afcc46f"
      unitRef="usd">7300000</var:InterestExpenseDebtContractualInterestCoupon>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RhYmxlOjJkMjhmZDZkMWNlMTRkMGNhZWYzZTNlZjBmOTRhNDYzL3RhYmxlcmFuZ2U6MmQyOGZkNmQxY2UxNGQwY2FlZjNlM2VmMGY5NGE0NjNfMy0xLTEtMS04MzI4NQ_3aabd322-69eb-45f8-89b9-7df02200bdd1"
      unitRef="usd">600000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RhYmxlOjJkMjhmZDZkMWNlMTRkMGNhZWYzZTNlZjBmOTRhNDYzL3RhYmxlcmFuZ2U6MmQyOGZkNmQxY2UxNGQwY2FlZjNlM2VmMGY5NGE0NjNfMy0zLTEtMS04MzI4NQ_9d689908-8841-40aa-96bf-82ee91064688"
      unitRef="usd">500000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RhYmxlOjJkMjhmZDZkMWNlMTRkMGNhZWYzZTNlZjBmOTRhNDYzL3RhYmxlcmFuZ2U6MmQyOGZkNmQxY2UxNGQwY2FlZjNlM2VmMGY5NGE0NjNfNC0xLTEtMS04MzI4NQ_415fa4df-71e5-4826-af01-f20e05bb25c2"
      unitRef="usd">0</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RhYmxlOjJkMjhmZDZkMWNlMTRkMGNhZWYzZTNlZjBmOTRhNDYzL3RhYmxlcmFuZ2U6MmQyOGZkNmQxY2UxNGQwY2FlZjNlM2VmMGY5NGE0NjNfNC0zLTEtMS04MzI4NQ_aaf85826-766c-4765-98a7-d53ba3fc8ab2"
      unitRef="usd">2100000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:InterestExpense
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RhYmxlOjJkMjhmZDZkMWNlMTRkMGNhZWYzZTNlZjBmOTRhNDYzL3RhYmxlcmFuZ2U6MmQyOGZkNmQxY2UxNGQwY2FlZjNlM2VmMGY5NGE0NjNfNS0xLTEtMS04MzI4NQ_0988406d-e309-4cd9-a16b-f0e387b89894"
      unitRef="usd">7500000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RhYmxlOjJkMjhmZDZkMWNlMTRkMGNhZWYzZTNlZjBmOTRhNDYzL3RhYmxlcmFuZ2U6MmQyOGZkNmQxY2UxNGQwY2FlZjNlM2VmMGY5NGE0NjNfNS0zLTEtMS04MzI4NQ_5a1c59c5-dbed-4053-b951-8e69a400bb93"
      unitRef="usd">9900000</us-gaap:InterestExpense>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i69f1e52e1cba4369877e4bf54fb6f0fa_I20200609"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RleHRyZWdpb246NDVhZDgwNGFmY2UzNGM3MDhjMjNlYWFlMzQxODRkOGRfMzA4_475387e8-991e-40ad-9713-3fe5699ff72d"
      unitRef="usd">200000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i69f1e52e1cba4369877e4bf54fb6f0fa_I20200609"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RleHRyZWdpb246NDVhZDgwNGFmY2UzNGM3MDhjMjNlYWFlMzQxODRkOGRfMzQ0_36d1794a-9285-4e25-907f-a883dea75cc3"
      unitRef="number">0.0400</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="ia56e2cecd1c944d1be9cbd9438c698cb_D20200609-20200609"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RleHRyZWdpb246NDVhZDgwNGFmY2UzNGM3MDhjMjNlYWFlMzQxODRkOGRfNTcw_b28bbb13-e9b4-4cbf-8223-dfb6d8c5e9dc"
      unitRef="usd">193100000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i69f1e52e1cba4369877e4bf54fb6f0fa_I20200609"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RleHRyZWdpb246NDVhZDgwNGFmY2UzNGM3MDhjMjNlYWFlMzQxODRkOGRfNjMy_a096e8b9-65a6-43ed-875b-516c315f91d2"
      unitRef="number">0.0400</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="ia56e2cecd1c944d1be9cbd9438c698cb_D20200609-20200609"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RleHRyZWdpb246NDVhZDgwNGFmY2UzNGM3MDhjMjNlYWFlMzQxODRkOGRfMTA5OTUxMTYyODU4NDk_34100924-df02-4489-92ea-9f7faf23dd45"
      unitRef="shares">48.048</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="i9d049c5854724aa9974c7beaa7a53f96_I20200605"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RleHRyZWdpb246NDVhZDgwNGFmY2UzNGM3MDhjMjNlYWFlMzQxODRkOGRfMTA5OTUxMTYyODU4NzE_659704d7-88fc-4950-bb9d-a7f4fd78300e"
      unitRef="usdPerShare">20.81</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentConvertibleNumberOfEquityInstruments
      contextRef="i4e0cf62911af4732b7b65d582effb57a_D20200604-20200605"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RleHRyZWdpb246NDVhZDgwNGFmY2UzNGM3MDhjMjNlYWFlMzQxODRkOGRfMTA5OTUxMTYyODU5NzE_97fe4fb8-9ead-4e78-847f-4d94a8a02b06"
      unitRef="shares">9600000</us-gaap:DebtInstrumentConvertibleNumberOfEquityInstruments>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="i9d049c5854724aa9974c7beaa7a53f96_I20200605"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RleHRyZWdpb246NDVhZDgwNGFmY2UzNGM3MDhjMjNlYWFlMzQxODRkOGRfMTUzOA_526a2740-2c21-44bc-ab42-58f7de661a53"
      unitRef="usdPerShare">20.81</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="i9d049c5854724aa9974c7beaa7a53f96_I20200605"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RleHRyZWdpb246NDVhZDgwNGFmY2UzNGM3MDhjMjNlYWFlMzQxODRkOGRfMTYzOA_659704d7-88fc-4950-bb9d-a7f4fd78300e"
      unitRef="usdPerShare">20.81</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentConvertibleNumberOfEquityInstruments
      contextRef="i4e0cf62911af4732b7b65d582effb57a_D20200604-20200605"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RleHRyZWdpb246NDVhZDgwNGFmY2UzNGM3MDhjMjNlYWFlMzQxODRkOGRfMTc2OQ_97fe4fb8-9ead-4e78-847f-4d94a8a02b06"
      unitRef="shares">9600000</us-gaap:DebtInstrumentConvertibleNumberOfEquityInstruments>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="i97ab3a4749584f83846ca650afd01c56_I20200604"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RleHRyZWdpb246NDVhZDgwNGFmY2UzNGM3MDhjMjNlYWFlMzQxODRkOGRfMjIzNg_d8c4646f-4212-454d-9493-cf0d785b363a"
      unitRef="usdPerShare">24.975</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <var:ClassOfWarrantOrRightPercentIncreaseOfStrikePriceOverSalePrice
      contextRef="i97ab3a4749584f83846ca650afd01c56_I20200604"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RleHRyZWdpb246NDVhZDgwNGFmY2UzNGM3MDhjMjNlYWFlMzQxODRkOGRfMjMyOA_b846b031-34c7-4d84-a0c0-d001fa6caea4"
      unitRef="number">0.50</var:ClassOfWarrantOrRightPercentIncreaseOfStrikePriceOverSalePrice>
    <us-gaap:DebtInstrumentConvertibleNumberOfEquityInstruments
      contextRef="i4e0cf62911af4732b7b65d582effb57a_D20200604-20200605"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RleHRyZWdpb246NDVhZDgwNGFmY2UzNGM3MDhjMjNlYWFlMzQxODRkOGRfMjcxOA_8d33de43-df21-4e42-b4c4-e58187b52e71"
      unitRef="shares">9600000</us-gaap:DebtInstrumentConvertibleNumberOfEquityInstruments>
    <us-gaap:DebtInstrumentConvertibleNumberOfEquityInstruments
      contextRef="i798fb4265b0e4636a6a91ab2434ed003_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RleHRyZWdpb246NDVhZDgwNGFmY2UzNGM3MDhjMjNlYWFlMzQxODRkOGRfMjc3MA_f1ec9d54-abaa-4ee3-9289-a584120dfe2c"
      unitRef="shares">9600000</us-gaap:DebtInstrumentConvertibleNumberOfEquityInstruments>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="id08284e24f7a44a1af87978abad620f1_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RleHRyZWdpb246NDVhZDgwNGFmY2UzNGM3MDhjMjNlYWFlMzQxODRkOGRfMjgwOQ_a70fc5fc-9410-4cfd-8a87-682a7ee0708c"
      unitRef="usd">300000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id08284e24f7a44a1af87978abad620f1_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RleHRyZWdpb246NDVhZDgwNGFmY2UzNGM3MDhjMjNlYWFlMzQxODRkOGRfMjg0Mg_cd98b885-d3ad-46f2-94eb-f4a672a4b654"
      unitRef="number">0.07875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="icb3ccdc0c44b4d1ea6e36338c7054f16_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RleHRyZWdpb246NDVhZDgwNGFmY2UzNGM3MDhjMjNlYWFlMzQxODRkOGRfNDU1MQ_3771a17c-a10d-47c9-bd4e-6b911c4a9ee8"
      unitRef="usd">100000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="i158d5c57020b4ef6a39dffc0260b3686_D20220930-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RleHRyZWdpb246NDVhZDgwNGFmY2UzNGM3MDhjMjNlYWFlMzQxODRkOGRfNTI3NA_d819bba1-8519-43c4-b5dc-387bb06074f0"
      unitRef="number">0.0025</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i6c3e3d6ed3d54b1db390bab6a91c9dbc_I20221230"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RleHRyZWdpb246NDVhZDgwNGFmY2UzNGM3MDhjMjNlYWFlMzQxODRkOGRfNTczMg_ceda7c54-71cf-4c65-9b45-edb5bdd6e392"
      unitRef="usd">100000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity
      contextRef="i6c3e3d6ed3d54b1db390bab6a91c9dbc_I20221230"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183MC9mcmFnOjQ1YWQ4MDRhZmNlMzRjNzA4YzIzZWFhZTM0MTg0ZDhkL3RleHRyZWdpb246NDVhZDgwNGFmY2UzNGM3MDhjMjNlYWFlMzQxODRkOGRfNTk2MQ_12efbad1-c88c-458b-b144-baf8c7d6214d"
      unitRef="usd">92000000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:MinorityInterestDisclosureTextBlock
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183My9mcmFnOjNhOTQ5ZjJjZDZjMDRkNWVhZmM1MGIyYmE2NzY2Y2MxL3RleHRyZWdpb246M2E5NDlmMmNkNmMwNGQ1ZWFmYzUwYjJiYTY3NjZjYzFfMjE2MQ_cf6b2987-4410-422e-9042-028c001e5587">NONCONTROLLING INTERESTS&lt;div style="margin-top:6pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In September 2018, the Company entered into a partnership in Saudi Arabia. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has majority voting rights with an approximate 75% interest. Accordingly, the Company has consolidated the operations of the Saudi Arabia partnership in its condensed consolidated financial statements and recorded the noncontrolling interests. The noncontrolling interest related to the partner&#x2019;s 25% interest in the joint venture is included in noncontrolling interests in the equity section of the Company&#x2019;s Condensed Consolidated Balance Sheets. Income representing the noncontrolling partner's share of income from operations is included in the Company's Condensed Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In April 2015, the Company acquired 73.5% of the then outstanding shares of &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;MeVis Medical Solutions AG (&#x201c;MeVis&#x201d;)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, a publicly traded company based in Bremen, Germany that provides image processing software and services for cancer screening. In August 2015, the Company, through one of its German subsidiaries, entered into a Domination and Profit and Loss Transfer Agreement (the &#x201c;DPLTA&#x201d;) with MeVis. In fiscal years 2017 and 2018, the Company purchased an additional 0.2% of outstanding shares such that the Company now owns 73.7% of the outstanding shares of common stock of MeVis. Under the DPLTA, MeVis subordinates its management to the Company and undertakes to transfer all its annual profits and losses to the Company. In return, the DPLTA grants the noncontrolling shareholders of MeVis an annual recurring net compensation of &#x20ac;0.95 per MeVis share. At December&#160;30, 2022, noncontrolling shareholders together held approximately 0.5 million shares of MeVis, representing 26.3% of the outstanding shares.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Changes in noncontrolling interests were as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Noncontrolling interests, at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Noncontrolling interests, at end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:MinorityInterestDisclosureTextBlock>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="ibe05cb3673834311b8aede71e8a50abf_I20180930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183My9mcmFnOjNhOTQ5ZjJjZDZjMDRkNWVhZmM1MGIyYmE2NzY2Y2MxL3RleHRyZWdpb246M2E5NDlmMmNkNmMwNGQ1ZWFmYzUwYjJiYTY3NjZjYzFfNzY4_388b7a2a-dafc-4811-8581-4be763f5745c"
      unitRef="number">0.75</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners
      contextRef="ibe05cb3673834311b8aede71e8a50abf_I20180930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183My9mcmFnOjNhOTQ5ZjJjZDZjMDRkNWVhZmM1MGIyYmE2NzY2Y2MxL3RleHRyZWdpb246M2E5NDlmMmNkNmMwNGQ1ZWFmYzUwYjJiYTY3NjZjYzFfMTAxNw_7f2ea2fb-aa8a-442d-9b55-f36868aa26df"
      unitRef="number">0.25</us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="iaa0abd3404e2408cb290b091be08936f_I20150430"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183My9mcmFnOjNhOTQ5ZjJjZDZjMDRkNWVhZmM1MGIyYmE2NzY2Y2MxL3RleHRyZWdpb246M2E5NDlmMmNkNmMwNGQ1ZWFmYzUwYjJiYTY3NjZjYzFfMTM0MQ_0bb1e019-faca-416e-ac0b-050d1a95ed0f"
      unitRef="number">0.735</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <var:PercentageOfAdditionalOutstandingSharesPurchased
      contextRef="i129fd5cad674437db5d8fc43fb2f24cc_D20170929-20170929"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183My9mcmFnOjNhOTQ5ZjJjZDZjMDRkNWVhZmM1MGIyYmE2NzY2Y2MxL3RleHRyZWdpb246M2E5NDlmMmNkNmMwNGQ1ZWFmYzUwYjJiYTY3NjZjYzFfMTA5OTUxMTYzMDQ5NA_c3b339c4-a794-4c9a-be20-1b9884f70604"
      unitRef="number">0.002</var:PercentageOfAdditionalOutstandingSharesPurchased>
    <var:PercentageOfAdditionalOutstandingSharesPurchased
      contextRef="ia34c4680d929483bb8b2f9d74fb41a7a_D20180928-20180928"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183My9mcmFnOjNhOTQ5ZjJjZDZjMDRkNWVhZmM1MGIyYmE2NzY2Y2MxL3RleHRyZWdpb246M2E5NDlmMmNkNmMwNGQ1ZWFmYzUwYjJiYTY3NjZjYzFfMTA5OTUxMTYzMDQ5NA_f9c1738d-22c1-4acd-8045-23e614671798"
      unitRef="number">0.002</var:PercentageOfAdditionalOutstandingSharesPurchased>
    <var:BusinessAcquisitionCumulativePercentageOfVotingInterestsAcquired
      contextRef="ic047dd7ba8bc4e4983adf9ec678cc993_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183My9mcmFnOjNhOTQ5ZjJjZDZjMDRkNWVhZmM1MGIyYmE2NzY2Y2MxL3RleHRyZWdpb246M2E5NDlmMmNkNmMwNGQ1ZWFmYzUwYjJiYTY3NjZjYzFfMjE5OTAyMzI1ODQ2NA_b2bf6bb6-b55f-43fc-85be-ebacd1e41bf2"
      unitRef="number">0.737</var:BusinessAcquisitionCumulativePercentageOfVotingInterestsAcquired>
    <var:BusinessAcquisitionAnnualRecurringCompensation
      contextRef="i6530ecc1b8854fcbb93120033ddfdde9_D20150801-20150831"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183My9mcmFnOjNhOTQ5ZjJjZDZjMDRkNWVhZmM1MGIyYmE2NzY2Y2MxL3RleHRyZWdpb246M2E5NDlmMmNkNmMwNGQ1ZWFmYzUwYjJiYTY3NjZjYzFfMTk1NA_29dfeaf7-c7b2-444b-a575-9f6af6ed4c6e"
      unitRef="eurPerShare">0.95</var:BusinessAcquisitionAnnualRecurringCompensation>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183My9mcmFnOjNhOTQ5ZjJjZDZjMDRkNWVhZmM1MGIyYmE2NzY2Y2MxL3RleHRyZWdpb246M2E5NDlmMmNkNmMwNGQ1ZWFmYzUwYjJiYTY3NjZjYzFfMjAzOA_3a937206-ce61-40e3-9fee-022746759903"
      unitRef="shares">500000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners
      contextRef="ia15cd7f933164e4fa3c90be25a2678a1_I20221230"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183My9mcmFnOjNhOTQ5ZjJjZDZjMDRkNWVhZmM1MGIyYmE2NzY2Y2MxL3RleHRyZWdpb246M2E5NDlmMmNkNmMwNGQ1ZWFmYzUwYjJiYTY3NjZjYzFfMjA3MQ_ec75f85a-d5c7-471d-b977-ae5191fb2206"
      unitRef="number">0.263</us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners>
    <var:NoncontrollingInterestTableTextBlock
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183My9mcmFnOjNhOTQ5ZjJjZDZjMDRkNWVhZmM1MGIyYmE2NzY2Y2MxL3RleHRyZWdpb246M2E5NDlmMmNkNmMwNGQ1ZWFmYzUwYjJiYTY3NjZjYzFfMjE1NQ_7191369c-bd7d-49e0-b0db-cefc0b83bb8c">Changes in noncontrolling interests were as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Noncontrolling interests, at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Noncontrolling interests, at end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</var:NoncontrollingInterestTableTextBlock>
    <us-gaap:MinorityInterest
      contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183My9mcmFnOjNhOTQ5ZjJjZDZjMDRkNWVhZmM1MGIyYmE2NzY2Y2MxL3RhYmxlOmEyODI2NGM3MzVmNzQ1MzM5ZmRlOGQ1MWY2NWNlNjA0L3RhYmxlcmFuZ2U6YTI4MjY0YzczNWY3NDUzMzlmZGU4ZDUxZjY1Y2U2MDRfMi0xLTEtMS04MzI4NQ_4e79cdde-9499-4caa-8274-d0aa92daf558"
      unitRef="usd">13300000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="i504e59968786494c96b1e46f5375a17d_I20211001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183My9mcmFnOjNhOTQ5ZjJjZDZjMDRkNWVhZmM1MGIyYmE2NzY2Y2MxL3RhYmxlOmEyODI2NGM3MzVmNzQ1MzM5ZmRlOGQ1MWY2NWNlNjA0L3RhYmxlcmFuZ2U6YTI4MjY0YzczNWY3NDUzMzlmZGU4ZDUxZjY1Y2U2MDRfMi0zLTEtMS04MzI4NQ_16ff1a76-2d46-458f-9243-65afeedb0746"
      unitRef="usd">13200000</us-gaap:MinorityInterest>
    <var:NetIncomeLossAttributableToNoncontrollingInterestNetOfDividends
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183My9mcmFnOjNhOTQ5ZjJjZDZjMDRkNWVhZmM1MGIyYmE2NzY2Y2MxL3RhYmxlOmEyODI2NGM3MzVmNzQ1MzM5ZmRlOGQ1MWY2NWNlNjA0L3RhYmxlcmFuZ2U6YTI4MjY0YzczNWY3NDUzMzlmZGU4ZDUxZjY1Y2U2MDRfMy0xLTEtMS04MzI4NQ_13a5af38-d4a1-48ca-a9a9-7a9f148e4c70"
      unitRef="usd">100000</var:NetIncomeLossAttributableToNoncontrollingInterestNetOfDividends>
    <var:NetIncomeLossAttributableToNoncontrollingInterestNetOfDividends
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183My9mcmFnOjNhOTQ5ZjJjZDZjMDRkNWVhZmM1MGIyYmE2NzY2Y2MxL3RhYmxlOmEyODI2NGM3MzVmNzQ1MzM5ZmRlOGQ1MWY2NWNlNjA0L3RhYmxlcmFuZ2U6YTI4MjY0YzczNWY3NDUzMzlmZGU4ZDUxZjY1Y2U2MDRfMy0zLTEtMS04MzI4NQ_2a38377d-5dd0-4f12-8cc4-8c85648c8c83"
      unitRef="usd">200000</var:NetIncomeLossAttributableToNoncontrollingInterestNetOfDividends>
    <var:NoncontrollingInterestOtherChanges
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183My9mcmFnOjNhOTQ5ZjJjZDZjMDRkNWVhZmM1MGIyYmE2NzY2Y2MxL3RhYmxlOmEyODI2NGM3MzVmNzQ1MzM5ZmRlOGQ1MWY2NWNlNjA0L3RhYmxlcmFuZ2U6YTI4MjY0YzczNWY3NDUzMzlmZGU4ZDUxZjY1Y2U2MDRfNC0xLTEtMS04MzI4NQ_12fc9d1c-94e2-4d7a-8683-f7162834c9fd"
      unitRef="usd">-100000</var:NoncontrollingInterestOtherChanges>
    <var:NoncontrollingInterestOtherChanges
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183My9mcmFnOjNhOTQ5ZjJjZDZjMDRkNWVhZmM1MGIyYmE2NzY2Y2MxL3RhYmxlOmEyODI2NGM3MzVmNzQ1MzM5ZmRlOGQ1MWY2NWNlNjA0L3RhYmxlcmFuZ2U6YTI4MjY0YzczNWY3NDUzMzlmZGU4ZDUxZjY1Y2U2MDRfNC0zLTEtMS04MzI4NQ_bd56c054-5b91-4d60-8ce9-afa0dd6e9048"
      unitRef="usd">-100000</var:NoncontrollingInterestOtherChanges>
    <us-gaap:MinorityInterest
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183My9mcmFnOjNhOTQ5ZjJjZDZjMDRkNWVhZmM1MGIyYmE2NzY2Y2MxL3RhYmxlOmEyODI2NGM3MzVmNzQ1MzM5ZmRlOGQ1MWY2NWNlNjA0L3RhYmxlcmFuZ2U6YTI4MjY0YzczNWY3NDUzMzlmZGU4ZDUxZjY1Y2U2MDRfNi0xLTEtMS04MzI4NQ_70d0c2e7-4e53-46df-ba7d-32ae4e237be7"
      unitRef="usd">13300000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="i4026880a25c245b7ae7af90aa89cf31c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183My9mcmFnOjNhOTQ5ZjJjZDZjMDRkNWVhZmM1MGIyYmE2NzY2Y2MxL3RhYmxlOmEyODI2NGM3MzVmNzQ1MzM5ZmRlOGQ1MWY2NWNlNjA0L3RhYmxlcmFuZ2U6YTI4MjY0YzczNWY3NDUzMzlmZGU4ZDUxZjY1Y2U2MDRfNi0zLTEtMS04MzI4NQ_fcc6b59e-c5c2-414e-9abc-206397c25322"
      unitRef="usd">13300000</us-gaap:MinorityInterest>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183Ni9mcmFnOjAxNjM5MGY4MmE3ZDRjNmJhNTY2ZTgxNDg1MTY2ZDQ0L3RleHRyZWdpb246MDE2MzkwZjgyYTdkNGM2YmE1NjZlODE0ODUxNjZkNDRfMTQ3Ng_d719418f-8b67-43e5-a237-6b09f6482209">NET INCOME PER SHARE&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Basic net income per common share is computed by dividing the net income for the period by the weighted average number of shares of common stock outstanding during the reporting period. Diluted net income per common share reflects the effects of potentially dilutive securities, which is computed by dividing net income by the sum of the weighted average number of common shares outstanding and dilutive common shares.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;A reconciliation of the numerator and denominator used in the calculation of basic and diluted net income common share is as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(In millions, except per share amounts)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Net income per share - basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Net income attributable to Varex&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Basic weighted average shares outstanding&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Basic net income per share attributable to Varex&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 13pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Net income per share - diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Net income attributable to Varex&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 10pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Basic weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dilutive effect of Convertible Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dilutive effect of share-based awards and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dilutive effect of warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:1pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Diluted weighted average shares outstanding&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Diluted net income per share attributable to Varex&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 10pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Anti-dilutive share summary&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:1pt;padding-left:15pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Restricted stock and options&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Convertible notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 4pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total anti-dilutive shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Potentially dilutive shares, which are based on the weighted-average shares of common stock underlying stock options, unvested stock awards, purchase rights granted under the employee stock purchase plan, warrants and Convertible Notes using the treasury stock method or the if-converted method, as applicable, are included when calculating diluted net income per share attributable to Varex when their effect is dilutive. As of October 1, 2022, the Company adopted ASU 2020-06 using the modified retrospective method. The standard requires the Company to apply the if-converted method in relation to the Convertible Notes, which requires the Company to assume that the Convertible Notes were converted using only share settlement at the beginning of the period, resulting in an additional 9.6&#160;million shares outstanding. Using this method, the numerator is affected by adding back interest expense and the denominator is affected by including the effect of potential share settlement, if the effect is dilutive. Prior to the adoption of ASU 2020-06, the Convertible Notes were accounted for using the treasury stock method for the purposes of net income per share. See Note 1, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Summary of Significant Accounting Policies, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;"Recently Adopted Accounting Pronouncements" for further details concerning the adoption of ASU 2020-06). Furthermore, in connection with the offering of the Convertible Notes, the Company entered into convertible note hedges and warrants (see Note 10, Borrowings). However, the Company's convertible note hedges are not included when calculating potentially dilutive shares since their effect is always anti-dilutive.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183Ni9mcmFnOjAxNjM5MGY4MmE3ZDRjNmJhNTY2ZTgxNDg1MTY2ZDQ0L3RleHRyZWdpb246MDE2MzkwZjgyYTdkNGM2YmE1NjZlODE0ODUxNjZkNDRfMTQ4MQ_1638bbe7-97cd-426a-bb03-f4cf49c4e85f">A reconciliation of the numerator and denominator used in the calculation of basic and diluted net income common share is as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(In millions, except per share amounts)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Net income per share - basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Net income attributable to Varex&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Basic weighted average shares outstanding&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Basic net income per share attributable to Varex&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 13pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Net income per share - diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Net income attributable to Varex&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 10pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Basic weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dilutive effect of Convertible Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dilutive effect of share-based awards and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dilutive effect of warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:1pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Diluted weighted average shares outstanding&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Diluted net income per share attributable to Varex&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 10pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Anti-dilutive share summary&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:1pt;padding-left:15pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Restricted stock and options&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Convertible notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 4pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total anti-dilutive shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183Ni9mcmFnOjAxNjM5MGY4MmE3ZDRjNmJhNTY2ZTgxNDg1MTY2ZDQ0L3RhYmxlOjJkNDdlZTAzMjZmZjQ0ZDhiYTdjMDg3M2RhMGViNjdkL3RhYmxlcmFuZ2U6MmQ0N2VlMDMyNmZmNDRkOGJhN2MwODczZGEwZWI2N2RfMy0xLTEtMS04MzI4NQ_4fe027c8-7e67-4a84-971c-4b09ac34ed69"
      unitRef="usd">3100000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183Ni9mcmFnOjAxNjM5MGY4MmE3ZDRjNmJhNTY2ZTgxNDg1MTY2ZDQ0L3RhYmxlOjJkNDdlZTAzMjZmZjQ0ZDhiYTdjMDg3M2RhMGViNjdkL3RhYmxlcmFuZ2U6MmQ0N2VlMDMyNmZmNDRkOGJhN2MwODczZGEwZWI2N2RfMy0zLTEtMS04MzI4NQ_bc92c7db-3355-45d9-ac17-f53da4090976"
      unitRef="usd">1400000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183Ni9mcmFnOjAxNjM5MGY4MmE3ZDRjNmJhNTY2ZTgxNDg1MTY2ZDQ0L3RhYmxlOjJkNDdlZTAzMjZmZjQ0ZDhiYTdjMDg3M2RhMGViNjdkL3RhYmxlcmFuZ2U6MmQ0N2VlMDMyNmZmNDRkOGJhN2MwODczZGEwZWI2N2RfNC0xLTEtMS04MzI4NQ_89bb18f0-b2aa-4d26-99af-1480b61253b2"
      unitRef="shares">40100000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183Ni9mcmFnOjAxNjM5MGY4MmE3ZDRjNmJhNTY2ZTgxNDg1MTY2ZDQ0L3RhYmxlOjJkNDdlZTAzMjZmZjQ0ZDhiYTdjMDg3M2RhMGViNjdkL3RhYmxlcmFuZ2U6MmQ0N2VlMDMyNmZmNDRkOGJhN2MwODczZGEwZWI2N2RfNC0zLTEtMS04MzI4NQ_1d132363-8397-402d-a4cf-8832048e94f2"
      unitRef="shares">39500000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183Ni9mcmFnOjAxNjM5MGY4MmE3ZDRjNmJhNTY2ZTgxNDg1MTY2ZDQ0L3RhYmxlOjJkNDdlZTAzMjZmZjQ0ZDhiYTdjMDg3M2RhMGViNjdkL3RhYmxlcmFuZ2U6MmQ0N2VlMDMyNmZmNDRkOGJhN2MwODczZGEwZWI2N2RfNS0xLTEtMS04MzI4NQ_10447bf3-333f-4ac6-b465-6266ebcf11c3"
      unitRef="usdPerShare">0.08</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183Ni9mcmFnOjAxNjM5MGY4MmE3ZDRjNmJhNTY2ZTgxNDg1MTY2ZDQ0L3RhYmxlOjJkNDdlZTAzMjZmZjQ0ZDhiYTdjMDg3M2RhMGViNjdkL3RhYmxlcmFuZ2U6MmQ0N2VlMDMyNmZmNDRkOGJhN2MwODczZGEwZWI2N2RfNS0zLTEtMS04MzI4NQ_cb5f5cef-d4a6-401d-bda5-a86f110994a1"
      unitRef="usdPerShare">0.04</us-gaap:EarningsPerShareBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183Ni9mcmFnOjAxNjM5MGY4MmE3ZDRjNmJhNTY2ZTgxNDg1MTY2ZDQ0L3RhYmxlOjJkNDdlZTAzMjZmZjQ0ZDhiYTdjMDg3M2RhMGViNjdkL3RhYmxlcmFuZ2U6MmQ0N2VlMDMyNmZmNDRkOGJhN2MwODczZGEwZWI2N2RfOC0xLTEtMS04MzI4NQ_1d4b25bd-50f8-49b4-8db7-d2d444e86e0c"
      unitRef="usd">3100000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183Ni9mcmFnOjAxNjM5MGY4MmE3ZDRjNmJhNTY2ZTgxNDg1MTY2ZDQ0L3RhYmxlOjJkNDdlZTAzMjZmZjQ0ZDhiYTdjMDg3M2RhMGViNjdkL3RhYmxlcmFuZ2U6MmQ0N2VlMDMyNmZmNDRkOGJhN2MwODczZGEwZWI2N2RfOC0zLTEtMS04MzI4NQ_6540653b-8524-4553-b450-f1479e691af8"
      unitRef="usd">1400000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183Ni9mcmFnOjAxNjM5MGY4MmE3ZDRjNmJhNTY2ZTgxNDg1MTY2ZDQ0L3RhYmxlOjJkNDdlZTAzMjZmZjQ0ZDhiYTdjMDg3M2RhMGViNjdkL3RhYmxlcmFuZ2U6MmQ0N2VlMDMyNmZmNDRkOGJhN2MwODczZGEwZWI2N2RfMTItMS0xLTEtOTgxMDc_f1cd5938-5d91-4b42-b851-d130d7d67b26"
      unitRef="shares">40100000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183Ni9mcmFnOjAxNjM5MGY4MmE3ZDRjNmJhNTY2ZTgxNDg1MTY2ZDQ0L3RhYmxlOjJkNDdlZTAzMjZmZjQ0ZDhiYTdjMDg3M2RhMGViNjdkL3RhYmxlcmFuZ2U6MmQ0N2VlMDMyNmZmNDRkOGJhN2MwODczZGEwZWI2N2RfMTItMy0xLTEtOTgxMDc_f920b728-d2ea-4b51-91e9-4f35e7a2e3ab"
      unitRef="shares">39500000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183Ni9mcmFnOjAxNjM5MGY4MmE3ZDRjNmJhNTY2ZTgxNDg1MTY2ZDQ0L3RhYmxlOjJkNDdlZTAzMjZmZjQ0ZDhiYTdjMDg3M2RhMGViNjdkL3RhYmxlcmFuZ2U6MmQ0N2VlMDMyNmZmNDRkOGJhN2MwODczZGEwZWI2N2RfMTMtMS0xLTEtOTgxMDc_a32ed214-d04f-4533-b579-708f8fafcd8f"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183Ni9mcmFnOjAxNjM5MGY4MmE3ZDRjNmJhNTY2ZTgxNDg1MTY2ZDQ0L3RhYmxlOjJkNDdlZTAzMjZmZjQ0ZDhiYTdjMDg3M2RhMGViNjdkL3RhYmxlcmFuZ2U6MmQ0N2VlMDMyNmZmNDRkOGJhN2MwODczZGEwZWI2N2RfMTMtMy0xLTEtOTgxMDc_70dd2fb3-0bfa-4b6a-bb79-2851d2e47176"
      unitRef="shares">2600000</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183Ni9mcmFnOjAxNjM5MGY4MmE3ZDRjNmJhNTY2ZTgxNDg1MTY2ZDQ0L3RhYmxlOjJkNDdlZTAzMjZmZjQ0ZDhiYTdjMDg3M2RhMGViNjdkL3RhYmxlcmFuZ2U6MmQ0N2VlMDMyNmZmNDRkOGJhN2MwODczZGEwZWI2N2RfMTQtMS0xLTEtOTgxMDc_c1b39875-78f1-44ca-a016-efcc4b2586c3"
      unitRef="shares">500000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183Ni9mcmFnOjAxNjM5MGY4MmE3ZDRjNmJhNTY2ZTgxNDg1MTY2ZDQ0L3RhYmxlOjJkNDdlZTAzMjZmZjQ0ZDhiYTdjMDg3M2RhMGViNjdkL3RhYmxlcmFuZ2U6MmQ0N2VlMDMyNmZmNDRkOGJhN2MwODczZGEwZWI2N2RfMTQtMy0xLTEtOTgxMDc_6ff9b41b-2f79-4a30-bac4-2fbf2ba80ace"
      unitRef="shares">700000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <var:IncrementalCommonSharesAttributableToDilutiveEffectOfWarrants
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183Ni9mcmFnOjAxNjM5MGY4MmE3ZDRjNmJhNTY2ZTgxNDg1MTY2ZDQ0L3RhYmxlOjJkNDdlZTAzMjZmZjQ0ZDhiYTdjMDg3M2RhMGViNjdkL3RhYmxlcmFuZ2U6MmQ0N2VlMDMyNmZmNDRkOGJhN2MwODczZGEwZWI2N2RfMTUtMS0xLTEtOTgxMDc_7b71c194-669c-4dbb-8bfe-542ebf625d54"
      unitRef="shares">0</var:IncrementalCommonSharesAttributableToDilutiveEffectOfWarrants>
    <var:IncrementalCommonSharesAttributableToDilutiveEffectOfWarrants
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183Ni9mcmFnOjAxNjM5MGY4MmE3ZDRjNmJhNTY2ZTgxNDg1MTY2ZDQ0L3RhYmxlOjJkNDdlZTAzMjZmZjQ0ZDhiYTdjMDg3M2RhMGViNjdkL3RhYmxlcmFuZ2U6MmQ0N2VlMDMyNmZmNDRkOGJhN2MwODczZGEwZWI2N2RfMTUtMy0xLTEtOTgxMDc_b91a55af-f93d-43db-ba71-f088031f49c3"
      unitRef="shares">1100000</var:IncrementalCommonSharesAttributableToDilutiveEffectOfWarrants>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183Ni9mcmFnOjAxNjM5MGY4MmE3ZDRjNmJhNTY2ZTgxNDg1MTY2ZDQ0L3RhYmxlOjJkNDdlZTAzMjZmZjQ0ZDhiYTdjMDg3M2RhMGViNjdkL3RhYmxlcmFuZ2U6MmQ0N2VlMDMyNmZmNDRkOGJhN2MwODczZGEwZWI2N2RfMTYtMS0xLTEtOTgxMDc_af097a95-38de-443e-9561-532b6617e9dd"
      unitRef="shares">40600000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183Ni9mcmFnOjAxNjM5MGY4MmE3ZDRjNmJhNTY2ZTgxNDg1MTY2ZDQ0L3RhYmxlOjJkNDdlZTAzMjZmZjQ0ZDhiYTdjMDg3M2RhMGViNjdkL3RhYmxlcmFuZ2U6MmQ0N2VlMDMyNmZmNDRkOGJhN2MwODczZGEwZWI2N2RfMTYtMy0xLTEtOTgxMDc_d7da7dcb-a994-4215-bbff-581cc13f9ed7"
      unitRef="shares">43900000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183Ni9mcmFnOjAxNjM5MGY4MmE3ZDRjNmJhNTY2ZTgxNDg1MTY2ZDQ0L3RhYmxlOjJkNDdlZTAzMjZmZjQ0ZDhiYTdjMDg3M2RhMGViNjdkL3RhYmxlcmFuZ2U6MmQ0N2VlMDMyNmZmNDRkOGJhN2MwODczZGEwZWI2N2RfMTctMS0xLTEtOTgyMTE_c2cfd4e9-fcf4-4b4b-bf15-7e36f85fda26"
      unitRef="usdPerShare">0.08</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183Ni9mcmFnOjAxNjM5MGY4MmE3ZDRjNmJhNTY2ZTgxNDg1MTY2ZDQ0L3RhYmxlOjJkNDdlZTAzMjZmZjQ0ZDhiYTdjMDg3M2RhMGViNjdkL3RhYmxlcmFuZ2U6MmQ0N2VlMDMyNmZmNDRkOGJhN2MwODczZGEwZWI2N2RfMTctMy0xLTEtOTgyMTE_f553991e-e505-4a6a-ab2b-62a8469534e3"
      unitRef="usdPerShare">0.03</us-gaap:EarningsPerShareDiluted>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i86ab0fdd202b48e9b5a3c7718d5598cc_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183Ni9mcmFnOjAxNjM5MGY4MmE3ZDRjNmJhNTY2ZTgxNDg1MTY2ZDQ0L3RhYmxlOjJkNDdlZTAzMjZmZjQ0ZDhiYTdjMDg3M2RhMGViNjdkL3RhYmxlcmFuZ2U6MmQ0N2VlMDMyNmZmNDRkOGJhN2MwODczZGEwZWI2N2RfMTctMS0xLTEtOTgxMDc_13812f8a-7b9d-40a0-8dee-2a74e2166d34"
      unitRef="shares">3000000.0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i601e32df192447cb959a2ba73a6fd2ba_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183Ni9mcmFnOjAxNjM5MGY4MmE3ZDRjNmJhNTY2ZTgxNDg1MTY2ZDQ0L3RhYmxlOjJkNDdlZTAzMjZmZjQ0ZDhiYTdjMDg3M2RhMGViNjdkL3RhYmxlcmFuZ2U6MmQ0N2VlMDMyNmZmNDRkOGJhN2MwODczZGEwZWI2N2RfMTctMy0xLTEtOTgxMDc_6b019c77-655d-4d29-a548-2a891c00506c"
      unitRef="shares">2500000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="idc160449c61b40539d3867651037cc59_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183Ni9mcmFnOjAxNjM5MGY4MmE3ZDRjNmJhNTY2ZTgxNDg1MTY2ZDQ0L3RhYmxlOjJkNDdlZTAzMjZmZjQ0ZDhiYTdjMDg3M2RhMGViNjdkL3RhYmxlcmFuZ2U6MmQ0N2VlMDMyNmZmNDRkOGJhN2MwODczZGEwZWI2N2RfMjEtMS0xLTEtMTA1MzQ0_81734146-d39a-4018-b5cd-488f75b0d6e1"
      unitRef="shares">9600000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i3bf31d7d7f764d569a16bae11d856ce7_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183Ni9mcmFnOjAxNjM5MGY4MmE3ZDRjNmJhNTY2ZTgxNDg1MTY2ZDQ0L3RhYmxlOjJkNDdlZTAzMjZmZjQ0ZDhiYTdjMDg3M2RhMGViNjdkL3RhYmxlcmFuZ2U6MmQ0N2VlMDMyNmZmNDRkOGJhN2MwODczZGEwZWI2N2RfMjEtMy0xLTEtMTA1MzQ0_ca3ab33c-c8db-4e44-898f-e77edb422b42"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ieb7fcbc8943f416c813c5266235d9ae1_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183Ni9mcmFnOjAxNjM5MGY4MmE3ZDRjNmJhNTY2ZTgxNDg1MTY2ZDQ0L3RhYmxlOjJkNDdlZTAzMjZmZjQ0ZDhiYTdjMDg3M2RhMGViNjdkL3RhYmxlcmFuZ2U6MmQ0N2VlMDMyNmZmNDRkOGJhN2MwODczZGEwZWI2N2RfMjItMS0xLTEtMTA1MzQ0_ea0e17bc-d157-4e3f-b264-49ebb0183ce6"
      unitRef="shares">1900000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i933696b07a5546158d133b6f7f13c96f_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183Ni9mcmFnOjAxNjM5MGY4MmE3ZDRjNmJhNTY2ZTgxNDg1MTY2ZDQ0L3RhYmxlOjJkNDdlZTAzMjZmZjQ0ZDhiYTdjMDg3M2RhMGViNjdkL3RhYmxlcmFuZ2U6MmQ0N2VlMDMyNmZmNDRkOGJhN2MwODczZGEwZWI2N2RfMjItMy0xLTEtMTA1MzQ0_46221ab1-a404-4a2d-b4c8-45ab80c9cc5c"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183Ni9mcmFnOjAxNjM5MGY4MmE3ZDRjNmJhNTY2ZTgxNDg1MTY2ZDQ0L3RhYmxlOjJkNDdlZTAzMjZmZjQ0ZDhiYTdjMDg3M2RhMGViNjdkL3RhYmxlcmFuZ2U6MmQ0N2VlMDMyNmZmNDRkOGJhN2MwODczZGEwZWI2N2RfMjMtMS0xLTEtMTA1Mzc0_68191a08-ef35-4545-a11f-4430de1a1194"
      unitRef="shares">14500000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183Ni9mcmFnOjAxNjM5MGY4MmE3ZDRjNmJhNTY2ZTgxNDg1MTY2ZDQ0L3RhYmxlOjJkNDdlZTAzMjZmZjQ0ZDhiYTdjMDg3M2RhMGViNjdkL3RhYmxlcmFuZ2U6MmQ0N2VlMDMyNmZmNDRkOGJhN2MwODczZGEwZWI2N2RfMjMtMy0xLTEtMTA1Mzc0_541da55f-8780-4f13-81a7-e8bcf194260a"
      unitRef="shares">2500000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:DebtInstrumentConvertibleNumberOfEquityInstruments
      contextRef="i4e0cf62911af4732b7b65d582effb57a_D20200604-20200605"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183Ni9mcmFnOjAxNjM5MGY4MmE3ZDRjNmJhNTY2ZTgxNDg1MTY2ZDQ0L3RleHRyZWdpb246MDE2MzkwZjgyYTdkNGM2YmE1NjZlODE0ODUxNjZkNDRfMTA5OTUxMTYyODgxMzA_97fe4fb8-9ead-4e78-847f-4d94a8a02b06"
      unitRef="shares">9600000</us-gaap:DebtInstrumentConvertibleNumberOfEquityInstruments>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RleHRyZWdpb246OGU5MGMxNDEzNzdiNGMzZGE1OTNjZjIwYWE3ZDljMGZfMTI2NQ_92135593-435e-43e2-9515-c0f24aeacb15">EMPLOYEE STOCK PLANS&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share-Based Compensation Expense&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Share-based compensation expense recognized in the Condensed Consolidated Statements of Operations is based on awards ultimately expected to vest. Share-based compensation expense includes expenses related to the Company&#x2019;s direct employees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The table below summarizes the effect of recording share-based compensation expense and the option component of the employee stock purchase plan shares:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Selling, general and administrative&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total share-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock Option Activity&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The following table summarizes the activity for stock options under Varex&#x2019;s employee incentive plans for the Company's employees:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(In thousands, except per share amounts and the remaining term)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Price Range&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Weighted Average Remaining Term (in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Aggregate Intrinsic Value&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Outstanding at September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$13.61 - $37.60&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28.97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,361.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;text-indent:-18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$22.13 &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;text-indent:-18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Canceled, expired or forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(196)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$25.06 - $37.10&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Outstanding at December 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$13.61 - $37.60&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27.96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,209.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Exercisable at December 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$13.61 - $37.60&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;672.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; The aggregate intrinsic value represents the total pre-tax intrinsic value, which is computed based on the difference between the exercise price and the closing price of Varex common stock of $20.30 as of December&#160;30, 2022, the last trading date of the Company's first quarter, and which represents the amount that would have been received by the option holders had all option holders exercised their options and sold the shares received upon exercise as of that date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restricted Stock Units, Restricted Stock Awards and Deferred Stock Units &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The following table summarizes the activity for restricted stock units, restricted stock awards and deferred stock units under Varex&#x2019;s 2020 Omnibus Stock Plan and 2017 Omnibus Stock Plan:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.762%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(In thousands, except per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Number&#160;of&#160;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted&#160;Average Grant-Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Outstanding at September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24.35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;text-indent:-18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;text-indent:-18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23.70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;text-indent:-18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Canceled or expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Outstanding at December 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RleHRyZWdpb246OGU5MGMxNDEzNzdiNGMzZGE1OTNjZjIwYWE3ZDljMGZfMTI3Ng_3cef7f9e-f150-482d-ac1b-1fe582606f63">The table below summarizes the effect of recording share-based compensation expense and the option component of the employee stock purchase plan shares:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Selling, general and administrative&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total share-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i9f1d152938084b8fb5c95daf2c0bebc9_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOjIyMTgxMjAwNTViMTRjY2FiZjM2NDFlYzU2ZmM3YjAxL3RhYmxlcmFuZ2U6MjIxODEyMDA1NWIxNGNjYWJmMzY0MWVjNTZmYzdiMDFfMi0xLTEtMS04MzI4NQ_7378455c-3b23-4024-a3ea-69506e82eac9"
      unitRef="usd">400000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="id8ef423cb3ad48e8887f0b4fd6e5cb77_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOjIyMTgxMjAwNTViMTRjY2FiZjM2NDFlYzU2ZmM3YjAxL3RhYmxlcmFuZ2U6MjIxODEyMDA1NWIxNGNjYWJmMzY0MWVjNTZmYzdiMDFfMi0zLTEtMS04MzI4NQ_9c464259-f3b0-436c-805b-dcc81b6ce96c"
      unitRef="usd">400000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ic4686bc0f01748e7bf2ccd6382ecb978_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOjIyMTgxMjAwNTViMTRjY2FiZjM2NDFlYzU2ZmM3YjAxL3RhYmxlcmFuZ2U6MjIxODEyMDA1NWIxNGNjYWJmMzY0MWVjNTZmYzdiMDFfMy0xLTEtMS04MzI4NQ_96b1a41a-8adb-4b1b-8ad0-0b2da98f4729"
      unitRef="usd">800000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="if0a9c4e86e3f4f929c53ebd89df0858a_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOjIyMTgxMjAwNTViMTRjY2FiZjM2NDFlYzU2ZmM3YjAxL3RhYmxlcmFuZ2U6MjIxODEyMDA1NWIxNGNjYWJmMzY0MWVjNTZmYzdiMDFfMy0zLTEtMS04MzI4NQ_e8311697-7746-43df-aec5-9409fcff3717"
      unitRef="usd">800000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i78f307374103493aa2a778a18fffd8c0_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOjIyMTgxMjAwNTViMTRjY2FiZjM2NDFlYzU2ZmM3YjAxL3RhYmxlcmFuZ2U6MjIxODEyMDA1NWIxNGNjYWJmMzY0MWVjNTZmYzdiMDFfNC0xLTEtMS04MzI4NQ_3d2aea49-f3c9-4513-a20a-514dd486fa43"
      unitRef="usd">2100000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ia84a05a959934c73ac14197dcf7f8950_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOjIyMTgxMjAwNTViMTRjY2FiZjM2NDFlYzU2ZmM3YjAxL3RhYmxlcmFuZ2U6MjIxODEyMDA1NWIxNGNjYWJmMzY0MWVjNTZmYzdiMDFfNC0zLTEtMS04MzI4NQ_1d036040-f109-4cd9-b4b8-bfe15fee4e41"
      unitRef="usd">2200000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOjIyMTgxMjAwNTViMTRjY2FiZjM2NDFlYzU2ZmM3YjAxL3RhYmxlcmFuZ2U6MjIxODEyMDA1NWIxNGNjYWJmMzY0MWVjNTZmYzdiMDFfNS0xLTEtMS04MzI4NQ_38ccf904-5246-49c4-8fd1-6572d3c024c6"
      unitRef="usd">3300000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOjIyMTgxMjAwNTViMTRjY2FiZjM2NDFlYzU2ZmM3YjAxL3RhYmxlcmFuZ2U6MjIxODEyMDA1NWIxNGNjYWJmMzY0MWVjNTZmYzdiMDFfNS0zLTEtMS04MzI4NQ_81d06953-e199-4202-817a-8be6f9ab20db"
      unitRef="usd">3400000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RleHRyZWdpb246OGU5MGMxNDEzNzdiNGMzZGE1OTNjZjIwYWE3ZDljMGZfMTI2Nw_5f9dd13c-bd08-4ff5-9750-de23f67415ce">The following table summarizes the activity for stock options under Varex&#x2019;s employee incentive plans for the Company's employees:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(In thousands, except per share amounts and the remaining term)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Price Range&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Weighted Average Remaining Term (in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Aggregate Intrinsic Value&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Outstanding at September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$13.61 - $37.60&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28.97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,361.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;text-indent:-18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$22.13 &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;text-indent:-18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Canceled, expired or forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(196)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$25.06 - $37.10&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Outstanding at December 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$13.61 - $37.60&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27.96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,209.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Exercisable at December 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$13.61 - $37.60&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;672.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; The aggregate intrinsic value represents the total pre-tax intrinsic value, which is computed based on the difference between the exercise price and the closing price of Varex common stock of $20.30 as of December&#160;30, 2022, the last trading date of the Company's first quarter, and which represents the amount that would have been received by the option holders had all option holders exercised their options and sold the shares received upon exercise as of that date.&lt;/span&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOjVlZGMwNmQyNmU3YTQ4ODE4NjFkMmRkZWY1ZWM0MmZmL3RhYmxlcmFuZ2U6NWVkYzA2ZDI2ZTdhNDg4MTg2MWQyZGRlZjVlYzQyZmZfMi0xLTEtMS04MzI4NQ_fc837286-358d-4449-a125-67853ebf93ec"
      unitRef="shares">2902000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <var:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingPrice
      contextRef="i351ede538c104bba9d98c61dffb4fb78_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOjVlZGMwNmQyNmU3YTQ4ODE4NjFkMmRkZWY1ZWM0MmZmL3RhYmxlcmFuZ2U6NWVkYzA2ZDI2ZTdhNDg4MTg2MWQyZGRlZjVlYzQyZmZfMi0zLTEtMS04MzI4NS90ZXh0cmVnaW9uOmMwMTRiN2UzY2EyNDQ2NmZiNDU5ZmU5MWM2NTk5MTYyXzQ_0c70bcd2-a201-4389-b4d6-19af2d8c8c8d"
      unitRef="usdPerShare">13.61</var:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingPrice>
    <var:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingPrice
      contextRef="i18c5d964291c4ea790a03cf8d6140a16_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOjVlZGMwNmQyNmU3YTQ4ODE4NjFkMmRkZWY1ZWM0MmZmL3RhYmxlcmFuZ2U6NWVkYzA2ZDI2ZTdhNDg4MTg2MWQyZGRlZjVlYzQyZmZfMi0zLTEtMS04MzI4NS90ZXh0cmVnaW9uOmMwMTRiN2UzY2EyNDQ2NmZiNDU5ZmU5MWM2NTk5MTYyXzk_435477aa-3033-4dd9-a8f0-0fcb598f6e63"
      unitRef="usdPerShare">37.60</var:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingPrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOjVlZGMwNmQyNmU3YTQ4ODE4NjFkMmRkZWY1ZWM0MmZmL3RhYmxlcmFuZ2U6NWVkYzA2ZDI2ZTdhNDg4MTg2MWQyZGRlZjVlYzQyZmZfMi01LTEtMS04MzI4NQ_54e158cd-f4ed-4c9b-9f7e-f932c4ae75f8"
      unitRef="usdPerShare">28.97</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="if053d543d68e4983b97631e65183a5d1_D20211002-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOjVlZGMwNmQyNmU3YTQ4ODE4NjFkMmRkZWY1ZWM0MmZmL3RhYmxlcmFuZ2U6NWVkYzA2ZDI2ZTdhNDg4MTg2MWQyZGRlZjVlYzQyZmZfMi03LTEtMS04MzI4NQ_e4ce2c7b-de12-4cec-ab02-d99eb3b0e889">P4Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOjVlZGMwNmQyNmU3YTQ4ODE4NjFkMmRkZWY1ZWM0MmZmL3RhYmxlcmFuZ2U6NWVkYzA2ZDI2ZTdhNDg4MTg2MWQyZGRlZjVlYzQyZmZfMi05LTEtMS04MzI4NQ_7486428b-9924-4795-8b5d-591e630cc879"
      unitRef="usd">1361400</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOjVlZGMwNmQyNmU3YTQ4ODE4NjFkMmRkZWY1ZWM0MmZmL3RhYmxlcmFuZ2U6NWVkYzA2ZDI2ZTdhNDg4MTg2MWQyZGRlZjVlYzQyZmZfMy0xLTEtMS04MzI4NQ_f41986a6-be6f-45fb-917c-e8bdc95afef5"
      unitRef="shares">385000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <var:SharebasedCompensationArrangementsbySharebasedPaymentAwardOptionsGrantsinPeriodPrice
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOjVlZGMwNmQyNmU3YTQ4ODE4NjFkMmRkZWY1ZWM0MmZmL3RhYmxlcmFuZ2U6NWVkYzA2ZDI2ZTdhNDg4MTg2MWQyZGRlZjVlYzQyZmZfMy0zLTEtMS04MzI4NS90ZXh0cmVnaW9uOmIxM2VmMGNiZWZkYjRlYjA5NTZhMTUzYzc3Y2MwODA3XzQ_3784d284-0741-482b-857c-9b36285b371e"
      unitRef="usdPerShare">22.13</var:SharebasedCompensationArrangementsbySharebasedPaymentAwardOptionsGrantsinPeriodPrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOjVlZGMwNmQyNmU3YTQ4ODE4NjFkMmRkZWY1ZWM0MmZmL3RhYmxlcmFuZ2U6NWVkYzA2ZDI2ZTdhNDg4MTg2MWQyZGRlZjVlYzQyZmZfMy01LTEtMS04MzI4NQ_2cbd4b2f-dea7-4f83-8f1f-8366f86b9ae7"
      unitRef="usdPerShare">22.13</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOjVlZGMwNmQyNmU3YTQ4ODE4NjFkMmRkZWY1ZWM0MmZmL3RhYmxlcmFuZ2U6NWVkYzA2ZDI2ZTdhNDg4MTg2MWQyZGRlZjVlYzQyZmZfNC0xLTEtMS04MzI4NQ_895b04f4-72a5-4404-9a76-a545ee0b83f3"
      unitRef="shares">196000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <var:SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsForfeituresandExpirationsinPeriodPrice
      contextRef="i67803683b0344dc78ee5545d3907c730_D20221001-20221230"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOjVlZGMwNmQyNmU3YTQ4ODE4NjFkMmRkZWY1ZWM0MmZmL3RhYmxlcmFuZ2U6NWVkYzA2ZDI2ZTdhNDg4MTg2MWQyZGRlZjVlYzQyZmZfNC0zLTEtMS04MzI4NS90ZXh0cmVnaW9uOjYwOGFhMTA5ZjI4MjRkMTViZmE3M2E5MjAwZmFlNDU5XzQ_67d5e29d-eec0-4798-9c6f-a7b7ad4c5ea0"
      unitRef="usdPerShare">25.06</var:SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsForfeituresandExpirationsinPeriodPrice>
    <var:SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsForfeituresandExpirationsinPeriodPrice
      contextRef="idd5d9702aa2d44ef9138ad61434eaa2a_D20221001-20221230"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOjVlZGMwNmQyNmU3YTQ4ODE4NjFkMmRkZWY1ZWM0MmZmL3RhYmxlcmFuZ2U6NWVkYzA2ZDI2ZTdhNDg4MTg2MWQyZGRlZjVlYzQyZmZfNC0zLTEtMS04MzI4NS90ZXh0cmVnaW9uOjYwOGFhMTA5ZjI4MjRkMTViZmE3M2E5MjAwZmFlNDU5Xzk_288df20b-e849-4a5f-b1fe-ca2c89d1ab99"
      unitRef="usdPerShare">37.10</var:SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsForfeituresandExpirationsinPeriodPrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOjVlZGMwNmQyNmU3YTQ4ODE4NjFkMmRkZWY1ZWM0MmZmL3RhYmxlcmFuZ2U6NWVkYzA2ZDI2ZTdhNDg4MTg2MWQyZGRlZjVlYzQyZmZfNC01LTEtMS04MzI4NQ_04edaea9-5e78-4130-b1ff-c65851ca714e"
      unitRef="usdPerShare">31.44</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOjVlZGMwNmQyNmU3YTQ4ODE4NjFkMmRkZWY1ZWM0MmZmL3RhYmxlcmFuZ2U6NWVkYzA2ZDI2ZTdhNDg4MTg2MWQyZGRlZjVlYzQyZmZfNi0xLTEtMS04MzI4NQ_e9189c6c-588e-4160-8e8f-0466e8821e4c"
      unitRef="shares">3091000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <var:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingPrice
      contextRef="i1d50db1d5d424029913ff40e007c62a2_I20221230"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOjVlZGMwNmQyNmU3YTQ4ODE4NjFkMmRkZWY1ZWM0MmZmL3RhYmxlcmFuZ2U6NWVkYzA2ZDI2ZTdhNDg4MTg2MWQyZGRlZjVlYzQyZmZfNi0zLTEtMS04MzI4NS90ZXh0cmVnaW9uOjcyNTkyZTBjZDA2MDRjNDZiOWU2OGU1NzJmNTFlMDQ0XzQ_1aa3e44c-508e-4271-a217-a0c62a49fbd6"
      unitRef="usdPerShare">13.61</var:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingPrice>
    <var:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingPrice
      contextRef="ibe78209ddb124767b1ede71bb79ea8dc_I20221230"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOjVlZGMwNmQyNmU3YTQ4ODE4NjFkMmRkZWY1ZWM0MmZmL3RhYmxlcmFuZ2U6NWVkYzA2ZDI2ZTdhNDg4MTg2MWQyZGRlZjVlYzQyZmZfNi0zLTEtMS04MzI4NS90ZXh0cmVnaW9uOjcyNTkyZTBjZDA2MDRjNDZiOWU2OGU1NzJmNTFlMDQ0Xzk_9f13db76-fab8-4918-bcf0-6c3381b5f0b0"
      unitRef="usdPerShare">37.60</var:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingPrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOjVlZGMwNmQyNmU3YTQ4ODE4NjFkMmRkZWY1ZWM0MmZmL3RhYmxlcmFuZ2U6NWVkYzA2ZDI2ZTdhNDg4MTg2MWQyZGRlZjVlYzQyZmZfNi01LTEtMS04MzI4NQ_d407ad46-5820-4f75-b5bf-fc5afad00db9"
      unitRef="usdPerShare">27.96</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOjVlZGMwNmQyNmU3YTQ4ODE4NjFkMmRkZWY1ZWM0MmZmL3RhYmxlcmFuZ2U6NWVkYzA2ZDI2ZTdhNDg4MTg2MWQyZGRlZjVlYzQyZmZfNi03LTEtMS04MzI4NQ_f75083a1-3a08-43a2-a1bd-824c5ff883d0">P5Y2M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOjVlZGMwNmQyNmU3YTQ4ODE4NjFkMmRkZWY1ZWM0MmZmL3RhYmxlcmFuZ2U6NWVkYzA2ZDI2ZTdhNDg4MTg2MWQyZGRlZjVlYzQyZmZfNi05LTEtMS04MzI4NQ_e12a8268-43e3-442b-a8e8-63ba87c0a070"
      unitRef="usd">1209500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOjVlZGMwNmQyNmU3YTQ4ODE4NjFkMmRkZWY1ZWM0MmZmL3RhYmxlcmFuZ2U6NWVkYzA2ZDI2ZTdhNDg4MTg2MWQyZGRlZjVlYzQyZmZfOC0xLTEtMS04MzI4NQ_5ee37f74-8f54-4bf0-a84f-0859a9869877"
      unitRef="shares">2070000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <var:SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisablePrice
      contextRef="i1d50db1d5d424029913ff40e007c62a2_I20221230"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOjVlZGMwNmQyNmU3YTQ4ODE4NjFkMmRkZWY1ZWM0MmZmL3RhYmxlcmFuZ2U6NWVkYzA2ZDI2ZTdhNDg4MTg2MWQyZGRlZjVlYzQyZmZfOC0zLTEtMS04MzI4NS90ZXh0cmVnaW9uOjQxYjhhMTI5YmMwYzQ2OGJiYzhkZTEzMzVhM2M2ZTY0XzQ_7ba7e2b8-1a5c-47a2-9953-3ddb11dd6edc"
      unitRef="usdPerShare">13.61</var:SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisablePrice>
    <var:SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisablePrice
      contextRef="ibe78209ddb124767b1ede71bb79ea8dc_I20221230"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOjVlZGMwNmQyNmU3YTQ4ODE4NjFkMmRkZWY1ZWM0MmZmL3RhYmxlcmFuZ2U6NWVkYzA2ZDI2ZTdhNDg4MTg2MWQyZGRlZjVlYzQyZmZfOC0zLTEtMS04MzI4NS90ZXh0cmVnaW9uOjQxYjhhMTI5YmMwYzQ2OGJiYzhkZTEzMzVhM2M2ZTY0Xzk_db8183b7-9e3d-4b20-b5e5-0b3872fc75c9"
      unitRef="usdPerShare">37.60</var:SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisablePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOjVlZGMwNmQyNmU3YTQ4ODE4NjFkMmRkZWY1ZWM0MmZmL3RhYmxlcmFuZ2U6NWVkYzA2ZDI2ZTdhNDg4MTg2MWQyZGRlZjVlYzQyZmZfOC01LTEtMS04MzI4NQ_c876f8e4-3fa2-4041-87d1-82cef74ec0b7"
      unitRef="usdPerShare">29.52</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOjVlZGMwNmQyNmU3YTQ4ODE4NjFkMmRkZWY1ZWM0MmZmL3RhYmxlcmFuZ2U6NWVkYzA2ZDI2ZTdhNDg4MTg2MWQyZGRlZjVlYzQyZmZfOC03LTEtMS04MzI4NQ_a85b1c9c-8eea-4d79-8c16-ae4dfa4cd08a">P3Y4M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOjVlZGMwNmQyNmU3YTQ4ODE4NjFkMmRkZWY1ZWM0MmZmL3RhYmxlcmFuZ2U6NWVkYzA2ZDI2ZTdhNDg4MTg2MWQyZGRlZjVlYzQyZmZfOC05LTEtMS04MzI4NQ_58c4fc8e-8829-4096-a1fb-f44ffa14a173"
      unitRef="usd">672300</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:SharePrice
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RleHRyZWdpb246OGU5MGMxNDEzNzdiNGMzZGE1OTNjZjIwYWE3ZDljMGZfODQ1_2d4e5e85-9612-49f7-a641-e5f1c61c3716"
      unitRef="usdPerShare">20.30</us-gaap:SharePrice>
    <us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RleHRyZWdpb246OGU5MGMxNDEzNzdiNGMzZGE1OTNjZjIwYWE3ZDljMGZfMTI2OQ_0190e056-9bd6-4e9f-80db-1bc63946fbc4">The following table summarizes the activity for restricted stock units, restricted stock awards and deferred stock units under Varex&#x2019;s 2020 Omnibus Stock Plan and 2017 Omnibus Stock Plan:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.762%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(In thousands, except per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Number&#160;of&#160;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted&#160;Average Grant-Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Outstanding at September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24.35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;text-indent:-18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;text-indent:-18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23.70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;text-indent:-18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Canceled or expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Outstanding at December 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOmExNDU5Zjg3OGFlZDQxZTFiOTZkZjM4NmFlZDkzY2QyL3RhYmxlcmFuZ2U6YTE0NTlmODc4YWVkNDFlMWI5NmRmMzg2YWVkOTNjZDJfMS0xLTEtMS04MzI4NQ_42980f10-70be-4225-9c88-17e81f543582"
      unitRef="shares">1045000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i967727602cae45adb24efc0f4e4bd947_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOmExNDU5Zjg3OGFlZDQxZTFiOTZkZjM4NmFlZDkzY2QyL3RhYmxlcmFuZ2U6YTE0NTlmODc4YWVkNDFlMWI5NmRmMzg2YWVkOTNjZDJfMS0zLTEtMS04MzI4NQ_aa09323a-8bb3-4c9e-bb8e-ac784de5f62f"
      unitRef="usdPerShare">24.35</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOmExNDU5Zjg3OGFlZDQxZTFiOTZkZjM4NmFlZDkzY2QyL3RhYmxlcmFuZ2U6YTE0NTlmODc4YWVkNDFlMWI5NmRmMzg2YWVkOTNjZDJfMi0xLTEtMS04MzI4NQ_ffaccdd0-43b0-41be-92a7-db84ea6d40e9"
      unitRef="shares">492000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOmExNDU5Zjg3OGFlZDQxZTFiOTZkZjM4NmFlZDkzY2QyL3RhYmxlcmFuZ2U6YTE0NTlmODc4YWVkNDFlMWI5NmRmMzg2YWVkOTNjZDJfMi0zLTEtMS04MzI4NQ_7beea28a-69c7-45c7-931b-ac42ac7738b3"
      unitRef="usdPerShare">20.12</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOmExNDU5Zjg3OGFlZDQxZTFiOTZkZjM4NmFlZDkzY2QyL3RhYmxlcmFuZ2U6YTE0NTlmODc4YWVkNDFlMWI5NmRmMzg2YWVkOTNjZDJfMy0xLTEtMS04MzI4NQ_d2ba5b27-ce31-428f-a796-9b672cb4e303"
      unitRef="shares">3000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOmExNDU5Zjg3OGFlZDQxZTFiOTZkZjM4NmFlZDkzY2QyL3RhYmxlcmFuZ2U6YTE0NTlmODc4YWVkNDFlMWI5NmRmMzg2YWVkOTNjZDJfMy0zLTEtMS04MzI4NQ_4f07a545-d3f8-419e-b26b-4daee9255e31"
      unitRef="usdPerShare">23.70</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOmExNDU5Zjg3OGFlZDQxZTFiOTZkZjM4NmFlZDkzY2QyL3RhYmxlcmFuZ2U6YTE0NTlmODc4YWVkNDFlMWI5NmRmMzg2YWVkOTNjZDJfNC0xLTEtMS04MzI4NQ_d21e02e9-d53c-4617-b53f-583cab9de2e0"
      unitRef="shares">28000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOmExNDU5Zjg3OGFlZDQxZTFiOTZkZjM4NmFlZDkzY2QyL3RhYmxlcmFuZ2U6YTE0NTlmODc4YWVkNDFlMWI5NmRmMzg2YWVkOTNjZDJfNC0zLTEtMS04MzI4NQ_11624040-053f-42ea-9fd2-fae0e36928b7"
      unitRef="usdPerShare">25.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOmExNDU5Zjg3OGFlZDQxZTFiOTZkZjM4NmFlZDkzY2QyL3RhYmxlcmFuZ2U6YTE0NTlmODc4YWVkNDFlMWI5NmRmMzg2YWVkOTNjZDJfNS0xLTEtMS04MzI4NQ_c7b38ea9-e470-452b-aa3d-1bd0b881259c"
      unitRef="shares">1506000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN183OS9mcmFnOjhlOTBjMTQxMzc3YjRjM2RhNTkzY2YyMGFhN2Q5YzBmL3RhYmxlOmExNDU5Zjg3OGFlZDQxZTFiOTZkZjM4NmFlZDkzY2QyL3RhYmxlcmFuZ2U6YTE0NTlmODc4YWVkNDFlMWI5NmRmMzg2YWVkOTNjZDJfNS0zLTEtMS04MzI4NQ_1a8cdc40-b271-4fab-9a6d-9f360fd7bc35"
      unitRef="usdPerShare">22.95</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN184Mi9mcmFnOjE2NjdhMTA2ZmEzMTRiOTlhMmMwNjZiNTM0ZWY1ZDczL3RleHRyZWdpb246MTY2N2ExMDZmYTMxNGI5OWEyYzA2NmI1MzRlZjVkNzNfMTcxNg_849659a7-7f28-4c38-9b8e-f4f4d0a6b064">TAXES ON INCOME&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;For the three months ended December 30, 2022, the Company recognized income tax expense of $2.2 million on $5.4 million of pre-tax income. For the three months ended December&#160;31, 2021, the Company recognized income tax expense of $1.7 million on $3.3 million of pre-tax income. The Company is unable to recognize a tax benefit for pre-tax book losses in certain foreign jurisdictions but has recognized tax expense for profitable foreign jurisdictions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company's tax expense for the three months ended December 30, 2022 increased, primarily due to increased pre-tax income in certain jurisdictions, valuation allowance positions in the U.S. on deferred tax attributes, and losses in certain foreign jurisdictions for which no benefit can be recorded. &lt;/span&gt;&lt;/div&gt;&#160;&#160;&#160;&#160;The Company is maintaining its reinvestment assertion with respect to foreign earnings for the three months ended December 30, 2022, which is that all earnings prior to fiscal year 2018 are permanently reinvested for all countries, and that all earnings for Direct Conversion, located primarily in Sweden and Finland, are also indefinitely reinvested in those countries, but post fiscal year 2017 earnings in all other countries are not permanently reinvested. Due to the level of earnings available for repatriation, the treaty benefits applicable to jurisdictions in which those earnings are located, and the now favorable U.S. tax treatment of repatriated foreign earnings, the amount of deferred tax liability recorded related to the potential repatriation is approximately $0.1&#160;million. This estimated liability is for U.S. state income taxes and foreign withholding taxes that would apply if the foreign earnings were repatriated in the form of a dividend.</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN184Mi9mcmFnOjE2NjdhMTA2ZmEzMTRiOTlhMmMwNjZiNTM0ZWY1ZDczL3RleHRyZWdpb246MTY2N2ExMDZmYTMxNGI5OWEyYzA2NmI1MzRlZjVkNzNfNzg_f473423d-5d0a-4ed9-9f14-ceb3fddfa3b9"
      unitRef="usd">2200000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN184Mi9mcmFnOjE2NjdhMTA2ZmEzMTRiOTlhMmMwNjZiNTM0ZWY1ZDczL3RleHRyZWdpb246MTY2N2ExMDZmYTMxNGI5OWEyYzA2NmI1MzRlZjVkNzNfODQ_d7bf3cab-9717-44a7-8a20-b693ed92ac77"
      unitRef="usd">5400000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN184Mi9mcmFnOjE2NjdhMTA2ZmEzMTRiOTlhMmMwNjZiNTM0ZWY1ZDczL3RleHRyZWdpb246MTY2N2ExMDZmYTMxNGI5OWEyYzA2NmI1MzRlZjVkNzNfMTcz_ee22540e-612a-43c6-9dff-c3788ef6b936"
      unitRef="usd">1700000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN184Mi9mcmFnOjE2NjdhMTA2ZmEzMTRiOTlhMmMwNjZiNTM0ZWY1ZDczL3RleHRyZWdpb246MTY2N2ExMDZmYTMxNGI5OWEyYzA2NmI1MzRlZjVkNzNfMTc5_824f3b3e-0f9f-4418-8857-9500a0238a21"
      unitRef="usd">3300000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings
      contextRef="i97383852c2e44f9090e25f67836d6e81_I20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN184Mi9mcmFnOjE2NjdhMTA2ZmEzMTRiOTlhMmMwNjZiNTM0ZWY1ZDczL3RleHRyZWdpb246MTY2N2ExMDZmYTMxNGI5OWEyYzA2NmI1MzRlZjVkNzNfMTU1NQ_4a229ce5-271a-45a3-8c1c-5e87652e7f1d"
      unitRef="usd">100000</us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN184NS9mcmFnOjg2NDJmODU0ZTA4ZTRjMmU5MTAwZDVmMDFkMWE4YjllL3RleHRyZWdpb246ODY0MmY4NTRlMDhlNGMyZTkxMDBkNWYwMWQxYThiOWVfMjQxOQ_11affc4f-725d-4351-8285-ac266138bfcf">SEGMENT INFORMATION&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company has two reportable operating segments: Medical and Industrial, which aligns with how the CODM reviews the Company&#x2019;s performance and evaluates the business for the allocation of resources. The segments align the Company&#x2019;s products and service offerings with customer use in medical and industrial markets. The CODM allocates resources to and evaluates the financial performance of each operating segment primarily based on revenues and gross profit. The reportable operating segment structure provides alignment between business strategies and operating results.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Description of Segments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Medical segment designs, manufactures, sells and services X-ray imaging components, including X-ray tubes, digital detectors, ionization chambers and buckys, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers. These components are used in a range of medical imaging applications including CT, mammography, oncology, cardiac, surgery, dental, and other diagnostic radiography uses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Industrial segment designs, develops, manufactures, sells and services X-ray imaging products for use in a number of markets, including security applications for cargo screening at ports and borders and baggage screening at airports, and nondestructive testing, irradiation and inspection applications used in a number of other vertical markets. The Company's industrial products include Linatron&#xae; X-ray linear accelerators, X-ray tubes, digital detectors, high voltage connectors and coolers. In addition, the Company licenses proprietary image-processing and detection software designed to work with other Varex products to provide packaged sub-assembly solutions to industrial customers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Accordingly, the following information is provided for purposes of achieving an understanding of operations, but it may not be indicative of the financial results of the reported segments were they independent organizations. In addition, comparisons of the Company&#x2019;s operations to similar operations of other companies may not be meaningful.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Information related to the Company&#x2019;s segments is as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.762%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Revenues, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 9.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Medical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;160.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;155.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 9.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Industrial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;205.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;198.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 9.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Medical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 9.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Industrial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total gross profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;63.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;64.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest and other expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(10.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income before taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income attributable to Varex&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company does not disclose total assets by segment as this information is not provided to the CODM.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN184NS9mcmFnOjg2NDJmODU0ZTA4ZTRjMmU5MTAwZDVmMDFkMWE4YjllL3RleHRyZWdpb246ODY0MmY4NTRlMDhlNGMyZTkxMDBkNWYwMWQxYThiOWVfNDY_4e7ac51e-900f-4409-b7c2-30515bdb84f8"
      unitRef="segment">2</us-gaap:NumberOfOperatingSegments>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN184NS9mcmFnOjg2NDJmODU0ZTA4ZTRjMmU5MTAwZDVmMDFkMWE4YjllL3RleHRyZWdpb246ODY0MmY4NTRlMDhlNGMyZTkxMDBkNWYwMWQxYThiOWVfMjQxMw_af23ef2c-7f3e-4f86-b5a3-3db36c91c19d">Information related to the Company&#x2019;s segments is as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.762%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Revenues, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 9.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Medical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;160.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;155.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 9.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Industrial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;205.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;198.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 9.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Medical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 9.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Industrial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total gross profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;63.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;64.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest and other expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(10.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income before taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income attributable to Varex&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iad2fceac1bb145229d93b69339db9f19_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN184NS9mcmFnOjg2NDJmODU0ZTA4ZTRjMmU5MTAwZDVmMDFkMWE4YjllL3RhYmxlOmQ2YjY5MjBmNjFkNzQzYzc5MmM2NTEyMzE5ZGVhM2UxL3RhYmxlcmFuZ2U6ZDZiNjkyMGY2MWQ3NDNjNzkyYzY1MTIzMTlkZWEzZTFfMy0xLTEtMS04MzI4NQ_6b6dc8ec-7602-4715-ad61-92476e1e789f"
      unitRef="usd">160100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if28f02563bbd40d0a3a931501b82e58f_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN184NS9mcmFnOjg2NDJmODU0ZTA4ZTRjMmU5MTAwZDVmMDFkMWE4YjllL3RhYmxlOmQ2YjY5MjBmNjFkNzQzYzc5MmM2NTEyMzE5ZGVhM2UxL3RhYmxlcmFuZ2U6ZDZiNjkyMGY2MWQ3NDNjNzkyYzY1MTIzMTlkZWEzZTFfMy0zLTEtMS04MzI4NQ_d68bc136-edd4-4884-8132-ca0b2bd9087c"
      unitRef="usd">155700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaab56d5aa0be4d758038ec0908970ec8_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN184NS9mcmFnOjg2NDJmODU0ZTA4ZTRjMmU5MTAwZDVmMDFkMWE4YjllL3RhYmxlOmQ2YjY5MjBmNjFkNzQzYzc5MmM2NTEyMzE5ZGVhM2UxL3RhYmxlcmFuZ2U6ZDZiNjkyMGY2MWQ3NDNjNzkyYzY1MTIzMTlkZWEzZTFfNC0xLTEtMS04MzI4NQ_e5f7cafd-1b9d-4f6a-984a-8c73a25d3d9b"
      unitRef="usd">45500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifbe1cf81bdb14d34b79718fe7f9ef5df_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN184NS9mcmFnOjg2NDJmODU0ZTA4ZTRjMmU5MTAwZDVmMDFkMWE4YjllL3RhYmxlOmQ2YjY5MjBmNjFkNzQzYzc5MmM2NTEyMzE5ZGVhM2UxL3RhYmxlcmFuZ2U6ZDZiNjkyMGY2MWQ3NDNjNzkyYzY1MTIzMTlkZWEzZTFfNC0zLTEtMS04MzI4NQ_c8861d3f-5ad8-4f0b-b1b8-4781210651ea"
      unitRef="usd">43100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN184NS9mcmFnOjg2NDJmODU0ZTA4ZTRjMmU5MTAwZDVmMDFkMWE4YjllL3RhYmxlOmQ2YjY5MjBmNjFkNzQzYzc5MmM2NTEyMzE5ZGVhM2UxL3RhYmxlcmFuZ2U6ZDZiNjkyMGY2MWQ3NDNjNzkyYzY1MTIzMTlkZWEzZTFfNS0xLTEtMS04MzI4NQ_d50a7d54-ebeb-4ce6-b351-43d18cbc7f86"
      unitRef="usd">205600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN184NS9mcmFnOjg2NDJmODU0ZTA4ZTRjMmU5MTAwZDVmMDFkMWE4YjllL3RhYmxlOmQ2YjY5MjBmNjFkNzQzYzc5MmM2NTEyMzE5ZGVhM2UxL3RhYmxlcmFuZ2U6ZDZiNjkyMGY2MWQ3NDNjNzkyYzY1MTIzMTlkZWEzZTFfNS0zLTEtMS04MzI4NQ_4b2b3c1d-4301-4fc4-94e9-3fbf34e3d315"
      unitRef="usd">198800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:GrossProfit
      contextRef="iad2fceac1bb145229d93b69339db9f19_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN184NS9mcmFnOjg2NDJmODU0ZTA4ZTRjMmU5MTAwZDVmMDFkMWE4YjllL3RhYmxlOmQ2YjY5MjBmNjFkNzQzYzc5MmM2NTEyMzE5ZGVhM2UxL3RhYmxlcmFuZ2U6ZDZiNjkyMGY2MWQ3NDNjNzkyYzY1MTIzMTlkZWEzZTFfNy0xLTEtMS04MzI4NQ_3d3b482f-9e7c-41ee-82d9-deb0a1bf6f51"
      unitRef="usd">46300000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="if28f02563bbd40d0a3a931501b82e58f_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN184NS9mcmFnOjg2NDJmODU0ZTA4ZTRjMmU5MTAwZDVmMDFkMWE4YjllL3RhYmxlOmQ2YjY5MjBmNjFkNzQzYzc5MmM2NTEyMzE5ZGVhM2UxL3RhYmxlcmFuZ2U6ZDZiNjkyMGY2MWQ3NDNjNzkyYzY1MTIzMTlkZWEzZTFfNy0zLTEtMS04MzI4NQ_86df307d-d2ca-46a0-a624-33af114d17cf"
      unitRef="usd">46000000.0</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="iaab56d5aa0be4d758038ec0908970ec8_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN184NS9mcmFnOjg2NDJmODU0ZTA4ZTRjMmU5MTAwZDVmMDFkMWE4YjllL3RhYmxlOmQ2YjY5MjBmNjFkNzQzYzc5MmM2NTEyMzE5ZGVhM2UxL3RhYmxlcmFuZ2U6ZDZiNjkyMGY2MWQ3NDNjNzkyYzY1MTIzMTlkZWEzZTFfOC0xLTEtMS04MzI4NQ_b9f56b02-526b-4a7d-b814-cbdc85360d1a"
      unitRef="usd">17000000.0</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="ifbe1cf81bdb14d34b79718fe7f9ef5df_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN184NS9mcmFnOjg2NDJmODU0ZTA4ZTRjMmU5MTAwZDVmMDFkMWE4YjllL3RhYmxlOmQ2YjY5MjBmNjFkNzQzYzc5MmM2NTEyMzE5ZGVhM2UxL3RhYmxlcmFuZ2U6ZDZiNjkyMGY2MWQ3NDNjNzkyYzY1MTIzMTlkZWEzZTFfOC0zLTEtMS04MzI4NQ_6984f1f1-f0a9-4ff8-85b5-150c2ea8a15d"
      unitRef="usd">18800000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN184NS9mcmFnOjg2NDJmODU0ZTA4ZTRjMmU5MTAwZDVmMDFkMWE4YjllL3RhYmxlOmQ2YjY5MjBmNjFkNzQzYzc5MmM2NTEyMzE5ZGVhM2UxL3RhYmxlcmFuZ2U6ZDZiNjkyMGY2MWQ3NDNjNzkyYzY1MTIzMTlkZWEzZTFfOS0xLTEtMS04MzI4NQ_e92c1921-f1b6-4bba-93ed-05e84668f25f"
      unitRef="usd">63300000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN184NS9mcmFnOjg2NDJmODU0ZTA4ZTRjMmU5MTAwZDVmMDFkMWE4YjllL3RhYmxlOmQ2YjY5MjBmNjFkNzQzYzc5MmM2NTEyMzE5ZGVhM2UxL3RhYmxlcmFuZ2U6ZDZiNjkyMGY2MWQ3NDNjNzkyYzY1MTIzMTlkZWEzZTFfOS0zLTEtMS04MzI4NQ_31e25729-5e4a-47f5-a0e4-9c534b283dc6"
      unitRef="usd">64800000</us-gaap:GrossProfit>
    <us-gaap:OperatingExpenses
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN184NS9mcmFnOjg2NDJmODU0ZTA4ZTRjMmU5MTAwZDVmMDFkMWE4YjllL3RhYmxlOmQ2YjY5MjBmNjFkNzQzYzc5MmM2NTEyMzE5ZGVhM2UxL3RhYmxlcmFuZ2U6ZDZiNjkyMGY2MWQ3NDNjNzkyYzY1MTIzMTlkZWEzZTFfMTAtMS0xLTEtODMyODU_ac04c7b4-7f19-4624-a0aa-9fb7c41fd1dd"
      unitRef="usd">50300000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN184NS9mcmFnOjg2NDJmODU0ZTA4ZTRjMmU5MTAwZDVmMDFkMWE4YjllL3RhYmxlOmQ2YjY5MjBmNjFkNzQzYzc5MmM2NTEyMzE5ZGVhM2UxL3RhYmxlcmFuZ2U6ZDZiNjkyMGY2MWQ3NDNjNzkyYzY1MTIzMTlkZWEzZTFfMTAtMy0xLTEtODMyODU_f7887913-16c1-4ae2-b648-23f1196a077d"
      unitRef="usd">50800000</us-gaap:OperatingExpenses>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN184NS9mcmFnOjg2NDJmODU0ZTA4ZTRjMmU5MTAwZDVmMDFkMWE4YjllL3RhYmxlOmQ2YjY5MjBmNjFkNzQzYzc5MmM2NTEyMzE5ZGVhM2UxL3RhYmxlcmFuZ2U6ZDZiNjkyMGY2MWQ3NDNjNzkyYzY1MTIzMTlkZWEzZTFfMTEtMS0xLTEtODMyODU_2981d0f9-d176-4f67-955b-887be5cb2ee0"
      unitRef="usd">-7600000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN184NS9mcmFnOjg2NDJmODU0ZTA4ZTRjMmU5MTAwZDVmMDFkMWE4YjllL3RhYmxlOmQ2YjY5MjBmNjFkNzQzYzc5MmM2NTEyMzE5ZGVhM2UxL3RhYmxlcmFuZ2U6ZDZiNjkyMGY2MWQ3NDNjNzkyYzY1MTIzMTlkZWEzZTFfMTEtMy0xLTEtODMyODU_8b5ae5ee-047b-4af5-93bf-1d2f4a3b1333"
      unitRef="usd">-10700000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN184NS9mcmFnOjg2NDJmODU0ZTA4ZTRjMmU5MTAwZDVmMDFkMWE4YjllL3RhYmxlOmQ2YjY5MjBmNjFkNzQzYzc5MmM2NTEyMzE5ZGVhM2UxL3RhYmxlcmFuZ2U6ZDZiNjkyMGY2MWQ3NDNjNzkyYzY1MTIzMTlkZWEzZTFfMTItMS0xLTEtODMyODU_d7bf3cab-9717-44a7-8a20-b693ed92ac77"
      unitRef="usd">5400000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN184NS9mcmFnOjg2NDJmODU0ZTA4ZTRjMmU5MTAwZDVmMDFkMWE4YjllL3RhYmxlOmQ2YjY5MjBmNjFkNzQzYzc5MmM2NTEyMzE5ZGVhM2UxL3RhYmxlcmFuZ2U6ZDZiNjkyMGY2MWQ3NDNjNzkyYzY1MTIzMTlkZWEzZTFfMTItMy0xLTEtODMyODU_824f3b3e-0f9f-4418-8857-9500a0238a21"
      unitRef="usd">3300000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN184NS9mcmFnOjg2NDJmODU0ZTA4ZTRjMmU5MTAwZDVmMDFkMWE4YjllL3RhYmxlOmQ2YjY5MjBmNjFkNzQzYzc5MmM2NTEyMzE5ZGVhM2UxL3RhYmxlcmFuZ2U6ZDZiNjkyMGY2MWQ3NDNjNzkyYzY1MTIzMTlkZWEzZTFfMTMtMS0xLTEtODMyODU_f473423d-5d0a-4ed9-9f14-ceb3fddfa3b9"
      unitRef="usd">2200000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN184NS9mcmFnOjg2NDJmODU0ZTA4ZTRjMmU5MTAwZDVmMDFkMWE4YjllL3RhYmxlOmQ2YjY5MjBmNjFkNzQzYzc5MmM2NTEyMzE5ZGVhM2UxL3RhYmxlcmFuZ2U6ZDZiNjkyMGY2MWQ3NDNjNzkyYzY1MTIzMTlkZWEzZTFfMTMtMy0xLTEtODMyODU_ee22540e-612a-43c6-9dff-c3788ef6b936"
      unitRef="usd">1700000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN184NS9mcmFnOjg2NDJmODU0ZTA4ZTRjMmU5MTAwZDVmMDFkMWE4YjllL3RhYmxlOmQ2YjY5MjBmNjFkNzQzYzc5MmM2NTEyMzE5ZGVhM2UxL3RhYmxlcmFuZ2U6ZDZiNjkyMGY2MWQ3NDNjNzkyYzY1MTIzMTlkZWEzZTFfMTQtMS0xLTEtODMyODU_05b360cc-5465-4341-8f2d-acd8e0c7038e"
      unitRef="usd">3200000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN184NS9mcmFnOjg2NDJmODU0ZTA4ZTRjMmU5MTAwZDVmMDFkMWE4YjllL3RhYmxlOmQ2YjY5MjBmNjFkNzQzYzc5MmM2NTEyMzE5ZGVhM2UxL3RhYmxlcmFuZ2U6ZDZiNjkyMGY2MWQ3NDNjNzkyYzY1MTIzMTlkZWEzZTFfMTQtMy0xLTEtODMyODU_bfd1f104-4f55-49e6-9533-51ce313635bd"
      unitRef="usd">1600000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN184NS9mcmFnOjg2NDJmODU0ZTA4ZTRjMmU5MTAwZDVmMDFkMWE4YjllL3RhYmxlOmQ2YjY5MjBmNjFkNzQzYzc5MmM2NTEyMzE5ZGVhM2UxL3RhYmxlcmFuZ2U6ZDZiNjkyMGY2MWQ3NDNjNzkyYzY1MTIzMTlkZWEzZTFfMTUtMS0xLTEtODMyODU_1df3b0fe-9a1c-4b87-bc5e-237bf403d90a"
      unitRef="usd">100000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN184NS9mcmFnOjg2NDJmODU0ZTA4ZTRjMmU5MTAwZDVmMDFkMWE4YjllL3RhYmxlOmQ2YjY5MjBmNjFkNzQzYzc5MmM2NTEyMzE5ZGVhM2UxL3RhYmxlcmFuZ2U6ZDZiNjkyMGY2MWQ3NDNjNzkyYzY1MTIzMTlkZWEzZTFfMTUtMy0xLTEtODMyODU_9487e490-f955-4abf-9206-9b933a08a0c8"
      unitRef="usd">200000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN184NS9mcmFnOjg2NDJmODU0ZTA4ZTRjMmU5MTAwZDVmMDFkMWE4YjllL3RhYmxlOmQ2YjY5MjBmNjFkNzQzYzc5MmM2NTEyMzE5ZGVhM2UxL3RhYmxlcmFuZ2U6ZDZiNjkyMGY2MWQ3NDNjNzkyYzY1MTIzMTlkZWEzZTFfMTYtMS0xLTEtODMyODU_4fe027c8-7e67-4a84-971c-4b09ac34ed69"
      unitRef="usd">3100000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i7fe5aac364564006abc3881183388748_D20211002-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhYjU3MzkwOWNiODQ5MzM5MzU3MTkzYjAxN2M3ZDM3L3NlYzo0YWI1NzM5MDljYjg0OTMzOTM1NzE5M2IwMTdjN2QzN184NS9mcmFnOjg2NDJmODU0ZTA4ZTRjMmU5MTAwZDVmMDFkMWE4YjllL3RhYmxlOmQ2YjY5MjBmNjFkNzQzYzc5MmM2NTEyMzE5ZGVhM2UxL3RhYmxlcmFuZ2U6ZDZiNjkyMGY2MWQ3NDNjNzkyYzY1MTIzMTlkZWEzZTFfMTYtMy0xLTEtODMyODU_bc92c7db-3355-45d9-ac17-f53da4090976"
      unitRef="usd">1400000</us-gaap:NetIncomeLoss>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>88
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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MQ41B /]?<ZY.-\D+BK/1\7]02P,$%     @ 0H$_5NGT2'%$ P  FPD  !@
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M5A;*_BDZ<EP,+8= .YJ6[ 01=PK\JGY1L:%"<7PI-UPD_[(8*@W/&4J* OH
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M^L-@?2/YMOJV=L>EY%EUN6$48"L!&+_G7+[<J,]U[>?9Y7]02P,$%     @
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M]OEC%*6O;[(?^=S_)N_U7U!+ P04    " !#@3]6G1L97"@(   P)@  &
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MX0VL>8"EP%84IENV&9@=:QN< ^009* 7)6N[4A6N:6&S1$%N+0BK62,#6%;
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MC<RS_LH('O:9N07B"O,EDBEYU"94C6 9G(@G<>K ?*VYO@SR6!-:2&'Y9NC
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M*KO3>%J+8QK9"%B6^@.?0-KP&;#W;*'A7]I5?\9R[(427 ;VB<H0 79X Z(
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MMP'KB4+GK5^<@?:C:OX/4$L#!!0    ( $.!/U:I+<9;EP0  &H2   9
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M4$Y$2<'6B?)[73&!1\IYH4VP8J&--(F6.<JR2:L7>!#5"(W,KO>H^Y)3R3O
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M=]I6'IC%_8BZ1DH';4]\+$>P&>X9->]*3PN)0@30TDMX 6X-N6JZV\[;X2&
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M82Y5,;BZX+%[>W5A*J]5 ?=6N"K/I5W?@#:KR\%XT Q\5,O,T\#PZJ*42W@
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MB4VK9\?;LQ\+TS=S\EI\,K[=_IQ.4UAC\B$5Q:(J4B>.!*?2^"VVXG$T>SZ
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MX7Z'_K/WG7R9,X.72GSAI5T-@SR $A>L$?:S6O^"6W^Z#J]0PO@OK%O>;A9
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MKNBG!K5CH/N%4G9W< KVOTFCOP%02P,$%     @ 0X$_5E=#-#:(#   52,
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M&FC\$%P-UB"G- =EZBUF%>S\<'(_&=]/GA[O;V]O)I_I9O+TZ?'3]&EZT?5
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M^V9.SRAJ%T#S4Z7LJN,6:![F_E]02P,$%     @ 0X$_5A8 ['+)!@  X \
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M'AQ2^.6$_E6H ;=%C4M.0#G<9]T6-S7H:X1 $U(J%C%-*U3 =F_ GXO7JG3
M. @:2@T3PA13=8X++'4M1F_>VZ=I.R9Y5>#>2JW9%;S5%>(B]9H7 40!RD@F
MY-PZ.&[FG8G?HG=D8^3A4PV&6[X!\4,38Q:-^A.VXBO#=@JDRXHA:@>^'Z4,
M?$MM_B:7LU5@"3SNN2$((/OV@86T_R$7^X@"I!L%'J=86'1N<CH:1G?IS'!2
M#L#0-L&T$V+)NB7/M$!(T:!8J!:]DH,S63C;K1'5@I9X 1" ]_!Q!IT*4!H:
MX2@1$\5<J6 =AZ>0%K1@KIMD8T'E-O!GL<4E^_O!V!MM""Z(Z,ANZ! (&?+.
MA&48O5:J6ULV*R"\H+MD2&H,DHL;4Q.8FC.T&Q.??%U[PZMZ(#C!GQ5,+S"1
M-@<[J+H2T9ZS*V0!2@(LRLR"QWRW7M>&MNS"((\861]["[S4<<14_;'4C2#6
M])B@$M004+X5^K1,B'[T/'0+^%17?C+X3<@C^44(NR"W!:,-C$#N3-4! _93
M-& _'7;[>D&BPF@$-C=FO.XXQ0Y*;C=6K"_QPH*<%S30\Z/^N;IG[JMW(!((
MJ% Z[QGXXB**7T!&H&V+1H1V"3O%<SQ?&CV'L ML$#GVRSE8'^WP$8NLZ[.5
M1U]&$B!<-Q2CO2L^@P*$ .K\\O6[$$!-%#H1O?&C<$Z4%B5["K&@!HP& <_L
M\40%QEQD =.$I'_>.023O5#*CJ/%P*)#WFIVDG(J)P?/ZBU#UG\#9!U-E7SS
MTPQ =__]V,?%,4@.XE#XY(<+@72/3U'!'C\\WFC].;AX,%UX/,*5MP[0!"H*
M/ ,>ZAI#X(2#'YY,U=L,C ,F?AA._O'IV+2#"4Y_(B#]<&>:4\+B(_.0PV70
M#R3NT".X7&7L^*N#8(P ,3[% T'X1AY#!1C]?4:_S_BO#00CZL:"(LQZG#LL
M*5GV;7;PK#]Y,IUO C0>%9>[34'<X)1+Q#1[XOB _=#JD[)32D$0N,_2!&18
M07,S#(_F V!NMUIGD8; 00[R@_P)F$6W FY(8KW:L+L)H7K"^.0=+>5F<.5]
MS_ JB!FRT/O.0>X8E0YCJ2ZD$,!)-N@\*\ K(-+I(<H=A8S%=0=F,S$GI$AP
M=$05!"H:C-.L(PS7^V5A;;4Q=2T9JQ9PMD$SSOL',ULX %<"_C!Y =XIY\@$
MO'RS.*[!-E?\4)H??D1W9AR=I9 A:9L!&?,QX"NHLO@BN*L!-Z\QG=5BB!W2
M.26E BH#,B".G#UU9,M!E3E-*G-Z.!@(*(\^O,FQ\@>-?HPP#?XXJDS?.7G/
MVZ:PNVM<6I/#IW*+/%H28*STBH1;0"J #P-8*6)6TB$X\J59+.LMG!VL5^6'
M([@13L:9A<%8&!C9.4%I[=*!(UQQ8AUL>ZW]CF($-(H:?*,/0>2#S.N?54JJ
MSPYFP5]>9%O!5=^E8";E<T>/Z3NRZ_EB^6E%($L96O@?MPT<S/G,$?@M, W.
M@<(C3GZAJ>D0WC-BY@=7NEV"<T*#EM+(9KX3NE 634 UL%]_T0Y0$$!70%<4
MNS68^9W7':5,3$"V&5U3]=K@J=Q(7,90'(T:X>1F0%%ZDKQ^R$,@Z/?!>)7=
MJI/<#'C?!KZ&HUD##"[*9<!_*UT$BU[UU@?$+FD(MI=DJ[,) V/3U$"QA=W^
M35DV$'60P1;".<F<.@W2W(A12;2C?";:85S"LB2W<XAQ@@VWQ#$*S;S@('1$
M3-ZA)>>'E^0?^TOVXY\ 5[]#I$@2DT7>0%BC,46=LGB<:*%9;O#P<'.E<<!L
M\&*<GD972?@6=@RRHU<8B;NM.)"*<@/,#3IW\!^4RDTGQ[GW1#%&_1AN \/F
M74VYG!+#7 []1G4W9\B/?CQ9D6<\8(#A?,>HHX%0#<,/KSY-KZ=T:H (MKW$
M!_T"L(3L[ T$*L'#E9**0+C65/3%:H4:!TNLBS6&*F J]5:(A"W2*'+R?'II
MF?Y!1\'H;;#2-VV^2Z"ZN"U,C3\>PP$?^P+=-W.?['YNCKG*)2D'+1OO)PYI
M2GA&@V:.Y&RY='&((*?I!!W"9\31XH<KKLS@TC@);!"]F&18%A32HS/AG %*
MZE?6R#/Q8!#9'"!B)^%$H7=ZB77\6RW0@=Q:S-L'U':>H[97LM]KW*_O2=_.
M:1$5!.YHGVEWR,!*0SBP,DTJ/ZZL;\F2-BV((N7*,-<)T6SDMLR]#<>WC_L[
MC".8&A-4XY2F,TFE(^:5@,T)1&#MH*[QH[\+OLU"Y*<3]189\CLRI!\7 VM
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MIX^/..L=_FCMFM[ >F-;0&[T<0GAF78X 'Z?6S@X^0,7B._D??G_4$L#!!0
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MT8%#31;N#88<B=J-/P.)*J6M9D1MK2?LL!HL+^[5>+XE99S2$[@D:-3X?!&
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MSS0K=/TRK3=6E?XUN%"6WI9^F=-C'K6[0.>I4G:U<0K:OP?C?P!02P,$%
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M,$'JAC03T/.)HA!6$Q907_N>_ -02P,$%     @ 0X$_5GU(7R*F @  I 4
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M!@)[2?G'VB^,;-P#N9 &X^.F*_R_H<H*X/E22K-;6 /[/Z;)WU!+ P04
M" !#@3]6MA^_Q*X$  !1"P  &0   'AL+W=O<FMS:&5E=',O<VAE970S,BYX
M;6R55MMRXS8,_16.-]DZ,XDLR]=X;<_DUC8/N\G82?>ATP=:@FQV*5(AJ3CI
MUQ>@+&WL<=ST01)% @<'  %RO-;FAUT!./:2264GC95S^:C5LO$*,FX#G8/"
ME52;C#O\-<N6S0WPQ"MELA6%8;^5<:$:T[&?NS?3L2Z<% KN#;-%EG'S>@E2
MKR>-=J.:F(GERM%$:SK.^1+FX![S>X-_K1HE$1DH*[1B!M))XZ(]NNR1O!?X
M0\#:OADS\F2A]0_ZN4TFC9 (@838$0+'SS-<@90$A#2>-IB-VB0IOAU7Z+]Z
MW]&7!;=PI>5WD;C5I#%LL 127D@WT^O?8>./)QAK:?V;K4O9Z+S!XL(ZG6V4
MD4$F5/GE+YLXO%$8AN\H1!N%R/,N#7F6U]SQZ=CH-3,DC6@T\*YZ;20G%"5E
M[@RN"M1ST\N[V>SN^^VWW^:L^< 7$NS)N.40F)9;\0;DL@2)W@'IL*]:N95E
M-RJ!9%N_A81J5E'%ZC(Z"'@-<< ZX2F+PB@Z@->IO>QXO,Z[> O'KH6-I;:%
M ?;GQ<(Z@SOBKWW.EEC=_5A4)2.;\Q@F#2P#"^89&M//G]K]\,L!IMV::?<0
M^G2.59<4$IA.&;'>Q^\PPL,*6*HE5IM02^8HIYN2$_^ 90Z7KW26<_7ZBV5V
MI8T[<V RQE7"I%;+\B]!VR-D$$.V %/G@LTA=SM3S5N%.U-*+#)[RN E1A%D
M8%@.)@;EL+;M";O(=*%<];G"_4+Q+[ADMPHM@G5LQAVPFS0%7ZD[\U>%,0B&
M>]\51CB!KF"(M@FS._3.E,,C%@7MS?N;5F?Q!_1'Q.L9C!,4M#DH@5X\*@NH
M# G".-1"R# ,POK;#<)C? V/*X7YEGC4[:!0^1X$Y\=L&$3';XEV@[Y_'K3#
M8*@/4SUBW>X ]:KOH^(9)A.3G#!A;<%5#"S6UEF?6F\KP1*@^-LMZ6J6G6WY
M7_)OMD_0Q.=/PZ@=?<%1,QH&@Y-#UMY#:7:"GG^W_T-];QQ1KU-AE*%"+OU@
M2.R:G1XMEM/>43Q^K$.WL01.F0+GHQ0%Y_1M=X,NNWDJA'M%DUFN%04;(_R!
MY#>C[6ATSX.!=PYK(-9*;<Z:M7 K7VD\T;F?0?B+^2,53'@6]D_]8K$O!P8D
M;O>$.;TIU=U0KKE%'PW$>JF\*F671&-NS"O5_#.7A6\@-+L37=+FR=]XL%#D
ME1=)A<$J>RJXP>U%>BF2P4B^ C?$N!.P&:2XA)R( VN?LGEYB)/T7""15,2<
MRCOV7A"+>RU%3'N76D%:F,V.=UQ(&_A WJI8%DG)@R>)H$"AV9R+Y RG8IX+
M2JA65202O R@.(XL@B<^3I=<>O?F= 3:X$ +[M4MN/?A%ESWH)N7G(SO:\<'
MT?8?%_^K1XN* Y0<1NQA90"VSMP]G?KG3-O/M+>:;@V*^<KI=H2;2/L4';&^
MKY-!T*%N3?N35UO8U];.C@JQ]X1!;[_LSX93U0SUX[)0=_WR-GOX/D?[^_+8
M>G/-R< L_67.,F^@O/'4L_5]\:*\)OT4+R^;7[E9"F69A!15PV" 233E!:[\
M<3KWEZ:%=G@%\\,5WGG!D "NIQH+8?-#!NI;]/1?4$L#!!0    ( $.!/U9?
MYZU+D@(  /T%   9    >&PO=V]R:W-H965T<R]S:&5E=#,S+GAM;'U4;6_:
M,!#^*Z=LFEJI(F^TJQA$*JS;D-I0 =L^3/O@) >QFMB9;9KNW^^<A(Q*P(?$
MOO,]SST7YVY<2_6L<T0#KV4A],3)C:E&KJO3'$NF![)"02<;J4IFR%1;5U<*
M6=: RL(-/._&+1D73C1N?$\J&LN=*;C )P5Z5Y9,_9UB(>N)XSM[QY)O<V,=
M;C2NV!97:+Y73XHLMV?)>(E"<RE X6;BW/FCZ=#&-P$_.-;Z8 ^VDD3*9VO,
MLXGC64%88&HL Z/E!6=8%):(9/SI.)T^I04>[O?L7YK:J9:$:9S)XB?/3#YQ
M;AW(<,-VA5G*^AMV]5Q;OE06NGE#W<:&UPZD.VUDV8%)0<E%N[+7[CL< &Z]
M$X"@ P2-[C91H_(S,RP:*UF#LM'$9C=-J0V:Q'%A+V5E%)URPIDH7L2S1;Q>
M+AX>YO%7F,?K^^7]:KV"BS5+"M278]=0&AOLIAWEM*4,3E"&\"B%R37<BPRS
MMWB7Y/4:@[W&:7"6\#.F PB]*PB\(#C#%_8UAPU?>*IF*5)2J&1!)UN8"X,*
MM8%?=XDVBOZ3W\>*;CF'QSEM[XQTQ5*<.-0<&M4+.M&'=_Z-]^F,XF&O>'B.
M_93B8S+/$AV7.<N9V*(&+D"\3<2[1!IJ6H%IV-")K/4(UKE"?'/3<#$7](L2
M4@I]"71K6":H^IL[\/B-QX?X1+HK8 82W'(AK%]NH$+%90;OP0\'8;L$$-/0
MXL10DC1C%$]VQOZT8.3I0KR!3T\ "Y.3D@LR+[OW63$HLA,R0CAVP>Y!2Y:H
MMLW@T9#*G3!M=_;>?K;=M2W]/[P=C(],T8?04."&H-[@(XT2U0Z;UC"R:AH\
MD8;&1;/-:3ZCL@%TOI'2[ V;H)_XT3]02P,$%     @ 0X$_5FU*==F, P
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M,H <UZP6=J&V7["-9^#X,B6,?\*VL4W).*N-564+)@4EE\V;O;3[L >XC(X
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MK$O4S"KM?>8H%>6CG]<&<^#26V5,9+7H@*M.9-Z(!$DW#6^"H4=)9L8? S?
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M7T)V:?03->URE[057^<"WP)VD&X!K2E)Y***%?6YV*D\+/8HT*I%JR65%]J
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M@M)N,.MS(?1V8A/4OZ3H%U!+ P04    " !#@3]6BIIRGZ(#  "E#0  &0
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M-4_P3?@&]3)0QJ6Y(BPD(CPV=A@$(B41?'W@401ZPFYUV+]5;N:]M:I[,YO
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M7Z#^7S%5ELJ3_#U4]69S^AU02P,$%     @ 0X$_5O1L_!%J P  _ \  !D
M  !X;"]W;W)K<VAE971S+W-H965T-#,N>&ULM5==;]HP%/TK5E9-G=21#R!
M!Y'XFE9I5 A*]S#MP0T7B)K$S#;0_?O93@@)I!&H@0>(DWN.[[DY)/>V=X2^
MLA4 1V^!'[*.MN)\?:_KS%U!@%F%K"$45Q:$!IB+)5WJ;$T!SQ4H\'7+,&P]
MP%ZH.6UU;DR=-MEPWPMA3!';! &F_WK@DUU',[7]B8FW7'%Y0G?::[R$*?#9
M>DS%2D]8YEX (?-(B"@L.EK7O.^;M@2HB&</=BQUC*24%T)>Y>)AWM$,F1'X
MX'))@<7/%OK@^Y))Y/$W)M62/24P?;QG_Z[$"S$OF$&?^+^\.5]UM*:&YK#
M&Y]/R.X'Q(+JDL\E/E/?:!?%-@P-N1O&21"#10:!%T:_^"TN1 H@>/(!5@RP
MC@&U=P#5&%!50J/,E*P!YMAI4[)#5$8+-GF@:J/00HT7RMLXY51<]02..Y/A
M\_!Q-D1?T<!C>+FDL,2JOF2!)K"%< /H=@ <>S[[(J)FTP&ZO?F";I 7HI'G
M^R*6M74N4I&$NAMOVXNVM=[9MHI&).0KAH;A'.99O"XD)#JLO8Z>54@X +>"
MJL8=L@S+RLFG?P[<5'"S()UJ4M:JXJN^Q_=N,7__%*'H@4/ _N35+>*MY?/*
M/_4]6V,7.IKXUS*@6]"<SY],V_B6)[HDLDP):DD):D7L3BR8W:$0>)[2"&XK
MN'S:;!W+J%?LMKY-2SB-,EO-2C.)RN163W*K%^;6#8!Z+LXU;B'RTAM0$EE&
MI)V(M*_D0;O,$I1$EBE!(RE!XV,>C.#UE+L:M92Y(@6G0;91J><[L)EDUBS,
M;#@:=O,2*D1=6OJ2R#("6XG UI7<URJS!"6194I@&H>7J_$Q_\7X1MI;M2/[
MQ3$9_S4J-2/U,?/-:*:Z +/X@3CN]G/S*X1=>C/*8LN*M XBK2M9,B8NJPPE
ML67+<&A-S,+7_AFFK)X:SCYY*N9$-8Q*ZQQ;'EH(L[B'F#T^/ T':/K4?1I.
M<U,MQ%]\8TIBRZH]-"5F_5K^++5I*8LM6X9#VV(6M@1G^-,^Z0G%6]MHI3_'
M9CV%U$^[2#TU1XD.<:G&2X9<L@EY-(HD9Y,1MJL&MZ/S/3G:JOGL0!/-Q2-,
MEU[(D \+06E4&J+6-!HUHP4G:S6MO1 N9C]UN!+C.5 9(*XO".'[A=P@&?B=
M_U!+ P04    " !#@3]6.@N' +,#  ".#   &0   'AL+W=O<FMS:&5E=',O
M<VAE970T-"YX;6RM5]MNXS80_15"712[0-:Z^9;4-I X6;1 4P0.LGVFI;'%
MKD2J)&5O^O4=2HILR;22![_8(C5S>,YPR!G-]D+^4 F )C^SE*NYDVB=W[BN
MBA+(J!J('#B^V0B948U#N755+H'&I5.6NH'GC=V,,NXL9N7<DUS,1*%3QN%)
M$E5D&96O=Y"*_=SQG;>)%=LFVDRXBUE.M_ ,^B5_DCAR&Y289< 5$YQ(V,R=
M6_]FZ8?&H;3XSF"OCIZ)D;(6XH<9_!'/'<\P@A0B;2 H_NU@"6EJD)#'OS6H
MTZQI'(^?W]"_E>)1S)HJ6(KT;Q;K9.Y,'1+#AA:I7HG][U +&AF\2*2J_"7[
MVM9S2%0H+;+:&1EDC%?_]&<=B",'Q+$[!+5#T'48GG$(:X<R<F[%K)1U3S5=
MS*38$VFL$<T\E+$IO5$-XV8;G[7$MPS]]&+U\/WAKY<'\I4\5QM)Q(8L!=<2
M TQNE0*M".4Q^9/1-4N99J#(YWO0E*7J"[J]/-^3SY^^D$^$<?+(TA0W1\U<
MC=S,"FY4\[BK> 1G>(3D$1=-%'G@,<1M?Q<U-<*"-V%W02_@/40#$GI7)/""
MP,)G^1%WOW3W>^B$39S#$B\\@]<)J2U %<#0#F".\XW*:01S!\^K KD#9_'K
M+_[8^\VF[D)@+:W#1NNP#WUQ1U/*(R!4DS5L&>>,;TU:Y2"9B&W2*[QQB6<N
MGMTB& V&,W=W+,EB-!R$C5&+ZJBA.NJENA0*\UM")'8@(28;*3*22Q$7N%42
M="&Y(G$AC0*=0(^$:IW1$;NO_F#4D?".44O"N)$P?D="G5G49%:E0"4LQ[L6
MI9FP5W+4%=[5ZW_P^B1:U-H^)FU\POI4F<UF:A<V:81-/II&@!=0;P)-3I:W
M))#%:#@8VTE.&Y+3WG.]@DW1OAUM]*:7/-H7 FO)O6[D7E_X:%^?!GTZ"#H[
M4QE-CHTF]GWQO4-A\WJIKK!5P/INV,EJD])ZDUZQ5$5I@77&U*R6CE>@\L3<
M6LT\VU$>=W2]9]66=E2S_5YIMW',3!.DJI/<8GLF VO$]@&==.G:C*[/L T.
M;(.+G>,:JI,N89>GQ6IRKA3XAQ+M]U;%PTVZ9SJIFR^05X=$N,)@[X 74%:,
M+6?_=5N56D5X4JJ&)SEO-?([&MRCS@ZY;,N&5Y%(%%Q7O5 SVS35MV4KV9F_
M,\UVV3$>8*I._9%*/ "*I+!!2&\PP;#*JOFM!EKD9?^X%AH#4CXF^,$ TAC@
M^XT0^FU@%F@^01;_ U!+ P04    " !#@3]6"J1^0($"  #"!@  &0   'AL
M+W=O<FMS:&5E=',O<VAE970T-2YX;6RM55UOTS 4_2M6F- F0?/5%5;22&TS
M!-*&IE6#!\2#F]PVUAP[V&X[_CW73AJZ*:UXV$MB7]]SKL]U?)+LI'K4)8 A
M3Q47>N*5QM1CW]=Y"175 UF#P)655!4U.%5K7]<*:.% %?>C(!CY%67"2Q,7
MNU-I(C>&,P%WBNA-55'U9P9<[B9>Z.T#]VQ=&AOPTZ2F:UB >:CO%,[\CJ5@
M%0C-I" *5A-O&HZSH<UW"=\9[/3!F%@E2RD?[>1K,?$"NR'@D!O+0/&UA3EP
M;HEP&[];3J\K:8&'XSW[9Z<=M2RIAKGD/UAARHGWT2,%K.B&FWNY^P*MGDO+
METNNW9/LFMS+H4?RC3:R:L&X@XJ)YDV?VCX< )"G'Q"U@.@EX%B%N 7$+P&C
M(X!A"W"M]ALIK@\9-31-E-P19;.1S0Y<,QT:Y3-ACWUA%*XRQ)GTYGJZN%Z0
M]^0;58K:,]#D/ -#&=<7&'Y89.3\[(*<$2;(+>,<#TLGOL'2EL#/VS*SIDQT
MI$Q,;J4PI2;7HH"B!Y^=QH?1"0(?-7?"H[WP6722,8-\0.+@'8F"*.K9T/Q_
MX*&#AWUZ3L,74!^K_DQ-W!UC[/CB8\<(^.UK\G.ZU$;A7?K5=T0-Q;"?POK+
M6-<TAXF'!J)!;<%+W[X)1\&GOO:\)EGV2F3/6C?L6C<\Q9[>2*T).A ZJ;T
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MI"Q$0AZR!X/'#",_#0H#PS+-D1$B$O4FX_3<G$W&="T"$N$Y WP=AH@]GN.
M;L]ZL/=TXI8\K$1RPIB,8_2 %UA\C>=,'AD%Q2<ACCBA$6!X>=:;PE/7LI.
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M#^#Z_<)4+,-10 UM4&\Q2%^^Z)]%'XZI_T]D#VHQ[&HQ?(X]_6H+U,",06N
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M61V[54>+PIU<B=#F''3-E;FIH+0!YOM""/W6L8=A<_>)?P%02P,$%     @
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M_<&+@OPTWT*$2?8_>BIBQP.TV"1*1$5CK2 *XOPO^U$,1*F!1VL:X*(!;MN
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M9PC<0."BGG^!B$](2_J\.WT!R;ET3TM1Z$$*/4B*USNG!PT%>J)L#Q?H-CZ
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M02FL<4G5@N\^0>UG:/@23J5]HET5&X4.2DJI>%Z#M8*<L.J-'^MS: $T3S?
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MSN!4"AV)U6#YWG.IY[7BFF=<<\J/N-C";>5.&0+G/"LKD OB=;2BF97R?GB
MK3^DISA\P:Q]'J="ZTJM3NV@0/;?\,(K:&TECRTN4T]N*>$*6(9::RTX:W=Q
MZE9>J@UK^UMOZ->?0M25TSJWX)E;T,KM-D\71$BL +_F7'^G;>GIS:> &M8R
M#6TEL32OQM;<:W5V,D&K=G5 <#1H6/W1&P9:/.Y!"Y:B7!>MK*(8Z35EN['J
M:M4NORN:1/=YN.VU/S*Y)E:0X(I,O=X5U2S2MJ_V1(MMT= MA*;VL#C<4,N/
MT@R@^RM!=5EY8AQ4?R),?P!02P,$%     @ 0X$_5N+S_%HX P  D0H  !D
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MPH*R 7A_(:7936S34S3%P3]02P,$%     @ 0X$_5E9X%LCC!@  _3T  !D
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M +A<D'R63T1]Y%+R:?YQPNB("=U ??_$N5PNZ Y6,[[[_P-02P,$%     @
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M@FPZD$')%ZZ*SMP"WME)'Z_1K@;>S8!WCP5N(%[JO@[G88-%*$U3XFH)"7.
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M>6;S0? ^@ Q7K!1VKG8W6.OQ!:9*&/^$71T;!9"6QJJB!E,%!9?5FSW4/AP
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M"+4+H.\K1>>GGK@$S0V7_ 502P,$%     @ 0X$_5H[')NIQ P  C0X  !D
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M'. -ERZ0^'K$"QP$TI/ \5_F=)#W*0W+UT?O'Q/R@LP:,;P@P3??X[OKP60
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MP]A6D%*-XW,H$JN0))9>D[28[5IP'36YVM9P-*IS/8<\L0I]8ND%BFK,*F;
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MII]N_[V^1K/[V\N/:/KI_/,,G:([$)*36$*"9I+%#PC3!$V!FS"@,52C;ZY
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MZ)^;79!57:XZ6BQ=:9L*;0JE:R[,4X;2!ICYF1!ZU[$)ZL<Q_0-02P,$%
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M5<&*IJD-U4TC8SJ@OZYFM-=EN\_2=0KVD*L/<ST=4?6A6.B-I"E;5/U%VAC
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M"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ 0X$_5ETF$WCD!0  /C$   \
M  !X;"]W;W)K8F]O:RYX;6S%F]]SHD@0@/^5*9_V'G)&?IG=VFP54334(:2
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M8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " !"@3]6_=SP >T    K @  $0
M            @ &O    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    " !"
M@3]6F5R<(Q &  "<)P  $P              @ '+ 0  >&PO=&AE;64O=&AE
M;64Q+GAM;%!+ 0(4 Q0    ( $*!/U8S.)W@R04  ,0>   8
M  " @0P(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4    " !"
M@3]6$@DZ7"8%   G%0  &               @($+#@  >&PO=V]R:W-H965T
M<R]S:&5E=#(N>&UL4$L! A0#%     @ 0H$_5NGT2'%$ P  FPD  !@
M         ("!9Q,  'AL+W=O<FMS:&5E=',O<VAE970S+GAM;%!+ 0(4 Q0
M   ( $*!/U;%"6(^[@8  *H=   8              " @>$6  !X;"]W;W)K
M<VAE971S+W-H965T-"YX;6Q02P$"% ,4    " !"@3]6(2JNI40#  "!"@
M&               @($%'@  >&PO=V]R:W-H965T<R]S:&5E=#4N>&UL4$L!
M A0#%     @ 0X$_5K?_)\$_"0  GU<  !@              ("!?R$  'AL
M+W=O<FMS:&5E=',O<VAE970V+GAM;%!+ 0(4 Q0    ( $.!/U:=&QE<* @
M # F   8              " @?0J  !X;"]W;W)K<VAE971S+W-H965T-RYX
M;6Q02P$"% ,4    " !#@3]6\,.*:,\A  "-:0  &               @(%2
M,P  >&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L! A0#%     @ 0X$_5B_#
M_U,V!0  8 T  !@              ("!5U4  'AL+W=O<FMS:&5E=',O<VAE
M970Y+GAM;%!+ 0(4 Q0    ( $.!/U:I+<9;EP0  &H2   9
M  " @<-:  !X;"]W;W)K<VAE971S+W-H965T,3 N>&UL4$L! A0#%     @
M0X$_5A5@-<@[!P  WQ(  !D              ("!D5\  'AL+W=O<FMS:&5E
M=',O<VAE970Q,2YX;6Q02P$"% ,4    " !#@3]60"U1D@D$   2"0  &0
M            @($#9P  >&PO=V]R:W-H965T<R]S:&5E=#$R+GAM;%!+ 0(4
M Q0    ( $.!/U9P&)56-P@  (L6   9              " @4-K  !X;"]W
M;W)K<VAE971S+W-H965T,3,N>&UL4$L! A0#%     @ 0X$_5MW648[>!P
MH!@  !D              ("!L7,  'AL+W=O<FMS:&5E=',O<VAE970Q-"YX
M;6Q02P$"% ,4    " !#@3]6?##M+9("  "4!0  &0              @('&
M>P  >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4 Q0    ( $.!/U;N
MZ276%@0  #()   9              " @8]^  !X;"]W;W)K<VAE971S+W-H
M965T,38N>&UL4$L! A0#%     @ 0X$_5E=#-#:(#   52,  !D
M     ("!W((  'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( $.!/U86 .QRR08  . /   9              "
M@?:D  !X;"]W;W)K<VAE971S+W-H965T,C(N>&UL4$L! A0#%     @ 0X$_
M5@J!BF_7&P  GU<  !D              ("!]JL  'AL+W=O<FMS:&5E=',O
M<VAE970R,RYX;6Q02P$"% ,4    " !#@3]6DP"A(T\$   ;#0  &0
M        @($$R   >&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;%!+ 0(4 Q0
M   ( $.!/U:N:OAKO0,  &T)   9              " @8K,  !X;"]W;W)K
M<VAE971S+W-H965T,C4N>&UL4$L! A0#%     @ 0X$_5I1-PC\:!   U@H
M !D              ("!?M   'AL+W=O<FMS:&5E=',O<VAE970R-BYX;6Q0
M2P$"% ,4    " !#@3]6X+:6F_<"  "#!@  &0              @('/U
M>&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+ 0(4 Q0    ( $.!/U;;*_"6
MN@0  "H,   9              " @?W7  !X;"]W;W)K<VAE971S+W-H965T
M,C@N>&UL4$L! A0#%     @ 0X$_5JW"WE"2!@   AX  !D
M ("![MP  'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6Q02P$"% ,4    " !#
M@3]6?4A?(J8"  "D!0  &0              @(&WXP  >&PO=V]R:W-H965T
M<R]S:&5E=#,P+GAM;%!+ 0(4 Q0    ( $.!/U9Y)+O)!00  #T)   9
M          " @93F  !X;"]W;W)K<VAE971S+W-H965T,S$N>&UL4$L! A0#
M%     @ 0X$_5K8?O\2N!   40L  !D              ("!T.H  'AL+W=O
M<FMS:&5E=',O<VAE970S,BYX;6Q02P$"% ,4    " !#@3]67^>M2Y("  #]
M!0  &0              @(&U[P  >&PO=V]R:W-H965T<R]S:&5E=#,S+GAM
M;%!+ 0(4 Q0    ( $.!/U9M2G79C ,  (X(   9              " @7[R
M  !X;"]W;W)K<VAE971S+W-H965T,S0N>&UL4$L! A0#%     @ 0X$_5MRO
MISC(!0  ,@X  !D              ("!0?8  'AL+W=O<FMS:&5E=',O<VAE
M970S-2YX;6Q02P$"% ,4    " !#@3]6/"6B_$,#   (!P  &0
M    @(% _   >&PO=V]R:W-H965T<R]S:&5E=#,V+GAM;%!+ 0(4 Q0    (
M $.!/U8T)WJ:4@(  -,$   9              " @;K_  !X;"]W;W)K<VAE
M971S+W-H965T,S<N>&UL4$L! A0#%     @ 0X$_5KV%\*P2 P  +@D  !D
M             ("!0P(! 'AL+W=O<FMS:&5E=',O<VAE970S."YX;6Q02P$"
M% ,4    " !#@3]6PQAQ0B8#   J#   &0              @(&,!0$ >&PO
M=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+ 0(4 Q0    ( $.!/U:NQ"3@IP(
M )X&   9              " @>D( 0!X;"]W;W)K<VAE971S+W-H965T-# N
M>&UL4$L! A0#%     @ 0X$_5HJ:<I^B P  I0T  !D              ("!
MQPL! 'AL+W=O<FMS:&5E=',O<VAE970T,2YX;6Q02P$"% ,4    " !#@3]6
MT=J*)XX$  #E'   &0              @(&@#P$ >&PO=V]R:W-H965T<R]S
M:&5E=#0R+GAM;%!+ 0(4 Q0    ( $.!/U;T;/P1:@,  /P/   9
M      " @644 0!X;"]W;W)K<VAE971S+W-H965T-#,N>&UL4$L! A0#%
M  @ 0X$_5CH+AP"S P  C@P  !D              ("!!A@! 'AL+W=O<FMS
M:&5E=',O<VAE970T-"YX;6Q02P$"% ,4    " !#@3]6"J1^0($"  #"!@
M&0              @('P&P$ >&PO=V]R:W-H965T<R]S:&5E=#0U+GAM;%!+
M 0(4 Q0    ( $.!/U8(ZFD*<@,  %4-   9              " @:@> 0!X
M;"]W;W)K<VAE971S+W-H965T-#8N>&UL4$L! A0#%     @ 0X$_5H5YKE%1
M P  DPD  !D              ("!42(! 'AL+W=O<FMS:&5E=',O<VAE970T
M-RYX;6Q02P$"% ,4    " !#@3]6R_5C*:D%  #N(P  &0
M@('9)0$ >&PO=V]R:W-H965T<R]S:&5E=#0X+GAM;%!+ 0(4 Q0    ( $.!
M/U8JF[!MA (  -T%   9              " @;DK 0!X;"]W;W)K<VAE971S
M+W-H965T-#DN>&UL4$L! A0#%     @ 0X$_5D@"XB>9 @  J04  !D
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M=#4T+GAM;%!+ 0(4 Q0    ( $.!/U8!6F)85@<  'TO   9
M  " @<8] 0!X;"]W;W)K<VAE971S+W-H965T-34N>&UL4$L! A0#%     @
M0X$_5B4U%_LC!   .!<  !D              ("!4T4! 'AL+W=O<FMS:&5E
M=',O<VAE970U-BYX;6Q02P$"% ,4    " !#@3]6E6@[Y=P"  #X"0  &0
M            @(&M20$ >&PO=V]R:W-H965T<R]S:&5E=#4W+GAM;%!+ 0(4
M Q0    ( $.!/U:#J M)O@8  &@]   9              " @<!, 0!X;"]W
M;W)K<VAE971S+W-H965T-3@N>&UL4$L! A0#%     @ 0X$_5K])/1:< @
MZ@8  !D              ("!M5,! 'AL+W=O<FMS:&5E=',O<VAE970U.2YX
M;6Q02P$"% ,4    " !#@3]6@/4%""X#  "H"P  &0              @(&(
M5@$ >&PO=V]R:W-H965T<R]S:&5E=#8P+GAM;%!+ 0(4 Q0    ( $.!/U8)
M+!=)P 0  $0:   9              " @>U9 0!X;"]W;W)K<VAE971S+W-H
M965T-C$N>&UL4$L! A0#%     @ 0X$_5O"+A@E[!0  Q"0  !D
M     ("!Y%X! 'AL+W=O<FMS:&5E=',O<VAE970V,BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( $.!/U8@LGQGYP(  " +   9              "
M@<AQ 0!X;"]W;W)K<VAE971S+W-H965T-C<N>&UL4$L! A0#%     @ 0X$_
M5E9X%LCC!@  _3T  !D              ("!YG0! 'AL+W=O<FMS:&5E=',O
M<VAE970V."YX;6Q02P$"% ,4    " !#@3]6NWJ64=\$  #"%0  &0
M        @($ ? $ >&PO=V]R:W-H965T<R]S:&5E=#8Y+GAM;%!+ 0(4 Q0
M   ( $.!/U::1S*KMP(  .T&   9              " @1:! 0!X;"]W;W)K
M<VAE971S+W-H965T-S N>&UL4$L! A0#%     @ 0X$_5H[')NIQ P  C0X
M !D              ("!!(0! 'AL+W=O<FMS:&5E=',O<VAE970W,2YX;6Q0
M2P$"% ,4    " !#@3]64"_4B00&   [(0  &0              @(&LAP$
M>&PO=V]R:W-H965T<R]S:&5E=#<R+GAM;%!+ 0(4 Q0    ( $.!/U:[\]S.
M9 ,  !$,   9              " @>>- 0!X;"]W;W)K<VAE971S+W-H965T
M-S,N>&UL4$L! A0#%     @ 0X$_5M/(MK"Y @  * <  !D
M ("!@I$! 'AL+W=O<FMS:&5E=',O<VAE970W-"YX;6Q02P$"% ,4    " !#
M@3]6+IT(GH0$  !.$P  &0              @(%RE $ >&PO=V]R:W-H965T
M<R]S:&5E=#<U+GAM;%!+ 0(4 Q0    ( $.!/U;#^%1";0,  )47   -
M          "  2V9 0!X;"]S='EL97,N>&UL4$L! A0#%     @ 0X$_5I>*
MNQS     $P(   L              ( !Q9P! %]R96QS+RYR96QS4$L! A0#
M%     @ 0X$_5ETF$WCD!0  /C$   \              ( !KIT! 'AL+W=O
M<FMB;V]K+GAM;%!+ 0(4 Q0    ( $.!/U9G_%)"3 (  &@L   :
M      "  ;^C 0!X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0
M   ( $.!/U:&IF-(# (  &$K   3              "  4.F 0!;0V]N=&5N
B=%]4>7!E<UTN>&UL4$L%!@    !3 %, O!8  ("H 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>183</ContextCount>
  <ElementCount>331</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>64</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>8</UnitCount>
  <MyReports>
    <Report instance="var-20221230.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.varex.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="var-20221230.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="var-20221230.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUnaudited</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="var-20221230.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="var-20221230.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="var-20221230.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="var-20221230.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="var-20221230.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="var-20221230.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Disclosure - REVENUE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.varex.com/role/REVENUE</Role>
      <ShortName>REVENUE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="var-20221230.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - LEASES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.varex.com/role/LEASES</Role>
      <ShortName>LEASES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="var-20221230.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - RELATED PARTY TRANSACTIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.varex.com/role/RELATEDPARTYTRANSACTIONS</Role>
      <ShortName>RELATED PARTY TRANSACTIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="var-20221230.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - RESTRUCTURING</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.varex.com/role/RESTRUCTURING</Role>
      <ShortName>RESTRUCTURING</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="var-20221230.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.varex.com/role/FINANCIALDERIVATIVESANDHEDGINGACTIVITIES</Role>
      <ShortName>FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="var-20221230.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - FAIR VALUE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.varex.com/role/FAIRVALUE</Role>
      <ShortName>FAIR VALUE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="var-20221230.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - INVENTORIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.varex.com/role/INVENTORIES</Role>
      <ShortName>INVENTORIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="var-20221230.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - GOODWILL AND INTANGIBLE ASSETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.varex.com/role/GOODWILLANDINTANGIBLEASSETS</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="var-20221230.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - BORROWINGS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.varex.com/role/BORROWINGS</Role>
      <ShortName>BORROWINGS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="var-20221230.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - NONCONTROLLING INTERESTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.varex.com/role/NONCONTROLLINGINTERESTS</Role>
      <ShortName>NONCONTROLLING INTERESTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="var-20221230.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - NET INCOME PER SHARE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.varex.com/role/NETINCOMEPERSHARE</Role>
      <ShortName>NET INCOME PER SHARE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="var-20221230.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - EMPLOYEE STOCK PLANS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.varex.com/role/EMPLOYEESTOCKPLANS</Role>
      <ShortName>EMPLOYEE STOCK PLANS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="var-20221230.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - TAXES ON INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.varex.com/role/TAXESONINCOME</Role>
      <ShortName>TAXES ON INCOME</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="var-20221230.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - SEGMENT INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.varex.com/role/SEGMENTINFORMATION</Role>
      <ShortName>SEGMENT INFORMATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="var-20221230.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="var-20221230.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="var-20221230.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0000025 - Disclosure - REVENUE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.varex.com/role/REVENUETables</Role>
      <ShortName>REVENUE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.varex.com/role/REVENUE</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="var-20221230.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0000026 - Disclosure - LEASES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.varex.com/role/LEASESTables</Role>
      <ShortName>LEASES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.varex.com/role/LEASES</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="var-20221230.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0000027 - Disclosure - RESTRUCTURING (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.varex.com/role/RESTRUCTURINGTables</Role>
      <ShortName>RESTRUCTURING (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.varex.com/role/RESTRUCTURING</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="var-20221230.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0000028 - Disclosure - FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.varex.com/role/FINANCIALDERIVATIVESANDHEDGINGACTIVITIESTables</Role>
      <ShortName>FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.varex.com/role/FINANCIALDERIVATIVESANDHEDGINGACTIVITIES</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="var-20221230.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0000029 - Disclosure - FAIR VALUE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.varex.com/role/FAIRVALUETables</Role>
      <ShortName>FAIR VALUE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.varex.com/role/FAIRVALUE</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="var-20221230.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0000030 - Disclosure - INVENTORIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.varex.com/role/INVENTORIESTables</Role>
      <ShortName>INVENTORIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.varex.com/role/INVENTORIES</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="var-20221230.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0000031 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.varex.com/role/GOODWILLANDINTANGIBLEASSETSTables</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.varex.com/role/GOODWILLANDINTANGIBLEASSETS</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="var-20221230.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0000032 - Disclosure - BORROWINGS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.varex.com/role/BORROWINGSTables</Role>
      <ShortName>BORROWINGS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.varex.com/role/BORROWINGS</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="var-20221230.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>0000033 - Disclosure - NONCONTROLLING INTERESTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.varex.com/role/NONCONTROLLINGINTERESTSTables</Role>
      <ShortName>NONCONTROLLING INTERESTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.varex.com/role/NONCONTROLLINGINTERESTS</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="var-20221230.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>0000034 - Disclosure - NET INCOME PER SHARE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.varex.com/role/NETINCOMEPERSHARETables</Role>
      <ShortName>NET INCOME PER SHARE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.varex.com/role/NETINCOMEPERSHARE</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="var-20221230.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>0000035 - Disclosure - EMPLOYEE STOCK PLANS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.varex.com/role/EMPLOYEESTOCKPLANSTables</Role>
      <ShortName>EMPLOYEE STOCK PLANS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.varex.com/role/EMPLOYEESTOCKPLANS</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="var-20221230.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>0000036 - Disclosure - SEGMENT INFORMATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.varex.com/role/SEGMENTINFORMATIONTables</Role>
      <ShortName>SEGMENT INFORMATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.varex.com/role/SEGMENTINFORMATION</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="var-20221230.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>0000037 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Segment Reporting (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSegmentReportingDetails</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Segment Reporting (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="var-20221230.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>0000038 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Cash and Cash Equivalents and Restricted Cash (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESCashandCashEquivalentsandRestrictedCashDetails</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Cash and Cash Equivalents and Restricted Cash (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="var-20221230.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>0000039 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Customer Concentration Risk (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESCustomerConcentrationRiskDetails</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Customer Concentration Risk (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="var-20221230.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>0000040 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESInvestmentsDetails</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="var-20221230.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>0000041 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Product Warranty (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESProductWarrantyDetails</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Product Warranty (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="var-20221230.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>0000042 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Recently Adopted Accounting Standards (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRecentlyAdoptedAccountingStandardsDetails</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Recently Adopted Accounting Standards (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="var-20221230.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>0000043 - Disclosure - REVENUE - Disaggregation of Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.varex.com/role/REVENUEDisaggregationofRevenueDetails</Role>
      <ShortName>REVENUE - Disaggregation of Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="var-20221230.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>0000044 - Disclosure - REVENUE - Summary of Contract Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.varex.com/role/REVENUESummaryofContractAssetsandLiabilitiesDetails</Role>
      <ShortName>REVENUE - Summary of Contract Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="var-20221230.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>0000045 - Disclosure - LEASES - Narratives (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.varex.com/role/LEASESNarrativesDetails</Role>
      <ShortName>LEASES - Narratives (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="var-20221230.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>0000046 - Disclosure - LEASES - Schedule of Lease Right-of-Use Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.varex.com/role/LEASESScheduleofLeaseRightofUseAssetsandLiabilitiesDetails</Role>
      <ShortName>LEASES - Schedule of Lease Right-of-Use Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="var-20221230.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>0000047 - Disclosure - LEASES - Schedule of Operating Lease Cost and Supplemental Cash Flow Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.varex.com/role/LEASESScheduleofOperatingLeaseCostandSupplementalCashFlowInformationDetails</Role>
      <ShortName>LEASES - Schedule of Operating Lease Cost and Supplemental Cash Flow Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="var-20221230.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>0000048 - Disclosure - RELATED PARTY TRANSACTIONS - Investment in Privately-Held Companies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.varex.com/role/RELATEDPARTYTRANSACTIONSInvestmentinPrivatelyHeldCompaniesDetails</Role>
      <ShortName>RELATED PARTY TRANSACTIONS - Investment in Privately-Held Companies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="var-20221230.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>0000049 - Disclosure - RESTRUCTURING - Summary of Restructuring Cost Incurred (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.varex.com/role/RESTRUCTURINGSummaryofRestructuringCostIncurredDetails</Role>
      <ShortName>RESTRUCTURING - Summary of Restructuring Cost Incurred (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="var-20221230.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>0000050 - Disclosure - FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.varex.com/role/FINANCIALDERIVATIVESANDHEDGINGACTIVITIESNarrativeDetails</Role>
      <ShortName>FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="var-20221230.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>0000051 - Disclosure - FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES - Summary of Derivative Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.varex.com/role/FINANCIALDERIVATIVESANDHEDGINGACTIVITIESSummaryofDerivativeInstrumentsDetails</Role>
      <ShortName>FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES - Summary of Derivative Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="var-20221230.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>0000052 - Disclosure - FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES - Summary of Income Recognized From Derivative Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.varex.com/role/FINANCIALDERIVATIVESANDHEDGINGACTIVITIESSummaryofIncomeRecognizedFromDerivativeInstrumentsDetails</Role>
      <ShortName>FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES - Summary of Income Recognized From Derivative Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="var-20221230.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>0000053 - Disclosure - FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES - Summary of Derivatives at Fair Value (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.varex.com/role/FINANCIALDERIVATIVESANDHEDGINGACTIVITIESSummaryofDerivativesatFairValueDetails</Role>
      <ShortName>FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES - Summary of Derivatives at Fair Value (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="var-20221230.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>0000054 - Disclosure - FAIR VALUE - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.varex.com/role/FAIRVALUENarrativeDetails</Role>
      <ShortName>FAIR VALUE - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="var-20221230.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>0000055 - Disclosure - FAIR VALUE - Schedule of Fair Value Inputs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.varex.com/role/FAIRVALUEScheduleofFairValueInputsDetails</Role>
      <ShortName>FAIR VALUE - Schedule of Fair Value Inputs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="var-20221230.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>0000056 - Disclosure - FAIR VALUE - Summary of Marketable Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.varex.com/role/FAIRVALUESummaryofMarketableSecuritiesDetails</Role>
      <ShortName>FAIR VALUE - Summary of Marketable Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="var-20221230.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>0000057 - Disclosure - FAIR VALUE - Contractual Maturities of Marketable Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.varex.com/role/FAIRVALUEContractualMaturitiesofMarketableSecuritiesDetails</Role>
      <ShortName>FAIR VALUE - Contractual Maturities of Marketable Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="var-20221230.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>0000058 - Disclosure - FAIR VALUE - Balance Sheet Marketable Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.varex.com/role/FAIRVALUEBalanceSheetMarketableSecuritiesDetails</Role>
      <ShortName>FAIR VALUE - Balance Sheet Marketable Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="var-20221230.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>0000059 - Disclosure - INVENTORIES - Summary of Inventory (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.varex.com/role/INVENTORIESSummaryofInventoryDetails</Role>
      <ShortName>INVENTORIES - Summary of Inventory (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="var-20221230.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>0000060 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Goodwill Rollforward (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.varex.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillRollforwardDetails</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS - Goodwill Rollforward (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="var-20221230.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>0000061 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.varex.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS - Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="var-20221230.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>0000062 - Disclosure - BORROWINGS - Schedule of Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.varex.com/role/BORROWINGSScheduleofDebtDetails</Role>
      <ShortName>BORROWINGS - Schedule of Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="var-20221230.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>0000063 - Disclosure - BORROWINGS - Schedule of Interest Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.varex.com/role/BORROWINGSScheduleofInterestExpenseDetails</Role>
      <ShortName>BORROWINGS - Schedule of Interest Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="var-20221230.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>0000064 - Disclosure - BORROWINGS - Convertible Senior Unsecured Notes Narrative (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.varex.com/role/BORROWINGSConvertibleSeniorUnsecuredNotesNarrativeDetails</Role>
      <ShortName>BORROWINGS - Convertible Senior Unsecured Notes Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="var-20221230.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>0000065 - Disclosure - BORROWINGS - Call Spread Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.varex.com/role/BORROWINGSCallSpreadNarrativeDetails</Role>
      <ShortName>BORROWINGS - Call Spread Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="var-20221230.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>0000066 - Disclosure - BORROWINGS - Senior Secured Notes Narrative (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.varex.com/role/BORROWINGSSeniorSecuredNotesNarrativeDetails</Role>
      <ShortName>BORROWINGS - Senior Secured Notes Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="var-20221230.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>0000067 - Disclosure - BORROWINGS - Asset-Based Loan Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.varex.com/role/BORROWINGSAssetBasedLoanNarrativeDetails</Role>
      <ShortName>BORROWINGS - Asset-Based Loan Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="var-20221230.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>0000068 - Disclosure - NONCONTROLLING INTERESTS - Noncontrolling Interest (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.varex.com/role/NONCONTROLLINGINTERESTSNoncontrollingInterestDetails</Role>
      <ShortName>NONCONTROLLING INTERESTS - Noncontrolling Interest (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="var-20221230.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>0000069 - Disclosure - NET INCOME PER SHARE - Reconciliation of Numerator and Denominator for Basic and Diluted Net (Loss) Income Per Common Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.varex.com/role/NETINCOMEPERSHAREReconciliationofNumeratorandDenominatorforBasicandDilutedNetLossIncomePerCommonShareDetails</Role>
      <ShortName>NET INCOME PER SHARE - Reconciliation of Numerator and Denominator for Basic and Diluted Net (Loss) Income Per Common Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="var-20221230.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>0000070 - Disclosure - NET INCOME PER SHARE - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.varex.com/role/NETINCOMEPERSHARENarrativeDetails</Role>
      <ShortName>NET INCOME PER SHARE - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="var-20221230.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>0000071 - Disclosure - EMPLOYEE STOCK PLANS - Share-based Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.varex.com/role/EMPLOYEESTOCKPLANSSharebasedCompensationExpenseDetails</Role>
      <ShortName>EMPLOYEE STOCK PLANS - Share-based Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="var-20221230.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>0000072 - Disclosure - EMPLOYEE STOCK PLANS - Stock Option Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.varex.com/role/EMPLOYEESTOCKPLANSStockOptionActivityDetails</Role>
      <ShortName>EMPLOYEE STOCK PLANS - Stock Option Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="var-20221230.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>0000073 - Disclosure - EMPLOYEE STOCK PLANS - Restricted Stock and Performance Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.varex.com/role/EMPLOYEESTOCKPLANSRestrictedStockandPerformanceStockDetails</Role>
      <ShortName>EMPLOYEE STOCK PLANS - Restricted Stock and Performance Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="var-20221230.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>0000074 - Disclosure - TAXES ON INCOME (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.varex.com/role/TAXESONINCOMEDetails</Role>
      <ShortName>TAXES ON INCOME (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.varex.com/role/TAXESONINCOME</ParentRole>
      <Position>74</Position>
    </Report>
    <Report instance="var-20221230.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>0000075 - Disclosure - SEGMENT INFORMATION - Income Statement Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.varex.com/role/SEGMENTINFORMATIONIncomeStatementInformationDetails</Role>
      <ShortName>SEGMENT INFORMATION - Income Statement Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="var-20221230.htm">var-20221230.htm</File>
    <File>var-20221230.xsd</File>
    <File>var-20221230_cal.xml</File>
    <File>var-20221230_def.xml</File>
    <File>var-20221230_lab.xml</File>
    <File>var-20221230_pre.xml</File>
    <File>varexq123exhibit311.htm</File>
    <File>varexq123exhibit312.htm</File>
    <File>varexq123exhibit321.htm</File>
    <File>varexq123exhibit322.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>var-20221230_g1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="758">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="29">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>93
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "var-20221230.htm": {
   "axisCustom": 0,
   "axisStandard": 28,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2022": 758,
    "http://xbrl.sec.gov/dei/2022": 29
   },
   "contextCount": 183,
   "dts": {
    "calculationLink": {
     "local": [
      "var-20221230_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "var-20221230_def.xml"
     ]
    },
    "inline": {
     "local": [
      "var-20221230.htm"
     ]
    },
    "labelLink": {
     "local": [
      "var-20221230_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "var-20221230_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "var-20221230.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 537,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 11,
    "http://xbrl.sec.gov/dei/2022": 5,
    "total": 16
   },
   "keyCustom": 35,
   "keyStandard": 296,
   "memberCustom": 13,
   "memberStandard": 49,
   "nsprefix": "var",
   "nsuri": "http://www.varex.com/20221230",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.varex.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000010 - Disclosure - LEASES",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://www.varex.com/role/LEASES",
     "shortName": "LEASES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000011 - Disclosure - RELATED PARTY TRANSACTIONS",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://www.varex.com/role/RELATEDPARTYTRANSACTIONS",
     "shortName": "RELATED PARTY TRANSACTIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000012 - Disclosure - RESTRUCTURING",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://www.varex.com/role/RESTRUCTURING",
     "shortName": "RESTRUCTURING",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000013 - Disclosure - FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://www.varex.com/role/FINANCIALDERIVATIVESANDHEDGINGACTIVITIES",
     "shortName": "FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000014 - Disclosure - FAIR VALUE",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://www.varex.com/role/FAIRVALUE",
     "shortName": "FAIR VALUE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000015 - Disclosure - INVENTORIES",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://www.varex.com/role/INVENTORIES",
     "shortName": "INVENTORIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000016 - Disclosure - GOODWILL AND INTANGIBLE ASSETS",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://www.varex.com/role/GOODWILLANDINTANGIBLEASSETS",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000017 - Disclosure - BORROWINGS",
     "menuCat": "Notes",
     "order": "17",
     "role": "http://www.varex.com/role/BORROWINGS",
     "shortName": "BORROWINGS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MinorityInterestDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000018 - Disclosure - NONCONTROLLING INTERESTS",
     "menuCat": "Notes",
     "order": "18",
     "role": "http://www.varex.com/role/NONCONTROLLINGINTERESTS",
     "shortName": "NONCONTROLLING INTERESTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MinorityInterestDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000019 - Disclosure - NET INCOME PER SHARE",
     "menuCat": "Notes",
     "order": "19",
     "role": "http://www.varex.com/role/NETINCOMEPERSHARE",
     "shortName": "NET INCOME PER SHARE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000002 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)",
     "menuCat": "Statements",
     "order": "2",
     "role": "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000020 - Disclosure - EMPLOYEE STOCK PLANS",
     "menuCat": "Notes",
     "order": "20",
     "role": "http://www.varex.com/role/EMPLOYEESTOCKPLANS",
     "shortName": "EMPLOYEE STOCK PLANS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000021 - Disclosure - TAXES ON INCOME",
     "menuCat": "Notes",
     "order": "21",
     "role": "http://www.varex.com/role/TAXESONINCOME",
     "shortName": "TAXES ON INCOME",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000022 - Disclosure - SEGMENT INFORMATION",
     "menuCat": "Notes",
     "order": "22",
     "role": "http://www.varex.com/role/SEGMENTINFORMATION",
     "shortName": "SEGMENT INFORMATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000023 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "menuCat": "Policies",
     "order": "23",
     "role": "http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000024 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "menuCat": "Tables",
     "order": "24",
     "role": "http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000025 - Disclosure - REVENUE (Tables)",
     "menuCat": "Tables",
     "order": "25",
     "role": "http://www.varex.com/role/REVENUETables",
     "shortName": "REVENUE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "var:AssetsAndLiabilitiesLesseeTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000026 - Disclosure - LEASES (Tables)",
     "menuCat": "Tables",
     "order": "26",
     "role": "http://www.varex.com/role/LEASESTables",
     "shortName": "LEASES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "var:AssetsAndLiabilitiesLesseeTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000027 - Disclosure - RESTRUCTURING (Tables)",
     "menuCat": "Tables",
     "order": "27",
     "role": "http://www.varex.com/role/RESTRUCTURINGTables",
     "shortName": "RESTRUCTURING (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000028 - Disclosure - FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES (Tables)",
     "menuCat": "Tables",
     "order": "28",
     "role": "http://www.varex.com/role/FINANCIALDERIVATIVESANDHEDGINGACTIVITIESTables",
     "shortName": "FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000029 - Disclosure - FAIR VALUE (Tables)",
     "menuCat": "Tables",
     "order": "29",
     "role": "http://www.varex.com/role/FAIRVALUETables",
     "shortName": "FAIR VALUE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000003 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited)",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUnaudited",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000030 - Disclosure - INVENTORIES (Tables)",
     "menuCat": "Tables",
     "order": "30",
     "role": "http://www.varex.com/role/INVENTORIESTables",
     "shortName": "INVENTORIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000031 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables)",
     "menuCat": "Tables",
     "order": "31",
     "role": "http://www.varex.com/role/GOODWILLANDINTANGIBLEASSETSTables",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000032 - Disclosure - BORROWINGS (Tables)",
     "menuCat": "Tables",
     "order": "32",
     "role": "http://www.varex.com/role/BORROWINGSTables",
     "shortName": "BORROWINGS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "var:NoncontrollingInterestTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000033 - Disclosure - NONCONTROLLING INTERESTS (Tables)",
     "menuCat": "Tables",
     "order": "33",
     "role": "http://www.varex.com/role/NONCONTROLLINGINTERESTSTables",
     "shortName": "NONCONTROLLING INTERESTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "var:NoncontrollingInterestTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000034 - Disclosure - NET INCOME PER SHARE (Tables)",
     "menuCat": "Tables",
     "order": "34",
     "role": "http://www.varex.com/role/NETINCOMEPERSHARETables",
     "shortName": "NET INCOME PER SHARE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000035 - Disclosure - EMPLOYEE STOCK PLANS (Tables)",
     "menuCat": "Tables",
     "order": "35",
     "role": "http://www.varex.com/role/EMPLOYEESTOCKPLANSTables",
     "shortName": "EMPLOYEE STOCK PLANS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000036 - Disclosure - SEGMENT INFORMATION (Tables)",
     "menuCat": "Tables",
     "order": "36",
     "role": "http://www.varex.com/role/SEGMENTINFORMATIONTables",
     "shortName": "SEGMENT INFORMATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000037 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Segment Reporting (Details)",
     "menuCat": "Details",
     "order": "37",
     "role": "http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSegmentReportingDetails",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Segment Reporting (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i97383852c2e44f9090e25f67836d6e81_I20221230",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000038 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Cash and Cash Equivalents and Restricted Cash (Details)",
     "menuCat": "Details",
     "order": "38",
     "role": "http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESCashandCashEquivalentsandRestrictedCashDetails",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Cash and Cash Equivalents and Restricted Cash (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i4026880a25c245b7ae7af90aa89cf31c_I20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i651cc3561a6c40d9a9e385495456c274_D20221001-20221230",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000039 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Customer Concentration Risk (Details)",
     "menuCat": "Details",
     "order": "39",
     "role": "http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESCustomerConcentrationRiskDetails",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Customer Concentration Risk (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i651cc3561a6c40d9a9e385495456c274_D20221001-20221230",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i97383852c2e44f9090e25f67836d6e81_I20221230",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000004 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i97383852c2e44f9090e25f67836d6e81_I20221230",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000040 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Investments (Details)",
     "menuCat": "Details",
     "order": "40",
     "role": "http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESInvestmentsDetails",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Investments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i967727602cae45adb24efc0f4e4bd947_I20220930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StandardProductWarrantyAccrual",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000041 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Product Warranty (Details)",
     "menuCat": "Details",
     "order": "41",
     "role": "http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESProductWarrantyDetails",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Product Warranty (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i967727602cae45adb24efc0f4e4bd947_I20220930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StandardProductWarrantyAccrual",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i97383852c2e44f9090e25f67836d6e81_I20221230",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AdditionalPaidInCapital",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000042 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Recently Adopted Accounting Standards (Details)",
     "menuCat": "Details",
     "order": "42",
     "role": "http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRecentlyAdoptedAccountingStandardsDetails",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Recently Adopted Accounting Standards (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i5d4da637b0cb434892a6570db3bf836d_I20221001",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:AdditionalPaidInCapital",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000043 - Disclosure - REVENUE - Disaggregation of Revenue (Details)",
     "menuCat": "Details",
     "order": "43",
     "role": "http://www.varex.com/role/REVENUEDisaggregationofRevenueDetails",
     "shortName": "REVENUE - Disaggregation of Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i77268675d9614be1856e94103b41aef3_D20221001-20221230",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i967727602cae45adb24efc0f4e4bd947_I20220930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000044 - Disclosure - REVENUE - Summary of Contract Assets and Liabilities (Details)",
     "menuCat": "Details",
     "order": "44",
     "role": "http://www.varex.com/role/REVENUESummaryofContractAssetsandLiabilitiesDetails",
     "shortName": "REVENUE - Summary of Contract Assets and Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i967727602cae45adb24efc0f4e4bd947_I20220930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GainLossOnTerminationOfLease",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000045 - Disclosure - LEASES - Narratives (Details)",
     "menuCat": "Details",
     "order": "45",
     "role": "http://www.varex.com/role/LEASESNarrativesDetails",
     "shortName": "LEASES - Narratives (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "if053d543d68e4983b97631e65183a5d1_D20211002-20220930",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:GainLossOnTerminationOfLease",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i97383852c2e44f9090e25f67836d6e81_I20221230",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000046 - Disclosure - LEASES - Schedule of Lease Right-of-Use Assets and Liabilities (Details)",
     "menuCat": "Details",
     "order": "46",
     "role": "http://www.varex.com/role/LEASESScheduleofLeaseRightofUseAssetsandLiabilitiesDetails",
     "shortName": "LEASES - Schedule of Lease Right-of-Use Assets and Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i97383852c2e44f9090e25f67836d6e81_I20221230",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseRightOfUseAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000047 - Disclosure - LEASES - Schedule of Operating Lease Cost and Supplemental Cash Flow Information (Details)",
     "menuCat": "Details",
     "order": "47",
     "role": "http://www.varex.com/role/LEASESScheduleofOperatingLeaseCostandSupplementalCashFlowInformationDetails",
     "shortName": "LEASES - Schedule of Operating Lease Cost and Supplemental Cash Flow Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "id11c0d105587406ea12579388d33acc6_I20221230",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000048 - Disclosure - RELATED PARTY TRANSACTIONS - Investment in Privately-Held Companies (Details)",
     "menuCat": "Details",
     "order": "48",
     "role": "http://www.varex.com/role/RELATEDPARTYTRANSACTIONSInvestmentinPrivatelyHeldCompaniesDetails",
     "shortName": "RELATED PARTY TRANSACTIONS - Investment in Privately-Held Companies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "id11c0d105587406ea12579388d33acc6_I20221230",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherAssetImpairmentCharges",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000049 - Disclosure - RESTRUCTURING - Summary of Restructuring Cost Incurred (Details)",
     "menuCat": "Details",
     "order": "49",
     "role": "http://www.varex.com/role/RESTRUCTURINGSummaryofRestructuringCostIncurredDetails",
     "shortName": "RESTRUCTURING - Summary of Restructuring Cost Incurred (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherAssetImpairmentCharges",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i97383852c2e44f9090e25f67836d6e81_I20221230",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000005 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i97383852c2e44f9090e25f67836d6e81_I20221230",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "var:DerivativeNumberOfInstrumentsTerminated",
      "reportCount": 1,
      "unique": true,
      "unitRef": "instrument",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000050 - Disclosure - FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES - Narrative (Details)",
     "menuCat": "Details",
     "order": "50",
     "role": "http://www.varex.com/role/FINANCIALDERIVATIVESANDHEDGINGACTIVITIESNarrativeDetails",
     "shortName": "FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "var:DerivativeNumberOfInstrumentsTerminated",
      "reportCount": 1,
      "unique": true,
      "unitRef": "instrument",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i4a06e1fd56de45429cf0fcaeadd92091_I20221230",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNumberOfInstrumentsHeld",
      "reportCount": 1,
      "unique": true,
      "unitRef": "derivativecontract",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000051 - Disclosure - FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES - Summary of Derivative Instruments (Details)",
     "menuCat": "Details",
     "order": "51",
     "role": "http://www.varex.com/role/FINANCIALDERIVATIVESANDHEDGINGACTIVITIESSummaryofDerivativeInstrumentsDetails",
     "shortName": "FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES - Summary of Derivative Instruments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i4a06e1fd56de45429cf0fcaeadd92091_I20221230",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNumberOfInstrumentsHeld",
      "reportCount": 1,
      "unique": true,
      "unitRef": "derivativecontract",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i1b3aa766e2904db9b8ab4aa605bdb4ee_D20221001-20221230",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000052 - Disclosure - FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES - Summary of Income Recognized From Derivative Instruments (Details)",
     "menuCat": "Details",
     "order": "52",
     "role": "http://www.varex.com/role/FINANCIALDERIVATIVESANDHEDGINGACTIVITIESSummaryofIncomeRecognizedFromDerivativeInstrumentsDetails",
     "shortName": "FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES - Summary of Income Recognized From Derivative Instruments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i1b3aa766e2904db9b8ab4aa605bdb4ee_D20221001-20221230",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i5c7f1146a6b1444882838f6b9709de23_I20221230",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000053 - Disclosure - FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES - Summary of Derivatives at Fair Value (Details)",
     "menuCat": "Details",
     "order": "53",
     "role": "http://www.varex.com/role/FINANCIALDERIVATIVESANDHEDGINGACTIVITIESSummaryofDerivativesatFairValueDetails",
     "shortName": "FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES - Summary of Derivatives at Fair Value (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i5c7f1146a6b1444882838f6b9709de23_I20221230",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i6c18314ffe0b4522b51d04b27d6bdac1_I20221230",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000054 - Disclosure - FAIR VALUE - Narrative (Details)",
     "menuCat": "Details",
     "order": "54",
     "role": "http://www.varex.com/role/FAIRVALUENarrativeDetails",
     "shortName": "FAIR VALUE - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i6c18314ffe0b4522b51d04b27d6bdac1_I20221230",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i488f141169664a4da02df7fb3f0314cf_I20221230",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MoneyMarketFundsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000055 - Disclosure - FAIR VALUE - Schedule of Fair Value Inputs (Details)",
     "menuCat": "Details",
     "order": "55",
     "role": "http://www.varex.com/role/FAIRVALUEScheduleofFairValueInputsDetails",
     "shortName": "FAIR VALUE - Schedule of Fair Value Inputs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i488f141169664a4da02df7fb3f0314cf_I20221230",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MoneyMarketFundsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i97383852c2e44f9090e25f67836d6e81_I20221230",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "var:MarketableSecuritiesAmortizedCost",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000056 - Disclosure - FAIR VALUE - Summary of Marketable Securities (Details)",
     "menuCat": "Details",
     "order": "56",
     "role": "http://www.varex.com/role/FAIRVALUESummaryofMarketableSecuritiesDetails",
     "shortName": "FAIR VALUE - Summary of Marketable Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i97383852c2e44f9090e25f67836d6e81_I20221230",
      "decimals": "-5",
      "lang": "en-US",
      "name": "var:MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i97383852c2e44f9090e25f67836d6e81_I20221230",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "var:MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateRollingWithinOneYearAmortizedCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000057 - Disclosure - FAIR VALUE - Contractual Maturities of Marketable Securities (Details)",
     "menuCat": "Details",
     "order": "57",
     "role": "http://www.varex.com/role/FAIRVALUEContractualMaturitiesofMarketableSecuritiesDetails",
     "shortName": "FAIR VALUE - Contractual Maturities of Marketable Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i97383852c2e44f9090e25f67836d6e81_I20221230",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "var:MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateRollingWithinOneYearAmortizedCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i97383852c2e44f9090e25f67836d6e81_I20221230",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MarketableSecurities",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000058 - Disclosure - FAIR VALUE - Balance Sheet Marketable Securities (Details)",
     "menuCat": "Details",
     "order": "58",
     "role": "http://www.varex.com/role/FAIRVALUEBalanceSheetMarketableSecuritiesDetails",
     "shortName": "FAIR VALUE - Balance Sheet Marketable Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i9fd818ca9813423087f30261388bf1ff_I20220930",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:MarketableSecurities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i97383852c2e44f9090e25f67836d6e81_I20221230",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000059 - Disclosure - INVENTORIES - Summary of Inventory (Details)",
     "menuCat": "Details",
     "order": "59",
     "role": "http://www.varex.com/role/INVENTORIESSummaryofInventoryDetails",
     "shortName": "INVENTORIES - Summary of Inventory (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i97383852c2e44f9090e25f67836d6e81_I20221230",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "ida04e40f3374405faf2b86c9faa3beae_I20211001",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited)",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "ief1f6f644eea437e9b8e1e8aa59dc455_D20211002-20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i967727602cae45adb24efc0f4e4bd947_I20220930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000060 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Goodwill Rollforward (Details)",
     "menuCat": "Details",
     "order": "60",
     "role": "http://www.varex.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillRollforwardDetails",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS - Goodwill Rollforward (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:GoodwillForeignCurrencyTranslationGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i97383852c2e44f9090e25f67836d6e81_I20221230",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000061 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Intangible Assets (Details)",
     "menuCat": "Details",
     "order": "61",
     "role": "http://www.varex.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS - Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i97383852c2e44f9090e25f67836d6e81_I20221230",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i97383852c2e44f9090e25f67836d6e81_I20221230",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000062 - Disclosure - BORROWINGS - Schedule of Debt (Details)",
     "menuCat": "Details",
     "order": "62",
     "role": "http://www.varex.com/role/BORROWINGSScheduleofDebtDetails",
     "shortName": "BORROWINGS - Schedule of Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i97383852c2e44f9090e25f67836d6e81_I20221230",
      "decimals": "-5",
      "lang": "en-US",
      "name": "var:LongtermDebtExcludingCurrentMaturitiesGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "var:InterestExpenseDebtContractualInterestCoupon",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000063 - Disclosure - BORROWINGS - Schedule of Interest Expense (Details)",
     "menuCat": "Details",
     "order": "63",
     "role": "http://www.varex.com/role/BORROWINGSScheduleofInterestExpenseDetails",
     "shortName": "BORROWINGS - Schedule of Interest Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "var:InterestExpenseDebtContractualInterestCoupon",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i2ddb8748822a4dd79f1844c4e1de6408_I20221230",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000064 - Disclosure - BORROWINGS - Convertible Senior Unsecured Notes Narrative (Details)",
     "menuCat": "Details",
     "order": "64",
     "role": "http://www.varex.com/role/BORROWINGSConvertibleSeniorUnsecuredNotesNarrativeDetails",
     "shortName": "BORROWINGS - Convertible Senior Unsecured Notes Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i69f1e52e1cba4369877e4bf54fb6f0fa_I20200609",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i9d049c5854724aa9974c7beaa7a53f96_I20200605",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentConvertibleConversionPrice1",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000065 - Disclosure - BORROWINGS - Call Spread Narrative (Details)",
     "menuCat": "Details",
     "order": "65",
     "role": "http://www.varex.com/role/BORROWINGSCallSpreadNarrativeDetails",
     "shortName": "BORROWINGS - Call Spread Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i97ab3a4749584f83846ca650afd01c56_I20200604",
      "decimals": "3",
      "lang": "en-US",
      "name": "us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "id08284e24f7a44a1af87978abad620f1_I20200930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000066 - Disclosure - BORROWINGS - Senior Secured Notes Narrative (Details)",
     "menuCat": "Details",
     "order": "66",
     "role": "http://www.varex.com/role/BORROWINGSSeniorSecuredNotesNarrativeDetails",
     "shortName": "BORROWINGS - Senior Secured Notes Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "id08284e24f7a44a1af87978abad620f1_I20200930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i6c3e3d6ed3d54b1db390bab6a91c9dbc_I20221230",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000067 - Disclosure - BORROWINGS - Asset-Based Loan Narrative (Details)",
     "menuCat": "Details",
     "order": "67",
     "role": "http://www.varex.com/role/BORROWINGSAssetBasedLoanNarrativeDetails",
     "shortName": "BORROWINGS - Asset-Based Loan Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i6c3e3d6ed3d54b1db390bab6a91c9dbc_I20221230",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i6530ecc1b8854fcbb93120033ddfdde9_D20150801-20150831",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "var:BusinessAcquisitionAnnualRecurringCompensation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eurPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000068 - Disclosure - NONCONTROLLING INTERESTS - Noncontrolling Interest (Details)",
     "menuCat": "Details",
     "order": "68",
     "role": "http://www.varex.com/role/NONCONTROLLINGINTERESTSNoncontrollingInterestDetails",
     "shortName": "NONCONTROLLING INTERESTS - Noncontrolling Interest (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i6530ecc1b8854fcbb93120033ddfdde9_D20150801-20150831",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "var:BusinessAcquisitionAnnualRecurringCompensation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eurPerShare",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000069 - Disclosure - NET INCOME PER SHARE - Reconciliation of Numerator and Denominator for Basic and Diluted Net (Loss) Income Per Common Share (Details)",
     "menuCat": "Details",
     "order": "69",
     "role": "http://www.varex.com/role/NETINCOMEPERSHAREReconciliationofNumeratorandDenominatorforBasicandDilutedNetLossIncomePerCommonShareDetails",
     "shortName": "NET INCOME PER SHARE - Reconciliation of Numerator and Denominator for Basic and Diluted Net (Loss) Income Per Common Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)",
     "menuCat": "Statements",
     "order": "7",
     "role": "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i4e0cf62911af4732b7b65d582effb57a_D20200604-20200605",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentConvertibleNumberOfEquityInstruments",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000070 - Disclosure - NET INCOME PER SHARE - Narrative (Details)",
     "menuCat": "Details",
     "order": "70",
     "role": "http://www.varex.com/role/NETINCOMEPERSHARENarrativeDetails",
     "shortName": "NET INCOME PER SHARE - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000071 - Disclosure - EMPLOYEE STOCK PLANS - Share-based Compensation Expense (Details)",
     "menuCat": "Details",
     "order": "71",
     "role": "http://www.varex.com/role/EMPLOYEESTOCKPLANSSharebasedCompensationExpenseDetails",
     "shortName": "EMPLOYEE STOCK PLANS - Share-based Compensation Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i967727602cae45adb24efc0f4e4bd947_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000072 - Disclosure - EMPLOYEE STOCK PLANS - Stock Option Activity (Details)",
     "menuCat": "Details",
     "order": "72",
     "role": "http://www.varex.com/role/EMPLOYEESTOCKPLANSStockOptionActivityDetails",
     "shortName": "EMPLOYEE STOCK PLANS - Stock Option Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i967727602cae45adb24efc0f4e4bd947_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000073 - Disclosure - EMPLOYEE STOCK PLANS - Restricted Stock and Performance Stock (Details)",
     "menuCat": "Details",
     "order": "73",
     "role": "http://www.varex.com/role/EMPLOYEESTOCKPLANSRestrictedStockandPerformanceStockDetails",
     "shortName": "EMPLOYEE STOCK PLANS - Restricted Stock and Performance Stock (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i967727602cae45adb24efc0f4e4bd947_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000074 - Disclosure - TAXES ON INCOME (Details)",
     "menuCat": "Details",
     "order": "74",
     "role": "http://www.varex.com/role/TAXESONINCOMEDetails",
     "shortName": "TAXES ON INCOME (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i97383852c2e44f9090e25f67836d6e81_I20221230",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000075 - Disclosure - SEGMENT INFORMATION - Income Statement Information (Details)",
     "menuCat": "Details",
     "order": "75",
     "role": "http://www.varex.com/role/SEGMENTINFORMATIONIncomeStatementInformationDetails",
     "shortName": "SEGMENT INFORMATION - Income Statement Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "iad2fceac1bb145229d93b69339db9f19_D20221001-20221230",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "menuCat": "Notes",
     "order": "8",
     "role": "http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000009 - Disclosure - REVENUE",
     "menuCat": "Notes",
     "order": "9",
     "role": "http://www.varex.com/role/REVENUE",
     "shortName": "REVENUE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "var-20221230.htm",
      "contextRef": "i8551b2719497405385b50a14d3c3b0f4_D20221001-20221230",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 64,
   "tag": {
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "UNITED STATES"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.varex.com/role/REVENUEDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.varex.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.varex.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover page."
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.varex.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.varex.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.varex.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.varex.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r749"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.varex.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r750"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.varex.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.varex.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.varex.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.varex.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.varex.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.varex.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r747"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.varex.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.varex.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.varex.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r747"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.varex.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.varex.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r747"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.varex.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.varex.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r751"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.varex.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r747"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.varex.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r747"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.varex.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r747"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Smaller Reporting Company"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.varex.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r747"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.varex.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.varex.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r746"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.varex.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r748"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.varex.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.varex.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_AmericasMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Americas [Member]",
        "terseLabel": "Americas"
       }
      }
     },
     "localname": "AmericasMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.varex.com/role/REVENUEDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_AsiaPacificMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asia Pacific [Member]",
        "terseLabel": "APAC"
       }
      }
     },
     "localname": "AsiaPacificMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.varex.com/role/REVENUEDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": {
     "auth_ref": [
      "r216",
      "r268",
      "r275",
      "r281",
      "r361",
      "r514",
      "r515",
      "r516",
      "r527",
      "r528",
      "r559",
      "r562",
      "r564",
      "r565",
      "r620"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]",
        "terseLabel": "Cumulative Effect, Period of Adoption, Adjustment"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAxis": {
     "auth_ref": [
      "r216",
      "r268",
      "r275",
      "r281",
      "r361",
      "r514",
      "r515",
      "r516",
      "r527",
      "r528",
      "r559",
      "r562",
      "r564",
      "r565",
      "r620"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Axis]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Axis]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionDomain": {
     "auth_ref": [
      "r216",
      "r268",
      "r275",
      "r281",
      "r361",
      "r514",
      "r515",
      "r516",
      "r527",
      "r528",
      "r559",
      "r562",
      "r564",
      "r565",
      "r620"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Domain]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Domain]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Domain]",
        "terseLabel": "Investment, Name [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvesteeNameDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.varex.com/role/RELATEDPARTYTRANSACTIONSInvestmentinPrivatelyHeldCompaniesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r348",
      "r728",
      "r805",
      "r833"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Axis]",
        "terseLabel": "Customer [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESCustomerConcentrationRiskDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r396",
      "r397",
      "r398",
      "r399",
      "r477",
      "r633",
      "r663",
      "r704",
      "r705",
      "r724",
      "r738",
      "r745",
      "r802",
      "r821",
      "r822",
      "r823",
      "r824",
      "r825",
      "r826"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.varex.com/role/EMPLOYEESTOCKPLANSStockOptionActivityDetails",
      "http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESProductWarrantyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r396",
      "r397",
      "r398",
      "r399",
      "r477",
      "r633",
      "r663",
      "r704",
      "r705",
      "r724",
      "r738",
      "r745",
      "r802",
      "r821",
      "r822",
      "r823",
      "r824",
      "r825",
      "r826"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.varex.com/role/BORROWINGSAssetBasedLoanNarrativeDetails",
      "http://www.varex.com/role/EMPLOYEESTOCKPLANSStockOptionActivityDetails",
      "http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESProductWarrantyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r348",
      "r728",
      "r805",
      "r833"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Domain]",
        "terseLabel": "Customer [Domain]"
       }
      }
     },
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESCustomerConcentrationRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_OwnershipAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Axis]",
        "terseLabel": "Ownership [Axis]"
       }
      }
     },
     "localname": "OwnershipAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.varex.com/role/NONCONTROLLINGINTERESTSNoncontrollingInterestDetails",
      "http://www.varex.com/role/RELATEDPARTYTRANSACTIONSInvestmentinPrivatelyHeldCompaniesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_OwnershipDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Domain]",
        "terseLabel": "Ownership [Domain]"
       }
      }
     },
     "localname": "OwnershipDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.varex.com/role/NONCONTROLLINGINTERESTSNoncontrollingInterestDetails",
      "http://www.varex.com/role/RELATEDPARTYTRANSACTIONSInvestmentinPrivatelyHeldCompaniesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r396",
      "r397",
      "r398",
      "r399",
      "r469",
      "r477",
      "r506",
      "r507",
      "r508",
      "r632",
      "r633",
      "r663",
      "r704",
      "r705",
      "r724",
      "r738",
      "r745",
      "r799",
      "r802",
      "r822",
      "r823",
      "r824",
      "r825",
      "r826"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.varex.com/role/BORROWINGSAssetBasedLoanNarrativeDetails",
      "http://www.varex.com/role/EMPLOYEESTOCKPLANSStockOptionActivityDetails",
      "http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESProductWarrantyDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r396",
      "r397",
      "r398",
      "r399",
      "r469",
      "r477",
      "r506",
      "r507",
      "r508",
      "r632",
      "r633",
      "r663",
      "r704",
      "r705",
      "r724",
      "r738",
      "r745",
      "r799",
      "r802",
      "r822",
      "r823",
      "r824",
      "r825",
      "r826"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.varex.com/role/BORROWINGSAssetBasedLoanNarrativeDetails",
      "http://www.varex.com/role/EMPLOYEESTOCKPLANSStockOptionActivityDetails",
      "http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESProductWarrantyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioForecastMember": {
     "auth_ref": [
      "r478",
      "r779"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forecast [Member]",
        "terseLabel": "Scenario, Forecast"
       }
      }
     },
     "localname": "ScenarioForecastMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.varex.com/role/RELATEDPARTYTRANSACTIONSInvestmentinPrivatelyHeldCompaniesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r281",
      "r478",
      "r752",
      "r779"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Domain]",
        "terseLabel": "Scenario [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.varex.com/role/RELATEDPARTYTRANSACTIONSInvestmentinPrivatelyHeldCompaniesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "auth_ref": [
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Axis]",
        "terseLabel": "Investment, Name [Axis]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.varex.com/role/RELATEDPARTYTRANSACTIONSInvestmentinPrivatelyHeldCompaniesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r345",
      "r346",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r727",
      "r744",
      "r805"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.varex.com/role/REVENUEDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r345",
      "r346",
      "r692",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r727",
      "r744",
      "r805"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.varex.com/role/REVENUEDisaggregationofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r281",
      "r478",
      "r752",
      "r753",
      "r779"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]",
        "terseLabel": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.varex.com/role/RELATEDPARTYTRANSACTIONSInvestmentinPrivatelyHeldCompaniesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingStandardsUpdate202006Member": {
     "auth_ref": [
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2020-06 Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity's Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity's Own Equity.",
        "label": "Accounting Standards Update 2020-06 [Member]",
        "terseLabel": "Accounting Standards Update 2020-06"
       }
      }
     },
     "localname": "AccountingStandardsUpdate202006Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRecentlyAdoptedAccountingStandardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingStandardsUpdateExtensibleList": {
     "auth_ref": [
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r269",
      "r270",
      "r271",
      "r353",
      "r354",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r514",
      "r515",
      "r516",
      "r527",
      "r528",
      "r539",
      "r540",
      "r541",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r597",
      "r598",
      "r602",
      "r603",
      "r604",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r778"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates amendment to accounting standards.",
        "label": "Accounting Standards Update [Extensible Enumeration]",
        "terseLabel": "Accounting Standards Update [Extensible List]"
       }
      }
     },
     "localname": "AccountingStandardsUpdateExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r15",
      "r743"
     ],
     "calculation": {
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent": {
     "auth_ref": [
      "r181",
      "r193",
      "r208",
      "r774"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount for accounts payable to related parties.",
        "label": "Accounts Payable, Related Parties",
        "terseLabel": "Accounts payable, related parties"
       }
      }
     },
     "localname": "AccountsPayableRelatedPartiesCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/RELATEDPARTYTRANSACTIONSInvestmentinPrivatelyHeldCompaniesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableMember": {
     "auth_ref": [
      "r693"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold.",
        "label": "Accounts Receivable [Member]",
        "terseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "AccountsReceivableMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESCustomerConcentrationRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r350",
      "r351"
     ],
     "calculation": {
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net of allowance for credit losses of $0.4\u00a0million and $0.6\u00a0million at December\u00a030, 2022 and September\u00a030, 2022, respectively"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r19"
     ],
     "calculation": {
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued liabilities and other current liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r30",
      "r32",
      "r33",
      "r231",
      "r658",
      "r671",
      "r675"
     ],
     "calculation": {
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r29",
      "r33",
      "r142",
      "r622",
      "r666",
      "r667",
      "r761",
      "r762",
      "r763",
      "r775",
      "r776",
      "r777"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "verboseLabel": "Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r7",
      "r743"
     ],
     "calculation": {
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "negatedTerseLabel": "Additional paid-in capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRecentlyAdoptedAccountingStandardsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r514",
      "r515",
      "r516",
      "r775",
      "r776",
      "r777",
      "r813"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r269",
      "r270",
      "r271",
      "r272",
      "r281",
      "r353",
      "r354",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r514",
      "r515",
      "r516",
      "r525",
      "r526",
      "r527",
      "r528",
      "r539",
      "r540",
      "r541",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r597",
      "r598",
      "r602",
      "r603",
      "r604",
      "r605",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r637",
      "r638",
      "r639",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by amendment to accounting standards.",
        "label": "Accounting Standards Update [Axis]",
        "terseLabel": "Adjustments for New Accounting Pronouncements [Axis]"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRecentlyAdoptedAccountingStandardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r127",
      "r128",
      "r480"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income to net cash (used in) provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r510"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-Based Payment Arrangement, Expense",
        "terseLabel": "Total share-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/EMPLOYEESTOCKPLANSSharebasedCompensationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivable": {
     "auth_ref": [
      "r232",
      "r352",
      "r364",
      "r365",
      "r367"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable.",
        "label": "Accounts Receivable, Allowance for Credit Loss",
        "terseLabel": "Accounts receivable, allowance for doubtful accounts"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfDebtDiscountPremium": {
     "auth_ref": [
      "r46",
      "r56",
      "r177",
      "r433"
     ],
     "calculation": {
      "http://www.varex.com/role/BORROWINGSScheduleofInterestExpenseDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InterestExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.",
        "label": "Amortization of Debt Discount (Premium)",
        "terseLabel": "Amortization of debt discounts"
       }
      }
     },
     "localname": "AmortizationOfDebtDiscountPremium",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/BORROWINGSScheduleofInterestExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfDeferredLoanOriginationFeesNet": {
     "auth_ref": [
      "r81",
      "r769"
     ],
     "calculation": {
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net increase(decrease) in interest income during the period representing the allocation of deferred loan origination fees less deferred loan origination costs using the effective interest method over the term of the debt arrangement to which they pertain taking into account the effect of prepayments.",
        "label": "Amortization of Deferred Loan Origination Fees, Net",
        "negatedTerseLabel": "Amortization of deferred loan costs"
       }
      }
     },
     "localname": "AmortizationOfDeferredLoanOriginationFeesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "auth_ref": [
      "r39",
      "r433",
      "r600",
      "r769"
     ],
     "calculation": {
      "http://www.varex.com/role/BORROWINGSScheduleofInterestExpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InterestExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs",
        "verboseLabel": "Amortization of debt issuance costs"
       }
      }
     },
     "localname": "AmortizationOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/BORROWINGSScheduleofInterestExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r56",
      "r90",
      "r95"
     ],
     "calculation": {
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization of intangible assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited",
      "http://www.varex.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r299"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Anti-dilutive shares (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/NETINCOMEPERSHAREReconciliationofNumeratorandDenominatorforBasicandDilutedNetLossIncomePerCommonShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r67"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/NETINCOMEPERSHAREReconciliationofNumeratorandDenominatorforBasicandDilutedNetLossIncomePerCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/NETINCOMEPERSHARENarrativeDetails",
      "http://www.varex.com/role/NETINCOMEPERSHAREReconciliationofNumeratorandDenominatorforBasicandDilutedNetLossIncomePerCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r67"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/NETINCOMEPERSHAREReconciliationofNumeratorandDenominatorforBasicandDilutedNetLossIncomePerCommonShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r187",
      "r202",
      "r227",
      "r261",
      "r322",
      "r334",
      "r340",
      "r357",
      "r400",
      "r401",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r409",
      "r410",
      "r543",
      "r547",
      "r578",
      "r743",
      "r800",
      "r801",
      "r819"
     ],
     "calculation": {
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.varex.com/role/FAIRVALUEScheduleofFairValueInputsDetails",
      "http://www.varex.com/role/LEASESScheduleofLeaseRightofUseAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r221",
      "r234",
      "r261",
      "r357",
      "r400",
      "r401",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r409",
      "r410",
      "r543",
      "r547",
      "r578",
      "r743",
      "r800",
      "r801",
      "r819"
     ],
     "calculation": {
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r170"
     ],
     "calculation": {
      "http://www.varex.com/role/FAIRVALUEScheduleofFairValueInputsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "totalLabel": "Total assets measured at fair value"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/FAIRVALUEScheduleofFairValueInputsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisRollingMaturityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Rolling Maturity [Abstract]",
        "terseLabel": "Amortized Costs"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisRollingMaturityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/FAIRVALUEContractualMaturitiesofMarketableSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Fair Value, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/FAIRVALUEContractualMaturitiesofMarketableSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/FAIRVALUEBalanceSheetMarketableSecuritiesDetails",
      "http://www.varex.com/role/FINANCIALDERIVATIVESANDHEDGINGACTIVITIESSummaryofDerivativesatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r155",
      "r159"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/FAIRVALUEBalanceSheetMarketableSecuritiesDetails",
      "http://www.varex.com/role/FINANCIALDERIVATIVESANDHEDGINGACTIVITIESSummaryofDerivativesatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r538",
      "r736",
      "r737"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/NONCONTROLLINGINTERESTSNoncontrollingInterestDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r132",
      "r133",
      "r538",
      "r736",
      "r737"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/NONCONTROLLINGINTERESTSNoncontrollingInterestDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": {
     "auth_ref": [
      "r131"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.",
        "label": "Business Acquisition, Percentage of Voting Interests Acquired",
        "terseLabel": "Percentage of voting interests acquired"
       }
      }
     },
     "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/NONCONTROLLINGINTERESTSNoncontrollingInterestDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r58",
      "r223",
      "r706"
     ],
     "calculation": {
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESCashandCashEquivalentsandRestrictedCashDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents",
        "verboseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESCashandCashEquivalentsandRestrictedCashDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents [Member]",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/FAIRVALUEBalanceSheetMarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": {
     "auth_ref": [
      "r59",
      "r186"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.",
        "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalents, Restricted Cash"
       }
      }
     },
     "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r53",
      "r58",
      "r64"
     ],
     "calculation": {
      "http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESCashandCashEquivalentsandRestrictedCashDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents and restricted cash at end of period",
        "periodStartLabel": "Cash and cash equivalents and restricted cash at beginning of period",
        "totalLabel": "Total as presented in the Condensed Consolidated Statements of Cash Flows"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited",
      "http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESCashandCashEquivalentsandRestrictedCashDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r53",
      "r176"
     ],
     "calculation": {
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net (decrease) increase in cash and cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ChangeInContractWithCustomerAssetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Contract with Customer, Asset [Abstract]",
        "terseLabel": "Contract Assets"
       }
      }
     },
     "localname": "ChangeInContractWithCustomerAssetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/REVENUESummaryofContractAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ChangeInContractWithCustomerLiabilityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Contract with Customer, Liability [Abstract]",
        "terseLabel": "Refund Liabilities"
       }
      }
     },
     "localname": "ChangeInContractWithCustomerLiabilityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/REVENUESummaryofContractAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "auth_ref": [
      "r441"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "terseLabel": "Warrant exercise price (in USD per share)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/BORROWINGSCallSpreadNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r106"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial paper"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/FAIRVALUEBalanceSheetMarketableSecuritiesDetails",
      "http://www.varex.com/role/FAIRVALUESummaryofMarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": {
     "auth_ref": [
      "r103",
      "r694"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.",
        "label": "Commitments and Contingencies, Policy [Policy Text Block]",
        "terseLabel": "Loss Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r775",
      "r776",
      "r813"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value per share (in USD per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares, issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r6",
      "r112"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Common stock, shares, outstanding, ending balance (in shares)",
        "periodStartLabel": "Common stock, shares, outstanding, beginning balance (in shares)",
        "terseLabel": "Common stock, shares, outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical",
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValueOutstanding": {
     "auth_ref": [
      "r6"
     ],
     "calculation": {
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of all classes of common stock held by shareholders. May be all or portion of the number of common shares authorized. These shares exclude common shares repurchased by the entity and held as treasury shares.",
        "label": "Common Stock, Value, Outstanding",
        "terseLabel": "Common stock, $.01 par value: 150,000,000 shares authorized Shares issued and outstanding: 40,087,100 and 40,085,126 at December\u00a030, 2022 and September\u00a030, 2022, respectively"
       }
      }
     },
     "localname": "CommonStockValueOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r34",
      "r242",
      "r244",
      "r250",
      "r655",
      "r660"
     ],
     "calculation": {
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income attributable to Varex"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r139",
      "r146",
      "r242",
      "r244",
      "r249",
      "r654",
      "r659"
     ],
     "calculation": {
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Total comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r70",
      "r71",
      "r173",
      "r174",
      "r348",
      "r693"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESCustomerConcentrationRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r70",
      "r71",
      "r173",
      "r174",
      "r348",
      "r676",
      "r693"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESCustomerConcentrationRiskDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r70",
      "r71",
      "r173",
      "r174",
      "r348",
      "r693",
      "r834"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESCustomerConcentrationRiskDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r200",
      "r307"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "terseLabel": "Concentration of Risk"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Concentration Risk [Line Items]",
        "terseLabel": "Concentration Risk [Line Items]"
       }
      }
     },
     "localname": "ConcentrationRiskLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESCustomerConcentrationRiskDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r70",
      "r71",
      "r173",
      "r174",
      "r348"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Concentration risk, percentage"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESCustomerConcentrationRiskDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTable": {
     "auth_ref": [
      "r68",
      "r70",
      "r71",
      "r72",
      "r173",
      "r175",
      "r693"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.",
        "label": "Concentration Risk [Table]",
        "terseLabel": "Concentration Risk [Table]"
       }
      }
     },
     "localname": "ConcentrationRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESCustomerConcentrationRiskDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r70",
      "r71",
      "r173",
      "r174",
      "r348",
      "r693"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESCustomerConcentrationRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r140",
      "r712"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": {
     "auth_ref": [
      "r804"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.",
        "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]",
        "terseLabel": "Summary of Contract Asset and Liabilities"
       }
      }
     },
     "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/REVENUETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerAssetCreditLossExpense": {
     "auth_ref": [
      "r366",
      "r463",
      "r725"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
        "label": "Contract with Customer, Asset, Credit Loss Expense (Reversal)",
        "negatedTerseLabel": "Costs recovered from product returns during the period"
       }
      }
     },
     "localname": "ContractWithCustomerAssetCreditLossExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/REVENUESummaryofContractAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerAssetNet": {
     "auth_ref": [
      "r443",
      "r445",
      "r465"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
        "label": "Contract with Customer, Asset, after Allowance for Credit Loss",
        "periodEndLabel": "Balance at end of period",
        "periodStartLabel": "Balance at beginning of period"
       }
      }
     },
     "localname": "ContractWithCustomerAssetNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/REVENUESummaryofContractAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r443",
      "r444",
      "r465"
     ],
     "calculation": {
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "terseLabel": "Deferred revenues"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "auth_ref": [
      "r466"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "terseLabel": "Contract with customer, liability, revenue recognized"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/REVENUESummaryofContractAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerRefundLiability": {
     "auth_ref": [
      "r806"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability for consideration received or receivable from customer which is not included in transaction price, when consideration is expected to be refunded to customer.",
        "label": "Contract with Customer, Refund Liability",
        "periodEndLabel": "Balance at end of period",
        "periodStartLabel": "Balance at beginning of period"
       }
      }
     },
     "localname": "ContractWithCustomerRefundLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/REVENUESummaryofContractAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleDebtMember": {
     "auth_ref": [
      "r108",
      "r411",
      "r412",
      "r423",
      "r424",
      "r425",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.",
        "label": "Convertible Debt [Member]",
        "terseLabel": "Convertible Debt"
       }
      }
     },
     "localname": "ConvertibleDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/BORROWINGSCallSpreadNarrativeDetails",
      "http://www.varex.com/role/BORROWINGSConvertibleSeniorUnsecuredNotesNarrativeDetails",
      "http://www.varex.com/role/BORROWINGSScheduleofDebtDetails",
      "http://www.varex.com/role/FAIRVALUENarrativeDetails",
      "http://www.varex.com/role/NETINCOMEPERSHARENarrativeDetails",
      "http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRecentlyAdoptedAccountingStandardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConvertibleDebtSecuritiesMember": {
     "auth_ref": [
      "r807"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities that can be exchanged for equity of the debt issuer at the option of the issuer or the holder.",
        "label": "Convertible Debt Securities [Member]",
        "terseLabel": "Convertible notes"
       }
      }
     },
     "localname": "ConvertibleDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/NETINCOMEPERSHAREReconciliationofNumeratorandDenominatorforBasicandDilutedNetLossIncomePerCommonShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateBondSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes information about long-term debt securities that are issued by either a domestic or foreign corporate business entity with a date certain promise of repayment and a return to the holder for the time value of money (for example, variable or fixed interest, original issue discount).",
        "label": "Corporate Bond Securities [Member]",
        "terseLabel": "Corporate notes/bonds"
       }
      }
     },
     "localname": "CorporateBondSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/FAIRVALUEBalanceSheetMarketableSecuritiesDetails",
      "http://www.varex.com/role/FAIRVALUESummaryofMarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r42",
      "r635"
     ],
     "calculation": {
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of revenues"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of revenues"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/EMPLOYEESTOCKPLANSSharebasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/BORROWINGSAssetBasedLoanNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/BORROWINGSAssetBasedLoanNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CrossCurrencyInterestRateContractMember": {
     "auth_ref": [
      "r807",
      "r812"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to interest rates and foreign exchange rates.",
        "label": "Cross Currency Interest Rate Contract [Member]",
        "terseLabel": "Cross currency swap contracts"
       }
      }
     },
     "localname": "CrossCurrencyInterestRateContractMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/FINANCIALDERIVATIVESANDHEDGINGACTIVITIESSummaryofDerivativeInstrumentsDetails",
      "http://www.varex.com/role/FINANCIALDERIVATIVESANDHEDGINGACTIVITIESSummaryofDerivativesatFairValueDetails",
      "http://www.varex.com/role/FINANCIALDERIVATIVESANDHEDGINGACTIVITIESSummaryofIncomeRecognizedFromDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "auth_ref": [
      "r69",
      "r348"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.",
        "label": "Customer Concentration Risk [Member]",
        "terseLabel": "Customer concentration risk"
       }
      }
     },
     "localname": "CustomerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESCustomerConcentrationRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtConversionConvertedInstrumentSharesIssued1": {
     "auth_ref": [
      "r61",
      "r63"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or payments in the period.",
        "label": "Debt Conversion, Converted Instrument, Shares Issued",
        "terseLabel": "Initial conversion rate (in shares)"
       }
      }
     },
     "localname": "DebtConversionConvertedInstrumentSharesIssued1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/BORROWINGSConvertibleSeniorUnsecuredNotesNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r111",
      "r260",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r427",
      "r434",
      "r435",
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "BORROWINGS"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/BORROWINGS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r1",
      "r2",
      "r3",
      "r188",
      "r189",
      "r201",
      "r264",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r417",
      "r423",
      "r424",
      "r425",
      "r426",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r601",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723",
      "r771"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/BORROWINGSAssetBasedLoanNarrativeDetails",
      "http://www.varex.com/role/BORROWINGSCallSpreadNarrativeDetails",
      "http://www.varex.com/role/BORROWINGSConvertibleSeniorUnsecuredNotesNarrativeDetails",
      "http://www.varex.com/role/BORROWINGSScheduleofDebtDetails",
      "http://www.varex.com/role/BORROWINGSSeniorSecuredNotesNarrativeDetails",
      "http://www.varex.com/role/NETINCOMEPERSHARENarrativeDetails",
      "http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRecentlyAdoptedAccountingStandardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent": {
     "auth_ref": [
      "r109"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying amount of the equity component of convertible debt which may be settled in cash upon conversion.",
        "label": "Debt Instrument, Convertible, Carrying Amount of Equity Component",
        "terseLabel": "Equity component of convertible senior unsecured notes"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/BORROWINGSScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionPrice1": {
     "auth_ref": [
      "r110",
      "r413"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The price per share of the conversion feature embedded in the debt instrument.",
        "label": "Debt Instrument, Convertible, Conversion Price",
        "terseLabel": "Conversion price (in USD per share)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionPrice1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/BORROWINGSCallSpreadNarrativeDetails",
      "http://www.varex.com/role/BORROWINGSConvertibleSeniorUnsecuredNotesNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments": {
     "auth_ref": [
      "r22",
      "r113",
      "r114",
      "r116",
      "r413"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity instruments that the holder of the debt instrument would receive if the debt was converted to equity.",
        "label": "Debt Instrument, Convertible, Number of Equity Instruments",
        "terseLabel": "Number of equity instruments for convertible debt"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleNumberOfEquityInstruments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/BORROWINGSCallSpreadNarrativeDetails",
      "http://www.varex.com/role/BORROWINGSConvertibleSeniorUnsecuredNotesNarrativeDetails",
      "http://www.varex.com/role/NETINCOMEPERSHARENarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r178",
      "r180",
      "r411",
      "r601",
      "r720",
      "r721"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Face amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/BORROWINGSConvertibleSeniorUnsecuredNotesNarrativeDetails",
      "http://www.varex.com/role/BORROWINGSSeniorSecuredNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r21",
      "r412"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Contractual Interest Rate",
        "verboseLabel": "Contractual interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/BORROWINGSConvertibleSeniorUnsecuredNotesNarrativeDetails",
      "http://www.varex.com/role/BORROWINGSScheduleofDebtDetails",
      "http://www.varex.com/role/BORROWINGSSeniorSecuredNotesNarrativeDetails",
      "http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRecentlyAdoptedAccountingStandardsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/BORROWINGSAssetBasedLoanNarrativeDetails",
      "http://www.varex.com/role/BORROWINGSCallSpreadNarrativeDetails",
      "http://www.varex.com/role/BORROWINGSConvertibleSeniorUnsecuredNotesNarrativeDetails",
      "http://www.varex.com/role/BORROWINGSScheduleofDebtDetails",
      "http://www.varex.com/role/BORROWINGSSeniorSecuredNotesNarrativeDetails",
      "http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRecentlyAdoptedAccountingStandardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r23",
      "r264",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r417",
      "r423",
      "r424",
      "r425",
      "r426",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r601",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723",
      "r771"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/BORROWINGSAssetBasedLoanNarrativeDetails",
      "http://www.varex.com/role/BORROWINGSCallSpreadNarrativeDetails",
      "http://www.varex.com/role/BORROWINGSConvertibleSeniorUnsecuredNotesNarrativeDetails",
      "http://www.varex.com/role/BORROWINGSScheduleofDebtDetails",
      "http://www.varex.com/role/BORROWINGSSeniorSecuredNotesNarrativeDetails",
      "http://www.varex.com/role/NETINCOMEPERSHARENarrativeDetails",
      "http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRecentlyAdoptedAccountingStandardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r23",
      "r113",
      "r115",
      "r116",
      "r117",
      "r177",
      "r178",
      "r180",
      "r199",
      "r264",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r417",
      "r423",
      "r424",
      "r425",
      "r426",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r436",
      "r601",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723",
      "r771"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/BORROWINGSAssetBasedLoanNarrativeDetails",
      "http://www.varex.com/role/BORROWINGSCallSpreadNarrativeDetails",
      "http://www.varex.com/role/BORROWINGSConvertibleSeniorUnsecuredNotesNarrativeDetails",
      "http://www.varex.com/role/BORROWINGSScheduleofDebtDetails",
      "http://www.varex.com/role/BORROWINGSSeniorSecuredNotesNarrativeDetails",
      "http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRecentlyAdoptedAccountingStandardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscount": {
     "auth_ref": [
      "r177",
      "r180",
      "r803"
     ],
     "calculation": {
      "http://www.varex.com/role/BORROWINGSScheduleofDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount.",
        "label": "Debt Instrument, Unamortized Discount",
        "negatedTerseLabel": "Unamortized discount"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/BORROWINGSScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet": {
     "auth_ref": [
      "r179",
      "r423",
      "r438",
      "r720",
      "r721"
     ],
     "calculation": {
      "http://www.varex.com/role/BORROWINGSScheduleofDebtDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unamortized debt discount (premium) and debt issuance costs.",
        "label": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net",
        "negatedTotalLabel": "Unamortized issuance costs and debt discounts, total"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/BORROWINGSScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net [Abstract]",
        "terseLabel": "Unamortized issuance costs and debt discounts"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/BORROWINGSScheduleofDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredCompensationPlanAssets": {
     "auth_ref": [
      "r757"
     ],
     "calculation": {
      "http://www.varex.com/role/FAIRVALUEScheduleofFairValueInputsDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of assets held under deferred compensation agreements.",
        "label": "Deferred Compensation Plan Assets",
        "terseLabel": "Deferred compensation plan"
       }
      }
     },
     "localname": "DeferredCompensationPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/FAIRVALUEScheduleofFairValueInputsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFinanceCostsNet": {
     "auth_ref": [
      "r179",
      "r803"
     ],
     "calculation": {
      "http://www.varex.com/role/BORROWINGSScheduleofDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Net",
        "negatedTerseLabel": "Unamortized issuance costs"
       }
      }
     },
     "localname": "DeferredFinanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/BORROWINGSScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r518",
      "r519"
     ],
     "calculation": {
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Deferred tax assets"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRecentlyAdoptedAccountingStandardsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r56",
      "r130",
      "r524",
      "r531",
      "r532",
      "r773"
     ],
     "calculation": {
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r518",
      "r519"
     ],
     "calculation": {
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings": {
     "auth_ref": [
      "r809"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from undistributed earnings of subsidiary and other recognized entity not within country of domicile. Includes, but is not limited to, other basis differences.",
        "label": "Deferred Tax Liabilities, Undistributed Foreign Earnings",
        "terseLabel": "Deferred tax liabilities of undistributed foreign earnings"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesUndistributedForeignEarnings",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r56",
      "r97"
     ],
     "calculation": {
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration": {
     "auth_ref": [
      "r549"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes derivative asset.",
        "label": "Derivative Asset, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Derivative Asset, Statement of Financial Position [Extensible Enumeration]"
       }
      }
     },
     "localname": "DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/FAIRVALUEScheduleofFairValueInputsDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_DerivativeAssets": {
     "auth_ref": [
      "r236",
      "r237",
      "r577",
      "r711"
     ],
     "calculation": {
      "http://www.varex.com/role/FAIRVALUEScheduleofFairValueInputsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Asset",
        "terseLabel": "Derivative assets"
       }
      }
     },
     "localname": "DerivativeAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/FAIRVALUEScheduleofFairValueInputsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeCashReceivedOnHedge": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash received during the period on settlement of a hedge.",
        "label": "Derivative, Cash Received on Hedge",
        "terseLabel": "Derivative, cash received on hedge"
       }
      }
     },
     "localname": "DerivativeCashReceivedOnHedge",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/FINANCIALDERIVATIVESANDHEDGINGACTIVITIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/FINANCIALDERIVATIVESANDHEDGINGACTIVITIESSummaryofDerivativeInstrumentsDetails",
      "http://www.varex.com/role/FINANCIALDERIVATIVESANDHEDGINGACTIVITIESSummaryofDerivativesatFairValueDetails",
      "http://www.varex.com/role/FINANCIALDERIVATIVESANDHEDGINGACTIVITIESSummaryofIncomeRecognizedFromDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeAsset": {
     "auth_ref": [
      "r27",
      "r157",
      "r184",
      "r235",
      "r711"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.",
        "label": "Derivative Asset, Subject to Master Netting Arrangement, before Offset",
        "terseLabel": "Derivative assets fair value, gross"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/FINANCIALDERIVATIVESANDHEDGINGACTIVITIESSummaryofDerivativesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeLiability": {
     "auth_ref": [
      "r27",
      "r157",
      "r184",
      "r235",
      "r711"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.",
        "label": "Derivative Liability, Subject to Master Netting Arrangement, before Offset",
        "verboseLabel": "Derivative liabilities fair value, gross"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/FINANCIALDERIVATIVESANDHEDGINGACTIVITIESSummaryofDerivativesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r156",
      "r158",
      "r162",
      "r164",
      "r711"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/FINANCIALDERIVATIVESANDHEDGINGACTIVITIESSummaryofDerivativeInstrumentsDetails",
      "http://www.varex.com/role/FINANCIALDERIVATIVESANDHEDGINGACTIVITIESSummaryofDerivativesatFairValueDetails",
      "http://www.varex.com/role/FINANCIALDERIVATIVESANDHEDGINGACTIVITIESSummaryofIncomeRecognizedFromDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r169",
      "r555"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "terseLabel": "FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/FINANCIALDERIVATIVESANDHEDGINGACTIVITIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r153",
      "r156",
      "r162"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/FINANCIALDERIVATIVESANDHEDGINGACTIVITIESSummaryofDerivativeInstrumentsDetails",
      "http://www.varex.com/role/FINANCIALDERIVATIVESANDHEDGINGACTIVITIESSummaryofDerivativesatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeLiabilities": {
     "auth_ref": [
      "r236",
      "r237",
      "r577",
      "r711"
     ],
     "calculation": {
      "http://www.varex.com/role/FAIRVALUEScheduleofFairValueInputsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Liability",
        "terseLabel": "Derivative liabilities"
       }
      }
     },
     "localname": "DerivativeLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/FAIRVALUEScheduleofFairValueInputsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration": {
     "auth_ref": [
      "r549"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes derivative liability.",
        "label": "Derivative Liability, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Derivative Liability, Statement of Financial Position [Extensible Enumeration]"
       }
      }
     },
     "localname": "DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/FAIRVALUEScheduleofFairValueInputsDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/FINANCIALDERIVATIVESANDHEDGINGACTIVITIESSummaryofDerivativeInstrumentsDetails",
      "http://www.varex.com/role/FINANCIALDERIVATIVESANDHEDGINGACTIVITIESSummaryofDerivativesatFairValueDetails",
      "http://www.varex.com/role/FINANCIALDERIVATIVESANDHEDGINGACTIVITIESSummaryofIncomeRecognizedFromDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r810",
      "r811"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Notional Value"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/FINANCIALDERIVATIVESANDHEDGINGACTIVITIESSummaryofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeNumberOfInstrumentsHeld": {
     "auth_ref": [
      "r149",
      "r151"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of derivative instruments of a particular group held by the entity.",
        "label": "Derivative, Number of Instruments Held",
        "terseLabel": "Number of Instruments"
       }
      }
     },
     "localname": "DerivativeNumberOfInstrumentsHeld",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/FINANCIALDERIVATIVESANDHEDGINGACTIVITIESSummaryofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r148",
      "r150",
      "r151",
      "r153",
      "r154",
      "r160",
      "r162",
      "r165",
      "r166",
      "r168",
      "r555"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/FINANCIALDERIVATIVESANDHEDGINGACTIVITIESSummaryofDerivativeInstrumentsDetails",
      "http://www.varex.com/role/FINANCIALDERIVATIVESANDHEDGINGACTIVITIESSummaryofDerivativesatFairValueDetails",
      "http://www.varex.com/role/FINANCIALDERIVATIVESANDHEDGINGACTIVITIESSummaryofIncomeRecognizedFromDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "auth_ref": [
      "r153"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Designated as Hedging Instrument [Member]",
        "terseLabel": "Designated as Hedging Instrument",
        "verboseLabel": "Derivatives Designated as Net Investment Hedges"
       }
      }
     },
     "localname": "DesignatedAsHedgingInstrumentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/FINANCIALDERIVATIVESANDHEDGINGACTIVITIESSummaryofDerivativeInstrumentsDetails",
      "http://www.varex.com/role/FINANCIALDERIVATIVESANDHEDGINGACTIVITIESSummaryofDerivativesatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DevelopedTechnologyRightsMember": {
     "auth_ref": [
      "r134"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property.",
        "label": "Developed Technology Rights [Member]",
        "terseLabel": "Acquired existing technology"
       }
      }
     },
     "localname": "DevelopedTechnologyRightsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/REVENUEDisaggregationofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r464",
      "r726",
      "r727",
      "r728",
      "r729",
      "r730",
      "r731",
      "r732"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/REVENUEDisaggregationofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r805"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregation of Revenue by Geographic Location"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/REVENUETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r483",
      "r511",
      "r512",
      "r513",
      "r517",
      "r739"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "terseLabel": "EMPLOYEE STOCK PLANS"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/EMPLOYEESTOCKPLANS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DueToRelatedPartiesCurrentAndNoncurrent": {
     "auth_ref": [
      "r192",
      "r208",
      "r402",
      "r403",
      "r404",
      "r408",
      "r409",
      "r410",
      "r626",
      "r774"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of obligations due all related parties.",
        "label": "Due to Related Parties",
        "terseLabel": "Due to related parties"
       }
      }
     },
     "localname": "DueToRelatedPartiesCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/RELATEDPARTYTRANSACTIONSInvestmentinPrivatelyHeldCompaniesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EMEAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Regions of Europe, Middle East and Africa.",
        "label": "EMEA [Member]",
        "terseLabel": "EMEA"
       }
      }
     },
     "localname": "EMEAMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/REVENUEDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Net income per common share attributable to Varex"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r251",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r282",
      "r284",
      "r296",
      "r297",
      "r298",
      "r302",
      "r565",
      "r566",
      "r656",
      "r661",
      "r715"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic net income per share attributable to Varex (in USD per share)",
        "verboseLabel": "Basic (in USD per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited",
      "http://www.varex.com/role/NETINCOMEPERSHAREReconciliationofNumeratorandDenominatorforBasicandDilutedNetLossIncomePerCommonShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r251",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r284",
      "r296",
      "r297",
      "r298",
      "r302",
      "r565",
      "r566",
      "r656",
      "r661",
      "r715"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted net income per share attributable to Varex (in USD per share)",
        "verboseLabel": "Diluted (in USD per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited",
      "http://www.varex.com/role/NETINCOMEPERSHAREReconciliationofNumeratorandDenominatorforBasicandDilutedNetLossIncomePerCommonShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r299",
      "r300",
      "r301",
      "r303"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "NET INCOME PER SHARE"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/NETINCOMEPERSHARE"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r589"
     ],
     "calculation": {
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations",
        "terseLabel": "Effects of exchange rate changes on cash and cash equivalents and restricted cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/EMPLOYEESTOCKPLANSSharebasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r112",
      "r216",
      "r245",
      "r246",
      "r247",
      "r265",
      "r266",
      "r267",
      "r270",
      "r278",
      "r280",
      "r304",
      "r361",
      "r442",
      "r514",
      "r515",
      "r516",
      "r527",
      "r528",
      "r564",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r596",
      "r622",
      "r666",
      "r667",
      "r668"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvesteeMember": {
     "auth_ref": [
      "r83",
      "r642",
      "r644",
      "r646",
      "r648",
      "r650",
      "r652"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An entity that issued voting stock held by an investor and that is accounted for under the equity method of accounting by the investor.",
        "label": "Equity Method Investee [Member]",
        "terseLabel": "Equity Method Investee"
       }
      }
     },
     "localname": "EquityMethodInvesteeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/RELATEDPARTYTRANSACTIONSInvestmentinPrivatelyHeldCompaniesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment": {
     "auth_ref": [
      "r84"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents an other than temporary decline in value that has been recognized against an investment accounted for under the equity method of accounting. The excess of the carrying amount over the fair value of the investment represents the amount of the write down which is or was reflected in earnings. The written down value is a new cost basis with the adjusted value of the investment becoming its new carrying value subject to the equity accounting method. Evidence of a loss in value might include, but would not necessarily be limited to, absence of an ability to recover the carrying amount of the investment or inability of the investee to sustain an earnings capacity which would justify the carrying amount of the investment.",
        "label": "Equity Method Investment, Other than Temporary Impairment",
        "terseLabel": "Equity method investment, amount written off"
       }
      }
     },
     "localname": "EquityMethodInvestmentOtherThanTemporaryImpairment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "auth_ref": [
      "r86"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.",
        "label": "Equity Method Investment, Ownership Percentage",
        "terseLabel": "Equity method investment, ownership percentage"
       }
      }
     },
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/RELATEDPARTYTRANSACTIONSInvestmentinPrivatelyHeldCompaniesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EquityMethodInvestments": {
     "auth_ref": [
      "r85",
      "r323",
      "r756"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.",
        "label": "Equity Method Investments",
        "terseLabel": "Equity method investments"
       }
      }
     },
     "localname": "EquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/RELATEDPARTYTRANSACTIONSInvestmentinPrivatelyHeldCompaniesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNi": {
     "auth_ref": [
      "r228",
      "r576",
      "r708"
     ],
     "calculation": {
      "http://www.varex.com/role/FAIRVALUEScheduleofFairValueInputsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.",
        "label": "Equity Securities, FV-NI, Current",
        "terseLabel": "Marketable equity securities"
       }
      }
     },
     "localname": "EquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/FAIRVALUEScheduleofFairValueInputsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/FAIRVALUENarrativeDetails",
      "http://www.varex.com/role/FAIRVALUEScheduleofFairValueInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r568",
      "r569",
      "r574"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/FAIRVALUENarrativeDetails",
      "http://www.varex.com/role/FAIRVALUEScheduleofFairValueInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": {
     "auth_ref": [
      "r170",
      "r171"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Fair Value, Assets Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Fair Value, Assets Measured on Recurring Basis"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/FAIRVALUETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r425",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r569",
      "r629",
      "r630",
      "r631",
      "r720",
      "r721",
      "r733",
      "r734",
      "r735"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/FAIRVALUENarrativeDetails",
      "http://www.varex.com/role/FAIRVALUEScheduleofFairValueInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r568",
      "r569",
      "r570",
      "r571",
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/FAIRVALUEScheduleofFairValueInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]",
        "terseLabel": "Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]"
       }
      }
     },
     "localname": "FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/FAIRVALUEBalanceSheetMarketableSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable": {
     "auth_ref": [
      "r573"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about fair value of asset and liability not measured at fair value.",
        "label": "Fair Value Disclosure of Asset and Liability Not Measured at Fair Value [Table]",
        "terseLabel": "Fair Value Disclosure of Asset and Liability Not Measured at Fair Value [Table]"
       }
      }
     },
     "localname": "FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/FAIRVALUEBalanceSheetMarketableSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "FAIR VALUE"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/FAIRVALUE"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r425",
      "r470",
      "r475",
      "r569",
      "r629",
      "r733",
      "r734",
      "r735"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1)",
        "verboseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/FAIRVALUENarrativeDetails",
      "http://www.varex.com/role/FAIRVALUEScheduleofFairValueInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r425",
      "r470",
      "r475",
      "r569",
      "r630",
      "r720",
      "r721",
      "r733",
      "r734",
      "r735"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Significant Other Observable Inputs (Level 2)"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/FAIRVALUEScheduleofFairValueInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r425",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r569",
      "r631",
      "r720",
      "r721",
      "r733",
      "r734",
      "r735"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Significant Unobservable Inputs (Level 3)"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/FAIRVALUEScheduleofFairValueInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]",
        "terseLabel": "Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]"
       }
      }
     },
     "localname": "FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/FAIRVALUESummaryofMarketableSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareTable": {
     "auth_ref": [
      "r172"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investments in certain entities that calculate net asset value per share or equivalent measured at fair value on a recurring or nonrecurring basis.",
        "label": "Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Table]",
        "terseLabel": "Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Table]"
       }
      }
     },
     "localname": "FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/FAIRVALUESummaryofMarketableSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock": {
     "auth_ref": [
      "r170",
      "r171"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/FAIRVALUETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/FAIRVALUEScheduleofFairValueInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r425",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r629",
      "r630",
      "r631",
      "r720",
      "r721",
      "r733",
      "r734",
      "r735"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/FAIRVALUENarrativeDetails",
      "http://www.varex.com/role/FAIRVALUEScheduleofFairValueInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r572",
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Fair Value, Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/FAIRVALUEScheduleofFairValueInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOfAssetsAcquired": {
     "auth_ref": [
      "r61",
      "r62",
      "r63"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of assets acquired in noncash investing or financing activities.",
        "label": "Fair Value of Assets Acquired",
        "terseLabel": "Purchases of property, plant and equipment financed through accounts payable"
       }
      }
     },
     "localname": "FairValueOfAssetsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "auth_ref": [
      "r608"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.",
        "label": "Finance Lease, Liability, Current",
        "terseLabel": "Finance lease liabilities (current)"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/LEASESScheduleofLeaseRightofUseAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r609"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes current finance lease liability.",
        "label": "Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Finance Lease, Liability, Current, Statement of Financial Position [Extensible List]"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/LEASESScheduleofLeaseRightofUseAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r608"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.",
        "label": "Finance Lease, Liability, Noncurrent",
        "terseLabel": "Finance lease liabilities (non-current)"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/LEASESScheduleofLeaseRightofUseAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r609"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes noncurrent finance lease liability.",
        "label": "Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/LEASESScheduleofLeaseRightofUseAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "auth_ref": [
      "r610",
      "r614"
     ],
     "calculation": {
      "http://www.varex.com/role/LEASESScheduleofOperatingLeaseCostandSupplementalCashFlowInformationDetails": {
       "order": 2.0,
       "parentTag": "var_CashPaidForOperatingAndFinanceLeases",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for principal payment on finance lease.",
        "label": "Finance Lease, Principal Payments",
        "terseLabel": "Financing cash flows from finance leases"
       }
      }
     },
     "localname": "FinanceLeasePrincipalPayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/LEASESScheduleofOperatingLeaseCostandSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAsset": {
     "auth_ref": [
      "r607"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization",
        "terseLabel": "Finance lease right-of-use assets"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/LEASESScheduleofLeaseRightofUseAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r609"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes finance lease right-of-use asset.",
        "label": "Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/LEASESScheduleofLeaseRightofUseAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r225",
      "r384"
     ],
     "calculation": {
      "http://www.varex.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedTerseLabel": "Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r382",
      "r383",
      "r384",
      "r385",
      "r636",
      "r640"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r94",
      "r640"
     ],
     "calculation": {
      "http://www.varex.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Gross Carrying Amount"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r91",
      "r93"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r94",
      "r636"
     ],
     "calculation": {
      "http://www.varex.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "totalLabel": "Net Carrying Amount"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiscalPeriod": {
     "auth_ref": [
      "r136"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining an entity's fiscal year or other fiscal period. This disclosure may include identification of the fiscal period end-date, the length of the fiscal period, any reporting period lag between the entity and its subsidiaries, or equity investees. If a reporting lag exists, the closing date of the entity having a different period end is generally noted, along with an explanation of the necessity for using different closing dates. Any intervening events that materially affect the entity's financial position or results of operations are generally also disclosed.",
        "label": "Fiscal Period, Policy [Policy Text Block]",
        "terseLabel": "Fiscal Year"
       }
      }
     },
     "localname": "FiscalPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GainLossOnInvestmentsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of realized and unrealized gain (loss) on investment in security.",
        "label": "Gain (Loss) on Securities [Table Text Block]",
        "terseLabel": "Schedule of Gains and (Losses) on Marketable Securities"
       }
      }
     },
     "localname": "GainLossOnInvestmentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/FAIRVALUETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GainLossOnTerminationOfLease": {
     "auth_ref": [
      "r606"
     ],
     "calculation": {
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on termination of lease before expiration of lease term.",
        "label": "Gain (Loss) on Termination of Lease",
        "negatedTerseLabel": "Loss on operating lease abandonment"
       }
      }
     },
     "localname": "GainLossOnTerminationOfLease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited",
      "http://www.varex.com/role/LEASESNarrativesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r224",
      "r370",
      "r653",
      "r718",
      "r743",
      "r786",
      "r793"
     ],
     "calculation": {
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Balance at December 30, 2022",
        "periodStartLabel": "Balance at September 30, 2022",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.varex.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillRollforwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r96"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "GOODWILL AND INTANGIBLE ASSETS"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/GOODWILLANDINTANGIBLEASSETS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r376"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Foreign currency translation adjustments"
       }
      }
     },
     "localname": "GoodwillForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillRollforwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillRollforwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillRollforwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r40",
      "r261",
      "r322",
      "r333",
      "r339",
      "r342",
      "r357",
      "r400",
      "r401",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r409",
      "r410",
      "r578",
      "r717",
      "r800"
     ],
     "calculation": {
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "terseLabel": "Gross profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited",
      "http://www.varex.com/role/SEGMENTINFORMATIONIncomeStatementInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r153",
      "r553"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/FINANCIALDERIVATIVESANDHEDGINGACTIVITIESSummaryofDerivativeInstrumentsDetails",
      "http://www.varex.com/role/FINANCIALDERIVATIVESANDHEDGINGACTIVITIESSummaryofDerivativesatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r153"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/FINANCIALDERIVATIVESANDHEDGINGACTIVITIESSummaryofDerivativeInstrumentsDetails",
      "http://www.varex.com/role/FINANCIALDERIVATIVESANDHEDGINGACTIVITIESSummaryofDerivativesatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r153"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship [Domain]"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/FINANCIALDERIVATIVESANDHEDGINGACTIVITIESSummaryofDerivativeInstrumentsDetails",
      "http://www.varex.com/role/FINANCIALDERIVATIVESANDHEDGINGACTIVITIESSummaryofDerivativesatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r35",
      "r185",
      "r196",
      "r211",
      "r322",
      "r333",
      "r339",
      "r342",
      "r657",
      "r717"
     ],
     "calculation": {
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "terseLabel": "Income before taxes",
        "totalLabel": "Income before taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited",
      "http://www.varex.com/role/SEGMENTINFORMATIONIncomeStatementInformationDetails",
      "http://www.varex.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r36",
      "r56",
      "r85",
      "r195",
      "r209",
      "r319"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).",
        "label": "Income (Loss) from Equity Method Investments",
        "verboseLabel": "Income (loss) from equity method investments"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/RELATEDPARTYTRANSACTIONSInvestmentinPrivatelyHeldCompaniesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions": {
     "auth_ref": [
      "r56"
     ],
     "calculation": {
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the undistributed income (or loss) of equity method investments, net of dividends or other distributions received from unconsolidated subsidiaries, certain corporate joint ventures, and certain noncontrolled corporations; such investments are accounted for under the equity method of accounting. This element excludes distributions that constitute a return of investment, which are classified as investing activities.",
        "label": "Income (Loss) from Equity Method Investments, Net of Dividends or Distributions",
        "negatedTerseLabel": "(Income) loss from equity method investments"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r386",
      "r390"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/EMPLOYEESTOCKPLANSSharebasedCompensationExpenseDetails",
      "http://www.varex.com/role/FINANCIALDERIVATIVESANDHEDGINGACTIVITIESSummaryofIncomeRecognizedFromDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r390"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/EMPLOYEESTOCKPLANSSharebasedCompensationExpenseDetails",
      "http://www.varex.com/role/FINANCIALDERIVATIVESANDHEDGINGACTIVITIESSummaryofIncomeRecognizedFromDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r262",
      "r521",
      "r522",
      "r523",
      "r529",
      "r533",
      "r535",
      "r536",
      "r537"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "TAXES ON INCOME"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/TAXESONINCOME"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r263",
      "r279",
      "r280",
      "r320",
      "r520",
      "r530",
      "r534",
      "r662"
     ],
     "calculation": {
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Income tax expense",
        "verboseLabel": "Income tax expense"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited",
      "http://www.varex.com/role/SEGMENTINFORMATIONIncomeStatementInformationDetails",
      "http://www.varex.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r60"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "terseLabel": "Income taxes paid, net of refunds"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r55"
     ],
     "calculation": {
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r55"
     ],
     "calculation": {
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedTerseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r55"
     ],
     "calculation": {
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "terseLabel": "Accrued liabilities and other current and long-term liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "auth_ref": [
      "r634",
      "r768"
     ],
     "calculation": {
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Contract with Customer, Liability",
        "terseLabel": "Deferred revenues"
       }
      }
     },
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r55"
     ],
     "calculation": {
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedTerseLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r55"
     ],
     "calculation": {
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedTerseLabel": "Prepaid expenses and other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities": {
     "auth_ref": [
      "r292",
      "r293",
      "r298"
     ],
     "calculation": {
      "http://www.varex.com/role/NETINCOMEPERSHAREReconciliationofNumeratorandDenominatorforBasicandDilutedNetLossIncomePerCommonShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible debt securities using the if-converted method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities",
        "terseLabel": "Dilutive effect of Convertible Notes (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToConversionOfDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/NETINCOMEPERSHAREReconciliationofNumeratorandDenominatorforBasicandDilutedNetLossIncomePerCommonShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r285",
      "r286",
      "r287",
      "r298",
      "r482"
     ],
     "calculation": {
      "http://www.varex.com/role/NETINCOMEPERSHAREReconciliationofNumeratorandDenominatorforBasicandDilutedNetLossIncomePerCommonShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements",
        "terseLabel": "Dilutive effect of share-based awards and other (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/NETINCOMEPERSHAREReconciliationofNumeratorandDenominatorforBasicandDilutedNetLossIncomePerCommonShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r89",
      "r92"
     ],
     "calculation": {
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntellectualPropertyMember": {
     "auth_ref": [
      "r135"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible asset arising from original creative thought. Include, but is not limited to, trademarks, patents, and copyrights.",
        "label": "Intellectual Property [Member]",
        "terseLabel": "Patents, licenses and other"
       }
      }
     },
     "localname": "IntellectualPropertyMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r179",
      "r198",
      "r248",
      "r316",
      "r599"
     ],
     "calculation": {
      "http://www.varex.com/role/BORROWINGSScheduleofInterestExpenseDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedTerseLabel": "Interest expense",
        "totalLabel": "Total interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/BORROWINGSScheduleofInterestExpenseDetails",
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseMember": {
     "auth_ref": [
      "r163"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing interest expense.",
        "label": "Interest Expense [Member]",
        "terseLabel": "Interest Expense"
       }
      }
     },
     "localname": "InterestExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/FINANCIALDERIVATIVESANDHEDGINGACTIVITIESSummaryofIncomeRecognizedFromDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of interest income and expense, including, but not limited to, interest income and expense from investments, loans, and securities.",
        "label": "Interest Income and Interest Expense Disclosure [Table Text Block]",
        "terseLabel": "Schedule of Interest Expense"
       }
      }
     },
     "localname": "InterestIncomeAndInterestExpenseDisclosureTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/BORROWINGSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r254",
      "r257",
      "r259"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Cash paid for interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]",
        "terseLabel": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "localname": "InventoryDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "auth_ref": [
      "r369"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.",
        "label": "Inventory Disclosure [Text Block]",
        "terseLabel": "INVENTORIES"
       }
      }
     },
     "localname": "InventoryDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/INVENTORIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r87",
      "r709"
     ],
     "calculation": {
      "http://www.varex.com/role/INVENTORIESSummaryofInventoryDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/INVENTORIESSummaryofInventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r233",
      "r707",
      "r743"
     ],
     "calculation": {
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.varex.com/role/INVENTORIESSummaryofInventoryDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories",
        "totalLabel": "Total inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.varex.com/role/INVENTORIESSummaryofInventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves": {
     "auth_ref": [
      "r87",
      "r759"
     ],
     "calculation": {
      "http://www.varex.com/role/INVENTORIESSummaryofInventoryDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregated amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed. This amount is net of valuation reserves and adjustments.",
        "label": "Inventory, Raw Materials and Supplies, Net of Reserves",
        "terseLabel": "Raw materials and parts"
       }
      }
     },
     "localname": "InventoryRawMaterialsAndSuppliesNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/INVENTORIESSummaryofInventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r87",
      "r710"
     ],
     "calculation": {
      "http://www.varex.com/role/INVENTORIESSummaryofInventoryDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Work-in-process"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/INVENTORIESSummaryofInventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWriteDown": {
     "auth_ref": [
      "r368"
     ],
     "calculation": {
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.",
        "label": "Inventory Write-down",
        "terseLabel": "Inventory write-down"
       }
      }
     },
     "localname": "InventoryWriteDown",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r44",
      "r315"
     ],
     "calculation": {
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Investment Income, Interest",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentPolicyTextBlock": {
     "auth_ref": [
      "r356",
      "r831"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment in financial asset.",
        "label": "Investment, Policy [Policy Text Block]",
        "terseLabel": "Investments and Marketable Securities"
       }
      }
     },
     "localname": "InvestmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentTypeAxis": {
     "auth_ref": [
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of investments.",
        "label": "Investment Type [Axis]",
        "terseLabel": "Investment Type [Axis]"
       }
      }
     },
     "localname": "InvestmentTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/FAIRVALUEBalanceSheetMarketableSecuritiesDetails",
      "http://www.varex.com/role/FAIRVALUESummaryofMarketableSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentTypeCategorizationMember": {
     "auth_ref": [
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset obtained to generate income or appreciate in value.",
        "label": "Investments [Domain]",
        "terseLabel": "Investments [Domain]"
       }
      }
     },
     "localname": "InvestmentTypeCategorizationMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/FAIRVALUEBalanceSheetMarketableSecuritiesDetails",
      "http://www.varex.com/role/FAIRVALUESummaryofMarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InvestmentsFairValueDisclosure": {
     "auth_ref": [
      "r568"
     ],
     "calculation": {
      "http://www.varex.com/role/FAIRVALUEScheduleofFairValueInputsDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.",
        "label": "Investments, Fair Value Disclosure",
        "terseLabel": "U.S. Treasury bills"
       }
      }
     },
     "localname": "InvestmentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/FAIRVALUEScheduleofFairValueInputsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures": {
     "auth_ref": [
      "r758"
     ],
     "calculation": {
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity method investee and investment in and advance to affiliate.",
        "label": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures",
        "terseLabel": "Investments in privately-held companies"
       }
      }
     },
     "localname": "InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r817"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Schedule of Lease Cost and Supplemental Cash Flow Information"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/LEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeFinanceLeasesTextBlock": {
     "auth_ref": [
      "r616"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.",
        "label": "Lessee, Finance Leases [Text Block]",
        "terseLabel": "LEASES"
       }
      }
     },
     "localname": "LesseeFinanceLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/LEASES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r612"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee, Leases [Policy Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r616"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "LEASES"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/LEASES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r18",
      "r261",
      "r357",
      "r400",
      "r401",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r409",
      "r410",
      "r544",
      "r547",
      "r548",
      "r578",
      "r716",
      "r800",
      "r819",
      "r820"
     ],
     "calculation": {
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities [Abstract]",
        "terseLabel": "Liabilities:",
        "verboseLabel": "Liabilities"
       }
      }
     },
     "localname": "LiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/FAIRVALUEScheduleofFairValueInputsDetails",
      "http://www.varex.com/role/LEASESScheduleofLeaseRightofUseAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r11",
      "r191",
      "r207",
      "r743",
      "r772",
      "r784",
      "r815"
     ],
     "calculation": {
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders' equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities and stockholders' equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r20",
      "r222",
      "r261",
      "r357",
      "r400",
      "r401",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r409",
      "r410",
      "r544",
      "r547",
      "r548",
      "r578",
      "r743",
      "r800",
      "r819",
      "r820"
     ],
     "calculation": {
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "auth_ref": [
      "r170"
     ],
     "calculation": {
      "http://www.varex.com/role/FAIRVALUEScheduleofFairValueInputsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial and nonfinancial obligations.",
        "label": "Liabilities, Fair Value Disclosure",
        "totalLabel": "Total liabilities measured at fair value"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/FAIRVALUEScheduleofFairValueInputsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityCommitmentFeePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.",
        "label": "Line of Credit Facility, Commitment Fee Percentage",
        "terseLabel": "Used capacity, commitment fee percentage"
       }
      }
     },
     "localname": "LineOfCreditFacilityCommitmentFeePercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/BORROWINGSAssetBasedLoanNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r16"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Maximum borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/BORROWINGSAssetBasedLoanNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": {
     "auth_ref": [
      "r16"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).",
        "label": "Line of Credit Facility, Remaining Borrowing Capacity",
        "terseLabel": "Available borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityRemainingBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/BORROWINGSAssetBasedLoanNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r3",
      "r189",
      "r203",
      "r424",
      "r439",
      "r720",
      "r721"
     ],
     "calculation": {
      "http://www.varex.com/role/BORROWINGSScheduleofDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.",
        "label": "Long-Term Debt",
        "totalLabel": "Total debt outstanding, net"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/BORROWINGSScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r17"
     ],
     "calculation": {
      "http://www.varex.com/role/BORROWINGSScheduleofDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      },
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-Term Debt, Current Maturities",
        "terseLabel": "Current maturities of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/BORROWINGSScheduleofDebtDetails",
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Debt, Current Maturities [Abstract]",
        "terseLabel": "Current maturities of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/BORROWINGSScheduleofDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongTermDebtFairValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.",
        "label": "Long-Term Debt, Fair Value",
        "terseLabel": "Long-term debt, fair value"
       }
      }
     },
     "localname": "LongTermDebtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/FAIRVALUENarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r229"
     ],
     "calculation": {
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.",
        "label": "Long-Term Debt, Excluding Current Maturities",
        "terseLabel": "Long-term debt, net"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRecentlyAdoptedAccountingStandardsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtWeightedAverageInterestRateOverTime": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average interest rate of long-term debt outstanding calculated over time.",
        "label": "Long-Term Debt, Weighted Average Interest Rate, over Time",
        "terseLabel": "Effective Interest Rate"
       }
      }
     },
     "localname": "LongTermDebtWeightedAverageInterestRateOverTime",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/BORROWINGSScheduleofDebtDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-Term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/BORROWINGSAssetBasedLoanNarrativeDetails",
      "http://www.varex.com/role/BORROWINGSCallSpreadNarrativeDetails",
      "http://www.varex.com/role/BORROWINGSConvertibleSeniorUnsecuredNotesNarrativeDetails",
      "http://www.varex.com/role/BORROWINGSScheduleofDebtDetails",
      "http://www.varex.com/role/BORROWINGSSeniorSecuredNotesNarrativeDetails",
      "http://www.varex.com/role/FAIRVALUENarrativeDetails",
      "http://www.varex.com/role/NETINCOMEPERSHARENarrativeDetails",
      "http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRecentlyAdoptedAccountingStandardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r23",
      "r107"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-Term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/BORROWINGSAssetBasedLoanNarrativeDetails",
      "http://www.varex.com/role/BORROWINGSCallSpreadNarrativeDetails",
      "http://www.varex.com/role/BORROWINGSConvertibleSeniorUnsecuredNotesNarrativeDetails",
      "http://www.varex.com/role/BORROWINGSScheduleofDebtDetails",
      "http://www.varex.com/role/BORROWINGSSeniorSecuredNotesNarrativeDetails",
      "http://www.varex.com/role/FAIRVALUENarrativeDetails",
      "http://www.varex.com/role/NETINCOMEPERSHARENarrativeDetails",
      "http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRecentlyAdoptedAccountingStandardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MarketableSecurities": {
     "auth_ref": [
      "r194"
     ],
     "calculation": {
      "http://www.varex.com/role/FAIRVALUEContractualMaturitiesofMarketableSecuritiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.varex.com/role/FAIRVALUESummaryofMarketableSecuritiesDetails": {
       "order": 2.0,
       "parentTag": "var_MarketableSecuritiesAmortizedCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in marketable security.",
        "label": "Marketable Securities",
        "terseLabel": "Total marketable debt securities",
        "totalLabel": "Total marketable debt securities"
       }
      }
     },
     "localname": "MarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/FAIRVALUEBalanceSheetMarketableSecuritiesDetails",
      "http://www.varex.com/role/FAIRVALUEContractualMaturitiesofMarketableSecuritiesDetails",
      "http://www.varex.com/role/FAIRVALUESummaryofMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets.",
        "label": "Marketable Securities [Table Text Block]",
        "terseLabel": "Schedule of Marketable Securities"
       }
      }
     },
     "localname": "MarketableSecuritiesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/FAIRVALUETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MarketableSecuritiesUnrealizedGainLoss": {
     "auth_ref": [
      "r38"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) on investment in marketable security.",
        "label": "Marketable Securities, Unrealized Gain (Loss)",
        "terseLabel": "Marketable securities credit loss"
       }
      }
     },
     "localname": "MarketableSecuritiesUnrealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MaturitiesOfLongTermDebtAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maturities of Long-Term Debt [Abstract]",
        "terseLabel": "Non-current maturities of long-term debt:"
       }
      }
     },
     "localname": "MaturitiesOfLongTermDebtAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/BORROWINGSScheduleofDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r26",
      "r190",
      "r206",
      "r261",
      "r357",
      "r400",
      "r403",
      "r404",
      "r405",
      "r409",
      "r410",
      "r578"
     ],
     "calculation": {
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "periodEndLabel": "Noncontrolling interests, at end of period",
        "periodStartLabel": "Noncontrolling interests, at beginning of period",
        "verboseLabel": "Noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.varex.com/role/NONCONTROLLINGINTERESTSNoncontrollingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDisclosureTextBlock": {
     "auth_ref": [
      "r147"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for noncontrolling interest in consolidated subsidiaries, which could include the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.",
        "label": "Noncontrolling Interest Disclosure [Text Block]",
        "terseLabel": "NONCONTROLLING INTERESTS"
       }
      }
     },
     "localname": "MinorityInterestDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/NONCONTROLLINGINTERESTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MinorityInterestLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Noncontrolling Interest [Line Items]",
        "terseLabel": "Noncontrolling Interest [Line Items]"
       }
      }
     },
     "localname": "MinorityInterestLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/NONCONTROLLINGINTERESTSNoncontrollingInterestDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.",
        "label": "Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners",
        "terseLabel": "Noncontrolling interest, ownership percentage by noncontrolling owners"
       }
      }
     },
     "localname": "MinorityInterestOwnershipPercentageByNoncontrollingOwners",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/NONCONTROLLINGINTERESTSNoncontrollingInterestDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_MinorityInterestOwnershipPercentageByParent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage.",
        "label": "Noncontrolling Interest, Ownership Percentage by Parent",
        "terseLabel": "Majority voting rights, percent"
       }
      }
     },
     "localname": "MinorityInterestOwnershipPercentageByParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/NONCONTROLLINGINTERESTSNoncontrollingInterestDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_MinorityInterestTable": {
     "auth_ref": [
      "r26",
      "r41",
      "r138",
      "r143"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of noncontrolling interest disclosure which includes the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.",
        "label": "Noncontrolling Interest [Table]",
        "terseLabel": "Noncontrolling Interest [Table]"
       }
      }
     },
     "localname": "MinorityInterestTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/NONCONTROLLINGINTERESTSNoncontrollingInterestDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MoneyMarketFundsAtCarryingValue": {
     "auth_ref": [],
     "calculation": {
      "http://www.varex.com/role/FAIRVALUEScheduleofFairValueInputsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment in short-term money-market instruments (such as commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and so forth) which are highly liquid (that is, readily convertible to known amounts of cash) and so near their maturity that they present an insignificant risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify as cash equivalents by definition. Original maturity means an original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three-years ago does not become a cash equivalent when its remaining maturity is three months.",
        "label": "Money Market Funds, at Carrying Value",
        "terseLabel": "Money market funds"
       }
      }
     },
     "localname": "MoneyMarketFundsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/FAIRVALUEScheduleofFairValueInputsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MovementInMinorityInterestRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]",
        "terseLabel": "Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]"
       }
      }
     },
     "localname": "MovementInMinorityInterestRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/NONCONTROLLINGINTERESTSNoncontrollingInterestDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MovementInStandardProductWarrantyAccrualRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Movement in Standard Product Warranty Accrual [Roll Forward]",
        "terseLabel": "Movement in Standard Product Warranty Accrual [Roll Forward]"
       }
      }
     },
     "localname": "MovementInStandardProductWarrantyAccrualRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESProductWarrantyDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r256"
     ],
     "calculation": {
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash (used in) provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r256"
     ],
     "calculation": {
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r53",
      "r54",
      "r57"
     ],
     "calculation": {
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash (used in) provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r37",
      "r57",
      "r197",
      "r210",
      "r220",
      "r241",
      "r243",
      "r247",
      "r261",
      "r269",
      "r273",
      "r274",
      "r275",
      "r276",
      "r279",
      "r280",
      "r294",
      "r322",
      "r333",
      "r339",
      "r342",
      "r357",
      "r400",
      "r401",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r409",
      "r410",
      "r566",
      "r578",
      "r717",
      "r800"
     ],
     "calculation": {
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net income attributable to Varex - basic",
        "totalLabel": "Net income attributable to Varex"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited",
      "http://www.varex.com/role/NETINCOMEPERSHAREReconciliationofNumeratorandDenominatorforBasicandDilutedNetLossIncomePerCommonShareDetails",
      "http://www.varex.com/role/SEGMENTINFORMATIONIncomeStatementInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r141",
      "r145",
      "r241",
      "r243",
      "r279",
      "r280",
      "r763"
     ],
     "calculation": {
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      },
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "terseLabel": "Less: Comprehensive income attributable to noncontrolling interests",
        "verboseLabel": "Less: Net income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUnaudited",
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited",
      "http://www.varex.com/role/SEGMENTINFORMATIONIncomeStatementInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": {
     "auth_ref": [
      "r283",
      "r288",
      "r289",
      "r290",
      "r291",
      "r295",
      "r298"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Diluted",
        "terseLabel": "Net income attributable to Varex - diluted"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/NETINCOMEPERSHAREReconciliationofNumeratorandDenominatorforBasicandDilutedNetLossIncomePerCommonShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetInvestmentHedgingMember": {
     "auth_ref": [
      "r152"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedges of a net investment in a foreign operation.",
        "label": "Net Investment Hedging [Member]",
        "terseLabel": "Net Investment Hedging"
       }
      }
     },
     "localname": "NetInvestmentHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/FINANCIALDERIVATIVESANDHEDGINGACTIVITIESSummaryofDerivativeInstrumentsDetails",
      "http://www.varex.com/role/FINANCIALDERIVATIVESANDHEDGINGACTIVITIESSummaryofDerivativesatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recently Adopted Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncash Investing and Financing Items [Abstract]",
        "terseLabel": "Supplemental non-cash activities:"
       }
      }
     },
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncontrolling Interest [Abstract]",
        "terseLabel": "Noncontrolling Interest [Abstract]"
       }
      }
     },
     "localname": "NoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r137",
      "r442",
      "r775",
      "r776",
      "r777"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Noncontrolling Interests"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r45"
     ],
     "calculation": {
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "terseLabel": "Interest and other expense, net",
        "totalLabel": "Interest and other expense, net"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited",
      "http://www.varex.com/role/SEGMENTINFORMATIONIncomeStatementInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r782"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "terseLabel": "Number of reportable operating segments"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/SEGMENTINFORMATIONIncomeStatementInformationDetails",
      "http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSegmentReportingDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited",
      "http://www.varex.com/role/SEGMENTINFORMATIONIncomeStatementInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r322",
      "r333",
      "r339",
      "r342",
      "r717"
     ],
     "calculation": {
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Operating income"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r613",
      "r742"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Total operating lease costs"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/LEASESScheduleofOperatingLeaseCostandSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r608"
     ],
     "calculation": {
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Current operating lease liabilities",
        "verboseLabel": "Operating lease liabilities (current)"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.varex.com/role/LEASESScheduleofLeaseRightofUseAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r608"
     ],
     "calculation": {
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating lease liabilities",
        "verboseLabel": "Operating lease liabilities (non-current)"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.varex.com/role/LEASESScheduleofLeaseRightofUseAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r611",
      "r614"
     ],
     "calculation": {
      "http://www.varex.com/role/LEASESScheduleofOperatingLeaseCostandSupplementalCashFlowInformationDetails": {
       "order": 1.0,
       "parentTag": "var_CashPaidForOperatingAndFinanceLeases",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating cash flows from operating leases"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/LEASESScheduleofOperatingLeaseCostandSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r607"
     ],
     "calculation": {
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease assets",
        "verboseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.varex.com/role/LEASESScheduleofLeaseRightofUseAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r65",
      "r66",
      "r76",
      "r147"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.",
        "label": "Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]",
        "netLabel": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES"
       }
      }
     },
     "localname": "OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAssetImpairmentCharges": {
     "auth_ref": [
      "r769",
      "r798"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The charge against earnings resulting from the write down of long lived assets other than goodwill due to the difference between the carrying value and lower fair value.",
        "label": "Other Asset Impairment Charges",
        "terseLabel": "Other assets impairment charges"
       }
      }
     },
     "localname": "OtherAssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/RESTRUCTURINGSummaryofRestructuringCostIncurredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsMember": {
     "auth_ref": [
      "r155",
      "r167"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other assets.",
        "label": "Other Assets [Member]",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/FAIRVALUEBalanceSheetMarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r226"
     ],
     "calculation": {
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax": {
     "auth_ref": [
      "r28",
      "r31",
      "r587",
      "r588",
      "r595"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit), before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "OCI, Foreign Currency Transaction and Translation Gain (Loss), Arising During Period, Tax",
        "negatedTerseLabel": "Foreign currency translation adjustments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r238",
      "r239",
      "r550",
      "r551",
      "r554"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax",
        "verboseLabel": "Amount of (Loss) Gain Recognized in OCI on Derivative"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/FINANCIALDERIVATIVESANDHEDGINGACTIVITIESSummaryofIncomeRecognizedFromDerivativeInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax": {
     "auth_ref": [
      "r239",
      "r240",
      "r552"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax",
        "terseLabel": "Amount of Gain Recognized in Income on Derivative (Amount Excluded from Effectiveness Testing)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/FINANCIALDERIVATIVESANDHEDGINGACTIVITIESSummaryofIncomeRecognizedFromDerivativeInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r28"
     ],
     "calculation": {
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Foreign currency translation adjustments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive loss"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherCurrentAssetsMember": {
     "auth_ref": [
      "r155",
      "r167"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other current assets.",
        "label": "Other Current Assets [Member]",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "OtherCurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/FINANCIALDERIVATIVESANDHEDGINGACTIVITIESSummaryofDerivativesatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherDebtSecuritiesMember": {
     "auth_ref": [
      "r783",
      "r785",
      "r807",
      "r814"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments in debt securities classified as other.",
        "label": "Other Debt Obligations [Member]",
        "terseLabel": "Other debt"
       }
      }
     },
     "localname": "OtherDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/BORROWINGSScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r24"
     ],
     "calculation": {
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedTerseLabel": "Other, net"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent assets.",
        "label": "Other Noncurrent Assets [Member]",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherNoncurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/FINANCIALDERIVATIVESANDHEDGINGACTIVITIESSummaryofDerivativesatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Member]",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/FINANCIALDERIVATIVESANDHEDGINGACTIVITIESSummaryofDerivativesatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other expense, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherReceivables": {
     "auth_ref": [
      "r230"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due from parties in nontrade transactions, classified as other.",
        "label": "Other Receivables",
        "terseLabel": "Other receivables"
       }
      }
     },
     "localname": "OtherReceivables",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/RELATEDPARTYTRANSACTIONSInvestmentinPrivatelyHeldCompaniesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ParentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Portion of equity, or net assets, in the consolidated entity attributable, directly or indirectly, to the parent. Excludes noncontrolling interests.",
        "label": "Parent [Member]",
        "terseLabel": "Total Varex Equity"
       }
      }
     },
     "localname": "ParentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r764",
      "r765"
     ],
     "calculation": {
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedTerseLabel": "Other, net"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt": {
     "auth_ref": [
      "r48",
      "r82",
      "r252"
     ],
     "calculation": {
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Payments to Acquire Debt Securities, Available-for-Sale",
        "negatedTerseLabel": "Purchase of marketable debt securities"
       }
      }
     },
     "localname": "PaymentsToAcquireAvailableForSaleSecuritiesDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireMarketableSecurities": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for purchase of marketable security.",
        "label": "Payments to Acquire Marketable Securities",
        "negatedTerseLabel": "Purchase of marketable equity securities"
       }
      }
     },
     "localname": "PaymentsToAcquireMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r49"
     ],
     "calculation": {
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedTerseLabel": "Purchases of property, plant and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r5",
      "r440"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in USD per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r5",
      "r440"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValueOutstanding": {
     "auth_ref": [
      "r5"
     ],
     "calculation": {
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by shareholders, which is net of related treasury stock. May be all or a portion of the number of preferred shares authorized. These shares represent the ownership interest of the preferred shareholders.",
        "label": "Preferred Stock, Value, Outstanding",
        "terseLabel": "Preferred stock, $.01 par value: 20,000,000 shares authorized, none issued"
       }
      }
     },
     "localname": "PreferredStockValueOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r760"
     ],
     "calculation": {
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing prepaid expenses and other current assets.",
        "label": "Prepaid Expenses and Other Current Assets [Member]",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpensesAndOtherCurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/FAIRVALUEBalanceSheetMarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PriorPeriodReclassificationAdjustmentDescription": {
     "auth_ref": [
      "r754"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.",
        "label": "Reclassification, Comparability Adjustment [Policy Text Block]",
        "terseLabel": "Reclassification of Prior Period Presentation"
       }
      }
     },
     "localname": "PriorPeriodReclassificationAdjustmentDescription",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ProceedsFromConvertibleDebt": {
     "auth_ref": [
      "r51"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.",
        "label": "Proceeds from Convertible Debt",
        "terseLabel": "Borrowings under credit agreements"
       }
      }
     },
     "localname": "ProceedsFromConvertibleDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/BORROWINGSConvertibleSeniorUnsecuredNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromHedgeInvestingActivities": {
     "auth_ref": [
      "r258",
      "r764"
     ],
     "calculation": {
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow for a financial contract that meets the hedge criteria as either a cash flow hedge, fair value hedge, or hedge of a net investment in a foreign operation.",
        "label": "Proceeds from Hedge, Investing Activities",
        "terseLabel": "Settlement of net investment hedge"
       }
      }
     },
     "localname": "ProceedsFromHedgeInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r766",
      "r767"
     ],
     "calculation": {
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Other, net"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities": {
     "auth_ref": [
      "r82",
      "r252",
      "r253"
     ],
     "calculation": {
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from sale, maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Proceeds from Sale and Maturity of Debt Securities, Available-for-Sale",
        "terseLabel": "Proceeds from maturities of marketable debt securities"
       }
      }
     },
     "localname": "ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r50",
      "r125"
     ],
     "calculation": {
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Proceeds from exercise of stock options"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockPlans": {
     "auth_ref": [
      "r50"
     ],
     "calculation": {
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the stock plan during the period.",
        "label": "Proceeds from Stock Plans",
        "terseLabel": "Proceeds from shares issued under employee stock purchase plan"
       }
      }
     },
     "localname": "ProceedsFromStockPlans",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductWarrantyLiabilityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Product Warranty Liability [Line Items]",
        "terseLabel": "Product Warranty Liability [Line Items]"
       }
      }
     },
     "localname": "ProductWarrantyLiabilityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESProductWarrantyDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ProductWarrantyLiabilityTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about product warranty liability, including, but not limited to, reductions in the liability for payments made under the warranty, changes in the liability for accruals related to product warranties issued, and changes in the liability for accruals related to preexisting warranties.",
        "label": "Product Warranty Liability [Table]",
        "terseLabel": "Product Warranty Liability [Table]"
       }
      }
     },
     "localname": "ProductWarrantyLiabilityTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESProductWarrantyDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r220",
      "r241",
      "r243",
      "r255",
      "r261",
      "r269",
      "r279",
      "r280",
      "r322",
      "r333",
      "r339",
      "r342",
      "r357",
      "r400",
      "r401",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r409",
      "r410",
      "r542",
      "r545",
      "r546",
      "r566",
      "r578",
      "r657",
      "r717",
      "r740",
      "r741",
      "r763",
      "r800"
     ],
     "calculation": {
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net income",
        "totalLabel": "Net income",
        "verboseLabel": "Net income"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited",
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUnaudited",
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited",
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited",
      "http://www.varex.com/role/SEGMENTINFORMATIONIncomeStatementInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization": {
     "auth_ref": [
      "r797",
      "r816"
     ],
     "calculation": {
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.",
        "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization",
        "terseLabel": "Property, plant, and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r476",
      "r625",
      "r626"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]",
        "terseLabel": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/RELATEDPARTYTRANSACTIONSInvestmentinPrivatelyHeldCompaniesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionAxis": {
     "auth_ref": [
      "r213",
      "r625",
      "r626",
      "r818"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party transaction.",
        "label": "Related Party Transaction [Axis]",
        "terseLabel": "Related Party Transaction [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/RELATEDPARTYTRANSACTIONSInvestmentinPrivatelyHeldCompaniesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionDomain": {
     "auth_ref": [
      "r213"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transaction between related party.",
        "label": "Related Party Transaction [Domain]",
        "terseLabel": "Related Party Transaction [Domain]"
       }
      }
     },
     "localname": "RelatedPartyTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/RELATEDPARTYTRANSACTIONSInvestmentinPrivatelyHeldCompaniesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Related Party Transaction [Line Items]",
        "terseLabel": "Related Party Transaction [Line Items]"
       }
      }
     },
     "localname": "RelatedPartyTransactionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/RELATEDPARTYTRANSACTIONSInvestmentinPrivatelyHeldCompaniesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchases during the period (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.",
        "label": "Related Party Transaction, Purchases from Related Party",
        "terseLabel": "Purchases from related party"
       }
      }
     },
     "localname": "RelatedPartyTransactionPurchasesFromRelatedParty",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/RELATEDPARTYTRANSACTIONSInvestmentinPrivatelyHeldCompaniesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]",
        "terseLabel": "Related Party Transactions [Abstract]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r476",
      "r625",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r818"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]",
        "terseLabel": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/RELATEDPARTYTRANSACTIONSInvestmentinPrivatelyHeldCompaniesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "auth_ref": [
      "r623",
      "r624",
      "r626",
      "r627",
      "r628"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Related Party Transactions Disclosure [Text Block]",
        "terseLabel": "RELATED PARTY TRANSACTIONS"
       }
      }
     },
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/RELATEDPARTYTRANSACTIONS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RepaymentsOfLongTermLinesOfCredit": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for the settlement of obligation drawn from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.",
        "label": "Repayments of Long-Term Lines of Credit",
        "negatedTerseLabel": "Repayments of borrowing under credit agreements"
       }
      }
     },
     "localname": "RepaymentsOfLongTermLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r129",
      "r212",
      "r827"
     ],
     "calculation": {
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/EMPLOYEESTOCKPLANSSharebasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCash": {
     "auth_ref": [
      "r755",
      "r770",
      "r828",
      "r830"
     ],
     "calculation": {
      "http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESCashandCashEquivalentsandRestrictedCashDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCash",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESCashandCashEquivalentsandRestrictedCashDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r67"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "terseLabel": "Restricted stock and options"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/NETINCOMEPERSHAREReconciliationofNumeratorandDenominatorforBasicandDilutedNetLossIncomePerCommonShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring and Related Activities [Abstract]",
        "terseLabel": "Restructuring and Related Activities [Abstract]"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r388",
      "r389",
      "r392",
      "r394",
      "r395"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.",
        "label": "Restructuring and Related Activities Disclosure [Text Block]",
        "terseLabel": "RESTRUCTURING"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/RESTRUCTURING"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r8",
      "r118",
      "r205",
      "r670",
      "r675",
      "r743"
     ],
     "calculation": {
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRecentlyAdoptedAccountingStandardsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r216",
      "r265",
      "r266",
      "r267",
      "r270",
      "r278",
      "r280",
      "r361",
      "r514",
      "r515",
      "r516",
      "r527",
      "r528",
      "r564",
      "r666",
      "r668"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r313",
      "r314",
      "r332",
      "r337",
      "r338",
      "r344",
      "r345",
      "r348",
      "r462",
      "r464",
      "r635"
     ],
     "calculation": {
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Revenues, net",
        "verboseLabel": "Revenues, net"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited",
      "http://www.varex.com/role/REVENUEDisaggregationofRevenueDetails",
      "http://www.varex.com/role/SEGMENTINFORMATIONIncomeStatementInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerMember": {
     "auth_ref": [
      "r348",
      "r781"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from satisfaction of performance obligation by transferring promised product and service to customer, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue from Contract with Customer Benchmark [Member]",
        "terseLabel": "Revenue from contract with customer"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESCustomerConcentrationRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r468",
      "r713"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r467",
      "r468"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "REVENUE"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/REVENUE"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/BORROWINGSAssetBasedLoanNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r615",
      "r742"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Noncash operating right-of-use assets obtained in exchange for new lease liabilities"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/LEASESScheduleofOperatingLeaseCostandSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r67"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/NETINCOMEPERSHARENarrativeDetails",
      "http://www.varex.com/role/NETINCOMEPERSHAREReconciliationofNumeratorandDenominatorforBasicandDilutedNetLossIncomePerCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of cash and cash equivalents.",
        "label": "Schedule of Cash and Cash Equivalents [Table Text Block]",
        "terseLabel": "Schedule of Cash and Cash Equivalents"
       }
      }
     },
     "localname": "ScheduleOfCashAndCashEquivalentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule of Debt [Table Text Block]",
        "terseLabel": "Schedule of Debt"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/BORROWINGSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsTextBlock": {
     "auth_ref": [
      "r148",
      "r150",
      "r151",
      "r153",
      "r154",
      "r160",
      "r162",
      "r165",
      "r166"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Schedule of Derivative Instruments [Table Text Block]",
        "terseLabel": "Schedule of Derivative Instruments"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/FINANCIALDERIVATIVESANDHEDGINGACTIVITIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r780"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Income Per Share, Basic and Diluted"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/NETINCOMEPERSHARETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "auth_ref": [
      "r123",
      "r126"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/EMPLOYEESTOCKPLANSSharebasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "auth_ref": [
      "r123"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "terseLabel": "Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/EMPLOYEESTOCKPLANSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r91",
      "r93",
      "r636"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r91",
      "r93"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/GOODWILLANDINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r718"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillRollforwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r718",
      "r786",
      "r787",
      "r788",
      "r789",
      "r790",
      "r791",
      "r792",
      "r793",
      "r794",
      "r795",
      "r796"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/GOODWILLANDINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r0",
      "r12",
      "r13",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Schedule of Inventory, Current"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/INVENTORIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": {
     "auth_ref": [
      "r161"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for net investment hedges of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position.",
        "label": "Schedule of Net Investment Hedges, Statements of Financial Performance and Financial Position, Location [Table Text Block]",
        "terseLabel": "Schedule of Net Investment Hedges"
       }
      }
     },
     "localname": "ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/FINANCIALDERIVATIVESANDHEDGINGACTIVITIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock": {
     "auth_ref": [
      "r105"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability.",
        "label": "Schedule of Product Warranty Liability [Table Text Block]",
        "terseLabel": "Schedule of Product Warranty Liability"
       }
      }
     },
     "localname": "ScheduleOfProductWarrantyLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "auth_ref": [
      "r182",
      "r183"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Schedule of Related Party Transactions, by Related Party [Table]",
        "terseLabel": "Schedule of Related Party Transactions, by Related Party [Table]"
       }
      }
     },
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/RELATEDPARTYTRANSACTIONSInvestmentinPrivatelyHeldCompaniesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock": {
     "auth_ref": [
      "r64",
      "r186",
      "r204"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage.",
        "label": "Restrictions on Cash and Cash Equivalents [Table Text Block]",
        "terseLabel": "Restrictions on Cash and Cash Equivalents"
       }
      }
     },
     "localname": "ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": {
     "auth_ref": [
      "r98",
      "r99",
      "r100"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.",
        "label": "Restructuring and Related Costs [Table Text Block]",
        "terseLabel": "Summary of Restructuring Costs Incurred"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/RESTRUCTURINGTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r77",
      "r78",
      "r79",
      "r88"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/SEGMENTINFORMATIONIncomeStatementInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r77",
      "r78",
      "r79",
      "r88"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/SEGMENTINFORMATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r479",
      "r481",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/EMPLOYEESTOCKPLANSStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r119",
      "r120",
      "r121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Schedule of Share-based Compensation, Stock Options, Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/EMPLOYEESTOCKPLANSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.",
        "label": "Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]",
        "terseLabel": "Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity"
       }
      }
     },
     "localname": "ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/EMPLOYEESTOCKPLANSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock": {
     "auth_ref": [
      "r68",
      "r70",
      "r71",
      "r72",
      "r173",
      "r175"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.",
        "label": "Schedules of Concentration of Risk, by Risk Factor [Table Text Block]",
        "terseLabel": "Summary of Customers with a Significant Portion of Revenue"
       }
      }
     },
     "localname": "SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SecuredDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets.",
        "label": "Secured Debt [Member]",
        "terseLabel": "Secured Debt"
       }
      }
     },
     "localname": "SecuredDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/BORROWINGSAssetBasedLoanNarrativeDetails",
      "http://www.varex.com/role/BORROWINGSScheduleofDebtDetails",
      "http://www.varex.com/role/BORROWINGSSeniorSecuredNotesNarrativeDetails",
      "http://www.varex.com/role/FAIRVALUENarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r310",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r342",
      "r348",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r391",
      "r393",
      "r718",
      "r832"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillRollforwardDetails",
      "http://www.varex.com/role/SEGMENTINFORMATIONIncomeStatementInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r310",
      "r311",
      "r312",
      "r322",
      "r325",
      "r336",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r347",
      "r348",
      "r349"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "SEGMENT INFORMATION"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/SEGMENTINFORMATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/SEGMENTINFORMATIONIncomeStatementInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "auth_ref": [
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for segment reporting.",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "terseLabel": "Segment Reporting"
       }
      }
     },
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r43"
     ],
     "calculation": {
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.",
        "label": "Selling, General and Administrative Expenses [Member]",
        "verboseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpensesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/EMPLOYEESTOCKPLANSSharebasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r55"
     ],
     "calculation": {
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Share-based compensation expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedTerseLabel": "Restricted stock units, canceled or expired in period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/EMPLOYEESTOCKPLANSRestrictedStockandPerformanceStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Restricted stock units, canceled or expired (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/EMPLOYEESTOCKPLANSRestrictedStockandPerformanceStockDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Restricted stock units, grants in period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/EMPLOYEESTOCKPLANSRestrictedStockandPerformanceStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Restricted stock units, grants in period (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/EMPLOYEESTOCKPLANSRestrictedStockandPerformanceStockDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r495",
      "r496"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Restricted stock units, nonvested, ending balance (in shares)",
        "periodStartLabel": "Restricted stock units, nonvested, beginning balance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/EMPLOYEESTOCKPLANSRestrictedStockandPerformanceStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Number\u00a0of\u00a0Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/EMPLOYEESTOCKPLANSRestrictedStockandPerformanceStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r495",
      "r496"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Restricted stock units, nonvested, end of period (in USD per share)",
        "periodStartLabel": "Restricted stock units, nonvested, beginning of period (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/EMPLOYEESTOCKPLANSRestrictedStockandPerformanceStockDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted\u00a0Average Grant-Date Fair Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/EMPLOYEESTOCKPLANSRestrictedStockandPerformanceStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedTerseLabel": "Restricted stock units, vested in period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/EMPLOYEESTOCKPLANSRestrictedStockandPerformanceStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Restricted stock units, vested in period (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/EMPLOYEESTOCKPLANSRestrictedStockandPerformanceStockDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/EMPLOYEESTOCKPLANSStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/EMPLOYEESTOCKPLANSStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r489"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Options, exercisable (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/EMPLOYEESTOCKPLANSStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r489"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Options, exercisable, weighted average exercise price (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/EMPLOYEESTOCKPLANSStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": {
     "auth_ref": [
      "r808"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period",
        "negatedTerseLabel": "Canceled, expired or forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/EMPLOYEESTOCKPLANSStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r808"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price of options that were either forfeited or expired.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price",
        "terseLabel": "Canceled, expired or forfeited (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/EMPLOYEESTOCKPLANSStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [
      "r491"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/EMPLOYEESTOCKPLANSStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r124"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Options, outstanding, aggregate intrinsic value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/EMPLOYEESTOCKPLANSStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r487",
      "r488"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Outstanding, ending balance (in shares)",
        "periodStartLabel": "Outstanding, beginning balance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/EMPLOYEESTOCKPLANSStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Options"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/EMPLOYEESTOCKPLANSStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r487",
      "r488"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Options outstanding ending balance (in USD per share)",
        "periodStartLabel": "Options outstanding beginning balance (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/EMPLOYEESTOCKPLANSStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/EMPLOYEESTOCKPLANSStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r491"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Granted (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/EMPLOYEESTOCKPLANSStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks of a company.",
        "label": "Share Price",
        "terseLabel": "Share price (in USD per share)"
       }
      }
     },
     "localname": "SharePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/EMPLOYEESTOCKPLANSStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r124"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value",
        "terseLabel": "Options, exercisable, aggregate intrinsic value"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/EMPLOYEESTOCKPLANSStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r124"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Options, exercisable, weighted average remaining contractual term (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/EMPLOYEESTOCKPLANSStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r122"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Options, outstanding, weighted average remaining contractual term (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/EMPLOYEESTOCKPLANSStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_StandardProductWarrantyAccrual": {
     "auth_ref": [
      "r104"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount as of the balance sheet date of the aggregate standard product warranty liability. Does not include the balance for the extended product warranty liability.",
        "label": "Standard Product Warranty Accrual",
        "periodEndLabel": "Accrued product warranty, at end of period",
        "periodStartLabel": "Accrued product warranty, at beginning of period"
       }
      }
     },
     "localname": "StandardProductWarrantyAccrual",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESProductWarrantyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StandardProductWarrantyAccrualPayments": {
     "auth_ref": [
      "r101"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in the standard product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard product warranty. Excludes extended product warranties.",
        "label": "Standard Product Warranty Accrual, Decrease for Payments",
        "negatedLabel": "Product warranty expenditures"
       }
      }
     },
     "localname": "StandardProductWarrantyAccrualPayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESProductWarrantyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StandardProductWarrantyAccrualWarrantiesIssued": {
     "auth_ref": [
      "r102"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in the standard product warranty accrual from warranties issued. Excludes extended product warranties.",
        "label": "Standard Product Warranty Accrual, Increase for Warranties Issued",
        "terseLabel": "New accruals charged to cost of revenues"
       }
      }
     },
     "localname": "StandardProductWarrantyAccrualWarrantiesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESProductWarrantyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StandardProductWarrantyPolicy": {
     "auth_ref": [
      "r103"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for standard warranties including the methodology for measuring the liability.",
        "label": "Standard Product Warranty, Policy [Policy Text Block]",
        "terseLabel": "Product Warranty"
       }
      }
     },
     "localname": "StandardProductWarrantyPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r219",
      "r310",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r342",
      "r348",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r387",
      "r391",
      "r393",
      "r718",
      "r832"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillRollforwardDetails",
      "http://www.varex.com/role/SEGMENTINFORMATIONIncomeStatementInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r25",
      "r112",
      "r216",
      "r245",
      "r246",
      "r247",
      "r265",
      "r266",
      "r267",
      "r270",
      "r278",
      "r280",
      "r304",
      "r361",
      "r442",
      "r514",
      "r515",
      "r516",
      "r527",
      "r528",
      "r564",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r596",
      "r622",
      "r666",
      "r667",
      "r668"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r265",
      "r266",
      "r267",
      "r304",
      "r635"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r5",
      "r6",
      "r112",
      "r118"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "terseLabel": "Common stock issued under employee stock purchase plan (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r5",
      "r6",
      "r112",
      "r118",
      "r492"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "terseLabel": "Exercise of stock options (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "auth_ref": [
      "r5",
      "r6",
      "r112",
      "r118"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.",
        "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan",
        "terseLabel": "Common stock issued under employee stock purchase plan"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r25",
      "r112",
      "r118"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Exercise of stock options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r6",
      "r9",
      "r10",
      "r80",
      "r743",
      "r772",
      "r784",
      "r815"
     ],
     "calculation": {
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total Varex stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r137",
      "r138",
      "r144",
      "r216",
      "r217",
      "r246",
      "r265",
      "r266",
      "r267",
      "r270",
      "r278",
      "r361",
      "r442",
      "r514",
      "r515",
      "r516",
      "r527",
      "r528",
      "r564",
      "r590",
      "r591",
      "r596",
      "r622",
      "r667",
      "r668",
      "r772",
      "r784",
      "r815"
     ],
     "calculation": {
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Stockholders' equity, outstanding, ending balance",
        "periodStartLabel": "Stockholders' equity, outstanding, beginning balance",
        "totalLabel": "Total stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]",
        "terseLabel": "Stockholders' equity:"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityOther": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.",
        "label": "Stockholders' Equity, Other",
        "negatedTerseLabel": "Other"
       }
      }
     },
     "localname": "StockholdersEquityOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SubsequentEventsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for reporting subsequent events.",
        "label": "Subsequent Events, Policy [Policy Text Block]",
        "terseLabel": "Subsequent Events"
       }
      }
     },
     "localname": "SubsequentEventsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental cash flow information:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquitySharesOutstanding": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Shares Outstanding",
        "terseLabel": "Temporary equity, shares outstanding (in shares)"
       }
      }
     },
     "localname": "TemporaryEquitySharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/NONCONTROLLINGINTERESTSNoncontrollingInterestDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r269",
      "r270",
      "r271",
      "r272",
      "r281",
      "r353",
      "r354",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r514",
      "r515",
      "r516",
      "r525",
      "r526",
      "r527",
      "r528",
      "r539",
      "r540",
      "r541",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r597",
      "r598",
      "r602",
      "r603",
      "r604",
      "r605",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r637",
      "r638",
      "r639",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment to accounting standards.",
        "label": "Accounting Standards Update [Domain]",
        "terseLabel": "Type of Adoption [Domain]"
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRecentlyAdoptedAccountingStandardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USGovernmentAgenciesDebtSecuritiesMember": {
     "auth_ref": [
      "r714",
      "r733",
      "r829"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debentures, notes, and other debt securities issued by US government agencies, for example, but not limited to, Government National Mortgage Association (GNMA or Ginnie Mae). Excludes US treasury securities and debt issued by government-sponsored Enterprises (GSEs), for example, but is not limited to, Federal Home Loan Mortgage Corporation (FHLMC or Freddie Mac), Federal National Mortgage Association (FNMA or Fannie Mae), and the Federal Home Loan Bank (FHLB).",
        "label": "US Government Agencies Debt Securities [Member]",
        "terseLabel": "Government agencies"
       }
      }
     },
     "localname": "USGovernmentAgenciesDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/FAIRVALUEBalanceSheetMarketableSecuritiesDetails",
      "http://www.varex.com/role/FAIRVALUESummaryofMarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USGovernmentAgenciesSecuritiesAtCarryingValue": {
     "auth_ref": [],
     "calculation": {
      "http://www.varex.com/role/FAIRVALUEScheduleofFairValueInputsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities issued by a United States government agency such as Government National Mortgage Association (Ginnie Mae), Federal Home Loan Mortgage Corporation (Freddie Mac), and Federal National Mortgage Association (Fannie Mae), which are short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three-years ago does not become a cash equivalent when its remaining maturity is three months.",
        "label": "US Government Agencies Securities, at Carrying Value",
        "terseLabel": "Government agencies"
       }
      }
     },
     "localname": "USGovernmentAgenciesSecuritiesAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/FAIRVALUEScheduleofFairValueInputsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_USTreasuryBillSecuritiesMember": {
     "auth_ref": [
      "r829"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes information about negotiable debt securities issued by the United States Department of the Treasury which generally have maturities of one year or less, are interest bearing, and are backed by the full faith and credit of the United States government.",
        "label": "US Treasury Bill Securities [Member]",
        "terseLabel": "U.S. Treasury bills"
       }
      }
     },
     "localname": "USTreasuryBillSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/FAIRVALUEBalanceSheetMarketableSecuritiesDetails",
      "http://www.varex.com/role/FAIRVALUESummaryofMarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r73",
      "r74",
      "r75",
      "r305",
      "r306",
      "r308",
      "r309"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_WarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.",
        "label": "Warrant [Member]",
        "terseLabel": "Warrants"
       }
      }
     },
     "localname": "WarrantMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/NETINCOMEPERSHAREReconciliationofNumeratorandDenominatorforBasicandDilutedNetLossIncomePerCommonShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r283",
      "r298"
     ],
     "calculation": {
      "http://www.varex.com/role/NETINCOMEPERSHAREReconciliationofNumeratorandDenominatorforBasicandDilutedNetLossIncomePerCommonShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "totalLabel": "Diluted weighted average shares outstanding (in shares)",
        "verboseLabel": "Diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited",
      "http://www.varex.com/role/NETINCOMEPERSHAREReconciliationofNumeratorandDenominatorforBasicandDilutedNetLossIncomePerCommonShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Weighted average common shares outstanding"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r282",
      "r298"
     ],
     "calculation": {
      "http://www.varex.com/role/NETINCOMEPERSHAREReconciliationofNumeratorandDenominatorforBasicandDilutedNetLossIncomePerCommonShareDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic weighted average shares outstanding (in shares)",
        "verboseLabel": "Basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited",
      "http://www.varex.com/role/NETINCOMEPERSHAREReconciliationofNumeratorandDenominatorforBasicandDilutedNetLossIncomePerCommonShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "var_AssetBasedLoanRevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset-Based Loan Revolving Credit Facility",
        "label": "Asset-Based Loan Revolving Credit Facility [Member]",
        "terseLabel": "Asset-Based Loan"
       }
      }
     },
     "localname": "AssetBasedLoanRevolvingCreditFacilityMember",
     "nsuri": "http://www.varex.com/20221230",
     "presentation": [
      "http://www.varex.com/role/BORROWINGSAssetBasedLoanNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "var_AssetsAndLiabilitiesLesseeTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assets And Liabilities, Lessee [Table Text Block]",
        "label": "Assets And Liabilities, Lessee [Table Text Block]",
        "terseLabel": "Schedule of Supplemental Balance Sheet Information"
       }
      }
     },
     "localname": "AssetsAndLiabilitiesLesseeTableTextBlock",
     "nsuri": "http://www.varex.com/20221230",
     "presentation": [
      "http://www.varex.com/role/LEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "var_BusinessAcquisitionAnnualRecurringCompensation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Acquisition, Annual Recurring Compensation",
        "label": "Business Acquisition, Annual Recurring Compensation",
        "terseLabel": "Annual recurring compensation (in euros per share)"
       }
      }
     },
     "localname": "BusinessAcquisitionAnnualRecurringCompensation",
     "nsuri": "http://www.varex.com/20221230",
     "presentation": [
      "http://www.varex.com/role/NONCONTROLLINGINTERESTSNoncontrollingInterestDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "var_BusinessAcquisitionCumulativePercentageOfVotingInterestsAcquired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Acquisition, Cumulative Percentage Of Voting Interests Acquired",
        "label": "Business Acquisition, Cumulative Percentage Of Voting Interests Acquired",
        "terseLabel": "Cumulative percentage of voting interests acquired"
       }
      }
     },
     "localname": "BusinessAcquisitionCumulativePercentageOfVotingInterestsAcquired",
     "nsuri": "http://www.varex.com/20221230",
     "presentation": [
      "http://www.varex.com/role/NONCONTROLLINGINTERESTSNoncontrollingInterestDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "var_CanonMedicalSystemsCorporationFormerlyToshibaMedicalSystemsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Canon Medical Systems Corporation (Formerly Toshiba Medical Systems) [Member]",
        "label": "Canon Medical Systems Corporation (Formerly Toshiba Medical Systems) [Member]",
        "terseLabel": "Canon Medical Systems Corporation"
       }
      }
     },
     "localname": "CanonMedicalSystemsCorporationFormerlyToshibaMedicalSystemsMember",
     "nsuri": "http://www.varex.com/20221230",
     "presentation": [
      "http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESCustomerConcentrationRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "var_CashPaidForOperatingAndFinanceLeases": {
     "auth_ref": [],
     "calculation": {
      "http://www.varex.com/role/LEASESScheduleofOperatingLeaseCostandSupplementalCashFlowInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash Paid For Operating And Finance Leases",
        "label": "Cash Paid For Operating And Finance Leases",
        "totalLabel": "Total cash paid for amounts included in the measurement of lease liabilities"
       }
      }
     },
     "localname": "CashPaidForOperatingAndFinanceLeases",
     "nsuri": "http://www.varex.com/20221230",
     "presentation": [
      "http://www.varex.com/role/LEASESScheduleofOperatingLeaseCostandSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "var_ClassOfWarrantOrRightPercentIncreaseOfStrikePriceOverSalePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class Of Warrant Or Right, Percent Increase Of Strike Price Over Sale Price",
        "label": "Class Of Warrant Or Right, Percent Increase Of Strike Price Over Sale Price",
        "terseLabel": "Percent increase of strike price over sale price"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightPercentIncreaseOfStrikePriceOverSalePrice",
     "nsuri": "http://www.varex.com/20221230",
     "presentation": [
      "http://www.varex.com/role/BORROWINGSCallSpreadNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "var_CommercialPaperReceivable": {
     "auth_ref": [],
     "calculation": {
      "http://www.varex.com/role/FAIRVALUEScheduleofFairValueInputsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commercial Paper Receivable",
        "label": "Commercial Paper Receivable",
        "terseLabel": "Commercial paper"
       }
      }
     },
     "localname": "CommercialPaperReceivable",
     "nsuri": "http://www.varex.com/20221230",
     "presentation": [
      "http://www.varex.com/role/FAIRVALUEScheduleofFairValueInputsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "var_ContractWithCustomerRefundLiabilityAdditions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract With Customer, Refund Liability, Additions",
        "label": "Contract With Customer, Refund Liability, Additions",
        "terseLabel": "Additions to refund liabilities"
       }
      }
     },
     "localname": "ContractWithCustomerRefundLiabilityAdditions",
     "nsuri": "http://www.varex.com/20221230",
     "presentation": [
      "http://www.varex.com/role/REVENUESummaryofContractAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "var_ContractWithCustomerRefundLiabilityAmountReleased": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract With Customer, Refund Liability, Amount Released",
        "label": "Contract With Customer, Refund Liability, Amount Released",
        "negatedLabel": "Release of refund liability included in beginning of year refund liability"
       }
      }
     },
     "localname": "ContractWithCustomerRefundLiabilityAmountReleased",
     "nsuri": "http://www.varex.com/20221230",
     "presentation": [
      "http://www.varex.com/role/REVENUESummaryofContractAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "var_ContractwithCustomerAssetShipments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with Customer, Asset, Shipments",
        "label": "Contract with Customer, Asset, Shipments",
        "terseLabel": "Contract asset from shipments of products, subject to return during the period"
       }
      }
     },
     "localname": "ContractwithCustomerAssetShipments",
     "nsuri": "http://www.varex.com/20221230",
     "presentation": [
      "http://www.varex.com/role/REVENUESummaryofContractAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "var_ConvertibleNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Convertible Notes",
        "label": "Convertible Notes [Member]",
        "terseLabel": "Convertible Notes"
       }
      }
     },
     "localname": "ConvertibleNotesMember",
     "nsuri": "http://www.varex.com/20221230",
     "presentation": [
      "http://www.varex.com/role/BORROWINGSCallSpreadNarrativeDetails",
      "http://www.varex.com/role/BORROWINGSConvertibleSeniorUnsecuredNotesNarrativeDetails",
      "http://www.varex.com/role/NETINCOMEPERSHARENarrativeDetails",
      "http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRecentlyAdoptedAccountingStandardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "var_CorporateBonds": {
     "auth_ref": [],
     "calculation": {
      "http://www.varex.com/role/FAIRVALUEScheduleofFairValueInputsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate Bonds",
        "label": "Corporate Bonds",
        "terseLabel": "Corporate notes/bonds"
       }
      }
     },
     "localname": "CorporateBonds",
     "nsuri": "http://www.varex.com/20221230",
     "presentation": [
      "http://www.varex.com/role/FAIRVALUEScheduleofFairValueInputsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "var_CustomerContractsandSupplierRelationshipsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer Contracts and Supplier Relationships [Member]",
        "label": "Customer Contracts and Supplier Relationships [Member]",
        "terseLabel": "Customer contracts and supplier relationship"
       }
      }
     },
     "localname": "CustomerContractsandSupplierRelationshipsMember",
     "nsuri": "http://www.varex.com/20221230",
     "presentation": [
      "http://www.varex.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "var_DerivativeNumberOfInstrumentsTerminated": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative Number Of Instruments Terminated",
        "label": "Derivative Number Of Instruments Terminated",
        "terseLabel": "Derivative number of instruments terminated"
       }
      }
     },
     "localname": "DerivativeNumberOfInstrumentsTerminated",
     "nsuri": "http://www.varex.com/20221230",
     "presentation": [
      "http://www.varex.com/role/FINANCIALDERIVATIVESANDHEDGINGACTIVITIESNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "var_DpiXHoldingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "dpiX Holding [Member]",
        "label": "dpiX Holding [Member]",
        "terseLabel": "dpiX Holding"
       }
      }
     },
     "localname": "DpiXHoldingMember",
     "nsuri": "http://www.varex.com/20221230",
     "presentation": [
      "http://www.varex.com/role/RELATEDPARTYTRANSACTIONSInvestmentinPrivatelyHeldCompaniesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "var_DpiXLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Dpi X LLC",
        "label": "Dpi X LLC [Member]",
        "terseLabel": "Dpi X LLC"
       }
      }
     },
     "localname": "DpiXLLCMember",
     "nsuri": "http://www.varex.com/20221230",
     "presentation": [
      "http://www.varex.com/role/RELATEDPARTYTRANSACTIONSInvestmentinPrivatelyHeldCompaniesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "var_ExercisePriceRangeRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise Price Range [Rollforward]",
        "label": "Exercise Price Range [Roll Forward]",
        "terseLabel": "Price Range"
       }
      }
     },
     "localname": "ExercisePriceRangeRollForward",
     "nsuri": "http://www.varex.com/20221230",
     "presentation": [
      "http://www.varex.com/role/EMPLOYEESTOCKPLANSStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "var_FixedCostCommitmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fixed Cost Commitments [Member]",
        "label": "Fixed Cost Commitments [Member]",
        "terseLabel": "Fixed Cost Commitments"
       }
      }
     },
     "localname": "FixedCostCommitmentsMember",
     "nsuri": "http://www.varex.com/20221230",
     "presentation": [
      "http://www.varex.com/role/RELATEDPARTYTRANSACTIONSInvestmentinPrivatelyHeldCompaniesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "var_GainLossOnSettlementOfHedgeInvestingActivities": {
     "auth_ref": [],
     "calculation": {
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain (Loss) On Settlement Of Hedge, Investing Activities",
        "label": "Gain (Loss) On Settlement Of Hedge, Investing Activities",
        "negatedTerseLabel": "Loss on settlement of cash flow hedge"
       }
      }
     },
     "localname": "GainLossOnSettlementOfHedgeInvestingActivities",
     "nsuri": "http://www.varex.com/20221230",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "var_IncrementalCommonSharesAttributableToDilutiveEffectOfWarrants": {
     "auth_ref": [],
     "calculation": {
      "http://www.varex.com/role/NETINCOMEPERSHAREReconciliationofNumeratorandDenominatorforBasicandDilutedNetLossIncomePerCommonShareDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental Common Shares Attributable To Dilutive Effect Of Warrants",
        "label": "Incremental Common Shares Attributable To Dilutive Effect Of Warrants",
        "terseLabel": "Dilutive effect of warrants (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToDilutiveEffectOfWarrants",
     "nsuri": "http://www.varex.com/20221230",
     "presentation": [
      "http://www.varex.com/role/NETINCOMEPERSHAREReconciliationofNumeratorandDenominatorforBasicandDilutedNetLossIncomePerCommonShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "var_IndustrialMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Industrial [Member]",
        "label": "Industrial [Member]",
        "terseLabel": "Industrial"
       }
      }
     },
     "localname": "IndustrialMember",
     "nsuri": "http://www.varex.com/20221230",
     "presentation": [
      "http://www.varex.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillRollforwardDetails",
      "http://www.varex.com/role/SEGMENTINFORMATIONIncomeStatementInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "var_InterestExpenseDebtContractualInterestCoupon": {
     "auth_ref": [],
     "calculation": {
      "http://www.varex.com/role/BORROWINGSScheduleofInterestExpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InterestExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Expense, Debt, Contractual Interest Coupon",
        "label": "Interest Expense, Debt, Contractual Interest Coupon",
        "terseLabel": "Contractual interest coupon and other"
       }
      }
     },
     "localname": "InterestExpenseDebtContractualInterestCoupon",
     "nsuri": "http://www.varex.com/20221230",
     "presentation": [
      "http://www.varex.com/role/BORROWINGSScheduleofInterestExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "var_JointVentureInSaudiArabiaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Joint Venture In Saudi Arabia [Member]",
        "label": "Joint Venture In Saudi Arabia [Member]",
        "terseLabel": "Joint Venture In Saudi Arabia"
       }
      }
     },
     "localname": "JointVentureInSaudiArabiaMember",
     "nsuri": "http://www.varex.com/20221230",
     "presentation": [
      "http://www.varex.com/role/NONCONTROLLINGINTERESTSNoncontrollingInterestDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "var_LeaseCostFinanceLeaseCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Cost, Finance Lease Costs",
        "label": "Lease, Cost, Finance Lease Costs",
        "terseLabel": "Total finance lease costs"
       }
      }
     },
     "localname": "LeaseCostFinanceLeaseCosts",
     "nsuri": "http://www.varex.com/20221230",
     "presentation": [
      "http://www.varex.com/role/LEASESScheduleofOperatingLeaseCostandSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "var_LongtermDebtExcludingCurrentMaturitiesGross": {
     "auth_ref": [],
     "calculation": {
      "http://www.varex.com/role/BORROWINGSScheduleofDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-term Debt Excluding Current Maturities, Gross",
        "label": "Long-term Debt Excluding Current Maturities, Gross",
        "terseLabel": "Total non-current maturities of long-term debt:"
       }
      }
     },
     "localname": "LongtermDebtExcludingCurrentMaturitiesGross",
     "nsuri": "http://www.varex.com/20221230",
     "presentation": [
      "http://www.varex.com/role/BORROWINGSScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "var_MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.varex.com/role/FAIRVALUESummaryofMarketableSecuritiesDetails": {
       "order": 1.0,
       "parentTag": "var_MarketableSecuritiesAmortizedCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Marketable Securities, Accumulated Gross Unrealized Loss, Before Tax",
        "label": "Marketable Securities, Accumulated Gross Unrealized Loss, Before Tax",
        "negatedTerseLabel": "Unrealized Losses"
       }
      }
     },
     "localname": "MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://www.varex.com/20221230",
     "presentation": [
      "http://www.varex.com/role/FAIRVALUESummaryofMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "var_MarketableSecuritiesAmortizedCost": {
     "auth_ref": [],
     "calculation": {
      "http://www.varex.com/role/FAIRVALUEContractualMaturitiesofMarketableSecuritiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.varex.com/role/FAIRVALUESummaryofMarketableSecuritiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Marketable Securities, Amortized Cost",
        "label": "Marketable Securities, Amortized Cost",
        "totalLabel": "Total marketable debt securities"
       }
      }
     },
     "localname": "MarketableSecuritiesAmortizedCost",
     "nsuri": "http://www.varex.com/20221230",
     "presentation": [
      "http://www.varex.com/role/FAIRVALUEContractualMaturitiesofMarketableSecuritiesDetails",
      "http://www.varex.com/role/FAIRVALUESummaryofMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "var_MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughFive": {
     "auth_ref": [],
     "calculation": {
      "http://www.varex.com/role/FAIRVALUEContractualMaturitiesofMarketableSecuritiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_MarketableSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Marketable Securities, Maturity, Allocated and Single Maturity Date, After Year One Through Five",
        "label": "Marketable Securities, Maturity, Allocated and Single Maturity Date, After Year One Through Five",
        "terseLabel": "Due after one year through five years"
       }
      }
     },
     "localname": "MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughFive",
     "nsuri": "http://www.varex.com/20221230",
     "presentation": [
      "http://www.varex.com/role/FAIRVALUEContractualMaturitiesofMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "var_MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateRollingAfterOneThroughFiveYearsAmortizedCost": {
     "auth_ref": [],
     "calculation": {
      "http://www.varex.com/role/FAIRVALUEContractualMaturitiesofMarketableSecuritiesDetails": {
       "order": 2.0,
       "parentTag": "var_MarketableSecuritiesAmortizedCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Marketable Securities, Maturity, Allocated and Single Maturity Date, Rolling After One Through Five Years, Amortized Cost",
        "label": "Marketable Securities, Maturity, Allocated and Single Maturity Date, Rolling After One Through Five Years, Amortized Cost",
        "terseLabel": "Due after one year through five years"
       }
      }
     },
     "localname": "MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateRollingAfterOneThroughFiveYearsAmortizedCost",
     "nsuri": "http://www.varex.com/20221230",
     "presentation": [
      "http://www.varex.com/role/FAIRVALUEContractualMaturitiesofMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "var_MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateRollingWithinOneYearAmortizedCost": {
     "auth_ref": [],
     "calculation": {
      "http://www.varex.com/role/FAIRVALUEContractualMaturitiesofMarketableSecuritiesDetails": {
       "order": 1.0,
       "parentTag": "var_MarketableSecuritiesAmortizedCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Marketable Securities, Maturity, Allocated and Single Maturity Date, Rolling Within One Year, Amortized Cost",
        "label": "Marketable Securities, Maturity, Allocated and Single Maturity Date, Rolling Within One Year, Amortized Cost",
        "terseLabel": "Due within one year"
       }
      }
     },
     "localname": "MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateRollingWithinOneYearAmortizedCost",
     "nsuri": "http://www.varex.com/20221230",
     "presentation": [
      "http://www.varex.com/role/FAIRVALUEContractualMaturitiesofMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "var_MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateYearOne": {
     "auth_ref": [],
     "calculation": {
      "http://www.varex.com/role/FAIRVALUEContractualMaturitiesofMarketableSecuritiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_MarketableSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Marketable Securities, Maturity, Allocated And Single Maturity Date, Year One",
        "label": "Marketable Securities, Maturity, Allocated And Single Maturity Date, Year One",
        "terseLabel": "Due within one year"
       }
      }
     },
     "localname": "MarketableSecuritiesMaturityAllocatedAndSingleMaturityDateYearOne",
     "nsuri": "http://www.varex.com/20221230",
     "presentation": [
      "http://www.varex.com/role/FAIRVALUEContractualMaturitiesofMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "var_MeVisMedicalSolutionsAGMeVisMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "MeVis Medical Solutions AG (MeVis) [Member]",
        "label": "MeVis Medical Solutions AG (MeVis) [Member]",
        "terseLabel": "MeVis Medical Solutions AG (MeVis)"
       }
      }
     },
     "localname": "MeVisMedicalSolutionsAGMeVisMember",
     "nsuri": "http://www.varex.com/20221230",
     "presentation": [
      "http://www.varex.com/role/NONCONTROLLINGINTERESTSNoncontrollingInterestDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "var_MedicalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medical [Member]",
        "label": "Medical [Member]",
        "terseLabel": "Medical"
       }
      }
     },
     "localname": "MedicalMember",
     "nsuri": "http://www.varex.com/20221230",
     "presentation": [
      "http://www.varex.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillRollforwardDetails",
      "http://www.varex.com/role/SEGMENTINFORMATIONIncomeStatementInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "var_NetIncomeLossAttributableToNoncontrollingInterestNetOfDividends": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Income (Loss) Attributable To Noncontrolling Interest, Net Of Dividends",
        "label": "Net Income (Loss) Attributable To Noncontrolling Interest, Net Of Dividends",
        "verboseLabel": "Net income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterestNetOfDividends",
     "nsuri": "http://www.varex.com/20221230",
     "presentation": [
      "http://www.varex.com/role/NONCONTROLLINGINTERESTSNoncontrollingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "var_NoncontrollingInterestOtherChanges": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncontrolling Interest, Other Changes",
        "label": "Noncontrolling Interest, Other Changes",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "NoncontrollingInterestOtherChanges",
     "nsuri": "http://www.varex.com/20221230",
     "presentation": [
      "http://www.varex.com/role/NONCONTROLLINGINTERESTSNoncontrollingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "var_NoncontrollingInterestTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncontrolling Interest",
        "label": "Noncontrolling Interest [Table Text Block]",
        "terseLabel": "Noncontrolling Interest"
       }
      }
     },
     "localname": "NoncontrollingInterestTableTextBlock",
     "nsuri": "http://www.varex.com/20221230",
     "presentation": [
      "http://www.varex.com/role/NONCONTROLLINGINTERESTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "var_PercentageOfAdditionalOutstandingSharesPurchased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage Of Additional Outstanding Shares Purchased",
        "label": "Percentage Of Additional Outstanding Shares Purchased",
        "terseLabel": "Percentage of additional outstanding shares purchased"
       }
      }
     },
     "localname": "PercentageOfAdditionalOutstandingSharesPurchased",
     "nsuri": "http://www.varex.com/20221230",
     "presentation": [
      "http://www.varex.com/role/NONCONTROLLINGINTERESTSNoncontrollingInterestDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "var_PercentageOfFixedCosts": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of fixed costs as defined in the agreement and determined at the beginning of each calendar year that the entity is required to pay.",
        "label": "Percentage Of Fixed Costs",
        "terseLabel": "Percentage of fixed costs"
       }
      }
     },
     "localname": "PercentageOfFixedCosts",
     "nsuri": "http://www.varex.com/20221230",
     "presentation": [
      "http://www.varex.com/role/RELATEDPARTYTRANSACTIONSInvestmentinPrivatelyHeldCompaniesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "var_PercentageOfManufacturingCapacity": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of manufacturing capacity that the entity has the guaranteed right to purchase up to.",
        "label": "Percentage Of Manufacturing Capacity",
        "terseLabel": "Percentage of manufacturing capacity"
       }
      }
     },
     "localname": "PercentageOfManufacturingCapacity",
     "nsuri": "http://www.varex.com/20221230",
     "presentation": [
      "http://www.varex.com/role/RELATEDPARTYTRANSACTIONSInvestmentinPrivatelyHeldCompaniesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "var_ProceedsFromSalesOfBusinessAndAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds From Sales Of Business And Assets",
        "label": "Proceeds From Sales Of Business And Assets",
        "terseLabel": "Proceeds from sales of business and assets"
       }
      }
     },
     "localname": "ProceedsFromSalesOfBusinessAndAssets",
     "nsuri": "http://www.varex.com/20221230",
     "presentation": [
      "http://www.varex.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "var_RelatedPartyTransactionApprovedPurchasesFromRelatedParty": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related Party Transaction, Approved Purchases From Related Party",
        "label": "Related Party Transaction, Approved Purchases From Related Party",
        "terseLabel": "Purchases approved from related party"
       }
      }
     },
     "localname": "RelatedPartyTransactionApprovedPurchasesFromRelatedParty",
     "nsuri": "http://www.varex.com/20221230",
     "presentation": [
      "http://www.varex.com/role/RELATEDPARTYTRANSACTIONSInvestmentinPrivatelyHeldCompaniesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "var_SeniorSecuredNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Secured Notes",
        "label": "Senior Secured Notes [Member]",
        "terseLabel": "Senior Secured Notes"
       }
      }
     },
     "localname": "SeniorSecuredNotesMember",
     "nsuri": "http://www.varex.com/20221230",
     "presentation": [
      "http://www.varex.com/role/BORROWINGSScheduleofDebtDetails",
      "http://www.varex.com/role/BORROWINGSSeniorSecuredNotesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "var_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingPrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement By Share-based Payment Award, Options, Outstanding, Price",
        "label": "Share-based Compensation Arrangement By Share-based Payment Award, Options, Outstanding, Price",
        "periodEndLabel": "Outstanding at period ending (in USD per share)",
        "periodStartLabel": "Outstanding at period beginning (in USD per share)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingPrice",
     "nsuri": "http://www.varex.com/20221230",
     "presentation": [
      "http://www.varex.com/role/EMPLOYEESTOCKPLANSStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "var_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisablePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Price",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Price",
        "terseLabel": "Exercisable (in USD per share)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisablePrice",
     "nsuri": "http://www.varex.com/20221230",
     "presentation": [
      "http://www.varex.com/role/EMPLOYEESTOCKPLANSStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "var_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsForfeituresandExpirationsinPeriodPrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Price",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Price",
        "terseLabel": "Canceled, expired or forfeited (in USD per share)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsForfeituresandExpirationsinPeriodPrice",
     "nsuri": "http://www.varex.com/20221230",
     "presentation": [
      "http://www.varex.com/role/EMPLOYEESTOCKPLANSStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "var_SharebasedCompensationArrangementsbySharebasedPaymentAwardOptionsGrantsinPeriodPrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "SharebasedCompensationArrangementsbySharebasedPaymentAwardOptionsGrantsinPeriodPrice",
        "label": "SharebasedCompensationArrangementsbySharebasedPaymentAwardOptionsGrantsinPeriodPrice",
        "terseLabel": "Granted (in USD per share)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementsbySharebasedPaymentAwardOptionsGrantsinPeriodPrice",
     "nsuri": "http://www.varex.com/20221230",
     "presentation": [
      "http://www.varex.com/role/EMPLOYEESTOCKPLANSStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "var_VECImagingGmbHCo.KGMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "VEC Imaging GmbH &amp; Co. KG [Member]",
        "label": "VEC Imaging GmbH &amp; Co. KG [Member]",
        "terseLabel": "VEC Imaging GmbH &amp; Co. KG"
       }
      }
     },
     "localname": "VECImagingGmbHCo.KGMember",
     "nsuri": "http://www.varex.com/20221230",
     "presentation": [
      "http://www.varex.com/role/RELATEDPARTYTRANSACTIONSInvestmentinPrivatelyHeldCompaniesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "var_WarrantyTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warranty Term",
        "label": "Warranty Term",
        "terseLabel": "Warranty term"
       }
      }
     },
     "localname": "WarrantyTerm",
     "nsuri": "http://www.varex.com/20221230",
     "presentation": [
      "http://www.varex.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESProductWarrantyDetails"
     ],
     "xbrltype": "durationItemType"
    }
   },
   "unitCount": 8
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "((c)(2))",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "((c)(3))",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1),(c)(5)",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466302&loc=d3e4852-112606",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org/topic&trid=2208564",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "44",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5558-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=d3e5291-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "https://asc.fasb.org/topic&trid=2197479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(iii)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41641-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=127000641&loc=SL5629052-113961",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "https://asc.fasb.org/topic&trid=2229140",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(3),(4))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.4)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126941378&loc=d3e61044-112788",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.17)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(10))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(5))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(2))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e689-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3151-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "27",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3581-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1707-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1757-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1500-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2029-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org/topic&trid=2144383",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e640-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "https://asc.fasb.org/topic&trid=2134510",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(12))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4542-108314",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "https://asc.fasb.org/topic&trid=2126998",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(7)(c))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(8))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(e))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "420",
   "URI": "https://asc.fasb.org/topic&trid=2175745",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.19)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130532-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130533-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130558-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130561-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130564-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130550-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "https://asc.fasb.org/topic&trid=49130388",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126962052&loc=d3e4991-113900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(l)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121577181&loc=SL110061190-113977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL7498357-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594786&loc=SL75136599-209740",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=126980362&loc=d3e28129-110885",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=125521441&loc=d3e30755-110894",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32262-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123386189&loc=SL77918607-209975",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918631-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918666-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/subtopic&trid=77888251",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL122150809-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "850",
   "URI": "https://asc.fasb.org/topic&trid=2122745",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=126938201&loc=d3e55415-109406",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "250",
   "URI": "https://asc.fasb.org/topic&trid=2122394",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "450",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491354&loc=d3e6049-115624",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r731": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r732": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r733": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r734": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r735": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r736": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r737": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r738": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r739": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r740": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r741": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r742": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r743": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r744": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r745": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r746": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r747": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r748": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r749": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r750": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r751": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r752": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r753": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r754": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=124429488&loc=d3e326-107755",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r755": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r756": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(10))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r757": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r758": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r759": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "https://asc.fasb.org/topic&trid=2134479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r760": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r761": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r762": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r763": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r764": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r765": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r766": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r767": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r768": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r769": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r770": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r771": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r772": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r773": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r774": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r775": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r776": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r777": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r778": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r779": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r780": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r781": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r782": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8672-108599",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r783": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27290-111563",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r784": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r785": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r786": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r787": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r788": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r789": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r790": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r791": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r792": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r793": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r794": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r795": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r796": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r797": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r798": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r799": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r800": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r801": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r802": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r803": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r804": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r805": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r806": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "27",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130611-203046-203046",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r807": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r808": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r809": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126974470&loc=d3e8622-111531",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r810": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r811": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r812": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(6)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r813": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r814": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r815": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r816": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r817": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r818": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r819": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r820": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r821": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r822": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r823": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r824": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r825": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r826": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r827": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r828": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r829": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62557-112803",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=126960272&loc=d3e32014-111567",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r830": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r831": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(b))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r832": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r833": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r834": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=126903467&loc=d3e32787-111569",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "https://asc.fasb.org/topic&trid=2144416",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.3)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>94
<FILENAME>0001681622-23-000013-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001681622-23-000013-xbrl.zip
M4$L#!!0    ( $.!/U8EQ9';"K " -M?&P 0    =F%R+3(P,C(Q,C,P+FAT
M;>Q]:5<;2=+N]_=7Z#+WWK?[G"Z<^T+W< \VF*%?2]@@FQ%??'*%$EH826#@
MU]_(DL1N [9 "]4S8*3:LC*>B'@B,C+SK_]WUFY53D.OGW<[_US"RVBI\O]6
M__I?6?;OMSL?*NM==](.G4'E72^80?"5;_G@L++G0_^H$GO==F6OVSO*3TV6
M%=>\ZQZ?]_*#PT&%($)O'>RM6(R<\EAGC%.;,1-E9EC &86SE4$2*Z/^.%@)
M&@7$@LJB@5\,89<I8])'YQ%G >EH__ KS%@NJ4;:6<4TI9IRB36U"$LG/97I
ML8<#>#MXPT[_GTN'@\'QRILWW[Y]6_Y&E[N]@S=8:_WF+)VS-#QI)3\;9/W@
M;IP,GY</NJ=O\DXK[X34+6\&/=/IQVZO;0;0;6\(PCQ#*J-X?)^S?G[? PE"
M^,V_JQ]VW6%HFRSO] >FX\+XJI-^=F#,\>65T?1M<=WH %Q/R.4C;*]U\R'I
MF_%CZ)O;-_?AZNSBS/%[P8&;-X;7//I^=Z6CXU-/3>_&B? YG"V[;KNX(284
M779LO\L(EC]J[_",*TE\[UQ,KXEB?'J_-[C;;?#EG2[SMWIA]'SQ9GAP?*KK
MGG0&O?/[>VQT\,:] 3GW-_A'L"$H0R3#ES>YT_,WNR@=MJ8_%.E*RW0._KD4
M.MGGW25 >C!^]:]V&)A*NCX+_SG)3_^Y]*[;&8#^9O7S8[C,#3_]<VD0S@9O
M"N"_6?VO__JOOP;YH!5607S96'!_O1E^]]>;X9UMUY^O_N7STTI_<-X*_USR
M>?^X9<Y7.MU.@.?G9ROIQ- ;_IE['SK%GW"\!C:DE[OAX\\&.R'^<RE7G&-+
M0&.9E@QQJKCER&#FJ0,=CNSK>M$4T)CL"DP=TTZ/#OG*&I@EGTS3^Y8Y6*H,
M>Q5N>S98B?E9\& M6JFG<@]?>OKEW*YW3S^0G=,&K9[XYL;I_J9N;C=W#AO-
MS[1Z<?1M>Z^6;Z]_XM6+*OS =_6CBT9S[:Q&JG1_O4H_T%JK<=%%C;TM7$OG
MK+>:C>8!VJY7+^ 'OMO@5;+UK5KWS1KY=%'#"GT@^^>-/2>JS0:KMJM\O[[%
M]YL;WVKKU?-&\<S]9JW^O@GWNZC5:X<-\NG4;[[/[>9GL;^WTZJM-\X:Y._#
M1KM!:^N^"??GM?K!MRJI'55)X[RVN=/:WML87?,%GL4[^_7CUO[F9U1KOF\V
MVN_S_:9#\ [P+D=X>WWM IYQL=_<0G .;WQ1WS[4-P;5773VH7YP46T>X*_1
M!T64#QD.$H'YU38S*H1,(^01QI((+9=6WZ]]V-WXZ\T- 3^GO,>>Z'W>=Z;5
M"*;W'K[IEP)^2,!G=P0<'(^8*9U)$< -6\(R303X5TFDHH([2?W2:O+@4Y/O
M1[A_UY<2?I2$S^](V%"'(F4BTTR&C$4#1 M9G1$M!,,Z<J/YTNHG_(+RW>B
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M%H"(-=JI/9_.X3NR7=]@M<U:?AM(U?H6KI+/ )@U4@6+4=O\ B ZS!L)2.L
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MO;>&<$_!DT<'9)Y00D"=B/$J>C/O,AGN$1;>=CN^2 \^9IAT5F0C!$(><Q_
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M,=)SL,_+,Y"X$BKW04419"75$F&+F&-:82H,H(1I!E Q?/:A\JK$)4P0#AP
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MNOYF-A->P:4"ED$X[G5/TWWF-(TYS![LUR'Z;_Y]V&@WSJJ;7YJU]<.\03;
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MUUK_H_04J ^E_YPA4JQJ6F,M$)I],%Z[A-(.02"6!BM]DE-8V\"_8H46IX;
M$_7;*L"V:L!6:PV4 FRU ML4_21>1D<# T]"2!8B,V CXN"8BCH)36LMQL#&
M:@N4693B*/>AIU<;W>>;-)2P_M$QMM/MC#J3NK##4=]].>AWDV2&_U454QG]
MK /-'6;TDJAI$J;OG^0,IEJ:0=_5_'^<4:ZR!71[-^CNCX7UD);0-?;Z?K1[
M-,5SWJRRTQ<] X_-:6[2,J<Y?%>7W.(2P^N><&FX7\U=N=Z,UU IA'<?NO=Y
M]D# (,5]CH+V.?"0\0#)@*400E#>"6N9HVL;2C3*VU@3(RB(LYR(4W-WL8(X
M#T.<*0,3<<.<9ABD<PB84@ZL0A32#F&2> C7B*UMR!JJPBSA^4;CB-W@)/C+
M#/^:EB*7WBTIHT_%E;)<+EGT!;SN UY?9D,OF50"4P(>(PN,$ >&: I><>Z%
M-E0RLK;!Q</C)TKH97/5M#Z"4=2T'C6=XAA<<RX8(L"5Y<"L2&IJO0&I)&&6
M*8L53E8-+JF>C><8YU[$_E0F1SVL8B7"O1XEJ>,<M4X+9MT#LPYGRUTI2Q03
MB@+U(6$65QRTCPBH0%XC2[34N7A.20%=9E5]E*2.HJH/5=7I$$WEI, !@]8L
M60'1.=#8*I >.6FB5=&%M8VE[%&VI.SBR(Q.!F,'1C^VNOTTVE$8'"4ELP^I
MJ;D2UE!-].*/-.G[:<ZWTI07H+H/4,U6KQ*8,AX\ HNQ!$;2*V5,!"F\BL10
MSR3)^>HE472)];,F3E'TLP;]G/93$.&8I!YP1%D_@P&#N0)GB1.:(^&P:9I^
M%C?%K56I!N%KZ)T4I\03L8:7Z:;YZ_[NC Y>G@S3HX=!L7<>!%.SU:EB5"8*
MA,%%$H$%H< H0L A9R1Q%ALEUS9THTYLBVNBF32B*.QC*.P4K["112%R0U--
M/#!,!6@NDOZF7<JHR))9*]8VY,.//YKGH%C,.E57FZA?=[91FBX_AT^B',T^
M#)JN*5YE7)#4!$ 8,6#<15!2<*!<1:TT]0'3M0W,:P"G!4N;+*K]I.Z,HMH/
M5NTIUD$U$<Q2#4Z9Q#J"TV!]Q,!\#!)K+BER2;4EK<V?L<R)@PW-ZOKCRME(
M:3KV/ <DI=[./5%KMB26XB:&P"18Q!PPC9*M9*D!)$-0UHF("%_;8 P]O,5'
M<6\T5TD?X92D*.G]E72:6D2GE, $M#8D40O)<KD5"SYX1!*>&NER[PZ\E*6W
MEX@]7&G>41)#GKV#QR4KJ.H/<+FR2NQ\#Q[.PJ!?X&LN^)JM%F4=0=1*!2&*
MQ#$\%J"\-J 91DYPPUWN&_"?_Z&2#']KT%EOB<5H)LOXJ1X7?9U/7V=:A6%%
M!*6@L$69;A!01DA002*;B$@0#*]MH&5LD;Z8YR?3?3X>>H*R$B;/X^:%%.OG
MGG#T888^>(5LLG ""!MS(> $3%I;FD]/.,X;"*:Y.Y@LN2'+K*Z/FQM2U/7^
MZCK%'J*6,6FF!L%I8OM4Y^S3:, BQ)!"A@F?V#Y6)3^DT;Z*<=./'[D@Q5WQ
M+#U +ILV!:/NAU%NMNX7EY$9P< (G8A$VE1 "QT@"0W[:+U53%2-0$I?\R76
MTSH;@10]K45/9U)-$3$$11#"*V LZ:G1/ +R2(@H7! D)#VEC=+3IXZ:>+;V
M'C6Y&6X,8UER^*D_2K/@S5QX<TT]4,&M$2&"%38 LTA!DI$%1;1W0OI(<\:H
MX+PV7\/=%O\">2%659OK#\PLVCRO-D^Q!\>3!EN-06%B@05.P1 A0:??4A*5
ML<0D;:9R72Z$-O^$6/C.\+AK3O-CA-L!X*FN7+8!+W<6SOMK6EZ\N)'8E68%
M<WO\GD6J;P;G04=52Y-?6_^X;5=[$P;O#\P@U,)5=]JOIK>WB]%4B^V-&>P-
MWH_,*/B_3/<D_/CVR<Z'RL[W\YWO;&>T^_+*SO?5O_Z+^?_YO?N1=+_:P^.#
M]MF'[^G9T(?]WX_:1Q_2'+P[VGO]KMO>WT1[KS_0]ME!FIL_OWWLIF=^^XD:
M3[FC$KQ-?[%$>L%0;(!'JVB2N_.:W,Z.;EI']V))91TMZ#H2T6))F $?>")@
M0CC0GA-@4B0X<<)1EPC8.II-B)GY1>O8#%I?LW!?M&Y<>,,L].'38%>UP(:;
M)Z.#_B"AL;];7[:R$)]\(9ZUWWYB4@>I*8-(K$\+D>MDX4L)*O+H#)6<1W0+
MH%V_KAX'R\JZ6J!U92B-EC.:C$N=^\<(G-85]D!SGVI'HU=1KVT0]&NB>/G/
M'7!NO-9:YF(!_-HDO-L9#D^FU^0UD=)E.3[Y<L3M;Y^0<!Q9PT @'(!Y04%1
M(P$9%)/XC7+N-M[V]#!7EE.3EY-.2X99CB HDY:3,@Z,P00B5TP'J@4-:3EE
M_\D=<*U3B;HDRS[)F=!57:MLHKV3T7!D>GGN2J)+7?HV=7P4>,3<$0L2)Q!F
M2!%0*EC S"*"L=,)EVM+="G!JLU5XYH.@XH:/XT:3]<EC0'E1BF 2<Z))TF-
MK2<,B$P\2AMKE:\O7VVQ@UB?IVQY_^BHWVN$/WL\E.*$K$\==W_&8K_L'FVG
M\;Y+#/:OPX]_?T#MOS\>[FWML-U#=_KQ<)-]R,]^^ 5_^$M]W]O\1)%Q+DD9
M*,(JL=CH()GL 4PRC5R"8!JR-C^G,[LLHL8O(LX43PLE@F TF4*84["21W &
M8QZ4#\30Q_=D/\*"*^[&!5F%9[N?/TG.O%9:@9;9O^-$>J4( L:9=@%+XC&?
MV[_S"%MA652+M*@T<I:G1:6<,\!DSOLF+!_242V<M]PXG$M2/LB)_1._SY('
MDRQ!H-,C5?;#LDEM#,:X-7%5CGLY_S"WG^W<>098K_.:%U!]"*C^^3-0[>[^
MO?-]E[PZ2.")TEC3G^[!A_T/IQ_^WC[]N/6%M/]N'WT@[2^3@T'A!#(Q:" !
M16#444BTC(,-#I'("+*T03OUC4ZELJH:M:H45]@I9,!ZGEB?D1$,%18\I@YC
M$8GGN?->VJ65_!7?::?.(-<4*Z3@6J-7($IDD=JT_$0R.3CC.>I!$3!&>]"(
M!(6L1L:&9SMA+KBVH*N*22]($CD$QW'"M>RBBTB!DXP'$4/:]^0$U_BOF(B[
MX-JHM15<.+)A,';(4_1K*Z^C"O'>A^/1->_]VDJ+YCBD6WP-W=-R5OU$/:PN
MM';VA*N<9,VGE],=,%FDFDL.R"F;.^PA,#(PX,*S:(UQW*I<R:U)G7#*870S
M#Z.+GM:HIU,GSM(Q0[PW0(1-&R 7$BRV$11ERJ>=43G$FJ:GR^_S>N#Q^#/
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M1&$9,)S(KDX<%S@G,CBEJ2:ZEH";Y0'G J0%2.MP&)! D4S_$>%88$1[:53
M2B0N9#PF!4@;#:0S$3$QR=!B:L 1[H!19,!&QT SJKDAGB#%UC9D?07E"I06
M*"U06KD,2! "6:$]\4QX9Q'E/&HA<>2&2U6@M.%0.E4W61LKF8X","$J0:FT
MH+QQH)"1'+-(;:1K&QSC=5FPM&!IP=(:L91C(I)-CQ"-.A&:J"A&/C*%$D-%
MFI5SK*9CZ51@85"&&X8"Q"148,8J4,)S\%0A06CBJH*O;>!"2PN4%BBMN>.'
MI(HJ3AP)C,6$GB@0'H545'@15#G):CJ43D5^LLBCBD: 4!PG6AHC&,DP8,%)
M3":(2Z),M)3P=;0$6%H%COZK6E+I7]_YNO'?Z:_S(4^^ :H;O0"LK@*9"WG5
M331TX[_MX%\;%\\^?:L:/U:-]F)6Q].39K1KCH?AQ?F+W\X/R#J]2KVK#_UV
M9 :?.[WSJ>;',[-3?=_X[=^^=?SH( /".AJ#PB3 =O+-D[?7J[>F9#U^CY!U
M0NF-;Z-U?.-[M]V6KVMUO[O>_EXRIU=ZK')=\)O??9*Q/N*1\,^?'Z,%$I98
M9^B9A37'6(FX[WB>>JQI$4ATO]L^RV 1EG>Z[4\R)'X:H\'XS+774/OQ'M6D
MM(G]@T$(K=UTW<&PM=WSP;=^9%+@*I,"7R$LDXDZ'^;D9KJ:E7O.G5YK#?K?
M9I(S;B(VUW";9L_Q.-NA53'X&[-2Z'P/?ENPT,5DSGG/A9C,'VVT6KF/%G1Z
MK4DGK:>8VKHVW=41EW,G1R==,TK 4N4>MG*;LT$X"+UAYVMH_=$?#HM./'"2
MWX612;_TK6TSZ*51EQE]\+;83X#2^LL,PO?6V-M2IO2!4WK5(=4Z]TB5M5K/
M6KWL'_ROZ];L]<0-RX<PM\>^].[[[+,/]=I+;YAS<H<Y;]3!P/4+[Y>=7BO=
MM9O8V' FK?V^:KP0*C=.6GY"PKD\4[=YU#_IC>XP=051;D&4NY]R-KDT\/4K
M9,^-^MG]<)WW8<YR,7=6FV4LUN -8H&A2*ED#/%H(K%*.!V-H3:84)T\XEQ-
M9M6+-1RE:[9VSM+8\.YA-[U^>[I[^-?!Q\.=T_2[[^W]7?;AK)W&X,ZFSQ,_
MOMY%NX=Y7'^>[OV]B])]3MM_OSK:/=Q)O]O&NV<'A[NDW6F?M6/[Y3CM8O<]
M8FE\K/WVD_),8:4"2!URY@4WH#A+RYA2'Z4@+""SMD'UPU.,Y]6(9RX*];B:
MO;@A%G,__F("VFP<15UH5N(HG@/WSJ9P+TIE,5(.DO <,"LM&*L42.HP-H1H
M(50ME14*[!786V38HR9&Z9GT,:2_%;(ADL074(A6^2!I@;TFPQZ>@CUG=;16
M8#!.)-B+/((.V(/@BIFTP3FB]=H&8ZO']YZTV$$!T]4$4T]XX"Y$)"1GR!!+
M/98&8<N)3VP$/368QO[@R(S2P+Z/7L3.]^#A+ SZ!63G UD^!;(AR18)30 %
MKX#Q$,"J8$$:[U2"W*"(O:ASOF(P6R"Q0.)52)0D1B:C4R2PH*3VUA@B#-%<
M:>6*6=UHZ/L^7?O5HF064,9!,ZN!(1I (\MS=H(SUAE$><(^2M=Y ;X"?*L,
M?#@1 1($IM8$YJ3(55N]\=8KKP(/Q;!N./!-E6IU26S16PQ)C@28,!:T%!R<
MENDM83'R"?B8JB'%M2!?0;Y%1CX>HM:4<QF88H)X380/*N@T(89$:0KR-1KY
MIFNK1NR322L=**(K<U>"<EP"%282YH@* 56Y_:0 7P&^E08^Q +76BBI!-/,
MZ40+ A.14\D-EKX 7[.!;XKR12J$X-P"MMX#\Y2 )MQ E(YH:[TE+%,^+1;'
MV/U)=%^M:4?ERG)EHZY<JB9EUV]6[3!J==)F<!1JZ$ZV%/W'[M=N=JZ)>.8Z
M4D6R1;)%L@LJV<?8!<MJ6=;5LF*2G</TCCH:&22FGN1(-Z(B=0%C:9QE4BE4
M=3;.IC>!Z@6A/['!WPSZL3/*U0.*'3V/'=V9/3/F/##-#8;<K! 8SH66>4"
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MI5]4Q5C7KX987YJ+R?=QEH9XW!]VJHB60>B:9..&W[YU_.C@?(>Z]*DQ8KQ
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M!#SB-&-#'+,:PX@1$QK9'G:H/P)6.#73K*\.+ETRGO1U?*04#V8M*OJ;UP3
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M*K"5]$/2,O1EA,"2!:@6J<QZ-'EG.M*#9^68=VS8>6NI*.=@KET93AE,9=W
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MTWD;96$_S+KH)<1QU=81[ZS.H,J)5>_6YW/PMNE QR78_/2LMR8$!$_:PD6
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M8CS# 1]/)]C"#D-+4I>G(#1+(0SG^OXN2E8- F\Z-\\MKIYN7C200H-D,D"
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MSGX#Y5SOGYU/$V/6%N,9('QPJ1%FP<MY*[4T+)OI>S>)@[)-^!"$A^D1KF6
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MM%MPAA:<8<TA%^9CJ?/1TLTJ":]TIP'37:."\)7OUF)@>[.VZAF@,UJ0C9^
MF=@LZEHIPL9*X#4V=?W6#UMC1?GP^M /E/T2_M5_I]B_;O([H=M+S*[G/%LO
M6^BQB95(L YU4S$,IV@LUA9DHRT[OS5^'P?@JH2![7(FJ0_>H4NEXN!U2YJ(
MF!;0SW9\UTG.C1ZX;F&PV2%XDT]QUO$ZPSVW^W'_&ASL0??L<'#<^TZ[9]VS
MH^LN_+US=03C/M[=<9KY%)UK?G74.[*/SKKIT? K/..? 3CD;L?MGG7<KVYG
M%W,K_OS>V?UG:6%DR&,W9C:1;N00RJ5#$LD] MMD^W'$!<<L8]?_^7JJ%D2C
ME6:;+,U\FTH_CH,HC (:4QX'B2-IH'PO])D3FG8;SMWM-EIIMCIIM@B2X45N
MJ"BAOHP(=5A,6*0"0D&ZN5["72'!N'/IMK?9TFQM#>!;BF8=;^/L7]."&3MQ
MP*!*-.SB+!'[]TRS45YOBKW<+G[9]?=OG[.DX499^AZV*YW\/<[S/=,"I96L
M#Y"L2\I*1<*4%P8!\83C@63U0A))'A)?4!"ZKH\Y6V_>.4O0AQ9B02UTQ@:R
M[LISYUO6?2K6;1I%7'(1,S<@ML<8H3:CA%$9DM@12@8!BQ47:\^Z:VOQW!+R
M<]QM=_."?M7)ECXR-S9/WD_/31?C6C+5EI5/DS.)S:'&A36T(F/H-93HK\P6
M^L&R2IA>-(7IEW+C6B'Z$"&Z6,GIBU#:2<Q(%&(U?NR$A'EA2)R0!Q$5- H<
M=[D07;=B_!95X]GK!UN6?0J6;=H]PO54*&))/![:A/IQ3.(DD<3V X>'/A,.
MH\BRZP^$LR;&S_I5'*[U<CW(2M[PXV'=P_/!!\-M*7];RO_(H^70B\!D=KDK
M*56Q'=O2]5408M_S0$;.\J["[6',T^G?Q:-EYO$X<*5;-,QS'$$8 PLZ4%'D
M1\R+'==?S='RFE?JM]@GK<!\;H%);3>((INY/G>IGX1,A@SD)F-1S)7G\.+T
M^O%AVU9@/EA@-AT6&@C)F&(DC+@BE'F*,,$E_"\ 7R5 A<;UZ?5+!XM:$P-^
M_3R.-5BNN_!=[M4%N\)<60Z1T18ZM85.:R@/7F6ATZ&IEOQ[5BVY.0GZ;:U3
M6^O4UCJUM4[KMWYMK=,:![/;6J>V.F"=:IV,"59AC;R0,,M?:6=XW#_H_=7O
MGATYW;//E]VS4_^HUZ&=X=>KX]W/WM'U=[MS]F>Z$&89[E\=#V$\&*8Y^^IV
M=_?<@]U!OW-]>G7<@W'LBK.#WN>KSL>_EI4\!5[D1]P)2<!52*CR&(FI'9,X
M"AFC<6+;%$N>HFUWLXL$VI*G5JBM;\E3*]1^2J@M5#Z)4/JVC(@K\;#-C7T2
M^S9^"EUL"24#3X%0"W^^P65;^?3@RJ>-S ,^E /)<@UTW$#,NBKA&S4ZY9RU
M?"59MG!Y6Q#U2Y. ;Y&R.T-8XDFQLZ*5N0^0N<M:[0D>^)$=$<\/7$)MZ1'F
M")\$,J(*)+ 32.Q%L.2X;HT**]J:J.>OB6JY]Q=P;]-B<@,9.(X*2. %-J&.
M3$@DN$L"I4+7ID+QR%E[[EU;<^C%E47MP$1P]W-3[=2$$&WKG-;%Q"GWJ96/
M#Y&/BQ5/,7."((DX\6WA@!_I)5@QFA W!M-&<1XG3*%\#->^?**M>%JKBJ>6
M>5?/O$WCQHMD:+/$(9&*!*+A"))X0A';20+%0N[12)<KMKV#VUS 9X^/;?AQ
M<5O[U*;ROY3:I_94YB?4\!)T30<\'9I$) Y! U,1>"0.I$V4"!,E0T<&/-)'
MS3^-1[?F&?UM"50K-Y];;CYE"50K-W]*;BY -X3*#F(G(HPSGU"/QX1)&1.'
M>HP)&;K<=_1I]DN7FYM1VK-JUO_)AF"[,Q"J^S1TVJKW@]-HGZ<C&(6H6L*!
M<?^0MJ6_!.6R$C5%9\3#:MAMQ]*E/<I  )T(%DG;#A7A$FPRBC99XK*0>"R(
M:$!5% ?LS3MZ8^)?V;54=R0' IF,8=^4S+(9L>3613_E?4M>ICE> O[A%WD^
MJ3<+*\ANV[H?G38[G:Z66'\)KF-+K ]MJ+?OG=#8BQUN^R2,>4+ TPM)XL>4
M1&$<V)%/F:\D$NMBP^4'$.NDCP&,&:T>\,FXHKF"Y!J]+A>U ^H%O3]W=D^G
M\9O;E8D3+6B3&W7VZM7,\C:9WK;UQ"TF_\9NT_*@[#+Z-Y[OY^O23?+@2T'\
MP\YEIW>8'IT=#CO#(S#I/KN=ZT'_>/?/[T#(@Z-OGR\[N_C,SW:3^(^N]RZ[
MP"1 ]%?'9T=V=_?H^N#;A^^=CY_]@V__P#/V+G#\W=U#U>GM7QWLG 3"X<)U
M L("%H/K+. 3$PFQ;04/C&T1"Z_9(3&1-@U9&#%F4^J"7$ML&H"_S5PF IHX
MS7Z2OV1;/Z0CC!2VFPJ;&ON!$SI)0$"1P*:"UB%)Y#!"_2AQ ]\309(T-U50
M&G :TL2&W90.C6Q/)DR"C/%")B+:W-2_]W:^['U9[,2YO#/GW9;MTA+UNRFM
MT>G45BH0( 0C)Z0@6Q,E;1[:"N; /3_R;GK/W9.??T]DQ[:*8%@2N,2+*0MB
MSW5 67!&N9_0-;/4>S5;IL_R6J-E;+*J#.=8.M_)-&D=*Y7"-S '+K>L"Y;)
M_GB:2WTYC'*J0 4:JZJXY(<$<VP@3>=7#@X82T>6_+^IP5BL;#"5HJEATE>7
M^P09VF3,&HQSA/R7J$Y9 @\=CW37ZP>:70HDBO I$'PD:1QY21P&GB,#'PPO
MY@MGWNQ:6C>4@P\)GYI"YR-,$,&S#T8]F0V+'N@'2HN?S;"V?K5L@G'8W1Z,
M:??T^F"7VZA\(DICQ[=)K#A()R?"ZJ!($3_D=AC97'#IW'9\6MA>6X4SD.9S
M&=.YA%]'IUO6J1P!O0\T;3(!FY5BP_M)^D.6/>W!FA:(@2[PDPXZ:%ONRP3^
MJ0"9"\,!+G@R2P7/[TVGTUK7ZU3F1L6M5??K9U!MUYT=,&UIZ$?8/LL&:@%A
MZY)81H*$D1N!5@NCR \7I#4/@T3$D4I R%/?3QRJ8A&$H>2N2+!?]MW]K\\S
MF6M"R*?GYP--%$!127$\F?>EG #-&;YON ,U$?=?M\O>WZT'=;:^<UX;!.#B
MV8]&6KGUL>ZV[SP6I.59 %PV"FTFOM=C7R\@Q4;!)I2Y%E^T,/M[S+6H>< L
M[X$PL5$+\A@<CI>Z%E5T=?EBK"AQ?9UY_]X=Z'^NEO,^,"V/3K3]F4%NZ@A7
ME$*W'J2Y_'2^"FD:.]+2YZ!DK(CVV1]/MVNY$OJ!OZ=@?J?\$6NSNN5X:"[-
MR\^&>9'Y+*O* YP_=SC$P1RHK[G4>F73HT)%)LO>5;?7'72O/U]TSW; =3\<
M')]UZ-$0Q_/Y"KYS#WI[M/NQNYC)TMMW.NY7K[N[XW9V=ZZ['_\9=J[[Z=&U
M^-[=W8?OCOQ.[]0^<O]2G70ADR6,1,!5@+4S&$E2(B*1]#QBA\(. \I#7P1O
MWKGNC<=XZU-KV,J=5NZL$NJJE3LKE#M.$TN<T<1A3)#0]T-"PUB2./%<DO#8
M]VP1P^X@'HSW\R!7*Y0[+\I96\YG'^IQU979PVNY#@^TA^=& 4_E)+TD_50(
M.?J]Y?[;N'\)Q)V2(H:5(Y*KF- @#DDBE(#_,2\)N!-)Q#9H5WQU*QZ*)/)C
M6$(F;9\ A2>$!4H13TK?CV);V8'[YMVG#$]9)E=;UOF C29;^JBE.HW>LD9R
M4O'__#]M=?/Z.E#U#)_6C/DIMEJH8W8YE2*A1 K%"15*$F8'E(1!0CWIV7;H
M1&_>V3]?!]""$*POFZ[(WVC9=&5LVO0VN"T=/P@4B05U$%*7DR0*'1*H.(AH
M[+#8E>O&IB\J_+[\9.AA33L>CP37/N-5^*[-$XL:_)7UED^S#&S8WZQ7Z\"^
M-RM02Z1:6*;6G-\ <WX^+EG5+A7;VYH*#S 5EB 3,=<#C]AV"-CR+J%!$!*F
M? 4&OF/[MO(QQQUK;M8?F:CEU.>VZ%M.726G-HUZ#RQX3R4V4<KS".54D-A/
M%*$>52()_%@ZNEIV58CRK5'_B!.$%=I@:[D4[2'"+^+_="&D[3HB"+F2X,\[
MX-3'X,\SVPZ)[U$ODK83,]D>(JQTQ0/?48R#Q T\;A/*E$TBX<=$. A;$(>Q
MM.,W[W8XSZ9R#GU8GR.,)WV9684,6.IU//Y(X55CPC_SD4)KU_P<ERUZ(+I^
MW"72%0*#E3Z!/R/"7-NFO@B#6%$,5JY39D3+I^OI@;1\NCH^74AA4J[B G$"
M. \PA4F -@25Z,6,NBP,A(?:<+WX]+5'@6$72.F%O-I \"TKU : -\#XNB&L
MU!V/>"O9'R[9%[,Z7)\'W \I<1P>$DH#,+Z21!)I!VZ@J*")G[QYYX1M$/@E
M<^O3!H%;;GTLMS;M,,2N$%)%X"7%8(<)[I H"20!#@XX4*B*8QNX-6H#P6L3
M"/YI,VPM5Z.-!?\:&7"PV.K2E@ZG7I"0* S!(9,(9&]CLSPW"KGG2>X$HEWQ
M5:YXQ)6C7.:#K*4VH3;C) +52.(@B9GK^(S:+K@:.N8[&(].R41FPU\;]6WK
M^UYF?=]3QK!;L^RQ J+I1/%(*9UIZP8>8FFJF"1V&!(5VM3UI./[L$'O[+:P
MN!4\FR)XGC(HWPJ>QPJ>IC_H*R6#)+1)%-"(T(@QDKB.0Z0K6<2X[X>,KYO@
MN:N_Q7V^:2(%%V3N4^"#\W&N&U?^KN$5TQ]R!CR(/%"[JX MM&>WL"0?#Z:3
MFV]9P-]Z)A1?QVL@P=?^W\]FZ&&GDB299-\)4S#8W]G@@EWE;_X]#[.<CDA]
M 9MSOW&&2CW-##W[7X:F!(+]ZCW_'6A19G@5C(FMS5BL?H;B\C_NAML/W[S3
MT*P($HM]&1 G]+__S=XMV\:E0)Z/A:V^!PSUIC23>7*,>%!2[\?YY+5CZ%YU
M=TX\ET:11*3_T L(!0^7Q(PE) FDLB/%'14O(*L[CG!8X&$L$OQC.V) >")V
M>,09V!+TGABZXQ^ID/D]@'+_O_^(7"?\XPZXW >AY=X]@_D9>S;WJ2^D%%)0
ME[FQ\!%,G+L\$5$0BTU"UPWH=A2Z+6!M$-WWL4O\IXWK#GSGV5B\F5BD/=W%
MJ3/679SVL(O3/<)NOV2EU\H'7@V$\=UHFQM!,X_!\ET-%.I+6[^B7=63L]Q:
MM%/_R3RIVSRLIXP&]<;8G:!9(<O!_JW.*U8Z*G\[\N\QL"7^._(%\;:=97WG
M8<S&*WSK_-;PI>YYQ/U:NQ,_>/HO);:Y\J:@\VDOZ$&^D+CF8-@] \_0/;KN
MGAW1H[//X#WNT8[[H0_CO88QT./A/\.#W:].,ZYY\.W([?1VKH_/.F[WK)]V
M=_\:=GJGUT??]G"L,-_^\/C;$>WV_D'(Q 4(K]!Q$V[C,8KO$QK8BB0^MXF*
MF1O)4"4!0K4ZV_Z*TES6IA7['1EKK2QK9=G3]HQM9=G/RK*%#%L91(*YTC0Y
MIE3XA-F4@RQ+/.9R$:L8X5]7EK+WPMNC/]B0;YP1H17YYEFPBIZH:\:ZC7!M
M"6'#*U_NX<S-A;[G7;G')/R^3"/A1=H!*_-IL+MDI?KKV1OX=][: @^P!;J+
MF:3<B2//42X)DQC\&A%QDG@1N#EQ$JK MP7GR4KR-=:OV*85/"]2\*S, 6D%
MSRH%3],)45["8R<2A(E0$2J91Q+&'.*!/ JQ*ZSMN)LA>-;6O&S]C-;/>/%^
MQJR>GK.\;ZG!^"*W5#8>-@^26L?C=>C_)SY,^<2NL!U'J_\?I/\7#U0<6SJN
MG0@"6Q03ROR()*'/2<"%M/W D3*0>* 2K+W^;QV/5O#\@I./5O \3O T'0\9
M!DGB^2$) @F"QW%C$CM2$%>$KN>&GLU9B()G_>%%7H"]N990 O< 5EAF;\ZG
M>=^8:?;:T?56;I_50S.?LA0VYYP-6FGY&&FYV+K.51&8:<PCL1\%A-IN2!C0
M+>%,)CS@TF-R-6&:]2LD;CGVJ0R;EF-7R+%-^X8RVXXBZA"F'!<YEI)$Q#:)
M92(=GCC,I1O"L2_ OKG%!O2W_76Q=&XH6-$G^-K*.6>IL-0XL]@09C?!6C@^
MF HIX(,N@!L"*T\S.=0MCM3=T):/3AEZ!<[Q/>?^4K3+2A,%W@.U?@)B_3#.
M*N]Y9R3J"J=5, ]1,$O IX2?V$$4121P'$FH5*!;8E PKNLR/T0/VJ/H0(=/
MG3ZX23&]5J"]&H&VT@2$5J"M7J U+>:0@B?K*"!;WZ&$NI$$@08&- );!&X<
M^TGT:_*A7Z,MW4Q2H&V20IND\-*2%!!?#/VH64J"9F0R5F0*CA+#-N.Y-4XF
M#&[53I6\Y'TV.I7:ZQK!('[:I7KY=L:+M"96'BYO=+<_*(AN?[17D%S=U)B'
MR7MC&00<&-;EY'>57DI!KF4V;@V0AQ1D]7;0^-!>U<%NYPJ>=^*Y*K03UR'4
M8RZBJ/LD4I01+I7D22("Y82(0A7!_OZQ]N>2;4)$*[J>Y-S@IT17*Z(>)J*N
MYD440J^"$8H-/['10\PY04A!DM@@H<)(,![[;;[VDUC ZS?@3;FR7=AV83?K
MRG9AVX7=K"O;A6T7=K.N;!?V*1?V%B#])DA^#=O;U"8NA4"^!Z3Q2OW@^\ "
MNC\%"V@]"9SAG?Z[AC+?-YD[N?6#9:E&@D:(ZKP_SB9%ER@=:):7YW*4RRWK
MHI_ROG4A,VFEPR&#2U+$]1AG.N]GHD%MAP;45B*HK;6 6:I?4'YKG,$2CG.[
M\@IO();[]%Y @M*$<B?DO>^^N9T*G>@70,PO9%OI?:';UA.CR1\:S/)/+)M<
M]3(8JO'/\]TTYX,QIF^M"<*\TTF+&,D9O^R<_75V_!&NV?WS^U'OL'_0&Z3=
MWMYEY_HX/?AXF'9Z\/[>GV=-A'EX[E5GV(5[OE]T/A[VN_", QA#I[=WW1WN
MT^./^Y?P7K_SL:NZNWN7W<\G++%]Z?*8.$&$F9-2DAB[JF$UNF2.B$#<-/'6
M0Q5Z?J)\)B4(J8@FU(T4=Q,E["2R0[>),'^X]_=.;V^7?-HY[!U9O<.=[I>=
M][W]@^Z7FV#A;^G </?+YP>K'.:PT'<42V)*J8QE8MN**6Y[<(^KWMS(%^Y3
M\H5^XK+6C<LY97_T0^83G6J8CJQ/6?H#R'IP1?Y'#D2!Q%\_'KN%W=>OH41O
MUDS ZK/<8M:-\=;1%.5I(^0J'(?;PK%]/P(Q$0#5NGX8>U$D/(]Q'BQOS^8V
M1<7>_TW3R55'3OIC,5ON@XN1S/)^>OY)9HCUS$YE%58E[BN3&0>]SR<R2"(>
M8Y<U#S/AF.N1B'F*P-K[L<V9&Z@$)/MBWLB_K'&YED##H%-AA9&8Q7GZO];_
MC <8^;3^_ON]]1;/?%S[C_H/^BOGC]^V@#KZQ;6\H)E)GTT>13@>V%BA)T,9
M2)<Z@1N!7@GM*%$@+JBM[.6$L]_]T)+.@TD'P^XG01S:5 :">(G+@'8"ES >
M,M XW(V22"G7 WD,"OUAQ-,DFCJQY-/S\T$*EME882)W=MX?3W,K3T'LCD<$
M+50!! 1/4NE@:$W01$CS"69]9QF[RK71I\"&L(#4Y""WIKG)54@GN2724Q3@
M8"/"U@*%3"2'._-M:W]D@> 99T+7QEVDD[XV'.<HO=8NY13L2228+6LD)]A[
M1>'3Q]C&-,]!_C*P0]D ;)1Z^Y6A-BTQ*WW9N])LR8+EVYNK(-(Y!3BWDFFN
M5V ZPM7!_=*=H?0B2<V8L%;(F9H$S(5PV[;UK2]']4XV5B;Y^'0$ \[U]N9]
M7'BX:?FNP _U86PMN03I!,8] JJXLLZG&>]K>M.5D_I>? &X2,-TA%N[;>U.
M,]V$Y^>]C*V%F66F= &DIK3>X@!_L\:C^BK=LL0PU_]\P"%HX#M<)+'M4RJH
MXF"KQ0%CKAM)+PS]R']P_L:^'O;?,.@/L';+Q6T^GZD!$I^(L>X8AH]=E[/0
M7Z^S=_>N3A(0K2Y+0.;ZRB8T\@6)N>N E2]LX;H>6L7+LSW+#B2:U/[S[0.(
MP)$A& 9NS.+8!B^5,D$#P:AB'A.Q*(C@]I/P/#T=P:='4L,KW?!.;\<_Z'V]
M[/2._G_VWG6IC61I&[T5A;_8^UTK8HI5YX/G#4<PQO9BOD$LVWB\X8^CCD8@
M))8DC.'J=U:W!$*(<X,EJ/GA =3JKJZJ?#*S,O/)T_::YQO'WZBER9D@$/@[
M$O2N\L@R^-4HB9U21%#'<AS[<O7"/R?K_QM@R/ 0%%SG!_@=*ZT:DRLPR3LC
MX\GMX23#WG0U5;]JVGUV_)+QMC.!9D"^7@9-^*E*_JQTX.<1_*]:Y@Q-X_0'
MN* >EP?=?9*?\\-VCRH$O]VPCL&&O O,W<_QN(QN!<_NM+W?D?;J-QRX,=$'
MY)DG".P)AZQPF=1;">ZXLD$&<$/X"K\!TNZ2VR-XL%Y+*4+@'""3.,L)^ Y"
M")Z8O&T[WK+>=UMONO'QFXF<10RN@S%:(VX2148X@J*G00F?DA%YO>FUZSV:
M-9:F[:C/\7 TY[,9X%M."_JQ[,ISF_9[UX(&F.,_G=FZHUQ:FT?Q2RW)*PZ$
M_S-^D<JBF+ZF".5\H5SG&ZO?')?>8.M1$$XAGCA#!A0B\J 1D^4F1 G^O+C1
MK'Q:J[)LB,?9$.WC;RQP0:5W2( EA+@*">GD-))@#3&."9=:Y U!K]P0<^S,
M83S#F<K<NPIJ+EB5U7%@/B'L]\;U^1-/O!//+-4KK,L_;+<Z3/F\&V/MSV<2
M_WR/081['-6>_7W,T^74'JO5:\Q7G;]=KSM'%\[VP^3\9=@ZM"=5(';4?X!V
M:,H 7QV/ZC_UH*;$'3;+VZ/! )9RM1=R15/]2P&!^2  ;[?Z+;($5CC'R#J?
M6^VH3#9G)$HD*"<DMS:95V_8"EL\R[QLA,8V F@#H;(&YME'BQ%Q$238[ 8C
M8;P"7:VL%REOA*O2YZ]0"<L)HJW9,&>&QBJ?/V/@W0)7#[2*Z72Q_7EP:C-M
MV-Y1@A%4WL);>VC]=!7)BXQ9;1Q_,U)232E#6.>HE202N<0EXD$$;(Q*3F2C
M9F[0JHX15$5LZO=AK>5:!]/3W/+C>:[#1B%4^547-6=G""+PWZ/.H [_@.ZL
MXAR+L6G>YY+(B^TA7N!.V3]IKWX30@9CDT9$9,TG#4<FMYL37+N@C$GDIIWR
M/^ QY_FL+,[A;]F,S7'%P4%5(VU'U;9P$6"N-X[+1.MW6WG:>\$.6B?1#JJ-
M]"?L,3LXR688N["9+CPA6\@'G?HT]'CF6:""[>'AH/\#?G$GYP%,U[>#*I86
M8#]6 <^\)UV\F\+&*4F+J</4@H40C.(VTNS$P5P)YZO-R#"I-R.[GB_D"A=N
M=3SZXLK=;2_OP;7?OVF*P:;"#%'%368\\L@D3E T8,:1*+5,Y-4;,D][GYEQ
M&:0N;,UJ.]:']+!ZU>'36?2[=0S?.DO>@LW3C<-:2YY'LH>CP5'&S7@6?:UK
M((>M?U2[-TVH!$;SGO#/)?6_9BV'*2FM<E\N1<//\US/<B7@]7/TPT5O*_:%
M$1ITAON3H$A.J8$I_JUVFW-MXN%OK:[U^]5$PASGI867&HXZOG(&;;50@WZW
M\MEJ%N"<(SMYWDIKP^Z!KPWW_M$?C7,8IG58#1YU)L,%=9CWT(^*[ %&$+^?
M-T<'_[D"I3I8='Y9/0<'&<URO+"3.M[V1MV3EDTI/^*" HXP[/Y!Q[?@GI7P
M@Y^_<L$T"WVX9:^?,XI^Y+&=O\49A44]CAXHXOYQ3C3H9Z3+L#*P77CNU*M-
MC7(F7:"Z17Z3",.(>=7R,_-W#@< /X.\5#W8SS"K\//,ER^,^/S=?AY6&:UY
M0%4\KEI,6(VC;GT 4G$8_NAW?TSD;;1[:>_D9(2I+)/YH;39)T_%U.Z8*5!"
M:+\"X4]7>?O[0T)H%_RS:BO/M2F6]< +[*<V6 Y53(1BHB]:X_\8[0) ?M]M
M]7MQ(E?'@*#=$Y0U56@-C]RP$T!P0>[_6<W.VW=;6^_>M5L?#MR_SU+5QG\\
MSU;+>S7KJ]:'F)'I3!8G!#@G%U,>O\,0![U:10+6V<Z@!B80L !:<B*L[F@(
M+SZL$.CO=V];ZP?V>Y;H:BS_KSTX_!W>;*7U?S^<#0RNFDZAV^L#JK?RX6D&
ME_$@,X1'\,?[AZU1]+L]6+'OM5>2U0MHX/\/#<!-Z8P?=G82>W5V7![;DZ7"
M74#0_QG.9 7DH=PWJ^PF93VY]Y4Z>D9FYM=^7"00$QRV^^72G.-.&.U.*"RF
MOE43!KS&YU^Q;MCO'HVN_LH4!T%V_,"Y_#422_C,[$S]NWO&JW8(CBER@VCW
MD4TPV->V>VQ/AJ_^=1&" '^F)W#VW:]\PY0>YPT9_G]JLH>0T_6JU7Y=[;JZ
MB.I_[<*,I;4[R.K[_]Q<?J1>O=FJ=CF(R=NL^7NY&[)],V\9%TT]S"] N;F@
MI*$H_&]W3^^T-R=B9?RYHY&&.0M,)'C3S& 3G%641,5S72)E7JM;!.$?ELE7
MC+AY1IS'FZO?&"%"&VV0"6"_<3#=D%,JH8!EX,P286G5R[C!8 ME*82H'#4V
M<2^4M5)3'KDVAB:JXJ,G=I;M,'<[D/;';Y)%KP%]D0J2(NZU1>!2!11$"-9C
MI7D*\QF+KDOTO,Y.NG/29#06O#NIB03X),IRRP47,&8BE-.A>'R/LCOV3W*^
M3J#2,<V0SBQ67 2"K'04.<94 KUM.=4Y#?SJ](P[@X67'/0BI4:PG!"DG2$X
M49>$ !2!]2\YDX^TW.WC;S$EKR)F2#$&#KZ7$6FJ'!*$*4R8,Y&%O-SB<5,F
M6]?ECUQWGTO9(]T^6'.M_M%H.(*O5;94OP*A>V6/-+4UUX[B5K^D"MP[50#&
MLT[;IQ]Q>^][3O454B7C'$&$6 PFC=?(89H0YDZKQ )6AMV)D[$IE5,6NMF%
M=M& ;<@$,BERQ"48L(8+CX(1(DKMO=(5O>+E=KC76"_G(0+PBF+G1W8^QVG(
M]W!]FMHZFWE$G\X'5/;(+?8(:Z]^TYH!.H-7 ]8*_)-$SB%*&GENB?2>82:K
MSEX-EGDTI1?*FM\'%\"G-=+A)#!'2>*$N&(2:6T]BH0Z(25//J6;?-J'VRT3
M&J Z<GE6/]LZ',2J-=BX7&TZ*#E6 !-N^^N3A"]F&:]</NB=D^AV2\H?L;B4
M/^()*'\F60)UVYBQPEX]"\4N'O=/^YP?F;0/-GYN?M@0[;5W=&/K(]\^6!?M
MK_#SUW=X^_2/+OQ^O+FUS6=E;OOT"]T^?<>W3_<QR-3/]MIN9WMOGVS#SR"[
M>QL?_H;?5T5[;S=MKJVS;RE2JYWR2 *49F15R'I*$4[>$DHEQES/DND(98T
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M?XP/6,&\[@PJKW!L]]]FYS^X1?&B;.7Y,_0Y5D4YO[6^QUZN2*F/- *X*!W
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M#H\&@%!+BS1O!S%T1C6.3^7B3TW5:*JS-UR2LMQ."+:'^^.%KI3%6>7#U%=
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M?$LNDN0I148$!_LP.>2H8$BRX(EG!MPW<!.HF$>I=&_024*"W6]%XI1S'A2
M4!31.I=4,-K0LMB/L=CBFTTT2>TCHCKFUH_:(<M\0I@P(ZV526L-B\W)'4!G
MZQQ"6KM@Q,8N? :X %;UT7!2PEUUF*@L\5S2#A]5$-3*5O\5E>8UK Q'L+7L
M(%37UY[G*/K=7N>_1V-TJH&'G@'/\ @>8*<#AX?]46M@*]""C7&<[W;8[_3&
M+IP'#.N,LNEMC[JC.LPX/!Q$&X8K,[WU2@/)*;.2R-) <@'&\H0-)&\\O9DY
M[<DC<D0GSY4%[T&:*!@8FRXQE8AEZLK3GL4[^GBJL\_Z:&ERDK39.SLWJHZ-
M7O!QZ.G&]V^>!.J550@;E\WF1)!C3"(3?321Y(ZF;G8/,MBE2FBEJ/-<AZ@Y
MV#N9+4V"GP6N[>QQZ%,M]-3!85GMRZO=_@BKK0B-!+Q?QA/BBG!DN8S(@$/@
M!)/,F$NK#;Z#-!9[2Z7F2D837 +G&>,00W9N9U=[O::GJ6(ZPY:+W?[Q;],N
M467/#./W0?Q>LPETN^.\\<ITF,JD@6_9445/<S!U#'SN;-7'P(.S8V"75QAL
MEOKHL770'XYJ\^APT,D'E=W*JLDD0&,*G:E;[7;BP [\[DF^"SRHWQL;6=D
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MH512(Q%-"GQ9[C+W$Y7(4AVDT\XIDHI]6="SH.<BAU^*?=DL2L[:E]Q%3PC
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MT92C1(D,)$E+"%LT;?RR(NA?5CZOM+8&5:^CDY;K=+LE?O[87OYZ[T<<CC(
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MKFM^P!!$+.?3>IA=N.:ZQ-O1KAW5]Q]$W[7#82=UX-;]HU&^@3VOZVKU\U@
M*0X.!W$W]H;Y&+S3@]_CRNVS7A=I1>:GX-Z84CN3@BM8PAYC$S&@I73>&"H
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MH$\GH)?.H06WG!.A$!@(!'$%+H^-3"$07"DH=[!X+M.8%@%]O@(JG'%2$&G
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MOZ<$> B?CCQ!M6-[6J3%N=/)=+RWM1/8+S5[#"/Y!9ML$%NG=P(W*V2D/OI
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M"DIK0M$4( G4&5"_)."EUFH656"*IB@7:DT4:HO7<EV@5EDVJ=7M%UO:#?L
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M^3\HL%5"8W(V$.2U]H@+[9 C'/2>36!#!$D)#V\^&'HS61W9\)<V2*]8E *
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MP&*BN4H3E6OL+CIX1;UHCW0 G!7?Y<TWWJ?%>?DK/OTEC<_?84H)D\8C%U1
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MH.HQMSW#T9S8,6=U"<=R@]CV+8U%.N@>AA='S(Z!2@-?-QAW9U4>=*L)1U_
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M&O<\_^AM8^CD7-_775!@7K+V<B"JRV9<B=O46>IH  4#6I?B!KF2/=MMS?+
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M-$'S?#O0K-A278/9JF5IENHSUU&9;=F<:X%GQN;16]V?GV@_5Y_R& :S!V'
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MKV=CG?-97J$;F!Z.B^26JZF6C:ULF1FI>A!I@>?IANUC[Z>.O6 (\9/R%#9
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M<@0?(-J4] J0$QPE""\X20D&$J7@I)XR.%0$<D7(E]_&K "^E=X!S@SS8J3
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M. =D"X6R#[2>$AZ]@;_25 WZ"4#[FH]JWP+B#I#!F^IS%H:@B1&7@37P%05
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M@<M4/PO&M><7%[L!#;#2%] *$_YC.';!;FNG53EC3C;D% K9NSW5JT[$26;
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MR2D[H#SP\)I/6"?U=, HSXCR+.BULB2O4=$B[E&\M4K ;33]$9I_G=K0\(/
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MVT77N ]9WO!$ <QDS%+E,@!Z(,B4^RDISS+E,ASER*D,33<[RBWP/"1NXI[
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MQXC=Y:@I)M351AAW8GTAF<'@PY''4>7,>(>650;6X&6F'(-MERJZ56'Z_!W
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M+/3>^<; DLP<&D* VE&@6.IC.R6%04)%^T_RVYP97^%V VHV$&I7\%]4PF<
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MN]TRKH!_^B%9[2.=&\[S\Q@HHUY$!\>)4E1^G[1-H<HG5(HN"D_(7)S"(@A
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M2'U)<6.PMCFU%60.[Q1;#M2\';5J6*=DA,;&<6O*.18^F77,]V7YUHM*NIV
M;NT->O*B9F6Y,&)?LV)%-FWN3[M_DUR;= A+Q7T-]1K#="$7-W*3BRHR>%N
MP]IY9OV4-SOQ%]$BJI[ET*&=5;925ZX/.GT>@X:]/8 >FD9[/-7LQD2(>[YO
M4@]W1?TDP<G8R)+W?4^Z)6'I> ^(FGKR25S<;O_CC.%YV&Z)SY?5M7Q)J*73
MKK%3^ZIM"^MZG!SD>3AHQ1+>MAURH1H4.L=%G;UI2UU8T>(HBZJA] )L-0@)
MWG'34XZ&\SU-2;)+;_MXB,]NI?I1$8C,11"UN>B>7K>2K',RKZ,QS[\M$S_)
M=#%5-/:^0S-!T=#1J*^[[;!B:+HZ/0ZIY+-GR=IHZ$2#S$T]EST<KVC2CBB
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M(B['=/'?]1IQ>40?1AO9*"V@\6$X6IG92O0,!0)8M!1QQ3T2?"R"S33: L.
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MDP0Q8C25%:$J/X_W0^Y"&F%+5TY0EL*A"H_'5CM]<IZ!!UOQAF/(G-2OX7:
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MXXJ(YA;!F2BY44G_,!56I<(<%I;%2CW".=[D@K"61E9A.*<!GRTM!9ER:F&
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M;4\[U)%P^"_W7&H\F;:B$3B[X,([A!B9(8]D(>$@TP+ MB":D>AFN-,'R%?
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M4V/A/-IHRE_#T3(\>@'2&(5/.KX,A(+@^6$YF2M;[L@@?688K<-2U%)IUN8
M5SYE;HME.DWK(!9(2-BJ5F0'\<S.!98D;9$<5"D5T6/O .73$-^YA9WGC406
M3+W$, %Q$?B0(:Y$,19X"@D#[9B0^_I[$X,3O-QZE]A9<\/U?0.P/M4XV8K9
M+*XXJ-GSH"WW]Z/J9/U=II![R1=@"_OO+MRN(30?1(NV(P'+P"[<&SZFLX_3
M>/91!)LXE 6[ \>P/()_Y!?D.MXX,)5P\ZR:G U4)+I2F*%-#)/J8,#?[L=K
MF&?PM.6F F42+1%="1471FU!YGYM'RFO4MB3$;#U5"2@C05&([X@+DN4CL><
M+1:0 8*+PUU;[P9K$G9PES[%RRCSY\M>M +7A>QOM_:A)\/DHW^] R090(K?
M>8.*S#PC38CM*QB .+#@6(H*/T!:"C*F$OGX:$<!-V=OC[F_&#!LO'=$RW;W
M</D#NNO:L@-RP._9J$"A)[!;%I?P3A^+<=\)AVO4O@W"97:1X+E<EW%XWCW2
MFAI%D%J*M6?IJG4$6R"?0EMT1KUI=R83VX^@DLZ@0&1NS($=_@,!M.I."X<+
M8AEE$2<0?;%NJ.T=%JC#!>%U?1V&S_.!KDO(F<(N"MVB8J"2>\20$Y-O.:!1
M6LZ:%40\9WLK</*ZLVC81,WMQ!.M,&VAE,5V)@GX3^TPXI],1=$^2CO&G/S$
M"!#_B,DJ<I.1II(7-'I=LBA';D6J":^Q*O'&P=Q@W*FUX#.6UMEJ,@RTDPMI
MA]^L>LF8F*^+C3@&6;%=QIJ!DPP0*G9O\%4\3+K&3=>;$[5FU(K3$]"/IJ"+
MV0.&)J,85":&2TTW DAN\)L28R<YSC@>$@R!RUA@*AU:5(G.:$\?2&.G&_Y*
M<A#BV:S!^/@T97TU.,SPCZ@31UM)$5:9RG8I$%%FUW$F3UL+-HJ*%YCS (;*
MN1P^&EX-9=X!79P2BV2Q0VN2#E"YR)O;<?0;)2[L2W;MJ]#_5TUJ&"N?.B6^
MAY#DH>.,$XQ3I3R"-)0WSH!BHO,Q!8NM+XV;!9"R?1*96)S\?8 (Z+2 KG8<
MO;K A).=/'8K@_#YO,E\(K=SQ+J%'&YBO8$\N3)_NR-IWTH[5X"\P /)#(OE
M#FSOHK85F2 \M;!A(N_'3RR)3?QL#]SQS+;&U!P2_PT.-#K!)H]X[[:<]VQK
MSFW?+<'NGP $QUHO.=/:F^TS%CRU06<0-D&O/V WM-E'.54&,+BY/3?7\11H
M%%M4@S#F65&Q: N\!\!^E]:*VC:L*=8N/AT8$[77]WN]:%#$.0ADRMSQ+92O
M<%D8+D60G$O,O+T$K]=Y&8*_SS[RD!+#(R][W=B^!G*+7N^B40OZT1..TEKL
M.2=K7#BM3CM,IH:/\-B&_=R![];Q\AU.?#ADCK_F$3%Z#081(SE,=CO"/!].
M$,]LZ6**X*&Q*"=-ZJUJ'ZV;VP$DV.9:Y(!!P9"=__]L['5'AT>3D0<N!*X)
M$JSC3YO%TMK'UQ"L2VRG3NV3WA,D'@PS8!KNPW6\._WZ^LU[I9S.6R#&/ZN
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M@,%,Q1/V=4ENUK#[B98L,&SY7"M5]T/=)!$>(9[&V;/'D\/['Q] -OV "<1
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M&Q8@WS0"J+_UEC'OWTX]+>/_6@,%B&.?:0D1&[.E64'0LI5-=&&DIG)AO_
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M,@7#D7:%WHAAI:HYQ(S]AV.U K,G)IHI;S>2B@T&?T]M]GMKN1JP"<R%>6X
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M3U]].'VCBHWL,B/D!4PD]!ZYQ1Q6U]K:-"'\?D##H[L:.I.\>*A*7= 4P=Z
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M6E6Q0:ZAHQGBRI@7UY5!4YUG*72M<V:M]J/<OC[OJ:PN WAZU;.+Z]9-?1K
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MT;]SNI6G] 7G\ 7[%D ":U>S2[]]?L*80W8N)8)400*:%L<QGMXU2I #-YU
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ME0CF<ER;;MQJQSYM\F7@!IW#^NWDU;_"RR6%)O,G\K?K,EEW\0B>$'E:39@
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MM6+6B$;7=C1)N,@2QREKD71,Y)MKCX,XI/B:FCD]*HN,40>PB.,IE)W83='
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MX(:0+[<<=:-3#>6YR+M07=J#O=P!;^1;AM<L<[&F7<6C?.OA:UI?3HS%2K%
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M\F 4$#$X=! 4B8%YW"$5D" A$1W+A=>&H67?:$['TU+] XV&0VJ^C7 K:_P
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M/#DF69*@M)< RG,*V>:@:1YU?WS7,-ZR(>>]GRV^G<W\9.[CE0"OP@J 6TE
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M,S362I\[AL;:**,']VAE0M\T)KZ;QMM<M6/,..4=@6PUOB?)$^=D("$*_#&
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M=]/)QS.8792/OVZH"O/EBS'23K@<2X"4)TEDH.7>&6V(,(XF;G5&A[7R*A^
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MY+B/XBF%T5KI=;WXJYM\^ZCX^P[1E<?8!%-/(;1->/830.NJJP=5WT'00Y&
M*<TE<$V<0V-9"N:(SU839KUR&KU]>7LS^[-3_B.!LR%TWT:^/>C\ WR9GG\I
MELGW;M-52D='RYE% T58223B))Y'1!AHZ5F7BJO:=80/ AK>5.RNLVE? A]F
M@**AX#U%[UBS%(CT6B'AD\>UIJBD-,Z;?IOW7M+!WU&^0PY0;(+K1ZV*::6S
MIM40NPA\T"[>,@\X1$HH<Q%YKP1Q1CL2/7<AV90#J]W^\=2K8GKA01LY5ZZ*
M^3XC\/!)E:W*D2I<;"B7@9=[85VB>%P9+6D"#MX\EEEI^<A]QXEVU=&T?P$/
M54[#I63:&22\,I3(["P)(GN"QZ$T409G:.T]X*F7TW0Q!SK+N(<Q/]NRQPU0
M_:CE-*TTUK"48@=Q#U=.$X,0H93V::M+QRM#)UAF6JI(F)+)95$]B?O4RVEZ
MX$ ;*0]23D.]1;?4Y=(WHA"&L,0"?N6<SR&+)%WU(8-/MYRFE78>+:=I(]J*
MA_U\MAA]\)./*PYKG[ADWA!MN,,E64^<0@/$.1&206LD-[M!"S_UCF[QNUN]
M?O? YWZ,[RZ]^RK<^8J]&Q!73&H"H\U!W429]5_-QT_D#L)?5U\'R57<=]?A
MN,"M"=$0D Y*(A*(5U81 [%4&0B3FAVR^U;@EM.TOO[:"*RRWGY#25U<7EQ/
M<0C>4>4,;N%*$PFT' T)B(T^!<ZY\KQ1(OT1S7WWT.'.Q4YBG]:0V0#UI,<G
MQX<GQV<?3MZ]>WO\Z]OCLZ,/1Z=GI\?324FYXY_@!WZ\[G[>O;9TI\=TK3/M
MOK:UFE-\.QG56N6$"E="E_N$7#(Y^1R5B7:TTQ.[6:_(KNEL.=E[]:GO;@H\
M&-?6JT )#R7%4JZ^0H)E(B@:=!0\XU [H;D53%<;??V#3_Z<P&S^:?SYMEKM
MU;?WJ/[E&(=D>4R2)$%UJ?_.I!1 $B.LH$8I)VSMX0@MX UOU]=AR+IIWY=&
M>HCP-8+Z_3NZ^I,1Z&"$\I3$E$J64@5B160D:9X=M5+3ZG,V=@;[0Q&KL[9Z
MB".\NIRC .;S@_C?E^/Y4O:WD$_R']/%G<U_]5?H&X^<Q*,C2_2#E0FDS+Q$
MBQ!EY5UB4HO(::R]3>^&]*40;  ]5<Q?EVS*77@'*2TA^_.3R\5\X2<)T9Y^
MPHUV_OYR%C^5G,N(6N8S"H'X5";26#15;0B:1&EXS$D)2M,C%MLNSWWN#.E=
MUA73& 7K!B8?7EY<GB_;FYIP.GG(T3B-CHR(1 KM44BX .VY#\R)G,$TX$E7
M'"^!-X/JHF)8;0OV@\GDTI]_*/';64G<3B\^PV3NRZ]&V@A)*77$NJ1*2Z0I
MURD",5(P'O  YKG)/8/MGOI".5)+SO<9H;K:,V=P\7DZ\[-OJZNC5OO>G8UP
MQ, &7\8J!!V0L0'PJQ \H1X,@-4YR=H5<X]A>NXLZ47V][FA.[M4TR^PFHNW
MOOX/:)*_F<[^]+,TLC$JI0PGN.Q8@IV)> 1&(O74"H,>H:K=:-,(V$MA27TM
MW*>*J>U]CP#MHI@M(SR)<H= \L1:K?"@DX$;QY'5M9/JZQCV0(#ZJGK$;VXE
MY\KU=<=0[OF:7L"[*9YVB\5L'"X7)?UX-MT<"\7_X"2_'G\9)YBD^<BS[&Q
M,\BE,AY::4Y<9@%?BF"L3\E(W>0ZC8XP7A)+AM9*90]X,[Z3Q2>8'7XJ.9KY
M"+)!%SV7JRDR;J1&H7^>D.Y<<T#&"PN@FW#FT2>].%K4E6T/I7KWMC;/G54Q
M:V+0:R+2!2#.*T.2E8PEJK(*M>?=/'R$=%_3JCI#@T]9!DMP(99(ZO!E8]X1
M97W,*.FH1.VZTXU AFI.'B:$W%ZV3Z5!>9/'6,H(( 7N.=<DN?("* TD1, 7
M7E'+4I#45)_SM07*OFJ;*NCX\;AP:UD/DU:XBAE=5^@U =A3R?*CX/93O5Q%
ME0WHT5T/>R&,TT)PB!XQ!OPG.7Q?''@2$]/)9>VR52^#*(]4..^')VW$7]DQ
M^PW^&,]_@S2._OQT>GY9T,T/?KWZ\;) R8!TU#M)#,,S5W))B144S^&(6VAV
MS'C5)'?T^).&MZ,KJV;:FUPK5S[?I-!7UWA)2X65J0 I)8B@2 @TD.BMM-&Q
MD(6M4+7WW4.?OY7038X5W>'O@%Q?I=< 2L5:Z+7'#U\/W4$1F]3908J5ZVO7
M(;F06!90;D0M0YK*-2:.LUAJ$(04T6LC&\VE> H*?: ^NA]]MA%>Y7/V_YVB
M(/Y !_!R!F\GI_XRC0]F/HS]U6'@O33:X0Z4&1@B)1XV-DM)(JXO6LFCDJ+!
M(?O(8X:ME>XD_FD_LJMXD#8\YB,3B;'(\82/$2T(G4EPTA)OE),R,Y/7.X>?
MO/E44[F5);CUM:U8(7]T]O;X\.2WH_=''T[_?O#AZ /$Z:1TL"^S]--\?'D!
MLT(:/TFO83*]&$_*=WDZ>^7GN$[\Z1@7"ND8%B7ROHK!OX=9&;LYG2QSNQTJ
MZX>$U[DB?V^R7*ODC]SPPK.H8I0I2JM%F0SODTW&@].C09%V\_</)HMQ*L\:
M?X%EPR5J!>9'7^/Y)2[X#;[&I:KD<K$$?I*/_*Q,ZIPCE"6(VY KUQ3]6R](
M9,F5F4S+B],BH3XK"EPH$1HY!BW" K6P=XV9?)<:&PGPT@K<?!0O8Z^<<L09
M]!2$5T8*[E.L?N7F=P"&]XSWPJ'UR,GN2NBA:> ?,/[X"5_?@R_XFG\$?-U1
M@"?Y7B7.\FT?646]Q*./9)WQ.$0#A7@&CB0=:+:*@Q&U2Z%: ?Q!&=6?$GN(
MVZZ+8 4J:GRVE9XX6RXD\Y81+S(E*I=F!VIRI+53G1N!_* ,ZJZ4'F;9?5_(
M\05MB%45QY5IL9C&?WZ:GN.SYE<VR$A'E:W,DGA8)<P-"66F>U#6J!!"*2CM
M\T1K O('95B_RNRA&@/1SI99;G]^QY9=*R@ZG$YPSYTOY5;&4-R*=Y29]D8R
M2:@,@LB "T'<F@2CT)G/)J94N^&I(^0?E)E#*KIB1T,K^->;.J3W_MMRWN%L
M5FJ>RI?SD0)GN9:)1%=***5 \*G<#1^#5TJB=9IJ;YO=4?^+K4.HNV+#18F+
M-4+_^DK&1SE#7)SD?Y2KK KPI)6(7E*D4^9HCU \$1P/A#D)!BGF'#0).G8"
M\8/1;EBE]=#"L<4WNC(R-G2<&!O+9;E$^^(=T53@>HM&B%6&&L3L:Y?MMX3X
M@S%P"$7VT ^R+H1KJS8IECE-I9S<2"*YI<3+J$E.TF;OO;6J]EF[!<H/RJ,:
MBKG/%]N5+QUE<W QO9PL1IJ&5"86DTA+88\VEMB 'CMDR0V'P%BN'=*M OP'
MY>+P2K_/7-=YL&C\!.GRO P2Z+:<5=52-C8I]*F(4;:TWT"YR)&BV\^49HRF
MI%)M"M==P5!-!4^"P7M4_E-I7NBX\%??-G_ :@PQ>F3X FMB;2Q%(*@DQS,0
M:0+^+\_&!_&T]O.'EK.O\LA]DK3NCE^-+#TD=C8CNW/+0A-\/35P/(9M/_T;
M3X8,C4C:49/[8)R.>'[)%$D4/!)T^<KM;B*4C +G63(-JO8ME_MAVB,-(,^6
M:&T4V,MM>O/%;!Q+?*$DJ*XJ]X('$V*VA!LTE21+AKB<<?\/D&D.+BI3>USB
M1B!/Q6G:55_W;M+K*NP>ZF-6>9_%&,_][],^U_# TQ(Y(()&M 6"XL0F!L10
MEZ2DRC>L7&_!A4<@O3!6U%1 #SO$59C["HR-TL?D' %=1G-F@V0->=G-K07S
MR>OJ]0?? 7AANM]=N%NK47HLF#XN:(L<*E8YW_O,ZJ7)#Z->JR=.@M/,@G6*
M*QDD..\<:,ZHXDY;P^_7$]_[^"=2!&RRT-IR2YPJW16AU)4XW#:H^/_;N[+>
MMFXL_#[_A1CNR\L 3NH&P21QD*0=S)/ Y; 58$L9+4727S^'DFS+MFQ+NN25
MO !%FL6X/,M'\FP\QPGI*(14_=P^EB+@F^-2UL[7RY3*LAG;]8^4:4A")N88
MR4Z%DDL1Z.Q*1;QA-D@EA/"UPQ"[4WDLAU]C-#X\>+*Z.AO85)7#,:6%"AB;
MB1&BO*8I;=>#+#T":2@/G96.M3.V+SQ@W 6N!U3^L02,-TR>U>4EF,Z!0(DF
M2DLS6K&6$9T7T^8"H]5'L1W/5.Y#0N+Q@=Z[J*;7^<U;T/52!WKOI+.M!SGO
M(? ^ 2' :DK+:PX(CDCF@ 2)1 )>]DYS3WUJ:Z0=WT#O)CC81<Z5W]NO6W?C
MV54,A%%NJ!4"2<"K6%I!B1<VDI0X1!W!Y=L!R8UUD9N_?D1CNG>2_+BJV/J:
MR.VL5CEJ20SZTVA:N4#*)#7"O HZ&:5R>,X3N8_(%.BLG@8OHNZ97;L-52]U
MF/=.&MMND/,^XNYOF#>N"TQE0:B3>*HEQ8CED1-A),_,6I]3[:YWQS[,NP$&
M=I%R ]W?RHI<#MU42:-G[DBD5A$I)1!77I4S!D([#S:'VNF'C80<S5#OG;3T
M<.)I#Q'W,-?T]./G#V?_/3W]^NWL[;\_?SCY]'5Q^X7R]&=]R,KIC_+;#IF)
M/1?JFJZHP=^M'$:P#G5/O>>:2>^X9\[Q%+3)TFI-8;#GFAV?"Z .QC\!39W)
M7\,(UP^XUE<\.5]\:&'PE$8M?XR&?T-"DV<XQI^;SJ;7(;ID#<W).Y(<967^
MKB6>>TVB0Y3::+/)M3LU5&:A<W'0<J75TY [A*RT-[ 20'/T"1G^O_1\-R0D
MR=!B=#91$5+FU2LLMZ*L_T/TD!B\4QE47WM-,QEU9+?T6CB D8$[DD'C'2.R
M(E8F3I3G-'!FI BUYPDU8:2OO,8QX?;PB#B6+,>RV\-7=- 7W_VPXG-AD#,*
M07$F26(YX+9-C'AC$Y$ZVQ29,RCSR@A_@)S#!SL.AI6[C\NKZ*R!QW,/:2M#
M?QOB&D5 'B3L,(&0:FK<#AX==- [4!*71B832AM/062.B@06+ G">J5YBI$V
MZ,K2-T >"9(<!A^[B+Y)R&0Z.\M?_?E5_!\==RHC Q*H1X*TER2  \)\Y%Y(
MZBVK'6N_0T3_5GY%)=V)F'21< /S_ M, 3_XYTGI7?H7G(^_%XY7OL.*Q,0=
ME\XAU&TNHQ# $FMX(-PHGP4PE5SM0L MR'I.L*BMA09GPU=8#(5[!R.8^',D
M]"1=H,2GLV7MZHK62U0#>,5+JV8&)I4C,A'ON"44I#:EJ%F:VKT*=R+P.8&G
MG69Z*!'?$$DL+UO.OB]'LB #P]G/JC'9^S_?(!*[)2^WXJ\9N. R6,.RE0HM
M"KP+:,@Q9'2R(Z1-\=?[5^JX[S<[6M?-LM[\O-M*JTRAO X6@#!1 YY<V693
MNA2&,CY)$U23DI"CYKYVSJ4[U9W/RWTI6"IQO4_/^FA/JK3@D>$%P("CZZJ
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M*"\A0B8N&8O&KZ=*.2VB:V)Z]<OFZ\9Z.B@[PJC.VEGR'CD;CJ;#^+L_G\,
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MX7ZPSX)=6X<N[. O\'T\F2U":U<+7/L'F>:4*>(4'&-$LEQ""AE--AV@9'$
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M&#];.04>Z<"M3DM94A"?EH#0V7B)V8;]DMP6'1@WC_MY*72:8B(*&NB->,D
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M-Z96 1G0(L2QV<<*NX%=9@">$0',6=]H/"4E(3^&101>"?B?/7#*)=-(G1D
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MQ\_&U6*#O&="G$/>KE-<276-_$\;IR*DZ&LQT B[U,E.54=U2^P1,(JOP:1
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M]A^=+9C%+(6F2[NL'>'YH8H)2K'-XV/U]G=T!DMO@,47"I \WF 3'##<>4O
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MJHX"S M4O)CTO8IBN)S^)+>PYF/;\8*^S&[]?\U&4 GPR2_(#0UW\/Z9R0-
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M&@1KN@^:?XYU((=D4P%]%4O6L)@&!^YK!.EYB",-LPT"5>C_=B.P4301K%3
MJ,8,[9]%T+&1O\MPG?9?9;C^KUPG?3@N&QV*#V.)?:L.A4%'@&6.!.\\+4PO
MJSFL[6J@](%ZG7/;JQ\!A\:O*RM>WO??]SY@>K1K*=9K,>!63KX]KM@ED#O.
M-YOD)_&ZA?'N3MO]S!^%ST?7.*\.5E]$:8Z2O#/JW^#CR(@-"C,A,RCWW6+S
MWH9.]("7K?)]&> F:P<A7-F+*69$R,C7X5=\;B^;7G]NX4_:I(@Z7+@<4+00
MGF>VPA_T(\%ON%3BY^3M-BMY@[>-!PL%>K<&'*> V: R\#J3 P[98J4SH>F,
M*> \?##DSQ$3_+3#1^D)C/G&DJI*+_BM%0LNNPA+;!U6P$<\&TX.S0S7.++N
M.<7K9W2&?9*?K$@0P<5I$89F"16N2H4\?3:*9*4OTJY2"H%Y36)3'57GGC5#
MQJ_MN&1>,ZDBBB%GP'"2X&(Z;?KF[?R;52[_WF6:=A&[#G]3IYRWE)QJ!?V8
M.Z'E["GH<4\AWD6P@PGI-)"1-OX)Q F]X'^)B$;%R*%.. F1I;5K GTAUG<_
MD=X=^H.)=]%YO9?.Q LK<^*7;A7GA6J_E9VZDTO#?Y''U<X?Y-J)D%]QX<X&
M!;'\F8P7'D92#4*#3CG6#*=(Q^8Z[K%/F7]?6FH*"]+0O$=.(7C/!4I'"#+^
M).GF7+E>\S'?@I%)Q9P]/(I80+<!*,[532!!A*T-7F[RN[2Y:R(N;[D6CN7@
M?MK1%WF%@;@1:!S_07\QIZ=2,STXKTM%<Y (I6WRJ<H_?_MSW=($4:9FSUE4
M),X_H_-LLD.$[365H>;/XX_M@-AS>OLKIF3QG:]U,'SA;S[FP-F&LNR)EH45
MO#@Y,\?:+JHOV)=M[V=-D(G@T%AHT9I3-MY!ZF_9NRJT9@I5/'XGK8G1MG8H
MR8@*>#6 OC_-79<"S4'G';G+^RNM_WZYYHPC:UJC2%&0#C@648IL@Q,> ?EE
M+8TP[N)WZ]S7UN_$A9ZZ>VLZ*+89U'=L$USLLT584>DI&NXU6+H2K_Q949DV
M1[D6/Z:;I,EB/\)CZBX6$ (-X#]*Z*Q/[VW?\GE6!88$*S<6U5S.'J@Y;6SD
M@ %%U8D'S8*YG2C P8$NU(!;5L4'UM#XU]_PRJH[%TI6UVB#.=(,6T.<=A0$
ME;YZXZJG'O:I\P;/,52M[49?, K?-=UP#?DEW= H.QO29N:6.GF;Y@C\B$8P
M$HJ)C0T2_4IJV0U=ZS(KBKGUS$9,3*-;;"5RQ)NS*&X3PFJSF>;K9QW;$C[B
M3S=LE!OM>@8V6%7WCJ(X"G:8*,Q=.%NB08L9ZH6T?7=[0CL5H&ND].%LB1C<
M[FT8S5O/KDMM3I3E4J\AP349#1(@\#Q\$*<>6"'PI:&<SFUE<=VJVA2RA:@%
M\8 M;YDP5-.(:T^\5(1.^68C(?SP(@NJK7P1N-@@'L>C_UE"6:O?^)W.Y\7'
M1;M*^@=;.K>WG)-BENV]UH*^YS[-0'W\)7+IETB!\JF,2#$-L_YG8W)!]Z9[
MI%'70GL_;< .Q1&,?W)_+1D;;W'G6(\4/E:P!&A$*A!TTC?>S1G&^H,GVQ!6
MA;"WI-7^U=T-KD8RF 4G8[5#!5RLG*%HGC6UI%,<$+U_TS&PM3>(EV*E7U6X
MGW)BXD[V*9N\T7-\UB-S*H8S,!;\KD$$Q[7XIDX]S]GL59K=1KK'WC5YUQ^M
M;Y4!/4Q?D*4P=V3$C&W?#H+!M"L">1>%8@FXD\-^_J"*+N0Q,MP@7.P4L]&Q
M6(T7'Q]Y)%0.HY>N/8%\,=I[ 3G[',?0'@ *=V$Z>)#I]26LW??RKU2B6)CM
MVDGKD5'8%V +2&';%#<T;WI7=:#P.-O<.=D>E1<9(92!F"$]BYX.*-,)G/_K
M_J6]G96@"#29M;=%01"1Y8A[?OWZE8OE[ <71/40$):^C,@UD+F6NBE]CV\N
M@=AA"D!'_(V-1G:/3CCDF->WAMR0+'\BNB<""(PU-]P26=_%R:\I7(J;=;[I
M*8?CV6O2O?LHE@.XE\K]&ZYEZ\9;H-LQ1J?9Q)#9T_5LT1 ]C.(,#R'.8'B7
M9UO:YWAX=7RMF[T(PZ@#(."0Z7L]"X?Y=W%QM?0"<&9Y"-,L<>:UH$P?23$'
MOE.D\<OZ9-3KP=2RV*5\/GAI,MD)NQ'J@ YB>M"W0R"E"!Q_]C58)8O6C[C)
M61]D#,Q:-PSTM&&(Y/.<57_RK$KC%XK,H?B.OGNYH/4;R(K5C%278FCX6W10
M/).9>=<6S2_]JO+I'V'LI%]/8@M+2A7"-7CM'K^ELWY_ X_;HH5(?(3ZPJ4(
M=ATQ>Z);\NCLQ%TM0^#&J6]! W('1/ 5Z#05<$R@8X9EI/7KJ<VA.ADS=#"R
M^V*F;0\0>T:<R.ANMG-%KC[>7#FI[4W.^N4I-_B/%=&,AD_[=);(0X:17^R$
MK]P\XL-U,$,4AU@#^1K8E@,^_YBVK["CO,R;W[*_!?*'S>@CEQ.$*J":(_V@
M+\AV(>P,9C#@[-J$K.YIE](XSWW;ZN];0)QP#KF\UVD;5QY4)%[4-T:/MINN
M]0X<T%JS.#A%WW5SI:72!];M:ZKCSU6&\FM=?(O6N_7=)A!P*&_U%WQB;PY(
MHF&;$W/8^%=$.1B'6XQESD),M^<"D,#7'!A,B?^7$?8#("OT)X+[$J$/9VZ&
M$[KVYBBL;!D'$K3,YQ#B7=.5TMS[6-#S-*.A_>K#R,@QH/3EF[_%.Q\&)]R8
M-N66U=_H<,J/>J=[B_%BT&DB*^DLZ+2*M&J!5<O"4ZC &$P%O56WKW('MO=3
M*NC.$[_"E4>/9A<.>!ZP9KTW-MB8&0M!'R;Q$-0_/]V^<]JD&N@V.($:/W,B
M&S;Z,(\*.-0;L)LOBHQYGSH_O^<PJ"%V58^>TIO[=U*J2_]]21_./5_5DBTF
M$J?YW+&!<N5KZ&'$%:+&)YHYT1^'KHG-U$11 76SE;E;(R7(%ZNYA'3<82H
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M7$.0OT-IPI+K:Z5$'B]T4?970(=>$HP32:"?=/5U=6:?[OK*S:R=&R!1$H[
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M.6$G%0#I>@;UHSO2'<%T'T3+V5ORXP_C4W=_]IZ.$(IEY3,Y$\R6>P'U&.2
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M=&76<5,OYK<VVXO_[&$5DHM<W,!!!31/$*0+S,S5%E85P*3[Y:2@A7=7_#1
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M$D96_5J1X0J@-MUC5@286?B/KU5\,=:@YT<R-[Z%ES'L!ZO.QH(39S@IO*M
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M6[F)?N9A$S>>N"5X/+IW \<3"XDF [A4./LP\/G0,"51,5Q$U]Q[.PMWT5K
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MW4"?P5NB9 #]R7;QLSX?5V'-6@Z@(]&IWE["TU+!PGS%@T<WAR61.0Y?I<F
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MBJN2%,'MM@]H,4<5%#"P\O8'.6 [%I):%$B,!/TQ@N3UIZ<+EXKX7 [MG,D
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MF.L:$YZQ;__.AK9P[153^XNMH]'L^[:3LV=(5UHP5>B&</37YN2BM/.>U\B
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M<R.KJ'V,C%QVG_5/$L)'Z?]0$8*3)$E0J,9K86]",$6=-FR7^!\EU'33^ ^
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MV[CIL1XUWXH""KK9TBZV'XR)W^217'QEFDIWM-P@308$V9(!7Z,7P,=G6\B
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MKR^_+JF=O:K>,]/XH^C&4(+&BR;+6(7VE.7X?IP+LP]2'6,%ERU"VGO5J'T
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MSMEQ?F+\UKN:FA"/HM-8>"N\<S?!M.",_CV:M^IZ%A6NTOG^BC?3/TIERHV
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MJN+Z^=/K6^W%-=CD ;1[6YHM6N<^2O:H"IBPH1*R86MV(2E+,FO/PYNW72W
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MX:DYQ$,&Z#%\1WWO,T6>EHQG-\V+=]*[&M6OA89[8+=3N/Z:R<>*YVXJD,!
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M5_VBL1V%L<=$8R>G+9D] ];UT-<0ZM.H/WUV(8X!>OU?O;ER=2*XT4D*GQ4
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M7"GLDC,7V:!)-IXZ4EDD-*T.R3DS%?OL3.PS^5Q3G/2Q>MW5QX&=:=F-K2[
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M][C9"IW,F?"_BND!K @#5%021:1,TM/ "5E>']O;Z..9CQ?78F;54\QD4)P
M%G1N\>XE=(3*P_<M>@Q7A?E*HK-'8JU3. +\]P-AT3_+C#R$CO NMO&[B;6$
MK<DL_@ZYE6=\N83_^\"M(H"41]9G@+BJ#BZ:&>:I>F >[$O/RN9/3-^S++@4
MV.E3AH&G%1QSB8V=NY7VCTI+6]$&$_;JB8!>0P 8+0Z,<0X4+=O=>C?B<(+K
MZ,^1']C:N9K7]/M5J;2OT ?S%:PXQRB!N1,?R,Z&";Y++CD-<:V"6AM:![ZK
ML!Q3;!EH[MO<6+A1=#S^QW9H=-SYM2\DJ0E8HY,8/L%/O.)JUF=U+U#8[4+6
MF>(REAGX%LQ0I49@C35M  ^K60T?.T,^BRO;Q++]#!3?;6':]FIOK]6L-69-
M*"8%;$:3)O-1#,AB^,!W%X8MS\7@3F,KNZ0^'))<H1NXG+6LP"@N[$60Q Z(
M2K0H-:VI5*B>D^<2+U6)#_U#4P!U%'"?L:CFIYT,T-+=  ;HYN/<#;$&0<DN
M98X/K1\==_(S8[+J51W#FJ\[;O L^(*F!J97E^.( 8"7XE45'W$8XWDVV_/(
M[?L&,!E@1\-OM8IW<ZE#+_Z\R?ICUW=EXYR$1LN!I&%!Y$7MH;5Q@UK'C3KZ
M@1'F.L;3ZXRA.Y*B_UC'PL[ .HZB'+D+>,FRW.X?T(!U11=XPS;D-I/"2;CB
M=^40?W?<Z7/[9N&H7=&#234/$_MN.>8%7ZEX_(M\,93J0*XDK"U.PNJ34;4#
MYF_FM\2CO]<EWH/*P1B@W=>RB W(3N-Z.$%O]04#Y-!3!'MI=(%*JG]8'@/X
M:O'!5X>#YQI>HTF=QEE^N<T&,4L=4!Y8"G^K&X+GG]2+^5)WRKODM55N-#XH
MK?R2*'DR475-\Y^Y/-'\X[LH*H0 G 2F 14TS!KJY($968[+C-!%Y 2WBB+9
MN'VE+>(0 $+<@R<7DBRTS<@^OI?65I[W%G4V/3_M=R[<]X[8+GK=SL!8\2^U
MC/0_J&7\$K]>3Z<?/$5 TX]B(?/TBY_]S@950EYYW'8I?>(GXZO05+J@UX:(
M@']"%]G5UI,;",&6A+5&3/:;JIZL0CK?F[7ONY:_O1;N:D.J_ID= PY[GKM\
M_FEEUX3U^;4[Y4,10#C9I7@-JXZ:2 80 2Q$F27;ZS3I_M;PH6W2\TAML^_U
MT="?T>A:=8'<]8^5PB1W<B:SZDER3O6TG5A6'O8!5J]]\1?5;FFPX-P_*W07
MW.XM^(B&;$#OS65JG(;Q:O'EQ90=SLLZ&= 9 ,/$_J.^NIUX(L 6E\^JUU4L
M\F('F>I\-K_>CISN+EJW=@[+@SSK=6)K$AWEWG%H?.KG?(+./JKU#]V<DP(!
MIXP$V^#%[H0HIA**1H)J,/%@"_\!Z8R%RQK$PT4RD#KO6%]V8#K_0P8E.2*K
MC<V]D^P!K*8/RA=R ><OA9 JF!]N3)8N!1#PRY7\:4C=Z0NVT#><UT+-GU,,
M"#U-1G"."I94KRQ8=4F?A!%*ZM(:.KT1]K',5G7!,0L3A)UX!^'<4B] J%2]
M?2ULT*,FV'1(V5J5PK]K8:9J&A-=KT^2YP=GIAL,US#U;F85_J>K=?_?K-I=
M]28+_14&6EZ\3,/!I;YONJ!JF/O2NP;_&#1J4 !G T0//?2?V(W0@[^BAQ$4
M$#TTHDG30/1PVSCWG^FP]<+Q.DOLC)<%,I-> ]P")TO@:S!O.V@BWM3/F-[Q
M02A=)Q>X^LWU9PQ0!MAB.XI@C-E^YP7!8=7FE$32JAYM_:ZZ"JQ,WB0^;9W
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M?.[N0X/(+K4_\0#EZ?QNC^G?X]_CW^/?X]_CW^/?XU\/,&/H?P%02P,$%
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M> -*(TX(@B%-S$42$I!D1/.8B(@BC =$6:7QVFEW;!;0%W.(KA'DVN;_M?3
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MP;C&LN=U8CN,-]MAW&A<_O2BD(IE'96F\F4C_116&6ZH_)63[5O@H<O4#C0
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M<@0QHJJ*_4DY(4$448I5Z+("M?8VMB6D%A:4TH*&N.#/2F#'+4@[U'9<[@W
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M_5W<&_=G+41 (Y(QR C1F^!8I) E:09%(GA$" D$LYKC73H?V_1_6;B7;C0
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MEEN9 17_N:K.#AT)QV$H+,]V>@&X[Z.?6N@+L$9Y+3=H" Z,Y'7$JL<#(F?
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MSDK/KU^ I"1:%PJ@ )HU'=%9F39)G/. ?' [YSDT51G"$@&E(06H2 T],"2
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M+)S>EVO#0VM_>0)R1 ?,]PFA"I%N)0@:A8)KOJHDW"=E0>V,#H*2EQ0@5FC
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MH$NC8V.%QN9D:W32LOJ"_6VG#G CC]"P1J:2 (CZ!R!Y0!0J/,BER6&#=SQ
M. BM\;FW;P[CP\-B7F4Z-&,G*C+)"@1!JC(!$)?(EC[5H,0YI(H5A4!>FNX'
M+8R-;&H#:W5QW]S$??#<N.,B2"(311N-"-.-DZX'2SG<?_[ B88GW#M,+SQU
M8<_C\<5</?_.EO]2ZP]/<[FZ7K]ER^6S(8TZ5)B9KQ9"E /-K29#D7+ .85
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M1P2)AIR4().< L3-P$W*% **S.*"0IE3K7W7$/U1C+]>:&'X3HD@$+H-J'U
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M2N> DR(%,#>.8X%@QCQSM8ZV,[;9:;.F7;.?&Z4(;UV(HW!FB$F)> $*I<R
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M/,VGZY4-!=K4SGBLM9\NK1,WFAZ(76;E-=^8R*-_@.(L-3JMG9154N&3K U
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MO:P8&].TA8@V^D-/<],5B6I<:'[WV#B1/)K[_:BG7W>YT5+T3HA,6;4@6NU
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M>/0HTWO4ZV#5>5\^?>"BO$==.ZS%>_RRU\GHO'E:K^SFCZ&7)@$P$XC3LM0
M"Y@#1#,[V3<,D%'S5TV4Q"*;/-;+F35;KATW6T+;Z?.][%L;[]-IF7F5<'4W
MG<_MC("S617D_&IYGH?=G&/-<)ZE0"*( ((I 3S/$(!%2HN22O-'VG3S^[G\
MRW3RQM:!NEA5_QUC_SINM[UFC\7>B N8Q_NBT\>6QWNR$T:2QWMHWU\JC_<D
MO*'S>$\WU'=:S]<?YZOULEI!_V&^E6;)8(4E%D_S]9>E>I@^/9@U1W7I:O5D
M6:Q*&OFLUA-::%Q 0@"%6 %4Y!H0G%.0<85SSDJ-:;F-47(O0'FA67T"EP:H
M5=GRHSJ%J<:#*FVNVC&PP=:);!PTA%*5S_1=9ES6G:[+DOB],]0RQD"^<^4J
M:7?1QIODE\:?7ZMNJN_9=%_E5%4I,^0"* B^P19,EUDS\ (K"'2'"[(PC^U'
MTINLF+K>9RUH6?W@_4\[A*B="%"U7-SIWRN2%K)(!<#0)B>GJ0(LQR7 .LO+
MC.000NFS2=/7D+'MYK3U\K<I8XT/?H3;NVO<F'8(P"-3[!;?IK9P([3[ O,7
M.KL1JQ)<"F<@1NUMQJ!4>BE8^QQZ\?,NW;BN)\PW>D?DJ[^KF9SD(L\15Q2@
MS.KT2DD QZD$4A4P1X*F4'A%39YM<6QT6)M9D^'6T+[[VZ=0]MWQ#H#=8'O@
MF_7^'H2)-3C&OO@9;(+OE)]J[Y7VSL^X?WHW_=R-?6N?6$I;/B[JRJ6V@(*9
M^9E)X?+Y[4*J"=,D1YD20*4% DCG)>!%:O6O<$$SA0AF3CK@CNV-C5UJDY,7
M-E]5=3V4K5[>6)Y8TWVKHG3CWLTX$=",S#<A@.Q1+\4)G@O*IG0_?^#J*4[.
M'A91<;OM@ECH^\7,W+%Z_]]/IK5*UWQ"\IQ"EG-0VAD+,O\$E$D(."100JR1
MP#[I@6>:Z[.E-E2Y@1[!R4?P=#P-N0"> 8.+&PO_+:EMO$JZ@>H7-GP:AI!A
MP4=:&3[L][2K1\-Z.R[OJ5^R*X^YTRV!F=)9J8&R!=50:688),]R( M>\ R7
M@IA!\(=:\H6S<LEA*SXO=KNM>.]WRTA/:9(C&!(H2EX*!'+%2H 0+0$K8 JT
M)IDN4%9DVD_[Y3($AYB/M4S\C\L!=&/-"V&)S)CMXL-11%M.>Q]*K.5("\.*
MM)QV\4"<I>/2?N1850>^T=>BVHJWF12+V50\UW_NMEQSG@K*2P8H+LRWCE,"
MJ,X(R+,LK4KX>NH\N34[ML^_KJ.]T,D7\]1-U+0?#SCB[48-X5&,S!9; '<F
M7R6UN<GWYK]1=J_]D K$+(Z-#DHV?D#L\X_GW?THZ;W62JQO]/N?XMZ&=EA!
MNYOY6[:ZM_^W\\(?;&;WG[XJ0X%3899+]A?7<_GR!ZTK)YDH%.=8@I1DA=6I
MXX 4F)A)G]!<4LFQ9C[\%<'&L9%=[6+UM:K&RV1I]TOJOU<R,I5PC#V5JOZB
M=LY4/UQN7:U^[T>4,=X"-U9]Y;Z-O1-6>6=[=>-?+?AI>M,:?57]F;1LOTIV
M;C67V,[=^^'+.ZS^Y'3^9&,W;QY5O;43,/$V8@\%HOX8%@XZ3D2$>']0B=E4
MSYJD]3L[OZM4GIM0PM6D9+B$J2P!1N8/!"&S$LP$E!DVHTJ!58&<\G2[FQG;
M.+"U<B<3UE2 6&Q_4ZG8^]8L/0ZR&T=?#EUDFMVAULBQ;VP,6+:T$X-0=4N/
M-S)LX=).1P\JEW9?W8\1VJKOFT7X\ZXP:G5L4:M9U5=.V>S+8E45FGO_<ZWF
M*UM!^=-TM9X@##/*8 IRQ4M;IA3;$TV;]I]+PB04&?-*_@MFV=AXYT7E@JMD
MZUN[!G!SA+?1,=QZF&Q<3+[OG$RLEYZYA^'ZW8W77J4W(U-A^(Y\/W]Z:&:5
M ?<(@F,?B(+#V34H:P>'<Y_HPS<05'#K'VSV5&O0O*PCI^0$2V6HGF.@RUR:
M,2 E@,@T-V, 5CPK298K3ZU!3PO&QO4;P^RW7ZMI+1Z[UXR!>L+CX#H6OD,<
M:9_0RZH<N&I4LAH?DJT3T86RSN,75R*KH_TQB&.=A\=1%LOA00-GQ]>'^ZU0
MPNJ<_YM9_C<6?E@LM9J:A?W'>>W#1%&2TRR%@#.M ,J( "0C!$"1XYRE*2KS
M7B$[P[DPTC"@UD9>3;U/\ZG=PQ-V<)V9GRZ6B?KY.%W:S+MY4N>!OT(J=H]W
MQI'=1_8*_&72MVO_7T1M5P@D:P/!+KE[BX)]?6H<1I#<W;_S7COMNX?E?XV$
M\/Y=$BQ5_ (3+B^N-1$E+O("(I"6# *42F;&.(V I"E,*2T$XVBR=D\%;S_<
M:\H_0$)W70:URMM>M-4?YAW9P.<1= RIZHE+[%BJ%W6QXA2^"AT\U7[TJY6V
M.ADN=>R:GD="E@<^+^;;,X\Z%:_)OYMD$&*F, 14IF9%3Q@"K* %D(1!P:!$
MCGDJ;LV-;?E>C_JJ-J[')WP&7,<CH6"0Q3X:JM!J6[K)[_VE,?;TE-K_D,@)
ME5"'1=V-#7MHY.3XP>&1VUU]8RTK&:O;>Z76GVS/V3G)S^EJ(F'.M=8IR*@J
MS+@/(2 TPT"0PKC.<IGFI5]TY?&&QL8;C9U)96BRL33Y;FWU/*@YB:T;>81
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MCO1FO*^L3=J.7-D0M)>_[E5#K%_'N7%4].Z(S%[1>L(_F.\2)$.%Y?6R8=@
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M",<I/;$+1#N^K0_*3#VAV2>OOH_I>12^6JGUZFU=76/"(%0:,01TR1% 2!!
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M<,:]'TZA9I.Z"1UV+*D7$ <32?VN[GJ>\,.$C?/%ZS9(;'0E$"I&.)8@T[8
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M8-#KN+E5VMCXIE8V6FL;;=3M5B'5#K4;LP0#L&=BN0"[#K-J'3 )-IBV3=;
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M*F/*4>JP^5%^4!QD0WE>?HJWFFO[V?STG_]C_3?F7S9+]3__Q_\#4$L#!!0
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MJ9"X)?2<UN_*\G6)BQ79_DTDWH ?N*@J>44LA9=30-E=^N_+Y@[X_2GX&7R
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MHW<A_[S0RQ>8#Z,?/66J=DORIZ_::W_R%5SNLUDY#9:)I!3!3] [-!@=.TA
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MB^G]%2974__U2VGINIS,8".C4@.Q* LBI44FK,]$J&Q<TD')]1*8[]PQ?Y.
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M@9:U5UH#;71YN[W_\.G@T[L/!Q]_/_SRX1\'7S_\X_#XX-/O?SO\_0^Z#.I
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MU["Q*J67.I<,+C%G!3!M0#!O>&8.='21?I;NS]W?&W*/$M,+JH9#PFP(M72
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M8,^0-"[N]M'V;#C1CXBDGS _>3<[.\-YFL#I9_B!<SIU./FYO.Y-UBIJQ5G
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M6.Q89_4]X"L'+DO2IHZRSY?+8KP2D@DAR>3D,L7[1<B#E)^NHVW<RM/!X3:
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M5.PC,-E5RAT!Y030"%_('PO.DQQ  @/,FD4EM8ZB&%%:YZBNOKL/2.RLQ$=
ML95$=T;"#YQ/9IFLWOEY4SR0)'#R;7I94)=^?9W#='&ZU,D?] #7*?<G,I5
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M63'@14:9!+2.NSU+U/B>XZ"@VE<-'5Q1]Z[?$PB2 X;$DD02CM3DJ>HB618
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M;421AIC7^AJZN89'6#/-=)'W_#R?)<2\>$^2O.<AGA174!4=6:H;L'0MYHQ
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MB!*Q>4/:;IO%7SI=NY5FG]\LOH68.\#)HS$J15Y@S)K>4:Z95D71]6LBRQY
M1<#  PQJS7:<JFWG .TF[^Y@<ZMOW'F-T5K%G,ADB4D.+ :DB]AGE:U1COMA
M,[.]=^MOI>A-N_6WD7IWZ'FR)UQ*XTVI0]6QF#K;%NDZY=5]1"--],3YL%-#
M7E^W?CN$-=-,PV[]81(*!XL%GO\&"R)K!M.FR81G/KIE(F$;+H9-(GC+,:4(
M+$BGZC)H,L"!T*@ I4)/EI4?HDSB99((SM!E6R0PZQW6(O%4&RH3BSEQC>A"
M2O^I281M]+Y)$F$;47?PL+VCKYS4AWER.CG_M71%0\$ 22F&,A;R+K"6H7A8
MKM'*!C/]IO72F8=4C(^5O11[O_1B/REWAY.5'RJ,E1JE92&X4)OX X/B+1,>
M3+#D/NKFB==U=(R+E7UU^R14=A!T!V#Y@C]GIS_K=I@[S%R%OFWR4GA'?'BR
M]H@O!C(11Y'7DB)-MEAK1_U)@GJ"SR[ZG@TE_ Z0M"8SYS@"\)29%3DR#=;0
MX<I LLG):.T"N&';3/O,.>SS/.TIY>YP<KO;L@Y8CXDS+D(BL1C%@K.!)9 A
M9I]+%,.N3^\XQ[V5CC=N2MY"X"/GN.\ZGT_?F\6;DK@AX41);H(!P4+F='DZ
MJWE&B>"><["W_,J>X+*K?F?#"[N#RV=M0D]J+6QP=+B,J[L5@V=1%6!T16N7
M= R.M[YX=DZ.OV@N8I^':F])=XB6JPJ3J%2L%2#6V]J()$1=8\9K*E@8G4-1
MO'4QUJM)CF^EX<V2X]N(NP/0/,S:<O!DPH=28^:&R%:>>:1?A0 E%I5U:-Y'
M\SJ2XUMI]MGD^#9B'A$GB_GYR1>8?KL\+Q:RU (<LTZ2^Y@\L&#H.0U!Q>SH
M;2V;[7FC3[V%"_K=#2;N?&%/32N[/S*[R[ 'Q:_P&J+T+B;'4 =B/%ID8+QA
M#I/,FBN7-WM&-E']F)? 'LJZK^X=)#>RPO^<3"=G%V=7HQ8B!&Z"HXO)6*:1
MUPLO(_,)<I12&I ;)7>>4?F=+QU9Z;NH;-9"?AV8 H\ET8.T!K721#P]4B0,
MNO+ <F911:C+#["Y ;E/_=,+S35N'1S;3=X=P*82?E3NN=OP5ST'O\WF\]F_
MJS,./^@GY[].M*9[T[O (M;&2Y,RBY:<_ Q%E.(ATI7:VAG9@KZ>0B,[ N*^
MES*4=CI%WKO9V=GD?%D3AGBK1(?$)+F0BB'/A6GG,P.RV1D"KS>Z2ZGYJI,M
MR.LIZC\<[EKHIE/8?<'J(M)9>GBH+'<A&HG,V.(8V1.:@8^*"0W)D@0Q0^L2
MF>TH["F2-QSX&FFHRVD GXX^O3OZ]/7+T<>/'S[]\>'3U\,OA\=?CS_-IFDV
M/:>_0A_X[:J"<?="OIV^9O^BOOVY:U3@M_X;KPN^3)$V)8R,ATBV8":;/PB4
MS'D#RCECK&Y]T)^F:-^+CKR9V7PY2NCR<R]-7HN0BXZ>>2WH8/) !U- 8,9#
M*J!C,JIU_F$M(>/::@VQ</_VVE_L'3R2OUTLZ!)>+ [2?U],%I.E6FI !<GS
M!2DMRP%JERMYUI$N6'*ON1<YTFO?O%7O$5+&Q4\#)<_:2[Q3X-1?SO$J#A^L
M4A(3$"^1_I,#B2L@L)2%S:'84'SK_3?/$C4NF)JH?@,X[:Z'D0LR_L1_3!9_
MDCF8X/1X=GI1N5D<_+'ZXV6PSJ$.'()F3@3%M-2<><4YDXF.7@G"@<G/V$>;
M?5-_4-E#K;/!9#QR)/SHWU/ZG.^3'Y>SK[7GRNM<":]I #0L1AY9 J]]"B(6
MY1M$PN]\Z;@Q@7;OTW[2[ 4&5X<C9E$4UBT(U2NM765!"OJM<4JK!-;IC4J,
M-P7"F*_+GHI;I_X=I#CRR_'_SB;3\W^0E"[F^&%Z#!=Y<C"'.('5E0:@G0UT
M(HI Q[2F*],7K5DB>22O93):;?!L//,U'0!@%]7-AI%C_\9$$BH+4?=/+O<,
M9EOJP%W/P)F@=1&NW*_1&]*8:/Y(M 1&8VEVX,'<?SIO8II"6@\FDL$3:X^$
M)R,H2EF8XDI%CB DMFYK>I28<:.^[=W?-E+O$#[7!^TF8_+;K\]+*9\XG[U,
M6;.LN*WS6NAD9.^84V17.V."\JU' FQ!7E\1EAT!\0S,6FGGM0#O;MSS\J^<
MH(U.&>#D(^;:^V4B^75)L&QE"=S7QV 4&*XCMB^WZ@5!N;?F.H#HFNC%#8M'
MY1^S\UO!^,4JL)%/@C8N%;(8R!B)K*ZN8\&0;"%DH:U*DJ?6[^YNE/;U*+<!
MYPOH;&2'X#8[!SDO6833HXOSQ3E,,W%W_)WDO_A\,4_?:Y_2"?<""@F-D;E3
MQ\];)*LY6I:TDZEDHSC?)-:X[?>.6TW=%EV#RWUD3*TY->\NSBY.EU-L-CD_
M&; D%RP#H\AI4A9(J,2P!0E1!%4*N@TPMB\=XY9LML?<B^JE/PP>3*<7</JE
M=K/,:PG-[.P'3A=+?9Y8<O0YYX'YD$T=]^A8M 69TTK(2$:&++ ;XI[XUHWP
M95\UOEK)O /[[2N>_9C-8?[K<D?5Y?U\Z\(^$>@CU"F2T48Z'1'I5S$"XX .
MT=N2=>L9#,_1M!'"W.M V"!ZZ !7?\Y^XN64OOOR^D+NSOO9_-\PSR<^)6.,
MDXS$E&HS3V9 C+#$@7OER%,WK0NT-B)L(X3YUX6P]AKI 6;W6#E!LAM3\8+)
MK.K*]0S,>VOH,==1NB#I!+5N9[A/P\A!MO9J?B:VL97,=\;,#YQ/9OGX'.;G
M>YM1G["N))N=X<<9O>OGY_-)O#BO\>ZOL_55A/0/CLKODY^3C-.\. %1@H]D
M+(9<-QX;*UDH(M(QC,Y#SD[;LH%=M2<9(\?-!L/92VNHX?S7'>&XEJ.C\^\X
M?_>]]D N3K"XH$VI:Y>+KJ,K-7%&1TQ:B73*E$>TFR#NV6\:.=XU+*C:RKG'
MYP]D\"85RURN]86UU#F <2Q[+43FIIC8>H_"3L_?<#&MEW_^MI'YGL_?X30/
MU;!R^/7#IW='?QY^/OQR_+>#+X?DW=)QF9Q.EI\[*Y\NSG!>X4C^R.\XG9U-
MIO5W93;_#1:35/]T<GIQCIENXGII7U[?G^EHS<[.9M.E0[-'H\M+DM>@068T
M:39JK#F$>>W,6M W+K_KNHVBE,15D81N<()I;1V+3G,FG 1Z;ZW@T+I;X#%:
M]AZTD[YCOCBMH>KI^217>4]^XG(NS.1\@HO#O]+I!8GR/5TR-<1S<0F#HW*?
MH,M2B>)\-D70-6!\-3FPMNKRPJ(P5@B>L\FMETNTY6!<OZ4)XAX,^1E/Q1U8
M!WOR_-NO]1]P.:<K@L%(HO ^U>I 4(P</7K^7*3_E\61;AJC?4!VQH7^F"B=
M]0F9;D_/[?&8B:/4.;&D)!F1Z.KH;Q49()!9J85%TWIX_G,TC8OC;L"S$:AW
MU&0'R/Q"7L=\DL@Z/#Z?I7^M:G(CH(NI>"8=DNLJLF.A%#KV$0LO,23C6I=\
MK26D1PSNJNL'\];W%7P'Z'DWF_[$^?F$GHHZZ>%&2%?L(/!L1$TJ)'H^HI',
M9X',\9"UY@8V;*C9 D?/D#1NH'-01+541@?8^F?=ZC2]WC:9-*0< D-;2QF+
MHX,1RS);996 #%;&QDBZ0\"XL<Q!<;.[H#M R9YVPDTZ5%INN"=3((D<ZH:+
MY5JYQ#@40[)51L6-FD!?S@GYN%6SQV!WVMOQ.'8#0P>'X$Z&ZT0A:*]28D;6
M+3#!!!:<\$R!<5I)R*GY9M([!/1HM V-@5DKA72 IG_BY-MWLDL/R)J ;_CI
MHKX+1^5!&=$RNGSB#0=MG&+%DMFJM;,,! :6;>3%&XE.M:[IVHK '@V^%T;C
M< KM *T///\E$XF>#.\UL. ],0%>,%"%,U-J1PQW)?'6N<NUA/1H-KXP^O97
M4 <HNUM#\A,FIY<%)*L46O7@O\].29N+5:Z-+')3O"ZZFN#+3*YCL0[ C,8[
M$V.L%;Q#OL*;$#EN>KT+= ZKV Z02]S-EU4,<'HKWWNO#NHR=+!8ROEN[."$
M3'%P6FC&=51,1V*<^+0L.J/I=R[EW+J[;D^2QVU*Z0+5+ZGTUX+QJ\<'\V?X
MM5QF5\,>WY;_;G%B,'AI=68IU+I3K8C9G.E7*8(QFJSWW/JZWI_J<=MC7@_2
MVZE^Y)ZMC;C]?:63PU(PG1^557QO<9*M40DT)R@62387IY<KR,A$T.@(GB'@
M)G-K]B)BW'Z;42'[L@KLX%I^Q.]<&5)KVI*<3P$@,0O5\^2YL@>>#"UO''?$
M([3NM]B2Q'%[>;JX<(=4ZNZ8G=&!&B2<<&7UU\29Y+E6_3O-M/2<@4Z6E:Q]
M 0#O36O[X!%2-L)@>-,8;*&D#N['/65Y<#:[F)Z?6!YS7:'+$J\37:WSS,?"
M&18MG<0H1&D=[F]"^&9I OZF@?SR".ASP\7]$O=/U>*I0FE8Y?_@,P<HS7^:
M[J'KZ9/5KG"C6>U)8]H3" $L(<(E,-P(CM Z5/-*ZNEKKS,Z7YA3J@Z:K+/:
MHJX-[SS6B=C&IM:6Y7]$/?TVB!NXGGX;%7?P]M]=C'2YC;1.0;4E,JQ%#R3,
MPGSV@MFRW%8=!6^^FODA%6^J>GTK3#RYOW%K!74'L5O%8@J]Y;SF=3&2Q2("
MLJB)&50Z!RN!0V[=;_$8+3VM9-Q>QT]"9D>!CQQAO%5$^FEV?ET[*KATW"M%
M)-<E?EZ19Z5\HGM?8K()0[E?$+XV=+C^TWL"P:Y:FS4580>WQ\?9]!M]VED5
MSU?Z-\O3$;PUA1Y]YJQW3,<06=V"S 28:+,SIL36V\'6T?&F"A[W>:3V5E*'
M0%N=/BR PA3%>-"E[E@3S,LDF7):%N$]E-QZ#]1Z2L:]G?;7\#.0V4'<'8#F
M7J_#U4IVDZVJ*XT3KQN.M486:LFE$*AL /0EM@[2KB6D+\CLHN&G6TMV$'<'
MF&D6\7.%N/;2LV#J-I-8BW^"0,954#IPC+EY5].+M@H,5H_8T<LY"A@Z. 1W
MK=W;INHJD7<Y,_+FKRQ.I":#5P3!2C"Q9O 4BT(;!D[XJ(U2"H9U%S>A\HTT
M'6R%IB?=S^:J[3)S</CGYX]'_W5X>/SUZ-W_^?SQX-/Q4J"QUOK<'J5[^%?]
MY1[IA!V_:/\<0PL.&R4>?I\LTNEL<3&OZ]=O??47/(7S2LWB?'%#W*K4:G$=
M+.;10'$$9L\YU.PL&2#+K%5,0?,0552M9QSL1W&[),8A(6SV"^ENF/^<)+RI
M1[M-U,'I\B.7-T2=\?1M.OD?(FHYK&M)Z>6K)Q&=CC*P@I:L+E4,\SI+9D#R
M*(73*K:><SL((R-'?5X.RX\G/L:"10=VR&71_3$I?%D.]W'%XM*]%?3.&2DT
MRZ+0J^2RH ?)9Z9M\3F)X)"W;L5]@IQ>,B*C@>5AQ6T3S?4+PI7#G*5V.KM8
M-QTJIDLR9!Q%SZ+R8*S,*?$!.A\>)VA<(#93^V9PVD$''0"J'K&C<@RGUU'_
M(!W7B1Z*R($8L*!9Q(!,0)*@- <O6D?,'Q#1)7!V4?"#J-0^TNX +E]($T3
M]X,ZN/,GGLY^5 FM+/D52UD&J4.@8^5+7=B.GGDG(Y..+!"%PN30.MBT 5GC
M9F"&@U1KC70 LF-<CJC^ Z<XAU-B[""?3::3:L@NFPPN>;LZ08A@9%V_*]#E
M>I5G!D%ZQE%;5T?):->Z<7HK L<-8 X'O.&T-.I(^NL*LB;&ZTV<+'O'2X;
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MVSHBEZ7#)]G4+31Z.<2)[.BL)(O>VQH43=Z@Y^";ATA:,_%*#T9#9 YW6':
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M2JL89$40#=PP4$HSYPV6I#6G_VGMYCY"R[XWW64QTU%97?+3;ZLO6I ;ETQ
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MEK*+>; ':_"N_L@_N=O-ZU>_ 5!+ P04    " !#@3]6B77,\&D(  "X)
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MAQBWF5F?\I6O:/)?]TV/_;KH_+]02P,$%     @ 0X$_5L3IANEF"   G"0
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M8N("LXP2J[P/,VP562]^\,UC* BY!>:S8'L=.#2R>'N29>^0W.#,_L&\-W6
M;E,>(".H$BG%K$45L GK/-*$RF !&9"(4X_'7,^Q1FS;%@ELT#7 6>X]$EWK
M$TQR?"@,RG)H\11@@37-]X4,C *F8YBP%$I5#/R!$98A,5$$NB'+$2 PSR _
MO0Z6^#M9,IC2.#=QARYD80BUG$_!>+6E)B]+TAYYQ%YN+].&%# 1<H"RS8 G
M<KU;@WTR'5U*,^QTPJ\W>L1;]%"&Y\QZ O0QF.(&!X]KL#OZK<LV78\]?5%D
MS<A6?)\1\YC^A>_G$AV\EFNWK)H(I>$^GN%A+>7#0G_80YD]86V9$@)3(!J?
M2!>*0_O(S'$$3RIIOM3KK=4JHFI9F#".#;-88!*<\4>1?.9PZ+AG<7$V>2)?
M_I]=M)M-WX<SK1?N/\U1.UC0K;R**@SR=<A7 8:@/:,@;?0/2]4H]!!:2+6L
M >8&+)G <50S]H44Y@FH,C@><-#/+'(,Q(",H3 CP7_L9!9L9G_D'-0WS,U3
MWQQAWFY_4')H.6)W.]F#<QS6:@YP8ON,C;C/&?B_R-_+MF[&Z#TF9%LK34HV
M5=Z<_!=GNF>A6G1@]O"R)1!I !,56\;A3@84O0%, 1BAA)=M55!0$E2>)-!&
M_LF,,47^VWKZ?3T9?W>_UX/$'DH(@#+XEIF8!73,TY "QK+-BSR=BGC*,#FF
M=%(\U)%%F+,DB\6<P>@L$C:VZ2.2 *@O4CFJSWK"^*5'P=HTD(6 !Q1@L@)P
MQ#13K+/XTH4,E<5TWN&I<:J9U 5Z3'A:\836(NG@.YLIICFH-<4F9C\[7+S.
M:;>KI\XIOM'1H*<.%AL7+WNJYF5/30>;8R=5YZRY<]2INCO'OK2J>UH].3E[
M\67K[6JKV7KQ99OU:L-I[+5LS?C7^AA05!E-WY4:I2<!V:EG#\3--,'_C6H=
M,5PC"8;K!J8B^_;!:UX"7F*C_;AJ%%[X/S'PWQ3:,#DG#;=LWL(^TTQK'BDL
M[CY]"WHX=KZ?_TT4NQL)[*E1-ME\)[O,.T5E/K>\)GID[I[AZ:#5I;U<]+*B
M12$ CG0P>LSS);+PX+-1^194VWCI:"!YY3"\(D_W(\Y"<K5L56[M,6>;NQ>J
M+>8WC1L.'()'HL:0FNF"GMF"/?F12R;LKWPZ]G'OE&W\[&45D:;+<E93J =A
MF>O-*5_YI4SQ:7^W8WY!=/$74$L#!!0    ( $.!/U8D\$A'  4  " 6   7
M    =F%R97AQ,3(S97AH:6)I=#,R,2YH=&W=6.N3VC80_]Z_8L--\YC!;]Z0
MFR% )F32XW)P3?.I(RP9-#&6(XL#^M=W)>.$1TAS:9J0W@<?]K[WMUJMU'G0
M'_4F;Z\',%>+&*YOG[T:]J!D.<Z;H.<X_4D?7DQ^>P45V_5@(DF2<<5%0F+'
M&5R5H#17*FTYSFJULE>!+>3,F=PX6E7%B87(F$T5+5UV]!=\,D(O?^D\L"SH
MBW"Y8(F"4#*B&(5EQI,9O*$L>P>6M>7JB70C^6RNP'?] -X(^8[?D9RNN(K9
M9:&GX^3O'<<8Z4P%W5QV*+\#3I^6>-0,PFFSP7P:L8K7H,W0H^&45FJNRZJ-
M</JGATXZR)[+9&H3LZ>E!4^L.=/V6Q7?KE=3U5YQJN8MSW5_+1G6RTXD$H7V
M),KG/W,U1\H46RN+Q'R6M$Q(I5RT((<B%K)UX9J_MJ98$5GP>--Z-.$+EL$5
M6\&-6)#D43E#&*R,21[EC!G_BZ%/Z)YY7>4NUU%/S!-6A.#YVNG!>LZG7$'@
MV]Z^Q[N!$SG#V)5(40K5[O@>8K*9_$'.]P8WD^'S8:\[&8ZN3GI_+MY>W]Z,
M;[M7$YB,P&O K3VV>S:,!SWM/7A!U3W[$+ICZ/9'UY-!'W:B.7NWBQPWW1J,
MGL/DQ0#&W9MGW:O!V!K]\6KP%KJ]B:;XKNM_Z2KXSV.I?#*680*A2!(6ZKX+
M*Z[FH.8,2!B*14J2C6Z;KY=$8K;C#=RP5$@%(H+?B61K&"[(3'/TA$0",3H>
M:_F'%PW?=]N]7(EY\]I/RH#TYT(NP'.MUQ ):8R]S_4#2RBVZCX+V6+*Y,,+
MK^:V [>LN[._IS9WXZ/681G&RR39P!@7 -HC<1FN)<LXU7L 22CTYIQ%,%BS
M<*GX'8-1%/$036(D6N_6SS+,F633#2!)\6@#Z5)F2X(ZE-A98]JS>MLLL3*0
M# @5J=YD=KFW/+I$MC;&1$Y)PC)KM([9!KJAR:,N$203C*;::!\5R\D-X+B0
MID(IL6@U$/:44(JP6#&+5"NH%2V6)SH?+<MK_+!R\^PBC.]O?3\MGFM7=1HT
M--NRCI8QUK@N_)BCT0^+0;+W2RZ9'@0RC5FV72U>\)@\ 2QBK_J8/OF ,]:8
MQ#$&-0S6X9PD,U: [36#"N+<;.N:/(GG^:+GGR5Z/,%&LLB;#_8R15"2XE?8
MA99PW;]2; H:Q;(FDS@&%$-G2(P89RG"BA0M%?&$)*'^C@JIF4E-&T&N99P7
M@4A9WO"R@R9B?]4B_M3>IL@T9@7#5$C*I(7)CDF:L5;QHTUYEL9DT^*)29D1
M:N_W!#U:WNF6%I)X:\38R\G;J;/9M.MN70^>"OU4M#"\G4EM,Y,ZBA[3:K;;
MJ)RDNK9WDO8YK5[=KM4:WUQM4+']H/[MU:*WWFG17;6.R6^>8T0QPZ)Y6@I*
M!\N_Y:=K\%(\F^#_P/:K^X.R7@5'F(KT^S<&<U;IZT/6_@ZVS<+_),"7),$A
M90.!9\:1X)YAYN'!-N+VX6'M?.)\MOE*%(\/<8=!Y<WF!\7U\*)2;V?F>3@J
M[L7ZA6O3U2&7OB@_WY9UNPN80P,65"9B3J%(W[TA^1YU=G2$,GC\S!C\1&G^
M< @JGSH!?2KSA9>%JHK)R)FCL<=J G',*'3/.>QH^"Y]3NH>Q[.#<_[]I\%_
MY\7!16,J\IO6EF0QT?5P=/7XL>.8$=+]*$*FV':6ZECD'VXKM\_\[M3<XE[^
M#5!+ P04    " !#@3]6)<Q*>^,$   X%0  %P   '9A<F5X<3$R,V5X:&EB
M:70S,C(N:'1MW5CK<]I&$/_>OV*#IWG,H#=OB&<(X F=Q#A&;II/G4-WH)M(
M.N5T&-._OGMZ)&!,FV32A-0?9&#?^]M=[=W@T7@V\M]=32!4<017-R]>34=0
M,RSKK3>RK+$_AI?^ZU?0,&T'?$F2C"LN$A)9UN2R!K50J;1G69O-QMQXII K
MR[^VM*J&%0F1,9,J6CL?Z%_PR0@]_V7PR#!@+()US!(%@61$,0KKC"<K>$M9
M]AX,H^0:B70K^2I4X-JN!V^%?,]O24%77$7LO-(SL(KO RLW,E@(NCT?4'X+
MG#ZO<=J@[46KV[;;+FTLNIVNXS:IVVT'K<#I=+S@3P>=M)"]D,G4-F+/:S%/
MC)!I^[V&:[:;J>IO.%5AS['M7VLYZ_E@*1*%]B3*%Q\+-0?*%+M3!HGX*NGE
M(=4*T8H<B$C(WIF=__4UQ5B2F$?;WA.?QRR#2[:!:Q&3Y$D]0QB,C$F^+!@S
M_A=#G]"]_.NF<+F->B*>L"H$Q]5.3^Y"ON */-=T]SW>#9S(%<:N1(I2J';'
M]P"3S>0/<GXTN?:G%]/1T)_.+H]Z?RK>7MU<SV^&ES[X,W Z<&/.S9$)\\E(
M>P^.U[1//H3A'(;CV94_&<-.-"?O=I7CKMV"V07X+R<P'UZ_&%Y.YL;LCU>3
M=S <^9KBVO9G=\%_'DOCP5BF"00B25B@YRYLN I!A0Q($(@X)<E6C\TW:R(Q
MV]$6KEDJI *QA-^)9'<PC<E*<XR$1 +)=3S5\H_/.JYK]T>%DOR;TW]6!Z1?
M"!F#8QMO8"ED;NQ#H1]80G%4CUG X@63C\^<EMWW[+J>SNZ>VL*-3UJG=9B'
MZT5(8GA-0I:%&R)Y'48A9TNXX E) DXBF"V7/$ [Z+Y65CI7AY!)MM@"DA1?
M;B%=RVQ-$ HE=AI+N]/NYWU5!Y(!H2+5;Y9=[I)'UT5I8T[D@B0L,V9W$=O"
M,,B3I^L"R01#:';Z!Q5R=.H?5L]"*"7B7@>Q3@FEB(41L:7J>:UJKG),:J)Z
MAM/Y837FF%48W]_Z?EH<VVSJ-&AHREI>KB,L;%WM$4>C'SM L@]K+IE^^V<:
MLZQL$<=[2IX!5J[3?$J??<29!6N)NPMJF-P%(4E6K +;Z7H-Q+G;!Y+0HWB>
M+GKN2:+'$YP><3%Q<( I@I(4?X5=: G70RN5+-,HUC691!&@&#J# P$)*<**
M%"VU_#@H4"'-%U$-F>9:1T41B)054RZ[-T3,KVKBAUYHBBPB5C$LA*1,&ICL
MB*09ZU4?^I1G:42V/9[D*<N%^OLS0>^3MWJD!20JC>3V"G*Y:G:[)FZM>MM4
MZ*>BE>%R$37S1=12])#6,NU.XRC5-IVCM'_2ZK3-5JOSS=5ZMMEVOKW:AF,Z
MWG'RKEHKSV^18T0QPZ)Y7O-J]]J_YZ9WX*1X(,'_GNDV][=CW04'F(KT^P^&
M_( RUB>K_3=8F87_28"_D00WDRUX3KZ#>%\89A$>E!'W[Y_03B?.%]NO1/'P
MY'8_J&+8_*"X'I\UVOTL?SZP'^Z%^YGM:>NH:Y^5HF_+6KX(\L,"UE0F(DZA
MRN 7H_(]2NW@Z)1#\I/#\!-E^LCAYZ%T5ZY5\HT\#2<.P1YK'HB5;T%?N(+=
MNX!+17$#V9,LPD7OEAU<R7WJR'S+LC^)D 6VY5H=BOS++5[Y+.X4\]O-\[\!
M4$L! A0#%     @ 0X$_5B7%D=L*L ( VU\; !               ( !
M '9A<BTR,#(R,3(S,"YH=&U02P$"% ,4    " !#@3]6]U6K4"P2   CP
M$               @ $XL ( =F%R+3(P,C(Q,C,P+GAS9%!+ 0(4 Q0    (
M $.!/U;V#KWCUB$  / ] 0 4              "  9+" @!V87(M,C R,C$R
M,S!?8V%L+GAM;%!+ 0(4 Q0    ( $.!/U;J[>-S<%P  /OU P 4
M      "  9KD @!V87(M,C R,C$R,S!?9&5F+GAM;%!+ 0(4 Q0    ( $.!
M/U9;P8P!N5 ! )RL 0 3              "  3Q! P!V87(M,C R,C$R,S!?
M9S$N:G!G4$L! A0#%     @ 0X$_5EA8SZ@._   ?U * !0
M ( !)I($ '9A<BTR,#(R,3(S,%]L86(N>&UL4$L! A0#%     @ 0X$_5@ :
M"<.1H   LR ' !0              ( !9HX% '9A<BTR,#(R,3(S,%]P<F4N
M>&UL4$L! A0#%     @ 0X$_5HEUS/!I"   N"0  !<              ( !
M*2\& '9A<F5X<3$R,V5X:&EB:70S,3$N:'1M4$L! A0#%     @ 0X$_5L3I
MANEF"   G"0  !<              ( !QS<& '9A<F5X<3$R,V5X:&EB:70S
M,3(N:'1M4$L! A0#%     @ 0X$_5B3P2$< !0  (!8  !<
M ( !8D & '9A<F5X<3$R,V5X:&EB:70S,C$N:'1M4$L! A0#%     @ 0X$_
M5B7,2GOC!   .!4  !<              ( !ET4& '9A<F5X<3$R,V5X:&EB
?:70S,C(N:'1M4$L%!@     +  L V0(  *]*!@    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
